,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1450,GO:0003677,1.18075621977707e-15,1,94,1913,DNA binding,MF,TIPARP;HES1;SNAI2;IVNS1ABP;MYC;ZNF57;HR;HES2;ZNF557;HIST1H2AG;ZNF750;ZNF419;HIST1H4L;ZNF222;ZNF561;POU3F1;ZNF526;ZNF841;ZNF574;TFCP2L1;TIGD5;BRPF1;NR2F2;ZNF696;HOXA9;SURF6;HIST1H2BJ;ZFP36L2;ZNF398;FOS;ZNF256;ZNF416;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ZNF200;HIST1H3J;HIST1H2AB;ZNF549;ZNF570;ZNF93;HJURP;UPF1;ZBTB7B;ZNF581;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;HIST1H2BO;ZBTB34;ZNF780A;JRK;ZNF275;GZF1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;SOX15;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;KLF16;HIST1H2AH;ZNF14;DCLRE1C;IRX5
12919,GO:0051252,3.0668144373149e-12,1,117,3024,regulation of RNA metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
16714,GO:0097659,3.68851455140466e-12,1,116,2989,nucleic acid-templated transcription,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
18442,GO:1903506,4.2893512679152e-12,1,112,2846,regulation of nucleic acid-templated transcription,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
20239,GO:2001141,4.50643987048023e-12,1,112,2848,regulation of RNA biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
8096,GO:0032774,4.67266102575596e-12,1,116,2999,RNA biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
2860,GO:0006351,6.37390564549422e-12,1,115,2975,transcription, DNA-templated,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
2864,GO:0006355,6.93257758567342e-12,1,111,2829,regulation of transcription, DNA-templated,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
1461,GO:0003700,4.84439576556986e-11,1,58,1084,DNA binding transcription factor activity,MF,ID1;HES1;SNAI2;TSC22D3;IVNS1ABP;MYC;ID3;HR;HES2;ZNF557;ZNF750;ZNF419;ZNF222;ZNF561;RBAK;POU3F1;ZNF841;TFCP2L1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;ZNF416;FOXQ1;ZNF3;ZKSCAN4;ZNF200;ZNF549;ZNF570;ZNF93;ZBTB7B;ZNF776;SOX9;ERF;CEBPA;ZNF530;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;SOX15;NR1D1;ZNF589;HOXA5;ZNF672;NACC2;HIC1;ZNF16;SOX12;ZNF701;KLF16;ZNF14;IRX5
19764,GO:2000112,7.21878567913651e-11,1,118,3207,regulation of cellular macromolecule biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
4509,GO:0010556,8.83826801885188e-11,1,119,3256,regulation of macromolecule biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
6074,GO:0019219,1.11391422477971e-10,1,119,3268,regulation of nucleobase-containing compound metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
7321,GO:0031326,1.23664277739111e-10,1,121,3351,regulation of cellular biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
284,GO:0000786,1.23942064331616e-10,0.999999999989391,16,84,nucleosome,CC,HIST1H2AG;HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HIST1H2AB;HIST1H4B;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;HIST1H2AH
18094,GO:1902679,1.34187847951921e-10,1,52,926,negative regulation of RNA biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
18443,GO:1903507,1.34187847951921e-10,1,52,926,negative regulation of nucleic acid-templated transcription,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
4340,GO:0009889,1.52580749288752e-10,1,122,3401,regulation of biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
12920,GO:0051253,1.78703264449071e-10,1,54,992,negative regulation of RNA metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;TFCP2L1;BAG3;NR2F2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
11454,GO:0045892,3.50378442991389e-10,1,50,893,negative regulation of transcription, DNA-templated,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZNF256;RNF168;FOXQ1;HIST1H3J;HIST1H2AB;ZNF93;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
11007,GO:0044815,3.74015941493535e-10,0.999999999965315,16,91,DNA packaging complex,CC,HIST1H2AG;HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HIST1H2AB;HIST1H4B;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;HIST1H2AH
17321,GO:0140110,4.17727032420677e-10,1,66,1402,transcription regulator activity,MF,ID1;HES1;SNAI2;TSC22D3;IVNS1ABP;MYC;ID3;HR;HES2;ZNF557;ZNF750;ZNF419;ZNF296;FHL2;ZNF222;ZNF561;RBAK;POU3F1;ZNF841;TFCP2L1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;FHL3;ZNF416;FOXQ1;ZNF3;ZKSCAN4;TOB1;ZNF200;ZNF549;ZNF570;ZNF93;SIAH2;ZBTB7B;ZNF776;SOX9;ERF;CEBPA;ZNF530;KCTD1;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;SOX15;NR1D1;ZNF589;HOXA5;PER2;ZNF672;BRF2;NACC2;HIC1;ZNF16;SOX12;ZNF701;KLF16;ZNF14;IRX5
15984,GO:0080090,4.92560501595999e-10,1,147,4505,regulation of primary metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;HES2;NOG;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;FAM212B;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;HSPA2;ZBTB34;TIMP3;ZNF780A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PYGO2;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;IRX5;CISH
8860,GO:0034654,6.06924583391861e-10,1,120,3383,nucleobase-containing compound biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
4475,GO:0010468,6.76627212965889e-10,1,123,3515,regulation of gene expression,BP,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
12866,GO:0051171,1.28766605199221e-09,1,143,4388,regulation of nitrogen compound metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;DUSP5;SERTAD1;FLRT3;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;FAM212B;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;HSPA2;ZBTB34;TIMP3;ZNF780A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PYGO2;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;IRX5;CISH
6152,GO:0019438,1.46559673930275e-09,1,120,3429,aromatic compound biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
5912,GO:0018130,1.56447099801278e-09,1,120,3432,heterocycle biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
11486,GO:0045934,2.19953217423128e-09,1,55,1097,negative regulation of nucleobase-containing compound metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;TFCP2L1;BAG3;NR2F2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
17652,GO:1901362,4.19692442372215e-09,1,121,3525,organic cyclic compound biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;FAXDC2;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
7318,GO:0031323,6.17199514995847e-09,1,146,4612,regulation of cellular metabolic process,BP,ID1;SPRY4;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;FAM212B;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;HSPA2;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PYGO2;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;IRX5;CISH
13716,GO:0060255,6.84190202728424e-09,1,145,4571,regulation of macromolecule metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;FAM212B;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;HSPA2;ZBTB34;TIMP3;ZNF780A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PYGO2;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;IRX5;CISH
5337,GO:0016070,7.84502228897659e-09,1,126,3759,RNA metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
19765,GO:2000113,1.00353476136928e-08,1,54,1116,negative regulation of cellular macromolecule biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;UPF1;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
2849,GO:0006334,1.01576526587988e-08,0.999999998665962,16,116,nucleosome assembly,BP,HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;TSPYL4
4511,GO:0010558,1.58426472965956e-08,1,55,1163,negative regulation of macromolecule biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
12867,GO:0051172,1.84235512909004e-08,1,73,1776,negative regulation of nitrogen compound metabolic process,BP,ID1;SPRY4;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;IRF2BPL;TXNIP;SERPINE1;MYC;ID3;HR;HES2;NOG;DUSP5;FLRT3;HIST1H2AG;HSPB1;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FAM212B;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;TIMP3;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;SOCS6;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;CISH
7322,GO:0031327,2.10464812390827e-08,1,56,1205,negative regulation of cellular biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
7319,GO:0031324,2.17863320434714e-08,1,76,1891,negative regulation of cellular metabolic process,BP,ID1;SPRY4;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;ID3;HR;HES2;NOG;DUSP5;FLRT3;HIST1H2AG;HSPB1;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FAM212B;FOXQ1;ZKSCAN4;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;TIMP3;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;SOCS6;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;CISH
4341,GO:0009890,3.34913865267865e-08,1,56,1221,negative regulation of biosynthetic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;MYC;ID3;HR;HES2;NOG;HIST1H2AG;ZNF296;HIST1H4L;FHL2;RBAK;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
8233,GO:0032993,3.99096051152354e-08,0.999999993262491,18,163,protein-DNA complex,CC,HIST1H2AG;HIST1H4L;HIST1H2BJ;FOS;HIST1H2BI;HIST1H3J;HIST1H2AB;HIST1H4B;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;SOX12;HIST1H4D;HIST1H2AH
6077,GO:0019222,4.4668198914631e-08,1,150,4909,regulation of metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;HES2;NOG;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;FAM212B;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;HSPA2;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PYGO2;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;IRX5;CISH
7416,GO:0031497,7.17246690882071e-08,0.999999988984276,16,134,chromatin assembly,BP,HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;TSPYL4
10800,GO:0044271,9.95071768606686e-08,1,127,3950,cellular nitrogen compound biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
8908,GO:0034728,1.14866371118067e-07,0.999999981678514,16,139,nucleosome organization,BP,HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;TSPYL4
12258,GO:0048523,1.23148704789522e-07,1,110,3288,negative regulation of cellular process,BP,ID1;SPRY4;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;GPR132;ZNF503;ID3;ANGPTL4;CYP1B1;HR;HES2;NOG;PTPRE;VASN;DUSP5;FLRT3;HIST1H2AG;HSPB1;APCDD1;ZNF296;HIST1H4L;FHL2;TNFRSF21;RBAK;GDNF;CTGF;MAP3K14;TFCP2L1;BAG3;NR2F2;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;ZNF256;RNF168;IGFBP2;FAM212B;RBM15;FOXQ1;ZKSCAN4;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;HIST1H2AB;CXCL14;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;GADD45B;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;HSPA2;TIMP3;DDIT4;GZF1;SNX33;TGIF1;KRT16;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;ZADH2;PER2;DNAJB2;NACC2;HIC1;ZNF16;SOCS6;IFITM1;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;CISH
4552,GO:0010629,1.25962948330111e-07,1,61,1431,negative regulation of gene expression,BP,ID1;TIPARP;HES1;SNAI2;TSC22D3;CDK5R1;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;HR;HES2;NOG;HIST1H2AG;HSPB1;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;CTGF;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;UPF1;AKIRIN2;ZBTB7B;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;HIST1H4D;NOTCH3;KLF16;HIST1H2AH
4537,GO:0010605,1.70720282212355e-07,1,77,2015,negative regulation of macromolecule metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;HR;HES2;NOG;DUSP5;FLRT3;HIST1H2AG;HSPB1;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;CTGF;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FAM212B;FOXQ1;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;GADD45B;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;TIMP3;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;SOCS6;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;CISH
2846,GO:0006323,2.08509739300781e-07,0.999999962610548,17,166,DNA packaging,BP,HIST1H4L;HIST1H2BJ;PHF13;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;TSPYL4
1449,GO:0003676,2.44907681117267e-07,1,108,3233,nucleic acid binding,MF,TIPARP;HES1;SNAI2;IVNS1ABP;MYC;ZNF503;ZNF57;HR;HES2;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;ZNF222;ZNF561;RBAK;POU3F1;ZNF526;ZNF841;ZNF574;AHNAK2;TFCP2L1;TIGD5;BRPF1;NR2F2;ZNF696;HOXA9;SURF6;HIST1H2BJ;ZFP36L2;ZNF398;CHAMP1;FOS;ZNF256;ZNF416;ZCCHC3;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ZNF200;HIST1H3J;HIST1H2AB;ZNF549;ZNF570;ZNF93;HJURP;UPF1;ZBTB7B;ESRP2;ZNF581;HIST1H4B;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;HIST1H2BO;ZBTB34;ZNF780A;JRK;ZNF275;GZF1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;SOX15;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;KLF16;HIST1H2AH;ZNF14;DCLRE1C;ZCCHC2;IRX5
2437,GO:0005634,2.90417142913861e-07,1,165,5701,nucleus,CC,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;MYC;ZNF503;ID3;ZNF57;HR;FAM110C;HES2;PTPRE;DUSP5;SERTAD1;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;ZNF526;ZNF841;ZNF574;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;TIGD5;BRPF1;NR2F2;ZNF696;HOXA9;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;FAT2;YPEL4;TOB1;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ZNF549;PAK6;ZNF570;ZNF93;SIAH2;SWT1;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;GZF1;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;KRT16;URB2;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;NOTCH3;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;FAM217B;IRX5
59,GO:0000122,3.16678576635055e-07,0.999999898720424,34,604,negative regulation of transcription by RNA polymerase II,BP,ID1;HES1;SNAI2;TSC22D3;IRF2BPL;TXNIP;MYC;ID3;HES2;NOG;ZNF296;FHL2;TFCP2L1;BAG3;NR2F2;RNF168;FOXQ1;AKIRIN2;SOX9;ERF;CEBPA;KCTD1;GZF1;TGIF1;SOX15;NR1D1;ZNF589;HIST1H1C;HIST1H1D;PER2;NACC2;HIC1;NOTCH3;KLF16
4343,GO:0009892,3.50997443079118e-07,1,80,2164,negative regulation of metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;HR;HES2;NOG;DUSP5;FLRT3;HIST1H2AG;HSPB1;ZNF296;HIST1H4L;FHL2;RBAK;GDNF;CTGF;TFCP2L1;BAG3;NR2F2;ZFP36L2;BCDIN3D;ZNF256;RNF168;FAM212B;FOXQ1;ZKSCAN4;TOB1;HIST1H3J;HIST1H2AB;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;GADD45B;HIST1H4B;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;TIMP3;DDIT4;GZF1;TGIF1;SOX15;CIPC;NR1D1;ZNF589;HIST1H1C;HIST1H1D;HIST1H4K;PER2;NACC2;HIC1;SOCS6;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;CISH
2848,GO:0006333,5.19913736791739e-07,0.999999906265244,16,156,chromatin assembly or disassembly,BP,HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;TSPYL4
12626,GO:0050794,5.68672017959705e-07,1,193,7120,regulation of cellular process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;HES2;NOG;PTPRE;RIN2;VASN;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;LURAP1L;ZNF750;HSPB1;ZNF419;APCDD1;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;TUBA4A;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;ZNF398;FOS;ZNF256;RNF168;ZNF416;CDC42EP2;IGFBP2;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;MN1;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;HJURP;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;VASP;HIST1H4B;SLC20A1;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;CNN2;ZNF530;FAM83A;CIART;KCTD1;HSPA2;BICD2;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;ARTN;ZNF169;ZNF783;KRT16;SOX15;PYGO2;NCDN;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PALMD;ZADH2;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;COL1A2;ZNF16;SOCS6;KRT17;SOX12;ZNF766;IFITM1;ZNF701;ADGRF4;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;VPS18;IRX5;CISH
363,GO:0000981,6.65764737936105e-07,0.999999765939074,37,713,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ID1;HES1;SNAI2;TSC22D3;MYC;ID3;HES2;ZNF750;RBAK;POU3F1;TFCP2L1;NR2F2;HOXA9;ZFP36L2;ZNF398;FOS;FOXQ1;ZNF3;ZNF200;ZBTB7B;SOX9;ERF;CEBPA;GZF1;ZNF160;TGIF1;SOX15;NR1D1;ZNF589;HOXA5;NACC2;HIC1;ZNF16;SOX12;KLF16;ZNF14;IRX5
14520,GO:0065004,1.71408711067421e-06,0.999999617986113,18,213,protein-DNA complex assembly,BP,HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;BRF2;HIST2H2BE;HIST3H2BB;SOX12;HIST1H4D;TSPYL4
15491,GO:0071824,1.80627931383119e-06,0.999999575666119,19,237,protein-DNA complex subunit organization,BP,MYC;HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;BRF2;HIST2H2BE;HIST3H2BB;SOX12;HIST1H4D;TSPYL4
8853,GO:0034645,1.89568272233319e-06,0.999999323082993,125,4046,cellular macromolecule biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SWT1;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
4029,GO:0009059,2.79933217830391e-06,0.999998992950816,126,4117,macromolecule biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
16261,GO:0090304,3.45100316550898e-06,0.999998753286006,127,4173,nucleic acid metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5
12254,GO:0048519,3.46250900244258e-06,0.99999875838525,114,3637,negative regulation of biological process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;GPR132;ZNF503;ID3;ANGPTL4;CYP1B1;HR;HES2;NOG;PTPRE;VASN;DUSP5;FLRT3;HIST1H2AG;HSPB1;APCDD1;ZNF296;HIST1H4L;FHL2;TNFRSF21;RBAK;GDNF;CTGF;MAP3K14;TFCP2L1;BAG3;FZD10;NR2F2;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;ZNF256;RNF168;IGFBP2;FAM212B;RBM15;FOXQ1;ZKSCAN4;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;HIST1H2AB;CXCL14;ZNF93;SIAH2;UPF1;AKIRIN2;ZBTB7B;GADD45B;HIST1H4B;PIK3R1;ZNF776;SOX9;ERF;CEBPA;CIART;KCTD1;HSPA2;TIMP3;DDIT4;GZF1;SNX33;TGIF1;KRT16;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;ZADH2;PER2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;IFITM1;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;CDC42SE1;CISH
4474,GO:0010467,4.8679448712253e-06,0.999997711104914,129,4269,gene expression,BP,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
18541,GO:1903707,7.37758393643185e-06,0.999998894281829,11,94,negative regulation of hemopoiesis,BP,HES1;MYC;HIST1H4L;HOXA9;RBM15;ZBTB7B;HIST1H4B;PIK3R1;HOXA5;HIST1H4K;HIST1H4D
11294,GO:0045596,1.69100262214536e-05,0.999994478002329,24,423,negative regulation of cell differentiation,BP,ID1;HES1;SNAI2;CDK5R1;PTHLH;MYC;ID3;NOG;VASN;HIST1H4L;HOXA9;ZFP36L2;RBM15;TOB1;CXCL14;ZBTB7B;HIST1H4B;PIK3R1;SOX9;HOXA5;HIST1H4K;ZADH2;HIST1H4D;NOTCH3
11327,GO:0045638,1.74340302524235e-05,0.999997778467468,9,67,negative regulation of myeloid cell differentiation,BP,MYC;HIST1H4L;HOXA9;RBM15;HIST1H4B;PIK3R1;HOXA5;HIST1H4K;HIST1H4D
7932,GO:0032502,1.84010466972416e-05,0.999989908020303,117,3899,developmental process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;SLC2A1;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;ZNF503;ID3;ANGPTL4;CYP1B1;NOG;VASN;DUSP5;FLRT3;ZNF750;HSPB1;APCDD1;KCTD15;HIST1H4L;FHL2;TNFRSF21;POU3F1;MGAT1;GDNF;CTGF;AHNAK2;TFCP2L1;BAG3;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;ZNF256;FHL3;RNF168;CDC42EP2;IGFBP2;TUFT1;PRR15;RHOD;RBM15;FOXQ1;ZNF3;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;TLE3;LRIG3;ADGRF1;LRRC8A;CBR1;MN1;CXCL14;SIAH2;PLCD1;TAGLN;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;ERF;CEBPA;GJB2;MALL;HSPA2;AKR1C1;DDIT4;GZF1;ZNF160;TGIF1;ARTN;KRT16;SOX15;PYGO2;NCDN;NR1D1;ING2;HOXA5;PHC2;HIST1H4K;PALMD;ZADH2;PER2;HIC1;COL1A2;ZNF16;KRT17;SOX12;IFITM1;HIST1H4D;HK2;NOTCH3;SOCS1;CLU;CDC42SE1;DCLRE1C;IRX5
283,GO:0000785,3.05997440208704e-05,0.999989359847735,25,458,chromatin,CC,SNAI2;MYC;HR;HIST1H2AG;HIST1H4L;HIST1H2BJ;HIST1H2BI;HIST1H3J;HIST1H2AB;UPF1;HIST1H4B;HIST1H2BO;HIST1H2BE;NR1D1;ING2;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;HIST2H2BE;NACC2;HIC1;HIST3H2BB;HIST1H4D;HIST1H2AH
19033,GO:1904837,3.27303675213085e-05,0.999996899047713,7,41,beta-catenin-TCF complex assembly,BP,MYC;HIST1H4L;TLE3;HIST1H4B;PYGO2;HIST1H4K;HIST1H4D
12420,GO:0048856,3.6720012424889e-05,0.999979220900233,109,3616,anatomical structure development,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;SLC2A1;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;DUSP5;FLRT3;ZNF750;HSPB1;APCDD1;KCTD15;HIST1H4L;FHL2;TNFRSF21;POU3F1;MGAT1;GDNF;CTGF;AHNAK2;TFCP2L1;BAG3;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;ZNF256;FHL3;RNF168;CDC42EP2;TUFT1;PRR15;RHOD;RBM15;FOXQ1;ZNF3;COL1A1;EPHB3;SLC30A1;HIST1H3J;TLE3;LRIG3;ADGRF1;LRRC8A;CBR1;MN1;CXCL14;SIAH2;PLCD1;TAGLN;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;CEBPA;GJB2;MALL;HSPA2;AKR1C1;DDIT4;GZF1;ZNF160;TGIF1;ARTN;KRT16;SOX15;PYGO2;NCDN;NR1D1;ING2;HOXA5;PHC2;HIST1H4K;PALMD;PER2;HIC1;COL1A2;ZNF16;KRT17;SOX12;HIST1H4D;HK2;NOTCH3;SOCS1;CLU;CDC42SE1;DCLRE1C;IRX5
15102,GO:0071103,3.69311313728557e-05,0.999989981084649,17,245,DNA conformation change,BP,HIST1H4L;HIST1H2BJ;PHF13;HIST1H2BI;HIST1H3J;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;TSPYL4
10600,GO:0043565,3.78471186379752e-05,0.99998435623259,34,753,sequence-specific DNA binding,MF,HES1;SNAI2;IVNS1ABP;MYC;HR;HES2;ZNF557;ZNF750;POU3F1;TFCP2L1;NR2F2;HOXA9;FOS;FOXQ1;ZNF200;ZNF93;UPF1;ZBTB7B;SOX9;ERF;CEBPA;CIART;GZF1;TGIF1;ZNF169;NR1D1;ZNF589;HOXA5;PER2;NACC2;HIC1;SOX12;KLF16;IRX5
12812,GO:0051093,3.97335102601125e-05,0.999985034707135,28,566,negative regulation of developmental process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SERPINE1;MYC;ID3;NOG;VASN;HIST1H4L;TNFRSF21;HOXA9;ZFP36L2;RBM15;TOB1;CXCL14;ZBTB7B;HIST1H4B;PIK3R1;SOX9;SOX15;HOXA5;HIST1H4K;ZADH2;HIST1H4D;NOTCH3
12622,GO:0050789,4.60349478237439e-05,0.999974874960014,195,7514,regulation of biological process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;HES2;NOG;PTPRE;RIN2;VASN;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;LURAP1L;ZNF750;HSPB1;ZNF419;APCDD1;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;TUBA4A;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;ZNF398;FOS;ZNF256;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;MN1;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;HJURP;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;VASP;HIST1H4B;SLC20A1;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;CNN2;ZNF530;FAM83A;CIART;KCTD1;HSPA2;BICD2;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;ARTN;ZNF169;ZNF783;KRT16;SOX15;PYGO2;NCDN;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PALMD;ZADH2;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;COL1A2;ZNF16;SOCS6;KRT17;SOX12;ZNF766;IFITM1;ZNF701;TRIM56;ADGRF4;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;VPS18;IRX5;CISH
878,GO:0002227,6.60389000954602e-05,0.999998055258738,4,10,innate immune response in mucosa,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
8498,GO:0033673,6.98353698570772e-05,0.999981848343872,15,212,negative regulation of kinase activity,BP,SPRY4;RGS2;DUSP4;MIDN;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;SOCS6;RGS3;SOCS1;CISH
364,GO:0000982,7.9925485790313e-05,0.999976824665091,17,269,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES1;SNAI2;MYC;HES2;ZNF750;FOS;FOXQ1;ZBTB7B;SOX9;CEBPA;GZF1;TGIF1;NR1D1;HOXA5;NACC2;SOX12;KLF16
2746,GO:0006139,8.31485859951416e-05,0.999950573303771,132,4608,nucleobase-containing compound metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5
9960,GO:0042326,8.54188084367463e-05,0.999972162834299,20,349,negative regulation of phosphorylation,BP,SPRY4;RGS2;DUSP4;MIDN;MYC;NOG;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;TIMP3;DDIT4;SOCS6;RGS3;PMEPA1;SOCS1;CISH
3461,GO:0007275,8.66431852056315e-05,0.999949440610203,100,3307,multicellular organism development,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;SLC2A1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;DUSP5;FLRT3;HSPB1;APCDD1;KCTD15;HIST1H4L;FHL2;TNFRSF21;POU3F1;MGAT1;GDNF;CTGF;AHNAK2;TFCP2L1;BAG3;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;ZNF256;FHL3;RNF168;TUFT1;PRR15;RBM15;FOXQ1;ZNF3;COL1A1;EPHB3;SLC30A1;HIST1H3J;TLE3;LRIG3;ADGRF1;LRRC8A;MN1;CXCL14;SIAH2;PLCD1;TAGLN;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;CEBPA;GJB2;MALL;DDIT4;GZF1;ZNF160;TGIF1;ARTN;KRT16;SOX15;PYGO2;NCDN;NR1D1;ING2;HOXA5;PHC2;HIST1H4K;PER2;HIC1;COL1A2;ZNF16;KRT17;SOX12;HIST1H4D;HK2;NOTCH3;SOCS1;CLU;DCLRE1C;IRX5
2866,GO:0006357,8.80770338406988e-05,0.999954310174754,57,1595,regulation of transcription by RNA polymerase II,BP,ID1;HES1;SNAI2;TSC22D3;IVNS1ABP;IRF2BPL;TXNIP;SERPINE1;MYC;ID3;HES2;NOG;SERTAD1;ZNF750;ZNF296;FHL2;RBAK;POU3F1;GDNF;TFCP2L1;BAG3;NR2F2;HOXA9;ZFP36L2;ZNF398;FOS;RNF168;RBM15;FOXQ1;ZNF3;TOB1;ZNF200;AKIRIN2;ZBTB7B;PIK3R1;SOX9;ERF;CEBPA;KCTD1;GZF1;ZNF160;TGIF1;SOX15;NR1D1;ZNF589;HIST1H1C;HOXA5;HIST1H1D;PER2;NACC2;HIC1;ZNF16;SOX12;NOTCH3;KLF16;ZNF14;IRX5
12250,GO:0048513,9.77704833967331e-05,0.999946177714756,71,2136,animal organ development,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SLC2A1;TXNIP;SERPINE1;MYC;ID3;CYP1B1;NOG;VASN;FLRT3;APCDD1;HIST1H4L;FHL2;POU3F1;GDNF;CTGF;TFCP2L1;BAG3;NR2F2;HOXA9;ZFP36L2;FOS;FHL3;TUFT1;RBM15;FOXQ1;COL1A1;EPHB3;HIST1H3J;TLE3;LRIG3;LRRC8A;CXCL14;PLCD1;TAGLN;ZBTB7B;ESRP2;BLOC1S3;HIST1H4B;PIK3R1;MFSD2A;SOX9;CEBPA;GJB2;DDIT4;GZF1;ZNF160;ARTN;KRT16;SOX15;PYGO2;ING2;HOXA5;HIST1H4K;COL1A2;ZNF16;KRT17;SOX12;HIST1H4D;HK2;NOTCH3;SOCS1;DCLRE1C;IRX5
711,GO:0001933,0.000100229129085092,0.999968011592737,19,325,negative regulation of protein phosphorylation,BP,SPRY4;RGS2;DUSP4;MYC;NOG;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;TIMP3;DDIT4;SOCS6;RGS3;PMEPA1;SOCS1;CISH
2847,GO:0006325,0.000126422335236958,0.999947183703555,30,661,chromatin organization,BP,SNAI2;MYC;HR;HIST1H2AG;HIST1H4L;BRPF1;HIST1H2BJ;PHF13;RNF168;HIST1H2BI;HIST1H3J;HIST1H2AB;HJURP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;SOX15;PYGO2;ING2;HIST1H1C;HIST1H1D;HIST1H4K;PER2;HIST2H2BE;NACC2;HIST3H2BB;HIST1H4D;TSPYL4;HIST1H2AH
2942,GO:0006469,0.00013639625417394,0.999964238892593,14,200,negative regulation of protein kinase activity,BP,SPRY4;RGS2;DUSP4;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;SOCS6;RGS3;SOCS1;CISH
12430,GO:0048869,0.000137710642923581,0.999920636336625,84,2681,cellular developmental process,BP,ID1;TIPARP;RGS2;HES1;SNAI2;CDK5R1;PTHLH;NET1;TXNIP;SERPINE1;MYC;ZNF503;ID3;ANGPTL4;NOG;VASN;FLRT3;ZNF750;APCDD1;HIST1H4L;FHL2;TNFRSF21;POU3F1;GDNF;CTGF;AHNAK2;TFCP2L1;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;CDC42EP2;RHOD;RBM15;FOXQ1;ZNF3;COL1A1;TOB1;EPHB3;HIST1H3J;ADGRF1;LRRC8A;CBR1;CXCL14;SIAH2;TAGLN;ZBTB7B;BLOC1S3;GADD45B;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;ERF;CEBPA;HSPA2;AKR1C1;DDIT4;ARTN;KRT16;SOX15;PYGO2;NCDN;NR1D1;ING2;HOXA5;HIST1H4K;PALMD;ZADH2;PER2;ZNF16;KRT17;SOX12;IFITM1;HIST1H4D;NOTCH3;SOCS1;CLU;CDC42SE1;DCLRE1C;IRX5
6740,GO:0030154,0.000147506348454061,0.999915319593382,80,2525,cell differentiation,BP,ID1;TIPARP;RGS2;HES1;SNAI2;CDK5R1;PTHLH;NET1;TXNIP;SERPINE1;MYC;ZNF503;ID3;ANGPTL4;NOG;VASN;FLRT3;ZNF750;APCDD1;HIST1H4L;FHL2;TNFRSF21;POU3F1;GDNF;CTGF;AHNAK2;TFCP2L1;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;RBM15;FOXQ1;ZNF3;COL1A1;TOB1;EPHB3;HIST1H3J;ADGRF1;LRRC8A;CBR1;CXCL14;SIAH2;TAGLN;ZBTB7B;BLOC1S3;GADD45B;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;ERF;CEBPA;HSPA2;AKR1C1;DDIT4;ARTN;KRT16;SOX15;PYGO2;NCDN;NR1D1;ING2;HOXA5;HIST1H4K;ZADH2;PER2;ZNF16;KRT17;SOX12;IFITM1;HIST1H4D;NOTCH3;SOCS1;CLU;DCLRE1C;IRX5
11704,GO:0046483,0.000163445122883826,0.999899861510057,133,4710,heterocycle metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5
13982,GO:0060675,0.000173702604295117,0.999982502290757,6,40,ureteric bud morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
15667,GO:0072171,0.000173702604295117,0.999982502290757,6,40,mesonephric tubule morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
964,GO:0002385,0.000188749712057514,0.999991935354572,4,13,mucosal immune response,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
3135,GO:0006725,0.000191599585339543,0.999881793872565,133,4724,cellular aromatic compound metabolic process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;AKR1C1;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5
17650,GO:1901360,0.000196014061187268,0.99987916100689,136,4857,organic cyclic compound metabolic process,BP,ID1;TIPARP;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;ZBTB34;ZNF780A;ZNF275;AKR1C1;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5
14170,GO:0061037,0.000196251795634642,0.999991353343472,4,14,negative regulation of cartilage development,BP,SNAI2;PTHLH;NOG;SOX9
358,GO:0000976,0.000198536218807039,0.999923434681001,24,497,transcription regulatory region sequence-specific DNA binding,MF,HES1;IVNS1ABP;MYC;HR;HES2;ZNF750;TFCP2L1;HOXA9;FOS;FOXQ1;ZNF93;ZBTB7B;SOX9;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;PER2;NACC2;SOX12;KLF16
454,GO:0001227,0.000213684024206619,0.99994840659891,12,161,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,HES1;SNAI2;HES2;FOXQ1;ERF;GZF1;TGIF1;NR1D1;ZNF589;NACC2;HIC1;KLF16
12979,GO:0051348,0.000227468361124255,0.999933833546402,15,235,negative regulation of transferase activity,BP,SPRY4;RGS2;DUSP4;MIDN;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;SOCS6;RGS3;SOCS1;CISH
10791,GO:0044249,0.000238088646133908,0.999852051672291,135,4837,cellular biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;IRF2BPL;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PCYT1A;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
14522,GO:0065007,0.000238509470847343,0.999859847081062,200,7909,biological regulation,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;HES2;NOG;PTPRE;RIN2;VASN;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;LURAP1L;ZNF750;HSPB1;ZNF419;APCDD1;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;ZNF696;HOXA9;TUBA4A;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;CDHR1;ZNF398;FOS;ZNF256;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;MN1;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;HJURP;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;HIST1H4B;SLC20A1;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;CNN2;ZNF530;MALL;FAM83A;CIART;KCTD1;HSPA2;BICD2;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;ARTN;ZNF169;ZNF783;KRT16;SOX15;PYGO2;NCDN;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PALMD;ZADH2;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;COL1A2;ZNF16;SOCS6;KRT17;SOX12;ZNF766;IFITM1;ZNF701;TRIM56;ADGRF4;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;VPS18;IRX5;CISH
11877,GO:0046872,0.000255720073747516,0.999847263798236,89,2932,metal ion binding,MF,TIPARP;SNAI2;CDK5R1;IRF2BPL;MAT2A;ZNF503;ZNF57;CYP1B1;HR;ZNF557;ZNF750;ZNF419;ZNF296;FHL2;ZNF222;ZNF561;RBAK;MGAT1;ZNF526;ZNF841;ZNF574;FAXDC2;BRPF1;NR2F2;ZNF696;ZFP36L2;PHF13;TRIM35;CDHR1;ZNF398;CHAMP1;ZNF256;FHL3;RNF168;ZNF416;ZCCHC3;PCDH7;ZNF3;ZKSCAN4;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;ZNF200;ZNF549;ZNF570;RNF39;ZNF93;SIAH2;PLCD1;UPF1;ZBTB7B;ZNF581;ZNF776;ZNF530;ZMYND19;ZBTB34;TIMP3;ZNF780A;ZNF275;GZF1;PLEKHM1;ZNF160;ZNF169;PYGO2;NR1D1;FKBP9;ING2;ZNF589;PHC2;ZADH2;ZNF672;BRF2;TRIM26;HIC1;COL1A2;ZNF16;ZNF766;ZNF701;NT5DC3;TRIM56;ZNF845;ZNF510;NOTCH3;KLF16;ZNF14;ZCCHC2;VPS18
10360,GO:0043169,0.000262829121259768,0.999842590216404,90,2974,cation binding,MF,TIPARP;SNAI2;CDK5R1;IRF2BPL;MAT2A;ZNF503;ZNF57;CYP1B1;HR;ZNF557;ZNF750;ZNF419;ZNF296;FHL2;ZNF222;ZNF561;RBAK;MGAT1;ZNF526;ZNF841;ZNF574;FAXDC2;BRPF1;NR2F2;ZNF696;ZFP36L2;PHF13;TRIM35;CDHR1;ZNF398;CHAMP1;ZNF256;FHL3;RNF168;ZNF416;ZCCHC3;PCDH7;ZNF3;ZKSCAN4;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;ZNF200;ZNF549;ZNF570;RNF39;ZNF93;SIAH2;PLCD1;UPF1;ZBTB7B;ZNF581;ZNF776;ZNF530;ZMYND19;ZBTB34;TIMP3;ZNF780A;ZNF275;GZF1;PLEKHM1;ZNF160;ZNF169;PCYT1A;PYGO2;NR1D1;FKBP9;ING2;ZNF589;PHC2;ZADH2;ZNF672;BRF2;TRIM26;HIC1;COL1A2;ZNF16;ZNF766;ZNF701;NT5DC3;TRIM56;ZNF845;ZNF510;NOTCH3;KLF16;ZNF14;ZCCHC2;VPS18
1097,GO:0002683,0.000280076664887781,0.99991299553432,16,266,negative regulation of immune system process,BP,HES1;TSC22D3;MYC;HIST1H4L;TNFRSF21;HOXA9;RBM15;ZBTB7B;HIST1H4B;PIK3R1;SOX9;NR1D1;HOXA5;HIST1H4K;SOCS6;HIST1H4D
17709,GO:1901576,0.00029123251239767,0.999817851807398,136,4900,organic substance biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;IRF2BPL;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PCYT1A;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
10770,GO:0044212,0.000318578435626001,0.999865526878999,27,609,transcription regulatory region DNA binding,MF,TIPARP;HES1;IVNS1ABP;MYC;HR;HES2;ZNF750;TFCP2L1;HOXA9;FOS;FOXQ1;ZNF200;ZNF93;ZBTB7B;SOX9;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;PER2;BRF2;NACC2;SOX12;KLF16
396,GO:0001067,0.000326561767022072,0.999861928703587,27,610,regulatory region nucleic acid binding,MF,TIPARP;HES1;IVNS1ABP;MYC;HR;HES2;ZNF750;TFCP2L1;HOXA9;FOS;FOXQ1;ZNF200;ZNF93;ZBTB7B;SOX9;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;PER2;BRF2;NACC2;SOX12;KLF16
402,GO:0001078,0.000330914314956638,0.999936110953528,9,100,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES1;SNAI2;HES2;FOXQ1;GZF1;TGIF1;NR1D1;NACC2;KLF16
888,GO:0002251,0.000338116394386694,0.999982492494046,4,15,organ or tissue specific immune response,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
8484,GO:0033629,0.000341336456056902,0.999992503052012,3,7,negative regulation of cell adhesion mediated by integrin,BP,SNAI2;SERPINE1;CYP1B1
2413,GO:0005584,0.000411808309889765,1,2,2,collagen type I trimer,CC,COL1A1;COL1A2
15610,GO:0072078,0.000426984461305638,0.999948326865433,6,47,nephron tubule morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
4028,GO:0009058,0.000453615618324834,0.999711873617092,136,4943,biosynthetic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;IRF2BPL;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;SERTAD1;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;TFCP2L1;BAG3;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;PCYT1A;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;IRX5
8392,GO:0033300,0.000479592136436663,1,2,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A1;SLC2A3
14957,GO:0070837,0.000479592136436663,1,2,2,dehydroascorbic acid transport,BP,SLC2A1;SLC2A3
2356,GO:0005436,0.000493265206651207,1,2,2,sodium:phosphate symporter activity,MF,SLC20A2;SLC20A1
5085,GO:0015319,0.000493265206651207,1,2,2,sodium:inorganic phosphate symporter activity,MF,SLC20A2;SLC20A1
5086,GO:0015321,0.000493265206651207,1,2,2,sodium-dependent phosphate transmembrane transporter activity,MF,SLC20A2;SLC20A1
19664,GO:1990837,0.000510094708644629,0.999789472486767,24,530,sequence-specific double-stranded DNA binding,MF,HES1;IVNS1ABP;MYC;HR;HES2;ZNF750;TFCP2L1;HOXA9;FOS;FOXQ1;ZNF93;ZBTB7B;SOX9;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;PER2;NACC2;SOX12;KLF16
14282,GO:0061333,0.000532747340440619,0.999932533609183,6,49,renal tubule morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
15616,GO:0072088,0.000542159200537915,0.999931111328678,6,49,nephron epithelium morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
6216,GO:0019731,0.000593960605108015,0.999963270047812,4,17,antibacterial humoral response,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
4339,GO:0009888,0.000594618028475945,0.999687043612157,44,1231,tissue development,BP,ID1;TIPARP;HES1;SNAI2;TSC22D3;DUSP4;PTHLH;TXNIP;SERPINE1;MYC;ID3;CYP1B1;NOG;VASN;DUSP5;FLRT3;ZNF750;APCDD1;FHL2;POU3F1;GDNF;CTGF;TFCP2L1;NR2F2;FOS;TUFT1;RBM15;FOXQ1;COL1A1;CBR1;TAGLN;ZBTB7B;ESRP2;VASP;SOX9;GJB2;AKR1C1;GZF1;ARTN;KRT16;SOX15;PYGO2;HOXA5;KRT17
15584,GO:0072028,0.000607285614197193,0.999921023492117,6,50,nephron morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
4570,GO:0010648,0.000649220055074572,0.999678376689786,36,937,negative regulation of cell communication,BP,SPRY4;RGS2;SNAI2;DUSP4;IVNS1ABP;MIDN;SERPINE1;MYC;NOG;PTPRE;VASN;DUSP5;FLRT3;HSPB1;APCDD1;GDNF;HIST1H2BJ;IGFBP2;VSNL1;TOB1;EPHB3;SLC30A1;SIAH2;SOX9;TIMP3;DDIT4;NR1D1;ING2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
11338,GO:0045653,0.000652694989487257,0.999958599657527,4,17,negative regulation of megakaryocyte differentiation,BP,HIST1H4L;HIST1H4B;HIST1H4K;HIST1H4D
6653,GO:0023057,0.000689392384861608,0.999657274522259,36,940,negative regulation of signaling,BP,SPRY4;RGS2;SNAI2;DUSP4;IVNS1ABP;MIDN;SERPINE1;MYC;NOG;PTPRE;VASN;DUSP5;FLRT3;HSPB1;APCDD1;GDNF;HIST1H2BJ;IGFBP2;VSNL1;TOB1;EPHB3;SLC30A1;SIAH2;SOX9;TIMP3;DDIT4;NR1D1;ING2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
2873,GO:0006366,0.000697106257382339,0.999601787525415,58,1761,transcription by RNA polymerase II,BP,ID1;HES1;SNAI2;TSC22D3;IVNS1ABP;IRF2BPL;TXNIP;SERPINE1;MYC;ID3;HES2;NOG;SERTAD1;ZNF750;ZNF296;FHL2;RBAK;POU3F1;GDNF;CTGF;TFCP2L1;BAG3;NR2F2;HOXA9;ZFP36L2;ZNF398;FOS;RNF168;RBM15;FOXQ1;ZNF3;TOB1;ZNF200;AKIRIN2;ZBTB7B;PIK3R1;SOX9;ERF;CEBPA;KCTD1;GZF1;ZNF160;TGIF1;SOX15;NR1D1;ZNF589;HIST1H1C;HOXA5;HIST1H1D;PER2;NACC2;HIC1;ZNF16;SOX12;NOTCH3;KLF16;ZNF14;IRX5
10794,GO:0044260,0.000728742241707847,0.999531823681991,163,6227,cellular macromolecule metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5;CISH
465,GO:0001503,0.000772790211929858,0.999757474433622,14,243,ossification,BP,ID1;SNAI2;PTHLH;ID3;NOG;FHL2;CTGF;TUFT1;COL1A1;TOB1;MN1;SOX9;CEBPA;IFITM1
11326,GO:0045637,0.000786060715022331,0.999779248302226,12,183,regulation of myeloid cell differentiation,BP,MYC;HIST1H4L;HOXA9;FOS;RBM15;HIST1H3J;HIST1H4B;PIK3R1;HOXA5;HIST1H4K;ZNF16;HIST1H4D
12681,GO:0050872,0.000792984301589325,0.999973930103964,3,9,white fat cell differentiation,BP,SNAI2;CEBPA;PER2
285,GO:0000788,0.000850938047087536,0.999910882085756,5,31,nuclear nucleosome,CC,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
540,GO:0001658,0.000901371797958119,0.999902935417076,5,36,branching involved in ureteric bud morphogenesis,BP,MYC;NOG;GDNF;SOX9;GZF1
2850,GO:0006335,0.00093295179380539,0.999899910581234,5,32,DNA replication-dependent nucleosome assembly,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
8905,GO:0034723,0.00093295179380539,0.999899910581234,5,32,DNA replication-dependent nucleosome organization,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
531,GO:0001649,0.00093608459968194,0.999768331938931,10,141,osteoblast differentiation,BP,ID1;SNAI2;PTHLH;ID3;NOG;FHL2;COL1A1;TOB1;CEBPA;IFITM1
15534,GO:0071901,0.000987739459785481,0.999776324241373,9,115,negative regulation of protein serine/threonine kinase activity,BP,SPRY4;RGS2;DUSP4;DUSP5;HSPB1;NR2F2;FAM212B;CEBPA;RGS3
11945,GO:0046982,0.000995431120821206,0.999626255585923,18,352,protein heterodimerization activity,MF,HIST1H2AG;HIST1H4L;HIST1H2BJ;FOS;HIST1H2BI;HIST1H3J;HIST1H2AB;HIST1H4B;PIK3R1;SOX9;HIST1H2BO;HIST1H2BE;SOX15;HIST1H4K;HIST2H2BE;HIST3H2BB;HIST1H4D;HIST1H2AH
15228,GO:0071364,0.00101327209586971,0.999887974246729,5,36,cellular response to epidermal growth factor stimulus,BP,ID1;SNAI2;ZFP36L2;COL1A1;SOX9
3389,GO:0007167,0.00105575929352127,0.999508900807229,28,693,enzyme linked receptor protein signaling pathway,BP,ID1;SPRY4;TIPARP;HES1;CDK5R1;TXNIP;NOG;PTPRE;VASN;FLRT3;HSPB1;CTGF;FOS;IGFBP2;CD3EAP;COL1A1;TOB1;EPHB3;ESRP2;PIK3R1;SOX9;FAM83A;DDIT4;ING2;COL1A2;PMEPA1;SOCS1;CISH
14168,GO:0061035,0.00108106846705923,0.999878424178391,5,37,regulation of cartilage development,BP,SNAI2;PTHLH;NOG;CTGF;SOX9
2317,GO:0005315,0.00130071369735323,0.999990831475153,2,3,inorganic phosphate transmembrane transporter activity,MF,SLC20A2;SLC20A1
11352,GO:0045667,0.00130416811656836,0.999761168213853,7,77,regulation of osteoblast differentiation,BP,ID1;SNAI2;ID3;NOG;TOB1;CEBPA;IFITM1
11946,GO:0046983,0.00135226936427785,0.999320338628417,33,854,protein dimerization activity,MF,ID1;HES1;MYC;ID3;HES2;NOG;FLRT3;HIST1H2AG;HSPB1;HIST1H4L;GDNF;NR2F2;HIST1H2BJ;FOS;HIST1H2BI;POLR1D;HIST1H3J;HIST1H2AB;ZBTB7B;HIST1H4B;PIK3R1;SOX9;CEBPA;HIST1H2BO;HIST1H2BE;SOX15;PCYT1A;HIST1H4K;HIST2H2BE;NACC2;HIST3H2BB;HIST1H4D;HIST1H2AH
7111,GO:0030903,0.00141910258993736,0.999939237624431,3,11,notochord development,BP,ID3;NOG;SOX9
10849,GO:0044341,0.00143076967664166,0.999989411404487,2,3,sodium-dependent phosphate transport,BP,SLC20A2;SLC20A1
13842,GO:0060425,0.0014396471193173,0.999826472614909,5,39,lung morphogenesis,BP,ID1;NOG;ESRP2;SOX9;HOXA5
14967,GO:0070848,0.00144471797090652,0.999393019866904,21,472,response to growth factor,BP,ID1;SPRY4;HES1;SNAI2;MYC;NOG;VASN;FLRT3;HSPB1;CTGF;ZFP36L2;FOS;COL1A1;TOB1;ESRP2;SOX9;DDIT4;TGIF1;ING2;COL1A2;PMEPA1
14968,GO:0070849,0.00144616644886977,0.999825507538397,5,39,response to epidermal growth factor,BP,ID1;SNAI2;ZFP36L2;COL1A1;SOX9
14155,GO:0061009,0.00150107027283638,0.999988615240041,2,3,common bile duct development,BP,HES1;SOX9
6825,GO:0030279,0.00154495720455366,0.999810376765801,5,40,negative regulation of ossification,BP,ID1;ID3;NOG;TOB1;SOX9
16183,GO:0090190,0.00156011914733024,0.9999309369066,3,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,NOG;GDNF;SOX9
14141,GO:0060993,0.00157941874309047,0.999749706047695,6,60,kidney morphogenesis,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
11488,GO:0045936,0.00158592922484675,0.999344054953517,20,439,negative regulation of phosphate metabolic process,BP,SPRY4;RGS2;DUSP4;MIDN;MYC;NOG;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;TIMP3;DDIT4;SOCS6;RGS3;PMEPA1;SOCS1;CISH
15612,GO:0072080,0.00161068550435971,0.999743761135972,6,60,nephron tubule development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
15611,GO:0072079,0.00162311993002127,0.99992713950797,3,11,nephron tubule formation,BP,NOG;GDNF;SOX9
4516,GO:0010563,0.00163106473774016,0.999323735053279,20,440,negative regulation of phosphorus metabolic process,BP,SPRY4;RGS2;DUSP4;MIDN;MYC;NOG;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;TIMP3;DDIT4;SOCS6;RGS3;PMEPA1;SOCS1;CISH
360,GO:0000978,0.00169298397172261,0.999396750367113,15,290,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HES1;MYC;HES2;HOXA9;FOS;FOXQ1;ZBTB7B;CEBPA;CIART;GZF1;TGIF1;NR1D1;HOXA5;NACC2;KLF16
15162,GO:0071260,0.00169755581507376,0.999727657215562,6,58,cellular response to mechanical stimulus,BP,SLC2A1;MAP3K14;BAG3;COL1A1;SOX9;CNN2
14222,GO:0061138,0.00173377881511576,0.999572324374012,9,129,morphogenesis of a branching epithelium,BP,SNAI2;MYC;NOG;GDNF;RBM15;ESRP2;SOX9;GZF1;HOXA5
14281,GO:0061326,0.00174568866044038,0.999717564062101,6,61,renal tubule development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
7794,GO:0032330,0.00177688440244532,0.999843175854766,4,25,regulation of chondrocyte differentiation,BP,SNAI2;PTHLH;CTGF;SOX9
12379,GO:0048754,0.00185890701669909,0.999583846247041,8,106,branching morphogenesis of an epithelial tube,BP,MYC;NOG;GDNF;RBM15;ESRP2;SOX9;GZF1;HOXA5
12365,GO:0048731,0.00187022912333393,0.998801034068875,85,2946,system development,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SLC2A1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;FLRT3;HSPB1;APCDD1;HIST1H4L;FHL2;TNFRSF21;POU3F1;GDNF;CTGF;AHNAK2;TFCP2L1;BAG3;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;FHL3;RNF168;TUFT1;RBM15;FOXQ1;COL1A1;EPHB3;HIST1H3J;TLE3;LRIG3;ADGRF1;LRRC8A;CXCL14;SIAH2;PLCD1;TAGLN;ZBTB7B;ESRP2;BLOC1S3;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;CEBPA;GJB2;MALL;DDIT4;GZF1;ZNF160;ARTN;KRT16;SOX15;PYGO2;NCDN;ING2;HOXA5;HIST1H4K;PER2;COL1A2;ZNF16;KRT17;SOX12;HIST1H4D;HK2;NOTCH3;SOCS1;CLU;DCLRE1C;IRX5
12912,GO:0051241,0.00190754694363587,0.999087698962831,27,679,negative regulation of multicellular organismal process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SERPINE1;MYC;ID3;NOG;VASN;HIST1H4L;TNFRSF21;NR2F2;HOXA9;RBM15;TOB1;ZBTB7B;HIST1H4B;PIK3R1;SOX9;SOX15;HOXA5;HIST1H4K;HIST1H4D;NOTCH3
4367,GO:0009968,0.00191782146298288,0.999013899128973,33,888,negative regulation of signal transduction,BP,SPRY4;RGS2;SNAI2;DUSP4;IVNS1ABP;SERPINE1;MYC;NOG;PTPRE;VASN;DUSP5;FLRT3;HSPB1;APCDD1;GDNF;HIST1H2BJ;IGFBP2;TOB1;EPHB3;SIAH2;SOX9;TIMP3;DDIT4;NR1D1;ING2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
12947,GO:0051291,0.00191926670767386,0.999569090130755,8,100,protein heterooligomerization,BP,MAT2A;HIST1H4L;COL1A1;HIST1H3J;HIST1H4B;HIST1H4K;COL1A2;HIST1H4D
10890,GO:0044427,0.00192286056715479,0.999043253137596,30,774,chromosomal part,CC,SNAI2;MYC;HR;HIST1H2AG;HIST1H4L;HIST1H2BJ;CHAMP1;RNF168;HIST1H2BI;HIST1H3J;HIST1H2AB;HJURP;UPF1;HIST1H4B;HSPA2;HIST1H2BO;HIST1H2BE;NR1D1;ING2;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;HIST2H2BE;NACC2;HIC1;HIST3H2BB;HIST1H4D;HIST1H2AH;DCLRE1C
20105,GO:2000736,0.00197052640945001,0.999505617835629,9,122,regulation of stem cell differentiation,BP,HES1;HIST1H4L;GDNF;ZFP36L2;HIST1H3J;HIST1H4B;SOX9;HIST1H4K;HIST1H4D
14479,GO:0061844,0.00197069199986458,0.999822830651738,4,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
7795,GO:0032331,0.00200497503655422,0.999900975541381,3,12,negative regulation of chondrocyte differentiation,BP,SNAI2;PTHLH;SOX9
11353,GO:0045668,0.00208319344192418,0.999807065943217,4,26,negative regulation of osteoblast differentiation,BP,ID1;ID3;NOG;TOB1
366,GO:0000987,0.00210131909602952,0.999233897056779,15,297,proximal promoter sequence-specific DNA binding,MF,HES1;MYC;HES2;HOXA9;FOS;FOXQ1;ZBTB7B;CEBPA;CIART;GZF1;TGIF1;NR1D1;HOXA5;NACC2;KLF16
6215,GO:0019730,0.00210235151267504,0.999723655041249,5,39,antimicrobial humoral response,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE;CLU
11671,GO:0046425,0.0021258897009785,0.999574738988385,7,81,regulation of JAK-STAT cascade,BP,HES1;CDK5R1;CYP1B1;FLRT3;SOCS6;SOCS1;CISH
12625,GO:0050793,0.00212879948600794,0.998742771799133,53,1658,regulation of developmental process,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;NET1;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;FLRT3;HSPB1;HIST1H4L;TNFRSF21;GDNF;CTGF;HOXA9;ZFP36L2;FOS;CDC42EP2;RHOD;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;CXCL14;ZBTB7B;HIST1H4B;PIK3R1;SOX9;CEBPA;SOX15;PYGO2;NR1D1;ING2;HOXA5;HIST1H4K;PALMD;ZADH2;PER2;ZNF16;KRT17;IFITM1;HIST1H4D;HK2;NOTCH3;SOCS1;CDC42SE1
539,GO:0001657,0.00215002750577179,0.999636797993717,6,63,ureteric bud development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
15227,GO:0071363,0.00216439071924994,0.999079882385231,20,455,cellular response to growth factor stimulus,BP,ID1;SPRY4;HES1;SNAI2;NOG;VASN;FLRT3;HSPB1;CTGF;ZFP36L2;FOS;COL1A1;TOB1;ESRP2;SOX9;DDIT4;TGIF1;ING2;COL1A2;PMEPA1
93,GO:0000183,0.00219849286556568,0.99970802454246,5,39,chromatin silencing at rDNA,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
13981,GO:0060674,0.00220429570027149,0.999792638798374,4,26,placenta blood vessel development,BP,HES1;NR2F2;RBM15;PLCD1
15572,GO:0072006,0.00224986951757728,0.999544194114521,7,86,nephron development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1;NOTCH3
15663,GO:0072163,0.00227538529422355,0.999610922471698,6,64,mesonephric epithelium development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
15664,GO:0072164,0.00227538529422355,0.999610922471698,6,64,mesonephric tubule development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
19065,GO:1904892,0.00228562364851538,0.999536603359787,7,82,regulation of STAT cascade,BP,HES1;CDK5R1;CYP1B1;FLRT3;SOCS6;SOCS1;CISH
8588,GO:0034080,0.00229275911275859,0.999691923983511,5,40,CENP-A containing nucleosome assembly,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
14400,GO:0061641,0.00229275911275859,0.999691923983511,5,40,CENP-A containing chromatin organization,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
15647,GO:0072132,0.00234688323950242,0.999774463648492,4,27,mesenchyme morphogenesis,BP,SNAI2;MYC;NOG;SOX9
10852,GO:0044344,0.00237223452354212,0.999447497755834,8,107,cellular response to fibroblast growth factor stimulus,BP,SPRY4;SNAI2;NOG;FLRT3;CTGF;ZFP36L2;COL1A1;ESRP2
4269,GO:0009612,0.00238511764304875,0.999382707346105,9,133,response to mechanical stimulus,BP,SLC2A1;TXNIP;MAP3K14;BAG3;FOS;IGFBP2;COL1A1;SOX9;CNN2
15187,GO:0071310,0.00245904454535587,0.998513512720637,57,1808,cellular response to organic substance,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;CDK5R1;SERPINE1;MYC;MAT2A;ID3;CYP1B1;NOG;PTPRE;VASN;FLRT3;HSPB1;FHL2;TNFRSF21;CTGF;MAP3K14;FZD10;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;CDC42EP2;IGFBP2;IL17RA;VSNL1;COL1A1;TOB1;HIST1H3J;UPF1;ESRP2;PIK3R1;SOX9;CEBPA;CNN2;GJB2;HSPA2;TIMP3;AKR1C1;DDIT4;TGIF1;NR1D1;ING2;TRIM26;COL1A2;ZNF16;SOCS6;IFITM1;HK2;PMEPA1;SOCS1;CLU;CISH
16489,GO:0097159,0.00246368414151081,0.998342635246353,124,4613,organic cyclic compound binding,MF,TIPARP;HES1;SNAI2;IVNS1ABP;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;ZNF222;ZNF561;RBAK;POU3F1;ZNF526;ZNF841;ZNF574;AHNAK2;MAP3K14;TFCP2L1;BAG3;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;ZNF398;CHAMP1;FOS;ZNF256;ZNF416;RHOD;ZCCHC3;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;EPHB3;ZNF200;HIST1H3J;HIST1H2AB;ZNF549;PAK6;ZNF570;ZNF93;HJURP;UPF1;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;HSPA2;HIST1H2BO;ZBTB34;ZNF780A;JRK;STK17A;ZNF275;AKR1C1;GZF1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;SOX15;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;HK2;KLF16;HIST1H2AH;ZNF14;DCLRE1C;ZCCHC2;IRX5
636,GO:0001823,0.00247842686314756,0.999568540815319,6,65,mesonephros development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
598,GO:0001763,0.00248477261240095,0.999352546151527,9,136,morphogenesis of a branching structure,BP,SNAI2;MYC;NOG;GDNF;RBM15;ESRP2;SOX9;GZF1;HOXA5
6859,GO:0030324,0.00255501852006468,0.999396946547881,8,111,lung development,BP,ID1;HES1;NOG;CTGF;ESRP2;SOX9;CEBPA;HOXA5
731,GO:0001957,0.00258357445895252,0.999963507895964,2,4,intramembranous ossification,BP,COL1A1;MN1
9468,GO:0036072,0.00258357445895252,0.999963507895964,2,4,direct ossification,BP,COL1A1;MN1
7362,GO:0031400,0.00258364140306443,0.998884358249141,20,457,negative regulation of protein modification process,BP,SPRY4;RGS2;DUSP4;MYC;NOG;DUSP5;FLRT3;HSPB1;NR2F2;FAM212B;GADD45B;CEBPA;TIMP3;DDIT4;PER2;SOCS6;RGS3;PMEPA1;SOCS1;CISH
17653,GO:1901363,0.00258856797548877,0.998256075971134,123,4575,heterocyclic compound binding,MF,TIPARP;HES1;SNAI2;IVNS1ABP;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;ZNF222;ZNF561;RBAK;POU3F1;ZNF526;ZNF841;ZNF574;AHNAK2;MAP3K14;TFCP2L1;BAG3;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;ZNF398;CHAMP1;FOS;ZNF256;ZNF416;RHOD;ZCCHC3;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;EPHB3;ZNF200;HIST1H3J;HIST1H2AB;ZNF549;PAK6;ZNF570;ZNF93;HJURP;UPF1;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;IMP3;ZNF776;SOX9;ERF;CEBPA;ZNF530;CIART;HSPA2;HIST1H2BO;ZBTB34;ZNF780A;JRK;STK17A;ZNF275;GZF1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;SOX15;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;HK2;KLF16;HIST1H2AH;ZNF14;DCLRE1C;ZCCHC2;IRX5
13908,GO:0060536,0.00263341023682046,0.999962437174287,2,4,cartilage morphogenesis,BP,SNAI2;HOXA5
16182,GO:0090189,0.00265066757488224,0.999852980070668,3,13,regulation of branching involved in ureteric bud morphogenesis,BP,NOG;GDNF;SOX9
7931,GO:0032501,0.00271142872112196,0.998179747144622,113,4178,multicellular organismal process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;SLC2A1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;DUSP5;FLRT3;HSPB1;APCDD1;KCTD15;ZNF296;HIST1H4L;FHL2;TNFRSF21;POU3F1;MGAT1;GDNF;CTGF;AHNAK2;TFCP2L1;BAG3;FZD10;NR2F2;HOXA9;ZFP36L2;CDHR1;FOS;ZNF256;FHL3;RNF168;IGFBP2;TUFT1;IL17RA;PRR15;RBM15;FOXQ1;ZNF3;FAT2;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;TLE3;LRIG3;ADGRF1;LRRC8A;MN1;CXCL14;SIAH2;PLCD1;TAGLN;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;VASP;HIST1H4B;PIK3R1;MFSD2A;SOX9;CEBPA;GJB2;MALL;CIART;HSPA2;TIMP3;AKR1C1;DDIT4;GZF1;PLEKHM1;ZNF160;TGIF1;ARTN;KRT16;SOX15;PYGO2;NCDN;NR1D1;ING2;HOXA5;PHC2;HIST1H4K;PER2;HIC1;COL1A2;ZNF16;KRT17;SOX12;IFITM1;TRIM56;HIST1H4D;HK2;NOTCH3;SOCS1;CLU;DCLRE1C;IRX5
14705,GO:0070318,0.00276007013815168,0.999959668587944,2,4,positive regulation of G0 to G1 transition,BP,CTGF;SOX15
15465,GO:0071774,0.00281121975179812,0.999326301389433,8,110,response to fibroblast growth factor,BP,SPRY4;SNAI2;NOG;FLRT3;CTGF;ZFP36L2;COL1A1;ESRP2
7178,GO:0031055,0.0028433379359268,0.999596926136702,5,42,chromatin remodeling at centromere,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
16177,GO:0090184,0.00286497769761189,0.999708995891285,4,27,positive regulation of kidney development,BP,MYC;NOG;GDNF;SOX9
3115,GO:0006692,0.00286770849229331,0.999708641222535,4,27,prostanoid metabolic process,BP,CBR1;AKR1C1;ZADH2;CES2
3116,GO:0006693,0.00286770849229331,0.999708641222535,4,27,prostaglandin metabolic process,BP,CBR1;AKR1C1;ZADH2;CES2
18540,GO:1903706,0.00288665587115001,0.998872508599028,16,329,regulation of hemopoiesis,BP,HES1;MYC;HIST1H4L;HOXA9;ZFP36L2;FOS;RBM15;HIST1H3J;ZBTB7B;HIST1H4B;PIK3R1;HOXA5;HIST1H4K;ZNF16;HIST1H4D;SOCS1
13983,GO:0060676,0.00291766661828671,0.999956130767128,2,4,ureteric bud formation,BP,NOG;GDNF
15668,GO:0072172,0.00291766661828671,0.999956130767128,2,4,mesonephric tubule formation,BP,NOG;GDNF
15890,GO:0072603,0.00292208328483052,0.999956030156858,2,4,interleukin-5 secretion,BP,TNFRSF21;IL17RA
20064,GO:2000662,0.00292208328483052,0.999956030156858,2,4,regulation of interleukin-5 secretion,BP,TNFRSF21;IL17RA
1457,GO:0003690,0.00296694562542486,0.998598079314029,24,602,double-stranded DNA binding,MF,HES1;IVNS1ABP;MYC;HR;HES2;ZNF750;TFCP2L1;HOXA9;FOS;FOXQ1;ZNF93;ZBTB7B;SOX9;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;PER2;NACC2;SOX12;KLF16
9028,GO:0035239,0.00300485164929246,0.998628306497675,22,542,tube morphogenesis,BP,ID1;TIPARP;HES1;SERPINE1;MYC;ANGPTL4;CYP1B1;NOG;HSPB1;GDNF;CTGF;NR2F2;RBM15;EPHB3;PLCD1;ESRP2;VASP;SOX9;GZF1;HOXA5;HK2;NOTCH3
16115,GO:0090083,0.00304367836426962,0.999820136923364,3,14,regulation of inclusion body assembly,BP,HSPA2;DNAJB2;CLU
2854,GO:0006342,0.00310765047596474,0.999243707611496,8,107,chromatin silencing,BP,HIST1H2AG;HIST1H4L;HIST1H3J;HIST1H2AB;HIST1H4B;HIST1H4K;HIST1H4D;HIST1H2AH
6668,GO:0030018,0.00319001901622206,0.999413178560451,6,71,Z disc,CC,SLC2A1;HSPB1;FHL2;AHNAK2;BAG3;FHL3
6858,GO:0030323,0.00320582678468817,0.999213883771473,8,115,respiratory tube development,BP,ID1;HES1;NOG;CTGF;ESRP2;SOX9;CEBPA;HOXA5
286,GO:0000790,0.00325325317285462,0.998757221495113,15,304,nuclear chromatin,CC,SNAI2;MYC;HIST1H2AG;HIST1H4L;HIST1H3J;HIST1H2AB;HIST1H4B;NR1D1;ING2;HIST1H1C;HIST1H1D;HIST1H4K;NACC2;HIST1H4D;HIST1H2AH
12946,GO:0051290,0.0032726510392274,0.999519794449641,5,43,protein heterotetramerization,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
15575,GO:0072009,0.00328328168895254,0.999393293035428,6,69,nephron epithelium development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
14254,GO:0061213,0.00332172775192628,0.999797491215454,3,14,positive regulation of mesonephros development,BP,NOG;GDNF;SOX9
7757,GO:0032269,0.00353586289110833,0.998143584651012,31,847,negative regulation of cellular protein metabolic process,BP,SPRY4;RGS2;DUSP4;SERPINE1;MYC;NOG;DUSP5;FLRT3;HSPB1;HIST1H4L;NR2F2;ZFP36L2;BCDIN3D;FAM212B;TOB1;HIST1H3J;SIAH2;UPF1;GADD45B;HIST1H4B;CEBPA;TIMP3;DDIT4;HIST1H4K;PER2;SOCS6;HIST1H4D;RGS3;PMEPA1;SOCS1;CISH
2835,GO:0006303,0.0036561995765194,0.99931041806795,6,67,double-strand break repair via nonhomologous end joining,BP,HIST1H4L;RNF168;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
11293,GO:0045595,0.00368061580377552,0.997924594811895,39,1156,regulation of cell differentiation,BP,ID1;HES1;SNAI2;CDK5R1;PTHLH;NET1;SERPINE1;MYC;ID3;NOG;VASN;HIST1H4L;TNFRSF21;GDNF;CTGF;HOXA9;ZFP36L2;FOS;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;CXCL14;ZBTB7B;HIST1H4B;PIK3R1;SOX9;CEBPA;NR1D1;HOXA5;HIST1H4K;ZADH2;PER2;ZNF16;IFITM1;HIST1H4D;NOTCH3;SOCS1
10314,GO:0043086,0.00374045700053779,0.998260724958439,22,536,negative regulation of catalytic activity,BP,SPRY4;RGS2;DUSP4;MIDN;TXNIP;SERPINE1;ANGPTL4;DUSP5;FLRT3;HSPB1;FZD10;NR2F2;FAM212B;SIAH2;GADD45B;CEBPA;TIMP3;SOCS6;RGS3;SOCS1;CDC42SE1;CISH
12915,GO:0051248,0.0037864369877681,0.997982058246144,32,887,negative regulation of protein metabolic process,BP,SPRY4;RGS2;DUSP4;SERPINE1;MYC;NOG;DUSP5;FLRT3;HSPB1;HIST1H4L;NR2F2;ZFP36L2;BCDIN3D;FAM212B;TOB1;HIST1H3J;SIAH2;UPF1;GADD45B;HIST1H4B;CEBPA;TIMP3;DDIT4;HIST1H4K;PER2;SOCS6;HIST1H4D;RGS3;PMEPA1;SOCS1;CLU;CISH
11347,GO:0045662,0.00389173250743692,0.99974590093272,3,15,negative regulation of myoblast differentiation,BP,ID3;CXCL14;SOX9
16798,GO:0098609,0.00391830125145828,0.998282418486277,19,445,cell-cell adhesion,BP,HES1;SNAI2;CDK5R1;CYP1B1;FLRT3;HSPB1;LGALS7B;TNFRSF21;MAP3K14;CDHR1;IGFBP2;PCDH7;FAT2;EPHB3;ZBTB7B;PIK3R1;SOX9;SOCS6;SOCS1
6824,GO:0030278,0.00392087265311179,0.999005302466321,8,118,regulation of ossification,BP,ID1;SNAI2;ID3;NOG;TOB1;SOX9;CEBPA;IFITM1
11337,GO:0045652,0.00401155268608913,0.999229495273418,6,66,regulation of megakaryocyte differentiation,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;ZNF16;HIST1H4D
10739,GO:0044092,0.00404305600288287,0.997928182793909,28,748,negative regulation of molecular function,BP,ID1;SPRY4;RGS2;DUSP4;MIDN;TXNIP;SERPINE1;ID3;ANGPTL4;CYP1B1;NOG;DUSP5;FLRT3;HSPB1;FZD10;NR2F2;FAM212B;SIAH2;GADD45B;CEBPA;TIMP3;PER2;DNAJB2;SOCS6;RGS3;SOCS1;CDC42SE1;CISH
10090,GO:0042587,0.00438910230779181,0.999905568285694,2,5,glycogen granule,CC,PPP1R3D;PCYT1A
368,GO:0000989,0.00448674126016428,0.99792005260915,21,517,transcription factor activity, transcription factor binding,MF,ID1;ID3;HR;ZNF296;FHL2;POU3F1;TFCP2L1;NR2F2;FOS;FHL3;TOB1;SIAH2;ERF;CEBPA;KCTD1;TGIF1;NR1D1;PER2;BRF2;NACC2;SOX12
13509,GO:0055056,0.0046012277664932,0.999898559917995,2,5,D-glucose transmembrane transporter activity,MF,SLC2A1;SLC2A3
13863,GO:0060452,0.00480249691812797,0.999891752026022,2,5,positive regulation of cardiac muscle contraction,BP,RGS2;CTGF
3944,GO:0008630,0.00481292732901259,0.998877252125015,7,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;PIK3R1;DDIT4;ING2;NACC2;HIC1;CLU
2097,GO:0004860,0.00482523863394531,0.999034049229989,6,71,protein kinase inhibitor activity,MF,FLRT3;HSPB1;FAM212B;SOCS6;SOCS1;CISH
15895,GO:0072611,0.00482864655041977,0.999890856372581,2,5,interleukin-13 secretion,BP,TNFRSF21;IL17RA
20067,GO:2000665,0.00482864655041977,0.999890856372581,2,5,regulation of interleukin-13 secretion,BP,TNFRSF21;IL17RA
10542,GO:0043486,0.00490487287783616,0.999202597543102,5,48,histone exchange,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
7506,GO:0031674,0.00495870342631618,0.998998237724729,6,77,I band,CC,SLC2A1;HSPB1;FHL2;AHNAK2;BAG3;FHL3
14256,GO:0061217,0.00498722895106102,0.99964038212976,3,16,regulation of mesonephros development,BP,NOG;GDNF;SOX9
367,GO:0000988,0.00501385822265172,0.997652259321892,21,522,transcription factor activity, protein binding,MF,ID1;ID3;HR;ZNF296;FHL2;POU3F1;TFCP2L1;NR2F2;FOS;FHL3;TOB1;SIAH2;ERF;CEBPA;KCTD1;TGIF1;NR1D1;PER2;BRF2;NACC2;SOX12
4551,GO:0010628,0.00513336594942709,0.996953092293338,44,1365,positive regulation of gene expression,BP,ID1;HES1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;HIST1H4L;FHL2;POU3F1;GDNF;CTGF;BRPF1;NR2F2;HOXA9;BCDIN3D;ZNF398;FOS;CD3EAP;RBM15;COL1A1;TOB1;HIST1H3J;AKIRIN2;ZBTB7B;SEC14L2;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;HIST1H4K;KRT17;SOX12;HIST1H4D;NOTCH3;CLU
11672,GO:0046426,0.0051547902091244,0.999372715162475,4,32,negative regulation of JAK-STAT cascade,BP,FLRT3;SOCS6;SOCS1;CISH
19066,GO:1904893,0.0051547902091244,0.999372715162475,4,32,negative regulation of STAT cascade,BP,FLRT3;SOCS6;SOCS1;CISH
11253,GO:0045444,0.00517543619873144,0.998489095250218,9,148,fat cell differentiation,BP,RGS2;HES1;SNAI2;ZFP36L2;CEBPA;NR1D1;ZADH2;PER2;SOCS1
15729,GO:0072273,0.00517548426869482,0.999618443945586,3,17,metanephric nephron morphogenesis,BP,HES1;GDNF;SOX9
6066,GO:0019210,0.00545812295381306,0.998877765746261,6,73,kinase inhibitor activity,MF,FLRT3;HSPB1;FAM212B;SOCS6;SOCS1;CISH
18043,GO:1902532,0.00558195990572519,0.997592586660295,17,390,negative regulation of intracellular signal transduction,BP,SPRY4;RGS2;SNAI2;DUSP4;IVNS1ABP;MYC;DUSP5;FLRT3;HSPB1;TIMP3;DDIT4;ING2;SOCS6;RGS3;SOCS1;CLU;CISH
5400,GO:0016233,0.00559249553827,0.999058623309243,5,51,telomere capping,BP,HIST1H4L;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
635,GO:0001822,0.00559456692601466,0.998215515817646,10,182,kidney development,BP,TIPARP;HES1;MYC;ID3;NOG;GDNF;SOX9;GZF1;PYGO2;NOTCH3
8807,GO:0034508,0.00559508881836099,0.999059154790152,5,50,centromere complex assembly,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
1467,GO:0003714,0.00568419090184472,0.998183678605807,10,178,transcription corepressor activity,MF,ID3;HR;TFCP2L1;NR2F2;TOB1;SIAH2;ERF;KCTD1;TGIF1;NR1D1
2851,GO:0006336,0.00569121073670173,0.999039093551324,5,50,DNA replication-independent nucleosome assembly,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
3391,GO:0007169,0.00600651186673185,0.997196708250928,20,498,transmembrane receptor protein tyrosine kinase signaling pathway,BP,SPRY4;TIPARP;CDK5R1;TXNIP;NOG;PTPRE;FLRT3;HSPB1;CTGF;IGFBP2;CD3EAP;COL1A1;EPHB3;ESRP2;PIK3R1;SOX9;FAM83A;DDIT4;SOCS1;CISH
260,GO:0000726,0.0060187382561136,0.99873634761569,6,74,non-recombinational repair,BP,HIST1H4L;RNF168;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
1344,GO:0003203,0.0060352792572068,0.999526025640067,3,18,endocardial cushion morphogenesis,BP,SNAI2;NOG;SOX9
8906,GO:0034724,0.0061518612297856,0.998940603271128,5,51,DNA replication-independent nucleosome organization,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
15732,GO:0072282,0.00618808615239249,0.999827139214241,2,6,metanephric nephron tubule morphogenesis,BP,HES1;SOX9
11418,GO:0045814,0.0062995193540687,0.998268346439924,8,121,negative regulation of gene expression, epigenetic,BP,HIST1H2AG;HIST1H4L;HIST1H3J;HIST1H2AB;HIST1H4B;HIST1H4K;HIST1H4D;HIST1H2AH
538,GO:0001656,0.00630311195793465,0.998902727284908,5,56,metanephros development,BP,HES1;MYC;ID3;GDNF;SOX9
13992,GO:0060688,0.00630976096014379,0.999182773542093,4,34,regulation of morphogenesis of a branching structure,BP,SNAI2;NOG;GDNF;SOX9
14960,GO:0070841,0.00635818374884439,0.999491149442668,3,18,inclusion body assembly,BP,HSPA2;DNAJB2;CLU
537,GO:0001655,0.00636709281500416,0.997797160937698,11,215,urogenital system development,BP,TIPARP;HES1;MYC;ID3;NOG;GDNF;EPHB3;SOX9;GZF1;PYGO2;NOTCH3
14392,GO:0061626,0.00639478491506024,0.999818292149601,2,6,pharyngeal arch artery morphogenesis,BP,HES1;NOG
17931,GO:1902229,0.00646477069744176,0.99915881736404,4,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;ING2;NACC2;CLU
506,GO:0001568,0.0065099655176178,0.997071798609098,18,439,blood vessel development,BP,ID1;TIPARP;HES1;SERPINE1;ANGPTL4;CYP1B1;NOG;HSPB1;CTGF;NR2F2;RBM15;COL1A1;EPHB3;PLCD1;HOXA5;COL1A2;HK2;NOTCH3
19721,GO:2000026,0.00659213839354654,0.99609363910408,41,1276,regulation of multicellular organismal development,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;FLRT3;HSPB1;HIST1H4L;TNFRSF21;GDNF;CTGF;HOXA9;ZFP36L2;FOS;RBM15;COL1A1;EPHB3;HIST1H3J;ZBTB7B;HIST1H4B;PIK3R1;SOX9;SOX15;PYGO2;HOXA5;HIST1H4K;PER2;ZNF16;KRT17;HIST1H4D;HK2;NOTCH3;SOCS1
8849,GO:0034641,0.0066518862749321,0.995335391064446,134,5143,cellular nitrogen compound metabolic process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;NOG;SERTAD1;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;TFCP2L1;BAG3;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;CD3EAP;RBM15;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;ZBTB34;ZNF780A;ZNF275;DDIT4;GZF1;ZNF160;TGIF1;ZNF169;ZNF783;SOX15;CIPC;NR1D1;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;HIST1H4D;HK2;NOTCH3;KLF16;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5
2478,GO:0005694,0.00675750913929639,0.996282340177238,31,884,chromosome,CC,SNAI2;MYC;HR;HIST1H2AG;HIST1H4L;HIST1H2BJ;CHAMP1;RNF168;CD3EAP;HIST1H2BI;HIST1H3J;HIST1H2AB;HJURP;UPF1;HIST1H4B;HSPA2;HIST1H2BO;HIST1H2BE;NR1D1;ING2;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;HIST2H2BE;NACC2;HIC1;HIST3H2BB;HIST1H4D;HIST1H2AH;DCLRE1C
11638,GO:0046332,0.00686005421881759,0.99878017143474,5,57,SMAD binding,MF,FOS;TOB1;TGIF1;COL1A2;PMEPA1
12894,GO:0051216,0.00695441934738501,0.998256815592637,7,104,cartilage development,BP,SNAI2;PTHLH;NOG;CTGF;COL1A1;SOX9;HOXA5
13912,GO:0060541,0.00698810302454481,0.998040377977346,8,131,respiratory system development,BP,ID1;HES1;NOG;CTGF;ESRP2;SOX9;CEBPA;HOXA5
10589,GO:0043549,0.00718429718461693,0.996346091088224,24,642,regulation of kinase activity,BP,SPRY4;RGS2;CDK5R1;DUSP4;MIDN;DUSP5;SERTAD1;FLRT3;HSPB1;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;GADD45B;PIK3R1;CEBPA;ZNF16;SOCS6;RGS3;SOCS1;CLU;CISH
16765,GO:0098532,0.00725782241520991,0.99977973720077,2,6,histone H3-K27 trimethylation,BP,HIST1H1C;HIST1H1D
9065,GO:0035295,0.00759848483334948,0.996116033256392,24,657,tube development,BP,ID1;TIPARP;HES1;SERPINE1;MYC;ANGPTL4;CYP1B1;NOG;HSPB1;GDNF;CTGF;NR2F2;RBM15;EPHB3;PLCD1;ESRP2;VASP;SOX9;CEBPA;GZF1;ING2;HOXA5;HK2;NOTCH3
11001,GO:0044798,0.00760194691957679,0.997639662928647,9,157,nuclear transcription factor complex,CC,FOS;CD3EAP;TLE3;SOX9;CEBPA;SOX15;PYGO2;NR1D1;ING2
16176,GO:0090183,0.00771926616245983,0.998936261955715,4,36,regulation of kidney development,BP,MYC;NOG;GDNF;SOX9
12651,GO:0050830,0.00781453405804195,0.99892383028262,4,34,defense response to Gram-positive bacterium,BP,HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
12251,GO:0048514,0.00787219354880381,0.996574542792097,16,379,blood vessel morphogenesis,BP,ID1;TIPARP;HES1;SERPINE1;ANGPTL4;CYP1B1;NOG;HSPB1;CTGF;NR2F2;RBM15;EPHB3;PLCD1;HOXA5;HK2;NOTCH3
15569,GO:0072001,0.00795820129239755,0.997324402155874,10,192,renal system development,BP,TIPARP;HES1;MYC;ID3;NOG;GDNF;SOX9;GZF1;PYGO2;NOTCH3
7596,GO:0031960,0.00803510234690209,0.997930397715393,7,104,response to corticosteroid,BP,CTGF;ZFP36L2;FOS;IGFBP2;COL1A1;GJB2;DDIT4
1407,GO:0003338,0.00813602396137147,0.999278636422423,3,20,metanephros morphogenesis,BP,HES1;GDNF;SOX9
11419,GO:0045815,0.00835940638963395,0.998116395469013,6,77,positive regulation of gene expression, epigenetic,BP,HIST1H4L;CD3EAP;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
4288,GO:0009653,0.00847171131973383,0.994649449604635,51,1705,anatomical structure morphogenesis,BP,ID1;TIPARP;HES1;SNAI2;CDK5R1;DUSP4;NET1;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;DUSP5;FLRT3;HSPB1;FHL2;GDNF;CTGF;AHNAK2;TFCP2L1;NR2F2;HOXA9;CDHR1;CDC42EP2;TUFT1;RHOD;RBM15;FOXQ1;COL1A1;EPHB3;TLE3;LRIG3;SIAH2;PLCD1;ESRP2;VASP;PIK3R1;SOX9;GZF1;ARTN;KRT16;HOXA5;PALMD;COL1A2;KRT17;HK2;NOTCH3;CLU;CDC42SE1;IRX5
13855,GO:0060441,0.00854129561067725,0.999229132057169,3,20,epithelial tube branching involved in lung morphogenesis,BP,ESRP2;SOX9;HOXA5
12543,GO:0050678,0.00859847534873607,0.996897827105232,11,220,regulation of epithelial cell proliferation,BP,ID1;HES1;SNAI2;MYC;NOG;NR2F2;ESRP2;SOX9;PYGO2;NR1D1;HOXA5
15669,GO:0072173,0.00864871697276127,0.999696611702771,2,7,metanephric tubule morphogenesis,BP,HES1;SOX9
9055,GO:0035272,0.00867831630952937,0.998758425510567,4,38,exocrine system development,BP,SNAI2;TFCP2L1;ESRP2;SOX9
4990,GO:0015114,0.00875506773965773,0.999690915632217,2,7,phosphate ion transmembrane transporter activity,MF,SLC20A2;SLC20A1
13882,GO:0060485,0.00901384414693117,0.997121884279101,9,163,mesenchyme development,BP,HES1;SNAI2;MYC;NOG;VASN;GDNF;COL1A1;SOX9;HOXA5
13906,GO:0060534,0.00903167607122263,0.999675928963144,2,7,trachea cartilage development,BP,SOX9;HOXA5
6788,GO:0030219,0.00915216338865892,0.997895564133688,6,79,megakaryocyte differentiation,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;ZNF16;HIST1H4D
15350,GO:0071560,0.0091691745303031,0.997063863920432,9,164,cellular response to transforming growth factor beta stimulus,BP,ID1;VASN;ZFP36L2;FOS;COL1A1;SOX9;ING2;COL1A2;PMEPA1
5519,GO:0016477,0.00945099957762235,0.99471731361881,30,887,cell migration,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FAM110C;NOG;FLRT3;HSPB1;APCDD1;GDNF;CTGF;NR2F2;IL17RA;RHOD;FAT2;COL1A1;EPHB3;CXCL14;PAK6;PIK3R1;SOX9;DDIT4;ARTN;KRT16;HOXA5;COL1A2;IFITM1
11296,GO:0045598,0.00953274279447385,0.997784825469341,6,83,regulation of fat cell differentiation,BP,HES1;SNAI2;ZFP36L2;CEBPA;NR1D1;ZADH2
13819,GO:0060394,0.00984869252006626,0.999630242106854,2,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,NOG;PMEPA1
12263,GO:0048534,0.00985866366014735,0.994921071357203,23,619,hematopoietic or lymphoid organ development,BP,TIPARP;HES1;MYC;HIST1H4L;HOXA9;ZFP36L2;FOS;RBM15;EPHB3;HIST1H3J;LRRC8A;ZBTB7B;HIST1H4B;PIK3R1;CEBPA;ZNF160;ARTN;HOXA5;HIST1H4K;ZNF16;HIST1H4D;SOCS1;DCLRE1C
7810,GO:0032355,0.00988908778094145,0.997684967130361,6,82,response to estradiol,BP,TXNIP;CTGF;NR2F2;IGFBP2;COL1A1;GJB2
11513,GO:0045989,0.00993690382313767,0.999625184741784,2,7,positive regulation of striated muscle contraction,BP,RGS2;CTGF
1023,GO:0002520,0.0100351322105055,0.994745661406847,24,656,immune system development,BP,TIPARP;HES1;MYC;HIST1H4L;HOXA9;ZFP36L2;FOS;RNF168;RBM15;EPHB3;HIST1H3J;LRRC8A;ZBTB7B;HIST1H4B;PIK3R1;CEBPA;ZNF160;ARTN;HOXA5;HIST1H4K;ZNF16;HIST1H4D;SOCS1;DCLRE1C
721,GO:0001944,0.0100574194900489,0.995268815224193,18,458,vasculature development,BP,ID1;TIPARP;HES1;SERPINE1;ANGPTL4;CYP1B1;NOG;HSPB1;CTGF;NR2F2;RBM15;COL1A1;EPHB3;PLCD1;HOXA5;COL1A2;HK2;NOTCH3
19236,GO:1905332,0.0100602369973461,0.999030736852867,3,21,positive regulation of morphogenesis of an epithelium,BP,NOG;GDNF;SOX9
15349,GO:0071559,0.0100880154911003,0.996718385731654,9,167,response to transforming growth factor beta,BP,ID1;VASN;ZFP36L2;FOS;COL1A1;SOX9;ING2;COL1A2;PMEPA1
5574,GO:0016584,0.0101216670767983,0.999614514356115,2,7,nucleosome positioning,BP,HIST1H1C;HIST1H1D
12926,GO:0051259,0.0104833120676133,0.995291804836814,16,379,protein complex oligomerization,BP,MAT2A;ANGPTL4;KCTD15;HIST1H4L;KCTD7;COL1A1;HIST1H3J;VASP;HIST1H4B;KCTD1;AKR1C1;HIST1H4K;NACC2;COL1A2;HIST1H4D;CLU
3504,GO:0007411,0.0108496514805872,0.996426172606432,9,173,axon guidance,BP,CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
9959,GO:0042325,0.0109976734805221,0.99356392471815,34,1039,regulation of phosphorylation,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;MIDN;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;CTGF;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;ZNF16;SOCS6;RGS3;PMEPA1;SOCS1;CLU;CISH
12226,GO:0048407,0.0110627810086354,0.999541816755288,2,8,platelet-derived growth factor binding,MF,COL1A1;COL1A2
13712,GO:0060249,0.0111290662887276,0.995439682189581,13,287,anatomical structure homeostasis,BP,MYC;HSPB1;HIST1H4L;CTGF;CDHR1;UPF1;HIST1H4B;SOX9;PLEKHM1;NCDN;HIST1H4K;HIST1H4D;DCLRE1C
16640,GO:0097485,0.0112702391363944,0.996264230866382,9,174,neuron projection guidance,BP,CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
15776,GO:0072358,0.0114461225231031,0.994541722816994,18,464,cardiovascular system development,BP,ID1;TIPARP;HES1;SERPINE1;ANGPTL4;CYP1B1;NOG;HSPB1;CTGF;NR2F2;RBM15;COL1A1;EPHB3;PLCD1;HOXA5;COL1A2;HK2;NOTCH3
9126,GO:0035435,0.011726565378004,0.999499246185346,2,8,phosphate ion transmembrane transport,BP,SLC20A2;SLC20A1
3388,GO:0007166,0.0117626183740804,0.992319398816567,55,1873,cell surface receptor signaling pathway,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;CDK5R1;TXNIP;SERPINE1;MYC;NOG;PTPRE;VASN;FLRT3;HSPB1;APCDD1;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;FZD10;HIST1H2BJ;FOS;IGFBP2;IL17RA;CD3EAP;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;TLE3;ADGRF1;SIAH2;ESRP2;PIK3R1;SOX9;CEBPA;CNN2;FAM83A;TIMP3;JRK;DDIT4;PYGO2;ING2;TRIM26;HIC1;COL1A2;SOCS6;IFITM1;ADGRF4;NOTCH3;PMEPA1;SOCS1;CISH
15861,GO:0072562,0.0119956858089564,0.998107976446524,4,40,blood microparticle,CC,SLC2A1;ANGPTL4;HSPA2;CLU
10608,GO:0043583,0.012064908597123,0.996630955063986,7,115,ear development,BP,HES1;NOG;LRIG3;CXCL14;SOX9;CEBPA;GJB2
8011,GO:0032634,0.0122238448234282,0.999466496033061,2,8,interleukin-5 production,BP,TNFRSF21;IL17RA
8035,GO:0032674,0.0122238448234282,0.999466496033061,2,8,regulation of interleukin-5 production,BP,TNFRSF21;IL17RA
2457,GO:0005667,0.012342556578772,0.995080910622649,12,261,transcription factor complex,CC,IVNS1ABP;POU3F1;HOXA9;FOS;CD3EAP;TLE3;SOX9;CEBPA;SOX15;PYGO2;NR1D1;ING2
20291,GO:2001234,0.0124487582840165,0.995809909484577,9,167,negative regulation of apoptotic signaling pathway,BP,SNAI2;IVNS1ABP;SERPINE1;NOG;HSPB1;GDNF;SIAH2;ING2;CLU
16889,GO:0098810,0.0124967906156024,0.999448213132412,2,8,neurotransmitter reuptake,BP,GDNF;PER2
3113,GO:0006690,0.0125058276402707,0.997415221104637,5,62,icosanoid metabolic process,BP,CYP1B1;CBR1;AKR1C1;ZADH2;CES2
13848,GO:0060433,0.0125102703755403,0.999447304621363,2,8,bronchus development,BP,SOX9;HOXA5
10079,GO:0042574,0.0125490088101186,0.999444690805399,2,8,retinal metabolic process,BP,CYP1B1;AKR1C1
98,GO:0000188,0.0125811246671685,0.998677265988979,3,22,inactivation of MAPK activity,BP,DUSP4;DUSP5;RGS3
3280,GO:0006959,0.0126844938888367,0.996864254336534,6,84,humoral immune response,BP,TNFRSF21;HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE;CLU
11778,GO:0046626,0.0127495558141767,0.997946769802095,4,42,regulation of insulin receptor signaling pathway,BP,PTPRE;PIK3R1;SOCS1;CISH
10508,GO:0043407,0.0127653576051829,0.997346263528037,5,63,negative regulation of MAP kinase activity,BP,SPRY4;RGS2;DUSP4;DUSP5;RGS3
6704,GO:0030099,0.0127767013956897,0.994669574862705,13,292,myeloid cell differentiation,BP,MYC;HIST1H4L;HOXA9;FOS;RBM15;HIST1H3J;HIST1H4B;PIK3R1;CEBPA;HOXA5;HIST1H4K;ZNF16;HIST1H4D
2412,GO:0005583,0.0131968261215394,0.999383652898247,2,9,fibrillar collagen trimer,CC,COL1A1;COL1A2
16812,GO:0098643,0.0131968261215394,0.999383652898247,2,9,banded collagen fibril,CC,COL1A1;COL1A2
15605,GO:0072073,0.0133389658845378,0.996655994606353,6,92,kidney epithelium development,BP,HES1;MYC;NOG;GDNF;SOX9;GZF1
8442,GO:0033559,0.0133555886556436,0.997192211332128,5,63,unsaturated fatty acid metabolic process,BP,CYP1B1;CBR1;AKR1C1;ZADH2;CES2
9993,GO:0042393,0.0133718887983183,0.995443243985287,9,172,histone binding,MF,HIST1H4L;PHF13;RNF168;HJURP;HIST1H4B;PYGO2;ING2;HIST1H4K;HIST1H4D
9839,GO:0042063,0.0133774112612299,0.99543994902495,9,174,gliogenesis,BP,HES1;CDK5R1;NOG;APCDD1;TNFRSF21;POU3F1;AHNAK2;SOX9;CLU
710,GO:0001932,0.0133864393311222,0.992241195164157,31,938,regulation of protein phosphorylation,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;CTGF;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;GADD45B;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;SOCS6;RGS3;PMEPA1;SOCS1;CLU;CISH
9795,GO:0040011,0.0134051434671217,0.991980569588527,35,1104,locomotion,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FAM110C;NOG;FLRT3;HSPB1;APCDD1;GDNF;CTGF;NR2F2;TRIM35;IL17RA;RHOD;FAT2;COL1A1;EPHB3;CXCL14;PAK6;SIAH2;VASP;PIK3R1;SOX9;DDIT4;ARTN;KRT16;ING2;HOXA5;TRIM26;COL1A2;IFITM1
400,GO:0001076,0.013417898422441,0.995773048384767,8,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,ID1;ID3;ZNF296;POU3F1;FOS;NR1D1;NACC2;SOX12
1341,GO:0003197,0.0134258911822253,0.998542119347916,3,24,endocardial cushion development,BP,SNAI2;NOG;SOX9
2095,GO:0004857,0.0135088906484854,0.994799826114746,11,230,enzyme inhibitor activity,MF,TXNIP;SERPINE1;ANGPTL4;FLRT3;HSPB1;FAM212B;TIMP3;SOCS6;SOCS1;CDC42SE1;CISH
12296,GO:0048608,0.013563019480417,0.994295660485955,13,299,reproductive structure development,BP,TIPARP;HES1;NOG;NR2F2;HOXA9;RBM15;PLCD1;SOX9;CEBPA;GJB2;SOX15;ING2;IRX5
359,GO:0000977,0.0137201125654015,0.993481145526223,17,434,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HES1;MYC;HES2;TFCP2L1;HOXA9;FOS;FOXQ1;ZBTB7B;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;NACC2;KLF16
9553,GO:0036312,0.0139407693034599,0.999329829785054,2,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1;FAM83A
12936,GO:0051276,0.0140188595191611,0.991647181625417,34,1050,chromosome organization,BP,SNAI2;MYC;HR;HIST1H2AG;HIST1H4L;BRPF1;HIST1H2BJ;PHF13;CHAMP1;RNF168;HIST1H2BI;HIST1H3J;HIST1H2AB;HJURP;UPF1;HIST1H4B;SOX9;HSPA2;HIST1H2BO;HIST1H2BE;SOX15;PYGO2;ING2;HIST1H1C;HIST1H1D;HIST1H4K;PER2;HIST2H2BE;NACC2;HIST3H2BB;HIST1H4D;TSPYL4;HIST1H2AH;DCLRE1C
12317,GO:0048646,0.0140266850485626,0.992430053134523,24,695,anatomical structure formation involved in morphogenesis,BP,ID1;HES1;SNAI2;CDK5R1;DUSP4;SERPINE1;ANGPTL4;CYP1B1;NOG;DUSP5;HSPB1;FHL2;GDNF;CTGF;AHNAK2;RBM15;COL1A1;EPHB3;PLCD1;VASP;SOX9;HOXA5;HK2;NOTCH3
14989,GO:0070887,0.0140415345722482,0.990574793298748,61,2123,cellular response to chemical stimulus,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;CDK5R1;NET1;SERPINE1;MYC;MAT2A;ID3;CYP1B1;NOG;PTPRE;VASN;FLRT3;HSPB1;FHL2;TNFRSF21;CTGF;MAP3K14;FZD10;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;CDC42EP2;IGFBP2;IL17RA;VSNL1;COL1A1;TOB1;HIST1H3J;CXCL14;UPF1;ESRP2;PIK3R1;SOX9;CEBPA;CNN2;GJB2;HSPA2;TIMP3;AKR1C1;DDIT4;TGIF1;NR1D1;ING2;CES2;BRF2;TRIM26;COL1A2;ZNF16;SOCS6;IFITM1;HK2;PMEPA1;SOCS1;CLU;CISH
20159,GO:2000826,0.0143889565130513,0.998396757862997,3,24,regulation of heart morphogenesis,BP,HES1;NOG;SOX9
10614,GO:0043589,0.0145124646292685,0.999287403749232,2,9,skin morphogenesis,BP,COL1A1;COL1A2
380,GO:0001012,0.0145794907407693,0.993025698408176,17,437,RNA polymerase II regulatory region DNA binding,MF,HES1;MYC;HES2;TFCP2L1;HOXA9;FOS;FOXQ1;ZBTB7B;CEBPA;CIART;GZF1;TGIF1;NR1D1;ZNF589;HOXA5;NACC2;KLF16
14328,GO:0061458,0.0146865455221989,0.993757984297544,13,302,reproductive system development,BP,TIPARP;HES1;NOG;NR2F2;HOXA9;RBM15;PLCD1;SOX9;CEBPA;GJB2;SOX15;ING2;IRX5
4385,GO:0010033,0.0151528969921361,0.989758934024514,62,2173,response to organic substance,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;CDK5R1;SLC2A1;TXNIP;SERPINE1;MYC;MAT2A;ID3;CYP1B1;NOG;PTPRE;VASN;FLRT3;HSPB1;FHL2;TNFRSF21;CTGF;MAP3K14;FZD10;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;CDC42EP2;IGFBP2;IL17RA;VSNL1;COL1A1;TOB1;HIST1H3J;UPF1;AKIRIN2;ESRP2;PIK3R1;SOX9;CEBPA;CNN2;GJB2;HSPA2;TIMP3;AKR1C1;DDIT4;TGIF1;NR1D1;ING2;DNAJB2;TRIM26;COL1A2;ZNF16;SOCS6;IFITM1;TRIM56;HK2;PMEPA1;SOCS1;CLU;CISH
12431,GO:0048870,0.0152571140940605,0.991064323914615,31,959,cell motility,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FAM110C;NOG;FLRT3;HSPB1;APCDD1;GDNF;CTGF;NR2F2;IL17RA;RHOD;FAT2;COL1A1;EPHB3;CXCL14;PAK6;PIK3R1;SOX9;DDIT4;ARTN;KRT16;ING2;HOXA5;COL1A2;IFITM1
13141,GO:0051674,0.0152571140940605,0.991064323914615,31,959,localization of cell,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FAM110C;NOG;FLRT3;HSPB1;APCDD1;GDNF;CTGF;NR2F2;IL17RA;RHOD;FAT2;COL1A1;EPHB3;CXCL14;PAK6;PIK3R1;SOX9;DDIT4;ARTN;KRT16;ING2;HOXA5;COL1A2;IFITM1
2337,GO:0005355,0.0153428551841353,0.999224166242272,2,9,glucose transmembrane transporter activity,MF,SLC2A1;SLC2A3
10912,GO:0044454,0.0154840203352109,0.992375516274662,18,465,nuclear chromosome part,CC,SNAI2;MYC;HIST1H2AG;HIST1H4L;HIST1H3J;HIST1H2AB;UPF1;HIST1H4B;HSPA2;NR1D1;ING2;HIST1H1C;HIST1H1D;HIST1H4K;NACC2;HIST1H4D;HIST1H2AH;DCLRE1C
12425,GO:0048863,0.0155121966756635,0.99422568252661,10,201,stem cell differentiation,BP,HES1;SNAI2;HIST1H4L;GDNF;ZFP36L2;HIST1H3J;HIST1H4B;SOX9;HIST1H4K;HIST1H4D
10171,GO:0042754,0.0155395464358447,0.99920891169704,2,9,negative regulation of circadian rhythm,BP,CIPC;PER2
2395,GO:0005536,0.015732885702148,0.999193815343323,2,9,glucose binding,MF,SLC2A3;HK2
15698,GO:0072210,0.0158421524463984,0.998163821855907,3,25,metanephric nephron development,BP,HES1;GDNF;SOX9
13086,GO:0051580,0.0159206210825217,0.999179060496684,2,9,regulation of neurotransmitter uptake,BP,GDNF;PER2
3747,GO:0008285,0.0160122897151525,0.992085763345421,18,471,negative regulation of cell proliferation,BP,HES1;SNAI2;PTHLH;MYC;ZNF503;CYP1B1;NOG;TNFRSF21;NR2F2;TOB1;HIST1H2AB;SOX9;CEBPA;ING2;PER2;DNAJB2;NACC2;IFITM1
7074,GO:0030857,0.0162357622506065,0.998100842114092,3,25,negative regulation of epithelial cell differentiation,BP,ID1;HES1;SOX9
8027,GO:0032656,0.0162944206864083,0.999149402184172,2,9,regulation of interleukin-13 production,BP,TNFRSF21;IL17RA
6264,GO:0019852,0.0163388731256606,0.99914585053479,2,9,L-ascorbic acid metabolic process,BP,SLC2A1;SLC2A3
12287,GO:0048585,0.0164928647804297,0.989981144946028,35,1104,negative regulation of response to stimulus,BP,SPRY4;RGS2;SNAI2;DUSP4;IVNS1ABP;SERPINE1;MYC;NOG;PTPRE;VASN;DUSP5;FLRT3;HSPB1;APCDD1;GDNF;HIST1H2BJ;BCDIN3D;IGFBP2;TOB1;EPHB3;SIAH2;ZBTB7B;SOX9;TIMP3;DDIT4;NR1D1;ING2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
2861,GO:0006352,0.016807497727331,0.993661580961621,10,207,DNA-templated transcription, initiation,BP,HIST1H4L;CTGF;CD3EAP;HIST1H4B;SOX9;NR1D1;HIST1H4K;BRF2;HIST1H4D;NOTCH3
12270,GO:0048545,0.0168126638210008,0.993004647532372,12,273,response to steroid hormone,BP,TXNIP;FHL2;CTGF;NR2F2;ZFP36L2;FOS;IGFBP2;COL1A1;GJB2;DDIT4;NR1D1;PMEPA1
3542,GO:0007565,0.0168181135523331,0.994981071401171,7,121,female pregnancy,BP,PTHLH;SLC2A1;TFCP2L1;NR2F2;FOS;IGFBP2;GJB2
13765,GO:0060325,0.0172648883108523,0.997926718853535,3,26,face morphogenesis,BP,TIPARP;NOG;COL1A1
14194,GO:0061077,0.0175221669462924,0.996046745147007,5,67,chaperone-mediated protein folding,BP,HSPB1;HSPA2;FKBP9;DNAJB2;CLU
13845,GO:0060429,0.0177194691506496,0.989883824470856,27,811,epithelium development,BP,ID1;HES1;SNAI2;TXNIP;SERPINE1;MYC;ID3;NOG;FLRT3;APCDD1;POU3F1;GDNF;TFCP2L1;NR2F2;RBM15;FOXQ1;CBR1;TAGLN;ESRP2;VASP;SOX9;AKR1C1;GZF1;KRT16;PYGO2;HOXA5;KRT17
3448,GO:0007259,0.0177587248048642,0.995256104525209,6,94,JAK-STAT cascade,BP,HES1;CYP1B1;FLRT3;SOCS6;SOCS1;CISH
16116,GO:0090084,0.0180687901414349,0.99898249438253,2,10,negative regulation of inclusion body assembly,BP,HSPA2;DNAJB2
10361,GO:0043170,0.0181010566437903,0.986851046357257,168,6854,macromolecule metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;DDIT4;GZF1;SNX33;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;RRP36;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5;CISH
12969,GO:0051338,0.0182774157706474,0.989769069515098,25,732,regulation of transferase activity,BP,SPRY4;RGS2;CDK5R1;DUSP4;MIDN;MYC;DUSP5;SERTAD1;FLRT3;HSPB1;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;GADD45B;PIK3R1;CEBPA;ZNF16;SOCS6;RGS3;SOCS1;CLU;CISH
9871,GO:0042127,0.018585978504977,0.988767303550751,33,1035,regulation of cell proliferation,BP,ID1;HES1;SNAI2;PTHLH;TXNIP;MYC;ZNF503;CYP1B1;NOG;SERTAD1;TNFRSF21;GDNF;CTGF;NR2F2;IGFBP2;TOB1;HIST1H2AB;PLCD1;AKIRIN2;ESRP2;SOX9;CEBPA;SOX15;PYGO2;NR1D1;ING2;HOXA5;PER2;DNAJB2;NACC2;ZNF16;IFITM1;NOTCH3
1255,GO:0003006,0.0186418476121601,0.991048349895133,16,414,developmental process involved in reproduction,BP,TIPARP;HES1;IRF2BPL;NOG;NR2F2;HOXA9;RBM15;PLCD1;SOX9;CEBPA;GJB2;HSPA2;SOX15;PYGO2;ING2;IRX5
16724,GO:0097696,0.0186473245358495,0.994962821428091,6,95,STAT cascade,BP,HES1;CYP1B1;FLRT3;SOCS6;SOCS1;CISH
5007,GO:0015149,0.0190702356673869,0.998894888598247,2,10,hexose transmembrane transporter activity,MF,SLC2A1;SLC2A3
14645,GO:0070208,0.0192456635792945,0.998879279810785,2,10,protein heterotrimerization,BP,COL1A1;COL1A2
391,GO:0001046,0.0193330976221514,0.995515893823978,5,72,core promoter sequence-specific DNA binding,MF,ZNF750;FOS;SOX9;CIART;NR1D1
7943,GO:0032526,0.0195313534072992,0.995460455503601,5,71,response to retinoic acid,BP,FZD10;IGFBP2;COL1A1;SOX9;GJB2
10298,GO:0043044,0.0197247508337928,0.99540888610421,5,69,ATP-dependent chromatin remodeling,BP,HIST1H4L;HJURP;HIST1H4B;HIST1H4K;HIST1H4D
13683,GO:0060192,0.0197282583010736,0.998835941797767,2,10,negative regulation of lipase activity,BP,RGS2;ANGPTL4
12407,GO:0048839,0.0197944630651456,0.994574762631371,6,99,inner ear development,BP,HES1;LRIG3;CXCL14;SOX9;CEBPA;GJB2
13268,GO:0051933,0.01985070049482,1,1,1,amino acid neurotransmitter reuptake,BP,PER2
13270,GO:0051935,0.01985070049482,1,1,1,glutamate reuptake,BP,PER2
13274,GO:0051941,0.01985070049482,1,1,1,regulation of amino acid uptake involved in synaptic transmission,BP,PER2
13277,GO:0051946,0.01985070049482,1,1,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,PER2
18077,GO:1902618,0.0201380676631471,1,1,1,cellular response to fluoride,BP,COL1A1
15702,GO:0072216,0.0201733099916757,0.998795460611113,2,10,positive regulation of metanephros development,BP,MYC;GDNF
8002,GO:0032616,0.0202525028182978,0.998788205966587,2,10,interleukin-13 production,BP,TNFRSF21;IL17RA
19588,GO:1990578,0.0202581432902193,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
17932,GO:1902230,0.0205851282533655,0.997358603940922,3,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;ING2;CLU
1242,GO:0002931,0.0205927012452849,0.997349472845138,3,27,response to ischemia,BP,GJB2;PER2;HK2
6702,GO:0030097,0.0206323767225187,0.988937167388546,21,590,hemopoiesis,BP,TIPARP;HES1;MYC;HIST1H4L;HOXA9;ZFP36L2;FOS;RBM15;HIST1H3J;LRRC8A;ZBTB7B;HIST1H4B;PIK3R1;CEBPA;ZNF160;HOXA5;HIST1H4K;ZNF16;HIST1H4D;SOCS1;DCLRE1C
11779,GO:0046627,0.0207012503493517,0.99733019584166,3,27,negative regulation of insulin receptor signaling pathway,BP,PTPRE;SOCS1;CISH
9710,GO:0038111,0.0207588383552295,0.997327828200905,3,26,interleukin-7-mediated signaling pathway,BP,HIST1H3J;SOCS1;CISH
16862,GO:0098760,0.0207588383552295,0.997327828200905,3,26,response to interleukin-7,BP,HIST1H3J;SOCS1;CISH
16863,GO:0098761,0.0207588383552295,0.997327828200905,3,26,cellular response to interleukin-7,BP,HIST1H3J;SOCS1;CISH
1241,GO:0002930,0.0207598435808446,1,1,1,trabecular meshwork development,BP,CYP1B1
15777,GO:0072359,0.0208022216128768,0.988505834396794,23,682,circulatory system development,BP,ID1;TIPARP;HES1;SNAI2;SERPINE1;ID3;ANGPTL4;CYP1B1;NOG;FLRT3;HSPB1;FHL2;CTGF;NR2F2;RBM15;COL1A1;EPHB3;PLCD1;SOX9;HOXA5;COL1A2;HK2;NOTCH3
14236,GO:0061158,0.0208480134653969,0.998711944833309,2,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L2;UPF1
8562,GO:0033993,0.0208987061415849,0.988779321659053,21,593,response to lipid,BP,SNAI2;TXNIP;SERPINE1;ID3;FHL2;TNFRSF21;CTGF;FZD10;NR2F2;ZFP36L2;FOS;IGFBP2;COL1A1;UPF1;AKIRIN2;SOX9;GJB2;DDIT4;NR1D1;PMEPA1;CLU
13925,GO:0060562,0.0209230162364276,0.991823032142548,10,222,epithelial tube morphogenesis,BP,HES1;MYC;NOG;GDNF;RBM15;ESRP2;VASP;SOX9;GZF1;HOXA5
10697,GO:0043972,0.0211028153055511,1,1,1,histone H3-K23 acetylation,BP,BRPF1
10708,GO:0043994,0.0211028153055511,1,1,1,histone acetyltransferase activity (H3-K23 specific),MF,BRPF1
8483,GO:0033628,0.0212266497343249,0.997236332554402,3,27,regulation of cell adhesion mediated by integrin,BP,SNAI2;SERPINE1;CYP1B1
4338,GO:0009887,0.0212990576800613,0.988367310589198,22,643,animal organ morphogenesis,BP,ID1;TIPARP;HES1;SNAI2;SERPINE1;MYC;ID3;NOG;FHL2;GDNF;CTGF;TUFT1;RBM15;COL1A1;TLE3;LRIG3;ESRP2;SOX9;GZF1;HOXA5;COL1A2;IRX5
3430,GO:0007219,0.0213399765652528,0.993311903123029,7,128,Notch signaling pathway,BP,HES1;SNAI2;MYC;RBM15;SOX9;CEBPA;NOTCH3
16320,GO:0090461,0.0214815092486593,1,1,1,glutamate homeostasis,BP,KCTD7
14131,GO:0060973,0.021615989013981,0.998638493895117,2,11,cell migration involved in heart development,BP,SNAI2;FLRT3
19680,GO:1990907,0.0216506331809539,0.998635146397725,2,11,beta-catenin-TCF complex,CC,TLE3;PYGO2
464,GO:0001502,0.0216948495807341,0.998630869734988,2,11,cartilage condensation,BP,CTGF;SOX9
16851,GO:0098743,0.0216948495807341,0.998630869734988,2,11,cell aggregation,BP,CTGF;SOX9
6741,GO:0030155,0.021763227487693,0.989353796516973,16,424,regulation of cell adhesion,BP,HES1;SNAI2;NET1;SERPINE1;CYP1B1;TNFRSF21;MAP3K14;IGFBP2;RHOD;COL1A1;EPHB3;ZBTB7B;PIK3R1;SOX9;SOCS6;SOCS1
4265,GO:0009607,0.021824993739671,0.988420228006899,20,551,response to biotic stimulus,BP,IVNS1ABP;TXNIP;SERPINE1;HSPB1;TNFRSF21;MAP3K14;HIST1H2BJ;FOS;IL17RA;HIST1H2BI;UPF1;AKIRIN2;GJB2;DDIT4;HIST1H2BE;NR1D1;HIST2H2BE;IFITM1;TRIM56;CLU
4834,GO:0014036,0.021827083806065,1,1,1,neural crest cell fate specification,BP,SOX9
9235,GO:0035622,0.021827083806065,1,1,1,intrahepatic bile duct development,BP,SOX9
12428,GO:0048866,0.021827083806065,1,1,1,stem cell fate specification,BP,SOX9
13569,GO:0060018,0.021827083806065,1,1,1,astrocyte fate commitment,BP,SOX9
13700,GO:0060221,0.021827083806065,1,1,1,retinal rod cell differentiation,BP,SOX9
13897,GO:0060516,0.021827083806065,1,1,1,primary prostatic bud elongation,BP,SOX9
13898,GO:0060517,0.021827083806065,1,1,1,epithelial cell proliferation involved in prostatic bud elongation,BP,SOX9
14057,GO:0060784,0.021827083806065,1,1,1,regulation of cell proliferation involved in tissue homeostasis,BP,SOX9
1342,GO:0003198,0.0218334799499889,0.9986174304087,2,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,SNAI2;NOG
4363,GO:0009956,0.0218393163834715,1,1,1,radial pattern formation,BP,NR2F2
14083,GO:0060849,0.0218393163834715,1,1,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,NR2F2
1414,GO:0003345,0.0218775515989462,1,1,1,proepicardium cell migration involved in pericardium morphogenesis,BP,FLRT3
5549,GO:0016534,0.0218996374870257,1,1,1,cyclin-dependent protein kinase 5 activator activity,MF,CDK5R1
6392,GO:0021586,0.0218996374870257,1,1,1,pons maturation,BP,CDK5R1
6441,GO:0021718,0.0218996374870257,1,1,1,superior olivary nucleus development,BP,CDK5R1
6442,GO:0021722,0.0218996374870257,1,1,1,superior olivary nucleus maturation,BP,CDK5R1
19773,GO:2000136,0.0219010354358508,0.9986108644209,2,11,regulation of cell proliferation involved in heart morphogenesis,BP,HES1;SOX9
20065,GO:2000663,0.0221097650622674,1,1,1,negative regulation of interleukin-5 secretion,BP,TNFRSF21
10487,GO:0043376,0.0221287995462729,1,1,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,ZBTB7B
4317,GO:0009792,0.0221317563214567,0.989151292573411,16,426,embryo development ending in birth or egg hatching,BP,HES1;CDK5R1;NOG;MGAT1;NR2F2;HOXA9;COL1A1;SLC30A1;PLCD1;AKIRIN2;VASP;SOX9;CEBPA;PYGO2;HOXA5;IRX5
15609,GO:0072077,0.0222011662936492,0.998581559900861,2,11,renal vesicle morphogenesis,BP,GDNF;SOX9
15615,GO:0072087,0.0222011662936492,0.998581559900861,2,11,renal vesicle development,BP,GDNF;SOX9
12353,GO:0048705,0.0222906042371495,0.992948369325124,7,131,skeletal system morphogenesis,BP,TIPARP;NOG;CTGF;COL1A1;SOX9;HOXA5;IRX5
2318,GO:0005316,0.0224161060274213,1,1,1,high-affinity inorganic phosphate:sodium symporter activity,MF,SLC20A1
6769,GO:0030199,0.0224172908073962,0.997004673256067,3,29,collagen fibril organization,BP,CYP1B1;COL1A1;COL1A2
1500,GO:0003842,0.0224449366648305,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
11346,GO:0045661,0.0224454528958766,0.997006991077144,3,28,regulation of myoblast differentiation,BP,ID3;CXCL14;SOX9
20040,GO:2000631,0.0224495200121158,1,1,1,regulation of pre-miRNA processing,BP,BCDIN3D
20041,GO:2000632,0.0224495200121158,1,1,1,negative regulation of pre-miRNA processing,BP,BCDIN3D
1033,GO:0002538,0.0225101031056345,1,1,1,arachidonic acid metabolite production involved in inflammatory response,BP,SERPINE1
1034,GO:0002540,0.0225101031056345,1,1,1,leukotriene production involved in inflammatory response,BP,SERPINE1
9145,GO:0035490,0.0225101031056345,1,1,1,regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9146,GO:0035491,0.0225101031056345,1,1,1,positive regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
14176,GO:0061044,0.0225101031056345,1,1,1,negative regulation of vascular wound healing,BP,SERPINE1
17639,GO:1901331,0.0225101031056345,1,1,1,positive regulation of odontoblast differentiation,BP,SERPINE1
18178,GO:1902913,0.0225101031056345,1,1,1,positive regulation of neuroepithelial cell differentiation,BP,SERPINE1
19753,GO:2000098,0.0225101031056345,1,1,1,negative regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
5006,GO:0015145,0.0225409515149748,0.998548121457231,2,11,monosaccharide transmembrane transporter activity,MF,SLC2A1;SLC2A3
6670,GO:0030021,0.0225643219654851,1,1,1,extracellular matrix structural constituent conferring compression resistance,MF,TUFT1
6874,GO:0030345,0.0225643219654851,1,1,1,structural constituent of tooth enamel,MF,TUFT1
3834,GO:0008431,0.0225817312406718,1,1,1,vitamin E binding,MF,SEC14L2
10441,GO:0043292,0.0226127102647787,0.99282195512144,7,134,contractile fiber,CC,CDK5R1;SLC2A1;HSPB1;FHL2;AHNAK2;BAG3;FHL3
19556,GO:1990439,0.0226383807168362,1,1,1,MAP kinase serine/threonine phosphatase activity,MF,DUSP4
12238,GO:0048486,0.0226406980620629,0.998538252733562,2,11,parasympathetic nervous system development,BP,HES1;GDNF
15147,GO:0071228,0.0226477260054613,1,1,1,cellular response to tumor cell,BP,TXNIP
2689,GO:0006049,0.0226509774890403,1,1,1,UDP-N-acetylglucosamine catabolic process,BP,MGAT1
12483,GO:0050346,0.0226634271919382,1,1,1,trans-L-3-hydroxyproline dehydratase activity,MF,L3HYPDH
15267,GO:0071424,0.0226634271919382,1,1,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,METTL15
15258,GO:0071407,0.0226769802367341,0.988852266022806,16,424,cellular response to organic cyclic compound,BP,ID1;TIPARP;SNAI2;ID3;CYP1B1;FHL2;NR2F2;ZFP36L2;BCDIN3D;COL1A1;CEBPA;GJB2;DDIT4;NR1D1;PMEPA1;CLU
8722,GO:0034366,0.0226822655273416,1,1,1,spherical high-density lipoprotein particle,CC,CLU
14347,GO:0061517,0.0226822655273416,1,1,1,macrophage proliferation,BP,CLU
14348,GO:0061518,0.0226822655273416,1,1,1,microglial cell proliferation,BP,CLU
18148,GO:1902847,0.0226822655273416,1,1,1,regulation of neuronal signal transduction,BP,CLU
18224,GO:1902998,0.0226822655273416,1,1,1,positive regulation of neurofibrillary tangle assembly,BP,CLU
19410,GO:1905891,0.0226822655273416,1,1,1,regulation of cellular response to thapsigargin,BP,CLU
19411,GO:1905892,0.0226822655273416,1,1,1,negative regulation of cellular response to thapsigargin,BP,CLU
19412,GO:1905894,0.0226822655273416,1,1,1,regulation of cellular response to tunicamycin,BP,CLU
19413,GO:1905895,0.0226822655273416,1,1,1,negative regulation of cellular response to tunicamycin,BP,CLU
1828,GO:0004478,0.0226911977954161,1,1,1,methionine adenosyltransferase activity,MF,MAT2A
17376,GO:1900077,0.0227076017538019,0.996958646101625,3,28,negative regulation of cellular response to insulin stimulus,BP,PTPRE;SOCS1;CISH
15934,GO:0072706,0.0227443388063259,1,1,1,response to sodium dodecyl sulfate,BP,ZNF16
15935,GO:0072707,0.0227443388063259,1,1,1,cellular response to sodium dodecyl sulfate,BP,ZNF16
15678,GO:0072185,0.0227592699267404,1,1,1,metanephric cap development,BP,MYC
15679,GO:0072186,0.0227592699267404,1,1,1,metanephric cap morphogenesis,BP,MYC
16125,GO:0090094,0.0227592699267404,1,1,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,MYC
16126,GO:0090095,0.0227592699267404,1,1,1,regulation of metanephric cap mesenchymal cell proliferation,BP,MYC
16127,GO:0090096,0.0227592699267404,1,1,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,MYC
9567,GO:0036351,0.0227618073480057,1,1,1,histone H2A-K13 ubiquitination,BP,RNF168
9568,GO:0036352,0.0227618073480057,1,1,1,histone H2A-K15 ubiquitination,BP,RNF168
13300,GO:0051977,0.0227712359304121,1,1,1,lysophospholipid transport,BP,MFSD2A
13301,GO:0051978,0.0227712359304121,1,1,1,lysophospholipid transporter activity,MF,MFSD2A
9387,GO:0035921,0.0227830860541797,1,1,1,desmosome disassembly,BP,SNAI2
17495,GO:1900387,0.0227830860541797,1,1,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,SNAI2
17509,GO:1900477,0.0227860680510688,1,1,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,NACC2
14278,GO:0061323,0.0227862944174989,0.99852380500367,2,11,cell proliferation involved in heart morphogenesis,BP,HES1;SOX9
15362,GO:0071579,0.0227987049826137,1,1,1,regulation of zinc ion transport,BP,SLC30A1
15363,GO:0071580,0.0227987049826137,1,1,1,regulation of zinc ion transmembrane transport,BP,SLC30A1
15364,GO:0071581,0.0227987049826137,1,1,1,regulation of zinc ion transmembrane import,BP,SLC30A1
15365,GO:0071582,0.0227987049826137,1,1,1,negative regulation of zinc ion transport,BP,SLC30A1
15366,GO:0071583,0.0227987049826137,1,1,1,negative regulation of zinc ion transmembrane transport,BP,SLC30A1
15367,GO:0071584,0.0227987049826137,1,1,1,negative regulation of zinc ion transmembrane import,BP,SLC30A1
15368,GO:0071585,0.0227987049826137,1,1,1,detoxification of cadmium ion,BP,SLC30A1
19490,GO:1990170,0.0227987049826137,1,1,1,stress response to cadmium ion,BP,SLC30A1
472,GO:0001515,0.0228081964130905,1,1,1,opioid peptide activity,MF,CDC42EP2
10391,GO:0043217,0.0228573625039483,0.998496616352764,2,12,myelin maintenance,BP,AHNAK2;CLU
13693,GO:0060212,0.0228655535721258,1,1,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TOB1
17427,GO:1900152,0.0228655535721258,1,1,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TOB1
13832,GO:0060412,0.0228888752489552,0.99691737785447,3,29,ventricular septum morphogenesis,BP,HES1;NOG;RBM15
13490,GO:0055011,0.0229359659438622,1,1,1,atrial cardiac muscle cell differentiation,BP,FHL2
13493,GO:0055014,0.0229359659438622,1,1,1,atrial cardiac muscle cell development,BP,FHL2
1399,GO:0003310,0.023153051208738,1,1,1,pancreatic A cell differentiation,BP,HES1
6377,GO:0021558,0.023153051208738,1,1,1,trochlear nerve development,BP,HES1
11507,GO:0045977,0.023153051208738,1,1,1,positive regulation of mitotic cell cycle, embryonic,BP,HES1
13668,GO:0060164,0.023153051208738,1,1,1,regulation of timing of neuron differentiation,BP,HES1
14210,GO:0061102,0.023153051208738,1,1,1,stomach neuroendocrine cell differentiation,BP,HES1
14211,GO:0061105,0.023153051208738,1,1,1,regulation of stomach neuroendocrine cell differentiation,BP,HES1
14212,GO:0061106,0.023153051208738,1,1,1,negative regulation of stomach neuroendocrine cell differentiation,BP,HES1
15489,GO:0071820,0.023153051208738,1,1,1,N-box binding,MF,HES1
15604,GO:0072071,0.023153051208738,1,1,1,kidney interstitial fibroblast differentiation,BP,HES1
15655,GO:0072141,0.023153051208738,1,1,1,renal interstitial fibroblast development,BP,HES1
19816,GO:2000226,0.023153051208738,1,1,1,regulation of pancreatic A cell differentiation,BP,HES1
19817,GO:2000227,0.023153051208738,1,1,1,negative regulation of pancreatic A cell differentiation,BP,HES1
11951,GO:0047006,0.023231138886237,1,1,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,AKR1C1
11960,GO:0047042,0.023231138886237,1,1,1,androsterone dehydrogenase (B-specific) activity,MF,AKR1C1
12042,GO:0047718,0.023231138886237,1,1,1,indanol dehydrogenase activity,MF,AKR1C1
15517,GO:0071877,0.0232702826340662,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
15521,GO:0071881,0.0232702826340662,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
16067,GO:0086096,0.0232702826340662,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17329,GO:0140193,0.0232702826340662,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17330,GO:0140194,0.0232702826340662,1,1,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
13850,GO:0060435,0.0232947104184188,1,1,1,bronchiole development,BP,HOXA5
13878,GO:0060480,0.0232947104184188,1,1,1,lung goblet cell differentiation,BP,HOXA5
15955,GO:0072750,0.0233502751763367,1,1,1,cellular response to leptomycin B,BP,ID3
17647,GO:1901344,0.0233502751763367,1,1,1,response to leptomycin B,BP,ID3
17769,GO:1901707,0.0233502751763367,1,1,1,leptomycin B binding,MF,ID3
15658,GO:0072148,0.0233686321319417,0.998465514346256,2,11,epithelial cell fate commitment,BP,HES1;NR2F2
11956,GO:0047021,0.0234055869212224,1,1,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,CBR1
12468,GO:0050221,0.0234055869212224,1,1,1,prostaglandin-E2 9-reductase activity,MF,CBR1
10510,GO:0043409,0.0234485633175116,0.992508186306569,7,129,negative regulation of MAPK cascade,BP,SPRY4;RGS2;DUSP4;MYC;DUSP5;TIMP3;RGS3
8957,GO:0035019,0.0234496660334243,0.995428211266921,4,50,somatic stem cell population maintenance,BP,HES1;NOG;ZFP36L2;SOX9
15316,GO:0071495,0.0235191485935054,0.98597021720807,29,912,cellular response to endogenous stimulus,BP,ID1;SPRY4;HES1;SNAI2;CDK5R1;NOG;PTPRE;VASN;FLRT3;FHL2;CTGF;NR2F2;ZFP36L2;FOS;IGFBP2;COL1A1;TOB1;ESRP2;PIK3R1;SOX9;GJB2;AKR1C1;DDIT4;NR1D1;ING2;COL1A2;PMEPA1;SOCS1;CISH
4378,GO:0010001,0.0235366855384589,0.992471606341811,7,131,glial cell differentiation,BP,HES1;NOG;TNFRSF21;POU3F1;AHNAK2;SOX9;CLU
3511,GO:0007422,0.0235595841906037,0.995392108559662,4,52,peripheral nervous system development,BP,POU3F1;GDNF;AHNAK2;ARTN
4547,GO:0010621,0.0236110102976686,1,1,1,negative regulation of transcription by transcription factor localization,BP,ID1
9514,GO:0036164,0.0236110102976686,1,1,1,cell-abiotic substrate adhesion,BP,ID1
12354,GO:0048706,0.0237093698686713,0.994195140788192,5,76,embryonic skeletal system development,BP,NOG;HOXA9;COL1A1;HOXA5;IRX5
804,GO:0002070,0.0237587649781193,0.998426014368796,2,11,epithelial cell maturation,BP,TFCP2L1;HOXA5
17113,GO:0099640,0.0239407582676117,1,1,1,axo-dendritic protein transport,BP,HSPB1
17114,GO:0099641,0.0239407582676117,1,1,1,anterograde axonal protein transport,BP,HSPB1
765,GO:0002009,0.0239571644326502,0.988441394758447,15,394,morphogenesis of an epithelium,BP,HES1;SNAI2;MYC;NOG;FLRT3;GDNF;RBM15;FOXQ1;ESRP2;VASP;SOX9;GZF1;KRT16;HOXA5;KRT17
15250,GO:0071396,0.0239747563368728,0.988433175895709,15,390,cellular response to lipid,BP,SNAI2;SERPINE1;ID3;FHL2;FZD10;NR2F2;ZFP36L2;COL1A1;UPF1;SOX9;GJB2;DDIT4;NR1D1;PMEPA1;CLU
6467,GO:0021784,0.0243267041277044,1,1,1,postganglionic parasympathetic fiber development,BP,GDNF
5792,GO:0017017,0.0244358960363809,0.998356610030468,2,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP4;DUSP5
3745,GO:0008283,0.0245592019578265,0.984173423496923,40,1333,cell proliferation,BP,ID1;HES1;SNAI2;CDK5R1;PTHLH;TXNIP;MYC;ZNF503;CYP1B1;NOG;SERTAD1;TNFRSF21;GDNF;CTGF;NR2F2;ZFP36L2;IGFBP2;TOB1;HIST1H2AB;PLCD1;AKIRIN2;ESRP2;SOX9;CEBPA;FAM83A;DDIT4;ARTN;KRT16;SOX15;PYGO2;NR1D1;ING2;HOXA5;PER2;DNAJB2;NACC2;ZNF16;IFITM1;NOTCH3;CLU
1051,GO:0002576,0.0246136692619737,0.993915255328185,5,76,platelet degranulation,BP,SERPINE1;TUBA4A;PCDH7;TIMP3;CLU
12910,GO:0051239,0.0246818707225724,0.983299092897927,52,1833,regulation of multicellular organismal process,BP,ID1;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;FLRT3;HSPB1;HIST1H4L;TNFRSF21;GDNF;CTGF;NR2F2;HOXA9;ZFP36L2;FOS;IL17RA;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;AKIRIN2;ZBTB7B;HIST1H4B;PIK3R1;SOX9;CEBPA;PLEKHM1;SOX15;PYGO2;HOXA5;HIST1H4K;PER2;ZNF16;KRT17;IFITM1;TRIM56;HIST1H4D;HK2;NOTCH3;SOCS1;CLU;IRX5
3578,GO:0007623,0.0249777298296324,0.991910604423552,7,133,circadian rhythm,BP,ID1;SERPINE1;ID3;CIART;CIPC;NR1D1;PER2
11254,GO:0045445,0.0249970940713064,0.995026267525603,4,51,myoblast differentiation,BP,ID3;CXCL14;SOX9;SOX15
6667,GO:0030017,0.0252154355766607,0.992684579553857,6,108,sarcomere,CC,SLC2A1;HSPB1;FHL2;AHNAK2;BAG3;FHL3
10388,GO:0043207,0.0254487911986048,0.98650796012273,19,524,response to external biotic stimulus,BP,IVNS1ABP;SERPINE1;HSPB1;TNFRSF21;MAP3K14;HIST1H2BJ;FOS;IL17RA;HIST1H2BI;UPF1;AKIRIN2;GJB2;DDIT4;HIST1H2BE;NR1D1;HIST2H2BE;IFITM1;TRIM56;CLU
13154,GO:0051707,0.0254487911986048,0.98650796012273,19,524,response to other organism,BP,IVNS1ABP;SERPINE1;HSPB1;TNFRSF21;MAP3K14;HIST1H2BJ;FOS;IL17RA;HIST1H2BI;UPF1;AKIRIN2;GJB2;DDIT4;HIST1H2BE;NR1D1;HIST2H2BE;IFITM1;TRIM56;CLU
7970,GO:0032570,0.0254748250425636,0.996426228397793,3,29,response to progesterone,BP,TXNIP;FOS;GJB2
12542,GO:0050673,0.0256327640158687,0.989131965358824,11,258,epithelial cell proliferation,BP,ID1;HES1;SNAI2;MYC;NOG;NR2F2;ESRP2;SOX9;PYGO2;NR1D1;HOXA5
3192,GO:0006817,0.025903485977681,0.998178261972083,2,12,phosphate ion transport,BP,SLC20A2;SLC20A1
11362,GO:0045686,0.0263714482569482,0.998127441864912,2,12,negative regulation of glial cell differentiation,BP,HES1;NOG
10250,GO:0042981,0.0266076396014773,0.983338737366383,34,1100,regulation of apoptotic process,BP,ID1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;HSPB1;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;TRIM35;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TIMP3;STK17A;ING2;HOXA5;NACC2;ZNF16;CLU
111,GO:0000228,0.0267407957057429,0.986005066835162,18,496,nuclear chromosome,CC,SNAI2;MYC;HIST1H2AG;HIST1H4L;HIST1H3J;HIST1H2AB;UPF1;HIST1H4B;HSPA2;NR1D1;ING2;HIST1H1C;HIST1H1D;HIST1H4K;NACC2;HIST1H4D;HIST1H2AH;DCLRE1C
4264,GO:0009605,0.0269399810174479,0.982520593227583,40,1342,response to external stimulus,BP,SNAI2;CDK5R1;IVNS1ABP;SLC2A1;TXNIP;SERPINE1;NOG;FLRT3;HSPB1;TNFRSF21;GDNF;MAP3K14;BAG3;HIST1H2BJ;FOS;IGFBP2;IL17RA;HIST1H2BI;COL1A1;EPHB3;CXCL14;SIAH2;UPF1;AKIRIN2;BLOC1S3;VASP;PIK3R1;SOX9;CNN2;GJB2;DDIT4;HIST1H2BE;ARTN;SOX15;NR1D1;PER2;HIST2H2BE;IFITM1;TRIM56;CLU
15577,GO:0072012,0.026983396278502,0.998060232803732,2,12,glomerulus vasculature development,BP,HES1;NOTCH3
10066,GO:0042552,0.0270620742010271,0.993132076494511,5,80,myelination,BP,TNFRSF21;POU3F1;AHNAK2;MALL;CLU
12366,GO:0048732,0.0272827514950575,0.987828149892963,12,296,gland development,BP,HES1;SNAI2;NOG;TFCP2L1;HOXA9;EPHB3;ESRP2;SOX9;CEBPA;PYGO2;HOXA5;HK2
6063,GO:0019207,0.0276264617777089,0.990046480442394,8,162,kinase regulator activity,MF,CDK5R1;FLRT3;HSPB1;FAM212B;PIK3R1;SOCS6;SOCS1;CISH
9947,GO:0042303,0.0276827591476585,0.992935781014564,5,79,molting cycle,BP,APCDD1;FOXQ1;SOX9;KRT16;KRT17
10118,GO:0042633,0.0276827591476585,0.992935781014564,5,79,hair cycle,BP,APCDD1;FOXQ1;SOX9;KRT16;KRT17
3371,GO:0007141,0.0278123900593512,0.997967838929053,2,12,male meiosis I,BP,HSPA2;ING2
12921,GO:0051254,0.0278418690794079,0.982500786462511,34,1119,positive regulation of RNA metabolic process,BP,HES1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;ZFP36L2;ZNF398;FOS;RBM15;COL1A1;TOB1;UPF1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;SOX12;NOTCH3
414,GO:0001101,0.0281520956218261,0.988455671264506,10,227,response to acid chemical,BP,ID3;CTGF;FZD10;IGFBP2;COL1A1;SOX9;GJB2;AKR1C1;COL1A2;SOCS1
3513,GO:0007431,0.0282584500121427,0.995856575913741,3,31,salivary gland development,BP,SNAI2;TFCP2L1;ESRP2
13763,GO:0060323,0.0284027682449334,0.995827253862765,3,31,head morphogenesis,BP,TIPARP;NOG;COL1A1
10961,GO:0044706,0.0285654422633964,0.990487069025368,7,135,multi-multicellular organism process,BP,PTHLH;SLC2A1;TFCP2L1;NR2F2;FOS;IGFBP2;GJB2
8435,GO:0033549,0.0287056497146324,0.997866566749779,2,12,MAP kinase phosphatase activity,MF,DUSP4;DUSP5
10035,GO:0042476,0.0287657307073018,0.99258261887756,5,80,odontogenesis,BP,SERPINE1;ID3;TUFT1;COL1A1;COL1A2
12374,GO:0048745,0.0290376626546336,0.997804260886641,2,13,smooth muscle tissue development,BP,TIPARP;SOX9
14123,GO:0060964,0.0293180576013782,0.991206998987306,6,103,regulation of gene silencing by miRNA,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
12382,GO:0048762,0.0296255026773835,0.990056253467514,7,137,mesenchymal cell differentiation,BP,HES1;SNAI2;NOG;VASN;GDNF;COL1A1;SOX9
15148,GO:0071229,0.0297020058910405,0.990025248687073,7,137,cellular response to acid chemical,BP,ID3;FZD10;COL1A1;SOX9;AKR1C1;COL1A2;SOCS1
7072,GO:0030855,0.0298677303431041,0.984814663583806,16,436,epithelial cell differentiation,BP,ID1;HES1;TXNIP;SERPINE1;ID3;POU3F1;GDNF;TFCP2L1;NR2F2;CBR1;TAGLN;SOX9;AKR1C1;KRT16;HOXA5;KRT17
3459,GO:0007272,0.0298713908336438,0.992215217122511,5,82,ensheathment of neurons,BP,TNFRSF21;POU3F1;AHNAK2;MALL;CLU
3797,GO:0008366,0.0298713908336438,0.992215217122511,5,82,axon ensheathment,BP,TNFRSF21;POU3F1;AHNAK2;MALL;CLU
4831,GO:0014032,0.0300713043206171,0.993651722864605,4,54,neural crest cell development,BP,HES1;SNAI2;GDNF;SOX9
3384,GO:0007162,0.0304158218514367,0.988831387802445,8,169,negative regulation of cell adhesion,BP,SNAI2;SERPINE1;CYP1B1;TNFRSF21;COL1A1;ZBTB7B;PIK3R1;SOCS6
2249,GO:0005159,0.0304595191308031,0.997636606724904,2,13,insulin-like growth factor receptor binding,MF,PIK3R1;SOCS1
13762,GO:0060322,0.0304679205277758,0.984125392647263,17,482,head development,BP,ID1;TIPARP;HES1;CDK5R1;SLC2A1;NOG;FLRT3;POU3F1;BAG3;NR2F2;COL1A1;EPHB3;MFSD2A;SOX9;DDIT4;PYGO2;NOTCH3
15135,GO:0071214,0.0305028624613608,0.98732381077606,10,230,cellular response to abiotic stimulus,BP,SNAI2;SLC2A1;NET1;MYC;MAP3K14;BAG3;COL1A1;PIK3R1;SOX9;CNN2
17198,GO:0104004,0.0305028624613608,0.98732381077606,10,230,cellular response to environmental stimulus,BP,SNAI2;SLC2A1;NET1;MYC;MAP3K14;BAG3;COL1A1;PIK3R1;SOX9;CNN2
10307,GO:0043067,0.0305492564615694,0.980655526227736,34,1112,regulation of programmed cell death,BP,ID1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;HSPB1;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;TRIM35;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TIMP3;STK17A;ING2;HOXA5;NACC2;ZNF16;CLU
13884,GO:0060487,0.030557443896961,0.997624897455582,2,13,lung epithelial cell differentiation,BP,SOX9;HOXA5
14326,GO:0061448,0.0306071021705864,0.989653905858134,7,139,connective tissue development,BP,SNAI2;PTHLH;NOG;CTGF;COL1A1;SOX9;HOXA5
1462,GO:0003705,0.030661574837862,0.993483193579722,4,55,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,SNAI2;SOX9;CEBPA;GZF1
4765,GO:0010941,0.030666753630299,0.980334790205366,36,1191,regulation of cell death,BP,ID1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;HSPB1;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;TRIM35;FOS;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TIMP3;STK17A;DDIT4;ING2;HOXA5;NACC2;ZNF16;CLU
17375,GO:1900076,0.0309860945571104,0.99339273874228,4,55,regulation of cellular response to insulin stimulus,BP,PTPRE;PIK3R1;SOCS1;CISH
12806,GO:0051087,0.0311616754415918,0.991797800823903,5,79,chaperone binding,MF,HES1;BAG3;DNAJB2;TBCC;CLU
11442,GO:0045859,0.0313546022244912,0.98270116798195,20,583,regulation of protein kinase activity,BP,SPRY4;RGS2;CDK5R1;DUSP4;DUSP5;SERTAD1;FLRT3;HSPB1;MAP3K14;FZD10;NR2F2;FAM212B;PAK6;GADD45B;CEBPA;SOCS6;RGS3;SOCS1;CLU;CISH
3696,GO:0008202,0.0313613128133834,0.987615213349113,9,197,steroid metabolic process,BP,TIPARP;SNAI2;CYP1B1;TFCP2L1;FAXDC2;SEC14L2;CEBPA;AKR1C1;NR1D1
13572,GO:0060021,0.0314089000542374,0.993264841179208,4,57,roof of mouth development,BP,TIPARP;SNAI2;EPHB3;PYGO2
449,GO:0001222,0.031424034156816,0.997520370877014,2,13,transcription corepressor binding,MF,NR1D1;PER2
13787,GO:0060351,0.0314649433715267,0.99751539645996,2,13,cartilage development involved in endochondral bone morphogenesis,BP,COL1A1;SOX9
7715,GO:0032200,0.0323320555143363,0.987992857042143,8,166,telomere organization,BP,MYC;HIST1H4L;HIST1H3J;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
3506,GO:0007413,0.0323603263778247,0.997381356403588,2,14,axonal fasciculation,BP,CDK5R1;EPHB3
17213,GO:0106030,0.0323603263778247,0.997381356403588,2,14,neuron projection fasciculation,BP,CDK5R1;EPHB3
11438,GO:0045843,0.0323820276992091,0.994985832751717,3,32,negative regulation of striated muscle tissue development,BP,TSC22D3;NOG;SOX15
17805,GO:1901862,0.0323820276992091,0.994985832751717,3,32,negative regulation of muscle tissue development,BP,TSC22D3;NOG;SOX15
401,GO:0001077,0.0325647508667122,0.987883206875004,8,171,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYC;ZNF750;FOS;ZBTB7B;SOX9;CEBPA;HOXA5;SOX12
20300,GO:2001243,0.0326640262650259,0.991295061443424,5,79,negative regulation of intrinsic apoptotic signaling pathway,BP,SNAI2;IVNS1ABP;HSPB1;ING2;CLU
8679,GO:0034249,0.032664374113373,0.986269623375854,10,232,negative regulation of cellular amide metabolic process,BP,HIST1H4L;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;CLU
17685,GO:1901532,0.0326709372205792,0.989953076877434,6,103,regulation of hematopoietic progenitor cell differentiation,BP,HES1;HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
4315,GO:0009790,0.0327194109091778,0.981332206020416,22,671,embryo development,BP,HES1;CDK5R1;DUSP4;ID3;NOG;DUSP5;FLRT3;MGAT1;GDNF;NR2F2;HOXA9;COL1A1;SLC30A1;LRIG3;PLCD1;AKIRIN2;VASP;SOX9;CEBPA;PYGO2;HOXA5;IRX5
16505,GO:0097190,0.0327757887666628,0.982777618400893,17,470,apoptotic signaling pathway,BP,SNAI2;IVNS1ABP;SERPINE1;CYP1B1;NOG;HSPB1;TNFRSF21;GDNF;BAG3;SIAH2;PIK3R1;TIMP3;DDIT4;ING2;NACC2;HIC1;CLU
13656,GO:0060147,0.0329648016847737,0.989834024436628,6,106,regulation of posttranscriptional gene silencing,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
14125,GO:0060966,0.0329648016847737,0.989834024436628,6,106,regulation of gene silencing by RNA,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
15710,GO:0072234,0.0330221049948003,0.997298377270344,2,14,metanephric nephron tubule development,BP,HES1;SOX9
14304,GO:0061383,0.0333061234327112,0.994767438391801,3,34,trabecula morphogenesis,BP,NOG;FHL2;COL1A1
4830,GO:0014031,0.0334267319960351,0.992697386567882,4,56,mesenchymal cell development,BP,HES1;SNAI2;GDNF;SOX9
11760,GO:0046597,0.0335024845058285,0.997263127416202,2,13,negative regulation of viral entry into host cell,BP,TRIM26;IFITM1
12363,GO:0048729,0.0337472762472705,0.982575562236018,16,450,tissue morphogenesis,BP,HES1;SNAI2;MYC;NOG;FLRT3;GDNF;RBM15;FOXQ1;ESRP2;VASP;SOX9;GZF1;ARTN;KRT16;HOXA5;KRT17
6584,GO:0022407,0.0338206410758575,0.985699556593732,10,234,regulation of cell-cell adhesion,BP,HES1;SNAI2;TNFRSF21;MAP3K14;IGFBP2;EPHB3;ZBTB7B;PIK3R1;SOCS6;SOCS1
1379,GO:0003272,0.0339747241190913,0.997177297567245,2,14,endocardial cushion formation,BP,SNAI2;NOG
17426,GO:1900151,0.0343463753742996,0.997129541441942,2,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;TOB1
17428,GO:1900153,0.0343463753742996,0.997129541441942,2,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;TOB1
13697,GO:0060216,0.0350735656708552,0.99703526407749,2,14,definitive hemopoiesis,BP,HOXA9;ZFP36L2
12307,GO:0048635,0.0350819285966862,0.994385871914318,3,33,negative regulation of muscle organ development,BP,TSC22D3;NOG;SOX15
3907,GO:0008544,0.0351607237697729,0.984336921534508,11,269,epidermis development,BP,HES1;PTHLH;TXNIP;ZNF750;APCDD1;POU3F1;CTGF;FOXQ1;SOX9;KRT16;KRT17
13877,GO:0060479,0.0353403104144188,0.997000405835989,2,14,lung cell differentiation,BP,SOX9;HOXA5
4425,GO:0010226,0.0354675166790453,0.99698373057645,2,14,response to lithium ion,BP,IGFBP2;CEBPA
20079,GO:2000678,0.0355876890064131,0.99696794663653,2,14,negative regulation of transcription regulatory region DNA binding,BP,ID1;PER2
12426,GO:0048864,0.0355941308459009,0.992064569500481,4,57,stem cell development,BP,HES1;SNAI2;GDNF;SOX9
14318,GO:0061437,0.0361694606575756,0.996891113154989,2,14,renal system vasculature development,BP,HES1;NOTCH3
14321,GO:0061440,0.0361694606575756,0.996891113154989,2,14,kidney vasculature development,BP,HES1;NOTCH3
6651,GO:0023052,0.0361905514043992,0.972955361084605,100,3934,signaling,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;MYC;GPR132;CYP1B1;FAM110C;NOG;PTPRE;RIN2;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;FHL2;TNFRSF21;GDNF;CTGF;AHNAK2;MAP3K14;BAG3;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;FOS;CDC42EP2;IGFBP2;TUFT1;IL17RA;RHOD;CD3EAP;RBM15;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;TLE3;ADGRF1;LRRC8A;CXCL14;PAK6;SIAH2;PLCD1;ESRP2;GADD45B;SLC20A1;PIK3R1;SOX9;CEBPA;CNN2;GJB2;FAM83A;TIMP3;JRK;STK17A;RIN1;DDIT4;PLEKHM1;ARTN;PYGO2;NCDN;NR1D1;ING2;HOXA5;PALMD;PER2;TRIM26;NACC2;HIC1;COL1A2;SOCS6;KRT17;IFITM1;ADGRF4;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;CDC42SE1;CISH
3906,GO:0008543,0.036286371777243,0.990037959716646,5,84,fibroblast growth factor receptor signaling pathway,BP,SPRY4;NOG;FLRT3;CTGF;ESRP2
13190,GO:0051782,0.0363131461992022,0.996872029697705,2,14,negative regulation of cell division,BP,TXNIP;MYC
2272,GO:0005201,0.0363270172189685,0.994078287701302,3,36,extracellular matrix structural constituent,MF,TUFT1;COL1A1;COL1A2
12827,GO:0051119,0.0363657762100538,0.996865029098383,2,14,sugar transmembrane transporter activity,MF,SLC2A1;SLC2A3
796,GO:0002062,0.0363721597165375,0.991825406634901,4,59,chondrocyte differentiation,BP,SNAI2;PTHLH;CTGF;SOX9
17912,GO:1902187,0.0364069094390646,0.996859553795845,2,14,negative regulation of viral release from host cell,BP,TRIM35;TRIM26
16324,GO:0090482,0.0365256569935461,0.996843727701748,2,14,vitamin transmembrane transporter activity,MF,SLC2A1;SLC2A3
4832,GO:0014033,0.0370032437290811,0.991644022694034,4,58,neural crest cell differentiation,BP,HES1;SNAI2;GDNF;SOX9
6259,GO:0019838,0.0374443441969231,0.989626661684543,5,86,growth factor binding,MF,VASN;CTGF;IGFBP2;COL1A1;COL1A2
15716,GO:0072243,0.0374858279011324,0.996688618395601,2,15,metanephric nephron epithelium development,BP,HES1;SOX9
12356,GO:0048709,0.0375679666285857,0.991476116838581,4,58,oligodendrocyte differentiation,BP,HES1;TNFRSF21;SOX9;CLU
13614,GO:0060070,0.0376125142351226,0.983806618127627,10,239,canonical Wnt signaling pathway,BP,SNAI2;MYC;NOG;FZD10;IGFBP2;COL1A1;SIAH2;SOX9;JRK;PYGO2
8139,GO:0032835,0.0376301214587234,0.993790427988667,3,35,glomerulus development,BP,HES1;NOG;NOTCH3
15666,GO:0072170,0.0378407215314892,0.996640083351624,2,15,metanephric tubule development,BP,HES1;SOX9
10785,GO:0044238,0.0379313872797083,0.97176927833088,184,7699,primary metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;AKR1C1;DDIT4;GZF1;SNX33;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5;CISH
14752,GO:0070412,0.0380860513154239,0.996606382468845,2,15,R-SMAD binding,MF,FOS;PMEPA1
1096,GO:0002682,0.0383276382463352,0.976128736134234,29,932,regulation of immune system process,BP,HES1;TSC22D3;SERPINE1;MYC;HIST1H4L;TNFRSF21;MAP3K14;HOXA9;ZFP36L2;FOS;IGFBP2;RBM15;COL1A1;HIST1H3J;CXCL14;ZBTB7B;HIST1H4B;PIK3R1;SOX9;NR1D1;HOXA5;HIST1H4K;COL1A2;ZNF16;SOCS6;IFITM1;HIST1H4D;SOCS1;CLU
3377,GO:0007155,0.0384650673458379,0.976891906952804,25,800,cell adhesion,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FLRT3;HSPB1;LGALS7B;TNFRSF21;CTGF;MAP3K14;CDHR1;IGFBP2;RHOD;PCDH7;FAT2;COL1A1;EPHB3;ZBTB7B;PIK3R1;SOX9;SOCS6;SOCS1
7361,GO:0031399,0.0385279502176055,0.974697755314279,37,1261,regulation of protein modification process,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;CTGF;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;SIAH2;GADD45B;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;PYGO2;ING2;PER2;DNAJB2;SOCS6;RGS3;PMEPA1;SOCS1;CLU;CISH
8390,GO:0033293,0.0386696457952892,0.9935609617416,3,34,monocarboxylic acid binding,MF,ID3;NR2F2;AKR1C1
13781,GO:0060343,0.0388695741487981,0.996497934187227,2,15,trabecula formation,BP,FHL2;COL1A1
18222,GO:1902996,0.0389566111480737,0.999614478788024,1,2,regulation of neurofibrillary tangle assembly,BP,CLU
18249,GO:1903037,0.0390467427859381,0.984949410939068,8,174,regulation of leukocyte cell-cell adhesion,BP,HES1;TNFRSF21;MAP3K14;IGFBP2;ZBTB7B;PIK3R1;SOCS6;SOCS1
8596,GO:0034097,0.0391672491321038,0.976196522373483,26,813,response to cytokine,BP,MYC;MAT2A;FLRT3;TNFRSF21;MAP3K14;HIST1H2BJ;ZFP36L2;FOS;CDC42EP2;IL17RA;COL1A1;HIST1H3J;UPF1;PIK3R1;SOX9;CEBPA;CNN2;TIMP3;TRIM26;COL1A2;SOCS6;IFITM1;TRIM56;HK2;SOCS1;CISH
16813,GO:0098644,0.0391799630822686,0.996430360434603,2,16,complex of collagen trimers,CC,COL1A1;COL1A2
4802,GO:0010991,0.039480334090211,0.999603936149955,1,2,negative regulation of SMAD protein complex assembly,BP,PMEPA1
4295,GO:0009719,0.0396293427676033,0.974685521163221,32,1071,response to endogenous stimulus,BP,ID1;SPRY4;HES1;SNAI2;CDK5R1;SLC2A1;TXNIP;NOG;PTPRE;VASN;FLRT3;FHL2;CTGF;NR2F2;ZFP36L2;FOS;IGFBP2;COL1A1;TOB1;ESRP2;PIK3R1;SOX9;GJB2;TIMP3;AKR1C1;DDIT4;NR1D1;ING2;COL1A2;PMEPA1;SOCS1;CISH
14158,GO:0061014,0.0396612034792738,0.993309086248331,3,36,positive regulation of mRNA catabolic process,BP,ZFP36L2;TOB1;UPF1
3398,GO:0007178,0.0397615567829906,0.98359970025094,9,212,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ID1;HES1;NOG;VASN;FOS;TOB1;ING2;COL1A2;PMEPA1
18173,GO:1902905,0.0397956225515331,0.985772661606183,7,145,positive regulation of supramolecular fiber organization,BP,ID1;RGS2;CDK5R1;CTGF;CDC42EP2;VASP;CLU
2735,GO:0006112,0.0397977442712622,0.990793473928589,4,60,energy reserve metabolic process,BP,MYC;PPP1R3D;NR1D1;PER2
6598,GO:0022610,0.0400249313839511,0.975859921789999,25,803,biological adhesion,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FLRT3;HSPB1;LGALS7B;TNFRSF21;CTGF;MAP3K14;CDHR1;IGFBP2;RHOD;PCDH7;FAT2;COL1A1;EPHB3;ZBTB7B;PIK3R1;SOX9;SOCS6;SOCS1
10907,GO:0044449,0.0404927649002381,0.98685491399426,6,121,contractile fiber part,CC,SLC2A1;HSPB1;FHL2;AHNAK2;BAG3;FHL3
958,GO:0002376,0.0406144147203773,0.971594269666066,52,1863,immune system process,BP,TIPARP;HES1;TSC22D3;SERPINE1;MYC;HIST1H4L;TNFRSF21;MAP3K14;HOXA9;HIST1H2BJ;ZFP36L2;TRIM35;FOS;RNF168;CDC42EP2;IGFBP2;IL17RA;RBM15;HIST1H2BI;ZNF3;COL1A1;EPHB3;HIST1H3J;LRRC8A;CXCL14;AKIRIN2;ZBTB7B;SLC2A3;HIST1H4B;PIK3R1;SOX9;CEBPA;CNN2;DDIT4;ZNF160;HIST1H2BE;ARTN;KRT16;NR1D1;HOXA5;HIST1H4K;HIST2H2BE;TRIM26;COL1A2;ZNF16;SOCS6;IFITM1;TRIM56;HIST1H4D;SOCS1;CLU;DCLRE1C
3432,GO:0007221,0.0406728773702841,0.996217983817933,2,16,positive regulation of transcription of Notch receptor target,BP,RBM15;NOTCH3
12412,GO:0048844,0.040686948679216,0.993057029190035,3,37,artery morphogenesis,BP,HES1;NOG;NOTCH3
19898,GO:2000352,0.0407815565658025,0.996228126419605,2,15,negative regulation of endothelial cell apoptotic process,BP,SERPINE1;ANGPTL4
7075,GO:0030858,0.040863477658157,0.993035596059686,3,35,positive regulation of epithelial cell differentiation,BP,SERPINE1;GDNF;SOX9
17767,GO:1901701,0.0408976900429123,0.975818946477194,23,717,cellular response to oxygen-containing compound,BP,ID1;SNAI2;CDK5R1;NET1;SERPINE1;ID3;CYP1B1;PTPRE;FZD10;FOS;VSNL1;COL1A1;UPF1;PIK3R1;SOX9;GJB2;AKR1C1;DDIT4;NR1D1;COL1A2;SOCS1;CLU;CISH
4536,GO:0010604,0.0409349712240505,0.970765835709802,60,2217,positive regulation of macromolecule metabolic process,BP,ID1;TIPARP;HES1;SNAI2;CDK5R1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;DUSP5;SERTAD1;ZNF750;HSPB1;HIST1H4L;FHL2;POU3F1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;RNF168;CD3EAP;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;PAK6;UPF1;AKIRIN2;ZBTB7B;GADD45B;SEC14L2;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;SNX33;SOX15;NR1D1;ING2;HOXA5;HIST1H4K;KRT17;SOX12;HIST1H4D;NOTCH3;SOCS1;CLU
683,GO:0001890,0.0409520633485327,0.986682788771719,6,116,placenta development,BP,HES1;NR2F2;RBM15;PLCD1;CEBPA;GJB2
15629,GO:0072103,0.0410580792402849,0.999571298031953,1,2,glomerulus vasculature morphogenesis,BP,NOTCH3
15630,GO:0072104,0.0410580792402849,0.999571298031953,1,2,glomerular capillary formation,BP,NOTCH3
10959,GO:0044691,0.0414608984614126,0.999562753586508,1,2,tooth eruption,BP,COL1A1
2625,GO:0005943,0.0418375670683329,0.999554685905111,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
16712,GO:0097651,0.0418375670683329,0.999554685905111,1,2,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
12316,GO:0048645,0.0418816999587002,0.992792662065336,3,35,animal organ formation,BP,HES1;NOG;GDNF
3538,GO:0007538,0.0419250980618773,0.999552800331573,1,2,primary sex determination,BP,SOX9
3539,GO:0007542,0.0419250980618773,0.999552800331573,1,2,primary sex determination, germ-line,BP,SOX9
5996,GO:0018992,0.0419250980618773,0.999552800331573,1,2,germ-line sex determination,BP,SOX9
6036,GO:0019100,0.0419250980618773,0.999552800331573,1,2,male germ-line sex determination,BP,SOX9
13852,GO:0060438,0.0420264285919363,0.996048564121337,2,15,trachea development,BP,SOX9;HOXA5
282,GO:0000784,0.0420693477321462,0.986237367668478,6,114,nuclear chromosome, telomeric region,CC,HIST1H4L;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
6438,GO:0021700,0.04252278367813,0.984572989818612,7,149,developmental maturation,BP,HES1;CDK5R1;TFCP2L1;BLOC1S3;CEBPA;HOXA5;IRX5
15185,GO:0071306,0.0425287837154225,0.999539684996655,1,2,cellular response to vitamin E,BP,COL1A1
6075,GO:0019220,0.0425596827028259,0.972130775447051,35,1193,regulation of phosphate metabolic process,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;PTHLH;MIDN;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;CTGF;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;ZNF16;SOCS6;RGS3;PMEPA1;SOCS1;CLU;CISH
1465,GO:0003712,0.0425763556498787,0.977359270703384,16,457,transcription cofactor activity,MF,ID3;HR;FHL2;POU3F1;TFCP2L1;NR2F2;FHL3;TOB1;SIAH2;ERF;CEBPA;KCTD1;TGIF1;NR1D1;PER2;SOX12
543,GO:0001661,0.0426414470698738,0.999537215883333,1,2,conditioned taste aversion,BP,FOS
15377,GO:0071603,0.0426473989929192,0.999537085254142,1,2,endothelial cell-cell adhesion,BP,CYP1B1
4833,GO:0014034,0.042688960056747,0.999536172572022,1,2,neural crest cell fate commitment,BP,SOX9
14993,GO:0070893,0.0428069038295038,0.999533577520131,1,2,transposon integration,BP,ZNF93
14994,GO:0070894,0.0428069038295038,0.999533577520131,1,2,regulation of transposon integration,BP,ZNF93
14995,GO:0070895,0.0428069038295038,0.999533577520131,1,2,negative regulation of transposon integration,BP,ZNF93
13905,GO:0060532,0.0428157881390725,0.999533381743858,1,2,bronchus cartilage development,BP,SOX9
14225,GO:0061145,0.0428157881390725,0.999533381743858,1,2,lung smooth muscle development,BP,SOX9
6308,GO:0019933,0.0428239315651086,0.989849567574631,4,62,cAMP-mediated signaling,BP,RGS2;PTHLH;ADGRF1;SOX9
143,GO:0000294,0.0428502282372258,0.999532622418641,1,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,UPF1
9412,GO:0035970,0.0428881740329334,0.995922487543419,2,15,peptidyl-threonine dephosphorylation,BP,DUSP4;DUSP5
3925,GO:0008594,0.0429529564534312,0.9995303537484,1,2,photoreceptor cell morphogenesis,BP,CDHR1
1656,GO:0004105,0.0430516002342358,0.999528169994662,1,2,choline-phosphate cytidylyltransferase activity,MF,PCYT1A
19118,GO:1905006,0.0430889217354994,0.999527342429442,1,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,NOG
14834,GO:0070563,0.0431224483009882,0.999526598380852,1,2,negative regulation of vitamin D receptor signaling pathway,BP,SNAI2
2652,GO:0005988,0.043160191148306,0.999525760045271,1,2,lactose metabolic process,BP,SLC2A1
2653,GO:0005989,0.043160191148306,0.999525760045271,1,2,lactose biosynthetic process,BP,SLC2A1
11647,GO:0046351,0.043160191148306,0.999525760045271,1,2,disaccharide biosynthetic process,BP,SLC2A1
15586,GO:0072034,0.0431996094294267,0.99952488368584,1,2,renal vesicle induction,BP,SOX9
15737,GO:0072289,0.0432303087263616,0.99952420059664,1,2,metanephric nephron tubule formation,BP,SOX9
6375,GO:0021555,0.0433352117133988,0.999521862616716,1,2,midbrain-hindbrain boundary morphogenesis,BP,HES1
16413,GO:0097021,0.0433611240609933,0.999521284204115,1,2,lymphocyte migration into lymphoid organs,BP,ARTN
6841,GO:0030299,0.0434162211474901,0.999520053144653,1,2,intestinal cholesterol absorption,BP,AKR1C1
10786,GO:0044241,0.0434162211474901,0.999520053144653,1,2,lipid digestion,BP,AKR1C1
16914,GO:0098856,0.0434162211474901,0.999520053144653,1,2,intestinal lipid absorption,BP,AKR1C1
2373,GO:0005499,0.0434202824490576,0.999519962337163,1,2,vitamin D binding,MF,IRX5
14049,GO:0060764,0.0435796307189996,0.999516392502352,1,2,cell-cell signaling involved in mammary gland development,BP,HOXA5
3637,GO:0008107,0.0435986234169933,0.999515966112234,1,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,FUT1
7236,GO:0031127,0.0435986234169933,0.999515966112234,1,2,alpha-(1,2)-fucosyltransferase activity,MF,FUT1
2644,GO:0005978,0.0437794015190692,0.992310858857622,3,37,glycogen biosynthetic process,BP,PPP1R3D;NR1D1;PER2
4178,GO:0009250,0.0437794015190692,0.992310858857622,3,37,glucan biosynthetic process,BP,PPP1R3D;NR1D1;PER2
15993,GO:0080144,0.0438296805136472,0.999510763442165,1,2,amino acid homeostasis,BP,KCTD7
8058,GO:0032714,0.0438521415174513,0.999510256174953,1,2,negative regulation of interleukin-5 production,BP,TNFRSF21
6287,GO:0019887,0.0439644993819211,0.983941722858464,7,146,protein kinase regulator activity,MF,CDK5R1;FLRT3;HSPB1;FAM212B;SOCS6;SOCS1;CISH
13587,GO:0060040,0.0440309595417938,0.999506208095408,1,2,retinal bipolar neuron differentiation,BP,IRX5
4568,GO:0010646,0.0440547212643051,0.968253064858345,62,2315,regulation of cell communication,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;SERPINE1;MYC;CYP1B1;FAM110C;NOG;PTPRE;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;HIST1H2BJ;CDC42EP2;IGFBP2;RHOD;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;CXCL14;PAK6;SIAH2;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;DDIT4;ARTN;NCDN;NR1D1;ING2;PER2;NACC2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
14074,GO:0060838,0.0440646675027984,0.999505443106054,1,2,lymphatic endothelial cell fate commitment,BP,NR2F2
15210,GO:0071345,0.044120959456262,0.973413301108839,24,746,cellular response to cytokine stimulus,BP,MYC;MAT2A;FLRT3;TNFRSF21;MAP3K14;HIST1H2BJ;ZFP36L2;FOS;CDC42EP2;IL17RA;COL1A1;HIST1H3J;UPF1;PIK3R1;SOX9;CEBPA;CNN2;TRIM26;COL1A2;SOCS6;IFITM1;HK2;SOCS1;CISH
15681,GO:0072190,0.0442142191936392,0.999502041782318,1,2,ureter urothelium development,BP,SOX9
15682,GO:0072191,0.0442142191936392,0.999502041782318,1,2,ureter smooth muscle development,BP,SOX9
15684,GO:0072193,0.0442142191936392,0.999502041782318,1,2,ureter smooth muscle cell differentiation,BP,SOX9
15686,GO:0072197,0.0442142191936392,0.999502041782318,1,2,ureter morphogenesis,BP,SOX9
2386,GO:0005520,0.0443766261111305,0.995672064638735,2,16,insulin-like growth factor binding,MF,CTGF;IGFBP2
20068,GO:2000666,0.0444144823042412,0.999497468428964,1,2,negative regulation of interleukin-13 secretion,BP,TNFRSF21
20260,GO:2001180,0.0444443854709586,0.999496783703356,1,2,negative regulation of interleukin-10 secretion,BP,TNFRSF21
14702,GO:0070315,0.0444465231483866,0.999496734736346,1,2,G1 to G0 transition involved in cell differentiation,BP,ZNF503
456,GO:0001300,0.0445324628696977,0.999494764127251,1,2,chronological cell aging,BP,SERPINE1
13879,GO:0060481,0.0446285895730294,0.999492555261313,1,2,lobar bronchus epithelium development,BP,HOXA5
6902,GO:0030432,0.044683602539903,0.999491288917307,1,2,peristalsis,BP,GDNF
3017,GO:0006562,0.0447042989920601,0.999490812087459,1,2,proline catabolic process,BP,ALDH4A1
4404,GO:0010133,0.0447042989920601,0.999490812087459,1,2,proline catabolic process to glutamate,BP,ALDH4A1
13628,GO:0060086,0.0447301763683359,0.999490215571686,1,2,circadian temperature homeostasis,BP,NR1D1
9843,GO:0042078,0.0447310687157554,0.999490194995248,1,2,germ-line stem cell division,BP,ING2
12112,GO:0048133,0.0447310687157554,0.999490194995248,1,2,male germ-line stem cell asymmetric division,BP,ING2
16844,GO:0098728,0.0447310687157554,0.999490194995248,1,2,germline stem cell asymmetric division,BP,ING2
19752,GO:2000097,0.0447488124938605,0.999489785757237,1,2,regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
8967,GO:0035034,0.0447733443262251,0.999489219684551,1,2,histone acetyltransferase regulator activity,MF,PYGO2
14679,GO:0070278,0.044777147997838,0.99948913188597,1,2,extracellular matrix constituent secretion,BP,CTGF
2074,GO:0004825,0.0447822528740483,0.999489014040085,1,2,methionine-tRNA ligase activity,MF,MARS2
2921,GO:0006431,0.0447822528740483,0.999489014040085,1,2,methionyl-tRNA aminoacylation,BP,MARS2
12004,GO:0047374,0.0447914788159211,0.99948880102427,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
124,GO:0000254,0.0448151096279207,0.999488255210287,1,2,C-4 methylsterol oxidase activity,MF,FAXDC2
1492,GO:0003827,0.0448189616262253,0.999488166210295,1,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,MGAT1
17638,GO:1901329,0.0448573566262476,0.999487278665257,1,2,regulation of odontoblast differentiation,BP,SERPINE1
5548,GO:0016533,0.0449223918497409,0.999485773505434,1,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,CDK5R1
3011,GO:0006556,0.0449608760545197,0.999484881772893,1,2,S-adenosylmethionine biosynthetic process,BP,MAT2A
12170,GO:0048269,0.0449608760545197,0.999484881772893,1,2,methionine adenosyltransferase complex,CC,MAT2A
14443,GO:0061741,0.044961641888161,0.99948486401944,1,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,CLU
14634,GO:0070194,0.044966558876674,0.999484750027012,1,2,synaptonemal complex disassembly,BP,HSPA2
9494,GO:0036128,0.0450131953579749,0.999483668193884,1,2,CatSper complex,CC,HSPA2
8303,GO:0033132,0.0450280991519831,0.99948332222363,1,2,negative regulation of glucokinase activity,BP,MIDN
18355,GO:1903300,0.0450280991519831,0.99948332222363,1,2,negative regulation of hexokinase activity,BP,MIDN
11137,GO:0045168,0.0450317219155786,0.999483238108441,1,2,cell-cell signaling involved in cell fate commitment,BP,HES1
11637,GO:0046331,0.0450317219155786,0.999483238108441,1,2,lateral inhibition,BP,HES1
6376,GO:0021557,0.0450419464925981,0.999483000671159,1,2,oculomotor nerve development,BP,HES1
5147,GO:0015671,0.0450578036722497,0.999482632321991,1,2,oxygen transport,BP,MYC
3263,GO:0006933,0.0451182075153479,0.999481227960998,1,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,SNAI2
18909,GO:1904576,0.0451322454016364,0.999480901307758,1,2,response to tunicamycin,BP,CLU
18910,GO:1904577,0.0451322454016364,0.999480901307758,1,2,cellular response to tunicamycin,BP,CLU
12302,GO:0048627,0.0451489958209987,0.999480511397809,1,2,myoblast development,BP,SOX15
4868,GO:0014717,0.0451508582483052,0.999480468035674,1,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,SOX15
4869,GO:0014718,0.0451508582483052,0.999480468035674,1,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,SOX15
4943,GO:0014901,0.0451508582483052,0.999480468035674,1,2,satellite cell activation involved in skeletal muscle regeneration,BP,SOX15
14068,GO:0060825,0.0452760575518573,0.99947754882393,1,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,NOG
19867,GO:2000313,0.0452760575518573,0.99947754882393,1,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,NOG
13747,GO:0060302,0.0453016053111997,0.999476952110799,1,2,negative regulation of cytokine activity,BP,NOG
15999,GO:0080182,0.0453141632716407,0.995529646413885,2,16,histone H3-K4 trimethylation,BP,HIST1H1C;HIST1H1D
17817,GO:1901896,0.0453392167208464,0.999476072995399,1,2,positive regulation of calcium-transporting ATPase activity,BP,HSPA2
8846,GO:0034637,0.045346196147923,0.989054615608862,4,62,cellular carbohydrate biosynthetic process,BP,SLC2A1;PPP1R3D;NR1D1;PER2
11339,GO:0045654,0.0453572481220101,0.999475651268048,1,2,positive regulation of megakaryocyte differentiation,BP,ZNF16
15291,GO:0071461,0.0456079641031817,0.9994697694014,1,2,cellular response to redox state,BP,VASN
19976,GO:2000501,0.0457075871720392,0.999467422892425,1,2,regulation of natural killer cell chemotaxis,BP,CXCL14
19977,GO:2000503,0.0457075871720392,0.999467422892425,1,2,positive regulation of natural killer cell chemotaxis,BP,CXCL14
19526,GO:1990379,0.0457335621504054,0.99946681020939,1,2,lipid transport across blood brain barrier,BP,MFSD2A
4306,GO:0009753,0.0458057903385915,0.99946510463643,1,2,response to jasmonic acid,BP,AKR1C1
5983,GO:0018636,0.0458057903385915,0.99946510463643,1,2,phenanthrene 9,10-monooxygenase activity,MF,AKR1C1
11957,GO:0047023,0.0458057903385915,0.99946510463643,1,2,androsterone dehydrogenase activity,MF,AKR1C1
11964,GO:0047086,0.0458057903385915,0.99946510463643,1,2,ketosteroid monooxygenase activity,MF,AKR1C1
11966,GO:0047115,0.0458057903385915,0.99946510463643,1,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,AKR1C1
15249,GO:0071395,0.0458057903385915,0.99946510463643,1,2,cellular response to jasmonic acid stimulus,BP,AKR1C1
9942,GO:0042289,0.0458109219800112,0.999464983353425,1,2,MHC class II protein binding,MF,KRT17
770,GO:0002020,0.0459126053276084,0.986546759746819,5,90,protease binding,MF,CDK5R1;SERPINE1;COL1A1;TIMP3;COL1A2
10135,GO:0042668,0.0459421802405823,0.99946187636502,1,2,auditory receptor cell fate determination,BP,HES1
20187,GO:2000977,0.0459421802405823,0.99946187636502,1,2,regulation of forebrain neuron differentiation,BP,HES1
20188,GO:2000978,0.0459421802405823,0.99946187636502,1,2,negative regulation of forebrain neuron differentiation,BP,HES1
16907,GO:0098840,0.0460635958510518,0.999458994159299,1,2,protein transport along microtubule,BP,HSPB1
17022,GO:0099118,0.0460635958510518,0.999458994159299,1,2,microtubule-based protein transport,BP,HSPB1
15701,GO:0072215,0.0461761998668444,0.995397212252601,2,16,regulation of metanephros development,BP,MYC;GDNF
466,GO:0001504,0.0464558500969191,0.995353945796514,2,16,neurotransmitter uptake,BP,GDNF;PER2
4344,GO:0009893,0.0465404005546998,0.966275602415284,63,2362,positive regulation of metabolic process,BP,ID1;TIPARP;HES1;SNAI2;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;DUSP5;SERTAD1;ZNF750;HSPB1;HIST1H4L;FHL2;POU3F1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;RNF168;CD3EAP;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;PAK6;UPF1;AKIRIN2;ZBTB7B;GADD45B;SEC14L2;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;SNX33;SOX15;NR1D1;ING2;HOXA5;HIST1H4K;ZNF16;KRT17;SOX12;HIST1H4D;HK2;NOTCH3;SOCS1;CLU
4342,GO:0009891,0.0465481189747078,0.968800189576075,38,1324,positive regulation of biosynthetic process,BP,HES1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;HSPB1;FHL2;POU3F1;GDNF;CTGF;BRPF1;NR2F2;HOXA9;BCDIN3D;ZNF398;FOS;RBM15;COL1A1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;IMP3;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;KRT17;SOX12;NOTCH3;CLU
6666,GO:0030016,0.0465701393870672,0.984359757666341,6,125,myofibril,CC,SLC2A1;HSPB1;FHL2;AHNAK2;BAG3;FHL3
18518,GO:1903644,0.0467420412485152,0.999442743856829,1,2,regulation of chaperone-mediated protein folding,BP,DNAJB2
16508,GO:0097193,0.046979088427825,0.97898814743261,10,245,intrinsic apoptotic signaling pathway,BP,SNAI2;IVNS1ABP;CYP1B1;HSPB1;PIK3R1;DDIT4;ING2;NACC2;HIC1;CLU
3264,GO:0006935,0.0475094387759519,0.976211286307269,13,357,chemotaxis,BP,CDK5R1;SERPINE1;NOG;FLRT3;HSPB1;GDNF;IL17RA;EPHB3;CXCL14;SIAH2;VASP;PIK3R1;ARTN
9963,GO:0042330,0.0475094387759519,0.976211286307269,13,357,taxis,BP,CDK5R1;SERPINE1;NOG;FLRT3;HSPB1;GDNF;IL17RA;EPHB3;CXCL14;SIAH2;VASP;PIK3R1;ARTN
480,GO:0001525,0.0477423266299348,0.976820559938338,12,323,angiogenesis,BP,ID1;SERPINE1;ANGPTL4;CYP1B1;HSPB1;CTGF;RBM15;EPHB3;PLCD1;HOXA5;HK2;NOTCH3
15695,GO:0072207,0.0480117153031197,0.995081591174464,2,17,metanephric epithelium development,BP,HES1;SOX9
14015,GO:0060716,0.0480577304577046,0.995103259396439,2,16,labyrinthine layer blood vessel development,BP,HES1;PLCD1
12869,GO:0051174,0.0484483638841565,0.967925306775929,35,1206,regulation of phosphorus metabolic process,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;PTHLH;MIDN;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;CTGF;MAP3K14;FZD10;NR2F2;FAM212B;EPHB3;PAK6;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;ZNF16;SOCS6;RGS3;PMEPA1;SOCS1;CLU;CISH
13859,GO:0060445,0.0485672572705885,0.994993068694962,2,17,branching involved in salivary gland morphogenesis,BP,SNAI2;ESRP2
8482,GO:0033627,0.048892326413787,0.991016909852941,3,38,cell adhesion mediated by integrin,BP,SNAI2;SERPINE1;CYP1B1
13584,GO:0060037,0.0489387134176125,0.994933555981681,2,17,pharyngeal system development,BP,HES1;NOG
12229,GO:0048469,0.0492444593608793,0.985288259213891,5,91,cell maturation,BP,HES1;TFCP2L1;CEBPA;HOXA5;IRX5
8084,GO:0032760,0.0492454994069907,0.990926088242873,3,38,positive regulation of tumor necrosis factor production,BP,HSPB1;PIK3R1;CLU
9906,GO:0042221,0.0495747483247406,0.963321072818434,73,2784,response to chemical,BP,ID1;SPRY4;TIPARP;HES1;SNAI2;CDK5R1;SLC2A1;NET1;TXNIP;SERPINE1;MYC;MAT2A;ID3;CYP1B1;NOG;PTPRE;VASN;FLRT3;HSPB1;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;FZD10;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;CDC42EP2;IGFBP2;IL17RA;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;CXCL14;SIAH2;UPF1;AKIRIN2;ESRP2;VASP;PIK3R1;SOX9;CEBPA;CNN2;GJB2;HSPA2;TIMP3;AKR1C1;DDIT4;TGIF1;ARTN;NR1D1;ING2;PER2;CES2;BRF2;DNAJB2;TRIM26;COL1A2;ZNF16;SOCS6;IFITM1;TRIM56;HK2;PMEPA1;SOCS1;CLU;CISH
5856,GO:0017148,0.0496607300813413,0.978661854775512,9,216,negative regulation of translation,BP,HIST1H4L;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;HIST1H4K;HIST1H4D
12248,GO:0048511,0.04971080136303,0.979882024273585,8,187,rhythmic process,BP,ID1;CDK5R1;SERPINE1;ID3;CIART;CIPC;NR1D1;PER2
20106,GO:2000737,0.0498311991596117,0.994789512303087,2,17,negative regulation of stem cell differentiation,BP,HES1;ZFP36L2
12820,GO:0051101,0.0499752572451888,0.985009677764053,5,91,regulation of DNA binding,BP,ID1;HES1;ID3;HJURP;PER2
2907,GO:0006417,0.0501442758890102,0.973990887345197,14,388,regulation of translation,BP,RGS2;HSPB1;HIST1H4L;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;HIST1H4K;PER2;KRT17;HIST1H4D
8463,GO:0033599,0.050284083942715,0.994715851289875,2,17,regulation of mammary gland epithelial cell proliferation,BP,PYGO2;HOXA5
15533,GO:0071900,0.05034113395301,0.973871666728809,14,392,regulation of protein serine/threonine kinase activity,BP,SPRY4;RGS2;CDK5R1;DUSP4;DUSP5;SERTAD1;HSPB1;MAP3K14;FZD10;NR2F2;FAM212B;GADD45B;CEBPA;RGS3
12929,GO:0051262,0.0503652343384756,0.982784518413575,6,118,protein tetramerization,BP,HIST1H4L;HIST1H3J;VASP;HIST1H4B;HIST1H4K;HIST1H4D
7237,GO:0031128,0.0505440970365758,0.994673388655046,2,17,developmental induction,BP,GDNF;SOX9
4710,GO:0010869,0.0509142270600281,0.994612727108825,2,17,regulation of receptor biosynthetic process,BP,NR1D1;HOXA5
6760,GO:0030178,0.0509820496210413,0.980757321421281,7,152,negative regulation of Wnt signaling pathway,BP,SNAI2;NOG;APCDD1;IGFBP2;SIAH2;SOX9;HIC1
13287,GO:0051961,0.0510419300976904,0.9792305845279,8,189,negative regulation of nervous system development,BP,ID1;HES1;CDK5R1;ID3;NOG;TNFRSF21;SOX9;NOTCH3
6556,GO:0021983,0.0511969104231624,0.994566227062213,2,17,pituitary gland development,BP,HES1;NOG
12357,GO:0048710,0.0513149310190785,0.994546769665159,2,17,regulation of astrocyte differentiation,BP,HES1;NOG
17599,GO:1901216,0.0513599821307606,0.987085259795932,4,64,positive regulation of neuron death,BP,CDK5R1;FOS;DDIT4;CLU
16251,GO:0090288,0.0515182126066604,0.984404724594508,5,94,negative regulation of cellular response to growth factor stimulus,BP,SPRY4;NOG;VASN;TOB1;PMEPA1
10854,GO:0044346,0.0516366907480734,0.994493592750291,2,17,fibroblast apoptotic process,BP,MYC;STK17A
7188,GO:0031069,0.0517953484797926,0.994467301512617,2,17,hair follicle morphogenesis,BP,FOXQ1;KRT17
12994,GO:0051384,0.0520674022025141,0.984201108801467,5,92,response to glucocorticoid,BP,ZFP36L2;FOS;IGFBP2;GJB2;DDIT4
11455,GO:0045893,0.0521967566347337,0.966058176138467,31,1057,positive regulation of transcription, DNA-templated,BP,HES1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;ZNF398;FOS;RBM15;COL1A1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;SOX12;NOTCH3
18444,GO:1903508,0.0521967566347337,0.966058176138467,31,1057,positive regulation of nucleic acid-templated transcription,BP,HES1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;ZNF398;FOS;RBM15;COL1A1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;SOX12;NOTCH3
14729,GO:0070371,0.0522498178227021,0.978644651322623,8,186,ERK1 and ERK2 cascade,BP,SPRY4;DUSP4;MYC;CTGF;ZFP36L2;EPHB3;SOX9;TIMP3
8678,GO:0034248,0.0526927526870305,0.971804051540506,15,427,regulation of cellular amide metabolic process,BP,RGS2;HSPB1;HIST1H4L;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;HIST1H4K;PER2;KRT17;HIST1H4D;CLU
18095,GO:1902680,0.0527612344704169,0.965657233153634,31,1058,positive regulation of RNA biosynthetic process,BP,HES1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;ZNF398;FOS;RBM15;COL1A1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;SOX12;NOTCH3
687,GO:0001894,0.0530936736268826,0.981602292856423,6,123,tissue homeostasis,BP,HSPB1;CTGF;CDHR1;SOX9;PLEKHM1;NCDN
15463,GO:0071772,0.0532588357578171,0.983721510072662,5,96,response to BMP,BP,ID1;HES1;NOG;TOB1;SOX9
15464,GO:0071773,0.0532588357578171,0.983721510072662,5,96,cellular response to BMP stimulus,BP,ID1;HES1;NOG;TOB1;SOX9
11424,GO:0045823,0.0533058584475458,0.994214688048942,2,17,positive regulation of heart contraction,BP,RGS2;CTGF
649,GO:0001837,0.0533380525536749,0.983699068500673,5,94,epithelial to mesenchymal transition,BP,SNAI2;NOG;VASN;COL1A1;SOX9
12355,GO:0048708,0.0533901168721252,0.98981525036536,3,40,astrocyte differentiation,BP,HES1;NOG;SOX9
720,GO:0001942,0.0533984680026029,0.986389649431531,4,66,hair follicle development,BP,APCDD1;FOXQ1;SOX9;KRT17
2370,GO:0005488,0.0534009006066389,0.963551261850505,233,10144,binding,MF,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;HES2;NOG;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;APCDD1;KCTD15;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;CDR2L;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;ZCCHC3;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ZNF549;LRRC8A;CBR1;CXCL14;PAK6;ZNF570;RNF39;ZNF93;SIAH2;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;PXDC1;VASP;SLC2A3;HIST1H4B;PIK3R1;IMP3;ZNF776;SOX9;ERF;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;SOX12;GFOD1;ZNF766;IFITM1;TBCC;ZNF701;NT5DC3;TRIM56;TMEM139;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;DCLRE1C;ZCCHC2;VPS18;IRX5;CISH
12873,GO:0051180,0.0534380274776276,0.994192386661617,2,17,vitamin transport,BP,SLC2A1;SLC2A3
257,GO:0000723,0.0535185593448073,0.979581847721227,7,153,telomere maintenance,BP,MYC;HIST1H4L;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
7073,GO:0030856,0.0539382970452675,0.983464738078258,5,94,regulation of epithelial cell differentiation,BP,ID1;HES1;SERPINE1;GDNF;SOX9
12672,GO:0050863,0.0543986996587782,0.97758556324255,8,186,regulation of T cell activation,BP,HES1;TNFRSF21;MAP3K14;IGFBP2;ZBTB7B;PIK3R1;SOCS6;SOCS1
6310,GO:0019935,0.0544634955069413,0.986022738495211,4,67,cyclic-nucleotide-mediated signaling,BP,RGS2;PTHLH;ADGRF1;SOX9
14032,GO:0060740,0.054492481055469,0.993982346712159,2,18,prostate gland epithelium morphogenesis,BP,NOG;SOX9
3702,GO:0008210,0.0552877450225283,0.993876961691998,2,17,estrogen metabolic process,BP,TIPARP;CYP1B1
567,GO:0001706,0.0556327646413706,0.989198909731276,3,41,endoderm formation,BP,DUSP4;NOG;DUSP5
10495,GO:0043392,0.0558613402869457,0.98914886192907,3,40,negative regulation of DNA binding,BP,ID1;ID3;PER2
18941,GO:1904659,0.0558916268984549,0.985535588936985,4,67,glucose transmembrane transport,BP,SLC2A1;SLC2A3;PIK3R1;HK2
3376,GO:0007154,0.0559249778181716,0.957234634432021,99,3959,cell communication,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;MYC;GPR132;CYP1B1;FAM110C;NOG;PTPRE;RIN2;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;FHL2;TNFRSF21;GDNF;CTGF;AHNAK2;MAP3K14;BAG3;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;FOS;CDC42EP2;IGFBP2;TUFT1;IL17RA;RHOD;CD3EAP;RBM15;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;TLE3;ADGRF1;LRRC8A;CXCL14;PAK6;SIAH2;PLCD1;ESRP2;GADD45B;SLC20A1;PIK3R1;SOX9;CEBPA;CNN2;GJB2;FAM83A;TIMP3;JRK;STK17A;RIN1;DDIT4;PLEKHM1;ARTN;PYGO2;NCDN;NR1D1;ING2;HOXA5;PER2;TRIM26;NACC2;HIC1;COL1A2;SOCS6;KRT17;IFITM1;ADGRF4;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;CDC42SE1;CISH
6650,GO:0023051,0.0559707067159478,0.959029193839796,62,2348,regulation of signaling,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;SERPINE1;MYC;CYP1B1;FAM110C;NOG;PTPRE;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;HIST1H2BJ;CDC42EP2;IGFBP2;RHOD;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;CXCL14;PAK6;SIAH2;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;DDIT4;ARTN;NCDN;NR1D1;ING2;PER2;NACC2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
18480,GO:1903557,0.0561604168452208,0.989067351342738,3,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,HSPB1;PIK3R1;CLU
2853,GO:0006338,0.0561699217083966,0.97833625663635,7,155,chromatin remodeling,BP,MYC;HIST1H4L;HJURP;HIST1H4B;SOX9;HIST1H4K;HIST1H4D
3881,GO:0008509,0.0561876896494279,0.976690976669742,8,189,anion transmembrane transporter activity,MF,SLC2A1;SLC7A5P2;SLC20A2;SLC22A15;LRRC8A;SLC2A3;SLC20A1;MFSD2A
9054,GO:0035270,0.0570542767895557,0.985135795436538,4,67,endocrine system development,BP,HES1;NOG;SOX9;HOXA5
792,GO:0002053,0.0571845438076234,0.993513822144142,2,18,positive regulation of mesenchymal cell proliferation,BP,MYC;SOX9
7108,GO:0030900,0.0579021659252356,0.974375565052222,9,230,forebrain development,BP,HES1;CDK5R1;SLC2A1;NOG;POU3F1;NR2F2;EPHB3;MFSD2A;NOTCH3
3941,GO:0008625,0.0580851819798334,0.984786108777464,4,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;BAG3;PIK3R1;TIMP3
6581,GO:0022404,0.0583810137584645,0.984669101669925,4,68,molting cycle process,BP,APCDD1;FOXQ1;SOX9;KRT17
6582,GO:0022405,0.0583810137584645,0.984669101669925,4,68,hair cycle process,BP,APCDD1;FOXQ1;SOX9;KRT17
9805,GO:0040029,0.0584248074834147,0.971721168746872,11,291,regulation of gene expression, epigenetic,BP,HIST1H2AG;HIST1H4L;BCDIN3D;CD3EAP;HIST1H3J;HIST1H2AB;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;HIST1H2AH
18215,GO:1902988,0.0584589970315799,0.998834578950594,1,3,neurofibrillary tangle assembly,BP,CLU
16867,GO:0098773,0.0586479727867526,0.984576123752828,4,68,skin epidermis development,BP,APCDD1;FOXQ1;SOX9;KRT17
14919,GO:0070734,0.0592009791012866,0.993154414923993,2,18,histone H3-K27 methylation,BP,HIST1H1C;HIST1H1D
7323,GO:0031328,0.0593819137228304,0.959579612835987,37,1310,positive regulation of cellular biosynthetic process,BP,HES1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;HSPB1;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;BCDIN3D;ZNF398;FOS;RBM15;COL1A1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;IMP3;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;KRT17;SOX12;NOTCH3;CLU
3399,GO:0007179,0.0594786136927699,0.978789904889588,6,129,transforming growth factor beta receptor signaling pathway,BP,ID1;VASN;FOS;ING2;COL1A2;PMEPA1
20110,GO:2000741,0.0598312254946487,0.99877844297822,1,3,positive regulation of mesenchymal stem cell differentiation,BP,SOX9
11361,GO:0045685,0.0598525428189614,0.988032685290661,3,41,regulation of glial cell differentiation,BP,HES1;NOG;TNFRSF21
6998,GO:0030674,0.0599604606396319,0.978578886192426,6,128,protein binding, bridging,MF,FLRT3;TOB1;PIK3R1;BICD2;COL1A2;VPS18
3454,GO:0007267,0.0600733085657934,0.961568582381848,27,908,cell-cell signaling,BP,HES1;SNAI2;PTHLH;SLC2A1;MIDN;MYC;NOG;APCDD1;GDNF;CTGF;FZD10;IGFBP2;VSNL1;COL1A1;SLC30A1;TLE3;CXCL14;SIAH2;SOX9;GJB2;JRK;PYGO2;NCDN;NR1D1;HOXA5;PER2;HIC1
4415,GO:0010171,0.0600899201868563,0.98795324252778,3,42,body morphogenesis,BP,TIPARP;NOG;COL1A1
4801,GO:0010990,0.0603759068495538,0.998755784423938,1,3,regulation of SMAD protein complex assembly,BP,PMEPA1
13895,GO:0060512,0.060500749203491,0.992886626569083,2,19,prostate gland morphogenesis,BP,NOG;SOX9
7259,GO:0031214,0.0605475732464092,0.983903167651167,4,69,biomineral tissue development,BP,PTHLH;TUFT1;COL1A1;SOX9
4607,GO:0010719,0.0605777104003778,0.992904910195562,2,18,negative regulation of epithelial to mesenchymal transition,BP,NOG;VASN
13764,GO:0060324,0.0607281991930945,0.987773222369855,3,42,face development,BP,TIPARP;NOG;COL1A1
20201,GO:2001022,0.0608113051978645,0.983824619762862,4,67,positive regulation of response to DNA damage stimulus,BP,MYC;RNF168;NACC2;HIC1
18042,GO:1902531,0.0608355112870032,0.95850438257371,37,1313,regulation of intracellular signal transduction,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;IVNS1ABP;NET1;MYC;CYP1B1;FAM110C;DUSP5;FLRT3;LURAP1L;HSPB1;CTGF;MAP3K14;FZD10;BRPF1;RHOD;EPHB3;PAK6;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;DDIT4;ING2;NACC2;HIC1;SOCS6;RGS3;SOCS1;CLU;CISH
7120,GO:0030916,0.0608798067986787,0.998734631666036,1,3,otic vesicle formation,BP,SOX9
15375,GO:0071600,0.0608798067986787,0.998734631666036,1,3,otic vesicle morphogenesis,BP,SOX9
15628,GO:0072102,0.0610710011839217,0.99872655769868,1,3,glomerulus morphogenesis,BP,NOTCH3
13907,GO:0060535,0.0610856692632784,0.998725937188042,1,3,trachea cartilage morphogenesis,BP,HOXA5
6391,GO:0021578,0.0611318398740904,0.998723982996217,1,3,hindbrain maturation,BP,CDK5R1
6409,GO:0021626,0.0611318398740904,0.998723982996217,1,3,central nervous system maturation,BP,CDK5R1
11916,GO:0046935,0.0613132141539802,0.998716291336214,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1
15646,GO:0072131,0.0613174853314087,0.998716109919009,1,3,kidney mesenchyme morphogenesis,BP,MYC
15648,GO:0072133,0.0613174853314087,0.998716109919009,1,3,metanephric mesenchyme morphogenesis,BP,MYC
10924,GO:0044530,0.0617873747025463,0.998696070945831,1,3,supraspliceosomal complex,CC,UPF1
8582,GO:0034059,0.0619417132953391,0.99868945416276,1,3,response to anoxia,BP,CTGF
1744,GO:0004340,0.0619569758465891,0.99868879889248,1,3,glucokinase activity,MF,HK2
1785,GO:0004396,0.0619569758465891,0.99868879889248,1,3,hexokinase activity,MF,HK2
3992,GO:0008865,0.0619569758465891,0.99868879889248,1,3,fructokinase activity,MF,HK2
6049,GO:0019158,0.0619569758465891,0.99868879889248,1,3,mannokinase activity,MF,HK2
815,GO:0002085,0.0619832842054727,0.998687668994639,1,3,inhibition of neuroepithelial cell differentiation,BP,HES1
11306,GO:0045608,0.0619832842054727,0.998687668994639,1,3,negative regulation of inner ear auditory receptor cell differentiation,BP,HES1
14030,GO:0060737,0.062025918853488,0.998685836848036,1,3,prostate gland morphogenetic growth,BP,SOX9
17766,GO:1901700,0.0620824199933964,0.959248442340619,30,1025,response to oxygen-containing compound,BP,ID1;SNAI2;CDK5R1;SLC2A1;NET1;TXNIP;SERPINE1;ID3;CYP1B1;PTPRE;TNFRSF21;CTGF;FZD10;NR2F2;FOS;IGFBP2;VSNL1;COL1A1;UPF1;AKIRIN2;PIK3R1;SOX9;GJB2;AKR1C1;DDIT4;NR1D1;COL1A2;SOCS1;CLU;CISH
10162,GO:0042742,0.0622594947088917,0.980138320021082,5,94,defense response to bacterium,BP,SERPINE1;HIST1H2BJ;HIST1H2BI;HIST1H2BE;HIST2H2BE
7089,GO:0030879,0.0622882386175737,0.980102073382642,5,99,mammary gland development,BP,HOXA9;SOX9;PYGO2;HOXA5;HK2
18681,GO:1903984,0.0624097966979455,0.998669281153851,1,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,TIMP3
3381,GO:0007159,0.0627959440523213,0.973347151179244,8,192,leukocyte cell-cell adhesion,BP,HES1;TNFRSF21;MAP3K14;IGFBP2;ZBTB7B;PIK3R1;SOCS6;SOCS1
11487,GO:0045935,0.0628586340620575,0.957213569698239,36,1277,positive regulation of nucleobase-containing compound metabolic process,BP,HES1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;ZFP36L2;ZNF398;FOS;RNF168;RBM15;COL1A1;TOB1;UPF1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;SOX12;NOTCH3
19289,GO:1905457,0.0628776407483737,0.998648959968823,1,3,negative regulation of lymphoid progenitor cell differentiation,BP,HES1
20186,GO:2000974,0.0628776407483737,0.998648959968823,1,3,negative regulation of pro-B cell differentiation,BP,HES1
13759,GO:0060317,0.0628908870218877,0.992443995353293,2,19,cardiac epithelial to mesenchymal transition,BP,SNAI2;NOG
8117,GO:0032800,0.0630112984456679,0.992421433400595,2,19,receptor biosynthetic process,BP,NR1D1;HOXA5
9380,GO:0035905,0.0634737491334659,0.998622837783813,1,3,ascending aorta development,BP,HES1
9383,GO:0035910,0.0634737491334659,0.998622837783813,1,3,ascending aorta morphogenesis,BP,HES1
14990,GO:0070888,0.0635243432903256,0.992325021093988,2,19,E-box binding,MF,MYC;CIART
12364,GO:0048730,0.0637790082346361,0.992276995146125,2,19,epidermis morphogenesis,BP,FOXQ1;KRT17
14223,GO:0061140,0.0638899715391385,0.99860444568521,1,3,lung secretory cell differentiation,BP,HOXA5
15670,GO:0072174,0.0641369060658809,0.998593474710797,1,3,metanephric tubule formation,BP,SOX9
7909,GO:0032474,0.0642686508365476,0.998587603363356,1,3,otolith morphogenesis,BP,LRIG3
17815,GO:1901894,0.0643685755158248,0.998583141711132,1,3,regulation of calcium-transporting ATPase activity,BP,HSPA2
7770,GO:0032286,0.0643732264776522,0.99858293386844,1,3,central nervous system myelin maintenance,BP,CLU
5005,GO:0015144,0.0645773098070129,0.992125723525181,2,19,carbohydrate transmembrane transporter activity,MF,SLC2A1;SLC2A3
12781,GO:0051043,0.0647548779897188,0.992091926857905,2,19,regulation of membrane protein ectodomain proteolysis,BP,TIMP3;SNX33
14226,GO:0061146,0.0648831707457987,0.99856005014904,1,3,Peyer's patch morphogenesis,BP,ARTN
6091,GO:0019249,0.064940224365572,0.998557478123038,1,3,lactate biosynthetic process,BP,PER2
685,GO:0001892,0.0649896118981709,0.982309484709984,4,70,embryonic placenta development,BP,HES1;NR2F2;PLCD1;CEBPA
7239,GO:0031134,0.065110968346613,0.998549766707957,1,3,sister chromatid biorientation,BP,CHAMP1
9495,GO:0036132,0.0651758111052784,0.998546832624227,1,3,13-prostaglandin reductase activity,MF,ZADH2
12021,GO:0047522,0.0651758111052784,0.998546832624227,1,3,15-oxoprostaglandin 13-oxidase activity,MF,ZADH2
5500,GO:0016434,0.0652687802694106,0.998542620511131,1,3,rRNA (cytosine) methyltransferase activity,MF,METTL15
14175,GO:0061043,0.0652696732146647,0.998542580024392,1,3,regulation of vascular wound healing,BP,SERPINE1
14739,GO:0070384,0.0652791161180449,0.998542151841325,1,3,Harderian gland development,BP,SOX9
9304,GO:0035747,0.0653171075546881,0.998540428486322,1,3,natural killer cell chemotaxis,BP,CXCL14
5156,GO:0015691,0.0653725291093914,0.99853791259033,1,3,cadmium ion transport,BP,SLC30A1
14844,GO:0070574,0.0653725291093914,0.99853791259033,1,3,cadmium ion transmembrane transport,BP,SLC30A1
15631,GO:0072106,0.0653884217735491,0.998537190720971,1,3,regulation of ureteric bud formation,BP,GDNF
15632,GO:0072107,0.0653884217735491,0.998537190720971,1,3,positive regulation of ureteric bud formation,BP,GDNF
19213,GO:1905278,0.0653884217735491,0.998537190720971,1,3,positive regulation of epithelial tube formation,BP,GDNF
12427,GO:0048865,0.0654526059356194,0.998534273508828,1,3,stem cell fate commitment,BP,SOX9
12753,GO:0051005,0.0654868160800567,0.998532717411702,1,3,negative regulation of lipoprotein lipase activity,BP,ANGPTL4
13880,GO:0060482,0.0654972576325185,0.998532242293321,1,3,lobar bronchus development,BP,HOXA5
11399,GO:0045766,0.0656402082116895,0.978716015550813,5,100,positive regulation of angiogenesis,BP,SERPINE1;ANGPTL4;CYP1B1;HSPB1;HK2
8051,GO:0032696,0.0656627581450427,0.998524700993068,1,3,negative regulation of interleukin-13 production,BP,TNFRSF21
14442,GO:0061740,0.0656697108620953,0.998524383745209,1,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,CLU
14266,GO:0061302,0.0656851593951937,0.99852367871306,1,3,smooth muscle cell-matrix adhesion,BP,SERPINE1
4775,GO:0010957,0.0657027939480412,0.998522873704313,1,3,negative regulation of vitamin D biosynthetic process,BP,SNAI2
11592,GO:0046137,0.0657027939480412,0.998522873704313,1,3,negative regulation of vitamin metabolic process,BP,SNAI2
14022,GO:0060729,0.0657301266640585,0.99852162553216,1,3,intestinal epithelial structure maintenance,BP,SOX9
12228,GO:0048468,0.0657309678537292,0.955080386648934,36,1299,cell development,BP,ID1;HES1;SNAI2;CDK5R1;PTHLH;NET1;ID3;NOG;FLRT3;FHL2;TNFRSF21;POU3F1;GDNF;AHNAK2;TFCP2L1;CDHR1;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;MFSD2A;SOX9;CEBPA;HSPA2;ARTN;SOX15;PYGO2;NCDN;ING2;HOXA5;PER2;NOTCH3;CLU;IRX5
19870,GO:2000317,0.0657324077337197,0.998521521340571,1,3,negative regulation of T-helper 17 type immune response,BP,ZBTB7B
19873,GO:2000320,0.0657324077337197,0.998521521340571,1,3,negative regulation of T-helper 17 cell differentiation,BP,ZBTB7B
14127,GO:0060968,0.065785317684638,0.975956737458445,6,127,regulation of gene silencing,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
10976,GO:0044752,0.0658530149238986,0.998516007019266,1,3,response to human chorionic gonadotropin,BP,GJB2
8467,GO:0033603,0.06589287266507,0.998514182343915,1,3,positive regulation of dopamine secretion,BP,GDNF
14519,GO:0065003,0.0658956985433459,0.954141003386773,40,1423,protein-containing complex assembly,BP,RGS2;HES1;CDK5R1;SLC2A1;MYC;MAT2A;ANGPTL4;KCTD15;HIST1H4L;HIST1H2BJ;CDC42EP2;KCTD7;HIST1H2BI;COL1A1;HIST1H3J;TLE3;HJURP;VASP;HIST1H4B;SOX9;KCTD1;HIST1H2BO;AKR1C1;HIST1H2BE;PYGO2;HIST1H1C;HIST1H1D;HIST1H4K;BRF2;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;SOX12;TBCC;HIST1H4D;PMEPA1;TSPYL4;CLU;VPS18
16541,GO:0097252,0.0660957856480155,0.998504875127699,1,3,oligodendrocyte apoptotic process,BP,TNFRSF21
20066,GO:2000664,0.0661493606682214,0.998502412747968,1,3,positive regulation of interleukin-5 secretion,BP,IL17RA
20069,GO:2000667,0.0661493606682214,0.998502412747968,1,3,positive regulation of interleukin-13 secretion,BP,IL17RA
13531,GO:0055088,0.0663129384964454,0.981829208772275,4,70,lipid homeostasis,BP,ANGPTL4;CEBPA;MALL;AKR1C1
6569,GO:0022011,0.0663729449219265,0.991718106298665,2,21,myelination in peripheral nervous system,BP,POU3F1;AHNAK2
7776,GO:0032292,0.0663729449219265,0.991718106298665,2,21,peripheral nervous system axon ensheathment,BP,POU3F1;AHNAK2
4861,GO:0014070,0.0664069264152766,0.960070960799964,20,638,response to organic cyclic compound,BP,ID1;TIPARP;SNAI2;TXNIP;ID3;CYP1B1;FHL2;CTGF;NR2F2;ZFP36L2;BCDIN3D;FOS;IGFBP2;COL1A1;CEBPA;GJB2;DDIT4;NR1D1;PMEPA1;CLU
10272,GO:0043009,0.0664321051566428,0.964096987982683,14,416,chordate embryonic development,BP,HES1;NOG;MGAT1;NR2F2;HOXA9;COL1A1;SLC30A1;PLCD1;VASP;SOX9;CEBPA;PYGO2;HOXA5;IRX5
5497,GO:0016429,0.0664507542098842,0.998488521360025,1,3,tRNA (adenine-N1-)-methyltransferase activity,MF,TRMT61A
14508,GO:0061953,0.0664507542098842,0.998488521360025,1,3,mRNA (adenine-N1-)-methyltransferase activity,MF,TRMT61A
13843,GO:0060426,0.0664564790112399,0.998488256860902,1,3,lung vasculature development,BP,ID1
16504,GO:0097187,0.0664757645812744,0.998487365647157,1,3,dentinogenesis,BP,SERPINE1
15633,GO:0072108,0.0665157152162929,0.998485518609639,1,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
7426,GO:0031515,0.0665446877274788,0.99848417839662,1,3,tRNA (m1A) methyltransferase complex,CC,TRMT61A
16245,GO:0090281,0.0665605868790478,0.998483442672481,1,3,negative regulation of calcium ion import,BP,SLC30A1
1360,GO:0003228,0.0666017264820595,0.998481538106466,1,3,atrial cardiac muscle tissue development,BP,NOG
13488,GO:0055009,0.0666017264820595,0.998481538106466,1,3,atrial cardiac muscle tissue morphogenesis,BP,NOG
18911,GO:1904578,0.0666249172612332,0.998480463941538,1,3,response to thapsigargin,BP,CLU
18912,GO:1904579,0.0666249172612332,0.998480463941538,1,3,cellular response to thapsigargin,BP,CLU
14974,GO:0070859,0.0666689395468154,0.998478423812457,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18782,GO:1904253,0.0666689395468154,0.998478423812457,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
6649,GO:0023041,0.0667811658950221,0.998473216509764,1,3,neuronal signal transduction,BP,CLU
9803,GO:0040019,0.066904044425138,0.991644883598516,2,20,positive regulation of embryonic development,BP,HES1;GDNF
3950,GO:0008645,0.0669618479055728,0.981584869276697,4,71,hexose transmembrane transport,BP,SLC2A1;SLC2A3;PIK3R1;HK2
5145,GO:0015669,0.0669850058885344,0.998463734866392,1,3,gas transport,BP,MYC
13745,GO:0060300,0.0670265794521299,0.998461797349803,1,3,regulation of cytokine activity,BP,NOG
4870,GO:0014719,0.0670460578029381,0.998460889137037,1,3,skeletal muscle satellite cell activation,BP,SOX15
19403,GO:1905867,0.0671005399211889,0.998458347343061,1,3,epididymis development,BP,GJB2
4167,GO:0009227,0.0671505634507591,0.998456011653891,1,3,nucleotide-sugar catabolic process,BP,MGAT1
15241,GO:0071385,0.06743250522415,0.9858198729775,3,43,cellular response to glucocorticoid stimulus,BP,ZFP36L2;GJB2;DDIT4
15181,GO:0071295,0.0675924655859088,0.99151030236833,2,20,cellular response to vitamin,BP,SNAI2;COL1A1
8077,GO:0032747,0.0675946691600572,0.99843519556753,1,3,positive regulation of interleukin-23 production,BP,IL17RA
12323,GO:0048664,0.0676731970519194,0.998431499851204,1,3,neuron fate determination,BP,HES1
3829,GO:0008426,0.0676813322479397,0.998431116731697,1,3,protein kinase C inhibitor activity,MF,HSPB1
19257,GO:1905383,0.0679207189082325,0.998419821426775,1,3,protein localization to presynapse,BP,HSPB1
20199,GO:2001020,0.0679684505786063,0.972627316449478,7,162,regulation of response to DNA damage stimulus,BP,SNAI2;MYC;RNF168;ING2;NACC2;HIC1;CLU
11759,GO:0046596,0.0679795107979512,0.991468815540205,2,19,regulation of viral entry into host cell,BP,TRIM26;IFITM1
7844,GO:0032395,0.0681042222179117,0.998411134631082,1,3,MHC class II receptor activity,MF,KRT17
4590,GO:0010677,0.0682248004025793,0.991385976568438,2,20,negative regulation of cellular carbohydrate metabolic process,BP,MIDN;DDIT4
8781,GO:0034457,0.0682417944448462,0.998404606031257,1,3,Mpp10 complex,CC,IMP3
16351,GO:0090575,0.0682979468842805,0.974789324786645,6,131,RNA polymerase II transcription factor complex,CC,FOS;TLE3;CEBPA;PYGO2;NR1D1;ING2
11460,GO:0045903,0.0688420979815658,0.998375956436823,1,3,positive regulation of translational fidelity,BP,IMP3
4505,GO:0010533,0.0689366539678109,0.998371419739028,1,3,regulation of activation of Janus kinase activity,BP,SOCS1
16770,GO:0098542,0.0690791241792595,0.966907897854902,10,261,defense response to other organism,BP,SERPINE1;MAP3K14;HIST1H2BJ;IL17RA;HIST1H2BI;DDIT4;HIST1H2BE;HIST2H2BE;IFITM1;TRIM56
8188,GO:0032922,0.0690893294252363,0.985299637911975,3,45,circadian regulation of gene expression,BP,CIART;NR1D1;PER2
1844,GO:0004497,0.0691063265339367,0.985321787367493,3,43,monooxygenase activity,MF,CYP1B1;FAXDC2;AKR1C1
12282,GO:0048568,0.069311581709553,0.966761695803319,10,271,embryonic organ development,BP,HES1;ID3;NOG;NR2F2;LRIG3;PLCD1;SOX9;CEBPA;HOXA5;IRX5
10588,GO:0043548,0.0693301324777761,0.991134946873947,2,21,phosphatidylinositol 3-kinase binding,MF,PIK3R1;FAM83A
7756,GO:0032268,0.0693544414458746,0.949733984266756,51,1897,regulation of cellular protein metabolic process,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;SERPINE1;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;HIST1H4L;CTGF;MAP3K14;FZD10;NR2F2;ZFP36L2;BCDIN3D;FAM212B;TOB1;EPHB3;HIST1H3J;PAK6;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;IMP3;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;SNX33;PYGO2;ING2;HIST1H4K;PER2;DNAJB2;SOCS6;KRT17;HIST1H4D;RGS3;PMEPA1;SOCS1;CLU;CISH
5189,GO:0015749,0.0694777200966903,0.980651224028615,4,72,monosaccharide transmembrane transport,BP,SLC2A1;SLC2A3;PIK3R1;HK2
15182,GO:0071300,0.0695278069127418,0.985181481625106,3,44,cellular response to retinoic acid,BP,FZD10;COL1A1;SOX9
20299,GO:2001242,0.0701404734739798,0.973947823768529,6,128,regulation of intrinsic apoptotic signaling pathway,BP,SNAI2;IVNS1ABP;HSPB1;ING2;NACC2;CLU
11673,GO:0046427,0.0704123420262471,0.984929489815476,3,43,positive regulation of JAK-STAT cascade,BP,HES1;CYP1B1;SOCS1
2590,GO:0005882,0.0705580935947944,0.980257610824448,4,71,intermediate filament,CC,IFFO2;KRT16;KRT17;IFFO1
16129,GO:0090101,0.0706870738525006,0.980194027508369,4,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,NOG;VASN;TOB1;PMEPA1
463,GO:0001501,0.0707016594112961,0.964635810502296,11,311,skeletal system development,BP,TIPARP;SNAI2;PTHLH;NOG;CTGF;HOXA9;COL1A1;SOX9;HOXA5;COL1A2;IRX5
4271,GO:0009617,0.070832979219572,0.964575144116921,11,298,response to bacterium,BP,SERPINE1;TNFRSF21;HIST1H2BJ;FOS;HIST1H2BI;UPF1;AKIRIN2;GJB2;HIST1H2BE;NR1D1;HIST2H2BE
4667,GO:0010812,0.0708572724484516,0.984766958181031,3,45,negative regulation of cell-substrate adhesion,BP,SERPINE1;COL1A1;PIK3R1
7774,GO:0032290,0.0708982572804224,0.99806427014874,1,4,peripheral nervous system myelin formation,BP,AHNAK2
12253,GO:0048518,0.0710311617654531,0.945000557452904,97,3902,positive regulation of biological process,BP,ID1;TIPARP;RGS2;HES1;SNAI2;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;FAM110C;NOG;DUSP5;SERTAD1;FLRT3;LURAP1L;ZNF750;HSPB1;HIST1H4L;FHL2;TNFRSF21;POU3F1;GDNF;CTGF;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;HOXA9;ZFP36L2;BCDIN3D;TRIM35;ZNF398;FOS;RNF168;CDC42EP2;IGFBP2;KCTD7;IL17RA;RHOD;CD3EAP;RBM15;VSNL1;COL1A1;TOB1;EPHB3;HIST1H3J;ADGRF1;CXCL14;PAK6;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;SEC14L2;VASP;HIST1H4B;SLC20A1;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;TIMP3;JRK;STK17A;DDIT4;SNX33;PLEKHM1;ARTN;SOX15;NR1D1;ING2;HOXA5;HIST1H4K;TRIM26;NACC2;HIC1;ZNF16;KRT17;SOX12;IFITM1;HIST1H4D;HK2;NOTCH3;SOCS1;CLU
5634,GO:0016709,0.0714248384017205,0.990746465743442,2,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,FAXDC2;AKR1C1
1311,GO:0003156,0.0714770226652919,0.990735894754364,2,20,regulation of animal organ formation,BP,HES1;GDNF
14235,GO:0061157,0.0715295734972462,0.990691625430416,2,21,mRNA destabilization,BP,ZFP36L2;UPF1
17863,GO:1902036,0.0717309877259743,0.976178994909464,5,95,regulation of hematopoietic stem cell differentiation,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
4510,GO:0010557,0.0717797178846028,0.950810916266883,35,1250,positive regulation of macromolecule biosynthetic process,BP,HES1;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;HSPB1;FHL2;POU3F1;GDNF;BRPF1;NR2F2;HOXA9;BCDIN3D;ZNF398;FOS;RBM15;COL1A1;AKIRIN2;ZBTB7B;SEC14L2;PIK3R1;IMP3;SOX9;CEBPA;SOX15;NR1D1;ING2;HOXA5;KRT17;SOX12;NOTCH3
12995,GO:0051385,0.0720192515622165,0.990625786602242,2,20,response to mineralocorticoid,BP,CTGF;FOS
13078,GO:0051568,0.0722051124604095,0.984356942577058,3,45,histone H3-K4 methylation,BP,PYGO2;HIST1H1C;HIST1H1D
3512,GO:0007423,0.0722289502100641,0.963739764577291,11,311,sensory organ development,BP,HES1;CYP1B1;NOG;LRIG3;CXCL14;BLOC1S3;SOX9;CEBPA;GJB2;PYGO2;IRX5
12432,GO:0048871,0.0729211307647945,0.968057336284995,8,201,multicellular organismal homeostasis,BP,HSPB1;CTGF;CDHR1;SOX9;PLEKHM1;KRT16;NCDN;NR1D1
2655,GO:0005996,0.0730697231399825,0.967983123513379,8,199,monosaccharide metabolic process,BP,SLC2A1;MIDN;FUT1;PPP1R3D;SLC2A3;NR1D1;PER2;HK2
17704,GO:1901568,0.0732565223461495,0.975497374978134,5,100,fatty acid derivative metabolic process,BP,CYP1B1;CBR1;AKR1C1;ZADH2;CES2
4823,GO:0014014,0.0738134528593415,0.990222722740112,2,21,negative regulation of gliogenesis,BP,HES1;NOG
3603,GO:0008038,0.0739789260250717,0.990156355512781,2,22,neuron recognition,BP,CDK5R1;EPHB3
5855,GO:0017147,0.0740590902873959,0.990171774981894,2,21,Wnt-protein binding,MF,APCDD1;FZD10
10520,GO:0043425,0.0741249066022753,0.990158107032439,2,21,bHLH transcription factor binding,MF,TSC22D3;SOX9
12070,GO:0048009,0.0741729518369891,0.99011594162679,2,22,insulin-like growth factor receptor signaling pathway,BP,IGFBP2;PIK3R1
19067,GO:1904894,0.0744756671440295,0.98367334795106,3,44,positive regulation of STAT cascade,BP,HES1;CYP1B1;SOCS1
14072,GO:0060836,0.0747184300444504,0.997846419814736,1,4,lymphatic endothelial cell differentiation,BP,NR2F2
16850,GO:0098742,0.0751077013327472,0.974666898515527,5,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,FLRT3;LGALS7B;CDHR1;PCDH7;FAT2
39,GO:0000079,0.0753979605944053,0.978424484776113,4,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDK5R1;SERTAD1;NR2F2;CEBPA
442,GO:0001190,0.075407908805941,0.9833413443335,3,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;FOS;SOX12
8663,GO:0034219,0.0754553519025455,0.978386236619744,4,74,carbohydrate transmembrane transport,BP,SLC2A1;SLC2A3;PIK3R1;HK2
934,GO:0002329,0.0755059811213311,0.997800016421417,1,4,pre-B cell differentiation,BP,LRRC8A
3259,GO:0006928,0.0756794393006106,0.947886030637409,35,1272,movement of cell or subcellular component,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;CYP1B1;FAM110C;NOG;FLRT3;HSPB1;APCDD1;GDNF;CTGF;NR2F2;IL17RA;RHOD;FAT2;COL1A1;EPHB3;CXCL14;PAK6;SIAH2;BLOC1S3;VASP;PIK3R1;SOX9;BICD2;DDIT4;ARTN;KRT16;ING2;HOXA5;COL1A2;IFITM1
16124,GO:0090092,0.0758273103873278,0.971241903081377,6,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HES1;NOG;VASN;TOB1;ING2;PMEPA1
1346,GO:0003206,0.0761078495970537,0.978128699128085,4,75,cardiac chamber morphogenesis,BP,HES1;NOG;FHL2;RBM15
1385,GO:0003281,0.0761945543893978,0.983095512714984,3,47,ventricular septum development,BP,HES1;NOG;RBM15
16250,GO:0090287,0.0765336493042009,0.968309227456801,7,171,regulation of cellular response to growth factor stimulus,BP,SPRY4;HES1;NOG;VASN;TOB1;ING2;PMEPA1
9811,GO:0040036,0.076576014607279,0.989644004932118,2,21,regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY4;NOG
6752,GO:0030168,0.0769238786996028,0.973887186817527,5,104,platelet activation,BP,HSPB1;COL1A1;BLOC1S3;PIK3R1;COL1A2
5803,GO:0017049,0.0770727190399894,0.989538622821452,2,21,GTP-Rho binding,MF,NET1;CDC42EP2
15793,GO:0072385,0.0772715213373538,0.997694129826455,1,4,minus-end-directed organelle transport along microtubule,BP,BICD2
6340,GO:0021510,0.0774628531815382,0.982696810894107,3,47,spinal cord development,BP,NOG;BAG3;SOX12
1380,GO:0003273,0.0775045392734746,0.997679962494603,1,4,cell migration involved in endocardial cushion formation,BP,SNAI2
13831,GO:0060411,0.0776937707836257,0.982623908849058,3,47,cardiac septum morphogenesis,BP,HES1;NOG;RBM15
7226,GO:0031116,0.0779125188970417,0.989324887157188,2,22,positive regulation of microtubule polymerization,BP,RGS2;CDK5R1
14268,GO:0061304,0.0779474293524352,0.99765291132989,1,4,retinal blood vessel morphogenesis,BP,CYP1B1
12616,GO:0050779,0.0780777543102464,0.989289404505693,2,22,RNA destabilization,BP,ZFP36L2;UPF1
18953,GO:1904684,0.078082345549466,0.99764463858173,1,4,negative regulation of metalloendopeptidase activity,BP,TIMP3
377,GO:0001007,0.0783739431778261,0.997626707039081,1,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,BRF2
10613,GO:0043588,0.0787743714686855,0.962997719685281,9,240,skin development,BP,TXNIP;APCDD1;POU3F1;FOXQ1;COL1A1;SOX9;KRT16;COL1A2;KRT17
7157,GO:0031012,0.0788382416272572,0.962956285492237,9,243,extracellular matrix,CC,SERPINE1;ANGPTL4;FLRT3;CTGF;ADAMTS15;COL1A1;TIMP3;COL1A2;CLU
9019,GO:0035195,0.0790611360854924,0.969708577816933,6,134,gene silencing by miRNA,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
3606,GO:0008046,0.0793072555655424,0.997568840555856,1,4,axon guidance receptor activity,MF,EPHB3
4297,GO:0009725,0.0794212458649053,0.951191215170331,20,654,response to hormone,BP,CDK5R1;SLC2A1;TXNIP;PTPRE;FHL2;CTGF;NR2F2;ZFP36L2;FOS;IGFBP2;COL1A1;PIK3R1;GJB2;TIMP3;AKR1C1;DDIT4;NR1D1;PMEPA1;SOCS1;CISH
4712,GO:0010871,0.0797773707429789,0.997539419523123,1,4,negative regulation of receptor biosynthetic process,BP,NR1D1
15240,GO:0071384,0.0797780885118199,0.981976259518896,3,46,cellular response to corticosteroid stimulus,BP,ZFP36L2;GJB2;DDIT4
4481,GO:0010484,0.0799715303101806,0.997527215040948,1,4,H3 histone acetyltransferase activity,MF,BRPF1
8213,GO:0032963,0.0802600666542505,0.976521735220822,4,75,collagen metabolic process,BP,ID1;CTGF;COL1A1;COL1A2
12079,GO:0048018,0.0802877112386427,0.966402958707496,7,166,receptor ligand activity,MF,PTHLH;FLRT3;GDNF;CTGF;CDC42EP2;CXCL14;ARTN
5601,GO:0016628,0.0805766875605916,0.988783801396236,2,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,AKR1C1;ZADH2
20108,GO:2000739,0.0805985920318412,0.997487585579018,1,4,regulation of mesenchymal stem cell differentiation,BP,SOX9
388,GO:0001032,0.0809006865495191,0.997468377112159,1,4,RNA polymerase III type 3 promoter DNA binding,MF,BRF2
2483,GO:0005719,0.0809287668481675,0.988706857883438,2,21,nuclear euchromatin,CC,HIST1H1C;HIST1H1D
4365,GO:0009966,0.0809824817311051,0.939907889219869,56,2144,regulation of signal transduction,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;NET1;SERPINE1;MYC;CYP1B1;FAM110C;NOG;PTPRE;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;HIST1H2BJ;CDC42EP2;IGFBP2;RHOD;COL1A1;TOB1;EPHB3;CXCL14;PAK6;SIAH2;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;DDIT4;ARTN;NR1D1;ING2;NACC2;HIC1;SOCS6;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
7121,GO:0030917,0.0812421773946622,0.997446572389041,1,4,midbrain-hindbrain boundary development,BP,HES1
18687,GO:1904016,0.0816439818254126,0.997420792464573,1,4,response to Thyroglobulin triiodothyronine,BP,SLC2A1
12674,GO:0050865,0.0817460090674559,0.958077541452395,11,310,regulation of cell activation,BP,HES1;TNFRSF21;CTGF;MAP3K14;ZFP36L2;IGFBP2;ZBTB7B;PIK3R1;SOX15;SOCS6;SOCS1
8125,GO:0032808,0.0823303965653133,0.997376441287172,1,4,lacrimal gland development,BP,SOX9
15928,GO:0072687,0.0823335242954859,0.997376238298691,1,4,meiotic spindle,CC,HSPA2
14319,GO:0061438,0.082401956066279,0.997371795065598,1,4,renal system vasculature morphogenesis,BP,NOTCH3
14320,GO:0061439,0.082401956066279,0.997371795065598,1,4,kidney vasculature morphogenesis,BP,NOTCH3
5511,GO:0016458,0.0824080914838042,0.960952529207374,9,237,gene silencing,BP,HIST1H2AG;HIST1H4L;BCDIN3D;HIST1H3J;HIST1H2AB;HIST1H4B;HIST1H4K;HIST1H4D;HIST1H2AH
11735,GO:0046533,0.082442012745562,0.997369192401566,1,4,negative regulation of photoreceptor cell differentiation,BP,SOX9
10521,GO:0043426,0.0824931264024284,0.99736586937632,1,4,MRF binding,MF,TSC22D3
3508,GO:0007417,0.0826950606671023,0.950295774484608,18,587,central nervous system development,BP,ID1;HES1;CDK5R1;SLC2A1;ID3;NOG;TNFRSF21;POU3F1;BAG3;NR2F2;EPHB3;MFSD2A;SOX9;DDIT4;PYGO2;SOX12;NOTCH3;CLU
14305,GO:0061384,0.0828599687502967,0.988208677024543,2,23,heart trabecula morphogenesis,BP,NOG;FHL2
18076,GO:1902617,0.0828775930932991,0.997340804540557,1,4,response to fluoride,BP,COL1A1
10056,GO:0042535,0.0833332013378958,0.99731094234138,1,4,positive regulation of tumor necrosis factor biosynthetic process,BP,HSPB1
14722,GO:0070345,0.0834594325071253,0.997302638100755,1,4,negative regulation of fat cell proliferation,BP,PER2
8371,GO:0033263,0.0835308627335839,0.997297933110056,1,4,CORVET complex,CC,VPS18
9797,GO:0040013,0.083590746602019,0.962295949800081,8,209,negative regulation of locomotion,BP,SERPINE1;CYP1B1;NOG;NR2F2;TRIM35;KRT16;TRIM26;IFITM1
4818,GO:0014009,0.0836491750591564,0.988031998653717,2,23,glial cell proliferation,BP,HES1;CLU
4766,GO:0010942,0.0837326053409073,0.951222338229336,16,498,positive regulation of cell death,BP,CDK5R1;NET1;TXNIP;MYC;ID3;CYP1B1;CTGF;TRIM35;FOS;GADD45B;TIMP3;STK17A;DDIT4;HOXA5;NACC2;CLU
14334,GO:0061476,0.0838165317933753,0.997279074043146,1,4,response to anticoagulant,BP,SOX9
15323,GO:0071503,0.0838165317933753,0.997279074043146,1,4,response to heparin,BP,SOX9
15324,GO:0071504,0.0838165317933753,0.997279074043146,1,4,cellular response to heparin,BP,SOX9
6798,GO:0030234,0.0838677846815435,0.946901986188377,22,733,enzyme regulator activity,MF,RGS2;CDK5R1;TXNIP;SERPINE1;ANGPTL4;RIN2;FLRT3;HSPB1;BAG3;CDC42EP2;FAM212B;PIK3R1;TIMP3;RIN1;RUNDC1;PYGO2;DNAJB2;SOCS6;RGS3;SOCS1;CDC42SE1;CISH
11323,GO:0045632,0.083869831976412,0.997275547783285,1,4,negative regulation of mechanoreceptor differentiation,BP,HES1
20190,GO:2000981,0.083869831976412,0.997275547783285,1,4,negative regulation of inner ear receptor cell differentiation,BP,HES1
5333,GO:0016055,0.0839229916559314,0.954140267079588,13,390,Wnt signaling pathway,BP,SNAI2;MYC;NOG;APCDD1;FZD10;IGFBP2;COL1A1;TLE3;SIAH2;SOX9;JRK;PYGO2;HIC1
16495,GO:0097167,0.0839392757476537,0.99727094993385,1,4,circadian regulation of translation,BP,PER2
16506,GO:0097191,0.0839631586255497,0.96448398379974,7,171,extrinsic apoptotic signaling pathway,BP,SNAI2;SERPINE1;GDNF;BAG3;SIAH2;PIK3R1;TIMP3
13698,GO:0060218,0.0840403820336047,0.970760944660487,5,100,hematopoietic stem cell differentiation,BP,HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
16544,GO:0097267,0.0843215078862517,0.997245570465982,1,4,omega-hydroxylase P450 pathway,BP,CYP1B1
20290,GO:2001233,0.0844391095650254,0.95645367431343,11,308,regulation of apoptotic signaling pathway,BP,SNAI2;IVNS1ABP;SERPINE1;NOG;HSPB1;GDNF;SIAH2;TIMP3;ING2;NACC2;CLU
1439,GO:0003415,0.0844841400551342,0.997234735040687,1,4,chondrocyte hypertrophy,BP,SOX9
13258,GO:0051918,0.0845714175204592,0.997228911047155,1,4,negative regulation of fibrinolysis,BP,SERPINE1
4841,GO:0014044,0.0846541766617273,0.98777289149791,2,24,Schwann cell development,BP,POU3F1;AHNAK2
15134,GO:0071211,0.0846711869981529,0.997222245677578,1,4,protein targeting to vacuole involved in autophagy,BP,CLU
18281,GO:1903121,0.0848001177016262,0.997213619805244,1,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,TIMP3
10336,GO:0043125,0.0848165675012829,0.997212518263192,1,4,ErbB-3 class receptor binding,MF,PIK3R1
16439,GO:0097065,0.0848274288926525,0.997211790818675,1,4,anterior head development,BP,SOX9
781,GO:0002036,0.084845818598519,0.997210558938749,1,4,regulation of L-glutamate import across plasma membrane,BP,PER2
4776,GO:0010958,0.084845818598519,0.997210558938749,1,4,regulation of amino acid import across plasma membrane,BP,PER2
2647,GO:0005981,0.0848490253719307,0.997210344096187,1,4,regulation of glycogen catabolic process,BP,PPP1R3D
19720,GO:2000020,0.0848553460908449,0.997209920605063,1,4,positive regulation of male gonad development,BP,SOX9
18699,GO:1904029,0.0850149933693457,0.974644088406868,4,75,regulation of cyclin-dependent protein kinase activity,BP,CDK5R1;SERTAD1;NR2F2;CEBPA
8629,GO:0034144,0.0850965771340957,0.997193733076516,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
12408,GO:0048840,0.085280557448828,0.997181354618721,1,4,otolith development,BP,LRIG3
12322,GO:0048663,0.0853691070369477,0.987643506087981,2,23,neuron fate commitment,BP,HES1;NOTCH3
12628,GO:0050796,0.0853773950717037,0.970116823031456,5,107,regulation of insulin secretion,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
14659,GO:0070236,0.0853934026850735,0.997173748237698,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D3
19420,GO:1905908,0.0856042738998641,0.997159505850708,1,4,positive regulation of amyloid fibril formation,BP,CLU
11203,GO:0045298,0.0856469770463822,0.997156617125413,1,4,tubulin complex,CC,CDK5R1
5588,GO:0016602,0.0857187201537764,0.997151760511801,1,4,CCAAT-binding factor complex,CC,ING2
4638,GO:0010757,0.085748707965359,0.997149729226752,1,4,negative regulation of plasminogen activation,BP,SERPINE1
20294,GO:2001237,0.0859462031860116,0.97426284075715,4,76,negative regulation of extrinsic apoptotic signaling pathway,BP,SNAI2;SERPINE1;GDNF;SIAH2
10515,GO:0043415,0.0861256763287354,0.997124130372119,1,4,positive regulation of skeletal muscle tissue regeneration,BP,SOX15
10516,GO:0043416,0.0861256763287354,0.997124130372119,1,4,regulation of skeletal muscle tissue regeneration,BP,SOX15
13589,GO:0060042,0.0863259336748788,0.987391694529717,2,24,retina morphogenesis in camera-type eye,BP,SOX9;IRX5
3183,GO:0006807,0.0863885784746972,0.932211930476967,174,7381,nitrogen compound metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;AKR1C1;DDIT4;GZF1;SNX33;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;RRP36;PER2;ZNF672;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5;CISH
17344,GO:0198738,0.0864989139600862,0.952503349399553,13,392,cell-cell signaling by wnt,BP,SNAI2;MYC;NOG;APCDD1;FZD10;IGFBP2;COL1A1;TLE3;SIAH2;SOX9;JRK;PYGO2;HIC1
12605,GO:0050768,0.0865340421213034,0.963120934661573,7,177,negative regulation of neurogenesis,BP,ID1;HES1;CDK5R1;ID3;NOG;SOX9;NOTCH3
10784,GO:0044237,0.0866174117724515,0.932535636117741,185,7890,cellular metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;AKR1C1;DDIT4;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;NT5DC3;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;VPS18;IRX5;CISH
13844,GO:0060428,0.0866672180093577,0.987347171066811,2,23,lung epithelium development,BP,SOX9;HOXA5
19897,GO:2000351,0.0866713308142499,0.987346227935243,2,23,regulation of endothelial cell apoptotic process,BP,SERPINE1;ANGPTL4
11466,GO:0045912,0.0867169591394187,0.987335762834943,2,23,negative regulation of carbohydrate metabolic process,BP,MIDN;DDIT4
16600,GO:0097396,0.0868460310545983,0.997074882459851,1,4,response to interleukin-17,BP,IL17RA
16601,GO:0097398,0.0868460310545983,0.997074882459851,1,4,cellular response to interleukin-17,BP,IL17RA
16602,GO:0097400,0.0868460310545983,0.997074882459851,1,4,interleukin-17-mediated signaling pathway,BP,IL17RA
534,GO:0001652,0.0868646052165862,0.997073606870761,1,4,granular component,CC,SURF6
11398,GO:0045765,0.0870435039926618,0.962856209956674,7,176,regulation of angiogenesis,BP,ID1;SERPINE1;ANGPTL4;CYP1B1;HSPB1;HOXA5;HK2
4318,GO:0009794,0.0870514300784115,0.99706076052047,1,4,regulation of mitotic cell cycle, embryonic,BP,HES1
11256,GO:0045448,0.0870514300784115,0.99706076052047,1,4,mitotic cell cycle, embryonic,BP,HES1
20265,GO:2001185,0.0870900680186039,0.997058100071357,1,4,regulation of CD8-positive, alpha-beta T cell activation,BP,ZBTB7B
13093,GO:0051588,0.0871127719556031,0.979554438574319,3,48,regulation of neurotransmitter transport,BP,GDNF;SLC30A1;PER2
16130,GO:0090102,0.0872510309406479,0.98721302526905,2,23,cochlea development,BP,HES1;SOX9
19419,GO:1905907,0.0874524142833843,0.9970330895438,1,4,negative regulation of amyloid fibril formation,BP,CLU
6157,GO:0019470,0.0876079137855342,0.997022322634728,1,4,4-hydroxyproline catabolic process,BP,ALDH4A1
5494,GO:0016426,0.0876135841864481,0.997021929628674,1,4,tRNA (adenine) methyltransferase activity,MF,TRMT61A
9675,GO:0038033,0.0876241733943824,0.997021195636129,1,4,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,HSPB1
11350,GO:0045665,0.0876417108937781,0.965486288297734,6,143,negative regulation of neuron differentiation,BP,ID1;HES1;CDK5R1;ID3;SOX9;NOTCH3
14209,GO:0061101,0.0876540868340518,0.997019121673757,1,4,neuroendocrine cell differentiation,BP,HES1
4898,GO:0014821,0.0877122860875341,0.99701508444642,1,4,phasic smooth muscle contraction,BP,GDNF
18194,GO:1902949,0.0877732228293441,0.997010854279083,1,4,positive regulation of tau-protein kinase activity,BP,CLU
20087,GO:2000698,0.08777903284964,0.997010450790756,1,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
13931,GO:0060574,0.087801094710581,0.99700891840351,1,4,intestinal epithelial cell maturation,BP,HOXA5
6762,GO:0030183,0.0879731428289346,0.973429399914498,4,78,B cell differentiation,BP,ZFP36L2;LRRC8A;PIK3R1;DCLRE1C
3777,GO:0008330,0.0880972259051486,0.996988310022168,1,4,protein tyrosine/threonine phosphatase activity,MF,DUSP4
8838,GO:0034622,0.088117370107035,0.941801144528182,26,884,cellular protein-containing complex assembly,BP,RGS2;CDK5R1;HIST1H4L;HIST1H2BJ;CDC42EP2;HIST1H2BI;HIST1H3J;HJURP;VASP;HIST1H4B;SOX9;HIST1H2BO;HIST1H2BE;HIST1H1C;HIST1H1D;HIST1H4K;BRF2;HIST2H2BE;HIST3H2BB;SOX12;TBCC;HIST1H4D;PMEPA1;TSPYL4;CLU;VPS18
6076,GO:0019221,0.0881223675099193,0.947414226948728,17,531,cytokine-mediated signaling pathway,BP,MYC;FLRT3;TNFRSF21;MAP3K14;HIST1H2BJ;FOS;IL17RA;HIST1H3J;PIK3R1;CEBPA;CNN2;TRIM26;COL1A2;SOCS6;IFITM1;SOCS1;CISH
4471,GO:0010464,0.0881490082650522,0.987005639464158,2,23,regulation of mesenchymal cell proliferation,BP,MYC;SOX9
15594,GO:0072049,0.0881808206240284,0.996982479181831,1,4,comma-shaped body morphogenesis,BP,HES1
18703,GO:1904036,0.0881810784698448,0.986998209363877,2,23,negative regulation of epithelial cell apoptotic process,BP,SERPINE1;ANGPTL4
12360,GO:0048713,0.0881969410709119,0.986994533679281,2,23,regulation of oligodendrocyte differentiation,BP,HES1;TNFRSF21
17570,GO:1901099,0.0882835201128229,0.987012509309193,2,22,negative regulation of signal transduction in absence of ligand,BP,SNAI2;GDNF
20297,GO:2001240,0.0882835201128229,0.987012509309193,2,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,SNAI2;GDNF
3318,GO:0007023,0.0883695905621666,0.99696929066738,1,4,post-chaperonin tubulin folding pathway,BP,TBCC
13629,GO:0060087,0.0887585869948023,0.996942018919889,1,4,relaxation of vascular smooth muscle,BP,RGS2
16232,GO:0090261,0.088808037151549,0.996938542970508,1,4,positive regulation of inclusion body assembly,BP,CLU
10734,GO:0044087,0.0888559305379527,0.944620959753176,20,668,regulation of cellular component biogenesis,BP,ID1;RGS2;SNAI2;CDK5R1;FAM110C;FLRT3;CTGF;CDC42EP2;RHOD;EPHB3;HJURP;VASP;PIK3R1;SOX9;HSPA2;PLEKHM1;DNAJB2;PMEPA1;CLU;VPS18
3370,GO:0007140,0.0890574869875217,0.986794533300547,2,23,male meiotic nuclear division,BP,HSPA2;ING2
10275,GO:0043014,0.0894906866815586,0.986693411718313,2,23,alpha-tubulin binding,MF,CDK5R1;FAM110C
13090,GO:0051584,0.0895134086060332,0.996888737436952,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
13273,GO:0051940,0.0895134086060332,0.996888737436952,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
12235,GO:0048483,0.0898082189347271,0.986583407197249,2,24,autonomic nervous system development,BP,HES1;GDNF
10306,GO:0043066,0.0898188433728083,0.944661280800646,19,619,negative regulation of apoptotic process,BP,ID1;SNAI2;TSC22D3;IVNS1ABP;SERPINE1;MYC;ANGPTL4;NOG;HSPB1;FHL2;GDNF;BAG3;EPHB3;SIAH2;PIK3R1;SOX9;ING2;ZNF16;CLU
1649,GO:0004090,0.0911323975620995,0.996772840403615,1,4,carbonyl reductase (NADPH) activity,MF,CBR1
12682,GO:0050873,0.0911582267493896,0.986301409709117,2,23,brown fat cell differentiation,BP,RGS2;CEBPA
7222,GO:0031112,0.0915049851890293,0.986182638338042,2,24,positive regulation of microtubule polymerization or depolymerization,BP,RGS2;CDK5R1
2941,GO:0006468,0.0917047054610079,0.935420948096961,36,1320,protein phosphorylation,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;GDNF;CTGF;MAP3K14;FZD10;NR2F2;ZFP36L2;FAM212B;EPHB3;PAK6;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;TIMP3;STK17A;DDIT4;ARTN;SOCS6;RGS3;PMEPA1;SOCS1;CLU;CISH
14524,GO:0065009,0.0919138252708562,0.93087018961423,58,2244,regulation of molecular function,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;PTHLH;MIDN;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;RIN2;DUSP5;SERTAD1;FLRT3;HSPB1;GDNF;CTGF;MAP3K14;BAG3;FZD10;NR2F2;FOS;CDC42EP2;KCTD7;FAM212B;EPHB3;SLC30A1;ADGRF1;CXCL14;PAK6;SIAH2;HJURP;AKIRIN2;GADD45B;PIK3R1;CEBPA;HSPA2;TIMP3;RIN1;RUNDC1;ARTN;PYGO2;PER2;DNAJB2;TRIM26;ZNF16;SOCS6;RGS3;SOCS1;CLU;CDC42SE1;CISH
13195,GO:0051787,0.0921332500337346,0.98607018771237,2,23,misfolded protein binding,MF,HSPA2;CLU
12813,GO:0051094,0.0923545388240769,0.939698962174566,24,831,positive regulation of developmental process,BP,HES1;SNAI2;NET1;SERPINE1;MYC;ANGPTL4;CYP1B1;NOG;FLRT3;HSPB1;GDNF;CTGF;FOS;COL1A1;EPHB3;SOX9;CEBPA;SOX15;HOXA5;ZNF16;KRT17;IFITM1;HK2;SOCS1
12650,GO:0050829,0.0924334929061499,0.986039439743151,2,22,defense response to Gram-negative bacterium,BP,SERPINE1;HIST1H2BJ
15294,GO:0071466,0.0926202075828341,0.966797975546871,5,108,cellular response to xenobiotic stimulus,BP,CYP1B1;GJB2;AKR1C1;DDIT4;CES2
14731,GO:0070373,0.0928522576704208,0.977601159814427,3,49,negative regulation of ERK1 and ERK2 cascade,BP,SPRY4;DUSP4;TIMP3
9018,GO:0035194,0.0932322661667876,0.962706773925887,6,140,posttranscriptional gene silencing by RNA,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
12716,GO:0050921,0.0935189872077171,0.971160691959034,4,78,positive regulation of chemotaxis,BP,SERPINE1;HSPB1;CXCL14;ARTN
1453,GO:0003682,0.0939828415315233,0.946467660326414,14,437,chromatin binding,MF,SNAI2;HR;ZNF750;PHF13;FOS;RNF168;HIST1H3J;UPF1;SOX9;SOX15;PYGO2;ING2;HIST1H1C;HIST1H1D
10596,GO:0043559,0.0940100272615947,0.996338173503429,1,5,insulin binding,MF,PIK3R1
447,GO:0001206,0.0943809151553485,0.996308634384111,1,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,GZF1
6590,GO:0022414,0.0944350388797767,0.938185026420391,24,827,reproductive process,BP,TIPARP;RGS2;HES1;PTHLH;SLC2A1;IRF2BPL;NOG;ZNF296;TFCP2L1;NR2F2;HOXA9;FOS;IGFBP2;RBM15;PLCD1;SOX9;CEBPA;GJB2;HSPA2;SOX15;PYGO2;ING2;PHC2;IRX5
5503,GO:0016441,0.0952756706237138,0.961669602399608,6,141,posttranscriptional gene silencing,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
2,GO:0000003,0.0954104868259554,0.937472553310082,24,828,reproduction,BP,TIPARP;RGS2;HES1;PTHLH;SLC2A1;IRF2BPL;NOG;ZNF296;TFCP2L1;NR2F2;HOXA9;FOS;IGFBP2;RBM15;PLCD1;SOX9;CEBPA;GJB2;HSPA2;SOX15;PYGO2;ING2;PHC2;IRX5
11808,GO:0046676,0.0954205558277815,0.985240641254856,2,24,negative regulation of insulin secretion,BP,MIDN;VSNL1
16242,GO:0090278,0.0954205558277815,0.985240641254856,2,24,negative regulation of peptide hormone secretion,BP,MIDN;VSNL1
18689,GO:1904018,0.0955715454742479,0.965398866082881,5,112,positive regulation of vasculature development,BP,SERPINE1;ANGPTL4;CYP1B1;HSPB1;HK2
3817,GO:0008406,0.0955913772267684,0.961496160245502,6,144,gonad development,BP,TIPARP;HOXA9;SOX9;SOX15;ING2;IRX5
6922,GO:0030510,0.0959280914237176,0.976492408242547,3,52,regulation of BMP signaling pathway,BP,HES1;NOG;TOB1
15444,GO:0071704,0.0959968211793418,0.924758433456886,185,7911,organic substance metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;AKR1C1;DDIT4;GZF1;SNX33;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;TRIM26;NACC2;HIC1;ZNF16;SOCS6;KRT17;SOX12;ZNF766;ZNF701;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;IRX5;CISH
3545,GO:0007568,0.0961320985070399,0.955310957463702,8,212,aging,BP,SERPINE1;CTGF;TFCP2L1;FOS;IGFBP2;GJB2;KRT16;ING2
14076,GO:0060840,0.0969042580927832,0.976136905865773,3,53,artery development,BP,HES1;NOG;NOTCH3
3254,GO:0006915,0.0970202582197896,0.930731556718631,38,1396,apoptotic process,BP,ID1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;HSPB1;FHL2;LGALS7B;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;TRIM35;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TIMP3;STK17A;DDIT4;ING2;HOXA5;NACC2;HIC1;ZNF16;HK2;CLU
9865,GO:0042113,0.0973762774980877,0.960583292122901,6,145,B cell activation,BP,TNFRSF21;ZFP36L2;RNF168;LRRC8A;PIK3R1;DCLRE1C
11833,GO:0046718,0.0974697865710391,0.969503915377873,4,79,viral entry into host cell,BP,SLC20A2;TRIM26;IFITM1;VPS18
13632,GO:0060090,0.0974792862117042,0.960526365508119,6,146,molecular adaptor activity,MF,FLRT3;TOB1;PIK3R1;BICD2;COL1A2;VPS18
8148,GO:0032870,0.0975794554812711,0.942941473907108,15,478,cellular response to hormone stimulus,BP,CDK5R1;PTPRE;FHL2;NR2F2;ZFP36L2;FOS;IGFBP2;PIK3R1;GJB2;AKR1C1;DDIT4;NR1D1;PMEPA1;SOCS1;CISH
1256,GO:0003007,0.0979876044537664,0.960249744501028,6,150,heart morphogenesis,BP,HES1;SNAI2;NOG;FHL2;RBM15;SOX9
15149,GO:0071230,0.0982336766284892,0.975700824795414,3,51,cellular response to amino acid stimulus,BP,COL1A1;COL1A2;SOCS1
12916,GO:0051249,0.0985733275262629,0.951567398697843,9,248,regulation of lymphocyte activation,BP,HES1;TNFRSF21;MAP3K14;ZFP36L2;IGFBP2;ZBTB7B;PIK3R1;SOCS6;SOCS1
2444,GO:0005642,0.0991839276002286,0.995914921848723,1,5,annulate lamellae,CC,BICD2
14815,GO:0070535,0.099256218886643,0.995908837058523,1,5,histone H2A K63-linked ubiquitination,BP,RNF168
4588,GO:0010675,0.099430818077537,0.968648623453789,4,82,regulation of cellular carbohydrate metabolic process,BP,MIDN;PPP1R3D;DDIT4;NR1D1
8462,GO:0033598,0.0995613501775177,0.984180433892388,2,25,mammary gland epithelial cell proliferation,BP,PYGO2;HOXA5
12359,GO:0048712,0.0996349423509221,0.995876882528989,1,5,negative regulation of astrocyte differentiation,BP,NOG
4682,GO:0010827,0.100619725515188,0.974840642008725,3,52,regulation of glucose transmembrane transport,BP,SLC2A1;PIK3R1;HK2
4539,GO:0010608,0.100738781488509,0.939741784010539,16,507,posttranscriptional regulation of gene expression,BP,RGS2;HSPB1;HIST1H4L;GDNF;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;HIST1H4K;PER2;NACC2;KRT17;HIST1H4D
9823,GO:0042026,0.101036174136845,0.983848320747829,2,24,protein refolding,BP,HSPA2;DNAJB2
11341,GO:0045656,0.101127472184359,0.99574968789672,1,5,negative regulation of monocyte differentiation,BP,MYC
13967,GO:0060638,0.101271724810036,0.995737287659622,1,5,mesenchymal-epithelial cell signaling,BP,HOXA5
2867,GO:0006359,0.101355739456863,0.983728372403533,2,25,regulation of transcription by RNA polymerase III,BP,CEBPA;BRF2
12284,GO:0048570,0.101588607016374,0.995709981625038,1,5,notochord morphogenesis,BP,NOG
11300,GO:0045602,0.101701252834995,0.995700252897216,1,5,negative regulation of endothelial cell differentiation,BP,ID1
8515,GO:0033692,0.101780952107536,0.974426305633801,3,52,cellular polysaccharide biosynthetic process,BP,PPP1R3D;NR1D1;PER2
3560,GO:0007601,0.101864647598405,0.967612586313963,4,82,visual perception,BP,CYP1B1;COL1A1;TIMP3;IRX5
12730,GO:0050953,0.101864647598405,0.967612586313963,4,82,sensory perception of light stimulus,BP,CYP1B1;COL1A1;TIMP3;IRX5
3163,GO:0006775,0.102013668770982,0.983601035201135,2,24,fat-soluble vitamin metabolic process,BP,SNAI2;CBR1
11734,GO:0046532,0.102017397867792,0.995672887360075,1,5,regulation of photoreceptor cell differentiation,BP,SOX9
6527,GO:0021903,0.102190637090136,0.995657853305977,1,5,rostrocaudal neural tube patterning,BP,HES1
16108,GO:0090074,0.102205012491869,0.995656604555624,1,5,negative regulation of protein homodimerization activity,BP,ID1
12236,GO:0048484,0.10228696441501,0.995649482042772,1,5,enteric nervous system development,BP,GDNF
4809,GO:0012501,0.10251215350946,0.925873131580079,40,1485,programmed cell death,BP,ID1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;HSPB1;FHL2;LGALS7B;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;TRIM35;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TIMP3;STK17A;DDIT4;KRT16;ING2;HOXA5;NACC2;HIC1;ZNF16;KRT17;HK2;CLU
17886,GO:1902106,0.102725594798692,0.974087650575986,3,52,negative regulation of leukocyte differentiation,BP,MYC;ZBTB7B;PIK3R1
18192,GO:1902947,0.102967587123925,0.995590092951279,1,5,regulation of tau-protein kinase activity,BP,CLU
11123,GO:0045137,0.103030535483168,0.957664254645131,6,147,development of primary sexual characteristics,BP,TIPARP;HOXA9;SOX9;SOX15;ING2;IRX5
12868,GO:0051173,0.1032156689566,0.9223170866868,54,2095,positive regulation of nitrogen compound metabolic process,BP,TIPARP;HES1;SNAI2;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;DUSP5;SERTAD1;ZNF750;HSPB1;FHL2;POU3F1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;RNF168;RBM15;COL1A1;TOB1;EPHB3;PAK6;UPF1;AKIRIN2;ZBTB7B;GADD45B;SEC14L2;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;SNX33;SOX15;NR1D1;ING2;HOXA5;KRT17;SOX12;NOTCH3;SOCS1;CLU
10563,GO:0043516,0.103243207971586,0.983247564428746,2,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;HIC1
6564,GO:0021999,0.103297440615673,0.995561159567622,1,5,neural plate anterior/posterior regionalization,BP,NOG
4350,GO:0009912,0.103309649219573,0.995560086782111,1,5,auditory receptor cell fate commitment,BP,HES1
13640,GO:0060120,0.103309649219573,0.995560086782111,1,5,inner ear receptor cell fate commitment,BP,HES1
9674,GO:0038031,0.103591350859753,0.995535295675777,1,5,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD10
6464,GO:0021781,0.103658972568713,0.995529333901843,1,5,glial cell fate commitment,BP,SOX9
10086,GO:0042583,0.10366475220113,0.995528824155735,1,5,chromaffin granule,CC,CLU
19775,GO:2000138,0.103748791529501,0.995521408709365,1,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,SOX9
12927,GO:0051260,0.103751350078902,0.950952092116072,8,215,protein homooligomerization,BP,ANGPTL4;KCTD15;KCTD7;VASP;KCTD1;AKR1C1;NACC2;CLU
651,GO:0001839,0.103811195742004,0.995515898143302,1,5,neural plate morphogenesis,BP,NOG
2882,GO:0006383,0.10396189420201,0.973659142780916,3,51,transcription by RNA polymerase III,BP,IVNS1ABP;CEBPA;BRF2
14701,GO:0070314,0.104061125579472,0.99549379274345,1,5,G1 to G0 transition,BP,ZNF503
6371,GO:0021548,0.104130296767225,0.99548766476047,1,5,pons development,BP,CDK5R1
9404,GO:0035947,0.104468467144938,0.995457643051901,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
10309,GO:0043069,0.104571527217252,0.934271846371126,19,632,negative regulation of programmed cell death,BP,ID1;SNAI2;TSC22D3;IVNS1ABP;SERPINE1;MYC;ANGPTL4;NOG;HSPB1;FHL2;GDNF;BAG3;EPHB3;SIAH2;PIK3R1;SOX9;ING2;ZNF16;CLU
13881,GO:0060484,0.104623569191201,0.995443838761555,1,5,lung-associated mesenchyme development,BP,HOXA5
11305,GO:0045607,0.104639241552897,0.995442442682099,1,5,regulation of inner ear auditory receptor cell differentiation,BP,HES1
11322,GO:0045631,0.104639241552897,0.995442442682099,1,5,regulation of mechanoreceptor differentiation,BP,HES1
20189,GO:2000980,0.104639241552897,0.995442442682099,1,5,regulation of inner ear receptor cell differentiation,BP,HES1
19718,GO:2000018,0.104855693103985,0.995423138505348,1,5,regulation of male gonad development,BP,SOX9
16608,GO:0097418,0.104932781643077,0.995416253080532,1,5,neurofibrillary tangle,CC,CLU
3387,GO:0007165,0.105057296084049,0.917060262265415,90,3672,signal transduction,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;GPR132;CYP1B1;FAM110C;NOG;PTPRE;RIN2;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;FOS;CDC42EP2;IGFBP2;TUFT1;IL17RA;RHOD;CD3EAP;RBM15;COL1A1;TOB1;EPHB3;HIST1H3J;TLE3;ADGRF1;LRRC8A;CXCL14;PAK6;SIAH2;PLCD1;ESRP2;GADD45B;SLC20A1;PIK3R1;SOX9;CEBPA;CNN2;FAM83A;TIMP3;JRK;STK17A;RIN1;DDIT4;PLEKHM1;ARTN;PYGO2;NR1D1;ING2;TRIM26;NACC2;HIC1;COL1A2;SOCS6;KRT17;IFITM1;ADGRF4;RGS3;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;CDC42SE1;CISH
6566,GO:0022008,0.105193260407299,0.928122548445912,28,1019,neurogenesis,BP,ID1;HES1;CDK5R1;ID3;NOG;FLRT3;APCDD1;TNFRSF21;POU3F1;GDNF;AHNAK2;FZD10;NR2F2;CDHR1;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;SOX9;DDIT4;ARTN;NCDN;PER2;NOTCH3;CLU;IRX5
10383,GO:0043200,0.105269005699741,0.966147701814825,4,82,response to amino acid,BP,CTGF;COL1A1;COL1A2;SOCS1
1377,GO:0003266,0.105312198395385,0.995382285298155,1,5,regulation of secondary heart field cardioblast proliferation,BP,HES1
18581,GO:1903789,0.105368222058418,0.995377258593097,1,5,regulation of amino acid transmembrane transport,BP,PER2
6557,GO:0021984,0.105401683649173,0.99537425489833,1,5,adenohypophysis development,BP,HES1
12266,GO:0048537,0.105461611570194,0.995368872891243,1,5,mucosal-associated lymphoid tissue development,BP,ARTN
12269,GO:0048541,0.105461611570194,0.995368872891243,1,5,Peyer's patch development,BP,ARTN
20222,GO:2001054,0.105505295879022,0.995364947627951,1,5,negative regulation of mesenchymal cell apoptotic process,BP,SOX9
13278,GO:0051952,0.105536564059227,0.982656090931673,2,25,regulation of amine transport,BP,GDNF;PER2
10485,GO:0043374,0.105654295622141,0.995351546138146,1,5,CD8-positive, alpha-beta T cell differentiation,BP,ZBTB7B
2034,GO:0004771,0.105804323188735,0.995338031753298,1,5,sterol esterase activity,MF,CES2
11485,GO:0045933,0.105895259685852,0.982562862023655,2,25,positive regulation of muscle contraction,BP,RGS2;CTGF
15903,GO:0072656,0.106034300671812,0.995317275687021,1,5,maintenance of protein location in mitochondrion,BP,HK2
14658,GO:0070235,0.106275124326692,0.99529548901713,1,5,regulation of activation-induced cell death of T cells,BP,TSC22D3
279,GO:0000781,0.106315868701687,0.955956168648638,6,146,chromosome, telomeric region,CC,HIST1H4L;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
10623,GO:0043615,0.106535924096036,0.995271835478571,1,5,astrocyte cell migration,BP,APCDD1
8469,GO:0033605,0.106738855735953,0.99525338741154,1,5,positive regulation of catecholamine secretion,BP,GDNF
7204,GO:0031089,0.106898573464739,0.995238841385403,1,5,platelet dense granule lumen,CC,TIMP3
10936,GO:0044557,0.107070501353603,0.99522315730466,1,5,relaxation of smooth muscle,BP,RGS2
1987,GO:0004704,0.107203473416689,0.9952110084442,1,5,NF-kappaB-inducing kinase activity,MF,MAP3K14
15846,GO:0072537,0.107305368342555,0.995201687984126,1,5,fibroblast activation,BP,IL17RA
12195,GO:0048318,0.107526328993279,0.99518144383674,1,5,axial mesoderm development,BP,NOG
17784,GO:1901797,0.107541403305155,0.982132526840181,2,25,negative regulation of signal transduction by p53 class mediator,BP,SNAI2;ING2
1408,GO:0003339,0.107577653855411,0.995176735129194,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
14973,GO:0070857,0.107749496469192,0.995160952209235,1,5,regulation of bile acid biosynthetic process,BP,NR1D1
9326,GO:0035795,0.107781534292582,0.995158006703159,1,5,negative regulation of mitochondrial membrane permeability,BP,HK2
19367,GO:1905709,0.107781534292582,0.995158006703159,1,5,negative regulation of membrane permeability,BP,HK2
14178,GO:0061046,0.107785935778062,0.995157601964328,1,5,regulation of branching involved in lung morphogenesis,BP,SOX9
686,GO:0001893,0.107992269148884,0.981974185988204,2,26,maternal placenta development,BP,NR2F2;GJB2
15528,GO:0071895,0.108074009587175,0.995131073601042,1,5,odontoblast differentiation,BP,SERPINE1
5054,GO:0015245,0.108085294817379,0.995130032813276,1,5,fatty acid transmembrane transporter activity,MF,MFSD2A
14273,GO:0061312,0.108246746083469,0.995115130109293,1,5,BMP signaling pathway involved in heart development,BP,NOG
11379,GO:0045736,0.108250413650227,0.981906015829774,2,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,NR2F2;CEBPA
57,GO:0000120,0.108356989439903,0.995104940433254,1,5,RNA polymerase I transcription factor complex,CC,CD3EAP
4476,GO:0010469,0.108374630529985,0.948272926581904,8,215,regulation of signaling receptor activity,BP,PTHLH;SERPINE1;NOG;GDNF;CTGF;CDC42EP2;CXCL14;ARTN
7646,GO:0032052,0.108449454633206,0.995096385398985,1,5,bile acid binding,MF,AKR1C1
19872,GO:2000319,0.108690334282162,0.995074062069382,1,5,regulation of T-helper 17 cell differentiation,BP,ZBTB7B
392,GO:0001047,0.108910390806329,0.958980634598673,5,117,core promoter binding,MF,ZNF750;FOS;SOX9;CIART;NR1D1
7162,GO:0031018,0.10898118918045,0.981712492198521,2,26,endocrine pancreas development,BP,HES1;SOX9
10571,GO:0043527,0.109283191780057,0.99501889320299,1,5,tRNA methyltransferase complex,CC,TRMT61A
6710,GO:0030111,0.109536753746106,0.944989699094477,9,257,regulation of Wnt signaling pathway,BP,SNAI2;NOG;APCDD1;IGFBP2;COL1A1;SIAH2;SOX9;JRK;HIC1
8008,GO:0032627,0.109575489493792,0.994991574688385,1,5,interleukin-23 production,BP,IL17RA
8032,GO:0032667,0.109575489493792,0.994991574688385,1,5,regulation of interleukin-23 production,BP,IL17RA
20259,GO:2001179,0.109605197839746,0.994988793725557,1,5,regulation of interleukin-10 secretion,BP,TNFRSF21
2409,GO:0005578,0.109647213991661,0.950535776769789,7,190,proteinaceous extracellular matrix,CC,ANGPTL4;FLRT3;CTGF;ADAMTS15;COL1A1;TIMP3;COL1A2
6926,GO:0030514,0.109666583409552,0.981492655224495,2,27,negative regulation of BMP signaling pathway,BP,NOG;TOB1
9415,GO:0035976,0.109666719974444,0.994983032139779,1,5,transcription factor AP-1 complex,CC,FOS
1375,GO:0003263,0.109844814972011,0.994966333874746,1,5,cardioblast proliferation,BP,HES1
6979,GO:0030638,0.109918939496843,0.994959375356889,1,5,polyketide metabolic process,BP,AKR1C1
6983,GO:0030647,0.109918939496843,0.994959375356889,1,5,aminoglycoside antibiotic metabolic process,BP,AKR1C1
10942,GO:0044597,0.109918939496843,0.994959375356889,1,5,daunorubicin metabolic process,BP,AKR1C1
10943,GO:0044598,0.109918939496843,0.994959375356889,1,5,doxorubicin metabolic process,BP,AKR1C1
18241,GO:1903026,0.11006407617524,0.994945735908385,1,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,ID1
9984,GO:0042373,0.110213184632426,0.994931703087096,1,5,vitamin K metabolic process,BP,CBR1
7457,GO:0031589,0.110322343543943,0.947107206236238,8,225,cell-substrate adhesion,BP,ID1;NET1;SERPINE1;CTGF;RHOD;COL1A1;EPHB3;PIK3R1
3282,GO:0006970,0.110417767667429,0.971259740795426,3,53,response to osmotic stress,BP,TSC22D3;SLC2A1;LRRC8A
7206,GO:0031091,0.110533640886737,0.971216671465992,3,53,platelet alpha granule,CC,SERPINE1;PCDH7;CLU
1612,GO:0004032,0.110695157855518,0.99488620433846,1,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR1C1
727,GO:0001953,0.11150563174746,0.980999272603232,2,27,negative regulation of cell-matrix adhesion,BP,SERPINE1;PIK3R1
12676,GO:0050867,0.111583851676102,0.949474479485699,7,183,positive regulation of cell activation,BP,HES1;CTGF;MAP3K14;IGFBP2;PIK3R1;SOX15;SOCS1
1413,GO:0003344,0.111688972242909,0.994581817117768,1,6,pericardium morphogenesis,BP,FLRT3
4470,GO:0010463,0.111716572579153,0.980942358034035,2,27,mesenchymal cell proliferation,BP,MYC;SOX9
5853,GO:0017145,0.112000043225351,0.980865769462151,2,27,stem cell division,BP,ZFP36L2;ING2
7605,GO:0031981,0.112110512063857,0.911313610971985,87,3519,nuclear lumen,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;MYC;HR;DUSP5;HIST1H2AG;HIST1H4L;FHL2;RBAK;POU3F1;MAP3K14;TFCP2L1;FZD10;BRPF1;NR2F2;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;RNF168;CD3EAP;RBM15;HIST1H2BI;ZKSCAN4;YPEL4;HIST1H3J;TLE3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;HIST1H4B;IMP3;SOX9;ERF;TRMT61A;CEBPA;CIART;KCTD1;HSPA2;HIST1H2BO;ZBTB34;STK17A;GZF1;PLEKHM1;TGIF1;HIST1H2BE;URB2;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;HIST1H4D;RGS3;NOTCH3;SOCS1;HIST1H2AH;DCLRE1C;FAM217B
932,GO:0002327,0.112193657996548,0.994531571298683,1,6,immature B cell differentiation,BP,LRRC8A
6599,GO:0022612,0.112284270582912,0.963032559381724,4,86,gland morphogenesis,BP,SNAI2;NOG;ESRP2;SOX9
15343,GO:0071549,0.112298013619096,0.980824092279977,2,26,cellular response to dexamethasone stimulus,BP,GJB2;DDIT4
18165,GO:1902893,0.112821286232173,0.980643208729607,2,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,FOS;SOX9
3514,GO:0007435,0.113161894962256,0.980550607630648,2,27,salivary gland morphogenesis,BP,SNAI2;ESRP2
9793,GO:0040008,0.113331620171432,0.933510660313065,14,450,regulation of growth,BP,CDK5R1;SERTAD3;NET1;NOG;CTGF;TFCP2L1;IGFBP2;SOX15;ING2;DNAJB2;SOCS6;KRT17;SOCS1;CISH
11809,GO:0046677,0.113408315461948,0.945311383218532,8,219,response to antibiotic,BP,ID1;NET1;TXNIP;ID3;CYP1B1;COL1A1;GJB2;CLU
3699,GO:0008206,0.113586748035032,0.980474488243051,2,26,bile acid metabolic process,BP,AKR1C1;NR1D1
1358,GO:0003223,0.11387613267149,0.994362309753397,1,6,ventricular compact myocardium morphogenesis,BP,NOG
6827,GO:0030282,0.113959776564558,0.969899269963748,3,55,bone mineralization,BP,PTHLH;TUFT1;SOX9
2643,GO:0005977,0.114136601561539,0.969832497576353,3,55,glycogen metabolic process,BP,PPP1R3D;NR1D1;PER2
13909,GO:0060537,0.114800013690468,0.944464067772037,8,228,muscle tissue development,BP,TIPARP;TSC22D3;NOG;FHL2;NR2F2;FOS;SOX9;SOX15
6941,GO:0030545,0.115416197051188,0.947314892190628,7,182,receptor regulator activity,MF,PTHLH;FLRT3;GDNF;CTGF;CDC42EP2;CXCL14;ARTN
12285,GO:0048583,0.115790814313524,0.909970977622239,68,2719,regulation of response to stimulus,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;NET1;SERPINE1;MYC;CYP1B1;FAM110C;NOG;PTPRE;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;FZD10;BRPF1;HIST1H2BJ;BCDIN3D;FOS;RNF168;CDC42EP2;IGFBP2;IL17RA;RHOD;VSNL1;COL1A1;TOB1;EPHB3;CXCL14;PAK6;SIAH2;ZBTB7B;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;DDIT4;ARTN;SOX15;NR1D1;ING2;PER2;NACC2;HIC1;COL1A2;SOCS6;IFITM1;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
10358,GO:0043167,0.115976808051729,0.907071412142813,105,4373,ion binding,MF,TIPARP;SNAI2;CDK5R1;IRF2BPL;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;ZNF557;ZNF750;ZNF419;ZNF296;FHL2;ZNF222;ZNF561;RBAK;MGAT1;ZNF526;ZNF841;ZNF574;CTGF;MAP3K14;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;TUBA4A;ZFP36L2;PHF13;TRIM35;CDHR1;ZNF398;CHAMP1;ZNF256;FHL3;RNF168;ZNF416;RHOD;ZCCHC3;PCDH7;ZNF3;ZKSCAN4;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;EPHB3;ZNF200;ZNF549;PAK6;ZNF570;RNF39;ZNF93;SIAH2;PLCD1;UPF1;ZBTB7B;ZNF581;SEC14L2;PXDC1;ZNF776;ZNF530;ZMYND19;HSPA2;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;AKR1C1;GZF1;SNX33;PLEKHM1;ZNF160;ZNF169;PCYT1A;PYGO2;NR1D1;FKBP9;ING2;ZNF589;PHC2;ZADH2;ZNF672;BRF2;TRIM26;HIC1;COL1A2;ZNF16;ZNF766;ZNF701;NT5DC3;TRIM56;ZNF845;ZNF510;HK2;NOTCH3;KLF16;ZNF14;ZCCHC2;VPS18
3530,GO:0007517,0.11603249586356,0.94373139063968,8,229,muscle organ development,BP,TSC22D3;ID3;NOG;NR2F2;FOS;FHL3;TAGLN;SOX15
14189,GO:0061061,0.116412768226607,0.934510461926281,12,381,muscle structure development,BP,HES1;TSC22D3;ID3;NOG;FHL2;NR2F2;FOS;FHL3;CXCL14;TAGLN;SOX9;SOX15
16240,GO:0090276,0.116420104014748,0.955258941657324,5,118,regulation of peptide hormone secretion,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
10201,GO:0042802,0.116614063507471,0.917545292682456,32,1165,identical protein binding,MF,ID1;HES1;SLC2A1;MAT2A;ANGPTL4;NOG;FLRT3;HSPB1;APCDD1;KCTD15;FHL2;GDNF;NR2F2;HIST1H2BI;ZNF3;ZKSCAN4;COL1A1;LRRC8A;HJURP;ZBTB7B;CEBPA;GJB2;ALDH4A1;KCTD1;SNX33;HIST1H2BE;ZNF783;PCYT1A;PHC2;NACC2;COL1A2;NOTCH3
15585,GO:0072033,0.116814997550956,0.994060153737964,1,6,renal vesicle formation,BP,SOX9
12294,GO:0048598,0.11713883826429,0.934033132575094,12,379,embryonic morphogenesis,BP,HES1;DUSP4;NOG;DUSP5;FLRT3;GDNF;HOXA9;LRIG3;VASP;SOX9;HOXA5;IRX5
13699,GO:0060219,0.117802838828719,0.993956729450455,1,6,camera-type eye photoreceptor cell differentiation,BP,SOX9
18952,GO:1904683,0.117918073665224,0.993944603599508,1,6,regulation of metalloendopeptidase activity,BP,TIMP3
12913,GO:0051246,0.118129851546613,0.91051760992477,52,2017,regulation of protein metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;SERPINE1;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;HIST1H4L;CTGF;MAP3K14;FZD10;NR2F2;ZFP36L2;BCDIN3D;FAM212B;TOB1;EPHB3;HIST1H3J;PAK6;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;IMP3;SOX9;CEBPA;HSPA2;TIMP3;DDIT4;SNX33;PYGO2;ING2;HIST1H4K;PER2;DNAJB2;SOCS6;KRT17;HIST1H4D;RGS3;PMEPA1;SOCS1;CLU;CISH
82,GO:0000165,0.11817449646603,0.9254484918815,18,607,MAPK cascade,BP,ID1;SPRY4;RGS2;DUSP4;MYC;DUSP5;GDNF;CTGF;MAP3K14;FZD10;ZFP36L2;EPHB3;PAK6;GADD45B;SOX9;TIMP3;ARTN;RGS3
14263,GO:0061299,0.118179274411113,0.993917070875787,1,6,retina vasculature morphogenesis in camera-type eye,BP,CYP1B1
2709,GO:0006073,0.118410042001409,0.968187044877925,3,56,cellular glucan metabolic process,BP,PPP1R3D;NR1D1;PER2
10724,GO:0044042,0.118410042001409,0.968187044877925,3,56,glucan metabolic process,BP,PPP1R3D;NR1D1;PER2
11421,GO:0045820,0.118441468645614,0.993889367431938,1,6,negative regulation of glycolytic process,BP,DDIT4
12888,GO:0051198,0.118441468645614,0.993889367431938,1,6,negative regulation of coenzyme metabolic process,BP,DDIT4
3519,GO:0007492,0.118464333546745,0.968149624571634,3,57,endoderm development,BP,DUSP4;NOG;DUSP5
9676,GO:0038034,0.118481632966018,0.968194493015479,3,54,signal transduction in absence of ligand,BP,SNAI2;GDNF;BAG3
16507,GO:0097192,0.118481632966018,0.968194493015479,3,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,SNAI2;GDNF;BAG3
11135,GO:0045165,0.118657841305916,0.954116012102793,5,121,cell fate commitment,BP,HES1;NR2F2;SOX9;SOX12;NOTCH3
20185,GO:2000973,0.118762604401017,0.993855346101871,1,6,regulation of pro-B cell differentiation,BP,HES1
8477,GO:0033619,0.118877658724216,0.968024329040927,3,55,membrane protein proteolysis,BP,TIMP3;SNX33;NOTCH3
18362,GO:1903313,0.119044093269593,0.967942961646238,3,56,positive regulation of mRNA metabolic process,BP,ZFP36L2;TOB1;UPF1
8219,GO:0032970,0.119153787288982,0.939089435207014,9,265,regulation of actin filament-based process,BP,ID1;CDK5R1;CTGF;FZD10;CDC42EP2;RHOD;VASP;PIK3R1;CNN2
4359,GO:0009952,0.119276865695086,0.953797511637911,5,122,anterior/posterior pattern specification,BP,HES1;NOG;NR2F2;HOXA9;HOXA5
6801,GO:0030238,0.11942471469033,0.993784888326776,1,6,male sex determination,BP,SOX9
2256,GO:0005168,0.119492964551748,0.993777601582888,1,6,neurotrophin TRKA receptor binding,MF,PIK3R1
10108,GO:0042622,0.119891641043137,0.99373494691484,1,6,photoreceptor outer segment membrane,CC,CDHR1
19135,GO:1905049,0.120015234088824,0.993721692500861,1,6,negative regulation of metallopeptidase activity,BP,TIMP3
11733,GO:0046530,0.120163325430653,0.978569148629921,2,28,photoreceptor cell differentiation,BP,CDHR1;SOX9
15374,GO:0071599,0.120541442710529,0.993665095753786,1,6,otic vesicle development,BP,SOX9
6125,GO:0019369,0.120575237910718,0.978492623937116,2,27,arachidonic acid metabolic process,BP,CYP1B1;CBR1
10231,GO:0042908,0.120994937364003,0.993616105473454,1,6,xenobiotic transport,BP,SLC2A1
10232,GO:0042910,0.120994937364003,0.993616105473454,1,6,xenobiotic transmembrane transporter activity,MF,SLC2A1
15816,GO:0072497,0.121107092282984,0.993603958942291,1,6,mesenchymal stem cell differentiation,BP,SOX9
12679,GO:0050870,0.121363199678299,0.952768832553336,5,118,positive regulation of T cell activation,BP,HES1;MAP3K14;IGFBP2;PIK3R1;SOCS1
3380,GO:0007158,0.121672899821858,0.993542495972775,1,6,neuron cell-cell adhesion,BP,CDK5R1
7613,GO:0031995,0.121689377281986,0.993540701412107,1,6,insulin-like growth factor II binding,MF,IGFBP2
13896,GO:0060513,0.121753023183403,0.993533767271076,1,6,prostatic bud formation,BP,NOG
12911,GO:0051240,0.121788348986946,0.91599443408259,27,982,positive regulation of multicellular organismal process,BP,RGS2;HES1;SERPINE1;MYC;ANGPTL4;CYP1B1;NOG;FLRT3;HSPB1;GDNF;CTGF;FOS;IL17RA;COL1A1;EPHB3;AKIRIN2;PIK3R1;SOX9;CEBPA;PLEKHM1;HOXA5;ZNF16;KRT17;IFITM1;HK2;SOCS1;CLU
8956,GO:0035014,0.121928745334947,0.993514602237017,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1
801,GO:0002067,0.12250617847847,0.97790221151505,2,28,glandular epithelial cell differentiation,BP,HES1;HOXA5
6916,GO:0030502,0.122592045860951,0.993441990707058,1,6,negative regulation of bone mineralization,BP,SOX9
8302,GO:0033131,0.12261930300261,0.993438997763812,1,6,regulation of glucokinase activity,BP,MIDN
14203,GO:0061088,0.12270269840447,0.99342983615054,1,6,regulation of sequestering of zinc ion,BP,SLC30A1
14833,GO:0070562,0.122710034744264,0.993429029876288,1,6,regulation of vitamin D receptor signaling pathway,BP,SNAI2
20140,GO:2000794,0.122806466571497,0.99341842703862,1,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,SOX9
10795,GO:0044262,0.12290488006888,0.942995714786833,7,191,cellular carbohydrate metabolic process,BP,SLC2A1;MIDN;PPP1R3D;DDIT4;NR1D1;PER2;HK2
19117,GO:1905005,0.12293727478999,0.993404030076259,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,NOG
17645,GO:1901342,0.122949484401901,0.942966242010515,7,192,regulation of vasculature development,BP,ID1;SERPINE1;ANGPTL4;CYP1B1;HSPB1;HOXA5;HK2
14084,GO:0060850,0.122986419032956,0.99339861690203,1,6,regulation of transcription involved in cell fate commitment,BP,NR2F2
14094,GO:0060897,0.123140766756977,0.99338160049873,1,6,neural plate regionalization,BP,NOG
9673,GO:0038030,0.123183733702894,0.99337685940943,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD10
12544,GO:0050679,0.123218481660021,0.951804421385032,5,121,positive regulation of epithelial cell proliferation,BP,ID1;MYC;NOG;ESRP2;SOX9
18700,GO:1904030,0.123249339464551,0.977688979797074,2,28,negative regulation of cyclin-dependent protein kinase activity,BP,NR2F2;CEBPA
16445,GO:0097084,0.123453993681979,0.99334699720249,1,6,vascular smooth muscle cell development,BP,HES1
14719,GO:0070341,0.1235359567329,0.993337926765841,1,6,fat cell proliferation,BP,PER2
14721,GO:0070344,0.1235359567329,0.993337926765841,1,6,regulation of fat cell proliferation,BP,PER2
9696,GO:0038089,0.123619215594496,0.993328706265274,1,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,HSPB1
8080,GO:0032754,0.123692804940902,0.993320551023552,1,6,positive regulation of interleukin-5 production,BP,IL17RA
15692,GO:0072203,0.123700254414736,0.993319725173274,1,6,cell proliferation involved in metanephros development,BP,MYC
16841,GO:0098722,0.12381170416929,0.993307363409175,1,6,asymmetric stem cell division,BP,ING2
6880,GO:0030368,0.123960401813506,0.993290851445984,1,6,interleukin-17 receptor activity,MF,IL17RA
717,GO:0001939,0.124070293705446,0.993278634852167,1,6,female pronucleus,CC,SLC2A1
12247,GO:0048505,0.124369893427402,0.99324526911867,1,6,regulation of timing of cell differentiation,BP,HES1
6101,GO:0019317,0.124390421391454,0.993242979780193,1,6,fucose catabolic process,BP,FUT1
9970,GO:0042354,0.124390421391454,0.993242979780193,1,6,L-fucose metabolic process,BP,FUT1
9971,GO:0042355,0.124390421391454,0.993242979780193,1,6,L-fucose catabolic process,BP,FUT1
14271,GO:0061309,0.124412905739376,0.993240471791103,1,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,HES1
13272,GO:0051938,0.12443257371433,0.993238277548853,1,6,L-glutamate import,BP,PER2
16838,GO:0098712,0.12443257371433,0.993238277548853,1,6,L-glutamate import across plasma membrane,BP,PER2
13996,GO:0060693,0.124477259825187,0.993233290783214,1,6,regulation of branching involved in salivary gland morphogenesis,BP,SNAI2
7482,GO:0031642,0.124489936469492,0.99323187577502,1,6,negative regulation of myelination,BP,TNFRSF21
12326,GO:0048667,0.124552235849539,0.929083680701142,12,388,cell morphogenesis involved in neuron differentiation,BP,ID1;HES1;CDK5R1;NOG;FLRT3;GDNF;CDHR1;EPHB3;SIAH2;VASP;PIK3R1;ARTN
1285,GO:0003084,0.124674901111141,0.993211211690281,1,6,positive regulation of systemic arterial blood pressure,BP,NR2F2
3404,GO:0007186,0.12517188141757,0.928684594035306,12,377,G-protein coupled receptor signaling pathway,BP,RGS2;CDK5R1;PTHLH;NET1;GPR132;FZD10;ADGRF1;PIK3R1;ADGRF4;RGS3;KLF16;CISH
17686,GO:1901533,0.125298388802532,0.99314131162986,1,6,negative regulation of hematopoietic progenitor cell differentiation,BP,HES1
15361,GO:0071578,0.125415483948996,0.99312814183877,1,6,zinc ion import across plasma membrane,BP,SLC30A1
19432,GO:1905941,0.125517890555504,0.993116613165083,1,6,positive regulation of gonad development,BP,SOX9
1376,GO:0003264,0.125650032947826,0.993101721860158,1,6,regulation of cardioblast proliferation,BP,HES1
4497,GO:0010519,0.125681527197788,0.993098170227315,1,6,negative regulation of phospholipase activity,BP,RGS2
13257,GO:0051917,0.125753812180867,0.993090014945365,1,6,regulation of fibrinolysis,BP,SERPINE1
20221,GO:2001053,0.125881246771677,0.993075625251135,1,6,regulation of mesenchymal cell apoptotic process,BP,SOX9
3675,GO:0008173,0.126016322189749,0.96523758976133,3,55,RNA methyltransferase activity,MF,METTL15;BCDIN3D;TRMT61A
9074,GO:0035312,0.126188152189738,0.993040905245278,1,6,5'-3' exodeoxyribonuclease activity,MF,DCLRE1C
15872,GO:0072577,0.126226433482204,0.976786752324078,2,29,endothelial cell apoptotic process,BP,SERPINE1;ANGPTL4
13918,GO:0060548,0.126477189894117,0.917487380471864,20,690,negative regulation of cell death,BP,ID1;SNAI2;TSC22D3;IVNS1ABP;SERPINE1;MYC;ANGPTL4;NOG;HSPB1;FHL2;GDNF;CTGF;BAG3;EPHB3;SIAH2;PIK3R1;SOX9;ING2;ZNF16;CLU
14174,GO:0061042,0.126575384438939,0.992996967255683,1,6,vascular wound healing,BP,SERPINE1
14750,GO:0070410,0.126891813303192,0.992767598393131,1,7,co-SMAD binding,MF,TGIF1
6921,GO:0030509,0.126913113233102,0.956323519642768,4,91,BMP signaling pathway,BP,ID1;HES1;NOG;TOB1
13919,GO:0060556,0.127088720954474,0.992938495775796,1,6,regulation of vitamin D biosynthetic process,BP,SNAI2
6129,GO:0019373,0.127109772975993,0.992936092376114,1,6,epoxygenase P450 pathway,BP,CYP1B1
16623,GO:0097449,0.127238803630244,0.992921352192754,1,6,astrocyte projection,CC,GJB2
16186,GO:0090193,0.127291011982933,0.992915383417428,1,6,positive regulation of glomerulus development,BP,NOG
15595,GO:0072050,0.12737288865145,0.992906017435917,1,6,S-shaped body morphogenesis,BP,HES1
10856,GO:0044351,0.127562639644367,0.992884286471253,1,6,macropinocytosis,BP,SNX33
8072,GO:0032736,0.127600996680777,0.992879889425143,1,6,positive regulation of interleukin-13 production,BP,IL17RA
14075,GO:0060839,0.127743172844175,0.992863578606906,1,6,endothelial cell fate commitment,BP,NR2F2
4268,GO:0009611,0.127808898758059,0.925137790343745,13,418,response to wounding,BP,SERPINE1;ID3;NOG;FLRT3;HSPB1;CTGF;ZFP36L2;COL1A1;HIST1H3J;BLOC1S3;PIK3R1;SOX15;COL1A2
4275,GO:0009629,0.127946723471356,0.992840192470878,1,6,response to gravity,BP,FOS
18781,GO:1904251,0.128186509157461,0.992812591455226,1,6,regulation of bile acid metabolic process,BP,NR1D1
19851,GO:2000288,0.128365920920492,0.992791903246242,1,6,positive regulation of myoblast proliferation,BP,SOX15
1157,GO:0002762,0.128501571893356,0.976118041341082,2,29,negative regulation of myeloid leukocyte differentiation,BP,MYC;PIK3R1
803,GO:0002069,0.128579723990265,0.992767208343653,1,6,columnar/cuboidal epithelial cell maturation,BP,HOXA5
3015,GO:0006560,0.128598156720387,0.992765077220113,1,6,proline metabolic process,BP,ALDH4A1
20293,GO:2001236,0.12866286366837,0.949006707762926,5,121,regulation of extrinsic apoptotic signaling pathway,BP,SNAI2;SERPINE1;GDNF;SIAH2;TIMP3
7900,GO:0032464,0.128732961965375,0.992749481465822,1,6,positive regulation of protein homooligomerization,BP,CLU
17772,GO:1901724,0.128741354686937,0.992748509917268,1,6,positive regulation of cell proliferation involved in kidney development,BP,MYC
12352,GO:0048704,0.129046511688988,0.96397618999936,3,58,embryonic skeletal system morphogenesis,BP,NOG;HOXA5;IRX5
11292,GO:0045591,0.12914228334846,0.992702018016022,1,6,positive regulation of regulatory T cell differentiation,BP,SOCS1
17876,GO:1902075,0.129145197287159,0.992701679539946,1,6,cellular response to salt,BP,ZNF16
11707,GO:0046487,0.129392729507949,0.992672896537796,1,6,glyoxylate metabolic process,BP,ALDH4A1
601,GO:0001766,0.129499029256228,0.992660517661465,1,6,membrane raft polarization,BP,MALL
7450,GO:0031580,0.129499029256228,0.992660517661465,1,6,membrane raft distribution,BP,MALL
15893,GO:0072608,0.129798540419548,0.992625579473486,1,6,interleukin-10 secretion,BP,TNFRSF21
13089,GO:0051583,0.130161436643263,0.992583129952926,1,6,dopamine uptake involved in synaptic transmission,BP,GDNF
13269,GO:0051934,0.130161436643263,0.992583129952926,1,6,catecholamine uptake involved in synaptic transmission,BP,GDNF
16325,GO:0090493,0.130161436643263,0.992583129952926,1,6,catecholamine uptake,BP,GDNF
16326,GO:0090494,0.130161436643263,0.992583129952926,1,6,dopamine uptake,BP,GDNF
287,GO:0000791,0.130547465802658,0.975552321726163,2,28,euchromatin,CC,HIST1H1C;HIST1H1D
7320,GO:0031325,0.130605944293898,0.899627411593067,55,2178,positive regulation of cellular metabolic process,BP,HES1;SNAI2;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;SERPINE1;MYC;NOG;DUSP5;SERTAD1;ZNF750;HSPB1;FHL2;POU3F1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HOXA9;ZFP36L2;BCDIN3D;ZNF398;FOS;RNF168;RBM15;COL1A1;TOB1;EPHB3;PAK6;UPF1;AKIRIN2;ZBTB7B;GADD45B;SEC14L2;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;SNX33;SOX15;NR1D1;ING2;HOXA5;ZNF16;KRT17;SOX12;HK2;NOTCH3;SOCS1;CLU
16070,GO:0086103,0.130856905676317,0.992295713464469,1,7,G-protein coupled receptor signaling pathway involved in heart process,BP,RGS2
13052,GO:0051495,0.131386811085273,0.94232085311505,6,158,positive regulation of cytoskeleton organization,BP,ID1;RGS2;CDK5R1;CTGF;CDC42EP2;VASP
17933,GO:1902231,0.131548564411257,0.992419684842942,1,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,NACC2
16260,GO:0090303,0.131711661377628,0.975161795429301,2,29,positive regulation of wound healing,BP,SERPINE1;SOX15
2198,GO:0005068,0.13191518866152,0.992167105040681,1,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
7171,GO:0031047,0.132589903615263,0.941663469179549,6,155,gene silencing by RNA,BP,HIST1H4L;BCDIN3D;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
15239,GO:0071383,0.132878093055007,0.937158926879645,7,195,cellular response to steroid hormone stimulus,BP,FHL2;NR2F2;ZFP36L2;GJB2;DDIT4;NR1D1;PMEPA1
12819,GO:0051100,0.132934052384279,0.946775937404361,5,122,negative regulation of binding,BP,ID1;ID3;NOG;PER2;DNAJB2
6851,GO:0030315,0.132964405155433,0.974706781386333,2,31,T-tubule,CC,AHNAK2;SLC30A1
11328,GO:0045639,0.13300912150518,0.962376625612466,3,58,positive regulation of myeloid cell differentiation,BP,FOS;HOXA5;ZNF16
3308,GO:0007009,0.133106907751844,0.962301608532998,3,60,plasma membrane organization,BP,AHNAK2;SNX33;CLU
8214,GO:0032964,0.133351182652845,0.974667675543555,2,29,collagen biosynthetic process,BP,CTGF;COL1A1
12623,GO:0050790,0.133385913619152,0.900529597904097,42,1615,regulation of catalytic activity,BP,SPRY4;RGS2;CDK5R1;DUSP4;MIDN;NET1;TXNIP;SERPINE1;MYC;ANGPTL4;RIN2;DUSP5;SERTAD1;FLRT3;HSPB1;GDNF;CTGF;MAP3K14;BAG3;FZD10;NR2F2;CDC42EP2;FAM212B;EPHB3;PAK6;SIAH2;AKIRIN2;GADD45B;PIK3R1;CEBPA;HSPA2;TIMP3;RIN1;RUNDC1;DNAJB2;ZNF16;SOCS6;RGS3;SOCS1;CLU;CDC42SE1;CISH
9688,GO:0038063,0.133404784857892,0.991984174877881,1,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,COL1A1
4835,GO:0014037,0.133461537988322,0.974556035270088,2,31,Schwann cell differentiation,BP,POU3F1;AHNAK2
17911,GO:1902186,0.133821111378223,0.974525336230458,2,29,regulation of viral release from host cell,BP,TRIM35;TRIM26
13782,GO:0060346,0.134321950834583,0.991870431781284,1,7,bone trabecula formation,BP,COL1A1
131,GO:0000271,0.135101070281217,0.96150464160689,3,59,polysaccharide biosynthetic process,BP,PPP1R3D;NR1D1;PER2
1448,GO:0003674,0.135631058757058,0.916535066492511,254,11313,molecular_function,MF,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;NOG;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;APCDD1;KCTD15;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;SLC7A5P2;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;CDR2L;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;ZCCHC3;CD3EAP;SLC22A15;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;MN1;CXCL14;PAK6;ZNF570;RNF39;ZNF93;SIAH2;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;L3HYPDH;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;PXDC1;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;IFFO1;SOX12;GFOD1;ZNF766;IFITM1;TBCC;ZNF701;NT5DC3;TRIM56;TMEM139;ADGRF4;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;ZCCHC2;VPS18;IRX5;CISH
5229,GO:0015837,0.135757847601323,0.973935367188759,2,29,amine transport,BP,GDNF;PER2
1435,GO:0003407,0.135859149539495,0.973824018852144,2,31,neural retina development,BP,SOX9;IRX5
6700,GO:0030073,0.135933071574819,0.945177944597837,5,125,insulin secretion,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
17885,GO:1902105,0.136053294594632,0.939694212107149,6,159,regulation of leukocyte differentiation,BP,MYC;ZFP36L2;FOS;ZBTB7B;PIK3R1;SOCS1
3083,GO:0006656,0.136282504528212,0.973774622031922,2,29,phosphatidylcholine biosynthetic process,BP,MFSD2A;PCYT1A
13786,GO:0060350,0.13638001179713,0.973702927745227,2,30,endochondral bone morphogenesis,BP,COL1A1;SOX9
14509,GO:0061971,0.13638001179713,0.973702927745227,2,30,replacement bone morphogenesis,BP,COL1A1;SOX9
11261,GO:0045475,0.136645217316325,0.99157851520082,1,7,locomotor rhythm,BP,CIART
2710,GO:0006081,0.136839028928795,0.960828103016462,3,57,cellular aldehyde metabolic process,BP,CYP1B1;ALDH4A1;AKR1C1
19288,GO:1905456,0.137962654809308,0.991410557672489,1,7,regulation of lymphoid progenitor cell differentiation,BP,HES1
14029,GO:0060736,0.138073053913967,0.991396403357822,1,7,prostate gland growth,BP,SOX9
11493,GO:0045944,0.138196091146736,0.90693049974753,22,792,positive regulation of transcription by RNA polymerase II,BP,HES1;IRF2BPL;SERPINE1;MYC;NOG;SERTAD1;ZNF750;POU3F1;GDNF;HOXA9;FOS;RBM15;AKIRIN2;ZBTB7B;PIK3R1;SOX9;CEBPA;SOX15;NR1D1;HOXA5;SOX12;NOTCH3
14069,GO:0060828,0.138783228726911,0.933648670410283,7,196,regulation of canonical Wnt signaling pathway,BP,SNAI2;NOG;IGFBP2;COL1A1;SIAH2;SOX9;JRK
679,GO:0001886,0.138884329000475,0.991292010778242,1,7,endothelial cell morphogenesis,BP,ID1
6594,GO:0022603,0.138964996002129,0.908170082735716,20,713,regulation of anatomical structure morphogenesis,BP,ID1;HES1;SNAI2;CDK5R1;NET1;SERPINE1;MYC;ANGPTL4;CYP1B1;NOG;HSPB1;GDNF;CDC42EP2;RHOD;EPHB3;SOX9;HOXA5;PALMD;HK2;CDC42SE1
10030,GO:0042471,0.139113303173245,0.95983049135422,3,60,ear morphogenesis,BP,NOG;LRIG3;SOX9
3711,GO:0008219,0.139260655608282,0.896058255602501,41,1571,cell death,BP,ID1;SNAI2;TSC22D3;CDK5R1;IVNS1ABP;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;HSPB1;FHL2;LGALS7B;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;TRIM35;FOS;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TIMP3;STK17A;DDIT4;KRT16;ING2;HOXA5;NACC2;HIC1;ZNF16;KRT17;HK2;CLU
9424,GO:0035988,0.139408220246437,0.991224243477511,1,7,chondrocyte proliferation,BP,CTGF
15680,GO:0072189,0.139824125180746,0.991170246388134,1,7,ureter development,BP,SOX9
14756,GO:0070419,0.14033991349822,0.991103037535534,1,7,nonhomologous end joining complex,CC,DCLRE1C
609,GO:0001775,0.140357570056454,0.903679541451937,24,863,cell activation,BP,HES1;HSPB1;TNFRSF21;CTGF;MAP3K14;HOXA9;ZFP36L2;RNF168;IGFBP2;IL17RA;ZNF3;COL1A1;LRRC8A;ZBTB7B;BLOC1S3;SLC2A3;PIK3R1;CNN2;SOX15;COL1A2;SOCS6;SOCS1;CLU;DCLRE1C
2253,GO:0005165,0.140436813164272,0.991090381060128,1,7,neurotrophin receptor binding,MF,PIK3R1
2255,GO:0005167,0.140436813164272,0.991090381060128,1,7,neurotrophin TRK receptor binding,MF,PIK3R1
382,GO:0001016,0.140467456133808,0.991086376667409,1,7,RNA polymerase III regulatory region DNA binding,MF,BRF2
3664,GO:0008152,0.14053530771225,0.887647981281942,191,8267,metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;HES2;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;HIST1H2BJ;ZFP36L2;BCDIN3D;ZNF398;FOS;ZNF256;RNF168;ZNF416;IGFBP2;KCTD7;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;COL1A1;TOB1;EPHB3;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;CBR1;MN1;PAK6;ZNF570;ZNF93;SIAH2;SWT1;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;ZNF530;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;STK17A;ZNF275;AKR1C1;DDIT4;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;FBXL12;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;TRIM26;NACC2;HIC1;COL1A2;ZNF16;SOCS6;KRT17;SOX12;GFOD1;ZNF766;ZNF701;NT5DC3;TRIM56;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;VPS18;IRX5;CISH
19838,GO:2000271,0.14056486555314,0.991073640966321,1,7,positive regulation of fibroblast apoptotic process,BP,STK17A
1438,GO:0003413,0.140896968741922,0.991030147991036,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,SOX9
12783,GO:0051045,0.141177625262429,0.990993305195331,1,7,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP3
6638,GO:0023014,0.141317276054609,0.908546225340323,18,625,signal transduction by protein phosphorylation,BP,ID1;SPRY4;RGS2;DUSP4;MYC;DUSP5;GDNF;CTGF;MAP3K14;FZD10;ZFP36L2;EPHB3;PAK6;GADD45B;SOX9;TIMP3;ARTN;RGS3
5099,GO:0015370,0.141492411241579,0.972071764892712,2,31,solute:sodium symporter activity,MF,SLC20A2;SLC20A1
14934,GO:0070775,0.141802248523725,0.990911021140095,1,7,H3 histone acetyltransferase complex,CC,BRPF1
14935,GO:0070776,0.141802248523725,0.990911021140095,1,7,MOZ/MORF histone acetyltransferase complex,CC,BRPF1
3746,GO:0008284,0.141880386901346,0.910645519246495,16,544,positive regulation of cell proliferation,BP,ID1;HES1;PTHLH;MYC;NOG;SERTAD1;GDNF;CTGF;IGFBP2;AKIRIN2;ESRP2;SOX9;SOX15;NACC2;ZNF16;NOTCH3
7771,GO:0032287,0.142141145166584,0.990684378096185,1,8,peripheral nervous system myelin maintenance,BP,AHNAK2
11741,GO:0046543,0.142148574782167,0.990865227166657,1,7,development of secondary female sexual characteristics,BP,IRF2BPL
9345,GO:0035845,0.142325948686942,0.990841726118206,1,7,photoreceptor cell outer segment organization,BP,CDHR1
18354,GO:1903299,0.142513426290333,0.990816851559942,1,7,regulation of hexokinase activity,BP,MIDN
14616,GO:0070168,0.142563000111549,0.990810268113093,1,7,negative regulation of biomineral tissue development,BP,SOX9
2650,GO:0005984,0.142580692680986,0.990807917918262,1,7,disaccharide metabolic process,BP,SLC2A1
3158,GO:0006766,0.14259999022392,0.948834579709828,4,91,vitamin metabolic process,BP,SNAI2;SLC2A1;CBR1;SLC2A3
7,GO:0000014,0.142637613083916,0.990800354725806,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,DCLRE1C
6660,GO:0030007,0.142749164267178,0.99078552299756,1,7,cellular potassium ion homeostasis,BP,KCTD7
8662,GO:0034214,0.143481773232265,0.990687800938252,1,7,protein hexamerization,BP,MAT2A
16482,GO:0097152,0.143487927305207,0.990686977734323,1,7,mesenchymal cell apoptotic process,BP,SOX9
5421,GO:0016264,0.14349608250698,0.99068588678847,1,7,gap junction assembly,BP,GJB2
6834,GO:0030291,0.143535989018614,0.971467039039196,2,30,protein serine/threonine kinase inhibitor activity,MF,HSPB1;FAM212B
12278,GO:0048562,0.143628731523425,0.935346907517276,6,165,embryonic organ morphogenesis,BP,HES1;NOG;LRIG3;SOX9;HOXA5;IRX5
556,GO:0001678,0.143690135325681,0.948290172369719,4,92,cellular glucose homeostasis,BP,VSNL1;PIK3R1;NR1D1;HK2
9472,GO:0036089,0.144203659244763,0.990590973788257,1,7,cleavage furrow formation,BP,SNX33
9178,GO:0035542,0.144238697346473,0.990586260566629,1,7,regulation of SNARE complex assembly,BP,VPS18
7485,GO:0031645,0.144625847650185,0.990534098808562,1,7,negative regulation of neurological system process,BP,TNFRSF21
2932,GO:0006449,0.144671238087261,0.990527973212572,1,7,regulation of translational termination,BP,UPF1
4609,GO:0010721,0.144671293016892,0.930085397326456,7,202,negative regulation of cell development,BP,ID1;HES1;CDK5R1;ID3;NOG;SOX9;NOTCH3
12677,GO:0050868,0.144704127914917,0.957483694472363,3,60,negative regulation of T cell activation,BP,TNFRSF21;ZBTB7B;SOCS6
15177,GO:0071285,0.144808326260948,0.990509459913694,1,7,cellular response to lithium ion,BP,CEBPA
9810,GO:0040034,0.144810460209013,0.990509171579395,1,7,regulation of development, heterochronic,BP,HES1
6127,GO:0019371,0.144843188598721,0.990504748809562,1,7,cyclooxygenase pathway,BP,CBR1
12313,GO:0048642,0.145022826451218,0.990480453854466,1,7,negative regulation of skeletal muscle tissue development,BP,TSC22D3
2287,GO:0005243,0.145122061608646,0.99046701874691,1,7,gap junction channel activity,MF,GJB2
13662,GO:0060155,0.14545059720423,0.990422467609685,1,7,platelet dense granule organization,BP,BLOC1S3
14331,GO:0061469,0.145485913835261,0.990417671921544,1,7,regulation of type B pancreatic cell proliferation,BP,NR1D1
6503,GO:0021861,0.14567803006599,0.990391561883419,1,7,forebrain radial glial cell differentiation,BP,HES1
7412,GO:0031490,0.14568738395992,0.947308901019539,4,92,chromatin DNA binding,MF,HR;HIST1H3J;HIST1H1C;HIST1H1D
13625,GO:0060081,0.145751009256314,0.990381633569597,1,7,membrane hyperpolarization,BP,KCTD7
3919,GO:0008584,0.145910924706982,0.947187562781268,4,93,male gonad development,BP,HOXA9;SOX9;SOX15;ING2
13161,GO:0051716,0.145921939328705,0.881065079773154,111,4670,cellular response to stimulus,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ID3;CYP1B1;FAM110C;NOG;PTPRE;RIN2;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;HIST1H4L;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;RNF168;CDC42EP2;IGFBP2;TUFT1;IL17RA;RHOD;CD3EAP;RBM15;VSNL1;COL1A1;TOB1;EPHB3;HIST1H3J;TLE3;ADGRF1;LRRC8A;CXCL14;PAK6;SIAH2;PLCD1;UPF1;ESRP2;BLOC1S3;GADD45B;HIST1H4B;SLC20A1;PIK3R1;SOX9;CEBPA;CNN2;GJB2;FAM83A;HSPA2;TIMP3;JRK;STK17A;RIN1;AKR1C1;DDIT4;PLEKHM1;TGIF1;ARTN;PYGO2;NR1D1;ING2;HIST1H4K;CES2;BRF2;TRIM26;NACC2;HIC1;COL1A2;ZNF16;SOCS6;KRT17;IFITM1;ADGRF4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;CDC42SE1;DCLRE1C;CISH
18021,GO:1902475,0.145944282187626,0.970655069544335,2,31,L-alpha-amino acid transmembrane transport,BP,SLC7A5P2;PER2
9864,GO:0042110,0.145968501049895,0.92208059762634,9,272,T cell activation,BP,HES1;TNFRSF21;MAP3K14;ZFP36L2;IGFBP2;ZBTB7B;PIK3R1;SOCS6;SOCS1
9606,GO:0036462,0.146063250632159,0.990339093762066,1,7,TRAIL-activated apoptotic signaling pathway,BP,TIMP3
9452,GO:0036037,0.146135834814988,0.99032919059169,1,7,CD8-positive, alpha-beta T cell activation,BP,ZBTB7B
6870,GO:0030336,0.146211694275872,0.933858352950521,6,165,negative regulation of cell migration,BP,SERPINE1;CYP1B1;NOG;NR2F2;KRT16;IFITM1
3084,GO:0006657,0.146240266483321,0.99031493278459,1,7,CDP-choline pathway,BP,PCYT1A
17048,GO:0099512,0.146262028342943,0.906095172334685,17,600,supramolecular fiber,CC,CDK5R1;SLC2A1;FAM110C;IFFO2;HSPB1;FHL2;AHNAK2;BAG3;TUBA4A;FHL3;COL1A1;KRT16;COL1A2;KRT17;IFFO1;TBCC;VPS18
3687,GO:0008191,0.146273848709712,0.99031034551103,1,7,metalloendopeptidase inhibitor activity,MF,TIMP3
19158,GO:1905114,0.146448443170346,0.912169670140414,13,431,cell surface receptor signaling pathway involved in cell-cell signaling,BP,SNAI2;MYC;NOG;APCDD1;FZD10;IGFBP2;COL1A1;TLE3;SIAH2;SOX9;JRK;PYGO2;HIC1
10247,GO:0042976,0.146509274870076,0.990278154289155,1,7,activation of Janus kinase activity,BP,SOCS1
13494,GO:0055015,0.146755095974901,0.990244481133403,1,7,ventricular cardiac muscle cell development,BP,FHL2
4636,GO:0010755,0.146823357731264,0.990235119496622,1,7,regulation of plasminogen activation,BP,SERPINE1
15300,GO:0071474,0.146948667599817,0.990217921673243,1,7,cellular hyperosmotic response,BP,SLC2A1
18251,GO:1903039,0.147006369371338,0.939244621638224,5,126,positive regulation of leukocyte cell-cell adhesion,BP,HES1;MAP3K14;IGFBP2;PIK3R1;SOCS1
9981,GO:0042368,0.147174244512357,0.990186922410925,1,7,vitamin D biosynthetic process,BP,SNAI2
1406,GO:0003337,0.147207516945479,0.990182345628671,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
9185,GO:0035556,0.14743983133709,0.886699657953755,50,1986,intracellular signal transduction,BP,ID1;SPRY4;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;NET1;MYC;CYP1B1;FAM110C;RIN2;DUSP5;FLRT3;LURAP1L;HSPB1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;ZFP36L2;CDC42EP2;TUFT1;RHOD;EPHB3;ADGRF1;PAK6;SIAH2;PLCD1;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;STK17A;DDIT4;PLEKHM1;ARTN;ING2;NACC2;HIC1;COL1A2;SOCS6;RGS3;SOCS1;CLU;CISH
6985,GO:0030656,0.147596723847723,0.990128724075553,1,7,regulation of vitamin metabolic process,BP,SNAI2
10891,GO:0044428,0.147677307474518,0.880561871435936,92,3797,nuclear part,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;MYC;HR;DUSP5;HIST1H2AG;HIST1H4L;FHL2;RBAK;POU3F1;MAP3K14;TFCP2L1;FZD10;BRPF1;NR2F2;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;RNF168;CD3EAP;RBM15;HIST1H2BI;ZKSCAN4;YPEL4;SLC30A1;HIST1H3J;TLE3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;HIST1H4B;IMP3;SOX9;ERF;TRMT61A;CEBPA;CIART;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;STK17A;GZF1;PLEKHM1;TGIF1;HIST1H2BE;URB2;SOX15;PCYT1A;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;BRF2;DNAJB2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;ZNF16;SOX12;HIST1H4D;RGS3;NOTCH3;SOCS1;HIST1H2AH;DCLRE1C;FAM217B
18369,GO:1903332,0.147828307048947,0.990096744838542,1,7,regulation of protein folding,BP,DNAJB2
4233,GO:0009409,0.147915779001025,0.970018737692516,2,31,response to cold,BP,FOS;HSPA2
19869,GO:2000316,0.148563620947973,0.98999484086692,1,7,regulation of T-helper 17 type immune response,BP,ZBTB7B
16406,GO:0097011,0.148634085573095,0.989985046336435,1,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,ZFP36L2
16407,GO:0097012,0.148634085573095,0.989985046336435,1,7,response to granulocyte macrophage colony-stimulating factor,BP,ZFP36L2
4553,GO:0010631,0.148689613485823,0.927641654621426,7,203,epithelial cell migration,BP,ID1;CYP1B1;HSPB1;NR2F2;FAT2;SOX9;KRT16
3117,GO:0006694,0.149054905828768,0.938130645737952,5,126,steroid biosynthetic process,BP,SNAI2;TFCP2L1;FAXDC2;SEC14L2;NR1D1
13137,GO:0051665,0.149270094335485,0.989896410817235,1,7,membrane raft localization,BP,MALL
4605,GO:0010717,0.149481924737206,0.955404695419136,3,62,regulation of epithelial to mesenchymal transition,BP,NOG;VASN;COL1A1
14418,GO:0061687,0.149630740844154,0.989845965662547,1,7,detoxification of inorganic compound,BP,SLC30A1
9690,GO:0038065,0.149655318752115,0.989640844562378,1,8,collagen-activated signaling pathway,BP,COL1A1
11744,GO:0046546,0.149774096935364,0.945261319256999,4,94,development of primary male sexual characteristics,BP,HOXA9;SOX9;SOX15;ING2
883,GO:0002244,0.150176912490791,0.931596491037811,6,158,hematopoietic progenitor cell differentiation,BP,HES1;HIST1H4L;HIST1H3J;HIST1H4B;HIST1H4K;HIST1H4D
16652,GO:0097501,0.15047084164131,0.989727938431648,1,7,stress response to metal ion,BP,SLC30A1
8207,GO:0032956,0.151003047597275,0.922198542008712,8,241,regulation of actin cytoskeleton organization,BP,ID1;CDK5R1;CTGF;FZD10;CDC42EP2;RHOD;VASP;PIK3R1
16145,GO:0090132,0.151241694770844,0.926078068970299,7,204,epithelium migration,BP,ID1;CYP1B1;HSPB1;NR2F2;FAT2;SOX9;KRT16
3317,GO:0007021,0.151635073212086,0.989563172159457,1,7,tubulin complex assembly,BP,TBCC
3949,GO:0008643,0.151724708906206,0.944275355213764,4,95,carbohydrate transport,BP,SLC2A1;SLC2A3;PIK3R1;HK2
3378,GO:0007156,0.151827075267507,0.954319615353756,3,66,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDHR1;PCDH7;FAT2
2107,GO:0004879,0.151949801361322,0.968656747250295,2,32,nuclear receptor activity,MF,NR2F2;NR1D1
16764,GO:0098531,0.151949801361322,0.968656747250295,2,32,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR2F2;NR1D1
3320,GO:0007028,0.152042182177046,0.989297027450194,1,8,cytoplasm organization,BP,TFCP2L1
17594,GO:1901203,0.152426218297156,0.989241150539917,1,8,positive regulation of extracellular matrix assembly,BP,SOX9
418,GO:0001105,0.153052006157019,0.968251223307056,2,33,RNA polymerase II transcription coactivator activity,MF,POU3F1;SOX12
17989,GO:1902373,0.15313250785726,0.968265185856899,2,32,negative regulation of mRNA catabolic process,BP,GDNF;TOB1
15317,GO:0071496,0.153255827426074,0.920774227209,8,238,cellular response to external stimulus,BP,SNAI2;SLC2A1;MAP3K14;BAG3;FOS;COL1A1;SOX9;CNN2
10910,GO:0044452,0.15334089816591,0.929718033446818,6,163,nucleolar part,CC,MAP3K14;TFCP2L1;SURF6;CD3EAP;PAK6;IMP3
1336,GO:0003188,0.153780504134887,0.989042865973298,1,8,heart valve formation,BP,SOX9
13675,GO:0060174,0.154004074739552,0.989009946861702,1,8,limb bud formation,BP,SOX9
16143,GO:0090130,0.154104777358744,0.924315206637965,7,205,tissue migration,BP,ID1;CYP1B1;HSPB1;NR2F2;FAT2;SOX9;KRT16
17497,GO:1900402,0.154201465095474,0.988980838856562,1,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
17009,GO:0099081,0.154641801257145,0.899873163990013,17,606,supramolecular polymer,CC,CDK5R1;SLC2A1;FAM110C;IFFO2;HSPB1;FHL2;AHNAK2;BAG3;TUBA4A;FHL3;COL1A1;KRT16;COL1A2;KRT17;IFFO1;TBCC;VPS18
11796,GO:0046649,0.154775021579235,0.908344227045524,12,392,lymphocyte activation,BP,HES1;TNFRSF21;MAP3K14;ZFP36L2;RNF168;IGFBP2;LRRC8A;ZBTB7B;PIK3R1;SOCS6;SOCS1;DCLRE1C
7761,GO:0032273,0.154929895469998,0.942662278953659,4,95,positive regulation of protein polymerization,BP,RGS2;CDK5R1;CDC42EP2;VASP
7043,GO:0030812,0.15507666710759,0.988851283478962,1,8,negative regulation of nucleotide catabolic process,BP,DDIT4
17008,GO:0099080,0.155919286805871,0.898919136433925,17,607,supramolecular complex,CC,CDK5R1;SLC2A1;FAM110C;IFFO2;HSPB1;FHL2;AHNAK2;BAG3;TUBA4A;FHL3;COL1A1;KRT16;COL1A2;KRT17;IFFO1;TBCC;VPS18
4822,GO:0014013,0.156602518260587,0.952282132288935,3,63,regulation of gliogenesis,BP,HES1;NOG;TNFRSF21
6359,GO:0021536,0.156697476829626,0.967030956716117,2,33,diencephalon development,BP,HES1;NOG
14093,GO:0060896,0.156740845802926,0.988602708010501,1,8,neural plate pattern specification,BP,NOG
323,GO:0000902,0.156744664488445,0.895794634501023,19,692,cell morphogenesis,BP,ID1;HES1;CDK5R1;NET1;NOG;FLRT3;GDNF;TFCP2L1;CDHR1;CDC42EP2;RHOD;EPHB3;SIAH2;VASP;PIK3R1;ARTN;PALMD;CLU;CDC42SE1
18588,GO:1903799,0.15676834646652,0.988598575722733,1,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,BCDIN3D
2279,GO:0005225,0.156827677543596,0.988589657830941,1,8,volume-sensitive anion channel activity,MF,LRRC8A
14383,GO:0061614,0.156837048843628,0.966983867719019,2,33,pri-miRNA transcription by RNA polymerase II,BP,FOS;SOX9
652,GO:0001840,0.157379837909222,0.988506485668566,1,8,neural plate development,BP,NOG
6813,GO:0030260,0.157475620860974,0.941371319721762,4,95,entry into host cell,BP,SLC20A2;TRIM26;IFITM1;VPS18
10878,GO:0044409,0.157475620860974,0.941371319721762,4,95,entry into host,BP,SLC20A2;TRIM26;IFITM1;VPS18
13209,GO:0051806,0.157475620860974,0.941371319721762,4,95,entry into cell of other organism involved in symbiotic interaction,BP,SLC20A2;TRIM26;IFITM1;VPS18
13216,GO:0051828,0.157475620860974,0.941371319721762,4,95,entry into other organism involved in symbiotic interaction,BP,SLC20A2;TRIM26;IFITM1;VPS18
11103,GO:0045104,0.157512984458229,0.96675543488056,2,33,intermediate filament cytoskeleton organization,BP,KRT16;KRT17
20200,GO:2001021,0.157594593715683,0.95186350912724,3,62,negative regulation of response to DNA damage stimulus,BP,SNAI2;ING2;CLU
16122,GO:0090090,0.157721613425539,0.933333970671752,5,129,negative regulation of canonical Wnt signaling pathway,BP,SNAI2;NOG;IGFBP2;SIAH2;SOX9
688,GO:0001895,0.15786204726215,0.966679805029883,2,32,retina homeostasis,BP,HSPB1;CDHR1
7006,GO:0030686,0.157874000658722,0.966675758592651,2,32,90S preribosome,CC,IMP3;RRP36
9027,GO:0035235,0.158238422658007,0.988376516080885,1,8,ionotropic glutamate receptor signaling pathway,BP,CDK5R1
18457,GO:1903524,0.158257850657373,0.966545712701927,2,32,positive regulation of blood circulation,BP,RGS2;CTGF
469,GO:0001510,0.158297842295875,0.951572492976684,3,61,RNA methylation,BP,METTL15;BCDIN3D;TRMT61A
12362,GO:0048715,0.158417665553295,0.9883492844608,1,8,negative regulation of oligodendrocyte differentiation,BP,HES1
12239,GO:0048487,0.158558900778284,0.966443575265889,2,32,beta-tubulin binding,MF,RGS2;CDK5R1
11911,GO:0046929,0.159121117926588,0.988242083017817,1,8,negative regulation of neurotransmitter secretion,BP,SLC30A1
10656,GO:0043691,0.159259184765353,0.988220980987571,1,8,reverse cholesterol transport,BP,CLU
3786,GO:0008347,0.159267053916732,0.96615967375099,2,33,glial cell migration,BP,CDK5R1;APCDD1
13941,GO:0060589,0.159267284465236,0.913320827758515,9,283,nucleoside-triphosphatase regulator activity,MF,RGS2;RIN2;BAG3;CDC42EP2;RIN1;RUNDC1;DNAJB2;RGS3;CDC42SE1
16487,GO:0097157,0.15937146546308,0.988203805190177,1,8,pre-mRNA intronic binding,MF,SOX9
9868,GO:0042118,0.159599922551766,0.988168816388067,1,8,endothelial cell activation,BP,HOXA9
10509,GO:0043408,0.159977917238823,0.900635195164301,14,476,regulation of MAPK cascade,BP,ID1;SPRY4;RGS2;DUSP4;MYC;DUSP5;CTGF;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;TIMP3;RGS3
18634,GO:1903901,0.160149444140899,0.950729387479132,3,62,negative regulation of viral life cycle,BP,TRIM35;TRIM26;IFITM1
13926,GO:0060563,0.160982600138009,0.96557285230651,2,33,neuroepithelial cell differentiation,BP,HES1;SERPINE1
13783,GO:0060347,0.161160437214941,0.987928337950871,1,8,heart trabecula formation,BP,FHL2
14153,GO:0061005,0.161280219705554,0.965429310566671,2,34,cell differentiation involved in kidney development,BP,HES1;GDNF
1308,GO:0003149,0.161450112642209,0.987883413698187,1,8,membranous septum morphogenesis,BP,NOG
11890,GO:0046888,0.162066699622476,0.965199914235002,2,33,negative regulation of hormone secretion,BP,MIDN;VSNL1
15848,GO:0072539,0.162072900399994,0.987786526600166,1,8,T-helper 17 cell differentiation,BP,ZBTB7B
15437,GO:0071695,0.162263868792243,0.938873883965784,4,99,anatomical structure maturation,BP,CDK5R1;TFCP2L1;HOXA5;IRX5
13891,GO:0060502,0.162394054069309,0.987736403424814,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,SOX9
17596,GO:1901213,0.162401316010207,0.987735268767886,1,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,NOG
12162,GO:0048260,0.162415152031584,0.965079697445936,2,33,positive regulation of receptor-mediated endocytosis,BP,SERPINE1;CLU
15885,GO:0072593,0.162904406947993,0.924034806584441,6,166,reactive oxygen species metabolic process,BP,CYP1B1;CTGF;STK17A;DDIT4;HK2;CLU
10054,GO:0042533,0.1629541292406,0.987648728452838,1,8,tumor necrosis factor biosynthetic process,BP,HSPB1
10055,GO:0042534,0.1629541292406,0.987648728452838,1,8,regulation of tumor necrosis factor biosynthetic process,BP,HSPB1
13029,GO:0051451,0.162965959937185,0.987646872854743,1,8,myoblast migration,BP,NET1
3726,GO:0008253,0.163141391177122,0.987619339652808,1,8,5'-nucleotidase activity,MF,NT5DC3
14269,GO:0061307,0.163288165635569,0.987596278811735,1,8,cardiac neural crest cell differentiation involved in heart development,BP,HES1
14270,GO:0061308,0.163288165635569,0.987596278811735,1,8,cardiac neural crest cell development involved in heart development,BP,HES1
7680,GO:0032105,0.163554937910172,0.987554305403296,1,8,negative regulation of response to extracellular stimulus,BP,SNAI2
7683,GO:0032108,0.163554937910172,0.987554305403296,1,8,negative regulation of response to nutrient levels,BP,SNAI2
15153,GO:0071242,0.163821404164426,0.964592825734522,2,33,cellular response to ammonium ion,BP,ID1;CDK5R1
11332,GO:0045647,0.163878933032475,0.987503226607532,1,8,negative regulation of erythrocyte differentiation,BP,HOXA5
650,GO:0001838,0.16404665628933,0.937952859902008,4,99,embryonic epithelial tube formation,BP,NOG;GDNF;VASP;SOX9
19852,GO:2000291,0.164136795118811,0.987462493848185,1,8,regulation of myoblast proliferation,BP,SOX15
17324,GO:0140131,0.164263039062972,0.987442526057364,1,8,positive regulation of lymphocyte chemotaxis,BP,CXCL14
2411,GO:0005581,0.164267807108822,0.964355254346246,2,35,collagen trimer,CC,COL1A1;COL1A2
3540,GO:0007548,0.164273672745015,0.92319163757823,6,170,sex differentiation,BP,TIPARP;HOXA9;SOX9;SOX15;ING2;IRX5
6568,GO:0022010,0.164274524796452,0.987440708534104,1,8,central nervous system myelination,BP,CLU
7775,GO:0032291,0.164274524796452,0.987440708534104,1,8,axon ensheathment in central nervous system,BP,CLU
15342,GO:0071548,0.164388024330081,0.964395875944326,2,33,response to dexamethasone,BP,GJB2;DDIT4
6266,GO:0019855,0.16456430744779,0.987394806201852,1,8,calcium channel inhibitor activity,MF,SLC30A1
13291,GO:0051965,0.164922068473151,0.964167132263005,2,34,positive regulation of synapse assembly,BP,FLRT3;EPHB3
14262,GO:0061298,0.165038781444337,0.987128840604192,1,9,retina vasculature development in camera-type eye,BP,CYP1B1
11102,GO:0045103,0.165399207774108,0.964000404110011,2,34,intermediate filament-based process,BP,KRT16;KRT17
18250,GO:1903038,0.16550099974428,0.948283825489542,3,64,negative regulation of leukocyte cell-cell adhesion,BP,TNFRSF21;ZBTB7B;SOCS6
7686,GO:0032119,0.16551011511808,0.987244363634651,1,8,sequestering of zinc ion,BP,SLC30A1
6024,GO:0019076,0.165566945555377,0.963984673232945,2,33,viral release from host cell,BP,TRIM35;TRIM26
9373,GO:0035890,0.165566945555377,0.963984673232945,2,33,exit from host,BP,TRIM35;TRIM26
9374,GO:0035891,0.165566945555377,0.963984673232945,2,33,exit from host cell,BP,TRIM35;TRIM26
13324,GO:0052126,0.165566945555377,0.963984673232945,2,33,movement in host environment,BP,TRIM35;TRIM26
13333,GO:0052192,0.165566945555377,0.963984673232945,2,33,movement in environment of other organism involved in symbiotic interaction,BP,TRIM35;TRIM26
12725,GO:0050930,0.165587797033667,0.987231964863489,1,8,induction of positive chemotaxis,BP,ARTN
19418,GO:1905906,0.165674777817553,0.987218074246851,1,8,regulation of amyloid fibril formation,BP,CLU
10022,GO:0042448,0.166010880390371,0.987164323447904,1,8,progesterone metabolic process,BP,AKR1C1
6356,GO:0021533,0.166116534194878,0.986954278002259,1,9,cell differentiation in hindbrain,BP,NOG
3510,GO:0007420,0.1666026281394,0.897755593016215,13,449,brain development,BP,ID1;HES1;CDK5R1;SLC2A1;NOG;POU3F1;BAG3;NR2F2;EPHB3;MFSD2A;DDIT4;PYGO2;NOTCH3
13727,GO:0060272,0.166944247395972,0.987014421801391,1,8,embryonic skeletal joint morphogenesis,BP,NOG
3257,GO:0006924,0.166956395098998,0.987012464692622,1,8,activation-induced cell death of T cells,BP,TSC22D3
1345,GO:0003205,0.167287698625067,0.936245426143229,4,101,cardiac chamber development,BP,HES1;NOG;FHL2;RBM15
7740,GO:0032231,0.167446900798976,0.947360198787771,3,66,regulation of actin filament bundle assembly,BP,ID1;CTGF;PIK3R1
16082,GO:0090026,0.167536358733396,0.986918843122704,1,8,positive regulation of monocyte chemotaxis,BP,SERPINE1
20078,GO:2000677,0.167827571755061,0.963146971139267,2,34,regulation of transcription regulatory region DNA binding,BP,ID1;PER2
11645,GO:0046348,0.16823356773733,0.98680581764579,1,8,amino sugar catabolic process,BP,MGAT1
8916,GO:0034754,0.168306779334826,0.947027069455343,3,63,cellular hormone metabolic process,BP,TIPARP;CYP1B1;AKR1C1
6302,GO:0019911,0.168576932856382,0.986749962579547,1,8,structural constituent of myelin sheath,MF,MALL
933,GO:0002328,0.168686387898918,0.986532955613884,1,9,pro-B cell differentiation,BP,HES1
10760,GO:0044183,0.168983462406583,0.962782152285793,2,33,protein binding involved in protein folding,MF,HSPB1;HSPA2
14145,GO:0060997,0.169970235156804,0.962345122976461,2,35,dendritic spine morphogenesis,BP,CDK5R1;EPHB3
2792,GO:0006228,0.169970741638722,0.986521931800967,1,8,UTP biosynthetic process,BP,NME9
12848,GO:0051145,0.170157530588868,0.962320462176719,2,34,smooth muscle cell differentiation,BP,HES1;SOX9
18248,GO:1903036,0.170210343860544,0.962301640848079,2,34,positive regulation of response to wounding,BP,SERPINE1;SOX15
7926,GO:0032496,0.170309716420327,0.914187039704338,7,204,response to lipopolysaccharide,BP,SERPINE1;TNFRSF21;FOS;UPF1;AKIRIN2;GJB2;NR1D1
9270,GO:0035690,0.17037662292431,0.90966521057296,8,245,cellular response to drug,BP,ID1;CDK5R1;NET1;MYC;CYP1B1;SOX9;GJB2;DDIT4
3783,GO:0008340,0.170507322661902,0.98623006865707,1,9,determination of adult lifespan,BP,TFCP2L1
443,GO:0001191,0.170609906146705,0.962159122252499,2,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ID1;ID3
18462,GO:1903531,0.170956747305206,0.934355698861218,4,98,negative regulation of secretion by cell,BP,MIDN;TNFRSF21;VSNL1;SLC30A1
9792,GO:0040007,0.171210229202311,0.88600402426273,18,653,growth,BP,CDK5R1;SERTAD3;NET1;NOG;FLRT3;CTGF;TFCP2L1;IGFBP2;SOX9;SOX15;PYGO2;ING2;HOXA5;DNAJB2;SOCS6;KRT17;SOCS1;CISH
13818,GO:0060393,0.171269689786517,0.961923304508203,2,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,NOG;PMEPA1
17456,GO:1900221,0.171895893941756,0.985996669249448,1,9,regulation of amyloid-beta clearance,BP,CLU
3628,GO:0008089,0.171966056742921,0.961673760855389,2,34,anterograde axonal transport,BP,HSPB1;BLOC1S3
4742,GO:0010906,0.172166495200592,0.945172395847554,3,67,regulation of glucose metabolic process,BP,MIDN;PPP1R3D;NR1D1
7612,GO:0031994,0.172195041165972,0.985946111060144,1,9,insulin-like growth factor I binding,MF,IGFBP2
13951,GO:0060601,0.172274098981599,0.985932733337114,1,9,lateral sprouting from an epithelium,BP,NOG
6465,GO:0021782,0.172667210621391,0.944940486432906,3,67,glial cell development,BP,POU3F1;AHNAK2;CLU
17033,GO:0099173,0.172756388499001,0.944899147646771,3,67,postsynapse organization,BP,CDK5R1;GDNF;EPHB3
3656,GO:0008138,0.172757429320946,0.96138936149311,2,34,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP4;DUSP5
10094,GO:0042592,0.172880210962793,0.874340043672206,29,1102,homeostatic process,BP,TSC22D3;MYC;ANGPTL4;HSPB1;HIST1H4L;CTGF;CDHR1;KCTD7;VSNL1;SLC30A1;NME9;LRRC8A;UPF1;HIST1H4B;PIK3R1;SOX9;CEBPA;MALL;AKR1C1;PLEKHM1;KRT16;NCDN;NR1D1;HOXA5;HIST1H4K;ZNF16;HIST1H4D;HK2;DCLRE1C
12638,GO:0050810,0.172893852877216,0.944874712627423,3,65,regulation of steroid biosynthetic process,BP,SNAI2;SEC14L2;NR1D1
3885,GO:0008514,0.172922693806995,0.924690672329741,5,134,organic anion transmembrane transporter activity,MF,SLC2A1;SLC7A5P2;SLC22A15;SLC2A3;MFSD2A
6597,GO:0022607,0.172986634048736,0.86387067615086,55,2217,cellular component assembly,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;SLC2A1;MYC;MAT2A;ANGPTL4;FAM110C;FLRT3;KCTD15;HIST1H4L;CTGF;AHNAK2;TUBA4A;HIST1H2BJ;CDC42EP2;KCTD7;RHOD;HIST1H2BI;COL1A1;EPHB3;HIST1H3J;TLE3;ADGRF1;HJURP;VASP;HIST1H4B;PIK3R1;SOX9;GJB2;KCTD1;HSPA2;HIST1H2BO;AKR1C1;PLEKHM1;HIST1H2BE;PYGO2;HIST1H1C;HIST1H1D;HIST1H4K;BRF2;DNAJB2;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;SOX12;TBCC;HIST1H4D;PMEPA1;TSPYL4;CLU;VPS18
13715,GO:0060253,0.173241751655182,0.985768438626109,1,9,negative regulation of glial cell proliferation,BP,HES1
6585,GO:0022408,0.17331435803842,0.933098379123565,4,99,negative regulation of cell-cell adhesion,BP,SNAI2;TNFRSF21;ZBTB7B;SOCS6
7301,GO:0031295,0.173434642261672,0.96114530411148,2,34,T cell costimulation,BP,MAP3K14;PIK3R1
10169,GO:0042752,0.173751896681921,0.944436947360653,3,67,regulation of circadian rhythm,BP,CIPC;NR1D1;PER2
1244,GO:0002934,0.17426745194891,0.985593168990133,1,9,desmosome organization,BP,SNAI2
11297,GO:0045599,0.175120118528241,0.960491194565889,2,35,negative regulation of fat cell differentiation,BP,ZFP36L2;ZADH2
17201,GO:0106003,0.1751318766353,0.985444562281538,1,9,amyloid-beta complex,CC,CLU
12885,GO:0051195,0.175321229897731,0.985411900335263,1,9,negative regulation of cofactor metabolic process,BP,DDIT4
3748,GO:0008286,0.175481942823386,0.931923294132779,4,101,insulin receptor signaling pathway,BP,PTPRE;PIK3R1;SOCS1;CISH
15671,GO:0072175,0.175852559871146,0.931714240196159,4,102,epithelial tube formation,BP,NOG;GDNF;VASP;SOX9
4665,GO:0010810,0.176051816308038,0.922844374689467,5,139,regulation of cell-substrate adhesion,BP,NET1;SERPINE1;RHOD;COL1A1;PIK3R1
20254,GO:2001170,0.176390305012834,0.9852267545088,1,9,negative regulation of ATP biosynthetic process,BP,DDIT4
18008,GO:1902430,0.176516266854477,0.985204857323318,1,9,negative regulation of amyloid-beta formation,BP,CLU
15733,GO:0072283,0.176749448701645,0.985164274983331,1,9,metanephric renal vesicle morphogenesis,BP,GDNF
18171,GO:1902903,0.177044365972118,0.90524042715021,8,251,regulation of supramolecular fiber organization,BP,ID1;RGS2;CDK5R1;CTGF;CDC42EP2;VASP;PIK3R1;CLU
563,GO:0001701,0.177053127870078,0.905234609067622,8,251,in utero embryonic development,BP,HES1;NOG;MGAT1;NR2F2;SLC30A1;PLCD1;CEBPA;PYGO2
12611,GO:0050774,0.177152766345963,0.985093941469406,1,9,negative regulation of dendrite morphogenesis,BP,ID1
15607,GO:0072075,0.177222895277155,0.985081693599634,1,9,metanephric mesenchyme development,BP,MYC
20296,GO:2001239,0.177345591189061,0.959723532172465,2,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,SNAI2;GDNF
1108,GO:0002694,0.177863868936727,0.900791873228571,9,285,regulation of leukocyte activation,BP,HES1;TNFRSF21;MAP3K14;ZFP36L2;IGFBP2;ZBTB7B;PIK3R1;SOCS6;SOCS1
11314,GO:0045623,0.178042035579211,0.984938231453107,1,9,negative regulation of T-helper cell differentiation,BP,ZBTB7B
8230,GO:0032989,0.178428514509101,0.877885882367177,20,750,cellular component morphogenesis,BP,ID1;HES1;CDK5R1;NET1;NOG;FLRT3;GDNF;AHNAK2;TFCP2L1;CDHR1;CDC42EP2;RHOD;EPHB3;SIAH2;VASP;PIK3R1;ARTN;PALMD;CLU;CDC42SE1
744,GO:0001972,0.17842990920879,0.984870042365769,1,9,retinoic acid binding,MF,NR2F2
19780,GO:2000146,0.178454667444372,0.914535224124294,6,175,negative regulation of cell motility,BP,SERPINE1;CYP1B1;NOG;NR2F2;KRT16;IFITM1
448,GO:0001221,0.178857882489902,0.959080013951118,2,36,transcription cofactor binding,MF,NR1D1;PER2
6717,GO:0030123,0.179435779889182,0.984692434942835,1,9,AP-3 adaptor complex,CC,VPS18
10690,GO:0043951,0.179550772125949,0.984672059549794,1,9,negative regulation of cAMP-mediated signaling,BP,RGS2
14832,GO:0070561,0.179659566375239,0.984652768932478,1,9,vitamin D receptor signaling pathway,BP,SNAI2
4421,GO:0010212,0.179764990868759,0.920708077495322,5,136,response to ionizing radiation,BP,SNAI2;NET1;MYC;RNF168;DCLRE1C
2664,GO:0006006,0.179845803930805,0.920652785809574,5,137,glucose metabolic process,BP,MIDN;PPP1R3D;NR1D1;PER2;HK2
7223,GO:0031113,0.179930656425067,0.958683352651597,2,36,regulation of microtubule polymerization,BP,RGS2;CDK5R1
7067,GO:0030850,0.180028313745745,0.958647165278339,2,36,prostate gland development,BP,NOG;SOX9
13853,GO:0060439,0.180098181587076,0.984574864228483,1,9,trachea morphogenesis,BP,HOXA5
11122,GO:0045136,0.180887918353184,0.984434058975689,1,9,development of secondary sexual characteristics,BP,IRF2BPL
7050,GO:0030819,0.181323633575279,0.984356078335179,1,9,positive regulation of cAMP biosynthetic process,BP,PTHLH
17853,GO:1902004,0.181351690604177,0.984351049724741,1,9,positive regulation of amyloid-beta formation,BP,CLU
18240,GO:1903025,0.181566614674638,0.984312500368921,1,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,ID1
7300,GO:0031294,0.18188741784248,0.957999626057112,2,35,lymphocyte costimulation,BP,MAP3K14;PIK3R1
7289,GO:0031272,0.182189475038766,0.984200493535842,1,9,regulation of pseudopodium assembly,BP,CDC42EP2
7290,GO:0031274,0.182189475038766,0.984200493535842,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP2
1029,GO:0002532,0.18226374197587,0.957859231842497,2,35,production of molecular mediator involved in inflammatory response,BP,SERPINE1;IL17RA
6592,GO:0022600,0.182357251637421,0.957780298866925,2,36,digestive system process,BP,SOX9;AKR1C1
14052,GO:0060767,0.182368516072893,0.98416821767038,1,9,epithelial cell proliferation involved in prostate gland development,BP,SOX9
13016,GO:0051428,0.18283402333696,0.984084134010832,1,9,peptide hormone receptor binding,MF,PTHLH
17350,GO:1900017,0.182919904623528,0.984068595187493,1,9,positive regulation of cytokine production involved in inflammatory response,BP,IL17RA
8628,GO:0034143,0.182939761980195,0.984065001156967,1,9,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
13491,GO:0055012,0.182958005876664,0.98406169876493,1,9,ventricular cardiac muscle cell differentiation,BP,FHL2
4843,GO:0014046,0.183012487882681,0.984051834587198,1,9,dopamine secretion,BP,GDNF
4851,GO:0014059,0.183012487882681,0.984051834587198,1,9,regulation of dopamine secretion,BP,GDNF
8039,GO:0032680,0.183015364475875,0.940072296292676,3,67,regulation of tumor necrosis factor production,BP,HSPB1;PIK3R1;CLU
14837,GO:0070567,0.183053845085377,0.984044344507248,1,9,cytidylyltransferase activity,MF,PCYT1A
6102,GO:0019318,0.18316162648636,0.91162561307482,6,174,hexose metabolic process,BP,MIDN;FUT1;PPP1R3D;NR1D1;PER2;HK2
17727,GO:1901623,0.183216334631219,0.984014898133958,1,9,regulation of lymphocyte chemotaxis,BP,CXCL14
13570,GO:0060019,0.183245719581919,0.984009569861829,1,9,radial glial cell differentiation,BP,HES1
2169,GO:0005001,0.183255701553083,0.983819869498985,1,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRE
6055,GO:0019198,0.183255701553083,0.983819869498985,1,10,transmembrane receptor protein phosphatase activity,MF,PTPRE
14643,GO:0070206,0.183419141256474,0.957426981341125,2,35,protein trimerization,BP,COL1A1;COL1A2
8681,GO:0034260,0.183478673188676,0.957360242802496,2,36,negative regulation of GTPase activity,BP,FZD10;CDC42SE1
11257,GO:0045453,0.183504379619802,0.957350593678667,2,36,bone resorption,BP,PLEKHM1;NCDN
14713,GO:0070330,0.184060965855662,0.983861361848542,1,9,aromatase activity,MF,CYP1B1
3676,GO:0008174,0.184441169706553,0.983791990115653,1,9,mRNA methyltransferase activity,MF,TRMT61A
799,GO:0002065,0.184520381320481,0.939331967235839,3,68,columnar/cuboidal epithelial cell differentiation,BP,HES1;SERPINE1;HOXA5
16185,GO:0090192,0.184679426879724,0.98374843598638,1,9,regulation of glomerulus development,BP,NOG
10535,GO:0043471,0.184682892888067,0.983747801923873,1,9,regulation of cellular carbohydrate catabolic process,BP,PPP1R3D
8776,GO:0034452,0.184710568439496,0.983551840686768,1,10,dynactin binding,MF,BICD2
11331,GO:0045646,0.184769070301038,0.956874767125787,2,36,regulation of erythrocyte differentiation,BP,HOXA5;ZNF16
13942,GO:0060590,0.184902989501584,0.956869180501393,2,35,ATPase regulator activity,MF,BAG3;DNAJB2
14086,GO:0060856,0.1849944867198,0.983690745176294,1,9,establishment of blood-brain barrier,BP,MFSD2A
4022,GO:0009048,0.185050219340871,0.98348892495014,1,10,dosage compensation by inactivation of X chromosome,BP,UPF1
9977,GO:0042362,0.185181518256937,0.983656445483684,1,9,fat-soluble vitamin biosynthetic process,BP,SNAI2
13933,GO:0060576,0.185763859035359,0.983549400769356,1,9,intestinal epithelial cell development,BP,HOXA5
2971,GO:0006509,0.185992756483537,0.956412290105728,2,36,membrane protein ectodomain proteolysis,BP,TIMP3;SNX33
14315,GO:0061430,0.186526477386549,0.983213961003662,1,10,bone trabecula morphogenesis,BP,COL1A1
2388,GO:0005522,0.187103418357119,0.983105834810365,1,10,profilin binding,MF,VASP
12267,GO:0048538,0.187534872074023,0.955783212722011,2,37,thymus development,BP,HES1;EPHB3
10117,GO:0042632,0.188124583035051,0.955601716153138,2,36,cholesterol homeostasis,BP,MALL;AKR1C1
13535,GO:0055092,0.188124583035051,0.955601716153138,2,36,sterol homeostasis,BP,MALL;AKR1C1
3563,GO:0007605,0.188464713144913,0.937410051396508,3,69,sensory perception of sound,BP,SNAI2;COL1A1;GJB2
11538,GO:0046051,0.188854240046185,0.982975006357103,1,9,UTP metabolic process,BP,NME9
18166,GO:1902894,0.188955195178799,0.982756252247795,1,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,SOX9
9796,GO:0040012,0.189121948531669,0.873655939919535,17,621,regulation of locomotion,BP,SNAI2;SERPINE1;CYP1B1;FAM110C;NOG;HSPB1;NR2F2;TRIM35;RHOD;COL1A1;CXCL14;PIK3R1;SOX9;ARTN;KRT16;TRIM26;IFITM1
11107,GO:0045111,0.189143740291364,0.924490132992161,4,104,intermediate filament cytoskeleton,CC,IFFO2;KRT16;KRT17;IFFO1
10597,GO:0043560,0.189327486670377,0.982685502808821,1,10,insulin receptor substrate binding,MF,PIK3R1
14784,GO:0070475,0.189452159598696,0.982862642210611,1,9,rRNA base methylation,BP,METTL15
12570,GO:0050709,0.190012552814818,0.936678561054102,3,68,negative regulation of protein secretion,BP,MIDN;TNFRSF21;VSNL1
5889,GO:0018023,0.190732114787729,0.954557414435702,2,37,peptidyl-lysine trimethylation,BP,HIST1H1C;HIST1H1D
3466,GO:0007286,0.190791126065248,0.9362785275136,3,69,spermatid development,BP,HSPA2;PYGO2;ING2
7796,GO:0032332,0.190873718290175,0.982389982930994,1,10,positive regulation of chondrocyte differentiation,BP,SOX9
11804,GO:0046661,0.190919677634791,0.923511052024725,4,104,male sex differentiation,BP,HOXA9;SOX9;SOX15;ING2
14239,GO:0061178,0.191005648109938,0.9544964306794,2,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1;NR1D1
3182,GO:0006805,0.191448016361084,0.935999879642699,3,67,xenobiotic metabolic process,BP,CYP1B1;AKR1C1;CES2
2768,GO:0006183,0.191897837758206,0.982398868615848,1,9,GTP biosynthetic process,BP,NME9
2215,GO:0005104,0.191922888836817,0.982187920782016,1,10,fibroblast growth factor receptor binding,MF,FLRT3
7098,GO:0030889,0.192097149565171,0.982154238637281,1,10,negative regulation of B cell proliferation,BP,TNFRSF21
3750,GO:0008289,0.19250402085465,0.878708611298461,13,455,lipid binding,MF,ID3;NR2F2;HIST1H2BJ;PLCD1;SEC14L2;PXDC1;HSPA2;AKR1C1;SNX33;PCYT1A;ING2;ZCCHC2;IRX5
18727,GO:1904115,0.192912586944622,0.953713460781311,2,37,axon cytoplasm,CC,HSPB1;BLOC1S3
3407,GO:0007189,0.192926954764871,0.953665107288281,2,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,PTHLH;ADGRF1
11494,GO:0045945,0.193376946112587,0.981905815729984,1,10,positive regulation of transcription by RNA polymerase III,BP,CEBPA
13814,GO:0060389,0.193730934675481,0.953395051118619,2,37,pathway-restricted SMAD protein phosphorylation,BP,NOG;PMEPA1
10601,GO:0043567,0.194040948231517,0.981776192138936,1,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
20207,GO:2001028,0.194217940435076,0.981741555843251,1,10,positive regulation of endothelial cell chemotaxis,BP,HSPB1
3555,GO:0007596,0.194454159562807,0.898499749970442,7,214,blood coagulation,BP,SERPINE1;HSPB1;COL1A1;HIST1H3J;BLOC1S3;PIK3R1;COL1A2
14011,GO:0060711,0.194681233093191,0.953024159842334,2,37,labyrinthine layer development,BP,HES1;PLCD1
6466,GO:0021783,0.194733448187991,0.981640470970082,1,10,preganglionic parasympathetic fiber development,BP,HES1
13562,GO:0060009,0.194801393854928,0.981627125074557,1,10,Sertoli cell development,BP,SOX9
15831,GO:0072520,0.194897446522459,0.981608249428858,1,10,seminiferous tubule development,BP,ING2
2936,GO:0006457,0.194923657715855,0.89820887094044,7,210,protein folding,BP,HSPB1;BAG3;HSPA2;FKBP9;DNAJB2;TBCC;CLU
6823,GO:0030277,0.195330726691556,0.981522973392618,1,10,maintenance of gastrointestinal epithelium,BP,SOX9
20107,GO:2000738,0.195453050812584,0.981498859447949,1,10,positive regulation of stem cell differentiation,BP,SOX9
3626,GO:0008083,0.195549007234348,0.933963552154118,3,68,growth factor activity,MF,GDNF;CTGF;ARTN
1172,GO:0002792,0.195955362718092,0.933741317745016,3,69,negative regulation of peptide secretion,BP,MIDN;TNFRSF21;VSNL1
1463,GO:0003707,0.196270390991771,0.952357324160418,2,38,steroid hormone receptor activity,MF,NR2F2;NR1D1
4829,GO:0014029,0.196361639389753,0.981319213930147,1,10,neural crest formation,BP,SOX9
10482,GO:0043371,0.196387210480294,0.981314144405686,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,ZBTB7B
11510,GO:0045986,0.196938716324542,0.981204625504982,1,10,negative regulation of smooth muscle contraction,BP,RGS2
4969,GO:0015074,0.197115504443933,0.98116944512294,1,10,DNA integration,BP,ZNF93
12643,GO:0050817,0.197236388153806,0.896652082151993,7,215,coagulation,BP,SERPINE1;HSPB1;COL1A1;HIST1H3J;BLOC1S3;PIK3R1;COL1A2
7430,GO:0031527,0.197260829201287,0.980962531115116,1,11,filopodium membrane,CC,VASP
13929,GO:0060572,0.197337446572811,0.981125228656222,1,10,morphogenesis of an epithelial bud,BP,NOG
16422,GO:0097038,0.197511150137303,0.981090583258088,1,10,perinuclear endoplasmic reticulum,CC,PIK3R1
20051,GO:2000647,0.197620241085579,0.98106880729701,1,10,negative regulation of stem cell proliferation,BP,SNAI2
3725,GO:0008252,0.197925593338065,0.981007782699459,1,10,nucleotidase activity,MF,NT5DC3
7208,GO:0031093,0.19815352832826,0.951658544340828,2,37,platelet alpha granule lumen,CC,SERPINE1;CLU
13008,GO:0051412,0.19817455585476,0.980957948662765,1,10,response to corticosterone,BP,FOS
19712,GO:2000009,0.198322780855259,0.980928245256919,1,10,negative regulation of protein localization to cell surface,BP,SNX33
6221,GO:0019748,0.198421932968066,0.951552303331969,2,37,secondary metabolic process,BP,CYP1B1;AKR1C1
11303,GO:0045605,0.198609906824501,0.980870635397386,1,10,negative regulation of epidermal cell differentiation,BP,HES1
6482,GO:0021819,0.198645241501838,0.980863539215001,1,10,layer formation in cerebral cortex,BP,CDK5R1
15847,GO:0072538,0.199566598335896,0.980678000444639,1,10,T-helper 17 type immune response,BP,ZBTB7B
13028,GO:0051450,0.199638222119266,0.980663536415041,1,10,myoblast proliferation,BP,SOX15
14007,GO:0060707,0.199870677646965,0.980616552776802,1,10,trophoblast giant cell differentiation,BP,NR2F2
13591,GO:0060044,0.199881971114778,0.980614268576049,1,10,negative regulation of cardiac muscle cell proliferation,BP,NOG
881,GO:0002237,0.200036181018902,0.894794209652509,7,214,response to molecule of bacterial origin,BP,SERPINE1;TNFRSF21;FOS;UPF1;AKIRIN2;GJB2;NR1D1
8015,GO:0032640,0.200242726215693,0.931587078560547,3,70,tumor necrosis factor production,BP,HSPB1;PIK3R1;CLU
7551,GO:0031848,0.200365618878214,0.980516309373633,1,10,protection from non-homologous end joining at telomere,BP,DCLRE1C
18478,GO:1903555,0.200393153626906,0.931511787685049,3,70,regulation of tumor necrosis factor superfamily cytokine production,BP,HSPB1;PIK3R1;CLU
1384,GO:0003279,0.200485387840518,0.931405078220412,3,73,cardiac septum development,BP,HES1;NOG;RBM15
6699,GO:0030072,0.20049597459732,0.908287893166664,5,143,peptide hormone secretion,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
17988,GO:1902369,0.200781468666824,0.950568787833788,2,38,negative regulation of RNA catabolic process,BP,GDNF;TOB1
8675,GO:0034244,0.200797893582059,0.980428528216881,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,RNF168
26,GO:0000050,0.2009329135419,0.98040106601343,1,10,urea cycle,BP,CEBPA
6192,GO:0019627,0.2009329135419,0.98040106601343,1,10,urea metabolic process,BP,CEBPA
3822,GO:0008417,0.201013713152578,0.98038462187149,1,10,fucosyltransferase activity,MF,FUT1
2057,GO:0004806,0.201250379388523,0.980336412976441,1,10,triglyceride lipase activity,MF,CES2
17335,GO:0150005,0.201360097742631,0.980314041523154,1,10,enzyme activator complex,CC,CDK5R1
14039,GO:0060749,0.201492087935385,0.980287110534716,1,10,mammary gland alveolus development,BP,HOXA5
14303,GO:0061377,0.201492087935385,0.980287110534716,1,10,mammary gland lobule development,BP,HOXA5
15516,GO:0071875,0.201535546927512,0.980092447289148,1,11,adrenergic receptor signaling pathway,BP,RGS2
12752,GO:0051004,0.201539105282537,0.980277512381983,1,10,regulation of lipoprotein lipase activity,BP,ANGPTL4
552,GO:0001673,0.201561213925608,0.98027299823044,1,10,male germ cell nucleus,CC,HSPA2
4711,GO:0010870,0.201573827828378,0.98027042246702,1,10,positive regulation of receptor biosynthetic process,BP,HOXA5
11717,GO:0046500,0.201819883810167,0.980220141162439,1,10,S-adenosylmethionine metabolic process,BP,MAT2A
2615,GO:0005922,0.201858199913636,0.980212305039208,1,10,connexin complex,CC,GJB2
3424,GO:0007213,0.201971658925532,0.980189091347979,1,10,G-protein coupled acetylcholine receptor signaling pathway,BP,CDK5R1
9251,GO:0035646,0.202018816225784,0.980179438618119,1,10,endosome to melanosome transport,BP,BLOC1S3
10541,GO:0043485,0.202018816225784,0.980179438618119,1,10,endosome to pigment granule transport,BP,BLOC1S3
12381,GO:0048757,0.202018816225784,0.980179438618119,1,10,pigment granule maturation,BP,BLOC1S3
4274,GO:0009628,0.20242959473606,0.855382954960099,23,869,response to abiotic stimulus,BP,SNAI2;TSC22D3;SLC2A1;NET1;TXNIP;MYC;ANGPTL4;VASN;CTGF;MAP3K14;BAG3;FOS;RNF168;IGFBP2;COL1A1;LRRC8A;PIK3R1;SOX9;CNN2;HSPA2;DDIT4;PER2;DCLRE1C
17406,GO:1900121,0.202627664098918,0.980054582465066,1,10,negative regulation of receptor binding,BP,NOG
5636,GO:0016712,0.202840275748908,0.980010881780967,1,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP1B1
14416,GO:0061684,0.202866166244825,0.980005556634284,1,10,chaperone-mediated autophagy,BP,CLU
941,GO:0002347,0.203096329879922,0.979958182734354,1,10,response to tumor cell,BP,TXNIP
1024,GO:0002521,0.203109114909344,0.883191873879149,9,298,leukocyte differentiation,BP,MYC;ZFP36L2;FOS;LRRC8A;ZBTB7B;PIK3R1;CEBPA;SOCS1;DCLRE1C
8720,GO:0034364,0.203330253252058,0.979909972450838,1,10,high-density lipoprotein particle,CC,CLU
11355,GO:0045670,0.203491617096579,0.949437185646669,2,39,regulation of osteoclast differentiation,BP,FOS;PIK3R1
11298,GO:0045600,0.203522569793503,0.949468548234144,2,38,positive regulation of fat cell differentiation,BP,SNAI2;CEBPA
15798,GO:0072393,0.203753976984934,0.979632566587791,1,11,microtubule anchoring at microtubule organizing center,BP,BICD2
10796,GO:0044264,0.203868026059028,0.929722578391516,3,72,cellular polysaccharide metabolic process,BP,PPP1R3D;NR1D1;PER2
3193,GO:0006820,0.203916662083799,0.878859467319906,10,338,anion transport,BP,SLC2A1;SLC7A5P2;SLC20A2;SLC22A15;LRRC8A;SLC2A3;SLC20A1;MFSD2A;AKR1C1;PER2
3558,GO:0007599,0.203993913231345,0.892132335575618,7,217,hemostasis,BP,SERPINE1;HSPB1;COL1A1;HIST1H3J;BLOC1S3;PIK3R1;COL1A2
10050,GO:0042501,0.204047496348415,0.979761759553267,1,10,serine phosphorylation of STAT protein,BP,CDK5R1
8049,GO:0032693,0.204285771007452,0.979712390606266,1,10,negative regulation of interleukin-10 production,BP,TNFRSF21
15817,GO:0072498,0.204656538300918,0.979635439769621,1,10,embryonic skeletal joint development,BP,NOG
12280,GO:0048565,0.204673381031528,0.929275443322329,3,74,digestive tract development,BP,HES1;EPHB3;HOXA5
17592,GO:1901201,0.204698949458634,0.979434937607714,1,11,regulation of extracellular matrix assembly,BP,SOX9
20320,GO:2001275,0.204978911920431,0.979376187535268,1,11,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R1
16866,GO:0098772,0.205250373347639,0.847703596714511,29,1128,molecular function regulator,MF,RGS2;CDK5R1;PTHLH;NET1;TXNIP;SERPINE1;ANGPTL4;RIN2;FLRT3;HSPB1;GDNF;CTGF;BAG3;CDC42EP2;FAM212B;SLC30A1;CXCL14;PIK3R1;TIMP3;RIN1;RUNDC1;ARTN;PYGO2;DNAJB2;SOCS6;RGS3;SOCS1;CDC42SE1;CISH
1156,GO:0002761,0.20528487864027,0.929005223073522,3,72,regulation of myeloid leukocyte differentiation,BP,MYC;FOS;PIK3R1
13187,GO:0051775,0.205329530730122,0.979495358146923,1,10,response to redox state,BP,VASN
15088,GO:0071044,0.205351845661832,0.979297785718463,1,11,histone mRNA catabolic process,BP,UPF1
15978,GO:0080009,0.205425689098371,0.979475300312999,1,10,mRNA methylation,BP,TRMT61A
482,GO:0001530,0.206675946338539,0.979213533845808,1,10,lipopolysaccharide binding,MF,HIST1H2BJ
1363,GO:0003231,0.206853098181284,0.928167961599375,3,74,cardiac ventricle development,BP,HES1;NOG;RBM15
11885,GO:0046883,0.206910226259687,0.904351697844036,5,144,regulation of hormone secretion,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
6952,GO:0030574,0.20703871073806,0.947954699122628,2,40,collagen catabolic process,BP,COL1A1;COL1A2
455,GO:0001228,0.207145100427537,0.884747559255092,8,261,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MYC;ZNF750;FOS;ZBTB7B;SOX9;CEBPA;HOXA5;SOX12
3402,GO:0007183,0.207505898158026,0.978841766808631,1,11,SMAD protein complex assembly,BP,PMEPA1
13692,GO:0060211,0.207851042428081,0.978768195368431,1,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TOB1
13694,GO:0060213,0.207851042428081,0.978768195368431,1,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TOB1
808,GO:0002076,0.208119177873262,0.978710943141074,1,11,osteoblast development,BP,PTHLH
6104,GO:0019320,0.208267838444571,0.947539860805418,2,38,hexose catabolic process,BP,FUT1;HK2
15756,GO:0072321,0.208589533565453,0.978809380361938,1,10,chaperone-mediated protein transport,BP,CLU
3406,GO:0007188,0.2086667108577,0.927261870281911,3,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,RGS2;PTHLH;ADGRF1
16617,GO:0097440,0.208777252510442,0.978570074775212,1,11,apical dendrite,CC,CLU
7207,GO:0031092,0.209370108402448,0.978442733275165,1,11,platelet alpha granule membrane,CC,PCDH7
11406,GO:0045780,0.209383561303856,0.97843983890597,1,11,positive regulation of bone resorption,BP,PLEKHM1
11872,GO:0046852,0.209383561303856,0.97843983890597,1,11,positive regulation of bone remodeling,BP,PLEKHM1
5572,GO:0016580,0.209474430806105,0.978420282932855,1,11,Sin3 complex,CC,ING2
2598,GO:0005891,0.20983165148903,0.978343311910316,1,11,voltage-gated calcium channel complex,CC,HSPA2
20085,GO:2000696,0.209871309833068,0.978334757429063,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
16616,GO:0097435,0.210091765157365,0.865425425381536,13,470,supramolecular fiber organization,BP,ID1;RGS2;CDK5R1;CYP1B1;CTGF;CDC42EP2;RHOD;COL1A1;VASP;PIK3R1;COL1A2;KRT17;CLU
3468,GO:0007289,0.210256299624645,0.978251617594011,1,11,spermatid nucleus differentiation,BP,PYGO2
12731,GO:0050954,0.210539691236693,0.92630117646814,3,73,sensory perception of mechanical stimulus,BP,SNAI2;COL1A1;GJB2
3453,GO:0007266,0.210706136776907,0.901963178315472,5,149,Rho protein signal transduction,BP,NET1;CDC42EP2;RHOD;PAK6;COL1A2
6071,GO:0019216,0.210950462445451,0.882096306399249,8,261,regulation of lipid metabolic process,BP,SNAI2;ANGPTL4;FHL2;TNFRSF21;CTGF;SEC14L2;PIK3R1;NR1D1
13550,GO:0055119,0.21111661623759,0.978065201007981,1,11,relaxation of cardiac muscle,BP,RGS2
11790,GO:0046639,0.211274280433097,0.978030943556007,1,11,negative regulation of alpha-beta T cell differentiation,BP,ZBTB7B
10564,GO:0043517,0.211714310416947,0.977935178900293,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,HIC1
3653,GO:0008134,0.211978335943129,0.861626981539604,14,505,transcription factor binding,MF,ID1;HES1;TSC22D3;MYC;ID3;HES2;FHL2;FOS;PIK3R1;SOX9;CEBPA;KCTD1;NR1D1;PER2
15151,GO:0071236,0.21200315128536,0.911538158723657,4,108,cellular response to antibiotic,BP,NET1;ID3;CYP1B1;CLU
10506,GO:0043405,0.212067204669272,0.881315556835159,8,261,regulation of MAP kinase activity,BP,SPRY4;RGS2;DUSP4;DUSP5;MAP3K14;FZD10;GADD45B;RGS3
12569,GO:0050708,0.212195011101217,0.881230021494817,8,260,regulation of protein secretion,BP,SLC2A1;MIDN;TNFRSF21;IL17RA;VSNL1;NR1D1;PER2;SOCS1
19080,GO:1904925,0.212256244862116,0.977816923880741,1,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,HK2
10685,GO:0043933,0.212325543065989,0.834303137522828,42,1674,protein-containing complex subunit organization,BP,RGS2;HES1;CDK5R1;SLC2A1;MYC;MAT2A;ANGPTL4;CYP1B1;KCTD15;HIST1H4L;HIST1H2BJ;CDC42EP2;KCTD7;HIST1H2BI;COL1A1;HIST1H3J;TLE3;HJURP;UPF1;VASP;HIST1H4B;SOX9;KCTD1;HIST1H2BO;AKR1C1;HIST1H2BE;PYGO2;HIST1H1C;HIST1H1D;HIST1H4K;BRF2;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;SOX12;TBCC;HIST1H4D;PMEPA1;TSPYL4;CLU;VPS18
16308,GO:0090399,0.212350900997659,0.977796233629126,1,11,replicative senescence,BP,SERPINE1
3507,GO:0007416,0.212749911739144,0.925101671733903,3,76,synapse assembly,BP,FLRT3;EPHB3;ADGRF1
18218,GO:1902992,0.212929513427883,0.977669529470614,1,11,negative regulation of amyloid precursor protein catabolic process,BP,CLU
12252,GO:0048515,0.213467982555177,0.924790140444913,3,73,spermatid differentiation,BP,HSPA2;PYGO2;ING2
16075,GO:0089718,0.213808683196757,0.977476255077048,1,11,amino acid import across plasma membrane,BP,PER2
3503,GO:0007409,0.213851429321269,0.875494370861947,9,310,axonogenesis,BP,CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
10736,GO:0044089,0.213866930243967,0.868206622336448,11,384,positive regulation of cellular component biogenesis,BP,ID1;RGS2;CDK5R1;FLRT3;CTGF;CDC42EP2;EPHB3;VASP;SOX9;PLEKHM1;CLU
3537,GO:0007530,0.214397263414738,0.977346354152442,1,11,sex determination,BP,SOX9
9085,GO:0035335,0.21460801571556,0.924178102746943,3,74,peptidyl-tyrosine dephosphorylation,BP,DUSP4;PTPRE;DUSP5
18377,GO:1903350,0.214743268754991,0.977269799344032,1,11,response to dopamine,BP,ID1
18378,GO:1903351,0.214743268754991,0.977269799344032,1,11,cellular response to dopamine,BP,ID1
12762,GO:0051017,0.215566127535806,0.909443938266852,4,110,actin filament bundle assembly,BP,ID1;CTGF;RHOD;PIK3R1
12069,GO:0048008,0.21561234047597,0.944358787051526,2,41,platelet-derived growth factor receptor signaling pathway,BP,TIPARP;TXNIP
3632,GO:0008093,0.215633086195504,0.977072275351231,1,11,cytoskeletal adaptor activity,MF,BICD2
9390,GO:0035925,0.215710738715614,0.977054993478,1,11,mRNA 3'-UTR AU-rich region binding,MF,ZFP36L2
9812,GO:0040037,0.215843693649567,0.977025387291306,1,11,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY4
10215,GO:0042827,0.215909905703358,0.977010635507243,1,11,platelet dense granule,CC,TIMP3
2170,GO:0005003,0.21597003042944,0.976997235466674,1,11,ephrin receptor activity,MF,EPHB3
2172,GO:0005005,0.21597003042944,0.976997235466674,1,11,transmembrane-ephrin receptor activity,MF,EPHB3
16597,GO:0097386,0.216055101730235,0.97697826826465,1,11,glial cell projection,CC,GJB2
2212,GO:0005095,0.216381194041635,0.97690548459212,1,11,GTPase inhibitor activity,MF,CDC42SE1
10062,GO:0042542,0.216389313708942,0.909002122974974,4,107,response to hydrogen peroxide,BP,NET1;TXNIP;CYP1B1;COL1A1
7288,GO:0031269,0.21683842494481,0.97680321901995,1,11,pseudopodium assembly,BP,CDC42EP2
19430,GO:1905939,0.217223690619332,0.976716857329748,1,11,regulation of gonad development,BP,SOX9
7382,GO:0031430,0.217708955734233,0.97627474234872,1,13,M band,CC,FHL2
3945,GO:0008631,0.217791607670635,0.94352894118619,2,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,CYP1B1;HSPB1
14814,GO:0070534,0.218150057422871,0.943331222754222,2,40,protein K63-linked ubiquitination,BP,RNF168;TRIM56
18219,GO:1902993,0.218175992309013,0.976502633697897,1,11,positive regulation of amyloid precursor protein catabolic process,BP,CLU
13548,GO:0055117,0.218182789395928,0.94327355486634,2,41,regulation of cardiac muscle contraction,BP,RGS2;CTGF
6252,GO:0019825,0.218289282355388,0.976477077158921,1,11,oxygen binding,MF,CYP1B1
8105,GO:0032785,0.218409869803554,0.976449857712374,1,11,negative regulation of DNA-templated transcription, elongation,BP,RNF168
19722,GO:2000027,0.218702324839206,0.888748876167532,6,184,regulation of organ morphogenesis,BP,HES1;SNAI2;MYC;NOG;GDNF;SOX9
8668,GO:0034236,0.218807967091476,0.976359875240665,1,11,protein kinase A catalytic subunit binding,MF,SOX9
10053,GO:0042532,0.218827105097301,0.976355544713798,1,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,SOCS1
4503,GO:0010528,0.218851859276891,0.97634994272055,1,11,regulation of transposition,BP,ZNF93
4504,GO:0010529,0.218851859276891,0.97634994272055,1,11,negative regulation of transposition,BP,ZNF93
12358,GO:0048711,0.219104434198484,0.976292742195714,1,11,positive regulation of astrocyte differentiation,BP,HES1
15552,GO:0071941,0.219135475521945,0.97628570705597,1,11,nitrogen cycle metabolic process,BP,CEBPA
6586,GO:0022409,0.219259563941027,0.896639081508238,5,146,positive regulation of cell-cell adhesion,BP,HES1;MAP3K14;IGFBP2;PIK3R1;SOCS1
597,GO:0001759,0.21956574175225,0.976188074575615,1,11,organ induction,BP,GDNF
4733,GO:0010893,0.219631945533555,0.976173032636227,1,11,positive regulation of steroid biosynthetic process,BP,NR1D1
12786,GO:0051048,0.219757688487495,0.907002715858201,4,109,negative regulation of secretion,BP,MIDN;TNFRSF21;VSNL1;SLC30A1
10120,GO:0042635,0.219758493681354,0.976144265564247,1,11,positive regulation of hair cycle,BP,KRT17
13205,GO:0051798,0.219758493681354,0.976144265564247,1,11,positive regulation of hair follicle development,BP,KRT17
9667,GO:0038023,0.21985499996847,0.863728668398824,11,386,signaling receptor activity,MF,GPR132;PTPRE;TNFRSF21;FZD10;NR2F2;IL17RA;EPHB3;ADGRF1;NR1D1;KRT17;ADGRF4
13631,GO:0060089,0.21985499996847,0.863728668398824,11,386,molecular transducer activity,MF,GPR132;PTPRE;TNFRSF21;FZD10;NR2F2;IL17RA;EPHB3;ADGRF1;NR1D1;KRT17;ADGRF4
2716,GO:0006089,0.219949234862083,0.976100870096717,1,11,lactate metabolic process,BP,PER2
13588,GO:0060041,0.220242895378115,0.921169531879252,3,77,retina development in camera-type eye,BP,CYP1B1;SOX9;IRX5
14365,GO:0061572,0.220351295820778,0.906628049683759,4,111,actin filament bundle organization,BP,ID1;CTGF;RHOD;PIK3R1
17358,GO:1900029,0.220436628835782,0.97598978677693,1,11,positive regulation of ruffle assembly,BP,PLEKHM1
10960,GO:0044703,0.220527502720904,0.852799194572932,15,548,multi-organism reproductive process,BP,RGS2;PTHLH;SLC2A1;ZNF296;TFCP2L1;NR2F2;HOXA9;FOS;IGFBP2;SOX9;GJB2;HSPA2;PYGO2;ING2;PHC2
2004,GO:0004725,0.220567852158919,0.921038406328254,3,75,protein tyrosine phosphatase activity,MF,DUSP4;PTPRE;DUSP5
7734,GO:0032225,0.220819877871256,0.975902240980732,1,11,regulation of synaptic transmission, dopaminergic,BP,GDNF
9078,GO:0035326,0.220976020820527,0.920823102999861,3,75,enhancer binding,MF,TIPARP;SOX9;GZF1
12120,GO:0048156,0.22101994763867,0.975856469488894,1,11,tau protein binding,MF,CLU
14633,GO:0070193,0.221283224673923,0.975796164973368,1,11,synaptonemal complex organization,BP,HSPA2
7160,GO:0031016,0.221486946100134,0.941865492994686,2,41,pancreas development,BP,HES1;SOX9
8347,GO:0033197,0.221498131312736,0.975746878674501,1,11,response to vitamin E,BP,COL1A1
16081,GO:0090025,0.221528570409841,0.975739893379323,1,11,regulation of monocyte chemotaxis,BP,SERPINE1
8425,GO:0033500,0.221606872320039,0.895147956653014,5,147,carbohydrate homeostasis,BP,VSNL1;PIK3R1;CEBPA;NR1D1;HK2
10095,GO:0042593,0.221606872320039,0.895147956653014,5,147,glucose homeostasis,BP,VSNL1;PIK3R1;CEBPA;NR1D1;HK2
272,GO:0000774,0.221763102462548,0.975686034933079,1,11,adenyl-nucleotide exchange factor activity,MF,BAG3
3541,GO:0007549,0.221814932442845,0.975486716249703,1,12,dosage compensation,BP,UPF1
2105,GO:0004871,0.222235244608546,0.845906958991288,18,678,signal transducer activity,MF,GPR132;PTPRE;FLRT3;TNFRSF21;MAP3K14;FZD10;NR2F2;IL17RA;RHOD;EPHB3;ADGRF1;PLCD1;SLC20A1;PIK3R1;NR1D1;KRT17;IFITM1;ADGRF4
12696,GO:0050896,0.222271420723669,0.812919578108104,128,5537,response to stimulus,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ID3;ANGPTL4;CYP1B1;FAM110C;NOG;PTPRE;RIN2;VASN;DUSP5;FLRT3;LURAP1L;HSPB1;APCDD1;HIST1H4L;FHL2;TNFRSF21;GDNF;CTGF;MAP3K14;BAG3;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;FOS;RNF168;CDC42EP2;IGFBP2;TUFT1;IL17RA;RHOD;CD3EAP;RBM15;HIST1H2BI;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;TLE3;ADGRF1;LRRC8A;CXCL14;PAK6;SIAH2;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;SOX9;CEBPA;CNN2;GJB2;FAM83A;HSPA2;TIMP3;JRK;STK17A;RIN1;AKR1C1;DDIT4;PLEKHM1;TGIF1;HIST1H2BE;ARTN;KRT16;SOX15;PYGO2;NR1D1;ING2;HIST1H4K;PER2;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;COL1A2;ZNF16;SOCS6;KRT17;IFITM1;TRIM56;ADGRF4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;KLF16;SOCS1;CLU;CDC42SE1;DCLRE1C;IRX5;CISH
17770,GO:1901722,0.222512690721373,0.975513458211772,1,11,regulation of cell proliferation involved in kidney development,BP,MYC
10033,GO:0042474,0.22257273695637,0.975499604857029,1,11,middle ear morphogenesis,BP,NOG
8319,GO:0033151,0.222638983426577,0.975295510204383,1,12,V(D)J recombination,BP,DCLRE1C
12260,GO:0048525,0.222689970348213,0.919959669048893,3,73,negative regulation of viral process,BP,TRIM35;TRIM26;IFITM1
14703,GO:0070316,0.222733251964987,0.941330567964004,2,41,regulation of G0 to G1 transition,BP,CTGF;SOX15
12909,GO:0051238,0.222784677128683,0.975450673440319,1,11,sequestering of metal ion,BP,SLC30A1
5073,GO:0015293,0.222905422884368,0.919802494379817,3,75,symporter activity,MF,SLC20A2;SLC20A1;MFSD2A
9317,GO:0035773,0.222932946318917,0.941289868301444,2,40,insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1;NR1D1
7899,GO:0032463,0.223138331524879,0.97536890456823,1,11,negative regulation of protein homooligomerization,BP,CLU
5358,GO:0016125,0.223408840169617,0.904835132378308,4,110,sterol metabolic process,BP,CYP1B1;FAXDC2;SEC14L2;CEBPA
16959,GO:0098930,0.223542730079174,0.940982014682331,2,41,axonal transport,BP,HSPB1;BLOC1S3
15426,GO:0071677,0.22365426297714,0.975249347550895,1,11,positive regulation of mononuclear cell migration,BP,SERPINE1
15446,GO:0071706,0.223920148438384,0.919285162104542,3,74,tumor necrosis factor superfamily cytokine production,BP,HSPB1;PIK3R1;CLU
7891,GO:0032454,0.224197847783511,0.974931573009355,1,12,histone demethylase activity (H3-K9 specific),MF,HR
9990,GO:0042383,0.224271354856559,0.919016292908346,3,78,sarcolemma,CC,SLC2A1;AHNAK2;SLC30A1
14103,GO:0060914,0.224568955059112,0.975036603614557,1,11,heart formation,BP,HES1
9007,GO:0035148,0.224675707716358,0.904045756152798,4,113,tube formation,BP,NOG;GDNF;VASP;SOX9
12348,GO:0048699,0.224748108486469,0.835960793597109,24,947,generation of neurons,BP,ID1;HES1;CDK5R1;ID3;NOG;FLRT3;TNFRSF21;GDNF;FZD10;NR2F2;CDHR1;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;SOX9;DDIT4;ARTN;NCDN;PER2;NOTCH3;IRX5
8805,GO:0034505,0.225089000508534,0.974722208443064,1,12,tooth mineralization,BP,COL1A1
10733,GO:0044085,0.225829150639094,0.816644390157685,60,2480,cellular component biogenesis,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;SLC2A1;MYC;MAT2A;ANGPTL4;FAM110C;FLRT3;METTL15;KCTD15;HIST1H4L;CTGF;AHNAK2;TUBA4A;SURF6;HIST1H2BJ;CDC42EP2;KCTD7;RHOD;HIST1H2BI;COL1A1;EPHB3;HIST1H3J;TLE3;ADGRF1;HJURP;VASP;HIST1H4B;PIK3R1;IMP3;SOX9;GJB2;KCTD1;HSPA2;HIST1H2BO;AKR1C1;PLEKHM1;HIST1H2BE;URB2;PYGO2;HIST1H1C;HIST1H1D;HIST1H4K;RRP36;BRF2;DNAJB2;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;SOX12;TBCC;HIST1H4D;PMEPA1;TSPYL4;CLU;VPS18
9801,GO:0040017,0.225892298834383,0.862719927459692,10,348,positive regulation of locomotion,BP,SNAI2;SERPINE1;FAM110C;HSPB1;RHOD;COL1A1;CXCL14;PIK3R1;SOX9;ARTN
18261,GO:1903055,0.22693857248,0.974284620520197,1,12,positive regulation of extracellular matrix organization,BP,SOX9
1877,GO:0004550,0.227911834802372,0.974250575057256,1,11,nucleoside diphosphate kinase activity,MF,NME9
11112,GO:0045120,0.227920669094063,0.974050588370269,1,12,pronucleus,CC,SLC2A1
5327,GO:0016049,0.228279165096679,0.86094103185527,10,349,cell growth,BP,CDK5R1;SERTAD3;NET1;FLRT3;CTGF;IGFBP2;SOX9;DNAJB2;KRT17;CISH
11051,GO:0045023,0.229130837754566,0.938507045745698,2,42,G0 to G1 transition,BP,CTGF;SOX15
4270,GO:0009615,0.229469712218601,0.874669848169124,7,224,response to virus,BP,IVNS1ABP;HSPB1;MAP3K14;DDIT4;IFITM1;TRIM56;CLU
14124,GO:0060965,0.22951741985437,0.973667593594143,1,12,negative regulation of gene silencing by miRNA,BP,BCDIN3D
6418,GO:0021675,0.230139234142804,0.938020824744638,2,43,nerve development,BP,HES1;AHNAK2
19078,GO:1904923,0.230198718850209,0.973503237512348,1,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,HK2
10538,GO:0043476,0.230256159572226,0.973489354811509,1,12,pigment accumulation,BP,BLOC1S3
10539,GO:0043482,0.230256159572226,0.973489354811509,1,12,cellular pigment accumulation,BP,BLOC1S3
8101,GO:0032781,0.230459363048785,0.938015345630941,2,40,positive regulation of ATPase activity,BP,HSPA2;DNAJB2
12257,GO:0048522,0.230714594732606,0.808306949023096,82,3485,positive regulation of cellular process,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;PTHLH;IVNS1ABP;SERTAD3;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;ID3;CYP1B1;FAM110C;NOG;DUSP5;SERTAD1;FLRT3;LURAP1L;ZNF750;HSPB1;FHL2;POU3F1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HOXA9;ZFP36L2;BCDIN3D;TRIM35;ZNF398;FOS;RNF168;CDC42EP2;IGFBP2;IL17RA;RHOD;RBM15;VSNL1;COL1A1;TOB1;EPHB3;CXCL14;PAK6;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;SEC14L2;VASP;SLC20A1;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;TIMP3;JRK;STK17A;DDIT4;SNX33;PLEKHM1;SOX15;NR1D1;ING2;HOXA5;NACC2;HIC1;ZNF16;KRT17;SOX12;IFITM1;HK2;NOTCH3;SOCS1;CLU
12694,GO:0050892,0.23139729382236,0.973212726536221,1,12,intestinal absorption,BP,AKR1C1
15918,GO:0072676,0.231488810084077,0.937513791856359,2,41,lymphocyte migration,BP,CXCL14;ARTN
18542,GO:1903708,0.231558332916625,0.899941939503651,4,112,positive regulation of hemopoiesis,BP,FOS;HOXA5;ZNF16;SOCS1
16131,GO:0090103,0.231601047003106,0.973163167177253,1,12,cochlea morphogenesis,BP,SOX9
10316,GO:0043090,0.231733084805831,0.973131024358873,1,12,amino acid import,BP,PER2
19982,GO:2000515,0.23201598007229,0.973062085939806,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ZBTB7B
9084,GO:0035333,0.232079749782135,0.973046532525253,1,12,Notch receptor processing, ligand-dependent,BP,NOTCH3
16147,GO:0090136,0.232116001787581,0.973037688465009,1,12,epithelial cell-cell adhesion,BP,CYP1B1
15606,GO:0072074,0.232202991215938,0.973016459950305,1,12,kidney mesenchyme development,BP,MYC
8994,GO:0035102,0.232741805630139,0.972884764827299,1,12,PRC1 complex,CC,PHC2
4984,GO:0015103,0.232943384488806,0.914373235427945,3,77,inorganic anion transmembrane transporter activity,MF,SLC20A2;LRRC8A;SLC20A1
11630,GO:0046324,0.233374297333282,0.93658859356665,2,43,regulation of glucose import,BP,PIK3R1;HK2
7256,GO:0031210,0.233705068773455,0.972648446088481,1,12,phosphatidylcholine binding,MF,PCYT1A
12747,GO:0050997,0.233705068773455,0.972648446088481,1,12,quaternary ammonium group binding,MF,PCYT1A
548,GO:0001667,0.23377564603741,0.86585395316934,8,272,ameboidal-type cell migration,BP,ID1;CYP1B1;HSPB1;GDNF;NR2F2;FAT2;SOX9;KRT16
9429,GO:0035994,0.233910183993862,0.97242181565332,1,13,response to muscle stretch,BP,FOS
5459,GO:0016331,0.233932957855899,0.89847036559327,4,115,morphogenesis of embryonic epithelium,BP,NOG;GDNF;VASP;SOX9
12684,GO:0050878,0.234252404411666,0.860655088455883,9,308,regulation of body fluid levels,BP,SERPINE1;HSPB1;COL1A1;HIST1H3J;BLOC1S3;PIK3R1;KRT16;COL1A2;HK2
7047,GO:0030816,0.234284607061524,0.97250572195388,1,12,positive regulation of cAMP metabolic process,BP,PTHLH
7131,GO:0030950,0.234631316958949,0.972420140981365,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOD
2374,GO:0005501,0.234833141873682,0.972370255443834,1,12,retinoid binding,MF,NR2F2
13968,GO:0060644,0.234918080686063,0.972349246041216,1,12,mammary gland epithelial cell differentiation,BP,HOXA5
10628,GO:0043621,0.23514897016206,0.93579694234477,2,43,protein self-association,MF,ID1;SLC2A1
8110,GO:0032793,0.235221824566661,0.972274043623066,1,12,positive regulation of CREB transcription factor activity,BP,ADGRF1
576,GO:0001725,0.235243591493397,0.935754614732901,2,43,stress fiber,CC,FHL3;CNN2
16661,GO:0097517,0.235243591493397,0.935754614732901,2,43,contractile actin filament bundle,CC,FHL3;CNN2
10305,GO:0043065,0.235243592597773,0.846024901571685,13,469,positive regulation of apoptotic process,BP,CDK5R1;NET1;TXNIP;MYC;ID3;CYP1B1;CTGF;TRIM35;GADD45B;TIMP3;STK17A;HOXA5;NACC2
11354,GO:0045669,0.235290646857658,0.935733560660989,2,43,positive regulation of osteoblast differentiation,BP,CEBPA;IFITM1
7287,GO:0031268,0.235365450211582,0.972238444806575,1,12,pseudopodium organization,BP,CDC42EP2
324,GO:0000904,0.23577620869392,0.845579846559872,13,485,cell morphogenesis involved in differentiation,BP,ID1;HES1;CDK5R1;NET1;NOG;FLRT3;GDNF;CDHR1;EPHB3;SIAH2;VASP;PIK3R1;ARTN
16400,GO:0095500,0.236028542213419,0.972073764839175,1,12,acetylcholine receptor signaling pathway,BP,CDK5R1
18602,GO:1903831,0.236028542213419,0.972073764839175,1,12,signal transduction involved in cellular response to ammonium ion,BP,CDK5R1
19163,GO:1905144,0.236028542213419,0.972073764839175,1,12,response to acetylcholine,BP,CDK5R1
19164,GO:1905145,0.236028542213419,0.972073764839175,1,12,cellular response to acetylcholine,BP,CDK5R1
13280,GO:0051954,0.23620759347822,0.972029204929823,1,12,positive regulation of amine transport,BP,GDNF
12495,GO:0050433,0.236388277187099,0.9719841989794,1,12,regulation of catecholamine secretion,BP,GDNF
10310,GO:0043073,0.236533743365119,0.971947936212352,1,12,germ cell nucleus,CC,HSPA2
10565,GO:0043518,0.236651846254957,0.971918475686445,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2
19713,GO:2000010,0.23678704765778,0.97188472899803,1,12,positive regulation of protein localization to cell surface,BP,SNX33
13610,GO:0060065,0.236940019347664,0.97166575697062,1,13,uterus development,BP,HOXA9
13932,GO:0060575,0.237127415321421,0.971799673018836,1,12,intestinal epithelial cell differentiation,BP,HOXA5
1528,GO:0003899,0.237319953492256,0.93491478294708,2,41,DNA-directed 5'-3' RNA polymerase activity,MF,CD3EAP;POLR1D
3272,GO:0006950,0.237806248051847,0.805061645773168,64,2667,response to stress,BP,SNAI2;TSC22D3;SLC2A1;NET1;TXNIP;SERPINE1;MYC;ID3;ANGPTL4;CYP1B1;NOG;VASN;FLRT3;HSPB1;HIST1H4L;TNFRSF21;CTGF;MAP3K14;BAG3;FZD10;HIST1H2BJ;ZFP36L2;TRIM35;FOS;RNF168;CDC42EP2;IL17RA;HIST1H2BI;COL1A1;SLC30A1;HIST1H3J;LRRC8A;PAK6;UPF1;AKIRIN2;BLOC1S3;GADD45B;HIST1H4B;PIK3R1;GJB2;HSPA2;DDIT4;HIST1H2BE;KRT16;SOX15;NR1D1;ING2;HIST1H4K;PER2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;COL1A2;SOCS6;IFITM1;TRIM56;HIST1H4D;HK2;SOCS1;CLU;DCLRE1C
12782,GO:0051044,0.237845617869074,0.971619732221838,1,12,positive regulation of membrane protein ectodomain proteolysis,BP,SNX33
16516,GO:0097201,0.237992571945747,0.971582835899311,1,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,BAG3
9188,GO:0035563,0.238091051230415,0.971558095498547,1,12,positive regulation of chromatin binding,BP,PYGO2
16849,GO:0098739,0.238144452542337,0.934451124880608,2,43,import across plasma membrane,BP,SLC30A1;PER2
7479,GO:0031639,0.238201820985017,0.97153025320786,1,12,plasminogen activation,BP,SERPINE1
3279,GO:0006958,0.238320657060779,0.971500366677808,1,12,complement activation, classical pathway,BP,CLU
20204,GO:2001025,0.238333913929897,0.971497031583212,1,12,positive regulation of response to drug,BP,GDNF
10850,GO:0044342,0.238380709114233,0.971485257367562,1,12,type B pancreatic cell proliferation,BP,NR1D1
3405,GO:0007187,0.238793275630085,0.91115278024527,3,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,RGS2;PTHLH;ADGRF1
6158,GO:0019471,0.239139859808919,0.97129387043313,1,12,4-hydroxyproline metabolic process,BP,ALDH4A1
7742,GO:0032233,0.239420194017106,0.933874303020865,2,43,positive regulation of actin filament bundle assembly,BP,ID1;CTGF
12698,GO:0050900,0.239514534980351,0.867597393113652,7,228,leukocyte migration,BP,SERPINE1;IL17RA;COL1A1;CXCL14;PIK3R1;ARTN;COL1A2
4693,GO:0010839,0.2396040129256,0.970991649587302,1,13,negative regulation of keratinocyte proliferation,BP,SNAI2
3551,GO:0007586,0.240273361063772,0.933487329036526,2,43,digestion,BP,SOX9;AKR1C1
17875,GO:1902074,0.240392297223307,0.970976573907827,1,12,response to salt,BP,ZNF16
927,GO:0002320,0.240403755046639,0.970787568742362,1,13,lymphoid progenitor cell differentiation,BP,HES1
10403,GO:0043231,0.240640381518053,0.799515705033524,189,8301,intracellular membrane-bounded organelle,CC,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;HES2;FUT1;PTPRE;VASN;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;FOXQ1;ZNF3;ZKSCAN4;POLR1D;FAT2;COL1A1;YPEL4;TOB1;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ZNF549;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;SWT1;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;GADD45B;ZNF581;SEC14L2;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;GJB2;ZNF530;MALL;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;DDIT4;GZF1;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;KRT16;URB2;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;VPS18;FAM217B;IRX5
16821,GO:0098656,0.241280048440687,0.882418311599447,5,154,anion transmembrane transport,BP,SLC7A5P2;SLC20A2;LRRC8A;SLC20A1;PER2
12237,GO:0048485,0.241461625538407,0.970516401480164,1,13,sympathetic nervous system development,BP,GDNF
20205,GO:2001026,0.241602695882784,0.970480135685839,1,13,regulation of endothelial cell chemotaxis,BP,HSPB1
7143,GO:0030971,0.241707250406488,0.932790776985288,2,44,receptor tyrosine kinase binding,MF,TOB1;PIK3R1
479,GO:0001523,0.241796922962709,0.932793854554248,2,43,retinoid metabolic process,BP,CYP1B1;AKR1C1
13289,GO:0051963,0.241806593951758,0.932745436687461,2,44,regulation of synapse assembly,BP,FLRT3;EPHB3
8329,GO:0033169,0.241859657633997,0.970414013584284,1,13,histone H3-K9 demethylation,BP,HR
10308,GO:0043068,0.241978697474749,0.840738369103417,13,472,positive regulation of programmed cell death,BP,CDK5R1;NET1;TXNIP;MYC;ID3;CYP1B1;CTGF;TRIM35;GADD45B;TIMP3;STK17A;HOXA5;NACC2
5211,GO:0015807,0.242263146925212,0.932581023237165,2,43,L-amino acid transport,BP,SLC7A5P2;PER2
565,GO:0001704,0.242510482834671,0.909055281106015,3,80,formation of primary germ layer,BP,DUSP4;NOG;DUSP5
2392,GO:0005527,0.242926408334001,0.970328662620212,1,12,macrolide binding,MF,FKBP9
2393,GO:0005528,0.242926408334001,0.970328662620212,1,12,FK506 binding,MF,FKBP9
3270,GO:0006942,0.243122405182598,0.932143653427472,2,44,regulation of striated muscle contraction,BP,RGS2;CTGF
13650,GO:0060135,0.243266855635695,0.932077447944237,2,44,maternal process involved in female pregnancy,BP,NR2F2;GJB2
3636,GO:0008106,0.243539416198449,0.970170740237866,1,12,alcohol dehydrogenase (NADP+) activity,MF,AKR1C1
426,GO:0001133,0.243815684883515,0.969907996538258,1,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1
13552,GO:0055123,0.244977682835993,0.907660386608668,3,81,digestive system development,BP,HES1;EPHB3;HOXA5
9104,GO:0035372,0.24514504885296,0.969561379550736,1,13,protein localization to microtubule,BP,CHAMP1
5790,GO:0017015,0.245295863827875,0.907502970516406,3,80,regulation of transforming growth factor beta receptor signaling pathway,BP,VASN;ING2;PMEPA1
608,GO:0001774,0.245304240696101,0.969519724461586,1,13,microglial cell activation,BP,CLU
13586,GO:0060039,0.245462996806382,0.969312037464629,1,14,pericardium development,BP,FLRT3
2797,GO:0006241,0.245516749358151,0.969658172092838,1,12,CTP biosynthetic process,BP,NME9
11530,GO:0046036,0.245516749358151,0.969658172092838,1,12,CTP metabolic process,BP,NME9
4372,GO:0009987,0.246237714754306,0.80939835938643,235,10480,cellular process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;HES2;FUT1;NOG;PTPRE;RIN2;VASN;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;LURAP1L;ZNF750;HSPB1;ZNF419;APCDD1;KCTD15;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;VSNL1;FAT2;COL1A1;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;MN1;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;SOX12;ZNF766;IFITM1;TBCC;ZNF701;NT5DC3;TRIM56;ADGRF4;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;VPS18;IRX5;CISH
13068,GO:0051546,0.246780673536955,0.969131886196915,1,13,keratinocyte migration,BP,KRT16
13094,GO:0051589,0.246948174019073,0.969087714288744,1,13,negative regulation of neurotransmitter transport,BP,SLC30A1
3793,GO:0008356,0.24745529888662,0.968953765548894,1,13,asymmetric cell division,BP,ING2
2435,GO:0005622,0.247661080241957,0.808885855765753,236,10522,intracellular,CC,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;CXCL14;PAK6;ZNF570;RNF39;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;URB2;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;IFFO1;SOX12;ZNF766;TBCC;ZNF701;TRIM56;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;ZCCHC2;VPS18;FAM217B;IRX5;CISH
10183,GO:0042771,0.247908716878204,0.929980699747364,2,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,DDIT4;ING2
1171,GO:0002791,0.248066576594297,0.855458275630944,8,272,regulation of peptide secretion,BP,SLC2A1;MIDN;TNFRSF21;IL17RA;VSNL1;NR1D1;PER2;SOCS1
20202,GO:2001023,0.248168705458745,0.92985992158748,2,43,regulation of response to drug,BP,GDNF;PER2
5217,GO:0015813,0.248174595301631,0.968763223605012,1,13,L-glutamate transmembrane transport,BP,PER2
18702,GO:1904035,0.248294021160098,0.929755939617871,2,44,regulation of epithelial cell apoptotic process,BP,SERPINE1;ANGPTL4
16540,GO:0097242,0.248654782036148,0.968465197147336,1,14,amyloid-beta clearance,BP,CLU
8710,GO:0034349,0.24878058617668,0.968602193772995,1,13,glial cell apoptotic process,BP,TNFRSF21
10315,GO:0043087,0.248934076258966,0.845326575708008,10,362,regulation of GTPase activity,BP,RGS2;NET1;RIN2;FZD10;CDC42EP2;EPHB3;RIN1;RUNDC1;RGS3;CDC42SE1
11359,GO:0045683,0.249043499077194,0.968532186914058,1,13,negative regulation of epidermis development,BP,HES1
5172,GO:0015721,0.249149447856396,0.968503951027078,1,13,bile acid and bile salt transport,BP,AKR1C1
19134,GO:1905048,0.249230065569797,0.968482456571814,1,13,regulation of metallopeptidase activity,BP,TIMP3
1254,GO:0003002,0.249411501061412,0.867860512037447,6,196,regionalization,BP,HES1;NOG;GDNF;NR2F2;HOXA9;HOXA5
10413,GO:0043247,0.249522825515126,0.968404331812863,1,13,telomere maintenance in response to DNA damage,BP,DCLRE1C
7896,GO:0032460,0.24993942820449,0.968292973555904,1,13,negative regulation of protein oligomerization,BP,CLU
7177,GO:0031054,0.250032237499301,0.96826813589334,1,13,pre-miRNA processing,BP,BCDIN3D
12917,GO:0051250,0.25009035505847,0.904829660204076,3,79,negative regulation of lymphocyte activation,BP,TNFRSF21;ZBTB7B;SOCS6
2642,GO:0005976,0.250342162912818,0.904665859944083,3,80,polysaccharide metabolic process,BP,PPP1R3D;NR1D1;PER2
7666,GO:0032091,0.250533427259491,0.90460130624268,3,78,negative regulation of protein binding,BP,ID1;NOG;DNAJB2
2271,GO:0005200,0.250537674401973,0.90455529872852,3,80,structural constituent of cytoskeleton,MF,TUBA4A;KRT16;KRT17
5567,GO:0016575,0.250567845411428,0.904538232846529,3,80,histone deacetylation,BP,ING2;PER2;NACC2
11403,GO:0045777,0.250585423564304,0.968119867716738,1,13,positive regulation of blood pressure,BP,NR2F2
11340,GO:0045655,0.250597668240449,0.96811658147994,1,13,regulation of monocyte differentiation,BP,MYC
3701,GO:0008209,0.250645086659734,0.968103853506725,1,13,androgen metabolic process,BP,TIPARP
96,GO:0000186,0.250817617564121,0.928533478962439,2,45,activation of MAPKK activity,BP,MAP3K14;GADD45B
19913,GO:2000377,0.250818784728467,0.888085112169783,4,115,regulation of reactive oxygen species metabolic process,BP,CYP1B1;STK17A;HK2;CLU
10885,GO:0044420,0.250992648110294,0.904197716939798,3,85,extracellular matrix component,CC,COL1A1;TIMP3;COL1A2
2197,GO:0005057,0.251130445326446,0.887838127432773,4,119,signal transducer activity, downstream of receptor,MF,FLRT3;MAP3K14;EPHB3;IFITM1
6869,GO:0030335,0.251265603064897,0.84795519954976,9,317,positive regulation of cell migration,BP,SNAI2;SERPINE1;FAM110C;HSPB1;RHOD;COL1A1;CXCL14;PIK3R1;SOX9
13281,GO:0051955,0.251271555575332,0.967935432544866,1,13,regulation of amino acid transport,BP,PER2
726,GO:0001952,0.251428649074489,0.904009224443742,3,82,regulation of cell-matrix adhesion,BP,SERPINE1;RHOD;PIK3R1
17390,GO:1900103,0.251563808143905,0.967856694114245,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
6577,GO:0022038,0.25173768487122,0.967809797431395,1,13,corpus callosum development,BP,EPHB3
13602,GO:0060055,0.251897271190761,0.967766721571538,1,13,angiogenesis involved in wound healing,BP,SERPINE1
5386,GO:0016202,0.252090613824379,0.903654274700346,3,81,regulation of striated muscle tissue development,BP,TSC22D3;NOG;SOX15
17804,GO:1901861,0.252090613824379,0.903654274700346,3,81,regulation of muscle tissue development,BP,TSC22D3;NOG;SOX15
6260,GO:0019840,0.252233027432634,0.967675988920789,1,13,isoprenoid binding,MF,NR2F2
6360,GO:0021537,0.252355096862673,0.875062119185152,5,158,telencephalon development,BP,HES1;CDK5R1;SLC2A1;EPHB3;MFSD2A
9371,GO:0035886,0.252420879641668,0.96762516301058,1,13,vascular smooth muscle cell differentiation,BP,HES1
12965,GO:0051315,0.252676075433212,0.967556045205141,1,13,attachment of mitotic spindle microtubules to kinetochore,BP,CHAMP1
12934,GO:0051271,0.252920983540586,0.86541296096876,6,197,negative regulation of cellular component movement,BP,SERPINE1;CYP1B1;NOG;NR2F2;KRT16;IFITM1
2687,GO:0006047,0.252986908894375,0.967471747540018,1,13,UDP-N-acetylglucosamine metabolic process,BP,MGAT1
16825,GO:0098661,0.25330634267379,0.927362613725307,2,45,inorganic anion transmembrane transport,BP,SLC20A2;SLC20A1
1609,GO:0004029,0.253668589228235,0.967286450202698,1,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH4A1
3464,GO:0007283,0.253882615186913,0.851160542805739,8,275,spermatogenesis,BP,RGS2;ZNF296;HOXA9;SOX9;HSPA2;PYGO2;ING2;PHC2
2663,GO:0006004,0.253888696669853,0.967226494452806,1,13,fucose metabolic process,BP,FUT1
1046,GO:0002562,0.254252203596246,0.926915439395956,2,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,RNF168;DCLRE1C
5505,GO:0016444,0.254252203596246,0.926915439395956,2,45,somatic cell DNA recombination,BP,RNF168;DCLRE1C
8584,GO:0034062,0.255154853191975,0.926580586861057,2,43,5'-3' RNA polymerase activity,MF,CD3EAP;POLR1D
16746,GO:0097747,0.255154853191975,0.926580586861057,2,43,RNA polymerase activity,MF,CD3EAP;POLR1D
3605,GO:0008045,0.255590658980634,0.966580716984819,1,14,motor neuron axon guidance,BP,NOG
13703,GO:0060231,0.255727203345179,0.966723307835132,1,13,mesenchymal to epithelial transition,BP,GDNF
6615,GO:0022829,0.256142912825531,0.966608938529726,1,13,wide pore channel activity,MF,GJB2
10867,GO:0044381,0.256224558275773,0.966405447093248,1,14,glucose import in response to insulin stimulus,BP,PIK3R1
20318,GO:2001273,0.256224558275773,0.966405447093248,1,14,regulation of glucose import in response to insulin stimulus,BP,PIK3R1
13152,GO:0051704,0.256409586925985,0.797395419591616,39,1584,multi-organism process,BP,RGS2;PTHLH;IVNS1ABP;SLC2A1;SERPINE1;HSPB1;ZNF296;TNFRSF21;MAP3K14;TFCP2L1;NR2F2;SLC20A2;HOXA9;HIST1H2BJ;TRIM35;FOS;IGFBP2;IL17RA;RBM15;HIST1H2BI;UPF1;AKIRIN2;PIK3R1;SOX9;CEBPA;GJB2;HSPA2;DDIT4;HIST1H2BE;PYGO2;NR1D1;ING2;PHC2;HIST2H2BE;TRIM26;IFITM1;TRIM56;CLU;VPS18
13224,GO:0051861,0.256697140210612,0.966456120067933,1,13,glycolipid binding,MF,HSPA2
10514,GO:0043414,0.257136188997845,0.854954361962707,7,234,macromolecule methylation,BP,METTL15;BCDIN3D;FOS;TRMT61A;PYGO2;HIST1H1C;HIST1H1D
18605,GO:1903844,0.257556356079527,0.900511732922444,3,82,regulation of cellular response to transforming growth factor beta stimulus,BP,VASN;ING2;PMEPA1
12306,GO:0048634,0.258052370468846,0.900226574928908,3,82,regulation of muscle organ development,BP,TSC22D3;NOG;SOX15
1310,GO:0003151,0.258120734272991,0.925029878160305,2,46,outflow tract morphogenesis,BP,HES1;NOG
8111,GO:0032794,0.258197335752291,0.965856712241399,1,14,GTPase activating protein binding,MF,PLCD1
5365,GO:0016137,0.259088978892773,0.965792144069569,1,13,glycoside metabolic process,BP,AKR1C1
532,GO:0001650,0.259150178059808,0.882797892294392,4,118,fibrillar center,CC,MAP3K14;TFCP2L1;CD3EAP;PAK6
2834,GO:0006302,0.259413573485541,0.860884015882639,6,194,double-strand break repair,BP,HIST1H4L;RNF168;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
5447,GO:0016310,0.259540767085446,0.794092004275225,40,1646,phosphorylation,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;MIDN;MYC;NOG;DUSP5;SERTAD1;FLRT3;HSPB1;GDNF;CTGF;MAP3K14;FZD10;NR2F2;ZFP36L2;FAM212B;EPHB3;NME9;PAK6;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;TIMP3;STK17A;DDIT4;ARTN;ZNF16;SOCS6;RGS3;HK2;PMEPA1;SOCS1;CLU;CISH
13520,GO:0055075,0.25980533185327,0.96540577146757,1,14,potassium ion homeostasis,BP,KCTD7
7105,GO:0030897,0.259894923113175,0.9653805496681,1,14,HOPS complex,CC,VPS18
4150,GO:0009209,0.260075818290357,0.965516078383669,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME9
15691,GO:0072202,0.260118200348843,0.965317647831423,1,14,cell differentiation involved in metanephros development,BP,GDNF
7297,GO:0031290,0.260272980308364,0.965274005682678,1,14,retinal ganglion cell axon guidance,BP,EPHB3
6073,GO:0019218,0.260306052479014,0.898970539282016,3,80,regulation of steroid metabolic process,BP,SNAI2;SEC14L2;NR1D1
7198,GO:0031083,0.260316519182086,0.965448554892328,1,13,BLOC-1 complex,CC,BLOC1S3
17866,GO:1902041,0.260720962777605,0.923825062830174,2,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;TIMP3
17901,GO:1902166,0.260895851277072,0.965285733015577,1,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ING2
378,GO:0001010,0.260958272959817,0.965080410513413,1,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1
14949,GO:0070822,0.26174942252501,0.964856162852954,1,14,Sin3-type complex,CC,ING2
15184,GO:0071305,0.262034234975657,0.964775237707145,1,14,cellular response to vitamin D,BP,SNAI2
11067,GO:0045056,0.262216409389351,0.964723421054285,1,14,transcytosis,BP,MFSD2A
6254,GO:0019827,0.262285817428048,0.880762663450654,4,121,stem cell population maintenance,BP,HES1;NOG;ZFP36L2;SOX9
4544,GO:0010614,0.26277479839948,0.9645643307694,1,14,negative regulation of cardiac muscle hypertrophy,BP,RGS2
4882,GO:0014741,0.26277479839948,0.9645643307694,1,14,negative regulation of muscle hypertrophy,BP,RGS2
2544,GO:0005801,0.263113142401516,0.922622620968257,2,46,cis-Golgi network,CC,CTGF;PIK3R1
7503,GO:0031670,0.263577191297207,0.922397166560409,2,46,cellular response to nutrient,BP,SNAI2;COL1A1
13658,GO:0060149,0.263733434606572,0.964290272531893,1,14,negative regulation of posttranscriptional gene silencing,BP,BCDIN3D
14126,GO:0060967,0.263733434606572,0.964290272531893,1,14,negative regulation of gene silencing by RNA,BP,BCDIN3D
17554,GO:1901070,0.26419487783536,0.964350371071896,1,13,guanosine-containing compound biosynthetic process,BP,NME9
7679,GO:0032104,0.264290237094057,0.964130549576387,1,14,regulation of response to extracellular stimulus,BP,SNAI2
7682,GO:0032107,0.264290237094057,0.964130549576387,1,14,regulation of response to nutrient levels,BP,SNAI2
11814,GO:0046686,0.264376053127845,0.922101912437746,2,44,response to cadmium ion,BP,FOS;SLC30A1
1800,GO:0004435,0.264522044250635,0.964063936367001,1,14,phosphatidylinositol phospholipase C activity,MF,PLCD1
16243,GO:0090279,0.264615268642593,0.964037127461264,1,14,regulation of calcium ion import,BP,SLC30A1
3185,GO:0006809,0.264669958003062,0.921865113927456,2,46,nitric oxide biosynthetic process,BP,CYP1B1;CLU
13561,GO:0060008,0.264996498230557,0.96392737932364,1,14,Sertoli cell differentiation,BP,SOX9
19836,GO:2000269,0.265012117917629,0.963922878746328,1,14,regulation of fibroblast apoptotic process,BP,STK17A
18587,GO:1903798,0.265178061982763,0.963875045059665,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BCDIN3D
16563,GO:0097320,0.265351576969355,0.963824991095766,1,14,plasma membrane tubulation,BP,SNX33
13682,GO:0060191,0.265543809734168,0.92143849547652,2,46,regulation of lipase activity,BP,RGS2;ANGPTL4
20150,GO:2000811,0.265948598111112,0.963652471586797,1,14,negative regulation of anoikis,BP,SNAI2
11484,GO:0045932,0.265960440571054,0.963649044855714,1,14,negative regulation of muscle contraction,BP,RGS2
2112,GO:0004888,0.266586807192845,0.836311430183758,9,321,transmembrane signaling receptor activity,MF,GPR132;PTPRE;TNFRSF21;FZD10;IL17RA;EPHB3;ADGRF1;KRT17;ADGRF4
3734,GO:0008270,0.267242857795405,0.81527242227077,15,574,zinc ion binding,MF,RBAK;NR2F2;TRIM35;ZCCHC3;ZNF3;ADAMTS15;ZNF93;SIAH2;UPF1;NR1D1;PHC2;ZADH2;TRIM26;TRIM56;ZCCHC2
12494,GO:0050432,0.267274044211741,0.963267817209164,1,14,catecholamine secretion,BP,GDNF
12722,GO:0050927,0.267586917672333,0.963176687923245,1,14,positive regulation of positive chemotaxis,BP,ARTN
10051,GO:0042509,0.267655165396957,0.920450031592645,2,45,regulation of tyrosine phosphorylation of STAT protein,BP,HES1;SOCS1
13533,GO:0055090,0.267761417130874,0.963125807250482,1,14,acylglycerol homeostasis,BP,ANGPTL4
14711,GO:0070328,0.267761417130874,0.963125807250482,1,14,triglyceride homeostasis,BP,ANGPTL4
3284,GO:0006972,0.268020650991782,0.96305014695015,1,14,hyperosmotic response,BP,SLC2A1
5609,GO:0016646,0.268537945123027,0.962898908985818,1,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,ALDH4A1
19441,GO:1990000,0.268674972708863,0.962858789075592,1,14,amyloid fibril formation,BP,CLU
3795,GO:0008360,0.268707114596754,0.876613204034494,4,123,regulation of cell shape,BP,CDC42EP2;RHOD;PALMD;CDC42SE1
7875,GO:0032432,0.268812678057411,0.919788734251481,2,47,actin filament bundle,CC,FHL3;CNN2
7713,GO:0032196,0.269195906284377,0.96270604445834,1,14,transposition,BP,ZNF93
19781,GO:2000147,0.269302236992639,0.834221834687672,9,323,positive regulation of cell motility,BP,SNAI2;SERPINE1;FAM110C;HSPB1;RHOD;COL1A1;CXCL14;PIK3R1;SOX9
13499,GO:0055022,0.269464833839873,0.96262705370806,1,14,negative regulation of cardiac muscle tissue growth,BP,NOG
14217,GO:0061117,0.269464833839873,0.96262705370806,1,14,negative regulation of heart growth,BP,NOG
6901,GO:0030431,0.270235475423746,0.96240017751131,1,14,sleep,BP,FOS
16194,GO:0090201,0.270388032548253,0.962355173449835,1,14,negative regulation of release of cytochrome c from mitochondria,BP,CLU
8977,GO:0035065,0.270491140484104,0.919003869703369,2,46,regulation of histone acetylation,BP,SNAI2;PYGO2
9147,GO:0035493,0.270542579732512,0.962309551514046,1,14,SNARE complex assembly,BP,VPS18
8627,GO:0034142,0.270669096353518,0.962272181040682,1,14,toll-like receptor 4 signaling pathway,BP,NR1D1
11076,GO:0045066,0.270816317478292,0.962228668699773,1,14,regulatory T cell differentiation,BP,SOCS1
11290,GO:0045589,0.270816317478292,0.962228668699773,1,14,regulation of regulatory T cell differentiation,BP,SOCS1
15636,GO:0072111,0.270876033216919,0.962211011225197,1,14,cell proliferation involved in kidney development,BP,MYC
16843,GO:0098727,0.271566328180745,0.874761548460838,4,123,maintenance of cell number,BP,HES1;NOG;ZFP36L2;SOX9
6765,GO:0030194,0.27237580438265,0.961766020206907,1,14,positive regulation of blood coagulation,BP,SERPINE1
17371,GO:1900048,0.27237580438265,0.961766020206907,1,14,positive regulation of hemostasis,BP,SERPINE1
12493,GO:0050431,0.273584240833368,0.961226695931913,1,15,transforming growth factor beta binding,MF,VASN
9974,GO:0042359,0.273609017779961,0.961397924423843,1,14,vitamin D metabolic process,BP,SNAI2
11491,GO:0045940,0.273705434535987,0.961369061890555,1,14,positive regulation of steroid metabolic process,BP,NR1D1
5573,GO:0016581,0.273869140458518,0.961141013112387,1,15,NuRD complex,CC,NACC2
16342,GO:0090545,0.273869140458518,0.961141013112387,1,15,CHD-type complex,CC,NACC2
2377,GO:0005504,0.27398856855468,0.961284235090981,1,14,fatty acid binding,MF,ID3
7110,GO:0030902,0.274145234986538,0.890743471587166,3,85,hindbrain development,BP,HES1;CDK5R1;NOG
10031,GO:0042472,0.274319423255103,0.917007083004994,2,48,inner ear morphogenesis,BP,LRIG3;SOX9
736,GO:0001963,0.274332474539708,0.961181060305508,1,14,synaptic transmission, dopaminergic,BP,GDNF
12089,GO:0048029,0.274491159281243,0.91701141199813,2,46,monosaccharide binding,MF,SLC2A3;HK2
6544,GO:0021952,0.274726948428262,0.960882387519612,1,15,central nervous system projection neuron axonogenesis,BP,EPHB3
6703,GO:0030098,0.275506302555839,0.849376635618127,6,201,lymphocyte differentiation,BP,ZFP36L2;LRRC8A;ZBTB7B;PIK3R1;SOCS1;DCLRE1C
12918,GO:0051251,0.275715237435759,0.859173792813423,5,159,positive regulation of lymphocyte activation,BP,HES1;MAP3K14;IGFBP2;PIK3R1;SOCS1
5801,GO:0017046,0.276014972607877,0.960492240889436,1,15,peptide hormone binding,MF,PIK3R1
11407,GO:0045785,0.27656473694813,0.840658408854199,7,242,positive regulation of cell adhesion,BP,HES1;NET1;MAP3K14;IGFBP2;RHOD;PIK3R1;SOCS1
17868,GO:1902043,0.276694262699963,0.960285604111802,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TIMP3
13952,GO:0060602,0.276824474088977,0.960245925138366,1,15,branch elongation of an epithelium,BP,SOX9
11654,GO:0046365,0.276887988385236,0.915807230636335,2,46,monosaccharide catabolic process,BP,FUT1;HK2
4149,GO:0009208,0.27691657621815,0.960400861424715,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME9
4662,GO:0010804,0.277129705134282,0.960336122662678,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,HIST1H2BJ
13149,GO:0051701,0.277704198853795,0.857785356681719,5,160,interaction with host,BP,SLC20A2;TRIM35;TRIM26;IFITM1;VPS18
11787,GO:0046636,0.278077753438287,0.95986287557601,1,15,negative regulation of alpha-beta T cell activation,BP,ZBTB7B
14157,GO:0061013,0.278119518497306,0.857496857554722,5,160,regulation of mRNA catabolic process,BP,HSPB1;GDNF;ZFP36L2;TOB1;UPF1
13641,GO:0060122,0.278428598716277,0.959755273305997,1,15,inner ear receptor cell stereocilium organization,BP,HES1
12715,GO:0050920,0.278487333887457,0.870254059176059,4,122,regulation of chemotaxis,BP,SERPINE1;HSPB1;CXCL14;ARTN
3348,GO:0007076,0.278553250677798,0.959555127892904,1,16,mitotic chromosome condensation,BP,PHF13
4672,GO:0010817,0.278780697996062,0.832434573521086,8,282,regulation of hormone levels,BP,TIPARP;SLC2A1;MIDN;CYP1B1;VSNL1;AKR1C1;NR1D1;PER2
1050,GO:0002573,0.278782382745864,0.870046772923961,4,123,myeloid leukocyte differentiation,BP,MYC;FOS;PIK3R1;CEBPA
3627,GO:0008088,0.278846434558122,0.914725096335229,2,48,axo-dendritic transport,BP,HSPB1;BLOC1S3
12368,GO:0048736,0.279290573529237,0.869673632090084,4,126,appendage development,BP,NOG;NR2F2;HOXA9;SOX9
13674,GO:0060173,0.279290573529237,0.869673632090084,4,126,limb development,BP,NOG;NR2F2;HOXA9;SOX9
5163,GO:0015698,0.279390488415296,0.887602938690855,3,85,inorganic anion transport,BP,SLC20A2;LRRC8A;SLC20A1
6664,GO:0030014,0.279518709674088,0.959419906435161,1,15,CCR4-NOT complex,CC,TOB1
4587,GO:0010669,0.279632787058492,0.959384720462191,1,15,epithelial structure maintenance,BP,SOX9
6868,GO:0030334,0.279961037381959,0.807373417950058,14,541,regulation of cell migration,BP,SNAI2;SERPINE1;CYP1B1;FAM110C;NOG;HSPB1;NR2F2;RHOD;COL1A1;CXCL14;PIK3R1;SOX9;KRT16;IFITM1
12652,GO:0050832,0.280221677968721,0.959390213438132,1,14,defense response to fungus,BP,IL17RA
3588,GO:0008009,0.280368611891364,0.959344949778754,1,14,chemokine activity,MF,CXCL14
599,GO:0001764,0.280495836680602,0.88689458324029,3,87,neuron migration,BP,CDK5R1;NR2F2;DDIT4
6842,GO:0030301,0.280586949975289,0.913840402734258,2,48,cholesterol transport,BP,AKR1C1;CLU
12817,GO:0051098,0.280715538805167,0.830958113836143,8,282,regulation of binding,BP,ID1;HES1;ID3;NOG;HJURP;PYGO2;PER2;DNAJB2
1933,GO:0004629,0.281145175562962,0.95891661432232,1,15,phospholipase C activity,MF,PLCD1
11811,GO:0046683,0.281183592268937,0.886521532513578,3,85,response to organophosphorus,BP,FOS;COL1A1;AKR1C1
1402,GO:0003333,0.281264566179002,0.91349487294436,2,48,amino acid transmembrane transport,BP,SLC7A5P2;PER2
3497,GO:0007398,0.281299210502482,0.958868768478376,1,15,ectoderm development,BP,ZBTB7B
13928,GO:0060571,0.281389406248671,0.958840737577308,1,15,morphogenesis of an epithelial fold,BP,NOG
3431,GO:0007220,0.282674383577688,0.958440223385812,1,15,Notch receptor processing,BP,NOTCH3
18494,GO:1903579,0.282692642806841,0.9584345163944,1,15,negative regulation of ATP metabolic process,BP,DDIT4
12721,GO:0050926,0.282743687361656,0.958418559877801,1,15,regulation of positive chemotaxis,BP,ARTN
17526,GO:1900745,0.282911914010161,0.95836594778723,1,15,positive regulation of p38MAPK cascade,BP,GADD45B
7088,GO:0030878,0.283076290400667,0.958314503561113,1,15,thyroid gland development,BP,HOXA5
4582,GO:0010664,0.283197998705298,0.958276389882015,1,15,negative regulation of striated muscle cell apoptotic process,BP,BAG3
4950,GO:0014912,0.283349815517588,0.958228819972097,1,15,negative regulation of smooth muscle cell migration,BP,SERPINE1
17722,GO:1901617,0.283461256321899,0.853760433803756,5,161,organic hydroxy compound biosynthetic process,BP,SNAI2;FAXDC2;SEC14L2;NR1D1;PER2
15009,GO:0070920,0.283676457176403,0.958126367068473,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,BCDIN3D
3449,GO:0007260,0.283736835681161,0.912275359900243,2,47,tyrosine phosphorylation of STAT protein,BP,HES1;SOCS1
7013,GO:0030695,0.283762486891728,0.835254830527724,7,248,GTPase regulator activity,MF,RGS2;RIN2;CDC42EP2;RIN1;RUNDC1;RGS3;CDC42SE1
14656,GO:0070233,0.283855584148711,0.958070122742324,1,15,negative regulation of T cell apoptotic process,BP,TSC22D3
5353,GO:0016101,0.283908519251548,0.912140763856889,2,48,diterpenoid metabolic process,BP,CYP1B1;AKR1C1
7035,GO:0030804,0.283943636072875,0.958042459561451,1,15,positive regulation of cyclic nucleotide biosynthetic process,BP,PTHLH
11357,GO:0045672,0.284116665877566,0.957988068938904,1,15,positive regulation of osteoclast differentiation,BP,FOS
4660,GO:0010801,0.284117137388042,0.957987920668731,1,15,negative regulation of peptidyl-threonine phosphorylation,BP,DDIT4
12146,GO:0048232,0.284702117273147,0.827892457926131,8,285,male gamete generation,BP,RGS2;ZNF296;HOXA9;SOX9;HSPA2;PYGO2;ING2;PHC2
10831,GO:0044321,0.28495434299994,0.957724188297059,1,15,response to leptin,BP,NR1D1
14364,GO:0061564,0.285069304622958,0.821961100141556,9,335,axon development,BP,CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
10292,GO:0043034,0.285120863101117,0.95735254081221,1,17,costamere,CC,AHNAK2
2347,GO:0005385,0.285244994079794,0.9576324106571,1,15,zinc ion transmembrane transporter activity,MF,SLC30A1
15360,GO:0071577,0.285244994079794,0.9576324106571,1,15,zinc ion transmembrane transport,BP,SLC30A1
4602,GO:0010714,0.285992683473107,0.957395798812908,1,15,positive regulation of collagen metabolic process,BP,CTGF
8217,GO:0032967,0.285992683473107,0.957395798812908,1,15,positive regulation of collagen biosynthetic process,BP,CTGF
7332,GO:0031338,0.286249620776637,0.910888884350244,2,49,regulation of vesicle fusion,BP,RUNDC1;VPS18
12545,GO:0050680,0.286263088136865,0.883393291333363,3,87,negative regulation of epithelial cell proliferation,BP,SNAI2;NR2F2;SOX9
6904,GO:0030449,0.286386242438418,0.957270954741899,1,15,regulation of complement activation,BP,CLU
19833,GO:2000257,0.286386242438418,0.957270954741899,1,15,regulation of protein activation cascade,BP,CLU
5836,GO:0017112,0.286409246963095,0.910806291243407,2,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN2;RIN1
17783,GO:1901796,0.286633096625771,0.851523546334067,5,162,regulation of signal transduction by p53 class mediator,BP,SNAI2;CDK5R1;BRPF1;ING2;HIC1
5251,GO:0015872,0.28679797060094,0.957140125866477,1,15,dopamine transport,BP,GDNF
12646,GO:0050820,0.286981690715212,0.957081674774483,1,15,positive regulation of coagulation,BP,SERPINE1
6761,GO:0030182,0.287141197781402,0.787079755130659,21,853,neuron differentiation,BP,ID1;HES1;CDK5R1;ID3;NOG;FLRT3;GDNF;FZD10;CDHR1;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;SOX9;DDIT4;ARTN;NCDN;NOTCH3;IRX5
3498,GO:0007399,0.287805580164279,0.772090998674677,35,1472,nervous system development,BP,ID1;HES1;CDK5R1;SLC2A1;ID3;NOG;FLRT3;APCDD1;TNFRSF21;POU3F1;GDNF;AHNAK2;BAG3;FZD10;NR2F2;CDHR1;FOS;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;MFSD2A;SOX9;MALL;DDIT4;ARTN;PYGO2;NCDN;PER2;SOX12;NOTCH3;CLU;IRX5
16436,GO:0097061,0.288482354529835,0.909686834769921,2,50,dendritic spine organization,BP,CDK5R1;EPHB3
11356,GO:0045671,0.288596074680169,0.956392384612722,1,16,negative regulation of osteoclast differentiation,BP,PIK3R1
12242,GO:0048490,0.288632243510562,0.956554523420619,1,15,anterograde synaptic vesicle transport,BP,BLOC1S3
17050,GO:0099514,0.288632243510562,0.956554523420619,1,15,synaptic vesicle cytoskeletal transport,BP,BLOC1S3
17053,GO:0099517,0.288632243510562,0.956554523420619,1,15,synaptic vesicle transport along microtubule,BP,BLOC1S3
9547,GO:0036297,0.288655333670791,0.909686063059339,2,48,interstrand cross-link repair,BP,RNF168;DCLRE1C
11612,GO:0046209,0.289017620223108,0.909451816225934,2,49,nitric oxide metabolic process,BP,CYP1B1;CLU
10155,GO:0042730,0.289411326294866,0.95630443442984,1,15,fibrinolysis,BP,SERPINE1
4734,GO:0010894,0.28964511051387,0.956229230015935,1,15,negative regulation of steroid biosynthetic process,BP,SNAI2
2624,GO:0005942,0.28978630537855,0.95600861312632,1,16,phosphatidylinositol 3-kinase complex,CC,PIK3R1
7678,GO:0032103,0.290267673145248,0.848958018662487,5,162,positive regulation of response to external stimulus,BP,SERPINE1;HSPB1;IL17RA;CXCL14;ARTN
10206,GO:0042813,0.29028560410242,0.955847054769683,1,16,Wnt-activated receptor activity,MF,FZD10
5595,GO:0016616,0.290854294593878,0.880667018121986,3,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,CBR1;AKR1C1;ZADH2
5554,GO:0016556,0.291793920330504,0.9555345586256,1,15,mRNA modification,BP,TRMT61A
4347,GO:0009896,0.291826848087913,0.8166721913697,9,331,positive regulation of catabolic process,BP,TIPARP;ZFP36L2;TOB1;UPF1;SOX9;CEBPA;SNX33;HK2;CLU
19211,GO:1905276,0.292320461667453,0.955185161133775,1,16,regulation of epithelial tube formation,BP,GDNF
11105,GO:0045109,0.292895522395418,0.954997094140512,1,16,intermediate filament organization,BP,KRT17
10688,GO:0043949,0.292934008991184,0.954984491589558,1,16,regulation of cAMP-mediated signaling,BP,RGS2
6453,GO:0021766,0.293096645399765,0.907270596316598,2,50,hippocampus development,BP,CDK5R1;MFSD2A
13821,GO:0060396,0.293284890600547,0.954869502012566,1,16,growth hormone receptor signaling pathway,BP,PIK3R1
14272,GO:0061311,0.294061768012381,0.954614314191667,1,16,cell surface receptor signaling pathway involved in heart development,BP,NOG
9370,GO:0035883,0.294404825100329,0.954501367154562,1,16,enteroendocrine cell differentiation,BP,HES1
3819,GO:0008409,0.294647933899701,0.954421230265308,1,16,5'-3' exonuclease activity,MF,DCLRE1C
502,GO:0001558,0.294881072296757,0.820015990922347,8,289,regulation of cell growth,BP,CDK5R1;SERTAD3;NET1;CTGF;IGFBP2;DNAJB2;KRT17;CISH
2757,GO:0006165,0.294987744853588,0.87801851795824,3,87,nucleoside diphosphate phosphorylation,BP,NME9;DDIT4;HK2
17900,GO:1902165,0.295370803366847,0.954364431818952,1,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,ING2
12935,GO:0051272,0.295525310009039,0.813750153162233,9,332,positive regulation of cellular component movement,BP,SNAI2;SERPINE1;FAM110C;HSPB1;RHOD;COL1A1;CXCL14;PIK3R1;SOX9
7750,GO:0032259,0.295620437082175,0.819458973687554,8,285,methylation,BP,MAT2A;METTL15;BCDIN3D;FOS;TRMT61A;PYGO2;HIST1H1C;HIST1H1D
1992,GO:0004709,0.295872407395702,0.905759765007698,2,51,MAP kinase kinase kinase activity,MF,MAP3K14;EPHB3
95,GO:0000185,0.296061424979698,0.95395370827225,1,16,activation of MAPKKK activity,BP,GADD45B
1104,GO:0002690,0.296393834205477,0.905619201451475,2,48,positive regulation of leukocyte chemotaxis,BP,SERPINE1;CXCL14
11821,GO:0046697,0.29647502634116,0.953816393892504,1,16,decidualization,BP,GJB2
8680,GO:0034250,0.296490241954256,0.858211611744546,4,124,positive regulation of cellular amide metabolic process,BP,BCDIN3D;IMP3;KRT17;CLU
16480,GO:0097150,0.296689873684663,0.95358314034777,1,17,neuronal stem cell population maintenance,BP,HES1
732,GO:0001958,0.297034399447935,0.953630313930794,1,16,endochondral ossification,BP,COL1A1
9469,GO:0036075,0.297034399447935,0.953630313930794,1,16,replacement ossification,BP,COL1A1
16109,GO:0090075,0.297087814040584,0.953612522884922,1,16,relaxation of muscle,BP,RGS2
17720,GO:1901615,0.297443495973422,0.812246286339284,9,328,organic hydroxy compound metabolic process,BP,SNAI2;CYP1B1;FAXDC2;PLCD1;SEC14L2;CEBPA;AKR1C1;NR1D1;PER2
2206,GO:0005088,0.298128283042159,0.843269408976154,5,172,Ras guanyl-nucleotide exchange factor activity,MF,NET1;RIN2;GDNF;RIN1;ARTN
5071,GO:0015291,0.298252538776176,0.85697449612595,4,127,secondary active transmembrane transporter activity,MF,SLC7A5P2;SLC20A2;SLC20A1;MFSD2A
4304,GO:0009749,0.298259187973321,0.856983463245964,4,126,response to glucose,BP,TXNIP;CTGF;VSNL1;NR1D1
8716,GO:0034358,0.298459213219632,0.95315441488686,1,16,plasma lipoprotein particle,CC,CLU
19645,GO:1990777,0.298459213219632,0.95315441488686,1,16,lipoprotein particle,CC,CLU
8938,GO:0034968,0.298507707680679,0.875780028523577,3,89,histone lysine methylation,BP,PYGO2;HIST1H1C;HIST1H1D
7187,GO:0031065,0.29865426734215,0.953089050083155,1,16,positive regulation of histone deacetylation,BP,ING2
18455,GO:1903522,0.298707030144163,0.856639034736444,4,129,regulation of blood circulation,BP,RGS2;CTGF;PER2;IRX5
1349,GO:0003209,0.299121868672334,0.952767653623517,1,17,cardiac atrium morphogenesis,BP,NOG
17785,GO:1901798,0.299433164236547,0.952827515797725,1,16,positive regulation of signal transduction by p53 class mediator,BP,HIC1
7133,GO:0030952,0.299501261319471,0.95280461113358,1,16,establishment or maintenance of cytoskeleton polarity,BP,RHOD
16739,GO:0097731,0.299897903332177,0.903612452118848,2,51,9+0 non-motile cilium,CC,CDHR1;TBCC
16741,GO:0097733,0.299897903332177,0.903612452118848,2,51,photoreceptor cell cilium,CC,CDHR1;TBCC
13713,GO:0060251,0.300234161011753,0.952391989742715,1,17,regulation of glial cell proliferation,BP,HES1
4399,GO:0010092,0.300343342759863,0.952520851090181,1,16,specification of animal organ identity,BP,GDNF
3663,GO:0008150,0.301275564657485,0.780671098192942,250,11228,biological_process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;HES2;FUT1;NOG;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;METTL15;LURAP1L;ZNF750;HSPB1;ZNF419;APCDD1;KCTD15;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;SLC7A5P2;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;PRR15;RHOD;FAM212B;CD3EAP;SLC22A15;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;VSNL1;FAT2;COL1A1;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;MN1;CXCL14;PAK6;ZNF570;SH3TC1;RNF39;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;URB2;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;SOX12;GFOD1;ZNF766;IFITM1;TBCC;ZNF701;NT5DC3;TRIM56;ADGRF4;ZNF845;ZNF510;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;VPS18;IRX5;CISH
2614,GO:0005921,0.301291012271512,0.952200351316171,1,16,gap junction,CC,GJB2
5600,GO:0016627,0.301389137063115,0.902902595077819,2,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,AKR1C1;ZADH2
11313,GO:0045622,0.301474512493532,0.952138149928119,1,16,regulation of T-helper cell differentiation,BP,ZBTB7B
7504,GO:0031672,0.301748912744678,0.951596109672782,1,19,A band,CC,FHL2
797,GO:0002063,0.301955731304635,0.951807205846136,1,17,chondrocyte development,BP,SOX9
7068,GO:0030851,0.302001707622401,0.951959189128422,1,16,granulocyte differentiation,BP,CEBPA
14523,GO:0065008,0.302328989103972,0.748907439712054,56,2391,regulation of biological quality,BP,ID1;TIPARP;RGS2;TSC22D3;CDK5R1;SLC2A1;MIDN;SERPINE1;MYC;ANGPTL4;CYP1B1;FLRT3;HSPB1;HIST1H4L;GDNF;CTGF;BAG3;NR2F2;ZFP36L2;CDHR1;CDC42EP2;KCTD7;RHOD;VSNL1;COL1A1;EPHB3;SLC30A1;HIST1H3J;NME9;LRRC8A;UPF1;BLOC1S3;VASP;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;MALL;AKR1C1;PLEKHM1;KRT16;NCDN;NR1D1;HOXA5;HIST1H4K;PALMD;PER2;COL1A2;ZNF16;HIST1H4D;HK2;CLU;CDC42SE1;DCLRE1C;IRX5
20117,GO:2000756,0.303148354812775,0.901907617139103,2,50,regulation of peptidyl-lysine acetylation,BP,SNAI2;PYGO2
14498,GO:0061900,0.303248204377384,0.951365502645079,1,17,glial cell activation,BP,CLU
3248,GO:0006907,0.303521227671511,0.951441243358972,1,16,pinocytosis,BP,SNX33
15221,GO:0071356,0.303856266915017,0.828551008475679,6,202,cellular response to tumor necrosis factor,BP,TNFRSF21;MAP3K14;HIST1H2BJ;ZFP36L2;COL1A1;CEBPA
17211,GO:0106027,0.304191648267864,0.901254418953786,2,52,neuron projection organization,BP,CDK5R1;EPHB3
738,GO:0001965,0.304199918994386,0.951208879520592,1,16,G-protein alpha-subunit binding,MF,RGS2
7897,GO:0032461,0.304397799797614,0.95114101176708,1,16,positive regulation of protein oligomerization,BP,CLU
11629,GO:0046323,0.304486094794503,0.90109472309411,2,52,glucose import,BP,PIK3R1;HK2
12109,GO:0048103,0.304758947475353,0.950846290548819,1,17,somatic stem cell division,BP,ZFP36L2
10214,GO:0042826,0.305071349805174,0.871645043355416,3,89,histone deacetylase binding,MF,HES1;NACC2;HIC1
3559,GO:0007600,0.305078023197532,0.82758588198091,6,209,sensory perception,BP,SNAI2;CYP1B1;COL1A1;GJB2;TIMP3;IRX5
6069,GO:0019213,0.305219358328708,0.900740215533655,2,51,deacetylase activity,MF,CES2;NACC2
9940,GO:0042287,0.305320228750732,0.950823932709722,1,16,MHC protein binding,MF,KRT17
10399,GO:0043227,0.305533632222616,0.744528756099091,208,9247,membrane-bounded organelle,CC,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;HES2;FUT1;PTPRE;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;FAT2;COL1A1;YPEL4;TOB1;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ZNF549;CBR1;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;SWT1;HJURP;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;C11ORF52;MALL;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;AKR1C1;DDIT4;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;KRT16;URB2;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;KRT17;SOX12;ZNF766;ZNF701;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;DCLRE1C;VPS18;FAM217B;IRX5
17739,GO:1901654,0.305755022921366,0.851828842989591,4,128,response to ketone,BP,TXNIP;FOS;GJB2;DDIT4
11490,GO:0045939,0.305833010256658,0.950647160631953,1,16,negative regulation of steroid metabolic process,BP,SNAI2
2732,GO:0006109,0.306113505481871,0.851555343338041,4,130,regulation of carbohydrate metabolic process,BP,MIDN;PPP1R3D;DDIT4;NR1D1
17405,GO:1900120,0.306168586765198,0.950531280556763,1,16,regulation of receptor binding,BP,NOG
8705,GO:0034341,0.306407363206474,0.851421264674872,4,125,response to interferon-gamma,BP,CDC42EP2;TRIM26;IFITM1;SOCS1
19647,GO:1990782,0.306555922704008,0.899968818767452,2,52,protein tyrosine kinase binding,MF,TOB1;PIK3R1
2248,GO:0005158,0.307153912910778,0.949862731273813,1,18,insulin receptor binding,MF,PIK3R1
8802,GO:0034501,0.307188641932405,0.950178084900675,1,16,protein localization to kinetochore,BP,CHAMP1
18505,GO:1903599,0.307322452740915,0.949958056400702,1,17,positive regulation of autophagy of mitochondrion,BP,HK2
11265,GO:0045499,0.307471250449619,0.949906220020976,1,17,chemorepellent activity,MF,FLRT3
13785,GO:0060349,0.307732041158213,0.899326470932877,2,52,bone morphogenesis,BP,COL1A1;SOX9
19788,GO:2000171,0.307853024604125,0.949773081740745,1,17,negative regulation of dendrite development,BP,ID1
3951,GO:0008649,0.30812648396373,0.949852087569077,1,16,rRNA methyltransferase activity,MF,METTL15
17318,GO:0140102,0.30812648396373,0.949852087569077,1,16,catalytic activity, acting on a rRNA,MF,METTL15
4303,GO:0009746,0.30819540207609,0.8501457075874,4,128,response to hexose,BP,TXNIP;CTGF;VSNL1;NR1D1
3329,GO:0007040,0.308237166097225,0.89909433007853,2,51,lysosome organization,BP,ZKSCAN4;VPS18
15998,GO:0080171,0.308237166097225,0.89909433007853,2,51,lytic vacuole organization,BP,ZKSCAN4;VPS18
17908,GO:1902176,0.308246941605334,0.949810127917573,1,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,HSPB1
6476,GO:0021801,0.308266669715625,0.9496286008655,1,17,cerebral cortex radial glia guided migration,BP,CDK5R1
6575,GO:0022030,0.308266669715625,0.9496286008655,1,17,telencephalon glial cell migration,BP,CDK5R1
7040,GO:0030809,0.308459859785175,0.949561040778818,1,17,negative regulation of nucleotide biosynthetic process,BP,DDIT4
17490,GO:1900372,0.308459859785175,0.949561040778818,1,17,negative regulation of purine nucleotide biosynthetic process,BP,DDIT4
3230,GO:0006884,0.308652924618993,0.94949347275252,1,17,cell volume homeostasis,BP,LRRC8A
6768,GO:0030198,0.308936481459513,0.824645159240446,6,215,extracellular matrix organization,BP,SERPINE1;CYP1B1;CTGF;COL1A1;SOX9;COL1A2
12678,GO:0050869,0.309251877791768,0.949283524340953,1,17,negative regulation of B cell activation,BP,TNFRSF21
15236,GO:0071378,0.309369132068791,0.949242365399034,1,17,cellular response to growth hormone stimulus,BP,PIK3R1
20149,GO:2000810,0.30937305970984,0.949240986376252,1,17,regulation of bicellular tight junction assembly,BP,SNAI2
17852,GO:1902003,0.30947061711432,0.949206726397139,1,17,regulation of amyloid-beta formation,BP,CLU
18663,GO:1903959,0.30988688785543,0.949060392775021,1,17,regulation of anion transmembrane transport,BP,PER2
1109,GO:0002695,0.31003965498636,0.868479814435849,3,89,negative regulation of leukocyte activation,BP,TNFRSF21;ZBTB7B;SOCS6
9858,GO:0042102,0.310165660683295,0.898082609023696,2,50,positive regulation of T cell proliferation,BP,HES1;IGFBP2
11869,GO:0046849,0.310203371284969,0.89797062129508,2,52,bone remodeling,BP,PLEKHM1;NCDN
1613,GO:0004033,0.310587723752451,0.94899076083131,1,16,aldo-keto reductase (NADP) activity,MF,AKR1C1
1265,GO:0003016,0.310715406556874,0.948768422452968,1,17,respiratory system process,BP,HOXA5
1554,GO:0003950,0.310746706986261,0.948757373440789,1,17,NAD+ ADP-ribosyltransferase activity,MF,TIPARP
8528,GO:0033764,0.311780748237273,0.948570229425953,1,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,AKR1C1
9873,GO:0042129,0.311813927422106,0.86736473890044,3,88,regulation of T cell proliferation,BP,HES1;TNFRSF21;IGFBP2
630,GO:0001817,0.312287836935688,0.790838359854607,11,415,regulation of cytokine production,BP,SNAI2;SERPINE1;CYP1B1;HSPB1;TNFRSF21;IL17RA;AKIRIN2;PIK3R1;TRIM56;SOCS1;CLU
16869,GO:0098780,0.312456701281695,0.948151672776511,1,17,response to mitochondrial depolarisation,BP,HK2
12596,GO:0050750,0.31247367813691,0.948145638921036,1,17,low-density lipoprotein particle receptor binding,MF,CLU
9166,GO:0035518,0.3124958407548,0.948137761354099,1,17,histone H2A monoubiquitination,BP,RNF168
467,GO:0001505,0.312593369850886,0.832815998436163,5,170,regulation of neurotransmitter levels,BP,CYP1B1;GDNF;SLC30A1;PER2;CLU
740,GO:0001968,0.313211585521889,0.947882985423632,1,17,fibronectin binding,MF,CTGF
2948,GO:0006476,0.313510182113352,0.866206698296456,3,91,protein deacetylation,BP,ING2;PER2;NACC2
14821,GO:0070542,0.313806017827496,0.895979249872049,2,52,response to fatty acid,BP,ID3;CTGF
722,GO:0001945,0.314076997576327,0.947412993238133,1,18,lymph vessel development,BP,NR2F2
570,GO:0001709,0.314111654374222,0.947561581151766,1,17,cell fate determination,BP,HES1
20225,GO:2001057,0.314274453556347,0.895719026034144,2,52,reactive nitrogen species metabolic process,BP,CYP1B1;CLU
9378,GO:0035902,0.31449595346708,0.947424007013491,1,17,response to immobilization stress,BP,FOS
6924,GO:0030512,0.314523361184596,0.895536772711938,2,53,negative regulation of transforming growth factor beta receptor signaling pathway,BP,VASN;PMEPA1
14959,GO:0070840,0.315098196362945,0.947045968606834,1,18,dynein complex binding,MF,BICD2
7480,GO:0031640,0.315103384098448,0.947388579816814,1,16,killing of cells of other organism,BP,HIST1H2BJ
10863,GO:0044364,0.315103384098448,0.947388579816814,1,16,disruption of cells of other organism,BP,HIST1H2BJ
19933,GO:2000403,0.315324390013013,0.947126733679835,1,17,positive regulation of lymphocyte migration,BP,CXCL14
14241,GO:0061180,0.315374277026974,0.895062855146886,2,53,mammary gland epithelium development,BP,PYGO2;HOXA5
3199,GO:0006829,0.315684606154288,0.946997174809454,1,17,zinc ion transport,BP,SLC30A1
148,GO:0000302,0.31588384556151,0.830432441852923,5,167,response to reactive oxygen species,BP,NET1;TXNIP;CYP1B1;FOS;COL1A1
11636,GO:0046330,0.315954840993908,0.864627228796827,3,91,positive regulation of JNK cascade,BP,CTGF;FZD10;GADD45B
13536,GO:0055093,0.316142160524583,0.946832343801223,1,17,response to hyperoxia,BP,COL1A1
10918,GO:0044464,0.316864984998096,0.761707596481683,247,11095,cell part,CC,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;APCDD1;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;SLC7A5P2;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;SLC22A15;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;CXCL14;PAK6;ZNF570;RNF39;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;URB2;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;IFFO1;SOX12;ZNF766;IFITM1;TBCC;ZNF701;TRIM56;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;ZCCHC2;VPS18;FAM217B;IRX5;CISH
5074,GO:0015294,0.316970791855338,0.894171019784699,2,53,solute:cation symporter activity,MF,SLC20A2;SLC20A1
4063,GO:0009110,0.317078746110636,0.946494027974492,1,17,vitamin biosynthetic process,BP,SNAI2
10124,GO:0042641,0.317570653333649,0.893792238937901,2,54,actomyosin,CC,FHL3;CNN2
15137,GO:0071216,0.317828782171152,0.843422009570494,4,129,cellular response to biotic stimulus,BP,TXNIP;SERPINE1;UPF1;NR1D1
12637,GO:0050808,0.31783365681479,0.828913646531134,5,176,synapse organization,BP,CDK5R1;FLRT3;GDNF;EPHB3;ADGRF1
1868,GO:0004529,0.318708210889951,0.945902487755059,1,17,exodeoxyribonuclease activity,MF,DCLRE1C
5752,GO:0016895,0.318708210889951,0.945902487755059,1,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,DCLRE1C
3142,GO:0006735,0.318781530420034,0.945875782834356,1,17,NADH regeneration,BP,HK2
14388,GO:0061621,0.318781530420034,0.945875782834356,1,17,canonical glycolysis,BP,HK2
14429,GO:0061718,0.318781530420034,0.945875782834356,1,17,glucose catabolic process to pyruvate,BP,HK2
9904,GO:0042219,0.320009623807209,0.945427351243533,1,17,cellular modified amino acid catabolic process,BP,ALDH4A1
9859,GO:0042104,0.320069278517799,0.94540551442724,1,17,positive regulation of activated T cell proliferation,BP,IGFBP2
3532,GO:0007519,0.320126941043806,0.861892836687764,3,92,skeletal muscle tissue development,BP,TSC22D3;NR2F2;FOS
10420,GO:0043255,0.321269330835101,0.891709048709955,2,54,regulation of carbohydrate biosynthetic process,BP,PPP1R3D;NR1D1
10587,GO:0043547,0.321340905423449,0.799100435620533,8,302,positive regulation of GTPase activity,BP,RGS2;NET1;RIN2;FZD10;CDC42EP2;RIN1;RUNDC1;RGS3
4229,GO:0009404,0.321500820044698,0.944879984673308,1,17,toxin metabolic process,BP,CYP1B1
10531,GO:0043462,0.321556684240586,0.891682308934401,2,51,regulation of ATPase activity,BP,HSPA2;DNAJB2
473,GO:0001516,0.32206067806466,0.944673667619304,1,17,prostaglandin biosynthetic process,BP,CBR1
11684,GO:0046457,0.32206067806466,0.944673667619304,1,17,prostanoid biosynthetic process,BP,CBR1
14708,GO:0070325,0.322235226986606,0.944439847706484,1,18,lipoprotein particle receptor binding,MF,CLU
8474,GO:0033613,0.322292919745066,0.891129243996007,2,54,activating transcription factor binding,MF,MYC;FOS
14650,GO:0070227,0.322443967579893,0.891132731747883,2,52,lymphocyte apoptotic process,BP,TSC22D3;TNFRSF21
4894,GO:0014812,0.322816835918645,0.89083192259517,2,54,muscle cell migration,BP,NET1;SERPINE1
2184,GO:0005031,0.322822653765324,0.944392153070449,1,17,tumor necrosis factor-activated receptor activity,MF,TNFRSF21
2186,GO:0005035,0.322822653765324,0.944392153070449,1,17,death receptor activity,MF,TNFRSF21
14861,GO:0070613,0.323005521815786,0.890768590202556,2,53,regulation of protein processing,BP,SERPINE1;CLU
592,GO:0001754,0.323033427734885,0.944143896597583,1,18,eye photoreceptor cell differentiation,BP,SOX9
17737,GO:1901652,0.323064767104679,0.791623600791002,9,341,response to peptide,BP,ID1;SLC2A1;PTPRE;CTGF;COL1A1;PIK3R1;GJB2;SOCS1;CISH
2719,GO:0006094,0.323323536965368,0.890633528813679,2,52,gluconeogenesis,BP,NR1D1;PER2
12839,GO:0051131,0.323364117421416,0.944191606836043,1,17,chaperone-mediated protein complex assembly,BP,CLU
7898,GO:0032462,0.323798409665323,0.94403045367506,1,17,regulation of protein homooligomerization,BP,CLU
10523,GO:0043434,0.324302765311158,0.79674004013624,8,299,response to peptide hormone,BP,SLC2A1;PTPRE;CTGF;COL1A1;PIK3R1;GJB2;SOCS1;CISH
5615,GO:0016655,0.324912241066134,0.889878418237838,2,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,CBR1;AKR1C1
4867,GO:0014706,0.325116811622775,0.812296988351749,6,219,striated muscle tissue development,BP,TSC22D3;NOG;FHL2;NR2F2;FOS;SOX15
2645,GO:0005979,0.325466416906445,0.943081732780638,1,19,regulation of glycogen biosynthetic process,BP,PPP1R3D
4780,GO:0010962,0.325466416906445,0.943081732780638,1,19,regulation of glucan biosynthetic process,BP,PPP1R3D
14692,GO:0070300,0.325832517315246,0.943098901702077,1,18,phosphatidic acid binding,MF,PLCD1
9382,GO:0035909,0.325885868032954,0.94292399808982,1,19,aorta morphogenesis,BP,HES1
14730,GO:0070372,0.326034461902811,0.822871293661535,5,172,regulation of ERK1 and ERK2 cascade,BP,SPRY4;DUSP4;CTGF;EPHB3;TIMP3
4234,GO:0009410,0.326059131887052,0.822862487408328,5,171,response to xenobiotic stimulus,BP,CYP1B1;GJB2;AKR1C1;DDIT4;CES2
56,GO:0000118,0.326196483094856,0.888862165088364,2,55,histone deacetylase complex,CC,ING2;NACC2
4096,GO:0009148,0.326263823309585,0.94311052595469,1,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME9
3267,GO:0006939,0.326286005733975,0.888853723700674,2,54,smooth muscle contraction,BP,RGS2;GDNF
868,GO:0002200,0.327322640578587,0.888259421727717,2,54,somatic diversification of immune receptors,BP,RNF168;DCLRE1C
11881,GO:0046879,0.327464765171047,0.821785044707921,5,174,hormone secretion,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
10027,GO:0042461,0.327474038789521,0.942480862304086,1,18,photoreceptor cell development,BP,CDHR1
8228,GO:0032986,0.327581635311458,0.942440217107958,1,18,protein-DNA complex disassembly,BP,MYC
2436,GO:0005623,0.327591123371616,0.752437247878777,247,11101,cell,CC,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;APCDD1;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;SLC7A5P2;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;SLC22A15;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;CXCL14;PAK6;ZNF570;RNF39;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;URB2;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;IFFO1;SOX12;ZNF766;IFITM1;TBCC;ZNF701;TRIM56;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;ZCCHC2;VPS18;FAM217B;IRX5;CISH
8687,GO:0034284,0.328117734830482,0.83609776878774,4,132,response to monosaccharide,BP,TXNIP;CTGF;VSNL1;NR1D1
291,GO:0000795,0.328586940373378,0.942059655644397,1,18,synaptonemal complex,CC,HSPA2
17013,GO:0099086,0.328586940373378,0.942059655644397,1,18,synaptonemal structure,CC,HSPA2
9210,GO:0035591,0.329062145130977,0.88721551755257,2,55,signaling adaptor activity,MF,TOB1;PIK3R1
13204,GO:0051797,0.329305795181968,0.941786641775104,1,18,regulation of hair follicle development,BP,KRT17
8234,GO:0032994,0.330035725173189,0.941508662100155,1,18,protein-lipid complex,CC,CLU
15824,GO:0072509,0.330608021783441,0.94129017818381,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC30A1
18363,GO:1903317,0.330727298456561,0.886297196226806,2,54,regulation of protein maturation,BP,SERPINE1;CLU
12636,GO:0050807,0.330856562032163,0.854773533857823,3,94,regulation of synapse organization,BP,CDK5R1;FLRT3;EPHB3
18606,GO:1903845,0.331319836456033,0.885910306419109,2,55,negative regulation of cellular response to transforming growth factor beta stimulus,BP,VASN;PMEPA1
12434,GO:0048873,0.331340583309042,0.941009822383365,1,18,homeostasis of number of cells within a tissue,BP,SOX9
11201,GO:0045296,0.3314371208053,0.790996740657407,8,298,cadherin binding,MF,CDK5R1;VASN;BAG3;HIST1H3J;PAK6;VASP;CNN2;NOTCH3
14867,GO:0070628,0.331790189181334,0.940837372521088,1,18,proteasome binding,MF,ID1
11917,GO:0046939,0.332291034898379,0.853838507707972,3,93,nucleotide phosphorylation,BP,NME9;DDIT4;HK2
1179,GO:0002823,0.332438960939338,0.940588017127068,1,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ZBTB7B
2290,GO:0005246,0.332652289896405,0.940505891432187,1,18,calcium channel regulator activity,MF,SLC30A1
7280,GO:0031258,0.333546730225202,0.93999865256639,1,19,lamellipodium membrane,CC,VASP
3277,GO:0006956,0.333953437128013,0.940003562368497,1,18,complement activation,BP,CLU
3133,GO:0006721,0.33428585585324,0.884229310786226,2,54,terpenoid metabolic process,BP,CYP1B1;AKR1C1
10077,GO:0042572,0.334514785685093,0.939786088429481,1,18,retinol metabolic process,BP,CYP1B1
14384,GO:0061615,0.33464483651983,0.939735639892989,1,18,glycolytic process through fructose-6-phosphate,BP,HK2
14387,GO:0061620,0.33464483651983,0.939735639892989,1,18,glycolytic process through glucose-6-phosphate,BP,HK2
14169,GO:0061036,0.334724127748262,0.939541543098433,1,19,positive regulation of cartilage development,BP,SOX9
5562,GO:0016570,0.334863715648149,0.776607486334865,10,389,histone modification,BP,SNAI2;HR;BRPF1;RNF168;PYGO2;ING2;HIST1H1C;HIST1H1D;PER2;NACC2
8093,GO:0032770,0.335336262139209,0.939467014680969,1,18,positive regulation of monooxygenase activity,BP,GDNF
10888,GO:0044424,0.335481431102955,0.728435988909638,232,10399,intracellular part,CC,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ZNF549;NME9;LRRC8A;CBR1;CXCL14;PAK6;ZNF570;RNF39;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;KRT16;URB2;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;IFFO1;SOX12;ZNF766;TBCC;ZNF701;TRIM56;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;ZCCHC2;VPS18;FAM217B;IRX5;CISH
9953,GO:0042311,0.335503965908741,0.939401755773367,1,18,vasodilation,BP,RGS2
5888,GO:0018022,0.335868147523413,0.851397738210821,3,95,peptidyl-lysine methylation,BP,PYGO2;HIST1H1C;HIST1H1D
17942,GO:1902254,0.336312577959905,0.939086526097449,1,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,ING2
5274,GO:0015918,0.336489069257063,0.882895578750104,2,55,sterol transport,BP,AKR1C1;CLU
632,GO:0001819,0.337248408496459,0.793776044187082,7,256,positive regulation of cytokine production,BP,SERPINE1;CYP1B1;HSPB1;IL17RA;AKIRIN2;PIK3R1;CLU
996,GO:0002455,0.337485087248555,0.938627747158679,1,18,humoral immune response mediated by circulating immunoglobulin,BP,CLU
4525,GO:0010575,0.337566170541411,0.938429857758873,1,19,positive regulation of vascular endothelial growth factor production,BP,CYP1B1
7197,GO:0031082,0.337832014359101,0.938491618266502,1,18,BLOC complex,CC,BLOC1S3
9313,GO:0035767,0.338099207388746,0.938220046487296,1,19,endothelial cell chemotaxis,BP,HSPB1
2371,GO:0005496,0.338427359012092,0.881755703053881,2,55,steroid binding,MF,AKR1C1;IRX5
11404,GO:0045778,0.338555264261188,0.881636813078479,2,56,positive regulation of ossification,BP,CEBPA;IFITM1
2933,GO:0006450,0.338823246399375,0.938101707935238,1,18,regulation of translational fidelity,BP,IMP3
9693,GO:0038084,0.3394591431372,0.937682876047037,1,19,vascular endothelial growth factor signaling pathway,BP,HSPB1
9838,GO:0042060,0.339709936736113,0.777948285642086,9,345,wound healing,BP,SERPINE1;NOG;HSPB1;COL1A1;HIST1H3J;BLOC1S3;PIK3R1;SOX15;COL1A2
4352,GO:0009914,0.340316127073399,0.812070437762882,5,177,hormone transport,BP,SLC2A1;MIDN;VSNL1;NR1D1;PER2
7855,GO:0032411,0.340419242855807,0.880535101644349,2,56,positive regulation of transporter activity,BP,KCTD7;HSPA2
4160,GO:0009220,0.340642396773968,0.937382398501843,1,18,pyrimidine ribonucleotide biosynthetic process,BP,NME9
11587,GO:0046132,0.340642396773968,0.937382398501843,1,18,pyrimidine ribonucleoside biosynthetic process,BP,NME9
8976,GO:0035064,0.341493090946708,0.879898229323709,2,56,methylated histone binding,MF,PHF13;ING2
17296,GO:0140034,0.341493090946708,0.879898229323709,2,56,methylation-dependent protein binding,MF,PHF13;ING2
8601,GO:0034105,0.341700734694003,0.9367915474105,1,19,positive regulation of tissue remodeling,BP,PLEKHM1
9410,GO:0035966,0.342100879943685,0.810740386024614,5,174,response to topologically incorrect protein,BP,HSPB1;PIK3R1;HSPA2;DNAJB2;CLU
14812,GO:0070530,0.34214987761855,0.936612067638769,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,RNF168
18167,GO:1902895,0.342391639269881,0.936515335796701,1,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,FOS
11263,GO:0045494,0.342991915360437,0.936274786407003,1,19,photoreceptor cell maintenance,BP,CDHR1
7220,GO:0031110,0.343342971169756,0.878754608259995,2,57,regulation of microtubule polymerization or depolymerization,BP,RGS2;CDK5R1
7048,GO:0030817,0.343433873226862,0.936097341328036,1,19,regulation of cAMP biosynthetic process,BP,PTHLH
7772,GO:0032288,0.343695289215569,0.935837459168889,1,20,myelin assembly,BP,AHNAK2
10352,GO:0043153,0.343782880762153,0.935957012430791,1,19,entrainment of circadian clock by photoperiod,BP,PER2
3527,GO:0007507,0.34433782135033,0.774069972832172,9,356,heart development,BP,ID1;HES1;SNAI2;ID3;NOG;FLRT3;FHL2;RBM15;SOX9
11378,GO:0045732,0.344585011313892,0.8088243587484,5,176,positive regulation of protein catabolic process,BP,TIPARP;SOX9;CEBPA;SNX33;CLU
13910,GO:0060538,0.344601778004354,0.845455994410202,3,96,skeletal muscle organ development,BP,TSC22D3;NR2F2;FOS
16269,GO:0090312,0.344617854262606,0.935620558207637,1,19,positive regulation of protein deacetylation,BP,ING2
12161,GO:0048259,0.344831281344527,0.877908288159124,2,56,regulation of receptor-mediated endocytosis,BP,SERPINE1;CLU
5330,GO:0016052,0.345414171520991,0.823529519680235,4,136,carbohydrate catabolic process,BP,FUT1;PPP1R3D;DDIT4;HK2
12400,GO:0048814,0.345619190599125,0.877393184234803,2,57,regulation of dendrite morphogenesis,BP,ID1;CDK5R1
17377,GO:1900078,0.345882139009867,0.93495240841145,1,20,positive regulation of cellular response to insulin stimulus,BP,PIK3R1
12568,GO:0050707,0.346012276046978,0.8445354262139,3,94,regulation of cytokine secretion,BP,TNFRSF21;IL17RA;SOCS1
5631,GO:0016705,0.346773929868683,0.843990913731382,3,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP1B1;FAXDC2;AKR1C1
6057,GO:0019200,0.34706261118503,0.934629520822213,1,19,carbohydrate kinase activity,MF,HK2
1176,GO:0002820,0.347566271858399,0.934424252370766,1,19,negative regulation of adaptive immune response,BP,ZBTB7B
10481,GO:0043370,0.347721167161207,0.93436104874961,1,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,ZBTB7B
13050,GO:0051493,0.347760694684669,0.76577385207153,10,395,regulation of cytoskeleton organization,BP,ID1;RGS2;CDK5R1;CTGF;FZD10;CDC42EP2;RHOD;VASP;PIK3R1;BICD2
6103,GO:0019319,0.347929826870968,0.876092641262564,2,55,hexose biosynthetic process,BP,NR1D1;PER2
5608,GO:0016645,0.348110784232583,0.934201911795205,1,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,ALDH4A1
9133,GO:0035455,0.348286974406474,0.934129873966291,1,19,response to interferon-alpha,BP,IFITM1
7849,GO:0032402,0.348391208037274,0.934087234899914,1,19,melanosome transport,BP,BLOC1S3
13254,GO:0051904,0.348391208037274,0.934087234899914,1,19,pigment granule transport,BP,BLOC1S3
1110,GO:0002696,0.349064358642638,0.805388073825254,5,176,positive regulation of leukocyte activation,BP,HES1;MAP3K14;IGFBP2;PIK3R1;SOCS1
3120,GO:0006699,0.349138956564258,0.933780879050615,1,19,bile acid biosynthetic process,BP,NR1D1
17319,GO:0140103,0.349210705985837,0.933751439337442,1,19,catalytic activity, acting on a glycoprotein,MF,MGAT1
5593,GO:0016614,0.349589348036428,0.842100896557061,3,93,oxidoreductase activity, acting on CH-OH group of donors,MF,CBR1;AKR1C1;ZADH2
10812,GO:0044295,0.350560910134418,0.93303503280055,1,20,axonal growth cone,CC,FLRT3
2213,GO:0005096,0.350584327565356,0.79234588616966,6,225,GTPase activator activity,MF,RGS2;RIN2;CDC42EP2;RIN1;RUNDC1;RGS3
2131,GO:0004930,0.350655437154034,0.819699047310953,4,134,G-protein coupled receptor activity,MF,GPR132;FZD10;ADGRF1;ADGRF4
6547,GO:0021955,0.351171066321542,0.93278258748291,1,20,central nervous system neuron axonogenesis,BP,EPHB3
7449,GO:0031579,0.351486593968014,0.932813639088397,1,19,membrane raft organization,BP,MALL
3419,GO:0007205,0.351806582629146,0.932519058731281,1,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,CISH
9318,GO:0035774,0.351849478279553,0.932663396042164,1,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
11299,GO:0045601,0.351912949308401,0.932474892842501,1,20,regulation of endothelial cell differentiation,BP,ID1
715,GO:0001937,0.352138163471651,0.932381322931498,1,20,negative regulation of endothelial cell proliferation,BP,NR2F2
11858,GO:0046827,0.352433696897768,0.93225842234996,1,20,positive regulation of protein export from nucleus,BP,BAG3
2646,GO:0005980,0.352980197235728,0.93203081035673,1,20,glycogen catabolic process,BP,PPP1R3D
3700,GO:0008207,0.353611592195425,0.931931041569733,1,19,C21-steroid hormone metabolic process,BP,AKR1C1
10042,GO:0042491,0.353936732339529,0.931631346290817,1,20,inner ear auditory receptor cell differentiation,BP,HES1
1362,GO:0003230,0.354395205514964,0.931290691354741,1,21,cardiac atrium development,BP,NOG
12286,GO:0048584,0.35473750848274,0.71228043813608,34,1444,positive regulation of response to stimulus,BP,HES1;SERPINE1;MYC;CYP1B1;FAM110C;DUSP5;LURAP1L;HSPB1;TNFRSF21;GDNF;CTGF;MAP3K14;FZD10;RNF168;IL17RA;VSNL1;COL1A1;TOB1;EPHB3;CXCL14;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;ARTN;SOX15;NR1D1;ING2;NACC2;HIC1;SOCS1;CLU
606,GO:0001772,0.354980710043749,0.931193798666869,1,20,immunological synapse,CC,SOCS6
719,GO:0001941,0.355234874049757,0.931087026772468,1,20,postsynaptic membrane organization,BP,GDNF
11284,GO:0045581,0.355369518474999,0.931030424586517,1,20,negative regulation of T cell differentiation,BP,ZBTB7B
8587,GO:0034067,0.355487153609916,0.930831339893241,1,21,protein localization to Golgi apparatus,BP,BICD2
15014,GO:0070932,0.355588994387433,0.930938102292405,1,20,histone H3 deacetylation,BP,PER2
14979,GO:0070873,0.355999191927355,0.930615321827814,1,21,regulation of glycogen metabolic process,BP,PPP1R3D
19779,GO:2000145,0.356593321510431,0.742222169966472,14,573,regulation of cell motility,BP,SNAI2;SERPINE1;CYP1B1;FAM110C;NOG;HSPB1;NR2F2;RHOD;COL1A1;CXCL14;PIK3R1;SOX9;KRT16;IFITM1
12072,GO:0048011,0.356609472111803,0.930507887678098,1,20,neurotrophin TRK receptor signaling pathway,BP,DDIT4
11695,GO:0046470,0.356892124654692,0.87059033212462,2,56,phosphatidylcholine metabolic process,BP,MFSD2A;PCYT1A
7325,GO:0031330,0.356953108940319,0.799246989156508,5,180,negative regulation of cellular catabolic process,BP,GDNF;ZKSCAN4;TOB1;TIMP3;DDIT4
11280,GO:0045577,0.357280349134247,0.930224203856105,1,20,regulation of B cell differentiation,BP,ZFP36L2
19810,GO:2000209,0.357722408233913,0.930036905980699,1,20,regulation of anoikis,BP,SNAI2
5396,GO:0016229,0.35776210184183,0.93018765647938,1,19,steroid dehydrogenase activity,MF,AKR1C1
4580,GO:0010662,0.357778035347524,0.930013316211056,1,20,regulation of striated muscle cell apoptotic process,BP,BAG3
6932,GO:0030521,0.358363761700117,0.869594336531234,2,58,androgen receptor signaling pathway,BP,FHL2;PMEPA1
5561,GO:0016569,0.358438326352828,0.756714419400388,10,397,covalent chromatin modification,BP,SNAI2;HR;BRPF1;RNF168;PYGO2;ING2;HIST1H1C;HIST1H1D;PER2;NACC2
2447,GO:0005654,0.358608905811484,0.692730436428531,70,3045,nucleoplasm,CC,ID1;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;IRF2BPL;MYC;HR;DUSP5;HIST1H4L;FHL2;RBAK;POU3F1;FZD10;BRPF1;NR2F2;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;RNF168;CD3EAP;RBM15;HIST1H2BI;ZKSCAN4;HIST1H3J;TLE3;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;HIST1H4B;IMP3;SOX9;ERF;TRMT61A;CEBPA;CIART;KCTD1;HIST1H2BO;ZBTB34;STK17A;GZF1;TGIF1;HIST1H2BE;PYGO2;NR1D1;ING2;ZNF589;PHC2;HIST1H4K;RRP36;ZNF672;BRF2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;SOX12;HIST1H4D;RGS3;NOTCH3;SOCS1;DCLRE1C;FAM217B
8831,GO:0034612,0.358688465071677,0.785943297001768,6,216,response to tumor necrosis factor,BP,TNFRSF21;MAP3K14;HIST1H2BJ;ZFP36L2;COL1A1;CEBPA
16355,GO:0090596,0.358813550498413,0.813521959331638,4,142,sensory organ morphogenesis,BP,NOG;LRIG3;SOX9;IRX5
7032,GO:0030801,0.358850848469362,0.929557454724796,1,20,positive regulation of cyclic nucleotide metabolic process,BP,PTHLH
13285,GO:0051959,0.359316320216826,0.928940805717182,1,23,dynein light intermediate chain binding,MF,BICD2
10505,GO:0043403,0.359641080933493,0.929220555144176,1,20,skeletal muscle tissue regeneration,BP,SOX15
13768,GO:0060330,0.360070675204311,0.929037009779052,1,20,regulation of response to interferon-gamma,BP,SOCS1
13772,GO:0060334,0.360070675204311,0.929037009779052,1,20,regulation of interferon-gamma-mediated signaling pathway,BP,SOCS1
4035,GO:0009065,0.360116140395116,0.929017568291677,1,20,glutamine family amino acid catabolic process,BP,ALDH4A1
13271,GO:0051937,0.360390996751964,0.928899969556618,1,20,catecholamine transport,BP,GDNF
2266,GO:0005179,0.36056079789772,0.928827262028982,1,20,hormone activity,MF,PTHLH
7848,GO:0032401,0.360829278988219,0.92871221131275,1,20,establishment of melanosome localization,BP,BLOC1S3
13255,GO:0051905,0.360829278988219,0.92871221131275,1,20,establishment of pigment granule localization,BP,BLOC1S3
17839,GO:1901983,0.360920949193474,0.868054985610904,2,57,regulation of protein acetylation,BP,SNAI2;PYGO2
17348,GO:1900015,0.361221827063802,0.928543798053857,1,20,regulation of cytokine production involved in inflammatory response,BP,IL17RA
10534,GO:0043470,0.361244230273238,0.867767047478974,2,59,regulation of carbohydrate catabolic process,BP,PPP1R3D;DDIT4
11310,GO:0045619,0.361320846832552,0.833836646709788,3,97,regulation of lymphocyte differentiation,BP,ZFP36L2;ZBTB7B;SOCS1
9079,GO:0035327,0.361747945155531,0.928317712996515,1,20,transcriptionally active chromatin,CC,HIST1H1C
9042,GO:0035255,0.362168391646598,0.927981514525303,1,21,ionotropic glutamate receptor binding,MF,CDK5R1
13049,GO:0051492,0.36216995057552,0.867190946702356,2,59,regulation of stress fiber assembly,BP,CTGF;PIK3R1
541,GO:0001659,0.362377552377501,0.928046603566034,1,20,temperature homeostasis,BP,NR1D1
8408,GO:0033363,0.362422143590955,0.927871944041491,1,21,secretory granule organization,BP,BLOC1S3
11846,GO:0046785,0.362961893664912,0.866697150667937,2,59,microtubule polymerization,BP,RGS2;CDK5R1
3260,GO:0006929,0.363533779160193,0.927390781758781,1,21,substrate-dependent cell migration,BP,SNAI2
10550,GO:0043496,0.36364602325001,0.92749856762529,1,20,regulation of protein homodimerization activity,BP,ID1
10380,GO:0043197,0.364030931516758,0.831858322049067,3,100,dendritic spine,CC,CDK5R1;NR1D1;PALMD
6314,GO:0019955,0.364529789300018,0.865760300651498,2,58,cytokine binding,MF,NOG;VASN
5169,GO:0015711,0.364612058106881,0.771500443428471,7,267,organic anion transport,BP,SLC2A1;SLC7A5P2;SLC22A15;SLC2A3;MFSD2A;AKR1C1;PER2
12399,GO:0048813,0.364615460995951,0.83142341143185,3,101,dendrite morphogenesis,BP,ID1;CDK5R1;EPHB3
11095,GO:0045087,0.364819676849064,0.73501608657901,14,561,innate immune response,BP,HIST1H2BJ;TRIM35;CDC42EP2;HIST1H2BI;AKIRIN2;HIST1H2BE;KRT16;NR1D1;HIST2H2BE;TRIM26;IFITM1;TRIM56;SOCS1;CLU
8614,GO:0034122,0.364832077010083,0.92682643712571,1,21,negative regulation of toll-like receptor signaling pathway,BP,NR1D1
14317,GO:0061436,0.364946885243227,0.926776408286413,1,21,establishment of skin barrier,BP,KRT16
10582,GO:0043542,0.365126806060575,0.808787243143927,4,141,endothelial cell migration,BP,ID1;CYP1B1;HSPB1;NR2F2
15424,GO:0071675,0.365246504390383,0.926803589275961,1,20,regulation of mononuclear cell migration,BP,SERPINE1
6474,GO:0021799,0.365709831384303,0.926443434595116,1,21,cerebral cortex radially oriented cell migration,BP,CDK5R1
4179,GO:0009251,0.365765265488444,0.926419206688849,1,21,glucan catabolic process,BP,PPP1R3D
4432,GO:0010259,0.365859546498651,0.926377989632011,1,21,multicellular organism aging,BP,TFCP2L1
3060,GO:0006622,0.366905764207246,0.925919697854997,1,21,protein targeting to lysosome,BP,CLU
13121,GO:0051642,0.36693631589421,0.925761587107769,1,22,centrosome localization,BP,BICD2
15289,GO:0071459,0.36696552361338,0.926052778423263,1,20,protein localization to chromosome, centromeric region,BP,CHAMP1
8826,GO:0034599,0.367729786440305,0.778617027380148,6,221,cellular response to oxidative stress,BP,NET1;CYP1B1;HSPB1;FOS;GJB2;BRF2
1040,GO:0002548,0.369074898199571,0.925125284937274,1,20,monocyte chemotaxis,BP,SERPINE1
6852,GO:0030316,0.369101613467915,0.862796538484904,2,60,osteoclast differentiation,BP,FOS;PIK3R1
798,GO:0002064,0.36911340802598,0.80573928770618,4,143,epithelial cell development,BP,ID1;TFCP2L1;SOX9;HOXA5
9216,GO:0035601,0.369137401508861,0.828228727300675,3,100,protein deacylation,BP,ING2;PER2;NACC2
13079,GO:0051569,0.369352189308582,0.9248414904989,1,21,regulation of histone H3-K4 methylation,BP,PYGO2
13503,GO:0055026,0.369367291318498,0.924834806029021,1,21,negative regulation of cardiac muscle tissue development,BP,NOG
8886,GO:0034698,0.369747940320734,0.924666206645627,1,21,response to gonadotropin,BP,GJB2
4158,GO:0009218,0.370271433095228,0.924596128010368,1,20,pyrimidine ribonucleotide metabolic process,BP,NME9
5336,GO:0016064,0.370330022011649,0.862105253447499,2,58,immunoglobulin mediated immune response,BP,RNF168;CLU
6213,GO:0019724,0.370330022011649,0.862105253447499,2,58,B cell mediated immunity,BP,RNF168;CLU
18217,GO:1902991,0.370658183482126,0.924262130225045,1,21,regulation of amyloid precursor protein catabolic process,BP,CLU
9134,GO:0035456,0.370694982952548,0.92440828845537,1,20,response to interferon-beta,BP,IFITM1
4361,GO:0009954,0.370888855151353,0.92415952705095,1,21,proximal/distal pattern formation,BP,HOXA9
9878,GO:0042136,0.371089106559129,0.861578982104558,2,59,neurotransmitter biosynthetic process,BP,CYP1B1;CLU
3379,GO:0007157,0.371127854521509,0.924053133014109,1,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,LGALS7B
4095,GO:0009147,0.371864673690142,0.923888106599607,1,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME9
1257,GO:0003008,0.371867439952692,0.715933696777646,19,803,system process,BP,RGS2;SNAI2;CYP1B1;TNFRSF21;GDNF;CTGF;AHNAK2;NR2F2;FOS;COL1A1;ADGRF1;SOX9;GJB2;TIMP3;AKR1C1;HOXA5;PER2;COL1A2;IRX5
10044,GO:0042493,0.372366479500432,0.725262269685495,15,613,response to drug,BP,ID1;CDK5R1;NET1;TXNIP;MYC;CYP1B1;GDNF;FOS;IGFBP2;COL1A1;SOX9;GJB2;DDIT4;TGIF1;PER2
8999,GO:0035115,0.372584690864727,0.923402691234106,1,21,embryonic forelimb morphogenesis,BP,HOXA9
4284,GO:0009648,0.37259944070675,0.923396088994228,1,21,photoperiodism,BP,PER2
17286,GO:0120111,0.372683669413816,0.860563937253658,2,59,neuron projection cytoplasm,CC,HSPB1;BLOC1S3
10024,GO:0042451,0.372942438004336,0.92340693510912,1,20,purine nucleoside biosynthetic process,BP,NME9
11584,GO:0046129,0.372942438004336,0.92340693510912,1,20,purine ribonucleoside biosynthetic process,BP,NME9
8068,GO:0032731,0.373175444096924,0.923137998038672,1,21,positive regulation of interleukin-1 beta production,BP,HSPB1
5237,GO:0015850,0.373750105188727,0.824900544408182,3,101,organic hydroxy compound transport,BP,GDNF;AKR1C1;CLU
6925,GO:0030513,0.373932005813372,0.922648025957715,1,22,positive regulation of BMP signaling pathway,BP,HES1
4527,GO:0010586,0.373955834891253,0.922787506152251,1,21,miRNA metabolic process,BP,BCDIN3D
3138,GO:0006730,0.373981423568103,0.922775997672636,1,21,one-carbon metabolic process,BP,MAT2A
14006,GO:0060706,0.374044086537171,0.92274781077746,1,21,cell differentiation involved in embryonic placenta development,BP,NR2F2
1428,GO:0003382,0.374457763876055,0.922410965357327,1,22,epithelial cell morphogenesis,BP,ID1
9186,GO:0035561,0.374660842301932,0.922470057872934,1,21,regulation of chromatin binding,BP,PYGO2
6335,GO:0020037,0.374726641171242,0.859258231157496,2,59,heme binding,MF,CYP1B1;NR1D1
10824,GO:0044309,0.374889210872452,0.824058517096811,3,102,neuron spine,CC,CDK5R1;NR1D1;PALMD
8986,GO:0035091,0.37515894738255,0.784849698835061,5,187,phosphatidylinositol binding,MF,PLCD1;PXDC1;SNX33;ING2;ZCCHC2
16845,GO:0098732,0.375383362809319,0.823723332508118,3,101,macromolecule deacylation,BP,ING2;PER2;NACC2
5542,GO:0016525,0.375383658455248,0.858751256097632,2,61,negative regulation of angiogenesis,BP,SERPINE1;HOXA5
5826,GO:0017091,0.376424313785494,0.921672623067416,1,21,AU-rich element binding,MF,ZFP36L2
2665,GO:0006007,0.376667094570476,0.92156245922492,1,21,glucose catabolic process,BP,HK2
8995,GO:0035107,0.376854866387442,0.822596716414976,3,104,appendage morphogenesis,BP,NOG;HOXA9;SOX9
8996,GO:0035108,0.376854866387442,0.822596716414976,3,104,limb morphogenesis,BP,NOG;HOXA9;SOX9
14128,GO:0060969,0.377292771381512,0.921125259616109,1,22,negative regulation of gene silencing,BP,BCDIN3D
11115,GO:0045124,0.377417196897251,0.921068543974077,1,22,regulation of bone resorption,BP,PLEKHM1
15304,GO:0071478,0.377645125203122,0.799226709205523,4,142,cellular response to radiation,BP,SNAI2;NET1;MYC;PIK3R1
9006,GO:0035145,0.377776375722714,0.921057943386915,1,21,exon-exon junction complex,CC,UPF1
8215,GO:0032965,0.378367946051099,0.920788103489563,1,21,regulation of collagen biosynthetic process,BP,CTGF
4351,GO:0009913,0.378937731606555,0.78186983839652,5,183,epidermal cell differentiation,BP,HES1;TXNIP;POU3F1;KRT16;KRT17
12632,GO:0050803,0.379099102120905,0.821011122003824,3,102,regulation of synapse structure or activity,BP,CDK5R1;FLRT3;EPHB3
11773,GO:0046621,0.379790857874577,0.919981940490458,1,22,negative regulation of organ growth,BP,NOG
17544,GO:1901021,0.379950813101691,0.91990839924317,1,22,positive regulation of calcium ion transmembrane transporter activity,BP,HSPA2
132,GO:0000272,0.379989072788551,0.919890802960598,1,22,polysaccharide catabolic process,BP,PPP1R3D
10789,GO:0044247,0.379989072788551,0.919890802960598,1,22,cellular polysaccharide catabolic process,BP,PPP1R3D
3228,GO:0006882,0.380150373566038,0.919971752626283,1,21,cellular zinc ion homeostasis,BP,SLC30A1
13516,GO:0055069,0.380150373566038,0.919971752626283,1,21,zinc ion homeostasis,BP,SLC30A1
18461,GO:1903530,0.380346489844957,0.737850559762362,10,400,regulation of secretion by cell,BP,SLC2A1;MIDN;TNFRSF21;GDNF;IL17RA;VSNL1;SLC30A1;NR1D1;PER2;SOCS1
682,GO:0001889,0.380450627659989,0.820028113698059,3,102,liver development,BP,HES1;SOX9;CEBPA
3673,GO:0008171,0.380562308645422,0.919782378089874,1,21,O-methyltransferase activity,MF,BCDIN3D
15235,GO:0071377,0.380670358928814,0.919577082815278,1,22,cellular response to glucagon stimulus,BP,GJB2
7211,GO:0031098,0.380960472162997,0.767756735801227,6,228,stress-activated protein kinase signaling cascade,BP,MYC;CTGF;MAP3K14;FZD10;PAK6;GADD45B
6923,GO:0030511,0.381050441234656,0.919401744632918,1,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,ING2
18607,GO:1903846,0.381050441234656,0.919401744632918,1,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,ING2
13590,GO:0060043,0.381091127086149,0.919382962121698,1,22,regulation of cardiac muscle cell proliferation,BP,NOG
8383,GO:0033280,0.381102793942364,0.919377575669231,1,22,response to vitamin D,BP,SNAI2
13096,GO:0051591,0.381139036938275,0.855034119592868,2,61,response to cAMP,BP,FOS;COL1A1
5265,GO:0015893,0.381504665635695,0.81930388979878,3,100,drug transport,BP,MYC;GDNF;PER2
10540,GO:0043484,0.38178491458061,0.819077201824486,3,101,regulation of RNA splicing,BP,AHNAK2;ESRP2;PIK3R1
10544,GO:0043488,0.381905761809261,0.795951084084999,4,141,regulation of mRNA stability,BP,HSPB1;GDNF;ZFP36L2;UPF1
8659,GO:0034205,0.382616661566214,0.918676822292932,1,22,amyloid-beta formation,BP,CLU
12154,GO:0048247,0.382910657205608,0.918697703134103,1,21,lymphocyte chemotaxis,BP,CXCL14
11333,GO:0045648,0.382945782717623,0.918523997532119,1,22,positive regulation of erythrocyte differentiation,BP,ZNF16
8777,GO:0034453,0.383022303299106,0.918344753731789,1,23,microtubule anchoring,BP,BICD2
11880,GO:0046875,0.383804449568931,0.918124477437637,1,22,ephrin receptor binding,MF,CDK5R1
7247,GO:0031167,0.383929221832238,0.91822453933824,1,21,rRNA methylation,BP,METTL15
7185,GO:0031063,0.383951324400769,0.918056022924501,1,22,regulation of histone deacetylation,BP,ING2
16830,GO:0098687,0.38414839222749,0.747105295944538,8,312,chromosomal region,CC,HIST1H4L;CHAMP1;HJURP;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
2488,GO:0005730,0.384321706491501,0.702648961133762,20,833,nucleolus,CC,RGS2;SERTAD3;MIDN;MYC;MAP3K14;TFCP2L1;SURF6;CD3EAP;YPEL4;PAK6;HJURP;IMP3;CEBPA;GZF1;PLEKHM1;URB2;RRP36;PER2;NACC2;ZNF16
4576,GO:0010658,0.38442393574655,0.917835519686737,1,22,striated muscle cell apoptotic process,BP,BAG3
13196,GO:0051788,0.384614180805529,0.917746658529472,1,22,response to misfolded protein,BP,CLU
2001,GO:0004721,0.384741326167002,0.793708850266447,4,144,phosphoprotein phosphatase activity,MF,DUSP4;PTPRE;DUSP5;PPP1R3D
4272,GO:0009620,0.384830617473128,0.917804439036159,1,21,response to fungus,BP,IL17RA
2734,GO:0006111,0.385018908437774,0.917557424588292,1,22,regulation of gluconeogenesis,BP,NR1D1
18044,GO:1902533,0.385032267546878,0.711091171796914,16,664,positive regulation of intracellular signal transduction,BP,HES1;CYP1B1;FAM110C;DUSP5;LURAP1L;CTGF;MAP3K14;FZD10;EPHB3;GADD45B;SLC20A1;PIK3R1;SOX9;NACC2;HIC1;SOCS1
12560,GO:0050699,0.385328024758066,0.917412719823997,1,22,WW domain binding,MF,PMEPA1
3577,GO:0007622,0.386085906560332,0.917057296310465,1,22,rhythmic behavior,BP,CIART
12249,GO:0048512,0.386085906560332,0.917057296310465,1,22,circadian behavior,BP,CIART
17249,GO:0110053,0.386346258630006,0.775862689411244,5,188,regulation of actin filament organization,BP,ID1;CTGF;CDC42EP2;VASP;PIK3R1
12683,GO:0050877,0.386797676918382,0.732205175730941,10,407,nervous system process,BP,SNAI2;CYP1B1;TNFRSF21;AHNAK2;FOS;COL1A1;ADGRF1;GJB2;TIMP3;IRX5
12177,GO:0048286,0.387209013709694,0.916382121870624,1,23,lung alveolus development,BP,HOXA5
7881,GO:0032438,0.387646912637802,0.916322358947586,1,22,melanosome organization,BP,BLOC1S3
3602,GO:0008037,0.387783868222998,0.850641605142341,2,62,cell recognition,BP,CDK5R1;EPHB3
1431,GO:0003401,0.388040595787298,0.915988981323558,1,23,axis elongation,BP,SOX9
17241,GO:0110020,0.388969887547774,0.849816967619858,2,63,regulation of actomyosin structure organization,BP,CTGF;PIK3R1
18259,GO:1903053,0.388974395586161,0.91554620239894,1,23,regulation of extracellular matrix organization,BP,SOX9
19234,GO:1905330,0.389319634269457,0.790136196895663,4,144,regulation of morphogenesis of an epithelium,BP,SNAI2;NOG;GDNF;SOX9
11653,GO:0046364,0.389325281958863,0.849710656516034,2,60,monosaccharide biosynthetic process,BP,NR1D1;PER2
7847,GO:0032400,0.389611547044956,0.915391878289555,1,22,melanosome localization,BP,BLOC1S3
13230,GO:0051875,0.389611547044956,0.915391878289555,1,22,pigment granule localization,BP,BLOC1S3
8306,GO:0033137,0.389931998879262,0.915239523547939,1,22,negative regulation of peptidyl-serine phosphorylation,BP,DDIT4
19796,GO:2000181,0.390426190479016,0.84885238313317,2,63,negative regulation of blood vessel morphogenesis,BP,SERPINE1;HOXA5
18361,GO:1903312,0.391140711215999,0.848463000975323,2,61,negative regulation of mRNA metabolic process,BP,GDNF;TOB1
617,GO:0001783,0.391215158966318,0.914627817308179,1,22,B cell apoptotic process,BP,TNFRSF21
14154,GO:0061008,0.391296726613009,0.812013207666863,3,104,hepaticobiliary system development,BP,HES1;SOX9;CEBPA
9122,GO:0035418,0.391398129552891,0.914390442309589,1,23,protein localization to synapse,BP,HSPB1
8843,GO:0034629,0.391747072912975,0.914373471687353,1,22,cellular protein-containing complex localization,BP,NACC2
17765,GO:1901699,0.391872536087664,0.722701429598767,11,454,cellular response to nitrogen compound,BP,ID1;CDK5R1;PTPRE;BCDIN3D;COL1A1;PIK3R1;SOX9;GJB2;COL1A2;SOCS1;CISH
8444,GO:0033561,0.392761508945446,0.913736177757926,1,23,regulation of water loss via skin,BP,KRT16
12859,GO:0051156,0.393077606713014,0.913735263502522,1,22,glucose 6-phosphate metabolic process,BP,HK2
427,GO:0001134,0.39317201636732,0.913538596963517,1,23,transcription factor activity, transcription factor recruiting,MF,NR1D1
12726,GO:0050931,0.3934496297815,0.913404825649985,1,23,pigment cell differentiation,BP,BLOC1S3
3382,GO:0007160,0.393558527852687,0.786727190520296,4,150,cell-matrix adhesion,BP,SERPINE1;CTGF;RHOD;PIK3R1
11692,GO:0046466,0.393682744050308,0.913444061250473,1,22,membrane lipid catabolic process,BP,CYP1B1
6294,GO:0019900,0.394271384825433,0.708715392997621,14,586,kinase binding,MF,CDK5R1;SLC2A1;MIDN;HSPB1;TUBA4A;RHOD;FAM212B;TOB1;EPHB3;PIK3R1;SOX9;CEBPA;FAM83A;SOCS1
13766,GO:0060326,0.394319402680017,0.786221681014757,4,143,cell chemotaxis,BP,SERPINE1;HSPB1;IL17RA;CXCL14
14478,GO:0061842,0.395444081129768,0.912299970064732,1,24,microtubule organizing center localization,BP,BICD2
13595,GO:0060048,0.395491300922445,0.84543286971991,2,64,cardiac muscle contraction,BP,RGS2;CTGF
550,GO:0001671,0.395711404656563,0.912463537609909,1,22,ATPase activator activity,MF,DNAJB2
8025,GO:0032653,0.395737383936787,0.912450937897753,1,22,regulation of interleukin-10 production,BP,TNFRSF21
507,GO:0001569,0.396017967125755,0.912161355171427,1,23,branching involved in blood vessel morphogenesis,BP,RBM15
10119,GO:0042634,0.396037648628463,0.912151785205694,1,23,regulation of hair cycle,BP,KRT17
16738,GO:0097730,0.396446808866723,0.844832533828866,2,63,non-motile cilium,CC,CDHR1;TBCC
4524,GO:0010574,0.397193733278537,0.911588549804089,1,23,regulation of vascular endothelial growth factor production,BP,CYP1B1
7934,GO:0032506,0.397355178748137,0.911509722741277,1,23,cytokinetic process,BP,SNX33
17525,GO:1900744,0.397420577453322,0.911477779279499,1,23,regulation of p38MAPK cascade,BP,GADD45B
18690,GO:1904019,0.39768140898533,0.844001816383765,2,63,epithelial cell apoptotic process,BP,SERPINE1;ANGPTL4
4574,GO:0010656,0.397766258117005,0.911308819290778,1,23,negative regulation of muscle cell apoptotic process,BP,BAG3
7841,GO:0032391,0.398011330221061,0.91118891691646,1,23,photoreceptor connecting cilium,CC,TBCC
15992,GO:0080135,0.398442278822471,0.708481488488253,13,537,regulation of cellular response to stress,BP,SNAI2;MYC;HSPB1;CTGF;BAG3;FZD10;RNF168;GADD45B;PIK3R1;ING2;NACC2;HIC1;CLU
2002,GO:0004722,0.399176669608097,0.843035768723223,2,62,protein serine/threonine phosphatase activity,MF,DUSP4;PPP1R3D
7299,GO:0031293,0.39942364885452,0.910496036233362,1,23,membrane protein intracellular domain proteolysis,BP,NOTCH3
4301,GO:0009743,0.399769591365503,0.781865077030384,4,146,response to carbohydrate,BP,TXNIP;CTGF;VSNL1;NR1D1
9988,GO:0042379,0.399793235207291,0.910470502088136,1,22,chemokine receptor binding,MF,CXCL14
405,GO:0001085,0.399941904708569,0.805509770657748,3,106,RNA polymerase II transcription factor binding,MF,ID1;ID3;FOS
4285,GO:0009649,0.400001784871389,0.910211469121815,1,23,entrainment of circadian clock,BP,PER2
555,GO:0001676,0.400931183771896,0.841847960999773,2,62,long-chain fatty acid metabolic process,BP,CYP1B1;CBR1
9465,GO:0036065,0.401033790171305,0.909702148693161,1,23,fucosylation,BP,FUT1
19826,GO:2000249,0.401061700534667,0.909688350135876,1,23,regulation of actin cytoskeleton reorganization,BP,RHOD
12378,GO:0048753,0.401083810179317,0.909677418484761,1,23,pigment granule organization,BP,BLOC1S3
12675,GO:0050866,0.401562495367058,0.804331166091146,3,104,negative regulation of cell activation,BP,TNFRSF21;ZBTB7B;SOCS6
4652,GO:0010771,0.401751797101939,0.841205538078764,2,64,negative regulation of cell morphogenesis involved in differentiation,BP,ID1;CDK5R1
6793,GO:0030225,0.40198675767671,0.909230293854334,1,23,macrophage differentiation,BP,CEBPA
14149,GO:0061001,0.402335556114964,0.908912226455392,1,24,regulation of dendritic spine morphogenesis,BP,CDK5R1
3066,GO:0006629,0.402841057678455,0.680323871422962,23,977,lipid metabolic process,BP,TIPARP;SNAI2;ANGPTL4;CYP1B1;FHL2;TNFRSF21;CTGF;TFCP2L1;FAXDC2;NR2F2;CBR1;PLCD1;SEC14L2;PIK3R1;MFSD2A;CEBPA;AKR1C1;PCYT1A;NR1D1;ZADH2;PER2;CES2;CLU
1102,GO:0002688,0.403117051365567,0.840406954954778,2,61,regulation of leukocyte chemotaxis,BP,SERPINE1;CXCL14
1030,GO:0002534,0.403195890210018,0.908629466365266,1,23,cytokine production involved in inflammatory response,BP,IL17RA
15305,GO:0071479,0.403498313930194,0.840058423852368,2,63,cellular response to ionizing radiation,BP,SNAI2;NET1
17812,GO:1901888,0.403710397092695,0.839830512012739,2,65,regulation of cell junction assembly,BP,SNAI2;RHOD
12271,GO:0048546,0.405423350841596,0.907233849770061,1,25,digestive tract morphogenesis,BP,EPHB3
15525,GO:0071889,0.405503895168413,0.907328715939031,1,24,14-3-3 protein binding,MF,DDIT4
7889,GO:0032452,0.405514306391643,0.907188100159631,1,25,histone demethylase activity,MF,HR
16271,GO:0090314,0.405564778180036,0.90744540869807,1,23,positive regulation of protein targeting to membrane,BP,CDK5R1
8377,GO:0033273,0.405863843511505,0.838440870782154,2,63,response to vitamin,BP,SNAI2;COL1A1
17356,GO:1900027,0.405874485939098,0.90728992466562,1,23,regulation of ruffle assembly,BP,PLEKHM1
13639,GO:0060119,0.40601646098913,0.907070990860231,1,24,inner ear receptor cell development,BP,HES1
1235,GO:0002920,0.406128549368252,0.907162258292394,1,23,regulation of humoral immune response,BP,CLU
2992,GO:0006536,0.406243543968977,0.907104438836788,1,23,glutamate metabolic process,BP,ALDH4A1
15787,GO:0072376,0.406502767504529,0.90697402106856,1,23,protein activation cascade,BP,CLU
13836,GO:0060416,0.407259330648449,0.906444262883551,1,24,response to growth hormone,BP,PIK3R1
4147,GO:0009206,0.407386420004658,0.799891898668169,3,105,purine ribonucleoside triphosphate biosynthetic process,BP,NME9;DDIT4;HK2
431,GO:0001158,0.407550724417737,0.837239632193902,2,64,enhancer sequence-specific DNA binding,MF,SOX9;GZF1
1330,GO:0003179,0.407617574759043,0.906126377826904,1,25,heart valve morphogenesis,BP,SOX9
12291,GO:0048593,0.407784078165543,0.836997271305773,2,66,camera-type eye morphogenesis,BP,SOX9;IRX5
15509,GO:0071868,0.407788511344336,0.906176645815965,1,24,cellular response to monoamine stimulus,BP,ID1
15511,GO:0071870,0.407788511344336,0.906176645815965,1,24,cellular response to catecholamine stimulus,BP,ID1
3591,GO:0008016,0.408123032249719,0.799266105445581,3,108,regulation of heart contraction,BP,RGS2;CTGF;IRX5
14562,GO:0070076,0.408153366533861,0.905854745252737,1,25,histone lysine demethylation,BP,HR
8146,GO:0032868,0.408362811015966,0.757767882876701,5,193,response to insulin,BP,SLC2A1;PTPRE;PIK3R1;SOCS1;CISH
15061,GO:0070997,0.408363999722357,0.74477917283376,6,235,neuron death,BP,CDK5R1;TNFRSF21;GDNF;FOS;DDIT4;CLU
12899,GO:0051224,0.408577431806937,0.79900542830355,3,104,negative regulation of protein transport,BP,MIDN;TNFRSF21;VSNL1
6449,GO:0021761,0.408684369544284,0.836417020662212,2,65,limbic system development,BP,CDK5R1;MFSD2A
12265,GO:0048536,0.408686334496813,0.905721541182197,1,24,spleen development,BP,RBM15
8159,GO:0032885,0.408687738976663,0.905583359465234,1,25,regulation of polysaccharide biosynthetic process,BP,PPP1R3D
6962,GO:0030595,0.408794395215861,0.79886236979269,3,103,leukocyte chemotaxis,BP,SERPINE1;IL17RA;CXCL14
12311,GO:0048640,0.409244879964372,0.83603011912925,2,65,negative regulation of developmental growth,BP,CDK5R1;NOG
17907,GO:1902175,0.409604766529562,0.905404782849746,1,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,HSPB1
10400,GO:0043228,0.40982998302712,0.643080120828367,74,3276,non-membrane-bounded organelle,CC,ID1;RGS2;SNAI2;CDK5R1;IVNS1ABP;SERTAD3;SLC2A1;MIDN;MYC;HR;FAM110C;IFFO2;HIST1H2AG;HSPB1;HIST1H4L;FHL2;AHNAK2;MAP3K14;TFCP2L1;BAG3;TUBA4A;SURF6;HIST1H2BJ;CHAMP1;FHL3;RNF168;CDC42EP2;CD3EAP;HIST1H2BI;YPEL4;HIST1H3J;HIST1H2AB;NME9;PAK6;HJURP;UPF1;VASP;HIST1H4B;IMP3;CEBPA;CNN2;HSPA2;BICD2;HIST1H2BO;RIN1;GZF1;PLEKHM1;HIST1H2BE;KRT16;URB2;NR1D1;ING2;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;ZNF16;KRT17;IFFO1;TBCC;HIST1H4D;NOTCH3;SOCS1;CLU;HIST1H2AH;CDC42SE1;DCLRE1C;VPS18
10404,GO:0043232,0.40982998302712,0.643080120828367,74,3276,intracellular non-membrane-bounded organelle,CC,ID1;RGS2;SNAI2;CDK5R1;IVNS1ABP;SERTAD3;SLC2A1;MIDN;MYC;HR;FAM110C;IFFO2;HIST1H2AG;HSPB1;HIST1H4L;FHL2;AHNAK2;MAP3K14;TFCP2L1;BAG3;TUBA4A;SURF6;HIST1H2BJ;CHAMP1;FHL3;RNF168;CDC42EP2;CD3EAP;HIST1H2BI;YPEL4;HIST1H3J;HIST1H2AB;NME9;PAK6;HJURP;UPF1;VASP;HIST1H4B;IMP3;CEBPA;CNN2;HSPA2;BICD2;HIST1H2BO;RIN1;GZF1;PLEKHM1;HIST1H2BE;KRT16;URB2;NR1D1;ING2;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;ZNF16;KRT17;IFFO1;TBCC;HIST1H4D;NOTCH3;SOCS1;CLU;HIST1H2AH;CDC42SE1;DCLRE1C;VPS18
10401,GO:0043229,0.410730966786322,0.645864009024466,207,9300,intracellular organelle,CC,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;PTPRE;VASN;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;FAT2;COL1A1;YPEL4;TOB1;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ZNF549;NME9;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;SWT1;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;MALL;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;DDIT4;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;KRT16;URB2;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;KRT17;IFFO1;SOX12;ZNF766;TBCC;ZNF701;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;VPS18;FAM217B;IRX5
3694,GO:0008200,0.410998655435388,0.904543288317059,1,24,ion channel inhibitor activity,MF,SLC30A1
17941,GO:1902253,0.411383029468753,0.904498021191519,1,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,ING2
3781,GO:0008334,0.411464753128102,0.904304712341583,1,24,histone mRNA metabolic process,BP,UPF1
14516,GO:0062014,0.411610850114195,0.834434005327822,2,64,negative regulation of small molecule metabolic process,BP,SNAI2;DDIT4
17740,GO:1901655,0.411963373743274,0.834147182733693,2,65,cellular response to ketone,BP,GJB2;DDIT4
12977,GO:0051346,0.412163839079738,0.731218447892512,7,278,negative regulation of hydrolase activity,BP,RGS2;SERPINE1;ANGPTL4;FZD10;SIAH2;TIMP3;CDC42SE1
8151,GO:0032874,0.412229381779928,0.796142247283455,3,107,positive regulation of stress-activated MAPK cascade,BP,CTGF;FZD10;GADD45B
11255,GO:0045446,0.412352889513453,0.833835656654408,2,66,endothelial cell differentiation,BP,ID1;NR2F2
10503,GO:0043401,0.412898636486932,0.771263629891377,4,151,steroid hormone mediated signaling pathway,BP,FHL2;NR2F2;NR1D1;PMEPA1
6792,GO:0030224,0.412917887702677,0.903558594750268,1,24,monocyte differentiation,BP,MYC
18284,GO:1903131,0.412917887702677,0.903558594750268,1,24,mononuclear cell differentiation,BP,MYC
17746,GO:1901661,0.41292380342711,0.903708114707649,1,23,quinone metabolic process,BP,AKR1C1
2944,GO:0006471,0.413041300004545,0.903495066274284,1,24,protein ADP-ribosylation,BP,TIPARP
5233,GO:0015844,0.413484305512064,0.903266812919101,1,24,monoamine transport,BP,GDNF
4093,GO:0009145,0.413508078653772,0.795180264878923,3,106,purine nucleoside triphosphate biosynthetic process,BP,NME9;DDIT4;HK2
5018,GO:0015175,0.413677568853884,0.9031671337416,1,24,neutral amino acid transmembrane transporter activity,MF,SLC7A5P2
12117,GO:0048147,0.413785447849709,0.90311146603724,1,24,negative regulation of fibroblast proliferation,BP,MYC
5359,GO:0016126,0.414087599027504,0.832710794108554,2,64,sterol biosynthetic process,BP,FAXDC2;SEC14L2
16002,GO:0085029,0.414502953733553,0.902599400503697,1,25,extracellular matrix assembly,BP,SOX9
8890,GO:0034704,0.415034455556833,0.902323859609472,1,25,calcium channel complex,CC,HSPA2
16162,GO:0090162,0.415497260900868,0.902083547214483,1,25,establishment of epithelial cell polarity,BP,HES1
11863,GO:0046835,0.4156241062677,0.902159692669975,1,24,carbohydrate phosphorylation,BP,HK2
10065,GO:0042551,0.415752126839264,0.901951054497683,1,25,neuron maturation,BP,IRX5
4691,GO:0010837,0.416002329838164,0.90182087993003,1,25,regulation of keratinocyte proliferation,BP,SNAI2
9546,GO:0036296,0.416004964483587,0.901961836134789,1,24,response to increased oxygen levels,BP,COL1A1
10543,GO:0043487,0.416289245560109,0.76855206135491,4,148,regulation of RNA stability,BP,HSPB1;GDNF;ZFP36L2;UPF1
5443,GO:0016303,0.416334953918595,0.901516154057919,1,26,1-phosphatidylinositol-3-kinase activity,MF,PIK3R1
16128,GO:0090100,0.417192518140672,0.830453607674363,2,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HES1;ING2
9004,GO:0035136,0.417370502425225,0.901107195346706,1,25,forelimb morphogenesis,BP,HOXA9
14655,GO:0070232,0.417533544911515,0.901165289329076,1,24,regulation of T cell apoptotic process,BP,TSC22D3
8499,GO:0033674,0.417874214014742,0.704637373267917,10,415,positive regulation of kinase activity,BP,CDK5R1;DUSP5;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;ZNF16;SOCS1;CLU
2762,GO:0006171,0.417921845653648,0.900818707320732,1,25,cAMP biosynthetic process,BP,PTHLH
14696,GO:0070304,0.418276864592585,0.791450407782171,3,108,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF;FZD10;GADD45B
3394,GO:0007173,0.41829310531304,0.791437801971888,3,108,epidermal growth factor receptor signaling pathway,BP,PIK3R1;SOX9;FAM83A
7368,GO:0031406,0.418657373646422,0.79119847198809,3,106,carboxylic acid binding,MF,ID3;NR2F2;AKR1C1
15142,GO:0071222,0.418698593093194,0.791166462241707,3,106,cellular response to lipopolysaccharide,BP,SERPINE1;UPF1;NR1D1
3159,GO:0006767,0.418877506451701,0.829309830561718,2,65,water-soluble vitamin metabolic process,BP,SLC2A1;SLC2A3
11376,GO:0045727,0.419210372723764,0.79076884990485,3,106,positive regulation of translation,BP,BCDIN3D;IMP3;KRT17
7326,GO:0031331,0.419454583398836,0.724837090777592,7,284,positive regulation of cellular catabolic process,BP,ZFP36L2;TOB1;UPF1;CEBPA;SNX33;HK2;CLU
8430,GO:0033522,0.419556895785315,0.899960165029547,1,25,histone H2A ubiquitination,BP,RNF168
4974,GO:0015081,0.420154892584264,0.828325961182295,2,67,sodium ion transmembrane transporter activity,MF,SLC20A2;SLC20A1
4600,GO:0010712,0.42025944011733,0.899735071135108,1,24,regulation of collagen metabolic process,BP,CTGF
11899,GO:0046906,0.420649381930485,0.828058956769218,2,65,tetrapyrrole binding,MF,CYP1B1;NR1D1
13771,GO:0060333,0.421004811871869,0.827850839218221,2,64,interferon-gamma-mediated signaling pathway,BP,TRIM26;SOCS1
12588,GO:0050729,0.421058140344385,0.827813100050197,2,64,positive regulation of inflammatory response,BP,SERPINE1;IL17RA
15508,GO:0071867,0.421295179014505,0.899042468910269,1,25,response to monoamine,BP,ID1
15510,GO:0071869,0.421295179014505,0.899042468910269,1,25,response to catecholamine,BP,ID1
6389,GO:0021575,0.421696387910355,0.898695095293774,1,26,hindbrain morphogenesis,BP,HES1
12533,GO:0050663,0.42185413280341,0.788687401109267,3,107,cytokine secretion,BP,TNFRSF21;IL17RA;SOCS1
10304,GO:0043062,0.422649439643261,0.732475796118439,6,244,extracellular structure organization,BP,SERPINE1;CYP1B1;CTGF;COL1A1;SOX9;COL1A2
4523,GO:0010573,0.422826767548067,0.898229655616303,1,25,vascular endothelial growth factor production,BP,CYP1B1
17514,GO:1900543,0.422833012277252,0.898226333398869,1,25,negative regulation of purine nucleotide metabolic process,BP,DDIT4
8000,GO:0032613,0.422893358327111,0.898341196054139,1,24,interleukin-10 production,BP,TNFRSF21
629,GO:0001816,0.423042609066855,0.694757691089701,11,455,cytokine production,BP,SNAI2;SERPINE1;CYP1B1;HSPB1;TNFRSF21;IL17RA;AKIRIN2;PIK3R1;TRIM56;SOCS1;CLU
6679,GO:0030036,0.42351907074846,0.694284340326995,11,470,actin cytoskeleton organization,BP,ID1;CDK5R1;CTGF;FZD10;FHL3;CDC42EP2;RHOD;PAK6;VASP;PIK3R1;CNN2
5412,GO:0016248,0.423925016113043,0.897644365101714,1,25,channel inhibitor activity,MF,SLC30A1
12158,GO:0048255,0.424450595663749,0.897363542060324,1,25,mRNA stabilization,BP,GDNF
11632,GO:0046326,0.424486534241374,0.897207738687558,1,26,positive regulation of glucose import,BP,PIK3R1
10367,GO:0043177,0.42459738702534,0.786541012387581,3,107,organic acid binding,MF,ID3;NR2F2;AKR1C1
11311,GO:0045620,0.424876970990164,0.897135379482578,1,25,negative regulation of lymphocyte differentiation,BP,ZBTB7B
9612,GO:0036473,0.425180701657051,0.82483913121861,2,65,cell death in response to oxidative stress,BP,CYP1B1;HSPB1
15170,GO:0071276,0.425218482717723,0.89710095833445,1,24,cellular response to cadmium ion,BP,FOS
8294,GO:0033120,0.425281876288148,0.896918419260847,1,25,positive regulation of RNA splicing,BP,PIK3R1
10340,GO:0043130,0.425372010944604,0.824702530051943,2,65,ubiquitin binding,MF,HSPB1;RNF168
11589,GO:0046134,0.425559226406587,0.896918430539171,1,24,pyrimidine nucleoside biosynthetic process,BP,NME9
8674,GO:0034243,0.426737204350106,0.896136302182297,1,25,regulation of transcription elongation from RNA polymerase II promoter,BP,RNF168
8771,GO:0034446,0.427599651790444,0.823023433356981,2,67,substrate adhesion-dependent cell spreading,BP,NET1;EPHB3
11295,GO:0045597,0.427687097812765,0.678194980200612,14,600,positive regulation of cell differentiation,BP,HES1;SNAI2;NET1;SERPINE1;GDNF;CTGF;FOS;COL1A1;SOX9;CEBPA;HOXA5;ZNF16;IFITM1;SOCS1
9066,GO:0035296,0.427704129554546,0.822990068727036,2,66,regulation of tube diameter,BP,RGS2;PER2
16745,GO:0097746,0.427704129554546,0.822990068727036,2,66,regulation of blood vessel diameter,BP,RGS2;PER2
6785,GO:0030216,0.428768147514419,0.75826771290945,4,151,keratinocyte differentiation,BP,TXNIP;POU3F1;KRT16;KRT17
2874,GO:0006367,0.429024436376627,0.758041786802122,4,152,transcription initiation from RNA polymerase II promoter,BP,CTGF;SOX9;NR1D1;NOTCH3
17646,GO:1901343,0.429580491364128,0.821558240648803,2,68,negative regulation of vasculature development,BP,SERPINE1;HOXA5
6078,GO:0019226,0.429826105863101,0.894194795283461,1,27,transmission of nerve impulse,BP,AHNAK2
15792,GO:0072384,0.430330242004945,0.821017436067147,2,68,organelle transport along microtubule,BP,BLOC1S3;BICD2
17388,GO:1900101,0.430453463398296,0.894122674314358,1,25,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
5563,GO:0016571,0.430468005509743,0.781828928845086,3,111,histone methylation,BP,PYGO2;HIST1H1C;HIST1H1D
6368,GO:0021545,0.430547921964271,0.893930769684401,1,26,cranial nerve development,BP,HES1
19981,GO:2000514,0.430728095596775,0.893972925654557,1,25,regulation of CD4-positive, alpha-beta T cell activation,BP,ZBTB7B
5401,GO:0016234,0.430805686892823,0.820674061936146,2,68,inclusion body,CC,URB2;CLU
6681,GO:0030038,0.431645919900346,0.820066415701026,2,68,contractile actin filament bundle assembly,BP,CTGF;PIK3R1
10351,GO:0043149,0.431645919900346,0.820066415701026,2,68,stress fiber assembly,BP,CTGF;PIK3R1
18408,GO:1903409,0.431961199845336,0.819879069346256,2,67,reactive oxygen species biosynthetic process,BP,CYP1B1;CLU
19089,GO:1904950,0.432104753351365,0.780595544041015,3,108,negative regulation of establishment of protein localization,BP,MIDN;TNFRSF21;VSNL1
5569,GO:0016577,0.432296821692263,0.892842556854866,1,27,histone demethylation,BP,HR
6595,GO:0022604,0.432846156694747,0.704382779974042,8,337,regulation of cell morphogenesis,BP,ID1;CDK5R1;NET1;CDC42EP2;RHOD;EPHB3;PALMD;CDC42SE1
9855,GO:0042098,0.432856551765207,0.779998367744187,3,108,T cell proliferation,BP,HES1;TNFRSF21;IGFBP2
4080,GO:0009132,0.43295307628703,0.779878155218111,3,110,nucleoside diphosphate metabolic process,BP,NME9;DDIT4;HK2
4773,GO:0010955,0.433010220665129,0.892581538763608,1,26,negative regulation of protein processing,BP,SERPINE1
18364,GO:1903318,0.433010220665129,0.892581538763608,1,26,negative regulation of protein maturation,BP,SERPINE1
7759,GO:0032271,0.43376824638829,0.75407237711971,4,154,regulation of protein polymerization,BP,RGS2;CDK5R1;CDC42EP2;VASP
14144,GO:0060996,0.433883173669172,0.818403407701976,2,69,dendritic spine development,BP,CDK5R1;EPHB3
13489,GO:0055010,0.434308810875402,0.891733585963596,1,27,ventricular cardiac muscle tissue morphogenesis,BP,NOG
13791,GO:0060359,0.434357403419592,0.818139619238576,2,67,response to ammonium ion,BP,ID1;CDK5R1
7603,GO:0031974,0.434989721803916,0.61509608390526,97,4311,membrane-enclosed lumen,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;HR;DUSP5;HIST1H2AG;HIST1H4L;FHL2;RBAK;POU3F1;MAP3K14;TFCP2L1;FZD10;BRPF1;NR2F2;MARS2;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;RNF168;CD3EAP;RBM15;HIST1H2BI;ZKSCAN4;COL1A1;YPEL4;HIST1H3J;TLE3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;HIST1H4B;IMP3;SOX9;ERF;TRMT61A;CEBPA;CNN2;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;STK17A;GZF1;PLEKHM1;TGIF1;HIST1H2BE;URB2;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;CES2;BRF2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOX12;HIST1H4D;RGS3;NOTCH3;SOCS1;CLU;HIST1H2AH;DCLRE1C;FAM217B
10405,GO:0043233,0.434989721803916,0.61509608390526,97,4311,organelle lumen,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;HR;DUSP5;HIST1H2AG;HIST1H4L;FHL2;RBAK;POU3F1;MAP3K14;TFCP2L1;FZD10;BRPF1;NR2F2;MARS2;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;RNF168;CD3EAP;RBM15;HIST1H2BI;ZKSCAN4;COL1A1;YPEL4;HIST1H3J;TLE3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;HIST1H4B;IMP3;SOX9;ERF;TRMT61A;CEBPA;CNN2;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;STK17A;GZF1;PLEKHM1;TGIF1;HIST1H2BE;URB2;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;CES2;BRF2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOX12;HIST1H4D;RGS3;NOTCH3;SOCS1;CLU;HIST1H2AH;DCLRE1C;FAM217B
14533,GO:0070013,0.434989721803916,0.61509608390526,97,4311,intracellular organelle lumen,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;HR;DUSP5;HIST1H2AG;HIST1H4L;FHL2;RBAK;POU3F1;MAP3K14;TFCP2L1;FZD10;BRPF1;NR2F2;MARS2;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;RNF168;CD3EAP;RBM15;HIST1H2BI;ZKSCAN4;COL1A1;YPEL4;HIST1H3J;TLE3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;HIST1H4B;IMP3;SOX9;ERF;TRMT61A;CEBPA;CNN2;CIART;ALDH4A1;KCTD1;HSPA2;HIST1H2BO;ZBTB34;TIMP3;STK17A;GZF1;PLEKHM1;TGIF1;HIST1H2BE;URB2;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;CES2;BRF2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOX12;HIST1H4D;RGS3;NOTCH3;SOCS1;CLU;HIST1H2AH;DCLRE1C;FAM217B
7481,GO:0031641,0.435057273448041,0.891451859476756,1,26,regulation of myelination,BP,TNFRSF21
11903,GO:0046914,0.435136476432551,0.662320290332507,17,734,transition metal ion binding,MF,CYP1B1;RBAK;FAXDC2;NR2F2;TRIM35;ZCCHC3;ZNF3;ADAMTS15;ZNF93;SIAH2;UPF1;NR1D1;PHC2;ZADH2;TRIM26;TRIM56;ZCCHC2
8158,GO:0032881,0.435466446626885,0.891092335934447,1,27,regulation of polysaccharide metabolic process,BP,PPP1R3D
15261,GO:0071417,0.435793585098369,0.694525178269298,9,380,cellular response to organonitrogen compound,BP,ID1;PTPRE;COL1A1;PIK3R1;SOX9;GJB2;COL1A2;SOCS1;CISH
618,GO:0001784,0.436180008578236,0.890695911076745,1,27,phosphotyrosine residue binding,MF,PIK3R1
11508,GO:0045980,0.436618951426089,0.8905851443109,1,26,negative regulation of nucleotide metabolic process,BP,DDIT4
9076,GO:0035315,0.436747240050096,0.890513756778315,1,26,hair cell differentiation,BP,HES1
8164,GO:0032890,0.437077110913743,0.890330065036808,1,26,regulation of organic acid transport,BP,PER2
11252,GO:0045429,0.437100911709702,0.890316803999571,1,26,positive regulation of nitric oxide biosynthetic process,BP,CLU
18844,GO:1904407,0.437100911709702,0.890316803999571,1,26,positive regulation of nitric oxide metabolic process,BP,CLU
17355,GO:1900026,0.437610984017386,0.890032370662468,1,26,positive regulation of substrate adhesion-dependent cell spreading,BP,NET1
11363,GO:0045687,0.437737214305721,0.889961910370506,1,26,positive regulation of glial cell differentiation,BP,HES1
6655,GO:0023061,0.437768488398505,0.719304600571641,6,244,signal release,BP,SLC2A1;MIDN;VSNL1;SLC30A1;NR1D1;PER2
7033,GO:0030802,0.438126532535051,0.889744422210313,1,26,regulation of cyclic nucleotide biosynthetic process,BP,PTHLH
15297,GO:0071470,0.438321555057694,0.889635375591688,1,26,cellular response to osmotic stress,BP,SLC2A1
16349,GO:0090568,0.438323045984794,0.889499994068365,1,27,nuclear transcriptional repressor complex,CC,NACC2
3289,GO:0006979,0.438357777380735,0.699481236107904,8,326,response to oxidative stress,BP,NET1;TXNIP;CYP1B1;HSPB1;FOS;COL1A1;GJB2;BRF2
9346,GO:0035850,0.439115692162754,0.889055626882762,1,27,epithelial cell differentiation involved in kidney development,BP,GDNF
16341,GO:0090543,0.439138883517397,0.889177644082203,1,26,Flemming body,CC,CHAMP1
6366,GO:0021543,0.439407567622923,0.774636039841792,3,114,pallium development,BP,CDK5R1;SLC2A1;MFSD2A
7413,GO:0031491,0.439733031052377,0.814249575274154,2,66,nucleosome binding,MF,RNF168;HIST1H3J
19414,GO:1905897,0.440043071214848,0.813978206086574,2,67,regulation of response to endoplasmic reticulum stress,BP,PIK3R1;CLU
7329,GO:0031334,0.440310849302337,0.730621614466278,5,199,positive regulation of protein complex assembly,BP,RGS2;CDK5R1;CDC42EP2;VASP;CLU
4256,GO:0009566,0.4404800093896,0.813656415680411,2,67,fertilization,BP,NR2F2;HOXA9
5850,GO:0017137,0.440635630721078,0.748266127021537,4,158,Rab GTPase binding,MF,RIN2;BICD2;RIN1;RUNDC1
5209,GO:0015804,0.44162622751543,0.887777447021499,1,26,neutral amino acid transport,BP,SLC7A5P2
8978,GO:0035066,0.441675839055868,0.887749408782949,1,26,positive regulation of histone acetylation,BP,SNAI2
6929,GO:0030517,0.441819964640654,0.88753128829886,1,27,negative regulation of axon extension,BP,CDK5R1
14652,GO:0070229,0.441991965384006,0.887570646554357,1,26,negative regulation of lymphocyte apoptotic process,BP,TSC22D3
11358,GO:0045682,0.442534474914685,0.812097276276699,2,68,regulation of epidermis development,BP,HES1;KRT17
3423,GO:0007212,0.442613971963168,0.887218402568406,1,26,dopamine receptor signaling pathway,BP,KLF16
4142,GO:0009201,0.44275349012192,0.772002840215911,3,111,ribonucleoside triphosphate biosynthetic process,BP,NME9;DDIT4;HK2
5597,GO:0016620,0.442771459382197,0.887129108930235,1,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH4A1
4815,GO:0014003,0.442933172519527,0.887037373878282,1,26,oligodendrocyte development,BP,CLU
3141,GO:0006734,0.443589574646182,0.886664543066355,1,26,NADH metabolic process,BP,HK2
4393,GO:0010043,0.44377506086414,0.886559050725185,1,26,response to zinc ion,BP,SLC30A1
12398,GO:0048812,0.443810273740574,0.681016397449994,10,434,neuron projection morphogenesis,BP,ID1;CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
11520,GO:0046006,0.443822448755596,0.886532089874418,1,26,regulation of activated T cell proliferation,BP,IGFBP2
6355,GO:0021532,0.44438111463204,0.886075757969843,1,27,neural tube patterning,BP,HES1
4206,GO:0009312,0.444690213089803,0.886037682935771,1,26,oligosaccharide biosynthetic process,BP,SLC2A1
4201,GO:0009306,0.444749954861973,0.693674827232845,8,333,protein secretion,BP,SLC2A1;MIDN;TNFRSF21;IL17RA;VSNL1;NR1D1;PER2;SOCS1
6510,GO:0021879,0.444754104394653,0.885862817279814,1,27,forebrain neuron differentiation,BP,HES1
8852,GO:0034644,0.445436813547674,0.809901892673451,2,69,cellular response to UV,BP,MYC;PIK3R1
227,GO:0000469,0.445579608720559,0.88552956975086,1,26,cleavage involved in rRNA processing,BP,RRP36
887,GO:0002250,0.445671124183411,0.725980915146252,5,198,adaptive immune response,BP,TNFRSF21;RNF168;ZBTB7B;CLU;DCLRE1C
10591,GO:0043551,0.445713345633222,0.885314053086302,1,27,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R1
9732,GO:0038179,0.445984267120366,0.885158768594872,1,27,neurotrophin signaling pathway,BP,DDIT4
1324,GO:0003170,0.446150741805107,0.884934046289404,1,28,heart valve development,BP,SOX9
3599,GO:0008028,0.44635341484501,0.885086353255679,1,26,monocarboxylic acid transmembrane transporter activity,MF,MFSD2A
3365,GO:0007127,0.446571241133318,0.809097933250229,2,68,meiosis I,BP,HSPA2;ING2
8147,GO:0032869,0.446838490123047,0.743022064465295,4,158,cellular response to insulin stimulus,BP,PTPRE;PIK3R1;SOCS1;CISH
12804,GO:0051085,0.446955531952844,0.884740741121613,1,26,chaperone cofactor-dependent protein refolding,BP,HSPA2
15139,GO:0071219,0.447043401586717,0.768525803412392,3,111,cellular response to molecule of bacterial origin,BP,SERPINE1;UPF1;NR1D1
17293,GO:0140030,0.447790848233008,0.767854059449337,3,114,modification-dependent protein binding,MF,PHF13;RNF168;ING2
619,GO:0001786,0.447896231177557,0.884059179712545,1,27,phosphatidylserine binding,MF,PLCD1
12714,GO:0050919,0.448066075678952,0.883830868243346,1,28,negative chemotaxis,BP,FLRT3
3496,GO:0007389,0.449064442972411,0.709284058685579,6,249,pattern specification process,BP,HES1;NOG;GDNF;NR2F2;HOXA9;HOXA5
12325,GO:0048666,0.449635742178796,0.651387431823448,16,708,neuron development,BP,ID1;HES1;CDK5R1;NOG;FLRT3;GDNF;CDHR1;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;ARTN;NCDN;IRX5
6814,GO:0030261,0.449652407970585,0.882912237890456,1,28,chromosome condensation,BP,PHF13
8107,GO:0032787,0.450681962851745,0.674729481135083,10,420,monocarboxylic acid metabolic process,BP,CYP1B1;CBR1;ALDH4A1;AKR1C1;DDIT4;NR1D1;ZADH2;PER2;CES2;HK2
3590,GO:0008015,0.450720604509093,0.707802615729513,6,250,blood circulation,BP,RGS2;CTGF;NR2F2;PER2;COL1A2;IRX5
15211,GO:0071346,0.451272741622507,0.765074474926642,3,111,cellular response to interferon-gamma,BP,CDC42EP2;TRIM26;SOCS1
12976,GO:0051345,0.451665335008364,0.659549961412481,13,561,positive regulation of hydrolase activity,BP,RGS2;NET1;MYC;RIN2;CTGF;FZD10;CDC42EP2;AKIRIN2;HSPA2;RIN1;RUNDC1;DNAJB2;RGS3
3324,GO:0007032,0.452195460495339,0.80483608295402,2,69,endosome organization,BP,SNX33;VPS18
11586,GO:0046131,0.452664516718872,0.881431716118563,1,26,pyrimidine ribonucleoside metabolic process,BP,NME9
19931,GO:2000401,0.452737180072021,0.881245951277999,1,27,regulation of lymphocyte migration,BP,CXCL14
20119,GO:2000758,0.453416336852663,0.880847912851813,1,27,positive regulation of peptidyl-lysine acetylation,BP,SNAI2
2681,GO:0006040,0.453613913990726,0.880731961598509,1,27,amino sugar metabolic process,BP,MGAT1
11870,GO:0046850,0.454272533767532,0.880211093138395,1,28,regulation of bone remodeling,BP,PLEKHM1
2400,GO:0005543,0.4548330014518,0.693285400084257,7,295,phospholipid binding,MF,PLCD1;SEC14L2;PXDC1;SNX33;PCYT1A;ING2;ZCCHC2
10580,GO:0043539,0.454982105214293,0.879927087962143,1,27,protein serine/threonine kinase activator activity,MF,CDK5R1
4198,GO:0009303,0.455278711433965,0.879752156557059,1,27,rRNA transcription,BP,CD3EAP
18633,GO:1903900,0.456177539887162,0.761020778403172,3,112,regulation of viral life cycle,BP,TRIM35;TRIM26;IFITM1
8082,GO:0032757,0.456364474357669,0.879110443468316,1,27,positive regulation of interleukin-8 production,BP,SERPINE1
7470,GO:0031624,0.456367262321485,0.878973755906294,1,28,ubiquitin conjugating enzyme binding,MF,SIAH2
1262,GO:0003013,0.456556511582308,0.702571357880312,6,252,circulatory system process,BP,RGS2;CTGF;NR2F2;PER2;COL1A2;IRX5
14746,GO:0070405,0.456705504857466,0.878908445970341,1,27,ammonium ion binding,MF,PCYT1A
7045,GO:0030814,0.457096431743534,0.878541180104326,1,28,regulation of cAMP metabolic process,BP,PTHLH
7716,GO:0032201,0.457408059691597,0.878491648383819,1,27,telomere maintenance via semi-conservative replication,BP,UPF1
16270,GO:0090313,0.457735946583051,0.87829682009193,1,27,regulation of protein targeting to membrane,BP,CDK5R1
12784,GO:0051046,0.457907422444047,0.668014068712548,10,426,regulation of secretion,BP,SLC2A1;MIDN;TNFRSF21;GDNF;IL17RA;VSNL1;SLC30A1;NR1D1;PER2;SOCS1
2954,GO:0006482,0.457912042008839,0.877929698979956,1,29,protein demethylation,BP,HR
3706,GO:0008214,0.457912042008839,0.877929698979956,1,29,protein dealkylation,BP,HR
9008,GO:0035150,0.458157173709239,0.800268644807855,2,70,regulation of tube size,BP,RGS2;PER2
12686,GO:0050880,0.458157173709239,0.800268644807855,2,70,regulation of blood vessel size,BP,RGS2;PER2
17867,GO:1902042,0.45822540704674,0.87800562295235,1,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1
10419,GO:0043254,0.458608543287424,0.681011886764208,8,338,regulation of protein complex assembly,BP,RGS2;CDK5R1;CDC42EP2;HJURP;VASP;PMEPA1;CLU;VPS18
12933,GO:0051270,0.458817557154242,0.649083893008267,14,615,regulation of cellular component movement,BP,SNAI2;SERPINE1;CYP1B1;FAM110C;NOG;HSPB1;NR2F2;RHOD;COL1A1;CXCL14;PIK3R1;SOX9;KRT16;IFITM1
15617,GO:0072089,0.459325129149091,0.799295367335981,2,72,stem cell proliferation,BP,SNAI2;ARTN
5805,GO:0017053,0.459807480353282,0.798887337868751,2,73,transcriptional repressor complex,CC,AKIRIN2;NACC2
6081,GO:0019229,0.460000550193502,0.876808751100029,1,28,regulation of vasoconstriction,BP,PER2
11533,GO:0046039,0.460387562959847,0.876714070692822,1,27,GTP metabolic process,BP,NME9
3293,GO:0006986,0.46071759130866,0.731140254555306,4,157,response to unfolded protein,BP,HSPB1;PIK3R1;HSPA2;DNAJB2
8149,GO:0032872,0.461192885692271,0.730688805883512,4,160,regulation of stress-activated MAPK cascade,BP,MYC;CTGF;FZD10;GADD45B
14511,GO:0061982,0.461288925361516,0.797869242935373,2,70,meiosis I cell cycle process,BP,HSPA2;ING2
11683,GO:0046456,0.461441038293792,0.876081696997569,1,27,icosanoid biosynthetic process,BP,CBR1
6307,GO:0019932,0.461681570702693,0.730239643201385,4,162,second-messenger-mediated signaling,BP,RGS2;PTHLH;ADGRF1;SOX9
10434,GO:0043276,0.461826699053703,0.875711508942336,1,28,anoikis,BP,SNAI2
5329,GO:0016051,0.46213396540918,0.729900171362936,4,158,carbohydrate biosynthetic process,BP,SLC2A1;PPP1R3D;NR1D1;PER2
9691,GO:0038066,0.462146565675507,0.875518689754491,1,28,p38MAPK cascade,BP,GADD45B
14883,GO:0070661,0.4630845740452,0.72908925048866,4,157,leukocyte proliferation,BP,HES1;TNFRSF21;IGFBP2;CLU
17265,GO:0120034,0.463397215436189,0.796164420737462,2,72,positive regulation of plasma membrane bounded cell projection assembly,BP,CDC42EP2;PLEKHM1
11904,GO:0046915,0.4640677764637,0.874356617875575,1,28,transition metal ion transmembrane transporter activity,MF,SLC30A1
15758,GO:0072330,0.464372548606436,0.709461338755677,5,204,monocarboxylic acid biosynthetic process,BP,CBR1;DDIT4;NR1D1;PER2;HK2
15759,GO:0072331,0.464583972191563,0.695374583323504,6,247,signal transduction by p53 class mediator,BP,SNAI2;CDK5R1;BRPF1;DDIT4;ING2;HIC1
19711,GO:2000008,0.464971742626411,0.873807496564884,1,28,regulation of protein localization to cell surface,BP,SNX33
3930,GO:0008608,0.465654283809966,0.873391885279664,1,28,attachment of spindle microtubules to kinetochore,BP,CHAMP1
10287,GO:0043029,0.465893124392882,0.873246248349855,1,28,T cell homeostasis,BP,TSC22D3
14694,GO:0070302,0.466154414734238,0.726365748546897,4,161,regulation of stress-activated protein kinase signaling cascade,BP,MYC;CTGF;FZD10;GADD45B
8069,GO:0032732,0.466318545439261,0.872986580408267,1,28,positive regulation of interleukin-1 production,BP,HSPB1
4307,GO:0009755,0.466850712083224,0.725745554906932,4,162,hormone-mediated signaling pathway,BP,FHL2;NR2F2;NR1D1;PMEPA1
2609,GO:0005911,0.46728371183027,0.681892427798578,7,302,cell-cell junction,CC,SLC2A1;FLRT3;FAT2;VASP;PIK3R1;CNN2;GJB2
11387,GO:0045744,0.467440870510835,0.872299933713775,1,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,RGS2
138,GO:0000288,0.467950053933707,0.79263380758799,2,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L2;TOB1
3677,GO:0008175,0.468025158856383,0.871941540138794,1,28,tRNA methyltransferase activity,MF,TRMT61A
12956,GO:0051302,0.468068911477553,0.75100757410786,3,117,regulation of cell division,BP,TXNIP;MYC;ZNF16
15523,GO:0071887,0.469220162599324,0.791683836842552,2,71,leukocyte apoptotic process,BP,TSC22D3;TNFRSF21
12125,GO:0048168,0.470013294509927,0.870584292813184,1,29,regulation of neuronal synaptic plasticity,BP,NCDN
5683,GO:0016791,0.470071660160407,0.704351559761131,5,206,phosphatase activity,MF,DUSP4;PTPRE;DUSP5;PPP1R3D;NT5DC3
12673,GO:0050864,0.470267594035509,0.790824386114114,2,72,regulation of B cell activation,BP,TNFRSF21;ZFP36L2
7879,GO:0032436,0.470782218473522,0.790462290799873,2,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,CEBPA;CLU
12497,GO:0050435,0.470907997990041,0.870030479126317,1,29,amyloid-beta metabolic process,BP,CLU
17597,GO:1901214,0.470962470600009,0.703552629499268,5,206,regulation of neuron death,BP,CDK5R1;GDNF;FOS;DDIT4;CLU
4455,GO:0010390,0.471578392346325,0.869614533729092,1,29,histone monoubiquitination,BP,RNF168
4208,GO:0009314,0.471856742081258,0.668763638125729,8,340,response to radiation,BP,SNAI2;NET1;MYC;FOS;RNF168;PIK3R1;PER2;DCLRE1C
12312,GO:0048641,0.471928561247688,0.869396938620248,1,29,regulation of skeletal muscle tissue development,BP,TSC22D3
7179,GO:0031056,0.472241098570827,0.747466246207966,3,118,regulation of histone modification,BP,SNAI2;PYGO2;ING2
361,GO:0000979,0.472685754023211,0.868925635956669,1,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,FOS
4683,GO:0010828,0.472725516816674,0.86877538784625,1,30,positive regulation of glucose transmembrane transport,BP,PIK3R1
6853,GO:0030317,0.472960706840133,0.868754230761593,1,29,flagellated sperm motility,BP,ING2
3273,GO:0006952,0.473299499317656,0.61705707617549,21,918,defense response,BP,SERPINE1;TNFRSF21;MAP3K14;HIST1H2BJ;TRIM35;FOS;CDC42EP2;IL17RA;HIST1H2BI;AKIRIN2;DDIT4;HIST1H2BE;KRT16;NR1D1;HIST2H2BE;TRIM26;SOCS6;IFITM1;TRIM56;SOCS1;CLU
15423,GO:0071674,0.473388020815054,0.868622425937221,1,28,mononuclear cell migration,BP,SERPINE1
4346,GO:0009895,0.473490886557528,0.701271095360329,5,207,negative regulation of catabolic process,BP,GDNF;ZKSCAN4;TOB1;TIMP3;DDIT4
12074,GO:0048013,0.473531606409114,0.788261959848848,2,72,ephrin receptor signaling pathway,BP,CDK5R1;EPHB3
10536,GO:0043473,0.474144405359009,0.787738986147378,2,73,pigmentation,BP,SNAI2;BLOC1S3
13109,GO:0051607,0.474406786229534,0.719146422564933,4,160,defense response to virus,BP,MAP3K14;DDIT4;IFITM1;TRIM56
9041,GO:0035254,0.474616715693241,0.867592447364415,1,30,glutamate receptor binding,MF,CDK5R1
10545,GO:0043489,0.474821448561883,0.867590526817323,1,29,RNA stabilization,BP,GDNF
12071,GO:0048010,0.475599293733509,0.786589970827898,2,73,vascular endothelial growth factor receptor signaling pathway,BP,HSPB1;PIK3R1
7064,GO:0030838,0.476107256183886,0.786228301456839,2,72,positive regulation of actin filament polymerization,BP,CDC42EP2;VASP
4316,GO:0009791,0.476318012157821,0.78590669853381,2,76,post-embryonic development,BP,TIPARP;PYGO2
6470,GO:0021795,0.476962875131248,0.866115595714588,1,30,cerebral cortex cell migration,BP,CDK5R1
12898,GO:0051223,0.477344356380151,0.644286708509513,11,477,regulation of protein transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TNFRSF21;BAG3;IL17RA;VSNL1;NR1D1;PER2;SOCS1
14693,GO:0070301,0.477380006263222,0.785219575400021,2,72,cellular response to hydrogen peroxide,BP,NET1;CYP1B1
9931,GO:0042274,0.477834284128532,0.784943367233481,2,70,ribosomal small subunit biogenesis,BP,SURF6;RRP36
2788,GO:0006221,0.47817659871178,0.865613281247507,1,28,pyrimidine nucleotide biosynthetic process,BP,NME9
17269,GO:0120039,0.478352393827142,0.648782585560756,10,446,plasma membrane bounded cell projection morphogenesis,BP,ID1;CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
10313,GO:0043085,0.478581931174377,0.608324825220103,23,1025,positive regulation of catalytic activity,BP,RGS2;CDK5R1;NET1;MYC;RIN2;DUSP5;GDNF;CTGF;MAP3K14;FZD10;CDC42EP2;EPHB3;PAK6;AKIRIN2;GADD45B;HSPA2;RIN1;RUNDC1;DNAJB2;ZNF16;RGS3;SOCS1;CLU
16732,GO:0097718,0.478888019422271,0.86489601094607,1,30,disordered domain specific binding,MF,HSPA2
8527,GO:0033762,0.479364256722601,0.864593231615638,1,30,response to glucagon,BP,GJB2
12571,GO:0050710,0.479703445364233,0.864506377400172,1,29,negative regulation of cytokine secretion,BP,TNFRSF21
655,GO:0001843,0.479882306198568,0.783110249267773,2,75,neural tube closure,BP,NOG;VASP
13955,GO:0060606,0.479882306198568,0.783110249267773,2,75,tube closure,BP,NOG;VASP
1361,GO:0003229,0.479980920909644,0.864079729529365,1,31,ventricular cardiac muscle tissue development,BP,NOG
7166,GO:0031032,0.479989666410682,0.740766590924714,3,123,actomyosin structure organization,BP,CTGF;PIK3R1;CNN2
3924,GO:0008593,0.480173871290136,0.782916118312375,2,74,regulation of Notch signaling pathway,BP,HES1;NOTCH3
1313,GO:0003158,0.4802486198121,0.782817913590507,2,75,endothelium development,BP,ID1;NR2F2
17738,GO:1901653,0.480882688136702,0.680433437619665,6,256,cellular response to peptide,BP,ID1;PTPRE;PIK3R1;GJB2;SOCS1;CISH
12422,GO:0048858,0.481401910982507,0.645891978501851,10,447,cell projection morphogenesis,BP,ID1;CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
16734,GO:0097722,0.481474675404239,0.863246304024893,1,30,sperm motility,BP,ING2
1101,GO:0002687,0.481801637722764,0.781695586167504,2,72,positive regulation of leukocyte migration,BP,SERPINE1;CXCL14
12540,GO:0050671,0.482178402103186,0.781393898635818,2,72,positive regulation of lymphocyte proliferation,BP,HES1;IGFBP2
12101,GO:0048066,0.482619015588761,0.862512412727281,1,30,developmental pigmentation,BP,BLOC1S3
14675,GO:0070268,0.4826441995349,0.781020612527436,2,72,cornification,BP,KRT16;KRT17
9389,GO:0035924,0.482935115636988,0.862309250570033,1,30,cellular response to vascular endothelial growth factor stimulus,BP,HSPB1
2870,GO:0006362,0.483205937736069,0.862265908144097,1,29,transcription elongation from RNA polymerase I promoter,BP,CD3EAP
9289,GO:0035725,0.483237085730396,0.780387329338522,2,76,sodium ion transmembrane transport,BP,SLC20A2;SLC20A1
16566,GO:0097327,0.483701659603186,0.780090824022419,2,74,response to antineoplastic agent,BP,GJB2;DDIT4
3070,GO:0006636,0.48389527618389,0.861822200412507,1,29,unsaturated fatty acid biosynthetic process,BP,CBR1
3132,GO:0006720,0.484144901616742,0.779774496892769,2,73,isoprenoid metabolic process,BP,CYP1B1;AKR1C1
15760,GO:0072332,0.484417943663883,0.779554853606311,2,73,intrinsic apoptotic signaling pathway by p53 class mediator,BP,DDIT4;ING2
10019,GO:0042445,0.485896236688362,0.735801614852766,3,117,hormone metabolic process,BP,TIPARP;CYP1B1;AKR1C1
10256,GO:0042987,0.486246425021524,0.8601695375098,1,30,amyloid precursor protein catabolic process,BP,CLU
3268,GO:0006940,0.486260796765233,0.8601602049124,1,30,regulation of smooth muscle contraction,BP,RGS2
10522,GO:0043433,0.486281956018099,0.73542598803329,3,119,negative regulation of DNA binding transcription factor activity,BP,ID1;ID3;CYP1B1
11788,GO:0046637,0.486364165769085,0.860093068358142,1,30,regulation of alpha-beta T cell differentiation,BP,ZBTB7B
19657,GO:1990823,0.486440692511803,0.77788377559146,2,74,response to leukemia inhibitory factor,BP,MAT2A;HK2
19660,GO:1990830,0.486440692511803,0.77788377559146,2,74,cellular response to leukemia inhibitory factor,BP,MAT2A;HK2
9914,GO:0042246,0.48692116554186,0.859730952141968,1,30,tissue regeneration,BP,SOX15
12539,GO:0050670,0.487722584700168,0.734198621711212,3,118,regulation of lymphocyte proliferation,BP,HES1;TNFRSF21;IGFBP2
12978,GO:0051347,0.48773656360409,0.634369964287835,11,483,positive regulation of transferase activity,BP,CDK5R1;MYC;DUSP5;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;ZNF16;SOCS1;CLU
3490,GO:0007369,0.489111965103606,0.732891117687566,3,123,gastrulation,BP,DUSP4;NOG;DUSP5
8204,GO:0032946,0.489549716854753,0.775404905250886,2,73,positive regulation of mononuclear cell proliferation,BP,HES1;IGFBP2
10740,GO:0044093,0.489849337723936,0.590103201182108,28,1259,positive regulation of molecular function,BP,RGS2;HES1;CDK5R1;NET1;MYC;RIN2;DUSP5;GDNF;CTGF;MAP3K14;FZD10;CDC42EP2;KCTD7;EPHB3;ADGRF1;PAK6;AKIRIN2;GADD45B;HSPA2;RIN1;RUNDC1;PYGO2;DNAJB2;TRIM26;ZNF16;RGS3;SOCS1;CLU
7895,GO:0032459,0.489998328937551,0.857719652974251,1,30,regulation of protein oligomerization,BP,CLU
3410,GO:0007193,0.490172811313922,0.857479289246418,1,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,RGS2
5205,GO:0015800,0.490177313553169,0.857476329352423,1,31,acidic amino acid transport,BP,PER2
12629,GO:0050798,0.490487635525074,0.857398145482891,1,30,activated T cell proliferation,BP,IGFBP2
7181,GO:0031058,0.490906776713081,0.774220145043211,2,75,positive regulation of histone modification,BP,SNAI2;ING2
2720,GO:0006096,0.491154972901624,0.773979182001314,2,76,glycolytic process,BP,DDIT4;HK2
3156,GO:0006757,0.491154972901624,0.773979182001314,2,76,ATP generation from ADP,BP,DDIT4;HK2
13585,GO:0060038,0.491211431634653,0.856795430904035,1,31,cardiac muscle cell proliferation,BP,NOG
7719,GO:0032204,0.492401443941894,0.772961372433873,2,76,regulation of telomere maintenance,BP,MYC;UPF1
11910,GO:0046928,0.492957847739815,0.855640814838594,1,31,regulation of neurotransmitter secretion,BP,SLC30A1
7005,GO:0030684,0.492996284593076,0.772553452390119,2,74,preribosome,CC,IMP3;RRP36
8202,GO:0032944,0.493486159042227,0.729156013118796,3,119,regulation of mononuclear cell proliferation,BP,HES1;TNFRSF21;IGFBP2
16823,GO:0098659,0.493693270689868,0.855152824309666,1,31,inorganic cation import across plasma membrane,BP,SLC30A1
17089,GO:0099587,0.493693270689868,0.855152824309666,1,31,inorganic ion import across plasma membrane,BP,SLC30A1
6531,GO:0021915,0.493797767417872,0.7287828262221,3,124,neural tube development,BP,HES1;NOG;VASP
12654,GO:0050839,0.494033871608321,0.64031184274054,9,394,cell adhesion molecule binding,MF,CDK5R1;VASN;CTGF;BAG3;HIST1H3J;PAK6;VASP;CNN2;NOTCH3
1170,GO:0002790,0.494435804191491,0.647515517538234,8,348,peptide secretion,BP,SLC2A1;MIDN;TNFRSF21;IL17RA;VSNL1;NR1D1;PER2;SOCS1
6766,GO:0030195,0.494467995681269,0.854765499737175,1,30,negative regulation of blood coagulation,BP,SERPINE1
17370,GO:1900047,0.494467995681269,0.854765499737175,1,30,negative regulation of hemostasis,BP,SERPINE1
8704,GO:0034340,0.494876110259552,0.771012427497963,2,74,response to type I interferon,BP,IFITM1;TRIM56
4866,GO:0014704,0.495103723379895,0.854093831741059,1,32,intercalated disc,CC,SLC2A1
9475,GO:0036092,0.495304659202388,0.853846782793824,1,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R1
11480,GO:0045926,0.495947695451247,0.699806709222232,4,166,negative regulation of growth,BP,CDK5R1;SERTAD3;NOG;DNAJB2
4090,GO:0009142,0.496030878120907,0.726903669724501,3,120,nucleoside triphosphate biosynthetic process,BP,NME9;DDIT4;HK2
2871,GO:0006363,0.496115941428474,0.853666487174931,1,30,termination of RNA polymerase I transcription,BP,CD3EAP
20126,GO:2000772,0.496308203110743,0.853409124415988,1,31,regulation of cellular senescence,BP,ING2
6927,GO:0030515,0.496378846761906,0.853490664033031,1,30,snoRNA binding,MF,IMP3
9717,GO:0038128,0.496615246375997,0.853203501863287,1,31,ERBB2 signaling pathway,BP,PIK3R1
5791,GO:0017016,0.496670826648217,0.637750244559602,9,406,Ras GTPase binding,MF,NET1;RIN2;GDNF;CDC42EP2;PAK6;BICD2;RIN1;RUNDC1;ARTN
13525,GO:0055081,0.497027422651611,0.852806158463599,1,32,anion homeostasis,BP,KCTD7
195,GO:0000413,0.498067657377916,0.852358002740911,1,30,protein peptidyl-prolyl isomerization,BP,FKBP9
1481,GO:0003755,0.498067657377916,0.852358002740911,1,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP9
12349,GO:0048701,0.498459825496203,0.851842623129993,1,32,embryonic cranial skeleton morphogenesis,BP,IRX5
13263,GO:0051926,0.500507352589626,0.850580930845332,1,31,negative regulation of calcium ion transport,BP,SLC30A1
13419,GO:0052742,0.500907697758322,0.850071307085683,1,33,phosphatidylinositol kinase activity,MF,PIK3R1
13637,GO:0060113,0.501071194312045,0.850075615062917,1,32,inner ear receptor cell differentiation,BP,HES1
13498,GO:0055021,0.501440347401501,0.849824735347898,1,32,regulation of cardiac muscle tissue growth,BP,NOG
5440,GO:0016298,0.501499570045642,0.765457454895777,2,76,lipase activity,MF,PLCD1;CES2
4387,GO:0010035,0.501789779878401,0.640509901951983,8,348,response to inorganic substance,BP,NET1;TXNIP;CYP1B1;FOS;IGFBP2;COL1A1;SLC30A1;CEBPA
1466,GO:0003713,0.502258640720656,0.660484237523884,6,261,transcription coactivator activity,MF,FHL2;POU3F1;CEBPA;NR1D1;PER2;SOX12
3695,GO:0008201,0.503151899361316,0.764041682639243,2,77,heparin binding,MF,CTGF;ADAMTS15
10674,GO:0043901,0.503319692720748,0.720463015475323,3,120,negative regulation of multi-organism process,BP,TRIM35;TRIM26;IFITM1
14887,GO:0070665,0.503341657605417,0.763961879588665,2,75,positive regulation of leukocyte proliferation,BP,HES1;IGFBP2
12803,GO:0051084,0.503432460903357,0.848590221360511,1,31,'de novo' posttranslational protein folding,BP,HSPA2
3554,GO:0007595,0.503814302988743,0.848204906657899,1,32,lactation,BP,HK2
3269,GO:0006941,0.503841137729404,0.763391233760238,2,79,striated muscle contraction,BP,RGS2;CTGF
12809,GO:0051090,0.504145573571172,0.647419834067329,7,304,regulation of DNA binding transcription factor activity,BP,ID1;ID3;CYP1B1;FOS;ADGRF1;TRIM26;CLU
14803,GO:0070509,0.504810814440568,0.847521609450441,1,32,calcium ion import,BP,SLC30A1
536,GO:0001654,0.505222558169117,0.672057208149017,5,219,eye development,BP,CYP1B1;BLOC1S3;SOX9;PYGO2;IRX5
10223,GO:0042866,0.505636324516924,0.76192473486775,2,78,pyruvate biosynthetic process,BP,DDIT4;HK2
14330,GO:0061462,0.505721077584822,0.846895718373568,1,32,protein localization to lysosome,BP,CLU
13594,GO:0060047,0.505735431523701,0.71819194390043,3,126,heart contraction,BP,RGS2;CTGF;IRX5
14292,GO:0061351,0.505736906065519,0.761803311547404,2,79,neural precursor cell proliferation,BP,ZNF503;ARTN
6847,GO:0030308,0.505865380437206,0.718154973457601,3,122,negative regulation of cell growth,BP,CDK5R1;SERTAD3;DNAJB2
9352,GO:0035861,0.506108051284854,0.846629135603494,1,32,site of double-strand break,CC,RNF168
3266,GO:0006937,0.506697841033554,0.761033333706162,2,78,regulation of muscle contraction,BP,RGS2;CTGF
7478,GO:0031638,0.506719244143752,0.846333039008281,1,31,zymogen activation,BP,SERPINE1
18416,GO:1903428,0.506990895652271,0.846019828809613,1,32,positive regulation of reactive oxygen species biosynthetic process,BP,CLU
2383,GO:0005516,0.508414031218767,0.715722871503013,3,130,calmodulin binding,MF,RGS2;CNN2;PCYT1A
3218,GO:0006865,0.508594870678165,0.759435782418107,2,78,amino acid transport,BP,SLC7A5P2;PER2
5724,GO:0016859,0.509784417643546,0.844208531804599,1,31,cis-trans isomerase activity,MF,FKBP9
8697,GO:0034329,0.509837891211021,0.686977587781676,4,175,cell junction assembly,BP,SNAI2;RHOD;VASP;GJB2
14885,GO:0070663,0.50995790399095,0.714492221966412,3,122,regulation of leukocyte proliferation,BP,HES1;TNFRSF21;IGFBP2
19759,GO:2000107,0.510129474994705,0.843841012843092,1,32,negative regulation of leukocyte apoptotic process,BP,TSC22D3
19825,GO:2000243,0.510701726438176,0.843441612437847,1,32,positive regulation of reproductive process,BP,SOX9
11360,GO:0045684,0.51092886420567,0.843282899059563,1,32,positive regulation of epidermis development,BP,KRT17
12984,GO:0051353,0.51096817242588,0.843255421696723,1,32,positive regulation of oxidoreductase activity,BP,GDNF
9716,GO:0038127,0.511302436513041,0.713223497654035,3,125,ERBB signaling pathway,BP,PIK3R1;SOX9;FAM83A
9433,GO:0036002,0.51196744998703,0.842555852602017,1,32,pre-mRNA binding,MF,SOX9
19666,GO:1990841,0.512176829965905,0.842288695723496,1,33,promoter-specific chromatin binding,MF,ZNF750
13888,GO:0060491,0.51257623343837,0.712076250748918,3,125,regulation of cell projection assembly,BP,FAM110C;CDC42EP2;PLEKHM1
9379,GO:0035904,0.512680998893875,0.841821129952042,1,34,aorta development,BP,HES1
16268,GO:0090311,0.512822183756694,0.841835261890825,1,33,regulation of protein deacetylation,BP,ING2
5671,GO:0016776,0.513119906300032,0.841746532338901,1,32,phosphotransferase activity, phosphate group as acceptor,MF,NME9
4495,GO:0010517,0.513722562991233,0.841201229560632,1,33,regulation of phospholipase activity,BP,RGS2
8922,GO:0034762,0.514220585286685,0.649105139957485,6,266,regulation of transmembrane transport,BP,SLC2A1;SLC30A1;PIK3R1;HSPA2;PER2;HK2
2102,GO:0004866,0.51437146426989,0.754574000408919,2,77,endopeptidase inhibitor activity,MF,SERPINE1;TIMP3
6892,GO:0030414,0.51437146426989,0.754574000408919,2,77,peptidase inhibitor activity,MF,SERPINE1;TIMP3
4826,GO:0014020,0.51443961293796,0.754402304728528,2,80,primary neural tube formation,BP,NOG;VASP
16500,GO:0097178,0.514518354128336,0.840760836398926,1,32,ruffle assembly,BP,PLEKHM1
11389,GO:0045746,0.514776437895408,0.840578490577223,1,32,negative regulation of Notch signaling pathway,BP,NOTCH3
11283,GO:0045580,0.514788883147204,0.754178943895136,2,78,regulation of T cell differentiation,BP,ZBTB7B;SOCS1
1264,GO:0003015,0.514884101375903,0.70993406589513,3,128,heart process,BP,RGS2;CTGF;IRX5
7446,GO:0031572,0.51508209992655,0.840240737097622,1,33,G2 DNA damage checkpoint,BP,MAP3K14
11905,GO:0046916,0.515088937064987,0.753961601225048,2,77,cellular transition metal ion homeostasis,BP,MYC;SLC30A1
1088,GO:0002673,0.515169822938735,0.840300287921751,1,32,regulation of acute inflammatory response,BP,CLU
10590,GO:0043550,0.515352628886354,0.840049162568328,1,33,regulation of lipid kinase activity,BP,PIK3R1
7484,GO:0031644,0.515413324579666,0.840006160503243,1,33,regulation of neurological system process,BP,TNFRSF21
3741,GO:0008277,0.515515158490675,0.753558462148465,2,78,regulation of G-protein coupled receptor protein signaling pathway,BP,RGS2;RGS3
7041,GO:0030810,0.515819823481357,0.839717967535022,1,33,positive regulation of nucleotide biosynthetic process,BP,PTHLH
17491,GO:1900373,0.515819823481357,0.839717967535022,1,33,positive regulation of purine nucleotide biosynthetic process,BP,PTHLH
3061,GO:0006623,0.515873247009269,0.839565322863195,1,34,protein targeting to vacuole,BP,CLU
13487,GO:0055008,0.515954968076341,0.839399127154223,1,35,cardiac muscle tissue morphogenesis,BP,NOG
10871,GO:0044390,0.516637695518567,0.839137101665078,1,33,ubiquitin-like protein conjugating enzyme binding,MF,SIAH2
16119,GO:0090087,0.516686213197585,0.60633488349378,11,491,regulation of peptide transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TNFRSF21;BAG3;IL17RA;VSNL1;NR1D1;PER2;SOCS1
593,GO:0001755,0.517048995525597,0.838844472064736,1,33,neural crest cell migration,BP,GDNF
6910,GO:0030488,0.517067376634795,0.838953891720988,1,32,tRNA methylation,BP,TRMT61A
12645,GO:0050819,0.517594746958651,0.838578390196237,1,32,negative regulation of coagulation,BP,SERPINE1
3501,GO:0007405,0.518193105471519,0.837912918376364,1,34,neuroblast proliferation,BP,ARTN
4658,GO:0010799,0.518221697350631,0.838008218719354,1,33,regulation of peptidyl-threonine phosphorylation,BP,DDIT4
6806,GO:0030246,0.518268412883456,0.706942202450979,3,124,carbohydrate binding,MF,LGALS7B;SLC2A3;HK2
12433,GO:0048872,0.518366824603461,0.679101917030899,4,171,homeostasis of number of cells,BP,TSC22D3;SOX9;HOXA5;ZNF16
11915,GO:0046934,0.518396542599539,0.837767485866178,1,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,PIK3R1
8833,GO:0034614,0.518432292648793,0.706813548941072,3,123,cellular response to reactive oxygen species,BP,NET1;CYP1B1;FOS
569,GO:0001708,0.518655801224544,0.837582024473721,1,34,cell fate specification,BP,SOX9
2903,GO:0006412,0.519013837320514,0.587534039447099,15,655,translation,BP,RGS2;HSPB1;HIST1H4L;MARS2;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;HIST1H4K;PER2;KRT17;HIST1H4D
3332,GO:0007043,0.519472983952829,0.750049936547117,2,81,cell-cell junction assembly,BP,SNAI2;GJB2
11525,GO:0046031,0.519865652283158,0.749747888625028,2,80,ADP metabolic process,BP,DDIT4;HK2
869,GO:0002204,0.519881994258204,0.836819425190587,1,33,somatic recombination of immunoglobulin genes involved in immune response,BP,RNF168
870,GO:0002208,0.519881994258204,0.836819425190587,1,33,somatic diversification of immunoglobulins involved in immune response,BP,RNF168
11152,GO:0045190,0.519881994258204,0.836819425190587,1,33,isotype switching,BP,RNF168
18596,GO:1903825,0.52008679591663,0.749557168510269,2,80,organic acid transmembrane transport,BP,SLC7A5P2;PER2
19128,GO:1905039,0.52008679591663,0.749557168510269,2,80,carboxylic acid transmembrane transport,BP,SLC7A5P2;PER2
8972,GO:0035051,0.520180699165699,0.749404133787854,2,82,cardiocyte differentiation,BP,HES1;FHL2
3426,GO:0007215,0.520955347299914,0.835930973648267,1,34,glutamate receptor signaling pathway,BP,CDK5R1
17035,GO:0099175,0.521134395527484,0.835801960574134,1,34,regulation of postsynapse organization,BP,CDK5R1
3067,GO:0006631,0.521233069522736,0.642420141800117,6,261,fatty acid metabolic process,BP,CYP1B1;CBR1;AKR1C1;ZADH2;PER2;CES2
6559,GO:0021987,0.52153156287768,0.748236923347557,2,82,cerebral cortex development,BP,CDK5R1;SLC2A1
17064,GO:0099531,0.521579688242111,0.74826755175281,2,80,presynaptic process involved in chemical synaptic transmission,BP,GDNF;SLC30A1
6574,GO:0022029,0.521624031185618,0.835448815137771,1,34,telencephalon cell migration,BP,CDK5R1
417,GO:0001104,0.521728911650095,0.748101847033963,2,81,RNA polymerase II transcription cofactor activity,MF,POU3F1;SOX12
10624,GO:0043616,0.521742750961674,0.835363114757377,1,34,keratinocyte proliferation,BP,SNAI2
15554,GO:0071944,0.521760017139468,0.536329928937405,63,2898,cell periphery,CC,SPRY4;RGS2;CDK5R1;SLC2A1;NET1;SERPINE1;GPR132;FAM110C;FUT1;PTPRE;VASN;C1ORF116;FLRT3;HSPB1;APCDD1;TNFRSF21;CTGF;SLC7A5P2;AHNAK2;BAG3;FZD10;BRPF1;SLC20A2;HIST1H2BJ;CDHR1;CDC42EP2;IGFBP2;KCTD7;IL17RA;RHOD;SLC22A15;PCDH7;FAT2;EPHB3;SLC30A1;LRIG3;ADGRF1;LRRC8A;PLCD1;VASP;SLC2A3;SLC20A1;PIK3R1;MFSD2A;GJB2;MALL;ZMYND19;HSPA2;BICD2;STK17A;RIN1;PCYT1A;ING2;SOCS6;KRT17;IFITM1;RGS3;NOTCH3;PMEPA1;CLU;FAM84B;CDC42SE1;CISH
17841,GO:1901985,0.522620703957931,0.834846037523747,1,33,positive regulation of protein acetylation,BP,SNAI2
4534,GO:0010596,0.522632435977298,0.834719946898224,1,34,negative regulation of endothelial cell migration,BP,NR2F2
9862,GO:0042108,0.522709822399795,0.834781561894617,1,33,positive regulation of cytokine biosynthetic process,BP,HSPB1
3335,GO:0007049,0.522943736967205,0.550943447368453,34,1548,cell cycle,BP,ID1;RGS2;HES1;CDK5R1;TXNIP;MYC;GPR132;ZNF503;ID3;SERTAD1;CTGF;MAP3K14;NR2F2;TUBA4A;ZFP36L2;PHF13;TRIM35;CHAMP1;RHOD;PAK6;SIAH2;HJURP;UPF1;GADD45B;SOX9;ERF;CEBPA;HSPA2;SNX33;SOX15;ING2;PER2;NACC2;ZNF16
10041,GO:0042490,0.524065684645458,0.833680370989636,1,34,mechanoreceptor differentiation,BP,HES1
7248,GO:0031175,0.524069901690301,0.585934789420777,14,648,neuron projection development,BP,ID1;HES1;CDK5R1;NOG;FLRT3;GDNF;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;ARTN;NCDN
3202,GO:0006836,0.524154383690602,0.70150558589867,3,127,neurotransmitter transport,BP,GDNF;SLC30A1;PER2
4165,GO:0009225,0.524264404004968,0.833654194617165,1,33,nucleotide-sugar metabolic process,BP,MGAT1
4388,GO:0010038,0.524616183700046,0.653733218805925,5,218,response to metal ion,BP,TXNIP;FOS;IGFBP2;SLC30A1;CEBPA
12655,GO:0050840,0.524667412048445,0.833242646900782,1,34,extracellular matrix binding,MF,ADAMTS15
14173,GO:0061041,0.524782545606743,0.745488389276198,2,80,regulation of wound healing,BP,SERPINE1;SOX15
5402,GO:0016235,0.525481863876637,0.832648974674113,1,34,aggresome,CC,URB2
7637,GO:0032040,0.52550342587012,0.832752064533613,1,33,small-subunit processome,CC,IMP3
13298,GO:0051973,0.525580448479482,0.832695878727838,1,33,positive regulation of telomerase activity,BP,MYC
4100,GO:0009152,0.526507355087447,0.67144209242437,4,172,purine ribonucleotide biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
10082,GO:0042578,0.52695500187873,0.636866425047252,6,266,phosphoric ester hydrolase activity,MF,DUSP4;PTPRE;DUSP5;PPP1R3D;PLCD1;NT5DC3
11390,GO:0045747,0.527369367539393,0.831155062781564,1,35,positive regulation of Notch signaling pathway,BP,HES1
7888,GO:0032451,0.527599857467836,0.830985798434718,1,35,demethylase activity,MF,HR
16992,GO:0099024,0.527616798703718,0.831086190269368,1,34,plasma membrane invagination,BP,SNX33
2380,GO:0005509,0.528040366646741,0.615024360437777,8,368,calcium ion binding,MF,CDK5R1;CDHR1;PCDH7;VSNL1;FAT2;PLCD1;FKBP9;NOTCH3
591,GO:0001750,0.529326714476889,0.829714099415208,1,35,photoreceptor outer segment,CC,CDHR1
908,GO:0002287,0.529374560986987,0.829792320838807,1,34,alpha-beta T cell activation involved in immune response,BP,ZBTB7B
911,GO:0002293,0.529374560986987,0.829792320838807,1,34,alpha-beta T cell differentiation involved in immune response,BP,ZBTB7B
912,GO:0002294,0.529374560986987,0.829792320838807,1,34,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ZBTB7B
9851,GO:0042093,0.529374560986987,0.829792320838807,1,34,T-helper cell differentiation,BP,ZBTB7B
6787,GO:0030218,0.529722291305579,0.741131457540877,2,81,erythrocyte differentiation,BP,HOXA5;ZNF16
11892,GO:0046890,0.53000288329207,0.696134209969871,3,126,regulation of lipid biosynthetic process,BP,SNAI2;SEC14L2;NR1D1
19207,GO:1905269,0.5301671360906,0.740740422524417,2,81,positive regulation of chromatin organization,BP,SNAI2;ING2
1158,GO:0002763,0.530189262079239,0.82919042237865,1,34,positive regulation of myeloid leukocyte differentiation,BP,FOS
139,GO:0000289,0.530807003575752,0.828618978654026,1,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,TOB1
2641,GO:0005975,0.530863239256393,0.59801630206544,10,449,carbohydrate metabolic process,BP,SLC2A1;MIDN;FUT1;PPP1R3D;MGAT1;SLC2A3;DDIT4;NR1D1;PER2;HK2
6507,GO:0021872,0.531838562110509,0.827853092080214,1,35,forebrain generation of neurons,BP,HES1
11634,GO:0046328,0.532121256415659,0.694110822743354,3,129,regulation of JNK cascade,BP,CTGF;FZD10;GADD45B
415,GO:0001102,0.532137832031517,0.82763047574936,1,35,RNA polymerase II activating transcription factor binding,MF,FOS
2203,GO:0005085,0.532587796845215,0.645981145980526,5,229,guanyl-nucleotide exchange factor activity,MF,NET1;RIN2;GDNF;RIN1;ARTN
10575,GO:0043534,0.532597184852609,0.738561865464462,2,82,blood vessel endothelial cell migration,BP,ID1;HSPB1
19740,GO:2000060,0.532916300230518,0.738354031375865,2,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,CEBPA;CLU
15252,GO:0071398,0.533072359022742,0.826934091376113,1,35,cellular response to fatty acid,BP,ID3
19415,GO:1905898,0.533633773730881,0.826630118120976,1,34,positive regulation of response to endoplasmic reticulum stress,BP,PIK3R1
5758,GO:0016903,0.533918820535928,0.826417115234069,1,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,ALDH4A1
4133,GO:0009190,0.534650261361559,0.825754068218756,1,35,cyclic nucleotide biosynthetic process,BP,PTHLH
13397,GO:0052652,0.534650261361559,0.825754068218756,1,35,cyclic purine nucleotide metabolic process,BP,PTHLH
8231,GO:0032990,0.535083173589535,0.59379285184999,10,465,cell part morphogenesis,BP,ID1;CDK5R1;NOG;FLRT3;GDNF;EPHB3;SIAH2;VASP;PIK3R1;ARTN
4239,GO:0009435,0.535309738225522,0.825375261739088,1,34,NAD biosynthetic process,BP,HK2
17499,GO:1900408,0.535819845534856,0.824992136554516,1,34,negative regulation of cellular response to oxidative stress,BP,HSPB1
18312,GO:1903202,0.535819845534856,0.824992136554516,1,34,negative regulation of oxidative stress-induced cell death,BP,HSPB1
2199,GO:0005070,0.536607281960119,0.824283148418125,1,35,SH3/SH2 adaptor activity,MF,TOB1
7621,GO:0032007,0.536682088604832,0.824226760374012,1,35,negative regulation of TOR signaling,BP,DDIT4
5236,GO:0015849,0.537592809929423,0.660845859011512,4,176,organic acid transport,BP,SLC7A5P2;MFSD2A;AKR1C1;PER2
11919,GO:0046942,0.537592809929423,0.660845859011512,4,176,carboxylic acid transport,BP,SLC7A5P2;MFSD2A;AKR1C1;PER2
9889,GO:0042162,0.537998926092921,0.823232185535559,1,35,telomeric DNA binding,MF,UPF1
16395,GO:0090734,0.538264093445075,0.823031461058048,1,35,site of DNA damage,CC,RNF168
12713,GO:0050918,0.538288755633866,0.823012784772645,1,35,positive chemotaxis,BP,ARTN
2202,GO:0005080,0.538324530989573,0.822985690338369,1,35,protein kinase C binding,MF,HSPB1
11204,GO:0045309,0.538474590345052,0.822761334088187,1,36,protein phosphorylated amino acid binding,MF,PIK3R1
5673,GO:0016779,0.538632821332637,0.688070949836786,3,127,nucleotidyltransferase activity,MF,CD3EAP;POLR1D;PCYT1A
7097,GO:0030888,0.53875307085697,0.82266092215499,1,35,regulation of B cell proliferation,BP,TNFRSF21
13433,GO:0052813,0.538864774307347,0.822465373777585,1,36,phosphatidylinositol bisphosphate kinase activity,MF,PIK3R1
3709,GO:0008217,0.539442163409132,0.732474506725407,2,82,regulation of blood pressure,BP,NR2F2;COL1A2
15233,GO:0071375,0.539533170077454,0.639284695515486,5,225,cellular response to peptide hormone stimulus,BP,PTPRE;PIK3R1;GJB2;SOCS1;CISH
13820,GO:0060395,0.539987503632597,0.821611938026232,1,36,SMAD protein signal transduction,BP,FOS
13097,GO:0051592,0.540921559554144,0.731076523494415,2,84,response to calcium ion,BP,TXNIP;FOS
962,GO:0002381,0.541175020838027,0.820818014444559,1,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,RNF168
7707,GO:0032182,0.541519549999957,0.730611386952583,2,82,ubiquitin-like protein binding,MF,HSPB1;RNF168
4786,GO:0010970,0.541636159305993,0.685168957005289,3,131,transport along microtubule,BP,HSPB1;BLOC1S3;BICD2
17020,GO:0099111,0.541636159305993,0.685168957005289,3,131,microtubule-based transport,BP,HSPB1;BLOC1S3;BICD2
6673,GO:0030029,0.541659887152021,0.581589429227731,11,514,actin filament-based process,BP,ID1;CDK5R1;CTGF;FZD10;FHL3;CDC42EP2;RHOD;PAK6;VASP;PIK3R1;CNN2
12017,GO:0047496,0.542379451244826,0.819784635316691,1,36,vesicle transport along microtubule,BP,BLOC1S3
13838,GO:0060420,0.543067519265317,0.819256697356911,1,36,regulation of heart growth,BP,NOG
16750,GO:0097755,0.543128368587532,0.819322435035345,1,35,positive regulation of blood vessel diameter,BP,RGS2
12290,GO:0048592,0.54387967123105,0.728344394859312,2,86,eye morphogenesis,BP,SOX9;IRX5
6933,GO:0030522,0.544224591270017,0.634707863211084,5,225,intracellular receptor signaling pathway,BP,SNAI2;FHL2;NR2F2;NR1D1;PMEPA1
77,GO:0000154,0.544709172438883,0.818225817855876,1,34,rRNA modification,BP,METTL15
10026,GO:0042455,0.544845821373756,0.818120468781446,1,34,ribonucleoside biosynthetic process,BP,NME9
2756,GO:0006164,0.545283335445338,0.653438940605086,4,176,purine nucleotide biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
12763,GO:0051018,0.545417537402074,0.81733862841735,1,37,protein kinase A binding,MF,SOX9
19532,GO:1990391,0.545715513591143,0.817215344331043,1,36,DNA repair complex,CC,DCLRE1C
2595,GO:0005887,0.545864140621746,0.557577857584024,16,741,integral component of plasma membrane,CC,SLC2A1;FUT1;FLRT3;APCDD1;TNFRSF21;SLC7A5P2;FZD10;SLC20A2;CDHR1;IL17RA;SLC22A15;PCDH7;EPHB3;SLC2A3;SLC20A1;MFSD2A
14654,GO:0070231,0.54609856338945,0.817032409169209,1,35,T cell apoptotic process,BP,TSC22D3
9875,GO:0042133,0.546203343952593,0.726346906887002,2,83,neurotransmitter metabolic process,BP,CYP1B1;CLU
12793,GO:0051055,0.547266500946057,0.816126648626144,1,35,negative regulation of lipid biosynthetic process,BP,SNAI2
10803,GO:0044275,0.547283054738567,0.815999702449176,1,36,cellular carbohydrate catabolic process,BP,PPP1R3D
8613,GO:0034121,0.547493258016876,0.815836278528251,1,36,regulation of toll-like receptor signaling pathway,BP,NR1D1
12634,GO:0050805,0.54761958321956,0.815738019522237,1,36,negative regulation of synaptic transmission,BP,SLC30A1
4541,GO:0010611,0.547864379999297,0.815439421100902,1,37,regulation of cardiac muscle hypertrophy,BP,RGS2
4884,GO:0014743,0.547864379999297,0.815439421100902,1,37,regulation of muscle hypertrophy,BP,RGS2
2869,GO:0006361,0.548025797603923,0.815536193701262,1,35,transcription initiation from RNA polymerase I promoter,BP,CD3EAP
910,GO:0002292,0.548378310707416,0.815147124246484,1,36,T cell differentiation involved in immune response,BP,ZBTB7B
3583,GO:0007631,0.548489272093786,0.81506060171052,1,36,feeding behavior,BP,FOS
4859,GO:0014068,0.548570144593343,0.814997524028806,1,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,SOX9
13492,GO:0055013,0.548740639871643,0.814653419010802,1,38,cardiac muscle cell development,BP,FHL2
11251,GO:0045428,0.549256768411214,0.814461401840028,1,36,regulation of nitric oxide biosynthetic process,BP,CLU
4824,GO:0014015,0.549315409367448,0.814415566315418,1,36,positive regulation of gliogenesis,BP,HES1
9080,GO:0035329,0.549497624713853,0.814061472867451,1,38,hippo signaling,BP,MAP3K14
14220,GO:0061135,0.549789422616166,0.723121522576067,2,82,endopeptidase regulator activity,MF,SERPINE1;TIMP3
12297,GO:0048609,0.549834480360741,0.57909696237734,10,460,multicellular organismal reproductive process,BP,RGS2;ZNF296;NR2F2;HOXA9;SOX9;GJB2;HSPA2;PYGO2;ING2;PHC2
8862,GO:0034656,0.549876063632827,0.814092055683904,1,35,nucleobase-containing small molecule catabolic process,BP,MGAT1
5565,GO:0016573,0.550181039456316,0.677062159465817,3,131,histone acetylation,BP,SNAI2;BRPF1;PYGO2
7462,GO:0031594,0.550893050047872,0.813070382618623,1,37,neuromuscular junction,CC,CDK5R1
9885,GO:0042149,0.551531827277056,0.812677582324165,1,36,cellular response to glucose starvation,BP,SLC2A1
6914,GO:0030500,0.551556828179615,0.812548466479879,1,37,regulation of bone mineralization,BP,SOX9
11519,GO:0045995,0.551915479814984,0.721033110837683,2,86,regulation of embryonic development,BP,HES1;GDNF
4856,GO:0014065,0.552038664628322,0.720954869098398,2,85,phosphatidylinositol 3-kinase signaling,BP,PIK3R1;SOX9
13377,GO:0052548,0.552211615785292,0.61209039026197,6,267,regulation of endopeptidase activity,BP,SERPINE1;MYC;CTGF;SIAH2;AKIRIN2;TIMP3
6514,GO:0021885,0.552400709545164,0.81188352899258,1,37,forebrain cell migration,BP,CDK5R1
1267,GO:0003018,0.552443943112255,0.720618700658328,2,84,vascular process in circulatory system,BP,RGS2;PER2
9874,GO:0042130,0.552446176474753,0.811957436451374,1,36,negative regulation of T cell proliferation,BP,TNFRSF21
11416,GO:0045807,0.552845842607006,0.720214213063368,2,85,positive regulation of endocytosis,BP,SERPINE1;CLU
7219,GO:0031109,0.554353535265073,0.718792877594791,2,86,microtubule polymerization or depolymerization,BP,RGS2;CDK5R1
6940,GO:0030544,0.554503226957646,0.810330503737001,1,36,Hsp70 protein binding,MF,DNAJB2
13481,GO:0055001,0.554538714607905,0.718554932870454,2,88,muscle cell development,BP,HES1;FHL2
4920,GO:0014855,0.554778806767473,0.810001189519825,1,37,striated muscle cell proliferation,BP,NOG
8023,GO:0032651,0.555682662021902,0.809393428088056,1,36,regulation of interleukin-1 beta production,BP,HSPB1
3463,GO:0007281,0.555815304070617,0.671620913368838,3,133,germ cell development,BP,HSPA2;PYGO2;ING2
15203,GO:0071333,0.556077527786488,0.717273397813622,2,84,cellular response to glucose stimulus,BP,VSNL1;NR1D1
13247,GO:0051897,0.556335550445889,0.71696408375455,2,86,positive regulation of protein kinase B signaling,BP,FAM110C;PIK3R1
18160,GO:1902883,0.556397419793742,0.808824030889076,1,36,negative regulation of response to oxidative stress,BP,HSPB1
13053,GO:0051496,0.556708084874879,0.808464833408889,1,37,positive regulation of stress fiber assembly,BP,CTGF
18490,GO:1903573,0.55691681570268,0.808409546871637,1,36,negative regulation of response to endoplasmic reticulum stress,BP,CLU
11415,GO:0045806,0.557042100056515,0.80830947794368,1,36,negative regulation of endocytosis,BP,SNX33
17122,GO:0101003,0.557201075737577,0.808070909184919,1,37,ficolin-1-rich granule membrane,CC,SLC2A3
5508,GO:0016447,0.55775327055767,0.807629030275927,1,37,somatic recombination of immunoglobulin gene segments,BP,RNF168
1985,GO:0004702,0.557837146283352,0.715539700909609,2,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAP3K14;EPHB3
7039,GO:0030808,0.557862865014362,0.715550175696811,2,86,regulation of nucleotide biosynthetic process,BP,PTHLH;DDIT4
17489,GO:1900371,0.557862865014362,0.715550175696811,2,86,regulation of purine nucleotide biosynthetic process,BP,PTHLH;DDIT4
10052,GO:0042531,0.558196323895086,0.80738590166871,1,36,positive regulation of tyrosine phosphorylation of STAT protein,BP,HES1
653,GO:0001841,0.55834705283016,0.715066735914586,2,87,neural tube formation,BP,NOG;VASP
1996,GO:0004714,0.558377106032468,0.807022958847289,1,38,transmembrane receptor protein tyrosine kinase activity,MF,EPHB3
7461,GO:0031593,0.559404239115362,0.806303796462842,1,37,polyubiquitin modification-dependent protein binding,MF,RNF168
4606,GO:0010718,0.559676062048256,0.805978518260337,1,38,positive regulation of epithelial to mesenchymal transition,BP,COL1A1
12116,GO:0048146,0.559852376708367,0.805943015839017,1,37,positive regulation of fibroblast proliferation,BP,MYC
16288,GO:0090342,0.560246580982389,0.805625280157525,1,37,regulation of cell aging,BP,ING2
8150,GO:0032873,0.560672990057743,0.805281191295368,1,37,negative regulation of stress-activated MAPK cascade,BP,MYC
14695,GO:0070303,0.560672990057743,0.805281191295368,1,37,negative regulation of stress-activated protein kinase signaling cascade,BP,MYC
6262,GO:0019842,0.560784639291919,0.712905559654293,2,84,vitamin binding,MF,SEC14L2;IRX5
3785,GO:0008344,0.560894644039265,0.804995239977254,1,38,adult locomotory behavior,BP,GDNF
6861,GO:0030326,0.561035066554373,0.712532191759813,2,88,embryonic limb morphogenesis,BP,NOG;HOXA9
8998,GO:0035113,0.561035066554373,0.712532191759813,2,88,embryonic appendage morphogenesis,BP,NOG;HOXA9
5711,GO:0016836,0.561157193575217,0.805002976362168,1,36,hydro-lyase activity,MF,L3HYPDH
14615,GO:0070167,0.56178947565267,0.804271056394083,1,38,regulation of biomineral tissue development,BP,SOX9
5802,GO:0017048,0.562656588273543,0.664888716266699,3,139,Rho GTPase binding,MF,NET1;CDC42EP2;PAK6
15199,GO:0071326,0.562719159025037,0.711062869750895,2,85,cellular response to monosaccharide stimulus,BP,VSNL1;NR1D1
15201,GO:0071331,0.562719159025037,0.711062869750895,2,85,cellular response to hexose stimulus,BP,VSNL1;NR1D1
15839,GO:0072528,0.562785470706,0.803684075008363,1,36,pyrimidine-containing compound biosynthetic process,BP,NME9
7488,GO:0031648,0.563123227245599,0.803188283012575,1,38,protein destabilization,BP,ID1
9020,GO:0035196,0.563405246808148,0.802958814161696,1,38,production of miRNAs involved in gene silencing by miRNA,BP,BCDIN3D
19914,GO:2000378,0.564032343998717,0.802555953030568,1,37,negative regulation of reactive oxygen species metabolic process,BP,HK2
10297,GO:0043043,0.56409057267082,0.542327930277859,15,674,peptide biosynthetic process,BP,RGS2;HSPB1;HIST1H4L;MARS2;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;HIST1H4K;PER2;KRT17;HIST1H4D
7933,GO:0032504,0.564462991584237,0.56431619712624,10,465,multicellular organism reproduction,BP,RGS2;ZNF296;NR2F2;HOXA9;SOX9;GJB2;HSPA2;PYGO2;ING2;PHC2
3546,GO:0007569,0.564563688442953,0.709298654015925,2,86,cell aging,BP,SERPINE1;ING2
2783,GO:0006213,0.565259583651911,0.801668500874236,1,36,pyrimidine nucleoside metabolic process,BP,NME9
9866,GO:0042116,0.565359021629347,0.801364118415271,1,38,macrophage activation,BP,CLU
11443,GO:0045860,0.565447864477695,0.577737760463494,8,371,positive regulation of protein kinase activity,BP,CDK5R1;DUSP5;MAP3K14;FZD10;PAK6;GADD45B;SOCS1;CLU
5969,GO:0018393,0.566134004654274,0.661585532364905,3,134,internal peptidyl-lysine acetylation,BP,SNAI2;BRPF1;PYGO2
800,GO:0002066,0.566233869575935,0.800647227377933,1,38,columnar/cuboidal epithelial cell development,BP,HOXA5
9385,GO:0035914,0.566334303288868,0.800564815088679,1,38,skeletal muscle cell differentiation,BP,FOS
19467,GO:1990089,0.566397275354132,0.800409882696323,1,39,response to nerve growth factor,BP,ID1
19468,GO:1990090,0.566397275354132,0.800409882696323,1,39,cellular response to nerve growth factor stimulus,BP,ID1
4515,GO:0010562,0.566879640830228,0.539444229643137,15,700,positive regulation of phosphorus metabolic process,BP,HES1;CDK5R1;PTHLH;DUSP5;CTGF;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;SOX9;HSPA2;ZNF16;SOCS1;CLU
11489,GO:0045937,0.566879640830228,0.539444229643137,15,700,positive regulation of phosphate metabolic process,BP,HES1;CDK5R1;PTHLH;DUSP5;CTGF;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;SOX9;HSPA2;ZNF16;SOCS1;CLU
17887,GO:1902107,0.566935359369083,0.707067065179222,2,86,positive regulation of leukocyte differentiation,BP,FOS;SOCS1
9952,GO:0042310,0.567046997813352,0.799979338678056,1,38,vasoconstriction,BP,PER2
18852,GO:1904427,0.567129073381389,0.799911838945157,1,38,positive regulation of calcium ion transmembrane transport,BP,HSPA2
12647,GO:0050821,0.567367973563872,0.660377162388996,3,134,protein stabilization,BP,BAG3;PIK3R1;CLU
3246,GO:0006904,0.567449854635988,0.799757121215982,1,37,vesicle docking involved in exocytosis,BP,VPS18
8689,GO:0034308,0.568048353671959,0.799264212311521,1,37,primary alcohol metabolic process,BP,CYP1B1
4578,GO:0010660,0.568235688405613,0.799000235468408,1,38,regulation of muscle cell apoptotic process,BP,BAG3
3311,GO:0007015,0.568522255776734,0.595638849250535,6,282,actin filament organization,BP,ID1;CTGF;CDC42EP2;RHOD;VASP;PIK3R1
11542,GO:0046058,0.568530081063978,0.798653281709833,1,39,cAMP metabolic process,BP,PTHLH
5171,GO:0015718,0.568787842043761,0.705281956905467,2,87,monocarboxylic acid transport,BP,MFSD2A;AKR1C1
5019,GO:0015179,0.569240234453969,0.798170270970384,1,38,L-amino acid transmembrane transporter activity,MF,SLC7A5P2
10333,GO:0043122,0.569806011275855,0.629255184989866,4,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LURAP1L;HSPB1;MAP3K14;SLC20A1
10478,GO:0043367,0.569891235615403,0.797631163986254,1,38,CD4-positive, alpha-beta T cell differentiation,BP,ZBTB7B
15308,GO:0071482,0.570008303778999,0.704125594070033,2,87,cellular response to light stimulus,BP,MYC;PIK3R1
4254,GO:0009451,0.570091745858499,0.657759901616004,3,131,RNA modification,BP,METTL15;BCDIN3D;TRMT61A
10269,GO:0043005,0.570465464906157,0.532616392089219,16,756,neuron projection,CC,RGS2;CDK5R1;FLRT3;HSPB1;TNFRSF21;BAG3;CDHR1;FOS;EPHB3;SIAH2;BLOC1S3;NCDN;NR1D1;PALMD;TBCC;CLU
3285,GO:0006974,0.570532826274831,0.532570552820169,16,740,cellular response to DNA damage stimulus,BP,SNAI2;MYC;HIST1H4L;MAP3K14;RNF168;UPF1;HIST1H4B;PIK3R1;DDIT4;ING2;HIST1H4K;NACC2;HIC1;HIST1H4D;CLU;DCLRE1C
10570,GO:0043525,0.570662993369018,0.796990785940163,1,38,positive regulation of neuron apoptotic process,BP,CDK5R1
6545,GO:0021953,0.570688792733128,0.703411604479282,2,89,central nervous system neuron differentiation,BP,HES1;EPHB3
9961,GO:0042327,0.571187370862584,0.538535367300718,14,655,positive regulation of phosphorylation,BP,HES1;CDK5R1;DUSP5;CTGF;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;SOX9;HSPA2;ZNF16;SOCS1;CLU
223,GO:0000462,0.571655529661741,0.796275922659366,1,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,RRP36
15887,GO:0072595,0.571959236981731,0.795912100016629,1,38,maintenance of protein localization in organelle,BP,HK2
7378,GO:0031424,0.572173991180565,0.702138661097774,2,85,keratinization,BP,KRT16;KRT17
16666,GO:0097529,0.573063051068549,0.70129131361136,2,85,myeloid leukocyte migration,BP,SERPINE1;IL17RA
18271,GO:1903078,0.5732634900947,0.794717244972846,1,39,positive regulation of protein localization to plasma membrane,BP,PIK3R1
1348,GO:0003208,0.573996479523006,0.794002593578237,1,40,cardiac ventricle morphogenesis,BP,NOG
6293,GO:0019899,0.57404948115399,0.495213813681819,39,1826,enzyme binding,MF,HES1;CDK5R1;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;RIN2;PPP1R3D;HIST1H2AG;HSPB1;GDNF;HOXA9;TUBA4A;CDC42EP2;RHOD;FAM212B;COL1A1;TOB1;EPHB3;PAK6;SIAH2;AKIRIN2;PIK3R1;SOX9;CEBPA;FAM83A;HSPA2;BICD2;TIMP3;RIN1;RUNDC1;ARTN;NACC2;HIC1;COL1A2;NOTCH3;SOCS1;CLU
7432,GO:0031529,0.574738335934064,0.793586256144372,1,38,ruffle organization,BP,PLEKHM1
16492,GO:0097164,0.574751733248969,0.653118420754235,3,133,ammonium ion metabolic process,BP,MFSD2A;AKR1C1;PCYT1A
11856,GO:0046825,0.5757041680729,0.792667332315189,1,39,regulation of protein export from nucleus,BP,BAG3
3550,GO:0007585,0.576309931157571,0.792156393430148,1,39,respiratory gaseous exchange,BP,HOXA5
12546,GO:0050681,0.576466672113551,0.792024047840132,1,39,androgen receptor binding,MF,FHL2
1485,GO:0003779,0.576667174658453,0.58731072064522,6,291,actin binding,MF,CDK5R1;FHL3;TAGLN;VASP;CNN2;VPS18
8598,GO:0034101,0.577136445591133,0.697283742788956,2,88,erythrocyte homeostasis,BP,HOXA5;ZNF16
5612,GO:0016651,0.577344340901587,0.697266848543242,2,83,oxidoreductase activity, acting on NAD(P)H,MF,CBR1;AKR1C1
6786,GO:0030217,0.578225139574435,0.649591274231593,3,137,T cell differentiation,BP,ZFP36L2;ZBTB7B;SOCS1
15911,GO:0072666,0.578573863823831,0.790137253941002,1,40,establishment of protein localization to vacuole,BP,CLU
14996,GO:0070897,0.579119554720285,0.789775285612935,1,39,DNA-templated transcriptional preinitiation complex assembly,BP,BRF2
1306,GO:0003143,0.579256714487004,0.78955639526345,1,40,embryonic heart tube morphogenesis,BP,HES1
17353,GO:1900024,0.579608943418767,0.789358630903813,1,39,regulation of substrate adhesion-dependent cell spreading,BP,NET1
2718,GO:0006091,0.580029616125161,0.562878154802191,8,366,generation of precursor metabolites and energy,BP,MYC;PPP1R3D;CEBPA;ALDH4A1;DDIT4;NR1D1;PER2;HK2
3462,GO:0007276,0.580053941347535,0.562810988567024,8,376,gamete generation,BP,RGS2;ZNF296;HOXA9;SOX9;HSPA2;PYGO2;ING2;PHC2
12591,GO:0050732,0.580712197573168,0.788417262749959,1,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,SOCS1
3330,GO:0007041,0.580747729679058,0.693732110098709,2,90,lysosomal transport,BP,CLU;VPS18
4770,GO:0010951,0.580924177631871,0.646933495538968,3,135,negative regulation of endopeptidase activity,BP,SERPINE1;SIAH2;TIMP3
4185,GO:0009260,0.581009863593832,0.617938042532352,4,184,ribonucleotide biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
568,GO:0001707,0.581070848813097,0.788007858152871,1,40,mesoderm formation,BP,NOG
2269,GO:0005198,0.581143014100041,0.541564813133217,11,511,structural molecule activity,MF,IFFO2;TUBA4A;TUFT1;COL1A1;IMP3;MALL;KRT16;COL1A2;KRT17;IFFO1;CDC42SE1
15618,GO:0072091,0.581468997469882,0.787666954404712,1,40,regulation of stem cell proliferation,BP,SNAI2
8954,GO:0035004,0.581600884028972,0.78745607483652,1,41,phosphatidylinositol 3-kinase activity,MF,PIK3R1
2406,GO:0005575,0.581936620301599,0.5613271375441,258,11705,cellular_component,CC,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;MAT2A;GPR132;ZNF503;ID3;ZNF57;ANGPTL4;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;NOG;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;APCDD1;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;TNFRSF21;RBAK;POU3F1;MGAT1;GDNF;ZNF526;ZNF841;ZNF574;CTGF;SLC7A5P2;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;CD3EAP;SLC22A15;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;ADAMTS15;VSNL1;FAT2;COL1A1;YPEL4;TOB1;EPHB3;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ADGRF1;ZNF549;NME9;LRRC8A;CBR1;MN1;CXCL14;PAK6;ZNF570;SH3TC1;RNF39;ZNF93;SIAH2;SWT1;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;C11ORF52;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;RUNDC1;GZF1;LRRC37A;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;URB2;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;FBXL18;HIST1H4K;PALMD;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;IFFO1;SOX12;GFOD1;ZNF766;IFITM1;TBCC;ZNF701;NT5DC3;TRIM56;TMEM139;ADGRF4;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;FAM84B;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;TMEM40;ZCCHC2;VPS18;FAM217B;IRX5;CISH
734,GO:0001960,0.582082727134948,0.787243810815233,1,39,negative regulation of cytokine-mediated signaling pathway,BP,HIST1H2BJ
999,GO:0002460,0.582977007355389,0.644857580789699,3,136,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RNF168;ZBTB7B;CLU
3763,GO:0008306,0.583323384927252,0.786074210550119,1,40,associative learning,BP,FOS
13835,GO:0060415,0.583509123222582,0.785722031400466,1,42,muscle tissue morphogenesis,BP,NOG
18979,GO:1904724,0.583746628473627,0.785922273653676,1,38,tertiary granule lumen,CC,CNN2
8747,GO:0034394,0.583802468674236,0.785661388074246,1,40,protein localization to cell surface,BP,SNX33
16751,GO:0097756,0.584544682670389,0.78502074344567,1,40,negative regulation of blood vessel diameter,BP,PER2
14640,GO:0070201,0.584921510117487,0.537655086364764,11,516,regulation of establishment of protein localization,BP,HES1;CDK5R1;SLC2A1;MIDN;TNFRSF21;BAG3;IL17RA;VSNL1;NR1D1;PER2;SOCS1
8037,GO:0032677,0.585015176184275,0.784717983911203,1,39,regulation of interleukin-8 production,BP,SERPINE1
18719,GO:1904063,0.585030138711383,0.784601005978661,1,40,negative regulation of cation transmembrane transport,BP,SLC30A1
8091,GO:0032768,0.585211731853804,0.784547946755037,1,39,regulation of monooxygenase activity,BP,GDNF
4948,GO:0014910,0.585246129383248,0.784315080881742,1,41,regulation of smooth muscle cell migration,BP,SERPINE1
325,GO:0000910,0.585618211513105,0.642128513075658,3,140,cytokinesis,BP,RHOD;PAK6;SNX33
4769,GO:0010950,0.586203461048935,0.641630346755771,3,135,positive regulation of endopeptidase activity,BP,MYC;CTGF;AKIRIN2
10273,GO:0043010,0.586334125647351,0.612437774781869,4,191,camera-type eye development,BP,CYP1B1;SOX9;PYGO2;IRX5
2947,GO:0006475,0.586554060653354,0.641220682246629,3,138,internal protein amino acid acetylation,BP,SNAI2;BRPF1;PYGO2
12288,GO:0048588,0.587714497345688,0.639960437814498,3,143,developmental cell growth,BP,CDK5R1;FLRT3;SOX9
2378,GO:0005506,0.587727855678758,0.686964357308104,2,89,iron ion binding,MF,CYP1B1;FAXDC2
11753,GO:0046580,0.588058176870989,0.781870232447864,1,41,negative regulation of Ras protein signal transduction,BP,SPRY4
14810,GO:0070527,0.588270126933317,0.781785109103014,1,40,platelet aggregation,BP,HSPB1
2296,GO:0005253,0.588503096361616,0.781581657095647,1,40,anion channel activity,MF,LRRC8A
15833,GO:0072522,0.590018411180575,0.608723044402199,4,186,purine-containing compound biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
11785,GO:0046634,0.590346438835197,0.779967227361263,1,40,regulation of alpha-beta T cell activation,BP,ZBTB7B
14954,GO:0070830,0.590354139133097,0.779859899359724,1,41,bicellular tight junction assembly,BP,SNAI2
5663,GO:0016763,0.59073600646941,0.77962498079759,1,40,transferase activity, transferring pentosyl groups,MF,TIPARP
12968,GO:0051336,0.590902534024844,0.503713667816776,19,897,regulation of hydrolase activity,BP,RGS2;NET1;SERPINE1;MYC;ANGPTL4;RIN2;CTGF;FZD10;CDC42EP2;EPHB3;SIAH2;AKIRIN2;HSPA2;TIMP3;RIN1;RUNDC1;DNAJB2;RGS3;CDC42SE1
4473,GO:0010466,0.591315413720261,0.636416884001916,3,137,negative regulation of peptidase activity,BP,SERPINE1;SIAH2;TIMP3
15931,GO:0072698,0.591614074485364,0.778655146799945,1,42,protein localization to microtubule cytoskeleton,BP,CHAMP1
7030,GO:0030799,0.591879333043038,0.778517361965188,1,41,regulation of cyclic nucleotide metabolic process,BP,PTHLH
9050,GO:0035265,0.592371374282851,0.682257413860935,2,93,organ growth,BP,NOG;SOX9
8104,GO:0032784,0.592929149280064,0.777691333603781,1,40,regulation of DNA-templated transcription, elongation,BP,RNF168
11382,GO:0045739,0.593088850836888,0.777550068895325,1,40,positive regulation of DNA repair,BP,RNF168
7501,GO:0031668,0.593257497267615,0.605368214590291,4,188,cellular response to extracellular stimulus,BP,SNAI2;SLC2A1;FOS;COL1A1
13485,GO:0055006,0.593289197624363,0.777082600523033,1,43,cardiac cell development,BP,FHL2
7174,GO:0031050,0.593435110737197,0.777142049857128,1,41,dsRNA fragmentation,BP,BCDIN3D
15008,GO:0070918,0.593435110737197,0.777142049857128,1,41,production of small RNA involved in gene silencing by RNA,BP,BCDIN3D
17955,GO:1902275,0.593486439367094,0.634116379796889,3,142,regulation of chromatin organization,BP,SNAI2;PYGO2;ING2
14651,GO:0070228,0.594060789833068,0.776688987940918,1,40,regulation of lymphocyte apoptotic process,BP,TSC22D3
15197,GO:0071322,0.594138518948108,0.680604560645786,2,90,cellular response to carbohydrate stimulus,BP,VSNL1;NR1D1
11662,GO:0046390,0.594240447483211,0.604366157010188,4,187,ribose phosphate biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
6295,GO:0019901,0.594296464056738,0.527910755046061,11,526,protein kinase binding,MF,CDK5R1;HSPB1;TUBA4A;RHOD;FAM212B;TOB1;EPHB3;PIK3R1;SOX9;FAM83A;SOCS1
7698,GO:0032147,0.59444345421105,0.584004789008904,5,238,activation of protein kinase activity,BP,DUSP5;MAP3K14;PAK6;GADD45B;SOCS1
5905,GO:0018107,0.594607099689857,0.680072534751837,2,92,peptidyl-threonine phosphorylation,BP,CDK5R1;DDIT4
2103,GO:0004867,0.595520500392332,0.77539140999429,1,40,serine-type endopeptidase inhibitor activity,MF,SERPINE1
4575,GO:0010657,0.595589735018515,0.775227549479879,1,41,muscle cell apoptotic process,BP,BAG3
11273,GO:0045540,0.59574701031212,0.775087354405566,1,41,regulation of cholesterol biosynthetic process,BP,SEC14L2
75,GO:0000152,0.596178913713364,0.77480441027016,1,40,nuclear ubiquitin ligase complex,CC,PHC2
1282,GO:0003073,0.596229667047099,0.774656733570552,1,41,regulation of systemic arterial blood pressure,BP,NR2F2
5970,GO:0018394,0.596418992685629,0.631154233291602,3,140,peptidyl-lysine acetylation,BP,SNAI2;BRPF1;PYGO2
17787,GO:1901800,0.596420333562917,0.678334548934562,2,90,positive regulation of proteasomal protein catabolic process,BP,CEBPA;CLU
17054,GO:0099518,0.596575736454902,0.774250045144541,1,42,vesicle cytoskeletal trafficking,BP,BLOC1S3
2405,GO:0005548,0.596756609653755,0.774088315972322,1,42,phospholipid transporter activity,MF,MFSD2A
9199,GO:0035580,0.597206407350146,0.77388622278287,1,40,specific granule lumen,CC,CNN2
11445,GO:0045862,0.59730161726855,0.566088526535073,6,281,positive regulation of proteolysis,BP,MYC;CTGF;AKIRIN2;CEBPA;SNX33;CLU
12198,GO:0048332,0.597480708773717,0.773440046528681,1,42,mesoderm morphogenesis,BP,NOG
14788,GO:0070482,0.597783426889153,0.565566810675902,6,284,response to oxygen levels,BP,MYC;ANGPTL4;VASN;CTGF;COL1A1;DDIT4
7386,GO:0031434,0.597788590075341,0.773164013974284,1,42,mitogen-activated protein kinase kinase binding,MF,EPHB3
6546,GO:0021954,0.598089087930036,0.772894374449367,1,42,central nervous system neuron development,BP,EPHB3
10533,GO:0043467,0.598111582663166,0.676546219262539,2,93,regulation of generation of precursor metabolites and energy,BP,PPP1R3D;DDIT4
10619,GO:0043604,0.598749817372661,0.503467597105645,16,735,amide biosynthetic process,BP,RGS2;HSPB1;HIST1H4L;MARS2;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;CEBPA;HIST1H4K;PER2;KRT17;HIST1H4D
2329,GO:0005342,0.599115259692211,0.675607037721574,2,91,organic acid transmembrane transporter activity,MF,SLC7A5P2;MFSD2A
11920,GO:0046943,0.599115259692211,0.675607037721574,2,91,carboxylic acid transmembrane transporter activity,MF,SLC7A5P2;MFSD2A
12421,GO:0048857,0.599179065278472,0.772012789541661,1,41,neural nucleus development,BP,CDK5R1
16192,GO:0090199,0.600211145664797,0.771186111525104,1,40,regulation of release of cytochrome c from mitochondria,BP,CLU
9287,GO:0035722,0.601419848389432,0.770093607435178,1,40,interleukin-12-mediated signaling pathway,BP,CNN2
15214,GO:0071349,0.601419848389432,0.770093607435178,1,40,cellular response to interleukin-12,BP,CNN2
1788,GO:0004407,0.601934750772528,0.769423783303284,1,42,histone deacetylase activity,MF,NACC2
10577,GO:0043536,0.602901103459179,0.768545867934007,1,42,positive regulation of blood vessel endothelial cell migration,BP,HSPB1
15171,GO:0071277,0.602976597913247,0.768382377172824,1,43,cellular response to calcium ion,BP,FOS
6061,GO:0019205,0.603066259450093,0.768495084644196,1,41,nucleobase-containing compound kinase activity,MF,NME9
8013,GO:0032637,0.603149434338709,0.768419402165465,1,41,interleukin-8 production,BP,SERPINE1
4110,GO:0009163,0.603540049163266,0.768168394600167,1,40,nucleoside biosynthetic process,BP,NME9
712,GO:0001934,0.60384923377797,0.508611308960656,13,621,positive regulation of protein phosphorylation,BP,HES1;CDK5R1;DUSP5;CTGF;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;SOX9;HSPA2;SOCS1;CLU
11509,GO:0045981,0.604047841332801,0.767501031382056,1,42,positive regulation of nucleotide metabolic process,BP,PTHLH
17515,GO:1900544,0.604047841332801,0.767501031382056,1,42,positive regulation of purine nucleotide metabolic process,BP,PTHLH
4678,GO:0010823,0.604685669198988,0.767018420932648,1,41,negative regulation of mitochondrion organization,BP,CLU
4443,GO:0010324,0.604990032989892,0.76664008551466,1,42,membrane invagination,BP,SNX33
4863,GO:0014074,0.605448956535203,0.669123681645048,2,94,response to purine-containing compound,BP,FOS;COL1A1
7328,GO:0031333,0.60556024155239,0.669042990032275,2,93,negative regulation of protein complex assembly,BP,PMEPA1;CLU
488,GO:0001540,0.605986003261378,0.765727560368445,1,42,amyloid-beta binding,MF,CLU
766,GO:0002011,0.606308076362658,0.765244823807843,1,44,morphogenesis of an epithelial sheet,BP,FLRT3
2594,GO:0005886,0.606623777233359,0.451172536893976,60,2826,plasma membrane,CC,SPRY4;RGS2;CDK5R1;SLC2A1;NET1;SERPINE1;GPR132;FUT1;PTPRE;VASN;C1ORF116;FLRT3;HSPB1;APCDD1;TNFRSF21;CTGF;SLC7A5P2;AHNAK2;BAG3;FZD10;BRPF1;SLC20A2;HIST1H2BJ;CDHR1;CDC42EP2;IGFBP2;KCTD7;IL17RA;RHOD;SLC22A15;PCDH7;FAT2;EPHB3;SLC30A1;LRIG3;ADGRF1;LRRC8A;PLCD1;VASP;SLC2A3;SLC20A1;PIK3R1;MFSD2A;GJB2;MALL;ZMYND19;HSPA2;BICD2;STK17A;RIN1;PCYT1A;ING2;SOCS6;IFITM1;RGS3;NOTCH3;PMEPA1;FAM84B;CDC42SE1;CISH
4083,GO:0009135,0.606725375829934,0.667827554938809,2,94,purine nucleoside diphosphate metabolic process,BP,DDIT4;HK2
4122,GO:0009179,0.606725375829934,0.667827554938809,2,94,purine ribonucleoside diphosphate metabolic process,BP,DDIT4;HK2
13243,GO:0051893,0.607924630120362,0.763756144633473,1,44,regulation of focal adhesion assembly,BP,RHOD
16134,GO:0090109,0.607924630120362,0.763756144633473,1,44,regulation of cell-substrate junction assembly,BP,RHOD
275,GO:0000777,0.608908348630611,0.665669147048845,2,92,condensed chromosome kinetochore,CC,CHAMP1;HJURP
10251,GO:0042982,0.609280705269873,0.762690961735219,1,42,amyloid precursor protein metabolic process,BP,CLU
12315,GO:0048644,0.609427619280354,0.762278001717796,1,45,muscle organ morphogenesis,BP,NOG
4650,GO:0010769,0.60970903209372,0.58812648801488,4,197,regulation of cell morphogenesis involved in differentiation,BP,ID1;CDK5R1;NET1;EPHB3
7998,GO:0032611,0.609816853227645,0.762194198117146,1,42,interleukin-1 beta production,BP,HSPB1
10334,GO:0043123,0.610267548528523,0.616799637716887,3,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LURAP1L;MAP3K14;SLC20A1
14893,GO:0070671,0.610515359808105,0.761647600324566,1,41,response to interleukin-12,BP,CNN2
818,GO:0002088,0.610593319164045,0.761283988600436,1,44,lens development in camera-type eye,BP,PYGO2
10494,GO:0043388,0.610826717473352,0.761256518769919,1,42,positive regulation of DNA binding,BP,HES1
8352,GO:0033209,0.610914985787643,0.616177347476656,3,138,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF21;MAP3K14;HIST1H2BJ
8441,GO:0033558,0.610929012498756,0.761064336898095,1,43,protein deacetylase activity,MF,NACC2
17316,GO:0140098,0.611187414530878,0.53979331423358,7,330,catalytic activity, acting on RNA,MF,METTL15;MARS2;BCDIN3D;CD3EAP;POLR1D;UPF1;TRMT61A
12836,GO:0051128,0.611723765256954,0.457156073801733,38,1807,regulation of cellular component organization,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;SERTAD3;NET1;SERPINE1;MYC;FAM110C;FLRT3;CTGF;FZD10;CDC42EP2;IGFBP2;RHOD;EPHB3;HJURP;UPF1;VASP;PIK3R1;SOX9;HSPA2;BICD2;RUNDC1;SNX33;PLEKHM1;PYGO2;ING2;PALMD;DNAJB2;KRT17;HK2;PMEPA1;CLU;CDC42SE1;VPS18;CISH
14514,GO:0062012,0.611803512654635,0.53910626446501,7,337,regulation of small molecule metabolic process,BP,SNAI2;PTHLH;MIDN;PPP1R3D;SEC14L2;DDIT4;NR1D1
8599,GO:0034103,0.611950212614532,0.760112914706705,1,43,regulation of tissue remodeling,BP,PLEKHM1
7286,GO:0031267,0.612095967207199,0.521499439137376,9,446,small GTPase binding,MF,NET1;RIN2;GDNF;CDC42EP2;PAK6;BICD2;RIN1;RUNDC1;ARTN
13297,GO:0051972,0.612524487075162,0.759674206688592,1,42,regulation of telomerase activity,BP,MYC
13376,GO:0052547,0.612641366156105,0.54994028503056,6,284,regulation of peptidase activity,BP,SERPINE1;MYC;CTGF;SIAH2;AKIRIN2;TIMP3
6713,GO:0030119,0.61284408440174,0.759277918946683,1,43,AP-type membrane coat adaptor complex,CC,VPS18
12608,GO:0050771,0.613352305079308,0.758708990142468,1,44,negative regulation of axonogenesis,BP,CDK5R1
5136,GO:0015629,0.613534320318495,0.537229167357976,7,346,actin cytoskeleton,CC,IVNS1ABP;SLC2A1;FHL3;VASP;CNN2;NOTCH3;VPS18
8203,GO:0032945,0.614027450076484,0.758169327044629,1,43,negative regulation of mononuclear cell proliferation,BP,TNFRSF21
12541,GO:0050672,0.614027450076484,0.758169327044629,1,43,negative regulation of lymphocyte proliferation,BP,TNFRSF21
2787,GO:0006220,0.614612998455672,0.757820454128365,1,41,pyrimidine nucleotide metabolic process,BP,NME9
892,GO:0002260,0.616623542386187,0.755724568558932,1,43,lymphocyte homeostasis,BP,TSC22D3
5934,GO:0018208,0.616722850752145,0.75572939575757,1,42,peptidyl-proline modification,BP,FKBP9
1098,GO:0002684,0.616949838332047,0.494827547377621,13,621,positive regulation of immune system process,BP,HES1;SERPINE1;TNFRSF21;MAP3K14;FOS;IGFBP2;CXCL14;PIK3R1;NR1D1;HOXA5;ZNF16;SOCS1;CLU
775,GO:0002027,0.616995456507533,0.755278650325965,1,44,regulation of heart rate,BP,IRX5
19302,GO:1905477,0.617121239549129,0.657154763588669,2,94,positive regulation of protein localization to membrane,BP,CDK5R1;PIK3R1
11285,GO:0045582,0.617208150602909,0.755171621471701,1,43,positive regulation of T cell differentiation,BP,SOCS1
678,GO:0001885,0.617639031535632,0.754669082028159,1,44,endothelial cell development,BP,ID1
7995,GO:0032608,0.617782684025736,0.754627334855364,1,43,interferon-beta production,BP,TRIM56
13168,GO:0051726,0.617866656507727,0.471344481453376,21,1002,regulation of cell cycle,BP,ID1;HES1;CDK5R1;MYC;GPR132;ID3;SERTAD1;CTGF;MAP3K14;NR2F2;TUBA4A;ZFP36L2;TRIM35;PAK6;GADD45B;SOX9;CEBPA;SOX15;PER2;NACC2;ZNF16
2837,GO:0006305,0.617957111896859,0.75436740978426,1,44,DNA alkylation,BP,FOS
2838,GO:0006306,0.617957111896859,0.75436740978426,1,44,DNA methylation,BP,FOS
14801,GO:0070507,0.617971198890027,0.608571486299552,3,148,regulation of microtubule cytoskeleton organization,BP,RGS2;CDK5R1;BICD2
14948,GO:0070821,0.61835863717502,0.753986219414939,1,44,tertiary granule membrane,CC,SLC2A3
2403,GO:0005546,0.618424350736563,0.75401842964165,1,43,phosphatidylinositol-4,5-bisphosphate binding,MF,PLCD1
14046,GO:0060761,0.618961923515918,0.753507474109365,1,43,negative regulation of response to cytokine stimulus,BP,HIST1H2BJ
4128,GO:0009185,0.618968921960814,0.655172137562326,2,96,ribonucleoside diphosphate metabolic process,BP,DDIT4;HK2
10809,GO:0044291,0.619423867041572,0.752882233460265,1,45,cell-cell contact zone,CC,SLC2A1
2114,GO:0004896,0.619504697325652,0.752990806556651,1,43,cytokine receptor activity,MF,IL17RA
14515,GO:0062013,0.620977544307678,0.653078405960839,2,96,positive regulation of small molecule metabolic process,BP,PTHLH;NR1D1
17744,GO:1901659,0.621364656054725,0.751314447006537,1,42,glycosyl compound biosynthetic process,BP,NME9
13672,GO:0060170,0.621820266333813,0.750591077094187,1,45,ciliary membrane,CC,CDHR1
18291,GO:1903146,0.621970697518772,0.750538064158959,1,44,regulation of autophagy of mitochondrion,BP,HK2
3549,GO:0007584,0.622174501093817,0.604158234072101,3,145,response to nutrient,BP,SNAI2;IGFBP2;COL1A1
12693,GO:0050891,0.622494847735286,0.749943389328717,1,45,multicellular organismal water homeostasis,BP,KRT16
12610,GO:0050773,0.622543875859794,0.651378654258689,2,98,regulation of dendrite development,BP,ID1;CDK5R1
4345,GO:0009894,0.623043960253778,0.477911136284203,16,770,regulation of catabolic process,BP,TIPARP;CDK5R1;PPP1R3D;HSPB1;GDNF;ZFP36L2;ZKSCAN4;TOB1;UPF1;SOX9;CEBPA;TIMP3;DDIT4;SNX33;HK2;CLU
524,GO:0001618,0.623148175094166,0.749406581726333,1,44,virus receptor activity,MF,SLC20A2
17199,GO:0104005,0.623148175094166,0.749406581726333,1,44,hijacked molecular function,MF,SLC20A2
3351,GO:0007080,0.623311567244822,0.749345241529703,1,43,mitotic metaphase plate congression,BP,CHAMP1
3607,GO:0008047,0.623398105579226,0.517302290498911,8,393,enzyme activator activity,MF,RGS2;CDK5R1;RIN2;CDC42EP2;RIN1;RUNDC1;DNAJB2;RGS3
7263,GO:0031226,0.623407989689475,0.477516252866931,16,777,intrinsic component of plasma membrane,CC,SLC2A1;FUT1;FLRT3;APCDD1;TNFRSF21;SLC7A5P2;FZD10;SLC20A2;CDHR1;IL17RA;SLC22A15;PCDH7;EPHB3;SLC2A3;SLC20A1;MFSD2A
7414,GO:0031492,0.623682161422035,0.74908897354375,1,42,nucleosomal DNA binding,MF,HIST1H3J
10072,GO:0042562,0.623920630628656,0.748662304285288,1,44,hormone binding,MF,PIK3R1
5458,GO:0016328,0.623959750655026,0.748532737669074,1,45,lateral plasma membrane,CC,GJB2
3155,GO:0006754,0.624037898089262,0.649873139963776,2,96,ATP biosynthetic process,BP,DDIT4;HK2
17542,GO:1901019,0.624057084041412,0.748438807165643,1,45,regulation of calcium ion transmembrane transporter activity,BP,HSPA2
12389,GO:0048771,0.624198166004546,0.649673588632663,2,97,tissue remodeling,BP,PLEKHM1;NCDN
5566,GO:0016574,0.624839331701286,0.747682992831795,1,45,histone ubiquitination,BP,RNF168
8271,GO:0033059,0.625207470739371,0.747418884476637,1,44,cellular pigmentation,BP,BLOC1S3
10507,GO:0043406,0.625370024902194,0.571460835141011,4,197,positive regulation of MAP kinase activity,BP,DUSP5;MAP3K14;FZD10;GADD45B
12604,GO:0050767,0.62570004335014,0.500431448066848,10,497,regulation of neurogenesis,BP,ID1;HES1;CDK5R1;ID3;NOG;TNFRSF21;EPHB3;SOX9;PER2;NOTCH3
18828,GO:1904377,0.625793963418126,0.746758411076828,1,45,positive regulation of protein localization to cell periphery,BP,PIK3R1
6313,GO:0019953,0.626935017307803,0.505725712651305,9,439,sexual reproduction,BP,RGS2;ZNF296;NR2F2;HOXA9;SOX9;HSPA2;PYGO2;ING2;PHC2
6118,GO:0019359,0.626972800632607,0.646750553580547,2,97,nicotinamide nucleotide biosynthetic process,BP,DDIT4;HK2
6120,GO:0019363,0.626972800632607,0.646750553580547,2,97,pyridine nucleotide biosynthetic process,BP,DDIT4;HK2
11891,GO:0046889,0.627475509873822,0.745216615495964,1,44,positive regulation of lipid biosynthetic process,BP,NR1D1
8081,GO:0032755,0.628003093935456,0.744702355385622,1,44,positive regulation of interleukin-6 production,BP,AKIRIN2
19062,GO:1904888,0.628364847204079,0.744167432906919,1,46,cranial skeletal system development,BP,IRX5
13286,GO:0051960,0.629618310846641,0.490581358325406,11,547,regulation of nervous system development,BP,ID1;HES1;CDK5R1;ID3;NOG;FLRT3;TNFRSF21;EPHB3;SOX9;PER2;NOTCH3
4947,GO:0014909,0.630069740367829,0.742497951970032,1,46,smooth muscle cell migration,BP,SERPINE1
3276,GO:0006955,0.630463249214242,0.449857477861105,26,1231,immune response,BP,TNFRSF21;MAP3K14;HIST1H2BJ;TRIM35;FOS;RNF168;CDC42EP2;HIST1H2BI;COL1A1;CXCL14;AKIRIN2;ZBTB7B;SLC2A3;PIK3R1;CNN2;HIST1H2BE;KRT16;NR1D1;HIST2H2BE;TRIM26;COL1A2;IFITM1;TRIM56;SOCS1;CLU;DCLRE1C
5506,GO:0016445,0.630490842076197,0.742173816199255,1,45,somatic diversification of immunoglobulins,BP,RNF168
11205,GO:0045321,0.630534494350459,0.469965045435227,16,768,leukocyte activation,BP,HES1;TNFRSF21;MAP3K14;ZFP36L2;RNF168;IGFBP2;ZNF3;LRRC8A;ZBTB7B;SLC2A3;PIK3R1;CNN2;SOCS6;SOCS1;CLU;DCLRE1C
10398,GO:0043226,0.631124858328535,0.429376567032069,214,9783,organelle,CC,ID1;TIPARP;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;NET1;TXNIP;SERPINE1;MYC;ZNF503;ID3;ZNF57;CYP1B1;HR;FAM110C;IFFO2;HES2;FUT1;PTPRE;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;ZNF557;HIST1H2AG;ZNF750;HSPB1;ZNF419;ZNF296;HIST1H4L;FHL2;ZNF222;LGALS7B;ZNF561;RBAK;POU3F1;MGAT1;ZNF526;ZNF841;ZNF574;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;TIGD5;BRPF1;NR2F2;MARS2;SLC20A2;ZNF696;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;TRIM35;CDHR1;ZNF398;CHAMP1;FOS;ZNF256;FHL3;RNF168;ZNF416;CDC42EP2;IGFBP2;RHOD;FAM212B;CD3EAP;RBM15;HIST1H2BI;PCDH7;FOXQ1;ZNF3;ZKSCAN4;POLR1D;FAT2;COL1A1;YPEL4;TOB1;SLC30A1;ZNF200;HIST1H3J;TLE3;LRIG3;HIST1H2AB;ZNF549;NME9;CBR1;CXCL14;PAK6;ZNF570;ZNF93;SIAH2;SWT1;HJURP;PLCD1;UPF1;AKIRIN2;ZBTB7B;ESRP2;BLOC1S3;GADD45B;ZNF581;SEC14L2;VASP;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;ZNF776;SOX9;ERF;TRMT61A;CEBPA;CNN2;GJB2;ZNF530;C11ORF52;MALL;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;ZNF780A;JRK;STK17A;ZNF275;RIN1;AKR1C1;DDIT4;GZF1;SNX33;PLEKHM1;ZNF160;TGIF1;HIST1H2BE;ZNF169;ZNF783;KRT16;URB2;SOX15;PCYT1A;PYGO2;CIPC;NR1D1;FKBP9;ING2;ZNF589;HIST1H1C;HOXA5;PHC2;HIST1H1D;HIST1H4K;ZADH2;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;KRT17;IFFO1;SOX12;ZNF766;TBCC;ZNF701;ZNF845;ZNF510;SERTAD4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;KLF16;SOCS1;CLU;HIST1H2AH;ZNF14;CDC42SE1;DCLRE1C;VPS18;FAM217B;IRX5
10202,GO:0042803,0.631237826591483,0.488886954375442,11,530,protein homodimerization activity,MF,ID1;HES1;NOG;FLRT3;HSPB1;GDNF;NR2F2;ZBTB7B;CEBPA;PCYT1A;NACC2
14886,GO:0070664,0.631332915298306,0.741345586977871,1,45,negative regulation of leukocyte proliferation,BP,TNFRSF21
5271,GO:0015914,0.63236912984374,0.740233876118428,1,46,phospholipid transport,BP,MFSD2A
18399,GO:1903391,0.632457146108008,0.740060865346288,1,47,regulation of adherens junction organization,BP,RHOD
10866,GO:0044380,0.632941396082062,0.739581991753631,1,47,protein localization to cytoskeleton,BP,CHAMP1
2061,GO:0004812,0.633069259750937,0.739725905082508,1,44,aminoacyl-tRNA ligase activity,MF,MARS2
5734,GO:0016875,0.633069259750937,0.739725905082508,1,44,ligase activity, forming carbon-oxygen bonds,MF,MARS2
9856,GO:0042100,0.63332497461445,0.739378615082394,1,45,B cell proliferation,BP,TNFRSF21
9281,GO:0035710,0.633504169288513,0.739201147572833,1,45,CD4-positive, alpha-beta T cell activation,BP,ZBTB7B
10547,GO:0043491,0.634357200411059,0.590972689954931,3,150,protein kinase B signaling,BP,FAM110C;PIK3R1;SOX9
2951,GO:0006479,0.634462895450651,0.590874448664984,3,149,protein methylation,BP,PYGO2;HIST1H1C;HIST1H1D
3705,GO:0008213,0.634462895450651,0.590874448664984,3,149,protein alkylation,BP,PYGO2;HIST1H1C;HIST1H1D
3201,GO:0006835,0.63488595599283,0.737739217211421,1,46,dicarboxylic acid transport,BP,PER2
8698,GO:0034330,0.635191653315292,0.560747478610119,4,205,cell junction organization,BP,SNAI2;RHOD;VASP;GJB2
10726,GO:0044057,0.635438165108506,0.540330193880656,5,252,regulation of system process,BP,RGS2;TNFRSF21;CTGF;PER2;IRX5
18464,GO:1903533,0.63641463917493,0.636720310989167,2,96,regulation of protein targeting,BP,HES1;CDK5R1
7017,GO:0030705,0.636512994514561,0.588596298508249,3,152,cytoskeleton-dependent intracellular transport,BP,HSPB1;BLOC1S3;BICD2
12914,GO:0051247,0.636548276719992,0.446371011833339,24,1150,positive regulation of protein metabolic process,BP,TIPARP;HES1;SNAI2;CDK5R1;MYC;DUSP5;HSPB1;CTGF;MAP3K14;FZD10;BCDIN3D;EPHB3;PAK6;AKIRIN2;GADD45B;IMP3;SOX9;CEBPA;HSPA2;SNX33;ING2;KRT17;SOCS1;CLU
7629,GO:0032024,0.636978293453896,0.735743142517544,1,45,positive regulation of insulin secretion,BP,VSNL1
3581,GO:0007626,0.637594332595653,0.635297577864665,2,101,locomotory behavior,BP,GDNF;CIART
3212,GO:0006855,0.638020405003318,0.734608104596979,1,46,drug transmembrane transport,BP,PER2
12796,GO:0051058,0.638082966629781,0.73445793874444,1,47,negative regulation of small GTPase mediated signal transduction,BP,SPRY4
14177,GO:0061045,0.63842480344056,0.73420216458599,1,46,negative regulation of wound healing,BP,SERPINE1
20301,GO:2001244,0.63877256830883,0.734039862503901,1,44,positive regulation of intrinsic apoptotic signaling pathway,BP,NACC2
8888,GO:0034702,0.639236377474657,0.633525049654528,2,101,ion channel complex,CC,LRRC8A;HSPA2
1860,GO:0004520,0.639355259859662,0.733358066893632,1,45,endodeoxyribonuclease activity,MF,DCLRE1C
8971,GO:0035050,0.63938999220178,0.733143761874905,1,47,embryonic heart tube development,BP,HES1
13501,GO:0055024,0.639611552475133,0.732920520124317,1,47,regulation of cardiac muscle tissue development,BP,NOG
13495,GO:0055017,0.639631185855757,0.732900731170484,1,47,cardiac muscle tissue growth,BP,NOG
10158,GO:0042733,0.639865419268289,0.732664559168352,1,47,embryonic digit morphogenesis,BP,NOG
11079,GO:0045071,0.640060175858605,0.732647738074137,1,45,negative regulation of viral genome replication,BP,IFITM1
174,GO:0000380,0.640618675804609,0.731992031678276,1,46,alternative mRNA splicing, via spliceosome,BP,ESRP2
4970,GO:0015075,0.641327511961352,0.490185415529962,9,445,ion transmembrane transporter activity,MF,SLC2A1;SLC7A5P2;SLC20A2;SLC22A15;SLC30A1;LRRC8A;SLC2A3;SLC20A1;MFSD2A
6612,GO:0022804,0.642448621252447,0.552835460305786,4,202,active transmembrane transporter activity,MF,SLC7A5P2;SLC20A2;SLC20A1;MFSD2A
15836,GO:0072525,0.64324287921339,0.62920664442501,2,100,pyridine-containing compound biosynthetic process,BP,DDIT4;HK2
15499,GO:0071840,0.643302621057574,0.405068487076161,103,4811,cellular component organization or biogenesis,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;SERTAD3;SLC2A1;NET1;SERPINE1;MYC;MAT2A;ANGPTL4;CYP1B1;HR;FAM110C;NOG;FLRT3;HIST1H2AG;METTL15;KCTD15;HIST1H4L;GDNF;CTGF;AHNAK2;TFCP2L1;FZD10;BRPF1;TUBA4A;SURF6;HIST1H2BJ;PHF13;CDHR1;CHAMP1;FHL3;RNF168;CDC42EP2;IGFBP2;KCTD7;RHOD;HIST1H2BI;ZKSCAN4;COL1A1;EPHB3;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;LRRC8A;PAK6;SIAH2;HJURP;UPF1;BLOC1S3;VASP;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;CNN2;GJB2;MALL;KCTD1;HSPA2;BICD2;HIST1H2BO;AKR1C1;RUNDC1;SNX33;PLEKHM1;HIST1H2BE;ARTN;KRT16;URB2;SOX15;PYGO2;NCDN;ING2;HIST1H1C;HIST1H1D;HIST1H4K;PALMD;RRP36;PER2;BRF2;DNAJB2;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;KRT17;SOX12;TBCC;HIST1H4D;HK2;PMEPA1;TSPYL4;CLU;HIST1H2AH;CDC42SE1;DCLRE1C;VPS18;CISH
13923,GO:0060560,0.643328578837024,0.581071583547614,3,156,developmental growth involved in morphogenesis,BP,CDK5R1;FLRT3;SOX9
3226,GO:0006879,0.644506774379497,0.728042150257441,1,46,cellular iron ion homeostasis,BP,MYC
20295,GO:2001238,0.644529750809748,0.728018682722976,1,46,positive regulation of extrinsic apoptotic signaling pathway,BP,TIMP3
7427,GO:0031519,0.64557201664669,0.726863403417841,1,47,PcG protein complex,CC,PHC2
18552,GO:1903725,0.645619493174717,0.726814756635676,1,47,regulation of phospholipid metabolic process,BP,PIK3R1
17552,GO:1901068,0.645871006767189,0.726646179770744,1,46,guanosine-containing compound metabolic process,BP,NME9
6708,GO:0030104,0.646139718995455,0.726195732398462,1,48,water homeostasis,BP,KRT16
2937,GO:0006458,0.646668948022431,0.725827238464946,1,46,'de novo' protein folding,BP,HSPA2
18246,GO:1903034,0.646859885456518,0.625253085210013,2,100,regulation of response to wounding,BP,SERPINE1;SOX15
18258,GO:1903052,0.646962550361175,0.625170863448374,2,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,CEBPA;CLU
15157,GO:0071248,0.64722676348213,0.624850555533056,2,100,cellular response to metal ion,BP,FOS;CEBPA
6764,GO:0030193,0.647772488314109,0.724691682827974,1,46,regulation of blood coagulation,BP,SERPINE1
17369,GO:1900046,0.647772488314109,0.724691682827974,1,46,regulation of hemostasis,BP,SERPINE1
906,GO:0002285,0.647903958970928,0.624106817748074,2,100,lymphocyte activation involved in immune response,BP,RNF168;ZBTB7B
8017,GO:0032642,0.648286201173611,0.724161886695377,1,46,regulation of chemokine production,BP,SNAI2
3697,GO:0008203,0.648483336099914,0.623469752024913,2,100,cholesterol metabolic process,BP,SEC14L2;CEBPA
1393,GO:0003300,0.649104185548215,0.722978459959155,1,50,cardiac muscle hypertrophy,BP,RGS2
4940,GO:0014897,0.649104185548215,0.722978459959155,1,50,striated muscle hypertrophy,BP,RGS2
13521,GO:0055076,0.649417768468745,0.62247130639491,2,99,transition metal ion homeostasis,BP,MYC;SLC30A1
508,GO:0001570,0.65007293404974,0.722053772047929,1,49,vasculogenesis,BP,TIPARP
3780,GO:0008333,0.650899027947256,0.721278537019858,1,48,endosome to lysosome transport,BP,VPS18
4360,GO:0009953,0.650904599745934,0.721272742491728,1,48,dorsal/ventral pattern formation,BP,NOG
9897,GO:0042176,0.650965291601202,0.508360080918177,6,300,regulation of protein catabolic process,BP,TIPARP;SOX9;CEBPA;TIMP3;SNX33;CLU
6865,GO:0030330,0.652120514142152,0.619424377402726,2,101,DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;HIC1
16822,GO:0098657,0.652298597904039,0.471674817262881,10,500,import into cell,BP,SERPINE1;RIN2;GDNF;SLC30A1;PIK3R1;RIN1;SNX33;PER2;CLU;CDC42SE1
5161,GO:0015696,0.652368732423856,0.719833964484478,1,47,ammonium transport,BP,GDNF
8276,GO:0033077,0.653483572485713,0.718581095729299,1,48,T cell differentiation in thymus,BP,ZFP36L2
18360,GO:1903311,0.653758066611536,0.520174718675017,5,251,regulation of mRNA metabolic process,BP,HSPB1;GDNF;ZFP36L2;TOB1;UPF1
7858,GO:0032414,0.654014807426347,0.717940514476761,1,49,positive regulation of ion transmembrane transporter activity,BP,HSPA2
4791,GO:0010977,0.654139581372993,0.617124859741501,2,103,negative regulation of neuron projection development,BP,ID1;CDK5R1
10732,GO:0044070,0.654431635228027,0.717586789374024,1,48,regulation of anion transport,BP,PER2
5324,GO:0016043,0.654570299893882,0.393792301793904,98,4602,cellular component organization,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;SERTAD3;SLC2A1;NET1;SERPINE1;MYC;MAT2A;ANGPTL4;CYP1B1;HR;FAM110C;NOG;FLRT3;HIST1H2AG;KCTD15;HIST1H4L;GDNF;CTGF;AHNAK2;TFCP2L1;FZD10;BRPF1;TUBA4A;HIST1H2BJ;PHF13;CDHR1;CHAMP1;FHL3;RNF168;CDC42EP2;IGFBP2;KCTD7;RHOD;HIST1H2BI;ZKSCAN4;COL1A1;EPHB3;HIST1H3J;TLE3;HIST1H2AB;ADGRF1;LRRC8A;PAK6;SIAH2;HJURP;UPF1;BLOC1S3;VASP;HIST1H4B;PIK3R1;SOX9;CEBPA;CNN2;GJB2;MALL;KCTD1;HSPA2;BICD2;HIST1H2BO;AKR1C1;RUNDC1;SNX33;PLEKHM1;HIST1H2BE;ARTN;KRT16;SOX15;PYGO2;NCDN;ING2;HIST1H1C;HIST1H1D;HIST1H4K;PALMD;PER2;BRF2;DNAJB2;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;KRT17;SOX12;TBCC;HIST1H4D;HK2;PMEPA1;TSPYL4;CLU;HIST1H2AH;CDC42SE1;DCLRE1C;VPS18;CISH
6056,GO:0019199,0.654977111815641,0.716848981014986,1,50,transmembrane receptor protein kinase activity,MF,EPHB3
4556,GO:0010634,0.655018406400497,0.616146633844947,2,103,positive regulation of epithelial cell migration,BP,HSPB1;SOX9
11302,GO:0045604,0.655701830461922,0.716250554436701,1,48,regulation of epidermal cell differentiation,BP,HES1
4555,GO:0010633,0.655944687099466,0.715910363232311,1,49,negative regulation of epithelial cell migration,BP,NR2F2
10445,GO:0043297,0.656031396719168,0.715818894399743,1,49,apical junction assembly,BP,SNAI2
5686,GO:0016796,0.656140097601373,0.715788413006789,1,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,DCLRE1C
907,GO:0002286,0.656361867197114,0.715554349568103,1,48,T cell activation involved in immune response,BP,ZBTB7B
11797,GO:0046651,0.656406130359696,0.566611984700938,3,151,lymphocyte proliferation,BP,HES1;TNFRSF21;IGFBP2
6676,GO:0030032,0.656905697765674,0.714895381747114,1,49,lamellipodium assembly,BP,RHOD
8924,GO:0034764,0.657411415356725,0.61344616439532,2,104,positive regulation of transmembrane transport,BP,PIK3R1;HSPA2
4939,GO:0014896,0.657667026577903,0.713930303113838,1,51,muscle hypertrophy,BP,RGS2
7324,GO:0031329,0.659048193984078,0.445771662359402,14,692,regulation of cellular catabolic process,BP,CDK5R1;PPP1R3D;HSPB1;GDNF;ZFP36L2;ZKSCAN4;TOB1;UPF1;CEBPA;TIMP3;DDIT4;SNX33;HK2;CLU
14146,GO:0060998,0.65923144389875,0.712346380866746,1,50,regulation of dendritic spine development,BP,CDK5R1
13005,GO:0051403,0.660369383571654,0.532856630966832,4,205,stress-activated MAPK cascade,BP,MYC;CTGF;FZD10;GADD45B
8201,GO:0032943,0.660901012232588,0.561530173405022,3,152,mononuclear cell proliferation,BP,HES1;TNFRSF21;IGFBP2
2397,GO:0005539,0.661037139892063,0.609403011125943,2,103,glycosaminoglycan binding,MF,CTGF;ADAMTS15
4771,GO:0010952,0.661137524521627,0.561279170929985,3,151,positive regulation of peptidase activity,BP,MYC;CTGF;AKIRIN2
3800,GO:0008375,0.661233787948609,0.710376024371668,1,48,acetylglucosaminyltransferase activity,MF,MGAT1
12076,GO:0048015,0.661266866911401,0.609115428408348,2,104,phosphatidylinositol-mediated signaling,BP,PIK3R1;SOX9
5664,GO:0016765,0.661910004965545,0.709740889332288,1,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,MAT2A
6201,GO:0019674,0.661910767746435,0.709650936968253,1,48,NAD metabolic process,BP,HK2
3178,GO:0006796,0.66203946490611,0.398242852880495,48,2289,phosphate-containing compound metabolic process,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;PTHLH;MIDN;MYC;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;GDNF;CTGF;MAP3K14;FZD10;NR2F2;ZFP36L2;FAM212B;EPHB3;NME9;PAK6;PLCD1;GADD45B;SLC20A1;PIK3R1;MFSD2A;SOX9;CEBPA;HSPA2;TIMP3;STK17A;DDIT4;ARTN;PCYT1A;ZNF16;SOCS6;NT5DC3;RGS3;HK2;PMEPA1;SOCS1;CLU;CISH
7190,GO:0031072,0.66216851270115,0.608155980677845,2,102,heat shock protein binding,MF,HSPA2;DNAJB2
5936,GO:0018210,0.662206710671168,0.608054892723282,2,104,peptidyl-threonine modification,BP,CDK5R1;DDIT4
10084,GO:0042581,0.66226208187009,0.608050306842404,2,102,specific granule,CC,SLC2A3;CNN2
12925,GO:0051258,0.662467359868927,0.53047954307639,4,206,protein polymerization,BP,RGS2;CDK5R1;CDC42EP2;VASP
16174,GO:0090181,0.662800163720071,0.708610611554232,1,49,regulation of cholesterol metabolic process,BP,SEC14L2
5014,GO:0015171,0.663211649433875,0.708168045525086,1,49,amino acid transmembrane transporter activity,MF,SLC7A5P2
8024,GO:0032652,0.66325820734806,0.708203701150486,1,48,regulation of interleukin-1 production,BP,HSPB1
2618,GO:0005925,0.663393381340042,0.482952566709637,7,355,focal adhesion,CC,SPRY4;FLRT3;HSPB1;FHL2;FHL3;VASP;CNN2
6912,GO:0030496,0.663921361831957,0.558042521968263,3,156,midbody,CC,SLC2A1;CHAMP1;URB2
3444,GO:0007254,0.664244931286324,0.557674779118413,3,156,JNK cascade,BP,CTGF;FZD10;GADD45B
2717,GO:0006090,0.664331164838077,0.605650603844008,2,104,pyruvate metabolic process,BP,DDIT4;HK2
1099,GO:0002685,0.664583290751217,0.605452707539941,2,101,regulation of leukocyte migration,BP,SERPINE1;CXCL14
4444,GO:0010332,0.665527624193928,0.705584948426751,1,50,response to gamma radiation,BP,MYC
9360,GO:0035869,0.665611699420947,0.705576657680298,1,49,ciliary transition zone,CC,TBCC
10633,GO:0043627,0.66576410832294,0.705411516799156,1,49,response to estrogen,BP,IGFBP2
12335,GO:0048678,0.666029636072608,0.705123640935871,1,49,response to axon injury,BP,FLRT3
10641,GO:0043647,0.666093261379143,0.704971733479479,1,50,inositol phosphate metabolic process,BP,PLCD1
15390,GO:0071621,0.666094274027194,0.705139907118648,1,48,granulocyte chemotaxis,BP,IL17RA
4034,GO:0009064,0.666183852652667,0.704956347627856,1,49,glutamine family amino acid metabolic process,BP,ALDH4A1
2617,GO:0005924,0.666418539857898,0.479568084552257,7,356,cell-substrate adherens junction,CC,SPRY4;FLRT3;HSPB1;FHL2;FHL3;VASP;CNN2
7862,GO:0032418,0.666861695542533,0.704220180304691,1,49,lysosome localization,BP,PLEKHM1
8369,GO:0033260,0.667569493830569,0.703450004845689,1,49,nuclear DNA replication,BP,UPF1
7182,GO:0031060,0.667594655880772,0.703259469103821,1,51,regulation of histone methylation,BP,PYGO2
14185,GO:0061053,0.667850023754447,0.702904228072833,1,52,somite development,BP,NOG
4554,GO:0010632,0.668020592812719,0.55332388359652,3,159,regulation of epithelial cell migration,BP,HSPB1;NR2F2;SOX9
18311,GO:1903201,0.668262063305451,0.702694938327501,1,49,regulation of oxidative stress-induced cell death,BP,HSPB1
11428,GO:0045833,0.669550054880976,0.701286863216147,1,49,negative regulation of lipid metabolic process,BP,SNAI2
13837,GO:0060419,0.669755321410922,0.700897987397705,1,51,heart growth,BP,NOG
18086,GO:1902652,0.669854014827172,0.599354422043788,2,104,secondary alcohol metabolic process,BP,SEC14L2;CEBPA
920,GO:0002312,0.670097622643564,0.700602993850333,1,50,B cell activation involved in immune response,BP,RNF168
6014,GO:0019058,0.670215088889,0.501642127853424,5,256,viral life cycle,BP,SLC20A2;TRIM35;TRIM26;IFITM1;VPS18
12644,GO:0050818,0.670673307554559,0.700054778978934,1,49,regulation of coagulation,BP,SERPINE1
6705,GO:0030100,0.67187991239059,0.54891244801077,3,158,regulation of endocytosis,BP,SERPINE1;SNX33;CLU
16273,GO:0090316,0.671955503746277,0.548840884808373,3,157,positive regulation of intracellular protein transport,BP,HES1;CDK5R1;BAG3
12801,GO:0051082,0.672006902570413,0.596940719328699,2,102,unfolded protein binding,MF,HSPA2;DNAJB2
17290,GO:0140013,0.672586432531509,0.596214696356228,2,104,meiotic nuclear division,BP,HSPA2;ING2
8926,GO:0034766,0.673383441122138,0.696900742732071,1,51,negative regulation of ion transmembrane transport,BP,SLC30A1
1787,GO:0004402,0.673856398310962,0.696376699678261,1,51,histone acetyltransferase activity,MF,BRPF1
2908,GO:0006418,0.674038660566911,0.696340313617071,1,49,tRNA aminoacylation for protein translation,BP,MARS2
2733,GO:0006110,0.674069532820634,0.696062255562189,1,52,regulation of glycolytic process,BP,DDIT4
277,GO:0000779,0.674187918469937,0.594366820390012,2,104,condensed chromosome, centromeric region,CC,CHAMP1;HJURP
362,GO:0000980,0.67518046874915,0.69490595089774,1,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,GZF1
3440,GO:0007249,0.675200926761626,0.515959343951573,4,207,I-kappaB kinase/NF-kappaB signaling,BP,LURAP1L;HSPB1;MAP3K14;SLC20A1
11855,GO:0046824,0.675495902950051,0.694476440421699,1,52,positive regulation of nucleocytoplasmic transport,BP,BAG3
17019,GO:0099106,0.676147440854,0.693828441085098,1,51,ion channel regulator activity,MF,SLC30A1
8199,GO:0032940,0.676609412486529,0.412575522799845,19,936,secretion by cell,BP,SLC2A1;MIDN;SERPINE1;TNFRSF21;GDNF;CTGF;TUBA4A;IL17RA;PCDH7;VSNL1;SLC30A1;SLC2A3;CNN2;TIMP3;NR1D1;PER2;SOCS1;CLU;VPS18
6691,GO:0030055,0.676627756271696,0.468065369613654,7,360,cell-substrate junction,CC,SPRY4;FLRT3;HSPB1;FHL2;FHL3;VASP;CNN2
12078,GO:0048017,0.676636565887297,0.591445989364153,2,107,inositol lipid-mediated signaling,BP,PIK3R1;SOX9
12206,GO:0048365,0.676650895800618,0.693187733193781,1,52,Rac GTPase binding,MF,PAK6
15910,GO:0072665,0.678060131776025,0.691609744123911,1,52,protein localization to vacuole,BP,CLU
7758,GO:0032270,0.678184076531033,0.404970764207805,22,1080,positive regulation of cellular protein metabolic process,BP,HES1;SNAI2;CDK5R1;MYC;DUSP5;CTGF;MAP3K14;FZD10;BCDIN3D;EPHB3;PAK6;AKIRIN2;GADD45B;IMP3;SOX9;CEBPA;HSPA2;SNX33;ING2;KRT17;SOCS1;CLU
2605,GO:0005901,0.678212582011998,0.691362811621356,1,53,caveola,CC,SLC2A1
16307,GO:0090398,0.678623035127823,0.691056638137039,1,51,cellular senescence,BP,ING2
5468,GO:0016358,0.678641239033047,0.541017982172787,3,163,dendrite development,BP,ID1;CDK5R1;EPHB3
10554,GO:0043502,0.678909169534675,0.690580067387672,1,53,regulation of muscle adaptation,BP,RGS2
893,GO:0002262,0.679390821791297,0.588266999261917,2,106,myeloid cell homeostasis,BP,HOXA5;ZNF16
15764,GO:0072341,0.680638448537185,0.688785960531946,1,51,modified amino acid binding,MF,PLCD1
7877,GO:0032434,0.680827728512413,0.586615630084881,2,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,CEBPA;CLU
5267,GO:0015908,0.681716957108497,0.687486097582988,1,52,fatty acid transport,BP,MFSD2A
5077,GO:0015297,0.6827510121892,0.686312415031448,1,52,antiporter activity,MF,SLC7A5P2
3553,GO:0007589,0.682895636986988,0.686147992415436,1,52,body fluid secretion,BP,HK2
13733,GO:0060284,0.683282730992136,0.431802406199579,11,570,regulation of cell development,BP,ID1;HES1;CDK5R1;NET1;ID3;NOG;TNFRSF21;EPHB3;SOX9;PER2;NOTCH3
648,GO:0001836,0.684194385864751,0.68483169101721,1,50,release of cytochrome c from mitochondria,BP,CLU
13004,GO:0051402,0.685299312425702,0.533279882015341,3,160,neuron apoptotic process,BP,CDK5R1;TNFRSF21;GDNF
19481,GO:1990138,0.685842274412978,0.580528954369588,2,112,neuron projection extension,BP,CDK5R1;FLRT3
18414,GO:1903426,0.685847354002765,0.682777710974041,1,52,regulation of reactive oxygen species biosynthetic process,BP,CLU
6837,GO:0030295,0.68587804894252,0.682742517636554,1,52,protein kinase activator activity,MF,CDK5R1
11312,GO:0045621,0.686508914033177,0.682018531108208,1,52,positive regulation of lymphocyte differentiation,BP,SOCS1
7991,GO:0032602,0.688043590212469,0.680332716106281,1,51,chemokine production,BP,SNAI2
14436,GO:0061733,0.688093252373464,0.680117048583605,1,53,peptide-lysine-N-acetyltransferase activity,MF,BRPF1
3947,GO:0008637,0.690134658073877,0.575623006260901,2,105,apoptotic mitochondrial changes,BP,HK2;CLU
3477,GO:0007338,0.690780695295416,0.677082542823929,1,52,single fertilization,BP,HOXA9
18182,GO:1902930,0.691219913259495,0.676493462348655,1,53,regulation of alcohol biosynthetic process,BP,SEC14L2
7279,GO:0031256,0.692146374041207,0.573030816607934,2,112,leading edge membrane,CC,SPRY4;VASP
15535,GO:0071902,0.692505734438182,0.475927431924232,5,265,positive regulation of protein serine/threonine kinase activity,BP,CDK5R1;DUSP5;MAP3K14;FZD10;GADD45B
3177,GO:0006793,0.692690902915111,0.365107565768627,49,2360,phosphorus metabolic process,BP,ID1;SPRY4;RGS2;HES1;CDK5R1;DUSP4;PTHLH;MIDN;MYC;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;MGAT1;GDNF;CTGF;MAP3K14;FZD10;NR2F2;ZFP36L2;FAM212B;EPHB3;NME9;PAK6;PLCD1;GADD45B;SLC20A1;PIK3R1;MFSD2A;SOX9;CEBPA;HSPA2;TIMP3;STK17A;DDIT4;ARTN;PCYT1A;ZNF16;SOCS6;NT5DC3;RGS3;HK2;PMEPA1;SOCS1;CLU;CISH
7487,GO:0031647,0.692723313609922,0.495516022294437,4,213,regulation of protein stability,BP,ID1;BAG3;PIK3R1;CLU
14947,GO:0070820,0.69338715445003,0.571649814612952,2,108,tertiary granule,CC,SLC2A3;CNN2
15054,GO:0070988,0.693709378480628,0.673436926667437,1,55,demethylation,BP,HR
7042,GO:0030811,0.693973777444587,0.673126813879448,1,55,regulation of nucleotide catabolic process,BP,DDIT4
9543,GO:0036293,0.694044249895281,0.474137873127618,5,264,response to decreased oxygen levels,BP,MYC;ANGPTL4;VASN;CTGF;DDIT4
5560,GO:0016567,0.694051892867517,0.407128355437512,14,706,protein ubiquitination,BP,HIST1H2BJ;RNF168;HIST1H2BI;SIAH2;HIST1H2BO;HIST1H2BE;FBXL12;FBXL18;PER2;DNAJB2;SOCS6;TRIM56;SOCS1;CISH
4661,GO:0010803,0.694079436117009,0.673230397926162,1,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,HIST1H2BJ
12789,GO:0051051,0.695265401844715,0.472709474044114,5,264,negative regulation of transport,BP,MIDN;TNFRSF21;VSNL1;SLC30A1;SNX33
2945,GO:0006473,0.695461559139236,0.521212603089528,3,162,protein acetylation,BP,SNAI2;BRPF1;PYGO2
8160,GO:0032886,0.695558884621716,0.52103856456329,3,166,regulation of microtubule-based process,BP,RGS2;CDK5R1;BICD2
17049,GO:0099513,0.696145224605972,0.429098201439814,9,472,polymeric cytoskeletal fiber,CC,CDK5R1;FAM110C;IFFO2;TUBA4A;KRT16;KRT17;IFFO1;TBCC;VPS18
10295,GO:0043039,0.696154884214876,0.670788488859805,1,52,tRNA aminoacylation,BP,MARS2
4532,GO:0010594,0.696221480712556,0.568160523501929,2,111,regulation of endothelial cell migration,BP,HSPB1;NR2F2
14219,GO:0061134,0.696756522089945,0.56759507261652,2,108,peptidase regulator activity,MF,SERPINE1;TIMP3
1476,GO:0003730,0.697054324303016,0.669570220223857,1,54,mRNA 3'-UTR binding,MF,ZFP36L2
16241,GO:0090277,0.697286938323038,0.669371234087816,1,53,positive regulation of peptide hormone secretion,BP,VSNL1
4560,GO:0010638,0.697504100537027,0.421230615274937,10,516,positive regulation of organelle organization,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;CTGF;CDC42EP2;VASP;ING2;HK2
2207,GO:0005089,0.699742725226151,0.666096483898144,1,58,Rho guanyl-nucleotide exchange factor activity,MF,NET1
7358,GO:0031396,0.700383565612264,0.515311957758849,3,162,regulation of protein ubiquitination,BP,SIAH2;PER2;DNAJB2
2977,GO:0006518,0.701509333219702,0.392545973140483,16,785,peptide metabolic process,BP,RGS2;HSPB1;HIST1H4L;MARS2;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;HIST1H4K;PER2;KRT17;HIST1H4D;CLU
12963,GO:0051310,0.701741780683841,0.663986843715082,1,54,metaphase plate congression,BP,CHAMP1
10034,GO:0042475,0.701892522141471,0.663660084148916,1,56,odontogenesis of dentin-containing tooth,BP,SERPINE1
9198,GO:0035579,0.701927002470132,0.663690373098084,1,55,specific granule membrane,CC,SLC2A3
6372,GO:0021549,0.702096406437738,0.663415390423047,1,56,cerebellum development,BP,CDK5R1
8602,GO:0034109,0.70256586268296,0.662923197899877,1,55,homotypic cell-cell adhesion,BP,HSPB1
10294,GO:0043038,0.70292138410546,0.662647505756825,1,53,amino acid activation,BP,MARS2
11783,GO:0046632,0.703022861812447,0.66237356506752,1,55,alpha-beta T cell differentiation,BP,ZBTB7B
5710,GO:0016835,0.703059194643756,0.662481716245613,1,53,carbon-oxygen lyase activity,MF,L3HYPDH
16233,GO:0090263,0.703283736790417,0.55960938729918,2,110,positive regulation of canonical Wnt signaling pathway,BP,COL1A1;JRK
6911,GO:0030490,0.703426138002366,0.662039960829819,1,53,maturation of SSU-rRNA,BP,RRP36
13264,GO:0051928,0.703551879874792,0.661736432795948,1,55,positive regulation of calcium ion transport,BP,HSPA2
4205,GO:0009311,0.703954588980106,0.66132545799082,1,54,oligosaccharide metabolic process,BP,SLC2A1
13189,GO:0051781,0.704482347412974,0.660613505742975,1,55,positive regulation of cell division,BP,ZNF16
18027,GO:1902495,0.704616845368061,0.557873779471967,2,114,transmembrane transporter complex,CC,LRRC8A;HSPA2
3265,GO:0006936,0.705602538332277,0.508904280952546,3,169,muscle contraction,BP,RGS2;GDNF;CTGF
11898,GO:0046903,0.7056985013312,0.378423415306715,20,1001,secretion,BP,SLC2A1;MIDN;SERPINE1;TNFRSF21;GDNF;CTGF;TUBA4A;IL17RA;PCDH7;VSNL1;SLC30A1;SLC2A3;CNN2;TIMP3;NR1D1;PER2;HK2;SOCS1;CLU;VPS18
10438,GO:0043280,0.705786199690346,0.556568456013869,2,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,MYC;CTGF
16103,GO:0090068,0.707940442694556,0.477352065335796,4,219,positive regulation of cell cycle process,BP,CDK5R1;CTGF;SOX15;ZNF16
10692,GO:0043966,0.7087269963054,0.655453403828877,1,55,histone H3 acetylation,BP,BRPF1
12972,GO:0051341,0.708802874413464,0.655360598103451,1,55,regulation of oxidoreductase activity,BP,GDNF
8830,GO:0034605,0.709044795854524,0.552445377123071,2,113,cellular response to heat,BP,BAG3;HSPA2
6883,GO:0030374,0.70976197390974,0.654042584108572,1,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1
9701,GO:0038095,0.709966777814518,0.551382341301777,2,110,Fc-epsilon receptor signaling pathway,BP,FOS;PIK3R1
11772,GO:0046620,0.710146488719853,0.653570587432088,1,57,regulation of organ growth,BP,NOG
4756,GO:0010927,0.71016375605862,0.653352384514407,1,60,cellular component assembly involved in morphogenesis,BP,AHNAK2
10557,GO:0043507,0.710184652024774,0.653523713552626,1,57,positive regulation of JUN kinase activity,BP,FZD10
7502,GO:0031669,0.710456936566786,0.503016920575483,3,167,cellular response to nutrient levels,BP,SNAI2;SLC2A1;COL1A1
14794,GO:0070491,0.710881129134974,0.652737880729738,1,56,repressing transcription factor binding,MF,MYC
7999,GO:0032612,0.711591460535255,0.651936079867143,1,55,interleukin-1 production,BP,HSPB1
15481,GO:0071806,0.711826263146635,0.651722462034271,1,54,protein transmembrane transport,BP,CLU
12624,GO:0050792,0.712397451707924,0.500682383469335,3,164,regulation of viral process,BP,TRIM35;TRIM26;IFITM1
11475,GO:0045921,0.713494874424158,0.649509555197082,1,56,positive regulation of exocytosis,BP,VSNL1
17513,GO:1900542,0.714330141202747,0.545822960719654,2,115,regulation of purine nucleotide metabolic process,BP,PTHLH;DDIT4
4130,GO:0009187,0.714514564902537,0.648103980816777,1,58,cyclic nucleotide metabolic process,BP,PTHLH
19758,GO:2000106,0.714841155068682,0.647837379390367,1,56,regulation of leukocyte apoptotic process,BP,TSC22D3
11481,GO:0045927,0.715182144712591,0.497159442549612,3,171,positive regulation of growth,BP,TFCP2L1;SOX15;KRT17
2622,GO:0005938,0.715724923721357,0.467867262825301,4,227,cell cortex,CC,SLC2A1;FAM110C;CTGF;RHOD
5799,GO:0017038,0.715949417308832,0.496268060327345,3,167,protein import,BP,TXNIP;SNX33;CLU
16101,GO:0090066,0.716054368678235,0.433598548975636,6,327,regulation of anatomical structure size,BP,RGS2;CDK5R1;CDC42EP2;LRRC8A;VASP;PER2
7080,GO:0030864,0.716064705815801,0.646105549526927,1,59,cortical actin cytoskeleton,CC,SLC2A1
20008,GO:2000573,0.716621489185588,0.64561626088368,1,56,positive regulation of DNA biosynthetic process,BP,MYC
12173,GO:0048278,0.716700529948024,0.645517390595008,1,56,vesicle docking,BP,VPS18
6930,GO:0030518,0.716765201160816,0.542771673746445,2,115,intracellular steroid hormone receptor signaling pathway,BP,FHL2;PMEPA1
17498,GO:1900407,0.717208284993118,0.644881722363191,1,56,regulation of cellular response to oxidative stress,BP,HSPB1
17292,GO:0140029,0.717360453158759,0.644691041676517,1,56,exocytic process,BP,VPS18
8753,GO:0034404,0.717622521304659,0.494200232953856,3,167,nucleobase-containing small molecule biosynthetic process,BP,NME9;DDIT4;HK2
18247,GO:1903035,0.717716241564505,0.644173351852088,1,57,negative regulation of response to wounding,BP,SERPINE1
3625,GO:0008081,0.718137580466296,0.643644348157306,1,57,phosphoric diester hydrolase activity,MF,PLCD1
8156,GO:0032879,0.718300117402864,0.346625358393129,34,1692,regulation of localization,BP,HES1;SNAI2;CDK5R1;SLC2A1;MIDN;SERPINE1;CYP1B1;FAM110C;NOG;HSPB1;TNFRSF21;GDNF;BAG3;NR2F2;KCTD7;IL17RA;RHOD;VSNL1;COL1A1;SLC30A1;CXCL14;PIK3R1;SOX9;HSPA2;RUNDC1;SNX33;KRT16;NR1D1;PER2;IFITM1;HK2;SOCS1;CLU;VPS18
8264,GO:0033043,0.719173155735342,0.36336718331381,20,1019,regulation of organelle organization,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;MYC;CTGF;FZD10;CDC42EP2;RHOD;UPF1;VASP;PIK3R1;BICD2;RUNDC1;PYGO2;ING2;HK2;CLU;VPS18
610,GO:0001776,0.719545932853187,0.641871517404022,1,57,leukocyte homeostasis,BP,TSC22D3
11167,GO:0045216,0.719555170747691,0.491709779214403,3,174,cell-cell junction organization,BP,SNAI2;RHOD;GJB2
10993,GO:0044786,0.719860422969697,0.641474667847844,1,57,cell cycle DNA replication,BP,UPF1
10496,GO:0043393,0.720939653594074,0.490055852994454,3,169,regulation of protein binding,BP,ID1;NOG;DNAJB2
12320,GO:0048661,0.721178623962312,0.639737836857036,1,58,positive regulation of smooth muscle cell proliferation,BP,NOTCH3
16667,GO:0097530,0.721376516943809,0.639628627616711,1,56,granulocyte migration,BP,IL17RA
3334,GO:0007045,0.721744273311247,0.638888145442255,1,60,cell-substrate adherens junction assembly,BP,RHOD
12097,GO:0048041,0.721744273311247,0.638888145442255,1,60,focal adhesion assembly,BP,RHOD
12787,GO:0051049,0.721987923861282,0.356615884474373,22,1116,regulation of transport,BP,HES1;CDK5R1;SLC2A1;MIDN;SERPINE1;TNFRSF21;GDNF;BAG3;KCTD7;IL17RA;VSNL1;SLC30A1;PIK3R1;HSPA2;RUNDC1;SNX33;NR1D1;PER2;HK2;SOCS1;CLU;VPS18
1709,GO:0004222,0.722086247539639,0.638586087046231,1,58,metalloendopeptidase activity,MF,ADAMTS15
17615,GO:1901264,0.722110487870924,0.638697158960361,1,56,carbohydrate derivative transport,BP,MFSD2A
15223,GO:0071359,0.722281529379266,0.638337890287185,1,58,cellular response to dsRNA,BP,BCDIN3D
982,GO:0002433,0.723726452882923,0.636497142265499,1,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R1
9702,GO:0038096,0.723726452882923,0.636497142265499,1,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R1
13784,GO:0060348,0.723841503125605,0.533723942171132,2,119,bone development,BP,COL1A1;SOX9
4238,GO:0009416,0.724303546571504,0.457407784537341,4,223,response to light stimulus,BP,MYC;FOS;PIK3R1;PER2
12945,GO:0051289,0.725159936381989,0.634663456843939,1,58,protein homotetramerization,BP,VASP
6065,GO:0019209,0.725187746692103,0.634627808167264,1,58,kinase activator activity,MF,CDK5R1
4366,GO:0009967,0.725328138446959,0.354597705981464,21,1065,positive regulation of signal transduction,BP,HES1;CYP1B1;FAM110C;DUSP5;LURAP1L;CTGF;MAP3K14;FZD10;COL1A1;TOB1;EPHB3;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;ING2;NACC2;HIC1;SOCS1
12760,GO:0051015,0.72586220168237,0.531098466344603,2,121,actin filament binding,MF,CDK5R1;TAGLN
5300,GO:0015980,0.726052893756535,0.45530717530829,4,217,energy derivation by oxidation of organic compounds,BP,MYC;PPP1R3D;NR1D1;PER2
7059,GO:0030833,0.726375350791651,0.530559184723558,2,116,regulation of actin filament polymerization,BP,CDC42EP2;VASP
13262,GO:0051924,0.726879448879855,0.529889046316114,2,117,regulation of calcium ion transport,BP,SLC30A1;HSPA2
7359,GO:0031397,0.727578102299963,0.631553117383812,1,58,negative regulation of protein ubiquitination,BP,PER2
4076,GO:0009127,0.727719533739966,0.528835661127308,2,116,purine nucleoside monophosphate biosynthetic process,BP,DDIT4;HK2
4115,GO:0009168,0.727719533739966,0.528835661127308,2,116,purine ribonucleoside monophosphate biosynthetic process,BP,DDIT4;HK2
3190,GO:0006814,0.72780730168157,0.528651168621174,2,119,sodium ion transport,BP,SLC20A2;SLC20A1
19915,GO:2000379,0.727910296944797,0.631124152774194,1,58,positive regulation of reactive oxygen species metabolic process,BP,CLU
9826,GO:0042035,0.72827406907584,0.630653943858583,1,58,regulation of cytokine biosynthetic process,BP,HSPB1
20253,GO:2001169,0.729084433569846,0.629470473357568,1,60,regulation of ATP biosynthetic process,BP,DDIT4
18384,GO:1903364,0.729443177732192,0.526618755457713,2,116,positive regulation of cellular protein catabolic process,BP,CEBPA;CLU
135,GO:0000281,0.729521610962693,0.628903300493308,1,60,mitotic cytokinesis,BP,SNX33
7109,GO:0030901,0.729710550903693,0.628724014210427,1,59,midbrain development,BP,HES1
10552,GO:0043500,0.729855037613281,0.628470251004168,1,60,muscle adaptation,BP,RGS2
12607,GO:0050770,0.72998342274879,0.525804442570455,2,121,regulation of axonogenesis,BP,CDK5R1;EPHB3
9700,GO:0038094,0.73008236202027,0.628240872436044,1,59,Fc-gamma receptor signaling pathway,BP,PIK3R1
11021,GO:0044853,0.730419041853858,0.627672823724207,1,61,plasma membrane raft,CC,SLC2A1
6263,GO:0019843,0.730641704671809,0.627725902302969,1,56,rRNA binding,MF,IMP3
99,GO:0000209,0.730670603458935,0.430243503702042,5,276,protein polyubiquitination,BP,RNF168;SIAH2;FBXL12;FBXL18;TRIM56
11258,GO:0045454,0.730861626827747,0.627366037930985,1,57,cell redox homeostasis,BP,NME9
2868,GO:0006360,0.731245051617188,0.62672671195919,1,59,transcription by RNA polymerase I,BP,CD3EAP
3118,GO:0006695,0.731531021254957,0.626353521429438,1,59,cholesterol biosynthetic process,BP,SEC14L2
8265,GO:0033044,0.731553849100283,0.429136067327807,5,280,regulation of chromosome organization,BP,SNAI2;MYC;UPF1;PYGO2;ING2
1595,GO:0004004,0.731557498699777,0.626318952849086,1,59,ATP-dependent RNA helicase activity,MF,UPF1
3326,GO:0007034,0.731587169611836,0.523778407952916,2,119,vacuolar transport,BP,CLU;VPS18
18254,GO:1903046,0.73262133818925,0.522486376778728,2,117,meiotic cell cycle process,BP,HSPA2;ING2
4488,GO:0010507,0.732746808181632,0.62469703813096,1,60,negative regulation of autophagy,BP,ZKSCAN4
16228,GO:0090257,0.73307717169692,0.521824123165104,2,120,regulation of muscle system process,BP,RGS2;CTGF
6576,GO:0022037,0.733356216568167,0.623833532869433,1,61,metencephalon development,BP,CDK5R1
7935,GO:0032507,0.733489964544836,0.623657933559995,1,61,maintenance of protein location in cell,BP,HK2
8660,GO:0034212,0.733594504171815,0.623585002320797,1,60,peptide N-acetyltransferase activity,MF,BRPF1
8236,GO:0033002,0.733621784928344,0.521163709664427,2,118,muscle cell proliferation,BP,NOG;NOTCH3
4278,GO:0009636,0.734156955229324,0.41183913759647,6,326,response to toxic substance,BP,NET1;TXNIP;CYP1B1;FOS;COL1A1;SLC30A1
14732,GO:0070374,0.734563417081301,0.519939005865366,2,118,positive regulation of ERK1 and ERK2 cascade,BP,CTGF;EPHB3
17742,GO:1901657,0.735148808502345,0.519249950984186,2,115,glycosyl compound metabolic process,BP,NME9;AKR1C1
3438,GO:0007229,0.7354142944301,0.621061465479049,1,62,integrin-mediated signaling pathway,BP,CTGF
6898,GO:0030426,0.735423841898719,0.518748047497973,2,121,growth cone,CC,CDK5R1;FLRT3
10970,GO:0044728,0.736265700592029,0.619998337115984,1,61,DNA methylation or demethylation,BP,FOS
2747,GO:0006140,0.737090064037255,0.516594206000684,2,120,regulation of nucleotide metabolic process,BP,PTHLH;DDIT4
3683,GO:0008186,0.737440271074388,0.618505769885024,1,60,RNA-dependent ATPase activity,MF,UPF1
17706,GO:1901570,0.737645277613629,0.618300518630314,1,59,fatty acid derivative biosynthetic process,BP,CBR1
1471,GO:0003724,0.737649332781399,0.618228037488973,1,60,RNA helicase activity,MF,UPF1
18087,GO:1902653,0.737675871118824,0.618192770085578,1,60,secondary alcohol biosynthetic process,BP,SEC14L2
1929,GO:0004620,0.737964338603138,0.617809244616193,1,60,phospholipase activity,MF,PLCD1
8930,GO:0034774,0.738508879392358,0.43975171518631,4,222,secretory granule lumen,CC,SERPINE1;CNN2;TIMP3;CLU
3589,GO:0008013,0.739467233533224,0.61561685763785,1,63,beta-catenin binding,MF,SOX9
3796,GO:0008361,0.739669891464169,0.513141618048762,2,123,regulation of cell size,BP,CDK5R1;LRRC8A
17083,GO:0099568,0.740595976588873,0.403917329843047,6,340,cytoplasmic region,CC,SLC2A1;FAM110C;HSPB1;CTGF;RHOD;BLOC1S3
12289,GO:0048589,0.74086266725659,0.392734491499676,7,396,developmental growth,BP,CDK5R1;NOG;FLRT3;SOX9;SOX15;PYGO2;HOXA5
10430,GO:0043270,0.741664103816327,0.510580632946445,2,120,positive regulation of ion transport,BP,GDNF;HSPA2
19523,GO:1990351,0.741880406403738,0.510249248486731,2,122,transporter complex,CC,LRRC8A;HSPA2
15152,GO:0071241,0.742210293599464,0.509858783716075,2,120,cellular response to inorganic substance,BP,FOS;CEBPA
6630,GO:0022857,0.742322968004141,0.369143408979294,10,536,transmembrane transporter activity,MF,SLC2A1;SLC7A5P2;SLC20A2;SLC22A15;SLC30A1;LRRC8A;SLC2A3;SLC20A1;MFSD2A;GJB2
3569,GO:0007613,0.743888663776315,0.609670803875646,1,63,memory,BP,ADGRF1
289,GO:0000793,0.744472253314117,0.460101887367256,3,176,condensed chromosome,CC,CHAMP1;HJURP;HSPA2
8141,GO:0032838,0.745180457982181,0.505873481797577,2,122,plasma membrane bounded cell projection cytoplasm,CC,HSPB1;BLOC1S3
12369,GO:0048738,0.74555132914352,0.505314033884772,2,125,cardiac muscle tissue development,BP,NOG;FHL2
17317,GO:0140101,0.745911775260914,0.505017086779242,2,117,catalytic activity, acting on a tRNA,MF,MARS2;TRMT61A
2214,GO:0005102,0.746053820004619,0.339312294086786,17,883,signaling receptor binding,MF,CDK5R1;PTHLH;SERPINE1;FLRT3;FHL2;GDNF;CTGF;CDC42EP2;IGFBP2;IL17RA;TOB1;CXCL14;PIK3R1;ARTN;KRT17;SOCS1;CLU
3247,GO:0006906,0.746076290942393,0.504703191456467,2,121,vesicle fusion,BP,RUNDC1;VPS18
4857,GO:0014066,0.746182962563731,0.606616913886395,1,62,regulation of phosphatidylinositol 3-kinase signaling,BP,SOX9
10511,GO:0043410,0.746398282551323,0.396804291704444,6,336,positive regulation of MAPK cascade,BP,DUSP5;CTGF;MAP3K14;FZD10;EPHB3;GADD45B
10182,GO:0042770,0.746497690663614,0.504141261665636,2,121,signal transduction in response to DNA damage,BP,SNAI2;HIC1
12115,GO:0048145,0.746804016416348,0.605770014348973,1,62,regulation of fibroblast proliferation,BP,MYC
17764,GO:1901698,0.747356871189162,0.346217523725394,14,741,response to nitrogen compound,BP,ID1;CDK5R1;SLC2A1;PTPRE;CTGF;BCDIN3D;FOS;COL1A1;PIK3R1;SOX9;GJB2;COL1A2;SOCS1;CISH
980,GO:0002431,0.747591775606027,0.604693579096334,1,62,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R1
1027,GO:0002526,0.748874594867369,0.602999469012215,1,61,acute inflammatory response,BP,CLU
274,GO:0000776,0.748938415902012,0.500876970817049,2,121,kinetochore,CC,CHAMP1;HJURP
4191,GO:0009266,0.749165750072448,0.453991260820166,3,177,response to temperature stimulus,BP,BAG3;FOS;HSPA2
13486,GO:0055007,0.749258662809479,0.602227160308552,1,65,cardiac muscle cell differentiation,BP,FHL2
2427,GO:0005604,0.749454165822336,0.601846917342757,1,67,basement membrane,CC,TIMP3
1874,GO:0004536,0.74952537913836,0.602105066658954,1,61,deoxyribonuclease activity,MF,DCLRE1C
6899,GO:0030427,0.749606547004184,0.499891772819397,2,125,site of polarized growth,CC,CDK5R1;FLRT3
12895,GO:0051219,0.749860237358413,0.601457595852107,1,64,phosphoprotein binding,MF,PIK3R1
20224,GO:2001056,0.750037741574036,0.49944796817,2,119,positive regulation of cysteine-type endopeptidase activity,BP,MYC;CTGF
13246,GO:0051896,0.75005914750869,0.49932743366541,2,123,regulation of protein kinase B signaling,BP,FAM110C;PIK3R1
17716,GO:1901606,0.750716045811559,0.600464265974241,1,61,alpha-amino acid catabolic process,BP,ALDH4A1
17263,GO:0120032,0.750856161236289,0.498255408667575,2,123,regulation of plasma membrane bounded cell projection assembly,BP,CDC42EP2;PLEKHM1
6299,GO:0019905,0.75202824181249,0.59852246984785,1,63,syntaxin binding,MF,VPS18
7363,GO:0031401,0.752358370336717,0.337299883683456,15,790,positive regulation of protein modification process,BP,HES1;SNAI2;CDK5R1;DUSP5;CTGF;MAP3K14;FZD10;EPHB3;PAK6;GADD45B;SOX9;HSPA2;ING2;SOCS1;CLU
12114,GO:0048144,0.752362087808104,0.598059532286585,1,63,fibroblast proliferation,BP,MYC
6936,GO:0030534,0.752766893432931,0.59737841259827,1,65,adult behavior,BP,GDNF
6729,GO:0030136,0.75332353051555,0.494903356217185,2,124,clathrin-coated vesicle,CC,MALL;VPS18
18159,GO:1902882,0.75354137219685,0.596483186713648,1,62,regulation of response to oxidative stress,BP,HSPB1
7339,GO:0031345,0.753769444958662,0.494299713155342,2,124,negative regulation of cell projection organization,BP,ID1;CDK5R1
11583,GO:0046128,0.754152473442798,0.59563173421932,1,62,purine ribonucleoside metabolic process,BP,NME9
7676,GO:0032101,0.75500423588923,0.366949810836119,8,439,regulation of response to external stimulus,BP,SNAI2;SERPINE1;HSPB1;IL17RA;CXCL14;ARTN;SOX15;CLU
2863,GO:0006354,0.755079414471221,0.4925904731408,2,121,DNA-templated transcription, elongation,BP,RNF168;CD3EAP
10406,GO:0043235,0.75548280353557,0.445609627945092,3,185,receptor complex,CC,EPHB3;NT5DC3;NOTCH3
8157,GO:0032880,0.755841366374545,0.339700754722076,13,692,regulation of protein localization,BP,HES1;CDK5R1;SLC2A1;MIDN;TNFRSF21;BAG3;IL17RA;VSNL1;PIK3R1;SNX33;NR1D1;PER2;SOCS1
10439,GO:0043281,0.75605868003683,0.444959657304047,3,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,MYC;CTGF;SIAH2
4235,GO:0009411,0.756617978299141,0.490452429165444,2,123,response to UV,BP,MYC;PIK3R1
18600,GO:1903829,0.758388739376798,0.395601297313618,5,288,positive regulation of cellular protein localization,BP,HES1;CDK5R1;BAG3;PIK3R1;SNX33
18720,GO:1904064,0.758626492254274,0.589167608549784,1,65,positive regulation of cation transmembrane transport,BP,HSPA2
3670,GO:0008168,0.758713678464108,0.441434559263615,3,177,methyltransferase activity,MF,METTL15;BCDIN3D;TRMT61A
16686,GO:0097581,0.758829890121468,0.58888004119218,1,65,lamellipodium organization,BP,RHOD
11873,GO:0046854,0.758889544113759,0.588738194031764,1,66,phosphatidylinositol phosphorylation,BP,PIK3R1
18662,GO:1903955,0.759590295981855,0.587924043658761,1,63,positive regulation of protein targeting to mitochondrion,BP,HES1
6928,GO:0030516,0.760009603099025,0.587095288819179,1,67,regulation of axon extension,BP,CDK5R1
2973,GO:0006513,0.760326422905226,0.586758891594613,1,65,protein monoubiquitination,BP,RNF168
12437,GO:0048878,0.760823973593226,0.337620140389055,12,647,chemical homeostasis,BP,MYC;ANGPTL4;KCTD7;VSNL1;SLC30A1;PIK3R1;CEBPA;MALL;AKR1C1;KRT16;NR1D1;HK2
2610,GO:0005912,0.761167201285598,0.359384043331931,8,447,adherens junction,CC,SPRY4;FLRT3;HSPB1;FHL2;FHL3;FAT2;VASP;CNN2
2703,GO:0006066,0.761233322213814,0.41061202766223,4,234,alcohol metabolic process,BP,CYP1B1;PLCD1;SEC14L2;CEBPA
11664,GO:0046394,0.761911147867651,0.391121419008524,5,287,carboxylic acid biosynthetic process,BP,CBR1;DDIT4;NR1D1;PER2;HK2
18269,GO:1903076,0.7630319240554,0.582900228745044,1,65,regulation of protein localization to plasma membrane,BP,PIK3R1
9847,GO:0042089,0.763059472214564,0.582920486517498,1,64,cytokine biosynthetic process,BP,HSPB1
13691,GO:0060205,0.763222128918247,0.408056375498991,4,230,cytoplasmic vesicle lumen,CC,SERPINE1;CNN2;TIMP3;CLU
7663,GO:0032088,0.763232426594248,0.582672755801825,1,64,negative regulation of NF-kappaB transcription factor activity,BP,CYP1B1
16991,GO:0099023,0.764373708911714,0.580975005430059,1,65,tethering complex,CC,VPS18
19738,GO:2000058,0.764395161151622,0.479747592240293,2,124,regulation of ubiquitin-dependent protein catabolic process,BP,CEBPA;CLU
5331,GO:0016053,0.764639322257497,0.387626395739094,5,288,organic acid biosynthetic process,BP,CBR1;DDIT4;NR1D1;PER2;HK2
12633,GO:0050804,0.764751343653028,0.433313234805694,3,183,modulation of chemical synaptic transmission,BP,GDNF;SLC30A1;NCDN
17036,GO:0099177,0.764751343653028,0.433313234805694,3,183,regulation of trans-synaptic signaling,BP,GDNF;SLC30A1;NCDN
10576,GO:0043535,0.765254188390131,0.579649391463256,1,66,regulation of blood vessel endothelial cell migration,BP,HSPB1
959,GO:0002377,0.765359179230436,0.579556125031873,1,65,immunoglobulin production,BP,RNF168
9935,GO:0042278,0.765400192852517,0.579556924917406,1,64,purine nucleoside metabolic process,BP,NME9
4112,GO:0009165,0.765411232454344,0.405164955857188,4,234,nucleotide biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
6757,GO:0030175,0.765451122459884,0.579254346883293,1,68,filopodium,CC,VASP
10676,GO:0043903,0.765961923841443,0.431737909516068,3,179,regulation of symbiosis, encompassing mutualism through parasitism,BP,TRIM35;TRIM26;IFITM1
16168,GO:0090174,0.766000261579022,0.477477575614867,2,126,organelle membrane fusion,BP,RUNDC1;VPS18
4113,GO:0009166,0.766020974963513,0.477448791067301,2,126,nucleotide catabolic process,BP,DDIT4;HK2
7607,GO:0031983,0.766210725424768,0.404143241617216,4,231,vesicle lumen,CC,SERPINE1;CNN2;TIMP3;CLU
13518,GO:0055072,0.766897617207473,0.577332730373042,1,65,iron ion homeostasis,BP,MYC
8923,GO:0034763,0.767112928819127,0.576962463950237,1,66,negative regulation of transmembrane transport,BP,SLC30A1
8036,GO:0032675,0.767443651739837,0.576541126653721,1,65,regulation of interleukin-6 production,BP,AKIRIN2
12576,GO:0050715,0.767471197568665,0.576501158345973,1,65,positive regulation of cytokine secretion,BP,IL17RA
14858,GO:0070603,0.767624857426621,0.576163244131967,1,67,SWI/SNF superfamily-type complex,CC,NACC2
9861,GO:0042107,0.76849182835753,0.575017924899262,1,65,cytokine metabolic process,BP,HSPB1
241,GO:0000502,0.768584489540858,0.575005481287014,1,63,proteasome complex,CC,HSPB1
1454,GO:0003684,0.76872626172429,0.574618163450037,1,66,damaged DNA binding,MF,DCLRE1C
10652,GO:0043679,0.768815917266401,0.574487554628959,1,66,axon terminus,CC,FLRT3
3451,GO:0007264,0.769599306665345,0.348953632474138,8,457,small GTPase mediated signal transduction,BP,SPRY4;NET1;RIN2;CDC42EP2;RHOD;PAK6;SIAH2;COL1A2
13962,GO:0060627,0.769600168908554,0.367726464906695,6,346,regulation of vesicle-mediated transport,BP,SERPINE1;VSNL1;RUNDC1;SNX33;CLU;VPS18
12586,GO:0050727,0.769850059901834,0.426474617817481,3,181,regulation of inflammatory response,BP,SERPINE1;IL17RA;CLU
288,GO:0000792,0.770028922277206,0.572717014586437,1,66,heterochromatin,CC,PHC2
8373,GO:0033267,0.770046882628911,0.399010172732891,4,243,axon part,CC,CDK5R1;FLRT3;HSPB1;BLOC1S3
290,GO:0000794,0.770167709819065,0.572457219270409,1,67,condensed nuclear chromosome,CC,HSPA2
8701,GO:0034333,0.770868472895642,0.57132217383453,1,69,adherens junction assembly,BP,RHOD
6682,GO:0030041,0.771037763624492,0.470418461766045,2,127,actin filament polymerization,BP,CDC42EP2;VASP
12957,GO:0051303,0.771517189336728,0.570535872200296,1,66,establishment of chromosome localization,BP,CHAMP1
17844,GO:1901989,0.771763795234519,0.570173513981496,1,66,positive regulation of cell cycle phase transition,BP,ZNF16
6214,GO:0019725,0.771950223980905,0.333473994424126,10,549,cellular homeostasis,BP,MYC;KCTD7;VSNL1;SLC30A1;NME9;LRRC8A;UPF1;PIK3R1;NR1D1;HK2
5188,GO:0015748,0.77275718553797,0.568654077380798,1,67,organophosphate ester transport,BP,MFSD2A
15838,GO:0072527,0.772799284086513,0.568707861405384,1,65,pyrimidine-containing compound metabolic process,BP,NME9
4427,GO:0010243,0.773268920171314,0.322687295482521,12,656,response to organonitrogen compound,BP,ID1;SLC2A1;PTPRE;CTGF;FOS;COL1A1;PIK3R1;SOX9;GJB2;COL1A2;SOCS1;CISH
2534,GO:0005788,0.773424462073929,0.421567841837863,3,186,endoplasmic reticulum lumen,CC,COL1A1;CES2;COL1A2
4104,GO:0009156,0.773539297170138,0.466895286401177,2,127,ribonucleoside monophosphate biosynthetic process,BP,DDIT4;HK2
19253,GO:1905369,0.773879479438547,0.567173372013524,1,64,endopeptidase complex,CC,HSPB1
11782,GO:0046631,0.774013963080619,0.566797548801219,1,67,alpha-beta T cell activation,BP,ZBTB7B
17621,GO:1901293,0.774307613159726,0.39342520201205,4,237,nucleoside phosphate biosynthetic process,BP,PTHLH;NME9;DDIT4;HK2
12810,GO:0051091,0.774342502015208,0.420340960864326,3,184,positive regulation of DNA binding transcription factor activity,BP,ADGRF1;TRIM26;CLU
19300,GO:1905475,0.774438929495502,0.465623604673835,2,127,regulation of protein localization to membrane,BP,CDK5R1;PIK3R1
6589,GO:0022412,0.775211436215903,0.419132698225368,3,186,cellular process involved in reproduction in multicellular organism,BP,HSPA2;PYGO2;ING2
10512,GO:0043412,0.775945734756836,0.268850595220438,66,3240,macromolecule modification,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;MYC;HR;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;METTL15;HSPB1;MGAT1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;RNF168;KCTD7;FAM212B;HIST1H2BI;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;TRMT61A;CEBPA;HSPA2;HIST1H2BO;TIMP3;STK17A;DDIT4;HIST1H2BE;ARTN;FBXL12;PYGO2;FKBP9;ING2;HIST1H1C;HIST1H1D;FBXL18;PER2;DNAJB2;NACC2;SOCS6;TRIM56;RGS3;PMEPA1;SOCS1;CLU;CISH
12838,GO:0051130,0.775949900683433,0.304434829981715,17,910,positive regulation of cellular component organization,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;NET1;SERPINE1;FLRT3;CTGF;CDC42EP2;EPHB3;VASP;SOX9;PLEKHM1;ING2;HK2;CLU
7974,GO:0032580,0.776123569024622,0.563665335603443,1,67,Golgi cisterna membrane,CC,FUT1
12446,GO:0050000,0.776270568530455,0.563446334317859,1,67,chromosome localization,BP,CHAMP1
12886,GO:0051196,0.776717648514312,0.562669907642033,1,69,regulation of coenzyme metabolic process,BP,DDIT4
733,GO:0001959,0.77772375876933,0.46093838602596,2,128,regulation of cytokine-mediated signaling pathway,BP,HIST1H2BJ;SOCS1
18185,GO:1902936,0.778225830889081,0.560468245572383,1,68,phosphatidylinositol bisphosphate binding,MF,PLCD1
18367,GO:1903321,0.778398625688573,0.560264981609221,1,67,negative regulation of protein modification by small protein conjugation or removal,BP,PER2
4569,GO:0010647,0.778478324191317,0.292179056567277,22,1150,positive regulation of cell communication,BP,HES1;CYP1B1;FAM110C;DUSP5;LURAP1L;CTGF;MAP3K14;FZD10;VSNL1;COL1A1;TOB1;EPHB3;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;ING2;NACC2;HIC1;SOCS1
11349,GO:0045664,0.778518403062435,0.346040675192515,7,409,regulation of neuron differentiation,BP,ID1;HES1;CDK5R1;ID3;EPHB3;SOX9;NOTCH3
11897,GO:0046902,0.778553185733467,0.560090676753827,1,66,regulation of mitochondrial membrane permeability,BP,HK2
14399,GO:0061640,0.779999865559303,0.557747295663452,1,69,cytoskeleton-dependent cytokinesis,BP,SNX33
16365,GO:0090630,0.780097339692175,0.557547570528683,1,70,activation of GTPase activity,BP,RUNDC1
10326,GO:0043112,0.780246003648188,0.45729342109022,2,130,receptor metabolic process,BP,NR1D1;HOXA5
6608,GO:0022625,0.780776665686562,0.556927590025801,1,63,cytosolic large ribosomal subunit,CC,SURF6
2434,GO:0005615,0.780973019406178,0.268443332798455,49,2408,extracellular space,CC,PTHLH;SLC2A1;IRF2BPL;SERPINE1;ANGPTL4;NOG;VASN;C1ORF116;FLRT3;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;CTGF;SLC20A2;TUBA4A;HIST1H2BJ;IGFBP2;HIST1H2BI;ADAMTS15;FAT2;COL1A1;HIST1H3J;LRIG3;HIST1H2AB;CBR1;CXCL14;PLCD1;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;HSPA2;TIMP3;AKR1C1;HIST1H2BE;ARTN;KRT16;HIST1H4K;CES2;HIST2H2BE;COL1A2;KRT17;HIST1H4D;CLU;HIST1H2AH
3920,GO:0008585,0.781531857191786,0.55543276825878,1,69,female gonad development,BP,TIPARP
6119,GO:0019362,0.782429838884999,0.454156878882892,2,130,pyridine nucleotide metabolic process,BP,DDIT4;HK2
11713,GO:0046496,0.782429838884999,0.454156878882892,2,130,nicotinamide nucleotide metabolic process,BP,DDIT4;HK2
2943,GO:0006470,0.783064558996467,0.381680416075077,4,244,protein dephosphorylation,BP,DUSP4;PTPRE;DUSP5;PPP1R3D
8927,GO:0034767,0.783398779535341,0.552544518957712,1,70,positive regulation of ion transmembrane transport,BP,HSPA2
5651,GO:0016741,0.78363187624036,0.40756417709932,3,185,transferase activity, transferring one-carbon groups,MF,METTL15;BCDIN3D;TRMT61A
3567,GO:0007611,0.78377407152223,0.452159681611371,2,133,learning or memory,BP,FOS;ADGRF1
12955,GO:0051301,0.783809371043577,0.324513039181165,9,507,cell division,BP,TXNIP;MYC;ZFP36L2;PHF13;RHOD;PAK6;SNX33;ING2;ZNF16
1866,GO:0004527,0.784481747594453,0.550945472237666,1,69,exonuclease activity,MF,DCLRE1C
17620,GO:1901292,0.784778326961511,0.450747105985867,2,131,nucleoside phosphate catabolic process,BP,DDIT4;HK2
10556,GO:0043506,0.784897403569723,0.550256765383192,1,70,regulation of JUN kinase activity,BP,FZD10
690,GO:0001906,0.785200606311718,0.549956968573955,1,67,cell killing,BP,HIST1H2BJ
12788,GO:0051050,0.785508563515411,0.311991493642568,11,611,positive regulation of transport,BP,HES1;CDK5R1;SERPINE1;GDNF;BAG3;KCTD7;IL17RA;VSNL1;PIK3R1;HSPA2;CLU
18320,GO:1903214,0.785647511275092,0.549215727990679,1,68,regulation of protein targeting to mitochondrion,BP,HES1
7700,GO:0032153,0.786499115563837,0.547799984869742,1,70,cell division site,CC,RHOD
6652,GO:0023056,0.786646357433271,0.282648473072154,22,1156,positive regulation of signaling,BP,HES1;CYP1B1;FAM110C;DUSP5;LURAP1L;CTGF;MAP3K14;FZD10;VSNL1;COL1A1;TOB1;EPHB3;GADD45B;SLC20A1;PIK3R1;SOX9;TIMP3;JRK;ING2;NACC2;HIC1;SOCS1
8012,GO:0032635,0.786777233760011,0.547425462082388,1,69,interleukin-6 production,BP,AKIRIN2
12765,GO:0051020,0.787600392675883,0.319743302373423,9,522,GTPase binding,MF,NET1;RIN2;GDNF;CDC42EP2;PAK6;BICD2;RIN1;RUNDC1;ARTN
3616,GO:0008064,0.788125357065024,0.445866017369682,2,132,regulation of actin polymerization or depolymerization,BP,CDC42EP2;VASP
9930,GO:0042273,0.789117252915762,0.543923254894512,1,67,ribosomal large subunit biogenesis,BP,SURF6
8837,GO:0034620,0.789122492773794,0.444430495962232,2,131,cellular response to unfolded protein,BP,PIK3R1;HSPA2
7058,GO:0030832,0.789499969043129,0.443839622336486,2,133,regulation of actin filament length,BP,CDC42EP2;VASP
3139,GO:0006732,0.789859619646601,0.354688934209741,5,296,coenzyme metabolic process,BP,SLC2A1;MAT2A;SLC2A3;DDIT4;HK2
7978,GO:0032587,0.790305802108227,0.541809616914799,1,72,ruffle membrane,CC,SPRY4
18366,GO:1903320,0.790604906543294,0.397806085639431,3,188,regulation of protein modification by small protein conjugation or removal,BP,SIAH2;PER2;DNAJB2
5695,GO:0016811,0.790794939730055,0.541150679131109,1,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,NACC2
15212,GO:0071347,0.790811159411507,0.441999064621145,2,129,cellular response to interleukin-1,BP,UPF1;SOX9
11743,GO:0046545,0.791034390227494,0.54072534168832,1,71,development of primary female sexual characteristics,BP,TIPARP
13775,GO:0060337,0.791163021680617,0.540630453520254,1,69,type I interferon signaling pathway,BP,IFITM1
15222,GO:0071357,0.791163021680617,0.540630453520254,1,69,cellular response to type I interferon,BP,IFITM1
11889,GO:0046887,0.791292364141671,0.54037501806712,1,70,positive regulation of hormone secretion,BP,VSNL1
10431,GO:0043271,0.791608336112752,0.539829544426826,1,71,negative regulation of ion transport,BP,SLC30A1
2929,GO:0006446,0.793008365247086,0.537689953520377,1,70,regulation of translational initiation,BP,HSPB1
3523,GO:0007498,0.79332540958776,0.537089238175683,1,72,mesoderm development,BP,NOG
12897,GO:0051222,0.793922674661913,0.349251670552852,5,301,positive regulation of protein transport,BP,HES1;CDK5R1;BAG3;IL17RA;VSNL1
11409,GO:0045787,0.793988274880684,0.349158853798441,5,302,positive regulation of cell cycle,BP,HES1;CDK5R1;CTGF;SOX15;ZNF16
6897,GO:0030425,0.794029568111175,0.336151062611852,6,361,dendrite,CC,CDK5R1;EPHB3;NCDN;NR1D1;PALMD;CLU
16622,GO:0097447,0.794029568111175,0.336151062611852,6,361,dendritic tree,CC,CDK5R1;EPHB3;NCDN;NR1D1;PALMD;CLU
17359,GO:1900034,0.794307505168514,0.535544412386862,1,72,regulation of cellular response to heat,BP,BAG3
3333,GO:0007044,0.794676860966129,0.534817723960076,1,75,cell-substrate junction assembly,BP,RHOD
4533,GO:0010595,0.794781994242987,0.534796350423823,1,72,positive regulation of endothelial cell migration,BP,HSPB1
14609,GO:0070161,0.795006814352155,0.316983984587255,8,464,anchoring junction,CC,SPRY4;FLRT3;HSPB1;FHL2;FHL3;FAT2;VASP;CNN2
14307,GO:0061387,0.795037487002631,0.534295419389511,1,74,regulation of extent of cell growth,BP,CDK5R1
3970,GO:0008757,0.795930577631966,0.434388279197466,2,132,S-adenosylmethionine-dependent methyltransferase activity,MF,METTL15;TRMT61A
10353,GO:0043154,0.79634070376315,0.532382134026584,1,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,SIAH2
1112,GO:0002698,0.797070183343968,0.531224319792533,1,71,negative regulation of immune effector process,BP,ZBTB7B
2592,GO:0005884,0.797743483671003,0.530052540488448,1,73,actin filament,CC,VPS18
5411,GO:0016247,0.797766479698429,0.530065604853197,1,72,channel regulator activity,MF,SLC30A1
4676,GO:0010821,0.797834703916938,0.387569500662669,3,190,regulation of mitochondrion organization,BP,HES1;HK2;CLU
3624,GO:0008080,0.797989332942941,0.529710579819619,1,72,N-acetyltransferase activity,MF,BRPF1
2939,GO:0006464,0.798080125659459,0.245198068949265,62,3082,cellular protein modification process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;MYC;HR;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;MGAT1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;RNF168;KCTD7;FAM212B;HIST1H2BI;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;HIST1H2BO;TIMP3;STK17A;DDIT4;HIST1H2BE;ARTN;FBXL12;PYGO2;FKBP9;ING2;HIST1H1C;HIST1H1D;FBXL18;PER2;DNAJB2;NACC2;SOCS6;TRIM56;RGS3;PMEPA1;SOCS1;CLU;CISH
9519,GO:0036211,0.798080125659459,0.245198068949265,62,3082,protein modification process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;MYC;HR;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;MGAT1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;HIST1H2BJ;ZFP36L2;RNF168;KCTD7;FAM212B;HIST1H2BI;EPHB3;PAK6;SIAH2;GADD45B;PIK3R1;SOX9;CEBPA;HSPA2;HIST1H2BO;TIMP3;STK17A;DDIT4;HIST1H2BE;ARTN;FBXL12;PYGO2;FKBP9;ING2;HIST1H1C;HIST1H1D;FBXL18;PER2;DNAJB2;NACC2;SOCS6;TRIM56;RGS3;PMEPA1;SOCS1;CLU;CISH
12772,GO:0051028,0.798082398095098,0.43113113640976,2,135,mRNA transport,BP,UPF1;BICD2
11698,GO:0046474,0.798180111188682,0.387035336013554,3,194,glycerophospholipid biosynthetic process,BP,PIK3R1;MFSD2A;PCYT1A
13129,GO:0051651,0.798791445653179,0.528332535574963,1,74,maintenance of location in cell,BP,HK2
12309,GO:0048638,0.798807437264383,0.386091035541309,3,199,regulation of developmental growth,BP,CDK5R1;NOG;SOX15
3568,GO:0007612,0.798995077566188,0.528007070023907,1,74,learning,BP,FOS
15835,GO:0072524,0.799577812250627,0.428898336660044,2,135,pyridine-containing compound metabolic process,BP,DDIT4;HK2
16347,GO:0090559,0.800687379948318,0.525443843995792,1,71,regulation of membrane permeability,BP,HK2
6759,GO:0030177,0.800979177028556,0.42679909299892,2,135,positive regulation of Wnt signaling pathway,BP,COL1A1;JRK
8803,GO:0034502,0.801063975142759,0.524786920531225,1,72,protein localization to chromosome,BP,CHAMP1
3932,GO:0008610,0.801315910479104,0.302461507705565,9,512,lipid biosynthetic process,BP,SNAI2;TFCP2L1;FAXDC2;CBR1;SEC14L2;PIK3R1;MFSD2A;PCYT1A;NR1D1
18826,GO:1904375,0.801556417275052,0.523943967210991,1,73,regulation of protein localization to cell periphery,BP,PIK3R1
7242,GO:0031146,0.801889337949189,0.523561262836064,1,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,FBXL18
2611,GO:0005913,0.802210099207388,0.52284072449359,1,74,cell-cell adherens junction,CC,FAT2
10472,GO:0043331,0.802495775167196,0.522427740136329,1,73,response to dsRNA,BP,BCDIN3D
18493,GO:1903578,0.80250991179089,0.522356264772314,1,74,regulation of ATP metabolic process,BP,DDIT4
4061,GO:0009108,0.802652418314556,0.380653873251055,3,193,coenzyme biosynthetic process,BP,MAT2A;DDIT4;HK2
8889,GO:0034703,0.802655623626047,0.522073321286389,1,75,cation channel complex,CC,HSPA2
7839,GO:0032388,0.802786286842682,0.380440845786219,3,195,positive regulation of intracellular transport,BP,HES1;CDK5R1;BAG3
6659,GO:0030004,0.803397511638253,0.520967990078508,1,73,cellular monovalent inorganic cation homeostasis,BP,KCTD7
19767,GO:2000116,0.803530596973778,0.379413710504348,3,191,regulation of cysteine-type endopeptidase activity,BP,MYC;CTGF;SIAH2
5286,GO:0015935,0.803802918285939,0.520575503179844,1,68,small ribosomal subunit,CC,IMP3
7853,GO:0032409,0.804750403929129,0.421043734500559,2,139,regulation of transporter activity,BP,KCTD7;HSPA2
337,GO:0000932,0.80497926461888,0.518348535471922,1,74,P-body,CC,UPF1
3452,GO:0007265,0.805620240426771,0.320817072438654,6,366,Ras protein signal transduction,BP,SPRY4;NET1;CDC42EP2;RHOD;PAK6;COL1A2
11878,GO:0046873,0.805699194319008,0.376197234399488,3,200,metal ion transmembrane transporter activity,MF,SLC20A2;SLC30A1;SLC20A1
14044,GO:0060759,0.806062648780477,0.419109011110921,2,136,regulation of response to cytokine stimulus,BP,HIST1H2BJ;SOCS1
4073,GO:0009124,0.806215930621912,0.418876303889355,2,136,nucleoside monophosphate biosynthetic process,BP,DDIT4;HK2
995,GO:0002449,0.806242012833542,0.418855283087231,2,135,lymphocyte mediated immunity,BP,RNF168;CLU
11862,GO:0046834,0.806242330083073,0.516192603760996,1,76,lipid phosphorylation,BP,PIK3R1
10568,GO:0043523,0.806933149188076,0.417768047608183,2,137,regulation of neuron apoptotic process,BP,CDK5R1;GDNF
3456,GO:0007269,0.807031020103121,0.514946962892358,1,75,neurotransmitter secretion,BP,SLC30A1
17115,GO:0099643,0.807031020103121,0.514946962892358,1,75,signal release from synapse,BP,SLC30A1
3221,GO:0006869,0.80734851453129,0.37382246056983,3,199,lipid transport,BP,MFSD2A;AKR1C1;CLU
13528,GO:0055085,0.808394947357502,0.26786118615249,16,875,transmembrane transport,BP,TSC22D3;SLC2A1;SLC7A5P2;SLC20A2;SLC22A15;SLC30A1;LRRC8A;SLC2A3;SLC20A1;PIK3R1;MFSD2A;GJB2;HSPA2;PER2;HK2;CLU
2507,GO:0005758,0.809715584591024,0.51072402337908,1,71,mitochondrial intermembrane space,CC,TXNIP
2445,GO:0005643,0.810072363666166,0.509887994082523,1,76,nuclear pore,CC,BICD2
18296,GO:1903169,0.810372560744395,0.509390560431052,1,76,regulation of calcium ion transmembrane transport,BP,HSPA2
22,GO:0000041,0.810895183828425,0.508617713183974,1,74,transition metal ion transport,BP,SLC30A1
1178,GO:0002822,0.811409449033753,0.507763062866433,1,74,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ZBTB7B
4666,GO:0010811,0.811686143711015,0.507162921708914,1,77,positive regulation of cell-substrate adhesion,BP,NET1
7277,GO:0031253,0.811751642718312,0.367380660251971,3,203,cell projection membrane,CC,SPRY4;CDHR1;VASP
12241,GO:0048489,0.811873342085558,0.506896508280112,1,76,synaptic vesicle transport,BP,BLOC1S3
16638,GO:0097480,0.811873342085558,0.506896508280112,1,76,establishment of synaptic vesicle localization,BP,BLOC1S3
2265,GO:0005178,0.812701892428521,0.505469023731246,1,77,integrin binding,MF,CTGF
19823,GO:2000241,0.813189792745336,0.504745450780704,1,75,regulation of reproductive process,BP,SOX9
9045,GO:0035258,0.813204993380219,0.504673387388775,1,76,steroid hormone receptor binding,MF,FHL2
7079,GO:0030863,0.813289839875993,0.504398637667921,1,79,cortical cytoskeleton,CC,SLC2A1
13482,GO:0055002,0.813797999196545,0.50354745935578,1,79,striated muscle cell development,BP,FHL2
10412,GO:0043244,0.814186796147815,0.502895269020162,1,79,regulation of protein complex disassembly,BP,UPF1
17760,GO:1901681,0.81421436636775,0.406546598233922,2,140,sulfur compound binding,MF,CTGF;ADAMTS15
10137,GO:0042692,0.814506420018772,0.363337479604346,3,204,muscle cell differentiation,BP,HES1;FHL2;SOX9
4232,GO:0009408,0.814666392449609,0.405847004937481,2,140,response to heat,BP,BAG3;HSPA2
2226,GO:0005126,0.814872050675152,0.405581756202968,2,137,cytokine receptor binding,MF,CXCL14;PIK3R1
11077,GO:0045069,0.814955419909464,0.501783246591688,1,75,regulation of viral genome replication,BP,IFITM1
7620,GO:0032006,0.815117150522358,0.50146433221877,1,76,regulation of TOR signaling,BP,DDIT4
10583,GO:0043543,0.815409933091776,0.362067584997946,3,198,protein acylation,BP,SNAI2;BRPF1;PYGO2
7435,GO:0031532,0.816064539616936,0.499821438611381,1,77,actin cytoskeleton reorganization,BP,RHOD
2893,GO:0006400,0.816294818197044,0.499572828595951,1,74,tRNA modification,BP,TRMT61A
4033,GO:0009063,0.816576676908615,0.499048246096473,1,75,cellular amino acid catabolic process,BP,ALDH4A1
6674,GO:0030030,0.81679504023453,0.25158879962112,19,1049,cell projection organization,BP,ID1;HES1;CDK5R1;FAM110C;NOG;FLRT3;GDNF;TUBA4A;CDC42EP2;RHOD;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;PLEKHM1;ARTN;NCDN
12818,GO:0051099,0.817235516636552,0.401856669332263,2,140,positive regulation of binding,BP,HES1;PYGO2
3672,GO:0008170,0.818157554285166,0.496320528391322,1,76,N-methyltransferase activity,MF,METTL15
2518,GO:0005769,0.818159223232735,0.333034114844674,4,258,early endosome,CC,RHOD;SIAH2;PMEPA1;VPS18
12883,GO:0051193,0.818498613177599,0.495650180073135,1,78,regulation of cofactor metabolic process,BP,DDIT4
35,GO:0000070,0.818944080311352,0.399155291561085,2,142,mitotic sister chromatid segregation,BP,PHF13;CHAMP1
6747,GO:0030162,0.81970467382685,0.278815014240721,9,519,regulation of proteolysis,BP,SERPINE1;MYC;CTGF;SIAH2;AKIRIN2;CEBPA;TIMP3;SNX33;CLU
714,GO:0001936,0.819953223251353,0.493168204445315,1,78,regulation of endothelial cell proliferation,BP,NR2F2
547,GO:0001666,0.820305870238944,0.329983608604601,4,256,response to hypoxia,BP,MYC;ANGPTL4;VASN;DDIT4
3325,GO:0007033,0.820782808351734,0.39627286793084,2,142,vacuole organization,BP,ZKSCAN4;VPS18
3235,GO:0006890,0.820893954531561,0.491601313264765,1,77,retrograde vesicle-mediated transport, Golgi to ER,BP,BICD2
201,GO:0000422,0.820936343513921,0.491528584941586,1,77,autophagy of mitochondrion,BP,HK2
14432,GO:0061726,0.820936343513921,0.491528584941586,1,77,mitochondrion disassembly,BP,HK2
4677,GO:0010822,0.821017131489186,0.395938843799323,2,140,positive regulation of mitochondrion organization,BP,HES1;HK2
10618,GO:0043603,0.821263388813576,0.249954268794264,17,909,cellular amide metabolic process,BP,RGS2;HSPB1;HIST1H4L;MARS2;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;UPF1;HIST1H4B;IMP3;CEBPA;HIST1H4K;PER2;KRT17;HIST1H4D;CLU
13015,GO:0051427,0.822241848291113,0.393959911086025,2,143,hormone receptor binding,MF,PTHLH;FHL2
18599,GO:1903828,0.822358780225339,0.489082154812438,1,77,negative regulation of cellular protein localization,BP,SNX33
11429,GO:0045834,0.822680692414257,0.488482242856055,1,78,positive regulation of lipid metabolic process,BP,NR1D1
19768,GO:2000117,0.822732544581782,0.488437413596521,1,77,negative regulation of cysteine-type endopeptidase activity,BP,SIAH2
16637,GO:0097479,0.823202069189739,0.487538126320538,1,79,synaptic vesicle localization,BP,BLOC1S3
15119,GO:0071158,0.823707874852276,0.486751213858136,1,77,positive regulation of cell cycle arrest,BP,CDK5R1
16857,GO:0098754,0.823756509924599,0.486760007392666,1,75,detoxification,BP,SLC30A1
11803,GO:0046660,0.823832535436144,0.486447020816937,1,79,female sex differentiation,BP,TIPARP
10821,GO:0044306,0.825747196309344,0.483119413564664,1,79,neuron projection terminus,CC,FLRT3
2836,GO:0006304,0.826562647739,0.481695737591847,1,79,DNA modification,BP,FOS
12661,GO:0050852,0.826787405590415,0.386805289940133,2,140,T cell receptor signaling pathway,BP,TNFRSF21;PIK3R1
13547,GO:0055114,0.827240485777331,0.25255387245036,13,720,oxidation-reduction process,BP,MYC;CYP1B1;HR;PPP1R3D;FAXDC2;CBR1;ALDH4A1;AKR1C1;NR1D1;ZADH2;PER2;GFOD1;HK2
7949,GO:0032535,0.827782228429566,0.31916823407245,4,265,regulation of cellular component size,BP,CDK5R1;CDC42EP2;LRRC8A;VASP
8804,GO:0034504,0.827832134261686,0.343504160429955,3,205,protein localization to nucleus,BP,TXNIP;COL1A1;SOX9
7884,GO:0032446,0.828176120389564,0.248454004340489,14,786,protein modification by small protein conjugation,BP,HIST1H2BJ;RNF168;HIST1H2BI;SIAH2;HIST1H2BO;HIST1H2BE;FBXL12;FBXL18;PER2;DNAJB2;SOCS6;TRIM56;SOCS1;CISH
2319,GO:0005319,0.828417785954597,0.478399767268146,1,80,lipid transporter activity,MF,MFSD2A
8438,GO:0033554,0.828779262030659,0.223503289131874,31,1621,cellular response to stress,BP,SNAI2;SLC2A1;NET1;MYC;CYP1B1;VASN;HSPB1;HIST1H4L;CTGF;MAP3K14;BAG3;FZD10;FOS;RNF168;PAK6;UPF1;GADD45B;HIST1H4B;PIK3R1;GJB2;HSPA2;DDIT4;ING2;HIST1H4K;BRF2;NACC2;HIC1;HIST1H4D;HK2;CLU;DCLRE1C
3275,GO:0006954,0.828864463518334,0.289338690189654,6,367,inflammatory response,BP,SERPINE1;TNFRSF21;FOS;IL17RA;KRT16;CLU
10642,GO:0043648,0.829276374342796,0.476973631900614,1,78,dicarboxylic acid metabolic process,BP,ALDH4A1
19088,GO:1904949,0.829281128126842,0.476837183529281,1,81,ATPase complex,CC,NACC2
2956,GO:0006487,0.829368645055232,0.476810824331535,1,78,protein N-linked glycosylation,BP,MGAT1
60,GO:0000123,0.829448363403284,0.476626342100934,1,79,histone acetyltransferase complex,CC,BRPF1
4371,GO:0009986,0.829532671694576,0.288393650909529,6,374,cell surface,CC,VASN;FZD10;ADAMTS15;LRRC8A;HSPA2;CLU
5323,GO:0016042,0.829737118922399,0.340654614438731,3,202,lipid catabolic process,BP,CYP1B1;PLCD1;CES2
15991,GO:0080134,0.831179070448533,0.235811934059512,18,990,regulation of response to stress,BP,SNAI2;SERPINE1;MYC;HSPB1;CTGF;BAG3;FZD10;RNF168;IL17RA;GADD45B;PIK3R1;SOX15;NR1D1;ING2;NACC2;HIC1;SOCS1;CLU
5481,GO:0016410,0.831446392861107,0.473044697920941,1,80,N-acyltransferase activity,MF,BRPF1
17846,GO:1901991,0.832160404259251,0.336978133445879,3,202,negative regulation of mitotic cell cycle phase transition,BP,GPR132;ZFP36L2;NACC2
8925,GO:0034765,0.832602053337809,0.336242627794095,3,209,regulation of ion transmembrane transport,BP,SLC30A1;HSPA2;PER2
3140,GO:0006733,0.832745320679282,0.377156336898509,2,145,oxidoreduction coenzyme metabolic process,BP,DDIT4;HK2
2225,GO:0005125,0.833911933237514,0.468731334978053,1,78,cytokine activity,MF,CXCL14
12175,GO:0048284,0.834592369146579,0.374146424665535,2,146,organelle fusion,BP,RUNDC1;VPS18
20306,GO:2001252,0.835654393520064,0.372403012544195,2,147,positive regulation of chromosome organization,BP,SNAI2;ING2
343,GO:0000956,0.836004052544899,0.331127985556542,3,200,nuclear-transcribed mRNA catabolic process,BP,ZFP36L2;TOB1;UPF1
7602,GO:0031970,0.836283074644048,0.464464860501971,1,78,organelle envelope lumen,CC,TXNIP
9411,GO:0035967,0.83641952915632,0.371171205344534,2,146,cellular response to topologically incorrect protein,BP,PIK3R1;HSPA2
12575,GO:0050714,0.836851564938945,0.370450007315661,2,147,positive regulation of protein secretion,BP,IL17RA;VSNL1
2407,GO:0005576,0.836935382967154,0.202719287741396,56,2799,extracellular region,CC,PTHLH;SLC2A1;IRF2BPL;SERPINE1;ANGPTL4;NOG;VASN;C1ORF116;FLRT3;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;GDNF;CTGF;SLC20A2;TUBA4A;HIST1H2BJ;IGFBP2;TUFT1;IL17RA;HIST1H2BI;ADAMTS15;FAT2;COL1A1;EPHB3;HIST1H3J;LRIG3;HIST1H2AB;ADGRF1;CBR1;CXCL14;PLCD1;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;HSPA2;TIMP3;AKR1C1;HIST1H2BE;ARTN;KRT16;HIST1H4K;CES2;HIST2H2BE;COL1A2;KRT17;GFOD1;HIST1H4D;NOTCH3;CLU;HIST1H2AH
3253,GO:0006914,0.837044195271424,0.269025091643461,7,428,autophagy,BP,CDK5R1;HSPB1;ZKSCAN4;PLEKHM1;HK2;CLU;VPS18
14500,GO:0061919,0.837044195271424,0.269025091643461,7,428,process utilizing autophagic mechanism,BP,CDK5R1;HSPB1;ZKSCAN4;PLEKHM1;HK2;CLU;VPS18
12613,GO:0050776,0.837267867777551,0.250810082646723,10,584,regulation of immune response,BP,TNFRSF21;FOS;COL1A1;ZBTB7B;PIK3R1;NR1D1;COL1A2;IFITM1;SOCS1;CLU
3191,GO:0006816,0.83763673636729,0.328521511123266,3,211,calcium ion transport,BP,CTGF;SLC30A1;HSPA2
12790,GO:0051052,0.838560119528026,0.287456414393438,5,323,regulation of DNA metabolic process,BP,MYC;ID3;RNF168;ZNF93;UPF1
16790,GO:0098589,0.838594510330148,0.327055419122619,3,210,membrane region,CC,SLC2A1;MALL;BICD2
5661,GO:0016757,0.839822382436093,0.325195638985941,3,206,transferase activity, transferring glycosyl groups,MF,TIPARP;FUT1;MGAT1
14829,GO:0070555,0.839843852211202,0.365574483693698,2,145,response to interleukin-1,BP,UPF1;SOX9
13526,GO:0055082,0.840213869111011,0.264667917131481,7,433,cellular chemical homeostasis,BP,MYC;KCTD7;VSNL1;SLC30A1;PIK3R1;NR1D1;HK2
10655,GO:0043687,0.840531771385395,0.28464623233269,5,319,post-translational protein modification,BP,KCTD7;FBXL12;FBXL18;SOCS6;CISH
3665,GO:0008154,0.840767224689341,0.363990429997405,2,149,actin polymerization or depolymerization,BP,CDC42EP2;VASP
11408,GO:0045786,0.840788294068927,0.251034308003052,9,535,negative regulation of cell cycle,BP,CDK5R1;MYC;GPR132;MAP3K14;NR2F2;ZFP36L2;TRIM35;CEBPA;NACC2
12333,GO:0048675,0.842144625574048,0.453406766103042,1,87,axon extension,BP,CDK5R1
1175,GO:0002819,0.842854355288508,0.452287186837469,1,82,regulation of adaptive immune response,BP,ZBTB7B
5138,GO:0015631,0.84324446545226,0.296392284952869,4,276,tubulin binding,MF,RGS2;CDK5R1;FAM110C;TBCC
2818,GO:0006282,0.843537918382767,0.450982278251682,1,83,regulation of DNA repair,BP,RNF168
14969,GO:0070851,0.843625358436535,0.450820252978744,1,83,growth factor receptor binding,MF,FLRT3
13139,GO:0051668,0.844552598558736,0.449059977307365,1,84,localization within membrane,BP,MALL
11048,GO:0045017,0.844980006977843,0.317130371462551,3,212,glycerolipid biosynthetic process,BP,PIK3R1;MFSD2A;PCYT1A
19844,GO:2000278,0.846198382274143,0.445991078687025,1,84,regulation of DNA biosynthetic process,BP,MYC
2524,GO:0005776,0.846987125905413,0.444513989657003,1,84,autophagosome,CC,VPS18
12589,GO:0050730,0.84735246847961,0.353018745573984,2,150,regulation of peptidyl-tyrosine phosphorylation,BP,HES1;SOCS1
11444,GO:0045861,0.847802987621884,0.312723833870332,3,210,negative regulation of proteolysis,BP,SERPINE1;SIAH2;TIMP3
4070,GO:0009119,0.848707039540752,0.441317901853749,1,83,ribonucleoside metabolic process,BP,NME9
10798,GO:0044267,0.848909147767984,0.184776686424565,79,3918,cellular protein metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;SERPINE1;MYC;HR;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;HIST1H4L;MGAT1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;MARS2;HIST1H2BJ;ZFP36L2;BCDIN3D;RNF168;IGFBP2;KCTD7;FAM212B;HIST1H2BI;TOB1;EPHB3;HIST1H3J;PAK6;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;HIST1H2BO;TIMP3;STK17A;DDIT4;SNX33;HIST1H2BE;ARTN;FBXL12;PYGO2;NR1D1;FKBP9;ING2;HIST1H1C;HIST1H1D;FBXL18;HIST1H4K;PER2;DNAJB2;NACC2;SOCS6;KRT17;TRIM56;HIST1H4D;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
12614,GO:0050777,0.848943626779593,0.440832189723181,1,84,negative regulation of immune response,BP,ZBTB7B
8322,GO:0033157,0.84959956420004,0.309869507047589,3,213,regulation of intracellular protein transport,BP,HES1;CDK5R1;BAG3
3249,GO:0006909,0.850156641328021,0.348267176944513,2,152,phagocytosis,BP,PIK3R1;CDC42SE1
12692,GO:0050890,0.85052923820811,0.34759465489691,2,155,cognition,BP,FOS;ADGRF1
17267,GO:0120036,0.851056990003848,0.21107404909086,18,1028,plasma membrane bounded cell projection organization,BP,ID1;HES1;CDK5R1;NOG;FLRT3;GDNF;TUBA4A;CDC42EP2;RHOD;EPHB3;ADGRF1;SIAH2;BLOC1S3;VASP;PIK3R1;PLEKHM1;ARTN;NCDN
6222,GO:0019751,0.851799353905418,0.43533636430211,1,86,polyol metabolic process,BP,PLCD1
4487,GO:0010506,0.8518223638724,0.283524127432723,4,273,regulation of autophagy,BP,CDK5R1;HSPB1;ZKSCAN4;HK2
2616,GO:0005923,0.851856353593873,0.435120601531065,1,89,bicellular tight junction,CC,VASP
13515,GO:0055067,0.852365798255605,0.43425463073813,1,86,monovalent inorganic cation homeostasis,BP,KCTD7
8305,GO:0033135,0.852449364706947,0.43409485830702,1,86,regulation of peptidyl-serine phosphorylation,BP,DDIT4
3309,GO:0007010,0.85248562083587,0.211039827498897,17,982,cytoskeleton organization,BP,ID1;RGS2;CDK5R1;CTGF;FZD10;TUBA4A;FHL3;CDC42EP2;RHOD;PAK6;VASP;PIK3R1;SOX9;CNN2;BICD2;KRT16;KRT17
5591,GO:0016605,0.852519502080105,0.433924219124687,1,87,PML body,CC,CIART
15287,GO:0071456,0.852588905365972,0.344157694350761,2,151,cellular response to hypoxia,BP,MYC;VASN
7609,GO:0031985,0.8526878567224,0.433638616440555,1,86,Golgi cisterna,CC,FUT1
5662,GO:0016758,0.852854043808325,0.343706544803568,2,151,transferase activity, transferring hexosyl groups,MF,FUT1;MGAT1
20292,GO:2001235,0.853361033862847,0.342857683506565,2,150,positive regulation of apoptotic signaling pathway,BP,TIMP3;NACC2
3187,GO:0006811,0.853466318333255,0.213876266143805,15,862,ion transport,BP,TSC22D3;SLC2A1;GDNF;CTGF;SLC7A5P2;SLC20A2;SLC22A15;SLC30A1;LRRC8A;SLC2A3;SLC20A1;MFSD2A;HSPA2;AKR1C1;PER2
9918,GO:0042254,0.854289899891428,0.264658448626229,5,317,ribosome biogenesis,BP,METTL15;SURF6;IMP3;URB2;RRP36
9245,GO:0035637,0.854294146520535,0.430380958250456,1,91,multicellular organismal signaling,BP,AHNAK2
11148,GO:0045185,0.855102786812837,0.428889494088538,1,89,maintenance of protein location,BP,HK2
3598,GO:0008026,0.855207628899598,0.428757635759833,1,87,ATP-dependent helicase activity,MF,UPF1
14541,GO:0070035,0.855207628899598,0.428757635759833,1,87,purine NTP-dependent helicase activity,MF,UPF1
2895,GO:0006402,0.855509905090402,0.262841005230756,5,322,mRNA catabolic process,BP,HSPB1;GDNF;ZFP36L2;TOB1;UPF1
12967,GO:0051321,0.855584796389291,0.33899873303962,2,154,meiotic cell cycle,BP,HSPA2;ING2
12319,GO:0048660,0.855696058103882,0.427813467737485,1,87,regulation of smooth muscle cell proliferation,BP,NOTCH3
3385,GO:0007163,0.855736265082323,0.338671261202841,2,159,establishment or maintenance of cell polarity,BP,HES1;RHOD
3631,GO:0008092,0.855861609202195,0.222148612956416,11,671,cytoskeletal protein binding,MF,RGS2;CDK5R1;FAM110C;FHL3;TAGLN;VASP;CNN2;BICD2;TBCC;CLU;VPS18
14221,GO:0061136,0.856218871960036,0.337924788533567,2,153,regulation of proteasomal protein catabolic process,BP,CEBPA;CLU
18718,GO:1904062,0.856300947082219,0.337728607471073,2,157,regulation of cation transmembrane transport,BP,SLC30A1;HSPA2
13405,GO:0052689,0.856533429356732,0.426227415834086,1,86,carboxylic ester hydrolase activity,MF,CES2
13826,GO:0060401,0.856640386143829,0.425878509143824,1,90,cytosolic calcium ion transport,BP,CTGF
17302,GO:0140056,0.856667342116703,0.337126178480683,2,155,organelle localization by membrane tethering,BP,TUBA4A;VPS18
14608,GO:0070160,0.857975019262813,0.423247656371686,1,91,occluding junction,CC,VASP
1173,GO:0002793,0.858577911559486,0.333832707060983,2,155,positive regulation of peptide secretion,BP,IL17RA;VSNL1
5478,GO:0016407,0.858607780145243,0.42211417870281,1,88,acetyltransferase activity,MF,BRPF1
12318,GO:0048659,0.858999643330032,0.421347350056844,1,88,smooth muscle cell proliferation,BP,NOTCH3
713,GO:0001935,0.859387545450767,0.420552256603363,1,89,endothelial cell proliferation,BP,NR2F2
18172,GO:1902904,0.859679203657982,0.419945833978854,1,90,negative regulation of supramolecular fiber organization,BP,CLU
16986,GO:0099003,0.859708028885072,0.419889241250319,1,90,vesicle-mediated transport in synapse,BP,BLOC1S3
7273,GO:0031248,0.859877429338048,0.419625615290326,1,88,protein acetyltransferase complex,CC,BRPF1
18025,GO:1902493,0.859877429338048,0.419625615290326,1,88,acetyltransferase complex,CC,BRPF1
19090,GO:1904951,0.8607300897484,0.255066828627299,5,333,positive regulation of establishment of protein localization,BP,HES1;CDK5R1;BAG3;IL17RA;VSNL1
5523,GO:0016485,0.86118202028702,0.329316309650717,2,155,protein processing,BP,SERPINE1;CLU
19252,GO:1905368,0.861188965206309,0.417152481299477,1,85,peptidase complex,CC,HSPB1
1261,GO:0003012,0.861305589174029,0.29108145949354,3,223,muscle system process,BP,RGS2;GDNF;CTGF
8700,GO:0034332,0.861606626584132,0.416082351106288,1,92,adherens junction organization,BP,RHOD
17843,GO:1901988,0.862367436984156,0.289420993716733,3,215,negative regulation of cell cycle phase transition,BP,GPR132;ZFP36L2;NACC2
9699,GO:0038093,0.863408567008786,0.325429295423221,2,155,Fc receptor signaling pathway,BP,FOS;PIK3R1
11036,GO:0044877,0.863612974854238,0.211806080913144,11,667,protein-containing complex binding,MF,ID1;CDK5R1;MYC;CTGF;RNF168;HIST1H3J;TAGLN;PIK3R1;BICD2;ING2;CLU
11822,GO:0046700,0.864505607926265,0.218878052256151,9,545,heterocycle catabolic process,BP,HSPB1;MGAT1;GDNF;ZFP36L2;TOB1;UPF1;ALDH4A1;DDIT4;HK2
11482,GO:0045930,0.864553302206001,0.263990540409905,4,275,negative regulation of mitotic cell cycle,BP,GPR132;ZFP36L2;TRIM35;NACC2
4788,GO:0010972,0.864723289727502,0.410055056968902,1,87,negative regulation of G2/M transition of mitotic cell cycle,BP,GPR132
5932,GO:0018205,0.865079243118885,0.248555420431888,5,337,peptidyl-lysine modification,BP,SNAI2;BRPF1;PYGO2;HIST1H1C;HIST1H1D
18463,GO:1903532,0.865095910991439,0.284939272988803,3,220,positive regulation of secretion by cell,BP,GDNF;IL17RA;VSNL1
4717,GO:0010876,0.865209277087851,0.28473180354682,3,223,lipid localization,BP,MFSD2A;AKR1C1;CLU
8894,GO:0034708,0.865309660559176,0.408775940023002,1,90,methyltransferase complex,CC,TRMT61A
6223,GO:0019752,0.86627813121184,0.20212788745638,13,756,carboxylic acid metabolic process,BP,SLC2A1;CYP1B1;MARS2;CBR1;SLC2A3;ALDH4A1;AKR1C1;DDIT4;NR1D1;ZADH2;PER2;CES2;HK2
8961,GO:0035023,0.866994753524077,0.405227012427395,1,95,regulation of Rho protein signal transduction,BP,NET1
3314,GO:0007018,0.867433128089149,0.281053234301523,3,228,microtubule-based movement,BP,HSPB1;BLOC1S3;BICD2
11853,GO:0046822,0.867573174155796,0.404152638974403,1,92,regulation of nucleocytoplasmic transport,BP,BAG3
3595,GO:0008022,0.867907422966721,0.317423759864144,2,161,protein C-terminus binding,MF,ID1;CTGF
9544,GO:0036294,0.868018271880893,0.317265710985679,2,158,cellular response to decreased oxygen levels,BP,MYC;VASN
3241,GO:0006897,0.868333471791051,0.225172138281264,7,453,endocytosis,BP,SERPINE1;RIN2;PIK3R1;RIN1;SNX33;CLU;CDC42SE1
40,GO:0000082,0.869114600517902,0.278336462646612,3,221,G1/S transition of mitotic cell cycle,BP,MYC;GPR132;NACC2
9607,GO:0036464,0.869787989809856,0.314093492564837,2,160,cytoplasmic ribonucleoprotein granule,CC,UPF1;SOCS1
7572,GO:0031929,0.869830426445377,0.399568930472802,1,92,TOR signaling,BP,DDIT4
12124,GO:0048167,0.869862723390188,0.399471090284095,1,93,regulation of synaptic plasticity,BP,NCDN
876,GO:0002224,0.871020734258276,0.397168535726644,1,91,toll-like receptor signaling pathway,BP,NR1D1
6711,GO:0030117,0.871412992926106,0.396331621370239,1,92,membrane coat,CC,VPS18
12231,GO:0048475,0.871412992926106,0.396331621370239,1,92,coated membrane,CC,VPS18
10886,GO:0044421,0.871994121249902,0.163829943969021,49,2518,extracellular region part,CC,PTHLH;SLC2A1;IRF2BPL;SERPINE1;ANGPTL4;NOG;VASN;C1ORF116;FLRT3;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;CTGF;SLC20A2;TUBA4A;HIST1H2BJ;IGFBP2;HIST1H2BI;ADAMTS15;FAT2;COL1A1;HIST1H3J;LRIG3;HIST1H2AB;CBR1;CXCL14;PLCD1;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;HSPA2;TIMP3;AKR1C1;HIST1H2BE;ARTN;KRT16;HIST1H4K;CES2;HIST2H2BE;COL1A2;KRT17;HIST1H4D;CLU;HIST1H2AH
5084,GO:0015318,0.872180658730324,0.22752059554381,6,399,inorganic molecular entity transmembrane transporter activity,MF,SLC7A5P2;SLC20A2;SLC30A1;LRRC8A;SLC20A1;MFSD2A
16629,GO:0097458,0.872535519828948,0.187201584029126,16,941,neuron part,CC,RGS2;CDK5R1;FLRT3;HSPB1;TNFRSF21;BAG3;CDHR1;FOS;EPHB3;SIAH2;BLOC1S3;NCDN;NR1D1;PALMD;TBCC;CLU
5061,GO:0015267,0.872562995997857,0.30907863793526,2,164,channel activity,MF,LRRC8A;GJB2
6611,GO:0022803,0.872562995997857,0.30907863793526,2,164,passive transmembrane transporter activity,MF,LRRC8A;GJB2
4025,GO:0009055,0.873174998157212,0.392839108531377,1,88,electron transfer activity,MF,ALDH4A1
16730,GO:0097711,0.873485221604277,0.391999492452737,1,94,ciliary basal body-plasma membrane docking,BP,TUBA4A
18558,GO:1903749,0.873539804436192,0.391982465254897,1,91,positive regulation of establishment of protein localization to mitochondrion,BP,HES1
13779,GO:0060341,0.873775636420121,0.201718780336495,10,618,regulation of cellular localization,BP,HES1;CDK5R1;GDNF;BAG3;VSNL1;SLC30A1;PIK3R1;SNX33;NR1D1;PER2
10569,GO:0043524,0.87383588465506,0.391304981800014,1,93,negative regulation of neuron apoptotic process,BP,GDNF
9339,GO:0035821,0.873881973041687,0.391241467607029,1,92,modification of morphology or physiology of other organism,BP,HIST1H2BJ
72,GO:0000149,0.874330039727727,0.390280532626674,1,93,SNARE binding,MF,VPS18
19772,GO:2000134,0.875094457485307,0.388691902458554,1,93,negative regulation of G1/S transition of mitotic cell cycle,BP,NACC2
10029,GO:0042470,0.875169108108015,0.388568447999223,1,92,melanosome,CC,SLC2A1
12388,GO:0048770,0.875169108108015,0.388568447999223,1,92,pigment granule,CC,SLC2A1
15902,GO:0072655,0.875337619928965,0.304149389416608,2,158,establishment of protein localization to mitochondrion,BP,HES1;HK2
6583,GO:0022406,0.875600775221741,0.30361004500079,2,163,membrane docking,BP,TUBA4A;VPS18
3068,GO:0006633,0.875848402535485,0.387120382400258,1,93,fatty acid biosynthetic process,BP,CBR1
5841,GO:0017124,0.876014937858045,0.386680852122859,1,96,SH3 domain binding,MF,VASP
3242,GO:0006898,0.876563005021578,0.301851926108138,2,164,receptor-mediated endocytosis,BP,SERPINE1;CLU
4374,GO:0009991,0.877004396254367,0.230447891474472,5,343,response to extracellular stimulus,BP,SNAI2;SLC2A1;FOS;IGFBP2;COL1A1
12660,GO:0050851,0.879883236066359,0.295825681039571,2,161,antigen receptor-mediated signaling pathway,BP,TNFRSF21;PIK3R1
3434,GO:0007224,0.880296440386245,0.377632359651095,1,97,smoothened signaling pathway,BP,HES1
16536,GO:0097237,0.880319486342521,0.295012406703771,2,162,cellular response to toxic substance,BP,NET1;CYP1B1
16870,GO:0098781,0.881360874200856,0.375455827605334,1,94,ncRNA transcription,BP,CD3EAP
14850,GO:0070585,0.881753981618826,0.292383448075972,2,161,protein localization to mitochondrion,BP,HES1;HK2
9900,GO:0042180,0.882283369564086,0.291381592185485,2,163,cellular ketone metabolic process,BP,AKR1C1;NR1D1
12015,GO:0047485,0.882779286808888,0.372360465972031,1,96,protein N-terminus binding,MF,ID1
18231,GO:1903008,0.883121706883475,0.371625190396611,1,96,organelle disassembly,BP,HK2
4489,GO:0010508,0.883206991210846,0.371384028055408,1,98,positive regulation of autophagy,BP,HK2
4971,GO:0015077,0.883329060324232,0.289410866101947,2,166,monovalent inorganic cation transmembrane transporter activity,MF,SLC20A2;SLC20A1
18137,GO:1902807,0.883717456032955,0.370343511727717,1,96,negative regulation of cell cycle G1/S phase transition,BP,NACC2
3954,GO:0008654,0.884490056757071,0.252439639881623,3,231,phospholipid biosynthetic process,BP,PIK3R1;MFSD2A;PCYT1A
9898,GO:0042177,0.885301162893341,0.366892036205876,1,97,negative regulation of protein catabolic process,BP,TIMP3
5906,GO:0018108,0.885670060730668,0.250410170860793,3,232,peptidyl-tyrosine phosphorylation,BP,HES1;EPHB3;SOCS1
1542,GO:0003924,0.885963967382588,0.249938236478661,3,227,GTPase activity,MF,TUBA4A;RHOD;TBCC
15117,GO:0071156,0.886155527818179,0.365065808361068,1,96,regulation of cell cycle arrest,BP,CDK5R1
6025,GO:0019079,0.886692996997003,0.363866068418962,1,97,viral genome replication,BP,IFITM1
2815,GO:0006275,0.887611851842661,0.361802349239912,1,99,regulation of DNA replication,BP,ID3
6297,GO:0019903,0.887818656548317,0.361349554503304,1,99,protein phosphatase binding,MF,PIK3R1
2875,GO:0006368,0.887957730435845,0.36110136075297,1,97,transcription elongation from RNA polymerase II promoter,BP,RNF168
5456,GO:0016324,0.888075359998103,0.280482868763088,2,172,apical plasma membrane,CC,SLC2A1;IGFBP2
12785,GO:0051047,0.88837483437227,0.245750019230299,3,232,positive regulation of secretion,BP,GDNF;IL17RA;VSNL1
9315,GO:0035770,0.888801471034046,0.279148280926056,2,169,ribonucleoprotein granule,CC,UPF1;SOCS1
10429,GO:0043269,0.889347697249947,0.224358572319769,4,296,regulation of ion transport,BP,GDNF;SLC30A1;HSPA2;PER2
3718,GO:0008237,0.889654300628306,0.357313377853901,1,99,metallopeptidase activity,MF,ADAMTS15
9616,GO:0036477,0.889750778370206,0.193866387103149,7,473,somatodendritic compartment,CC,CDK5R1;EPHB3;SIAH2;NCDN;NR1D1;PALMD;CLU
4430,GO:0010256,0.89026508847931,0.209785152396896,5,358,endomembrane system organization,BP,AHNAK2;BLOC1S3;SNX33;CLU;VPS18
10444,GO:0043296,0.890272080363306,0.355841830745643,1,103,apical junction complex,CC,VASP
5938,GO:0018212,0.890876000276248,0.241392735516462,3,235,peptidyl-tyrosine modification,BP,HES1;EPHB3;SOCS1
11017,GO:0044843,0.891057873790031,0.241088618871918,3,233,cell cycle G1/S phase transition,BP,MYC;GPR132;NACC2
5781,GO:0016999,0.891140112866431,0.354080075582491,1,97,antibiotic metabolic process,BP,AKR1C1
6896,GO:0030424,0.891612999744472,0.207646321789004,5,362,axon,CC,CDK5R1;FLRT3;HSPB1;TNFRSF21;BLOC1S3
3052,GO:0006611,0.891820881038434,0.273419670694392,2,170,protein export from nucleus,BP,BAG3;UPF1
18124,GO:1902750,0.892263578047988,0.351578916885526,1,97,negative regulation of cell cycle G2/M phase transition,BP,GPR132
3690,GO:0008194,0.892620127114436,0.350726337782938,1,99,UDP-glycosyltransferase activity,MF,MGAT1
5339,GO:0016072,0.892665321751196,0.218954053728574,4,284,rRNA metabolic process,BP,METTL15;CD3EAP;IMP3;RRP36
6662,GO:0030010,0.893311742060149,0.349047226368771,1,104,establishment of cell polarity,BP,HES1
2894,GO:0006401,0.89405530292859,0.203825617979507,5,346,RNA catabolic process,BP,HSPB1;GDNF;ZFP36L2;TOB1;UPF1
18556,GO:1903747,0.894550675683395,0.346394000036989,1,99,regulation of establishment of protein localization to mitochondrion,BP,HES1
12310,GO:0048639,0.894571317654187,0.346191799587063,1,105,positive regulation of developmental growth,BP,SOX15
5448,GO:0016311,0.895342768833281,0.201737792710601,5,359,dephosphorylation,BP,DUSP4;PTPRE;DUSP5;PPP1R3D;NT5DC3
2552,GO:0005819,0.895520545969741,0.214160153076218,4,299,spindle,CC,FAM110C;HSPB1;CHAMP1;HSPA2
4068,GO:0009116,0.895697036274756,0.343804482000464,1,99,nucleoside metabolic process,BP,NME9
17651,GO:1901361,0.895815207972115,0.174684683260482,9,570,organic cyclic compound catabolic process,BP,HSPB1;MGAT1;GDNF;ZFP36L2;TOB1;UPF1;ALDH4A1;DDIT4;HK2
11674,GO:0046434,0.896354616142836,0.264700237098304,2,173,organophosphate catabolic process,BP,DDIT4;HK2
9934,GO:0042277,0.896375303391721,0.264670664277832,2,172,peptide binding,MF,PIK3R1;CLU
273,GO:0000775,0.896398142550857,0.264616219948607,2,173,chromosome, centromeric region,CC,CHAMP1;HJURP
6748,GO:0030163,0.896420843792654,0.163963343868616,12,741,protein catabolic process,BP,TIPARP;RNF168;SIAH2;SOX9;CEBPA;TIMP3;SNX33;FBXL12;NR1D1;FBXL18;SOCS6;CLU
12527,GO:0050657,0.896556141167686,0.264311142983757,2,173,nucleic acid transport,BP,UPF1;BICD2
12528,GO:0050658,0.896556141167686,0.264311142983757,2,173,RNA transport,BP,UPF1;BICD2
9049,GO:0035264,0.896707119656551,0.34135684093319,1,105,multicellular organism growth,BP,HOXA5
3305,GO:0007006,0.89705825702104,0.340712953437338,1,99,mitochondrial membrane organization,BP,HK2
15284,GO:0071453,0.897128515869838,0.263214987317747,2,172,cellular response to oxygen levels,BP,MYC;VASN
2538,GO:0005793,0.897595554286758,0.339407752281381,1,102,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2
5383,GO:0016197,0.898462794402475,0.260597050332664,2,175,endosomal transport,BP,BLOC1S3;SNX33
8861,GO:0034655,0.899037339989935,0.174482641414482,8,519,nucleobase-containing compound catabolic process,BP,HSPB1;MGAT1;GDNF;ZFP36L2;TOB1;UPF1;DDIT4;HK2
4146,GO:0009205,0.899406754208889,0.226389009387116,3,233,purine ribonucleoside triphosphate metabolic process,BP,NME9;DDIT4;HK2
2899,GO:0006406,0.899525778393854,0.334956739345097,1,103,mRNA export from nucleus,BP,UPF1
15270,GO:0071427,0.899525778393854,0.334956739345097,1,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,UPF1
18256,GO:1903050,0.900269207359583,0.257086262660963,2,174,regulation of proteolysis involved in cellular protein catabolic process,BP,CEBPA;CLU
12908,GO:0051236,0.901296158874382,0.255055441927794,2,176,establishment of RNA localization,BP,UPF1;BICD2
97,GO:0000187,0.901333057139536,0.330754020480415,1,104,activation of MAPK activity,BP,DUSP5
17343,GO:0150034,0.901712218300464,0.254209890083724,2,179,distal axon,CC,CDK5R1;FLRT3
12590,GO:0050731,0.902121468270286,0.328921021466499,1,104,positive regulation of peptidyl-tyrosine phosphorylation,BP,HES1
14958,GO:0070838,0.903191885313286,0.219544234473697,3,245,divalent metal ion transport,BP,CTGF;SLC30A1;HSPA2
2525,GO:0005777,0.904527545153718,0.323286876648567,1,104,peroxisome,CC,ZADH2
10083,GO:0042579,0.904527545153718,0.323286876648567,1,104,microbody,CC,ZADH2
15826,GO:0072511,0.904618445162374,0.216966611290089,3,246,divalent inorganic cation transport,BP,CTGF;SLC30A1;HSPA2
14161,GO:0061025,0.904681061841743,0.248368707273863,2,177,membrane fusion,BP,RUNDC1;VPS18
10625,GO:0043618,0.904970416462275,0.322268004423095,1,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,BAG3
11213,GO:0045335,0.905220848792865,0.321627661391003,1,105,phagocytic vesicle,CC,CDC42EP2
2906,GO:0006415,0.90545683528526,0.321196711993981,1,100,translational termination,BP,UPF1
15530,GO:0071897,0.905947732610799,0.245840911967854,2,178,DNA biosynthetic process,BP,MYC;CTGF
7563,GO:0031901,0.906812378519935,0.317807970651089,1,107,early endosome membrane,CC,PMEPA1
4651,GO:0010770,0.90730932643148,0.316556875772821,1,110,positive regulation of cell morphogenesis involved in differentiation,BP,NET1
12791,GO:0051053,0.908002051366201,0.314924690130464,1,109,negative regulation of DNA metabolic process,BP,ZNF93
12880,GO:0051188,0.908406140042505,0.210101756364953,3,243,cofactor biosynthetic process,BP,MAT2A;DDIT4;HK2
3566,GO:0007610,0.908460449290351,0.192258804369608,4,312,behavior,BP,GDNF;FOS;ADGRF1;CIART
4140,GO:0009199,0.90850133633865,0.209949895924391,3,239,ribonucleoside triphosphate metabolic process,BP,NME9;DDIT4;HK2
10813,GO:0044297,0.908524389991134,0.192156066600116,4,310,cell body,CC,CDK5R1;SIAH2;GJB2;NCDN
7564,GO:0031902,0.908666387558861,0.313425644839208,1,105,late endosome membrane,CC,VPS18
10806,GO:0044282,0.908755043104324,0.191788970047242,4,302,small molecule catabolic process,BP,FUT1;MGAT1;ALDH4A1;HK2
7911,GO:0032479,0.909109848425376,0.312313433977458,1,107,regulation of type I interferon production,BP,TRIM56
17838,GO:1901981,0.90920675446797,0.312035083855579,1,109,phosphatidylinositol phosphate binding,MF,PLCD1
3298,GO:0006996,0.90979140412474,0.116458902625812,59,3097,organelle organization,BP,ID1;RGS2;HES1;SNAI2;CDK5R1;MYC;HR;HIST1H2AG;HIST1H4L;CTGF;FZD10;BRPF1;TUBA4A;HIST1H2BJ;PHF13;CHAMP1;FHL3;RNF168;CDC42EP2;RHOD;HIST1H2BI;ZKSCAN4;HIST1H3J;HIST1H2AB;PAK6;HJURP;UPF1;BLOC1S3;VASP;HIST1H4B;PIK3R1;SOX9;CEBPA;CNN2;HSPA2;BICD2;HIST1H2BO;RUNDC1;SNX33;HIST1H2BE;KRT16;SOX15;PYGO2;ING2;HIST1H1C;HIST1H1D;HIST1H4K;PER2;HIST2H2BE;NACC2;HIST3H2BB;KRT17;HIST1H4D;HK2;TSPYL4;CLU;HIST1H2AH;DCLRE1C;VPS18
4092,GO:0009144,0.910224561190748,0.206787387549994,3,240,purine nucleoside triphosphate metabolic process,BP,NME9;DDIT4;HK2
4454,GO:0010389,0.910853236709099,0.235965534970447,2,180,regulation of G2/M transition of mitotic cell cycle,BP,GPR132;TUBA4A
1475,GO:0003729,0.910981390972684,0.235705759969063,2,180,mRNA binding,MF,ZFP36L2;ESRP2
7993,GO:0032606,0.911233547726869,0.307159125962185,1,108,type I interferon production,BP,TRIM56
1995,GO:0004713,0.911406810017636,0.30667237584992,1,111,protein tyrosine kinase activity,MF,EPHB3
7338,GO:0031344,0.911525658090306,0.167118083329533,6,436,regulation of cell projection organization,BP,ID1;CDK5R1;FAM110C;CDC42EP2;EPHB3;PLEKHM1
12792,GO:0051054,0.911695246365229,0.234247563839101,2,181,positive regulation of DNA metabolic process,BP,MYC;RNF168
11751,GO:0046578,0.913144059866572,0.231218632441786,2,190,regulation of Ras protein signal transduction,BP,SPRY4;NET1
2862,GO:0006353,0.913186682746067,0.302416845799732,1,107,DNA-templated transcription, termination,BP,CD3EAP
7598,GO:0031965,0.913547113178567,0.200597240333814,3,251,nuclear membrane,CC,RBM15;SLC30A1;DNAJB2
1859,GO:0004519,0.913975864531901,0.300456180133508,1,108,endonuclease activity,MF,DCLRE1C
6292,GO:0019898,0.91432134122251,0.228833000112792,2,187,extrinsic component of membrane,CC,PIK3R1;SNX33
10916,GO:0044459,0.914655788318737,0.121928290682042,25,1456,plasma membrane part,CC,SPRY4;RGS2;SLC2A1;FUT1;FLRT3;APCDD1;TNFRSF21;SLC7A5P2;AHNAK2;FZD10;SLC20A2;CDHR1;IGFBP2;IL17RA;SLC22A15;PCDH7;EPHB3;SLC30A1;VASP;SLC2A3;SLC20A1;MFSD2A;GJB2;HSPA2;SOCS6
10627,GO:0043620,0.914723036451699,0.298614570879706,1,108,regulation of DNA-templated transcription in response to stress,BP,BAG3
4777,GO:0010959,0.914724887052514,0.228012788427635,2,186,regulation of metal ion transport,BP,SLC30A1;HSPA2
5525,GO:0016491,0.91480709267674,0.150767823666859,8,529,oxidoreductase activity,MF,CYP1B1;HR;FAXDC2;CBR1;ALDH4A1;AKR1C1;ZADH2;GFOD1
5694,GO:0016810,0.915212493495798,0.297360606784369,1,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,NACC2
2817,GO:0006281,0.915258120234898,0.154970121753135,7,484,DNA repair,BP,HIST1H4L;RNF168;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
2438,GO:0005635,0.915521824899212,0.168805528003766,5,375,nuclear envelope,CC,RBM15;SLC30A1;BICD2;PCYT1A;DNAJB2
2085,GO:0004842,0.915824728099982,0.168294864284652,5,377,ubiquitin-protein transferase activity,MF,RNF168;SIAH2;FBXL12;FBXL18;TRIM56
12837,GO:0051129,0.915850011471767,0.154029795479567,7,493,negative regulation of cellular component organization,BP,ID1;CDK5R1;HSPA2;SNX33;DNAJB2;PMEPA1;CLU
2467,GO:0005681,0.916689347272862,0.224004623418601,2,181,spliceosomal complex,CC,IVNS1ABP;UPF1
11598,GO:0046165,0.917282767794019,0.292189437433894,1,111,alcohol biosynthetic process,BP,SEC14L2
16876,GO:0098794,0.91774849900835,0.192715719238386,3,259,postsynapse,CC,CDK5R1;NR1D1;PALMD
3233,GO:0006887,0.918818280410649,0.140699662306805,9,602,exocytosis,BP,SERPINE1;TUBA4A;PCDH7;VSNL1;SLC2A3;CNN2;TIMP3;CLU;VPS18
12863,GO:0051168,0.919525503668613,0.218052966892257,2,187,nuclear export,BP,BAG3;UPF1
10807,GO:0044283,0.91996919482738,0.142828853781521,8,543,small molecule biosynthetic process,BP,SNAI2;NME9;CBR1;SEC14L2;DDIT4;NR1D1;PER2;HK2
11483,GO:0045931,0.920186959001273,0.284795150273783,1,115,positive regulation of mitotic cell cycle,BP,HES1
3049,GO:0006606,0.92067577074176,0.283553813938033,1,115,protein import into nucleus,BP,TXNIP
5667,GO:0016772,0.920889383702026,0.129282783360612,12,779,transferase activity, transferring phosphorus-containing groups,MF,CDK5R1;MAP3K14;CD3EAP;POLR1D;EPHB3;NME9;PAK6;PIK3R1;SOX9;STK17A;PCYT1A;HK2
134,GO:0000280,0.921079587886868,0.170204682531627,4,319,nuclear division,BP,PHF13;CHAMP1;HSPA2;ING2
6580,GO:0022402,0.921260304655737,0.118259422815549,19,1141,cell cycle process,BP,CDK5R1;MYC;GPR132;ZNF503;CTGF;TUBA4A;ZFP36L2;PHF13;CHAMP1;RHOD;PAK6;UPF1;SOX9;HSPA2;SNX33;SOX15;ING2;NACC2;ZNF16
5328,GO:0016050,0.921316963948081,0.169782823722086,4,319,vesicle organization,BP,BLOC1S3;RUNDC1;SNX33;VPS18
7677,GO:0032102,0.921480449970536,0.213940843741702,2,188,negative regulation of response to external stimulus,BP,SNAI2;SERPINE1
9686,GO:0038061,0.921791314414652,0.280789838765887,1,111,NIK/NF-kappaB signaling,BP,MAP3K14
2892,GO:0006399,0.922167977179998,0.212531110119275,2,183,tRNA metabolic process,BP,MARS2;TRMT61A
2540,GO:0005795,0.922181592700699,0.27971040136136,1,115,Golgi stack,CC,FUT1
12878,GO:0051186,0.922295011604969,0.149727931733884,6,430,cofactor metabolic process,BP,SLC2A1;MAT2A;SLC2A3;AKR1C1;DDIT4;HK2
986,GO:0002440,0.922978855047779,0.277683024647945,1,114,production of molecular mediator of immune response,BP,RNF168
4192,GO:0009267,0.923004207337919,0.277598275458536,1,115,cellular response to starvation,BP,SLC2A1
12794,GO:0051056,0.923130565102327,0.182484966934185,3,266,regulation of small GTPase mediated signal transduction,BP,SPRY4;NET1;RHOD
1162,GO:0002768,0.923381308061613,0.182053743960243,3,255,immune response-regulating cell surface receptor signaling pathway,BP,TNFRSF21;FOS;PIK3R1
7500,GO:0031667,0.92423250966279,0.164574533363471,4,320,response to nutrient levels,BP,SNAI2;SLC2A1;IGFBP2;COL1A1
12811,GO:0051092,0.924405606635757,0.273998828579328,1,114,positive regulation of NF-kappaB transcription factor activity,BP,CLU
10799,GO:0044270,0.924765502131818,0.135388958423666,8,545,cellular nitrogen compound catabolic process,BP,HSPB1;MGAT1;GDNF;ZFP36L2;TOB1;UPF1;DDIT4;HK2
17842,GO:1901987,0.925188909534326,0.152457600546137,5,379,regulation of cell cycle phase transition,BP,GPR132;TUBA4A;ZFP36L2;NACC2;ZNF16
5681,GO:0016788,0.925318171319374,0.134517366782284,8,553,hydrolase activity, acting on ester bonds,MF,DUSP4;PTPRE;DUSP5;PPP1R3D;PLCD1;CES2;NT5DC3;DCLRE1C
6298,GO:0019904,0.925914712330634,0.133576503798131,8,561,protein domain specific binding,MF,ID3;HIST1H4L;VASP;HIST1H4B;HSPA2;HIST1H4K;HIST1H4D;PMEPA1
3088,GO:0006661,0.926292333745856,0.268991211451774,1,119,phosphatidylinositol biosynthetic process,BP,PIK3R1
6846,GO:0030307,0.926771830793583,0.267734635793411,1,119,positive regulation of cell growth,BP,KRT17
10525,GO:0043436,0.926955874169023,0.118522247467465,13,822,oxoacid metabolic process,BP,SLC2A1;CYP1B1;MARS2;CBR1;SLC2A3;ALDH4A1;AKR1C1;DDIT4;NR1D1;ZADH2;PER2;CES2;HK2
7140,GO:0030968,0.927274912483834,0.266449092140709,1,117,endoplasmic reticulum unfolded protein response,BP,PIK3R1
16312,GO:0090407,0.927843626747694,0.134982137511051,7,500,organophosphate biosynthetic process,BP,PTHLH;NME9;PIK3R1;MFSD2A;DDIT4;PCYT1A;HK2
4349,GO:0009898,0.928741114020012,0.262522497327106,1,120,cytoplasmic side of plasma membrane,CC,RGS2
6609,GO:0022626,0.929102374707301,0.26175388921029,1,110,cytosolic ribosome,CC,SURF6
2584,GO:0005874,0.930157426826209,0.153819371122118,4,333,microtubule,CC,CDK5R1;FAM110C;TUBA4A;TBCC
6993,GO:0030667,0.93033373286843,0.194898264288347,2,196,secretory granule membrane,CC,PCDH7;SLC2A3
14878,GO:0070647,0.930441334176186,0.110319083762713,15,946,protein modification by small protein conjugation or removal,BP,MYC;HIST1H2BJ;RNF168;HIST1H2BI;SIAH2;HIST1H2BO;HIST1H2BE;FBXL12;FBXL18;PER2;DNAJB2;SOCS6;TRIM56;SOCS1;CISH
10284,GO:0043025,0.930481673619048,0.168256364285871,3,266,neuronal cell body,CC,CDK5R1;SIAH2;NCDN
7212,GO:0031099,0.93087845697704,0.256821896791464,1,120,regeneration,BP,SOX15
16916,GO:0098858,0.930891789685917,0.256735435641188,1,123,actin-based cell projection,CC,VASP
10872,GO:0044391,0.931586278590352,0.192262715005583,2,182,ribosomal subunit,CC,SURF6;IMP3
2711,GO:0006082,0.931906291564189,0.111335167819807,13,829,organic acid metabolic process,BP,SLC2A1;CYP1B1;MARS2;CBR1;SLC2A3;ALDH4A1;AKR1C1;DDIT4;NR1D1;ZADH2;PER2;CES2;HK2
4089,GO:0009141,0.932107978200246,0.165096507950101,3,257,nucleoside triphosphate metabolic process,BP,NME9;DDIT4;HK2
6153,GO:0019439,0.932461892267029,0.123275369198093,8,554,aromatic compound catabolic process,BP,HSPB1;MGAT1;GDNF;ZFP36L2;TOB1;UPF1;DDIT4;HK2
18123,GO:1902749,0.932554316704475,0.190036155961733,2,195,regulation of cell cycle G2/M phase transition,BP,GPR132;TUBA4A
4517,GO:0010564,0.933104752740277,0.118811030412774,9,622,regulation of cell cycle process,BP,CDK5R1;GPR132;CTGF;TUBA4A;ZFP36L2;SOX9;SOX15;NACC2;ZNF16
5862,GO:0017157,0.933523673964085,0.249639352442805,1,122,regulation of exocytosis,BP,VSNL1
15269,GO:0071426,0.933680932268067,0.249227754734562,1,121,ribonucleoprotein complex export from nucleus,BP,UPF1
7856,GO:0032412,0.934452074208526,0.247056781212452,1,125,regulation of ion transmembrane transporter activity,BP,HSPA2
74,GO:0000151,0.934640046869654,0.160044191391048,3,266,ubiquitin ligase complex,CC,RNF168;FBXL12;PHC2
6634,GO:0022890,0.934874097123344,0.159566645609731,3,269,inorganic cation transmembrane transporter activity,MF,SLC20A2;SLC30A1;SLC20A1
5442,GO:0016301,0.93505066996788,0.115767334095191,9,635,kinase activity,MF,CDK5R1;MAP3K14;EPHB3;NME9;PAK6;PIK3R1;SOX9;STK17A;HK2
2872,GO:0006364,0.935089099632898,0.159194890248871,3,255,rRNA processing,BP,METTL15;IMP3;RRP36
3299,GO:0006997,0.935179296926418,0.245078344235561,1,124,nucleus organization,BP,PYGO2
15123,GO:0071166,0.935206382040934,0.245036335551614,1,122,ribonucleoprotein complex localization,BP,UPF1
2274,GO:0005215,0.935603951770785,0.112119574195987,10,682,transporter activity,MF,SLC2A1;SLC7A5P2;SLC20A2;SLC22A15;SLC30A1;LRRC8A;SLC2A3;SLC20A1;MFSD2A;GJB2
8356,GO:0033218,0.935737811715272,0.182954469383948,2,198,amide binding,MF,PIK3R1;CLU
10906,GO:0044448,0.936229347953985,0.242137489636034,1,127,cell cortex part,CC,SLC2A1
874,GO:0002221,0.936293589404182,0.242022372021413,1,123,pattern recognition receptor signaling pathway,BP,NR1D1
5455,GO:0016323,0.936472598999676,0.241464537938105,1,127,basolateral plasma membrane,CC,SLC2A1
5285,GO:0015934,0.936683078395685,0.241081843738062,1,115,large ribosomal subunit,CC,SURF6
11113,GO:0045121,0.936928039117702,0.180263356865663,2,202,membrane raft,CC,SLC2A1;MALL
3600,GO:0008033,0.936941641672008,0.240276095166624,1,120,tRNA processing,BP,TRMT61A
5668,GO:0016773,0.937197660562833,0.11568874949382,8,582,phosphotransferase activity, alcohol group as acceptor,MF,CDK5R1;MAP3K14;EPHB3;PAK6;PIK3R1;SOX9;STK17A;HK2
5720,GO:0016853,0.937648811758768,0.238291856162347,1,121,isomerase activity,MF,FKBP9
3064,GO:0006626,0.937942718059672,0.237471756050305,1,121,protein targeting to mitochondrion,BP,HES1
16915,GO:0098857,0.938064448054162,0.177699466186177,2,203,membrane microdomain,CC,SLC2A1;MALL
10982,GO:0044770,0.938238060900458,0.118016781506902,7,511,cell cycle phase transition,BP,MYC;GPR132;TUBA4A;ZFP36L2;UPF1;NACC2;ZNF16
16329,GO:0090501,0.938276789416282,0.236505317152469,1,123,RNA phosphodiester bond hydrolysis,BP,RRP36
2955,GO:0006486,0.93832575856349,0.177109528732457,2,203,protein glycosylation,BP,FUT1;MGAT1
10513,GO:0043413,0.93832575856349,0.177109528732457,2,203,macromolecule glycosylation,BP,FUT1;MGAT1
6635,GO:0022898,0.938872592402651,0.234758581373162,1,128,regulation of transmembrane transporter activity,BP,HSPA2
3079,GO:0006650,0.938976840000821,0.15132218643412,3,272,glycerophospholipid metabolic process,BP,PIK3R1;MFSD2A;PCYT1A
18382,GO:1903362,0.939053254742741,0.175476013223404,2,201,regulation of cellular protein catabolic process,BP,CEBPA;CLU
4518,GO:0010565,0.93911427586434,0.234140279706347,1,124,regulation of cellular ketone metabolic process,BP,NR1D1
545,GO:0001664,0.93934384367924,0.233478749237763,1,125,G-protein coupled receptor binding,MF,CXCL14
6239,GO:0019787,0.939538971784033,0.127341333970178,5,401,ubiquitin-like protein transferase activity,MF,RNF168;SIAH2;FBXL12;FBXL18;TRIM56
11066,GO:0045055,0.939863666497083,0.115320204840407,7,514,regulated exocytosis,BP,SERPINE1;TUBA4A;PCDH7;SLC2A3;CNN2;TIMP3;CLU
2556,GO:0005829,0.940204610559891,0.0774216738997064,79,4103,cytosol,CC,SPRY4;RGS2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;TXNIP;MYC;MAT2A;RIN2;C1ORF116;FLRT3;HSPB1;CTGF;AHNAK2;MAP3K14;BAG3;BRPF1;NR2F2;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;RNF168;CDC42EP2;KCTD7;RHOD;CD3EAP;HIST1H2BI;ZKSCAN4;VSNL1;EPHB3;CBR1;SIAH2;HJURP;PLCD1;UPF1;BLOC1S3;SEC14L2;VASP;PIK3R1;ERF;GJB2;HSPA2;BICD2;HIST1H2BO;RIN1;AKR1C1;DDIT4;SNX33;HIST1H2BE;KRT16;FBXL12;PCYT1A;NCDN;CIPC;ING2;FBXL18;DNAJB2;HIST2H2BE;TRIM26;HIC1;HIST3H2BB;SOCS6;KRT17;TBCC;TRIM56;RGS3;HK2;NOTCH3;SOCS1;CLU;FAM217B;CISH
94,GO:0000184,0.940394358557273,0.230608076891736,1,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,UPF1
3804,GO:0008380,0.940851121304486,0.125010903919873,5,392,RNA splicing,BP,IVNS1ABP;AHNAK2;RBM15;ESRP2;PIK3R1
3483,GO:0007346,0.941752329697817,0.108339168538003,8,577,regulation of mitotic cell cycle,BP,HES1;GPR132;MAP3K14;TUBA4A;ZFP36L2;TRIM35;PAK6;NACC2
8664,GO:0034220,0.942780734119159,0.106660805735969,8,583,ion transmembrane transport,BP,TSC22D3;SLC7A5P2;SLC20A2;SLC30A1;LRRC8A;SLC20A1;HSPA2;PER2
1111,GO:0002697,0.943564223372912,0.165120666896275,2,205,regulation of immune effector process,BP,ZBTB7B;CLU
6728,GO:0030135,0.944185295319294,0.163663707023125,2,208,coated vesicle,CC,MALL;VPS18
9044,GO:0035257,0.944811146731964,0.217738422906224,1,131,nuclear hormone receptor binding,MF,FHL2
14568,GO:0070085,0.944984824986931,0.161798566411208,2,209,glycosylation,BP,FUT1;MGAT1
5903,GO:0018105,0.945012275944357,0.161723470827121,2,211,peptidyl-serine phosphorylation,BP,CDK5R1;DDIT4
1966,GO:0004672,0.945236203658529,0.110950787986481,6,475,protein kinase activity,MF,CDK5R1;MAP3K14;EPHB3;PAK6;SOX9;STK17A
17598,GO:1901215,0.945445631083352,0.215887152972418,1,131,negative regulation of neuron death,BP,GDNF
17572,GO:1901136,0.945876410426816,0.214653498177267,1,129,carbohydrate derivative catabolic process,BP,MGAT1
5283,GO:0015931,0.946157333860052,0.159064108780296,2,208,nucleobase-containing compound transport,BP,UPF1;BICD2
2896,GO:0006403,0.946882807606999,0.157355188371859,2,209,RNA localization,BP,UPF1;BICD2
9189,GO:0035567,0.947191845148198,0.210739562485692,1,132,non-canonical Wnt signaling pathway,BP,FZD10
4027,GO:0009057,0.947296517795267,0.0829575880245172,18,1127,macromolecule catabolic process,BP,TIPARP;PPP1R3D;HSPB1;GDNF;ZFP36L2;RNF168;TOB1;SIAH2;UPF1;SOX9;CEBPA;TIMP3;SNX33;FBXL12;NR1D1;FBXL18;SOCS6;CLU
3077,GO:0006644,0.947299120504632,0.121592925863864,4,345,phospholipid metabolic process,BP,PLCD1;PIK3R1;MFSD2A;PCYT1A
5705,GO:0016829,0.947815735909372,0.208931568755764,1,129,lyase activity,MF,L3HYPDH
3224,GO:0006875,0.948338713250176,0.131996165726073,3,282,cellular metal ion homeostasis,BP,MYC;KCTD7;SLC30A1
2898,GO:0006405,0.949244040557212,0.204617240897529,1,133,RNA export from nucleus,BP,UPF1
1781,GO:0004386,0.949348583420858,0.204253780037659,1,137,helicase activity,MF,UPF1
11141,GO:0045177,0.949675274655487,0.150698748820828,2,217,apical part of cell,CC,SLC2A1;IGFBP2
10903,GO:0044445,0.949710015449663,0.150690878755004,2,203,cytosolic part,CC,SURF6;BLOC1S3
577,GO:0001726,0.949812123148674,0.202849404232601,1,138,ruffle,CC,SPRY4
8788,GO:0034470,0.949928743623661,0.108483405298301,5,396,ncRNA processing,BP,METTL15;BCDIN3D;IMP3;TRMT61A;RRP36
12865,GO:0051170,0.950204811628925,0.201702937548506,1,135,import into nucleus,BP,TXNIP
11528,GO:0046034,0.950383277084168,0.149053527803288,2,208,ATP metabolic process,BP,DDIT4;HK2
13106,GO:0051603,0.950827485327077,0.0933984541359291,8,590,proteolysis involved in cellular protein catabolic process,BP,RNF168;SIAH2;CEBPA;FBXL12;NR1D1;FBXL18;SOCS6;CLU
13107,GO:0051604,0.950830001117036,0.147966554202168,2,211,protein maturation,BP,SERPINE1;CLU
19728,GO:2000045,0.951235978775482,0.198581254168886,1,135,regulation of G1/S transition of mitotic cell cycle,BP,NACC2
2842,GO:0006310,0.951956154721598,0.145235175200823,2,215,DNA recombination,BP,RNF168;DCLRE1C
308,GO:0000819,0.951994151877269,0.14513845209252,2,216,sister chromatid segregation,BP,PHF13;CHAMP1
12907,GO:0051235,0.952277276131447,0.144430115361846,2,221,maintenance of location,BP,SLC30A1;HK2
3336,GO:0007050,0.95239741850129,0.144168550460567,2,215,cell cycle arrest,BP,CDK5R1;MYC
5733,GO:0016874,0.952509163297695,0.194696082039163,1,135,ligase activity,MF,MARS2
3029,GO:0006575,0.953006529901653,0.193181196675617,1,134,cellular modified amino acid metabolic process,BP,ALDH4A1
14555,GO:0070062,0.953258671861218,0.0665051146802915,36,2042,extracellular exosome,CC,SLC2A1;SERPINE1;VASN;C1ORF116;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;SLC20A2;TUBA4A;IGFBP2;HIST1H2BI;FAT2;HIST1H3J;HIST1H2AB;CBR1;PLCD1;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;HSPA2;TIMP3;AKR1C1;HIST1H2BE;KRT16;HIST1H4K;HIST2H2BE;COL1A2;KRT17;HIST1H4D;CLU;HIST1H2AH
10917,GO:0044463,0.953352133120558,0.0793169546169832,13,892,cell projection part,CC,SPRY4;CDK5R1;FLRT3;HSPB1;CDHR1;EPHB3;BLOC1S3;VASP;NCDN;NR1D1;PALMD;TBCC;CLU
17268,GO:0120038,0.953352133120558,0.0793169546169832,13,892,plasma membrane bounded cell projection part,CC,SPRY4;CDK5R1;FLRT3;HSPB1;CDHR1;EPHB3;BLOC1S3;VASP;NCDN;NR1D1;PALMD;TBCC;CLU
2804,GO:0006261,0.95412327237981,0.189696411485706,1,137,DNA-dependent DNA replication,BP,UPF1
10673,GO:0043900,0.954218496271516,0.119472729862955,3,284,regulation of multi-organism process,BP,TRIM35;TRIM26;IFITM1
16779,GO:0098562,0.954281524512243,0.189182390796165,1,139,cytoplasmic side of membrane,CC,RGS2
18598,GO:1903827,0.954373627901468,0.100164638215331,5,418,regulation of cellular protein localization,BP,HES1;CDK5R1;BAG3;PIK3R1;SNX33
12176,GO:0048285,0.954546896882978,0.107336184098684,4,356,organelle fission,BP,PHF13;CHAMP1;HSPA2;ING2
3455,GO:0007268,0.954938942937184,0.117890405498498,3,293,chemical synaptic transmission,BP,GDNF;SLC30A1;NCDN
16949,GO:0098916,0.954938942937184,0.117890405498498,3,293,anterograde trans-synaptic signaling,BP,GDNF;SLC30A1;NCDN
4484,GO:0010498,0.955306612670749,0.0984121969087873,5,415,proteasomal protein catabolic process,BP,CEBPA;NR1D1;FBXL18;SOCS6;CLU
7419,GO:0031503,0.955524822123628,0.136515835102106,2,219,protein-containing complex localization,BP,UPF1;NACC2
1159,GO:0002764,0.955563548514266,0.105309197921479,4,354,immune response-regulating signaling pathway,BP,TNFRSF21;FOS;PIK3R1;NR1D1
10096,GO:0042594,0.955775550856274,0.184508960677899,1,140,response to starvation,BP,SLC2A1
6296,GO:0019902,0.955914155889404,0.184052004526058,1,142,phosphatase binding,MF,PIK3R1
10402,GO:0043230,0.956201709632423,0.0625940959046389,36,2051,extracellular organelle,CC,SLC2A1;SERPINE1;VASN;C1ORF116;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;SLC20A2;TUBA4A;IGFBP2;HIST1H2BI;FAT2;HIST1H3J;HIST1H2AB;CBR1;PLCD1;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;HSPA2;TIMP3;AKR1C1;HIST1H2BE;KRT16;HIST1H4K;HIST2H2BE;COL1A2;KRT17;HIST1H4D;CLU;HIST1H2AH
18481,GO:1903561,0.956201709632423,0.0625940959046389,36,2051,extracellular vesicle,CC,SLC2A1;SERPINE1;VASN;C1ORF116;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;SLC20A2;TUBA4A;IGFBP2;HIST1H2BI;FAT2;HIST1H3J;HIST1H2AB;CBR1;PLCD1;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;HSPA2;TIMP3;AKR1C1;HIST1H2BE;KRT16;HIST1H4K;HIST2H2BE;COL1A2;KRT17;HIST1H4D;CLU;HIST1H2AH
17266,GO:0120035,0.956377979940071,0.0963678063230614,5,429,regulation of plasma membrane bounded cell projection organization,BP,ID1;CDK5R1;CDC42EP2;EPHB3;PLEKHM1
17067,GO:0099537,0.957023242972774,0.113347344318384,3,296,trans-synaptic signaling,BP,GDNF;SLC30A1;NCDN
332,GO:0000922,0.9573899103639,0.179391628859125,1,142,spindle pole,CC,FAM110C
6733,GO:0030141,0.957488038551629,0.0852488940846237,7,539,secretory granule,CC,SERPINE1;PCDH7;COL1A1;SLC2A3;CNN2;TIMP3;CLU
10390,GO:0043209,0.95759267470739,0.178779810085829,1,139,myelin sheath,CC,HSPA2
17066,GO:0099536,0.957653925875741,0.111963349016677,3,297,synaptic signaling,BP,GDNF;SLC30A1;NCDN
17845,GO:1901990,0.957954046944274,0.100492953954258,4,357,regulation of mitotic cell cycle phase transition,BP,GPR132;TUBA4A;ZFP36L2;NACC2
4860,GO:0014069,0.958567620894591,0.175574417086168,1,148,postsynaptic density,CC,CDK5R1
5852,GO:0017144,0.958898119004831,0.0827716387208499,7,536,drug metabolic process,BP,MAT2A;CYP1B1;CBR1;AKR1C1;DDIT4;HK2;CLU
6177,GO:0019538,0.958965936656209,0.0541830318305856,80,4211,protein metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;SERPINE1;MYC;HR;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;HIST1H4L;MGAT1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;MARS2;HIST1H2BJ;ZFP36L2;BCDIN3D;RNF168;IGFBP2;KCTD7;FAM212B;HIST1H2BI;ADAMTS15;TOB1;EPHB3;HIST1H3J;PAK6;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;HSPA2;HIST1H2BO;TIMP3;STK17A;DDIT4;SNX33;HIST1H2BE;ARTN;FBXL12;PYGO2;NR1D1;FKBP9;ING2;HIST1H1C;HIST1H1D;FBXL18;HIST1H4K;PER2;DNAJB2;NACC2;SOCS6;KRT17;TRIM56;HIST1H4D;RGS3;NOTCH3;PMEPA1;SOCS1;CLU;CISH
17086,GO:0099572,0.959469097575346,0.172666759787602,1,149,postsynaptic specialization,CC,CDK5R1
10801,GO:0044272,0.959627644130595,0.172214154297711,1,143,sulfur compound biosynthetic process,BP,MAT2A
4098,GO:0009150,0.96001877620767,0.0962960510004674,4,357,purine ribonucleotide metabolic process,BP,PTHLH;NME9;DDIT4;HK2
12849,GO:0051146,0.960195840027738,0.170315535989262,1,149,striated muscle cell differentiation,BP,FHL2
7767,GO:0032279,0.960255047961561,0.170114039220491,1,150,asymmetric synapse,CC,CDK5R1
890,GO:0002253,0.960525994420238,0.0952502664835571,4,362,activation of immune response,BP,TNFRSF21;PIK3R1;NR1D1;CLU
5935,GO:0018209,0.960897097135814,0.123037843608584,2,229,peptidyl-serine modification,BP,CDK5R1;DDIT4
42,GO:0000086,0.961255706301562,0.122141770897546,2,225,G2/M transition of mitotic cell cycle,BP,GPR132;TUBA4A
4768,GO:0010948,0.961573463503429,0.103282350867994,3,295,negative regulation of cell cycle process,BP,GPR132;ZFP36L2;NACC2
18136,GO:1902806,0.96187610950322,0.164855305822026,1,146,regulation of cell cycle G1/S phase transition,BP,NACC2
16981,GO:0098984,0.961958135968054,0.16452987628542,1,152,neuron to neuron synapse,CC,CDK5R1
2514,GO:0005765,0.962002099051117,0.102314272292862,3,298,lysosomal membrane,CC,VASN;PLEKHM1;VPS18
16913,GO:0098852,0.962002099051117,0.102314272292862,3,298,lytic vacuole membrane,CC,VASN;PLEKHM1;VPS18
2275,GO:0005216,0.962090895447767,0.164110767744566,1,150,ion channel activity,MF,LRRC8A
38,GO:0000077,0.96269046498908,0.162158396733822,1,147,DNA damage checkpoint,BP,MAP3K14
3341,GO:0007059,0.963480406851277,0.0989740307727976,3,302,chromosome segregation,BP,PHF13;CHAMP1;HJURP
4380,GO:0010008,0.963609178990188,0.088883396419825,4,367,endosome membrane,CC,RHOD;PLEKHM1;PMEPA1;VPS18
17121,GO:0101002,0.963778616278495,0.158548461754453,1,146,ficolin-1-rich granule,CC,SLC2A3
6675,GO:0030031,0.963846880301669,0.0819854152858301,5,438,cell projection assembly,BP,FAM110C;TUBA4A;CDC42EP2;RHOD;PLEKHM1
2573,GO:0005856,0.963944423333207,0.0552254945484401,25,1567,cytoskeleton,CC,ID1;CDK5R1;IVNS1ABP;SLC2A1;FAM110C;IFFO2;HSPB1;TUBA4A;CHAMP1;FHL3;CDC42EP2;NME9;VASP;CNN2;HSPA2;BICD2;RIN1;KRT16;KRT17;IFFO1;TBCC;NOTCH3;CLU;CDC42SE1;VPS18
10787,GO:0044242,0.964181754885078,0.157189724490933,1,147,cellular lipid catabolic process,BP,CYP1B1
3252,GO:0006913,0.96422007396749,0.0972948982094976,3,303,nucleocytoplasmic transport,BP,TXNIP;BAG3;UPF1
16826,GO:0098662,0.964258714792183,0.0875222270160661,4,373,inorganic cation transmembrane transport,BP,SLC20A2;SLC30A1;SLC20A1;HSPA2
6620,GO:0022838,0.964664111987181,0.155515864154749,1,153,substrate-specific channel activity,MF,LRRC8A
2495,GO:0005741,0.964735356116706,0.155320012012363,1,148,mitochondrial outer membrane,CC,HK2
7343,GO:0031349,0.96476504007459,0.0960571413915445,3,302,positive regulation of defense response,BP,SERPINE1;IL17RA;NR1D1
2802,GO:0006259,0.964893908420766,0.06253224008936,12,843,DNA metabolic process,BP,MYC;ID3;HIST1H4L;CTGF;FOS;RNF168;ZNF93;UPF1;HIST1H4B;HIST1H4K;HIST1H4D;DCLRE1C
6672,GO:0030027,0.964893992938052,0.154724502141943,1,155,lamellipodium,CC,VASP
6636,GO:0022900,0.965039236905617,0.154351760370443,1,142,electron transport chain,BP,ALDH4A1
5407,GO:0016241,0.965572522639925,0.152463062690527,1,151,regulation of macroautophagy,BP,CDK5R1
978,GO:0002429,0.966002296625866,0.109838992431587,2,232,immune response-activating cell surface receptor signaling pathway,BP,TNFRSF21;PIK3R1
12864,GO:0051169,0.966070010114512,0.0930632988691431,3,306,nuclear transport,BP,TXNIP;BAG3;UPF1
10884,GO:0044419,0.966268318567455,0.0630998362054534,10,727,interspecies interaction between organisms,BP,IVNS1ABP;SLC20A2;HIST1H2BJ;TRIM35;RBM15;PIK3R1;CEBPA;TRIM26;IFITM1;VPS18
3773,GO:0008324,0.966300499943721,0.0925294761922853,3,308,cation transmembrane transporter activity,MF,SLC20A2;SLC30A1;SLC20A1
14853,GO:0070588,0.966367443755704,0.149714878931722,1,156,calcium ion transmembrane transport,BP,HSPA2
8864,GO:0034660,0.96685943194602,0.0685089024754349,7,545,ncRNA metabolic process,BP,METTL15;MARS2;BCDIN3D;CD3EAP;IMP3;TRMT61A;RRP36
17715,GO:1901605,0.967369324613057,0.146317559927003,1,151,alpha-amino acid metabolic process,BP,ALDH4A1
16435,GO:0097060,0.967590058848099,0.145491514285479,1,159,synaptic membrane,CC,FLRT3
133,GO:0000278,0.967857988270391,0.0566644218570374,13,913,mitotic cell cycle,BP,HES1;MYC;GPR132;MAP3K14;TUBA4A;ZFP36L2;PHF13;TRIM35;CHAMP1;PAK6;ERF;SNX33;NACC2
4789,GO:0010975,0.967957358876955,0.0886830712195047,3,317,regulation of neuron projection development,BP,ID1;CDK5R1;EPHB3
4184,GO:0009259,0.968024604122226,0.0795964502664162,4,371,ribonucleotide metabolic process,BP,PTHLH;NME9;DDIT4;HK2
17261,GO:0120025,0.968182206560922,0.0517508790871189,19,1262,plasma membrane bounded cell projection,CC,SPRY4;RGS2;CDK5R1;FLRT3;HSPB1;TNFRSF21;BAG3;CDHR1;FOS;EPHB3;SIAH2;BLOC1S3;VASP;GJB2;NCDN;NR1D1;PALMD;TBCC;CLU
17291,GO:0140014,0.968604113760028,0.102914096886249,2,240,mitotic nuclear division,BP,PHF13;CHAMP1
2755,GO:0006163,0.968628561596001,0.078308343660368,4,372,purine nucleotide metabolic process,BP,PTHLH;NME9;DDIT4;HK2
6690,GO:0030054,0.968662432291999,0.0564333597568039,12,872,cell junction,CC,SPRY4;SLC2A1;FLRT3;HSPB1;FHL2;FHL3;FAT2;PAK6;VASP;PIK3R1;CNN2;GJB2
3048,GO:0006605,0.969177189642378,0.0771413849220657,4,368,protein targeting,BP,HES1;CDK5R1;RHOD;CLU
2562,GO:0005840,0.969764679751512,0.0998469580122885,2,225,ribosome,CC,SURF6;IMP3
7444,GO:0031570,0.970203681792887,0.136367620766702,1,157,DNA integrity checkpoint,BP,MAP3K14
5319,GO:0016032,0.970257336020616,0.05796875402419,9,680,viral process,BP,IVNS1ABP;SLC20A2;TRIM35;RBM15;PIK3R1;CEBPA;TRIM26;IFITM1;VPS18
6656,GO:0030001,0.970362837331704,0.0690231458125197,5,452,metal ion transport,BP,CTGF;SLC20A2;SLC30A1;SLC20A1;HSPA2
11708,GO:0046488,0.970417199428961,0.135588736478499,1,160,phosphatidylinositol metabolic process,BP,PIK3R1
11016,GO:0044839,0.970477076871515,0.097871298375405,2,239,cell cycle G2/M phase transition,BP,GPR132;TUBA4A
12230,GO:0048471,0.970595941868479,0.0646135755544667,6,514,perinuclear region of cytoplasm,CC,CDK5R1;CTGF;PIK3R1;GJB2;PER2;CLU
5571,GO:0016579,0.970966048418199,0.0965297134559255,2,243,protein deubiquitination,BP,MYC;SIAH2
2539,GO:0005794,0.971056442166135,0.0485330353318939,17,1152,Golgi apparatus,CC,ID1;PTHLH;SLC2A1;FUT1;MGAT1;CTGF;COL1A1;SLC30A1;CXCL14;PIK3R1;MALL;BICD2;ING2;NOTCH3;PMEPA1;CLU;DCLRE1C
10793,GO:0044257,0.971325233011185,0.0579748777982954,8,633,cellular protein catabolic process,BP,RNF168;SIAH2;CEBPA;FBXL12;NR1D1;FBXL18;SOCS6;CLU
2972,GO:0006511,0.971781827515642,0.0623243598179641,6,513,ubiquitin-dependent protein catabolic process,BP,RNF168;SIAH2;CEBPA;FBXL12;FBXL18;CLU
8943,GO:0034976,0.971911294017488,0.0939491617994156,2,242,response to endoplasmic reticulum stress,BP,PIK3R1;CLU
11706,GO:0046486,0.97219162735312,0.0787126331317238,3,319,glycerolipid metabolic process,BP,PIK3R1;MFSD2A;PCYT1A
1968,GO:0004674,0.972649824236566,0.0695952687064276,4,397,protein serine/threonine kinase activity,MF,MAP3K14;EPHB3;PAK6;STK17A
7837,GO:0032386,0.972953440348249,0.0768876770675252,3,320,regulation of intracellular transport,BP,HES1;CDK5R1;BAG3
889,GO:0002252,0.973640014442986,0.0505671226057536,10,753,immune effector process,BP,MAP3K14;RNF168;ZBTB7B;SLC2A3;PIK3R1;CNN2;DDIT4;IFITM1;TRIM56;CLU
10805,GO:0044281,0.973694073034122,0.0415380856139019,24,1505,small molecule metabolic process,BP,SNAI2;PTHLH;SLC2A1;MIDN;MAT2A;CYP1B1;FUT1;PPP1R3D;MGAT1;MARS2;NME9;CBR1;PLCD1;SEC14L2;SLC2A3;CEBPA;ALDH4A1;AKR1C1;DDIT4;NR1D1;ZADH2;PER2;CES2;HK2
631,GO:0001818,0.973897250745781,0.123017423348223,1,161,negative regulation of cytokine production,BP,TNFRSF21
13119,GO:0051640,0.974187912457167,0.0576271505407838,6,523,organelle localization,BP,TUBA4A;CHAMP1;BLOC1S3;BICD2;PLEKHM1;VPS18
7601,GO:0031968,0.974291556482109,0.12155165042092,1,163,organelle outer membrane,CC,HK2
13288,GO:0051962,0.97439400835375,0.0733985597404807,3,329,positive regulation of nervous system development,BP,HES1;FLRT3;EPHB3
5148,GO:0015672,0.974404255264359,0.0870206612812772,2,249,monovalent inorganic cation transport,BP,SLC20A2;SLC20A1
6206,GO:0019693,0.974524065967471,0.0654893763549177,4,385,ribose phosphate metabolic process,BP,PTHLH;NME9;DDIT4;HK2
13514,GO:0055065,0.974824055734203,0.0723606654722065,3,325,metal ion homeostasis,BP,MYC;KCTD7;SLC30A1
6311,GO:0019941,0.974890807299521,0.0562465521880584,6,521,modification-dependent protein catabolic process,BP,RNF168;SIAH2;CEBPA;FBXL12;FBXL18;CLU
17708,GO:1901575,0.975063213598415,0.0389622304621264,26,1627,organic substance catabolic process,BP,TIPARP;CYP1B1;FUT1;PPP1R3D;HSPB1;MGAT1;GDNF;ZFP36L2;RNF168;TOB1;SIAH2;PLCD1;UPF1;SOX9;CEBPA;ALDH4A1;TIMP3;DDIT4;SNX33;FBXL12;NR1D1;FBXL18;CES2;SOCS6;HK2;CLU
6277,GO:0019867,0.975292941378154,0.117822244228689,1,165,outer membrane,CC,HK2
10792,GO:0044255,0.975500561635264,0.0473410693032936,10,761,cellular lipid metabolic process,BP,CYP1B1;CBR1;PLCD1;PIK3R1;MFSD2A;AKR1C1;PCYT1A;ZADH2;PER2;CES2
16262,GO:0090305,0.975628447341528,0.0835778007083974,2,248,nucleic acid phosphodiester bond hydrolysis,BP,RRP36;DCLRE1C
7340,GO:0031346,0.975901721201195,0.0827780989326816,2,258,positive regulation of cell projection organization,BP,CDC42EP2;PLEKHM1
6600,GO:0022613,0.976037246942785,0.0573758291064425,5,448,ribonucleoprotein complex biogenesis,BP,METTL15;SURF6;IMP3;URB2;RRP36
7341,GO:0031347,0.976060628981178,0.0573179816741661,5,459,regulation of defense response,BP,SERPINE1;IL17RA;NR1D1;SOCS1;CLU
1477,GO:0003735,0.976078051603895,0.114952391431186,1,154,structural constituent of ribosome,MF,IMP3
10900,GO:0044440,0.9763980216153,0.061308932994135,4,394,endosomal part,CC,RHOD;PLEKHM1;PMEPA1;VPS18
11842,GO:0046777,0.976519419598357,0.113172218757929,1,172,protein autophosphorylation,BP,EPHB3
16890,GO:0098813,0.976864859459794,0.0800446149638157,2,254,nuclear chromosome segregation,BP,PHF13;CHAMP1
4075,GO:0009126,0.976882584276617,0.0800090977843943,2,248,purine nucleoside monophosphate metabolic process,BP,DDIT4;HK2
4114,GO:0009167,0.976882584276617,0.0800090977843943,2,248,purine ribonucleoside monophosphate metabolic process,BP,DDIT4;HK2
3204,GO:0006839,0.97764533350439,0.0778160367075775,2,249,mitochondrial transport,BP,HES1;HK2
15832,GO:0072521,0.977676886683181,0.0584325767164161,4,393,purine-containing compound metabolic process,BP,PTHLH;NME9;DDIT4;HK2
4058,GO:0009101,0.97792552158261,0.0769833365926606,2,259,glycoprotein biosynthetic process,BP,FUT1;MGAT1
10638,GO:0043632,0.977960368802619,0.0501390544279568,6,530,modification-dependent macromolecule catabolic process,BP,RNF168;SIAH2;CEBPA;FBXL12;FBXL18;CLU
1152,GO:0002757,0.978247185492004,0.0639175103309142,3,330,immune response-activating signal transduction,BP,TNFRSF21;PIK3R1;NR1D1
14877,GO:0070646,0.978283333355868,0.0759501135078761,2,258,protein modification by small protein removal,BP,MYC;SIAH2
16824,GO:0098660,0.978609637705725,0.0563043409643548,4,406,inorganic ion transmembrane transport,BP,SLC20A2;SLC30A1;SLC20A1;HSPA2
5656,GO:0016747,0.979047514361449,0.103462524756451,1,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,BRPF1
10893,GO:0044430,0.97939031149316,0.0355240866260092,17,1191,cytoskeletal part,CC,ID1;CDK5R1;SLC2A1;FAM110C;IFFO2;HSPB1;TUBA4A;CHAMP1;FHL3;CNN2;HSPA2;BICD2;KRT16;KRT17;IFFO1;TBCC;VPS18
6658,GO:0030003,0.979468032572282,0.0608438983524056,3,336,cellular cation homeostasis,BP,MYC;KCTD7;SLC30A1
2803,GO:0006260,0.979561125835375,0.0722179936528653,2,260,DNA replication,BP,ID3;UPF1
3053,GO:0006612,0.9796092385058,0.101302341995116,1,165,protein targeting to membrane,BP,CDK5R1
14160,GO:0061024,0.979812946236047,0.0423775060663924,8,663,membrane organization,BP,GDNF;AHNAK2;MALL;RUNDC1;SNX33;HK2;CLU;VPS18
10260,GO:0042995,0.980282313898342,0.0332934185018688,19,1312,cell projection,CC,SPRY4;RGS2;CDK5R1;FLRT3;HSPB1;TNFRSF21;BAG3;CDHR1;FOS;EPHB3;SIAH2;BLOC1S3;VASP;GJB2;NCDN;NR1D1;PALMD;TBCC;CLU
10876,GO:0044403,0.980845084270291,0.0390556382734966,9,715,symbiont process,BP,IVNS1ABP;SLC20A2;TRIM35;RBM15;PIK3R1;CEBPA;TRIM26;IFITM1;VPS18
17702,GO:1901566,0.980914027054377,0.0308280191198542,24,1535,organonitrogen compound biosynthetic process,BP,RGS2;PTHLH;FUT1;HSPB1;HIST1H4L;MGAT1;MARS2;ZFP36L2;BCDIN3D;TOB1;HIST1H3J;NME9;UPF1;HIST1H4B;MFSD2A;IMP3;CEBPA;DDIT4;PCYT1A;HIST1H4K;PER2;KRT17;HIST1H4D;HK2
6588,GO:0022411,0.981360664988419,0.0460357832715368,5,476,cellular component disassembly,BP,SNAI2;MYC;UPF1;HSPA2;HK2
4108,GO:0009161,0.98140821220726,0.0667454529116771,2,259,ribonucleoside monophosphate metabolic process,BP,DDIT4;HK2
1858,GO:0004518,0.981622294793209,0.0932258370424809,1,177,nuclease activity,MF,DCLRE1C
17315,GO:0140097,0.981654137462237,0.0930926318600461,1,178,catalytic activity, acting on DNA,MF,DCLRE1C
16820,GO:0098655,0.981658691849433,0.0492738861533612,4,415,cation transmembrane transport,BP,SLC20A2;SLC30A1;SLC20A1;HSPA2
10901,GO:0044441,0.981918541770244,0.0651937977223179,2,269,ciliary part,CC,CDHR1;TBCC
3222,GO:0006873,0.982076056569538,0.0541740406980584,3,344,cellular ion homeostasis,BP,MYC;KCTD7;SLC30A1
10914,GO:0044456,0.982210057260342,0.0479803249657468,4,421,synapse part,CC,CDK5R1;FLRT3;NR1D1;PALMD
15906,GO:0072659,0.982329509199833,0.090331421720151,1,183,protein localization to plasma membrane,BP,PIK3R1
10797,GO:0044265,0.982471389854688,0.0326245787756031,13,959,cellular macromolecule catabolic process,BP,HSPB1;GDNF;ZFP36L2;RNF168;TOB1;SIAH2;UPF1;CEBPA;FBXL12;NR1D1;FBXL18;SOCS6;CLU
2522,GO:0005774,0.982753084139652,0.0524194649150811,3,343,vacuolar membrane,CC,VASN;PLEKHM1;VPS18
10630,GO:0043624,0.983029467256211,0.0874826506573943,1,179,cellular protein complex disassembly,BP,UPF1
3076,GO:0006643,0.983076376063941,0.0872894962639126,1,179,membrane lipid metabolic process,BP,CYP1B1
7471,GO:0031625,0.983102748236791,0.0616081075077249,2,268,ubiquitin protein ligase binding,MF,TXNIP;CLU
13132,GO:0051656,0.983293010138353,0.0510041981814147,3,349,establishment of organelle localization,BP,CHAMP1;BLOC1S3;BICD2
4026,GO:0009056,0.983562454987635,0.0254639734103196,32,1987,catabolic process,BP,TIPARP;CDK5R1;CYP1B1;FUT1;PPP1R3D;HSPB1;MGAT1;GDNF;ZFP36L2;RNF168;ZKSCAN4;COL1A1;TOB1;SIAH2;PLCD1;UPF1;SOX9;CEBPA;ALDH4A1;TIMP3;DDIT4;SNX33;PLEKHM1;FBXL12;NR1D1;FBXL18;CES2;COL1A2;SOCS6;HK2;CLU;VPS18
17046,GO:0099503,0.983596207862264,0.0366852447759326,7,609,secretory vesicle,CC,SERPINE1;PCDH7;COL1A1;SLC2A3;CNN2;TIMP3;CLU
110,GO:0000226,0.98368948325569,0.0444865949031058,4,427,microtubule cytoskeleton organization,BP,RGS2;CDK5R1;TUBA4A;BICD2
10984,GO:0044772,0.983787442363443,0.0407197522200643,5,484,mitotic cell cycle phase transition,BP,MYC;GPR132;TUBA4A;ZFP36L2;NACC2
13128,GO:0051650,0.984289795994339,0.0822087818791031,1,188,establishment of vesicle localization,BP,BLOC1S3
17573,GO:1901137,0.984760766202098,0.0361542816376451,6,556,carbohydrate derivative biosynthetic process,BP,PTHLH;FUT1;MGAT1;NME9;DDIT4;HK2
17262,GO:0120031,0.984837823627088,0.0417441267036586,4,428,plasma membrane bounded cell projection assembly,BP,TUBA4A;CDC42EP2;RHOD;PLEKHM1
16879,GO:0098797,0.985098496803274,0.0554252738252701,2,281,plasma membrane protein complex,CC,GJB2;HSPA2
4072,GO:0009123,0.985413209112258,0.0544558156765456,2,271,nucleoside monophosphate metabolic process,BP,DDIT4;HK2
17701,GO:1901565,0.985589866491984,0.0272657242297305,13,979,organonitrogen compound catabolic process,BP,TIPARP;RNF168;SIAH2;SOX9;CEBPA;ALDH4A1;TIMP3;SNX33;FBXL12;NR1D1;FBXL18;SOCS6;CLU
8227,GO:0032984,0.985655815215055,0.0536866648436313,2,275,protein-containing complex disassembly,BP,MYC;UPF1
5655,GO:0016746,0.986177598805256,0.0741615220524677,1,190,transferase activity, transferring acyl groups,MF,BRPF1
13126,GO:0051648,0.986242401510789,0.0738671635989859,1,194,vesicle localization,BP,BLOC1S3
2519,GO:0005770,0.986452734840322,0.0729649475334918,1,191,late endosome,CC,VPS18
9991,GO:0042391,0.986481347536954,0.0728303011653796,1,194,regulation of membrane potential,BP,KCTD7
5332,GO:0016054,0.986639222693988,0.0721564995488629,1,190,organic acid catabolic process,BP,ALDH4A1
11665,GO:0046395,0.986639222693988,0.0721564995488629,1,190,carboxylic acid catabolic process,BP,ALDH4A1
2391,GO:0005525,0.986743266890035,0.0502330179148165,2,278,GTP binding,MF,TUBA4A;RHOD
10109,GO:0042623,0.986756638933536,0.0501744987048171,2,289,ATPase activity, coupled,MF,UPF1;HSPA2
10870,GO:0044389,0.986952495125373,0.0495590403359319,2,281,ubiquitin-like protein ligase binding,MF,TXNIP;CLU
11159,GO:0045202,0.986997442413261,0.0335043057719916,5,512,synapse,CC,CDK5R1;FLRT3;ZMYND19;NR1D1;PALMD
6811,GO:0030258,0.987203427811223,0.0696637422399671,1,196,lipid modification,BP,PIK3R1
2904,GO:0006413,0.987311994584093,0.0692186337393908,1,186,translational initiation,BP,HSPB1
3223,GO:0006874,0.987421397762,0.068695466051207,1,198,cellular calcium ion homeostasis,BP,SLC30A1
2978,GO:0006520,0.987505867006777,0.0477812610984852,2,279,cellular amino acid metabolic process,BP,MARS2;ALDH4A1
7956,GO:0032550,0.987526342052169,0.0477122598627912,2,281,purine ribonucleoside binding,MF,TUBA4A;RHOD
6987,GO:0030659,0.987744487149872,0.0317970091116041,5,508,cytoplasmic vesicle membrane,CC,AHNAK2;PCDH7;LRIG3;SLC2A3;SNX33
676,GO:0001883,0.988026359833776,0.046087472712607,2,283,purine nucleoside binding,MF,TUBA4A;RHOD
3188,GO:0006812,0.988399779139831,0.0283450619071383,6,577,cation transport,BP,GDNF;CTGF;SLC20A2;SLC30A1;SLC20A1;HSPA2
7955,GO:0032549,0.98843480635577,0.0447506357215548,2,285,ribonucleoside binding,MF,TUBA4A;RHOD
7967,GO:0032561,0.988449328305451,0.0447030440656085,2,285,guanyl ribonucleotide binding,MF,TUBA4A;RHOD
1153,GO:0002758,0.988475703777111,0.0639834474538249,1,199,innate immune response-activating signal transduction,BP,NR1D1
5999,GO:0019001,0.988679730763095,0.0439452081461911,2,286,guanyl nucleotide binding,MF,TUBA4A;RHOD
11096,GO:0045088,0.988944318454122,0.043066761263241,2,291,regulation of innate immune response,BP,NR1D1;SOCS1
7276,GO:0031252,0.988984178578201,0.0429221660065284,2,302,cell leading edge,CC,SPRY4;VASP
4962,GO:0015031,0.989170062595517,0.0184940382824579,22,1503,protein transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;BAG3;IL17RA;RHOD;VSNL1;COL1A1;UPF1;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;SOCS1;CLU;VPS18
13519,GO:0055074,0.989258958652993,0.0604047843878254,1,205,calcium ion homeostasis,BP,SLC30A1
15443,GO:0071702,0.989501624044939,0.0168957201420866,30,1938,organic substance transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;GDNF;SLC7A5P2;BAG3;IL17RA;RHOD;SLC22A15;VSNL1;COL1A1;UPF1;SLC2A3;PIK3R1;MFSD2A;BICD2;AKR1C1;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;HK2;SOCS1;CLU;VPS18
19646,GO:1990778,0.98965876908255,0.0585591845355077,1,207,protein localization to cell periphery,BP,PIK3R1
10355,GO:0043161,0.989742980718556,0.0334722094927198,3,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,CEBPA;FBXL18;CLU
675,GO:0001882,0.989751440941357,0.0403824704739696,2,291,nucleoside binding,MF,TUBA4A;RHOD
68,GO:0000139,0.989906679859917,0.0250263942098041,6,585,Golgi membrane,CC,SLC2A1;FUT1;MGAT1;MALL;NOTCH3;PMEPA1
6731,GO:0030139,0.990329553737491,0.0554329576406239,1,208,endocytic vesicle,CC,CDC42EP2
16875,GO:0098793,0.990515127791894,0.0545580499146469,1,209,presynapse,CC,FLRT3
4811,GO:0012506,0.990573932611405,0.0251835052629624,5,525,vesicle membrane,CC,AHNAK2;PCDH7;LRIG3;SLC2A3;SNX33
36,GO:0000075,0.990638991539718,0.0539759914980519,1,208,cell cycle checkpoint,BP,MAP3K14
13524,GO:0055080,0.990707741477615,0.0307128752476511,3,381,cation homeostasis,BP,MYC;KCTD7;SLC30A1
10894,GO:0044431,0.99074986660297,0.0209660846239522,8,723,Golgi apparatus part,CC,SLC2A1;FUT1;MGAT1;CTGF;PIK3R1;MALL;NOTCH3;PMEPA1
5228,GO:0015833,0.991005378970437,0.0155470914605648,22,1521,peptide transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;BAG3;IL17RA;RHOD;VSNL1;COL1A1;UPF1;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;SOCS1;CLU;VPS18
12615,GO:0050778,0.991147475002655,0.026026317383736,4,453,positive regulation of immune response,BP,TNFRSF21;PIK3R1;NR1D1;CLU
3313,GO:0007017,0.991155567798025,0.0222275427973041,6,605,microtubule-based process,BP,RGS2;CDK5R1;HSPB1;TUBA4A;BLOC1S3;BICD2
172,GO:0000377,0.991507356612672,0.0343990551128161,2,299,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,RBM15;ESRP2
184,GO:0000398,0.991507356612672,0.0343990551128161,2,299,mRNA splicing, via spliceosome,BP,RBM15;ESRP2
872,GO:0002218,0.991713405414089,0.0488198558510591,1,214,activation of innate immune response,BP,NR1D1
11147,GO:0045184,0.991756758138076,0.0141911702879299,23,1584,establishment of protein localization,BP,HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;BAG3;IL17RA;RHOD;VSNL1;COL1A1;UPF1;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;HK2;SOCS1;CLU;VPS18
16865,GO:0098771,0.991918523381618,0.0271919637767206,3,389,inorganic ion homeostasis,BP,MYC;KCTD7;SLC30A1
171,GO:0000375,0.992021746978822,0.0326069231679037,2,302,RNA splicing, via transesterification reactions,BP,RBM15;ESRP2
15820,GO:0072503,0.992069162644152,0.0470782963277493,1,218,cellular divalent inorganic cation homeostasis,BP,SLC30A1
4057,GO:0009100,0.992100970683074,0.032321650169559,2,311,glycoprotein metabolic process,BP,FUT1;MGAT1
10224,GO:0042886,0.992236212808507,0.0135464408972888,22,1535,amide transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;BAG3;IL17RA;RHOD;VSNL1;COL1A1;UPF1;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;SOCS1;CLU;VPS18
8410,GO:0033365,0.993046623814646,0.0161776873486759,8,731,protein localization to organelle,BP,HES1;TXNIP;CHAMP1;COL1A1;SOX9;BICD2;HK2;CLU
10896,GO:0044433,0.9930867102754,0.0138625538277056,13,1041,cytoplasmic vesicle part,CC,SERPINE1;AHNAK2;RHOD;PCDH7;LRIG3;SLC2A3;CNN2;TIMP3;SNX33;PLEKHM1;PMEPA1;CLU;VPS18
16791,GO:0098590,0.993391801421913,0.0170988404113369,6,626,plasma membrane region,CC,SPRY4;SLC2A1;FLRT3;CDHR1;IGFBP2;VASP
15886,GO:0072594,0.993396410120174,0.0200799453011964,4,462,establishment of protein localization to organelle,BP,HES1;TXNIP;HK2;CLU
3232,GO:0006886,0.993620679317661,0.0135108360723361,11,920,intracellular protein transport,BP,HES1;CDK5R1;TXNIP;HSPB1;BAG3;RHOD;UPF1;RUNDC1;SNX33;CLU;VPS18
950,GO:0002366,0.993664633275648,0.0193518799483753,4,471,leukocyte activation involved in immune response,BP,RNF168;ZBTB7B;SLC2A3;CNN2
15823,GO:0072507,0.993783511633551,0.0384617507876688,1,229,divalent inorganic cation homeostasis,BP,SLC30A1
7606,GO:0031982,0.993883944102317,0.00929264510841228,51,3059,vesicle,CC,SLC2A1;SERPINE1;VASN;C1ORF116;HIST1H2AG;HSPB1;HIST1H4L;LGALS7B;MGAT1;AHNAK2;SLC20A2;TUBA4A;CDC42EP2;IGFBP2;RHOD;HIST1H2BI;PCDH7;FAT2;COL1A1;HIST1H3J;LRIG3;HIST1H2AB;CBR1;SIAH2;PLCD1;BLOC1S3;SEC14L2;VASP;SLC2A3;HIST1H4B;CNN2;C11ORF52;MALL;HSPA2;BICD2;TIMP3;AKR1C1;SNX33;PLEKHM1;HIST1H2BE;KRT16;HIST1H4K;HIST2H2BE;COL1A2;KRT17;HIST1H4D;PMEPA1;SOCS1;CLU;HIST1H2AH;VPS18
894,GO:0002263,0.993937204148869,0.0186099782769484,4,474,cell activation involved in immune response,BP,RNF168;ZBTB7B;SLC2A3;CNN2
5338,GO:0016071,0.994414319528749,0.013250329963354,8,738,mRNA metabolic process,BP,HSPB1;GDNF;ZFP36L2;RBM15;TOB1;UPF1;ESRP2;TRMT61A
9896,GO:0042175,0.994569923573417,0.0124110606212301,9,812,nuclear outer membrane-endoplasmic reticulum membrane network,CC,CYP1B1;FLRT3;FAXDC2;PIK3R1;MFSD2A;BICD2;PCYT1A;DNAJB2;NOTCH3
13529,GO:0055086,0.994590899786095,0.0153260185489796,5,546,nucleobase-containing small molecule metabolic process,BP,PTHLH;MGAT1;NME9;DDIT4;HK2
5922,GO:0018193,0.994629002144276,0.0115289409112293,11,945,peptidyl-amino acid modification,BP,HES1;SNAI2;CDK5R1;BRPF1;EPHB3;DDIT4;PYGO2;FKBP9;HIST1H1C;HIST1H1D;SOCS1
4069,GO:0009117,0.994632041509754,0.0167005935403333,4,476,nucleotide metabolic process,BP,PTHLH;NME9;DDIT4;HK2
1700,GO:0004175,0.994704952771578,0.033643776646787,1,231,endopeptidase activity,MF,ADAMTS15
18255,GO:1903047,0.994891232804856,0.0122114198024357,8,760,mitotic cell cycle process,BP,MYC;GPR132;TUBA4A;ZFP36L2;PHF13;CHAMP1;SNX33;NACC2
3154,GO:0006753,0.995095161495764,0.0154098609226134,4,481,nucleoside phosphate metabolic process,BP,PTHLH;NME9;DDIT4;HK2
4608,GO:0010720,0.995173511298337,0.0211315845677887,2,340,positive regulation of cell development,BP,HES1;NET1
14420,GO:0061695,0.995376424636961,0.030020816146351,1,240,transferase complex, transferring phosphorus-containing groups,CC,PIK3R1
2620,GO:0005929,0.995509812825098,0.0198492280871845,2,340,cilium,CC,CDHR1;TBCC
2889,GO:0006396,0.995589949413157,0.00990595729082693,10,877,RNA processing,BP,IVNS1ABP;METTL15;AHNAK2;BCDIN3D;RBM15;ESRP2;PIK3R1;IMP3;TRMT61A;RRP36
5744,GO:0016887,0.995696416051836,0.019127593967197,2,348,ATPase activity,MF,UPF1;HSPA2
3304,GO:0007005,0.995819393388724,0.013360992634091,4,487,mitochondrion organization,BP,HES1;CEBPA;HK2;CLU
12630,GO:0050801,0.995826868953511,0.0152083562648622,3,425,ion homeostasis,BP,MYC;KCTD7;SLC30A1
2970,GO:0006508,0.995858094837379,0.00813470910035927,16,1255,proteolysis,BP,SERPINE1;MYC;CTGF;RNF168;ADAMTS15;SIAH2;AKIRIN2;CEBPA;TIMP3;SNX33;FBXL12;NR1D1;FBXL18;SOCS6;NOTCH3;CLU
5592,GO:0016607,0.995879452422736,0.0184225555141936,2,340,nuclear speck,CC,RBM15;STK17A
5382,GO:0016192,0.995921105678896,0.00766914196287831,19,1440,vesicle-mediated transport,BP,SERPINE1;RIN2;TUBA4A;PCDH7;VSNL1;BLOC1S3;SLC2A3;PIK3R1;MFSD2A;CNN2;HSPA2;BICD2;TIMP3;RIN1;RUNDC1;SNX33;CLU;CDC42SE1;VPS18
7370,GO:0031410,0.995937963260374,0.00737340170902227,22,1605,cytoplasmic vesicle,CC,SLC2A1;SERPINE1;AHNAK2;CDC42EP2;IGFBP2;RHOD;PCDH7;COL1A1;LRIG3;SIAH2;BLOC1S3;SLC2A3;CNN2;MALL;BICD2;TIMP3;SNX33;PLEKHM1;PMEPA1;SOCS1;CLU;VPS18
11097,GO:0045089,0.99598589872966,0.0266496258241052,1,246,positive regulation of innate immune response,BP,NR1D1
15445,GO:0071705,0.996004652717096,0.00711609440035158,24,1707,nitrogen compound transport,BP,HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;GDNF;SLC7A5P2;BAG3;IL17RA;RHOD;VSNL1;COL1A1;UPF1;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;SOCS1;CLU;VPS18
16728,GO:0097708,0.996024180803812,0.00722601963825683,22,1607,intracellular vesicle,CC,SLC2A1;SERPINE1;AHNAK2;CDC42EP2;IGFBP2;RHOD;PCDH7;COL1A1;LRIG3;SIAH2;BLOC1S3;SLC2A3;CNN2;MALL;BICD2;TIMP3;SNX33;PLEKHM1;PMEPA1;SOCS1;CLU;VPS18
19503,GO:1990234,0.996206145648149,0.00976003834928813,7,713,transferase complex,CC,MAT2A;BRPF1;RNF168;PIK3R1;TRMT61A;FBXL12;PHC2
10895,GO:0044432,0.996296378297224,0.00817788816602036,11,965,endoplasmic reticulum part,CC,CYP1B1;FLRT3;FAXDC2;COL1A1;PIK3R1;MFSD2A;PCYT1A;CES2;DNAJB2;COL1A2;NOTCH3
5590,GO:0016604,0.99640483597385,0.00985449358642354,6,652,nuclear body,CC,HR;RBM15;CIART;STK17A;NR1D1;NACC2
898,GO:0002274,0.996493803236949,0.0130357724470247,3,428,myeloid leukocyte activation,BP,SLC2A3;CNN2;CLU
2382,GO:0005515,0.996530678584768,0.00507659148237423,163,8318,protein binding,MF,ID1;SPRY4;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;PTHLH;SERTAD3;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;MYC;MAT2A;ID3;ANGPTL4;FAM110C;HES2;NOG;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;HIST1H2AG;ZNF750;HSPB1;ZNF419;APCDD1;KCTD15;HIST1H4L;FHL2;GDNF;CTGF;AHNAK2;MAP3K14;BAG3;FZD10;BRPF1;NR2F2;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;PHF13;BCDIN3D;ZNF398;CHAMP1;FOS;CDR2L;ZNF256;FHL3;RNF168;CDC42EP2;IGFBP2;KCTD7;TUFT1;IL17RA;RHOD;FAM212B;RBM15;HIST1H2BI;ZNF3;ZKSCAN4;POLR1D;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;HIST1H3J;TLE3;HIST1H2AB;LRRC8A;CBR1;CXCL14;PAK6;SIAH2;HJURP;PLCD1;TAGLN;UPF1;AKIRIN2;ZBTB7B;BLOC1S3;GADD45B;ZNF581;VASP;HIST1H4B;PIK3R1;IMP3;SOX9;CEBPA;CNN2;GJB2;MALL;FAM83A;CIART;ZMYND19;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;TIMP3;JRK;RIN1;AKR1C1;DDIT4;RUNDC1;SNX33;TGIF1;HIST1H2BE;ARTN;ZNF169;ZNF783;KRT16;FBXL12;SOX15;PCYT1A;PYGO2;NCDN;CIPC;NR1D1;ING2;HIST1H1C;HOXA5;PHC2;HIST1H4K;PER2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;SOCS6;KRT17;GFOD1;IFITM1;TBCC;TMEM139;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;TSPYL4;SOCS1;CLU;FAM84B;HIST1H2AH;DCLRE1C;VPS18;CISH
989,GO:0002443,0.996545697101384,0.0112607313671519,4,504,leukocyte mediated immunity,BP,RNF168;SLC2A3;CNN2;CLU
6726,GO:0030133,0.996697619643416,0.022591796193469,1,253,transport vesicle,CC,BLOC1S3
16873,GO:0098791,0.996916373375597,0.00857008909764039,6,662,Golgi subcompartment,CC,SLC2A1;FUT1;MGAT1;MALL;NOTCH3;PMEPA1
10458,GO:0043312,0.996922171800767,0.0142820144678617,2,351,neutrophil degranulation,BP,SLC2A3;CNN2
905,GO:0002283,0.996985681270454,0.0140236777383543,2,352,neutrophil activation involved in immune response,BP,SLC2A3;CNN2
8832,GO:0034613,0.997073198928982,0.00561567397435472,19,1460,cellular protein localization,BP,ID1;HES1;CDK5R1;TXNIP;HSPB1;BAG3;CHAMP1;RHOD;COL1A1;UPF1;PIK3R1;SOX9;BICD2;RUNDC1;SNX33;NACC2;HK2;CLU;VPS18
16773,GO:0098552,0.997215980242266,0.0195361012849553,1,262,side of membrane,CC,RGS2
12093,GO:0048037,0.997269630011567,0.0128594300786098,2,355,cofactor binding,MF,CYP1B1;NR1D1
9869,GO:0042119,0.997290072282547,0.0127744044882645,2,357,neutrophil activation,BP,SLC2A3;CNN2
14916,GO:0070727,0.997405634765716,0.00501372123507796,19,1470,cellular macromolecule localization,BP,ID1;HES1;CDK5R1;TXNIP;HSPB1;BAG3;CHAMP1;RHOD;COL1A1;UPF1;PIK3R1;SOX9;BICD2;RUNDC1;SNX33;NACC2;HK2;CLU;VPS18
992,GO:0002446,0.997504528620923,0.0118823479492227,2,361,neutrophil mediated immunity,BP,SLC2A3;CNN2
10790,GO:0044248,0.997506044890255,0.00451733620220782,25,1801,cellular catabolic process,BP,CDK5R1;CYP1B1;PPP1R3D;HSPB1;MGAT1;GDNF;ZFP36L2;RNF168;ZKSCAN4;TOB1;SIAH2;UPF1;CEBPA;ALDH4A1;TIMP3;DDIT4;SNX33;PLEKHM1;FBXL12;NR1D1;FBXL18;SOCS6;HK2;CLU;VPS18
9527,GO:0036230,0.997507906493703,0.011868232870408,2,361,granulocyte activation,BP,SLC2A3;CNN2
2517,GO:0005768,0.997616181167661,0.0067770976395553,6,677,endosome,CC,RHOD;SIAH2;SNX33;PLEKHM1;PMEPA1;VPS18
10897,GO:0044437,0.997754370154046,0.00876705974143445,3,453,vacuolar part,CC,VASN;PLEKHM1;VPS18
5403,GO:0016236,0.99776390120775,0.0161992428842951,1,270,macroautophagy,BP,CDK5R1
16153,GO:0090150,0.997953936136692,0.0150155573033776,1,265,establishment of protein localization to membrane,BP,CDK5R1
3176,GO:0006790,0.997962776026706,0.0149560840173963,1,272,sulfur compound metabolic process,BP,MAT2A
5650,GO:0016740,0.998003469858162,0.00362616126374223,26,1894,transferase activity,MF,TIPARP;CDK5R1;MAT2A;FUT1;METTL15;MGAT1;MAP3K14;BRPF1;BCDIN3D;RNF168;CD3EAP;POLR1D;EPHB3;NME9;PAK6;SIAH2;PIK3R1;SOX9;TRMT61A;STK17A;FBXL12;PCYT1A;FBXL18;TRIM26;TRIM56;HK2
12872,GO:0051179,0.998099888468094,0.00289800634067654,73,4314,localization,BP,ID1;HES1;SNAI2;TSC22D3;CDK5R1;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;MYC;CYP1B1;FAM110C;NOG;RIN2;FLRT3;HSPB1;APCDD1;TNFRSF21;GDNF;CTGF;SLC7A5P2;BAG3;NR2F2;SLC20A2;TUBA4A;CHAMP1;KCTD7;IL17RA;RHOD;SLC22A15;PCDH7;VSNL1;FAT2;COL1A1;EPHB3;SLC30A1;LRRC8A;CXCL14;PAK6;UPF1;BLOC1S3;SLC2A3;SLC20A1;PIK3R1;MFSD2A;SOX9;CNN2;GJB2;MALL;HSPA2;BICD2;TIMP3;RIN1;AKR1C1;DDIT4;RUNDC1;SNX33;PLEKHM1;ARTN;KRT16;NR1D1;ING2;HOXA5;PER2;NACC2;COL1A2;IFITM1;HK2;SOCS1;CLU;CDC42SE1;VPS18
4561,GO:0010639,0.998101703419798,0.0140716741488574,1,282,negative regulation of organelle organization,BP,CLU
5137,GO:0015630,0.998106143986345,0.00453085282853696,10,967,microtubule cytoskeleton,CC,ID1;CDK5R1;FAM110C;HSPB1;TUBA4A;CHAMP1;CDC42EP2;HSPA2;BICD2;TBCC
3635,GO:0008104,0.998112554431805,0.00335506491472529,29,2059,protein localization,BP,ID1;HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;BAG3;CHAMP1;IL17RA;RHOD;VSNL1;COL1A1;UPF1;PIK3R1;SOX9;MALL;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;NACC2;HK2;SOCS1;CLU;VPS18
1470,GO:0003723,0.998158315660567,0.00363106767570036,19,1483,RNA binding,MF,HSPB1;HIST1H4L;AHNAK2;SURF6;ZFP36L2;ZCCHC3;CD3EAP;RBM15;UPF1;ESRP2;HIST1H4B;IMP3;SOX9;HIST1H1C;HIST1H1D;HIST1H4K;RRP36;TRIM56;HIST1H4D
10446,GO:0043299,0.998224029815676,0.00880476185128047,2,378,leukocyte degranulation,BP,SLC2A3;CNN2
13726,GO:0060271,0.998233844774491,0.0132242256509651,1,285,cilium assembly,BP,TUBA4A
17700,GO:1901564,0.998337370969,0.00250767257663252,86,4910,organonitrogen compound metabolic process,BP,ID1;SPRY4;TIPARP;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;SERPINE1;MYC;HR;FUT1;NOG;PTPRE;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;HIST1H4L;MGAT1;GDNF;CTGF;MAP3K14;FZD10;BRPF1;NR2F2;MARS2;HIST1H2BJ;ZFP36L2;BCDIN3D;RNF168;IGFBP2;KCTD7;FAM212B;HIST1H2BI;ADAMTS15;TOB1;EPHB3;HIST1H3J;NME9;PAK6;SIAH2;UPF1;AKIRIN2;GADD45B;HIST1H4B;PIK3R1;MFSD2A;IMP3;SOX9;CEBPA;ALDH4A1;HSPA2;HIST1H2BO;TIMP3;STK17A;DDIT4;SNX33;HIST1H2BE;ARTN;FBXL12;PCYT1A;PYGO2;NR1D1;FKBP9;ING2;HIST1H1C;HIST1H1D;FBXL18;HIST1H4K;PER2;DNAJB2;NACC2;SOCS6;KRT17;TRIM56;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;SOCS1;CLU;CISH
899,GO:0002275,0.998367107508639,0.00817443788174092,2,382,myeloid cell activation involved in immune response,BP,SLC2A3;CNN2
10989,GO:0044782,0.998457861193326,0.0117636421188563,1,291,cilium organization,BP,TUBA4A
990,GO:0002444,0.998503325295628,0.00756760799747782,2,386,myeloid leukocyte mediated immunity,BP,SLC2A3;CNN2
12606,GO:0050769,0.998529240857121,0.0112899868345583,1,297,positive regulation of neurogenesis,BP,HES1
5835,GO:0017111,0.998625830257495,0.00442557702778647,5,646,nucleoside-triphosphatase activity,MF,TUBA4A;RHOD;UPF1;HSPA2;TBCC
6193,GO:0019637,0.998843453361983,0.00311036397266375,8,850,organophosphate metabolic process,BP,PTHLH;NME9;PLCD1;PIK3R1;MFSD2A;DDIT4;PCYT1A;HK2
19679,GO:1990904,0.998870869377574,0.00341714683950375,6,701,ribonucleoprotein complex,CC,IVNS1ABP;SURF6;UPF1;IMP3;RRP36;SOCS1
2508,GO:0005759,0.998940334079173,0.00556957080396204,2,393,mitochondrial matrix,CC,MARS2;ALDH4A1
12133,GO:0048193,0.998963012157687,0.00833706015695963,1,309,Golgi vesicle transport,BP,BICD2
2535,GO:0005789,0.999094539659659,0.00261422726455198,7,797,endoplasmic reticulum membrane,CC,CYP1B1;FLRT3;FAXDC2;MFSD2A;PCYT1A;DNAJB2;NOTCH3
16897,GO:0098827,0.999152989560899,0.00245765449822929,7,801,endoplasmic reticulum subcompartment,CC,CYP1B1;FLRT3;FAXDC2;MFSD2A;PCYT1A;DNAJB2;NOTCH3
2529,GO:0005783,0.9992580101747,0.00164999345227105,15,1325,endoplasmic reticulum,CC,CYP1B1;FLRT3;FAXDC2;FOS;COL1A1;SLC30A1;PIK3R1;MFSD2A;PCYT1A;FKBP9;CES2;DNAJB2;COL1A2;NOTCH3;CLU
5515,GO:0016462,0.999301343438318,0.00238104248045404,5,684,pyrophosphatase activity,MF,TUBA4A;RHOD;UPF1;HSPA2;TBCC
8232,GO:0032991,0.99930684159179,0.00112042513484253,62,3846,protein-containing complex,CC,CDK5R1;IVNS1ABP;MYC;MAT2A;HIST1H2AG;HSPB1;HIST1H4L;POU3F1;BRPF1;HOXA9;SURF6;HIST1H2BJ;CHAMP1;FOS;RNF168;CD3EAP;HIST1H2BI;COL1A1;TOB1;EPHB3;HIST1H3J;TLE3;HIST1H2AB;LRRC8A;HJURP;UPF1;AKIRIN2;BLOC1S3;HIST1H4B;PIK3R1;IMP3;SOX9;TRMT61A;CEBPA;GJB2;HSPA2;BICD2;HIST1H2BO;HIST1H2BE;FBXL12;SOX15;PYGO2;NR1D1;ING2;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;HIST2H2BE;NACC2;HIST3H2BB;COL1A2;SOX12;NT5DC3;HIST1H4D;NOTCH3;SOCS1;CLU;HIST1H2AH;DCLRE1C;VPS18
5700,GO:0016817,0.999327768018933,0.00229812977246496,5,686,hydrolase activity, acting on acid anhydrides,MF,TUBA4A;RHOD;UPF1;HSPA2;TBCC
5701,GO:0016818,0.999327768018933,0.00229812977246496,5,686,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TUBA4A;RHOD;UPF1;HSPA2;TBCC
10904,GO:0044446,0.999342976851701,0.00100543968799471,131,7077,intracellular organelle part,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;CYP1B1;HR;FAM110C;IFFO2;FUT1;VASN;DUSP5;FLRT3;HIST1H2AG;HSPB1;HIST1H4L;FHL2;RBAK;POU3F1;MGAT1;CTGF;AHNAK2;MAP3K14;TFCP2L1;FZD10;FAXDC2;BRPF1;NR2F2;MARS2;TUBA4A;SURF6;HIST1H2BJ;PHF13;CHAMP1;FOS;FHL3;RNF168;RHOD;CD3EAP;RBM15;HIST1H2BI;PCDH7;ZKSCAN4;COL1A1;YPEL4;SLC30A1;HIST1H3J;TLE3;LRIG3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;SOX9;ERF;TRMT61A;CEBPA;CNN2;MALL;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;STK17A;GZF1;SNX33;PLEKHM1;TGIF1;HIST1H2BE;KRT16;URB2;SOX15;PCYT1A;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;KRT17;IFFO1;SOX12;TBCC;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;SOCS1;CLU;HIST1H2AH;DCLRE1C;VPS18;FAM217B
8260,GO:0033036,0.999362589940932,0.00117476012473806,31,2268,macromolecule localization,BP,ID1;HES1;CDK5R1;SLC2A1;MIDN;TXNIP;HSPB1;TNFRSF21;BAG3;CHAMP1;IL17RA;RHOD;VSNL1;COL1A1;UPF1;PIK3R1;MFSD2A;SOX9;MALL;BICD2;AKR1C1;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;NACC2;HK2;SOCS1;CLU;VPS18
160,GO:0000323,0.999364503801196,0.00281261921332351,3,519,lytic vacuole,CC,VASN;PLEKHM1;VPS18
2513,GO:0005764,0.999364503801196,0.00281261921332351,3,519,lysosome,CC,VASN;PLEKHM1;VPS18
10887,GO:0044422,0.999380285082999,0.000950562083814431,133,7173,organelle part,CC,ID1;RGS2;HES1;SNAI2;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SERTAD3;SLC2A1;MIDN;IRF2BPL;TXNIP;SERPINE1;MYC;CYP1B1;HR;FAM110C;IFFO2;FUT1;VASN;DUSP5;FLRT3;HIST1H2AG;HSPB1;HIST1H4L;FHL2;RBAK;POU3F1;MGAT1;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;BRPF1;NR2F2;MARS2;TUBA4A;SURF6;HIST1H2BJ;PHF13;CDHR1;CHAMP1;FOS;FHL3;RNF168;RHOD;CD3EAP;RBM15;HIST1H2BI;PCDH7;ZKSCAN4;COL1A1;YPEL4;SLC30A1;HIST1H3J;TLE3;LRIG3;HIST1H2AB;PAK6;SIAH2;HJURP;UPF1;AKIRIN2;ZBTB7B;ESRP2;SLC2A3;HIST1H4B;PIK3R1;MFSD2A;IMP3;SOX9;ERF;TRMT61A;CEBPA;CNN2;MALL;CIART;ALDH4A1;KCTD1;HSPA2;BICD2;HIST1H2BO;ZBTB34;TIMP3;STK17A;GZF1;SNX33;PLEKHM1;TGIF1;HIST1H2BE;KRT16;URB2;SOX15;PCYT1A;PYGO2;NR1D1;ING2;ZNF589;HIST1H1C;PHC2;HIST1H1D;HIST1H4K;RRP36;PER2;ZNF672;CES2;BRF2;DNAJB2;HIST2H2BE;NACC2;HIC1;HIST3H2BB;COL1A2;ZNF16;KRT17;IFFO1;SOX12;TBCC;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;SOCS1;CLU;HIST1H2AH;DCLRE1C;VPS18;FAM217B
2547,GO:0005813,0.999423487230819,0.00323015142851998,2,440,centrosome,CC,ID1;BICD2
2890,GO:0006397,0.999532533154032,0.00267582519328194,2,440,mRNA processing,BP,RBM15;ESRP2
15904,GO:0072657,0.999644459830625,0.00209083217728064,2,452,protein localization to membrane,BP,CDK5R1;PIK3R1
17314,GO:0140096,0.999647963227701,0.000746700413192609,20,1702,catalytic activity, acting on a protein,MF,CDK5R1;DUSP4;HR;PTPRE;DUSP5;PPP1R3D;MGAT1;MAP3K14;RNF168;ADAMTS15;EPHB3;PAK6;SIAH2;SOX9;STK17A;FBXL12;FKBP9;FBXL18;NACC2;TRIM56
14531,GO:0070011,0.999712866547893,0.00269259670198769,1,360,peptidase activity, acting on L-amino acid peptides,MF,ADAMTS15
13120,GO:0051641,0.99976296974215,0.000467315761860757,28,2186,cellular localization,BP,ID1;HES1;CDK5R1;TXNIP;HSPB1;GDNF;BAG3;TUBA4A;CHAMP1;RHOD;VSNL1;COL1A1;SLC30A1;UPF1;BLOC1S3;PIK3R1;SOX9;MALL;BICD2;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;NACC2;HK2;CLU;VPS18
16878,GO:0098796,0.999768847371757,0.000857768058471313,5,731,membrane protein complex,CC,LRRC8A;PIK3R1;GJB2;HSPA2;VPS18
3714,GO:0008233,0.999806133294306,0.00189750130570657,1,377,peptidase activity,MF,ADAMTS15
13127,GO:0051649,0.999806887542566,0.00042814124427204,19,1674,establishment of localization in cell,BP,HES1;CDK5R1;TXNIP;HSPB1;GDNF;BAG3;CHAMP1;RHOD;VSNL1;SLC30A1;UPF1;BLOC1S3;BICD2;RUNDC1;SNX33;NR1D1;PER2;CLU;VPS18
10909,GO:0044451,0.999818384171729,0.000553341988390768,8,975,nucleoplasm part,CC,HR;BRPF1;RBM15;CIART;STK17A;NR1D1;ING2;NACC2
3186,GO:0006810,0.999852578410607,0.000261705598136142,49,3353,transport,BP,HES1;TSC22D3;CDK5R1;SLC2A1;MIDN;TXNIP;SERPINE1;MYC;RIN2;HSPB1;TNFRSF21;GDNF;CTGF;SLC7A5P2;BAG3;SLC20A2;TUBA4A;KCTD7;IL17RA;RHOD;SLC22A15;PCDH7;VSNL1;COL1A1;SLC30A1;LRRC8A;UPF1;BLOC1S3;SLC2A3;SLC20A1;PIK3R1;MFSD2A;CNN2;GJB2;HSPA2;BICD2;TIMP3;RIN1;AKR1C1;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;HK2;SOCS1;CLU;CDC42SE1;VPS18
7600,GO:0031967,0.999867036521453,0.000413029097541575,8,971,organelle envelope,CC,TXNIP;RBM15;SLC30A1;BICD2;PCYT1A;DNAJB2;HK2;CLU
7604,GO:0031975,0.999867036521453,0.000413029097541575,8,971,envelope,CC,TXNIP;RBM15;SLC30A1;BICD2;PCYT1A;DNAJB2;HK2;CLU
16886,GO:0098805,0.999867318764709,0.000362035410437015,11,1197,whole membrane,CC,SLC2A1;VASN;RHOD;PCDH7;SLC2A3;MALL;BICD2;PLEKHM1;HK2;PMEPA1;VPS18
17571,GO:1901135,0.999870905127368,0.00042596751810123,7,912,carbohydrate derivative metabolic process,BP,PTHLH;FUT1;MGAT1;NME9;AKR1C1;DDIT4;HK2
2549,GO:0005815,0.999877783907464,0.000622998542422677,3,610,microtubule organizing center,CC,ID1;FAM110C;BICD2
2521,GO:0005773,0.999877917602759,0.000622444146118418,3,602,vacuole,CC,VASN;PLEKHM1;VPS18
2493,GO:0005739,0.999879587415856,0.000294988261161863,15,1424,mitochondrion,CC,RGS2;TXNIP;CYP1B1;VASN;TFCP2L1;MARS2;CD3EAP;HJURP;ALDH4A1;HSPA2;DDIT4;ZADH2;NACC2;HK2;CLU
12906,GO:0051234,0.99989784051367,0.000182971012526547,50,3437,establishment of localization,BP,HES1;TSC22D3;CDK5R1;SLC2A1;MIDN;TXNIP;SERPINE1;MYC;RIN2;HSPB1;TNFRSF21;GDNF;CTGF;SLC7A5P2;BAG3;SLC20A2;TUBA4A;CHAMP1;KCTD7;IL17RA;RHOD;SLC22A15;PCDH7;VSNL1;COL1A1;SLC30A1;LRRC8A;UPF1;BLOC1S3;SLC2A3;SLC20A1;PIK3R1;MFSD2A;CNN2;GJB2;HSPA2;BICD2;TIMP3;RIN1;AKR1C1;RUNDC1;SNX33;PLEKHM1;NR1D1;PER2;HK2;SOCS1;CLU;CDC42SE1;VPS18
7608,GO:0031984,0.999904092701408,0.000257607759811898,12,1279,organelle subcompartment,CC,SLC2A1;CYP1B1;FUT1;FLRT3;MGAT1;FAXDC2;MFSD2A;MALL;PCYT1A;DNAJB2;NOTCH3;PMEPA1
6950,GO:0030554,0.99991543345993,0.000245589707184226,10,1181,adenyl nucleotide binding,MF,MAT2A;MAP3K14;BAG3;MARS2;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
5316,GO:0016021,0.99991967372532,0.000155484260289777,36,2706,integral component of membrane,CC,SLC2A1;GPR132;FUT1;PTPRE;VASN;FLRT3;APCDD1;TNFRSF21;MGAT1;SLC7A5P2;FZD10;FAXDC2;SLC20A2;CDHR1;IL17RA;SLC22A15;PCDH7;FAT2;EPHB3;SLC30A1;LRIG3;ADGRF1;LRRC8A;SLC2A3;SLC20A1;MFSD2A;GJB2;MALL;HSPA2;LRRC37A;IFITM1;TMEM139;ADGRF4;NOTCH3;PMEPA1;TMEM40
10359,GO:0043168,0.999920845147974,0.000172479945523639,23,1999,anion binding,MF,MAT2A;ID3;CTGF;MAP3K14;NR2F2;MARS2;TUBA4A;RHOD;ADAMTS15;EPHB3;PAK6;PLCD1;UPF1;SEC14L2;PXDC1;HSPA2;STK17A;AKR1C1;SNX33;PCYT1A;ING2;HK2;ZCCHC2
3661,GO:0008144,0.999937029633305,0.000178811908624821,11,1266,drug binding,MF,MAT2A;CYP1B1;MAP3K14;MARS2;EPHB3;PAK6;UPF1;HSPA2;STK17A;FKBP9;HK2
2494,GO:0005740,0.999938778813131,0.00032933169846888,3,616,mitochondrial envelope,CC,TXNIP;HK2;CLU
2390,GO:0005524,0.999955342182062,0.000140346606378094,9,1150,ATP binding,MF,MAT2A;MAP3K14;MARS2;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
7261,GO:0031224,0.999964598304084,7.05697039308256e-05,36,2771,intrinsic component of membrane,CC,SLC2A1;GPR132;FUT1;PTPRE;VASN;FLRT3;APCDD1;TNFRSF21;MGAT1;SLC7A5P2;FZD10;FAXDC2;SLC20A2;CDHR1;IL17RA;SLC22A15;PCDH7;FAT2;EPHB3;SLC30A1;LRIG3;ADGRF1;LRRC8A;SLC2A3;SLC20A1;MFSD2A;GJB2;MALL;HSPA2;LRRC37A;IFITM1;TMEM139;ADGRF4;NOTCH3;PMEPA1;TMEM40
7965,GO:0032559,0.999967668264136,0.000103386401136198,9,1169,adenyl ribonucleotide binding,MF,MAT2A;MAP3K14;MARS2;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
18026,GO:1902494,0.999978177001727,6.80591403892267e-05,10,1230,catalytic complex,CC,MAT2A;HSPB1;BRPF1;RNF168;PIK3R1;TRMT61A;FBXL12;ING2;PHC2;NACC2
7599,GO:0031966,0.999981482787692,0.000140086517446287,2,577,mitochondrial membrane,CC,HK2;CLU
16789,GO:0098588,0.999981635575488,5.03987113154479e-05,14,1520,bounding membrane of organelle,CC,SLC2A1;FUT1;VASN;MGAT1;CDHR1;RHOD;PCDH7;SLC2A3;MALL;PLEKHM1;HK2;NOTCH3;PMEPA1;VPS18
10892,GO:0044429,0.999983726769056,7.19510483038869e-05,5,850,mitochondrial part,CC,TXNIP;MARS2;ALDH4A1;HK2;CLU
11900,GO:0046907,0.999984218690203,4.48786791000324e-05,13,1460,intracellular transport,BP,HES1;CDK5R1;TXNIP;HSPB1;BAG3;RHOD;UPF1;BLOC1S3;BICD2;RUNDC1;SNX33;CLU;VPS18
9477,GO:0036094,0.999986286189829,3.47666065309241e-05,18,1810,small molecule binding,MF,MAT2A;ID3;MAP3K14;BAG3;NR2F2;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;SEC14L2;SLC2A3;HSPA2;STK17A;AKR1C1;HK2;IRX5
5818,GO:0017076,0.999988955484276,3.29638634023425e-05,12,1437,purine nucleotide binding,MF,MAT2A;MAP3K14;BAG3;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
16587,GO:0097367,0.999990826119001,2.59550558159396e-05,14,1583,carbohydrate derivative binding,MF,MAT2A;CTGF;MAP3K14;MARS2;TUBA4A;HIST1H2BJ;RHOD;ADAMTS15;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
4810,GO:0012505,0.999992374201095,1.54991068352881e-05,41,3169,endomembrane system,CC,ID1;PTHLH;SLC2A1;SERPINE1;CYP1B1;FUT1;FLRT3;MGAT1;CTGF;FAXDC2;FOS;CDC42EP2;RHOD;RBM15;PCDH7;COL1A1;SLC30A1;CXCL14;SIAH2;BLOC1S3;SLC2A3;PIK3R1;MFSD2A;CNN2;MALL;BICD2;TIMP3;RUNDC1;SNX33;PLEKHM1;PCYT1A;FKBP9;ING2;CES2;DNAJB2;COL1A2;NOTCH3;PMEPA1;CLU;DCLRE1C;VPS18
9247,GO:0035639,0.999993995551717,1.91111262178236e-05,11,1404,purine ribonucleoside triphosphate binding,MF,MAT2A;MAP3K14;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
7961,GO:0032555,0.999995655190727,1.40306682368747e-05,11,1423,purine ribonucleotide binding,MF,MAT2A;MAP3K14;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
7959,GO:0032553,0.999996418560269,1.16646633514515e-05,11,1434,ribonucleotide binding,MF,MAT2A;MAP3K14;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
10889,GO:0044425,0.999998173550789,3.71616729038848e-06,49,3704,membrane part,CC,SPRY4;RGS2;SLC2A1;GPR132;CYP1B1;FUT1;PTPRE;VASN;FLRT3;APCDD1;TNFRSF21;MGAT1;SLC7A5P2;AHNAK2;FZD10;FAXDC2;SLC20A2;CDHR1;IGFBP2;IL17RA;SLC22A15;PCDH7;FAT2;EPHB3;SLC30A1;LRIG3;ADGRF1;LRRC8A;VASP;SLC2A3;SLC20A1;PIK3R1;MFSD2A;GJB2;MALL;HSPA2;BICD2;LRRC37A;SNX33;PCYT1A;DNAJB2;SOCS6;IFITM1;TMEM139;ADGRF4;NOTCH3;PMEPA1;TMEM40;VPS18
7205,GO:0031090,0.999999358046805,1.69728364986381e-06,22,2224,organelle membrane,CC,SLC2A1;CYP1B1;FUT1;VASN;MGAT1;AHNAK2;CDHR1;RHOD;RBM15;PCDH7;SLC30A1;LRIG3;SLC2A3;MALL;SNX33;PLEKHM1;DNAJB2;HK2;NOTCH3;PMEPA1;CLU;VPS18
15011,GO:0070925,0.999999427890858,9.12039243881502e-06,1,636,organelle assembly,BP,TUBA4A
5680,GO:0016787,0.999999607922954,1.22158553737291e-06,15,1817,hydrolase activity,MF,DUSP4;PTPRE;DUSP5;PPP1R3D;TUBA4A;RHOD;ADAMTS15;PLCD1;UPF1;HSPA2;CES2;NACC2;TBCC;NT5DC3;DCLRE1C
83,GO:0000166,0.999999620125445,1.30509137040736e-06,12,1628,nucleotide binding,MF,MAT2A;MAP3K14;BAG3;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
17616,GO:1901265,0.999999627445533,1.28089841836823e-06,12,1629,nucleoside phosphate binding,MF,MAT2A;MAP3K14;BAG3;MARS2;TUBA4A;RHOD;EPHB3;PAK6;UPF1;HSPA2;STK17A;HK2
5315,GO:0016020,0.999999927256015,1.4531630107156e-07,85,5743,membrane,CC,SPRY4;RGS2;CDK5R1;SLC2A1;NET1;SERPINE1;GPR132;CYP1B1;FUT1;PTPRE;VASN;C1ORF116;FLRT3;HSPB1;APCDD1;HIST1H4L;TNFRSF21;MGAT1;CTGF;SLC7A5P2;AHNAK2;TFCP2L1;BAG3;FZD10;FAXDC2;BRPF1;SLC20A2;HIST1H2BJ;CDHR1;FOS;CDC42EP2;IGFBP2;KCTD7;IL17RA;RHOD;SLC22A15;RBM15;PCDH7;VSNL1;FAT2;EPHB3;SLC30A1;HIST1H3J;LRIG3;ADGRF1;LRRC8A;PLCD1;VASP;SLC2A3;HIST1H4B;SLC20A1;PIK3R1;MFSD2A;CNN2;GJB2;MALL;ZMYND19;HSPA2;BICD2;STK17A;RIN1;LRRC37A;SNX33;PLEKHM1;PCYT1A;NCDN;ING2;HIST1H4K;PALMD;DNAJB2;SOCS6;IFITM1;TMEM139;ADGRF4;HIST1H4D;RGS3;HK2;NOTCH3;PMEPA1;CLU;FAM84B;CDC42SE1;TMEM40;VPS18;CISH
2492,GO:0005737,0.99999994655038,1.06418768787364e-07,144,8364,cytoplasm,CC,ID1;SPRY4;RGS2;HES1;SNAI2;TSC22D3;CDK5R1;DUSP4;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;MYC;MAT2A;ID3;CYP1B1;FAM110C;FUT1;PTPRE;RIN2;VASN;C1ORF116;DUSP5;SERTAD1;FLRT3;PPP1R3D;HSPB1;FHL2;LGALS7B;MGAT1;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FZD10;FAXDC2;BRPF1;NR2F2;MARS2;HOXA9;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;BCDIN3D;TRIM35;CHAMP1;FOS;FHL3;RNF168;CDC42EP2;IGFBP2;KCTD7;TUFT1;RHOD;CD3EAP;HIST1H2BI;PCDH7;ZKSCAN4;VSNL1;COL1A1;TOB1;EPHB3;SLC30A1;LRIG3;NME9;LRRC8A;CBR1;CXCL14;PAK6;RNF39;SIAH2;HJURP;PLCD1;TAGLN;UPF1;BLOC1S3;GADD45B;SEC14L2;VASP;SLC2A3;PIK3R1;MFSD2A;IMP3;ERF;TRMT61A;CNN2;GJB2;MALL;FAM83A;ZMYND19;ALDH4A1;HSPA2;BICD2;HIST1H2BO;TIMP3;RIN1;AKR1C1;DDIT4;SNX33;PLEKHM1;HIST1H2BE;KRT16;FBXL12;SOX15;PCYT1A;NCDN;CIPC;NR1D1;FKBP9;ING2;FBXL18;PALMD;ZADH2;PER2;CES2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;SOCS6;KRT17;TBCC;TRIM56;RGS3;HK2;NOTCH3;PMEPA1;SOCS1;CLU;FAM84B;CDC42SE1;DCLRE1C;ZCCHC2;VPS18;FAM217B;CISH
10902,GO:0044444,0.999999955176304,8.84720441843977e-08,116,7177,cytoplasmic part,CC,ID1;SPRY4;RGS2;TSC22D3;CDK5R1;PTHLH;IVNS1ABP;SLC2A1;MIDN;NET1;TXNIP;SERPINE1;MYC;MAT2A;CYP1B1;FAM110C;FUT1;RIN2;VASN;C1ORF116;FLRT3;PPP1R3D;HSPB1;FHL2;MGAT1;CTGF;AHNAK2;MAP3K14;TFCP2L1;BAG3;FAXDC2;BRPF1;NR2F2;MARS2;TUBA4A;SURF6;HIST1H2BJ;ZFP36L2;BCDIN3D;FOS;FHL3;RNF168;CDC42EP2;IGFBP2;KCTD7;RHOD;CD3EAP;HIST1H2BI;PCDH7;ZKSCAN4;VSNL1;COL1A1;EPHB3;SLC30A1;LRIG3;CBR1;CXCL14;SIAH2;HJURP;PLCD1;UPF1;BLOC1S3;SEC14L2;VASP;SLC2A3;PIK3R1;MFSD2A;IMP3;ERF;TRMT61A;CNN2;GJB2;MALL;ALDH4A1;HSPA2;BICD2;HIST1H2BO;TIMP3;RIN1;AKR1C1;DDIT4;SNX33;PLEKHM1;HIST1H2BE;KRT16;FBXL12;PCYT1A;NCDN;CIPC;FKBP9;ING2;FBXL18;ZADH2;PER2;CES2;DNAJB2;HIST2H2BE;TRIM26;NACC2;HIC1;HIST3H2BB;COL1A2;SOCS6;KRT17;TBCC;TRIM56;RGS3;HK2;NOTCH3;PMEPA1;SOCS1;CLU;DCLRE1C;VPS18;FAM217B;CISH
1490,GO:0003824,0.999999998998541,2.44233705395001e-09,52,4348,catalytic activity,MF,TIPARP;CDK5R1;DUSP4;MAT2A;CYP1B1;HR;FUT1;PTPRE;DUSP5;PPP1R3D;METTL15;MGAT1;MAP3K14;FAXDC2;BRPF1;MARS2;TUBA4A;BCDIN3D;RNF168;RHOD;CD3EAP;POLR1D;ADAMTS15;EPHB3;NME9;CBR1;PAK6;SIAH2;PLCD1;UPF1;L3HYPDH;PIK3R1;SOX9;TRMT61A;ALDH4A1;HSPA2;STK17A;AKR1C1;FBXL12;PCYT1A;FKBP9;FBXL18;ZADH2;CES2;TRIM26;NACC2;GFOD1;TBCC;NT5DC3;TRIM56;HK2;DCLRE1C
1,GO:0000002,1,0.583909825566094,0,24,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.977241481608143,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.955331427056851,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.977336572808046,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.835565427259491,0,8,single strand break repair,BP,
8,GO:0000015,1,0.977133489949994,0,1,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.276068085947521,0,58,regulation of DNA recombination,BP,
10,GO:0000019,1,0.935776857552645,0,3,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.800714573381708,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.938239611646836,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.936036467934078,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.548720263130987,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.647475379204843,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.608207326110866,0,22,mannosyltransferase activity,MF,
17,GO:0000032,1,0.9771102875795,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.932885075900004,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.951850414874843,0,2,acyl binding,MF,
20,GO:0000036,1,0.951850414874843,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.592398098568193,0,23,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.15539028899337,0,84,autophagosome assembly,BP,
24,GO:0000048,1,0.977240918008823,0,1,peptidyltransferase activity,MF,
25,GO:0000049,1,0.293668583415388,0,54,tRNA binding,MF,
27,GO:0000052,1,0.861175421504724,0,7,citrulline metabolic process,BP,
28,GO:0000053,1,0.977137044961173,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.739221048942481,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.830699497478157,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.84992162309168,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.440660599937195,0,37,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.675681672325888,0,17,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.919836858230388,0,4,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.696168886354819,0,16,DNA replication checkpoint,BP,
41,GO:0000083,1,0.583961433875987,0,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.977232227459996,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.511002912797753,0,30,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.730062353262618,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.853862672024561,0,7,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.919325445219513,0,4,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.935725634708307,0,3,sulfur amino acid transport,BP,
49,GO:0000103,1,0.933459040090726,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.890210003262809,0,5,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.955486142287365,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.798136530034475,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.936417361815692,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.977874998614676,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.979613716948927,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
58,GO:0000121,1,0.977470046949509,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000124,1,0.740975558174481,0,13,SAGA complex,CC,
62,GO:0000125,1,0.897260865641879,0,5,PCAF complex,CC,
63,GO:0000126,1,0.961688887656332,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.874782746440048,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.673156881695245,0,18,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.801620070440916,0,10,Golgi cis cisterna,CC,
67,GO:0000138,1,0.87151266739694,0,6,Golgi trans cisterna,CC,
69,GO:0000145,1,0.701039002331288,0,16,exocyst,CC,
70,GO:0000146,1,0.761198981229584,0,14,microfilament motor activity,MF,
71,GO:0000147,1,0.938285230881025,0,3,actin cortical patch assembly,BP,
73,GO:0000150,1,0.831122195305376,0,8,recombinase activity,MF,
76,GO:0000153,1,0.780943388706709,0,11,cytoplasmic ubiquitin ligase complex,CC,
78,GO:0000155,1,0.981384023788327,0,1,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.637040250962411,0,20,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.959756167518956,0,2,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.782615517816458,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000171,1,0.956598179508916,0,2,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.870414343714844,0,6,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.977029043601808,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000175,1,0.511027180684077,0,30,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.73888292006499,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.710761250967345,0,15,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.605823635459232,0,22,exosome (RNase complex),CC,
91,GO:0000179,1,0.911524742784882,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.809887144459249,0,10,rDNA binding,MF,
100,GO:0000210,1,0.977755183855241,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000212,1,0.810907381865786,0,10,meiotic spindle organization,BP,
102,GO:0000213,1,0.911885625241554,0,4,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.91180083713228,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.954118163067375,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.59663703238377,0,23,DNA secondary structure binding,MF,
106,GO:0000220,1,0.89338981921227,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
107,GO:0000221,1,0.9358006099116,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000224,1,0.977252448864821,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.976468775992457,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000229,1,0.97698428186558,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.840999020211729,0,8,astral microtubule,CC,
114,GO:0000242,1,0.670881671336126,0,19,pericentriolar material,CC,
115,GO:0000243,1,0.829911551252725,0,8,commitment complex,CC,
116,GO:0000244,1,0.764410993696992,0,12,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.294127089196429,0,54,spliceosomal complex assembly,BP,
118,GO:0000246,1,0.978518490751344,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.976471669318154,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.956454673482018,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.978489824335089,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.976988516646319,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.910134697285303,0,4,3-keto sterol reductase activity,MF,
125,GO:0000255,1,0.937666695257901,0,3,allantoin metabolic process,BP,
126,GO:0000257,1,0.97674769101636,0,1,nitrilase activity,MF,
127,GO:0000262,1,0.97698428186558,0,1,mitochondrial chromosome,CC,
128,GO:0000266,1,0.482082576277832,0,33,mitochondrial fission,BP,
129,GO:0000268,1,0.913079242418834,0,4,peroxisome targeting sequence binding,MF,
130,GO:0000270,1,0.954176976775803,0,2,peptidoglycan metabolic process,BP,
136,GO:0000285,1,0.936041200318855,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
137,GO:0000287,1,0.0312232346687927,0,156,magnesium ion binding,MF,
140,GO:0000290,1,0.820715966478865,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.451729295133233,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.934612840712603,0,3,ferric-chelate reductase activity,MF,
144,GO:0000295,1,0.777754269244902,0,11,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000296,1,0.977236636622913,0,1,spermine transport,BP,
146,GO:0000298,1,0.91310481226447,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.933534980804645,0,3,retrograde transport, vesicle recycling within Golgi,BP,
149,GO:0000303,1,0.633275122225701,0,20,response to superoxide,BP,
150,GO:0000305,1,0.591455690833105,0,23,response to oxygen radical,BP,
151,GO:0000306,1,0.915634366657566,0,4,extrinsic component of vacuolar membrane,CC,
152,GO:0000307,1,0.437116221641519,0,37,cyclin-dependent protein kinase holoenzyme complex,CC,
153,GO:0000308,1,0.957741790004683,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000309,1,0.958029329710443,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
155,GO:0000313,1,0.135174033210557,0,84,organellar ribosome,CC,
156,GO:0000314,1,0.513753180253444,0,28,organellar small ribosomal subunit,CC,
157,GO:0000315,1,0.297758933336719,0,51,organellar large ribosomal subunit,CC,
158,GO:0000320,1,0.957502943059803,0,2,re-entry into mitotic cell cycle,BP,
159,GO:0000322,1,0.934888347872446,0,3,storage vacuole,CC,
161,GO:0000332,1,0.975228493115318,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
162,GO:0000333,1,0.955726841711642,0,2,telomerase catalytic core complex,CC,
163,GO:0000338,1,0.794118903997968,0,10,protein deneddylation,BP,
164,GO:0000339,1,0.685945741564863,0,17,RNA cap binding,MF,
165,GO:0000340,1,0.821071700402556,0,9,RNA 7-methylguanosine cap binding,MF,
166,GO:0000346,1,0.743326270502342,0,13,transcription export complex,CC,
167,GO:0000347,1,0.871650064982081,0,6,THO complex,CC,
168,GO:0000349,1,0.955025254398237,0,2,generation of catalytic spliceosome for first transesterification step,BP,
169,GO:0000350,1,0.932948757305328,0,3,generation of catalytic spliceosome for second transesterification step,BP,
170,GO:0000354,1,0.958802109421031,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000379,1,0.933181069836851,0,3,tRNA-type intron splice site recognition and cleavage,BP,
175,GO:0000381,1,0.471073606910861,0,34,regulation of alternative mRNA splicing, via spliceosome,BP,
176,GO:0000384,1,0.954554853553517,0,2,first spliceosomal transesterification activity,MF,
177,GO:0000386,1,0.937115013556476,0,3,second spliceosomal transesterification activity,MF,
178,GO:0000387,1,0.426739465878819,0,37,spliceosomal snRNP assembly,BP,
179,GO:0000389,1,0.873065012798606,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000390,1,0.954402716166861,0,2,spliceosomal complex disassembly,BP,
181,GO:0000393,1,0.890978931578713,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000394,1,0.674671815787634,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
183,GO:0000395,1,0.871031797743639,0,6,mRNA 5'-splice site recognition,BP,
185,GO:0000400,1,0.695629620727858,0,16,four-way junction DNA binding,MF,
186,GO:0000403,1,0.878388914958329,0,6,Y-form DNA binding,MF,
187,GO:0000404,1,0.935611676453715,0,3,heteroduplex DNA loop binding,MF,
188,GO:0000405,1,0.857259841865014,0,7,bubble DNA binding,MF,
189,GO:0000406,1,0.956784001139064,0,2,double-strand/single-strand DNA junction binding,MF,
190,GO:0000407,1,0.492037095761246,0,32,phagophore assembly site,CC,
191,GO:0000408,1,0.889945903095537,0,5,EKC/KEOPS complex,CC,
192,GO:0000409,1,0.980551080711447,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,1,0.980551080711447,0,1,positive regulation of transcription by galactose,BP,
194,GO:0000412,1,0.977334444637191,0,1,histone peptidyl-prolyl isomerization,BP,
196,GO:0000414,1,0.922278949925073,0,4,regulation of histone H3-K36 methylation,BP,
197,GO:0000415,1,0.980159247126154,0,1,negative regulation of histone H3-K36 methylation,BP,
198,GO:0000416,1,0.977979947023664,0,1,positive regulation of histone H3-K36 methylation,BP,
199,GO:0000417,1,0.97827869321164,0,1,HIR complex,CC,
200,GO:0000421,1,0.555929957010837,0,26,autophagosome membrane,CC,
202,GO:0000423,1,0.658837816695964,0,19,mitophagy,BP,
203,GO:0000428,1,0.0559832742847729,0,128,DNA-directed RNA polymerase complex,CC,
204,GO:0000429,1,0.936070850352388,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
205,GO:0000430,1,0.95464079440875,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000431,1,0.980551080711447,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000432,1,0.95464079440875,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000435,1,0.980551080711447,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000436,1,0.936070850352388,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
210,GO:0000438,1,0.932737985179698,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
211,GO:0000439,1,0.815909313636913,0,9,core TFIIH complex,CC,
212,GO:0000444,1,0.918195655828798,0,4,MIS12/MIND type complex,CC,
213,GO:0000445,1,0.871650064982081,0,6,THO complex part of transcription export complex,CC,
214,GO:0000447,1,0.814435692809189,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
215,GO:0000448,1,0.958097995834105,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000451,1,0.956854883226006,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,1,0.956854883226006,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
218,GO:0000454,1,0.930613260546604,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
219,GO:0000455,1,0.954869689450693,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
220,GO:0000459,1,0.850533501397068,0,7,exonucleolytic trimming involved in rRNA processing,BP,
221,GO:0000460,1,0.471945847685806,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000461,1,0.952131806957623,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000463,1,0.793313726272641,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000466,1,0.607293297969141,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000467,1,0.850533501397068,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000470,1,0.575605578787088,0,24,maturation of LSU-rRNA,BP,
229,GO:0000472,1,0.937979966595965,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000478,1,0.716406703761225,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
231,GO:0000479,1,0.733107532438204,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000480,1,0.875981016131552,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000481,1,0.977872149572893,0,1,maturation of 5S rRNA,BP,
234,GO:0000491,1,0.81403834945855,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
235,GO:0000492,1,0.852467572505668,0,7,box C/D snoRNP assembly,BP,
236,GO:0000493,1,0.954946429618861,0,2,box H/ACA snoRNP assembly,BP,
237,GO:0000494,1,0.976490366137579,0,1,box C/D snoRNA 3'-end processing,BP,
238,GO:0000495,1,0.977256678260932,0,1,box H/ACA snoRNA 3'-end processing,BP,
239,GO:0000496,1,0.975228493115318,0,1,base pairing,MF,
240,GO:0000497,1,0.975228493115318,0,1,base pairing with DNA,MF,
242,GO:0000506,1,0.810349634297159,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.626116000199882,0,22,embryonic axis specification,BP,
244,GO:0000700,1,0.911730602290902,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.954390736227344,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.888863895433711,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.95384644927423,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.956588055837423,0,2,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.831203916714655,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.915284829525151,0,4,meiotic mismatch repair,BP,
251,GO:0000712,1,0.821787849634766,0,9,resolution of meiotic recombination intermediates,BP,
252,GO:0000715,1,0.589331232418891,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.605561291607935,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.977082433676462,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.933873692316773,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000722,1,0.740219347562379,0,14,telomere maintenance via recombination,BP,
258,GO:0000724,1,0.105684360091402,0,101,double-strand break repair via homologous recombination,BP,
259,GO:0000725,1,0.103269106195771,0,102,recombinational repair,BP,
261,GO:0000727,1,0.891567109637782,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000729,1,0.615585474208175,0,22,DNA double-strand break processing,BP,
263,GO:0000730,1,0.793875591463513,0,10,DNA recombinase assembly,BP,
264,GO:0000731,1,0.220943325380052,0,68,DNA synthesis involved in DNA repair,BP,
265,GO:0000732,1,0.58034889313686,0,25,strand displacement,BP,
266,GO:0000733,1,0.816785108912597,0,9,DNA strand renaturation,BP,
267,GO:0000737,1,0.62420917548845,0,21,DNA catabolic process, endonucleolytic,BP,
268,GO:0000738,1,0.912928366269757,0,4,DNA catabolic process, exonucleolytic,BP,
269,GO:0000741,1,0.977094753002521,0,1,karyogamy,BP,
270,GO:0000768,1,0.548044434385521,0,28,syncytium formation by plasma membrane fusion,BP,
271,GO:0000773,1,0.976223502460596,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
276,GO:0000778,1,0.759225382170309,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.636275222712536,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000782,1,0.79580615369561,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.79580615369561,0,10,nuclear telomere cap complex,CC,
292,GO:0000796,1,0.862390160858779,0,7,condensin complex,CC,
293,GO:0000797,1,0.978985609505631,0,1,condensin core heterodimer,CC,
294,GO:0000798,1,0.935073895916647,0,3,nuclear cohesin complex,CC,
295,GO:0000799,1,0.938604173209624,0,3,nuclear condensin complex,CC,
296,GO:0000800,1,0.863068154591917,0,7,lateral element,CC,
297,GO:0000801,1,0.978392839784014,0,1,central element,CC,
298,GO:0000803,1,0.577498673310232,0,25,sex chromosome,CC,
299,GO:0000805,1,0.861950560215409,0,7,X chromosome,CC,
300,GO:0000806,1,0.956939056380854,0,2,Y chromosome,CC,
301,GO:0000808,1,0.813816251522955,0,9,origin recognition complex,CC,
302,GO:0000811,1,0.933700090864403,0,3,GINS complex,CC,
303,GO:0000812,1,0.80488179362882,0,10,Swr1 complex,CC,
304,GO:0000813,1,0.832199923140563,0,8,ESCRT I complex,CC,
305,GO:0000814,1,0.933131558470407,0,3,ESCRT II complex,CC,
306,GO:0000815,1,0.759080964053134,0,12,ESCRT III complex,CC,
307,GO:0000818,1,0.954999230289249,0,2,nuclear MIS12/MIND complex,CC,
309,GO:0000820,1,0.93955482620261,0,3,regulation of glutamine family amino acid metabolic process,BP,
310,GO:0000821,1,0.959560755479384,0,2,regulation of arginine metabolic process,BP,
311,GO:0000822,1,0.942148537340386,0,3,inositol hexakisphosphate binding,MF,
312,GO:0000823,1,0.977121003627211,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,1,0.977121003627211,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,1,0.977121003627211,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
315,GO:0000827,1,0.916915717609613,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
316,GO:0000828,1,0.916915717609613,0,4,inositol hexakisphosphate kinase activity,MF,
317,GO:0000829,1,0.916915717609613,0,4,inositol heptakisphosphate kinase activity,MF,
318,GO:0000832,1,0.916915717609613,0,4,inositol hexakisphosphate 5-kinase activity,MF,
319,GO:0000835,1,0.877181389729707,0,6,ER ubiquitin ligase complex,CC,
320,GO:0000836,1,0.896171701495916,0,5,Hrd1p ubiquitin ligase complex,CC,
321,GO:0000839,1,0.936141493531356,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
322,GO:0000900,1,0.806031562251786,0,10,translation repressor activity, mRNA regulatory element binding,MF,
326,GO:0000912,1,0.878156130436027,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
327,GO:0000915,1,0.878156130436027,0,6,actomyosin contractile ring assembly,BP,
328,GO:0000916,1,0.977227904061852,0,1,actomyosin contractile ring contraction,BP,
329,GO:0000917,1,0.977147198817636,0,1,division septum assembly,BP,
330,GO:0000920,1,0.676317575611507,0,17,cell separation after cytokinesis,BP,
331,GO:0000921,1,0.801169178374534,0,10,septin ring assembly,BP,
333,GO:0000923,1,0.875276965334832,0,6,equatorial microtubule organizing center,CC,
334,GO:0000928,1,0.977336572808046,0,1,gamma-tubulin small complex, spindle pole body,CC,
335,GO:0000930,1,0.660451511762475,0,19,gamma-tubulin complex,CC,
336,GO:0000931,1,0.840332068498978,0,8,gamma-tubulin large complex,CC,
338,GO:0000938,1,0.915974874395288,0,4,GARP complex,CC,
339,GO:0000939,1,0.932898900999831,0,3,condensed chromosome inner kinetochore,CC,
340,GO:0000940,1,0.75113029235096,0,13,condensed chromosome outer kinetochore,CC,
341,GO:0000941,1,0.977234223585788,0,1,condensed nuclear chromosome inner kinetochore,CC,
342,GO:0000942,1,0.912472183747926,0,4,condensed nuclear chromosome outer kinetochore,CC,
344,GO:0000957,1,0.896527413064471,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000958,1,0.935701364147429,0,3,mitochondrial mRNA catabolic process,BP,
346,GO:0000959,1,0.397195391926874,0,41,mitochondrial RNA metabolic process,BP,
347,GO:0000960,1,0.916479034166016,0,4,regulation of mitochondrial RNA catabolic process,BP,
348,GO:0000961,1,0.958144374078149,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000962,1,0.956521388700872,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000963,1,0.694027354379452,0,16,mitochondrial RNA processing,BP,
351,GO:0000964,1,0.912553986826409,0,4,mitochondrial RNA 5'-end processing,BP,
352,GO:0000965,1,0.891761651423453,0,5,mitochondrial RNA 3'-end processing,BP,
353,GO:0000966,1,0.618467940046592,0,21,RNA 5'-end processing,BP,
354,GO:0000967,1,0.937979966595965,0,3,rRNA 5'-end processing,BP,
355,GO:0000972,1,0.855056994605128,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000973,1,0.935302920638121,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
357,GO:0000974,1,0.744104679030223,0,13,Prp19 complex,CC,
365,GO:0000983,1,0.720834803484131,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
369,GO:0000990,1,0.823808010264757,0,9,transcription factor activity, core RNA polymerase binding,MF,
370,GO:0000991,1,0.957129664555258,0,2,transcription factor activity, core RNA polymerase II binding,MF,
371,GO:0000992,1,0.958399668540061,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
372,GO:0000993,1,0.547647710580982,0,27,RNA polymerase II core binding,MF,
373,GO:0000994,1,0.977112483717795,0,1,RNA polymerase III core binding,MF,
374,GO:0000995,1,0.921786070819989,0,4,transcription factor activity, core RNA polymerase III binding,MF,
375,GO:0001002,1,0.958399668540061,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,1,0.958399668540061,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
379,GO:0001011,1,0.981573388025847,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
381,GO:0001013,1,0.839617851133623,0,8,RNA polymerase I regulatory region DNA binding,MF,
383,GO:0001018,1,0.955155851911287,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
384,GO:0001025,1,0.946650596954517,0,3,RNA polymerase III transcription factor binding,MF,
385,GO:0001026,1,0.961688887656332,0,2,TFIIIB-type transcription factor activity,MF,
386,GO:0001030,1,0.901420796764994,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1,0.901420796764994,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
389,GO:0001034,1,0.977126368685332,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
390,GO:0001042,1,0.877601401444443,0,6,RNA polymerase I core binding,MF,
393,GO:0001054,1,0.776603093642695,0,11,RNA polymerase I activity,MF,
394,GO:0001055,1,0.775262852545996,0,11,RNA polymerase II activity,MF,
395,GO:0001056,1,0.707291280528782,0,15,RNA polymerase III activity,MF,
397,GO:0001069,1,0.958573784446474,0,2,regulatory region RNA binding,MF,
398,GO:0001074,1,0.97725792550323,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
399,GO:0001075,1,0.878451555941002,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001083,1,0.900421825844245,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
404,GO:0001084,1,0.97725792550323,0,1,transcription factor activity, TFIID-class binding,MF,
406,GO:0001087,1,0.981573388025847,0,1,transcription factor activity, TFIIB-class binding,MF,
407,GO:0001091,1,0.705138245054057,0,16,RNA polymerase II basal transcription factor binding,MF,
408,GO:0001093,1,0.940066917372711,0,3,TFIIB-class transcription factor binding,MF,
409,GO:0001094,1,0.819380865023299,0,9,TFIID-class transcription factor binding,MF,
410,GO:0001096,1,0.977930532111252,0,1,TFIIF-class transcription factor binding,MF,
411,GO:0001097,1,0.936228490815638,0,3,TFIIH-class transcription factor binding,MF,
412,GO:0001098,1,0.393221782809302,0,42,basal transcription machinery binding,MF,
413,GO:0001099,1,0.393221782809302,0,42,basal RNA polymerase II transcription machinery binding,MF,
416,GO:0001103,1,0.5244134739407,0,29,RNA polymerase II repressing transcription factor binding,MF,
419,GO:0001106,1,0.627560508370193,0,21,RNA polymerase II transcription corepressor activity,MF,
420,GO:0001112,1,0.977406808363639,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,1,0.977406808363639,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,1,0.977406808363639,0,1,protein-DNA complex remodeling,BP,
423,GO:0001128,1,0.976726086765761,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
424,GO:0001129,1,0.9386831934905,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,1,0.9386831934905,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
428,GO:0001135,1,0.855563665271559,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
429,GO:0001147,1,0.961491976388977,0,2,transcription termination site sequence-specific DNA binding,MF,
430,GO:0001156,1,0.946650596954517,0,3,TFIIIC-class transcription factor binding,MF,
432,GO:0001160,1,0.961491976388977,0,2,transcription termination site DNA binding,MF,
433,GO:0001161,1,0.805804825884049,0,10,intronic transcription regulatory region sequence-specific DNA binding,MF,
434,GO:0001162,1,0.841540795322188,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
435,GO:0001163,1,0.839617851133623,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
436,GO:0001164,1,0.839617851133623,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
437,GO:0001165,1,0.978779001001374,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
438,GO:0001172,1,0.955676863015193,0,2,transcription, RNA-templated,BP,
439,GO:0001179,1,0.97715230884973,0,1,RNA polymerase I transcription factor binding,MF,
440,GO:0001181,1,0.955514892947706,0,2,transcription factor activity, core RNA polymerase I binding,MF,
441,GO:0001188,1,0.839617851133623,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
444,GO:0001192,1,0.976021571606809,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,1,0.976021571606809,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
446,GO:0001205,1,0.642616739377974,0,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
450,GO:0001223,1,0.699735681586572,0,17,transcription coactivator binding,MF,
451,GO:0001224,1,0.939897272864925,0,3,RNA polymerase II transcription cofactor binding,MF,
452,GO:0001225,1,0.961450887045262,0,2,RNA polymerase II transcription coactivator binding,MF,
453,GO:0001226,1,0.977585479454205,0,1,RNA polymerase II transcription corepressor binding,MF,
457,GO:0001302,1,0.873695772905684,0,6,replicative cell aging,BP,
458,GO:0001306,1,0.976271479433318,0,1,age-dependent response to oxidative stress,BP,
459,GO:0001315,1,0.976271479433318,0,1,age-dependent response to reactive oxygen species,BP,
460,GO:0001325,1,0.715405704957493,0,15,formation of extrachromosomal circular DNA,BP,
461,GO:0001401,1,0.955212936519001,0,2,mitochondrial sorting and assembly machinery complex,CC,
462,GO:0001405,1,0.891687304282239,0,5,presequence translocase-associated import motor,CC,
468,GO:0001508,1,0.238723706597401,0,67,action potential,BP,
470,GO:0001512,1,0.976451322230561,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
471,GO:0001514,1,0.856116607978163,0,7,selenocysteine incorporation,BP,
474,GO:0001517,1,0.897761674019166,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
475,GO:0001518,1,0.8887300293527,0,6,voltage-gated sodium channel complex,CC,
476,GO:0001519,1,0.977982380337757,0,1,peptide amidation,BP,
477,GO:0001520,1,0.957901247474856,0,2,outer dense fiber,CC,
478,GO:0001522,1,0.657825350674678,0,18,pseudouridine synthesis,BP,
481,GO:0001527,1,0.847875485986579,0,8,microfibril,CC,
483,GO:0001533,1,0.373042968669374,0,44,cornified envelope,CC,
484,GO:0001534,1,0.978020931967393,0,1,radial spoke,CC,
485,GO:0001536,1,0.978020931967393,0,1,radial spoke stalk,CC,
486,GO:0001537,1,0.957386243573285,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
487,GO:0001539,1,0.725378162029726,0,15,cilium or flagellum-dependent cell motility,BP,
489,GO:0001541,1,0.391671741697634,0,42,ovarian follicle development,BP,
490,GO:0001542,1,0.880050461316232,0,6,ovulation from ovarian follicle,BP,
491,GO:0001543,1,0.981017362211532,0,1,ovarian follicle rupture,BP,
492,GO:0001544,1,0.980853215832052,0,1,initiation of primordial ovarian follicle growth,BP,
493,GO:0001545,1,0.97830024638832,0,1,primary ovarian follicle growth,BP,
494,GO:0001546,1,0.977029424191677,0,1,preantral ovarian follicle growth,BP,
495,GO:0001547,1,0.9003455890365,0,5,antral ovarian follicle growth,BP,
496,GO:0001550,1,0.958799772261469,0,2,ovarian cumulus expansion,BP,
497,GO:0001552,1,0.977181342858884,0,1,ovarian follicle atresia,BP,
498,GO:0001553,1,0.899319721142021,0,5,luteinization,BP,
499,GO:0001554,1,0.89855500306088,0,5,luteolysis,BP,
500,GO:0001555,1,0.955193052203544,0,2,oocyte growth,BP,
501,GO:0001556,1,0.684901928316127,0,17,oocyte maturation,BP,
503,GO:0001560,1,0.959167381554056,0,2,regulation of cell growth by extracellular stimulus,BP,
504,GO:0001561,1,0.87267890855083,0,6,fatty acid alpha-oxidation,BP,
505,GO:0001562,1,0.819297818415636,0,9,response to protozoan,BP,
509,GO:0001572,1,0.978972485356465,0,1,lactosylceramide biosynthetic process,BP,
510,GO:0001573,1,0.799230377647608,0,10,ganglioside metabolic process,BP,
511,GO:0001574,1,0.912847818912817,0,4,ganglioside biosynthetic process,BP,
512,GO:0001575,1,0.954903198759313,0,2,globoside metabolic process,BP,
513,GO:0001576,1,0.97721578479866,0,1,globoside biosynthetic process,BP,
514,GO:0001578,1,0.378723810702539,0,45,microtubule bundle formation,BP,
515,GO:0001579,1,0.955680449009429,0,2,medium-chain fatty acid transport,BP,
516,GO:0001580,1,0.889389427174653,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
517,GO:0001582,1,0.977254532392453,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
518,GO:0001588,1,0.953716102189713,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
519,GO:0001595,1,0.976510286432813,0,1,angiotensin receptor activity,MF,
520,GO:0001605,1,0.979123887660731,0,1,adrenomedullin receptor activity,MF,
521,GO:0001608,1,0.892150800066654,0,5,G-protein coupled nucleotide receptor activity,MF,
522,GO:0001609,1,0.933333609435871,0,3,G-protein coupled adenosine receptor activity,MF,
523,GO:0001614,1,0.871805849600508,0,6,purinergic nucleotide receptor activity,MF,
525,GO:0001631,1,0.955179742564803,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,1,0.955179742564803,0,2,leukotriene B4 receptor activity,MF,
527,GO:0001635,1,0.933978343735012,0,3,calcitonin gene-related peptide receptor activity,MF,
528,GO:0001637,1,0.871528974308523,0,6,G-protein coupled chemoattractant receptor activity,MF,
529,GO:0001640,1,0.979990412670674,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,1,0.979990412670674,0,1,group III metabotropic glutamate receptor activity,MF,
533,GO:0001651,1,0.954357792832602,0,2,dense fibrillar component,CC,
535,GO:0001653,1,0.527184444309498,0,28,peptide receptor activity,MF,
542,GO:0001660,1,0.85309984162577,0,7,fever generation,BP,
544,GO:0001662,1,0.671268004907576,0,18,behavioral fear response,BP,
546,GO:0001665,1,0.911760664285193,0,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
549,GO:0001669,1,0.31336634286894,0,52,acrosomal vesicle,CC,
551,GO:0001672,1,0.862260463209086,0,7,regulation of chromatin assembly or disassembly,BP,
553,GO:0001674,1,0.956235085930359,0,2,female germ cell nucleus,CC,
554,GO:0001675,1,0.843193786961712,0,8,acrosome assembly,BP,
557,GO:0001680,1,0.977235739684677,0,1,tRNA 3'-terminal CCA addition,BP,
558,GO:0001681,1,0.977316622033018,0,1,sialate O-acetylesterase activity,MF,
559,GO:0001682,1,0.755727420081723,0,12,tRNA 5'-leader removal,BP,
560,GO:0001692,1,0.976076229080863,0,1,histamine metabolic process,BP,
561,GO:0001695,1,0.976076229080863,0,1,histamine catabolic process,BP,
562,GO:0001696,1,0.87432480825513,0,6,gastric acid secretion,BP,
564,GO:0001702,1,0.687608949836391,0,18,gastrulation with mouth forming second,BP,
566,GO:0001705,1,0.956507664346352,0,2,ectoderm formation,BP,
571,GO:0001710,1,0.873646996684113,0,6,mesodermal cell fate commitment,BP,
572,GO:0001711,1,0.798912153741705,0,10,endodermal cell fate commitment,BP,
573,GO:0001712,1,0.956507664346352,0,2,ectodermal cell fate commitment,BP,
574,GO:0001714,1,0.911479334410987,0,4,endodermal cell fate specification,BP,
575,GO:0001715,1,0.978097417232454,0,1,ectodermal cell fate specification,BP,
578,GO:0001727,1,0.896193369929865,0,5,lipid kinase activity,MF,
579,GO:0001729,1,0.956500405878574,0,2,ceramide kinase activity,MF,
580,GO:0001730,1,0.91501691243943,0,4,2'-5'-oligoadenylate synthetase activity,MF,
581,GO:0001731,1,0.837177526838024,0,8,formation of translation preinitiation complex,BP,
582,GO:0001732,1,0.957027458039533,0,2,formation of cytoplasmic translation initiation complex,BP,
583,GO:0001733,1,0.977252448864821,0,1,galactosylceramide sulfotransferase activity,MF,
584,GO:0001735,1,0.95713542168462,0,2,prenylcysteine oxidase activity,MF,
585,GO:0001736,1,0.0870607124237954,0,109,establishment of planar polarity,BP,
586,GO:0001738,1,0.0675059257254696,0,121,morphogenesis of a polarized epithelium,BP,
587,GO:0001739,1,0.87257931426118,0,6,sex chromatin,CC,
588,GO:0001740,1,0.937570291589657,0,3,Barr body,CC,
589,GO:0001741,1,0.781184042856809,0,11,XY body,CC,
590,GO:0001743,1,0.958628882764735,0,2,optic placode formation,BP,
594,GO:0001756,1,0.438475801061359,0,39,somitogenesis,BP,
595,GO:0001757,1,0.957434096220752,0,2,somite specification,BP,
596,GO:0001758,1,0.934056996634136,0,3,retinal dehydrogenase activity,MF,
600,GO:0001765,1,0.813828828744679,0,9,membrane raft assembly,BP,
602,GO:0001767,1,0.882153286349696,0,6,establishment of lymphocyte polarity,BP,
603,GO:0001768,1,0.899535141591265,0,5,establishment of T cell polarity,BP,
604,GO:0001770,1,0.980684478967206,0,1,establishment of natural killer cell polarity,BP,
605,GO:0001771,1,0.87646138242433,0,6,immunological synapse formation,BP,
607,GO:0001773,1,0.742690471920131,0,13,myeloid dendritic cell activation,BP,
611,GO:0001777,1,0.975913291000001,0,1,T cell homeostatic proliferation,BP,
612,GO:0001778,1,0.921501036960106,0,4,plasma membrane repair,BP,
613,GO:0001779,1,0.751612880560968,0,13,natural killer cell differentiation,BP,
614,GO:0001780,1,0.800404927168919,0,10,neutrophil homeostasis,BP,
615,GO:0001781,1,0.874701024461437,0,6,neutrophil apoptotic process,BP,
616,GO:0001782,1,0.617015844366584,0,22,B cell homeostasis,BP,
620,GO:0001787,1,0.892350467597954,0,5,natural killer cell proliferation,BP,
621,GO:0001792,1,0.978508502207886,0,1,polymeric immunoglobulin receptor activity,MF,
622,GO:0001794,1,0.979228390876785,0,1,type IIa hypersensitivity,BP,
623,GO:0001796,1,0.979228390876785,0,1,regulation of type IIa hypersensitivity,BP,
624,GO:0001798,1,0.979228390876785,0,1,positive regulation of type IIa hypersensitivity,BP,
625,GO:0001806,1,0.932964699470551,0,3,type IV hypersensitivity,BP,
626,GO:0001807,1,0.954513759964806,0,2,regulation of type IV hypersensitivity,BP,
627,GO:0001808,1,0.977207154540857,0,1,negative regulation of type IV hypersensitivity,BP,
628,GO:0001809,1,0.976779281456844,0,1,positive regulation of type IV hypersensitivity,BP,
633,GO:0001820,1,0.935798047137076,0,3,serotonin secretion,BP,
634,GO:0001821,1,0.829220227059306,0,8,histamine secretion,BP,
637,GO:0001824,1,0.343475449337235,0,48,blastocyst development,BP,
638,GO:0001825,1,0.613983221699638,0,22,blastocyst formation,BP,
639,GO:0001826,1,0.90087770291988,0,5,inner cell mass cell differentiation,BP,
640,GO:0001827,1,0.958894740927407,0,2,inner cell mass cell fate commitment,BP,
641,GO:0001828,1,0.958894740927407,0,2,inner cell mass cellular morphogenesis,BP,
642,GO:0001829,1,0.80104102546388,0,10,trophectodermal cell differentiation,BP,
643,GO:0001831,1,0.980468843601973,0,1,trophectodermal cellular morphogenesis,BP,
644,GO:0001832,1,0.721676111866889,0,15,blastocyst growth,BP,
645,GO:0001833,1,0.803085834801804,0,10,inner cell mass cell proliferation,BP,
646,GO:0001834,1,0.958576759709335,0,2,trophectodermal cell proliferation,BP,
647,GO:0001835,1,0.977555063335181,0,1,blastocyst hatching,BP,
654,GO:0001842,1,0.896303773276412,0,5,neural fold formation,BP,
656,GO:0001844,1,0.503335817458779,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
657,GO:0001845,1,0.817262403336711,0,9,phagolysosome assembly,BP,
658,GO:0001846,1,0.87281127613302,0,6,opsonin binding,MF,
659,GO:0001848,1,0.853410034786742,0,7,complement binding,MF,
660,GO:0001849,1,0.932413294021232,0,3,complement component C1q binding,MF,
661,GO:0001850,1,0.97713774560675,0,1,complement component C3a binding,MF,
662,GO:0001851,1,0.97713774560675,0,1,complement component C3b binding,MF,
663,GO:0001855,1,0.976975260365865,0,1,complement component C4b binding,MF,
664,GO:0001865,1,0.917789393669486,0,4,NK T cell differentiation,BP,
665,GO:0001866,1,0.911307118080487,0,4,NK T cell proliferation,BP,
666,GO:0001867,1,0.911748394968094,0,4,complement activation, lectin pathway,BP,
667,GO:0001868,1,0.977164754479537,0,1,regulation of complement activation, lectin pathway,BP,
668,GO:0001869,1,0.977164754479537,0,1,negative regulation of complement activation, lectin pathway,BP,
669,GO:0001871,1,0.859462334188729,0,7,pattern binding,MF,
670,GO:0001872,1,0.977179450989824,0,1,(1->3)-beta-D-glucan binding,MF,
671,GO:0001875,1,0.934794251806323,0,3,lipopolysaccharide receptor activity,MF,
672,GO:0001878,1,0.95493471840504,0,2,response to yeast,BP,
673,GO:0001880,1,0.958934692612517,0,2,Mullerian duct regression,BP,
674,GO:0001881,1,0.53926312536056,0,28,receptor recycling,BP,
677,GO:0001884,1,0.957317090363781,0,2,pyrimidine nucleoside binding,MF,
680,GO:0001887,1,0.912789070275764,0,4,selenium compound metabolic process,BP,
681,GO:0001888,1,0.957790772190987,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
684,GO:0001891,1,0.699875836979556,0,16,phagocytic cup,CC,
689,GO:0001905,1,0.960717916129185,0,2,activation of membrane attack complex,BP,
691,GO:0001907,1,0.933640936044419,0,3,killing by symbiont of host cells,BP,
692,GO:0001909,1,0.299787279190197,0,53,leukocyte mediated cytotoxicity,BP,
693,GO:0001910,1,0.505594445566564,0,30,regulation of leukocyte mediated cytotoxicity,BP,
694,GO:0001911,1,0.794983310241656,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
695,GO:0001912,1,0.681709109365684,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
696,GO:0001913,1,0.633478507809071,0,20,T cell mediated cytotoxicity,BP,
697,GO:0001914,1,0.742332651708024,0,13,regulation of T cell mediated cytotoxicity,BP,
698,GO:0001915,1,0.933860797196022,0,3,negative regulation of T cell mediated cytotoxicity,BP,
699,GO:0001916,1,0.832940339259091,0,8,positive regulation of T cell mediated cytotoxicity,BP,
700,GO:0001917,1,0.619572112342795,0,22,photoreceptor inner segment,CC,
701,GO:0001918,1,0.977298802134056,0,1,farnesylated protein binding,MF,
702,GO:0001919,1,0.641573570907441,0,20,regulation of receptor recycling,BP,
703,GO:0001920,1,0.934525444099105,0,3,negative regulation of receptor recycling,BP,
704,GO:0001921,1,0.751211766404396,0,13,positive regulation of receptor recycling,BP,
705,GO:0001922,1,0.937838568056827,0,3,B-1 B cell homeostasis,BP,
706,GO:0001923,1,0.935537372837327,0,3,B-1 B cell differentiation,BP,
707,GO:0001927,1,0.936489493791873,0,3,exocyst assembly,BP,
708,GO:0001928,1,0.977234510015904,0,1,regulation of exocyst assembly,BP,
709,GO:0001931,1,0.840323415498315,0,8,uropod,CC,
716,GO:0001938,1,0.268609382807104,0,60,positive regulation of endothelial cell proliferation,BP,
718,GO:0001940,1,0.900805143592151,0,5,male pronucleus,CC,
723,GO:0001946,1,0.830028040087001,0,9,lymphangiogenesis,BP,
724,GO:0001947,1,0.468404240161787,0,35,heart looping,BP,
725,GO:0001951,1,0.935928937767156,0,3,intestinal D-glucose absorption,BP,
728,GO:0001954,1,0.442860767625167,0,38,positive regulation of cell-matrix adhesion,BP,
729,GO:0001955,1,0.896463525271937,0,5,blood vessel maturation,BP,
730,GO:0001956,1,0.820012732025024,0,9,positive regulation of neurotransmitter secretion,BP,
735,GO:0001961,1,0.482249954973649,0,33,positive regulation of cytokine-mediated signaling pathway,BP,
737,GO:0001964,1,0.861907651672399,0,7,startle response,BP,
739,GO:0001967,1,0.85830540250687,0,7,suckling behavior,BP,
741,GO:0001969,1,0.960717916129185,0,2,regulation of activation of membrane attack complex,BP,
742,GO:0001970,1,0.979228390876785,0,1,positive regulation of activation of membrane attack complex,BP,
743,GO:0001971,1,0.981098358259333,0,1,negative regulation of activation of membrane attack complex,BP,
745,GO:0001973,1,0.891027891193314,0,5,adenosine receptor signaling pathway,BP,
746,GO:0001974,1,0.585664079305137,0,25,blood vessel remodeling,BP,
747,GO:0001975,1,0.753937249221318,0,13,response to amphetamine,BP,
748,GO:0001976,1,0.919185968623723,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
749,GO:0001977,1,0.81435539764114,0,9,renal system process involved in regulation of blood volume,BP,
750,GO:0001978,1,0.977228058558821,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
751,GO:0001983,1,0.977228058558821,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
752,GO:0001985,1,0.977228058558821,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001990,1,0.695631736682775,0,16,regulation of systemic arterial blood pressure by hormone,BP,
754,GO:0001991,1,0.83485637458172,0,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
755,GO:0001992,1,0.978578831257478,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
756,GO:0001993,1,0.915760736480737,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
757,GO:0001994,1,0.977228058558821,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
758,GO:0001996,1,0.937126642665487,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
759,GO:0001997,1,0.977228058558821,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
760,GO:0001998,1,0.977174189107549,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
761,GO:0001999,1,0.913473322940532,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
762,GO:0002001,1,0.913473322940532,0,4,renin secretion into blood stream,BP,
763,GO:0002002,1,0.913964218325257,0,4,regulation of angiotensin levels in blood,BP,
764,GO:0002003,1,0.913964218325257,0,4,angiotensin maturation,BP,
767,GO:0002016,1,0.97569188921866,0,1,regulation of blood volume by renin-angiotensin,BP,
768,GO:0002017,1,0.977159980095357,0,1,regulation of blood volume by renal aldosterone,BP,
769,GO:0002019,1,0.97569188921866,0,1,regulation of renal output by angiotensin,BP,
771,GO:0002021,1,0.798566880352707,0,10,response to dietary excess,BP,
772,GO:0002024,1,0.894574175731113,0,5,diet induced thermogenesis,BP,
773,GO:0002025,1,0.977206121775138,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
774,GO:0002026,1,0.738126538766036,0,14,regulation of the force of heart contraction,BP,
776,GO:0002028,1,0.296386140808198,0,56,regulation of sodium ion transport,BP,
777,GO:0002029,1,0.758780254827836,0,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,
778,GO:0002031,1,0.7946249778397,0,10,G-protein coupled receptor internalization,BP,
779,GO:0002032,1,0.954893930126354,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
780,GO:0002034,1,0.977174189107549,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
782,GO:0002037,1,0.977221063299534,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
783,GO:0002038,1,0.977234999346512,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
784,GO:0002039,1,0.264764993746107,0,61,p53 binding,MF,
785,GO:0002040,1,0.20861448269016,0,72,sprouting angiogenesis,BP,
786,GO:0002041,1,0.977236698931318,0,1,intussusceptive angiogenesis,BP,
787,GO:0002042,1,0.44536986814978,0,37,cell migration involved in sprouting angiogenesis,BP,
788,GO:0002043,1,0.802032731136189,0,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
789,GO:0002046,1,0.976194302499549,0,1,opsin binding,MF,
790,GO:0002051,1,0.921159987426559,0,4,osteoblast fate commitment,BP,
791,GO:0002052,1,0.774398423681875,0,12,positive regulation of neuroblast proliferation,BP,
793,GO:0002054,1,0.931930902342976,0,3,nucleobase binding,MF,
794,GO:0002055,1,0.975783880507505,0,1,adenine binding,MF,
795,GO:0002060,1,0.931930902342976,0,3,purine nucleobase binding,MF,
802,GO:0002068,1,0.690135823836081,0,17,glandular epithelial cell development,BP,
805,GO:0002071,1,0.955311424431099,0,2,glandular epithelial cell maturation,BP,
806,GO:0002072,1,0.884478599528762,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
807,GO:0002074,1,0.936653483230079,0,3,extraocular skeletal muscle development,BP,
809,GO:0002079,1,0.959371782517494,0,2,inner acrosomal membrane,CC,
810,GO:0002080,1,0.800491555432239,0,10,acrosomal membrane,CC,
811,GO:0002081,1,0.981406930781633,0,1,outer acrosomal membrane,CC,
812,GO:0002082,1,0.728624110813638,0,14,regulation of oxidative phosphorylation,BP,
813,GO:0002083,1,0.977021734723393,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
814,GO:0002084,1,0.814449329035255,0,9,protein depalmitoylation,BP,
816,GO:0002086,1,0.977862671251014,0,1,diaphragm contraction,BP,
817,GO:0002087,1,0.898001725682472,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
819,GO:0002089,1,0.779543860672559,0,12,lens morphogenesis in camera-type eye,BP,
820,GO:0002090,1,0.574347254883394,0,25,regulation of receptor internalization,BP,
821,GO:0002091,1,0.857015152983196,0,7,negative regulation of receptor internalization,BP,
822,GO:0002092,1,0.718520630114931,0,15,positive regulation of receptor internalization,BP,
823,GO:0002093,1,0.855874925231313,0,7,auditory receptor cell morphogenesis,BP,
824,GO:0002094,1,0.955127764322173,0,2,polyprenyltransferase activity,MF,
825,GO:0002097,1,0.694557854912219,0,16,tRNA wobble base modification,BP,
826,GO:0002098,1,0.75899409171999,0,12,tRNA wobble uridine modification,BP,
827,GO:0002100,1,0.980071073247669,0,1,tRNA wobble adenosine to inosine editing,BP,
828,GO:0002101,1,0.933801646585234,0,3,tRNA wobble cytosine modification,BP,
829,GO:0002102,1,0.555649841270382,0,27,podosome,CC,
830,GO:0002114,1,0.978060610843588,0,1,interleukin-33 receptor activity,MF,
831,GO:0002115,1,0.750598685701111,0,13,store-operated calcium entry,BP,
832,GO:0002116,1,0.82020649701165,0,10,semaphorin receptor complex,CC,
833,GO:0002118,1,0.977703516615882,0,1,aggressive behavior,BP,
834,GO:0002121,1,0.977703516615882,0,1,inter-male aggressive behavior,BP,
835,GO:0002127,1,0.976829705745857,0,1,tRNA wobble base cytosine methylation,BP,
836,GO:0002133,1,0.964830661225928,0,2,polycystin complex,CC,
837,GO:0002134,1,0.957317090363781,0,2,UTP binding,MF,
838,GO:0002135,1,0.977253118713482,0,1,CTP binding,MF,
839,GO:0002138,1,0.891479536944811,0,5,retinoic acid biosynthetic process,BP,
840,GO:0002143,1,0.911785462315993,0,4,tRNA wobble position uridine thiolation,BP,
841,GO:0002144,1,0.977218158304585,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
842,GO:0002151,1,0.877722880628462,0,6,G-quadruplex RNA binding,MF,
843,GO:0002153,1,0.977243934022399,0,1,steroid receptor RNA activator RNA binding,MF,
844,GO:0002154,1,0.901524032246314,0,5,thyroid hormone mediated signaling pathway,BP,
845,GO:0002155,1,0.93641116346354,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
846,GO:0002158,1,0.956373968784492,0,2,osteoclast proliferation,BP,
847,GO:0002159,1,0.918064893963437,0,4,desmosome assembly,BP,
848,GO:0002161,1,0.781698773818605,0,11,aminoacyl-tRNA editing activity,MF,
849,GO:0002162,1,0.870417504608918,0,7,dystroglycan binding,MF,
850,GO:0002169,1,0.955690610524585,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
851,GO:0002174,1,0.977356057038789,0,1,mammary stem cell proliferation,BP,
852,GO:0002175,1,0.920702978956569,0,4,protein localization to paranode region of axon,BP,
853,GO:0002176,1,0.93119878838252,0,3,male germ cell proliferation,BP,
854,GO:0002177,1,0.932471355022115,0,3,manchette,CC,
855,GO:0002178,1,0.779439637902548,0,11,palmitoyltransferase complex,CC,
856,GO:0002181,1,0.137016579250502,0,85,cytoplasmic translation,BP,
857,GO:0002182,1,0.781316920085912,0,11,cytoplasmic translational elongation,BP,
858,GO:0002183,1,0.669364044916902,0,18,cytoplasmic translational initiation,BP,
859,GO:0002184,1,0.958485281952184,0,2,cytoplasmic translational termination,BP,
860,GO:0002188,1,0.940509660168177,0,3,translation reinitiation,BP,
861,GO:0002189,1,0.977252401924239,0,1,ribose phosphate diphosphokinase complex,CC,
862,GO:0002190,1,0.889865449606133,0,5,cap-independent translational initiation,BP,
863,GO:0002191,1,0.935112451899834,0,3,cap-dependent translational initiation,BP,
864,GO:0002192,1,0.953566767049371,0,2,IRES-dependent translational initiation of linear mRNA,BP,
865,GO:0002193,1,0.940382526035874,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
866,GO:0002196,1,0.977166971322993,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
867,GO:0002199,1,0.851297572757777,0,7,zona pellucida receptor complex,CC,
871,GO:0002209,1,0.671268004907576,0,18,behavioral defense response,BP,
873,GO:0002220,1,0.111358710000161,0,98,innate immune response activating cell surface receptor signaling pathway,BP,
875,GO:0002223,1,0.111358710000161,0,98,stimulatory C-type lectin receptor signaling pathway,BP,
877,GO:0002225,1,0.954524885379294,0,2,positive regulation of antimicrobial peptide production,BP,
879,GO:0002228,1,0.443457912508401,0,36,natural killer cell mediated immunity,BP,
880,GO:0002230,1,0.68676337626966,0,17,positive regulation of defense response to virus by host,BP,
882,GO:0002238,1,0.979148195395373,0,1,response to molecule of fungal origin,BP,
884,GO:0002246,1,0.871947032793826,0,6,wound healing involved in inflammatory response,BP,
885,GO:0002248,1,0.892533614514865,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
886,GO:0002249,1,0.960758338390513,0,2,lymphocyte anergy,BP,
891,GO:0002254,1,0.9549549686668,0,2,kinin cascade,BP,
895,GO:0002265,1,0.944551658484762,0,3,astrocyte activation involved in immune response,BP,
896,GO:0002266,1,0.955095606697283,0,2,follicular dendritic cell activation,BP,
897,GO:0002268,1,0.955095606697283,0,2,follicular dendritic cell differentiation,BP,
900,GO:0002276,1,0.956134685336283,0,2,basophil activation involved in immune response,BP,
901,GO:0002277,1,0.976059241732398,0,1,myeloid dendritic cell activation involved in immune response,BP,
902,GO:0002278,1,0.911668303987733,0,4,eosinophil activation involved in immune response,BP,
903,GO:0002279,1,0.548134937272764,0,27,mast cell activation involved in immune response,BP,
904,GO:0002281,1,0.896674212573557,0,5,macrophage activation involved in immune response,BP,
909,GO:0002291,1,0.933130190281189,0,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
913,GO:0002295,1,0.835970278248686,0,8,T-helper cell lineage commitment,BP,
914,GO:0002296,1,0.959194104280002,0,2,T-helper 1 cell lineage commitment,BP,
915,GO:0002299,1,0.976954895969588,0,1,alpha-beta intraepithelial T cell differentiation,BP,
916,GO:0002300,1,0.976954895969588,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
917,GO:0002304,1,0.976954895969588,0,1,gamma-delta intraepithelial T cell differentiation,BP,
918,GO:0002305,1,0.976954895969588,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
919,GO:0002309,1,0.975948552737966,0,1,T cell proliferation involved in immune response,BP,
921,GO:0002313,1,0.717770020468504,0,15,mature B cell differentiation involved in immune response,BP,
922,GO:0002314,1,0.954697344828005,0,2,germinal center B cell differentiation,BP,
923,GO:0002315,1,0.844468054468705,0,8,marginal zone B cell differentiation,BP,
924,GO:0002316,1,0.978498490151427,0,1,follicular B cell differentiation,BP,
925,GO:0002317,1,0.931302182960867,0,3,plasma cell differentiation,BP,
926,GO:0002318,1,0.934024822852061,0,3,myeloid progenitor cell differentiation,BP,
928,GO:0002322,1,0.958350798093901,0,2,B cell proliferation involved in immune response,BP,
929,GO:0002323,1,0.814968612886465,0,9,natural killer cell activation involved in immune response,BP,
930,GO:0002325,1,0.976500354292079,0,1,natural killer cell differentiation involved in immune response,BP,
931,GO:0002326,1,0.942683450720232,0,3,B cell lineage commitment,BP,
935,GO:0002331,1,0.964073508527611,0,2,pre-B cell allelic exclusion,BP,
936,GO:0002332,1,0.979612589015614,0,1,transitional stage B cell differentiation,BP,
937,GO:0002333,1,0.979612589015614,0,1,transitional one stage B cell differentiation,BP,
938,GO:0002335,1,0.657124556551954,0,19,mature B cell differentiation,BP,
939,GO:0002337,1,0.955472053208554,0,2,B-1a B cell differentiation,BP,
940,GO:0002339,1,0.953688863177052,0,2,B cell selection,BP,
942,GO:0002349,1,0.890109536258332,0,5,histamine production involved in inflammatory response,BP,
943,GO:0002351,1,0.979148195395373,0,1,serotonin production involved in inflammatory response,BP,
944,GO:0002352,1,0.953688863177052,0,2,B cell negative selection,BP,
945,GO:0002353,1,0.9549549686668,0,2,plasma kallikrein-kinin cascade,BP,
946,GO:0002357,1,0.977291572676308,0,1,defense response to tumor cell,BP,
947,GO:0002358,1,0.975913291000001,0,1,B cell homeostatic proliferation,BP,
948,GO:0002360,1,0.737903340930583,0,14,T cell lineage commitment,BP,
949,GO:0002363,1,0.798970321054467,0,10,alpha-beta T cell lineage commitment,BP,
951,GO:0002367,1,0.293948323600738,0,54,cytokine production involved in immune response,BP,
952,GO:0002368,1,0.977238192651982,0,1,B cell cytokine production,BP,
953,GO:0002369,1,0.634473835264177,0,20,T cell cytokine production,BP,
954,GO:0002370,1,0.933848064799851,0,3,natural killer cell cytokine production,BP,
955,GO:0002371,1,0.914580509187118,0,4,dendritic cell cytokine production,BP,
956,GO:0002373,1,0.976133335782055,0,1,plasmacytoid dendritic cell cytokine production,BP,
957,GO:0002374,1,0.763799360280138,0,12,cytokine secretion involved in immune response,BP,
960,GO:0002378,1,0.978678733051777,0,1,immunoglobulin biosynthetic process,BP,
961,GO:0002380,1,0.978704010261509,0,1,immunoglobulin secretion involved in immune response,BP,
963,GO:0002384,1,0.955390516095331,0,2,hepatic immune response,BP,
965,GO:0002386,1,0.978508502207886,0,1,immune response in mucosal-associated lymphoid tissue,BP,
966,GO:0002396,1,0.977172823365079,0,1,MHC protein complex assembly,BP,
967,GO:0002397,1,0.977172823365079,0,1,MHC class I protein complex assembly,BP,
968,GO:0002407,1,0.779604444927196,0,11,dendritic cell chemotaxis,BP,
969,GO:0002408,1,0.979506517690272,0,1,myeloid dendritic cell chemotaxis,BP,
970,GO:0002414,1,0.956102590211672,0,2,immunoglobulin transcytosis in epithelial cells,BP,
971,GO:0002415,1,0.978508502207886,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
972,GO:0002416,1,0.977103823631464,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
973,GO:0002418,1,0.83434366057433,0,8,immune response to tumor cell,BP,
974,GO:0002420,1,0.914798681829776,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
975,GO:0002423,1,0.914798681829776,0,4,natural killer cell mediated immune response to tumor cell,BP,
976,GO:0002424,1,0.955441366894514,0,2,T cell mediated immune response to tumor cell,BP,
977,GO:0002428,1,0.933078497048528,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
979,GO:0002430,1,0.977236605385541,0,1,complement receptor mediated signaling pathway,BP,
981,GO:0002432,1,0.978631277001237,0,1,granuloma formation,BP,
983,GO:0002437,1,0.621505883949368,0,21,inflammatory response to antigenic stimulus,BP,
984,GO:0002438,1,0.832413246371841,0,8,acute inflammatory response to antigenic stimulus,BP,
985,GO:0002439,1,0.932845732663195,0,3,chronic inflammatory response to antigenic stimulus,BP,
987,GO:0002441,1,0.890109536258332,0,5,histamine secretion involved in inflammatory response,BP,
988,GO:0002442,1,0.979148195395373,0,1,serotonin secretion involved in inflammatory response,BP,
991,GO:0002445,1,0.979228390876785,0,1,type II hypersensitivity,BP,
993,GO:0002447,1,0.911668303987733,0,4,eosinophil mediated immunity,BP,
994,GO:0002448,1,0.536260414019423,0,28,mast cell mediated immunity,BP,
997,GO:0002456,1,0.287469356071515,0,55,T cell mediated immunity,BP,
998,GO:0002457,1,0.914515425134026,0,4,T cell antigen processing and presentation,BP,
1000,GO:0002461,1,0.977238535630964,0,1,tolerance induction dependent upon immune response,BP,
1001,GO:0002467,1,0.804833126121424,0,10,germinal center formation,BP,
1002,GO:0002468,1,0.916563030874428,0,4,dendritic cell antigen processing and presentation,BP,
1003,GO:0002474,1,0.146979955551651,0,83,antigen processing and presentation of peptide antigen via MHC class I,BP,
1004,GO:0002475,1,0.873953417117357,0,6,antigen processing and presentation via MHC class Ib,BP,
1005,GO:0002476,1,0.955820748168939,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1006,GO:0002477,1,0.97621056248551,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1007,GO:0002478,1,0.0399001107031616,0,141,antigen processing and presentation of exogenous peptide antigen,BP,
1008,GO:0002479,1,0.214080764258882,0,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1009,GO:0002480,1,0.811360098650901,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1010,GO:0002481,1,0.97621056248551,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1011,GO:0002483,1,0.835843114560328,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1012,GO:0002488,1,0.978273888349958,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1013,GO:0002489,1,0.978273888349958,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1014,GO:0002495,1,0.183832299237852,0,76,antigen processing and presentation of peptide antigen via MHC class II,BP,
1015,GO:0002501,1,0.977172823365079,0,1,peptide antigen assembly with MHC protein complex,BP,
1016,GO:0002502,1,0.977172823365079,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1017,GO:0002504,1,0.180084074773845,0,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1018,GO:0002507,1,0.769250230413697,0,12,tolerance induction,BP,
1019,GO:0002513,1,0.934959887625877,0,3,tolerance induction to self antigen,BP,
1020,GO:0002514,1,0.97884689532132,0,1,B cell tolerance induction,BP,
1021,GO:0002517,1,0.897600058144674,0,5,T cell tolerance induction,BP,
1022,GO:0002519,1,0.977238535630964,0,1,natural killer cell tolerance induction,BP,
1025,GO:0002523,1,0.8889238550794,0,5,leukocyte migration involved in inflammatory response,BP,
1026,GO:0002524,1,0.91358051663766,0,4,hypersensitivity,BP,
1028,GO:0002528,1,0.959134377877748,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1031,GO:0002536,1,0.95375820242249,0,2,respiratory burst involved in inflammatory response,BP,
1032,GO:0002537,1,0.981028080218143,0,1,nitric oxide production involved in inflammatory response,BP,
1035,GO:0002541,1,0.954967282466775,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
1036,GO:0002542,1,0.977210306330478,0,1,Factor XII activation,BP,
1037,GO:0002543,1,0.956664552882339,0,2,activation of blood coagulation via clotting cascade,BP,
1038,GO:0002544,1,0.759933529203848,0,12,chronic inflammatory response,BP,
1039,GO:0002545,1,0.977160758322415,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1041,GO:0002551,1,0.834412834936556,0,8,mast cell chemotaxis,BP,
1042,GO:0002553,1,0.890109536258332,0,5,histamine secretion by mast cell,BP,
1043,GO:0002554,1,0.979148195395373,0,1,serotonin secretion by platelet,BP,
1044,GO:0002560,1,0.978425880734245,0,1,basophil mediated immunity,BP,
1045,GO:0002561,1,0.978425880734245,0,1,basophil degranulation,BP,
1047,GO:0002566,1,0.714639928312049,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1048,GO:0002568,1,0.903407095312153,0,5,somatic diversification of T cell receptor genes,BP,
1049,GO:0002572,1,0.956140345518795,0,2,pro-T cell differentiation,BP,
1052,GO:0002577,1,0.834326202672228,0,8,regulation of antigen processing and presentation,BP,
1053,GO:0002578,1,0.913737604853917,0,4,negative regulation of antigen processing and presentation,BP,
1054,GO:0002579,1,0.913119824541063,0,4,positive regulation of antigen processing and presentation,BP,
1055,GO:0002580,1,0.934051001097612,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1056,GO:0002581,1,0.956965214800789,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002582,1,0.976059241732398,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1058,GO:0002583,1,0.910304973767961,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
1059,GO:0002584,1,0.932638831162255,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002585,1,0.976059241732398,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1061,GO:0002586,1,0.953370807259211,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1062,GO:0002587,1,0.976757153908769,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1063,GO:0002588,1,0.976059241732398,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1064,GO:0002589,1,0.954835738990844,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1065,GO:0002590,1,0.954835738990844,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1066,GO:0002604,1,0.916563030874428,0,4,regulation of dendritic cell antigen processing and presentation,BP,
1067,GO:0002605,1,0.979738867231149,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1068,GO:0002606,1,0.935522482785348,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
1069,GO:0002625,1,0.977182886223586,0,1,regulation of T cell antigen processing and presentation,BP,
1070,GO:0002626,1,0.977182886223586,0,1,negative regulation of T cell antigen processing and presentation,BP,
1071,GO:0002634,1,0.898515441515564,0,5,regulation of germinal center formation,BP,
1072,GO:0002635,1,0.983376122674036,0,1,negative regulation of germinal center formation,BP,
1073,GO:0002636,1,0.976933244458608,0,1,positive regulation of germinal center formation,BP,
1074,GO:0002637,1,0.457784476298891,0,35,regulation of immunoglobulin production,BP,
1075,GO:0002638,1,0.89953787397595,0,5,negative regulation of immunoglobulin production,BP,
1076,GO:0002639,1,0.610041335481156,0,22,positive regulation of immunoglobulin production,BP,
1077,GO:0002643,1,0.822972945620288,0,9,regulation of tolerance induction,BP,
1078,GO:0002645,1,0.898809747926321,0,5,positive regulation of tolerance induction,BP,
1079,GO:0002649,1,0.97884689532132,0,1,regulation of tolerance induction to self antigen,BP,
1080,GO:0002651,1,0.97884689532132,0,1,positive regulation of tolerance induction to self antigen,BP,
1081,GO:0002652,1,0.977238535630964,0,1,regulation of tolerance induction dependent upon immune response,BP,
1082,GO:0002661,1,0.97884689532132,0,1,regulation of B cell tolerance induction,BP,
1083,GO:0002663,1,0.97884689532132,0,1,positive regulation of B cell tolerance induction,BP,
1084,GO:0002664,1,0.897600058144674,0,5,regulation of T cell tolerance induction,BP,
1085,GO:0002666,1,0.91574851521356,0,4,positive regulation of T cell tolerance induction,BP,
1086,GO:0002667,1,0.960758338390513,0,2,regulation of T cell anergy,BP,
1087,GO:0002669,1,0.980178763984006,0,1,positive regulation of T cell anergy,BP,
1089,GO:0002674,1,0.917090845009744,0,4,negative regulation of acute inflammatory response,BP,
1090,GO:0002675,1,0.760038526392116,0,12,positive regulation of acute inflammatory response,BP,
1091,GO:0002676,1,0.870909730269201,0,6,regulation of chronic inflammatory response,BP,
1092,GO:0002677,1,0.956146772976236,0,2,negative regulation of chronic inflammatory response,BP,
1093,GO:0002678,1,0.932727337746901,0,3,positive regulation of chronic inflammatory response,BP,
1094,GO:0002679,1,0.934159618983529,0,3,respiratory burst involved in defense response,BP,
1095,GO:0002681,1,0.903407095312153,0,5,somatic recombination of T cell receptor gene segments,BP,
1100,GO:0002686,1,0.681384355356071,0,17,negative regulation of leukocyte migration,BP,
1103,GO:0002689,1,0.851323592834762,0,7,negative regulation of leukocyte chemotaxis,BP,
1105,GO:0002691,1,0.749369091216896,0,13,regulation of cellular extravasation,BP,
1106,GO:0002692,1,0.916217837971258,0,4,negative regulation of cellular extravasation,BP,
1107,GO:0002693,1,0.837065781165648,0,8,positive regulation of cellular extravasation,BP,
1113,GO:0002699,1,0.098634819078122,0,103,positive regulation of immune effector process,BP,
1114,GO:0002700,1,0.189679664374525,0,74,regulation of production of molecular mediator of immune response,BP,
1115,GO:0002701,1,0.641941437637021,0,20,negative regulation of production of molecular mediator of immune response,BP,
1116,GO:0002702,1,0.338225963896924,0,48,positive regulation of production of molecular mediator of immune response,BP,
1117,GO:0002703,1,0.0977798144687202,0,103,regulation of leukocyte mediated immunity,BP,
1118,GO:0002704,1,0.554502124444822,0,26,negative regulation of leukocyte mediated immunity,BP,
1119,GO:0002705,1,0.259404484791156,0,60,positive regulation of leukocyte mediated immunity,BP,
1120,GO:0002706,1,0.18789678711254,0,74,regulation of lymphocyte mediated immunity,BP,
1121,GO:0002707,1,0.632566480074385,0,20,negative regulation of lymphocyte mediated immunity,BP,
1122,GO:0002708,1,0.348276003269565,0,47,positive regulation of lymphocyte mediated immunity,BP,
1123,GO:0002709,1,0.470917986409598,0,33,regulation of T cell mediated immunity,BP,
1124,GO:0002710,1,0.831722717105296,0,8,negative regulation of T cell mediated immunity,BP,
1125,GO:0002711,1,0.620564595244384,0,21,positive regulation of T cell mediated immunity,BP,
1126,GO:0002712,1,0.548063620446696,0,27,regulation of B cell mediated immunity,BP,
1127,GO:0002713,1,0.913083377499138,0,4,negative regulation of B cell mediated immunity,BP,
1128,GO:0002714,1,0.655974459841876,0,19,positive regulation of B cell mediated immunity,BP,
1129,GO:0002715,1,0.668002014463149,0,18,regulation of natural killer cell mediated immunity,BP,
1130,GO:0002716,1,0.814598494495428,0,9,negative regulation of natural killer cell mediated immunity,BP,
1131,GO:0002717,1,0.801327224238705,0,10,positive regulation of natural killer cell mediated immunity,BP,
1132,GO:0002718,1,0.378436792170601,0,43,regulation of cytokine production involved in immune response,BP,
1133,GO:0002719,1,0.71363887194124,0,15,negative regulation of cytokine production involved in immune response,BP,
1134,GO:0002720,1,0.567849618718497,0,25,positive regulation of cytokine production involved in immune response,BP,
1135,GO:0002724,1,0.727914954229058,0,14,regulation of T cell cytokine production,BP,
1136,GO:0002725,1,0.933014499282285,0,3,negative regulation of T cell cytokine production,BP,
1137,GO:0002726,1,0.797533393265838,0,10,positive regulation of T cell cytokine production,BP,
1138,GO:0002727,1,0.933848064799851,0,3,regulation of natural killer cell cytokine production,BP,
1139,GO:0002728,1,0.978674797814988,0,1,negative regulation of natural killer cell cytokine production,BP,
1140,GO:0002729,1,0.954200123208304,0,2,positive regulation of natural killer cell cytokine production,BP,
1141,GO:0002730,1,0.914580509187118,0,4,regulation of dendritic cell cytokine production,BP,
1142,GO:0002731,1,0.956093056871498,0,2,negative regulation of dendritic cell cytokine production,BP,
1143,GO:0002732,1,0.978697921976875,0,1,positive regulation of dendritic cell cytokine production,BP,
1144,GO:0002736,1,0.976133335782055,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1145,GO:0002737,1,0.976133335782055,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1146,GO:0002739,1,0.798276241587639,0,10,regulation of cytokine secretion involved in immune response,BP,
1147,GO:0002740,1,0.954578789136851,0,2,negative regulation of cytokine secretion involved in immune response,BP,
1148,GO:0002741,1,0.855503096326344,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1149,GO:0002753,1,0.330212803400547,0,50,cytoplasmic pattern recognition receptor signaling pathway,BP,
1150,GO:0002755,1,0.586021005245293,0,24,MyD88-dependent toll-like receptor signaling pathway,BP,
1151,GO:0002756,1,0.554761596821101,0,26,MyD88-independent toll-like receptor signaling pathway,BP,
1154,GO:0002759,1,0.912106481341196,0,4,regulation of antimicrobial humoral response,BP,
1155,GO:0002760,1,0.954524885379294,0,2,positive regulation of antimicrobial humoral response,BP,
1160,GO:0002765,1,0.933147259254502,0,3,immune response-inhibiting signal transduction,BP,
1161,GO:0002767,1,0.954916246895928,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
1163,GO:0002774,1,0.977426114024553,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
1164,GO:0002775,1,0.933447109205482,0,3,antimicrobial peptide production,BP,
1165,GO:0002778,1,0.933447109205482,0,3,antibacterial peptide production,BP,
1166,GO:0002784,1,0.933447109205482,0,3,regulation of antimicrobial peptide production,BP,
1167,GO:0002785,1,0.977921863160307,0,1,negative regulation of antimicrobial peptide production,BP,
1168,GO:0002786,1,0.933447109205482,0,3,regulation of antibacterial peptide production,BP,
1169,GO:0002787,1,0.977921863160307,0,1,negative regulation of antibacterial peptide production,BP,
1174,GO:0002803,1,0.954524885379294,0,2,positive regulation of antibacterial peptide production,BP,
1177,GO:0002821,1,0.31661413455193,0,51,positive regulation of adaptive immune response,BP,
1180,GO:0002824,1,0.346487101833986,0,47,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1181,GO:0002825,1,0.796345402313755,0,10,regulation of T-helper 1 type immune response,BP,
1182,GO:0002826,1,0.935388878613579,0,3,negative regulation of T-helper 1 type immune response,BP,
1183,GO:0002827,1,0.851386624124924,0,7,positive regulation of T-helper 1 type immune response,BP,
1184,GO:0002828,1,0.632839892914854,0,20,regulation of type 2 immune response,BP,
1185,GO:0002829,1,0.834331740551725,0,8,negative regulation of type 2 immune response,BP,
1186,GO:0002830,1,0.776369796865757,0,11,positive regulation of type 2 immune response,BP,
1187,GO:0002831,1,0.119558759721097,0,95,regulation of response to biotic stimulus,BP,
1188,GO:0002832,1,0.444734141608237,0,36,negative regulation of response to biotic stimulus,BP,
1189,GO:0002833,1,0.563263043114336,0,26,positive regulation of response to biotic stimulus,BP,
1190,GO:0002834,1,0.874023164582531,0,6,regulation of response to tumor cell,BP,
1191,GO:0002835,1,0.955484101622174,0,2,negative regulation of response to tumor cell,BP,
1192,GO:0002836,1,0.935629909507263,0,3,positive regulation of response to tumor cell,BP,
1193,GO:0002837,1,0.874023164582531,0,6,regulation of immune response to tumor cell,BP,
1194,GO:0002838,1,0.955484101622174,0,2,negative regulation of immune response to tumor cell,BP,
1195,GO:0002839,1,0.935629909507263,0,3,positive regulation of immune response to tumor cell,BP,
1196,GO:0002840,1,0.955441366894514,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1197,GO:0002842,1,0.977238192651982,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1198,GO:0002855,1,0.914798681829776,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002856,1,0.955484101622174,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002857,1,0.95742618365614,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1201,GO:0002858,1,0.914798681829776,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1202,GO:0002859,1,0.955484101622174,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1203,GO:0002860,1,0.95742618365614,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1204,GO:0002861,1,0.829931948736283,0,8,regulation of inflammatory response to antigenic stimulus,BP,
1205,GO:0002862,1,0.909836398809535,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
1206,GO:0002863,1,0.912206881464258,0,4,positive regulation of inflammatory response to antigenic stimulus,BP,
1207,GO:0002864,1,0.912362376158475,0,4,regulation of acute inflammatory response to antigenic stimulus,BP,
1208,GO:0002865,1,0.977207154540857,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1209,GO:0002866,1,0.93364830474165,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1210,GO:0002870,1,0.960758338390513,0,2,T cell anergy,BP,
1211,GO:0002874,1,0.954578789136851,0,2,regulation of chronic inflammatory response to antigenic stimulus,BP,
1212,GO:0002875,1,0.97701229250306,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1213,GO:0002876,1,0.977040650790622,0,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1214,GO:0002880,1,0.977160758322415,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1215,GO:0002882,1,0.977160758322415,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1216,GO:0002883,1,0.934683538299514,0,3,regulation of hypersensitivity,BP,
1217,GO:0002884,1,0.977207154540857,0,1,negative regulation of hypersensitivity,BP,
1218,GO:0002885,1,0.956488230282996,0,2,positive regulation of hypersensitivity,BP,
1219,GO:0002886,1,0.546558979832949,0,27,regulation of myeloid leukocyte mediated immunity,BP,
1220,GO:0002887,1,0.917068222968496,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
1221,GO:0002888,1,0.746098275074927,0,13,positive regulation of myeloid leukocyte mediated immunity,BP,
1222,GO:0002889,1,0.548063620446696,0,27,regulation of immunoglobulin mediated immune response,BP,
1223,GO:0002890,1,0.913083377499138,0,4,negative regulation of immunoglobulin mediated immune response,BP,
1224,GO:0002891,1,0.655974459841876,0,19,positive regulation of immunoglobulin mediated immune response,BP,
1225,GO:0002892,1,0.979228390876785,0,1,regulation of type II hypersensitivity,BP,
1226,GO:0002894,1,0.979228390876785,0,1,positive regulation of type II hypersensitivity,BP,
1227,GO:0002901,1,0.909729153366947,0,4,mature B cell apoptotic process,BP,
1228,GO:0002902,1,0.681333431292069,0,17,regulation of B cell apoptotic process,BP,
1229,GO:0002903,1,0.761432149892468,0,12,negative regulation of B cell apoptotic process,BP,
1230,GO:0002904,1,0.934704733725172,0,3,positive regulation of B cell apoptotic process,BP,
1231,GO:0002905,1,0.909729153366947,0,4,regulation of mature B cell apoptotic process,BP,
1232,GO:0002906,1,0.909729153366947,0,4,negative regulation of mature B cell apoptotic process,BP,
1233,GO:0002911,1,0.960758338390513,0,2,regulation of lymphocyte anergy,BP,
1234,GO:0002913,1,0.980178763984006,0,1,positive regulation of lymphocyte anergy,BP,
1236,GO:0002921,1,0.895391956373727,0,5,negative regulation of humoral immune response,BP,
1237,GO:0002922,1,0.871613935350157,0,6,positive regulation of humoral immune response,BP,
1238,GO:0002923,1,0.954795853480761,0,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1239,GO:0002924,1,0.977234438884145,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1240,GO:0002925,1,0.977040650790622,0,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1243,GO:0002933,1,0.954853961206842,0,2,lipid hydroxylation,BP,
1245,GO:0002940,1,0.955079370482683,0,2,tRNA N2-guanine methylation,BP,
1246,GO:0002943,1,0.911885215606136,0,4,tRNA dihydrouridine synthesis,BP,
1247,GO:0002944,1,0.959188195035621,0,2,cyclin K-CDK12 complex,CC,
1248,GO:0002945,1,0.958216401323051,0,2,cyclin K-CDK13 complex,CC,
1249,GO:0002946,1,0.976829705745857,0,1,tRNA C5-cytosine methylation,BP,
1250,GO:0002947,1,0.978367064055265,0,1,tumor necrosis factor receptor superfamily complex,CC,
1251,GO:0002949,1,0.932880471632377,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1252,GO:0002950,1,0.936296427016427,0,3,ceramide phosphoethanolamine synthase activity,MF,
1253,GO:0002951,1,0.977240918008823,0,1,leukotriene-C(4) hydrolase,MF,
1258,GO:0003009,1,0.671598889498644,0,18,skeletal muscle contraction,BP,
1259,GO:0003010,1,0.957242260272553,0,2,voluntary skeletal muscle contraction,BP,
1260,GO:0003011,1,0.957472714845115,0,2,involuntary skeletal muscle contraction,BP,
1263,GO:0003014,1,0.277690668131163,0,58,renal system process,BP,
1266,GO:0003017,1,0.98214548681278,0,1,lymph circulation,BP,
1268,GO:0003025,1,0.960889406215572,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1269,GO:0003032,1,0.95525071346709,0,2,detection of oxygen,BP,
1270,GO:0003044,1,0.621816345298127,0,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1271,GO:0003050,1,0.97751116840425,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1272,GO:0003056,1,0.89878745750263,0,5,regulation of vascular smooth muscle contraction,BP,
1273,GO:0003057,1,0.933280660429147,0,3,regulation of the force of heart contraction by chemical signal,BP,
1274,GO:0003062,1,0.917453297404528,0,4,regulation of heart rate by chemical signal,BP,
1275,GO:0003064,1,0.977144564979688,0,1,regulation of heart rate by hormone,BP,
1276,GO:0003065,1,0.977118912985926,0,1,positive regulation of heart rate by epinephrine,BP,
1277,GO:0003068,1,0.976271479433318,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1278,GO:0003069,1,0.976271479433318,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1279,GO:0003070,1,0.976271479433318,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1280,GO:0003071,1,0.777950836094149,0,11,renal system process involved in regulation of systemic arterial blood pressure,BP,
1281,GO:0003072,1,0.977174189107549,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1283,GO:0003081,1,0.795942090280505,0,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1284,GO:0003083,1,0.97569188921866,0,1,negative regulation of renal output by angiotensin,BP,
1286,GO:0003085,1,0.81866870525591,0,9,negative regulation of systemic arterial blood pressure,BP,
1287,GO:0003091,1,0.651181244142767,0,20,renal water homeostasis,BP,
1288,GO:0003093,1,0.833403232199827,0,8,regulation of glomerular filtration,BP,
1289,GO:0003094,1,0.781751954726737,0,11,glomerular filtration,BP,
1290,GO:0003096,1,0.914985779942394,0,4,renal sodium ion transport,BP,
1291,GO:0003097,1,0.912485995069007,0,4,renal water transport,BP,
1292,GO:0003099,1,0.977228058558821,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
1293,GO:0003100,1,0.913785374410412,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
1294,GO:0003104,1,0.912398961298773,0,4,positive regulation of glomerular filtration,BP,
1295,GO:0003105,1,0.932796810349503,0,3,negative regulation of glomerular filtration,BP,
1296,GO:0003106,1,0.97569188921866,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1297,GO:0003127,1,0.979172403723587,0,1,detection of nodal flow,BP,
1298,GO:0003128,1,0.890897104559298,0,5,heart field specification,BP,
1299,GO:0003129,1,0.933257627639818,0,3,heart induction,BP,
1300,GO:0003130,1,0.955108884637864,0,2,BMP signaling pathway involved in heart induction,BP,
1301,GO:0003131,1,0.977311400824801,0,1,mesodermal-endodermal cell signaling,BP,
1302,GO:0003133,1,0.955108884637864,0,2,endodermal-mesodermal cell signaling,BP,
1303,GO:0003134,1,0.955108884637864,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1304,GO:0003139,1,0.911760216191808,0,4,secondary heart field specification,BP,
1305,GO:0003140,1,0.917842281233898,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
1307,GO:0003148,1,0.707049877159673,0,16,outflow tract septum morphogenesis,BP,
1309,GO:0003150,1,0.917990751070812,0,4,muscular septum morphogenesis,BP,
1312,GO:0003157,1,0.842382383074141,0,8,endocardium development,BP,
1314,GO:0003159,1,0.779092514531201,0,11,morphogenesis of an endothelium,BP,
1315,GO:0003160,1,0.937764325127975,0,3,endocardium morphogenesis,BP,
1316,GO:0003161,1,0.825055452616668,0,9,cardiac conduction system development,BP,
1317,GO:0003162,1,0.96228678560457,0,2,atrioventricular node development,BP,
1318,GO:0003163,1,0.95884003687115,0,2,sinoatrial node development,BP,
1319,GO:0003164,1,0.958980482735495,0,2,His-Purkinje system development,BP,
1320,GO:0003165,1,0.979631001819682,0,1,Purkinje myocyte development,BP,
1321,GO:0003166,1,0.978921720490555,0,1,bundle of His development,BP,
1322,GO:0003167,1,0.978921720490555,0,1,atrioventricular bundle cell differentiation,BP,
1323,GO:0003169,1,0.960428843012661,0,2,coronary vein morphogenesis,BP,
1325,GO:0003171,1,0.715249685071612,0,16,atrioventricular valve development,BP,
1326,GO:0003174,1,0.830076601218732,0,9,mitral valve development,BP,
1327,GO:0003175,1,0.920784804989416,0,4,tricuspid valve development,BP,
1328,GO:0003176,1,0.916453834207894,0,4,aortic valve development,BP,
1329,GO:0003177,1,0.88552447257504,0,6,pulmonary valve development,BP,
1331,GO:0003180,1,0.916453834207894,0,4,aortic valve morphogenesis,BP,
1332,GO:0003181,1,0.748806172912871,0,14,atrioventricular valve morphogenesis,BP,
1333,GO:0003183,1,0.849202985985223,0,8,mitral valve morphogenesis,BP,
1334,GO:0003184,1,0.88552447257504,0,6,pulmonary valve morphogenesis,BP,
1335,GO:0003186,1,0.920784804989416,0,4,tricuspid valve morphogenesis,BP,
1337,GO:0003190,1,0.926968863607892,0,4,atrioventricular valve formation,BP,
1338,GO:0003192,1,0.944082889479278,0,3,mitral valve formation,BP,
1339,GO:0003193,1,0.977490942931953,0,1,pulmonary valve formation,BP,
1340,GO:0003195,1,0.977550479987897,0,1,tricuspid valve formation,BP,
1343,GO:0003199,1,0.976926156918786,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1347,GO:0003207,1,0.922502310306086,0,4,cardiac chamber formation,BP,
1350,GO:0003211,1,0.922502310306086,0,4,cardiac ventricle formation,BP,
1351,GO:0003213,1,0.962372016738679,0,2,cardiac right atrium morphogenesis,BP,
1352,GO:0003214,1,0.881017149971943,0,6,cardiac left ventricle morphogenesis,BP,
1353,GO:0003215,1,0.774434240426288,0,12,cardiac right ventricle morphogenesis,BP,
1354,GO:0003219,1,0.959715646731853,0,2,cardiac right ventricle formation,BP,
1355,GO:0003220,1,0.981876228906368,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1356,GO:0003221,1,0.983026093186884,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1357,GO:0003222,1,0.798857181213099,0,11,ventricular trabecula myocardium morphogenesis,BP,
1359,GO:0003226,1,0.983026093186884,0,1,right ventricular compact myocardium morphogenesis,BP,
1364,GO:0003241,1,0.9380008091299,0,3,growth involved in heart morphogenesis,BP,
1365,GO:0003245,1,0.954952085040479,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1366,GO:0003247,1,0.97701939608159,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1367,GO:0003249,1,0.966226949380095,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003250,1,0.966226949380095,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1369,GO:0003251,1,0.981876228906368,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1370,GO:0003252,1,0.984062955739729,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1371,GO:0003253,1,0.914750985746636,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1372,GO:0003254,1,0.547630107697996,0,27,regulation of membrane depolarization,BP,
1373,GO:0003256,1,0.939297155087749,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1374,GO:0003257,1,0.978544712616752,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1378,GO:0003270,1,0.982252137884812,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1381,GO:0003274,1,0.936862674820299,0,3,endocardial cushion fusion,BP,
1382,GO:0003275,1,0.957450714890542,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1383,GO:0003278,1,0.935652453938239,0,3,apoptotic process involved in heart morphogenesis,BP,
1386,GO:0003283,1,0.745659885285038,0,14,atrial septum development,BP,
1387,GO:0003284,1,0.915929280197557,0,4,septum primum development,BP,
1388,GO:0003289,1,0.937025951219435,0,3,atrial septum primum morphogenesis,BP,
1389,GO:0003292,1,0.979675262318631,0,1,cardiac septum cell differentiation,BP,
1390,GO:0003294,1,0.955461677033048,0,2,atrial ventricular junction remodeling,BP,
1391,GO:0003298,1,0.755898870478722,0,13,physiological muscle hypertrophy,BP,
1392,GO:0003299,1,0.77747565660479,0,12,muscle hypertrophy in response to stress,BP,
1394,GO:0003301,1,0.755898870478722,0,13,physiological cardiac muscle hypertrophy,BP,
1395,GO:0003306,1,0.875650175323793,0,6,Wnt signaling pathway involved in heart development,BP,
1396,GO:0003307,1,0.933377372213759,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
1397,GO:0003308,1,0.955119072406396,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
1398,GO:0003309,1,0.722339765393245,0,15,type B pancreatic cell differentiation,BP,
1400,GO:0003321,1,0.937126642665487,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1401,GO:0003323,1,0.739141725091869,0,14,type B pancreatic cell development,BP,
1403,GO:0003334,1,0.790011367669984,0,11,keratinocyte development,BP,
1404,GO:0003335,1,0.977252924886945,0,1,corneocyte development,BP,
1405,GO:0003336,1,0.977252924886945,0,1,corneocyte desquamation,BP,
1409,GO:0003340,1,0.956023303829672,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1410,GO:0003341,1,0.579904302963068,0,25,cilium movement,BP,
1411,GO:0003342,1,0.977399377001488,0,1,proepicardium development,BP,
1412,GO:0003343,1,0.977399377001488,0,1,septum transversum development,BP,
1415,GO:0003348,1,0.921161494500731,0,4,cardiac endothelial cell differentiation,BP,
1416,GO:0003350,1,0.956970601454225,0,2,pulmonary myocardium development,BP,
1417,GO:0003351,1,0.795499642762577,0,10,epithelial cilium movement,BP,
1418,GO:0003352,1,0.891512466307973,0,5,regulation of cilium movement,BP,
1419,GO:0003356,1,0.891512466307973,0,5,regulation of cilium beat frequency,BP,
1420,GO:0003357,1,0.961230512709572,0,2,noradrenergic neuron differentiation,BP,
1421,GO:0003360,1,0.938121070377266,0,3,brainstem development,BP,
1422,GO:0003363,1,0.979872350572458,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1423,GO:0003365,1,0.942696269062883,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1424,GO:0003366,1,0.979955563408742,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1425,GO:0003373,1,0.840070130782521,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1426,GO:0003374,1,0.840070130782521,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1427,GO:0003376,1,0.81576330775582,0,9,sphingosine-1-phosphate signaling pathway,BP,
1429,GO:0003383,1,0.940945265927953,0,3,apical constriction,BP,
1430,GO:0003400,1,0.97722651415779,0,1,regulation of COPII vesicle coating,BP,
1432,GO:0003402,1,0.920826783401186,0,4,planar cell polarity pathway involved in axis elongation,BP,
1433,GO:0003404,1,0.977594247778204,0,1,optic vesicle morphogenesis,BP,
1434,GO:0003406,1,0.937436075347764,0,3,retinal pigment epithelium development,BP,
1436,GO:0003408,1,0.961661291321442,0,2,optic cup formation involved in camera-type eye development,BP,
1437,GO:0003409,1,0.977594247778204,0,1,optic cup structural organization,BP,
1440,GO:0003416,1,0.754612379394559,0,13,endochondral bone growth,BP,
1441,GO:0003417,1,0.835838821996921,0,8,growth plate cartilage development,BP,
1442,GO:0003418,1,0.915788363046988,0,4,growth plate cartilage chondrocyte differentiation,BP,
1443,GO:0003419,1,0.955139763085536,0,2,growth plate cartilage chondrocyte proliferation,BP,
1444,GO:0003420,1,0.955139763085536,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1445,GO:0003430,1,0.956638374224749,0,2,growth plate cartilage chondrocyte growth,BP,
1446,GO:0003431,1,0.915788363046988,0,4,growth plate cartilage chondrocyte development,BP,
1447,GO:0003433,1,0.89492901069822,0,5,chondrocyte development involved in endochondral bone morphogenesis,BP,
1451,GO:0003678,1,0.367011348985324,0,46,DNA helicase activity,MF,
1452,GO:0003680,1,0.873247510182164,0,6,AT DNA binding,MF,
1455,GO:0003688,1,0.728069095453081,0,14,DNA replication origin binding,MF,
1456,GO:0003689,1,0.832927179852164,0,8,DNA clamp loader activity,MF,
1458,GO:0003691,1,0.81542018428702,0,9,double-stranded telomeric DNA binding,MF,
1459,GO:0003696,1,0.915772758005299,0,4,satellite DNA binding,MF,
1460,GO:0003697,1,0.114784227163809,0,96,single-stranded DNA binding,MF,
1464,GO:0003708,1,0.914646278587507,0,4,retinoic acid receptor activity,MF,
1468,GO:0003720,1,0.835277020997972,0,8,telomerase activity,MF,
1469,GO:0003721,1,0.975228493115318,0,1,telomerase RNA reverse transcriptase activity,MF,
1472,GO:0003725,1,0.247139659317006,0,63,double-stranded RNA binding,MF,
1473,GO:0003726,1,0.959772869146169,0,2,double-stranded RNA adenosine deaminase activity,MF,
1474,GO:0003727,1,0.203126443992506,0,71,single-stranded RNA binding,MF,
1478,GO:0003743,1,0.329157641473831,0,49,translation initiation factor activity,MF,
1479,GO:0003746,1,0.696376300777117,0,16,translation elongation factor activity,MF,
1480,GO:0003747,1,0.875279407021766,0,6,translation release factor activity,MF,
1482,GO:0003756,1,0.680976853699414,0,17,protein disulfide isomerase activity,MF,
1483,GO:0003774,1,0.141712245683401,0,94,motor activity,MF,
1484,GO:0003777,1,0.186276154621238,0,82,microtubule motor activity,MF,
1486,GO:0003785,1,0.670332054459583,0,18,actin monomer binding,MF,
1487,GO:0003796,1,0.976911240072323,0,1,lysozyme activity,MF,
1488,GO:0003810,1,0.933553761171477,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
1489,GO:0003823,1,0.584019221142625,0,24,antigen binding,MF,
1491,GO:0003826,1,0.95489406555091,0,2,alpha-ketoacid dehydrogenase activity,MF,
1493,GO:0003828,1,0.961218927842432,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1494,GO:0003829,1,0.957736242138188,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1495,GO:0003831,1,0.836813912793216,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1496,GO:0003835,1,0.959390913987361,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1497,GO:0003836,1,0.874995934002805,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1498,GO:0003839,1,0.910498715188594,0,4,gamma-glutamylcyclotransferase activity,MF,
1499,GO:0003841,1,0.660204278811418,0,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1501,GO:0003844,1,0.977454821840281,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1502,GO:0003845,1,0.95448936810671,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1503,GO:0003846,1,0.955715667362029,0,2,2-acylglycerol O-acyltransferase activity,MF,
1504,GO:0003847,1,0.910970267040862,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1505,GO:0003854,1,0.933056624252266,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1506,GO:0003857,1,0.811646127819884,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1507,GO:0003858,1,0.955526552912562,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1508,GO:0003860,1,0.97717767811455,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1509,GO:0003863,1,0.95489406555091,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1510,GO:0003865,1,0.955018702635051,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1511,GO:0003867,1,0.979054784048604,0,1,4-aminobutyrate transaminase activity,MF,
1512,GO:0003868,1,0.977122039215241,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1513,GO:0003870,1,0.977239483611023,0,1,5-aminolevulinate synthase activity,MF,
1514,GO:0003872,1,0.933800197916762,0,3,6-phosphofructokinase activity,MF,
1515,GO:0003873,1,0.937092928500933,0,3,6-phosphofructo-2-kinase activity,MF,
1516,GO:0003874,1,0.976125001747232,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1517,GO:0003875,1,0.977709666757861,0,1,ADP-ribosylarginine hydrolase activity,MF,
1518,GO:0003876,1,0.957034516120005,0,2,AMP deaminase activity,MF,
1519,GO:0003877,1,0.977219134094223,0,1,ATP adenylyltransferase activity,MF,
1520,GO:0003878,1,0.978581066454552,0,1,ATP citrate synthase activity,MF,
1521,GO:0003880,1,0.934453107200135,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1522,GO:0003881,1,0.977157612252884,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1523,GO:0003882,1,0.977245766449705,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1524,GO:0003883,1,0.956025260789719,0,2,CTP synthase activity,MF,
1525,GO:0003886,1,0.937502206556863,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1526,GO:0003887,1,0.566165965878364,0,26,DNA-directed DNA polymerase activity,MF,
1527,GO:0003896,1,0.932982438404916,0,3,DNA primase activity,MF,
1529,GO:0003905,1,0.976369312322026,0,1,alkylbase DNA N-glycosylase activity,MF,
1530,GO:0003906,1,0.739372363388316,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1531,GO:0003908,1,0.976623657855814,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1532,GO:0003909,1,0.853397059213029,0,7,DNA ligase activity,MF,
1533,GO:0003910,1,0.873301182805659,0,6,DNA ligase (ATP) activity,MF,
1534,GO:0003916,1,0.876794068770047,0,6,DNA topoisomerase activity,MF,
1535,GO:0003917,1,0.913919270033219,0,4,DNA topoisomerase type I activity,MF,
1536,GO:0003918,1,0.959391502315882,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1537,GO:0003919,1,0.977190576982258,0,1,FMN adenylyltransferase activity,MF,
1538,GO:0003920,1,0.977160758322415,0,1,GMP reductase activity,MF,
1539,GO:0003921,1,0.977246674896045,0,1,GMP synthase activity,MF,
1540,GO:0003922,1,0.977246674896045,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1541,GO:0003923,1,0.892646097017878,0,5,GPI-anchor transamidase activity,MF,
1543,GO:0003933,1,0.977185145506478,0,1,GTP cyclohydrolase activity,MF,
1544,GO:0003934,1,0.977185145506478,0,1,GTP cyclohydrolase I activity,MF,
1545,GO:0003937,1,0.977217229594296,0,1,IMP cyclohydrolase activity,MF,
1546,GO:0003938,1,0.954831471792747,0,2,IMP dehydrogenase activity,MF,
1547,GO:0003939,1,0.977251621836658,0,1,L-iditol 2-dehydrogenase activity,MF,
1548,GO:0003940,1,0.977229204468921,0,1,L-iduronidase activity,MF,
1549,GO:0003941,1,0.954563450345936,0,2,L-serine ammonia-lyase activity,MF,
1550,GO:0003943,1,0.956096049305692,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1551,GO:0003944,1,0.977230421572801,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1552,GO:0003945,1,0.913051963355133,0,4,N-acetyllactosamine synthase activity,MF,
1553,GO:0003948,1,0.97721578479866,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1555,GO:0003951,1,0.75203620652218,0,13,NAD+ kinase activity,MF,
1556,GO:0003952,1,0.977245329737199,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1557,GO:0003953,1,0.976890457067696,0,1,NAD+ nucleosidase activity,MF,
1558,GO:0003954,1,0.379922124203794,0,40,NADH dehydrogenase activity,MF,
1559,GO:0003955,1,0.932972188377553,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1560,GO:0003956,1,0.97701939608159,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1561,GO:0003957,1,0.978856154605981,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1562,GO:0003958,1,0.896369905034039,0,5,NADPH-hemoprotein reductase activity,MF,
1563,GO:0003960,1,0.932702128379417,0,3,NADPH:quinone reductase activity,MF,
1564,GO:0003962,1,0.977093250950237,0,1,cystathionine gamma-synthase activity,MF,
1565,GO:0003963,1,0.955077850319303,0,2,RNA-3'-phosphate cyclase activity,MF,
1566,GO:0003964,1,0.835277020997972,0,8,RNA-directed DNA polymerase activity,MF,
1567,GO:0003968,1,0.955676863015193,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1568,GO:0003972,1,0.977336572808046,0,1,RNA ligase (ATP) activity,MF,
1569,GO:0003973,1,0.979956305315631,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1570,GO:0003974,1,0.976999341220801,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1571,GO:0003975,1,0.977223816792192,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1572,GO:0003976,1,0.934892852900751,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1573,GO:0003977,1,0.955395226059709,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1574,GO:0003978,1,0.976999341220801,0,1,UDP-glucose 4-epimerase activity,MF,
1575,GO:0003979,1,0.977514059501863,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1576,GO:0003980,1,0.96273612131564,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1577,GO:0003983,1,0.97722369219082,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1578,GO:0003985,1,0.933130740754497,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1579,GO:0003986,1,0.931431705511455,0,3,acetyl-CoA hydrolase activity,MF,
1580,GO:0003987,1,0.95655302918574,0,2,acetate-CoA ligase activity,MF,
1581,GO:0003988,1,0.870680040033672,0,6,acetyl-CoA C-acyltransferase activity,MF,
1582,GO:0003989,1,0.965107029366396,0,2,acetyl-CoA carboxylase activity,MF,
1583,GO:0003990,1,0.977245329737199,0,1,acetylcholinesterase activity,MF,
1584,GO:0003991,1,0.977213057172693,0,1,acetylglutamate kinase activity,MF,
1585,GO:0003993,1,0.87017433384432,0,6,acid phosphatase activity,MF,
1586,GO:0003994,1,0.955612460076703,0,2,aconitate hydratase activity,MF,
1587,GO:0003995,1,0.747866018190773,0,13,acyl-CoA dehydrogenase activity,MF,
1588,GO:0003996,1,0.977233931975529,0,1,acyl-CoA ligase activity,MF,
1589,GO:0003997,1,0.936819238604187,0,3,acyl-CoA oxidase activity,MF,
1590,GO:0003998,1,0.952739188396251,0,2,acylphosphatase activity,MF,
1591,GO:0003999,1,0.975783880507505,0,1,adenine phosphoribosyltransferase activity,MF,
1592,GO:0004000,1,0.877624505008583,0,6,adenosine deaminase activity,MF,
1593,GO:0004001,1,0.977209732806107,0,1,adenosine kinase activity,MF,
1594,GO:0004003,1,0.484649093766998,0,33,ATP-dependent DNA helicase activity,MF,
1596,GO:0004008,1,0.96218893718623,0,2,copper-exporting ATPase activity,MF,
1597,GO:0004012,1,0.77229333931652,0,13,phospholipid-translocating ATPase activity,MF,
1598,GO:0004013,1,0.936091505332414,0,3,adenosylhomocysteinase activity,MF,
1599,GO:0004014,1,0.977565470883024,0,1,adenosylmethionine decarboxylase activity,MF,
1600,GO:0004016,1,0.887511876519076,0,6,adenylate cyclase activity,MF,
1601,GO:0004017,1,0.89372473642855,0,5,adenylate kinase activity,MF,
1602,GO:0004018,1,0.976876239670921,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1603,GO:0004019,1,0.97729129831349,0,1,adenylosuccinate synthase activity,MF,
1604,GO:0004020,1,0.955855844035446,0,2,adenylylsulfate kinase activity,MF,
1605,GO:0004021,1,0.978170959920368,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1606,GO:0004022,1,0.977265812951165,0,1,alcohol dehydrogenase (NAD) activity,MF,
1607,GO:0004027,1,0.976572774474266,0,1,alcohol sulfotransferase activity,MF,
1608,GO:0004028,1,0.852611206843461,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1610,GO:0004030,1,0.892517035962246,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1611,GO:0004031,1,0.979089442523572,0,1,aldehyde oxidase activity,MF,
1614,GO:0004034,1,0.97724799426136,0,1,aldose 1-epimerase activity,MF,
1615,GO:0004040,1,0.956072720769098,0,2,amidase activity,MF,
1616,GO:0004042,1,0.977213057172693,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1617,GO:0004043,1,0.977824130376218,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1618,GO:0004044,1,0.978001389152488,0,1,amidophosphoribosyltransferase activity,MF,
1619,GO:0004045,1,0.909385552009954,0,4,aminoacyl-tRNA hydrolase activity,MF,
1620,GO:0004046,1,0.932849176326593,0,3,aminoacylase activity,MF,
1621,GO:0004047,1,0.954639206131409,0,2,aminomethyltransferase activity,MF,
1622,GO:0004052,1,0.95500696655404,0,2,arachidonate 12-lipoxygenase activity,MF,
1623,GO:0004053,1,0.954563853604802,0,2,arginase activity,MF,
1624,GO:0004055,1,0.977137044961173,0,1,argininosuccinate synthase activity,MF,
1625,GO:0004056,1,0.977195985462535,0,1,argininosuccinate lyase activity,MF,
1626,GO:0004057,1,0.977231131838627,0,1,arginyltransferase activity,MF,
1627,GO:0004060,1,0.977201753312878,0,1,arylamine N-acetyltransferase activity,MF,
1628,GO:0004061,1,0.977062668863997,0,1,arylformamidase activity,MF,
1629,GO:0004062,1,0.910654263595504,0,4,aryl sulfotransferase activity,MF,
1630,GO:0004064,1,0.932949960122034,0,3,arylesterase activity,MF,
1631,GO:0004065,1,0.85571379030086,0,7,arylsulfatase activity,MF,
1632,GO:0004066,1,0.955001934549734,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1633,GO:0004069,1,0.954984103970313,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1634,GO:0004070,1,0.960813351532309,0,2,aspartate carbamoyltransferase activity,MF,
1635,GO:0004074,1,0.952918022801273,0,2,biliverdin reductase activity,MF,
1636,GO:0004075,1,0.943151138150901,0,3,biotin carboxylase activity,MF,
1637,GO:0004077,1,0.979895406366628,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1638,GO:0004078,1,0.979895406366628,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1639,GO:0004079,1,0.979895406366628,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1640,GO:0004080,1,0.979895406366628,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1641,GO:0004081,1,0.954043533057798,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1642,GO:0004082,1,0.9328598651858,0,3,bisphosphoglycerate mutase activity,MF,
1643,GO:0004083,1,0.977336572808046,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1644,GO:0004084,1,0.958952381526928,0,2,branched-chain-amino-acid transaminase activity,MF,
1645,GO:0004085,1,0.977174864359116,0,1,butyryl-CoA dehydrogenase activity,MF,
1646,GO:0004087,1,0.960813351532309,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1647,GO:0004088,1,0.960813351532309,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1648,GO:0004089,1,0.89527014262485,0,5,carbonate dehydratase activity,MF,
1650,GO:0004092,1,0.977309488325015,0,1,carnitine O-acetyltransferase activity,MF,
1651,GO:0004095,1,0.913184906182116,0,4,carnitine O-palmitoyltransferase activity,MF,
1652,GO:0004096,1,0.932562497525084,0,3,catalase activity,MF,
1653,GO:0004098,1,0.97716896148513,0,1,cerebroside-sulfatase activity,MF,
1654,GO:0004103,1,0.954812219944385,0,2,choline kinase activity,MF,
1655,GO:0004104,1,0.955035337621511,0,2,cholinesterase activity,MF,
1657,GO:0004108,1,0.977379167004355,0,1,citrate (Si)-synthase activity,MF,
1658,GO:0004109,1,0.955042320865244,0,2,coproporphyrinogen oxidase activity,MF,
1659,GO:0004111,1,0.914651430850206,0,4,creatine kinase activity,MF,
1660,GO:0004112,1,0.77121810806466,0,12,cyclic-nucleotide phosphodiesterase activity,MF,
1661,GO:0004113,1,0.979294790892384,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1662,GO:0004114,1,0.78753877411872,0,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1663,GO:0004115,1,0.878902552471828,0,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1664,GO:0004117,1,0.977277200092737,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1665,GO:0004118,1,0.978440687775049,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1666,GO:0004122,1,0.977259564888281,0,1,cystathionine beta-synthase activity,MF,
1667,GO:0004123,1,0.977093250950237,0,1,cystathionine gamma-lyase activity,MF,
1668,GO:0004126,1,0.849583638300341,0,7,cytidine deaminase activity,MF,
1669,GO:0004127,1,0.955214399141751,0,2,cytidylate kinase activity,MF,
1670,GO:0004128,1,0.851109657101114,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1671,GO:0004129,1,0.647034423086108,0,18,cytochrome-c oxidase activity,MF,
1672,GO:0004132,1,0.977204744162578,0,1,dCMP deaminase activity,MF,
1673,GO:0004133,1,0.98076969582673,0,1,glycogen debranching enzyme activity,MF,
1674,GO:0004134,1,0.98076969582673,0,1,4-alpha-glucanotransferase activity,MF,
1675,GO:0004135,1,0.98076969582673,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1676,GO:0004137,1,0.956894555363394,0,2,deoxycytidine kinase activity,MF,
1677,GO:0004138,1,0.976252393437505,0,1,deoxyguanosine kinase activity,MF,
1678,GO:0004139,1,0.977082433676462,0,1,deoxyribose-phosphate aldolase activity,MF,
1679,GO:0004140,1,0.954961408559572,0,2,dephospho-CoA kinase activity,MF,
1680,GO:0004142,1,0.934420798422883,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1681,GO:0004143,1,0.842255410172567,0,8,diacylglycerol kinase activity,MF,
1682,GO:0004144,1,0.955715667362029,0,2,diacylglycerol O-acyltransferase activity,MF,
1683,GO:0004145,1,0.953154223838733,0,2,diamine N-acetyltransferase activity,MF,
1684,GO:0004146,1,0.955029467706515,0,2,dihydrofolate reductase activity,MF,
1685,GO:0004148,1,0.977845685106633,0,1,dihydrolipoyl dehydrogenase activity,MF,
1686,GO:0004149,1,0.977319992203879,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1687,GO:0004151,1,0.960813351532309,0,2,dihydroorotase activity,MF,
1688,GO:0004152,1,0.977212342356133,0,1,dihydroorotate dehydrogenase activity,MF,
1689,GO:0004155,1,0.977029424191677,0,1,6,7-dihydropteridine reductase activity,MF,
1690,GO:0004157,1,0.978747259715764,0,1,dihydropyrimidinase activity,MF,
1691,GO:0004161,1,0.954711526660458,0,2,dimethylallyltranstransferase activity,MF,
1692,GO:0004163,1,0.977124091038638,0,1,diphosphomevalonate decarboxylase activity,MF,
1693,GO:0004164,1,0.977119961558301,0,1,diphthine synthase activity,MF,
1694,GO:0004165,1,0.934320749300455,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1695,GO:0004167,1,0.9516519515049,0,2,dopachrome isomerase activity,MF,
1696,GO:0004168,1,0.97722968210587,0,1,dolichol kinase activity,MF,
1697,GO:0004169,1,0.89029443564783,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1698,GO:0004170,1,0.977157212746886,0,1,dUTP diphosphatase activity,MF,
1699,GO:0004174,1,0.955299103165276,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1701,GO:0004176,1,0.914364895370972,0,4,ATP-dependent peptidase activity,MF,
1702,GO:0004177,1,0.474281734922992,0,33,aminopeptidase activity,MF,
1703,GO:0004180,1,0.683823349901373,0,17,carboxypeptidase activity,MF,
1704,GO:0004181,1,0.840128728645285,0,8,metallocarboxypeptidase activity,MF,
1705,GO:0004185,1,0.838676576306037,0,8,serine-type carboxypeptidase activity,MF,
1706,GO:0004190,1,0.729566890437501,0,14,aspartic-type endopeptidase activity,MF,
1707,GO:0004197,1,0.187449720847034,0,75,cysteine-type endopeptidase activity,MF,
1708,GO:0004198,1,0.693308618791601,0,16,calcium-dependent cysteine-type endopeptidase activity,MF,
1710,GO:0004252,1,0.181045986334024,0,75,serine-type endopeptidase activity,MF,
1711,GO:0004298,1,0.649540393857202,0,18,threonine-type endopeptidase activity,MF,
1712,GO:0004300,1,0.831428494843461,0,8,enoyl-CoA hydratase activity,MF,
1713,GO:0004301,1,0.850494408663368,0,7,epoxide hydrolase activity,MF,
1714,GO:0004303,1,0.84910186516891,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1715,GO:0004304,1,0.977114653211488,0,1,estrone sulfotransferase activity,MF,
1716,GO:0004305,1,0.912797989808632,0,4,ethanolamine kinase activity,MF,
1717,GO:0004306,1,0.977151050857025,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1718,GO:0004307,1,0.954130766779081,0,2,ethanolaminephosphotransferase activity,MF,
1719,GO:0004308,1,0.912031412354181,0,4,exo-alpha-sialidase activity,MF,
1720,GO:0004309,1,0.920492136843271,0,4,exopolyphosphatase activity,MF,
1721,GO:0004310,1,0.977218762474379,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1722,GO:0004311,1,0.933441067101671,0,3,farnesyltranstransferase activity,MF,
1723,GO:0004312,1,0.816797061302976,0,9,fatty acid synthase activity,MF,
1724,GO:0004313,1,0.981680997075231,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1725,GO:0004314,1,0.959281074585099,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1726,GO:0004315,1,0.958745442956402,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1727,GO:0004316,1,0.981680997075231,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1728,GO:0004317,1,0.981680997075231,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1729,GO:0004319,1,0.981680997075231,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1730,GO:0004320,1,0.95920016514415,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1731,GO:0004322,1,0.938466281686526,0,3,ferroxidase activity,MF,
1732,GO:0004324,1,0.977166788417474,0,1,ferredoxin-NADP+ reductase activity,MF,
1733,GO:0004325,1,0.980815806766174,0,1,ferrochelatase activity,MF,
1734,GO:0004326,1,0.977248508865168,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1735,GO:0004329,1,0.95610644832085,0,2,formate-tetrahydrofolate ligase activity,MF,
1736,GO:0004331,1,0.915850061753819,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1737,GO:0004332,1,0.954491884994123,0,2,fructose-bisphosphate aldolase activity,MF,
1738,GO:0004333,1,0.977119961558301,0,1,fumarate hydratase activity,MF,
1739,GO:0004334,1,0.976851202454075,0,1,fumarylacetoacetase activity,MF,
1740,GO:0004335,1,0.954763043507092,0,2,galactokinase activity,MF,
1741,GO:0004336,1,0.977344024735263,0,1,galactosylceramidase activity,MF,
1742,GO:0004337,1,0.954711526660458,0,2,geranyltranstransferase activity,MF,
1743,GO:0004339,1,0.980272114660414,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1745,GO:0004342,1,0.954928812725109,0,2,glucosamine-6-phosphate deaminase activity,MF,
1746,GO:0004343,1,0.978176827587538,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1747,GO:0004344,1,0.982108466062127,0,1,glucose dehydrogenase activity,MF,
1748,GO:0004345,1,0.959753747769046,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1749,GO:0004346,1,0.977018613282344,0,1,glucose-6-phosphatase activity,MF,
1750,GO:0004347,1,0.977215620358776,0,1,glucose-6-phosphate isomerase activity,MF,
1751,GO:0004348,1,0.955623368056293,0,2,glucosylceramidase activity,MF,
1752,GO:0004349,1,0.977739877776167,0,1,glutamate 5-kinase activity,MF,
1753,GO:0004350,1,0.977739877776167,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1754,GO:0004351,1,0.956312705769805,0,2,glutamate decarboxylase activity,MF,
1755,GO:0004352,1,0.977750668747366,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1756,GO:0004353,1,0.977750668747366,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1757,GO:0004356,1,0.978585979820246,0,1,glutamate-ammonia ligase activity,MF,
1758,GO:0004357,1,0.955908231498647,0,2,glutamate-cysteine ligase activity,MF,
1759,GO:0004359,1,0.934558632550245,0,3,glutaminase activity,MF,
1760,GO:0004360,1,0.981792338239022,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1761,GO:0004361,1,0.977072742778256,0,1,glutaryl-CoA dehydrogenase activity,MF,
1762,GO:0004362,1,0.977235340029555,0,1,glutathione-disulfide reductase activity,MF,
1763,GO:0004363,1,0.977170030291347,0,1,glutathione synthase activity,MF,
1764,GO:0004364,1,0.652871262192271,0,18,glutathione transferase activity,MF,
1765,GO:0004365,1,0.976686626112186,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1766,GO:0004366,1,0.894196438239199,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1767,GO:0004367,1,0.978162152233292,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1768,GO:0004368,1,0.979829165235173,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1769,GO:0004370,1,0.961252106607981,0,2,glycerol kinase activity,MF,
1770,GO:0004371,1,0.977336572808046,0,1,glycerone kinase activity,MF,
1771,GO:0004372,1,0.954995661654482,0,2,glycine hydroxymethyltransferase activity,MF,
1772,GO:0004373,1,0.977715841262133,0,1,glycogen (starch) synthase activity,MF,
1773,GO:0004375,1,0.978077783305344,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1774,GO:0004376,1,0.912108564367275,0,4,glycolipid mannosyltransferase activity,MF,
1775,GO:0004377,1,0.977252168997648,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1776,GO:0004378,1,0.977342241478123,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1777,GO:0004379,1,0.958596775303166,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1778,GO:0004382,1,0.955461580076807,0,2,guanosine-diphosphatase activity,MF,
1779,GO:0004383,1,0.887511876519076,0,6,guanylate cyclase activity,MF,
1780,GO:0004385,1,0.789157273332787,0,11,guanylate kinase activity,MF,
1782,GO:0004392,1,0.954562369660319,0,2,heme oxygenase (decyclizing) activity,MF,
1783,GO:0004394,1,0.978406366883663,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1784,GO:0004395,1,0.976624973023742,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1786,GO:0004397,1,0.977485040241761,0,1,histidine ammonia-lyase activity,MF,
1789,GO:0004408,1,0.977236511336517,0,1,holocytochrome-c synthase activity,MF,
1790,GO:0004415,1,0.893042011700046,0,5,hyalurononglucosaminidase activity,MF,
1791,GO:0004416,1,0.954860242865957,0,2,hydroxyacylglutathione hydrolase activity,MF,
1792,GO:0004418,1,0.976864867857557,0,1,hydroxymethylbilane synthase activity,MF,
1793,GO:0004419,1,0.976899940073369,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
1794,GO:0004420,1,0.978717895330391,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1795,GO:0004421,1,0.977751570891526,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
1796,GO:0004422,1,0.954513932197007,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1797,GO:0004423,1,0.979743351335701,0,1,iduronate-2-sulfatase activity,MF,
1798,GO:0004427,1,0.932264130574238,0,3,inorganic diphosphatase activity,MF,
1799,GO:0004430,1,0.87463297121661,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1801,GO:0004438,1,0.744769499239425,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1802,GO:0004439,1,0.840986082275145,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1803,GO:0004441,1,0.977216192453007,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1804,GO:0004445,1,0.893605317854433,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1805,GO:0004446,1,0.977318107723408,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1806,GO:0004448,1,0.890615182092996,0,5,isocitrate dehydrogenase activity,MF,
1807,GO:0004449,1,0.932742838737921,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1808,GO:0004450,1,0.954846191584479,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1809,GO:0004452,1,0.954491967142109,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1810,GO:0004454,1,0.977243790917716,0,1,ketohexokinase activity,MF,
1811,GO:0004457,1,0.911427798267169,0,4,lactate dehydrogenase activity,MF,
1812,GO:0004458,1,0.977258170732843,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1813,GO:0004459,1,0.9326433064182,0,3,L-lactate dehydrogenase activity,MF,
1814,GO:0004461,1,0.956143535138624,0,2,lactose synthase activity,MF,
1815,GO:0004462,1,0.977207763120795,0,1,lactoylglutathione lyase activity,MF,
1816,GO:0004463,1,0.97721323378471,0,1,leukotriene-A4 hydrolase activity,MF,
1817,GO:0004464,1,0.952116786671986,0,2,leukotriene-C4 synthase activity,MF,
1818,GO:0004465,1,0.934386035623659,0,3,lipoprotein lipase activity,MF,
1819,GO:0004466,1,0.911874489375033,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1820,GO:0004467,1,0.817045795372749,0,9,long-chain fatty acid-CoA ligase activity,MF,
1821,GO:0004468,1,0.918454052682546,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1822,GO:0004470,1,0.91322067922044,0,4,malic enzyme activity,MF,
1823,GO:0004471,1,0.935076202889251,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1824,GO:0004473,1,0.935076202889251,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1825,GO:0004475,1,0.976992711783788,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1826,GO:0004476,1,0.9771102875795,0,1,mannose-6-phosphate isomerase activity,MF,
1827,GO:0004477,1,0.913064877086438,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1829,GO:0004479,1,0.977287315003688,0,1,methionyl-tRNA formyltransferase activity,MF,
1830,GO:0004482,1,0.980039279721722,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1831,GO:0004483,1,0.955184890372083,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1832,GO:0004484,1,0.978682228111654,0,1,mRNA guanylyltransferase activity,MF,
1833,GO:0004485,1,0.955690610524585,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1834,GO:0004486,1,0.977740774546047,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1835,GO:0004487,1,0.93372889566042,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
1836,GO:0004488,1,0.913064877086438,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1837,GO:0004489,1,0.980731452524532,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1838,GO:0004490,1,0.976980865585239,0,1,methylglutaconyl-CoA hydratase activity,MF,
1839,GO:0004491,1,0.977228313431764,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
1840,GO:0004492,1,0.97721993569695,0,1,methylmalonyl-CoA decarboxylase activity,MF,
1841,GO:0004493,1,0.97601467912555,0,1,methylmalonyl-CoA epimerase activity,MF,
1842,GO:0004494,1,0.977369344881453,0,1,methylmalonyl-CoA mutase activity,MF,
1843,GO:0004496,1,0.977213145582803,0,1,mevalonate kinase activity,MF,
1845,GO:0004498,1,0.977248508865168,0,1,calcidiol 1-monooxygenase activity,MF,
1846,GO:0004499,1,0.977223566955566,0,1,N,N-dimethylaniline monooxygenase activity,MF,
1847,GO:0004500,1,0.977414407292839,0,1,dopamine beta-monooxygenase activity,MF,
1848,GO:0004504,1,0.977982380337757,0,1,peptidylglycine monooxygenase activity,MF,
1849,GO:0004505,1,0.954022974939844,0,2,phenylalanine 4-monooxygenase activity,MF,
1850,GO:0004506,1,0.97738502767589,0,1,squalene monooxygenase activity,MF,
1851,GO:0004511,1,0.977169675328271,0,1,tyrosine 3-monooxygenase activity,MF,
1852,GO:0004512,1,0.977234861043822,0,1,inositol-3-phosphate synthase activity,MF,
1853,GO:0004513,1,0.977237844310421,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
1854,GO:0004514,1,0.934533668642647,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
1855,GO:0004515,1,0.93849447131068,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
1856,GO:0004516,1,0.977336572808046,0,1,nicotinate phosphoribosyltransferase activity,MF,
1857,GO:0004517,1,0.95840999489715,0,2,nitric-oxide synthase activity,MF,
1861,GO:0004521,1,0.340851059430383,0,47,endoribonuclease activity,MF,
1862,GO:0004522,1,0.976958047958631,0,1,ribonuclease A activity,MF,
1863,GO:0004523,1,0.869740658753608,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1864,GO:0004525,1,0.918571361275258,0,4,ribonuclease III activity,MF,
1865,GO:0004526,1,0.773516645866351,0,11,ribonuclease P activity,MF,
1867,GO:0004528,1,0.915187939997233,0,4,phosphodiesterase I activity,MF,
1869,GO:0004530,1,0.960724500860256,0,2,deoxyribonuclease I activity,MF,
1870,GO:0004531,1,0.977199896100396,0,1,deoxyribonuclease II activity,MF,
1871,GO:0004532,1,0.470733474512314,0,34,exoribonuclease activity,MF,
1872,GO:0004534,1,0.943591874826533,0,3,5'-3' exoribonuclease activity,MF,
1873,GO:0004535,1,0.771617206816363,0,12,poly(A)-specific ribonuclease activity,MF,
1875,GO:0004540,1,0.142882371189179,0,86,ribonuclease activity,MF,
1876,GO:0004549,1,0.689808638394317,0,16,tRNA-specific ribonuclease activity,MF,
1878,GO:0004551,1,0.759921858366344,0,12,nucleotide diphosphatase activity,MF,
1879,GO:0004553,1,0.249141885914166,0,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
1880,GO:0004556,1,0.977228211873771,0,1,alpha-amylase activity,MF,
1881,GO:0004557,1,0.955302672583759,0,2,alpha-galactosidase activity,MF,
1882,GO:0004558,1,0.938239611646836,0,3,alpha-1,4-glucosidase activity,MF,
1883,GO:0004559,1,0.754645984076437,0,13,alpha-mannosidase activity,MF,
1884,GO:0004560,1,0.954954223986258,0,2,alpha-L-fucosidase activity,MF,
1885,GO:0004561,1,0.977296116323511,0,1,alpha-N-acetylglucosaminidase activity,MF,
1886,GO:0004563,1,0.893539573023316,0,5,beta-N-acetylhexosaminidase activity,MF,
1887,GO:0004565,1,0.912335686938345,0,4,beta-galactosidase activity,MF,
1888,GO:0004566,1,0.954861908487739,0,2,beta-glucuronidase activity,MF,
1889,GO:0004567,1,0.977611209058413,0,1,beta-mannosidase activity,MF,
1890,GO:0004568,1,0.955634304383434,0,2,chitinase activity,MF,
1891,GO:0004569,1,0.978768730636046,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1892,GO:0004571,1,0.859230174520661,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1893,GO:0004572,1,0.959741962784858,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1894,GO:0004573,1,0.97728273340919,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
1895,GO:0004574,1,0.977862671251014,0,1,oligo-1,6-glucosidase activity,MF,
1896,GO:0004576,1,0.792364682182565,0,10,oligosaccharyl transferase activity,MF,
1897,GO:0004577,1,0.954272163655612,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
1898,GO:0004578,1,0.978188551837522,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1899,GO:0004579,1,0.811453552539078,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1900,GO:0004581,1,0.976493939743326,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1901,GO:0004582,1,0.930165385424198,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
1902,GO:0004583,1,0.917608437295991,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1903,GO:0004584,1,0.977240783787953,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
1904,GO:0004586,1,0.934536381557484,0,3,ornithine decarboxylase activity,MF,
1905,GO:0004587,1,0.977193272419246,0,1,ornithine-oxo-acid transaminase activity,MF,
1906,GO:0004588,1,0.977267803941922,0,1,orotate phosphoribosyltransferase activity,MF,
1907,GO:0004590,1,0.977267803941922,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1908,GO:0004591,1,0.915208988000481,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
1909,GO:0004594,1,0.91232069756704,0,4,pantothenate kinase activity,MF,
1910,GO:0004595,1,0.977237129103543,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1911,GO:0004596,1,0.798508248059841,0,10,peptide alpha-N-acetyltransferase activity,MF,
1912,GO:0004597,1,0.977888803645362,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1913,GO:0004598,1,0.977982380337757,0,1,peptidylamidoglycolate lyase activity,MF,
1914,GO:0004601,1,0.52211647734376,0,28,peroxidase activity,MF,
1915,GO:0004602,1,0.699624568778176,0,15,glutathione peroxidase activity,MF,
1916,GO:0004605,1,0.934821863595803,0,3,phosphatidate cytidylyltransferase activity,MF,
1917,GO:0004607,1,0.976736942780589,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
1918,GO:0004608,1,0.976223502460596,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
1919,GO:0004609,1,0.955010193964402,0,2,phosphatidylserine decarboxylase activity,MF,
1920,GO:0004610,1,0.977197729060916,0,1,phosphoacetylglucosamine mutase activity,MF,
1921,GO:0004611,1,0.977189187541157,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1922,GO:0004613,1,0.977189187541157,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
1923,GO:0004614,1,0.916425598755223,0,4,phosphoglucomutase activity,MF,
1924,GO:0004615,1,0.954419223336772,0,2,phosphomannomutase activity,MF,
1925,GO:0004616,1,0.93387667394967,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
1926,GO:0004617,1,0.977202658023853,0,1,phosphoglycerate dehydrogenase activity,MF,
1927,GO:0004618,1,0.977244310465255,0,1,phosphoglycerate kinase activity,MF,
1928,GO:0004619,1,0.9328598651858,0,3,phosphoglycerate mutase activity,MF,
1930,GO:0004621,1,0.977236605385541,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
1931,GO:0004622,1,0.696319262044191,0,16,lysophospholipase activity,MF,
1932,GO:0004623,1,0.635509206163039,0,20,phospholipase A2 activity,MF,
1934,GO:0004630,1,0.893549350216494,0,5,phospholipase D activity,MF,
1935,GO:0004631,1,0.976666399097686,0,1,phosphomevalonate kinase activity,MF,
1936,GO:0004632,1,0.976621682785188,0,1,phosphopantothenate--cysteine ligase activity,MF,
1937,GO:0004633,1,0.977231476472172,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1938,GO:0004634,1,0.977133489949994,0,1,phosphopyruvate hydratase activity,MF,
1939,GO:0004637,1,0.977717167499657,0,1,phosphoribosylamine-glycine ligase activity,MF,
1940,GO:0004638,1,0.977629279820664,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1941,GO:0004639,1,0.977629279820664,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1942,GO:0004641,1,0.977717167499657,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1943,GO:0004642,1,0.979438040142143,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1944,GO:0004643,1,0.977217229594296,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
1945,GO:0004644,1,0.977717167499657,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1946,GO:0004645,1,0.914648523044723,0,4,phosphorylase activity,MF,
1947,GO:0004647,1,0.954936091008998,0,2,phosphoserine phosphatase activity,MF,
1948,GO:0004648,1,0.977220575494279,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
1949,GO:0004649,1,0.956044922850123,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
1950,GO:0004651,1,0.956192767308905,0,2,polynucleotide 5'-phosphatase activity,MF,
1951,GO:0004652,1,0.840729256034697,0,8,polynucleotide adenylyltransferase activity,MF,
1952,GO:0004653,1,0.766133764541282,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1953,GO:0004654,1,0.978792659281888,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1954,GO:0004655,1,0.977509008442652,0,1,porphobilinogen synthase activity,MF,
1955,GO:0004656,1,0.933344143389622,0,3,procollagen-proline 4-dioxygenase activity,MF,
1956,GO:0004657,1,0.977231476472172,0,1,proline dehydrogenase activity,MF,
1957,GO:0004658,1,0.954901232128952,0,2,propionyl-CoA carboxylase activity,MF,
1958,GO:0004659,1,0.714007332028957,0,15,prenyltransferase activity,MF,
1959,GO:0004660,1,0.954821370670679,0,2,protein farnesyltransferase activity,MF,
1960,GO:0004661,1,0.89176316269746,0,5,protein geranylgeranyltransferase activity,MF,
1961,GO:0004662,1,0.954794437712483,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
1962,GO:0004663,1,0.912499824598886,0,4,Rab geranylgeranyltransferase activity,MF,
1963,GO:0004666,1,0.958299928725559,0,2,prostaglandin-endoperoxide synthase activity,MF,
1964,GO:0004668,1,0.977514784258995,0,1,protein-arginine deiminase activity,MF,
1965,GO:0004671,1,0.978969199055055,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1967,GO:0004673,1,0.957602715260742,0,2,protein histidine kinase activity,MF,
1969,GO:0004675,1,0.781854305834766,0,12,transmembrane receptor protein serine/threonine kinase activity,MF,
1970,GO:0004676,1,0.980655533044656,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1971,GO:0004677,1,0.946679467504767,0,3,DNA-dependent protein kinase activity,MF,
1972,GO:0004679,1,0.859247865574636,0,7,AMP-activated protein kinase activity,MF,
1973,GO:0004683,1,0.617385175801713,0,22,calmodulin-dependent protein kinase activity,MF,
1974,GO:0004686,1,0.980923580995754,0,1,elongation factor-2 kinase activity,MF,
1975,GO:0004687,1,0.96272284744824,0,2,myosin light chain kinase activity,MF,
1976,GO:0004689,1,0.898349004345126,0,5,phosphorylase kinase activity,MF,
1977,GO:0004690,1,0.863741783152825,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1978,GO:0004691,1,0.883115799558652,0,6,cAMP-dependent protein kinase activity,MF,
1979,GO:0004692,1,0.978071894479869,0,1,cGMP-dependent protein kinase activity,MF,
1980,GO:0004693,1,0.512292947929245,0,30,cyclin-dependent protein serine/threonine kinase activity,MF,
1981,GO:0004694,1,0.917042894911226,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
1982,GO:0004697,1,0.753895445087701,0,13,protein kinase C activity,MF,
1983,GO:0004698,1,0.981880381810184,0,1,calcium-dependent protein kinase C activity,MF,
1984,GO:0004699,1,0.936014436171639,0,3,calcium-independent protein kinase C activity,MF,
1986,GO:0004703,1,0.955135701126268,0,2,G-protein coupled receptor kinase activity,MF,
1988,GO:0004705,1,0.935040812317497,0,3,JUN kinase activity,MF,
1989,GO:0004706,1,0.936522792401487,0,3,JUN kinase kinase kinase activity,MF,
1990,GO:0004707,1,0.762774001284297,0,12,MAP kinase activity,MF,
1991,GO:0004708,1,0.763390142635421,0,12,MAP kinase kinase activity,MF,
1993,GO:0004711,1,0.862624924896488,0,7,ribosomal protein S6 kinase activity,MF,
1994,GO:0004712,1,0.450702985892691,0,36,protein serine/threonine/tyrosine kinase activity,MF,
1997,GO:0004715,1,0.50553562962811,0,31,non-membrane spanning protein tyrosine kinase activity,MF,
1998,GO:0004716,1,0.879523204416014,0,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
1999,GO:0004719,1,0.935084254951369,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2000,GO:0004720,1,0.893136172972979,0,5,protein-lysine 6-oxidase activity,MF,
2003,GO:0004723,1,0.858861327914198,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2005,GO:0004726,1,0.836036751664213,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2006,GO:0004727,1,0.977209732806107,0,1,prenylated protein tyrosine phosphatase activity,MF,
2007,GO:0004728,1,0.977258170732843,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2008,GO:0004729,1,0.977093853074133,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2009,GO:0004730,1,0.977041386033977,0,1,pseudouridylate synthase activity,MF,
2010,GO:0004731,1,0.956776392959928,0,2,purine-nucleoside phosphorylase activity,MF,
2011,GO:0004733,1,0.977734506770714,0,1,pyridoxamine-phosphate oxidase activity,MF,
2012,GO:0004735,1,0.954746350300906,0,2,pyrroline-5-carboxylate reductase activity,MF,
2013,GO:0004736,1,0.978267152266581,0,1,pyruvate carboxylase activity,MF,
2014,GO:0004738,1,0.893145823984244,0,5,pyruvate dehydrogenase activity,MF,
2015,GO:0004739,1,0.955105099269665,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2016,GO:0004740,1,0.938155468500368,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2017,GO:0004741,1,0.939153743079414,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2018,GO:0004742,1,0.978575252532462,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2019,GO:0004743,1,0.977336572808046,0,1,pyruvate kinase activity,MF,
2020,GO:0004745,1,0.850841136886326,0,7,retinol dehydrogenase activity,MF,
2021,GO:0004747,1,0.976534171950475,0,1,ribokinase activity,MF,
2022,GO:0004748,1,0.935640111087652,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2023,GO:0004749,1,0.911940232182134,0,4,ribose phosphate diphosphokinase activity,MF,
2024,GO:0004750,1,0.977237189735326,0,1,ribulose-phosphate 3-epimerase activity,MF,
2025,GO:0004751,1,0.977141877782396,0,1,ribose-5-phosphate isomerase activity,MF,
2026,GO:0004753,1,0.979800091119017,0,1,saccharopine dehydrogenase activity,MF,
2027,GO:0004756,1,0.955010019310361,0,2,selenide, water dikinase activity,MF,
2028,GO:0004757,1,0.976852262282894,0,1,sepiapterin reductase activity,MF,
2029,GO:0004758,1,0.895378174555079,0,5,serine C-palmitoyltransferase activity,MF,
2030,GO:0004766,1,0.976638056445863,0,1,spermidine synthase activity,MF,
2031,GO:0004767,1,0.894376183440562,0,5,sphingomyelin phosphodiesterase activity,MF,
2032,GO:0004768,1,0.935653127854079,0,3,stearoyl-CoA 9-desaturase activity,MF,
2033,GO:0004769,1,0.976471669318154,0,1,steroid delta-isomerase activity,MF,
2035,GO:0004772,1,0.977679168026864,0,1,sterol O-acyltransferase activity,MF,
2036,GO:0004773,1,0.98016477210318,0,1,steryl-sulfatase activity,MF,
2037,GO:0004774,1,0.932877990138341,0,3,succinate-CoA ligase activity,MF,
2038,GO:0004775,1,0.954608233167782,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2039,GO:0004776,1,0.954621698217706,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2040,GO:0004777,1,0.979243290333626,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2041,GO:0004779,1,0.955855844035446,0,2,sulfate adenylyltransferase activity,MF,
2042,GO:0004781,1,0.955855844035446,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2043,GO:0004782,1,0.977277200092737,0,1,sulfinoalanine decarboxylase activity,MF,
2044,GO:0004784,1,0.909234376658282,0,4,superoxide dismutase activity,MF,
2045,GO:0004790,1,0.977254324184692,0,1,thioether S-methyltransferase activity,MF,
2046,GO:0004791,1,0.869737819973706,0,6,thioredoxin-disulfide reductase activity,MF,
2047,GO:0004792,1,0.932134029243168,0,3,thiosulfate sulfurtransferase activity,MF,
2048,GO:0004793,1,0.954995661654482,0,2,threonine aldolase activity,MF,
2049,GO:0004794,1,0.976789590983809,0,1,L-threonine ammonia-lyase activity,MF,
2050,GO:0004795,1,0.977219791568534,0,1,threonine synthase activity,MF,
2051,GO:0004797,1,0.956626265624915,0,2,thymidine kinase activity,MF,
2052,GO:0004798,1,0.954358089954436,0,2,thymidylate kinase activity,MF,
2053,GO:0004799,1,0.976975693894645,0,1,thymidylate synthase activity,MF,
2054,GO:0004801,1,0.976597096140632,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2055,GO:0004802,1,0.977219060135812,0,1,transketolase activity,MF,
2056,GO:0004803,1,0.957455072530918,0,2,transposase activity,MF,
2058,GO:0004807,1,0.976855433144151,0,1,triose-phosphate isomerase activity,MF,
2059,GO:0004809,1,0.933286639474767,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2060,GO:0004810,1,0.977235739684677,0,1,tRNA adenylyltransferase activity,MF,
2062,GO:0004813,1,0.935212662120489,0,3,alanine-tRNA ligase activity,MF,
2063,GO:0004814,1,0.933145030330948,0,3,arginine-tRNA ligase activity,MF,
2064,GO:0004815,1,0.955388765475763,0,2,aspartate-tRNA ligase activity,MF,
2065,GO:0004816,1,0.955078678991808,0,2,asparagine-tRNA ligase activity,MF,
2066,GO:0004817,1,0.954940998348588,0,2,cysteine-tRNA ligase activity,MF,
2067,GO:0004818,1,0.957775612283667,0,2,glutamate-tRNA ligase activity,MF,
2068,GO:0004819,1,0.956741910314564,0,2,glutamine-tRNA ligase activity,MF,
2069,GO:0004820,1,0.954794994607254,0,2,glycine-tRNA ligase activity,MF,
2070,GO:0004821,1,0.954956168626435,0,2,histidine-tRNA ligase activity,MF,
2071,GO:0004822,1,0.95698479748787,0,2,isoleucine-tRNA ligase activity,MF,
2072,GO:0004823,1,0.957925583028019,0,2,leucine-tRNA ligase activity,MF,
2073,GO:0004824,1,0.977219134094223,0,1,lysine-tRNA ligase activity,MF,
2075,GO:0004826,1,0.891251484790453,0,5,phenylalanine-tRNA ligase activity,MF,
2076,GO:0004827,1,0.934314442443649,0,3,proline-tRNA ligase activity,MF,
2077,GO:0004828,1,0.954899388630432,0,2,serine-tRNA ligase activity,MF,
2078,GO:0004829,1,0.933681597296411,0,3,threonine-tRNA ligase activity,MF,
2079,GO:0004830,1,0.955096281388368,0,2,tryptophan-tRNA ligase activity,MF,
2080,GO:0004831,1,0.955201540196755,0,2,tyrosine-tRNA ligase activity,MF,
2081,GO:0004832,1,0.936821936852314,0,3,valine-tRNA ligase activity,MF,
2082,GO:0004833,1,0.976964294955507,0,1,tryptophan 2,3-dioxygenase activity,MF,
2083,GO:0004835,1,0.979247988421086,0,1,tubulin-tyrosine ligase activity,MF,
2084,GO:0004839,1,0.896585939141113,0,5,ubiquitin activating enzyme activity,MF,
2086,GO:0004843,1,0.219908018571433,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2087,GO:0004844,1,0.890545099531098,0,5,uracil DNA N-glycosylase activity,MF,
2088,GO:0004849,1,0.890641193665106,0,5,uridine kinase activity,MF,
2089,GO:0004850,1,0.977129601820744,0,1,uridine phosphorylase activity,MF,
2090,GO:0004852,1,0.976740537538781,0,1,uroporphyrinogen-III synthase activity,MF,
2091,GO:0004853,1,0.976775820284562,0,1,uroporphyrinogen decarboxylase activity,MF,
2092,GO:0004854,1,0.959207939564463,0,2,xanthine dehydrogenase activity,MF,
2093,GO:0004855,1,0.979695484131236,0,1,xanthine oxidase activity,MF,
2094,GO:0004856,1,0.977950823386135,0,1,xylulokinase activity,MF,
2096,GO:0004859,1,0.848466043182175,0,7,phospholipase inhibitor activity,MF,
2098,GO:0004861,1,0.777889047814902,0,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2099,GO:0004862,1,0.851361967168519,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2100,GO:0004864,1,0.600772785848739,0,23,protein phosphatase inhibitor activity,MF,
2101,GO:0004865,1,0.868963508680796,0,6,protein serine/threonine phosphatase inhibitor activity,MF,
2104,GO:0004869,1,0.522328191598463,0,29,cysteine-type endopeptidase inhibitor activity,MF,
2106,GO:0004874,1,0.959443326906526,0,2,aryl hydrocarbon receptor activity,MF,
2108,GO:0004882,1,0.977575222695287,0,1,androgen receptor activity,MF,
2109,GO:0004883,1,0.980338817730491,0,1,glucocorticoid receptor activity,MF,
2110,GO:0004886,1,0.957322281098163,0,2,9-cis retinoic acid receptor activity,MF,
2111,GO:0004887,1,0.896759908426549,0,5,thyroid hormone receptor activity,MF,
2113,GO:0004890,1,0.977485040241761,0,1,GABA-A receptor activity,MF,
2115,GO:0004897,1,0.939955608416876,0,3,ciliary neurotrophic factor receptor activity,MF,
2116,GO:0004900,1,0.977148065011189,0,1,erythropoietin receptor activity,MF,
2117,GO:0004904,1,0.893357870228149,0,5,interferon receptor activity,MF,
2118,GO:0004905,1,0.957224905578368,0,2,type I interferon receptor activity,MF,
2119,GO:0004906,1,0.954969255224319,0,2,interferon-gamma receptor activity,MF,
2120,GO:0004908,1,0.8937221998692,0,5,interleukin-1 receptor activity,MF,
2121,GO:0004909,1,0.956715932040097,0,2,interleukin-1, Type I, activating receptor activity,MF,
2122,GO:0004910,1,0.976825338219214,0,1,interleukin-1, Type II, blocking receptor activity,MF,
2123,GO:0004913,1,0.977242182842648,0,1,interleukin-4 receptor activity,MF,
2124,GO:0004915,1,0.956373368796995,0,2,interleukin-6 receptor activity,MF,
2125,GO:0004917,1,0.97712661976418,0,1,interleukin-7 receptor activity,MF,
2126,GO:0004918,1,0.977247778643839,0,1,interleukin-8 receptor activity,MF,
2127,GO:0004920,1,0.914451393438536,0,4,interleukin-10 receptor activity,MF,
2128,GO:0004921,1,0.977514784258995,0,1,interleukin-11 receptor activity,MF,
2129,GO:0004923,1,0.960735467997315,0,2,leukemia inhibitory factor receptor activity,MF,
2130,GO:0004924,1,0.939501687214958,0,3,oncostatin-M receptor activity,MF,
2132,GO:0004931,1,0.977205278740426,0,1,extracellularly ATP-gated cation channel activity,MF,
2133,GO:0004935,1,0.954951335528656,0,2,adrenergic receptor activity,MF,
2134,GO:0004936,1,0.977228058558821,0,1,alpha-adrenergic receptor activity,MF,
2135,GO:0004937,1,0.977228058558821,0,1,alpha1-adrenergic receptor activity,MF,
2136,GO:0004939,1,0.977206121775138,0,1,beta-adrenergic receptor activity,MF,
2137,GO:0004941,1,0.977206121775138,0,1,beta2-adrenergic receptor activity,MF,
2138,GO:0004945,1,0.976510286432813,0,1,angiotensin type II receptor activity,MF,
2139,GO:0004947,1,0.955582945865456,0,2,bradykinin receptor activity,MF,
2140,GO:0004948,1,0.979123887660731,0,1,calcitonin receptor activity,MF,
2141,GO:0004950,1,0.871528974308523,0,6,chemokine receptor activity,MF,
2142,GO:0004952,1,0.953716102189713,0,2,dopamine neurotransmitter receptor activity,MF,
2143,GO:0004953,1,0.891739428689866,0,5,icosanoid receptor activity,MF,
2144,GO:0004954,1,0.933593907479089,0,3,prostanoid receptor activity,MF,
2145,GO:0004955,1,0.955345751338504,0,2,prostaglandin receptor activity,MF,
2146,GO:0004957,1,0.97768694948875,0,1,prostaglandin E receptor activity,MF,
2147,GO:0004960,1,0.97723530628057,0,1,thromboxane receptor activity,MF,
2148,GO:0004961,1,0.97723530628057,0,1,thromboxane A2 receptor activity,MF,
2149,GO:0004962,1,0.978074838772482,0,1,endothelin receptor activity,MF,
2150,GO:0004965,1,0.957475709707982,0,2,G-protein coupled GABA receptor activity,MF,
2151,GO:0004966,1,0.932114189878207,0,3,galanin receptor activity,MF,
2152,GO:0004968,1,0.980071073247669,0,1,gonadotropin-releasing hormone receptor activity,MF,
2153,GO:0004969,1,0.956429004424863,0,2,histamine receptor activity,MF,
2154,GO:0004970,1,0.958216679386278,0,2,ionotropic glutamate receptor activity,MF,
2155,GO:0004972,1,0.958216679386278,0,2,NMDA glutamate receptor activity,MF,
2156,GO:0004974,1,0.955179742564803,0,2,leukotriene receptor activity,MF,
2157,GO:0004977,1,0.955111886773823,0,2,melanocortin receptor activity,MF,
2158,GO:0004979,1,0.977153966145555,0,1,beta-endorphin receptor activity,MF,
2159,GO:0004980,1,0.977444509304036,0,1,melanocyte-stimulating hormone receptor activity,MF,
2160,GO:0004984,1,0.931389910460792,0,3,olfactory receptor activity,MF,
2161,GO:0004985,1,0.932943708531711,0,3,opioid receptor activity,MF,
2162,GO:0004990,1,0.978578831257478,0,1,oxytocin receptor activity,MF,
2163,GO:0004992,1,0.978381611755302,0,1,platelet activating factor receptor activity,MF,
2164,GO:0004993,1,0.932833936673599,0,3,G-protein coupled serotonin receptor activity,MF,
2165,GO:0004996,1,0.978120976366248,0,1,thyroid-stimulating hormone receptor activity,MF,
2166,GO:0004998,1,0.979252292085138,0,1,transferrin receptor activity,MF,
2167,GO:0004999,1,0.977301270214272,0,1,vasoactive intestinal polypeptide receptor activity,MF,
2168,GO:0005000,1,0.956590028564571,0,2,vasopressin receptor activity,MF,
2171,GO:0005004,1,0.980149299505197,0,1,GPI-linked ephrin receptor activity,MF,
2173,GO:0005006,1,0.955052044709543,0,2,epidermal growth factor-activated receptor activity,MF,
2174,GO:0005007,1,0.895944392628746,0,5,fibroblast growth factor-activated receptor activity,MF,
2175,GO:0005008,1,0.980373208015615,0,1,hepatocyte growth factor-activated receptor activity,MF,
2176,GO:0005009,1,0.982070361661799,0,1,insulin-activated receptor activity,MF,
2177,GO:0005010,1,0.946225901189528,0,3,insulin-like growth factor-activated receptor activity,MF,
2178,GO:0005011,1,0.978945309492403,0,1,macrophage colony-stimulating factor receptor activity,MF,
2179,GO:0005021,1,0.957131289642466,0,2,vascular endothelial growth factor-activated receptor activity,MF,
2180,GO:0005024,1,0.863282675370595,0,7,transforming growth factor beta-activated receptor activity,MF,
2181,GO:0005025,1,0.938375463870146,0,3,transforming growth factor beta receptor activity, type I,MF,
2182,GO:0005026,1,0.97884689532132,0,1,transforming growth factor beta receptor activity, type II,MF,
2183,GO:0005030,1,0.980641773285771,0,1,neurotrophin receptor activity,MF,
2185,GO:0005034,1,0.977486770047155,0,1,osmosensor activity,MF,
2187,GO:0005041,1,0.834254824868383,0,9,low-density lipoprotein particle receptor activity,MF,
2188,GO:0005042,1,0.979128677520571,0,1,netrin receptor activity,MF,
2189,GO:0005044,1,0.626156538301636,0,21,scavenger receptor activity,MF,
2190,GO:0005046,1,0.954755591478253,0,2,KDEL sequence binding,MF,
2191,GO:0005047,1,0.891962583231493,0,5,signal recognition particle binding,MF,
2192,GO:0005048,1,0.423182789121405,0,39,signal sequence binding,MF,
2193,GO:0005049,1,0.845587675489361,0,8,nuclear export signal receptor activity,MF,
2194,GO:0005052,1,0.955845536811527,0,2,peroxisome matrix targeting signal-1 binding,MF,
2195,GO:0005053,1,0.976882368066496,0,1,peroxisome matrix targeting signal-2 binding,MF,
2196,GO:0005055,1,0.954200123267599,0,2,laminin receptor activity,MF,
2200,GO:0005072,1,0.846249707226771,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2201,GO:0005078,1,0.867215052326684,0,7,MAP-kinase scaffold activity,MF,
2204,GO:0005086,1,0.733169519802401,0,15,ARF guanyl-nucleotide exchange factor activity,MF,
2205,GO:0005087,1,0.910732464027525,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2208,GO:0005090,1,0.97722651415779,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2209,GO:0005092,1,0.745192547763639,0,13,GDP-dissociation inhibitor activity,MF,
2210,GO:0005093,1,0.955004027862495,0,2,Rab GDP-dissociation inhibitor activity,MF,
2211,GO:0005094,1,0.954245415691603,0,2,Rho GDP-dissociation inhibitor activity,MF,
2216,GO:0005105,1,0.977235772555551,0,1,type 1 fibroblast growth factor receptor binding,MF,
2217,GO:0005109,1,0.601804123041007,0,23,frizzled binding,MF,
2218,GO:0005112,1,0.733236169661446,0,15,Notch binding,MF,
2219,GO:0005113,1,0.895956493264914,0,5,patched binding,MF,
2220,GO:0005114,1,0.858315250198789,0,7,type II transforming growth factor beta receptor binding,MF,
2221,GO:0005115,1,0.979762027781853,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2222,GO:0005119,1,0.959295281908592,0,2,smoothened binding,MF,
2223,GO:0005123,1,0.730006852138924,0,14,death receptor binding,MF,
2224,GO:0005124,1,0.954978874853356,0,2,scavenger receptor binding,MF,
2227,GO:0005127,1,0.93875326690251,0,3,ciliary neurotrophic factor receptor binding,MF,
2228,GO:0005128,1,0.977569748182814,0,1,erythropoietin receptor binding,MF,
2229,GO:0005129,1,0.975858034960307,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2230,GO:0005131,1,0.916972014250265,0,4,growth hormone receptor binding,MF,
2231,GO:0005132,1,0.953849391565577,0,2,type I interferon receptor binding,MF,
2232,GO:0005134,1,0.933401497975678,0,3,interleukin-2 receptor binding,MF,
2233,GO:0005135,1,0.977569748182814,0,1,interleukin-3 receptor binding,MF,
2234,GO:0005136,1,0.977464033759951,0,1,interleukin-4 receptor binding,MF,
2235,GO:0005137,1,0.97722640335749,0,1,interleukin-5 receptor binding,MF,
2236,GO:0005138,1,0.872944578251378,0,6,interleukin-6 receptor binding,MF,
2237,GO:0005141,1,0.97701229250306,0,1,interleukin-10 receptor binding,MF,
2238,GO:0005142,1,0.977240299425335,0,1,interleukin-11 receptor binding,MF,
2239,GO:0005143,1,0.957022352974179,0,2,interleukin-12 receptor binding,MF,
2240,GO:0005146,1,0.95570145491358,0,2,leukemia inhibitory factor receptor binding,MF,
2241,GO:0005149,1,0.79725890969138,0,10,interleukin-1 receptor binding,MF,
2242,GO:0005150,1,0.955481159241913,0,2,interleukin-1, Type I receptor binding,MF,
2243,GO:0005151,1,0.956977019063804,0,2,interleukin-1, Type II receptor binding,MF,
2244,GO:0005152,1,0.936343066474274,0,3,interleukin-1 receptor antagonist activity,MF,
2245,GO:0005153,1,0.955310122613709,0,2,interleukin-8 receptor binding,MF,
2246,GO:0005154,1,0.563647166738801,0,26,epidermal growth factor receptor binding,MF,
2247,GO:0005157,1,0.977244427651838,0,1,macrophage colony-stimulating factor receptor binding,MF,
2250,GO:0005160,1,0.576325916199002,0,25,transforming growth factor beta receptor binding,MF,
2251,GO:0005161,1,0.802218522324154,0,10,platelet-derived growth factor receptor binding,MF,
2252,GO:0005164,1,0.616695057322851,0,21,tumor necrosis factor receptor binding,MF,
2254,GO:0005166,1,0.976225115676963,0,1,neurotrophin p75 receptor binding,MF,
2257,GO:0005169,1,0.956095623853743,0,2,neurotrophin TRKB receptor binding,MF,
2258,GO:0005170,1,0.979382122497001,0,1,neurotrophin TRKC receptor binding,MF,
2259,GO:0005171,1,0.977207561177537,0,1,hepatocyte growth factor receptor binding,MF,
2260,GO:0005172,1,0.834785192760786,0,8,vascular endothelial growth factor receptor binding,MF,
2261,GO:0005173,1,0.939964628515118,0,3,stem cell factor receptor binding,MF,
2262,GO:0005174,1,0.977236129917361,0,1,CD40 receptor binding,MF,
2263,GO:0005175,1,0.975660243218196,0,1,CD27 receptor binding,MF,
2264,GO:0005176,1,0.933845551750297,0,3,ErbB-2 class receptor binding,MF,
2267,GO:0005183,1,0.977072742778256,0,1,gonadotropin hormone-releasing hormone activity,MF,
2268,GO:0005184,1,0.931161861350438,0,3,neuropeptide hormone activity,MF,
2270,GO:0005199,1,0.977650173421349,0,1,structural constituent of cell wall,MF,
2273,GO:0005212,1,0.910570532110471,0,4,structural constituent of eye lens,MF,
2276,GO:0005217,1,0.724153196389442,0,16,intracellular ligand-gated ion channel activity,MF,
2277,GO:0005219,1,0.949366787545922,0,3,ryanodine-sensitive calcium-release channel activity,MF,
2278,GO:0005220,1,0.950144407590714,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2280,GO:0005227,1,0.749160209495075,0,13,calcium activated cation channel activity,MF,
2281,GO:0005229,1,0.801259767698351,0,10,intracellular calcium activated chloride channel activity,MF,
2282,GO:0005230,1,0.818691599764825,0,9,extracellular ligand-gated ion channel activity,MF,
2283,GO:0005231,1,0.855912318154823,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
2284,GO:0005234,1,0.979200065537114,0,1,extracellularly glutamate-gated ion channel activity,MF,
2285,GO:0005237,1,0.977485040241761,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2286,GO:0005242,1,0.851989933122064,0,7,inward rectifier potassium channel activity,MF,
2288,GO:0005244,1,0.251634510432749,0,63,voltage-gated ion channel activity,MF,
2289,GO:0005245,1,0.740388047441646,0,14,voltage-gated calcium channel activity,MF,
2291,GO:0005247,1,0.859852275966606,0,7,voltage-gated chloride channel activity,MF,
2292,GO:0005248,1,0.831601105063705,0,9,voltage-gated sodium channel activity,MF,
2293,GO:0005249,1,0.58751062010839,0,24,voltage-gated potassium channel activity,MF,
2294,GO:0005250,1,0.978893013866702,0,1,A-type (transient outward) potassium channel activity,MF,
2295,GO:0005251,1,0.840647743672887,0,8,delayed rectifier potassium channel activity,MF,
2297,GO:0005254,1,0.525448138177227,0,29,chloride channel activity,MF,
2298,GO:0005261,1,0.103564361556767,0,105,cation channel activity,MF,
2299,GO:0005262,1,0.326532986730083,0,53,calcium channel activity,MF,
2300,GO:0005267,1,0.478772326198716,0,33,potassium channel activity,MF,
2301,GO:0005272,1,0.728273312861112,0,15,sodium channel activity,MF,
2302,GO:0005275,1,0.977401076918419,0,1,amine transmembrane transporter activity,MF,
2303,GO:0005280,1,0.936109908586307,0,3,amino acid:proton symporter activity,MF,
2304,GO:0005283,1,0.857401851521834,0,7,amino acid:sodium symporter activity,MF,
2305,GO:0005287,1,0.958699268866548,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2306,GO:0005289,1,0.958699268866548,0,2,high-affinity arginine transmembrane transporter activity,MF,
2307,GO:0005290,1,0.955108741352842,0,2,L-histidine transmembrane transporter activity,MF,
2308,GO:0005292,1,0.958699268866548,0,2,high-affinity lysine transmembrane transporter activity,MF,
2309,GO:0005294,1,0.982477643801759,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2310,GO:0005295,1,0.977531669431364,0,1,neutral amino acid:sodium symporter activity,MF,
2311,GO:0005298,1,0.978578831257478,0,1,proline:sodium symporter activity,MF,
2312,GO:0005308,1,0.977804608375111,0,1,creatine transmembrane transporter activity,MF,
2313,GO:0005309,1,0.977804608375111,0,1,creatine:sodium symporter activity,MF,
2314,GO:0005310,1,0.644348045811728,0,20,dicarboxylic acid transmembrane transporter activity,MF,
2315,GO:0005313,1,0.87747814863938,0,6,L-glutamate transmembrane transporter activity,MF,
2316,GO:0005314,1,0.955699827956194,0,2,high-affinity glutamate transmembrane transporter activity,MF,
2320,GO:0005324,1,0.955661795596188,0,2,long-chain fatty acid transporter activity,MF,
2321,GO:0005326,1,0.588718930900676,0,24,neurotransmitter transporter activity,MF,
2322,GO:0005328,1,0.803330903151275,0,10,neurotransmitter:sodium symporter activity,MF,
2323,GO:0005329,1,0.95877852994936,0,2,dopamine transmembrane transporter activity,MF,
2324,GO:0005330,1,0.978740367579142,0,1,dopamine:sodium symporter activity,MF,
2325,GO:0005332,1,0.97719723613118,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
2326,GO:0005335,1,0.978740367579142,0,1,serotonin:sodium symporter activity,MF,
2327,GO:0005337,1,0.87103970142498,0,6,nucleoside transmembrane transporter activity,MF,
2328,GO:0005338,1,0.780590694999572,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2330,GO:0005343,1,0.752304415148229,0,13,organic acid:sodium symporter activity,MF,
2331,GO:0005344,1,0.977184099442717,0,1,oxygen carrier activity,MF,
2332,GO:0005345,1,0.891859648596543,0,5,purine nucleobase transmembrane transporter activity,MF,
2333,GO:0005346,1,0.777754269244902,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2334,GO:0005347,1,0.833457073390098,0,8,ATP transmembrane transporter activity,MF,
2335,GO:0005350,1,0.955145538314789,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
2336,GO:0005351,1,0.837570520069981,0,8,carbohydrate:proton symporter activity,MF,
2338,GO:0005365,1,0.964677110743606,0,2,myo-inositol transmembrane transporter activity,MF,
2339,GO:0005366,1,0.980622208367133,0,1,myo-inositol:proton symporter activity,MF,
2340,GO:0005367,1,0.983741008886816,0,1,myo-inositol:sodium symporter activity,MF,
2341,GO:0005368,1,0.980261838873054,0,1,taurine transmembrane transporter activity,MF,
2342,GO:0005369,1,0.980261838873054,0,1,taurine:sodium symporter activity,MF,
2343,GO:0005372,1,0.911709482361934,0,4,water transmembrane transporter activity,MF,
2344,GO:0005375,1,0.878236135560428,0,6,copper ion transmembrane transporter activity,MF,
2345,GO:0005381,1,0.874892287466692,0,6,iron ion transmembrane transporter activity,MF,
2346,GO:0005384,1,0.914842547220151,0,4,manganese ion transmembrane transporter activity,MF,
2348,GO:0005388,1,0.847809869717935,0,8,calcium-transporting ATPase activity,MF,
2349,GO:0005391,1,0.893887740972581,0,5,sodium:potassium-exchanging ATPase activity,MF,
2350,GO:0005402,1,0.785761464683562,0,11,carbohydrate:cation symporter activity,MF,
2351,GO:0005412,1,0.956754891829866,0,2,glucose:sodium symporter activity,MF,
2352,GO:0005415,1,0.954995372770954,0,2,nucleoside:sodium symporter activity,MF,
2353,GO:0005416,1,0.821256349506997,0,9,amino acid:cation symporter activity,MF,
2354,GO:0005427,1,0.977476810747067,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2355,GO:0005432,1,0.935895914277698,0,3,calcium:sodium antiporter activity,MF,
2357,GO:0005451,1,0.82027860605774,0,9,monovalent cation:proton antiporter activity,MF,
2358,GO:0005452,1,0.752939418369678,0,13,inorganic anion exchanger activity,MF,
2359,GO:0005456,1,0.977131071584347,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2360,GO:0005457,1,0.958448296382179,0,2,GDP-fucose transmembrane transporter activity,MF,
2361,GO:0005459,1,0.954138233994557,0,2,UDP-galactose transmembrane transporter activity,MF,
2362,GO:0005461,1,0.980228784660249,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2363,GO:0005462,1,0.958153794208925,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2364,GO:0005464,1,0.980486329843763,0,1,UDP-xylose transmembrane transporter activity,MF,
2365,GO:0005471,1,0.933753188344776,0,3,ATP:ADP antiporter activity,MF,
2366,GO:0005476,1,0.95591913460925,0,2,carnitine:acyl carnitine antiporter activity,MF,
2367,GO:0005477,1,0.97780183254831,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2368,GO:0005483,1,0.934712676255262,0,3,soluble NSF attachment protein activity,MF,
2369,GO:0005484,1,0.460917282906614,0,34,SNAP receptor activity,MF,
2372,GO:0005497,1,0.953587052118119,0,2,androgen binding,MF,
2375,GO:0005502,1,0.978865395948723,0,1,11-cis retinal binding,MF,
2376,GO:0005503,1,0.978865395948723,0,1,all-trans retinal binding,MF,
2379,GO:0005507,1,0.429325906487956,0,37,copper ion binding,MF,
2381,GO:0005513,1,0.85374445527873,0,7,detection of calcium ion,BP,
2384,GO:0005518,1,0.396951504444134,0,42,collagen binding,MF,
2385,GO:0005519,1,0.978225559486726,0,1,cytoskeletal regulatory protein binding,MF,
2387,GO:0005521,1,0.73631684055426,0,14,lamin binding,MF,
2389,GO:0005523,1,0.856262235033262,0,7,tropomyosin binding,MF,
2394,GO:0005534,1,0.933250828962612,0,3,galactose binding,MF,
2396,GO:0005537,1,0.837507289189381,0,8,mannose binding,MF,
2398,GO:0005540,1,0.836543250622782,0,8,hyaluronic acid binding,MF,
2399,GO:0005542,1,0.872084648356635,0,6,folic acid binding,MF,
2401,GO:0005544,1,0.482956169890992,0,33,calcium-dependent phospholipid binding,MF,
2402,GO:0005545,1,0.773625272417514,0,12,1-phosphatidylinositol binding,MF,
2404,GO:0005547,1,0.534372973065477,0,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2408,GO:0005577,1,0.939847227969508,0,3,fibrinogen complex,CC,
2410,GO:0005579,1,0.979507275974749,0,1,membrane attack complex,CC,
2414,GO:0005586,1,0.979536052513124,0,1,collagen type III trimer,CC,
2415,GO:0005587,1,0.907597791898837,0,5,collagen type IV trimer,CC,
2416,GO:0005588,1,0.943439133871434,0,3,collagen type V trimer,CC,
2417,GO:0005589,1,0.955872913097059,0,2,collagen type VI trimer,CC,
2418,GO:0005590,1,0.982224150622458,0,1,collagen type VII trimer,CC,
2419,GO:0005591,1,0.977262961465507,0,1,collagen type VIII trimer,CC,
2420,GO:0005592,1,0.980829481289986,0,1,collagen type XI trimer,CC,
2421,GO:0005593,1,0.919367368744763,0,4,FACIT collagen trimer,CC,
2422,GO:0005594,1,0.955086390710625,0,2,collagen type IX trimer,CC,
2423,GO:0005595,1,0.982633034806971,0,1,collagen type XII trimer,CC,
2424,GO:0005597,1,0.979621985961865,0,1,collagen type XVI trimer,CC,
2425,GO:0005598,1,0.977262961465507,0,1,short-chain collagen trimer,CC,
2426,GO:0005600,1,0.977423380013825,0,1,collagen type XIII trimer,CC,
2428,GO:0005605,1,0.71377186323466,0,17,basal lamina,CC,
2429,GO:0005606,1,0.944533645643841,0,3,laminin-1 complex,CC,
2430,GO:0005607,1,0.959398439428364,0,2,laminin-2 complex,CC,
2431,GO:0005608,1,0.962534389622651,0,2,laminin-3 complex,CC,
2432,GO:0005610,1,0.944418156377043,0,3,laminin-5 complex,CC,
2433,GO:0005614,1,0.844624589370974,0,8,interstitial matrix,CC,
2439,GO:0005637,1,0.370555298802478,0,45,nuclear inner membrane,CC,
2440,GO:0005638,1,0.913631637795412,0,4,lamin filament,CC,
2441,GO:0005639,1,0.836321436630939,0,8,integral component of nuclear inner membrane,CC,
2442,GO:0005640,1,0.699002521869436,0,17,nuclear outer membrane,CC,
2443,GO:0005641,1,0.861185300809595,0,7,nuclear envelope lumen,CC,
2446,GO:0005652,1,0.819852656382165,0,9,nuclear lamina,CC,
2448,GO:0005655,1,0.828502270037435,0,8,nucleolar ribonuclease P complex,CC,
2449,GO:0005656,1,0.933010252629771,0,3,nuclear pre-replicative complex,CC,
2450,GO:0005657,1,0.216224556365554,0,68,replication fork,CC,
2451,GO:0005658,1,0.873188766176848,0,6,alpha DNA polymerase:primase complex,CC,
2452,GO:0005662,1,0.729436673298025,0,14,DNA replication factor A complex,CC,
2453,GO:0005663,1,0.871458322236047,0,6,DNA replication factor C complex,CC,
2454,GO:0005664,1,0.813816251522955,0,9,nuclear origin of replication recognition complex,CC,
2455,GO:0005665,1,0.677434833439312,0,17,DNA-directed RNA polymerase II, core complex,CC,
2456,GO:0005666,1,0.675137841254607,0,17,DNA-directed RNA polymerase III complex,CC,
2458,GO:0005668,1,0.954399167275928,0,2,RNA polymerase transcription factor SL1 complex,CC,
2459,GO:0005669,1,0.450762055643188,0,35,transcription factor TFIID complex,CC,
2460,GO:0005671,1,0.732080521220095,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2461,GO:0005672,1,0.910868132076958,0,4,transcription factor TFIIA complex,CC,
2462,GO:0005673,1,0.954859291282447,0,2,transcription factor TFIIE complex,CC,
2463,GO:0005674,1,0.95462825677759,0,2,transcription factor TFIIF complex,CC,
2464,GO:0005675,1,0.74166450696195,0,13,holo TFIIH complex,CC,
2465,GO:0005677,1,0.828923753387805,0,9,chromatin silencing complex,CC,
2466,GO:0005680,1,0.617845995308056,0,21,anaphase-promoting complex,CC,
2468,GO:0005682,1,0.617812990196604,0,22,U5 snRNP,CC,
2469,GO:0005683,1,0.845887380819919,0,7,U7 snRNP,CC,
2470,GO:0005684,1,0.265854606136004,0,58,U2-type spliceosomal complex,CC,
2471,GO:0005685,1,0.632818265277171,0,20,U1 snRNP,CC,
2472,GO:0005686,1,0.630728970789563,0,20,U2 snRNP,CC,
2473,GO:0005687,1,0.776638783966182,0,11,U4 snRNP,CC,
2474,GO:0005688,1,0.82611555582064,0,8,U6 snRNP,CC,
2475,GO:0005689,1,0.545329513600737,0,26,U12-type spliceosomal complex,CC,
2476,GO:0005690,1,0.955079756539491,0,2,U4atac snRNP,CC,
2477,GO:0005691,1,0.978602910472053,0,1,U6atac snRNP,CC,
2479,GO:0005697,1,0.610345700974506,0,22,telomerase holoenzyme complex,CC,
2480,GO:0005712,1,0.958912015544857,0,2,chiasma,CC,
2481,GO:0005713,1,0.977246943874661,0,1,recombination nodule,CC,
2482,GO:0005715,1,0.977246943874661,0,1,late recombination nodule,CC,
2484,GO:0005720,1,0.47964134289178,0,33,nuclear heterochromatin,CC,
2485,GO:0005721,1,0.677032862195002,0,18,pericentric heterochromatin,CC,
2486,GO:0005724,1,0.97701939608159,0,1,nuclear telomeric heterochromatin,CC,
2487,GO:0005726,1,0.917776964567918,0,4,perichromatin fibrils,CC,
2489,GO:0005731,1,0.977076665296094,0,1,nucleolus organizer region,CC,
2490,GO:0005732,1,0.565586869760835,0,24,small nucleolar ribonucleoprotein complex,CC,
2491,GO:0005736,1,0.759987653874734,0,12,DNA-directed RNA polymerase I complex,CC,
2496,GO:0005742,1,0.828187970875185,0,8,mitochondrial outer membrane translocase complex,CC,
2497,GO:0005743,1,6.6873120154135e-05,0,406,mitochondrial inner membrane,CC,
2498,GO:0005744,1,0.738823157109032,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2499,GO:0005745,1,0.955163568209279,0,2,m-AAA complex,CC,
2500,GO:0005746,1,0.177878559094071,0,72,mitochondrial respiratory chain,CC,
2501,GO:0005747,1,0.361903001252937,0,42,mitochondrial respiratory chain complex I,CC,
2502,GO:0005749,1,0.890210003262809,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2503,GO:0005750,1,0.773898456609917,0,11,mitochondrial respiratory chain complex III,CC,
2504,GO:0005751,1,0.783470845806534,0,10,mitochondrial respiratory chain complex IV,CC,
2505,GO:0005753,1,0.977229396982722,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2506,GO:0005757,1,0.91069198203246,0,4,mitochondrial permeability transition pore complex,CC,
2509,GO:0005760,1,0.957767472382833,0,2,gamma DNA polymerase complex,CC,
2510,GO:0005761,1,0.135174033210557,0,84,mitochondrial ribosome,CC,
2511,GO:0005762,1,0.297758933336719,0,51,mitochondrial large ribosomal subunit,CC,
2512,GO:0005763,1,0.513753180253444,0,28,mitochondrial small ribosomal subunit,CC,
2515,GO:0005766,1,0.0631296667627079,0,122,primary lysosome,CC,
2516,GO:0005767,1,0.7936682916066,0,10,secondary lysosome,CC,
2520,GO:0005771,1,0.565137475217221,0,25,multivesicular body,CC,
2523,GO:0005775,1,0.0578840873142235,0,126,vacuolar lumen,CC,
2526,GO:0005778,1,0.3197664082503,0,51,peroxisomal membrane,CC,
2527,GO:0005779,1,0.709282246211651,0,15,integral component of peroxisomal membrane,CC,
2528,GO:0005782,1,0.505983079439743,0,30,peroxisomal matrix,CC,
2530,GO:0005784,1,0.908511234246471,0,4,Sec61 translocon complex,CC,
2531,GO:0005785,1,0.849971873205239,0,7,signal recognition particle receptor complex,CC,
2532,GO:0005786,1,0.869707453147357,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2533,GO:0005787,1,0.890200482872982,0,5,signal peptidase complex,CC,
2536,GO:0005790,1,0.594946777147566,0,24,smooth endoplasmic reticulum,CC,
2537,GO:0005791,1,0.24269915561923,0,62,rough endoplasmic reticulum,CC,
2541,GO:0005796,1,0.337550946478385,0,51,Golgi lumen,CC,
2542,GO:0005797,1,0.853531521761304,0,7,Golgi medial cisterna,CC,
2543,GO:0005798,1,0.0481946257748808,0,136,Golgi-associated vesicle,CC,
2545,GO:0005802,1,0.0239016403216118,0,168,trans-Golgi network,CC,
2546,GO:0005811,1,0.245225627725318,0,63,lipid droplet,CC,
2548,GO:0005814,1,0.0883596617136829,0,111,centriole,CC,
2550,GO:0005816,1,0.855430367934596,0,7,spindle pole body,CC,
2551,GO:0005818,1,0.840999020211729,0,8,aster,CC,
2553,GO:0005826,1,0.899081866938185,0,5,actomyosin contractile ring,CC,
2554,GO:0005827,1,0.896324891730526,0,5,polar microtubule,CC,
2555,GO:0005828,1,0.86531863730305,0,7,kinetochore microtubule,CC,
2557,GO:0005832,1,0.798338471024833,0,10,chaperonin-containing T-complex,CC,
2558,GO:0005833,1,0.97738181525755,0,1,hemoglobin complex,CC,
2559,GO:0005834,1,0.652414086687996,0,19,heterotrimeric G-protein complex,CC,
2560,GO:0005838,1,0.613661394764274,0,21,proteasome regulatory particle,CC,
2561,GO:0005839,1,0.623095916256227,0,20,proteasome core complex,CC,
2563,GO:0005844,1,0.204300965721784,0,69,polysome,CC,
2564,GO:0005845,1,0.783732016178977,0,11,mRNA cap binding complex,CC,
2565,GO:0005846,1,0.957112456979471,0,2,nuclear cap binding complex,CC,
2566,GO:0005847,1,0.699440824206369,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2567,GO:0005849,1,0.669591327954234,0,18,mRNA cleavage factor complex,CC,
2568,GO:0005850,1,0.914419561077047,0,4,eukaryotic translation initiation factor 2 complex,CC,
2569,GO:0005851,1,0.871509878422566,0,6,eukaryotic translation initiation factor 2B complex,CC,
2570,GO:0005852,1,0.676662004983774,0,17,eukaryotic translation initiation factor 3 complex,CC,
2571,GO:0005853,1,0.932221722037409,0,3,eukaryotic translation elongation factor 1 complex,CC,
2572,GO:0005854,1,0.955811157320975,0,2,nascent polypeptide-associated complex,CC,
2574,GO:0005858,1,0.865182762435738,0,8,axonemal dynein complex,CC,
2575,GO:0005859,1,0.876537777660795,0,7,muscle myosin complex,CC,
2576,GO:0005861,1,0.933532576376846,0,3,troponin complex,CC,
2577,GO:0005862,1,0.912645150320708,0,4,muscle thin filament tropomyosin,CC,
2578,GO:0005863,1,0.977967794427033,0,1,striated muscle myosin thick filament,CC,
2579,GO:0005865,1,0.799783460695171,0,11,striated muscle thin filament,CC,
2580,GO:0005868,1,0.645261153984081,0,20,cytoplasmic dynein complex,CC,
2581,GO:0005869,1,0.831727963025326,0,8,dynactin complex,CC,
2582,GO:0005871,1,0.390695048148079,0,44,kinesin complex,CC,
2583,GO:0005873,1,0.937643679063031,0,3,plus-end kinesin complex,CC,
2585,GO:0005875,1,0.0769025367165104,0,119,microtubule associated complex,CC,
2586,GO:0005876,1,0.293859224216818,0,56,spindle microtubule,CC,
2587,GO:0005879,1,0.897852271006741,0,5,axonemal microtubule,CC,
2588,GO:0005880,1,0.9768538493317,0,1,nuclear microtubule,CC,
2589,GO:0005881,1,0.318433745254646,0,52,cytoplasmic microtubule,CC,
2591,GO:0005883,1,0.857309209773596,0,7,neurofilament,CC,
2593,GO:0005885,1,0.792205257935489,0,10,Arp2/3 protein complex,CC,
2596,GO:0005889,1,0.9561693496453,0,2,potassium:proton exchanging ATPase complex,CC,
2597,GO:0005890,1,0.914151191225518,0,4,sodium:potassium-exchanging ATPase complex,CC,
2599,GO:0005892,1,0.896149461174807,0,5,acetylcholine-gated channel complex,CC,
2600,GO:0005895,1,0.97722640335749,0,1,interleukin-5 receptor complex,CC,
2601,GO:0005896,1,0.933904711613403,0,3,interleukin-6 receptor complex,CC,
2602,GO:0005898,1,0.978257511229425,0,1,interleukin-13 receptor complex,CC,
2603,GO:0005899,1,0.964240407241898,0,2,insulin receptor complex,CC,
2604,GO:0005900,1,0.955911548988882,0,2,oncostatin-M receptor complex,CC,
2606,GO:0005902,1,0.338479894279426,0,49,microvillus,CC,
2607,GO:0005903,1,0.283853414836366,0,58,brush border,CC,
2608,GO:0005905,1,0.297302360873588,0,56,clathrin-coated pit,CC,
2612,GO:0005915,1,0.876314423306466,0,6,zonula adherens,CC,
2613,GO:0005916,1,0.878755236329262,0,6,fascia adherens,CC,
2619,GO:0005927,1,0.976942561332237,0,1,muscle tendon junction,CC,
2621,GO:0005930,1,0.261889288512539,0,62,axoneme,CC,
2623,GO:0005940,1,0.818411405153009,0,9,septin ring,CC,
2626,GO:0005945,1,0.955528984115646,0,2,6-phosphofructokinase complex,CC,
2627,GO:0005947,1,0.896125441625123,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2628,GO:0005952,1,0.893205253121511,0,5,cAMP-dependent protein kinase complex,CC,
2629,GO:0005953,1,0.954794437712483,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2630,GO:0005954,1,0.97724749556811,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2631,GO:0005955,1,0.919085680346838,0,4,calcineurin complex,CC,
2632,GO:0005956,1,0.954250472831329,0,2,protein kinase CK2 complex,CC,
2633,GO:0005958,1,0.941463464907095,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2634,GO:0005960,1,0.955484203803117,0,2,glycine cleavage complex,CC,
2635,GO:0005964,1,0.898349004345126,0,5,phosphorylase kinase complex,CC,
2636,GO:0005965,1,0.954821370670679,0,2,protein farnesyltransferase complex,CC,
2637,GO:0005967,1,0.935996213775444,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2638,GO:0005968,1,0.915928706899874,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2639,GO:0005969,1,0.981351921308059,0,1,serine-pyruvate aminotransferase complex,CC,
2640,GO:0005971,1,0.935640111087652,0,3,ribonucleoside-diphosphate reductase complex,CC,
2648,GO:0005982,1,0.980272114660414,0,1,starch metabolic process,BP,
2649,GO:0005983,1,0.980272114660414,0,1,starch catabolic process,BP,
2651,GO:0005985,1,0.977862671251014,0,1,sucrose metabolic process,BP,
2654,GO:0005991,1,0.977366323426459,0,1,trehalose metabolic process,BP,
2656,GO:0005997,1,0.910849760468191,0,4,xylulose metabolic process,BP,
2657,GO:0005998,1,0.977950823386135,0,1,xylulose catabolic process,BP,
2658,GO:0005999,1,0.95434734024492,0,2,xylulose biosynthetic process,BP,
2659,GO:0006000,1,0.778925813984723,0,11,fructose metabolic process,BP,
2660,GO:0006001,1,0.912368362030743,0,4,fructose catabolic process,BP,
2661,GO:0006002,1,0.874828689088176,0,6,fructose 6-phosphate metabolic process,BP,
2662,GO:0006003,1,0.915850061753819,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2666,GO:0006011,1,0.877764079365362,0,6,UDP-glucose metabolic process,BP,
2667,GO:0006012,1,0.780020764670501,0,11,galactose metabolic process,BP,
2668,GO:0006013,1,0.836870553368958,0,8,mannose metabolic process,BP,
2669,GO:0006014,1,0.931827171375525,0,3,D-ribose metabolic process,BP,
2670,GO:0006015,1,0.933316185561717,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2671,GO:0006020,1,0.809811122279081,0,10,inositol metabolic process,BP,
2672,GO:0006021,1,0.915399684391294,0,4,inositol biosynthetic process,BP,
2673,GO:0006022,1,0.0747014710766939,0,117,aminoglycan metabolic process,BP,
2674,GO:0006023,1,0.150206143871349,0,86,aminoglycan biosynthetic process,BP,
2675,GO:0006024,1,0.168510254022552,0,81,glycosaminoglycan biosynthetic process,BP,
2676,GO:0006026,1,0.387327945050741,0,43,aminoglycan catabolic process,BP,
2677,GO:0006027,1,0.405372347841127,0,41,glycosaminoglycan catabolic process,BP,
2678,GO:0006029,1,0.278901479636392,0,59,proteoglycan metabolic process,BP,
2679,GO:0006030,1,0.955634304383434,0,2,chitin metabolic process,BP,
2680,GO:0006032,1,0.955634304383434,0,2,chitin catabolic process,BP,
2682,GO:0006041,1,0.91278099400736,0,4,glucosamine metabolic process,BP,
2683,GO:0006043,1,0.954928812725109,0,2,glucosamine catabolic process,BP,
2684,GO:0006044,1,0.748281454782746,0,13,N-acetylglucosamine metabolic process,BP,
2685,GO:0006045,1,0.957853679000455,0,2,N-acetylglucosamine biosynthetic process,BP,
2686,GO:0006046,1,0.93309654492292,0,3,N-acetylglucosamine catabolic process,BP,
2688,GO:0006048,1,0.817304156733057,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2690,GO:0006050,1,0.976968710419452,0,1,mannosamine metabolic process,BP,
2691,GO:0006051,1,0.976968710419452,0,1,N-acetylmannosamine metabolic process,BP,
2692,GO:0006054,1,0.799662763500993,0,10,N-acetylneuraminate metabolic process,BP,
2693,GO:0006055,1,0.976590379383944,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2694,GO:0006056,1,0.9771102875795,0,1,mannoprotein metabolic process,BP,
2695,GO:0006057,1,0.9771102875795,0,1,mannoprotein biosynthetic process,BP,
2696,GO:0006059,1,0.93236967203888,0,3,hexitol metabolic process,BP,
2697,GO:0006060,1,0.954570608664004,0,2,sorbitol metabolic process,BP,
2698,GO:0006061,1,0.976793002735808,0,1,sorbitol biosynthetic process,BP,
2699,GO:0006062,1,0.977251621836658,0,1,sorbitol catabolic process,BP,
2700,GO:0006063,1,0.75928868180284,0,12,uronic acid metabolic process,BP,
2701,GO:0006064,1,0.890078446792012,0,5,glucuronate catabolic process,BP,
2702,GO:0006065,1,0.93635838116729,0,3,UDP-glucuronate biosynthetic process,BP,
2704,GO:0006067,1,0.776783781601089,0,11,ethanol metabolic process,BP,
2705,GO:0006068,1,0.850383984996764,0,7,ethanol catabolic process,BP,
2706,GO:0006069,1,0.872521338749743,0,6,ethanol oxidation,BP,
2707,GO:0006071,1,0.782581237269925,0,11,glycerol metabolic process,BP,
2708,GO:0006072,1,0.862455365872682,0,7,glycerol-3-phosphate metabolic process,BP,
2712,GO:0006083,1,0.936694851851535,0,3,acetate metabolic process,BP,
2713,GO:0006084,1,0.529917352456015,0,29,acetyl-CoA metabolic process,BP,
2714,GO:0006085,1,0.67175304189071,0,18,acetyl-CoA biosynthetic process,BP,
2715,GO:0006086,1,0.751576915372838,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2721,GO:0006097,1,0.954846191584479,0,2,glyoxylate cycle,BP,
2722,GO:0006098,1,0.677786561951201,0,17,pentose-phosphate shunt,BP,
2723,GO:0006099,1,0.526700557814305,0,28,tricarboxylic acid cycle,BP,
2724,GO:0006101,1,0.483188537809828,0,32,citrate metabolic process,BP,
2725,GO:0006102,1,0.890631828906081,0,5,isocitrate metabolic process,BP,
2726,GO:0006103,1,0.698343435772632,0,16,2-oxoglutarate metabolic process,BP,
2727,GO:0006104,1,0.892137142751227,0,5,succinyl-CoA metabolic process,BP,
2728,GO:0006105,1,0.780594447901127,0,11,succinate metabolic process,BP,
2729,GO:0006106,1,0.933130293255287,0,3,fumarate metabolic process,BP,
2730,GO:0006107,1,0.797629834970948,0,10,oxaloacetate metabolic process,BP,
2731,GO:0006108,1,0.871499475712573,0,6,malate metabolic process,BP,
2736,GO:0006113,1,0.977336572808046,0,1,fermentation,BP,
2737,GO:0006114,1,0.933410561336776,0,3,glycerol biosynthetic process,BP,
2738,GO:0006116,1,0.957476772077207,0,2,NADH oxidation,BP,
2739,GO:0006117,1,0.977256678260932,0,1,acetaldehyde metabolic process,BP,
2740,GO:0006119,1,0.103010181918536,0,96,oxidative phosphorylation,BP,
2741,GO:0006120,1,0.337849707266213,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2742,GO:0006121,1,0.910939965903907,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2743,GO:0006122,1,0.742557614260611,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2744,GO:0006123,1,0.715057540346855,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2745,GO:0006127,1,0.979829165235173,0,1,glycerophosphate shuttle,BP,
2748,GO:0006144,1,0.65037219019929,0,19,purine nucleobase metabolic process,BP,
2749,GO:0006145,1,0.91832805980321,0,4,purine nucleobase catabolic process,BP,
2750,GO:0006147,1,0.979461680775088,0,1,guanine catabolic process,BP,
2751,GO:0006148,1,0.977243563733998,0,1,inosine catabolic process,BP,
2752,GO:0006152,1,0.870019375833518,0,6,purine nucleoside catabolic process,BP,
2753,GO:0006154,1,0.954711672088872,0,2,adenosine catabolic process,BP,
2754,GO:0006157,1,0.976933244458608,0,1,deoxyadenosine catabolic process,BP,
2758,GO:0006166,1,0.891095675211202,0,5,purine ribonucleoside salvage,BP,
2759,GO:0006167,1,0.889616490611773,0,5,AMP biosynthetic process,BP,
2760,GO:0006168,1,0.931395318022204,0,3,adenine salvage,BP,
2761,GO:0006169,1,0.977209732806107,0,1,adenosine salvage,BP,
2763,GO:0006172,1,0.97723632169056,0,1,ADP biosynthetic process,BP,
2764,GO:0006175,1,0.977209732806107,0,1,dATP biosynthetic process,BP,
2765,GO:0006177,1,0.890648217071253,0,5,GMP biosynthetic process,BP,
2766,GO:0006178,1,0.954513932197007,0,2,guanine salvage,BP,
2767,GO:0006182,1,0.74233218512037,0,14,cGMP biosynthetic process,BP,
2769,GO:0006185,1,0.976218657093727,0,1,dGDP biosynthetic process,BP,
2770,GO:0006188,1,0.798378539511947,0,10,IMP biosynthetic process,BP,
2771,GO:0006189,1,0.874021697714909,0,6,'de novo' IMP biosynthetic process,BP,
2772,GO:0006193,1,0.976391248641661,0,1,ITP catabolic process,BP,
2773,GO:0006195,1,0.467804472175144,0,34,purine nucleotide catabolic process,BP,
2774,GO:0006196,1,0.957334082176344,0,2,AMP catabolic process,BP,
2775,GO:0006198,1,0.825422695350712,0,9,cAMP catabolic process,BP,
2776,GO:0006203,1,0.932050431197089,0,3,dGTP catabolic process,BP,
2777,GO:0006206,1,0.682591352256856,0,17,pyrimidine nucleobase metabolic process,BP,
2778,GO:0006207,1,0.880492615857637,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2779,GO:0006208,1,0.955204944545166,0,2,pyrimidine nucleobase catabolic process,BP,
2780,GO:0006210,1,0.955204944545166,0,2,thymine catabolic process,BP,
2781,GO:0006211,1,0.949019424628884,0,3,5-methylcytosine catabolic process,BP,
2782,GO:0006212,1,0.977465363898827,0,1,uracil catabolic process,BP,
2784,GO:0006214,1,0.977465363898827,0,1,thymidine catabolic process,BP,
2785,GO:0006216,1,0.869372574426837,0,6,cytidine catabolic process,BP,
2786,GO:0006218,1,0.977129601820744,0,1,uridine catabolic process,BP,
2789,GO:0006222,1,0.815046709604301,0,9,UMP biosynthetic process,BP,
2790,GO:0006226,1,0.932916449954761,0,3,dUMP biosynthetic process,BP,
2791,GO:0006227,1,0.954358089954436,0,2,dUDP biosynthetic process,BP,
2793,GO:0006231,1,0.93297656334304,0,3,dTMP biosynthetic process,BP,
2794,GO:0006233,1,0.954358089954436,0,2,dTDP biosynthetic process,BP,
2795,GO:0006235,1,0.910644085720014,0,4,dTTP biosynthetic process,BP,
2796,GO:0006238,1,0.976598435848024,0,1,CMP salvage,BP,
2798,GO:0006244,1,0.756218272679769,0,12,pyrimidine nucleotide catabolic process,BP,
2799,GO:0006253,1,0.976414449986851,0,1,dCTP catabolic process,BP,
2800,GO:0006256,1,0.977354156610639,0,1,UDP catabolic process,BP,
2801,GO:0006258,1,0.954472922924733,0,2,UDP-glucose catabolic process,BP,
2805,GO:0006264,1,0.799662191037544,0,10,mitochondrial DNA replication,BP,
2806,GO:0006265,1,0.818355081484758,0,9,DNA topological change,BP,
2807,GO:0006266,1,0.590861660509235,0,23,DNA ligation,BP,
2808,GO:0006267,1,0.933010252629771,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
2809,GO:0006268,1,0.852693100359351,0,7,DNA unwinding involved in DNA replication,BP,
2810,GO:0006269,1,0.893410514760812,0,5,DNA replication, synthesis of RNA primer,BP,
2811,GO:0006270,1,0.393604598196661,0,41,DNA replication initiation,BP,
2812,GO:0006271,1,0.636298395231434,0,20,DNA strand elongation involved in DNA replication,BP,
2813,GO:0006272,1,0.938737679425491,0,3,leading strand elongation,BP,
2814,GO:0006273,1,0.780382966400062,0,11,lagging strand elongation,BP,
2816,GO:0006278,1,0.232090111471004,0,66,RNA-dependent DNA biosynthetic process,BP,
2819,GO:0006283,1,0.188606214317098,0,73,transcription-coupled nucleotide-excision repair,BP,
2820,GO:0006284,1,0.399489852468952,0,41,base-excision repair,BP,
2821,GO:0006285,1,0.792643135573779,0,10,base-excision repair, AP site formation,BP,
2822,GO:0006286,1,0.954053249022097,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
2823,GO:0006287,1,0.896125292539515,0,5,base-excision repair, gap-filling,BP,
2824,GO:0006288,1,0.933064137663782,0,3,base-excision repair, DNA ligation,BP,
2825,GO:0006289,1,0.0762717971425473,0,113,nucleotide-excision repair,BP,
2826,GO:0006290,1,0.857860835154009,0,7,pyrimidine dimer repair,BP,
2827,GO:0006293,1,0.624273611650641,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
2828,GO:0006294,1,0.51564836094892,0,29,nucleotide-excision repair, preincision complex assembly,BP,
2829,GO:0006295,1,0.624273611650641,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
2830,GO:0006296,1,0.430806081143575,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
2831,GO:0006297,1,0.592144171410745,0,23,nucleotide-excision repair, DNA gap filling,BP,
2832,GO:0006298,1,0.49749703177814,0,31,mismatch repair,BP,
2833,GO:0006301,1,0.332228706097814,0,49,postreplication repair,BP,
2839,GO:0006307,1,0.795287489878626,0,10,DNA dealkylation involved in DNA repair,BP,
2840,GO:0006308,1,0.523311145073275,0,29,DNA catabolic process,BP,
2841,GO:0006309,1,0.700141675084854,0,16,apoptotic DNA fragmentation,BP,
2843,GO:0006311,1,0.977485731533649,0,1,meiotic gene conversion,BP,
2844,GO:0006312,1,0.617724184693846,0,22,mitotic recombination,BP,
2845,GO:0006313,1,0.978283492504957,0,1,transposition, DNA-mediated,BP,
2852,GO:0006337,1,0.705418542653369,0,16,nucleosome disassembly,BP,
2855,GO:0006343,1,0.978093981058656,0,1,establishment of chromatin silencing,BP,
2856,GO:0006344,1,0.919767523091107,0,4,maintenance of chromatin silencing,BP,
2857,GO:0006346,1,0.718217166945323,0,15,methylation-dependent chromatin silencing,BP,
2858,GO:0006348,1,0.835774623684062,0,8,chromatin silencing at telomere,BP,
2859,GO:0006349,1,0.757704943931405,0,13,regulation of gene expression by genetic imprinting,BP,
2865,GO:0006356,1,0.517792250036379,0,30,regulation of transcription by RNA polymerase I,BP,
2876,GO:0006369,1,0.207516760733359,0,69,termination of RNA polymerase II transcription,BP,
2877,GO:0006370,1,0.481215659464828,0,32,7-methylguanosine mRNA capping,BP,
2878,GO:0006376,1,0.559178660071846,0,26,mRNA splice site selection,BP,
2879,GO:0006378,1,0.420337902498914,0,39,mRNA polyadenylation,BP,
2880,GO:0006379,1,0.542797660640786,0,27,mRNA cleavage,BP,
2881,GO:0006382,1,0.900701311226934,0,5,adenosine to inosine editing,BP,
2883,GO:0006384,1,0.860929873345273,0,7,transcription initiation from RNA polymerase III promoter,BP,
2884,GO:0006386,1,0.975884861390397,0,1,termination of RNA polymerase III transcription,BP,
2885,GO:0006388,1,0.722077241076119,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2886,GO:0006390,1,0.749718215123619,0,13,mitochondrial transcription,BP,
2887,GO:0006391,1,0.933870521942406,0,3,transcription initiation from mitochondrial promoter,BP,
2888,GO:0006393,1,0.955184890372083,0,2,termination of mitochondrial transcription,BP,
2891,GO:0006398,1,0.894297067888315,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2897,GO:0006404,1,0.937294406758163,0,3,RNA import into nucleus,BP,
2900,GO:0006407,1,0.936332750176882,0,3,rRNA export from nucleus,BP,
2901,GO:0006408,1,0.954832906783708,0,2,snRNA export from nucleus,BP,
2902,GO:0006409,1,0.497252026909741,0,32,tRNA export from nucleus,BP,
2905,GO:0006414,1,0.053368266948307,0,125,translational elongation,BP,
2909,GO:0006419,1,0.935212662120489,0,3,alanyl-tRNA aminoacylation,BP,
2910,GO:0006420,1,0.933145030330948,0,3,arginyl-tRNA aminoacylation,BP,
2911,GO:0006421,1,0.933721964606957,0,3,asparaginyl-tRNA aminoacylation,BP,
2912,GO:0006422,1,0.977239152518945,0,1,aspartyl-tRNA aminoacylation,BP,
2913,GO:0006423,1,0.954940998348588,0,2,cysteinyl-tRNA aminoacylation,BP,
2914,GO:0006424,1,0.957775612283667,0,2,glutamyl-tRNA aminoacylation,BP,
2915,GO:0006425,1,0.956741910314564,0,2,glutaminyl-tRNA aminoacylation,BP,
2916,GO:0006426,1,0.954794994607254,0,2,glycyl-tRNA aminoacylation,BP,
2917,GO:0006427,1,0.954956168626435,0,2,histidyl-tRNA aminoacylation,BP,
2918,GO:0006428,1,0.95698479748787,0,2,isoleucyl-tRNA aminoacylation,BP,
2919,GO:0006429,1,0.957925583028019,0,2,leucyl-tRNA aminoacylation,BP,
2920,GO:0006430,1,0.977219134094223,0,1,lysyl-tRNA aminoacylation,BP,
2922,GO:0006432,1,0.891251484790453,0,5,phenylalanyl-tRNA aminoacylation,BP,
2923,GO:0006433,1,0.934314442443649,0,3,prolyl-tRNA aminoacylation,BP,
2924,GO:0006434,1,0.954899388630432,0,2,seryl-tRNA aminoacylation,BP,
2925,GO:0006435,1,0.933681597296411,0,3,threonyl-tRNA aminoacylation,BP,
2926,GO:0006436,1,0.955096281388368,0,2,tryptophanyl-tRNA aminoacylation,BP,
2927,GO:0006437,1,0.955201540196755,0,2,tyrosyl-tRNA aminoacylation,BP,
2928,GO:0006438,1,0.936821936852314,0,3,valyl-tRNA aminoacylation,BP,
2930,GO:0006447,1,0.936630814270321,0,3,regulation of translational initiation by iron,BP,
2931,GO:0006448,1,0.681415634172746,0,17,regulation of translational elongation,BP,
2934,GO:0006451,1,0.856116607978163,0,7,translational readthrough,BP,
2935,GO:0006452,1,0.956694316655034,0,2,translational frameshifting,BP,
2938,GO:0006463,1,0.97799651045296,0,1,steroid hormone receptor complex assembly,BP,
2940,GO:0006465,1,0.692072773208009,0,16,signal peptide processing,BP,
2946,GO:0006474,1,0.738494967192153,0,14,N-terminal protein amino acid acetylation,BP,
2949,GO:0006477,1,0.896466756514059,0,5,protein sulfation,BP,
2950,GO:0006478,1,0.954910553805508,0,2,peptidyl-tyrosine sulfation,BP,
2952,GO:0006480,1,0.977336572808046,0,1,N-terminal protein amino acid methylation,BP,
2953,GO:0006481,1,0.934453107200135,0,3,C-terminal protein methylation,BP,
2957,GO:0006488,1,0.637513664169575,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
2958,GO:0006489,1,0.852811103886663,0,7,dolichyl diphosphate biosynthetic process,BP,
2959,GO:0006490,1,0.622987337820198,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
2960,GO:0006491,1,0.705998305136569,0,16,N-glycan processing,BP,
2961,GO:0006493,1,0.140911024808752,0,90,protein O-linked glycosylation,BP,
2962,GO:0006497,1,0.0848263798495338,0,109,protein lipidation,BP,
2963,GO:0006498,1,0.898404204338103,0,5,N-terminal protein lipidation,BP,
2964,GO:0006499,1,0.919351113092662,0,4,N-terminal protein myristoylation,BP,
2965,GO:0006500,1,0.977222672323362,0,1,N-terminal protein palmitoylation,BP,
2966,GO:0006501,1,0.464589070762565,0,34,C-terminal protein lipidation,BP,
2967,GO:0006505,1,0.469418300348679,0,33,GPI anchor metabolic process,BP,
2968,GO:0006506,1,0.480383272461123,0,32,GPI anchor biosynthetic process,BP,
2969,GO:0006507,1,0.977236605385541,0,1,GPI anchor release,BP,
2974,GO:0006515,1,0.588618983719542,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,
2975,GO:0006516,1,0.715459105832823,0,15,glycoprotein catabolic process,BP,
2976,GO:0006517,1,0.494510953141113,0,32,protein deglycosylation,BP,
2979,GO:0006521,1,0.297525701705508,0,52,regulation of cellular amino acid metabolic process,BP,
2980,GO:0006522,1,0.978170959920368,0,1,alanine metabolic process,BP,
2981,GO:0006524,1,0.978170959920368,0,1,alanine catabolic process,BP,
2982,GO:0006525,1,0.70132794379071,0,16,arginine metabolic process,BP,
2983,GO:0006526,1,0.896516547569509,0,5,arginine biosynthetic process,BP,
2984,GO:0006527,1,0.81926946325253,0,9,arginine catabolic process,BP,
2985,GO:0006528,1,0.932686175751371,0,3,asparagine metabolic process,BP,
2986,GO:0006529,1,0.955001934549734,0,2,asparagine biosynthetic process,BP,
2987,GO:0006531,1,0.873662452456706,0,6,aspartate metabolic process,BP,
2988,GO:0006532,1,0.954984103970313,0,2,aspartate biosynthetic process,BP,
2989,GO:0006533,1,0.954984103970313,0,2,aspartate catabolic process,BP,
2990,GO:0006534,1,0.779571336574291,0,11,cysteine metabolic process,BP,
2991,GO:0006535,1,0.977259564888281,0,1,cysteine biosynthetic process from serine,BP,
2993,GO:0006537,1,0.914382053733089,0,4,glutamate biosynthetic process,BP,
2994,GO:0006538,1,0.87438806563416,0,6,glutamate catabolic process,BP,
2995,GO:0006540,1,0.956955110441563,0,2,glutamate decarboxylation to succinate,BP,
2996,GO:0006541,1,0.691145877944985,0,17,glutamine metabolic process,BP,
2997,GO:0006542,1,0.978585979820246,0,1,glutamine biosynthetic process,BP,
2998,GO:0006543,1,0.935281786928128,0,3,glutamine catabolic process,BP,
2999,GO:0006544,1,0.832457345309036,0,8,glycine metabolic process,BP,
3000,GO:0006545,1,0.954995661654482,0,2,glycine biosynthetic process,BP,
3001,GO:0006546,1,0.933707787402824,0,3,glycine catabolic process,BP,
3002,GO:0006547,1,0.890952491940315,0,5,histidine metabolic process,BP,
3003,GO:0006548,1,0.932471033593407,0,3,histidine catabolic process,BP,
3004,GO:0006549,1,0.895227568646637,0,5,isoleucine metabolic process,BP,
3005,GO:0006550,1,0.954750345705265,0,2,isoleucine catabolic process,BP,
3006,GO:0006551,1,0.856120954519525,0,7,leucine metabolic process,BP,
3007,GO:0006552,1,0.892782877760503,0,5,leucine catabolic process,BP,
3008,GO:0006553,1,0.81706911699918,0,9,lysine metabolic process,BP,
3009,GO:0006554,1,0.836039899708862,0,8,lysine catabolic process,BP,
3010,GO:0006555,1,0.685404394865523,0,17,methionine metabolic process,BP,
3012,GO:0006557,1,0.977565470883024,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3013,GO:0006558,1,0.910032543376827,0,4,L-phenylalanine metabolic process,BP,
3014,GO:0006559,1,0.910032543376827,0,4,L-phenylalanine catabolic process,BP,
3016,GO:0006561,1,0.912194629611591,0,4,proline biosynthetic process,BP,
3018,GO:0006563,1,0.793814202520456,0,10,L-serine metabolic process,BP,
3019,GO:0006564,1,0.870813905055639,0,6,L-serine biosynthetic process,BP,
3020,GO:0006565,1,0.932851149954355,0,3,L-serine catabolic process,BP,
3021,GO:0006566,1,0.932554021911967,0,3,threonine metabolic process,BP,
3022,GO:0006567,1,0.954296880343535,0,2,threonine catabolic process,BP,
3023,GO:0006568,1,0.894728075643816,0,5,tryptophan metabolic process,BP,
3024,GO:0006569,1,0.932816318383674,0,3,tryptophan catabolic process,BP,
3025,GO:0006570,1,0.910983152924804,0,4,tyrosine metabolic process,BP,
3026,GO:0006572,1,0.932272786414054,0,3,tyrosine catabolic process,BP,
3027,GO:0006573,1,0.81991047124656,0,9,valine metabolic process,BP,
3028,GO:0006574,1,0.911887633347136,0,4,valine catabolic process,BP,
3030,GO:0006576,1,0.504914913356935,0,30,cellular biogenic amine metabolic process,BP,
3031,GO:0006577,1,0.74302370060748,0,13,amino-acid betaine metabolic process,BP,
3032,GO:0006578,1,0.871511815737139,0,6,amino-acid betaine biosynthetic process,BP,
3033,GO:0006580,1,0.977274802144166,0,1,ethanolamine metabolic process,BP,
3034,GO:0006582,1,0.825853198123045,0,9,melanin metabolic process,BP,
3035,GO:0006584,1,0.556894482353321,0,26,catecholamine metabolic process,BP,
3036,GO:0006585,1,0.977169675328271,0,1,dopamine biosynthetic process from tyrosine,BP,
3037,GO:0006586,1,0.894728075643816,0,5,indolalkylamine metabolic process,BP,
3038,GO:0006589,1,0.977414407292839,0,1,octopamine biosynthetic process,BP,
3039,GO:0006590,1,0.822528450885222,0,9,thyroid hormone generation,BP,
3040,GO:0006591,1,0.852298484269416,0,7,ornithine metabolic process,BP,
3041,GO:0006592,1,0.977739877776167,0,1,ornithine biosynthetic process,BP,
3042,GO:0006595,1,0.722264694218305,0,14,polyamine metabolic process,BP,
3043,GO:0006596,1,0.757723524213893,0,12,polyamine biosynthetic process,BP,
3044,GO:0006597,1,0.955138149229168,0,2,spermine biosynthetic process,BP,
3045,GO:0006598,1,0.888682676820663,0,5,polyamine catabolic process,BP,
3046,GO:0006600,1,0.834732855617184,0,8,creatine metabolic process,BP,
3047,GO:0006601,1,0.976244399509456,0,1,creatine biosynthetic process,BP,
3050,GO:0006607,1,0.657207269906947,0,20,NLS-bearing protein import into nucleus,BP,
3051,GO:0006610,1,0.841230864141443,0,8,ribosomal protein import into nucleus,BP,
3054,GO:0006613,1,0.098155227908224,0,96,cotranslational protein targeting to membrane,BP,
3055,GO:0006614,1,0.109355633412102,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3056,GO:0006616,1,0.868306090200701,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3057,GO:0006617,1,0.953820725104193,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3058,GO:0006620,1,0.856264147103807,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3059,GO:0006621,1,0.833454324809598,0,8,protein retention in ER lumen,BP,
3062,GO:0006624,1,0.953649252995691,0,2,vacuolar protein processing,BP,
3063,GO:0006625,1,0.681992072101998,0,17,protein targeting to peroxisome,BP,
3065,GO:0006627,1,0.870106019551047,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3069,GO:0006635,1,0.252761768957532,0,61,fatty acid beta-oxidation,BP,
3071,GO:0006637,1,0.177304589146004,0,77,acyl-CoA metabolic process,BP,
3072,GO:0006638,1,0.220948330487813,0,68,neutral lipid metabolic process,BP,
3073,GO:0006639,1,0.226064224409147,0,67,acylglycerol metabolic process,BP,
3074,GO:0006641,1,0.307088392138898,0,53,triglyceride metabolic process,BP,
3075,GO:0006642,1,0.936146998267363,0,3,triglyceride mobilization,BP,
3078,GO:0006646,1,0.782328681798785,0,11,phosphatidylethanolamine biosynthetic process,BP,
3080,GO:0006651,1,0.95745039036364,0,2,diacylglycerol biosynthetic process,BP,
3081,GO:0006654,1,0.531023938298748,0,29,phosphatidic acid biosynthetic process,BP,
3082,GO:0006655,1,0.796843452474283,0,10,phosphatidylglycerol biosynthetic process,BP,
3085,GO:0006658,1,0.62244995488815,0,21,phosphatidylserine metabolic process,BP,
3086,GO:0006659,1,0.912553325787959,0,4,phosphatidylserine biosynthetic process,BP,
3087,GO:0006660,1,0.977114653211488,0,1,phosphatidylserine catabolic process,BP,
3089,GO:0006662,1,0.815451191860646,0,9,glycerol ether metabolic process,BP,
3090,GO:0006663,1,0.935192203897026,0,3,platelet activating factor biosynthetic process,BP,
3091,GO:0006664,1,0.103156703528003,0,100,glycolipid metabolic process,BP,
3092,GO:0006665,1,0.0540284338506788,0,129,sphingolipid metabolic process,BP,
3093,GO:0006666,1,0.979280004496956,0,1,3-keto-sphinganine metabolic process,BP,
3094,GO:0006667,1,0.958387513906507,0,2,sphinganine metabolic process,BP,
3095,GO:0006668,1,0.955471634093223,0,2,sphinganine-1-phosphate metabolic process,BP,
3096,GO:0006669,1,0.97736985222872,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3097,GO:0006670,1,0.796687083094771,0,10,sphingosine metabolic process,BP,
3098,GO:0006671,1,0.978610907250826,0,1,phytosphingosine metabolic process,BP,
3099,GO:0006672,1,0.225683001321537,0,66,ceramide metabolic process,BP,
3100,GO:0006677,1,0.728354668021474,0,14,glycosylceramide metabolic process,BP,
3101,GO:0006678,1,0.854938591072481,0,7,glucosylceramide metabolic process,BP,
3102,GO:0006679,1,0.956700319593179,0,2,glucosylceramide biosynthetic process,BP,
3103,GO:0006680,1,0.933926059906946,0,3,glucosylceramide catabolic process,BP,
3104,GO:0006681,1,0.873314088186656,0,6,galactosylceramide metabolic process,BP,
3105,GO:0006682,1,0.933840238957038,0,3,galactosylceramide biosynthetic process,BP,
3106,GO:0006683,1,0.977344024735263,0,1,galactosylceramide catabolic process,BP,
3107,GO:0006684,1,0.748116052900226,0,13,sphingomyelin metabolic process,BP,
3108,GO:0006685,1,0.894600821367523,0,5,sphingomyelin catabolic process,BP,
3109,GO:0006686,1,0.875981520485117,0,6,sphingomyelin biosynthetic process,BP,
3110,GO:0006687,1,0.305059423968643,0,53,glycosphingolipid metabolic process,BP,
3111,GO:0006688,1,0.748994944680562,0,13,glycosphingolipid biosynthetic process,BP,
3112,GO:0006689,1,0.912522053746689,0,4,ganglioside catabolic process,BP,
3114,GO:0006691,1,0.760129711557738,0,12,leukotriene metabolic process,BP,
3119,GO:0006696,1,0.954958803941541,0,2,ergosterol biosynthetic process,BP,
3121,GO:0006700,1,0.708010056035067,0,15,C21-steroid hormone biosynthetic process,BP,
3122,GO:0006701,1,0.913415579155279,0,4,progesterone biosynthetic process,BP,
3123,GO:0006702,1,0.895969229144602,0,5,androgen biosynthetic process,BP,
3124,GO:0006703,1,0.82979020884495,0,8,estrogen biosynthetic process,BP,
3125,GO:0006704,1,0.834910059040358,0,8,glucocorticoid biosynthetic process,BP,
3126,GO:0006705,1,0.913762088984811,0,4,mineralocorticoid biosynthetic process,BP,
3127,GO:0006706,1,0.745075518925312,0,13,steroid catabolic process,BP,
3128,GO:0006707,1,0.914874584613014,0,4,cholesterol catabolic process,BP,
3129,GO:0006710,1,0.977158010364025,0,1,androgen catabolic process,BP,
3130,GO:0006711,1,0.977114653211488,0,1,estrogen catabolic process,BP,
3131,GO:0006713,1,0.977118386253927,0,1,glucocorticoid catabolic process,BP,
3134,GO:0006722,1,0.977243143114247,0,1,triterpenoid metabolic process,BP,
3136,GO:0006726,1,0.97898069188158,0,1,eye pigment biosynthetic process,BP,
3137,GO:0006729,1,0.849518808386618,0,7,tetrahydrobiopterin biosynthetic process,BP,
3143,GO:0006738,1,0.977243563733998,0,1,nicotinamide riboside catabolic process,BP,
3144,GO:0006739,1,0.527425831755129,0,28,NADP metabolic process,BP,
3145,GO:0006740,1,0.934799140001202,0,3,NADPH regeneration,BP,
3146,GO:0006741,1,0.912620623777127,0,4,NADP biosynthetic process,BP,
3147,GO:0006742,1,0.977755183855241,0,1,NADP catabolic process,BP,
3148,GO:0006743,1,0.707469290059731,0,15,ubiquinone metabolic process,BP,
3149,GO:0006744,1,0.722872109944903,0,14,ubiquinone biosynthetic process,BP,
3150,GO:0006747,1,0.977190576982258,0,1,FAD biosynthetic process,BP,
3151,GO:0006749,1,0.37571866242992,0,42,glutathione metabolic process,BP,
3152,GO:0006750,1,0.724727791040015,0,14,glutathione biosynthetic process,BP,
3153,GO:0006751,1,0.89041183277357,0,5,glutathione catabolic process,BP,
3157,GO:0006760,1,0.60991111994074,0,22,folic acid-containing compound metabolic process,BP,
3160,GO:0006768,1,0.787614933346422,0,11,biotin metabolic process,BP,
3161,GO:0006771,1,0.874182784865531,0,6,riboflavin metabolic process,BP,
3162,GO:0006772,1,0.977121522229934,0,1,thiamine metabolic process,BP,
3164,GO:0006776,1,0.93296716735506,0,3,vitamin A metabolic process,BP,
3165,GO:0006777,1,0.87278013360123,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3166,GO:0006778,1,0.494130344353303,0,31,porphyrin-containing compound metabolic process,BP,
3167,GO:0006779,1,0.622860676645319,0,21,porphyrin-containing compound biosynthetic process,BP,
3168,GO:0006780,1,0.954494914580415,0,2,uroporphyrinogen III biosynthetic process,BP,
3169,GO:0006781,1,0.977226624391861,0,1,succinyl-CoA pathway,BP,
3170,GO:0006782,1,0.850092675843141,0,7,protoporphyrinogen IX biosynthetic process,BP,
3171,GO:0006783,1,0.667381709265656,0,18,heme biosynthetic process,BP,
3172,GO:0006784,1,0.958493941771161,0,2,heme a biosynthetic process,BP,
3173,GO:0006787,1,0.868663346651302,0,6,porphyrin-containing compound catabolic process,BP,
3174,GO:0006788,1,0.954562369660319,0,2,heme oxidation,BP,
3175,GO:0006789,1,0.954997909395387,0,2,bilirubin conjugation,BP,
3179,GO:0006797,1,0.899607200061556,0,5,polyphosphate metabolic process,BP,
3180,GO:0006798,1,0.920492136843271,0,4,polyphosphate catabolic process,BP,
3181,GO:0006801,1,0.442727984500475,0,36,superoxide metabolic process,BP,
3184,GO:0006808,1,0.954535854109407,0,2,regulation of nitrogen utilization,BP,
3189,GO:0006813,1,0.127914890976577,0,94,potassium ion transport,BP,
3194,GO:0006821,1,0.394661081200713,0,42,chloride transport,BP,
3195,GO:0006824,1,0.956122784277232,0,2,cobalt ion transport,BP,
3196,GO:0006825,1,0.668645057842637,0,18,copper ion transport,BP,
3197,GO:0006826,1,0.390366969932829,0,42,iron ion transport,BP,
3198,GO:0006828,1,0.936259732875399,0,3,manganese ion transport,BP,
3200,GO:0006833,1,0.871574667959469,0,6,water transport,BP,
3203,GO:0006837,1,0.876606568648494,0,6,serotonin transport,BP,
3205,GO:0006842,1,0.914118303764161,0,4,tricarboxylic acid transport,BP,
3206,GO:0006843,1,0.976991038494323,0,1,mitochondrial citrate transmembrane transport,BP,
3207,GO:0006844,1,0.954915396691432,0,2,acyl carnitine transport,BP,
3208,GO:0006848,1,0.933977923074141,0,3,pyruvate transport,BP,
3209,GO:0006850,1,0.955184890372083,0,2,mitochondrial pyruvate transmembrane transport,BP,
3210,GO:0006851,1,0.635053709042649,0,20,mitochondrial calcium ion transmembrane transport,BP,
3211,GO:0006853,1,0.809750451391845,0,10,carnitine shuttle,BP,
3213,GO:0006857,1,0.836728961899109,0,8,oligopeptide transport,BP,
3214,GO:0006858,1,0.933380928310711,0,3,extracellular transport,BP,
3215,GO:0006862,1,0.694083654404058,0,16,nucleotide transport,BP,
3216,GO:0006863,1,0.871184756743644,0,6,purine nucleobase transport,BP,
3217,GO:0006864,1,0.956188464797075,0,2,pyrimidine nucleotide transport,BP,
3219,GO:0006867,1,0.977295823748791,0,1,asparagine transport,BP,
3220,GO:0006868,1,0.91488732156288,0,4,glutamine transport,BP,
3225,GO:0006878,1,0.745854401266903,0,13,cellular copper ion homeostasis,BP,
3227,GO:0006880,1,0.931410782830451,0,3,intracellular sequestering of iron ion,BP,
3229,GO:0006883,1,0.841557352817285,0,8,cellular sodium ion homeostasis,BP,
3231,GO:0006885,1,0.212696753504883,0,69,regulation of pH,BP,
3234,GO:0006888,1,0.0226351607968891,0,170,ER to Golgi vesicle-mediated transport,BP,
3236,GO:0006891,1,0.51039445292845,0,30,intra-Golgi vesicle-mediated transport,BP,
3237,GO:0006892,1,0.145058467107499,0,89,post-Golgi vesicle-mediated transport,BP,
3238,GO:0006893,1,0.373690214933814,0,45,Golgi to plasma membrane transport,BP,
3239,GO:0006895,1,0.674233210951062,0,19,Golgi to endosome transport,BP,
3240,GO:0006896,1,0.732731358616888,0,14,Golgi to vacuole transport,BP,
3243,GO:0006900,1,0.147797404071878,0,86,vesicle budding from membrane,BP,
3244,GO:0006901,1,0.263473571569484,0,60,vesicle coating,BP,
3245,GO:0006903,1,0.18075604668865,0,77,vesicle targeting,BP,
3250,GO:0006910,1,0.875646030454289,0,6,phagocytosis, recognition,BP,
3251,GO:0006911,1,0.578295233230764,0,25,phagocytosis, engulfment,BP,
3255,GO:0006919,1,0.173570183063207,0,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3256,GO:0006921,1,0.571162736098672,0,25,cellular component disassembly involved in execution phase of apoptosis,BP,
3258,GO:0006925,1,0.727966240050483,0,14,inflammatory cell apoptotic process,BP,
3261,GO:0006930,1,0.839344241162085,0,8,substrate-dependent cell migration, cell extension,BP,
3262,GO:0006931,1,0.939442477294284,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
3271,GO:0006949,1,0.535743346530751,0,29,syncytium formation,BP,
3274,GO:0006953,1,0.665223324032859,0,18,acute-phase response,BP,
3278,GO:0006957,1,0.937349751070726,0,3,complement activation, alternative pathway,BP,
3281,GO:0006968,1,0.654756397129521,0,19,cellular defense response,BP,
3283,GO:0006971,1,0.84290710421016,0,8,hypotonic response,BP,
3286,GO:0006975,1,0.85865264991907,0,7,DNA damage induced protein phosphorylation,BP,
3287,GO:0006977,1,0.265128929575873,0,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3288,GO:0006978,1,0.675797301127571,0,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3290,GO:0006982,1,0.953742568758197,0,2,response to lipid hydroperoxide,BP,
3291,GO:0006983,1,0.802047225451879,0,10,ER overload response,BP,
3292,GO:0006984,1,0.408373244113583,0,40,ER-nucleus signaling pathway,BP,
3294,GO:0006987,1,0.834452902922679,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3295,GO:0006990,1,0.937496550366006,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3296,GO:0006991,1,0.816762719730407,0,9,response to sterol depletion,BP,
3297,GO:0006995,1,0.792781583207722,0,10,cellular response to nitrogen starvation,BP,
3300,GO:0006998,1,0.169157318949494,0,80,nuclear envelope organization,BP,
3301,GO:0006999,1,0.723613640124109,0,15,nuclear pore organization,BP,
3302,GO:0007000,1,0.855208757559036,0,7,nucleolus organization,BP,
3303,GO:0007004,1,0.241606140540333,0,64,telomere maintenance via telomerase,BP,
3306,GO:0007007,1,0.600800492660816,0,22,inner mitochondrial membrane organization,BP,
3307,GO:0007008,1,0.977662033732478,0,1,outer mitochondrial membrane organization,BP,
3310,GO:0007014,1,0.977967794427033,0,1,actin ubiquitination,BP,
3312,GO:0007016,1,0.854184622648738,0,8,cytoskeletal anchoring at plasma membrane,BP,
3315,GO:0007019,1,0.507093885700879,0,32,microtubule depolymerization,BP,
3316,GO:0007020,1,0.569848209364797,0,26,microtubule nucleation,BP,
3319,GO:0007026,1,0.685095191977947,0,18,negative regulation of microtubule depolymerization,BP,
3321,GO:0007029,1,0.384833710439926,0,43,endoplasmic reticulum organization,BP,
3322,GO:0007030,1,0.0831967819952309,0,114,Golgi organization,BP,
3323,GO:0007031,1,0.534561088298887,0,28,peroxisome organization,BP,
3327,GO:0007035,1,0.654059441339911,0,19,vacuolar acidification,BP,
3328,GO:0007039,1,0.76803080578905,0,12,protein catabolic process in the vacuole,BP,
3331,GO:0007042,1,0.829655430657827,0,8,lysosomal lumen acidification,BP,
3337,GO:0007051,1,0.033628649764488,0,155,spindle organization,BP,
3338,GO:0007052,1,0.100131288068111,0,105,mitotic spindle organization,BP,
3339,GO:0007056,1,0.954976287003118,0,2,spindle assembly involved in female meiosis,BP,
3340,GO:0007057,1,0.954976287003118,0,2,spindle assembly involved in female meiosis I,BP,
3342,GO:0007060,1,0.955097285446109,0,2,male meiosis chromosome segregation,BP,
3343,GO:0007062,1,0.0696764866827165,0,120,sister chromatid cohesion,BP,
3344,GO:0007063,1,0.633294597187491,0,21,regulation of sister chromatid cohesion,BP,
3345,GO:0007064,1,0.624540554827448,0,22,mitotic sister chromatid cohesion,BP,
3346,GO:0007066,1,0.976130004850096,0,1,female meiosis sister chromatid cohesion,BP,
3347,GO:0007072,1,0.977076665296094,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3349,GO:0007077,1,0.397383071178043,0,42,mitotic nuclear envelope disassembly,BP,
3350,GO:0007079,1,0.93894020968198,0,3,mitotic chromosome movement towards spindle pole,BP,
3352,GO:0007084,1,0.794284287753193,0,10,mitotic nuclear envelope reassembly,BP,
3353,GO:0007088,1,0.0443046234686377,0,141,regulation of mitotic nuclear division,BP,
3354,GO:0007089,1,0.915624813764627,0,4,traversing start control point of mitotic cell cycle,BP,
3355,GO:0007091,1,0.338443152371827,0,49,metaphase/anaphase transition of mitotic cell cycle,BP,
3356,GO:0007093,1,0.0314729342013545,0,154,mitotic cell cycle checkpoint,BP,
3357,GO:0007094,1,0.52711748042969,0,29,mitotic spindle assembly checkpoint,BP,
3358,GO:0007095,1,0.661176245693137,0,19,mitotic G2 DNA damage checkpoint,BP,
3359,GO:0007096,1,0.712613472103074,0,15,regulation of exit from mitosis,BP,
3360,GO:0007097,1,0.718876085558998,0,16,nuclear migration,BP,
3361,GO:0007098,1,0.0929015310717986,0,108,centrosome cycle,BP,
3362,GO:0007099,1,0.528072149205754,0,29,centriole replication,BP,
3363,GO:0007100,1,0.752833731415465,0,13,mitotic centrosome separation,BP,
3364,GO:0007113,1,0.932243453608466,0,3,endomitotic cell cycle,BP,
3366,GO:0007129,1,0.650272404886371,0,19,synapsis,BP,
3367,GO:0007130,1,0.834394323668846,0,8,synaptonemal complex assembly,BP,
3368,GO:0007131,1,0.448531222582048,0,36,reciprocal meiotic recombination,BP,
3369,GO:0007135,1,0.871705610365815,0,6,meiosis II,BP,
3372,GO:0007143,1,0.670159685353263,0,18,female meiotic nuclear division,BP,
3373,GO:0007144,1,0.874087956943786,0,6,female meiosis I,BP,
3374,GO:0007146,1,0.977336572808046,0,1,meiotic recombination nodule assembly,BP,
3375,GO:0007147,1,0.977886419461107,0,1,female meiosis II,BP,
3383,GO:0007161,1,0.924552771849174,0,4,calcium-independent cell-matrix adhesion,BP,
3386,GO:0007164,1,0.0870607124237954,0,109,establishment of tissue polarity,BP,
3390,GO:0007168,1,0.955457340745764,0,2,receptor guanylyl cyclase signaling pathway,BP,
3392,GO:0007171,1,0.874514433072852,0,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3393,GO:0007172,1,0.8553844862629,0,7,signal complex assembly,BP,
3395,GO:0007174,1,0.977232630646704,0,1,epidermal growth factor catabolic process,BP,
3396,GO:0007175,1,0.751511785432106,0,13,negative regulation of epidermal growth factor-activated receptor activity,BP,
3397,GO:0007176,1,0.613115172538937,0,22,regulation of epidermal growth factor-activated receptor activity,BP,
3400,GO:0007181,1,0.957431802054138,0,2,transforming growth factor beta receptor complex assembly,BP,
3401,GO:0007182,1,0.882234632183696,0,6,common-partner SMAD protein phosphorylation,BP,
3403,GO:0007185,1,0.926273716202414,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3408,GO:0007190,1,0.739291133805031,0,14,activation of adenylate cyclase activity,BP,
3409,GO:0007191,1,0.872492286977226,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3411,GO:0007194,1,0.859263331478504,0,7,negative regulation of adenylate cyclase activity,BP,
3412,GO:0007195,1,0.959372352928483,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3413,GO:0007196,1,0.979990412670674,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3414,GO:0007197,1,0.956355511035102,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3415,GO:0007198,1,0.954571068620171,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3416,GO:0007200,1,0.49488571218174,0,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
3417,GO:0007202,1,0.794296822768545,0,10,activation of phospholipase C activity,BP,
3418,GO:0007204,1,0.0558634261337291,0,132,positive regulation of cytosolic calcium ion concentration,BP,
3420,GO:0007206,1,0.978451758946981,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3421,GO:0007207,1,0.955023675929187,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3422,GO:0007210,1,0.932833936673599,0,3,serotonin receptor signaling pathway,BP,
3425,GO:0007214,1,0.876101700451395,0,6,gamma-aminobutyric acid signaling pathway,BP,
3427,GO:0007216,1,0.876425940414051,0,6,G-protein coupled glutamate receptor signaling pathway,BP,
3428,GO:0007217,1,0.977255496193493,0,1,tachykinin receptor signaling pathway,BP,
3429,GO:0007218,1,0.677607358882361,0,17,neuropeptide signaling pathway,BP,
3433,GO:0007223,1,0.501431461729348,0,32,Wnt signaling pathway, calcium modulating pathway,BP,
3435,GO:0007225,1,0.978913832498589,0,1,patched ligand maturation,BP,
3436,GO:0007227,1,0.936649184220579,0,3,signal transduction downstream of smoothened,BP,
3437,GO:0007228,1,0.957528290255773,0,2,positive regulation of hh target transcription factor activity,BP,
3439,GO:0007231,1,0.955031065263857,0,2,osmosensory signaling pathway,BP,
3441,GO:0007250,1,0.698192120124747,0,16,activation of NF-kappaB-inducing kinase activity,BP,
3442,GO:0007252,1,0.748208916887638,0,13,I-kappaB phosphorylation,BP,
3443,GO:0007253,1,0.850118035397612,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3445,GO:0007256,1,0.882922997820245,0,6,activation of JNKK activity,BP,
3446,GO:0007257,1,0.543558265335082,0,28,activation of JUN kinase activity,BP,
3447,GO:0007258,1,0.913923224422951,0,4,JUN phosphorylation,BP,
3450,GO:0007263,1,0.840643365508268,0,8,nitric oxide mediated signal transduction,BP,
3457,GO:0007270,1,0.885064151821575,0,6,neuron-neuron synaptic transmission,BP,
3458,GO:0007271,1,0.803163059742612,0,10,synaptic transmission, cholinergic,BP,
3460,GO:0007274,1,0.824508564636291,0,9,neuromuscular synaptic transmission,BP,
3465,GO:0007284,1,0.957533683671065,0,2,spermatogonial cell division,BP,
3467,GO:0007288,1,0.801802860940905,0,10,sperm axoneme assembly,BP,
3469,GO:0007290,1,0.978938285848068,0,1,spermatid nucleus elongation,BP,
3470,GO:0007292,1,0.192000589875106,0,75,female gamete generation,BP,
3471,GO:0007296,1,0.921892035748825,0,4,vitellogenesis,BP,
3472,GO:0007308,1,0.977255939027595,0,1,oocyte construction,BP,
3473,GO:0007309,1,0.977255939027595,0,1,oocyte axis specification,BP,
3474,GO:0007314,1,0.977255939027595,0,1,oocyte anterior/posterior axis specification,BP,
3475,GO:0007315,1,0.977255939027595,0,1,pole plasm assembly,BP,
3476,GO:0007320,1,0.916601708074131,0,4,insemination,BP,
3478,GO:0007339,1,0.7073544286205,0,15,binding of sperm to zona pellucida,BP,
3479,GO:0007340,1,0.763972587507174,0,12,acrosome reaction,BP,
3480,GO:0007341,1,0.934276449824687,0,3,penetration of zona pellucida,BP,
3481,GO:0007342,1,0.909886375607032,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3482,GO:0007344,1,0.977094753002521,0,1,pronuclear fusion,BP,
3484,GO:0007350,1,0.769294003270316,0,12,blastoderm segmentation,BP,
3485,GO:0007351,1,0.821866385896992,0,9,tripartite regional subdivision,BP,
3486,GO:0007352,1,0.983008226798335,0,1,zygotic specification of dorsal/ventral axis,BP,
3487,GO:0007354,1,0.933622871508625,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
3488,GO:0007356,1,0.95502300820876,0,2,thorax and anterior abdomen determination,BP,
3489,GO:0007368,1,0.222994392779693,0,69,determination of left/right symmetry,BP,
3491,GO:0007371,1,0.97799455983445,0,1,ventral midline determination,BP,
3492,GO:0007379,1,0.779777315842806,0,11,segment specification,BP,
3493,GO:0007386,1,0.896167691375268,0,5,compartment pattern specification,BP,
3494,GO:0007387,1,0.977278391118737,0,1,anterior compartment pattern formation,BP,
3495,GO:0007388,1,0.977278391118737,0,1,posterior compartment specification,BP,
3499,GO:0007402,1,0.976225115676963,0,1,ganglion mother cell fate determination,BP,
3500,GO:0007403,1,0.977699138804462,0,1,glial cell fate determination,BP,
3502,GO:0007406,1,0.919471835896912,0,4,negative regulation of neuroblast proliferation,BP,
3505,GO:0007412,1,0.955110978657553,0,2,axon target recognition,BP,
3509,GO:0007418,1,0.958878063283808,0,2,ventral midline development,BP,
3515,GO:0007439,1,0.977370360650261,0,1,ectodermal digestive tract development,BP,
3516,GO:0007440,1,0.891873851004731,0,6,foregut morphogenesis,BP,
3517,GO:0007442,1,0.92143557718295,0,4,hindgut morphogenesis,BP,
3518,GO:0007468,1,0.977208955707023,0,1,regulation of rhodopsin gene expression,BP,
3520,GO:0007494,1,0.858245064152062,0,7,midgut development,BP,
3521,GO:0007495,1,0.977506139705084,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3522,GO:0007497,1,0.979040615659215,0,1,posterior midgut development,BP,
3524,GO:0007499,1,0.978823667602505,0,1,ectoderm and mesoderm interaction,BP,
3525,GO:0007500,1,0.954985229547163,0,2,mesodermal cell fate determination,BP,
3526,GO:0007501,1,0.936029061270108,0,3,mesodermal cell fate specification,BP,
3528,GO:0007509,1,0.980296321620362,0,1,mesoderm migration involved in gastrulation,BP,
3529,GO:0007512,1,0.898621612290719,0,5,adult heart development,BP,
3531,GO:0007518,1,0.977241132658391,0,1,myoblast fate determination,BP,
3533,GO:0007520,1,0.64811275263006,0,20,myoblast fusion,BP,
3534,GO:0007525,1,0.968883711788164,0,2,somatic muscle development,BP,
3535,GO:0007528,1,0.544234370208355,0,29,neuromuscular junction development,BP,
3536,GO:0007529,1,0.957025735846941,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3543,GO:0007566,1,0.454209309896372,0,35,embryo implantation,BP,
3544,GO:0007567,1,0.818006037995306,0,9,parturition,BP,
3547,GO:0007571,1,0.976271479433318,0,1,age-dependent general metabolic decline,BP,
3548,GO:0007576,1,0.977253216370375,0,1,nucleolar fragmentation,BP,
3552,GO:0007588,1,0.631280734211808,0,21,excretion,BP,
3556,GO:0007597,1,0.890457923511715,0,5,blood coagulation, intrinsic pathway,BP,
3557,GO:0007598,1,0.9772401914015,0,1,blood coagulation, extrinsic pathway,BP,
3561,GO:0007602,1,0.595689368495564,0,23,phototransduction,BP,
3562,GO:0007603,1,0.697593943473669,0,16,phototransduction, visible light,BP,
3564,GO:0007606,1,0.52139887226572,0,29,sensory perception of chemical stimulus,BP,
3565,GO:0007608,1,0.733503986987929,0,14,sensory perception of smell,BP,
3570,GO:0007614,1,0.871103297302699,0,6,short-term memory,BP,
3571,GO:0007616,1,0.638099723957486,0,21,long-term memory,BP,
3572,GO:0007617,1,0.781848795471844,0,11,mating behavior,BP,
3573,GO:0007618,1,0.668640320592141,0,18,mating,BP,
3574,GO:0007619,1,0.936742911341966,0,3,courtship behavior,BP,
3575,GO:0007620,1,0.835844819653908,0,8,copulation,BP,
3576,GO:0007621,1,0.980955831804615,0,1,negative regulation of female receptivity,BP,
3579,GO:0007624,1,0.978385825802639,0,1,ultradian rhythm,BP,
3580,GO:0007625,1,0.87125978163183,0,6,grooming behavior,BP,
3582,GO:0007628,1,0.777839537409646,0,12,adult walking behavior,BP,
3584,GO:0007632,1,0.466495094835088,0,35,visual behavior,BP,
3585,GO:0007634,1,0.977245145809998,0,1,optokinetic behavior,BP,
3586,GO:0007635,1,0.882707350077963,0,6,chemosensory behavior,BP,
3587,GO:0007638,1,0.853199485478624,0,8,mechanosensory behavior,BP,
3592,GO:0008017,1,0.0102288898514486,0,213,microtubule binding,MF,
3593,GO:0008020,1,0.955194756772626,0,2,G-protein coupled photoreceptor activity,MF,
3594,GO:0008021,1,0.0952612840144638,0,104,synaptic vesicle,CC,
3596,GO:0008023,1,0.362981173684369,0,46,transcription elongation factor complex,CC,
3597,GO:0008024,1,0.840978964328212,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3601,GO:0008035,1,0.913197599038169,0,4,high-density lipoprotein particle binding,MF,
3604,GO:0008043,1,0.953147657860971,0,2,intracellular ferritin complex,CC,
3608,GO:0008048,1,0.977235204612038,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3609,GO:0008049,1,0.977170383952602,0,1,male courtship behavior,BP,
3610,GO:0008050,1,0.958631538639434,0,2,female courtship behavior,BP,
3611,GO:0008052,1,0.976225115676963,0,1,sensory organ boundary specification,BP,
3612,GO:0008053,1,0.632827457734825,0,20,mitochondrial fusion,BP,
3613,GO:0008057,1,0.980942219379264,0,1,eye pigment granule organization,BP,
3614,GO:0008061,1,0.955634304383434,0,2,chitin binding,MF,
3615,GO:0008063,1,0.913067202685935,0,4,Toll signaling pathway,BP,
3617,GO:0008065,1,0.956509120829393,0,2,establishment of blood-nerve barrier,BP,
3618,GO:0008066,1,0.939040108102612,0,3,glutamate receptor activity,MF,
3619,GO:0008073,1,0.954165761722485,0,2,ornithine decarboxylase inhibitor activity,MF,
3620,GO:0008074,1,0.887511876519076,0,6,guanylate cyclase complex, soluble,CC,
3621,GO:0008076,1,0.530295189999928,0,29,voltage-gated potassium channel complex,CC,
3622,GO:0008078,1,0.980296321620362,0,1,mesodermal cell migration,BP,
3623,GO:0008079,1,0.875279407021766,0,6,translation termination factor activity,MF,
3629,GO:0008090,1,0.861565413316391,0,7,retrograde axonal transport,BP,
3630,GO:0008091,1,0.893318937477346,0,6,spectrin,CC,
3633,GO:0008094,1,0.177551727697739,0,79,DNA-dependent ATPase activity,MF,
3634,GO:0008097,1,0.791897980298273,0,10,5S rRNA binding,MF,
3638,GO:0008108,1,0.976716347107442,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3639,GO:0008109,1,0.95689841648878,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3640,GO:0008111,1,0.977191124917862,0,1,alpha-methylacyl-CoA racemase activity,MF,
3641,GO:0008112,1,0.976967830446069,0,1,nicotinamide N-methyltransferase activity,MF,
3642,GO:0008113,1,0.954128427448803,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3643,GO:0008116,1,0.979588882644265,0,1,prostaglandin-I synthase activity,MF,
3644,GO:0008117,1,0.979717184398271,0,1,sphinganine-1-phosphate aldolase activity,MF,
3645,GO:0008118,1,0.977231939343979,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3646,GO:0008119,1,0.977554297624547,0,1,thiopurine S-methyltransferase activity,MF,
3647,GO:0008120,1,0.977015465853354,0,1,ceramide glucosyltransferase activity,MF,
3648,GO:0008121,1,0.848266285358185,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3649,GO:0008124,1,0.954022974939844,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3650,GO:0008126,1,0.977316622033018,0,1,acetylesterase activity,MF,
3651,GO:0008127,1,0.976667672864632,0,1,quercetin 2,3-dioxygenase activity,MF,
3652,GO:0008131,1,0.935297877318487,0,3,primary amine oxidase activity,MF,
3654,GO:0008135,1,0.161631316953811,0,81,translation factor activity, RNA binding,MF,
3655,GO:0008137,1,0.397971999737999,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3657,GO:0008139,1,0.610783158657457,0,23,nuclear localization sequence binding,MF,
3658,GO:0008140,1,0.836683503681085,0,8,cAMP response element binding protein binding,MF,
3659,GO:0008142,1,0.920062901064699,0,4,oxysterol binding,MF,
3660,GO:0008143,1,0.734773614659372,0,14,poly(A) binding,MF,
3662,GO:0008146,1,0.537483514466339,0,28,sulfotransferase activity,MF,
3666,GO:0008156,1,0.483378149291323,0,33,negative regulation of DNA replication,BP,
3667,GO:0008157,1,0.731814055789246,0,14,protein phosphatase 1 binding,MF,
3668,GO:0008158,1,0.957781294201875,0,2,hedgehog receptor activity,MF,
3669,GO:0008160,1,0.977261454809581,0,1,protein tyrosine phosphatase activator activity,MF,
3671,GO:0008169,1,0.934050528196198,0,3,C-methyltransferase activity,MF,
3674,GO:0008172,1,0.896286491213786,0,5,S-methyltransferase activity,MF,
3678,GO:0008176,1,0.954226296864097,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3679,GO:0008177,1,0.890210003262809,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
3680,GO:0008179,1,0.80592967420288,0,10,adenylate cyclase binding,MF,
3681,GO:0008180,1,0.547483218466419,0,27,COP9 signalosome,CC,
3682,GO:0008184,1,0.956178276708108,0,2,glycogen phosphorylase activity,MF,
3684,GO:0008187,1,0.640970473183175,0,20,poly-pyrimidine tract binding,MF,
3685,GO:0008188,1,0.891106528781441,0,5,neuropeptide receptor activity,MF,
3686,GO:0008190,1,0.83987353815642,0,8,eukaryotic initiation factor 4E binding,MF,
3688,GO:0008192,1,0.935160742240382,0,3,RNA guanylyltransferase activity,MF,
3689,GO:0008193,1,0.955534045943895,0,2,tRNA guanylyltransferase activity,MF,
3691,GO:0008195,1,0.818574005518299,0,9,phosphatidate phosphatase activity,MF,
3692,GO:0008198,1,0.683640689077253,0,17,ferrous iron binding,MF,
3693,GO:0008199,1,0.892398592778354,0,5,ferric iron binding,MF,
3698,GO:0008204,1,0.954958803941541,0,2,ergosterol metabolic process,BP,
3703,GO:0008211,1,0.744730016096821,0,13,glucocorticoid metabolic process,BP,
3704,GO:0008212,1,0.913762088984811,0,4,mineralocorticoid metabolic process,BP,
3707,GO:0008215,1,0.869219655259017,0,6,spermine metabolic process,BP,
3708,GO:0008216,1,0.848445060923679,0,7,spermidine metabolic process,BP,
3710,GO:0008218,1,0.977751570891526,0,1,bioluminescence,BP,
3712,GO:0008227,1,0.832607371305332,0,8,G-protein coupled amine receptor activity,MF,
3713,GO:0008228,1,0.938877332366281,0,3,opsonization,BP,
3715,GO:0008234,1,0.0362798426006463,0,150,cysteine-type peptidase activity,MF,
3716,GO:0008235,1,0.501297476959728,0,31,metalloexopeptidase activity,MF,
3717,GO:0008236,1,0.120572391116461,0,93,serine-type peptidase activity,MF,
3719,GO:0008238,1,0.238474072143033,0,64,exopeptidase activity,MF,
3720,GO:0008239,1,0.871880102686021,0,6,dipeptidyl-peptidase activity,MF,
3721,GO:0008240,1,0.957171532422118,0,2,tripeptidyl-peptidase activity,MF,
3722,GO:0008242,1,0.835843047412621,0,8,omega peptidase activity,MF,
3723,GO:0008250,1,0.754412859497966,0,12,oligosaccharyltransferase complex,CC,
3724,GO:0008251,1,0.957805456603356,0,2,tRNA-specific adenosine deaminase activity,MF,
3727,GO:0008254,1,0.980779789104338,0,1,3'-nucleotidase activity,MF,
3728,GO:0008260,1,0.977828801233376,0,1,3-oxoacid CoA-transferase activity,MF,
3729,GO:0008263,1,0.955308846949405,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3730,GO:0008265,1,0.97728405824096,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3731,GO:0008266,1,0.700105321711275,0,16,poly(U) RNA binding,MF,
3732,GO:0008267,1,0.981351215330624,0,1,poly-glutamine tract binding,MF,
3733,GO:0008269,1,0.977230511923351,0,1,JAK pathway signal transduction adaptor activity,MF,
3735,GO:0008271,1,0.897221604297329,0,5,secondary active sulfate transmembrane transporter activity,MF,
3736,GO:0008272,1,0.857090844907963,0,7,sulfate transport,BP,
3737,GO:0008273,1,0.958786997161403,0,2,calcium, potassium:sodium antiporter activity,MF,
3738,GO:0008274,1,0.840332068498978,0,8,gamma-tubulin ring complex,CC,
3739,GO:0008275,1,0.915115212854179,0,4,gamma-tubulin small complex,CC,
3740,GO:0008276,1,0.199997542834923,0,72,protein methyltransferase activity,MF,
3742,GO:0008278,1,0.84208750783292,0,8,cohesin complex,CC,
3743,GO:0008281,1,0.978877969143607,0,1,sulfonylurea receptor activity,MF,
3744,GO:0008282,1,0.956787277814729,0,2,inward rectifying potassium channel,CC,
3749,GO:0008287,1,0.357713390951022,0,46,protein serine/threonine phosphatase complex,CC,
3751,GO:0008290,1,0.872194238113903,0,6,F-actin capping protein complex,CC,
3752,GO:0008291,1,0.977266136864643,0,1,acetylcholine metabolic process,BP,
3753,GO:0008292,1,0.977266136864643,0,1,acetylcholine biosynthetic process,BP,
3754,GO:0008294,1,0.984336061412047,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3755,GO:0008295,1,0.911576837608679,0,4,spermidine biosynthetic process,BP,
3756,GO:0008296,1,0.834277039528237,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3757,GO:0008297,1,0.874050030614268,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3758,GO:0008298,1,0.759136741500694,0,12,intracellular mRNA localization,BP,
3759,GO:0008299,1,0.605512698274959,0,22,isoprenoid biosynthetic process,BP,
3760,GO:0008300,1,0.956480054122055,0,2,isoprenoid catabolic process,BP,
3761,GO:0008301,1,0.749648700469356,0,13,DNA binding, bending,MF,
3762,GO:0008305,1,0.699941874092174,0,17,integrin complex,CC,
3764,GO:0008307,1,0.607627770954551,0,25,structural constituent of muscle,MF,
3765,GO:0008308,1,0.765563034953222,0,12,voltage-gated anion channel activity,MF,
3766,GO:0008309,1,0.911889187327728,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3767,GO:0008310,1,0.914902885999649,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3768,GO:0008311,1,0.954604459532329,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3769,GO:0008312,1,0.849893586869182,0,7,7S RNA binding,MF,
3770,GO:0008318,1,0.856475094165825,0,7,protein prenyltransferase activity,MF,
3771,GO:0008320,1,0.736231658869991,0,13,protein transmembrane transporter activity,MF,
3772,GO:0008321,1,0.959774303221081,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3774,GO:0008327,1,0.701237389583937,0,16,methyl-CpG binding,MF,
3775,GO:0008328,1,0.678207927370586,0,18,ionotropic glutamate receptor complex,CC,
3776,GO:0008329,1,0.852176389634945,0,7,signaling pattern recognition receptor activity,MF,
3778,GO:0008331,1,0.934339035717113,0,3,high voltage-gated calcium channel activity,MF,
3779,GO:0008332,1,0.977179450989824,0,1,low voltage-gated calcium channel activity,MF,
3782,GO:0008336,1,0.977163816563072,0,1,gamma-butyrobetaine dioxygenase activity,MF,
3784,GO:0008343,1,0.981337091910749,0,1,adult feeding behavior,BP,
3787,GO:0008348,1,0.977921863160307,0,1,negative regulation of antimicrobial humoral response,BP,
3788,GO:0008349,1,0.807526998899477,0,10,MAP kinase kinase kinase kinase activity,MF,
3789,GO:0008352,1,0.977268493365159,0,1,katanin complex,CC,
3790,GO:0008353,1,0.696463322431889,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3791,GO:0008354,1,0.854915325507755,0,7,germ cell migration,BP,
3792,GO:0008355,1,0.978625972312934,0,1,olfactory learning,BP,
3794,GO:0008358,1,0.977255939027595,0,1,maternal determination of anterior/posterior axis, embryo,BP,
3798,GO:0008373,1,0.735617478813581,0,14,sialyltransferase activity,MF,
3799,GO:0008374,1,0.42887282550523,0,38,O-acyltransferase activity,MF,
3801,GO:0008376,1,0.475967527436767,0,33,acetylgalactosaminyltransferase activity,MF,
3802,GO:0008378,1,0.55452864544274,0,26,galactosyltransferase activity,MF,
3803,GO:0008379,1,0.886889659861803,0,5,thioredoxin peroxidase activity,MF,
3805,GO:0008381,1,0.93456056488628,0,3,mechanosensitive ion channel activity,MF,
3806,GO:0008384,1,0.935015374815608,0,3,IkappaB kinase activity,MF,
3807,GO:0008385,1,0.818397507674922,0,9,IkappaB kinase complex,CC,
3808,GO:0008391,1,0.954932085978955,0,2,arachidonic acid monooxygenase activity,MF,
3809,GO:0008392,1,0.954932085978955,0,2,arachidonic acid epoxygenase activity,MF,
3810,GO:0008395,1,0.832866003178303,0,8,steroid hydroxylase activity,MF,
3811,GO:0008396,1,0.977242564015669,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
3812,GO:0008398,1,0.977432568158039,0,1,sterol 14-demethylase activity,MF,
3813,GO:0008401,1,0.956474451252145,0,2,retinoic acid 4-hydroxylase activity,MF,
3814,GO:0008403,1,0.977497964125548,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3815,GO:0008404,1,0.97715189095406,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3816,GO:0008405,1,0.97715189095406,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
3818,GO:0008408,1,0.357859692990097,0,46,3'-5' exonuclease activity,MF,
3820,GO:0008410,1,0.933812301085201,0,3,CoA-transferase activity,MF,
3821,GO:0008413,1,0.953491609886851,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
3823,GO:0008418,1,0.976411470785858,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
3824,GO:0008419,1,0.977266960423174,0,1,RNA lariat debranching enzyme activity,MF,
3825,GO:0008420,1,0.834734960740187,0,8,CTD phosphatase activity,MF,
3826,GO:0008422,1,0.958261622960658,0,2,beta-glucosidase activity,MF,
3827,GO:0008424,1,0.977585479454205,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3828,GO:0008425,1,0.976624973023742,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3830,GO:0008427,1,0.953978832241373,0,2,calcium-dependent protein kinase inhibitor activity,MF,
3831,GO:0008428,1,0.934516276254071,0,3,ribonuclease inhibitor activity,MF,
3832,GO:0008429,1,0.837650451275308,0,8,phosphatidylethanolamine binding,MF,
3833,GO:0008430,1,0.977102388666805,0,1,selenium binding,MF,
3835,GO:0008432,1,0.839411752056147,0,8,JUN kinase binding,MF,
3836,GO:0008434,1,0.978890092158254,0,1,calcitriol receptor activity,MF,
3837,GO:0008440,1,0.916033935890624,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
3838,GO:0008441,1,0.95846204562281,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
3839,GO:0008442,1,0.977192341549255,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
3840,GO:0008443,1,0.875042917395961,0,6,phosphofructokinase activity,MF,
3841,GO:0008444,1,0.977229204468921,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
3842,GO:0008446,1,0.97704864724505,0,1,GDP-mannose 4,6-dehydratase activity,MF,
3843,GO:0008448,1,0.977141197574411,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
3844,GO:0008449,1,0.958149615410926,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
3845,GO:0008452,1,0.977336572808046,0,1,RNA ligase activity,MF,
3846,GO:0008453,1,0.977336572808046,0,1,alanine-glyoxylate transaminase activity,MF,
3847,GO:0008454,1,0.957652215743869,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
3848,GO:0008455,1,0.977277200092737,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3849,GO:0008456,1,0.977981893603352,0,1,alpha-N-acetylgalactosaminidase activity,MF,
3850,GO:0008457,1,0.978360477457001,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3851,GO:0008458,1,0.977555829770683,0,1,carnitine O-octanoyltransferase activity,MF,
3852,GO:0008459,1,0.958273819138881,0,2,chondroitin 6-sulfotransferase activity,MF,
3853,GO:0008460,1,0.977170383952602,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
3854,GO:0008465,1,0.976589032395952,0,1,glycerate dehydrogenase activity,MF,
3855,GO:0008466,1,0.977127620109969,0,1,glycogenin glucosyltransferase activity,MF,
3856,GO:0008467,1,0.933118148630277,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
3857,GO:0008469,1,0.831611292689771,0,8,histone-arginine N-methyltransferase activity,MF,
3858,GO:0008470,1,0.978813495813653,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3859,GO:0008474,1,0.795785222485378,0,10,palmitoyl-(protein) hydrolase activity,MF,
3860,GO:0008475,1,0.934545515365231,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3861,GO:0008476,1,0.954910553805508,0,2,protein-tyrosine sulfotransferase activity,MF,
3862,GO:0008478,1,0.980896317712718,0,1,pyridoxal kinase activity,MF,
3863,GO:0008479,1,0.910442576783256,0,4,queuine tRNA-ribosyltransferase activity,MF,
3864,GO:0008481,1,0.955038929194623,0,2,sphinganine kinase activity,MF,
3865,GO:0008482,1,0.977239207937073,0,1,sulfite oxidase activity,MF,
3866,GO:0008483,1,0.767339863677957,0,12,transaminase activity,MF,
3867,GO:0008484,1,0.768449077769657,0,12,sulfuric ester hydrolase activity,MF,
3868,GO:0008486,1,0.91310481226447,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3869,GO:0008488,1,0.977496201098925,0,1,gamma-glutamyl carboxylase activity,MF,
3870,GO:0008489,1,0.977340696152359,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3871,GO:0008493,1,0.977153347332236,0,1,tetracycline transmembrane transporter activity,MF,
3872,GO:0008494,1,0.852177471553494,0,7,translation activator activity,MF,
3873,GO:0008495,1,0.977388822753119,0,1,protoheme IX farnesyltransferase activity,MF,
3874,GO:0008496,1,0.978487540910759,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
3875,GO:0008499,1,0.795573646941004,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3876,GO:0008503,1,0.953847653253374,0,2,benzodiazepine receptor activity,MF,
3877,GO:0008504,1,0.915647555784501,0,4,monoamine transmembrane transporter activity,MF,
3878,GO:0008506,1,0.955817062276187,0,2,sucrose:proton symporter activity,MF,
3879,GO:0008507,1,0.977843803940328,0,1,sodium:iodide symporter activity,MF,
3880,GO:0008508,1,0.954588853343886,0,2,bile acid:sodium symporter activity,MF,
3882,GO:0008510,1,0.900150151384382,0,5,sodium:bicarbonate symporter activity,MF,
3883,GO:0008511,1,0.980531452822081,0,1,sodium:potassium:chloride symporter activity,MF,
3884,GO:0008513,1,0.97722930097085,0,1,secondary active organic cation transmembrane transporter activity,MF,
3886,GO:0008515,1,0.955817062276187,0,2,sucrose transmembrane transporter activity,MF,
3887,GO:0008517,1,0.915647420435238,0,4,folic acid transmembrane transporter activity,MF,
3888,GO:0008518,1,0.977315155888289,0,1,reduced folate carrier activity,MF,
3889,GO:0008519,1,0.667751239705621,0,18,ammonium transmembrane transporter activity,MF,
3890,GO:0008520,1,0.980592472679763,0,1,L-ascorbate:sodium symporter activity,MF,
3891,GO:0008521,1,0.977268319780716,0,1,acetyl-CoA transmembrane transporter activity,MF,
3892,GO:0008523,1,0.977597054626655,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3893,GO:0008525,1,0.87954921225491,0,6,phosphatidylcholine transporter activity,MF,
3894,GO:0008526,1,0.839449527643117,0,8,phosphatidylinositol transporter activity,MF,
3895,GO:0008527,1,0.888249260291731,0,5,taste receptor activity,MF,
3896,GO:0008528,1,0.53922781437921,0,27,G-protein coupled peptide receptor activity,MF,
3897,GO:0008531,1,0.977277200092737,0,1,riboflavin kinase activity,MF,
3898,GO:0008532,1,0.813403388966498,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
3899,GO:0008534,1,0.909832305039504,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3900,GO:0008535,1,0.575185305289027,0,24,respiratory chain complex IV assembly,BP,
3901,GO:0008536,1,0.502536651365206,0,32,Ran GTPase binding,MF,
3902,GO:0008537,1,0.931462290817306,0,3,proteasome activator complex,CC,
3903,GO:0008540,1,0.756879672225399,0,12,proteasome regulatory particle, base subcomplex,CC,
3904,GO:0008541,1,0.84985670149606,0,7,proteasome regulatory particle, lid subcomplex,CC,
3905,GO:0008542,1,0.511422347717266,0,31,visual learning,BP,
3908,GO:0008545,1,0.956147081502363,0,2,JUN kinase kinase activity,MF,
3909,GO:0008553,1,0.818554254780509,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3910,GO:0008555,1,0.979415103909916,0,1,chloride-transporting ATPase activity,MF,
3911,GO:0008556,1,0.893887740972581,0,5,potassium-transporting ATPase activity,MF,
3912,GO:0008559,1,0.916955835375731,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
3913,GO:0008565,1,0.20384200708822,0,71,protein transporter activity,MF,
3914,GO:0008568,1,0.800942370380643,0,10,microtubule-severing ATPase activity,MF,
3915,GO:0008569,1,0.825906609158168,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3916,GO:0008574,1,0.608410114620541,0,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,
3917,GO:0008579,1,0.979344375947913,0,1,JUN kinase phosphatase activity,MF,
3918,GO:0008582,1,0.961292349035247,0,2,regulation of synaptic growth at neuromuscular junction,BP,
3921,GO:0008589,1,0.312590685786603,0,54,regulation of smoothened signaling pathway,BP,
3922,GO:0008591,1,0.977125613061449,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
3923,GO:0008592,1,0.977545923000585,0,1,regulation of Toll signaling pathway,BP,
3926,GO:0008595,1,0.821866385896992,0,9,anterior/posterior axis specification, embryo,BP,
3927,GO:0008597,1,0.954825687658901,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
3928,GO:0008603,1,0.891936165637935,0,5,cAMP-dependent protein kinase regulator activity,MF,
3929,GO:0008607,1,0.933503945844289,0,3,phosphorylase kinase regulator activity,MF,
3931,GO:0008609,1,0.981106551600309,0,1,alkylglycerone-phosphate synthase activity,MF,
3933,GO:0008611,1,0.895961369551916,0,5,ether lipid biosynthetic process,BP,
3934,GO:0008612,1,0.912884138573534,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3935,GO:0008614,1,0.955460414317025,0,2,pyridoxine metabolic process,BP,
3936,GO:0008615,1,0.955460414317025,0,2,pyridoxine biosynthetic process,BP,
3937,GO:0008616,1,0.932152143990216,0,3,queuosine biosynthetic process,BP,
3938,GO:0008617,1,0.976252393437505,0,1,guanosine metabolic process,BP,
3939,GO:0008622,1,0.893342895334851,0,5,epsilon DNA polymerase complex,CC,
3940,GO:0008623,1,0.95757481112559,0,2,CHRAC,CC,
3942,GO:0008626,1,0.935305928366044,0,3,granzyme-mediated apoptotic signaling pathway,BP,
3943,GO:0008627,1,0.857900681575698,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3946,GO:0008635,1,0.816353435852129,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3948,GO:0008641,1,0.799069597661478,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3952,GO:0008650,1,0.977832544003,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3953,GO:0008652,1,0.271376169291495,0,58,cellular amino acid biosynthetic process,BP,
3955,GO:0008655,1,0.758045015857493,0,12,pyrimidine-containing compound salvage,BP,
3956,GO:0008656,1,0.731251328729122,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3957,GO:0008670,1,0.954124827878603,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
3958,GO:0008689,1,0.976624973023742,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
3959,GO:0008700,1,0.977336572808046,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3960,GO:0008705,1,0.983098747328444,0,1,methionine synthase activity,MF,
3961,GO:0008709,1,0.97615407253902,0,1,cholate 7-alpha-dehydrogenase activity,MF,
3962,GO:0008721,1,0.977247707407595,0,1,D-serine ammonia-lyase activity,MF,
3963,GO:0008725,1,0.976369312322026,0,1,DNA-3-methyladenine glycosylase activity,MF,
3964,GO:0008732,1,0.954995661654482,0,2,L-allo-threonine aldolase activity,MF,
3965,GO:0008745,1,0.954176976775803,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
3966,GO:0008746,1,0.978856154605981,0,1,NAD(P)+ transhydrogenase activity,MF,
3967,GO:0008747,1,0.97695263295385,0,1,N-acetylneuraminate lyase activity,MF,
3968,GO:0008750,1,0.978856154605981,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3969,GO:0008753,1,0.977722927133916,0,1,NADPH dehydrogenase (quinone) activity,MF,
3971,GO:0008761,1,0.979356721228469,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3972,GO:0008768,1,0.976007773466902,0,1,UDP-sugar diphosphatase activity,MF,
3973,GO:0008775,1,0.977136340876034,0,1,acetate CoA-transferase activity,MF,
3974,GO:0008781,1,0.954217016053482,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
3975,GO:0008783,1,0.977229587547401,0,1,agmatinase activity,MF,
3976,GO:0008785,1,0.976958047958631,0,1,alkyl hydroperoxide reductase activity,MF,
3977,GO:0008792,1,0.977336572808046,0,1,arginine decarboxylase activity,MF,
3978,GO:0008794,1,0.976086380226651,0,1,arsenate reductase (glutaredoxin) activity,MF,
3979,GO:0008796,1,0.954043533057798,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
3980,GO:0008798,1,0.979683877602165,0,1,beta-aspartyl-peptidase activity,MF,
3981,GO:0008802,1,0.977824130376218,0,1,betaine-aldehyde dehydrogenase activity,MF,
3982,GO:0008803,1,0.976215422094742,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
3983,GO:0008808,1,0.978052764708119,0,1,cardiolipin synthase activity,MF,
3984,GO:0008817,1,0.978380206127441,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3985,GO:0008821,1,0.814077882274977,0,9,crossover junction endodeoxyribonuclease activity,MF,
3986,GO:0008823,1,0.895869228814857,0,5,cupric reductase activity,MF,
3987,GO:0008832,1,0.977516963269521,0,1,dGTPase activity,MF,
3988,GO:0008841,1,0.977248508865168,0,1,dihydrofolate synthase activity,MF,
3989,GO:0008852,1,0.977312993489896,0,1,exodeoxyribonuclease I activity,MF,
3990,GO:0008853,1,0.934521318950077,0,3,exodeoxyribonuclease III activity,MF,
3991,GO:0008859,1,0.976161503092202,0,1,exoribonuclease II activity,MF,
3993,GO:0008887,1,0.977545166083941,0,1,glycerate kinase activity,MF,
3994,GO:0008889,1,0.935770090704715,0,3,glycerophosphodiester phosphodiesterase activity,MF,
3995,GO:0008890,1,0.97697482644469,0,1,glycine C-acetyltransferase activity,MF,
3996,GO:0008892,1,0.979461680775088,0,1,guanine deaminase activity,MF,
3997,GO:0008893,1,0.976301408164014,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
3998,GO:0008894,1,0.977284302470422,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3999,GO:0008897,1,0.977323851811228,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4000,GO:0008900,1,0.977840984579522,0,1,potassium:proton exchanging ATPase activity,MF,
4001,GO:0008903,1,0.976404003908319,0,1,hydroxypyruvate isomerase activity,MF,
4002,GO:0008905,1,0.976992711783788,0,1,mannose-phosphate guanylyltransferase activity,MF,
4003,GO:0008934,1,0.915628296581455,0,4,inositol monophosphate 1-phosphatase activity,MF,
4004,GO:0008940,1,0.934643470776916,0,3,nitrate reductase activity,MF,
4005,GO:0008941,1,0.954951169470876,0,2,nitric oxide dioxygenase activity,MF,
4006,GO:0008948,1,0.913611594401603,0,4,oxaloacetate decarboxylase activity,MF,
4007,GO:0008962,1,0.954972503133421,0,2,phosphatidylglycerophosphatase activity,MF,
4008,GO:0008963,1,0.977223816792192,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4009,GO:0008967,1,0.955184441869974,0,2,phosphoglycolate phosphatase activity,MF,
4010,GO:0008970,1,0.85321613753844,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4011,GO:0008973,1,0.977552004854401,0,1,phosphopentomutase activity,MF,
4012,GO:0008988,1,0.955184890372083,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4013,GO:0008995,1,0.977258170732843,0,1,ribonuclease E activity,MF,
4014,GO:0009000,1,0.977246741726947,0,1,selenocysteine lyase activity,MF,
4015,GO:0009007,1,0.977931496380103,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4016,GO:0009008,1,0.895369437321541,0,5,DNA-methyltransferase activity,MF,
4017,GO:0009013,1,0.979243290333626,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4018,GO:0009019,1,0.914241459383191,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4019,GO:0009020,1,0.977186760389047,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4020,GO:0009032,1,0.977036949778233,0,1,thymidine phosphorylase activity,MF,
4021,GO:0009041,1,0.932710945368719,0,3,uridylate kinase activity,MF,
4023,GO:0009051,1,0.932289682995085,0,3,pentose-phosphate shunt, oxidative branch,BP,
4024,GO:0009052,1,0.89132357622284,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4030,GO:0009060,1,0.206140898922942,0,68,aerobic respiration,BP,
4031,GO:0009061,1,0.977242618752739,0,1,anaerobic respiration,BP,
4032,GO:0009062,1,0.137336525802468,0,88,fatty acid catabolic process,BP,
4036,GO:0009066,1,0.397228811670492,0,41,aspartate family amino acid metabolic process,BP,
4037,GO:0009067,1,0.623769045715088,0,21,aspartate family amino acid biosynthetic process,BP,
4038,GO:0009068,1,0.761861428279768,0,12,aspartate family amino acid catabolic process,BP,
4039,GO:0009069,1,0.492796138403327,0,31,serine family amino acid metabolic process,BP,
4040,GO:0009070,1,0.724516888711875,0,14,serine family amino acid biosynthetic process,BP,
4041,GO:0009071,1,0.851143154487682,0,7,serine family amino acid catabolic process,BP,
4042,GO:0009072,1,0.777379835986208,0,11,aromatic amino acid family metabolic process,BP,
4043,GO:0009074,1,0.829440012101212,0,8,aromatic amino acid family catabolic process,BP,
4044,GO:0009078,1,0.978170959920368,0,1,pyruvate family amino acid metabolic process,BP,
4045,GO:0009080,1,0.978170959920368,0,1,pyruvate family amino acid catabolic process,BP,
4046,GO:0009081,1,0.600106372103032,0,23,branched-chain amino acid metabolic process,BP,
4047,GO:0009082,1,0.958952381526928,0,2,branched-chain amino acid biosynthetic process,BP,
4048,GO:0009083,1,0.640068861116889,0,20,branched-chain amino acid catabolic process,BP,
4049,GO:0009084,1,0.731671953893915,0,14,glutamine family amino acid biosynthetic process,BP,
4050,GO:0009085,1,0.957580312632139,0,2,lysine biosynthetic process,BP,
4051,GO:0009086,1,0.782309973535582,0,11,methionine biosynthetic process,BP,
4052,GO:0009088,1,0.977219791568534,0,1,threonine biosynthetic process,BP,
4053,GO:0009092,1,0.912014008824347,0,4,homoserine metabolic process,BP,
4054,GO:0009093,1,0.977259564888281,0,1,cysteine catabolic process,BP,
4055,GO:0009098,1,0.958952381526928,0,2,leucine biosynthetic process,BP,
4056,GO:0009099,1,0.958952381526928,0,2,valine biosynthetic process,BP,
4059,GO:0009106,1,0.955399881417546,0,2,lipoate metabolic process,BP,
4060,GO:0009107,1,0.977047568657905,0,1,lipoate biosynthetic process,BP,
4062,GO:0009109,1,0.779101638596908,0,11,coenzyme catabolic process,BP,
4064,GO:0009111,1,0.833088122041802,0,8,vitamin catabolic process,BP,
4065,GO:0009112,1,0.453923034705375,0,35,nucleobase metabolic process,BP,
4066,GO:0009113,1,0.741616753932921,0,13,purine nucleobase biosynthetic process,BP,
4067,GO:0009115,1,0.959207939564463,0,2,xanthine catabolic process,BP,
4071,GO:0009120,1,0.87134430171521,0,6,deoxyribonucleoside metabolic process,BP,
4074,GO:0009125,1,0.815223779234951,0,9,nucleoside monophosphate catabolic process,BP,
4077,GO:0009128,1,0.834141013919065,0,8,purine nucleoside monophosphate catabolic process,BP,
4078,GO:0009129,1,0.725885727855177,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4079,GO:0009130,1,0.725885727855177,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4081,GO:0009133,1,0.910444695826706,0,4,nucleoside diphosphate biosynthetic process,BP,
4082,GO:0009134,1,0.852409654536346,0,7,nucleoside diphosphate catabolic process,BP,
4084,GO:0009136,1,0.953994344005048,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4085,GO:0009137,1,0.913877091467208,0,4,purine nucleoside diphosphate catabolic process,BP,
4086,GO:0009138,1,0.932742096149821,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4087,GO:0009139,1,0.954358089954436,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4088,GO:0009140,1,0.977354156610639,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4091,GO:0009143,1,0.778642587510237,0,11,nucleoside triphosphate catabolic process,BP,
4094,GO:0009146,1,0.871167082267924,0,6,purine nucleoside triphosphate catabolic process,BP,
4097,GO:0009149,1,0.954108446105776,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4099,GO:0009151,1,0.811732255612519,0,9,purine deoxyribonucleotide metabolic process,BP,
4101,GO:0009153,1,0.953968385172898,0,2,purine deoxyribonucleotide biosynthetic process,BP,
4102,GO:0009154,1,0.600959623883753,0,23,purine ribonucleotide catabolic process,BP,
4103,GO:0009155,1,0.871634698758651,0,6,purine deoxyribonucleotide catabolic process,BP,
4105,GO:0009157,1,0.812863000355103,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4106,GO:0009158,1,0.834141013919065,0,8,ribonucleoside monophosphate catabolic process,BP,
4107,GO:0009159,1,0.977336572808046,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4109,GO:0009162,1,0.775517887015238,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4111,GO:0009164,1,0.628884478201298,0,20,nucleoside catabolic process,BP,
4116,GO:0009169,1,0.834141013919065,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4117,GO:0009170,1,0.976218657093727,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4118,GO:0009173,1,0.815046709604301,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4119,GO:0009174,1,0.815046709604301,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4120,GO:0009176,1,0.890685564019636,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4121,GO:0009177,1,0.890685564019636,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4123,GO:0009180,1,0.953994344005048,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4124,GO:0009181,1,0.913877091467208,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4125,GO:0009182,1,0.953680757613498,0,2,purine deoxyribonucleoside diphosphate metabolic process,BP,
4126,GO:0009183,1,0.976218657093727,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4127,GO:0009184,1,0.976915124173167,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4129,GO:0009186,1,0.910145372631458,0,4,deoxyribonucleoside diphosphate metabolic process,BP,
4131,GO:0009188,1,0.953994344005048,0,2,ribonucleoside diphosphate biosynthetic process,BP,
4132,GO:0009189,1,0.931658239307333,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
4134,GO:0009191,1,0.872217951137066,0,6,ribonucleoside diphosphate catabolic process,BP,
4135,GO:0009192,1,0.976915124173167,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4136,GO:0009193,1,0.977354156610639,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4137,GO:0009195,1,0.977354156610639,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4138,GO:0009196,1,0.954358089954436,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4139,GO:0009197,1,0.954358089954436,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4141,GO:0009200,1,0.706732602831894,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4143,GO:0009202,1,0.889883049056331,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4144,GO:0009203,1,0.976391248641661,0,1,ribonucleoside triphosphate catabolic process,BP,
4145,GO:0009204,1,0.851277240732906,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4148,GO:0009207,1,0.976391248641661,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4151,GO:0009211,1,0.868838861863417,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4152,GO:0009212,1,0.910644085720014,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4153,GO:0009213,1,0.954108446105776,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4154,GO:0009214,1,0.792542949933699,0,11,cyclic nucleotide catabolic process,BP,
4155,GO:0009215,1,0.830927303495403,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4156,GO:0009216,1,0.977209732806107,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4157,GO:0009217,1,0.892240686383137,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4159,GO:0009219,1,0.657289919551717,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4161,GO:0009221,1,0.830192330603649,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4162,GO:0009222,1,0.977354156610639,0,1,pyrimidine ribonucleotide catabolic process,BP,
4163,GO:0009223,1,0.7737573604591,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4164,GO:0009224,1,0.976598435848024,0,1,CMP biosynthetic process,BP,
4166,GO:0009226,1,0.620975087539763,0,21,nucleotide-sugar biosynthetic process,BP,
4168,GO:0009231,1,0.977277200092737,0,1,riboflavin biosynthetic process,BP,
4169,GO:0009233,1,0.955911405881871,0,2,menaquinone metabolic process,BP,
4170,GO:0009234,1,0.977905537403098,0,1,menaquinone biosynthetic process,BP,
4171,GO:0009235,1,0.767066627862146,0,12,cobalamin metabolic process,BP,
4172,GO:0009236,1,0.93690869356278,0,3,cobalamin biosynthetic process,BP,
4173,GO:0009237,1,0.977350409268411,0,1,siderophore metabolic process,BP,
4174,GO:0009240,1,0.890122115637635,0,5,isopentenyl diphosphate biosynthetic process,BP,
4175,GO:0009245,1,0.951850414874843,0,2,lipid A biosynthetic process,BP,
4176,GO:0009247,1,0.298546586277195,0,53,glycolipid biosynthetic process,BP,
4177,GO:0009249,1,0.846406748539276,0,7,protein lipoylation,BP,
4180,GO:0009253,1,0.954176976775803,0,2,peptidoglycan catabolic process,BP,
4181,GO:0009256,1,0.916585619828603,0,4,10-formyltetrahydrofolate metabolic process,BP,
4182,GO:0009257,1,0.95610644832085,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4183,GO:0009258,1,0.981000204728113,0,1,10-formyltetrahydrofolate catabolic process,BP,
4186,GO:0009261,1,0.587324609525377,0,24,ribonucleotide catabolic process,BP,
4187,GO:0009262,1,0.487497280589212,0,31,deoxyribonucleotide metabolic process,BP,
4188,GO:0009263,1,0.740938022697619,0,13,deoxyribonucleotide biosynthetic process,BP,
4189,GO:0009264,1,0.658867463089236,0,18,deoxyribonucleotide catabolic process,BP,
4190,GO:0009265,1,0.791951141725729,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4193,GO:0009268,1,0.607379460061645,0,22,response to pH,BP,
4194,GO:0009295,1,0.405836755856244,0,40,nucleoid,CC,
4195,GO:0009298,1,0.911107610357217,0,4,GDP-mannose biosynthetic process,BP,
4196,GO:0009299,1,0.645981319132394,0,20,mRNA transcription,BP,
4197,GO:0009301,1,0.21855843907136,0,67,snRNA transcription,BP,
4199,GO:0009304,1,0.855424791975195,0,7,tRNA transcription,BP,
4200,GO:0009305,1,0.979895406366628,0,1,protein biotinylation,BP,
4202,GO:0009308,1,0.119642835325099,0,92,amine metabolic process,BP,
4203,GO:0009309,1,0.740592244231683,0,13,amine biosynthetic process,BP,
4204,GO:0009310,1,0.760304412566105,0,12,amine catabolic process,BP,
4207,GO:0009313,1,0.815307078928417,0,9,oligosaccharide catabolic process,BP,
4209,GO:0009328,1,0.912105168789561,0,4,phenylalanine-tRNA ligase complex,CC,
4210,GO:0009330,1,0.958123139430925,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4211,GO:0009331,1,0.958430181919312,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4212,GO:0009346,1,0.978581066454552,0,1,citrate lyase complex,CC,
4213,GO:0009353,1,0.976701580238665,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4214,GO:0009360,1,0.977275933574193,0,1,DNA polymerase III complex,CC,
4215,GO:0009368,1,0.954241521724729,0,2,endopeptidase Clp complex,CC,
4216,GO:0009372,1,0.97757836626664,0,1,quorum sensing,BP,
4217,GO:0009374,1,0.899198507244835,0,5,biotin binding,MF,
4218,GO:0009378,1,0.896949654444717,0,5,four-way junction helicase activity,MF,
4219,GO:0009383,1,0.95641034572637,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4220,GO:0009384,1,0.979356721228469,0,1,N-acylmannosamine kinase activity,MF,
4221,GO:0009386,1,0.977237726899621,0,1,translational attenuation,BP,
4222,GO:0009394,1,0.533367837014005,0,27,2'-deoxyribonucleotide metabolic process,BP,
4223,GO:0009395,1,0.532641261059844,0,28,phospholipid catabolic process,BP,
4224,GO:0009396,1,0.813105612580867,0,9,folic acid-containing compound biosynthetic process,BP,
4225,GO:0009397,1,0.937269882184007,0,3,folic acid-containing compound catabolic process,BP,
4226,GO:0009398,1,0.977277200092737,0,1,FMN biosynthetic process,BP,
4227,GO:0009400,1,0.977317734472646,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4228,GO:0009403,1,0.894490622198753,0,5,toxin biosynthetic process,BP,
4230,GO:0009405,1,0.959709260846214,0,2,pathogenesis,BP,
4231,GO:0009407,1,0.91034552549741,0,4,toxin catabolic process,BP,
4236,GO:0009414,1,0.87098558557342,0,6,response to water deprivation,BP,
4237,GO:0009415,1,0.801718891655069,0,10,response to water,BP,
4240,GO:0009436,1,0.977336572808046,0,1,glyoxylate catabolic process,BP,
4241,GO:0009437,1,0.759892174897139,0,12,carnitine metabolic process,BP,
4242,GO:0009438,1,0.890050351822067,0,5,methylglyoxal metabolic process,BP,
4243,GO:0009439,1,0.9538415903895,0,2,cyanate metabolic process,BP,
4244,GO:0009440,1,0.9538415903895,0,2,cyanate catabolic process,BP,
4245,GO:0009441,1,0.957388358830467,0,2,glycolate metabolic process,BP,
4246,GO:0009443,1,0.980896317712718,0,1,pyridoxal 5'-phosphate salvage,BP,
4247,GO:0009444,1,0.979364042009095,0,1,pyruvate oxidation,BP,
4248,GO:0009445,1,0.85047884472949,0,7,putrescine metabolic process,BP,
4249,GO:0009446,1,0.892296642868628,0,5,putrescine biosynthetic process,BP,
4250,GO:0009447,1,0.931287516042741,0,3,putrescine catabolic process,BP,
4251,GO:0009448,1,0.91620718840662,0,4,gamma-aminobutyric acid metabolic process,BP,
4252,GO:0009449,1,0.935632655111421,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4253,GO:0009450,1,0.958731225639918,0,2,gamma-aminobutyric acid catabolic process,BP,
4255,GO:0009452,1,0.470576831956568,0,33,7-methylguanosine RNA capping,BP,
4257,GO:0009581,1,0.362871049235501,0,47,detection of external stimulus,BP,
4258,GO:0009582,1,0.355312546105101,0,48,detection of abiotic stimulus,BP,
4259,GO:0009583,1,0.534381058762285,0,28,detection of light stimulus,BP,
4260,GO:0009584,1,0.611583804657638,0,22,detection of visible light,BP,
4261,GO:0009593,1,0.578142381618457,0,24,detection of chemical stimulus,BP,
4262,GO:0009595,1,0.818346155258411,0,9,detection of biotic stimulus,BP,
4263,GO:0009597,1,0.893303366024835,0,5,detection of virus,BP,
4266,GO:0009608,1,0.955187327987785,0,2,response to symbiont,BP,
4267,GO:0009609,1,0.955187327987785,0,2,response to symbiotic bacterium,BP,
4273,GO:0009624,1,0.97726049325861,0,1,response to nematode,BP,
4276,GO:0009631,1,0.979208733901174,0,1,cold acclimation,BP,
4277,GO:0009635,1,0.758765246869267,0,12,response to herbicide,BP,
4279,GO:0009637,1,0.956429761191157,0,2,response to blue light,BP,
4280,GO:0009642,1,0.855845861026156,0,7,response to light intensity,BP,
4281,GO:0009644,1,0.957017992964128,0,2,response to high light intensity,BP,
4282,GO:0009645,1,0.977751570891526,0,1,response to low light intensity stimulus,BP,
4283,GO:0009646,1,0.977587862754326,0,1,response to absence of light,BP,
4286,GO:0009650,1,0.761387011150847,0,12,UV protection,BP,
4287,GO:0009651,1,0.712838138679676,0,15,response to salt stress,BP,
4289,GO:0009669,1,0.955817062276187,0,2,sucrose:cation symporter activity,MF,
4290,GO:0009674,1,0.980531452822081,0,1,potassium:sodium symporter activity,MF,
4291,GO:0009692,1,0.97726049325861,0,1,ethylene metabolic process,BP,
4292,GO:0009698,1,0.97726049325861,0,1,phenylpropanoid metabolic process,BP,
4293,GO:0009712,1,0.556894482353321,0,26,catechol-containing compound metabolic process,BP,
4294,GO:0009713,1,0.79626540580138,0,10,catechol-containing compound biosynthetic process,BP,
4296,GO:0009720,1,0.977381018028125,0,1,detection of hormone stimulus,BP,
4298,GO:0009726,1,0.957022787425672,0,2,detection of endogenous stimulus,BP,
4299,GO:0009737,1,0.978577042266034,0,1,response to abscisic acid,BP,
4300,GO:0009738,1,0.978577042266034,0,1,abscisic acid-activated signaling pathway,BP,
4302,GO:0009744,1,0.935408749921763,0,3,response to sucrose,BP,
4305,GO:0009750,1,0.913299332105524,0,4,response to fructose,BP,
4308,GO:0009756,1,0.871968746354361,0,6,carbohydrate mediated signaling,BP,
4309,GO:0009757,1,0.892281991670272,0,5,hexose mediated signaling,BP,
4310,GO:0009758,1,0.981876921102702,0,1,carbohydrate utilization,BP,
4311,GO:0009785,1,0.956429761191157,0,2,blue light signaling pathway,BP,
4312,GO:0009786,1,0.96048763604261,0,2,regulation of asymmetric cell division,BP,
4313,GO:0009787,1,0.978577042266034,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4314,GO:0009789,1,0.978577042266034,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4319,GO:0009798,1,0.310888906811842,0,54,axis specification,BP,
4320,GO:0009799,1,0.193991792276031,0,75,specification of symmetry,BP,
4321,GO:0009804,1,0.97726049325861,0,1,coumarin metabolic process,BP,
4322,GO:0009810,1,0.977230511923351,0,1,stilbene metabolic process,BP,
4323,GO:0009812,1,0.811995850754023,0,9,flavonoid metabolic process,BP,
4324,GO:0009814,1,0.977229869789122,0,1,defense response, incompatible interaction,BP,
4325,GO:0009817,1,0.977229869789122,0,1,defense response to fungus, incompatible interaction,BP,
4326,GO:0009820,1,0.912006939802572,0,4,alkaloid metabolic process,BP,
4327,GO:0009822,1,0.97707405710445,0,1,alkaloid catabolic process,BP,
4328,GO:0009826,1,0.957892146231249,0,2,unidimensional cell growth,BP,
4329,GO:0009838,1,0.890638265890949,0,5,abscission,BP,
4330,GO:0009841,1,0.977240568802332,0,1,mitochondrial endopeptidase Clp complex,CC,
4331,GO:0009850,1,0.977136340876034,0,1,auxin metabolic process,BP,
4332,GO:0009852,1,0.977136340876034,0,1,auxin catabolic process,BP,
4333,GO:0009855,1,0.198563252328029,0,74,determination of bilateral symmetry,BP,
4334,GO:0009880,1,0.466204610176353,0,36,embryonic pattern specification,BP,
4335,GO:0009881,1,0.913569680236702,0,4,photoreceptor activity,MF,
4336,GO:0009882,1,0.956429761191157,0,2,blue light photoreceptor activity,MF,
4337,GO:0009886,1,0.806812029028308,0,10,post-embryonic animal morphogenesis,BP,
4348,GO:0009897,1,0.0891758937483717,0,108,external side of plasma membrane,CC,
4353,GO:0009918,1,0.977267548769485,0,1,sterol delta7 reductase activity,MF,
4354,GO:0009922,1,0.892309679212437,0,5,fatty acid elongase activity,MF,
4355,GO:0009925,1,0.645454034603749,0,21,basal plasma membrane,CC,
4356,GO:0009931,1,0.855530557955928,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4357,GO:0009948,1,0.544410769569952,0,28,anterior/posterior axis specification,BP,
4358,GO:0009950,1,0.794388401549453,0,11,dorsal/ventral axis specification,BP,
4362,GO:0009955,1,0.977230147772224,0,1,adaxial/abaxial pattern specification,BP,
4364,GO:0009957,1,0.958882513767064,0,2,epidermal cell fate specification,BP,
4368,GO:0009972,1,0.869372574426837,0,6,cytidine deamination,BP,
4369,GO:0009975,1,0.828403522356222,0,9,cyclase activity,MF,
4370,GO:0009982,1,0.741688560838334,0,13,pseudouridine synthase activity,MF,
4373,GO:0009988,1,0.551326184938813,0,26,cell-cell recognition,BP,
4375,GO:0009992,1,0.977227748373361,0,1,cellular water homeostasis,BP,
4376,GO:0009994,1,0.528403761764481,0,29,oocyte differentiation,BP,
4377,GO:0009996,1,0.955722197596294,0,2,negative regulation of cell fate specification,BP,
4379,GO:0010002,1,0.840554678773548,0,8,cardioblast differentiation,BP,
4381,GO:0010009,1,0.891465867719548,0,5,cytoplasmic side of endosome membrane,CC,
4382,GO:0010015,1,0.97585624064459,0,1,root morphogenesis,BP,
4383,GO:0010025,1,0.957027150185686,0,2,wax biosynthetic process,BP,
4384,GO:0010032,1,0.900666562192385,0,5,meiotic chromosome condensation,BP,
4386,GO:0010034,1,0.977800908016924,0,1,response to acetate,BP,
4389,GO:0010039,1,0.585483329412525,0,24,response to iron ion,BP,
4390,GO:0010040,1,0.911756230512781,0,4,response to iron(II) ion,BP,
4391,GO:0010041,1,0.894356873735583,0,5,response to iron(III) ion,BP,
4392,GO:0010042,1,0.76600806919382,0,12,response to manganese ion,BP,
4394,GO:0010044,1,0.91225879483695,0,4,response to aluminum ion,BP,
4395,GO:0010046,1,0.912195362776855,0,4,response to mycotoxin,BP,
4396,GO:0010053,1,0.97585624064459,0,1,root epidermal cell differentiation,BP,
4397,GO:0010054,1,0.97585624064459,0,1,trichoblast differentiation,BP,
4398,GO:0010070,1,0.977243620331862,0,1,zygote asymmetric cell division,BP,
4400,GO:0010106,1,0.977182886223586,0,1,cellular response to iron ion starvation,BP,
4401,GO:0010107,1,0.673564408983453,0,18,potassium ion import,BP,
4402,GO:0010121,1,0.977193272419246,0,1,arginine catabolic process to proline via ornithine,BP,
4403,GO:0010124,1,0.977136340876034,0,1,phenylacetate catabolic process,BP,
4405,GO:0010138,1,0.911200675888666,0,4,pyrimidine ribonucleotide salvage,BP,
4406,GO:0010139,1,0.977001800900464,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4407,GO:0010142,1,0.977751570891526,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4408,GO:0010155,1,0.813238841081942,0,9,regulation of proton transport,BP,
4409,GO:0010157,1,0.981216035439939,0,1,response to chlorate,BP,
4410,GO:0010159,1,0.935047189772863,0,3,specification of animal organ position,BP,
4411,GO:0010160,1,0.976225115676963,0,1,formation of animal organ boundary,BP,
4412,GO:0010164,1,0.977001800900464,0,1,response to cesium ion,BP,
4413,GO:0010165,1,0.487468226486146,0,33,response to X-ray,BP,
4414,GO:0010166,1,0.957027150185686,0,2,wax metabolic process,BP,
4416,GO:0010172,1,0.811045992617056,0,10,embryonic body morphogenesis,BP,
4417,GO:0010181,1,0.799356307068911,0,10,FMN binding,MF,
4418,GO:0010182,1,0.892281991670272,0,5,sugar mediated signaling pathway,BP,
4419,GO:0010189,1,0.97704900594132,0,1,vitamin E biosynthetic process,BP,
4420,GO:0010193,1,0.954971505704271,0,2,response to ozone,BP,
4422,GO:0010216,1,0.877292338969619,0,6,maintenance of DNA methylation,BP,
4423,GO:0010224,1,0.729679650197822,0,14,response to UV-B,BP,
4424,GO:0010225,1,0.755718610980005,0,13,response to UV-C,BP,
4426,GO:0010232,1,0.977465363898827,0,1,vascular transport,BP,
4428,GO:0010248,1,0.870828284323416,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4429,GO:0010255,1,0.892281991670272,0,5,glucose mediated signaling pathway,BP,
4431,GO:0010257,1,0.267603084063124,0,55,NADH dehydrogenase complex assembly,BP,
4433,GO:0010260,1,0.977336572808046,0,1,animal organ senescence,BP,
4434,GO:0010265,1,0.874452750258699,0,6,SCF complex assembly,BP,
4435,GO:0010266,1,0.935633741988486,0,3,response to vitamin B1,BP,
4436,GO:0010269,1,0.932233688359592,0,3,response to selenium ion,BP,
4437,GO:0010273,1,0.888728432908975,0,5,detoxification of copper ion,BP,
4438,GO:0010286,1,0.88984290151045,0,5,heat acclimation,BP,
4439,GO:0010288,1,0.63872270389336,0,20,response to lead ion,BP,
4440,GO:0010309,1,0.977046486326053,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4441,GO:0010310,1,0.796970267241214,0,10,regulation of hydrogen peroxide metabolic process,BP,
4442,GO:0010314,1,0.806390795306392,0,10,phosphatidylinositol-5-phosphate binding,MF,
4445,GO:0010335,1,0.978702271597768,0,1,response to non-ionic osmotic stress,BP,
4446,GO:0010340,1,0.853964717941893,0,7,carboxyl-O-methyltransferase activity,MF,
4447,GO:0010348,1,0.977336572808046,0,1,lithium:proton antiporter activity,MF,
4448,GO:0010359,1,0.873646442493285,0,6,regulation of anion channel activity,BP,
4449,GO:0010360,1,0.93491676072831,0,3,negative regulation of anion channel activity,BP,
4450,GO:0010369,1,0.7511525953214,0,13,chromocenter,CC,
4451,GO:0010370,1,0.955784009284795,0,2,perinucleolar chromocenter,CC,
4452,GO:0010385,1,0.894115038417194,0,5,double-stranded methylated DNA binding,MF,
4453,GO:0010387,1,0.977236761020266,0,1,COP9 signalosome assembly,BP,
4456,GO:0010412,1,0.977611209058413,0,1,mannan metabolic process,BP,
4457,GO:0010420,1,0.976624973023742,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4458,GO:0010421,1,0.780984223346874,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4459,GO:0010428,1,0.979810531285133,0,1,methyl-CpNpG binding,MF,
4460,GO:0010430,1,0.978882989247659,0,1,fatty acid omega-oxidation,BP,
4461,GO:0010447,1,0.780425951254686,0,11,response to acidic pH,BP,
4462,GO:0010452,1,0.831096794121829,0,9,histone H3-K36 methylation,BP,
4463,GO:0010453,1,0.748385168694363,0,13,regulation of cell fate commitment,BP,
4464,GO:0010454,1,0.934184274389404,0,3,negative regulation of cell fate commitment,BP,
4465,GO:0010455,1,0.91408455398643,0,4,positive regulation of cell fate commitment,BP,
4466,GO:0010457,1,0.794139809441173,0,11,centriole-centriole cohesion,BP,
4467,GO:0010458,1,0.558372377644387,0,26,exit from mitosis,BP,
4468,GO:0010459,1,0.910975042095471,0,4,negative regulation of heart rate,BP,
4469,GO:0010460,1,0.800218357832537,0,10,positive regulation of heart rate,BP,
4472,GO:0010465,1,0.980641773285771,0,1,nerve growth factor receptor activity,MF,
4477,GO:0010470,1,0.605282208386044,0,23,regulation of gastrulation,BP,
4478,GO:0010477,1,0.977552768382949,0,1,response to sulfur dioxide,BP,
4479,GO:0010481,1,0.934328658298543,0,3,epidermal cell division,BP,
4480,GO:0010482,1,0.934328658298543,0,3,regulation of epidermal cell division,BP,
4482,GO:0010485,1,0.673952052339655,0,18,H4 histone acetyltransferase activity,MF,
4483,GO:0010494,1,0.419563509362515,0,40,cytoplasmic stress granule,CC,
4485,GO:0010499,1,0.59626074484095,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4486,GO:0010501,1,0.397327774165343,0,41,RNA secondary structure unwinding,BP,
4490,GO:0010509,1,0.979536052513124,0,1,polyamine homeostasis,BP,
4491,GO:0010510,1,0.786871726725378,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4492,GO:0010511,1,0.911707430646173,0,4,regulation of phosphatidylinositol biosynthetic process,BP,
4493,GO:0010512,1,0.955136860941441,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4494,GO:0010513,1,0.954538332297647,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
4496,GO:0010518,1,0.577383508147755,0,25,positive regulation of phospholipase activity,BP,
4498,GO:0010520,1,0.955259375806073,0,2,regulation of reciprocal meiotic recombination,BP,
4499,GO:0010521,1,0.933445945579757,0,3,telomerase inhibitor activity,MF,
4500,GO:0010522,1,0.30787710637575,0,54,regulation of calcium ion transport into cytosol,BP,
4501,GO:0010523,1,0.74521919648948,0,13,negative regulation of calcium ion transport into cytosol,BP,
4502,GO:0010524,1,0.550786963148451,0,27,positive regulation of calcium ion transport into cytosol,BP,
4506,GO:0010536,1,0.953421617296278,0,2,positive regulation of activation of Janus kinase activity,BP,
4507,GO:0010543,1,0.624997191760102,0,21,regulation of platelet activation,BP,
4508,GO:0010544,1,0.729050177370051,0,14,negative regulation of platelet activation,BP,
4512,GO:0010559,1,0.538345814841639,0,28,regulation of glycoprotein biosynthetic process,BP,
4513,GO:0010560,1,0.736733039949711,0,14,positive regulation of glycoprotein biosynthetic process,BP,
4514,GO:0010561,1,0.779722946223668,0,11,negative regulation of glycoprotein biosynthetic process,BP,
4519,GO:0010566,1,0.834573995226047,0,8,regulation of ketone biosynthetic process,BP,
4520,GO:0010569,1,0.576342780218445,0,25,regulation of double-strand break repair via homologous recombination,BP,
4521,GO:0010571,1,0.882567481500503,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4522,GO:0010572,1,0.955129878011043,0,2,positive regulation of platelet activation,BP,
4526,GO:0010585,1,0.977176859905498,0,1,glutamine secretion,BP,
4528,GO:0010587,1,0.895597557422949,0,5,miRNA catabolic process,BP,
4529,GO:0010591,1,0.57955882879057,0,25,regulation of lamellipodium assembly,BP,
4530,GO:0010592,1,0.738626125887115,0,14,positive regulation of lamellipodium assembly,BP,
4531,GO:0010593,1,0.959644629088161,0,2,negative regulation of lamellipodium assembly,BP,
4535,GO:0010603,1,0.864993757212755,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4538,GO:0010606,1,0.903487956787105,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4540,GO:0010609,1,0.955042867649173,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4542,GO:0010612,1,0.881478495938887,0,6,regulation of cardiac muscle adaptation,BP,
4543,GO:0010613,1,0.637739524992051,0,21,positive regulation of cardiac muscle hypertrophy,BP,
4545,GO:0010615,1,0.97883677363974,0,1,positive regulation of cardiac muscle adaptation,BP,
4546,GO:0010616,1,0.900544356316392,0,5,negative regulation of cardiac muscle adaptation,BP,
4548,GO:0010623,1,0.860065367779385,0,7,programmed cell death involved in cell development,BP,
4549,GO:0010624,1,0.920470960315902,0,4,regulation of Schwann cell proliferation,BP,
4550,GO:0010626,1,0.920470960315902,0,4,negative regulation of Schwann cell proliferation,BP,
4557,GO:0010635,1,0.835285408011849,0,8,regulation of mitochondrial fusion,BP,
4558,GO:0010636,1,0.957870183254828,0,2,positive regulation of mitochondrial fusion,BP,
4559,GO:0010637,1,0.892326107317216,0,5,negative regulation of mitochondrial fusion,BP,
4562,GO:0010640,1,0.705842053136072,0,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4563,GO:0010641,1,0.917709675307196,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4564,GO:0010642,1,0.786298101862104,0,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4565,GO:0010643,1,0.933858905772147,0,3,cell communication by chemical coupling,BP,
4566,GO:0010644,1,0.658510034719553,0,19,cell communication by electrical coupling,BP,
4567,GO:0010645,1,0.955461677033048,0,2,regulation of cell communication by chemical coupling,BP,
4571,GO:0010649,1,0.824575348321731,0,9,regulation of cell communication by electrical coupling,BP,
4572,GO:0010650,1,0.982675003825129,0,1,positive regulation of cell communication by electrical coupling,BP,
4573,GO:0010652,1,0.955461677033048,0,2,positive regulation of cell communication by chemical coupling,BP,
4577,GO:0010659,1,0.643938333438,0,20,cardiac muscle cell apoptotic process,BP,
4579,GO:0010661,1,0.717851168810178,0,15,positive regulation of muscle cell apoptotic process,BP,
4581,GO:0010663,1,0.876999473758001,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4583,GO:0010665,1,0.671807103869812,0,18,regulation of cardiac muscle cell apoptotic process,BP,
4584,GO:0010666,1,0.876999473758001,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4585,GO:0010667,1,0.766129889594591,0,12,negative regulation of cardiac muscle cell apoptotic process,BP,
4586,GO:0010668,1,0.895407753371255,0,5,ectodermal cell differentiation,BP,
4589,GO:0010676,1,0.472127821220715,0,35,positive regulation of cellular carbohydrate metabolic process,BP,
4591,GO:0010692,1,0.846564234612267,0,8,regulation of alkaline phosphatase activity,BP,
4592,GO:0010693,1,0.936436498163497,0,3,negative regulation of alkaline phosphatase activity,BP,
4593,GO:0010694,1,0.904049933770355,0,5,positive regulation of alkaline phosphatase activity,BP,
4594,GO:0010698,1,0.953851723716815,0,2,acetyltransferase activator activity,MF,
4595,GO:0010700,1,0.97744963657025,0,1,negative regulation of norepinephrine secretion,BP,
4596,GO:0010701,1,0.95628365361549,0,2,positive regulation of norepinephrine secretion,BP,
4597,GO:0010705,1,0.97877215664454,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4598,GO:0010710,1,0.932726608753313,0,3,regulation of collagen catabolic process,BP,
4599,GO:0010711,1,0.975847258136945,0,1,negative regulation of collagen catabolic process,BP,
4601,GO:0010713,1,0.849734410371121,0,7,negative regulation of collagen metabolic process,BP,
4603,GO:0010715,1,0.79057669433696,0,11,regulation of extracellular matrix disassembly,BP,
4604,GO:0010716,1,0.931975777919949,0,3,negative regulation of extracellular matrix disassembly,BP,
4610,GO:0010722,1,0.980739394112815,0,1,regulation of ferrochelatase activity,BP,
4611,GO:0010724,1,0.935238592568892,0,3,regulation of definitive erythrocyte differentiation,BP,
4612,GO:0010726,1,0.955209367939518,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4613,GO:0010727,1,0.91594543401223,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4614,GO:0010728,1,0.914858729529016,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4615,GO:0010729,1,0.977203766870113,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4616,GO:0010730,1,0.936205926241075,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4617,GO:0010731,1,0.97723956588711,0,1,protein glutathionylation,BP,
4618,GO:0010732,1,0.97723956588711,0,1,regulation of protein glutathionylation,BP,
4619,GO:0010734,1,0.97723956588711,0,1,negative regulation of protein glutathionylation,BP,
4620,GO:0010735,1,0.93679941222974,0,3,positive regulation of transcription via serum response element binding,BP,
4621,GO:0010736,1,0.978544712616752,0,1,serum response element binding,MF,
4622,GO:0010737,1,0.688717790715466,0,18,protein kinase A signaling,BP,
4623,GO:0010738,1,0.773295800277664,0,12,regulation of protein kinase A signaling,BP,
4624,GO:0010739,1,0.893660066649253,0,5,positive regulation of protein kinase A signaling,BP,
4625,GO:0010742,1,0.647184966178209,0,20,macrophage derived foam cell differentiation,BP,
4626,GO:0010743,1,0.705610792142975,0,16,regulation of macrophage derived foam cell differentiation,BP,
4627,GO:0010744,1,0.851838419614076,0,7,positive regulation of macrophage derived foam cell differentiation,BP,
4628,GO:0010745,1,0.828432875839532,0,9,negative regulation of macrophage derived foam cell differentiation,BP,
4629,GO:0010746,1,0.91954553164539,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4630,GO:0010748,1,0.91954553164539,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4631,GO:0010749,1,0.940134810645708,0,3,regulation of nitric oxide mediated signal transduction,BP,
4632,GO:0010750,1,0.977254848732398,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4633,GO:0010751,1,0.96201923707128,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4634,GO:0010752,1,0.958743977530998,0,2,regulation of cGMP-mediated signaling,BP,
4635,GO:0010754,1,0.979738867231149,0,1,negative regulation of cGMP-mediated signaling,BP,
4637,GO:0010756,1,0.933218823085431,0,3,positive regulation of plasminogen activation,BP,
4639,GO:0010758,1,0.727544203177662,0,14,regulation of macrophage chemotaxis,BP,
4640,GO:0010759,1,0.853981654355954,0,7,positive regulation of macrophage chemotaxis,BP,
4641,GO:0010760,1,0.910787272502129,0,4,negative regulation of macrophage chemotaxis,BP,
4642,GO:0010761,1,0.487896111100131,0,33,fibroblast migration,BP,
4643,GO:0010762,1,0.586580754553489,0,24,regulation of fibroblast migration,BP,
4644,GO:0010763,1,0.821397963450787,0,9,positive regulation of fibroblast migration,BP,
4645,GO:0010764,1,0.873923979311513,0,6,negative regulation of fibroblast migration,BP,
4646,GO:0010765,1,0.633659237124592,0,21,positive regulation of sodium ion transport,BP,
4647,GO:0010766,1,0.80535204066555,0,10,negative regulation of sodium ion transport,BP,
4648,GO:0010767,1,0.939808077149975,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4649,GO:0010768,1,0.961667149257657,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4653,GO:0010792,1,0.871792206495894,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4654,GO:0010793,1,0.898063549107672,0,5,regulation of mRNA export from nucleus,BP,
4655,GO:0010795,1,0.976624973023742,0,1,regulation of ubiquinone biosynthetic process,BP,
4656,GO:0010796,1,0.932490036980023,0,3,regulation of multivesicular body size,BP,
4657,GO:0010797,1,0.976554967222198,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4659,GO:0010800,1,0.628742230208649,0,21,positive regulation of peptidyl-threonine phosphorylation,BP,
4663,GO:0010807,1,0.876445362890753,0,6,regulation of synaptic vesicle priming,BP,
4664,GO:0010808,1,0.980181708779369,0,1,positive regulation of synaptic vesicle priming,BP,
4668,GO:0010813,1,0.956573031497953,0,2,neuropeptide catabolic process,BP,
4669,GO:0010814,1,0.979223678691072,0,1,substance P catabolic process,BP,
4670,GO:0010815,1,0.915432052009817,0,4,bradykinin catabolic process,BP,
4671,GO:0010816,1,0.979223678691072,0,1,calcitonin catabolic process,BP,
4673,GO:0010818,1,0.817311416492844,0,9,T cell chemotaxis,BP,
4674,GO:0010819,1,0.873993626648433,0,6,regulation of T cell chemotaxis,BP,
4675,GO:0010820,1,0.873993626648433,0,6,positive regulation of T cell chemotaxis,BP,
4679,GO:0010824,1,0.439203392783386,0,37,regulation of centrosome duplication,BP,
4680,GO:0010825,1,0.87648961190505,0,6,positive regulation of centrosome duplication,BP,
4681,GO:0010826,1,0.767944916373312,0,12,negative regulation of centrosome duplication,BP,
4684,GO:0010829,1,0.763818585117485,0,12,negative regulation of glucose transmembrane transport,BP,
4685,GO:0010830,1,0.515004463014608,0,30,regulation of myotube differentiation,BP,
4686,GO:0010831,1,0.684492706192327,0,17,positive regulation of myotube differentiation,BP,
4687,GO:0010832,1,0.86158337489912,0,7,negative regulation of myotube differentiation,BP,
4688,GO:0010833,1,0.193130462333962,0,74,telomere maintenance via telomere lengthening,BP,
4689,GO:0010835,1,0.853939087299572,0,7,regulation of protein ADP-ribosylation,BP,
4690,GO:0010836,1,0.933049565860207,0,3,negative regulation of protein ADP-ribosylation,BP,
4692,GO:0010838,1,0.896673313012787,0,5,positive regulation of keratinocyte proliferation,BP,
4694,GO:0010842,1,0.735369899584114,0,15,retina layer formation,BP,
4695,GO:0010845,1,0.9772636315043,0,1,positive regulation of reciprocal meiotic recombination,BP,
4696,GO:0010847,1,0.91956042934669,0,4,regulation of chromatin assembly,BP,
4697,GO:0010848,1,0.977576007551264,0,1,regulation of chromatin disassembly,BP,
4698,GO:0010849,1,0.977229396982722,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4699,GO:0010851,1,0.977235204612038,0,1,cyclase regulator activity,MF,
4700,GO:0010853,1,0.977235204612038,0,1,cyclase activator activity,MF,
4701,GO:0010856,1,0.977581520852198,0,1,adenylate cyclase activator activity,MF,
4702,GO:0010857,1,0.836071931247693,0,8,calcium-dependent protein kinase activity,MF,
4703,GO:0010858,1,0.953978832241373,0,2,calcium-dependent protein kinase regulator activity,MF,
4704,GO:0010859,1,0.978597571093175,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4705,GO:0010862,1,0.576857103873873,0,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4706,GO:0010863,1,0.719761466439758,0,15,positive regulation of phospholipase C activity,BP,
4707,GO:0010866,1,0.746683669119312,0,13,regulation of triglyceride biosynthetic process,BP,
4708,GO:0010867,1,0.816014348294623,0,9,positive regulation of triglyceride biosynthetic process,BP,
4709,GO:0010868,1,0.957341071927611,0,2,negative regulation of triglyceride biosynthetic process,BP,
4713,GO:0010872,1,0.888976252646336,0,5,regulation of cholesterol esterification,BP,
4714,GO:0010873,1,0.93065418567271,0,3,positive regulation of cholesterol esterification,BP,
4715,GO:0010874,1,0.744600702900456,0,14,regulation of cholesterol efflux,BP,
4716,GO:0010875,1,0.778606602498351,0,12,positive regulation of cholesterol efflux,BP,
4718,GO:0010877,1,0.954272527151703,0,2,lipid transport involved in lipid storage,BP,
4719,GO:0010878,1,0.786760038623917,0,11,cholesterol storage,BP,
4720,GO:0010879,1,0.977234999346512,0,1,cholesterol transport involved in cholesterol storage,BP,
4721,GO:0010880,1,0.726174634809447,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4722,GO:0010881,1,0.783660936604452,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4723,GO:0010882,1,0.722364010035942,0,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4724,GO:0010883,1,0.517242265450224,0,30,regulation of lipid storage,BP,
4725,GO:0010884,1,0.766973586743084,0,12,positive regulation of lipid storage,BP,
4726,GO:0010885,1,0.823497405265737,0,9,regulation of cholesterol storage,BP,
4727,GO:0010886,1,0.934998621551562,0,3,positive regulation of cholesterol storage,BP,
4728,GO:0010887,1,0.880775465345706,0,6,negative regulation of cholesterol storage,BP,
4729,GO:0010888,1,0.738250057418454,0,14,negative regulation of lipid storage,BP,
4730,GO:0010889,1,0.861241819963059,0,7,regulation of sequestering of triglyceride,BP,
4731,GO:0010890,1,0.955489367880732,0,2,positive regulation of sequestering of triglyceride,BP,
4732,GO:0010891,1,0.90137804728158,0,5,negative regulation of sequestering of triglyceride,BP,
4735,GO:0010896,1,0.935288879323717,0,3,regulation of triglyceride catabolic process,BP,
4736,GO:0010897,1,0.977236605385541,0,1,negative regulation of triglyceride catabolic process,BP,
4737,GO:0010898,1,0.957078793396889,0,2,positive regulation of triglyceride catabolic process,BP,
4738,GO:0010899,1,0.933389758642657,0,3,regulation of phosphatidylcholine catabolic process,BP,
4739,GO:0010900,1,0.975254192171299,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
4740,GO:0010904,1,0.977228313431764,0,1,regulation of UDP-glucose catabolic process,BP,
4741,GO:0010905,1,0.977228313431764,0,1,negative regulation of UDP-glucose catabolic process,BP,
4743,GO:0010907,1,0.614025963301732,0,23,positive regulation of glucose metabolic process,BP,
4744,GO:0010908,1,0.934734983011878,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4745,GO:0010909,1,0.934734983011878,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4746,GO:0010911,1,0.858752511726174,0,7,regulation of isomerase activity,BP,
4747,GO:0010912,1,0.858752511726174,0,7,positive regulation of isomerase activity,BP,
4748,GO:0010915,1,0.95278730021583,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4749,GO:0010916,1,0.95278730021583,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
4750,GO:0010917,1,0.832944030015616,0,8,negative regulation of mitochondrial membrane potential,BP,
4751,GO:0010918,1,0.853583539487734,0,7,positive regulation of mitochondrial membrane potential,BP,
4752,GO:0010919,1,0.855932092479534,0,7,regulation of inositol phosphate biosynthetic process,BP,
4753,GO:0010921,1,0.052790146737277,0,134,regulation of phosphatase activity,BP,
4754,GO:0010922,1,0.614792537216443,0,23,positive regulation of phosphatase activity,BP,
4755,GO:0010923,1,0.197672007298786,0,74,negative regulation of phosphatase activity,BP,
4757,GO:0010931,1,0.981508894351346,0,1,macrophage tolerance induction,BP,
4758,GO:0010932,1,0.981508894351346,0,1,regulation of macrophage tolerance induction,BP,
4759,GO:0010933,1,0.981508894351346,0,1,positive regulation of macrophage tolerance induction,BP,
4760,GO:0010934,1,0.801682720346933,0,10,macrophage cytokine production,BP,
4761,GO:0010935,1,0.838745442846189,0,8,regulation of macrophage cytokine production,BP,
4762,GO:0010936,1,0.896594546425709,0,5,negative regulation of macrophage cytokine production,BP,
4763,GO:0010939,1,0.574895020680946,0,24,regulation of necrotic cell death,BP,
4764,GO:0010940,1,0.889866381300323,0,5,positive regulation of necrotic cell death,BP,
4767,GO:0010944,1,0.874462146372791,0,6,negative regulation of transcription by competitive promoter binding,BP,
4772,GO:0010954,1,0.767462759322554,0,12,positive regulation of protein processing,BP,
4774,GO:0010956,1,0.956083370171786,0,2,negative regulation of calcidiol 1-monooxygenase activity,BP,
4778,GO:0010960,1,0.865137788332355,0,7,magnesium ion homeostasis,BP,
4779,GO:0010961,1,0.960228950294642,0,2,cellular magnesium ion homeostasis,BP,
4781,GO:0010963,1,0.976844813365906,0,1,regulation of L-arginine import,BP,
4782,GO:0010965,1,0.330198177251834,0,50,regulation of mitotic sister chromatid separation,BP,
4783,GO:0010966,1,0.940136917893825,0,3,regulation of phosphate transport,BP,
4784,GO:0010967,1,0.977062668863997,0,1,regulation of polyamine biosynthetic process,BP,
4785,GO:0010968,1,0.873296401100721,0,6,regulation of microtubule nucleation,BP,
4787,GO:0010971,1,0.654708404344465,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4790,GO:0010976,1,0.017172323554503,0,187,positive regulation of neuron projection development,BP,
4792,GO:0010979,1,0.956617116532848,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
4793,GO:0010980,1,0.956617116532848,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
4794,GO:0010982,1,0.956110804716187,0,2,regulation of high-density lipoprotein particle clearance,BP,
4795,GO:0010983,1,0.956110804716187,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
4796,GO:0010984,1,0.777014850513477,0,11,regulation of lipoprotein particle clearance,BP,
4797,GO:0010985,1,0.889964402882791,0,5,negative regulation of lipoprotein particle clearance,BP,
4798,GO:0010986,1,0.914827513989247,0,4,positive regulation of lipoprotein particle clearance,BP,
4799,GO:0010988,1,0.871014892209874,0,6,regulation of low-density lipoprotein particle clearance,BP,
4800,GO:0010989,1,0.93407566291665,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
4803,GO:0010992,1,0.854746257516399,0,7,ubiquitin recycling,BP,
4804,GO:0010994,1,0.891488755554327,0,5,free ubiquitin chain polymerization,BP,
4805,GO:0010996,1,0.777615138098598,0,12,response to auditory stimulus,BP,
4806,GO:0010997,1,0.894863762291171,0,5,anaphase-promoting complex binding,MF,
4807,GO:0010998,1,0.802464773098228,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
4808,GO:0010999,1,0.978680044021769,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4812,GO:0012507,1,0.358951847154993,0,46,ER to Golgi transport vesicle membrane,CC,
4813,GO:0012510,1,0.751071127647001,0,13,trans-Golgi network transport vesicle membrane,CC,
4814,GO:0014002,1,0.667362618926731,0,19,astrocyte development,BP,
4816,GO:0014004,1,0.95591338550137,0,2,microglia differentiation,BP,
4817,GO:0014005,1,0.95591338550137,0,2,microglia development,BP,
4819,GO:0014010,1,0.901916387009573,0,5,Schwann cell proliferation,BP,
4820,GO:0014011,1,0.977336572808046,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4821,GO:0014012,1,0.914906236301272,0,4,peripheral nervous system axon regeneration,BP,
4825,GO:0014016,1,0.977245329737199,0,1,neuroblast differentiation,BP,
4827,GO:0014022,1,0.935579140338883,0,3,neural plate elongation,BP,
4828,GO:0014028,1,0.976926156918786,0,1,notochord formation,BP,
4836,GO:0014038,1,0.938530868034109,0,3,regulation of Schwann cell differentiation,BP,
4837,GO:0014040,1,0.960535465039437,0,2,positive regulation of Schwann cell differentiation,BP,
4838,GO:0014041,1,0.860002618120934,0,7,regulation of neuron maturation,BP,
4839,GO:0014042,1,0.921583435523016,0,4,positive regulation of neuron maturation,BP,
4840,GO:0014043,1,0.955827950878354,0,2,negative regulation of neuron maturation,BP,
4842,GO:0014045,1,0.913359789342059,0,4,establishment of endothelial blood-brain barrier,BP,
4844,GO:0014047,1,0.66292460394017,0,19,glutamate secretion,BP,
4845,GO:0014048,1,0.894281824079361,0,5,regulation of glutamate secretion,BP,
4846,GO:0014049,1,0.914878482210867,0,4,positive regulation of glutamate secretion,BP,
4847,GO:0014051,1,0.904499202034634,0,5,gamma-aminobutyric acid secretion,BP,
4848,GO:0014052,1,0.937406772799242,0,3,regulation of gamma-aminobutyric acid secretion,BP,
4849,GO:0014053,1,0.979054784048604,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4850,GO:0014054,1,0.978370823159187,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
4852,GO:0014061,1,0.934715527404869,0,3,regulation of norepinephrine secretion,BP,
4853,GO:0014062,1,0.955730103356955,0,2,regulation of serotonin secretion,BP,
4854,GO:0014063,1,0.976491796432686,0,1,negative regulation of serotonin secretion,BP,
4855,GO:0014064,1,0.978740367579142,0,1,positive regulation of serotonin secretion,BP,
4858,GO:0014067,1,0.820391637381151,0,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
4862,GO:0014072,1,0.685907445997658,0,17,response to isoquinoline alkaloid,BP,
4864,GO:0014075,1,0.606155479952941,0,23,response to amine,BP,
4865,GO:0014701,1,0.927561907588215,0,4,junctional sarcoplasmic reticulum membrane,CC,
4871,GO:0014721,1,0.957242260272553,0,2,twitch skeletal muscle contraction,BP,
4872,GO:0014722,1,0.913730025802221,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
4873,GO:0014731,1,0.88673532105208,0,6,spectrin-associated cytoskeleton,CC,
4874,GO:0014732,1,0.93508419213694,0,3,skeletal muscle atrophy,BP,
4875,GO:0014733,1,0.844385938117811,0,8,regulation of skeletal muscle adaptation,BP,
4876,GO:0014734,1,0.981876921102702,0,1,skeletal muscle hypertrophy,BP,
4877,GO:0014735,1,0.959064105351891,0,2,regulation of muscle atrophy,BP,
4878,GO:0014736,1,0.959064105351891,0,2,negative regulation of muscle atrophy,BP,
4879,GO:0014738,1,0.933498868566553,0,3,regulation of muscle hyperplasia,BP,
4880,GO:0014739,1,0.977373176117378,0,1,positive regulation of muscle hyperplasia,BP,
4881,GO:0014740,1,0.955113746071758,0,2,negative regulation of muscle hyperplasia,BP,
4883,GO:0014742,1,0.637739524992051,0,21,positive regulation of muscle hypertrophy,BP,
4885,GO:0014744,1,0.939346062899745,0,3,positive regulation of muscle adaptation,BP,
4886,GO:0014745,1,0.824877925169609,0,9,negative regulation of muscle adaptation,BP,
4887,GO:0014802,1,0.941114188648846,0,3,terminal cisterna,CC,
4888,GO:0014805,1,0.909975799570758,0,4,smooth muscle adaptation,BP,
4889,GO:0014806,1,0.954713747163728,0,2,smooth muscle hyperplasia,BP,
4890,GO:0014807,1,0.875597739142699,0,6,regulation of somitogenesis,BP,
4891,GO:0014808,1,0.699425474934336,0,17,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4892,GO:0014809,1,0.93493399472519,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4893,GO:0014810,1,0.975863413517129,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4895,GO:0014816,1,0.961787746460158,0,2,skeletal muscle satellite cell differentiation,BP,
4896,GO:0014819,1,0.891254587178753,0,5,regulation of skeletal muscle contraction,BP,
4897,GO:0014820,1,0.87395992762229,0,6,tonic smooth muscle contraction,BP,
4899,GO:0014823,1,0.417338853788009,0,40,response to activity,BP,
4900,GO:0014824,1,0.912852089548319,0,4,artery smooth muscle contraction,BP,
4901,GO:0014825,1,0.97592036803824,0,1,stomach fundus smooth muscle contraction,BP,
4902,GO:0014826,1,0.977217150969366,0,1,vein smooth muscle contraction,BP,
4903,GO:0014827,1,0.977232308880205,0,1,intestine smooth muscle contraction,BP,
4904,GO:0014829,1,0.771677933219564,0,12,vascular smooth muscle contraction,BP,
4905,GO:0014831,1,0.912989622347465,0,4,gastro-intestinal system smooth muscle contraction,BP,
4906,GO:0014832,1,0.937299269634739,0,3,urinary bladder smooth muscle contraction,BP,
4907,GO:0014834,1,0.916009489217047,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
4908,GO:0014835,1,0.978544712616752,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4909,GO:0014839,1,0.954473026821659,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4910,GO:0014841,1,0.858237919102495,0,7,skeletal muscle satellite cell proliferation,BP,
4911,GO:0014842,1,0.858237919102495,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4912,GO:0014843,1,0.980452075850445,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4913,GO:0014846,1,0.978476563304904,0,1,esophagus smooth muscle contraction,BP,
4914,GO:0014847,1,0.97592036803824,0,1,proximal stomach smooth muscle contraction,BP,
4915,GO:0014848,1,0.937299269634739,0,3,urinary tract smooth muscle contraction,BP,
4916,GO:0014850,1,0.73323120310999,0,14,response to muscle activity,BP,
4917,GO:0014852,1,0.977326025758058,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4918,GO:0014853,1,0.977326025758058,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4919,GO:0014854,1,0.845600087905447,0,8,response to inactivity,BP,
4921,GO:0014856,1,0.858237919102495,0,7,skeletal muscle cell proliferation,BP,
4922,GO:0014857,1,0.858237919102495,0,7,regulation of skeletal muscle cell proliferation,BP,
4923,GO:0014858,1,0.958883219015756,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4924,GO:0014859,1,0.977616107347336,0,1,negative regulation of skeletal muscle cell proliferation,BP,
4925,GO:0014866,1,0.957302204900804,0,3,skeletal myofibril assembly,BP,
4926,GO:0014870,1,0.885675947206553,0,6,response to muscle inactivity,BP,
4927,GO:0014874,1,0.866896362368592,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4928,GO:0014876,1,0.976767696490327,0,1,response to injury involved in regulation of muscle adaptation,BP,
4929,GO:0014877,1,0.906221560460506,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4930,GO:0014878,1,0.979375971984195,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4931,GO:0014883,1,0.919139416972899,0,4,transition between fast and slow fiber,BP,
4932,GO:0014886,1,0.956740008388004,0,2,transition between slow and fast fiber,BP,
4933,GO:0014887,1,0.77747565660479,0,12,cardiac muscle adaptation,BP,
4934,GO:0014888,1,0.62430000338422,0,22,striated muscle adaptation,BP,
4935,GO:0014889,1,0.856409194736402,0,7,muscle atrophy,BP,
4936,GO:0014891,1,0.91383746272696,0,4,striated muscle atrophy,BP,
4937,GO:0014894,1,0.906221560460506,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4938,GO:0014895,1,0.97569188921866,0,1,smooth muscle hypertrophy,BP,
4941,GO:0014898,1,0.77747565660479,0,12,cardiac muscle hypertrophy in response to stress,BP,
4942,GO:0014900,1,0.911970998005936,0,4,muscle hyperplasia,BP,
4944,GO:0014902,1,0.291544533608347,0,57,myotube differentiation,BP,
4945,GO:0014904,1,0.693944933608527,0,17,myotube cell development,BP,
4946,GO:0014908,1,0.980090280369481,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4949,GO:0014911,1,0.627992600028056,0,22,positive regulation of smooth muscle cell migration,BP,
4951,GO:0014916,1,0.942197779442676,0,3,regulation of lung blood pressure,BP,
4952,GO:0015002,1,0.647034423086108,0,18,heme-copper terminal oxidase activity,MF,
4953,GO:0015012,1,0.646840034624612,0,20,heparan sulfate proteoglycan biosynthetic process,BP,
4954,GO:0015014,1,0.918023554275583,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4955,GO:0015015,1,0.9153356867126,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4956,GO:0015016,1,0.960017630059577,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
4957,GO:0015018,1,0.976835133309604,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
4958,GO:0015019,1,0.979298676902749,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
4959,GO:0015020,1,0.727345102262014,0,14,glucuronosyltransferase activity,MF,
4960,GO:0015026,1,0.648535928475673,0,20,coreceptor activity,MF,
4961,GO:0015030,1,0.313459004338673,0,51,Cajal body,CC,
4963,GO:0015035,1,0.626377711387346,0,20,protein disulfide oxidoreductase activity,MF,
4964,GO:0015036,1,0.453175144276329,0,34,disulfide oxidoreductase activity,MF,
4965,GO:0015037,1,0.754381573734749,0,12,peptide disulfide oxidoreductase activity,MF,
4966,GO:0015038,1,0.888165439842935,0,5,glutathione disulfide oxidoreductase activity,MF,
4967,GO:0015039,1,0.977166788417474,0,1,NADPH-adrenodoxin reductase activity,MF,
4968,GO:0015057,1,0.934132480869461,0,3,thrombin-activated receptor activity,MF,
4972,GO:0015078,1,0.179756695678999,0,75,proton transmembrane transporter activity,MF,
4973,GO:0015079,1,0.310068152554917,0,53,potassium ion transmembrane transporter activity,MF,
4975,GO:0015085,1,0.253491086909831,0,65,calcium ion transmembrane transporter activity,MF,
4976,GO:0015086,1,0.978411021284441,0,1,cadmium ion transmembrane transporter activity,MF,
4977,GO:0015087,1,0.978411021284441,0,1,cobalt ion transmembrane transporter activity,MF,
4978,GO:0015091,1,0.979252292085138,0,1,ferric iron transmembrane transporter activity,MF,
4979,GO:0015093,1,0.957735936693075,0,2,ferrous iron transmembrane transporter activity,MF,
4980,GO:0015094,1,0.978411021284441,0,1,lead ion transmembrane transporter activity,MF,
4981,GO:0015095,1,0.685487917382772,0,17,magnesium ion transmembrane transporter activity,MF,
4982,GO:0015098,1,0.977166971322993,0,1,molybdate ion transmembrane transporter activity,MF,
4983,GO:0015101,1,0.665105780416226,0,18,organic cation transmembrane transporter activity,MF,
4985,GO:0015105,1,0.97664714062796,0,1,arsenite transmembrane transporter activity,MF,
4986,GO:0015106,1,0.789380704807173,0,11,bicarbonate transmembrane transporter activity,MF,
4987,GO:0015108,1,0.453438103123893,0,36,chloride transmembrane transporter activity,MF,
4988,GO:0015111,1,0.936748457655843,0,3,iodide transmembrane transporter activity,MF,
4989,GO:0015112,1,0.977267127518835,0,1,nitrate transmembrane transporter activity,MF,
4991,GO:0015116,1,0.876724227889668,0,6,sulfate transmembrane transporter activity,MF,
4992,GO:0015117,1,0.977163816563072,0,1,thiosulfate transmembrane transporter activity,MF,
4993,GO:0015119,1,0.934565764540628,0,3,hexose phosphate transmembrane transporter activity,MF,
4994,GO:0015125,1,0.91261352885994,0,4,bile acid transmembrane transporter activity,MF,
4995,GO:0015127,1,0.979182692621462,0,1,bilirubin transmembrane transporter activity,MF,
4996,GO:0015129,1,0.934851347186133,0,3,lactate transmembrane transporter activity,MF,
4997,GO:0015130,1,0.978381611755302,0,1,mevalonate transmembrane transporter activity,MF,
4998,GO:0015131,1,0.977163816563072,0,1,oxaloacetate transmembrane transporter activity,MF,
4999,GO:0015136,1,0.977608768516803,0,1,sialic acid transmembrane transporter activity,MF,
5000,GO:0015137,1,0.914118303764161,0,4,citrate transmembrane transporter activity,MF,
5001,GO:0015140,1,0.954798108515481,0,2,malate transmembrane transporter activity,MF,
5002,GO:0015141,1,0.934481387981746,0,3,succinate transmembrane transporter activity,MF,
5003,GO:0015142,1,0.914118303764161,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5004,GO:0015143,1,0.977155194195259,0,1,urate transmembrane transporter activity,MF,
5008,GO:0015152,1,0.977218612542004,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5009,GO:0015154,1,0.955817062276187,0,2,disaccharide transmembrane transporter activity,MF,
5010,GO:0015157,1,0.955817062276187,0,2,oligosaccharide transmembrane transporter activity,MF,
5011,GO:0015165,1,0.817085026659224,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5012,GO:0015166,1,0.921309481841539,0,4,polyol transmembrane transporter activity,MF,
5013,GO:0015168,1,0.955050362908039,0,2,glycerol transmembrane transporter activity,MF,
5015,GO:0015172,1,0.87747814863938,0,6,acidic amino acid transmembrane transporter activity,MF,
5016,GO:0015173,1,0.977246943874661,0,1,aromatic amino acid transmembrane transporter activity,MF,
5017,GO:0015174,1,0.819007285544156,0,9,basic amino acid transmembrane transporter activity,MF,
5020,GO:0015180,1,0.895165061291357,0,5,L-alanine transmembrane transporter activity,MF,
5021,GO:0015181,1,0.89795789438426,0,5,arginine transmembrane transporter activity,MF,
5022,GO:0015182,1,0.977295823748791,0,1,L-asparagine transmembrane transporter activity,MF,
5023,GO:0015183,1,0.934545402109587,0,3,L-aspartate transmembrane transporter activity,MF,
5024,GO:0015184,1,0.957467661015148,0,2,L-cystine transmembrane transporter activity,MF,
5025,GO:0015185,1,0.97719723613118,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
5026,GO:0015186,1,0.91488732156288,0,4,L-glutamine transmembrane transporter activity,MF,
5027,GO:0015187,1,0.89413677261416,0,5,glycine transmembrane transporter activity,MF,
5028,GO:0015189,1,0.89795789438426,0,5,L-lysine transmembrane transporter activity,MF,
5029,GO:0015190,1,0.977295823748791,0,1,L-leucine transmembrane transporter activity,MF,
5030,GO:0015191,1,0.977295823748791,0,1,L-methionine transmembrane transporter activity,MF,
5031,GO:0015193,1,0.897109679352199,0,5,L-proline transmembrane transporter activity,MF,
5032,GO:0015194,1,0.852339511567451,0,7,L-serine transmembrane transporter activity,MF,
5033,GO:0015195,1,0.978531621802318,0,1,L-threonine transmembrane transporter activity,MF,
5034,GO:0015196,1,0.977246943874661,0,1,L-tryptophan transmembrane transporter activity,MF,
5035,GO:0015203,1,0.977336572808046,0,1,polyamine transmembrane transporter activity,MF,
5036,GO:0015204,1,0.93442382863671,0,3,urea transmembrane transporter activity,MF,
5037,GO:0015205,1,0.874543472538184,0,6,nucleobase transmembrane transporter activity,MF,
5038,GO:0015207,1,0.933753188344776,0,3,adenine transmembrane transporter activity,MF,
5039,GO:0015211,1,0.977247425568655,0,1,purine nucleoside transmembrane transporter activity,MF,
5040,GO:0015215,1,0.710105999725154,0,15,nucleotide transmembrane transporter activity,MF,
5041,GO:0015216,1,0.777754269244902,0,11,purine nucleotide transmembrane transporter activity,MF,
5042,GO:0015217,1,0.814485772633983,0,9,ADP transmembrane transporter activity,MF,
5043,GO:0015218,1,0.956188464797075,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5044,GO:0015220,1,0.89333179088361,0,5,choline transmembrane transporter activity,MF,
5045,GO:0015222,1,0.956393273855403,0,2,serotonin transmembrane transporter activity,MF,
5046,GO:0015226,1,0.913198103366858,0,4,carnitine transmembrane transporter activity,MF,
5047,GO:0015227,1,0.954915396691432,0,2,acyl carnitine transmembrane transporter activity,MF,
5048,GO:0015228,1,0.933485551759478,0,3,coenzyme A transmembrane transporter activity,MF,
5049,GO:0015229,1,0.980592472679763,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5050,GO:0015230,1,0.955150321780958,0,2,FAD transmembrane transporter activity,MF,
5051,GO:0015232,1,0.856244258212029,0,7,heme transporter activity,MF,
5052,GO:0015234,1,0.955421353043865,0,2,thiamine transmembrane transporter activity,MF,
5053,GO:0015238,1,0.249804253578907,0,62,drug transmembrane transporter activity,MF,
5055,GO:0015247,1,0.938412521239078,0,3,aminophospholipid transmembrane transporter activity,MF,
5056,GO:0015248,1,0.638990457055907,0,20,sterol transporter activity,MF,
5057,GO:0015250,1,0.911709482361934,0,4,water channel activity,MF,
5058,GO:0015252,1,0.97745874848291,0,1,proton channel activity,MF,
5059,GO:0015254,1,0.955050362908039,0,2,glycerol channel activity,MF,
5060,GO:0015265,1,0.977401076918419,0,1,urea channel activity,MF,
5062,GO:0015269,1,0.854798906020821,0,7,calcium-activated potassium channel activity,MF,
5063,GO:0015271,1,0.918662228594212,0,4,outward rectifier potassium channel activity,MF,
5064,GO:0015272,1,0.977434431276119,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5065,GO:0015275,1,0.956235747779954,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
5066,GO:0015276,1,0.424086264627564,0,40,ligand-gated ion channel activity,MF,
5067,GO:0015278,1,0.724153196389442,0,16,calcium-release channel activity,MF,
5068,GO:0015279,1,0.899191146737229,0,5,store-operated calcium channel activity,MF,
5069,GO:0015280,1,0.937251614070036,0,3,ligand-gated sodium channel activity,MF,
5070,GO:0015288,1,0.870203831413134,0,6,porin activity,MF,
5072,GO:0015292,1,0.977336572808046,0,1,uniporter activity,MF,
5075,GO:0015295,1,0.669369407440955,0,18,solute:proton symporter activity,MF,
5076,GO:0015296,1,0.861877118077528,0,7,anion:cation symporter activity,MF,
5078,GO:0015298,1,0.643700458658396,0,20,solute:cation antiporter activity,MF,
5079,GO:0015299,1,0.767175562496594,0,12,solute:proton antiporter activity,MF,
5080,GO:0015301,1,0.673870219255646,0,18,anion:anion antiporter activity,MF,
5081,GO:0015307,1,0.955041476911605,0,2,drug:proton antiporter activity,MF,
5082,GO:0015315,1,0.934565764540628,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5083,GO:0015317,1,0.977052924076275,0,1,phosphate:proton symporter activity,MF,
5087,GO:0015322,1,0.977476810747067,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5088,GO:0015327,1,0.982477643801759,0,1,cystine:glutamate antiporter activity,MF,
5089,GO:0015328,1,0.982477643801759,0,1,cystine secondary active transmembrane transporter activity,MF,
5090,GO:0015333,1,0.935702272405101,0,3,peptide:proton symporter activity,MF,
5091,GO:0015347,1,0.819936091035457,0,9,sodium-independent organic anion transmembrane transporter activity,MF,
5092,GO:0015349,1,0.956374041383991,0,2,thyroid hormone transmembrane transporter activity,MF,
5093,GO:0015350,1,0.958005876693282,0,2,methotrexate transmembrane transporter activity,MF,
5094,GO:0015355,1,0.912105634092233,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5095,GO:0015362,1,0.978308359624985,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5096,GO:0015367,1,0.977113571783947,0,1,oxoglutarate:malate antiporter activity,MF,
5097,GO:0015368,1,0.878899797587635,0,6,calcium:cation antiporter activity,MF,
5098,GO:0015369,1,0.979485263702979,0,1,calcium:proton antiporter activity,MF,
5100,GO:0015373,1,0.958805015464862,0,2,anion:sodium symporter activity,MF,
5101,GO:0015375,1,0.977531669431364,0,1,glycine:sodium symporter activity,MF,
5102,GO:0015377,1,0.881415095843743,0,6,cation:chloride symporter activity,MF,
5103,GO:0015378,1,0.980531452822081,0,1,sodium:chloride symporter activity,MF,
5104,GO:0015379,1,0.881415095843743,0,6,potassium:chloride symporter activity,MF,
5105,GO:0015385,1,0.839098192045389,0,8,sodium:proton antiporter activity,MF,
5106,GO:0015386,1,0.858567300410929,0,7,potassium:proton antiporter activity,MF,
5107,GO:0015389,1,0.977231814346738,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5108,GO:0015390,1,0.977231814346738,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5109,GO:0015391,1,0.977231814346738,0,1,nucleobase:cation symporter activity,MF,
5110,GO:0015399,1,0.20173568704998,0,73,primary active transmembrane transporter activity,MF,
5111,GO:0015405,1,0.20173568704998,0,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5112,GO:0015410,1,0.93503402096459,0,3,manganese-transporting ATPase activity,MF,
5113,GO:0015420,1,0.9801861254092,0,1,cobalamin-transporting ATPase activity,MF,
5114,GO:0015421,1,0.977798136672564,0,1,oligopeptide-transporting ATPase activity,MF,
5115,GO:0015431,1,0.9801861254092,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5116,GO:0015432,1,0.977802294953917,0,1,bile acid-exporting ATPase activity,MF,
5117,GO:0015433,1,0.956523903710992,0,2,peptide antigen-transporting ATPase activity,MF,
5118,GO:0015439,1,0.977381283509465,0,1,heme-transporting ATPase activity,MF,
5119,GO:0015440,1,0.914109607420397,0,4,peptide-transporting ATPase activity,MF,
5120,GO:0015450,1,0.846620751655183,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5121,GO:0015459,1,0.579971767508508,0,25,potassium channel regulator activity,MF,
5122,GO:0015464,1,0.854362192709046,0,7,acetylcholine receptor activity,MF,
5123,GO:0015467,1,0.955173296625746,0,2,G-protein activated inward rectifier potassium channel activity,MF,
5124,GO:0015485,1,0.516181824332362,0,30,cholesterol binding,MF,
5125,GO:0015489,1,0.977336572808046,0,1,putrescine transmembrane transporter activity,MF,
5126,GO:0015491,1,0.674147407582984,0,18,cation:cation antiporter activity,MF,
5127,GO:0015499,1,0.977267548769485,0,1,formate transmembrane transporter activity,MF,
5128,GO:0015501,1,0.955699827956194,0,2,glutamate:sodium symporter activity,MF,
5129,GO:0015526,1,0.934565764540628,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5130,GO:0015538,1,0.977608768516803,0,1,sialic acid:proton symporter activity,MF,
5131,GO:0015556,1,0.853303441141472,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5132,GO:0015562,1,0.916600949811709,0,4,efflux transmembrane transporter activity,MF,
5133,GO:0015578,1,0.977246021034258,0,1,mannose transmembrane transporter activity,MF,
5134,GO:0015605,1,0.608473180030777,0,22,organophosphate ester transmembrane transporter activity,MF,
5135,GO:0015616,1,0.92267415062657,0,4,DNA translocase activity,MF,
5139,GO:0015643,1,0.85480683152081,0,7,toxic substance binding,MF,
5140,GO:0015645,1,0.798433067593388,0,10,fatty acid ligase activity,MF,
5141,GO:0015651,1,0.874200313192947,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5142,GO:0015658,1,0.977295823748791,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5143,GO:0015660,1,0.977267548769485,0,1,formate efflux transmembrane transporter activity,MF,
5144,GO:0015662,1,0.622426287639039,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5146,GO:0015670,1,0.977042119621865,0,1,carbon dioxide transport,BP,
5149,GO:0015677,1,0.843817910022117,0,8,copper ion import,BP,
5150,GO:0015679,1,0.961011730306757,0,2,plasma membrane copper ion transport,BP,
5151,GO:0015680,1,0.933264487947616,0,3,intracellular copper ion transport,BP,
5152,GO:0015682,1,0.487332543337823,0,32,ferric iron transport,BP,
5153,GO:0015684,1,0.957735936693075,0,2,ferrous iron transport,BP,
5154,GO:0015688,1,0.953711487214675,0,2,iron chelate transport,BP,
5155,GO:0015689,1,0.977166971322993,0,1,molybdate ion transport,BP,
5157,GO:0015692,1,0.978411021284441,0,1,lead ion transport,BP,
5158,GO:0015693,1,0.685487917382772,0,17,magnesium ion transport,BP,
5159,GO:0015694,1,0.979182692621462,0,1,mercury ion transport,BP,
5160,GO:0015695,1,0.533636061326676,0,28,organic cation transport,BP,
5162,GO:0015697,1,0.819130235865942,0,9,quaternary ammonium group transport,BP,
5164,GO:0015700,1,0.97664714062796,0,1,arsenite transport,BP,
5165,GO:0015701,1,0.65923552819198,0,19,bicarbonate transport,BP,
5166,GO:0015705,1,0.919767547408255,0,4,iodide transport,BP,
5167,GO:0015706,1,0.977267127518835,0,1,nitrate transport,BP,
5168,GO:0015709,1,0.977163816563072,0,1,thiosulfate transport,BP,
5170,GO:0015712,1,0.91308274848666,0,4,hexose phosphate transport,BP,
5173,GO:0015722,1,0.935804650863569,0,3,canalicular bile acid transport,BP,
5174,GO:0015723,1,0.979182692621462,0,1,bilirubin transport,BP,
5175,GO:0015724,1,0.977267548769485,0,1,formate transport,BP,
5176,GO:0015727,1,0.914782066796935,0,4,lactate transport,BP,
5177,GO:0015728,1,0.978381611755302,0,1,mevalonate transport,BP,
5178,GO:0015729,1,0.977163816563072,0,1,oxaloacetate transport,BP,
5179,GO:0015732,1,0.83378729723094,0,8,prostaglandin transport,BP,
5180,GO:0015734,1,0.980261838873054,0,1,taurine transport,BP,
5181,GO:0015739,1,0.977608768516803,0,1,sialic acid transport,BP,
5182,GO:0015740,1,0.818005639377445,0,9,C4-dicarboxylate transport,BP,
5183,GO:0015742,1,0.977113571783947,0,1,alpha-ketoglutarate transport,BP,
5184,GO:0015743,1,0.977163816563072,0,1,malate transport,BP,
5185,GO:0015744,1,0.934481387981746,0,3,succinate transport,BP,
5186,GO:0015746,1,0.914118303764161,0,4,citrate transport,BP,
5187,GO:0015747,1,0.954928057789599,0,2,urate transport,BP,
5190,GO:0015760,1,0.91308274848666,0,4,glucose-6-phosphate transport,BP,
5191,GO:0015761,1,0.977246021034258,0,1,mannose transmembrane transport,BP,
5192,GO:0015766,1,0.955817062276187,0,2,disaccharide transport,BP,
5193,GO:0015770,1,0.955817062276187,0,2,sucrose transport,BP,
5194,GO:0015772,1,0.955817062276187,0,2,oligosaccharide transport,BP,
5195,GO:0015780,1,0.762804454187441,0,12,nucleotide-sugar transmembrane transport,BP,
5196,GO:0015782,1,0.977131071584347,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5197,GO:0015783,1,0.958448296382179,0,2,GDP-fucose transmembrane transport,BP,
5198,GO:0015786,1,0.977235340029555,0,1,UDP-glucose transmembrane transport,BP,
5199,GO:0015787,1,0.980228784660249,0,1,UDP-glucuronic acid transmembrane transport,BP,
5200,GO:0015790,1,0.980486329843763,0,1,UDP-xylose transmembrane transport,BP,
5201,GO:0015791,1,0.88545998892936,0,6,polyol transport,BP,
5202,GO:0015793,1,0.955050362908039,0,2,glycerol transport,BP,
5203,GO:0015797,1,0.977267548769485,0,1,mannitol transport,BP,
5204,GO:0015798,1,0.948717393255787,0,3,myo-inositol transport,BP,
5206,GO:0015801,1,0.954997947357116,0,2,aromatic amino acid transport,BP,
5207,GO:0015802,1,0.81856877287914,0,9,basic amino acid transport,BP,
5208,GO:0015803,1,0.93458402304331,0,3,branched-chain amino acid transport,BP,
5210,GO:0015805,1,0.977232227459996,0,1,S-adenosyl-L-methionine transport,BP,
5212,GO:0015808,1,0.895165061291357,0,5,L-alanine transport,BP,
5213,GO:0015809,1,0.877092598569076,0,6,arginine transport,BP,
5214,GO:0015810,1,0.956260108186374,0,2,aspartate transmembrane transport,BP,
5215,GO:0015811,1,0.957467661015148,0,2,L-cystine transport,BP,
5216,GO:0015812,1,0.883866418360667,0,6,gamma-aminobutyric acid transport,BP,
5218,GO:0015816,1,0.87572612836057,0,6,glycine transport,BP,
5219,GO:0015817,1,0.97729941197207,0,1,histidine transport,BP,
5220,GO:0015819,1,0.977163060157982,0,1,lysine transport,BP,
5221,GO:0015820,1,0.956299623126251,0,2,leucine transport,BP,
5222,GO:0015821,1,0.977295823748791,0,1,methionine transport,BP,
5223,GO:0015822,1,0.919916503171473,0,4,ornithine transport,BP,
5224,GO:0015824,1,0.877884775039113,0,6,proline transport,BP,
5225,GO:0015825,1,0.852339511567451,0,7,L-serine transport,BP,
5226,GO:0015826,1,0.978531621802318,0,1,threonine transport,BP,
5227,GO:0015827,1,0.954997947357116,0,2,tryptophan transport,BP,
5230,GO:0015838,1,0.855680508549452,0,7,amino-acid betaine transport,BP,
5231,GO:0015840,1,0.93442382863671,0,3,urea transport,BP,
5232,GO:0015842,1,0.954858312790649,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
5234,GO:0015846,1,0.872312632800514,0,6,polyamine transport,BP,
5235,GO:0015847,1,0.977336572808046,0,1,putrescine transport,BP,
5238,GO:0015851,1,0.854268521916066,0,7,nucleobase transport,BP,
5239,GO:0015853,1,0.912110818397531,0,4,adenine transport,BP,
5240,GO:0015855,1,0.955145538314789,0,2,pyrimidine nucleobase transport,BP,
5241,GO:0015858,1,0.87103970142498,0,6,nucleoside transport,BP,
5242,GO:0015860,1,0.954995372770954,0,2,purine nucleoside transmembrane transport,BP,
5243,GO:0015862,1,0.97723904137672,0,1,uridine transport,BP,
5244,GO:0015864,1,0.954987178786782,0,2,pyrimidine nucleoside transport,BP,
5245,GO:0015865,1,0.760211486518579,0,12,purine nucleotide transport,BP,
5246,GO:0015866,1,0.814485772633983,0,9,ADP transport,BP,
5247,GO:0015867,1,0.814662705499513,0,9,ATP transport,BP,
5248,GO:0015868,1,0.760211486518579,0,12,purine ribonucleotide transport,BP,
5249,GO:0015870,1,0.977266136864643,0,1,acetylcholine transport,BP,
5250,GO:0015871,1,0.857466787620732,0,7,choline transport,BP,
5252,GO:0015874,1,0.894773192551223,0,5,norepinephrine transport,BP,
5253,GO:0015876,1,0.977268319780716,0,1,acetyl-CoA transport,BP,
5254,GO:0015878,1,0.977597054626655,0,1,biotin transport,BP,
5255,GO:0015879,1,0.89238784370664,0,5,carnitine transport,BP,
5256,GO:0015880,1,0.933485551759478,0,3,coenzyme A transport,BP,
5257,GO:0015881,1,0.977804608375111,0,1,creatine transmembrane transport,BP,
5258,GO:0015882,1,0.980592472679763,0,1,L-ascorbic acid transmembrane transport,BP,
5259,GO:0015884,1,0.893641606448325,0,5,folic acid transport,BP,
5260,GO:0015886,1,0.856244258212029,0,7,heme transport,BP,
5261,GO:0015887,1,0.977597054626655,0,1,pantothenate transmembrane transport,BP,
5262,GO:0015888,1,0.955727402307429,0,2,thiamine transport,BP,
5263,GO:0015889,1,0.957167732158974,0,2,cobalamin transport,BP,
5264,GO:0015891,1,0.953711487214675,0,2,siderophore transport,BP,
5266,GO:0015904,1,0.977153347332236,0,1,tetracycline transport,BP,
5268,GO:0015909,1,0.44253091606179,0,37,long-chain fatty acid transport,BP,
5269,GO:0015910,1,0.955661795596188,0,2,peroxisomal long-chain fatty acid import,BP,
5270,GO:0015911,1,0.898611214420483,0,5,plasma membrane long-chain fatty acid transport,BP,
5272,GO:0015916,1,0.977268319780716,0,1,fatty-acyl-CoA transport,BP,
5273,GO:0015917,1,0.920452145565465,0,4,aminophospholipid transport,BP,
5275,GO:0015919,1,0.697568129959438,0,16,peroxisomal membrane transport,BP,
5276,GO:0015920,1,0.977272718880293,0,1,lipopolysaccharide transport,BP,
5277,GO:0015923,1,0.737732680663156,0,14,mannosidase activity,MF,
5278,GO:0015924,1,0.824619895298868,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5279,GO:0015925,1,0.871542978013131,0,6,galactosidase activity,MF,
5280,GO:0015926,1,0.842897984988174,0,8,glucosidase activity,MF,
5281,GO:0015928,1,0.954954223986258,0,2,fucosidase activity,MF,
5282,GO:0015929,1,0.761057672098084,0,12,hexosaminidase activity,MF,
5284,GO:0015932,1,0.471964189849351,0,33,nucleobase-containing compound transmembrane transporter activity,MF,
5287,GO:0015936,1,0.709411010940157,0,15,coenzyme A metabolic process,BP,
5288,GO:0015937,1,0.793742172836398,0,10,coenzyme A biosynthetic process,BP,
5289,GO:0015938,1,0.976252393437505,0,1,coenzyme A catabolic process,BP,
5290,GO:0015939,1,0.894991786438136,0,5,pantothenate metabolic process,BP,
5291,GO:0015942,1,0.932948996670854,0,3,formate metabolic process,BP,
5292,GO:0015949,1,0.533595283293169,0,27,nucleobase-containing small molecule interconversion,BP,
5293,GO:0015950,1,0.977160758322415,0,1,purine nucleotide interconversion,BP,
5294,GO:0015951,1,0.977160758322415,0,1,purine ribonucleotide interconversion,BP,
5295,GO:0015959,1,0.852795891963666,0,7,diadenosine polyphosphate metabolic process,BP,
5296,GO:0015960,1,0.933973609670445,0,3,diadenosine polyphosphate biosynthetic process,BP,
5297,GO:0015961,1,0.91310481226447,0,4,diadenosine polyphosphate catabolic process,BP,
5298,GO:0015965,1,0.933973609670445,0,3,diadenosine tetraphosphate metabolic process,BP,
5299,GO:0015966,1,0.933973609670445,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5301,GO:0015985,1,0.832304235121419,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5302,GO:0015986,1,0.832304235121419,0,8,ATP synthesis coupled proton transport,BP,
5303,GO:0015988,1,0.617489810321233,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5304,GO:0015990,1,0.975874150780741,0,1,electron transport coupled proton transport,BP,
5305,GO:0015991,1,0.632782153863111,0,20,ATP hydrolysis coupled proton transport,BP,
5306,GO:0016004,1,0.836244252057383,0,8,phospholipase activator activity,MF,
5307,GO:0016005,1,0.956822073112544,0,2,phospholipase A2 activator activity,MF,
5308,GO:0016010,1,0.775860995560311,0,12,dystrophin-associated glycoprotein complex,CC,
5309,GO:0016011,1,0.936624085124583,0,3,dystroglycan complex,CC,
5310,GO:0016012,1,0.956074349366814,0,2,sarcoglycan complex,CC,
5311,GO:0016013,1,0.958570626137269,0,2,syntrophin complex,CC,
5312,GO:0016015,1,0.954810150227785,0,2,morphogen activity,MF,
5313,GO:0016018,1,0.796480417357861,0,10,cyclosporin A binding,MF,
5314,GO:0016019,1,0.954176976775803,0,2,peptidoglycan receptor activity,MF,
5317,GO:0016024,1,0.753165406167993,0,13,CDP-diacylglycerol biosynthetic process,BP,
5318,GO:0016031,1,0.977662033732478,0,1,tRNA import into mitochondrion,BP,
5320,GO:0016034,1,0.976716347107442,0,1,maleylacetoacetate isomerase activity,MF,
5321,GO:0016035,1,0.96003428347287,0,2,zeta DNA polymerase complex,CC,
5322,GO:0016036,1,0.97723530628057,0,1,cellular response to phosphate starvation,BP,
5325,GO:0016045,1,0.856243198746821,0,7,detection of bacterium,BP,
5326,GO:0016048,1,0.854427251682349,0,7,detection of temperature stimulus,BP,
5334,GO:0016056,1,0.747699035541083,0,13,rhodopsin mediated signaling pathway,BP,
5335,GO:0016062,1,0.977255278157001,0,1,adaptation of rhodopsin mediated signaling,BP,
5340,GO:0016073,1,0.14619164487763,0,84,snRNA metabolic process,BP,
5341,GO:0016074,1,0.754934943815252,0,12,snoRNA metabolic process,BP,
5342,GO:0016075,1,0.711931743482239,0,15,rRNA catabolic process,BP,
5343,GO:0016077,1,0.979903954714144,0,1,snoRNA catabolic process,BP,
5344,GO:0016078,1,0.870403638417758,0,6,tRNA catabolic process,BP,
5345,GO:0016079,1,0.337111362562073,0,50,synaptic vesicle exocytosis,BP,
5346,GO:0016080,1,0.938339033142877,0,3,synaptic vesicle targeting,BP,
5347,GO:0016081,1,0.876778227425671,0,6,synaptic vesicle docking,BP,
5348,GO:0016082,1,0.787009958760006,0,11,synaptic vesicle priming,BP,
5349,GO:0016093,1,0.871720436583783,0,6,polyprenol metabolic process,BP,
5350,GO:0016094,1,0.935266971902824,0,3,polyprenol biosynthetic process,BP,
5351,GO:0016095,1,0.977268319780716,0,1,polyprenol catabolic process,BP,
5352,GO:0016098,1,0.977467365682333,0,1,monoterpenoid metabolic process,BP,
5354,GO:0016102,1,0.891479536944811,0,5,diterpenoid biosynthetic process,BP,
5355,GO:0016103,1,0.978730009672984,0,1,diterpenoid catabolic process,BP,
5356,GO:0016114,1,0.832142025914545,0,8,terpenoid biosynthetic process,BP,
5357,GO:0016115,1,0.978730009672984,0,1,terpenoid catabolic process,BP,
5360,GO:0016127,1,0.914874584613014,0,4,sterol catabolic process,BP,
5361,GO:0016128,1,0.933246533353124,0,3,phytosteroid metabolic process,BP,
5362,GO:0016129,1,0.933246533353124,0,3,phytosteroid biosynthetic process,BP,
5363,GO:0016131,1,0.977267548769485,0,1,brassinosteroid metabolic process,BP,
5364,GO:0016132,1,0.977267548769485,0,1,brassinosteroid biosynthetic process,BP,
5366,GO:0016139,1,0.851936854856202,0,7,glycoside catabolic process,BP,
5367,GO:0016149,1,0.977945017214682,0,1,translation release factor activity, codon specific,MF,
5368,GO:0016150,1,0.9770042461586,0,1,translation release factor activity, codon nonspecific,MF,
5369,GO:0016154,1,0.977036949778233,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5370,GO:0016155,1,0.981000204728113,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
5371,GO:0016160,1,0.957947911070659,0,2,amylase activity,MF,
5372,GO:0016165,1,0.955019551901395,0,2,linoleate 13S-lipoxygenase activity,MF,
5373,GO:0016174,1,0.91692486209319,0,4,NAD(P)H oxidase activity,MF,
5374,GO:0016175,1,0.953482394645142,0,2,superoxide-generating NADPH oxidase activity,MF,
5375,GO:0016176,1,0.899976100036217,0,5,superoxide-generating NADPH oxidase activator activity,MF,
5376,GO:0016180,1,0.607155468596527,0,22,snRNA processing,BP,
5377,GO:0016182,1,0.97898069188158,0,1,synaptic vesicle budding from endosome,BP,
5378,GO:0016185,1,0.916603729593032,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5379,GO:0016188,1,0.895478697490133,0,5,synaptic vesicle maturation,BP,
5380,GO:0016189,1,0.981351921308059,0,1,synaptic vesicle to endosome fusion,BP,
5381,GO:0016191,1,0.918962431427248,0,4,synaptic vesicle uncoating,BP,
5384,GO:0016198,1,0.899104898401981,0,5,axon choice point recognition,BP,
5385,GO:0016199,1,0.919779278983451,0,4,axon midline choice point recognition,BP,
5387,GO:0016206,1,0.955167802157117,0,2,catechol O-methyltransferase activity,MF,
5388,GO:0016208,1,0.812003806958327,0,9,AMP binding,MF,
5389,GO:0016209,1,0.292276132138996,0,53,antioxidant activity,MF,
5390,GO:0016211,1,0.978585979820246,0,1,ammonia ligase activity,MF,
5391,GO:0016212,1,0.954993935310529,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5392,GO:0016213,1,0.977485731533649,0,1,linoleoyl-CoA desaturase activity,MF,
5393,GO:0016215,1,0.935653127854079,0,3,acyl-CoA desaturase activity,MF,
5394,GO:0016222,1,0.955091970557798,0,2,procollagen-proline 4-dioxygenase complex,CC,
5395,GO:0016226,1,0.628739195346791,0,20,iron-sulfur cluster assembly,BP,
5397,GO:0016230,1,0.955115549032575,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5398,GO:0016231,1,0.979226035213429,0,1,beta-N-acetylglucosaminidase activity,MF,
5399,GO:0016232,1,0.977307108771681,0,1,HNK-1 sulfotransferase activity,MF,
5404,GO:0016237,1,0.979101482028327,0,1,lysosomal microautophagy,BP,
5405,GO:0016239,1,0.284104491886825,0,58,positive regulation of macroautophagy,BP,
5406,GO:0016240,1,0.915000144423731,0,4,autophagosome membrane docking,BP,
5408,GO:0016242,1,0.526171699231975,0,29,negative regulation of macroautophagy,BP,
5409,GO:0016243,1,0.978251716857322,0,1,regulation of autophagosome size,BP,
5410,GO:0016246,1,0.716327190926153,0,15,RNA interference,BP,
5413,GO:0016250,1,0.977292681326719,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5414,GO:0016254,1,0.675679876161119,0,17,preassembly of GPI anchor in ER membrane,BP,
5415,GO:0016255,1,0.857526210499757,0,7,attachment of GPI anchor to protein,BP,
5416,GO:0016256,1,0.95668609586733,0,2,N-glycan processing to lysosome,BP,
5417,GO:0016259,1,0.914179702291068,0,4,selenocysteine metabolic process,BP,
5418,GO:0016260,1,0.955010019310361,0,2,selenocysteine biosynthetic process,BP,
5419,GO:0016262,1,0.935424564923175,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5420,GO:0016263,1,0.954827844431641,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5422,GO:0016266,1,0.39955637406223,0,43,O-glycan processing,BP,
5423,GO:0016267,1,0.954827844431641,0,2,O-glycan processing, core 1,BP,
5424,GO:0016269,1,0.977248658952485,0,1,O-glycan processing, core 3,BP,
5425,GO:0016272,1,0.845197933140919,0,7,prefoldin complex,CC,
5426,GO:0016273,1,0.776162359221516,0,11,arginine N-methyltransferase activity,MF,
5427,GO:0016274,1,0.776162359221516,0,11,protein-arginine N-methyltransferase activity,MF,
5428,GO:0016277,1,0.977243004293828,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5429,GO:0016278,1,0.346881389468728,0,48,lysine N-methyltransferase activity,MF,
5430,GO:0016279,1,0.354956953551775,0,47,protein-lysine N-methyltransferase activity,MF,
5431,GO:0016281,1,0.818475308246183,0,9,eukaryotic translation initiation factor 4F complex,CC,
5432,GO:0016282,1,0.97869966233347,0,1,eukaryotic 43S preinitiation complex,CC,
5433,GO:0016286,1,0.977249871329806,0,1,small conductance calcium-activated potassium channel activity,MF,
5434,GO:0016287,1,0.977273897110666,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5435,GO:0016289,1,0.740255729475967,0,13,CoA hydrolase activity,MF,
5436,GO:0016290,1,0.849865273972189,0,7,palmitoyl-CoA hydrolase activity,MF,
5437,GO:0016295,1,0.95920016514415,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5438,GO:0016296,1,0.95920016514415,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5439,GO:0016297,1,0.95920016514415,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5441,GO:0016300,1,0.934616977976858,0,3,tRNA (uracil) methyltransferase activity,MF,
5444,GO:0016307,1,0.740058187863399,0,14,phosphatidylinositol phosphate kinase activity,MF,
5445,GO:0016308,1,0.878168825951938,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5446,GO:0016309,1,0.936619472361754,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5449,GO:0016312,1,0.91624091055033,0,4,inositol bisphosphate phosphatase activity,MF,
5450,GO:0016314,1,0.958975300971276,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5451,GO:0016316,1,0.959162434431509,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5452,GO:0016320,1,0.958517459860881,0,2,endoplasmic reticulum membrane fusion,BP,
5453,GO:0016321,1,0.933410112589465,0,3,female meiosis chromosome segregation,BP,
5454,GO:0016322,1,0.876341753497958,0,6,neuron remodeling,BP,
5457,GO:0016327,1,0.750264692041051,0,13,apicolateral plasma membrane,CC,
5460,GO:0016332,1,0.978160194037388,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5461,GO:0016333,1,0.977358216214398,0,1,morphogenesis of follicular epithelium,BP,
5462,GO:0016334,1,0.977358216214398,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5463,GO:0016338,1,0.812081483178598,0,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5464,GO:0016339,1,0.687395209157823,0,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5465,GO:0016340,1,0.960868332733886,0,2,calcium-dependent cell-matrix adhesion,BP,
5466,GO:0016342,1,0.755520639354135,0,13,catenin complex,CC,
5467,GO:0016344,1,0.955951844392658,0,2,meiotic chromosome movement towards spindle pole,BP,
5469,GO:0016361,1,0.955000345544675,0,2,activin receptor activity, type I,MF,
5470,GO:0016362,1,0.967938591547881,0,2,activin receptor activity, type II,MF,
5471,GO:0016363,1,0.126623099451933,0,94,nuclear matrix,CC,
5472,GO:0016401,1,0.958563059012926,0,2,palmitoyl-CoA oxidase activity,MF,
5473,GO:0016402,1,0.977319802391314,0,1,pristanoyl-CoA oxidase activity,MF,
5474,GO:0016403,1,0.955463022555375,0,2,dimethylargininase activity,MF,
5475,GO:0016404,1,0.978681791379653,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5476,GO:0016405,1,0.729591420871693,0,14,CoA-ligase activity,MF,
5477,GO:0016406,1,0.872418349005519,0,6,carnitine O-acyltransferase activity,MF,
5479,GO:0016408,1,0.743900923578116,0,13,C-acyltransferase activity,MF,
5480,GO:0016409,1,0.475860167496679,0,33,palmitoyltransferase activity,MF,
5482,GO:0016411,1,0.602504561183535,0,23,acylglycerol O-acyltransferase activity,MF,
5483,GO:0016413,1,0.87460113168543,0,6,O-acetyltransferase activity,MF,
5484,GO:0016414,1,0.977555829770683,0,1,O-octanoyltransferase activity,MF,
5485,GO:0016415,1,0.977555829770683,0,1,octanoyltransferase activity,MF,
5486,GO:0016416,1,0.913184906182116,0,4,O-palmitoyltransferase activity,MF,
5487,GO:0016417,1,0.546227599825175,0,27,S-acyltransferase activity,MF,
5488,GO:0016418,1,0.960647279583051,0,2,S-acetyltransferase activity,MF,
5489,GO:0016419,1,0.959281074585099,0,2,S-malonyltransferase activity,MF,
5490,GO:0016420,1,0.959281074585099,0,2,malonyltransferase activity,MF,
5491,GO:0016421,1,0.880729450422685,0,6,CoA carboxylase activity,MF,
5492,GO:0016422,1,0.933278487725223,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5493,GO:0016423,1,0.744619757210683,0,13,tRNA (guanine) methyltransferase activity,MF,
5495,GO:0016427,1,0.838091950856301,0,8,tRNA (cytosine) methyltransferase activity,MF,
5496,GO:0016428,1,0.915102919959091,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5498,GO:0016430,1,0.977336572808046,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5499,GO:0016433,1,0.870489641031377,0,6,rRNA (adenine) methyltransferase activity,MF,
5501,GO:0016435,1,0.912694834077632,0,4,rRNA (guanine) methyltransferase activity,MF,
5502,GO:0016436,1,0.955740614879834,0,2,rRNA (uridine) methyltransferase activity,MF,
5504,GO:0016442,1,0.790839259311282,0,11,RISC complex,CC,
5507,GO:0016446,1,0.729029448083323,0,14,somatic hypermutation of immunoglobulin genes,BP,
5509,GO:0016453,1,0.911639721637396,0,4,C-acetyltransferase activity,MF,
5510,GO:0016454,1,0.895378174555079,0,5,C-palmitoyltransferase activity,MF,
5512,GO:0016459,1,0.493967912134601,0,35,myosin complex,CC,
5513,GO:0016460,1,0.774762707336638,0,13,myosin II complex,CC,
5514,GO:0016461,1,0.864033412588465,0,7,unconventional myosin complex,CC,
5516,GO:0016469,1,0.575305272457402,0,24,proton-transporting two-sector ATPase complex,CC,
5517,GO:0016471,1,0.77959500775109,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5518,GO:0016476,1,0.935670922218737,0,3,regulation of embryonic cell shape,BP,
5520,GO:0016479,1,0.937455137749802,0,3,negative regulation of transcription by RNA polymerase I,BP,
5521,GO:0016480,1,0.931803542449323,0,3,negative regulation of transcription by RNA polymerase III,BP,
5522,GO:0016482,1,0.0570336856385281,0,131,cytosolic transport,BP,
5524,GO:0016486,1,0.68385836094328,0,17,peptide hormone processing,BP,
5526,GO:0016492,1,0.978370823159187,0,1,G-protein coupled neurotensin receptor activity,MF,
5527,GO:0016493,1,0.955355977724006,0,2,C-C chemokine receptor activity,MF,
5528,GO:0016494,1,0.933430260178292,0,3,C-X-C chemokine receptor activity,MF,
5529,GO:0016500,1,0.881324118568532,0,6,protein-hormone receptor activity,MF,
5530,GO:0016502,1,0.871805849600508,0,6,nucleotide receptor activity,MF,
5531,GO:0016503,1,0.976677817110756,0,1,pheromone receptor activity,MF,
5532,GO:0016504,1,0.487380631369597,0,32,peptidase activator activity,MF,
5533,GO:0016505,1,0.700037771179971,0,16,peptidase activator activity involved in apoptotic process,MF,
5534,GO:0016507,1,0.977417970267519,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5535,GO:0016508,1,0.934338835868889,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5536,GO:0016509,1,0.933428984033339,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5537,GO:0016514,1,0.756151343805653,0,13,SWI/SNF complex,CC,
5538,GO:0016517,1,0.977194319940977,0,1,interleukin-12 receptor activity,MF,
5539,GO:0016519,1,0.977205278740426,0,1,gastric inhibitory peptide receptor activity,MF,
5540,GO:0016520,1,0.978788395407958,0,1,growth hormone-releasing hormone receptor activity,MF,
5541,GO:0016524,1,0.955184890372083,0,2,latrotoxin receptor activity,MF,
5543,GO:0016528,1,0.40743709555838,0,43,sarcoplasm,CC,
5544,GO:0016529,1,0.460980638181929,0,37,sarcoplasmic reticulum,CC,
5545,GO:0016530,1,0.8726159917236,0,6,metallochaperone activity,MF,
5546,GO:0016531,1,0.889760786197079,0,5,copper chaperone activity,MF,
5547,GO:0016532,1,0.935523785833757,0,3,superoxide dismutase copper chaperone activity,MF,
5550,GO:0016538,1,0.52567340837639,0,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5551,GO:0016540,1,0.816881748058594,0,9,protein autoprocessing,BP,
5552,GO:0016553,1,0.784909123579726,0,11,base conversion or substitution editing,BP,
5553,GO:0016554,1,0.871489362847175,0,6,cytidine to uridine editing,BP,
5555,GO:0016557,1,0.932486603329874,0,3,peroxisome membrane biogenesis,BP,
5556,GO:0016558,1,0.76247495633595,0,12,protein import into peroxisome matrix,BP,
5557,GO:0016559,1,0.850131272894679,0,7,peroxisome fission,BP,
5558,GO:0016560,1,0.914142071383814,0,4,protein import into peroxisome matrix, docking,BP,
5559,GO:0016561,1,0.955455059293261,0,2,protein import into peroxisome matrix, translocation,BP,
5564,GO:0016572,1,0.525468607957062,0,29,histone phosphorylation,BP,
5568,GO:0016576,1,0.935114329430366,0,3,histone dephosphorylation,BP,
5570,GO:0016578,1,0.628967913064759,0,21,histone deubiquitination,BP,
5575,GO:0016586,1,0.960114743992819,0,2,RSC-type complex,CC,
5576,GO:0016589,1,0.861578698497961,0,7,NURF complex,CC,
5577,GO:0016590,1,0.979874210582587,0,1,ACF complex,CC,
5578,GO:0016591,1,0.0988927015032192,0,103,DNA-directed RNA polymerase II, holoenzyme,CC,
5579,GO:0016592,1,0.461790610330413,0,35,mediator complex,CC,
5580,GO:0016593,1,0.840015783746382,0,8,Cdc73/Paf1 complex,CC,
5581,GO:0016594,1,0.912824427148221,0,4,glycine binding,MF,
5582,GO:0016595,1,0.875699273175907,0,6,glutamate binding,MF,
5583,GO:0016596,1,0.977336572808046,0,1,thienylcyclohexylpiperidine binding,MF,
5584,GO:0016597,1,0.4774425010147,0,33,amino acid binding,MF,
5585,GO:0016598,1,0.954890219670928,0,2,protein arginylation,BP,
5586,GO:0016600,1,0.843825582564128,0,8,flotillin complex,CC,
5587,GO:0016601,1,0.474680210838012,0,34,Rac protein signal transduction,BP,
5589,GO:0016603,1,0.954813777734179,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5594,GO:0016615,1,0.871573264582414,0,6,malate dehydrogenase activity,MF,
5596,GO:0016618,1,0.9330920921624,0,3,hydroxypyruvate reductase activity,MF,
5598,GO:0016623,1,0.979089442523572,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5599,GO:0016624,1,0.834660480157468,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5602,GO:0016634,1,0.874189502340091,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5603,GO:0016635,1,0.869915439800251,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5604,GO:0016638,1,0.763213830640041,0,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5605,GO:0016639,1,0.977750668747366,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5606,GO:0016641,1,0.798108586842636,0,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5607,GO:0016642,1,0.978077783305344,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5610,GO:0016647,1,0.954796565456556,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5611,GO:0016649,1,0.955299103165276,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5613,GO:0016652,1,0.978856154605981,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5614,GO:0016653,1,0.765530448339757,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5616,GO:0016657,1,0.977160758322415,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5617,GO:0016661,1,0.891867715886639,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5618,GO:0016662,1,0.977259564888281,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5619,GO:0016667,1,0.315124193030859,0,50,oxidoreductase activity, acting on a sulfur group of donors,MF,
5620,GO:0016668,1,0.775338600135046,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5621,GO:0016670,1,0.85591349983728,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5622,GO:0016671,1,0.757794486075294,0,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5623,GO:0016672,1,0.953310591884465,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5624,GO:0016675,1,0.632290524978016,0,19,oxidoreductase activity, acting on a heme group of donors,MF,
5625,GO:0016676,1,0.647034423086108,0,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5626,GO:0016679,1,0.828965338200823,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5627,GO:0016681,1,0.848266285358185,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5628,GO:0016684,1,0.475778299744975,0,32,oxidoreductase activity, acting on peroxide as acceptor,MF,
5629,GO:0016701,1,0.724729271913369,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5630,GO:0016702,1,0.724729271913369,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5632,GO:0016706,1,0.424392996706158,0,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
5633,GO:0016708,1,0.954951169470876,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5635,GO:0016711,1,0.97726049325861,0,1,flavonoid 3'-monooxygenase activity,MF,
5637,GO:0016714,1,0.932238514075797,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5638,GO:0016715,1,0.955892241157611,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5639,GO:0016717,1,0.894899841405109,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5640,GO:0016721,1,0.909234376658282,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5641,GO:0016722,1,0.733547034911192,0,14,oxidoreductase activity, oxidizing metal ions,MF,
5642,GO:0016723,1,0.79991139856151,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5643,GO:0016724,1,0.938466281686526,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5644,GO:0016725,1,0.877233701659278,0,6,oxidoreductase activity, acting on CH or CH2 groups,MF,
5645,GO:0016726,1,0.959207939564463,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5646,GO:0016727,1,0.979695484131236,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5647,GO:0016728,1,0.935640111087652,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5648,GO:0016730,1,0.977166788417474,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5649,GO:0016731,1,0.977166788417474,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5652,GO:0016742,1,0.874753742371708,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
5653,GO:0016743,1,0.960813351532309,0,2,carboxyl- or carbamoyltransferase activity,MF,
5654,GO:0016744,1,0.95434734024492,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
5657,GO:0016748,1,0.955073789075131,0,2,succinyltransferase activity,MF,
5658,GO:0016749,1,0.977239483611023,0,1,N-succinyltransferase activity,MF,
5659,GO:0016751,1,0.977319992203879,0,1,S-succinyltransferase activity,MF,
5660,GO:0016755,1,0.812925846732427,0,9,transferase activity, transferring amino-acyl groups,MF,
5665,GO:0016768,1,0.977059918247809,0,1,spermine synthase activity,MF,
5666,GO:0016769,1,0.749432980175052,0,13,transferase activity, transferring nitrogenous groups,MF,
5669,GO:0016774,1,0.933712519113131,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
5670,GO:0016775,1,0.87585996001243,0,6,phosphotransferase activity, nitrogenous group as acceptor,MF,
5672,GO:0016778,1,0.911940232182134,0,4,diphosphotransferase activity,MF,
5674,GO:0016780,1,0.666260065269697,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5675,GO:0016781,1,0.955010019310361,0,2,phosphotransferase activity, paired acceptors,MF,
5676,GO:0016782,1,0.353165221192846,0,46,transferase activity, transferring sulfur-containing groups,MF,
5677,GO:0016783,1,0.755225890780771,0,12,sulfurtransferase activity,MF,
5678,GO:0016784,1,0.97687057577203,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
5679,GO:0016785,1,0.979621985961865,0,1,transferase activity, transferring selenium-containing groups,MF,
5682,GO:0016790,1,0.526620157018846,0,28,thiolester hydrolase activity,MF,
5684,GO:0016793,1,0.977516963269521,0,1,triphosphoric monoester hydrolase activity,MF,
5685,GO:0016794,1,0.976301408164014,0,1,diphosphoric monoester hydrolase activity,MF,
5687,GO:0016798,1,0.148876918574772,0,84,hydrolase activity, acting on glycosyl bonds,MF,
5688,GO:0016799,1,0.63106388212074,0,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
5689,GO:0016801,1,0.743276157737575,0,13,hydrolase activity, acting on ether bonds,MF,
5690,GO:0016802,1,0.936091505332414,0,3,trialkylsulfonium hydrolase activity,MF,
5691,GO:0016803,1,0.79406630986376,0,10,ether hydrolase activity,MF,
5692,GO:0016805,1,0.855884883723725,0,7,dipeptidase activity,MF,
5693,GO:0016807,1,0.977336572808046,0,1,cysteine-type carboxypeptidase activity,MF,
5696,GO:0016812,1,0.899540844451716,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5697,GO:0016813,1,0.871219565796826,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5698,GO:0016814,1,0.595266140414944,0,23,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
5699,GO:0016815,1,0.97674769101636,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
5702,GO:0016822,1,0.954431292782282,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5703,GO:0016823,1,0.954431292782282,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
5704,GO:0016826,1,0.977292681326719,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
5706,GO:0016830,1,0.391182833237692,0,41,carbon-carbon lyase activity,MF,
5707,GO:0016831,1,0.527974466818952,0,28,carboxy-lyase activity,MF,
5708,GO:0016832,1,0.852773580806864,0,7,aldehyde-lyase activity,MF,
5709,GO:0016833,1,0.891114737324118,0,5,oxo-acid-lyase activity,MF,
5712,GO:0016838,1,0.953886676075617,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
5713,GO:0016840,1,0.775084041301928,0,11,carbon-nitrogen lyase activity,MF,
5714,GO:0016841,1,0.933067780094694,0,3,ammonia-lyase activity,MF,
5715,GO:0016842,1,0.849999171933803,0,7,amidine-lyase activity,MF,
5716,GO:0016843,1,0.977336572808046,0,1,amine-lyase activity,MF,
5717,GO:0016844,1,0.977336572808046,0,1,strictosidine synthase activity,MF,
5718,GO:0016846,1,0.847742101148805,0,7,carbon-sulfur lyase activity,MF,
5719,GO:0016849,1,0.829021864415849,0,9,phosphorus-oxygen lyase activity,MF,
5721,GO:0016854,1,0.7467765589306,0,13,racemase and epimerase activity,MF,
5722,GO:0016855,1,0.977247707407595,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5723,GO:0016857,1,0.801268931469529,0,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
5725,GO:0016860,1,0.398111244034519,0,40,intramolecular oxidoreductase activity,MF,
5726,GO:0016861,1,0.830604781365827,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5727,GO:0016862,1,0.9516519515049,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
5728,GO:0016863,1,0.790013512983137,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5729,GO:0016864,1,0.680976853699414,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
5730,GO:0016866,1,0.565328092542362,0,25,intramolecular transferase activity,MF,
5731,GO:0016868,1,0.815888764063125,0,9,intramolecular transferase activity, phosphotransferases,MF,
5732,GO:0016872,1,0.977234861043822,0,1,intramolecular lyase activity,MF,
5735,GO:0016877,1,0.531560647191815,0,28,ligase activity, forming carbon-sulfur bonds,MF,
5736,GO:0016878,1,0.665453206214675,0,18,acid-thiol ligase activity,MF,
5737,GO:0016879,1,0.383558954675428,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
5738,GO:0016880,1,0.956406083250528,0,2,acid-ammonia (or amide) ligase activity,MF,
5739,GO:0016881,1,0.696952844630378,0,16,acid-amino acid ligase activity,MF,
5740,GO:0016882,1,0.95428787787213,0,2,cyclo-ligase activity,MF,
5741,GO:0016884,1,0.800221422415652,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5742,GO:0016885,1,0.841944623588591,0,8,ligase activity, forming carbon-carbon bonds,MF,
5743,GO:0016886,1,0.796552703694303,0,10,ligase activity, forming phosphoric ester bonds,MF,
5745,GO:0016888,1,0.783046505448034,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5746,GO:0016889,1,0.630529510782632,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5747,GO:0016890,1,0.956023711369835,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
5748,GO:0016891,1,0.539006935940269,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5749,GO:0016892,1,0.870014948127591,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5750,GO:0016893,1,0.449440074660314,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5751,GO:0016894,1,0.548437628094792,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5753,GO:0016896,1,0.493141811765328,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
5754,GO:0016898,1,0.977258170732843,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
5755,GO:0016899,1,0.958414717815842,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5756,GO:0016900,1,0.953149914608873,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
5757,GO:0016901,1,0.979829165235173,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5759,GO:0016907,1,0.956355511035102,0,2,G-protein coupled acetylcholine receptor activity,MF,
5760,GO:0016909,1,0.935040812317497,0,3,SAP kinase activity,MF,
5761,GO:0016917,1,0.935914700106942,0,3,GABA receptor activity,MF,
5762,GO:0016918,1,0.889973901653727,0,5,retinal binding,MF,
5763,GO:0016920,1,0.980678692167699,0,1,pyroglutamyl-peptidase activity,MF,
5764,GO:0016922,1,0.684487294397991,0,18,ligand-dependent nuclear receptor binding,MF,
5765,GO:0016925,1,0.152143851309672,0,85,protein sumoylation,BP,
5766,GO:0016926,1,0.85870338226011,0,7,protein desumoylation,BP,
5767,GO:0016929,1,0.878885300292915,0,6,SUMO-specific protease activity,MF,
5768,GO:0016936,1,0.954587762865021,0,2,galactoside binding,MF,
5769,GO:0016938,1,0.977364082902431,0,1,kinesin I complex,CC,
5770,GO:0016939,1,0.938723786229175,0,3,kinesin II complex,CC,
5771,GO:0016941,1,0.977716725298581,0,1,natriuretic peptide receptor activity,MF,
5772,GO:0016942,1,0.935665974993933,0,3,insulin-like growth factor binding protein complex,CC,
5773,GO:0016964,1,0.985821895388937,0,1,alpha-2 macroglobulin receptor activity,MF,
5774,GO:0016971,1,0.934806817646279,0,3,flavin-linked sulfhydryl oxidase activity,MF,
5775,GO:0016972,1,0.915096590553734,0,4,thiol oxidase activity,MF,
5776,GO:0016973,1,0.797166717436195,0,10,poly(A)+ mRNA export from nucleus,BP,
5777,GO:0016979,1,0.976804285345518,0,1,lipoate-protein ligase activity,MF,
5778,GO:0016992,1,0.977047568657905,0,1,lipoate synthase activity,MF,
5779,GO:0016997,1,0.912031412354181,0,4,alpha-sialidase activity,MF,
5780,GO:0016998,1,0.955037480534597,0,2,cell wall macromolecule catabolic process,BP,
5782,GO:0017000,1,0.731820441635093,0,14,antibiotic biosynthetic process,BP,
5783,GO:0017001,1,0.525280001993308,0,28,antibiotic catabolic process,BP,
5784,GO:0017002,1,0.905251531219705,0,5,activin-activated receptor activity,MF,
5785,GO:0017003,1,0.977236511336517,0,1,protein-heme linkage,BP,
5786,GO:0017004,1,0.457341227993281,0,34,cytochrome complex assembly,BP,
5787,GO:0017005,1,0.97790074857919,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5788,GO:0017006,1,0.977236511336517,0,1,protein-tetrapyrrole linkage,BP,
5789,GO:0017014,1,0.803363029042873,0,10,protein nitrosylation,BP,
5793,GO:0017018,1,0.95937050821043,0,2,myosin phosphatase activity,MF,
5794,GO:0017020,1,0.977326025758058,0,1,myosin phosphatase regulator activity,MF,
5795,GO:0017022,1,0.38088802325764,0,44,myosin binding,MF,
5796,GO:0017024,1,0.976059241732398,0,1,myosin I binding,MF,
5797,GO:0017025,1,0.596859756068916,0,23,TBP-class protein binding,MF,
5798,GO:0017034,1,0.901956231801083,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
5800,GO:0017040,1,0.911831703518092,0,4,N-acylsphingosine amidohydrolase activity,MF,
5804,GO:0017050,1,0.955038929194623,0,2,D-erythro-sphingosine kinase activity,MF,
5806,GO:0017055,1,0.955446980677158,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
5807,GO:0017056,1,0.580518944766458,0,25,structural constituent of nuclear pore,MF,
5808,GO:0017057,1,0.958816887391431,0,2,6-phosphogluconolactonase activity,MF,
5809,GO:0017059,1,0.835106253293922,0,8,serine C-palmitoyltransferase complex,CC,
5810,GO:0017060,1,0.955172761219738,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
5811,GO:0017061,1,0.979058017339559,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5812,GO:0017062,1,0.815097172202716,0,9,respiratory chain complex III assembly,BP,
5813,GO:0017064,1,0.977218310459923,0,1,fatty acid amide hydrolase activity,MF,
5814,GO:0017065,1,0.976961626989816,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
5815,GO:0017069,1,0.418283064749011,0,38,snRNA binding,MF,
5816,GO:0017070,1,0.776859401261861,0,11,U6 snRNA binding,MF,
5817,GO:0017075,1,0.736163997850735,0,14,syntaxin-1 binding,MF,
5819,GO:0017080,1,0.617338195043057,0,22,sodium channel regulator activity,MF,
5820,GO:0017081,1,0.766299160399409,0,12,chloride channel regulator activity,MF,
5821,GO:0017082,1,0.977336572808046,0,1,mineralocorticoid receptor activity,MF,
5822,GO:0017084,1,0.977739877776167,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5823,GO:0017085,1,0.715704198370368,0,15,response to insecticide,BP,
5824,GO:0017087,1,0.97817487208623,0,1,mitochondrial processing peptidase complex,CC,
5825,GO:0017089,1,0.954950663978945,0,2,glycolipid transporter activity,MF,
5827,GO:0017095,1,0.957369787288807,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5828,GO:0017098,1,0.977253118713482,0,1,sulfonylurea receptor binding,MF,
5829,GO:0017099,1,0.911874489375033,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5830,GO:0017101,1,0.761206280079353,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5831,GO:0017102,1,0.955232652550234,0,2,methionyl glutamyl tRNA synthetase complex,CC,
5832,GO:0017108,1,0.872543795586959,0,6,5'-flap endonuclease activity,MF,
5833,GO:0017109,1,0.955908231498647,0,2,glutamate-cysteine ligase complex,CC,
5834,GO:0017110,1,0.748328401350121,0,13,nucleoside-diphosphatase activity,MF,
5837,GO:0017113,1,0.977465363898827,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5838,GO:0017116,1,0.93518343697033,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
5839,GO:0017119,1,0.764309922626637,0,12,Golgi transport complex,CC,
5840,GO:0017121,1,0.853550770659777,0,7,phospholipid scrambling,BP,
5842,GO:0017125,1,0.978916740068657,0,1,deoxycytidyl transferase activity,MF,
5843,GO:0017126,1,0.979382506750191,0,1,nucleologenesis,BP,
5844,GO:0017127,1,0.797146555722451,0,10,cholesterol transporter activity,MF,
5845,GO:0017128,1,0.873453548123166,0,6,phospholipid scramblase activity,MF,
5846,GO:0017130,1,0.980491792086748,0,1,poly(C) RNA binding,MF,
5847,GO:0017133,1,0.977240299425335,0,1,mitochondrial electron transfer flavoprotein complex,CC,
5848,GO:0017134,1,0.672463113836737,0,18,fibroblast growth factor binding,MF,
5849,GO:0017136,1,0.701761853914784,0,16,NAD-dependent histone deacetylase activity,MF,
5851,GO:0017143,1,0.95504564418334,0,2,insecticide metabolic process,BP,
5854,GO:0017146,1,0.937458130162552,0,3,NMDA selective glutamate receptor complex,CC,
5857,GO:0017150,1,0.911885215606136,0,4,tRNA dihydrouridine synthase activity,MF,
5858,GO:0017151,1,0.857317836612444,0,7,DEAD/H-box RNA helicase binding,MF,
5859,GO:0017153,1,0.913951535513033,0,4,sodium:dicarboxylate symporter activity,MF,
5860,GO:0017154,1,0.82020649701165,0,10,semaphorin receptor activity,MF,
5861,GO:0017156,1,0.22927871139539,0,67,calcium ion regulated exocytosis,BP,
5863,GO:0017158,1,0.388066271227907,0,43,regulation of calcium ion-dependent exocytosis,BP,
5864,GO:0017160,1,0.739882454596782,0,14,Ral GTPase binding,MF,
5865,GO:0017161,1,0.959162434431509,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5866,GO:0017162,1,0.839158298962436,0,8,aryl hydrocarbon receptor binding,MF,
5867,GO:0017166,1,0.813448249659565,0,10,vinculin binding,MF,
5868,GO:0017168,1,0.97827869321164,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
5869,GO:0017169,1,0.851338899383119,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5870,GO:0017171,1,0.112734510659368,0,96,serine hydrolase activity,MF,
5871,GO:0017176,1,0.848738195542472,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5872,GO:0017177,1,0.978155297178691,0,1,glucosidase II complex,CC,
5873,GO:0017178,1,0.977336572808046,0,1,diphthine-ammonia ligase activity,MF,
5874,GO:0017182,1,0.814105728063515,0,9,peptidyl-diphthamide metabolic process,BP,
5875,GO:0017183,1,0.814105728063515,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5876,GO:0017185,1,0.833701980095705,0,8,peptidyl-lysine hydroxylation,BP,
5877,GO:0017186,1,0.954813777734179,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
5878,GO:0017187,1,0.911051826761595,0,4,peptidyl-glutamic acid carboxylation,BP,
5879,GO:0017196,1,0.875755690196995,0,6,N-terminal peptidyl-methionine acetylation,BP,
5880,GO:0017198,1,0.976043880359759,0,1,N-terminal peptidyl-serine acetylation,BP,
5881,GO:0018002,1,0.976043880359759,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
5882,GO:0018008,1,0.958596775303166,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5883,GO:0018009,1,0.977222672323362,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
5884,GO:0018011,1,0.977336572808046,0,1,N-terminal peptidyl-alanine methylation,BP,
5885,GO:0018012,1,0.977336572808046,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5886,GO:0018013,1,0.977336572808046,0,1,N-terminal peptidyl-glycine methylation,BP,
5887,GO:0018016,1,0.977336572808046,0,1,N-terminal peptidyl-proline dimethylation,BP,
5890,GO:0018024,1,0.417023328906339,0,40,histone-lysine N-methyltransferase activity,MF,
5891,GO:0018025,1,0.977336572808046,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5892,GO:0018026,1,0.820149056319958,0,9,peptidyl-lysine monomethylation,BP,
5893,GO:0018027,1,0.737231333392743,0,14,peptidyl-lysine dimethylation,BP,
5894,GO:0018032,1,0.977982380337757,0,1,protein amidation,BP,
5895,GO:0018057,1,0.934359735283696,0,3,peptidyl-lysine oxidation,BP,
5896,GO:0018063,1,0.977236511336517,0,1,cytochrome c-heme linkage,BP,
5897,GO:0018065,1,0.770925515738968,0,11,protein-cofactor linkage,BP,
5898,GO:0018076,1,0.924904456442972,0,4,N-terminal peptidyl-lysine acetylation,BP,
5899,GO:0018094,1,0.977684350864559,0,1,protein polyglycylation,BP,
5900,GO:0018095,1,0.835559239987862,0,8,protein polyglutamylation,BP,
5901,GO:0018101,1,0.977514784258995,0,1,protein citrullination,BP,
5902,GO:0018103,1,0.877553261808575,0,6,protein C-linked glycosylation,BP,
5904,GO:0018106,1,0.975769274177315,0,1,peptidyl-histidine phosphorylation,BP,
5907,GO:0018114,1,0.977247707407595,0,1,threonine racemase activity,MF,
5908,GO:0018117,1,0.977027899375247,0,1,protein adenylylation,BP,
5909,GO:0018119,1,0.803363029042873,0,10,peptidyl-cysteine S-nitrosylation,BP,
5910,GO:0018125,1,0.933314681518404,0,3,peptidyl-cysteine methylation,BP,
5911,GO:0018126,1,0.639407639650331,0,20,protein hydroxylation,BP,
5913,GO:0018146,1,0.624346084115097,0,21,keratan sulfate biosynthetic process,BP,
5914,GO:0018149,1,0.51741856199613,0,29,peptide cross-linking,BP,
5915,GO:0018153,1,0.955077809291452,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5916,GO:0018158,1,0.81300899980137,0,9,protein oxidation,BP,
5917,GO:0018160,1,0.976864867857557,0,1,peptidyl-pyrromethane cofactor linkage,BP,
5918,GO:0018166,1,0.979247988421086,0,1,C-terminal protein-tyrosinylation,BP,
5919,GO:0018171,1,0.911967428696153,0,4,peptidyl-cysteine oxidation,BP,
5920,GO:0018175,1,0.977027899375247,0,1,protein nucleotidylation,BP,
5921,GO:0018192,1,0.977245957030739,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
5923,GO:0018194,1,0.977336572808046,0,1,peptidyl-alanine modification,BP,
5924,GO:0018195,1,0.67502682389486,0,17,peptidyl-arginine modification,BP,
5925,GO:0018196,1,0.414066652582017,0,39,peptidyl-asparagine modification,BP,
5926,GO:0018197,1,0.938015509083108,0,3,peptidyl-aspartic acid modification,BP,
5927,GO:0018198,1,0.424484028624425,0,38,peptidyl-cysteine modification,BP,
5928,GO:0018199,1,0.911914168955074,0,4,peptidyl-glutamine modification,BP,
5929,GO:0018200,1,0.694670179735869,0,16,peptidyl-glutamic acid modification,BP,
5930,GO:0018201,1,0.936868271430388,0,3,peptidyl-glycine modification,BP,
5931,GO:0018202,1,0.778904979187955,0,11,peptidyl-histidine modification,BP,
5933,GO:0018206,1,0.798591688774782,0,10,peptidyl-methionine modification,BP,
5937,GO:0018211,1,0.877553261808575,0,6,peptidyl-tryptophan modification,BP,
5939,GO:0018214,1,0.911051826761595,0,4,protein carboxylation,BP,
5940,GO:0018216,1,0.742176123941299,0,13,peptidyl-arginine methylation,BP,
5941,GO:0018217,1,0.978251716857322,0,1,peptidyl-aspartic acid phosphorylation,BP,
5942,GO:0018230,1,0.666074581025221,0,18,peptidyl-L-cysteine S-palmitoylation,BP,
5943,GO:0018231,1,0.666074581025221,0,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
5944,GO:0018242,1,0.748753351674791,0,13,protein O-linked glycosylation via serine,BP,
5945,GO:0018243,1,0.766133764541282,0,12,protein O-linked glycosylation via threonine,BP,
5946,GO:0018262,1,0.955077809291452,0,2,isopeptide cross-linking,BP,
5947,GO:0018271,1,0.979895406366628,0,1,biotin-protein ligase activity,MF,
5948,GO:0018272,1,0.977093250950237,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
5949,GO:0018277,1,0.977240783787953,0,1,protein deamination,BP,
5950,GO:0018279,1,0.422304609183987,0,38,protein N-linked glycosylation via asparagine,BP,
5951,GO:0018282,1,0.958417761324736,0,2,metal incorporation into metallo-sulfur cluster,BP,
5952,GO:0018283,1,0.958417761324736,0,2,iron incorporation into metallo-sulfur cluster,BP,
5953,GO:0018293,1,0.976543909332159,0,1,protein-FAD linkage,BP,
5954,GO:0018298,1,0.934680278534664,0,3,protein-chromophore linkage,BP,
5955,GO:0018307,1,0.953912219077036,0,2,enzyme active site formation,BP,
5956,GO:0018312,1,0.955902809568939,0,2,peptidyl-serine ADP-ribosylation,BP,
5957,GO:0018315,1,0.978498490151427,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5958,GO:0018317,1,0.877553261808575,0,6,protein C-linked glycosylation via tryptophan,BP,
5959,GO:0018322,1,0.979247988421086,0,1,protein tyrosinylation,BP,
5960,GO:0018323,1,0.976125001747232,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
5961,GO:0018335,1,0.914069282974158,0,4,protein succinylation,BP,
5962,GO:0018342,1,0.820823269878864,0,9,protein prenylation,BP,
5963,GO:0018343,1,0.93314205972133,0,3,protein farnesylation,BP,
5964,GO:0018344,1,0.874510278334328,0,6,protein geranylgeranylation,BP,
5965,GO:0018345,1,0.543656648625475,0,27,protein palmitoylation,BP,
5966,GO:0018352,1,0.954853827674216,0,2,protein-pyridoxal-5-phosphate linkage,BP,
5967,GO:0018364,1,0.952546830546373,0,2,peptidyl-glutamine methylation,BP,
5968,GO:0018377,1,0.919351113092662,0,4,protein myristoylation,BP,
5971,GO:0018395,1,0.977879752558832,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5972,GO:0018400,1,0.980364431449361,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
5973,GO:0018401,1,0.894500052656935,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5974,GO:0018406,1,0.877553261808575,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5975,GO:0018410,1,0.415913932427433,0,39,C-terminal protein amino acid modification,BP,
5976,GO:0018423,1,0.954531137091481,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
5977,GO:0018444,1,0.937342570921714,0,3,translation release factor complex,CC,
5978,GO:0018455,1,0.976641957177529,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
5979,GO:0018467,1,0.977265812951165,0,1,formaldehyde dehydrogenase activity,MF,
5980,GO:0018478,1,0.977228313431764,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
5981,GO:0018479,1,0.977218005402564,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
5982,GO:0018585,1,0.977225897673674,0,1,fluorene oxygenase activity,MF,
5984,GO:0018738,1,0.976529981244123,0,1,S-formylglutathione hydrolase activity,MF,
5985,GO:0018773,1,0.977050793171147,0,1,acetylpyruvate hydrolase activity,MF,
5986,GO:0018812,1,0.912370967001907,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5987,GO:0018872,1,0.977247011818277,0,1,arsonoacetate metabolic process,BP,
5988,GO:0018879,1,0.933272486985665,0,3,biphenyl metabolic process,BP,
5989,GO:0018894,1,0.933522272566665,0,3,dibenzo-p-dioxin metabolic process,BP,
5990,GO:0018904,1,0.743439671316607,0,13,ether metabolic process,BP,
5991,GO:0018916,1,0.911350402800307,0,4,nitrobenzene metabolic process,BP,
5992,GO:0018917,1,0.977225897673674,0,1,fluorene metabolic process,BP,
5993,GO:0018931,1,0.976793002735808,0,1,naphthalene metabolic process,BP,
5994,GO:0018958,1,0.354370112866315,0,47,phenol-containing compound metabolic process,BP,
5995,GO:0018963,1,0.95495688311921,0,2,phthalate metabolic process,BP,
5997,GO:0018993,1,0.97734492320892,0,1,somatic sex determination,BP,
5998,GO:0018995,1,0.258504099537698,0,61,host,CC,
6000,GO:0019002,1,0.95688419139124,0,2,GMP binding,MF,
6001,GO:0019003,1,0.305744677785812,0,52,GDP binding,MF,
6002,GO:0019005,1,0.309648053982996,0,52,SCF ubiquitin ligase complex,CC,
6003,GO:0019008,1,0.955718037037433,0,2,molybdopterin synthase complex,CC,
6004,GO:0019034,1,0.95809161598972,0,2,viral replication complex,CC,
6005,GO:0019035,1,0.979678259337669,0,1,viral integration complex,CC,
6006,GO:0019042,1,0.782720683158184,0,11,viral latency,BP,
6007,GO:0019043,1,0.813470724438748,0,9,establishment of viral latency,BP,
6008,GO:0019045,1,0.962227767608755,0,2,latent virus replication,BP,
6009,GO:0019046,1,0.962227767608755,0,2,release from viral latency,BP,
6010,GO:0019048,1,0.520727011756501,0,30,modulation by virus of host morphology or physiology,BP,
6011,GO:0019049,1,0.916356812184139,0,4,evasion or tolerance of host defenses by virus,BP,
6012,GO:0019050,1,0.932491614906825,0,3,suppression by virus of host apoptotic process,BP,
6013,GO:0019054,1,0.641870344213363,0,20,modulation by virus of host process,BP,
6015,GO:0019060,1,0.953407760728623,0,2,intracellular transport of viral protein in host cell,BP,
6016,GO:0019061,1,0.977235673746285,0,1,uncoating of virus,BP,
6017,GO:0019062,1,0.912002836124082,0,4,virion attachment to host cell,BP,
6018,GO:0019064,1,0.933252847370079,0,3,fusion of virus membrane with host plasma membrane,BP,
6019,GO:0019065,1,0.935194243496949,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6020,GO:0019068,1,0.438897970571886,0,36,virion assembly,BP,
6021,GO:0019072,1,0.958756724669497,0,2,viral genome packaging,BP,
6022,GO:0019074,1,0.958756724669497,0,2,viral RNA genome packaging,BP,
6023,GO:0019075,1,0.955184890372083,0,2,virus maturation,BP,
6026,GO:0019080,1,0.0132694695442584,0,185,viral gene expression,BP,
6027,GO:0019081,1,0.732182091062738,0,14,viral translation,BP,
6028,GO:0019082,1,0.978427734470736,0,1,viral protein processing,BP,
6029,GO:0019083,1,0.0182164013800994,0,171,viral transcription,BP,
6030,GO:0019085,1,0.956820442299615,0,2,early viral transcription,BP,
6031,GO:0019086,1,0.913412792055513,0,4,late viral transcription,BP,
6032,GO:0019087,1,0.937607677769155,0,3,transformation of host cell by virus,BP,
6033,GO:0019088,1,0.976975693894645,0,1,immortalization of host cell by virus,BP,
6034,GO:0019089,1,0.980178763984006,0,1,transmission of virus,BP,
6035,GO:0019098,1,0.683203145950727,0,17,reproductive behavior,BP,
6037,GO:0019101,1,0.97734492320892,0,1,female somatic sex determination,BP,
6038,GO:0019103,1,0.871258311426939,0,6,pyrimidine nucleotide binding,MF,
6039,GO:0019104,1,0.70451302653687,0,15,DNA N-glycosylase activity,MF,
6040,GO:0019107,1,0.958596775303166,0,2,myristoyltransferase activity,MF,
6041,GO:0019118,1,0.97674769101636,0,1,phenanthrene-epoxide hydrolase activity,MF,
6042,GO:0019119,1,0.97674769101636,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6043,GO:0019135,1,0.977162489297414,0,1,deoxyhypusine monooxygenase activity,MF,
6044,GO:0019136,1,0.912662510188306,0,4,deoxynucleoside kinase activity,MF,
6045,GO:0019144,1,0.954015713130766,0,2,ADP-sugar diphosphatase activity,MF,
6046,GO:0019145,1,0.977249669661019,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6047,GO:0019150,1,0.977210590130378,0,1,D-ribulokinase activity,MF,
6048,GO:0019153,1,0.976986827483947,0,1,protein-disulfide reductase (glutathione) activity,MF,
6050,GO:0019166,1,0.93292891357007,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6051,GO:0019171,1,0.981680997075231,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6052,GO:0019184,1,0.692569507766445,0,16,nonribosomal peptide biosynthetic process,BP,
6053,GO:0019185,1,0.956595115730873,0,2,snRNA-activating protein complex,CC,
6054,GO:0019187,1,0.978188551837522,0,1,beta-1,4-mannosyltransferase activity,MF,
6058,GO:0019201,1,0.642608586727528,0,20,nucleotide kinase activity,MF,
6059,GO:0019202,1,0.977739877776167,0,1,amino acid kinase activity,MF,
6060,GO:0019203,1,0.894795682843417,0,5,carbohydrate phosphatase activity,MF,
6062,GO:0019206,1,0.794283788093518,0,10,nucleoside kinase activity,MF,
6064,GO:0019208,1,0.201556134623094,0,72,phosphatase regulator activity,MF,
6067,GO:0019211,1,0.799669668978631,0,10,phosphatase activator activity,MF,
6068,GO:0019212,1,0.58730064527227,0,24,phosphatase inhibitor activity,MF,
6070,GO:0019215,1,0.78898888459465,0,11,intermediate filament binding,MF,
6072,GO:0019217,1,0.281975588101562,0,58,regulation of fatty acid metabolic process,BP,
6079,GO:0019227,1,0.937147909058496,0,3,neuronal action potential propagation,BP,
6080,GO:0019228,1,0.761324047530656,0,13,neuronal action potential,BP,
6082,GO:0019230,1,0.960983749136324,0,2,proprioception,BP,
6083,GO:0019233,1,0.41186774987914,0,40,sensory perception of pain,BP,
6084,GO:0019236,1,0.955357918797887,0,2,response to pheromone,BP,
6085,GO:0019237,1,0.875064262844778,0,6,centromeric DNA binding,MF,
6086,GO:0019238,1,0.871890395803628,0,6,cyclohydrolase activity,MF,
6087,GO:0019239,1,0.580374144330948,0,24,deaminase activity,MF,
6088,GO:0019240,1,0.922429215636921,0,4,citrulline biosynthetic process,BP,
6089,GO:0019242,1,0.977215620358776,0,1,methylglyoxal biosynthetic process,BP,
6090,GO:0019243,1,0.954860242865957,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6092,GO:0019254,1,0.955084725980246,0,2,carnitine metabolic process, CoA-linked,BP,
6093,GO:0019255,1,0.954938866084709,0,2,glucose 1-phosphate metabolic process,BP,
6094,GO:0019262,1,0.890583387729535,0,5,N-acetylneuraminate catabolic process,BP,
6095,GO:0019264,1,0.954995661654482,0,2,glycine biosynthetic process from serine,BP,
6096,GO:0019276,1,0.977326624918034,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6097,GO:0019285,1,0.977824130376218,0,1,glycine betaine biosynthetic process from choline,BP,
6098,GO:0019287,1,0.932572529841197,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6099,GO:0019290,1,0.977350409268411,0,1,siderophore biosynthetic process,BP,
6100,GO:0019303,1,0.953629186497869,0,2,D-ribose catabolic process,BP,
6105,GO:0019321,1,0.773938150620163,0,11,pentose metabolic process,BP,
6106,GO:0019322,1,0.911336378747837,0,4,pentose biosynthetic process,BP,
6107,GO:0019323,1,0.911364668633798,0,4,pentose catabolic process,BP,
6108,GO:0019336,1,0.892247943651626,0,5,phenol-containing compound catabolic process,BP,
6109,GO:0019341,1,0.97726049325861,0,1,dibenzo-p-dioxin catabolic process,BP,
6110,GO:0019343,1,0.954871812979583,0,2,cysteine biosynthetic process via cystathionine,BP,
6111,GO:0019344,1,0.933136079754553,0,3,cysteine biosynthetic process,BP,
6112,GO:0019346,1,0.912014008824347,0,4,transsulfuration,BP,
6113,GO:0019348,1,0.891709438182553,0,5,dolichol metabolic process,BP,
6114,GO:0019353,1,0.977277846148232,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6115,GO:0019355,1,0.958029329710443,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6116,GO:0019357,1,0.977336572808046,0,1,nicotinate nucleotide biosynthetic process,BP,
6117,GO:0019358,1,0.977336572808046,0,1,nicotinate nucleotide salvage,BP,
6121,GO:0019364,1,0.977755183855241,0,1,pyridine nucleotide catabolic process,BP,
6122,GO:0019365,1,0.977336572808046,0,1,pyridine nucleotide salvage,BP,
6123,GO:0019367,1,0.892309679212437,0,5,fatty acid elongation, saturated fatty acid,BP,
6124,GO:0019368,1,0.892309679212437,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6126,GO:0019370,1,0.850224976946093,0,7,leukotriene biosynthetic process,BP,
6128,GO:0019372,1,0.812473625776322,0,9,lipoxygenase pathway,BP,
6130,GO:0019374,1,0.873314088186656,0,6,galactolipid metabolic process,BP,
6131,GO:0019375,1,0.933840238957038,0,3,galactolipid biosynthetic process,BP,
6132,GO:0019376,1,0.977344024735263,0,1,galactolipid catabolic process,BP,
6133,GO:0019377,1,0.777496272431554,0,11,glycolipid catabolic process,BP,
6134,GO:0019388,1,0.834740004540256,0,8,galactose catabolic process,BP,
6135,GO:0019389,1,0.977265332913864,0,1,glucuronoside metabolic process,BP,
6136,GO:0019391,1,0.977265332913864,0,1,glucuronoside catabolic process,BP,
6137,GO:0019395,1,0.169340362578604,0,79,fatty acid oxidation,BP,
6138,GO:0019400,1,0.729607915326191,0,14,alditol metabolic process,BP,
6139,GO:0019401,1,0.911743362702569,0,4,alditol biosynthetic process,BP,
6140,GO:0019402,1,0.976746502113978,0,1,galactitol metabolic process,BP,
6141,GO:0019405,1,0.878734725406625,0,6,alditol catabolic process,BP,
6142,GO:0019406,1,0.976793002735808,0,1,hexitol biosynthetic process,BP,
6143,GO:0019407,1,0.977251621836658,0,1,hexitol catabolic process,BP,
6144,GO:0019408,1,0.956707395916486,0,2,dolichol biosynthetic process,BP,
6145,GO:0019413,1,0.95655302918574,0,2,acetate biosynthetic process,BP,
6146,GO:0019417,1,0.956452626803049,0,2,sulfur oxidation,BP,
6147,GO:0019418,1,0.909317316752405,0,4,sulfide oxidation,BP,
6148,GO:0019427,1,0.95655302918574,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6149,GO:0019430,1,0.677208081069954,0,17,removal of superoxide radicals,BP,
6150,GO:0019432,1,0.572601829160615,0,25,triglyceride biosynthetic process,BP,
6151,GO:0019433,1,0.781016497378751,0,11,triglyceride catabolic process,BP,
6154,GO:0019441,1,0.932816318383674,0,3,tryptophan catabolic process to kynurenine,BP,
6155,GO:0019448,1,0.977259564888281,0,1,L-cysteine catabolic process,BP,
6156,GO:0019464,1,0.933707787402824,0,3,glycine decarboxylation via glycine cleavage system,BP,
6159,GO:0019474,1,0.935770857447579,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6160,GO:0019477,1,0.935770857447579,0,3,L-lysine catabolic process,BP,
6161,GO:0019482,1,0.955791949163422,0,2,beta-alanine metabolic process,BP,
6162,GO:0019483,1,0.977465363898827,0,1,beta-alanine biosynthetic process,BP,
6163,GO:0019493,1,0.977193272419246,0,1,arginine catabolic process to proline,BP,
6164,GO:0019509,1,0.892316876350741,0,5,L-methionine salvage from methylthioadenosine,BP,
6165,GO:0019510,1,0.977236761020266,0,1,S-adenosylhomocysteine catabolic process,BP,
6166,GO:0019511,1,0.781872596673281,0,11,peptidyl-proline hydroxylation,BP,
6167,GO:0019516,1,0.977258170732843,0,1,lactate oxidation,BP,
6168,GO:0019518,1,0.97697482644469,0,1,L-threonine catabolic process to glycine,BP,
6169,GO:0019519,1,0.977251621836658,0,1,pentitol metabolic process,BP,
6170,GO:0019520,1,0.955034074459794,0,2,aldonic acid metabolic process,BP,
6171,GO:0019521,1,0.955034074459794,0,2,D-gluconate metabolic process,BP,
6172,GO:0019527,1,0.977251621836658,0,1,pentitol catabolic process,BP,
6173,GO:0019530,1,0.916355184818037,0,4,taurine metabolic process,BP,
6174,GO:0019531,1,0.897221604297329,0,5,oxalate transmembrane transporter activity,MF,
6175,GO:0019532,1,0.897221604297329,0,5,oxalate transport,BP,
6176,GO:0019534,1,0.920179854852339,0,4,toxin transmembrane transporter activity,MF,
6178,GO:0019541,1,0.934729676273483,0,3,propionate metabolic process,BP,
6179,GO:0019542,1,0.95655302918574,0,2,propionate biosynthetic process,BP,
6180,GO:0019543,1,0.977189187541157,0,1,propionate catabolic process,BP,
6181,GO:0019544,1,0.977193272419246,0,1,arginine catabolic process to glutamate,BP,
6182,GO:0019547,1,0.954563853604802,0,2,arginine catabolic process to ornithine,BP,
6183,GO:0019550,1,0.954984103970313,0,2,glutamate catabolic process to aspartate,BP,
6184,GO:0019551,1,0.954984103970313,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6185,GO:0019556,1,0.977485040241761,0,1,histidine catabolic process to glutamate and formamide,BP,
6186,GO:0019557,1,0.977485040241761,0,1,histidine catabolic process to glutamate and formate,BP,
6187,GO:0019563,1,0.899198104842436,0,5,glycerol catabolic process,BP,
6188,GO:0019585,1,0.75928868180284,0,12,glucuronate metabolic process,BP,
6189,GO:0019605,1,0.977174864359116,0,1,butyrate metabolic process,BP,
6190,GO:0019614,1,0.892247943651626,0,5,catechol-containing compound catabolic process,BP,
6191,GO:0019626,1,0.85224297881089,0,7,short-chain fatty acid catabolic process,BP,
6194,GO:0019640,1,0.890078446792012,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6195,GO:0019646,1,0.715057540346855,0,14,aerobic electron transport chain,BP,
6196,GO:0019659,1,0.977336572808046,0,1,glucose catabolic process to lactate,BP,
6197,GO:0019660,1,0.977336572808046,0,1,glycolytic fermentation,BP,
6198,GO:0019661,1,0.977336572808046,0,1,glucose catabolic process to lactate via pyruvate,BP,
6199,GO:0019666,1,0.977336572808046,0,1,nitrogenous compound fermentation,BP,
6200,GO:0019673,1,0.848793170248495,0,7,GDP-mannose metabolic process,BP,
6202,GO:0019676,1,0.978585979820246,0,1,ammonia assimilation cycle,BP,
6203,GO:0019677,1,0.977755183855241,0,1,NAD catabolic process,BP,
6204,GO:0019682,1,0.618308069499982,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6205,GO:0019692,1,0.5093894226604,0,29,deoxyribose phosphate metabolic process,BP,
6207,GO:0019694,1,0.916355184818037,0,4,alkanesulfonate metabolic process,BP,
6208,GO:0019695,1,0.914000989050722,0,4,choline metabolic process,BP,
6209,GO:0019706,1,0.595488852835236,0,23,protein-cysteine S-palmitoyltransferase activity,MF,
6210,GO:0019707,1,0.595488852835236,0,23,protein-cysteine S-acyltransferase activity,MF,
6211,GO:0019720,1,0.87278013360123,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6212,GO:0019722,1,0.13337882379957,0,92,calcium-mediated signaling,BP,
6217,GO:0019732,1,0.955200236993224,0,2,antifungal humoral response,BP,
6218,GO:0019740,1,0.934091866974236,0,3,nitrogen utilization,BP,
6219,GO:0019742,1,0.977243143114247,0,1,pentacyclic triterpenoid metabolic process,BP,
6220,GO:0019747,1,0.97606264604046,0,1,regulation of isoprenoid metabolic process,BP,
6224,GO:0019755,1,0.912966033595298,0,4,one-carbon compound transport,BP,
6225,GO:0019763,1,0.956102590211672,0,2,immunoglobulin receptor activity,MF,
6226,GO:0019770,1,0.977103823631464,0,1,IgG receptor activity,MF,
6227,GO:0019773,1,0.845920418035127,0,7,proteasome core complex, alpha-subunit complex,CC,
6228,GO:0019774,1,0.785880102780726,0,10,proteasome core complex, beta-subunit complex,CC,
6229,GO:0019776,1,0.934294809740965,0,3,Atg8 ligase activity,MF,
6230,GO:0019777,1,0.954372166621359,0,2,Atg12 transferase activity,MF,
6231,GO:0019778,1,0.979101482028327,0,1,Atg12 activating enzyme activity,MF,
6232,GO:0019779,1,0.979101482028327,0,1,Atg8 activating enzyme activity,MF,
6233,GO:0019780,1,0.980233928921456,0,1,FAT10 activating enzyme activity,MF,
6234,GO:0019781,1,0.954875188820433,0,2,NEDD8 activating enzyme activity,MF,
6235,GO:0019782,1,0.977618565028868,0,1,ISG15 activating enzyme activity,MF,
6236,GO:0019783,1,0.122256813251344,0,97,ubiquitin-like protein-specific protease activity,MF,
6237,GO:0019784,1,0.850183984842632,0,7,NEDD8-specific protease activity,MF,
6238,GO:0019785,1,0.956018675184603,0,2,ISG15-specific protease activity,MF,
6240,GO:0019788,1,0.871539765765316,0,6,NEDD8 transferase activity,MF,
6241,GO:0019789,1,0.701962386905813,0,16,SUMO transferase activity,MF,
6242,GO:0019797,1,0.933533439989935,0,3,procollagen-proline 3-dioxygenase activity,MF,
6243,GO:0019798,1,0.871292433584075,0,6,procollagen-proline dioxygenase activity,MF,
6244,GO:0019799,1,0.977336572808046,0,1,tubulin N-acetyltransferase activity,MF,
6245,GO:0019800,1,0.976890959500661,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6246,GO:0019808,1,0.931766847365463,0,3,polyamine binding,MF,
6247,GO:0019809,1,0.953154223838733,0,2,spermidine binding,MF,
6248,GO:0019810,1,0.977565470883024,0,1,putrescine binding,MF,
6249,GO:0019811,1,0.978740367579142,0,1,cocaine binding,MF,
6250,GO:0019814,1,0.979148195395373,0,1,immunoglobulin complex,CC,
6251,GO:0019815,1,0.979148195395373,0,1,B cell receptor complex,CC,
6253,GO:0019826,1,0.958216833226879,0,2,oxygen sensor activity,MF,
6255,GO:0019828,1,0.976686626112186,0,1,aspartic-type endopeptidase inhibitor activity,MF,
6256,GO:0019829,1,0.471106755334102,0,34,cation-transporting ATPase activity,MF,
6257,GO:0019834,1,0.932401132776372,0,3,phospholipase A2 inhibitor activity,MF,
6258,GO:0019835,1,0.67270803576253,0,17,cytolysis,BP,
6261,GO:0019841,1,0.910397919803126,0,4,retinol binding,MF,
6265,GO:0019853,1,0.97687057577203,0,1,L-ascorbic acid biosynthetic process,BP,
6267,GO:0019856,1,0.880492615857637,0,6,pyrimidine nucleobase biosynthetic process,BP,
6268,GO:0019857,1,0.949019424628884,0,3,5-methylcytosine metabolic process,BP,
6269,GO:0019858,1,0.954648037224172,0,2,cytosine metabolic process,BP,
6270,GO:0019859,1,0.955204944545166,0,2,thymine metabolic process,BP,
6271,GO:0019860,1,0.954957997264777,0,2,uracil metabolic process,BP,
6272,GO:0019862,1,0.976960734559609,0,1,IgA binding,MF,
6273,GO:0019863,1,0.976796402062362,0,1,IgE binding,MF,
6274,GO:0019864,1,0.977103823631464,0,1,IgG binding,MF,
6275,GO:0019865,1,0.93243638626943,0,3,immunoglobulin binding,MF,
6276,GO:0019866,1,2.44692090513869e-05,0,450,organelle inner membrane,CC,
6278,GO:0019869,1,0.857885049450743,0,7,chloride channel inhibitor activity,MF,
6279,GO:0019870,1,0.900877869012874,0,5,potassium channel inhibitor activity,MF,
6280,GO:0019871,1,0.89950818715709,0,5,sodium channel inhibitor activity,MF,
6281,GO:0019878,1,0.957580312632139,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6282,GO:0019882,1,0.0201855827306254,0,171,antigen processing and presentation,BP,
6283,GO:0019883,1,0.780459310996317,0,11,antigen processing and presentation of endogenous antigen,BP,
6284,GO:0019884,1,0.0373426587878267,0,144,antigen processing and presentation of exogenous antigen,BP,
6285,GO:0019885,1,0.855487879754726,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6286,GO:0019886,1,0.192343531566786,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6288,GO:0019888,1,0.254269970961645,0,61,protein phosphatase regulator activity,MF,
6289,GO:0019894,1,0.479230349458919,0,34,kinesin binding,MF,
6290,GO:0019896,1,0.78726902443365,0,11,axonal transport of mitochondrion,BP,
6291,GO:0019897,1,0.111312503448374,0,100,extrinsic component of plasma membrane,CC,
6300,GO:0019907,1,0.85556802519486,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6301,GO:0019908,1,0.702759286751955,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6303,GO:0019912,1,0.954985360219948,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6304,GO:0019915,1,0.361295412831782,0,46,lipid storage,BP,
6305,GO:0019918,1,0.912198147299399,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6306,GO:0019919,1,0.850987064876418,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6309,GO:0019934,1,0.895932053809219,0,5,cGMP-mediated signaling,BP,
6312,GO:0019948,1,0.955033064411746,0,2,SUMO activating enzyme activity,MF,
6315,GO:0019956,1,0.781632968728412,0,11,chemokine binding,MF,
6316,GO:0019957,1,0.955231205576897,0,2,C-C chemokine binding,MF,
6317,GO:0019958,1,0.93379328553852,0,3,C-X-C chemokine binding,MF,
6318,GO:0019959,1,0.977247778643839,0,1,interleukin-8 binding,MF,
6319,GO:0019960,1,0.939795030053156,0,3,C-X3-C chemokine binding,MF,
6320,GO:0019961,1,0.958138080636622,0,2,interferon binding,MF,
6321,GO:0019962,1,0.979956305315631,0,1,type I interferon binding,MF,
6322,GO:0019964,1,0.977737190205982,0,1,interferon-gamma binding,MF,
6323,GO:0019966,1,0.854503111767757,0,7,interleukin-1 binding,MF,
6324,GO:0019970,1,0.977514784258995,0,1,interleukin-11 binding,MF,
6325,GO:0019981,1,0.956373368796995,0,2,interleukin-6 binding,MF,
6326,GO:0019985,1,0.41625831018058,0,39,translesion synthesis,BP,
6327,GO:0019988,1,0.977287315003688,0,1,charged-tRNA amino acid modification,BP,
6328,GO:0019992,1,0.840742409824531,0,8,diacylglycerol binding,MF,
6329,GO:0020003,1,0.977336572808046,0,1,symbiont-containing vacuole,CC,
6330,GO:0020012,1,0.957034319356571,0,2,evasion or tolerance of host immune response,BP,
6331,GO:0020016,1,0.935791958072182,0,3,ciliary pocket,CC,
6332,GO:0020018,1,0.935791958072182,0,3,ciliary pocket membrane,CC,
6333,GO:0020021,1,0.976975693894645,0,1,immortalization of host cell,BP,
6334,GO:0020027,1,0.834410886558686,0,8,hemoglobin metabolic process,BP,
6336,GO:0021501,1,0.977215289100987,0,1,prechordal plate formation,BP,
6337,GO:0021502,1,0.957001073165167,0,2,neural fold elevation formation,BP,
6338,GO:0021503,1,0.98165204135509,0,1,neural fold bending,BP,
6339,GO:0021508,1,0.980454992691561,0,1,floor plate formation,BP,
6341,GO:0021511,1,0.842485032825641,0,8,spinal cord patterning,BP,
6342,GO:0021512,1,0.978488454428129,0,1,spinal cord anterior/posterior patterning,BP,
6343,GO:0021513,1,0.861017160861955,0,7,spinal cord dorsal/ventral patterning,BP,
6344,GO:0021514,1,0.92275658144085,0,4,ventral spinal cord interneuron differentiation,BP,
6345,GO:0021515,1,0.695878712012339,0,17,cell differentiation in spinal cord,BP,
6346,GO:0021516,1,0.957178180552542,0,2,dorsal spinal cord development,BP,
6347,GO:0021517,1,0.69276668331718,0,17,ventral spinal cord development,BP,
6348,GO:0021520,1,0.879122340654353,0,6,spinal cord motor neuron cell fate specification,BP,
6349,GO:0021521,1,0.942136662152308,0,3,ventral spinal cord interneuron specification,BP,
6350,GO:0021522,1,0.708468724955594,0,16,spinal cord motor neuron differentiation,BP,
6351,GO:0021523,1,0.954872630414649,0,2,somatic motor neuron differentiation,BP,
6352,GO:0021524,1,0.954919959607864,0,2,visceral motor neuron differentiation,BP,
6353,GO:0021526,1,0.977156409538995,0,1,medial motor column neuron differentiation,BP,
6354,GO:0021527,1,0.979434221499239,0,1,spinal cord association neuron differentiation,BP,
6357,GO:0021534,1,0.901139093579364,0,5,cell proliferation in hindbrain,BP,
6358,GO:0021535,1,0.810474233549016,0,10,cell migration in hindbrain,BP,
6361,GO:0021538,1,0.977794446841555,0,1,epithalamus development,BP,
6362,GO:0021539,1,0.954729061165532,0,2,subthalamus development,BP,
6363,GO:0021540,1,0.91262537977454,0,4,corpus callosum morphogenesis,BP,
6364,GO:0021541,1,0.978459583460763,0,1,ammon gyrus development,BP,
6365,GO:0021542,1,0.839558763106944,0,8,dentate gyrus development,BP,
6367,GO:0021544,1,0.70677436827314,0,16,subpallium development,BP,
6369,GO:0021546,1,0.955136332030713,0,2,rhombomere development,BP,
6370,GO:0021547,1,0.977215289100987,0,1,midbrain-hindbrain boundary initiation,BP,
6373,GO:0021553,1,0.983026093186884,0,1,olfactory nerve development,BP,
6374,GO:0021554,1,0.882967951862735,0,6,optic nerve development,BP,
6378,GO:0021559,1,0.876812234959666,0,6,trigeminal nerve development,BP,
6379,GO:0021560,1,0.955389722559965,0,2,abducens nerve development,BP,
6380,GO:0021561,1,0.87787933056911,0,6,facial nerve development,BP,
6381,GO:0021562,1,0.917751548747196,0,4,vestibulocochlear nerve development,BP,
6382,GO:0021563,1,0.961213227045708,0,2,glossopharyngeal nerve development,BP,
6383,GO:0021564,1,0.960598578578652,0,2,vagus nerve development,BP,
6384,GO:0021566,1,0.979076571761333,0,1,hypoglossal nerve development,BP,
6385,GO:0021569,1,0.976985980526725,0,1,rhombomere 3 development,BP,
6386,GO:0021570,1,0.976985980526725,0,1,rhombomere 4 development,BP,
6387,GO:0021571,1,0.977637592450911,0,1,rhombomere 5 development,BP,
6388,GO:0021572,1,0.977637592450911,0,1,rhombomere 6 development,BP,
6390,GO:0021577,1,0.978215840467631,0,1,hindbrain structural organization,BP,
6393,GO:0021587,1,0.604250321571582,0,24,cerebellum morphogenesis,BP,
6394,GO:0021589,1,0.978215840467631,0,1,cerebellum structural organization,BP,
6395,GO:0021590,1,0.959892664603267,0,2,cerebellum maturation,BP,
6396,GO:0021591,1,0.691219068754799,0,17,ventricular system development,BP,
6397,GO:0021592,1,0.979341286534124,0,1,fourth ventricle development,BP,
6398,GO:0021598,1,0.955389722559965,0,2,abducens nerve morphogenesis,BP,
6399,GO:0021599,1,0.955389722559965,0,2,abducens nerve formation,BP,
6400,GO:0021602,1,0.722091198563914,0,15,cranial nerve morphogenesis,BP,
6401,GO:0021603,1,0.915073199859178,0,4,cranial nerve formation,BP,
6402,GO:0021604,1,0.896647900267264,0,5,cranial nerve structural organization,BP,
6403,GO:0021610,1,0.87787933056911,0,6,facial nerve morphogenesis,BP,
6404,GO:0021612,1,0.896647900267264,0,5,facial nerve structural organization,BP,
6405,GO:0021615,1,0.97755736481163,0,1,glossopharyngeal nerve morphogenesis,BP,
6406,GO:0021618,1,0.979076571761333,0,1,hypoglossal nerve morphogenesis,BP,
6407,GO:0021622,1,0.977594247778204,0,1,oculomotor nerve morphogenesis,BP,
6408,GO:0021623,1,0.977594247778204,0,1,oculomotor nerve formation,BP,
6410,GO:0021631,1,0.941362943807315,0,3,optic nerve morphogenesis,BP,
6411,GO:0021636,1,0.917776358679866,0,4,trigeminal nerve morphogenesis,BP,
6412,GO:0021637,1,0.917776358679866,0,4,trigeminal nerve structural organization,BP,
6413,GO:0021644,1,0.976932304387576,0,1,vagus nerve morphogenesis,BP,
6414,GO:0021648,1,0.957468852502899,0,2,vestibulocochlear nerve morphogenesis,BP,
6415,GO:0021649,1,0.977248066779519,0,1,vestibulocochlear nerve structural organization,BP,
6416,GO:0021650,1,0.979762027781853,0,1,vestibulocochlear nerve formation,BP,
6417,GO:0021670,1,0.841174647727091,0,8,lateral ventricle development,BP,
6419,GO:0021678,1,0.932226582830992,0,3,third ventricle development,BP,
6420,GO:0021679,1,0.955530074830908,0,2,cerebellar molecular layer development,BP,
6421,GO:0021680,1,0.73345466005813,0,15,cerebellar Purkinje cell layer development,BP,
6422,GO:0021681,1,0.859229775216316,0,7,cerebellar granular layer development,BP,
6423,GO:0021682,1,0.979659520661845,0,1,nerve maturation,BP,
6424,GO:0021683,1,0.898642066773902,0,5,cerebellar granular layer morphogenesis,BP,
6425,GO:0021684,1,0.937554790762849,0,3,cerebellar granular layer formation,BP,
6426,GO:0021685,1,0.980835956353949,0,1,cerebellar granular layer structural organization,BP,
6427,GO:0021687,1,0.955530074830908,0,2,cerebellar molecular layer morphogenesis,BP,
6428,GO:0021688,1,0.977604713806028,0,1,cerebellar molecular layer formation,BP,
6429,GO:0021691,1,0.959892664603267,0,2,cerebellar Purkinje cell layer maturation,BP,
6430,GO:0021692,1,0.85642741355045,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6431,GO:0021693,1,0.958868271954563,0,2,cerebellar Purkinje cell layer structural organization,BP,
6432,GO:0021694,1,0.910243488634291,0,5,cerebellar Purkinje cell layer formation,BP,
6433,GO:0021695,1,0.513934579515079,0,31,cerebellar cortex development,BP,
6434,GO:0021696,1,0.671956388565979,0,19,cerebellar cortex morphogenesis,BP,
6435,GO:0021697,1,0.780217227367084,0,12,cerebellar cortex formation,BP,
6436,GO:0021698,1,0.958868271954563,0,2,cerebellar cortex structural organization,BP,
6437,GO:0021699,1,0.959892664603267,0,2,cerebellar cortex maturation,BP,
6439,GO:0021702,1,0.910243488634291,0,5,cerebellar Purkinje cell differentiation,BP,
6440,GO:0021707,1,0.937554790762849,0,3,cerebellar granule cell differentiation,BP,
6443,GO:0021730,1,0.981447762631557,0,1,trigeminal sensory nucleus development,BP,
6444,GO:0021740,1,0.981447762631557,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6445,GO:0021747,1,0.937527623402899,0,3,cochlear nucleus development,BP,
6446,GO:0021756,1,0.754097777270017,0,13,striatum development,BP,
6447,GO:0021757,1,0.97790074857919,0,1,caudate nucleus development,BP,
6448,GO:0021758,1,0.97790074857919,0,1,putamen development,BP,
6450,GO:0021762,1,0.498308846447386,0,31,substantia nigra development,BP,
6451,GO:0021763,1,0.977232789220866,0,1,subthalamic nucleus development,BP,
6452,GO:0021764,1,0.964818282614367,0,2,amygdala development,BP,
6454,GO:0021768,1,0.977766064200526,0,1,nucleus accumbens development,BP,
6455,GO:0021769,1,0.936534528492768,0,3,orbitofrontal cortex development,BP,
6456,GO:0021771,1,0.979672264864762,0,1,lateral geniculate nucleus development,BP,
6457,GO:0021772,1,0.71437532055668,0,16,olfactory bulb development,BP,
6458,GO:0021773,1,0.940306435272532,0,3,striatal medium spiny neuron differentiation,BP,
6459,GO:0021775,1,0.942136662152308,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6460,GO:0021776,1,0.942136662152308,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6461,GO:0021778,1,0.981994673640345,0,1,oligodendrocyte cell fate specification,BP,
6462,GO:0021779,1,0.981994673640345,0,1,oligodendrocyte cell fate commitment,BP,
6463,GO:0021780,1,0.981994673640345,0,1,glial cell fate specification,BP,
6468,GO:0021785,1,0.886616606536898,0,6,branchiomotor neuron axon guidance,BP,
6469,GO:0021794,1,0.864396710260854,0,7,thalamus development,BP,
6471,GO:0021796,1,0.934629413169259,0,3,cerebral cortex regionalization,BP,
6472,GO:0021797,1,0.977676153662534,0,1,forebrain anterior/posterior pattern specification,BP,
6473,GO:0021798,1,0.960931779479574,0,2,forebrain dorsal/ventral pattern formation,BP,
6475,GO:0021800,1,0.900771564900391,0,5,cerebral cortex tangential migration,BP,
6477,GO:0021812,1,0.979790393365001,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6478,GO:0021814,1,0.862323183814909,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6479,GO:0021815,1,0.90165100477009,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6480,GO:0021816,1,0.957663405291331,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6481,GO:0021817,1,0.941520634065151,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6483,GO:0021822,1,0.977223251075684,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6484,GO:0021823,1,0.960435050551676,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6485,GO:0021824,1,0.957342999018987,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6486,GO:0021825,1,0.91945967886143,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6487,GO:0021826,1,0.95538558790533,0,2,substrate-independent telencephalic tangential migration,BP,
6488,GO:0021827,1,0.960435050551676,0,2,postnatal olfactory bulb interneuron migration,BP,
6489,GO:0021828,1,0.957342999018987,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6490,GO:0021830,1,0.95538558790533,0,2,interneuron migration from the subpallium to the cortex,BP,
6491,GO:0021836,1,0.960435050551676,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6492,GO:0021840,1,0.977241750571342,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6493,GO:0021842,1,0.977241750571342,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6494,GO:0021843,1,0.95538558790533,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
6495,GO:0021846,1,0.749236495741463,0,14,cell proliferation in forebrain,BP,
6496,GO:0021847,1,0.958396505359444,0,2,ventricular zone neuroblast division,BP,
6497,GO:0021849,1,0.956135028909806,0,2,neuroblast division in subventricular zone,BP,
6498,GO:0021854,1,0.780162074983046,0,11,hypothalamus development,BP,
6499,GO:0021855,1,0.935543437895149,0,3,hypothalamus cell migration,BP,
6500,GO:0021856,1,0.957342999018987,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6501,GO:0021859,1,0.900205997635043,0,5,pyramidal neuron differentiation,BP,
6502,GO:0021860,1,0.900205997635043,0,5,pyramidal neuron development,BP,
6504,GO:0021869,1,0.938879754881398,0,3,forebrain ventricular zone progenitor cell division,BP,
6505,GO:0021870,1,0.979950369533019,0,1,Cajal-Retzius cell differentiation,BP,
6506,GO:0021871,1,0.788326423164992,0,11,forebrain regionalization,BP,
6508,GO:0021873,1,0.88101290386949,0,6,forebrain neuroblast division,BP,
6509,GO:0021877,1,0.897144308839238,0,5,forebrain neuron fate commitment,BP,
6511,GO:0021881,1,0.977676153662534,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6512,GO:0021882,1,0.954989419583485,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6513,GO:0021884,1,0.708968650572634,0,16,forebrain neuron development,BP,
6515,GO:0021886,1,0.934536572958781,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6516,GO:0021888,1,0.934536572958781,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6517,GO:0021889,1,0.880097784612282,0,6,olfactory bulb interneuron differentiation,BP,
6518,GO:0021891,1,0.900998135318518,0,5,olfactory bulb interneuron development,BP,
6519,GO:0021892,1,0.93238040961402,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
6520,GO:0021893,1,0.954989419583485,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6521,GO:0021894,1,0.976329427262412,0,1,cerebral cortex GABAergic interneuron development,BP,
6522,GO:0021895,1,0.803605507382585,0,10,cerebral cortex neuron differentiation,BP,
6523,GO:0021896,1,0.963999090055522,0,2,forebrain astrocyte differentiation,BP,
6524,GO:0021897,1,0.963999090055522,0,2,forebrain astrocyte development,BP,
6525,GO:0021898,1,0.933666734079641,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6526,GO:0021902,1,0.960892706634587,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6528,GO:0021904,1,0.675275424784887,0,18,dorsal/ventral neural tube patterning,BP,
6529,GO:0021910,1,0.88079728231356,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6530,GO:0021914,1,0.955947011704156,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6532,GO:0021924,1,0.901139093579364,0,5,cell proliferation in external granule layer,BP,
6533,GO:0021930,1,0.901139093579364,0,5,cerebellar granule cell precursor proliferation,BP,
6534,GO:0021932,1,0.860184278769777,0,7,hindbrain radial glia guided cell migration,BP,
6535,GO:0021934,1,0.963616495588639,0,2,hindbrain tangential cell migration,BP,
6536,GO:0021935,1,0.963616495588639,0,2,cerebellar granule cell precursor tangential migration,BP,
6537,GO:0021936,1,0.938489480508755,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6538,GO:0021937,1,0.958878063283808,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6539,GO:0021938,1,0.958878063283808,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6540,GO:0021940,1,0.958878063283808,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6541,GO:0021941,1,0.978740367579142,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6542,GO:0021942,1,0.937261919372651,0,3,radial glia guided migration of Purkinje cell,BP,
6543,GO:0021943,1,0.917782166723015,0,4,formation of radial glial scaffolds,BP,
6548,GO:0021956,1,0.97719723613118,0,1,central nervous system interneuron axonogenesis,BP,
6549,GO:0021957,1,0.919392918675993,0,4,corticospinal tract morphogenesis,BP,
6550,GO:0021960,1,0.939653314928016,0,3,anterior commissure morphogenesis,BP,
6551,GO:0021965,1,0.95993900354374,0,2,spinal cord ventral commissure morphogenesis,BP,
6552,GO:0021966,1,0.979106290648909,0,1,corticospinal neuron axon guidance,BP,
6553,GO:0021972,1,0.979106290648909,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6554,GO:0021978,1,0.892662437983769,0,5,telencephalon regionalization,BP,
6555,GO:0021979,1,0.914100267551904,0,4,hypothalamus cell differentiation,BP,
6558,GO:0021986,1,0.977794446841555,0,1,habenula development,BP,
6560,GO:0021988,1,0.698372451025671,0,17,olfactory lobe development,BP,
6561,GO:0021993,1,0.979341286534124,0,1,initiation of neural tube closure,BP,
6562,GO:0021997,1,0.961699923742789,0,2,neural plate axis specification,BP,
6563,GO:0021998,1,0.977879752558832,0,1,neural plate mediolateral regionalization,BP,
6565,GO:0022007,1,0.935579140338883,0,3,convergent extension involved in neural plate elongation,BP,
6567,GO:0022009,1,0.913359789342059,0,4,central nervous system vasculogenesis,BP,
6570,GO:0022012,1,0.981489937335134,0,1,subpallium cell proliferation in forebrain,BP,
6571,GO:0022018,1,0.981489937335134,0,1,lateral ganglionic eminence cell proliferation,BP,
6572,GO:0022027,1,0.928929737472669,0,4,interkinetic nuclear migration,BP,
6573,GO:0022028,1,0.919646473428764,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6578,GO:0022400,1,0.782770072063218,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6579,GO:0022401,1,0.758780254827836,0,12,negative adaptation of signaling pathway,BP,
6587,GO:0022410,1,0.81731437935355,0,9,circadian sleep/wake cycle process,BP,
6591,GO:0022417,1,0.810290170996318,0,9,protein maturation by protein folding,BP,
6593,GO:0022602,1,0.570316829806772,0,26,ovulation cycle process,BP,
6596,GO:0022605,1,0.914235956367916,0,4,mammalian oogenesis stage,BP,
6601,GO:0022614,1,0.91637703811422,0,4,membrane to membrane docking,BP,
6602,GO:0022615,1,0.911518380326075,0,4,protein to membrane docking,BP,
6603,GO:0022616,1,0.57215089495204,0,25,DNA strand elongation,BP,
6604,GO:0022617,1,0.290160407393695,0,57,extracellular matrix disassembly,BP,
6605,GO:0022618,1,0.0121591841740251,0,194,ribonucleoprotein complex assembly,BP,
6606,GO:0022622,1,0.97585624064459,0,1,root system development,BP,
6607,GO:0022624,1,0.571527952185388,0,24,proteasome accessory complex,CC,
6610,GO:0022627,1,0.356565443569977,0,43,cytosolic small ribosomal subunit,CC,
6613,GO:0022821,1,0.823163276985712,0,9,potassium ion antiporter activity,MF,
6614,GO:0022824,1,0.856327941825313,0,7,transmitter-gated ion channel activity,MF,
6616,GO:0022832,1,0.251634510432749,0,63,voltage-gated channel activity,MF,
6617,GO:0022834,1,0.424086264627564,0,40,ligand-gated channel activity,MF,
6618,GO:0022835,1,0.856327941825313,0,7,transmitter-gated channel activity,MF,
6619,GO:0022836,1,0.0937663802506203,0,108,gated channel activity,MF,
6621,GO:0022839,1,0.0959601933058482,0,107,ion gated channel activity,MF,
6622,GO:0022840,1,0.911949508850411,0,4,leak channel activity,MF,
6623,GO:0022841,1,0.933144952554852,0,3,potassium ion leak channel activity,MF,
6624,GO:0022842,1,0.911949508850411,0,4,narrow pore channel activity,MF,
6625,GO:0022843,1,0.425392056056359,0,39,voltage-gated cation channel activity,MF,
6626,GO:0022848,1,0.914276253527769,0,4,acetylcholine-gated cation-selective channel activity,MF,
6627,GO:0022849,1,0.979200065537114,0,1,glutamate-gated calcium ion channel activity,MF,
6628,GO:0022851,1,0.977485040241761,0,1,GABA-gated chloride ion channel activity,MF,
6629,GO:0022853,1,0.461035435839306,0,35,active ion transmembrane transporter activity,MF,
6631,GO:0022858,1,0.895165061291357,0,5,alanine transmembrane transporter activity,MF,
6632,GO:0022884,1,0.720155094385656,0,14,macromolecule transmembrane transporter activity,MF,
6633,GO:0022889,1,0.852339511567451,0,7,serine transmembrane transporter activity,MF,
6637,GO:0022904,1,0.107486439794523,0,94,respiratory electron transport chain,BP,
6639,GO:0023016,1,0.960898750891734,0,2,signal transduction by trans-phosphorylation,BP,
6640,GO:0023019,1,0.822200604531618,0,9,signal transduction involved in regulation of gene expression,BP,
6641,GO:0023021,1,0.933314683709688,0,3,termination of signal transduction,BP,
6642,GO:0023023,1,0.75806931128571,0,12,MHC protein complex binding,MF,
6643,GO:0023024,1,0.977514059501863,0,1,MHC class I protein complex binding,MF,
6644,GO:0023025,1,0.955254328489592,0,2,MHC class Ib protein complex binding,MF,
6645,GO:0023026,1,0.793610081993794,0,10,MHC class II protein complex binding,MF,
6646,GO:0023029,1,0.913340410184311,0,4,MHC class Ib protein binding,MF,
6647,GO:0023030,1,0.955254328489592,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
6648,GO:0023035,1,0.874899288308584,0,6,CD40 signaling pathway,BP,
6654,GO:0023058,1,0.741504306082412,0,13,adaptation of signaling pathway,BP,
6657,GO:0030002,1,0.881540831644616,0,6,cellular anion homeostasis,BP,
6661,GO:0030008,1,0.73992593007669,0,13,TRAPP complex,CC,
6663,GO:0030011,1,0.828903659010854,0,9,maintenance of cell polarity,BP,
6665,GO:0030015,1,0.894560359961288,0,5,CCR4-NOT core complex,CC,
6669,GO:0030020,1,0.938496590054239,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
6671,GO:0030023,1,0.948307498721621,0,3,extracellular matrix constituent conferring elasticity,MF,
6677,GO:0030033,1,0.722470330298525,0,15,microvillus assembly,BP,
6678,GO:0030035,1,0.937388248374299,0,3,microspike assembly,BP,
6680,GO:0030037,1,0.979100680194488,0,1,actin filament reorganization involved in cell cycle,BP,
6683,GO:0030042,1,0.470960002755112,0,35,actin filament depolymerization,BP,
6684,GO:0030043,1,0.911562501457305,0,4,actin filament fragmentation,BP,
6685,GO:0030046,1,0.936199863221169,0,3,parallel actin filament bundle assembly,BP,
6686,GO:0030047,1,0.935720723262214,0,3,actin modification,BP,
6687,GO:0030048,1,0.236307887016565,0,69,actin filament-based movement,BP,
6688,GO:0030049,1,0.754829638737827,0,14,muscle filament sliding,BP,
6689,GO:0030050,1,0.881895950742386,0,6,vesicle transport along actin filament,BP,
6692,GO:0030056,1,0.89769385678023,0,6,hemidesmosome,CC,
6693,GO:0030057,1,0.598633084776396,0,24,desmosome,CC,
6694,GO:0030060,1,0.932104487599588,0,3,L-malate dehydrogenase activity,MF,
6695,GO:0030061,1,0.894011891698402,0,5,mitochondrial crista,CC,
6696,GO:0030062,1,0.875721677773019,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6697,GO:0030070,1,0.937291316185495,0,3,insulin processing,BP,
6698,GO:0030071,1,0.360770312149504,0,46,regulation of mitotic metaphase/anaphase transition,BP,
6701,GO:0030091,1,0.849148214954205,0,7,protein repair,BP,
6706,GO:0030101,1,0.423962779161399,0,38,natural killer cell activation,BP,
6707,GO:0030103,1,0.977486770047155,0,1,vasopressin secretion,BP,
6709,GO:0030108,1,0.97687057577203,0,1,HLA-A specific activating MHC class I receptor activity,MF,
6712,GO:0030118,1,0.373028257072785,0,45,clathrin coat,CC,
6714,GO:0030120,1,0.314598045428873,0,52,vesicle coat,CC,
6715,GO:0030121,1,0.878089969337106,0,6,AP-1 adaptor complex,CC,
6716,GO:0030122,1,0.769449255649131,0,12,AP-2 adaptor complex,CC,
6718,GO:0030124,1,0.914565219889679,0,4,AP-4 adaptor complex,CC,
6719,GO:0030125,1,0.592296735796169,0,24,clathrin vesicle coat,CC,
6720,GO:0030126,1,0.71024654069578,0,15,COPI vesicle coat,CC,
6721,GO:0030127,1,0.732781523792818,0,14,COPII vesicle coat,CC,
6722,GO:0030128,1,0.753158426985622,0,13,clathrin coat of endocytic vesicle,CC,
6723,GO:0030130,1,0.787144662124834,0,11,clathrin coat of trans-Golgi network vesicle,CC,
6724,GO:0030131,1,0.540992494926531,0,28,clathrin adaptor complex,CC,
6725,GO:0030132,1,0.690255024329084,0,17,clathrin coat of coated pit,CC,
6727,GO:0030134,1,0.219699926464194,0,68,COPII-coated ER to Golgi transport vesicle,CC,
6730,GO:0030137,1,0.591648742121226,0,23,COPI-coated vesicle,CC,
6732,GO:0030140,1,0.544556696696788,0,28,trans-Golgi network transport vesicle,CC,
6734,GO:0030144,1,0.934374353659357,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
6735,GO:0030145,1,0.402812342450514,0,41,manganese ion binding,MF,
6736,GO:0030148,1,0.172247206441027,0,78,sphingolipid biosynthetic process,BP,
6737,GO:0030149,1,0.649332781404948,0,19,sphingolipid catabolic process,BP,
6738,GO:0030150,1,0.657531870540793,0,18,protein import into mitochondrial matrix,BP,
6739,GO:0030151,1,0.912231019457971,0,4,molybdenum ion binding,MF,
6742,GO:0030156,1,0.97578205711471,0,1,benzodiazepine receptor binding,MF,
6743,GO:0030157,1,0.881686276490765,0,6,pancreatic juice secretion,BP,
6744,GO:0030158,1,0.938716531299054,0,3,protein xylosyltransferase activity,MF,
6745,GO:0030159,1,0.664564211444004,0,19,receptor signaling complex scaffold activity,MF,
6746,GO:0030160,1,0.94154494732871,0,3,GKAP/Homer scaffold activity,MF,
6749,GO:0030165,1,0.268341198421864,0,61,PDZ domain binding,MF,
6750,GO:0030166,1,0.389232310999579,0,44,proteoglycan biosynthetic process,BP,
6751,GO:0030167,1,0.933849787171903,0,3,proteoglycan catabolic process,BP,
6753,GO:0030169,1,0.881911829662207,0,6,low-density lipoprotein particle binding,MF,
6754,GO:0030170,1,0.475110123462577,0,33,pyridoxal phosphate binding,MF,
6755,GO:0030173,1,0.433377297065375,0,37,integral component of Golgi membrane,CC,
6756,GO:0030174,1,0.872228226948225,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6758,GO:0030176,1,0.060853971361448,0,123,integral component of endoplasmic reticulum membrane,CC,
6763,GO:0030185,1,0.977217150969366,0,1,nitric oxide transport,BP,
6767,GO:0030197,1,0.978632160490589,0,1,extracellular matrix constituent, lubricant activity,MF,
6770,GO:0030200,1,0.933849787171903,0,3,heparan sulfate proteoglycan catabolic process,BP,
6771,GO:0030201,1,0.590959441883646,0,24,heparan sulfate proteoglycan metabolic process,BP,
6772,GO:0030202,1,0.919159820870088,0,4,heparin metabolic process,BP,
6773,GO:0030203,1,0.0877583446831299,0,110,glycosaminoglycan metabolic process,BP,
6774,GO:0030204,1,0.559619961537136,0,27,chondroitin sulfate metabolic process,BP,
6775,GO:0030205,1,0.82584822336081,0,9,dermatan sulfate metabolic process,BP,
6776,GO:0030206,1,0.6805773903127,0,18,chondroitin sulfate biosynthetic process,BP,
6777,GO:0030207,1,0.822631042373595,0,9,chondroitin sulfate catabolic process,BP,
6778,GO:0030208,1,0.845103956748541,0,8,dermatan sulfate biosynthetic process,BP,
6779,GO:0030209,1,0.977229204468921,0,1,dermatan sulfate catabolic process,BP,
6780,GO:0030210,1,0.919159820870088,0,4,heparin biosynthetic process,BP,
6781,GO:0030212,1,0.571539312753127,0,25,hyaluronan metabolic process,BP,
6782,GO:0030213,1,0.781930920700582,0,11,hyaluronan biosynthetic process,BP,
6783,GO:0030214,1,0.746430651635694,0,13,hyaluronan catabolic process,BP,
6784,GO:0030215,1,0.695681816427473,0,17,semaphorin receptor binding,MF,
6789,GO:0030220,1,0.737271507226492,0,14,platelet formation,BP,
6790,GO:0030222,1,0.977884513297394,0,1,eosinophil differentiation,BP,
6791,GO:0030223,1,0.872107763231974,0,6,neutrophil differentiation,BP,
6794,GO:0030226,1,0.950189789219708,0,3,apolipoprotein receptor activity,MF,
6795,GO:0030228,1,0.81528169566407,0,10,lipoprotein particle receptor activity,MF,
6796,GO:0030229,1,0.937025726307692,0,3,very-low-density lipoprotein particle receptor activity,MF,
6797,GO:0030233,1,0.977024058709545,0,1,deoxynucleotide transmembrane transporter activity,MF,
6799,GO:0030235,1,0.857109367066819,0,7,nitric-oxide synthase regulator activity,MF,
6800,GO:0030237,1,0.955990422261053,0,2,female sex determination,BP,
6802,GO:0030239,1,0.579853917906137,0,27,myofibril assembly,BP,
6803,GO:0030240,1,0.999055027153641,0,1,skeletal muscle thin filament assembly,BP,
6804,GO:0030241,1,0.97965270172124,0,2,skeletal muscle myosin thick filament assembly,BP,
6805,GO:0030242,1,0.896950675450666,0,5,autophagy of peroxisome,BP,
6807,GO:0030247,1,0.859462334188729,0,7,polysaccharide binding,MF,
6808,GO:0030249,1,0.977235204612038,0,1,guanylate cyclase regulator activity,MF,
6809,GO:0030250,1,0.977235204612038,0,1,guanylate cyclase activator activity,MF,
6810,GO:0030252,1,0.862743784633608,0,7,growth hormone secretion,BP,
6812,GO:0030259,1,0.913416717720026,0,4,lipid glycosylation,BP,
6815,GO:0030262,1,0.59821383632515,0,23,apoptotic nuclear changes,BP,
6816,GO:0030263,1,0.916161441961926,0,4,apoptotic chromosome condensation,BP,
6817,GO:0030264,1,0.977336572808046,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6818,GO:0030267,1,0.9330920921624,0,3,glyoxylate reductase (NADP) activity,MF,
6819,GO:0030272,1,0.976038744721883,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
6820,GO:0030274,1,0.916174510117388,0,4,LIM domain binding,MF,
6821,GO:0030275,1,0.702470454441758,0,16,LRR domain binding,MF,
6822,GO:0030276,1,0.358339923261559,0,47,clathrin binding,MF,
6826,GO:0030280,1,0.788238211567365,0,11,structural constituent of epidermis,MF,
6828,GO:0030283,1,0.97615407253902,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
6829,GO:0030284,1,0.894774023151394,0,5,estrogen receptor activity,MF,
6830,GO:0030285,1,0.857871591375031,0,7,integral component of synaptic vesicle membrane,CC,
6831,GO:0030286,1,0.491683727439698,0,34,dynein complex,CC,
6832,GO:0030289,1,0.912145995053806,0,4,protein phosphatase 4 complex,CC,
6833,GO:0030290,1,0.977839106612381,0,1,sphingolipid activator protein activity,MF,
6835,GO:0030292,1,0.935545682982752,0,3,protein tyrosine kinase inhibitor activity,MF,
6836,GO:0030294,1,0.977230556928449,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
6838,GO:0030296,1,0.78508947070261,0,11,protein tyrosine kinase activator activity,MF,
6839,GO:0030297,1,0.936832116906822,0,3,transmembrane receptor protein tyrosine kinase activator activity,MF,
6840,GO:0030298,1,0.976570048009942,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
6843,GO:0030302,1,0.977024058709545,0,1,deoxynucleotide transport,BP,
6844,GO:0030305,1,0.977105247915274,0,1,heparanase activity,MF,
6845,GO:0030306,1,0.884556239767527,0,6,ADP-ribosylation factor binding,MF,
6848,GO:0030309,1,0.83227854019733,0,8,poly-N-acetyllactosamine metabolic process,BP,
6849,GO:0030311,1,0.83227854019733,0,8,poly-N-acetyllactosamine biosynthetic process,BP,
6850,GO:0030314,1,0.943632519776818,0,3,junctional membrane complex,CC,
6854,GO:0030318,1,0.760283123235808,0,13,melanocyte differentiation,BP,
6855,GO:0030320,1,0.881540831644616,0,6,cellular monovalent inorganic anion homeostasis,BP,
6856,GO:0030321,1,0.958239938725084,0,2,transepithelial chloride transport,BP,
6857,GO:0030322,1,0.955007484579652,0,2,stabilization of membrane potential,BP,
6860,GO:0030325,1,0.789908512737753,0,11,adrenal gland development,BP,
6862,GO:0030327,1,0.93558403444479,0,3,prenylated protein catabolic process,BP,
6863,GO:0030328,1,0.95713542168462,0,2,prenylcysteine catabolic process,BP,
6864,GO:0030329,1,0.95713542168462,0,2,prenylcysteine metabolic process,BP,
6866,GO:0030331,1,0.487322775544252,0,33,estrogen receptor binding,MF,
6867,GO:0030332,1,0.591309030046779,0,24,cyclin binding,MF,
6871,GO:0030337,1,0.954578072955094,0,2,DNA polymerase processivity factor activity,MF,
6872,GO:0030342,1,0.977497964125548,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6873,GO:0030343,1,0.977001800900464,0,1,vitamin D3 25-hydroxylase activity,MF,
6875,GO:0030346,1,0.877676030284652,0,6,protein phosphatase 2B binding,MF,
6876,GO:0030348,1,0.956616207219215,0,2,syntaxin-3 binding,MF,
6877,GO:0030350,1,0.958428197035475,0,2,iron-responsive element binding,MF,
6878,GO:0030351,1,0.977318107723408,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6879,GO:0030366,1,0.954376171420116,0,2,molybdopterin synthase activity,MF,
6881,GO:0030371,1,0.647323337781185,0,20,translation repressor activity,MF,
6882,GO:0030372,1,0.978959327398272,0,1,high molecular weight B cell growth factor receptor binding,MF,
6884,GO:0030375,1,0.940044617646113,0,3,thyroid hormone receptor coactivator activity,MF,
6885,GO:0030377,1,0.97683296653735,0,1,urokinase plasminogen activator receptor activity,MF,
6886,GO:0030378,1,0.977247707407595,0,1,serine racemase activity,MF,
6887,GO:0030379,1,0.980641773285771,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6888,GO:0030388,1,0.911860163407414,0,4,fructose 1,6-bisphosphate metabolic process,BP,
6889,GO:0030389,1,0.9756807407816,0,1,fructosamine metabolic process,BP,
6890,GO:0030395,1,0.975439797030923,0,1,lactose binding,MF,
6891,GO:0030397,1,0.363657117465492,0,46,membrane disassembly,BP,
6893,GO:0030421,1,0.97606264604046,0,1,defecation,BP,
6894,GO:0030422,1,0.815513138989357,0,9,production of siRNA involved in RNA interference,BP,
6895,GO:0030423,1,0.918253327444038,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6900,GO:0030430,1,0.914044225769263,0,4,host cell cytoplasm,CC,
6903,GO:0030433,1,0.216649966198998,0,68,ubiquitin-dependent ERAD pathway,BP,
6905,GO:0030473,1,0.901805801188321,0,5,nuclear migration along microtubule,BP,
6906,GO:0030474,1,0.977336572808046,0,1,spindle pole body duplication,BP,
6907,GO:0030478,1,0.915583838886748,0,4,actin cap,CC,
6908,GO:0030479,1,0.900671201766862,0,5,actin cortical patch,CC,
6909,GO:0030485,1,0.956233679396922,0,2,smooth muscle contractile fiber,CC,
6913,GO:0030497,1,0.79493432943614,0,10,fatty acid elongation,BP,
6915,GO:0030501,1,0.622598881957959,0,22,positive regulation of bone mineralization,BP,
6917,GO:0030504,1,0.98148361535093,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6918,GO:0030505,1,0.96278444214678,0,2,inorganic diphosphate transport,BP,
6919,GO:0030506,1,0.774729047937883,0,13,ankyrin binding,MF,
6920,GO:0030507,1,0.716057054202926,0,16,spectrin binding,MF,
6931,GO:0030520,1,0.356375294112259,0,47,intracellular estrogen receptor signaling pathway,BP,
6934,GO:0030523,1,0.978575252532462,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6935,GO:0030532,1,0.209524121842853,0,69,small nuclear ribonucleoprotein complex,CC,
6937,GO:0030538,1,0.956143283103847,0,2,embryonic genitalia morphogenesis,BP,
6938,GO:0030539,1,0.840288646050043,0,8,male genitalia development,BP,
6939,GO:0030540,1,0.807182851376826,0,10,female genitalia development,BP,
6942,GO:0030546,1,0.860578825074473,0,7,receptor activator activity,MF,
6943,GO:0030547,1,0.710492749569625,0,15,receptor inhibitor activity,MF,
6944,GO:0030548,1,0.870960957401463,0,6,acetylcholine receptor regulator activity,MF,
6945,GO:0030549,1,0.976463701895273,0,1,acetylcholine receptor activator activity,MF,
6946,GO:0030550,1,0.934507108201289,0,3,acetylcholine receptor inhibitor activity,MF,
6947,GO:0030551,1,0.706860713673672,0,16,cyclic nucleotide binding,MF,
6948,GO:0030552,1,0.789224370917372,0,11,cAMP binding,MF,
6949,GO:0030553,1,0.938316728905478,0,3,cGMP binding,MF,
6951,GO:0030572,1,0.978052764708119,0,1,phosphatidyltransferase activity,MF,
6954,GO:0030576,1,0.934202759122954,0,3,Cajal body organization,BP,
6955,GO:0030578,1,0.921759099497607,0,4,PML body organization,BP,
6956,GO:0030579,1,0.896051628896279,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
6957,GO:0030580,1,0.976624973023742,0,1,quinone cofactor methyltransferase activity,MF,
6958,GO:0030581,1,0.953407760728623,0,2,symbiont intracellular protein transport in host,BP,
6959,GO:0030586,1,0.977587862754326,0,1,[methionine synthase] reductase activity,MF,
6960,GO:0030593,1,0.438578752493944,0,36,neutrophil chemotaxis,BP,
6961,GO:0030594,1,0.620553868279,0,21,neurotransmitter receptor activity,MF,
6963,GO:0030611,1,0.976086380226651,0,1,arsenate reductase activity,MF,
6964,GO:0030613,1,0.930509442267683,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6965,GO:0030614,1,0.930509442267683,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
6966,GO:0030616,1,0.981876228906368,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6967,GO:0030617,1,0.977438811238266,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6968,GO:0030618,1,0.923125922862644,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
6969,GO:0030619,1,0.854541357767186,0,7,U1 snRNA binding,MF,
6970,GO:0030620,1,0.871199868532144,0,6,U2 snRNA binding,MF,
6971,GO:0030621,1,0.874347557676336,0,6,U4 snRNA binding,MF,
6972,GO:0030622,1,0.935452660552435,0,3,U4atac snRNA binding,MF,
6973,GO:0030623,1,0.980857529029305,0,1,U5 snRNA binding,MF,
6974,GO:0030624,1,0.978602910472053,0,1,U6atac snRNA binding,MF,
6975,GO:0030626,1,0.955744357841248,0,2,U12 snRNA binding,MF,
6976,GO:0030627,1,0.954387797169423,0,2,pre-mRNA 5'-splice site binding,MF,
6977,GO:0030628,1,0.869243247838987,0,6,pre-mRNA 3'-splice site binding,MF,
6978,GO:0030629,1,0.977336572808046,0,1,U6 snRNA 3'-end binding,MF,
6980,GO:0030641,1,0.238677839067901,0,64,regulation of cellular pH,BP,
6981,GO:0030643,1,0.921653241073277,0,4,cellular phosphate ion homeostasis,BP,
6982,GO:0030644,1,0.95649083202429,0,2,cellular chloride ion homeostasis,BP,
6984,GO:0030653,1,0.979182692621462,0,1,beta-lactam antibiotic metabolic process,BP,
6986,GO:0030658,1,0.060362188059677,0,126,transport vesicle membrane,CC,
6988,GO:0030660,1,0.140046642607718,0,88,Golgi-associated vesicle membrane,CC,
6989,GO:0030662,1,0.0586559753859359,0,127,coated vesicle membrane,CC,
6990,GO:0030663,1,0.662304535873912,0,18,COPI-coated vesicle membrane,CC,
6991,GO:0030665,1,0.226934716383491,0,67,clathrin-coated vesicle membrane,CC,
6992,GO:0030666,1,0.0813416805451844,0,112,endocytic vesicle membrane,CC,
6994,GO:0030669,1,0.579507262443807,0,25,clathrin-coated endocytic vesicle membrane,CC,
6995,GO:0030670,1,0.245359604759919,0,62,phagocytic vesicle membrane,CC,
6996,GO:0030672,1,0.3122062483683,0,52,synaptic vesicle membrane,CC,
6997,GO:0030673,1,0.813600140602389,0,10,axolemma,CC,
6999,GO:0030676,1,0.788091612641695,0,11,Rac guanyl-nucleotide exchange factor activity,MF,
7000,GO:0030677,1,0.737923872002985,0,13,ribonuclease P complex,CC,
7001,GO:0030678,1,0.932331410027725,0,3,mitochondrial ribonuclease P complex,CC,
7002,GO:0030681,1,0.791531090138813,0,10,multimeric ribonuclease P complex,CC,
7003,GO:0030682,1,0.957034319356571,0,2,evasion or tolerance of host defense response,BP,
7004,GO:0030683,1,0.957034319356571,0,2,evasion or tolerance by virus of host immune response,BP,
7007,GO:0030687,1,0.58329066865618,0,24,preribosome, large subunit precursor,CC,
7008,GO:0030688,1,0.765739841144068,0,12,preribosome, small subunit precursor,CC,
7009,GO:0030689,1,0.933220649290081,0,3,Noc complex,CC,
7010,GO:0030690,1,0.977306107754147,0,1,Noc1p-Noc2p complex,CC,
7011,GO:0030691,1,0.977306107754147,0,1,Noc2p-Noc3p complex,CC,
7012,GO:0030692,1,0.954894640457561,0,2,Noc4p-Nop14p complex,CC,
7014,GO:0030696,1,0.977490245365459,0,1,tRNA (m5U54) methyltransferase activity,MF,
7015,GO:0030697,1,0.977490245365459,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7016,GO:0030702,1,0.97827869321164,0,1,chromatin silencing at centromere,BP,
7018,GO:0030718,1,0.978085145472471,0,1,germ-line stem cell population maintenance,BP,
7019,GO:0030719,1,0.977255939027595,0,1,P granule organization,BP,
7020,GO:0030728,1,0.768629398033753,0,12,ovulation,BP,
7021,GO:0030729,1,0.97762185071701,0,1,acetoacetate-CoA ligase activity,MF,
7022,GO:0030730,1,0.806333032970783,0,10,sequestering of triglyceride,BP,
7023,GO:0030731,1,0.976244399509456,0,1,guanidinoacetate N-methyltransferase activity,MF,
7024,GO:0030735,1,0.977336572808046,0,1,carnosine N-methyltransferase activity,MF,
7025,GO:0030742,1,0.642668151343781,0,20,GTP-dependent protein binding,MF,
7026,GO:0030748,1,0.977254324184692,0,1,amine N-methyltransferase activity,MF,
7027,GO:0030760,1,0.976967830446069,0,1,pyridine N-methyltransferase activity,MF,
7028,GO:0030791,1,0.977247011818277,0,1,arsenite methyltransferase activity,MF,
7029,GO:0030792,1,0.977247011818277,0,1,methylarsonite methyltransferase activity,MF,
7031,GO:0030800,1,0.804848496600857,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7034,GO:0030803,1,0.839752591597855,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7036,GO:0030805,1,0.939180191926713,0,3,regulation of cyclic nucleotide catabolic process,BP,
7037,GO:0030806,1,0.958461994833667,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7038,GO:0030807,1,0.979885740014327,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7044,GO:0030813,1,0.778201581708335,0,12,positive regulation of nucleotide catabolic process,BP,
7046,GO:0030815,1,0.804848496600857,0,10,negative regulation of cAMP metabolic process,BP,
7049,GO:0030818,1,0.839752591597855,0,8,negative regulation of cAMP biosynthetic process,BP,
7051,GO:0030820,1,0.939180191926713,0,3,regulation of cAMP catabolic process,BP,
7052,GO:0030821,1,0.958461994833667,0,2,negative regulation of cAMP catabolic process,BP,
7053,GO:0030822,1,0.979885740014327,0,1,positive regulation of cAMP catabolic process,BP,
7054,GO:0030823,1,0.752229656609723,0,13,regulation of cGMP metabolic process,BP,
7055,GO:0030825,1,0.837469642489292,0,8,positive regulation of cGMP metabolic process,BP,
7056,GO:0030826,1,0.855986669363369,0,7,regulation of cGMP biosynthetic process,BP,
7057,GO:0030828,1,0.874739424543664,0,6,positive regulation of cGMP biosynthetic process,BP,
7060,GO:0030834,1,0.501820391129743,0,32,regulation of actin filament depolymerization,BP,
7061,GO:0030835,1,0.599711087838693,0,24,negative regulation of actin filament depolymerization,BP,
7062,GO:0030836,1,0.856547905683448,0,7,positive regulation of actin filament depolymerization,BP,
7063,GO:0030837,1,0.43537537974339,0,38,negative regulation of actin filament polymerization,BP,
7065,GO:0030846,1,0.98339437073446,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7066,GO:0030849,1,0.979234668470325,0,1,autosome,CC,
7069,GO:0030852,1,0.818062252725983,0,9,regulation of granulocyte differentiation,BP,
7070,GO:0030853,1,0.894952788971792,0,5,negative regulation of granulocyte differentiation,BP,
7071,GO:0030854,1,0.893895589657129,0,5,positive regulation of granulocyte differentiation,BP,
7076,GO:0030859,1,0.723509056839277,0,15,polarized epithelial cell differentiation,BP,
7077,GO:0030860,1,0.957261068470148,0,2,regulation of polarized epithelial cell differentiation,BP,
7078,GO:0030862,1,0.979548525332537,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7081,GO:0030865,1,0.399099410917527,0,42,cortical cytoskeleton organization,BP,
7082,GO:0030866,1,0.477108006326789,0,34,cortical actin cytoskeleton organization,BP,
7083,GO:0030867,1,0.557530076489862,0,25,rough endoplasmic reticulum membrane,CC,
7084,GO:0030868,1,0.935908582296148,0,3,smooth endoplasmic reticulum membrane,CC,
7085,GO:0030870,1,0.896478956611698,0,5,Mre11 complex,CC,
7086,GO:0030874,1,0.977076665296094,0,1,nucleolar chromatin,CC,
7087,GO:0030877,1,0.807715089236992,0,10,beta-catenin destruction complex,CC,
7090,GO:0030880,1,0.0533243358928899,0,130,RNA polymerase complex,CC,
7091,GO:0030881,1,0.870962476893819,0,6,beta-2-microglobulin binding,MF,
7092,GO:0030882,1,0.978034634836764,0,1,lipid antigen binding,MF,
7093,GO:0030883,1,0.978034634836764,0,1,endogenous lipid antigen binding,MF,
7094,GO:0030884,1,0.978034634836764,0,1,exogenous lipid antigen binding,MF,
7095,GO:0030885,1,0.954772141378944,0,2,regulation of myeloid dendritic cell activation,BP,
7096,GO:0030886,1,0.954772141378944,0,2,negative regulation of myeloid dendritic cell activation,BP,
7099,GO:0030890,1,0.596416429506074,0,23,positive regulation of B cell proliferation,BP,
7100,GO:0030891,1,0.911677757232734,0,4,VCB complex,CC,
7101,GO:0030893,1,0.939402785226336,0,3,meiotic cohesin complex,CC,
7102,GO:0030894,1,0.553863873882221,0,26,replisome,CC,
7103,GO:0030895,1,0.977286547589272,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
7104,GO:0030896,1,0.892571842726002,0,5,checkpoint clamp complex,CC,
7106,GO:0030898,1,0.850138698789097,0,8,actin-dependent ATPase activity,MF,
7107,GO:0030899,1,0.976247599989537,0,1,calcium-dependent ATPase activity,MF,
7112,GO:0030904,1,0.64299403989895,0,20,retromer complex,CC,
7113,GO:0030905,1,0.91600130714164,0,4,retromer, tubulation complex,CC,
7114,GO:0030906,1,0.912193223851645,0,4,retromer, cargo-selective complex,CC,
7115,GO:0030910,1,0.958161561770872,0,2,olfactory placode formation,BP,
7116,GO:0030911,1,0.839521423910184,0,8,TPR domain binding,MF,
7117,GO:0030913,1,0.862359310793351,0,7,paranodal junction assembly,BP,
7118,GO:0030914,1,0.764493534396315,0,12,STAGA complex,CC,
7119,GO:0030915,1,0.853158769128868,0,7,Smc5-Smc6 complex,CC,
7122,GO:0030920,1,0.976043880359759,0,1,peptidyl-serine acetylation,BP,
7123,GO:0030934,1,0.965164751221391,0,2,anchoring collagen complex,CC,
7124,GO:0030935,1,0.977262961465507,0,1,sheet-forming collagen trimer,CC,
7125,GO:0030936,1,0.977423380013825,0,1,transmembrane collagen trimer,CC,
7126,GO:0030942,1,0.932486905376703,0,3,endoplasmic reticulum signal peptide binding,MF,
7127,GO:0030943,1,0.933502811280992,0,3,mitochondrion targeting sequence binding,MF,
7128,GO:0030947,1,0.658642450989624,0,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7129,GO:0030948,1,0.83834035149913,0,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7130,GO:0030949,1,0.856534277908063,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7132,GO:0030951,1,0.915325006139897,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7134,GO:0030953,1,0.86211026256573,0,7,astral microtubule organization,BP,
7135,GO:0030955,1,0.8243151933376,0,9,potassium ion binding,MF,
7136,GO:0030956,1,0.932426079361129,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7137,GO:0030957,1,0.798263201408247,0,10,Tat protein binding,MF,
7138,GO:0030961,1,0.977336572808046,0,1,peptidyl-arginine hydroxylation,BP,
7139,GO:0030964,1,0.361903001252937,0,42,NADH dehydrogenase complex,CC,
7141,GO:0030969,1,0.934426130199848,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7142,GO:0030970,1,0.5695280802498,0,25,retrograde protein transport, ER to cytosol,BP,
7144,GO:0030974,1,0.954810610075237,0,2,thiamine pyrophosphate transmembrane transport,BP,
7145,GO:0030976,1,0.89483238102402,0,5,thiamine pyrophosphate binding,MF,
7146,GO:0030981,1,0.940533841877938,0,3,cortical microtubule cytoskeleton,CC,
7147,GO:0030983,1,0.747298327409354,0,13,mismatched DNA binding,MF,
7148,GO:0030984,1,0.954352189756946,0,2,kininogen binding,MF,
7149,GO:0030990,1,0.510699434899581,0,30,intraciliary transport particle,CC,
7150,GO:0030991,1,0.841186873005174,0,8,intraciliary transport particle A,CC,
7151,GO:0030992,1,0.64920814718145,0,19,intraciliary transport particle B,CC,
7152,GO:0030997,1,0.937827254318624,0,3,regulation of centriole-centriole cohesion,BP,
7153,GO:0031000,1,0.763585230330156,0,13,response to caffeine,BP,
7154,GO:0031005,1,0.803593636286506,0,10,filamin binding,MF,
7155,GO:0031010,1,0.807862199693684,0,10,ISWI-type complex,CC,
7156,GO:0031011,1,0.708907229559347,0,15,Ino80 complex,CC,
7158,GO:0031013,1,0.977062668863997,0,1,troponin I binding,MF,
7159,GO:0031014,1,0.952595656704915,0,2,troponin T binding,MF,
7161,GO:0031017,1,0.915114558096746,0,4,exocrine pancreas development,BP,
7163,GO:0031021,1,0.932608761181913,0,3,interphase microtubule organizing center,CC,
7164,GO:0031022,1,0.962720926022786,0,2,nuclear migration along microfilament,BP,
7165,GO:0031023,1,0.080107507060956,0,115,microtubule organizing center organization,BP,
7167,GO:0031033,1,0.917241861393814,0,5,myosin filament organization,BP,
7168,GO:0031034,1,0.938630070703673,0,4,myosin filament assembly,BP,
7169,GO:0031038,1,0.977218762474379,0,1,myosin II filament organization,BP,
7170,GO:0031045,1,0.880048628713706,0,6,dense core granule,CC,
7172,GO:0031048,1,0.956535019849717,0,2,chromatin silencing by small RNA,BP,
7173,GO:0031049,1,0.977311400824801,0,1,programmed DNA elimination,BP,
7175,GO:0031052,1,0.977311400824801,0,1,chromosome breakage,BP,
7176,GO:0031053,1,0.804775955352456,0,10,primary miRNA processing,BP,
7180,GO:0031057,1,0.501023950583961,0,32,negative regulation of histone modification,BP,
7183,GO:0031061,1,0.708114234430447,0,16,negative regulation of histone methylation,BP,
7184,GO:0031062,1,0.520733518627926,0,30,positive regulation of histone methylation,BP,
7186,GO:0031064,1,0.96331382312856,0,2,negative regulation of histone deacetylation,BP,
7189,GO:0031071,1,0.977241642902885,0,1,cysteine desulfurase activity,MF,
7191,GO:0031074,1,0.935768783060336,0,3,nucleocytoplasmic transport complex,CC,
7192,GO:0031076,1,0.592283776266147,0,25,embryonic camera-type eye development,BP,
7193,GO:0031077,1,0.856078551730034,0,7,post-embryonic camera-type eye development,BP,
7194,GO:0031078,1,0.787084888717206,0,11,histone deacetylase activity (H3-K14 specific),MF,
7195,GO:0031080,1,0.802501618877407,0,10,nuclear pore outer ring,CC,
7196,GO:0031081,1,0.956250505555545,0,2,nuclear pore distribution,BP,
7199,GO:0031084,1,0.936245660805337,0,3,BLOC-2 complex,CC,
7200,GO:0031085,1,0.956294624962913,0,2,BLOC-3 complex,CC,
7201,GO:0031086,1,0.836147159787229,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7202,GO:0031087,1,0.855493052338718,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7203,GO:0031088,1,0.897254387171856,0,5,platelet dense granule membrane,CC,
7209,GO:0031094,1,0.854104312794648,0,8,platelet dense tubular network,CC,
7210,GO:0031095,1,0.873276129069369,0,7,platelet dense tubular network membrane,CC,
7213,GO:0031100,1,0.27555519085729,0,58,animal organ regeneration,BP,
7214,GO:0031102,1,0.43314904306379,0,38,neuron projection regeneration,BP,
7215,GO:0031103,1,0.494698718585836,0,32,axon regeneration,BP,
7216,GO:0031104,1,0.978334500209956,0,1,dendrite regeneration,BP,
7217,GO:0031105,1,0.818411405153009,0,9,septin complex,CC,
7218,GO:0031106,1,0.767520391537575,0,12,septin ring organization,BP,
7221,GO:0031111,1,0.559346968604203,0,27,negative regulation of microtubule polymerization or depolymerization,BP,
7224,GO:0031114,1,0.633084828032313,0,22,regulation of microtubule depolymerization,BP,
7225,GO:0031115,1,0.816686962223895,0,9,negative regulation of microtubule polymerization,BP,
7227,GO:0031117,1,0.955265143589923,0,2,positive regulation of microtubule depolymerization,BP,
7228,GO:0031118,1,0.827722910700196,0,8,rRNA pseudouridine synthesis,BP,
7229,GO:0031119,1,0.850397217896608,0,7,tRNA pseudouridine synthesis,BP,
7230,GO:0031120,1,0.908591077286241,0,4,snRNA pseudouridine synthesis,BP,
7231,GO:0031122,1,0.333210630059964,0,51,cytoplasmic microtubule organization,BP,
7232,GO:0031123,1,0.0670709667498055,0,119,RNA 3'-end processing,BP,
7233,GO:0031124,1,0.136641767450898,0,88,mRNA 3'-end processing,BP,
7234,GO:0031125,1,0.753864806748626,0,12,rRNA 3'-end processing,BP,
7235,GO:0031126,1,0.847718548534813,0,7,snoRNA 3'-end processing,BP,
7238,GO:0031133,1,0.955424224063184,0,2,regulation of axon diameter,BP,
7240,GO:0031143,1,0.762664932666764,0,12,pseudopodium,CC,
7241,GO:0031145,1,0.165619008969603,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7243,GO:0031151,1,0.980947951743045,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7244,GO:0031161,1,0.977478856641542,0,1,phosphatidylinositol catabolic process,BP,
7245,GO:0031163,1,0.628739195346791,0,20,metallo-sulfur cluster assembly,BP,
7246,GO:0031166,1,0.935365641629002,0,3,integral component of vacuolar membrane,CC,
7249,GO:0031177,1,0.934410254921374,0,3,phosphopantetheine binding,MF,
7250,GO:0031179,1,0.977982380337757,0,1,peptide modification,BP,
7251,GO:0031201,1,0.375904241228541,0,43,SNARE complex,CC,
7252,GO:0031204,1,0.935880226946134,0,3,posttranslational protein targeting to membrane, translocation,BP,
7253,GO:0031205,1,0.955523626521722,0,2,endoplasmic reticulum Sec complex,CC,
7254,GO:0031208,1,0.958166822446824,0,2,POZ domain binding,MF,
7255,GO:0031209,1,0.840965300062642,0,8,SCAR complex,CC,
7257,GO:0031211,1,0.835106253293922,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7258,GO:0031213,1,0.957806374813188,0,2,RSF complex,CC,
7260,GO:0031223,1,0.888137385583008,0,6,auditory behavior,BP,
7262,GO:0031225,1,0.20300186091239,0,70,anchored component of membrane,CC,
7264,GO:0031227,1,0.0569912653259822,0,126,intrinsic component of endoplasmic reticulum membrane,CC,
7265,GO:0031228,1,0.395340907459119,0,41,intrinsic component of Golgi membrane,CC,
7266,GO:0031229,1,0.836321436630939,0,8,intrinsic component of nuclear inner membrane,CC,
7267,GO:0031231,1,0.709282246211651,0,15,intrinsic component of peroxisomal membrane,CC,
7268,GO:0031232,1,0.933458057549614,0,3,extrinsic component of external side of plasma membrane,CC,
7269,GO:0031233,1,0.763418449919534,0,12,intrinsic component of external side of plasma membrane,CC,
7270,GO:0031234,1,0.234171195698219,0,66,extrinsic component of cytoplasmic side of plasma membrane,CC,
7271,GO:0031235,1,0.797102772587433,0,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7272,GO:0031247,1,0.955013642933664,0,2,actin rod assembly,BP,
7274,GO:0031249,1,0.977244078037487,0,1,denatured protein binding,MF,
7275,GO:0031251,1,0.959408463559607,0,2,PAN complex,CC,
7278,GO:0031254,1,0.840323415498315,0,8,cell trailing edge,CC,
7281,GO:0031260,1,0.976364746093636,0,1,pseudopodium membrane,CC,
7282,GO:0031261,1,0.891698674981667,0,5,DNA replication preinitiation complex,CC,
7283,GO:0031262,1,0.909957599894408,0,4,Ndc80 complex,CC,
7284,GO:0031264,1,0.815252311080641,0,9,death-inducing signaling complex,CC,
7285,GO:0031265,1,0.873110542678514,0,6,CD95 death-inducing signaling complex,CC,
7291,GO:0031279,1,0.675168456228848,0,18,regulation of cyclase activity,BP,
7292,GO:0031280,1,0.859263331478504,0,7,negative regulation of cyclase activity,BP,
7293,GO:0031281,1,0.822735410141477,0,9,positive regulation of cyclase activity,BP,
7294,GO:0031282,1,0.915192362043276,0,4,regulation of guanylate cyclase activity,BP,
7295,GO:0031284,1,0.915192362043276,0,4,positive regulation of guanylate cyclase activity,BP,
7296,GO:0031289,1,0.97741559106125,0,1,actin phosphorylation,BP,
7298,GO:0031291,1,0.933341450787834,0,3,Ran protein signal transduction,BP,
7302,GO:0031296,1,0.976518050729576,0,1,B cell costimulation,BP,
7303,GO:0031297,1,0.56537224644437,0,26,replication fork processing,BP,
7304,GO:0031298,1,0.817209218947195,0,9,replication fork protection complex,CC,
7305,GO:0031300,1,0.028341556496134,0,156,intrinsic component of organelle membrane,CC,
7306,GO:0031301,1,0.0391380136668152,0,142,integral component of organelle membrane,CC,
7307,GO:0031302,1,0.979223678691072,0,1,intrinsic component of endosome membrane,CC,
7308,GO:0031304,1,0.434865436190952,0,36,intrinsic component of mitochondrial inner membrane,CC,
7309,GO:0031305,1,0.434865436190952,0,36,integral component of mitochondrial inner membrane,CC,
7310,GO:0031306,1,0.605300809852118,0,22,intrinsic component of mitochondrial outer membrane,CC,
7311,GO:0031307,1,0.618431658790032,0,21,integral component of mitochondrial outer membrane,CC,
7312,GO:0031310,1,0.935365641629002,0,3,intrinsic component of vacuolar membrane,CC,
7313,GO:0031312,1,0.534156476150806,0,28,extrinsic component of organelle membrane,CC,
7314,GO:0031313,1,0.854983110727862,0,7,extrinsic component of endosome membrane,CC,
7315,GO:0031314,1,0.894267696605206,0,5,extrinsic component of mitochondrial inner membrane,CC,
7316,GO:0031315,1,0.980620758573205,0,1,extrinsic component of mitochondrial outer membrane,CC,
7317,GO:0031320,1,0.977251621836658,0,1,hexitol dehydrogenase activity,MF,
7327,GO:0031332,1,0.790839259311282,0,11,RNAi effector complex,CC,
7330,GO:0031335,1,0.97723530628057,0,1,regulation of sulfur amino acid metabolic process,BP,
7331,GO:0031337,1,0.97723530628057,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7333,GO:0031339,1,0.937212230768879,0,3,negative regulation of vesicle fusion,BP,
7334,GO:0031340,1,0.876161791381435,0,6,positive regulation of vesicle fusion,BP,
7335,GO:0031341,1,0.440001435603669,0,36,regulation of cell killing,BP,
7336,GO:0031342,1,0.776884502861428,0,11,negative regulation of cell killing,BP,
7337,GO:0031343,1,0.607197986576543,0,22,positive regulation of cell killing,BP,
7342,GO:0031348,1,0.0770730326249497,0,114,negative regulation of defense response,BP,
7344,GO:0031362,1,0.816705234510606,0,9,anchored component of external side of plasma membrane,CC,
7345,GO:0031365,1,0.591141542435418,0,24,N-terminal protein amino acid modification,BP,
7346,GO:0031369,1,0.530966865654669,0,28,translation initiation factor binding,MF,
7347,GO:0031370,1,0.978917985645258,0,1,eukaryotic initiation factor 4G binding,MF,
7348,GO:0031371,1,0.833051729974367,0,8,ubiquitin conjugating enzyme complex,CC,
7349,GO:0031372,1,0.954693698264327,0,2,UBC13-MMS2 complex,CC,
7350,GO:0031379,1,0.953004114321313,0,2,RNA-directed RNA polymerase complex,CC,
7351,GO:0031380,1,0.977587862754326,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7352,GO:0031386,1,0.752973368729531,0,12,protein tag,MF,
7353,GO:0031389,1,0.977338729997246,0,1,Rad17 RFC-like complex,CC,
7354,GO:0031390,1,0.832199433381757,0,8,Ctf18 RFC-like complex,CC,
7355,GO:0031392,1,0.91396922154608,0,4,regulation of prostaglandin biosynthetic process,BP,
7356,GO:0031393,1,0.956049873620019,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7357,GO:0031394,1,0.955992147607759,0,2,positive regulation of prostaglandin biosynthetic process,BP,
7360,GO:0031398,1,0.127918885838448,0,91,positive regulation of protein ubiquitination,BP,
7364,GO:0031402,1,0.843862707820537,0,8,sodium ion binding,MF,
7365,GO:0031403,1,0.958997788414489,0,2,lithium ion binding,MF,
7366,GO:0031404,1,0.935388739035034,0,3,chloride ion binding,MF,
7367,GO:0031405,1,0.983253238618624,0,1,lipoic acid binding,MF,
7369,GO:0031407,1,0.977240944844536,0,1,oxylipin metabolic process,BP,
7371,GO:0031414,1,0.82265591315246,0,9,N-terminal protein acetyltransferase complex,CC,
7372,GO:0031415,1,0.913519798208648,0,4,NatA complex,CC,
7373,GO:0031416,1,0.956576306247753,0,2,NatB complex,CC,
7374,GO:0031417,1,0.941457025339704,0,3,NatC complex,CC,
7375,GO:0031418,1,0.664372943193216,0,18,L-ascorbic acid binding,MF,
7376,GO:0031419,1,0.876735245098882,0,6,cobalamin binding,MF,
7377,GO:0031420,1,0.756649759032222,0,13,alkali metal ion binding,MF,
7379,GO:0031427,1,0.935998409877879,0,3,response to methotrexate,BP,
7380,GO:0031428,1,0.890306445601577,0,5,box C/D snoRNP complex,CC,
7381,GO:0031429,1,0.887182694660258,0,5,box H/ACA snoRNP complex,CC,
7383,GO:0031431,1,0.95596249573748,0,2,Dbf4-dependent protein kinase complex,CC,
7384,GO:0031432,1,0.84376538070721,0,8,titin binding,MF,
7385,GO:0031433,1,0.999055027153641,0,1,telethonin binding,MF,
7387,GO:0031435,1,0.701488139426513,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7388,GO:0031436,1,0.958407909674349,0,2,BRCA1-BARD1 complex,CC,
7389,GO:0031437,1,0.93476631723061,0,3,regulation of mRNA cleavage,BP,
7390,GO:0031438,1,0.977431948995382,0,1,negative regulation of mRNA cleavage,BP,
7391,GO:0031439,1,0.95635291820746,0,2,positive regulation of mRNA cleavage,BP,
7392,GO:0031440,1,0.6125290247271,0,22,regulation of mRNA 3'-end processing,BP,
7393,GO:0031441,1,0.817265495576366,0,9,negative regulation of mRNA 3'-end processing,BP,
7394,GO:0031442,1,0.819984310183045,0,9,positive regulation of mRNA 3'-end processing,BP,
7395,GO:0031443,1,0.980533997945977,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7396,GO:0031444,1,0.976247599989537,0,1,slow-twitch skeletal muscle fiber contraction,BP,
7397,GO:0031445,1,0.959960918452438,0,2,regulation of heterochromatin assembly,BP,
7398,GO:0031453,1,0.959960918452438,0,2,positive regulation of heterochromatin assembly,BP,
7399,GO:0031455,1,0.977824130376218,0,1,glycine betaine metabolic process,BP,
7400,GO:0031456,1,0.977824130376218,0,1,glycine betaine biosynthetic process,BP,
7401,GO:0031460,1,0.979035343601167,0,1,glycine betaine transport,BP,
7402,GO:0031461,1,0.0298256597816246,0,157,cullin-RING ubiquitin ligase complex,CC,
7403,GO:0031462,1,0.765487471785594,0,12,Cul2-RING ubiquitin ligase complex,CC,
7404,GO:0031463,1,0.325567135314392,0,51,Cul3-RING ubiquitin ligase complex,CC,
7405,GO:0031464,1,0.761550427386486,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7406,GO:0031465,1,0.893867459588039,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7407,GO:0031466,1,0.913764731722741,0,4,Cul5-RING ubiquitin ligase complex,CC,
7408,GO:0031467,1,0.892926272658809,0,5,Cul7-RING ubiquitin ligase complex,CC,
7409,GO:0031468,1,0.662909543765331,0,18,nuclear envelope reassembly,BP,
7410,GO:0031475,1,0.976916091447488,0,1,myosin V complex,CC,
7411,GO:0031489,1,0.744954730882589,0,13,myosin V binding,MF,
7415,GO:0031493,1,0.934142619886514,0,3,nucleosomal histone binding,MF,
7417,GO:0031498,1,0.689579709003841,0,17,chromatin disassembly,BP,
7418,GO:0031501,1,0.908989860510444,0,4,mannosyltransferase complex,CC,
7420,GO:0031506,1,0.9771102875795,0,1,cell wall glycoprotein biosynthetic process,BP,
7421,GO:0031507,1,0.807982123479102,0,10,heterochromatin assembly,BP,
7422,GO:0031508,1,0.954469457736328,0,2,pericentric heterochromatin assembly,BP,
7423,GO:0031509,1,0.97701939608159,0,1,telomeric heterochromatin assembly,BP,
7424,GO:0031510,1,0.93291633845275,0,3,SUMO activating enzyme complex,CC,
7425,GO:0031514,1,0.182769115469868,0,77,motile cilium,CC,
7428,GO:0031523,1,0.959407394487779,0,2,Myb complex,CC,
7429,GO:0031526,1,0.582602964343594,0,25,brush border membrane,CC,
7431,GO:0031528,1,0.732641277784397,0,14,microvillus membrane,CC,
7433,GO:0031530,1,0.977072742778256,0,1,gonadotropin-releasing hormone receptor binding,MF,
7434,GO:0031531,1,0.976701580238665,0,1,thyrotropin-releasing hormone receptor binding,MF,
7436,GO:0031533,1,0.980039279721722,0,1,mRNA cap methyltransferase complex,CC,
7437,GO:0031536,1,0.91034519469526,0,4,positive regulation of exit from mitosis,BP,
7438,GO:0031543,1,0.797546076259016,0,10,peptidyl-proline dioxygenase activity,MF,
7439,GO:0031544,1,0.912433863058418,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7440,GO:0031545,1,0.874126966245382,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7441,GO:0031547,1,0.959775449108039,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7442,GO:0031554,1,0.98339437073446,0,1,regulation of DNA-templated transcription, termination,BP,
7443,GO:0031559,1,0.978489824335089,0,1,oxidosqualene cyclase activity,MF,
7445,GO:0031571,1,0.218836242921934,0,68,mitotic G1 DNA damage checkpoint,BP,
7447,GO:0031573,1,0.7267593621236,0,14,intra-S DNA damage checkpoint,BP,
7448,GO:0031577,1,0.491748678433886,0,32,spindle checkpoint,BP,
7451,GO:0031581,1,0.797398556137389,0,11,hemidesmosome assembly,BP,
7452,GO:0031583,1,0.977217150969366,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7453,GO:0031584,1,0.893345187356712,0,5,activation of phospholipase D activity,BP,
7454,GO:0031585,1,0.92841185737488,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7455,GO:0031587,1,0.943364333450719,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7456,GO:0031588,1,0.821546063408807,0,9,nucleotide-activated protein kinase complex,CC,
7458,GO:0031590,1,0.955193052203544,0,2,wybutosine metabolic process,BP,
7459,GO:0031591,1,0.955193052203544,0,2,wybutosine biosynthetic process,BP,
7460,GO:0031592,1,0.981296092286635,0,1,centrosomal corona,CC,
7463,GO:0031595,1,0.83030879173401,0,8,nuclear proteasome complex,CC,
7464,GO:0031597,1,0.758962505775917,0,12,cytosolic proteasome complex,CC,
7465,GO:0031616,1,0.814666394417556,0,9,spindle pole centrosome,CC,
7466,GO:0031618,1,0.84465304193945,0,8,nuclear pericentric heterochromatin,CC,
7467,GO:0031620,1,0.913080303605295,0,4,regulation of fever generation,BP,
7468,GO:0031622,1,0.913080303605295,0,4,positive regulation of fever generation,BP,
7469,GO:0031623,1,0.270524480882624,0,59,receptor internalization,BP,
7472,GO:0031626,1,0.979280783508255,0,1,beta-endorphin binding,MF,
7473,GO:0031627,1,0.934095585709057,0,3,telomeric loop formation,BP,
7474,GO:0031628,1,0.917710069968628,0,4,opioid receptor binding,MF,
7475,GO:0031629,1,0.796555242480779,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7476,GO:0031630,1,0.978167535553689,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7477,GO:0031635,1,0.977153966145555,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7483,GO:0031643,1,0.822884488133813,0,9,positive regulation of myelination,BP,
7486,GO:0031646,1,0.739712546556032,0,14,positive regulation of neurological system process,BP,
7489,GO:0031649,1,0.74484308318429,0,13,heat generation,BP,
7490,GO:0031650,1,0.815850223524902,0,9,regulation of heat generation,BP,
7491,GO:0031651,1,0.978402639635041,0,1,negative regulation of heat generation,BP,
7492,GO:0031652,1,0.833871825715745,0,8,positive regulation of heat generation,BP,
7493,GO:0031657,1,0.773006531693275,0,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7494,GO:0031658,1,0.85793956930128,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7495,GO:0031659,1,0.901057628264178,0,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7496,GO:0031663,1,0.435518192531216,0,37,lipopolysaccharide-mediated signaling pathway,BP,
7497,GO:0031664,1,0.717224708814921,0,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7498,GO:0031665,1,0.835094364719108,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7499,GO:0031666,1,0.918321067345717,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7505,GO:0031673,1,0.987366393268336,0,1,H zone,CC,
7507,GO:0031681,1,0.893191877816815,0,5,G-protein beta-subunit binding,MF,
7508,GO:0031682,1,0.977410587049509,0,1,G-protein gamma-subunit binding,MF,
7509,GO:0031683,1,0.764377364686891,0,12,G-protein beta/gamma-subunit complex binding,MF,
7510,GO:0031685,1,0.956247216156283,0,2,adenosine receptor binding,MF,
7511,GO:0031686,1,0.97744963657025,0,1,A1 adenosine receptor binding,MF,
7512,GO:0031690,1,0.751907731687337,0,13,adrenergic receptor binding,MF,
7513,GO:0031691,1,0.954917274247971,0,2,alpha-1A adrenergic receptor binding,MF,
7514,GO:0031692,1,0.954917274247971,0,2,alpha-1B adrenergic receptor binding,MF,
7515,GO:0031694,1,0.976430758027218,0,1,alpha-2A adrenergic receptor binding,MF,
7516,GO:0031697,1,0.91900344954152,0,4,beta-1 adrenergic receptor binding,MF,
7517,GO:0031698,1,0.918562639515144,0,4,beta-2 adrenergic receptor binding,MF,
7518,GO:0031699,1,0.978402639635041,0,1,beta-3 adrenergic receptor binding,MF,
7519,GO:0031700,1,0.976842672222388,0,1,adrenomedullin receptor binding,MF,
7520,GO:0031701,1,0.839814973551561,0,8,angiotensin receptor binding,MF,
7521,GO:0031702,1,0.859394398986937,0,7,type 1 angiotensin receptor binding,MF,
7522,GO:0031704,1,0.977531669431364,0,1,apelin receptor binding,MF,
7523,GO:0031705,1,0.977217150969366,0,1,bombesin receptor binding,MF,
7524,GO:0031707,1,0.977217150969366,0,1,endothelin A receptor binding,MF,
7525,GO:0031708,1,0.977217150969366,0,1,endothelin B receptor binding,MF,
7526,GO:0031714,1,0.979228390876785,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7527,GO:0031715,1,0.979228390876785,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7528,GO:0031726,1,0.976570048009942,0,1,CCR1 chemokine receptor binding,MF,
7529,GO:0031729,1,0.976570048009942,0,1,CCR4 chemokine receptor binding,MF,
7530,GO:0031730,1,0.893101149993536,0,5,CCR5 chemokine receptor binding,MF,
7531,GO:0031731,1,0.951811968708214,0,2,CCR6 chemokine receptor binding,MF,
7532,GO:0031748,1,0.894871853210546,0,5,D1 dopamine receptor binding,MF,
7533,GO:0031749,1,0.955946917818308,0,2,D2 dopamine receptor binding,MF,
7534,GO:0031752,1,0.959135965826287,0,2,D5 dopamine receptor binding,MF,
7535,GO:0031753,1,0.97729941197207,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7536,GO:0031755,1,0.97729941197207,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
7537,GO:0031762,1,0.954917274247971,0,2,follicle-stimulating hormone receptor binding,MF,
7538,GO:0031763,1,0.97585624064459,0,1,galanin receptor binding,MF,
7539,GO:0031764,1,0.97585624064459,0,1,type 1 galanin receptor binding,MF,
7540,GO:0031765,1,0.97585624064459,0,1,type 2 galanin receptor binding,MF,
7541,GO:0031766,1,0.97585624064459,0,1,type 3 galanin receptor binding,MF,
7542,GO:0031775,1,0.981506086750235,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7543,GO:0031798,1,0.981086954756831,0,1,type 1 metabotropic glutamate receptor binding,MF,
7544,GO:0031802,1,0.936947056247895,0,3,type 5 metabotropic glutamate receptor binding,MF,
7545,GO:0031811,1,0.978146968392275,0,1,G-protein coupled nucleotide receptor binding,MF,
7546,GO:0031812,1,0.978146968392275,0,1,P2Y1 nucleotide receptor binding,MF,
7547,GO:0031821,1,0.873981266857257,0,6,G-protein coupled serotonin receptor binding,MF,
7548,GO:0031826,1,0.932934661026296,0,3,type 2A serotonin receptor binding,MF,
7549,GO:0031839,1,0.97592036803824,0,1,type 1 neuromedin U receptor binding,MF,
7550,GO:0031840,1,0.97592036803824,0,1,type 2 neuromedin U receptor binding,MF,
7552,GO:0031849,1,0.978010178153567,0,1,olfactory receptor binding,MF,
7553,GO:0031852,1,0.917710069968628,0,4,mu-type opioid receptor binding,MF,
7554,GO:0031859,1,0.977169319060442,0,1,platelet activating factor receptor binding,MF,
7555,GO:0031860,1,0.937823047176092,0,3,telomeric 3' overhang formation,BP,
7556,GO:0031862,1,0.958467936383328,0,2,prostanoid receptor binding,MF,
7557,GO:0031867,1,0.978088581449022,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7558,GO:0031870,1,0.979941463598154,0,1,thromboxane A2 receptor binding,MF,
7559,GO:0031871,1,0.935864505574515,0,3,proteinase activated receptor binding,MF,
7560,GO:0031883,1,0.977217697347356,0,1,taste receptor binding,MF,
7561,GO:0031893,1,0.977230009308281,0,1,vasopressin receptor binding,MF,
7562,GO:0031896,1,0.977230009308281,0,1,V2 vasopressin receptor binding,MF,
7565,GO:0031903,1,0.3197664082503,0,51,microbody membrane,CC,
7566,GO:0031904,1,0.679511605942188,0,17,endosome lumen,CC,
7567,GO:0031905,1,0.933562741739449,0,3,early endosome lumen,CC,
7568,GO:0031906,1,0.954949258641165,0,2,late endosome lumen,CC,
7569,GO:0031907,1,0.505983079439743,0,30,microbody lumen,CC,
7570,GO:0031914,1,0.935326233208222,0,3,negative regulation of synaptic plasticity,BP,
7571,GO:0031915,1,0.894072957027274,0,5,positive regulation of synaptic plasticity,BP,
7573,GO:0031930,1,0.976857539853567,0,1,mitochondria-nucleus signaling pathway,BP,
7574,GO:0031931,1,0.860806687260507,0,7,TORC1 complex,CC,
7575,GO:0031932,1,0.749236463876475,0,13,TORC2 complex,CC,
7576,GO:0031933,1,0.938986727997141,0,3,telomeric heterochromatin,CC,
7577,GO:0031935,1,0.650226181535875,0,20,regulation of chromatin silencing,BP,
7578,GO:0031936,1,0.845926489382984,0,8,negative regulation of chromatin silencing,BP,
7579,GO:0031937,1,0.840746727680852,0,8,positive regulation of chromatin silencing,BP,
7580,GO:0031938,1,0.954717525387562,0,2,regulation of chromatin silencing at telomere,BP,
7581,GO:0031940,1,0.97701939608159,0,1,positive regulation of chromatin silencing at telomere,BP,
7582,GO:0031941,1,0.56290693835585,0,26,filamentous actin,CC,
7583,GO:0031943,1,0.83395736389608,0,8,regulation of glucocorticoid metabolic process,BP,
7584,GO:0031944,1,0.913628321918219,0,4,negative regulation of glucocorticoid metabolic process,BP,
7585,GO:0031945,1,0.978152358173514,0,1,positive regulation of glucocorticoid metabolic process,BP,
7586,GO:0031946,1,0.874739573759832,0,6,regulation of glucocorticoid biosynthetic process,BP,
7587,GO:0031947,1,0.913628321918219,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7588,GO:0031948,1,0.978152358173514,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7589,GO:0031952,1,0.482422211519046,0,33,regulation of protein autophosphorylation,BP,
7590,GO:0031953,1,0.799024358129828,0,10,negative regulation of protein autophosphorylation,BP,
7591,GO:0031954,1,0.644767510099889,0,20,positive regulation of protein autophosphorylation,BP,
7592,GO:0031956,1,0.916078715815025,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7593,GO:0031957,1,0.853539456299162,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7594,GO:0031958,1,0.708555839830339,0,16,corticosteroid receptor signaling pathway,BP,
7595,GO:0031959,1,0.957161680166266,0,2,mineralocorticoid receptor signaling pathway,BP,
7597,GO:0031962,1,0.979815377247189,0,1,mineralocorticoid receptor binding,MF,
7610,GO:0031987,1,0.842453320449707,0,8,locomotion involved in locomotory behavior,BP,
7611,GO:0031990,1,0.960176301731203,0,2,mRNA export from nucleus in response to heat stress,BP,
7614,GO:0031996,1,0.797032338112247,0,10,thioesterase binding,MF,
7615,GO:0031997,1,0.933889252751786,0,3,N-terminal myristoylation domain binding,MF,
7616,GO:0031998,1,0.798886580213439,0,11,regulation of fatty acid beta-oxidation,BP,
7617,GO:0031999,1,0.959958771672057,0,2,negative regulation of fatty acid beta-oxidation,BP,
7618,GO:0032000,1,0.906407073397705,0,5,positive regulation of fatty acid beta-oxidation,BP,
7619,GO:0032002,1,0.95503193782551,0,2,interleukin-28 receptor complex,CC,
7622,GO:0032008,1,0.5105944098775,0,30,positive regulation of TOR signaling,BP,
7623,GO:0032009,1,0.859739551958302,0,7,early phagosome,CC,
7624,GO:0032010,1,0.93349918553232,0,3,phagolysosome,CC,
7625,GO:0032011,1,0.423574665820024,0,40,ARF protein signal transduction,BP,
7626,GO:0032012,1,0.423574665820024,0,40,regulation of ARF protein signal transduction,BP,
7627,GO:0032020,1,0.869308170767216,0,6,ISG15-protein conjugation,BP,
7628,GO:0032021,1,0.912370967001907,0,4,NELF complex,CC,
7630,GO:0032025,1,0.797661645020005,0,10,response to cobalt ion,BP,
7631,GO:0032026,1,0.852280286601126,0,8,response to magnesium ion,BP,
7632,GO:0032027,1,0.936495986958566,0,3,myosin light chain binding,MF,
7633,GO:0032028,1,0.977218612542004,0,1,myosin head/neck binding,MF,
7634,GO:0032029,1,0.983877347961415,0,1,myosin tail binding,MF,
7635,GO:0032036,1,0.897640026819893,0,5,myosin heavy chain binding,MF,
7636,GO:0032039,1,0.758372715315668,0,13,integrator complex,CC,
7638,GO:0032041,1,0.787084888717206,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7639,GO:0032042,1,0.730358338970237,0,14,mitochondrial DNA metabolic process,BP,
7640,GO:0032044,1,0.955373900702503,0,2,DSIF complex,CC,
7641,GO:0032045,1,0.839488703417319,0,8,guanyl-nucleotide exchange factor complex,CC,
7642,GO:0032048,1,0.728611216059075,0,14,cardiolipin metabolic process,BP,
7643,GO:0032049,1,0.833105295065246,0,8,cardiolipin biosynthetic process,BP,
7644,GO:0032050,1,0.862869852113426,0,7,clathrin heavy chain binding,MF,
7645,GO:0032051,1,0.902131313876713,0,5,clathrin light chain binding,MF,
7647,GO:0032053,1,0.958170101300504,0,2,ciliary basal body organization,BP,
7648,GO:0032055,1,0.875600388296615,0,6,negative regulation of translation in response to stress,BP,
7649,GO:0032056,1,0.875724216167839,0,6,positive regulation of translation in response to stress,BP,
7650,GO:0032057,1,0.916596644390937,0,4,negative regulation of translational initiation in response to stress,BP,
7651,GO:0032058,1,0.917072749142215,0,4,positive regulation of translational initiation in response to stress,BP,
7652,GO:0032059,1,0.856901875845462,0,7,bleb,CC,
7653,GO:0032060,1,0.803334500509431,0,10,bleb assembly,BP,
7654,GO:0032069,1,0.51658537748656,0,29,regulation of nuclease activity,BP,
7655,GO:0032070,1,0.81292335795893,0,9,regulation of deoxyribonuclease activity,BP,
7656,GO:0032071,1,0.851679034289197,0,7,regulation of endodeoxyribonuclease activity,BP,
7657,GO:0032072,1,0.977697391253987,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7658,GO:0032074,1,0.872353871382987,0,6,negative regulation of nuclease activity,BP,
7659,GO:0032075,1,0.693226431063687,0,16,positive regulation of nuclease activity,BP,
7660,GO:0032076,1,0.977278942128016,0,1,negative regulation of deoxyribonuclease activity,BP,
7661,GO:0032077,1,0.890604556893542,0,5,positive regulation of deoxyribonuclease activity,BP,
7662,GO:0032079,1,0.911843435047673,0,4,positive regulation of endodeoxyribonuclease activity,BP,
7664,GO:0032089,1,0.9571157204266,0,2,NACHT domain binding,MF,
7665,GO:0032090,1,0.954383355641031,0,2,Pyrin domain binding,MF,
7667,GO:0032092,1,0.200795615850264,0,73,positive regulation of protein binding,BP,
7668,GO:0032093,1,0.977336572808046,0,1,SAM domain binding,MF,
7669,GO:0032094,1,0.673492736824095,0,18,response to food,BP,
7670,GO:0032095,1,0.838689096350395,0,8,regulation of response to food,BP,
7671,GO:0032096,1,0.874159615354182,0,6,negative regulation of response to food,BP,
7672,GO:0032097,1,0.977153966145555,0,1,positive regulation of response to food,BP,
7673,GO:0032098,1,0.836748376999999,0,8,regulation of appetite,BP,
7674,GO:0032099,1,0.874159615354182,0,6,negative regulation of appetite,BP,
7675,GO:0032100,1,0.977153966145555,0,1,positive regulation of appetite,BP,
7681,GO:0032106,1,0.933165586044199,0,3,positive regulation of response to extracellular stimulus,BP,
7684,GO:0032109,1,0.933165586044199,0,3,positive regulation of response to nutrient levels,BP,
7685,GO:0032116,1,0.960538467427994,0,2,SMC loading complex,CC,
7687,GO:0032127,1,0.977481596433604,0,1,dense core granule membrane,CC,
7688,GO:0032129,1,0.955614941195307,0,2,histone deacetylase activity (H3-K9 specific),MF,
7689,GO:0032133,1,0.911415578878783,0,4,chromosome passenger complex,CC,
7690,GO:0032135,1,0.873920959356765,0,6,DNA insertion or deletion binding,MF,
7691,GO:0032137,1,0.934749721723617,0,3,guanine/thymine mispair binding,MF,
7692,GO:0032138,1,0.915014864194493,0,4,single base insertion or deletion binding,MF,
7693,GO:0032139,1,0.934502334133124,0,3,dinucleotide insertion or deletion binding,MF,
7694,GO:0032142,1,0.936257723467489,0,3,single guanine insertion binding,MF,
7695,GO:0032143,1,0.956517001872317,0,2,single thymine insertion binding,MF,
7696,GO:0032144,1,0.979054784048604,0,1,4-aminobutyrate transaminase complex,CC,
7697,GO:0032145,1,0.979054784048604,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7699,GO:0032148,1,0.593171241499946,0,24,activation of protein kinase B activity,BP,
7701,GO:0032154,1,0.348086743947001,0,48,cleavage furrow,CC,
7702,GO:0032155,1,0.278973624770117,0,58,cell division site part,CC,
7703,GO:0032156,1,0.800768959821376,0,10,septin cytoskeleton,CC,
7704,GO:0032160,1,0.818411405153009,0,9,septin filament array,CC,
7705,GO:0032173,1,0.977389095767125,0,1,septin collar,CC,
7706,GO:0032181,1,0.956784001139064,0,2,dinucleotide repeat insertion binding,MF,
7708,GO:0032183,1,0.756274601928724,0,13,SUMO binding,MF,
7709,GO:0032184,1,0.917339351004056,0,4,SUMO polymer binding,MF,
7710,GO:0032185,1,0.750108637518617,0,13,septin cytoskeleton organization,BP,
7711,GO:0032190,1,0.954146107532838,0,2,acrosin binding,MF,
7712,GO:0032194,1,0.977905537403098,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7714,GO:0032197,1,0.978179760085014,0,1,transposition, RNA-mediated,BP,
7717,GO:0032202,1,0.912888539088825,0,4,telomere assembly,BP,
7718,GO:0032203,1,0.977150839933651,0,1,telomere formation via telomerase,BP,
7720,GO:0032205,1,0.470483663555749,0,35,negative regulation of telomere maintenance,BP,
7721,GO:0032206,1,0.336369177369392,0,49,positive regulation of telomere maintenance,BP,
7722,GO:0032207,1,0.977339164903848,0,1,regulation of telomere maintenance via recombination,BP,
7723,GO:0032208,1,0.977339164903848,0,1,negative regulation of telomere maintenance via recombination,BP,
7724,GO:0032210,1,0.325074039103288,0,51,regulation of telomere maintenance via telomerase,BP,
7725,GO:0032211,1,0.66134464761128,0,19,negative regulation of telomere maintenance via telomerase,BP,
7726,GO:0032212,1,0.479216219058076,0,33,positive regulation of telomere maintenance via telomerase,BP,
7727,GO:0032213,1,0.95520576961532,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7728,GO:0032214,1,0.95520576961532,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7729,GO:0032216,1,0.97723407843947,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
7730,GO:0032217,1,0.955184890372083,0,2,riboflavin transmembrane transporter activity,MF,
7731,GO:0032218,1,0.955184890372083,0,2,riboflavin transport,BP,
7732,GO:0032222,1,0.982537419321369,0,1,regulation of synaptic transmission, cholinergic,BP,
7733,GO:0032224,1,0.982537419321369,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7735,GO:0032226,1,0.893063436544377,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
7736,GO:0032227,1,0.93633237331014,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7737,GO:0032228,1,0.727938821731889,0,15,regulation of synaptic transmission, GABAergic,BP,
7738,GO:0032229,1,0.955170689227537,0,2,negative regulation of synaptic transmission, GABAergic,BP,
7739,GO:0032230,1,0.85853384193181,0,7,positive regulation of synaptic transmission, GABAergic,BP,
7741,GO:0032232,1,0.741593404709787,0,14,negative regulation of actin filament bundle assembly,BP,
7743,GO:0032237,1,0.916154403028639,0,4,activation of store-operated calcium channel activity,BP,
7744,GO:0032239,1,0.710611476920541,0,16,regulation of nucleobase-containing compound transport,BP,
7745,GO:0032240,1,0.962558065044216,0,2,negative regulation of nucleobase-containing compound transport,BP,
7746,GO:0032241,1,0.858627085828722,0,7,positive regulation of nucleobase-containing compound transport,BP,
7747,GO:0032252,1,0.941748979662572,0,3,secretory granule localization,BP,
7748,GO:0032253,1,0.977336572808046,0,1,dense core granule localization,BP,
7749,GO:0032258,1,0.955075280362396,0,2,protein localization by the Cvt pathway,BP,
7751,GO:0032261,1,0.850941383008589,0,7,purine nucleotide salvage,BP,
7752,GO:0032262,1,0.890237464958807,0,5,pyrimidine nucleotide salvage,BP,
7753,GO:0032263,1,0.954513932197007,0,2,GMP salvage,BP,
7754,GO:0032264,1,0.913495758935414,0,4,IMP salvage,BP,
7755,GO:0032266,1,0.522033291638178,0,30,phosphatidylinositol-3-phosphate binding,MF,
7760,GO:0032272,1,0.347100807461155,0,48,negative regulation of protein polymerization,BP,
7762,GO:0032274,1,0.860367571103426,0,7,gonadotropin secretion,BP,
7763,GO:0032275,1,0.900136502620593,0,5,luteinizing hormone secretion,BP,
7764,GO:0032276,1,0.937773073350425,0,3,regulation of gonadotropin secretion,BP,
7765,GO:0032277,1,0.977226843172614,0,1,negative regulation of gonadotropin secretion,BP,
7766,GO:0032278,1,0.937773073350425,0,3,positive regulation of gonadotropin secretion,BP,
7768,GO:0032280,1,0.921009172708575,0,4,symmetric synapse,CC,
7769,GO:0032281,1,0.783159386659399,0,11,AMPA glutamate receptor complex,CC,
7773,GO:0032289,1,0.933750909233624,0,3,central nervous system myelin formation,BP,
7777,GO:0032296,1,0.918571361275258,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7778,GO:0032298,1,0.977233370615845,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
7779,GO:0032299,1,0.932302174732277,0,3,ribonuclease H2 complex,CC,
7780,GO:0032300,1,0.766659136459575,0,12,mismatch repair complex,CC,
7781,GO:0032301,1,0.956517001872317,0,2,MutSalpha complex,CC,
7782,GO:0032302,1,0.956784001139064,0,2,MutSbeta complex,CC,
7783,GO:0032303,1,0.815480780904983,0,9,regulation of icosanoid secretion,BP,
7784,GO:0032304,1,0.979153362770796,0,1,negative regulation of icosanoid secretion,BP,
7785,GO:0032305,1,0.832859223114649,0,8,positive regulation of icosanoid secretion,BP,
7786,GO:0032306,1,0.889452267160275,0,5,regulation of prostaglandin secretion,BP,
7787,GO:0032308,1,0.889452267160275,0,5,positive regulation of prostaglandin secretion,BP,
7788,GO:0032309,1,0.681959024387001,0,17,icosanoid secretion,BP,
7789,GO:0032310,1,0.870482475810709,0,6,prostaglandin secretion,BP,
7790,GO:0032311,1,0.953905485148277,0,2,angiogenin-PRI complex,CC,
7791,GO:0032324,1,0.852721405227592,0,7,molybdopterin cofactor biosynthetic process,BP,
7792,GO:0032328,1,0.876390495224855,0,6,alanine transport,BP,
7793,GO:0032329,1,0.832943320668136,0,8,serine transport,BP,
7797,GO:0032341,1,0.913762088984811,0,4,aldosterone metabolic process,BP,
7798,GO:0032342,1,0.913762088984811,0,4,aldosterone biosynthetic process,BP,
7799,GO:0032344,1,0.913762088984811,0,4,regulation of aldosterone metabolic process,BP,
7800,GO:0032345,1,0.934176816901087,0,3,negative regulation of aldosterone metabolic process,BP,
7801,GO:0032346,1,0.978152358173514,0,1,positive regulation of aldosterone metabolic process,BP,
7802,GO:0032347,1,0.913762088984811,0,4,regulation of aldosterone biosynthetic process,BP,
7803,GO:0032348,1,0.934176816901087,0,3,negative regulation of aldosterone biosynthetic process,BP,
7804,GO:0032349,1,0.978152358173514,0,1,positive regulation of aldosterone biosynthetic process,BP,
7805,GO:0032350,1,0.598141393930198,0,23,regulation of hormone metabolic process,BP,
7806,GO:0032351,1,0.854398192494946,0,7,negative regulation of hormone metabolic process,BP,
7807,GO:0032352,1,0.816464588042275,0,9,positive regulation of hormone metabolic process,BP,
7808,GO:0032353,1,0.854398192494946,0,7,negative regulation of hormone biosynthetic process,BP,
7809,GO:0032354,1,0.772350067368032,0,12,response to follicle-stimulating hormone,BP,
7811,GO:0032356,1,0.799184238132317,0,10,oxidized DNA binding,MF,
7812,GO:0032357,1,0.817828586551395,0,9,oxidized purine DNA binding,MF,
7813,GO:0032358,1,0.975966066517488,0,1,oxidized pyrimidine DNA binding,MF,
7814,GO:0032361,1,0.977198217831443,0,1,pyridoxal phosphate catabolic process,BP,
7815,GO:0032364,1,0.895251435940483,0,5,oxygen homeostasis,BP,
7816,GO:0032365,1,0.534761368353018,0,29,intracellular lipid transport,BP,
7817,GO:0032366,1,0.690274677462466,0,17,intracellular sterol transport,BP,
7818,GO:0032367,1,0.690274677462466,0,17,intracellular cholesterol transport,BP,
7819,GO:0032368,1,0.307339223572561,0,54,regulation of lipid transport,BP,
7820,GO:0032369,1,0.737230978049094,0,14,negative regulation of lipid transport,BP,
7821,GO:0032370,1,0.493280837054164,0,32,positive regulation of lipid transport,BP,
7822,GO:0032371,1,0.567169679602414,0,26,regulation of sterol transport,BP,
7823,GO:0032372,1,0.913016313431588,0,4,negative regulation of sterol transport,BP,
7824,GO:0032373,1,0.71048092435649,0,16,positive regulation of sterol transport,BP,
7825,GO:0032374,1,0.567169679602414,0,26,regulation of cholesterol transport,BP,
7826,GO:0032375,1,0.913016313431588,0,4,negative regulation of cholesterol transport,BP,
7827,GO:0032376,1,0.71048092435649,0,16,positive regulation of cholesterol transport,BP,
7828,GO:0032377,1,0.856069307926735,0,7,regulation of intracellular lipid transport,BP,
7829,GO:0032378,1,0.977898834755835,0,1,negative regulation of intracellular lipid transport,BP,
7830,GO:0032379,1,0.932749279454471,0,3,positive regulation of intracellular lipid transport,BP,
7831,GO:0032380,1,0.856069307926735,0,7,regulation of intracellular sterol transport,BP,
7832,GO:0032381,1,0.977898834755835,0,1,negative regulation of intracellular sterol transport,BP,
7833,GO:0032382,1,0.932749279454471,0,3,positive regulation of intracellular sterol transport,BP,
7834,GO:0032383,1,0.856069307926735,0,7,regulation of intracellular cholesterol transport,BP,
7835,GO:0032384,1,0.977898834755835,0,1,negative regulation of intracellular cholesterol transport,BP,
7836,GO:0032385,1,0.932749279454471,0,3,positive regulation of intracellular cholesterol transport,BP,
7838,GO:0032387,1,0.38755486628087,0,42,negative regulation of intracellular transport,BP,
7840,GO:0032389,1,0.853991732746858,0,7,MutLalpha complex,CC,
7842,GO:0032392,1,0.165278916421144,0,81,DNA geometric change,BP,
7843,GO:0032393,1,0.954031645676002,0,2,MHC class I receptor activity,MF,
7845,GO:0032397,1,0.97687057577203,0,1,activating MHC class I receptor activity,MF,
7846,GO:0032398,1,0.977050079530036,0,1,MHC class Ib protein complex,CC,
7850,GO:0032404,1,0.836089276742927,0,8,mismatch repair complex binding,MF,
7851,GO:0032405,1,0.895919944775465,0,5,MutLalpha complex binding,MF,
7852,GO:0032407,1,0.894964505076318,0,5,MutSalpha complex binding,MF,
7854,GO:0032410,1,0.395283378906973,0,42,negative regulation of transporter activity,BP,
7857,GO:0032413,1,0.451398432342589,0,36,negative regulation of ion transmembrane transporter activity,BP,
7859,GO:0032415,1,0.934186586591448,0,3,regulation of sodium:proton antiporter activity,BP,
7860,GO:0032416,1,0.977198702465349,0,1,negative regulation of sodium:proton antiporter activity,BP,
7861,GO:0032417,1,0.955987998269186,0,2,positive regulation of sodium:proton antiporter activity,BP,
7863,GO:0032419,1,0.977232630646704,0,1,extrinsic component of lysosome membrane,CC,
7864,GO:0032420,1,0.587838828696391,0,24,stereocilium,CC,
7865,GO:0032421,1,0.536787117017025,0,28,stereocilium bundle,CC,
7866,GO:0032422,1,0.937878887211668,0,3,purine-rich negative regulatory element binding,MF,
7867,GO:0032423,1,0.977697391253987,0,1,regulation of mismatch repair,BP,
7868,GO:0032425,1,0.977697391253987,0,1,positive regulation of mismatch repair,BP,
7869,GO:0032426,1,0.855088496356887,0,7,stereocilium tip,CC,
7870,GO:0032427,1,0.956448414688514,0,2,GBD domain binding,MF,
7871,GO:0032428,1,0.977839106612381,0,1,beta-N-acetylgalactosaminidase activity,MF,
7872,GO:0032429,1,0.860584016090432,0,7,regulation of phospholipase A2 activity,BP,
7873,GO:0032430,1,0.934040585275629,0,3,positive regulation of phospholipase A2 activity,BP,
7874,GO:0032431,1,0.953991815035094,0,2,activation of phospholipase A2 activity,BP,
7876,GO:0032433,1,0.777871712201432,0,12,filopodium tip,CC,
7878,GO:0032435,1,0.559003135568386,0,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7880,GO:0032437,1,0.939594712826649,0,3,cuticular plate,CC,
7882,GO:0032440,1,0.976606448497193,0,1,2-alkenal reductase [NAD(P)] activity,MF,
7883,GO:0032444,1,0.965191266691915,0,2,activin responsive factor complex,CC,
7885,GO:0032447,1,0.977245957030739,0,1,protein urmylation,BP,
7886,GO:0032449,1,0.894600876796353,0,5,CBM complex,CC,
7887,GO:0032450,1,0.938239611646836,0,3,maltose alpha-glucosidase activity,MF,
7890,GO:0032453,1,0.884760370907686,0,6,histone demethylase activity (H3-K4 specific),MF,
7892,GO:0032455,1,0.935121441671787,0,3,nerve growth factor processing,BP,
7893,GO:0032456,1,0.483770536171902,0,33,endocytic recycling,BP,
7894,GO:0032458,1,0.978124901628004,0,1,slow endocytic recycling,BP,
7901,GO:0032465,1,0.228266779233688,0,68,regulation of cytokinesis,BP,
7902,GO:0032466,1,0.873115908506785,0,6,negative regulation of cytokinesis,BP,
7903,GO:0032467,1,0.580225426459619,0,25,positive regulation of cytokinesis,BP,
7904,GO:0032468,1,0.977765155163641,0,1,Golgi calcium ion homeostasis,BP,
7905,GO:0032469,1,0.642274400672656,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
7906,GO:0032470,1,0.981506086750235,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7907,GO:0032471,1,0.851576162350286,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7908,GO:0032472,1,0.955459261536175,0,2,Golgi calcium ion transport,BP,
7910,GO:0032475,1,0.977266136864643,0,1,otolith formation,BP,
7912,GO:0032480,1,0.374473513409412,0,44,negative regulation of type I interferon production,BP,
7913,GO:0032481,1,0.245305099707713,0,63,positive regulation of type I interferon production,BP,
7914,GO:0032482,1,0.266665484077658,0,58,Rab protein signal transduction,BP,
7915,GO:0032483,1,0.917366506163817,0,4,regulation of Rab protein signal transduction,BP,
7916,GO:0032484,1,0.93876577450973,0,3,Ral protein signal transduction,BP,
7917,GO:0032485,1,0.93876577450973,0,3,regulation of Ral protein signal transduction,BP,
7918,GO:0032486,1,0.756214284526217,0,13,Rap protein signal transduction,BP,
7919,GO:0032487,1,0.93873309923551,0,3,regulation of Rap protein signal transduction,BP,
7920,GO:0032488,1,0.788229770955307,0,11,Cdc42 protein signal transduction,BP,
7921,GO:0032489,1,0.918942461919951,0,4,regulation of Cdc42 protein signal transduction,BP,
7922,GO:0032490,1,0.916194561887828,0,4,detection of molecule of bacterial origin,BP,
7923,GO:0032493,1,0.93599080523792,0,3,response to bacterial lipoprotein,BP,
7924,GO:0032494,1,0.875507296054609,0,6,response to peptidoglycan,BP,
7925,GO:0032495,1,0.771476269740178,0,12,response to muramyl dipeptide,BP,
7927,GO:0032497,1,0.977272718880293,0,1,detection of lipopolysaccharide,BP,
7928,GO:0032498,1,0.978697921976875,0,1,detection of muramyl dipeptide,BP,
7929,GO:0032499,1,0.978697921976875,0,1,detection of peptidoglycan,BP,
7930,GO:0032500,1,0.978697921976875,0,1,muramyl dipeptide binding,MF,
7936,GO:0032508,1,0.20759242622489,0,71,DNA duplex unwinding,BP,
7937,GO:0032509,1,0.640005682775726,0,20,endosome transport via multivesicular body sorting pathway,BP,
7938,GO:0032510,1,0.879038726818253,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7939,GO:0032511,1,0.832009012682519,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7940,GO:0032515,1,0.460304533214525,0,35,negative regulation of phosphoprotein phosphatase activity,BP,
7941,GO:0032516,1,0.74290751412804,0,14,positive regulation of phosphoprotein phosphatase activity,BP,
7942,GO:0032525,1,0.879959323688051,0,6,somite rostral/caudal axis specification,BP,
7944,GO:0032527,1,0.470772167087939,0,34,protein exit from endoplasmic reticulum,BP,
7945,GO:0032528,1,0.676525829544895,0,18,microvillus organization,BP,
7946,GO:0032530,1,0.820327587239149,0,9,regulation of microvillus organization,BP,
7947,GO:0032532,1,0.933971855317909,0,3,regulation of microvillus length,BP,
7948,GO:0032534,1,0.878350800384799,0,6,regulation of microvillus assembly,BP,
7950,GO:0032536,1,0.872832342706573,0,6,regulation of cell projection size,BP,
7951,GO:0032541,1,0.892306668114105,0,5,cortical endoplasmic reticulum,CC,
7952,GO:0032542,1,0.955513928907817,0,2,sulfiredoxin activity,MF,
7953,GO:0032543,1,0.0479253519123834,0,129,mitochondrial translation,BP,
7954,GO:0032545,1,0.933818196677981,0,3,CURI complex,CC,
7957,GO:0032551,1,0.957317090363781,0,2,pyrimidine ribonucleoside binding,MF,
7958,GO:0032552,1,0.869416990323336,0,6,deoxyribonucleotide binding,MF,
7960,GO:0032554,1,0.911249925686079,0,4,purine deoxyribonucleotide binding,MF,
7962,GO:0032556,1,0.954108446105776,0,2,pyrimidine deoxyribonucleotide binding,MF,
7963,GO:0032557,1,0.935509406913316,0,3,pyrimidine ribonucleotide binding,MF,
7964,GO:0032558,1,0.932214401452988,0,3,adenyl deoxyribonucleotide binding,MF,
7966,GO:0032560,1,0.977516963269521,0,1,guanyl deoxyribonucleotide binding,MF,
7968,GO:0032564,1,0.932214401452988,0,3,dATP binding,MF,
7969,GO:0032567,1,0.977516963269521,0,1,dGTP binding,MF,
7971,GO:0032571,1,0.955295803700581,0,2,response to vitamin K,BP,
7972,GO:0032574,1,0.978211948619386,0,1,5'-3' RNA helicase activity,MF,
7973,GO:0032575,1,0.978211948619386,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7975,GO:0032581,1,0.977145668861862,0,1,ER-dependent peroxisome organization,BP,
7976,GO:0032584,1,0.935093214422331,0,3,growth cone membrane,CC,
7977,GO:0032585,1,0.795025244767159,0,10,multivesicular body membrane,CC,
7979,GO:0032588,1,0.233643795109247,0,65,trans-Golgi network membrane,CC,
7980,GO:0032589,1,0.586172881306753,0,25,neuron projection membrane,CC,
7981,GO:0032590,1,0.719410534768512,0,15,dendrite membrane,CC,
7982,GO:0032591,1,0.880925603397329,0,6,dendritic spine membrane,CC,
7983,GO:0032592,1,0.223653752157237,0,65,integral component of mitochondrial membrane,CC,
7984,GO:0032593,1,0.879411812164699,0,6,insulin-responsive compartment,CC,
7985,GO:0032594,1,0.623370944232187,0,21,protein transport within lipid bilayer,BP,
7986,GO:0032595,1,0.977227380413047,0,1,B cell receptor transport within lipid bilayer,BP,
7987,GO:0032596,1,0.893587365545553,0,5,protein transport into membrane raft,BP,
7988,GO:0032597,1,0.977227380413047,0,1,B cell receptor transport into membrane raft,BP,
7989,GO:0032599,1,0.977227380413047,0,1,protein transport out of membrane raft,BP,
7990,GO:0032600,1,0.977227380413047,0,1,chemokine receptor transport out of membrane raft,BP,
7992,GO:0032604,1,0.834944432553746,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7994,GO:0032607,1,0.617048250206182,0,22,interferon-alpha production,BP,
7996,GO:0032609,1,0.3003030908681,0,53,interferon-gamma production,BP,
7997,GO:0032610,1,0.847436005146094,0,7,interleukin-1 alpha production,BP,
8001,GO:0032615,1,0.484751821750574,0,32,interleukin-12 production,BP,
8003,GO:0032618,1,0.954689769476637,0,2,interleukin-15 production,BP,
8004,GO:0032620,1,0.740737572466674,0,13,interleukin-17 production,BP,
8005,GO:0032621,1,0.874006296049645,0,6,interleukin-18 production,BP,
8006,GO:0032623,1,0.429057136768328,0,38,interleukin-2 production,BP,
8007,GO:0032625,1,0.977824597077808,0,1,interleukin-21 production,BP,
8009,GO:0032632,1,0.956859602628911,0,2,interleukin-3 production,BP,
8010,GO:0032633,1,0.681081112482054,0,17,interleukin-4 production,BP,
8014,GO:0032639,1,0.977050079530036,0,1,TRAIL production,BP,
8016,GO:0032641,1,0.955238761684938,0,2,lymphotoxin A production,BP,
8018,GO:0032645,1,0.834944432553746,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8019,GO:0032647,1,0.631702451084972,0,21,regulation of interferon-alpha production,BP,
8020,GO:0032648,1,0.400143217508688,0,41,regulation of interferon-beta production,BP,
8021,GO:0032649,1,0.343383461440754,0,47,regulation of interferon-gamma production,BP,
8022,GO:0032650,1,0.868697488532221,0,6,regulation of interleukin-1 alpha production,BP,
8026,GO:0032655,1,0.496041857290026,0,31,regulation of interleukin-12 production,BP,
8028,GO:0032658,1,0.977115728022905,0,1,regulation of interleukin-15 production,BP,
8029,GO:0032660,1,0.776048787185494,0,11,regulation of interleukin-17 production,BP,
8030,GO:0032661,1,0.893448432181549,0,5,regulation of interleukin-18 production,BP,
8031,GO:0032663,1,0.491643011000111,0,32,regulation of interleukin-2 production,BP,
8033,GO:0032672,1,0.956859602628911,0,2,regulation of interleukin-3 production,BP,
8034,GO:0032673,1,0.725510784669747,0,14,regulation of interleukin-4 production,BP,
8038,GO:0032679,1,0.977050079530036,0,1,regulation of TRAIL production,BP,
8040,GO:0032681,1,0.977279275650516,0,1,regulation of lymphotoxin A production,BP,
8041,GO:0032682,1,0.776107189417225,0,11,negative regulation of chemokine production,BP,
8042,GO:0032685,1,0.977566635302409,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8043,GO:0032687,1,0.89625170149077,0,5,negative regulation of interferon-alpha production,BP,
8044,GO:0032688,1,0.745730615943666,0,13,negative regulation of interferon-beta production,BP,
8045,GO:0032689,1,0.677478344841864,0,17,negative regulation of interferon-gamma production,BP,
8046,GO:0032690,1,0.976825338219214,0,1,negative regulation of interleukin-1 alpha production,BP,
8047,GO:0032691,1,0.777444869389769,0,11,negative regulation of interleukin-1 beta production,BP,
8048,GO:0032692,1,0.69294239333969,0,16,negative regulation of interleukin-1 production,BP,
8050,GO:0032695,1,0.783728176137012,0,11,negative regulation of interleukin-12 production,BP,
8052,GO:0032700,1,0.891148189299288,0,5,negative regulation of interleukin-17 production,BP,
8053,GO:0032701,1,0.955092725858584,0,2,negative regulation of interleukin-18 production,BP,
8054,GO:0032703,1,0.765175032483794,0,12,negative regulation of interleukin-2 production,BP,
8055,GO:0032707,1,0.977241159487971,0,1,negative regulation of interleukin-23 production,BP,
8056,GO:0032712,1,0.977238535630964,0,1,negative regulation of interleukin-3 production,BP,
8057,GO:0032713,1,0.913375427072144,0,4,negative regulation of interleukin-4 production,BP,
8059,GO:0032715,1,0.654825202423201,0,19,negative regulation of interleukin-6 production,BP,
8060,GO:0032717,1,0.763823259400845,0,12,negative regulation of interleukin-8 production,BP,
8061,GO:0032720,1,0.554948028650774,0,26,negative regulation of tumor necrosis factor production,BP,
8062,GO:0032722,1,0.463628048930333,0,34,positive regulation of chemokine production,BP,
8063,GO:0032725,1,0.854116367531338,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8064,GO:0032727,1,0.704928684342315,0,16,positive regulation of interferon-alpha production,BP,
8065,GO:0032728,1,0.560844114514235,0,26,positive regulation of interferon-beta production,BP,
8066,GO:0032729,1,0.520093588663307,0,29,positive regulation of interferon-gamma production,BP,
8067,GO:0032730,1,0.889316062753975,0,5,positive regulation of interleukin-1 alpha production,BP,
8070,GO:0032733,1,0.724431513248982,0,14,positive regulation of interleukin-10 production,BP,
8071,GO:0032735,1,0.661009427722674,0,18,positive regulation of interleukin-12 production,BP,
8073,GO:0032738,1,0.977115728022905,0,1,positive regulation of interleukin-15 production,BP,
8074,GO:0032740,1,0.851053058418879,0,7,positive regulation of interleukin-17 production,BP,
8075,GO:0032741,1,0.956959196210183,0,2,positive regulation of interleukin-18 production,BP,
8076,GO:0032743,1,0.642809776232361,0,20,positive regulation of interleukin-2 production,BP,
8078,GO:0032752,1,0.979148195395373,0,1,positive regulation of interleukin-3 production,BP,
8079,GO:0032753,1,0.794380558370591,0,10,positive regulation of interleukin-4 production,BP,
8083,GO:0032759,1,0.977050079530036,0,1,positive regulation of TRAIL production,BP,
8085,GO:0032761,1,0.977279275650516,0,1,positive regulation of lymphotoxin A production,BP,
8086,GO:0032762,1,0.914432384507529,0,4,mast cell cytokine production,BP,
8087,GO:0032763,1,0.914432384507529,0,4,regulation of mast cell cytokine production,BP,
8088,GO:0032764,1,0.95525073701737,0,2,negative regulation of mast cell cytokine production,BP,
8089,GO:0032765,1,0.9572766834178,0,2,positive regulation of mast cell cytokine production,BP,
8090,GO:0032767,1,0.936375268939354,0,3,copper-dependent protein binding,MF,
8092,GO:0032769,1,0.855298703490256,0,7,negative regulation of monooxygenase activity,BP,
8094,GO:0032771,1,0.978515768926212,0,1,regulation of monophenol monooxygenase activity,BP,
8095,GO:0032773,1,0.978515768926212,0,1,positive regulation of monophenol monooxygenase activity,BP,
8097,GO:0032775,1,0.977931496380103,0,1,DNA methylation on adenine,BP,
8098,GO:0032776,1,0.937502206556863,0,3,DNA methylation on cytosine,BP,
8099,GO:0032777,1,0.912569493649383,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8100,GO:0032780,1,0.853552131015662,0,7,negative regulation of ATPase activity,BP,
8102,GO:0032782,1,0.954911743727239,0,2,bile acid secretion,BP,
8103,GO:0032783,1,0.922032502351287,0,4,ELL-EAF complex,CC,
8106,GO:0032786,1,0.583962529221222,0,24,positive regulation of DNA-templated transcription, elongation,BP,
8108,GO:0032790,1,0.835832730919678,0,8,ribosome disassembly,BP,
8109,GO:0032792,1,0.914606756515654,0,4,negative regulation of CREB transcription factor activity,BP,
8112,GO:0032795,1,0.976357114780002,0,1,heterotrimeric G-protein binding,MF,
8113,GO:0032796,1,0.958450798458493,0,2,uropod organization,BP,
8114,GO:0032797,1,0.778673218657901,0,11,SMN complex,CC,
8115,GO:0032798,1,0.955184890372083,0,2,Swi5-Sfr1 complex,CC,
8116,GO:0032799,1,0.655818207851266,0,19,low-density lipoprotein receptor particle metabolic process,BP,
8118,GO:0032801,1,0.496762918458664,0,32,receptor catabolic process,BP,
8119,GO:0032802,1,0.747813559278977,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8120,GO:0032803,1,0.892230815636647,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8121,GO:0032804,1,0.955940669514814,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8122,GO:0032805,1,0.954920821450655,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8123,GO:0032806,1,0.572089253244518,0,25,carboxy-terminal domain protein kinase complex,CC,
8124,GO:0032807,1,0.913189995221251,0,4,DNA ligase IV complex,CC,
8126,GO:0032809,1,0.861274610259827,0,7,neuronal cell body membrane,CC,
8127,GO:0032810,1,0.956529008606549,0,2,sterol response element binding,MF,
8128,GO:0032813,1,0.471218629658131,0,33,tumor necrosis factor receptor superfamily binding,MF,
8129,GO:0032814,1,0.681896613636551,0,17,regulation of natural killer cell activation,BP,
8130,GO:0032815,1,0.890195309113583,0,5,negative regulation of natural killer cell activation,BP,
8131,GO:0032816,1,0.782501468997386,0,11,positive regulation of natural killer cell activation,BP,
8132,GO:0032817,1,0.912076114157982,0,4,regulation of natural killer cell proliferation,BP,
8133,GO:0032819,1,0.912076114157982,0,4,positive regulation of natural killer cell proliferation,BP,
8134,GO:0032823,1,0.838053619248012,0,8,regulation of natural killer cell differentiation,BP,
8135,GO:0032824,1,0.976500354292079,0,1,negative regulation of natural killer cell differentiation,BP,
8136,GO:0032825,1,0.876602528732217,0,6,positive regulation of natural killer cell differentiation,BP,
8137,GO:0032826,1,0.976500354292079,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8138,GO:0032827,1,0.976500354292079,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8140,GO:0032836,1,0.844394418959932,0,8,glomerular basement membrane development,BP,
8142,GO:0032839,1,0.61187693196134,0,22,dendrite cytoplasm,CC,
8143,GO:0032847,1,0.955640046657769,0,2,regulation of cellular pH reduction,BP,
8144,GO:0032848,1,0.97809692635028,0,1,negative regulation of cellular pH reduction,BP,
8145,GO:0032849,1,0.977042119621865,0,1,positive regulation of cellular pH reduction,BP,
8152,GO:0032875,1,0.86286393482079,0,7,regulation of DNA endoreduplication,BP,
8153,GO:0032876,1,0.921317607306639,0,4,negative regulation of DNA endoreduplication,BP,
8154,GO:0032877,1,0.958115172518246,0,2,positive regulation of DNA endoreduplication,BP,
8155,GO:0032878,1,0.651033149185829,0,20,regulation of establishment or maintenance of cell polarity,BP,
8161,GO:0032887,1,0.980765369020107,0,1,regulation of spindle elongation,BP,
8162,GO:0032888,1,0.980765369020107,0,1,regulation of mitotic spindle elongation,BP,
8163,GO:0032889,1,0.977251354390594,0,1,regulation of vacuole fusion, non-autophagic,BP,
8165,GO:0032891,1,0.842093489780003,0,8,negative regulation of organic acid transport,BP,
8166,GO:0032892,1,0.745076795074343,0,13,positive regulation of organic acid transport,BP,
8167,GO:0032897,1,0.622162387127495,0,21,negative regulation of viral transcription,BP,
8168,GO:0032898,1,0.93559021236075,0,3,neurotrophin production,BP,
8169,GO:0032899,1,0.978137654399097,0,1,regulation of neurotrophin production,BP,
8170,GO:0032901,1,0.978137654399097,0,1,positive regulation of neurotrophin production,BP,
8171,GO:0032902,1,0.956505116175547,0,2,nerve growth factor production,BP,
8172,GO:0032905,1,0.876162597940029,0,6,transforming growth factor beta1 production,BP,
8173,GO:0032906,1,0.881264651748712,0,6,transforming growth factor beta2 production,BP,
8174,GO:0032907,1,0.940787908314491,0,3,transforming growth factor beta3 production,BP,
8175,GO:0032908,1,0.876162597940029,0,6,regulation of transforming growth factor beta1 production,BP,
8176,GO:0032909,1,0.881264651748712,0,6,regulation of transforming growth factor beta2 production,BP,
8177,GO:0032910,1,0.940787908314491,0,3,regulation of transforming growth factor beta3 production,BP,
8178,GO:0032911,1,0.936496047962711,0,3,negative regulation of transforming growth factor beta1 production,BP,
8179,GO:0032912,1,0.978515768926212,0,1,negative regulation of transforming growth factor beta2 production,BP,
8180,GO:0032913,1,0.977227380413047,0,1,negative regulation of transforming growth factor beta3 production,BP,
8181,GO:0032914,1,0.935590700893559,0,3,positive regulation of transforming growth factor beta1 production,BP,
8182,GO:0032915,1,0.977220221818081,0,1,positive regulation of transforming growth factor beta2 production,BP,
8183,GO:0032916,1,0.962714541494122,0,2,positive regulation of transforming growth factor beta3 production,BP,
8184,GO:0032917,1,0.953154223838733,0,2,polyamine acetylation,BP,
8185,GO:0032918,1,0.953154223838733,0,2,spermidine acetylation,BP,
8186,GO:0032919,1,0.976176308571746,0,1,spermine acetylation,BP,
8187,GO:0032920,1,0.976176308571746,0,1,putrescine acetylation,BP,
8189,GO:0032924,1,0.622767114668483,0,22,activin receptor signaling pathway,BP,
8190,GO:0032925,1,0.706008328587901,0,16,regulation of activin receptor signaling pathway,BP,
8191,GO:0032926,1,0.857032326388286,0,7,negative regulation of activin receptor signaling pathway,BP,
8192,GO:0032927,1,0.883155968373741,0,6,positive regulation of activin receptor signaling pathway,BP,
8193,GO:0032928,1,0.776629275244801,0,11,regulation of superoxide anion generation,BP,
8194,GO:0032929,1,0.954719685403567,0,2,negative regulation of superoxide anion generation,BP,
8195,GO:0032930,1,0.830828614624246,0,8,positive regulation of superoxide anion generation,BP,
8196,GO:0032933,1,0.835638927268582,0,8,SREBP signaling pathway,BP,
8197,GO:0032934,1,0.485555107290164,0,33,sterol binding,MF,
8198,GO:0032937,1,0.934555730192096,0,3,SREBP-SCAP-Insig complex,CC,
8200,GO:0032941,1,0.686005023033168,0,17,secretion by tissue,BP,
8205,GO:0032947,1,0.212716879190088,0,72,protein-containing complex scaffold activity,MF,
8206,GO:0032954,1,0.958185378446522,0,2,regulation of cytokinetic process,BP,
8208,GO:0032957,1,0.83897287424657,0,8,inositol trisphosphate metabolic process,BP,
8209,GO:0032958,1,0.689689075908958,0,17,inositol phosphate biosynthetic process,BP,
8210,GO:0032959,1,0.875763094021119,0,6,inositol trisphosphate biosynthetic process,BP,
8211,GO:0032960,1,0.914798229916367,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8212,GO:0032962,1,0.934834352748842,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8216,GO:0032966,1,0.870776855258674,0,6,negative regulation of collagen biosynthetic process,BP,
8218,GO:0032968,1,0.716170410540175,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8220,GO:0032976,1,0.975913291000001,0,1,release of matrix enzymes from mitochondria,BP,
8221,GO:0032977,1,0.978725686860298,0,1,membrane insertase activity,MF,
8222,GO:0032978,1,0.978725686860298,0,1,protein insertion into membrane from inner side,BP,
8223,GO:0032979,1,0.978725686860298,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8224,GO:0032980,1,0.977243733920925,0,1,keratinocyte activation,BP,
8225,GO:0032981,1,0.267603084063124,0,55,mitochondrial respiratory chain complex I assembly,BP,
8226,GO:0032982,1,0.869664531649611,0,7,myosin filament,CC,
8229,GO:0032988,1,0.746376323401179,0,13,ribonucleoprotein complex disassembly,BP,
8235,GO:0032996,1,0.977154786260896,0,1,Bcl3-Bcl10 complex,CC,
8237,GO:0033003,1,0.609742831421117,0,22,regulation of mast cell activation,BP,
8238,GO:0033004,1,0.933410760769276,0,3,negative regulation of mast cell activation,BP,
8239,GO:0033005,1,0.799326607974495,0,10,positive regulation of mast cell activation,BP,
8240,GO:0033006,1,0.651992156094549,0,19,regulation of mast cell activation involved in immune response,BP,
8241,GO:0033007,1,0.933410760769276,0,3,negative regulation of mast cell activation involved in immune response,BP,
8242,GO:0033008,1,0.835183019878253,0,8,positive regulation of mast cell activation involved in immune response,BP,
8243,GO:0033010,1,0.882899465629149,0,6,paranodal junction,CC,
8244,GO:0033013,1,0.378764144108814,0,43,tetrapyrrole metabolic process,BP,
8245,GO:0033014,1,0.583495816285976,0,24,tetrapyrrole biosynthetic process,BP,
8246,GO:0033015,1,0.868663346651302,0,6,tetrapyrrole catabolic process,BP,
8247,GO:0033017,1,0.648826508063861,0,21,sarcoplasmic reticulum membrane,CC,
8248,GO:0033018,1,0.955366398989198,0,2,sarcoplasmic reticulum lumen,CC,
8249,GO:0033023,1,0.957708046651186,0,2,mast cell homeostasis,BP,
8250,GO:0033024,1,0.957708046651186,0,2,mast cell apoptotic process,BP,
8251,GO:0033025,1,0.957708046651186,0,2,regulation of mast cell apoptotic process,BP,
8252,GO:0033026,1,0.979428490519811,0,1,negative regulation of mast cell apoptotic process,BP,
8253,GO:0033028,1,0.608494783360378,0,22,myeloid cell apoptotic process,BP,
8254,GO:0033029,1,0.895750551476714,0,5,regulation of neutrophil apoptotic process,BP,
8255,GO:0033030,1,0.980005229526759,0,1,negative regulation of neutrophil apoptotic process,BP,
8256,GO:0033031,1,0.914032544134273,0,4,positive regulation of neutrophil apoptotic process,BP,
8257,GO:0033032,1,0.667246218823963,0,18,regulation of myeloid cell apoptotic process,BP,
8258,GO:0033033,1,0.83577432237826,0,8,negative regulation of myeloid cell apoptotic process,BP,
8259,GO:0033034,1,0.872962470347245,0,6,positive regulation of myeloid cell apoptotic process,BP,
8261,GO:0033037,1,0.979696607030293,0,1,polysaccharide localization,BP,
8262,GO:0033038,1,0.908930643122151,0,4,bitter taste receptor activity,MF,
8263,GO:0033041,1,0.977254532392453,0,1,sweet taste receptor activity,MF,
8266,GO:0033045,1,0.213909070836663,0,70,regulation of sister chromatid segregation,BP,
8267,GO:0033046,1,0.454345623520058,0,36,negative regulation of sister chromatid segregation,BP,
8268,GO:0033047,1,0.2627672408899,0,61,regulation of mitotic sister chromatid segregation,BP,
8269,GO:0033048,1,0.474251335418059,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8270,GO:0033058,1,0.977336572808046,0,1,directional locomotion,BP,
8272,GO:0033061,1,0.812353047254703,0,9,DNA recombinase mediator complex,CC,
8273,GO:0033063,1,0.850490544153014,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8274,GO:0033065,1,0.953930906918261,0,2,Rad51C-XRCC3 complex,CC,
8275,GO:0033076,1,0.977169675328271,0,1,isoquinoline alkaloid metabolic process,BP,
8277,GO:0033078,1,0.956604429232314,0,2,extrathymic T cell differentiation,BP,
8278,GO:0033079,1,0.893353408924892,0,5,immature T cell proliferation,BP,
8279,GO:0033080,1,0.935606081929227,0,3,immature T cell proliferation in thymus,BP,
8280,GO:0033081,1,0.71453276371896,0,15,regulation of T cell differentiation in thymus,BP,
8281,GO:0033082,1,0.979055188315136,0,1,regulation of extrathymic T cell differentiation,BP,
8282,GO:0033083,1,0.913313891909112,0,4,regulation of immature T cell proliferation,BP,
8283,GO:0033084,1,0.956506959362608,0,2,regulation of immature T cell proliferation in thymus,BP,
8284,GO:0033085,1,0.892186892280124,0,5,negative regulation of T cell differentiation in thymus,BP,
8285,GO:0033087,1,0.934573255439228,0,3,negative regulation of immature T cell proliferation,BP,
8286,GO:0033088,1,0.956506959362608,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8287,GO:0033089,1,0.895724116963105,0,5,positive regulation of T cell differentiation in thymus,BP,
8288,GO:0033091,1,0.97725804780624,0,1,positive regulation of immature T cell proliferation,BP,
8289,GO:0033093,1,0.915200752548294,0,4,Weibel-Palade body,CC,
8290,GO:0033106,1,0.954406036458197,0,2,cis-Golgi network membrane,CC,
8291,GO:0033108,1,0.121577092875275,0,89,mitochondrial respiratory chain complex assembly,BP,
8292,GO:0033116,1,0.291274957520437,0,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8293,GO:0033119,1,0.589618087945609,0,23,negative regulation of RNA splicing,BP,
8295,GO:0033121,1,0.939180191926713,0,3,regulation of purine nucleotide catabolic process,BP,
8296,GO:0033122,1,0.958461994833667,0,2,negative regulation of purine nucleotide catabolic process,BP,
8297,GO:0033123,1,0.979885740014327,0,1,positive regulation of purine nucleotide catabolic process,BP,
8298,GO:0033127,1,0.764767443120023,0,12,regulation of histone phosphorylation,BP,
8299,GO:0033128,1,0.95495587937712,0,2,negative regulation of histone phosphorylation,BP,
8300,GO:0033129,1,0.838176763625079,0,8,positive regulation of histone phosphorylation,BP,
8301,GO:0033130,1,0.877209627622982,0,6,acetylcholine receptor binding,MF,
8304,GO:0033133,1,0.918763765335033,0,4,positive regulation of glucokinase activity,BP,
8307,GO:0033138,1,0.255878417840419,0,61,positive regulation of peptidyl-serine phosphorylation,BP,
8308,GO:0033139,1,0.872309624413079,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8309,GO:0033140,1,0.95496721974398,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8310,GO:0033141,1,0.913458892728462,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8311,GO:0033142,1,0.977228911994286,0,1,progesterone receptor binding,MF,
8312,GO:0033143,1,0.247117589070813,0,63,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8313,GO:0033144,1,0.56336445927664,0,26,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8314,GO:0033145,1,0.74783903802358,0,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8315,GO:0033146,1,0.482789880945554,0,33,regulation of intracellular estrogen receptor signaling pathway,BP,
8316,GO:0033147,1,0.786422096992977,0,11,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8317,GO:0033148,1,0.838252558026703,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8318,GO:0033149,1,0.958920867452108,0,2,FFAT motif binding,MF,
8320,GO:0033152,1,0.920836810160418,0,4,immunoglobulin V(D)J recombination,BP,
8321,GO:0033153,1,0.903407095312153,0,5,T cell receptor V(D)J recombination,BP,
8323,GO:0033158,1,0.693690476210413,0,17,regulation of protein import into nucleus, translocation,BP,
8324,GO:0033159,1,0.934935173412144,0,3,negative regulation of protein import into nucleus, translocation,BP,
8325,GO:0033160,1,0.814601336426441,0,10,positive regulation of protein import into nucleus, translocation,BP,
8326,GO:0033162,1,0.86955738654313,0,6,melanosome membrane,CC,
8327,GO:0033167,1,0.982891111748644,0,1,ARC complex,CC,
8328,GO:0033168,1,0.982891111748644,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8330,GO:0033170,1,0.832927179852164,0,8,protein-DNA loading ATPase activity,MF,
8331,GO:0033173,1,0.593012314117641,0,24,calcineurin-NFAT signaling cascade,BP,
8332,GO:0033176,1,0.631580925452662,0,20,proton-transporting V-type ATPase complex,CC,
8333,GO:0033177,1,0.81322386445625,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8334,GO:0033178,1,0.794920116046458,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8335,GO:0033179,1,0.832566950235482,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8336,GO:0033180,1,0.83289107960999,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8337,GO:0033181,1,0.977045762692849,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
8338,GO:0033182,1,0.803922248923277,0,10,regulation of histone ubiquitination,BP,
8339,GO:0033183,1,0.940995512635375,0,3,negative regulation of histone ubiquitination,BP,
8340,GO:0033184,1,0.894645091603491,0,5,positive regulation of histone ubiquitination,BP,
8341,GO:0033185,1,0.930165385424198,0,3,dolichol-phosphate-mannose synthase complex,CC,
8342,GO:0033186,1,0.937505862363678,0,3,CAF-1 complex,CC,
8343,GO:0033188,1,0.936296427016427,0,3,sphingomyelin synthase activity,MF,
8344,GO:0033189,1,0.778368353350703,0,11,response to vitamin A,BP,
8345,GO:0033192,1,0.898540285199329,0,5,calmodulin-dependent protein phosphatase activity,MF,
8346,GO:0033194,1,0.729737961927457,0,14,response to hydroperoxide,BP,
8348,GO:0033198,1,0.659261438479575,0,19,response to ATP,BP,
8349,GO:0033202,1,0.708907229559347,0,15,DNA helicase complex,CC,
8350,GO:0033204,1,0.977247958124236,0,1,ribonuclease P RNA binding,MF,
8351,GO:0033206,1,0.915277862832988,0,4,meiotic cytokinesis,BP,
8353,GO:0033210,1,0.854647503770101,0,7,leptin-mediated signaling pathway,BP,
8354,GO:0033211,1,0.892668043374198,0,5,adiponectin-activated signaling pathway,BP,
8355,GO:0033216,1,0.895707549459536,0,5,ferric iron import,BP,
8357,GO:0033220,1,0.914109607420397,0,4,amide-transporting ATPase activity,MF,
8358,GO:0033227,1,0.934213875783844,0,3,dsRNA transport,BP,
8359,GO:0033233,1,0.637052437153734,0,20,regulation of protein sumoylation,BP,
8360,GO:0033234,1,0.797516825551331,0,10,negative regulation of protein sumoylation,BP,
8361,GO:0033235,1,0.798844884094147,0,10,positive regulation of protein sumoylation,BP,
8362,GO:0033238,1,0.242858663245241,0,61,regulation of cellular amine metabolic process,BP,
8363,GO:0033239,1,0.918404749591683,0,4,negative regulation of cellular amine metabolic process,BP,
8364,GO:0033240,1,0.851605586217329,0,7,positive regulation of cellular amine metabolic process,BP,
8365,GO:0033241,1,0.981915309359245,0,1,regulation of cellular amine catabolic process,BP,
8366,GO:0033242,1,0.981915309359245,0,1,negative regulation of cellular amine catabolic process,BP,
8367,GO:0033256,1,0.851952951737163,0,7,I-kappaB/NF-kappaB complex,CC,
8368,GO:0033257,1,0.955095606697283,0,2,Bcl3/NF-kappaB2 complex,CC,
8370,GO:0033262,1,0.768722415008199,0,12,regulation of nuclear cell cycle DNA replication,BP,
8372,GO:0033265,1,0.955035337621511,0,2,choline binding,MF,
8374,GO:0033268,1,0.834178008789852,0,9,node of Ranvier,CC,
8375,GO:0033269,1,0.956059377131459,0,2,internode region of axon,CC,
8376,GO:0033270,1,0.847635152397447,0,8,paranode region of axon,CC,
8378,GO:0033274,1,0.980731452524532,0,1,response to vitamin B2,BP,
8379,GO:0033275,1,0.754829638737827,0,14,actin-myosin filament sliding,BP,
8380,GO:0033276,1,0.731079961175873,0,14,transcription factor TFTC complex,CC,
8381,GO:0033277,1,0.957786408594742,0,2,abortive mitotic cell cycle,BP,
8382,GO:0033278,1,0.91607138167997,0,4,cell proliferation in midbrain,BP,
8384,GO:0033283,1,0.977802294953917,0,1,organic acid-transporting ATPase activity,MF,
8385,GO:0033284,1,0.977802294953917,0,1,carboxylic acid-transporting ATPase activity,MF,
8386,GO:0033285,1,0.977802294953917,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8387,GO:0033290,1,0.978405435382506,0,1,eukaryotic 48S preinitiation complex,CC,
8388,GO:0033291,1,0.975080028268313,0,1,eukaryotic 80S initiation complex,CC,
8389,GO:0033292,1,0.963268046906891,0,2,T-tubule organization,BP,
8391,GO:0033299,1,0.893115078516505,0,5,secretion of lysosomal enzymes,BP,
8393,GO:0033301,1,0.977974110803297,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8394,GO:0033306,1,0.955678484358601,0,2,phytol metabolic process,BP,
8395,GO:0033313,1,0.89298202764169,0,5,meiotic cell cycle checkpoint,BP,
8396,GO:0033314,1,0.834650913862602,0,8,mitotic DNA replication checkpoint,BP,
8397,GO:0033316,1,0.977406519426437,0,1,meiotic spindle assembly checkpoint,BP,
8398,GO:0033319,1,0.977216434697137,0,1,UDP-D-xylose metabolic process,BP,
8399,GO:0033320,1,0.977216434697137,0,1,UDP-D-xylose biosynthetic process,BP,
8400,GO:0033326,1,0.979057613283236,0,1,cerebrospinal fluid secretion,BP,
8401,GO:0033327,1,0.877015502931414,0,6,Leydig cell differentiation,BP,
8402,GO:0033328,1,0.977873573779148,0,1,peroxisome membrane targeting sequence binding,MF,
8403,GO:0033341,1,0.958933918150905,0,2,regulation of collagen binding,BP,
8404,GO:0033342,1,0.977251266131954,0,1,negative regulation of collagen binding,BP,
8405,GO:0033343,1,0.981257864438312,0,1,positive regulation of collagen binding,BP,
8406,GO:0033344,1,0.622534837105262,0,22,cholesterol efflux,BP,
8407,GO:0033353,1,0.915106543207962,0,4,S-adenosylmethionine cycle,BP,
8409,GO:0033364,1,0.984960755845811,0,1,mast cell secretory granule organization,BP,
8411,GO:0033383,1,0.954711526660458,0,2,geranyl diphosphate metabolic process,BP,
8412,GO:0033384,1,0.954711526660458,0,2,geranyl diphosphate biosynthetic process,BP,
8413,GO:0033385,1,0.977305446674391,0,1,geranylgeranyl diphosphate metabolic process,BP,
8414,GO:0033386,1,0.977305446674391,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8415,GO:0033387,1,0.934536381557484,0,3,putrescine biosynthetic process from ornithine,BP,
8416,GO:0033388,1,0.977229587547401,0,1,putrescine biosynthetic process from arginine,BP,
8417,GO:0033391,1,0.876374477763452,0,6,chromatoid body,CC,
8418,GO:0033477,1,0.977196237704058,0,1,S-methylmethionine metabolic process,BP,
8419,GO:0033483,1,0.835927884888374,0,8,gas homeostasis,BP,
8420,GO:0033484,1,0.933761943692539,0,3,nitric oxide homeostasis,BP,
8421,GO:0033488,1,0.977432568158039,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8422,GO:0033489,1,0.912601538334149,0,4,cholesterol biosynthetic process via desmosterol,BP,
8423,GO:0033490,1,0.912601538334149,0,4,cholesterol biosynthetic process via lathosterol,BP,
8424,GO:0033499,1,0.954492147156482,0,2,galactose catabolic process via UDP-galactose,BP,
8426,GO:0033503,1,0.913976097403683,0,4,HULC complex,CC,
8427,GO:0033504,1,0.940196493648105,0,3,floor plate development,BP,
8428,GO:0033505,1,0.980454992691561,0,1,floor plate morphogenesis,BP,
8429,GO:0033512,1,0.935770857447579,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8431,GO:0033523,1,0.766997521635205,0,12,histone H2B ubiquitination,BP,
8432,GO:0033526,1,0.977277846148232,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
8433,GO:0033539,1,0.762730101710546,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8434,GO:0033540,1,0.744524133013549,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8436,GO:0033552,1,0.97725792550323,0,1,response to vitamin B3,BP,
8437,GO:0033553,1,0.917114446686314,0,4,rDNA heterochromatin,CC,
8439,GO:0033555,1,0.495541589259233,0,32,multicellular organismal response to stress,BP,
8440,GO:0033557,1,0.933533439989935,0,3,Slx1-Slx4 complex,CC,
8443,GO:0033560,1,0.978167046268588,0,1,folate reductase activity,MF,
8445,GO:0033564,1,0.959397704143827,0,2,anterior/posterior axon guidance,BP,
8446,GO:0033565,1,0.935810077236161,0,3,ESCRT-0 complex,CC,
8447,GO:0033566,1,0.955094259534695,0,2,gamma-tubulin complex localization,BP,
8448,GO:0033567,1,0.891796849642053,0,5,DNA replication, Okazaki fragment processing,BP,
8449,GO:0033570,1,0.979252292085138,0,1,transferrin transmembrane transporter activity,MF,
8450,GO:0033572,1,0.520380184542588,0,29,transferrin transport,BP,
8451,GO:0033574,1,0.488577386211707,0,32,response to testosterone,BP,
8452,GO:0033577,1,0.955107932757893,0,2,protein glycosylation in endoplasmic reticulum,BP,
8453,GO:0033578,1,0.89473625173381,0,5,protein glycosylation in Golgi,BP,
8454,GO:0033588,1,0.891448902520378,0,5,Elongator holoenzyme complex,CC,
8455,GO:0033590,1,0.93303722652535,0,3,response to cobalamin,BP,
8456,GO:0033591,1,0.914970707209311,0,4,response to L-ascorbic acid,BP,
8457,GO:0033592,1,0.89550166577678,0,5,RNA strand annealing activity,MF,
8458,GO:0033593,1,0.983635488295301,0,1,BRCA2-MAGE-D1 complex,CC,
8459,GO:0033594,1,0.977254848732398,0,1,response to hydroxyisoflavone,BP,
8460,GO:0033596,1,0.940418782013551,0,3,TSC1-TSC2 complex,CC,
8461,GO:0033597,1,0.977224850709475,0,1,mitotic checkpoint complex,CC,
8464,GO:0033600,1,0.921235835776096,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8465,GO:0033601,1,0.845108022049922,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8466,GO:0033602,1,0.979054784048604,0,1,negative regulation of dopamine secretion,BP,
8468,GO:0033604,1,0.9569750051005,0,2,negative regulation of catecholamine secretion,BP,
8470,GO:0033606,1,0.977227380413047,0,1,chemokine receptor transport within lipid bilayer,BP,
8471,GO:0033608,1,0.977336572808046,0,1,formyl-CoA transferase activity,MF,
8472,GO:0033609,1,0.977336572808046,0,1,oxalate metabolic process,BP,
8473,GO:0033612,1,0.782422284186675,0,11,receptor serine/threonine kinase binding,MF,
8475,GO:0033615,1,0.93406873476959,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
8476,GO:0033617,1,0.628945614924971,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8478,GO:0033622,1,0.790412735130981,0,11,integrin activation,BP,
8479,GO:0033623,1,0.876563203276631,0,6,regulation of integrin activation,BP,
8480,GO:0033624,1,0.958948937349632,0,2,negative regulation of integrin activation,BP,
8481,GO:0033625,1,0.956126802244909,0,2,positive regulation of integrin activation,BP,
8485,GO:0033630,1,0.765360475163043,0,12,positive regulation of cell adhesion mediated by integrin,BP,
8486,GO:0033631,1,0.819518569518057,0,9,cell-cell adhesion mediated by integrin,BP,
8487,GO:0033632,1,0.894419683076474,0,5,regulation of cell-cell adhesion mediated by integrin,BP,
8488,GO:0033633,1,0.97900115117559,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8489,GO:0033634,1,0.935188035262594,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
8490,GO:0033643,1,0.819634453803187,0,9,host cell part,CC,
8491,GO:0033644,1,0.978425880734245,0,1,host cell membrane,CC,
8492,GO:0033646,1,0.855781443458548,0,7,host intracellular part,CC,
8493,GO:0033647,1,0.894434836231178,0,5,host intracellular organelle,CC,
8494,GO:0033648,1,0.894434836231178,0,5,host intracellular membrane-bounded organelle,CC,
8495,GO:0033650,1,0.977098313568905,0,1,host cell mitochondrion,CC,
8496,GO:0033655,1,0.914044225769263,0,4,host cell cytoplasm part,CC,
8497,GO:0033668,1,0.912330467483676,0,4,negative regulation by symbiont of host apoptotic process,BP,
8500,GO:0033676,1,0.976797532405183,0,1,double-stranded DNA-dependent ATPase activity,MF,
8501,GO:0033677,1,0.93482684593748,0,3,DNA/RNA helicase activity,MF,
8502,GO:0033678,1,0.977269019072474,0,1,5'-3' DNA/RNA helicase activity,MF,
8503,GO:0033679,1,0.978813071508849,0,1,3'-5' DNA/RNA helicase activity,MF,
8504,GO:0033680,1,0.956561919139494,0,2,ATP-dependent DNA/RNA helicase activity,MF,
8505,GO:0033681,1,0.978813071508849,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8506,GO:0033682,1,0.977269019072474,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
8507,GO:0033683,1,0.411370432664617,0,39,nucleotide-excision repair, DNA incision,BP,
8508,GO:0033684,1,0.959630232105933,0,2,regulation of luteinizing hormone secretion,BP,
8509,GO:0033686,1,0.959630232105933,0,2,positive regulation of luteinizing hormone secretion,BP,
8510,GO:0033687,1,0.688316947894459,0,17,osteoblast proliferation,BP,
8511,GO:0033688,1,0.737348830280424,0,14,regulation of osteoblast proliferation,BP,
8512,GO:0033689,1,0.87861356802672,0,6,negative regulation of osteoblast proliferation,BP,
8513,GO:0033690,1,0.877931145911914,0,6,positive regulation of osteoblast proliferation,BP,
8514,GO:0033691,1,0.959608114769051,0,2,sialic acid binding,MF,
8516,GO:0033693,1,0.934622229762518,0,3,neurofilament bundle assembly,BP,
8517,GO:0033695,1,0.977467365682333,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8518,GO:0033699,1,0.977202658023853,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
8519,GO:0033700,1,0.880789360345457,0,6,phospholipid efflux,BP,
8520,GO:0033737,1,0.977249669661019,0,1,1-pyrroline dehydrogenase activity,MF,
8521,GO:0033743,1,0.912691562985511,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
8522,GO:0033745,1,0.934458071247612,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
8523,GO:0033746,1,0.977879752558832,0,1,histone demethylase activity (H3-R2 specific),MF,
8524,GO:0033749,1,0.977879752558832,0,1,histone demethylase activity (H4-R3 specific),MF,
8525,GO:0033750,1,0.739221048942481,0,13,ribosome localization,BP,
8526,GO:0033754,1,0.976964294955507,0,1,indoleamine 2,3-dioxygenase activity,MF,
8529,GO:0033765,1,0.955018702635051,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
8530,GO:0033768,1,0.955296355460244,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8531,GO:0033787,1,0.977318107723408,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8532,GO:0033814,1,0.976813211330368,0,1,propanoyl-CoA C-acyltransferase activity,MF,
8533,GO:0033823,1,0.977383416774801,0,1,procollagen glucosyltransferase activity,MF,
8534,GO:0033829,1,0.933122571025967,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
8535,GO:0033842,1,0.95595336981881,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
8536,GO:0033857,1,0.959394162680512,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8537,GO:0033858,1,0.977495145748707,0,1,N-acetylgalactosamine kinase activity,MF,
8538,GO:0033860,1,0.93075011950703,0,3,regulation of NAD(P)H oxidase activity,BP,
8539,GO:0033862,1,0.97738181525755,0,1,UMP kinase activity,MF,
8540,GO:0033864,1,0.93075011950703,0,3,positive regulation of NAD(P)H oxidase activity,BP,
8541,GO:0033865,1,0.473358690914957,0,33,nucleoside bisphosphate metabolic process,BP,
8542,GO:0033866,1,0.695055217263445,0,16,nucleoside bisphosphate biosynthetic process,BP,
8543,GO:0033867,1,0.977024830109918,0,1,Fas-activated serine/threonine kinase activity,MF,
8544,GO:0033869,1,0.976252393437505,0,1,nucleoside bisphosphate catabolic process,BP,
8545,GO:0033871,1,0.977183191309273,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
8546,GO:0033872,1,0.977204420557191,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
8547,GO:0033875,1,0.473358690914957,0,33,ribonucleoside bisphosphate metabolic process,BP,
8548,GO:0033878,1,0.978061101327842,0,1,hormone-sensitive lipase activity,MF,
8549,GO:0033882,1,0.976476000886788,0,1,choloyl-CoA hydrolase activity,MF,
8550,GO:0033883,1,0.977198217831443,0,1,pyridoxal phosphatase activity,MF,
8551,GO:0033885,1,0.977230511923351,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
8552,GO:0033897,1,0.976603782496339,0,1,ribonuclease T2 activity,MF,
8553,GO:0033906,1,0.954929560416164,0,2,hyaluronoglucuronidase activity,MF,
8554,GO:0033919,1,0.978155297178691,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8555,GO:0033925,1,0.978702271597768,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8556,GO:0033961,1,0.97709564901882,0,1,cis-stilbene-oxide hydrolase activity,MF,
8557,GO:0033962,1,0.685583217463976,0,18,cytoplasmic mRNA processing body assembly,BP,
8558,GO:0033967,1,0.976490366137579,0,1,box C/D snoRNA metabolic process,BP,
8559,GO:0033979,1,0.977256678260932,0,1,box H/ACA snoRNA metabolic process,BP,
8560,GO:0033981,1,0.97560773296622,0,1,D-dopachrome decarboxylase activity,MF,
8561,GO:0033989,1,0.977274096635437,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
8563,GO:0034012,1,0.977336572808046,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8564,GO:0034014,1,0.977236605385541,0,1,response to triglyceride,BP,
8565,GO:0034021,1,0.975858034960307,0,1,response to silicon dioxide,BP,
8566,GO:0034030,1,0.695055217263445,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
8567,GO:0034031,1,0.976252393437505,0,1,ribonucleoside bisphosphate catabolic process,BP,
8568,GO:0034032,1,0.473358690914957,0,33,purine nucleoside bisphosphate metabolic process,BP,
8569,GO:0034033,1,0.695055217263445,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
8570,GO:0034034,1,0.976252393437505,0,1,purine nucleoside bisphosphate catabolic process,BP,
8571,GO:0034035,1,0.667604363310886,0,18,purine ribonucleoside bisphosphate metabolic process,BP,
8572,GO:0034036,1,0.875769674192635,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8573,GO:0034038,1,0.976517346327039,0,1,deoxyhypusine synthase activity,MF,
8574,GO:0034039,1,0.954837246415643,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
8575,GO:0034040,1,0.938266903342473,0,3,lipid-transporting ATPase activity,MF,
8576,GO:0034041,1,0.977381018028125,0,1,sterol-transporting ATPase activity,MF,
8577,GO:0034045,1,0.706663457676163,0,16,phagophore assembly site membrane,CC,
8578,GO:0034046,1,0.86256931359128,0,7,poly(G) binding,MF,
8579,GO:0034056,1,0.936962957956649,0,3,estrogen response element binding,MF,
8580,GO:0034057,1,0.956025394185974,0,2,RNA strand-exchange activity,MF,
8581,GO:0034058,1,0.806210214295335,0,10,endosomal vesicle fusion,BP,
8583,GO:0034061,1,0.472723135172717,0,34,DNA polymerase activity,MF,
8585,GO:0034063,1,0.757017695800525,0,13,stress granule assembly,BP,
8586,GO:0034066,1,0.954532339353876,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
8589,GO:0034085,1,0.858113611733075,0,7,establishment of sister chromatid cohesion,BP,
8590,GO:0034086,1,0.773922439452421,0,12,maintenance of sister chromatid cohesion,BP,
8591,GO:0034087,1,0.961028708026524,0,2,establishment of mitotic sister chromatid cohesion,BP,
8592,GO:0034088,1,0.773922439452421,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8593,GO:0034091,1,0.842266543432857,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8594,GO:0034092,1,0.943064010015797,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8595,GO:0034093,1,0.893139330019179,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8597,GO:0034098,1,0.819183898927281,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8600,GO:0034104,1,0.766502897020499,0,12,negative regulation of tissue remodeling,BP,
8603,GO:0034110,1,0.62753183205836,0,21,regulation of homotypic cell-cell adhesion,BP,
8604,GO:0034111,1,0.782040444408138,0,11,negative regulation of homotypic cell-cell adhesion,BP,
8605,GO:0034112,1,0.894064618327146,0,5,positive regulation of homotypic cell-cell adhesion,BP,
8606,GO:0034113,1,0.517901620156763,0,30,heterotypic cell-cell adhesion,BP,
8607,GO:0034114,1,0.727172500367802,0,14,regulation of heterotypic cell-cell adhesion,BP,
8608,GO:0034115,1,0.851178910152314,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8609,GO:0034116,1,0.834741592200163,0,8,positive regulation of heterotypic cell-cell adhesion,BP,
8610,GO:0034117,1,0.975439797030923,0,1,erythrocyte aggregation,BP,
8611,GO:0034118,1,0.975439797030923,0,1,regulation of erythrocyte aggregation,BP,
8612,GO:0034120,1,0.975439797030923,0,1,positive regulation of erythrocyte aggregation,BP,
8615,GO:0034123,1,0.760060314938739,0,12,positive regulation of toll-like receptor signaling pathway,BP,
8616,GO:0034124,1,0.955515311213906,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
8617,GO:0034127,1,0.915314601976249,0,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8618,GO:0034128,1,0.936683864988312,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8619,GO:0034134,1,0.797069360639262,0,10,toll-like receptor 2 signaling pathway,BP,
8620,GO:0034135,1,0.873233821574017,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8621,GO:0034136,1,0.937217768387331,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
8622,GO:0034137,1,0.931745961060978,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
8623,GO:0034138,1,0.680005243159424,0,17,toll-like receptor 3 signaling pathway,BP,
8624,GO:0034139,1,0.835810693241916,0,8,regulation of toll-like receptor 3 signaling pathway,BP,
8625,GO:0034140,1,0.935768008908129,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
8626,GO:0034141,1,0.872949825449256,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8630,GO:0034145,1,0.893090041395003,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
8631,GO:0034146,1,0.978645391491612,0,1,toll-like receptor 5 signaling pathway,BP,
8632,GO:0034147,1,0.978645391491612,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8633,GO:0034148,1,0.978645391491612,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
8634,GO:0034150,1,0.979791139459405,0,1,toll-like receptor 6 signaling pathway,BP,
8635,GO:0034154,1,0.914257164472625,0,4,toll-like receptor 7 signaling pathway,BP,
8636,GO:0034155,1,0.977777005089629,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8637,GO:0034157,1,0.977777005089629,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8638,GO:0034162,1,0.731991715494123,0,14,toll-like receptor 9 signaling pathway,BP,
8639,GO:0034163,1,0.93719337616362,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
8640,GO:0034164,1,0.980363699947147,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
8641,GO:0034165,1,0.95596820556944,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8642,GO:0034166,1,0.977601481697828,0,1,toll-like receptor 10 signaling pathway,BP,
8643,GO:0034182,1,0.842266543432857,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8644,GO:0034183,1,0.943064010015797,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
8645,GO:0034184,1,0.893139330019179,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8646,GO:0034185,1,0.782359813360663,0,12,apolipoprotein binding,MF,
8647,GO:0034186,1,0.91695587675986,0,4,apolipoprotein A-I binding,MF,
8648,GO:0034188,1,0.963857353631067,0,2,apolipoprotein A-I receptor activity,MF,
8649,GO:0034189,1,0.956251282872995,0,2,very-low-density lipoprotein particle binding,MF,
8650,GO:0034190,1,0.916826828236686,0,4,apolipoprotein receptor binding,MF,
8651,GO:0034191,1,0.937552807794347,0,3,apolipoprotein A-I receptor binding,MF,
8652,GO:0034196,1,0.977258668731482,0,1,acylglycerol transport,BP,
8653,GO:0034197,1,0.977258668731482,0,1,triglyceride transport,BP,
8654,GO:0034198,1,0.406566257699257,0,40,cellular response to amino acid starvation,BP,
8655,GO:0034199,1,0.810770769145883,0,10,activation of protein kinase A activity,BP,
8656,GO:0034201,1,0.893820513807466,0,5,response to oleic acid,BP,
8657,GO:0034203,1,0.979203219051076,0,1,glycolipid translocation,BP,
8658,GO:0034204,1,0.74009055145353,0,15,lipid translocation,BP,
8661,GO:0034213,1,0.976942561332237,0,1,quinolinate catabolic process,BP,
8665,GO:0034224,1,0.977233821249331,0,1,cellular response to zinc ion starvation,BP,
8666,GO:0034227,1,0.890754393676389,0,5,tRNA thio-modification,BP,
8667,GO:0034235,1,0.872860995511257,0,6,GPI anchor binding,MF,
8669,GO:0034237,1,0.729435156748433,0,15,protein kinase A regulatory subunit binding,MF,
8670,GO:0034238,1,0.978235262384458,0,1,macrophage fusion,BP,
8671,GO:0034239,1,0.978235262384458,0,1,regulation of macrophage fusion,BP,
8672,GO:0034241,1,0.978235262384458,0,1,positive regulation of macrophage fusion,BP,
8673,GO:0034242,1,0.957529966513609,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
8676,GO:0034245,1,0.978066987948802,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8677,GO:0034247,1,0.976657447192621,0,1,snoRNA splicing,BP,
8682,GO:0034271,1,0.935268711531405,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8683,GO:0034272,1,0.935268711531405,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
8684,GO:0034274,1,0.936436398791311,0,3,Atg12-Atg5-Atg16 complex,CC,
8685,GO:0034275,1,0.976964294955507,0,1,kynurenic acid metabolic process,BP,
8686,GO:0034276,1,0.976964294955507,0,1,kynurenic acid biosynthetic process,BP,
8688,GO:0034285,1,0.935408749921763,0,3,response to disaccharide,BP,
8690,GO:0034309,1,0.976125001747232,0,1,primary alcohol biosynthetic process,BP,
8691,GO:0034310,1,0.850383984996764,0,7,primary alcohol catabolic process,BP,
8692,GO:0034311,1,0.67670634512414,0,17,diol metabolic process,BP,
8693,GO:0034312,1,0.708891947950266,0,15,diol biosynthetic process,BP,
8694,GO:0034314,1,0.519750048030615,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8695,GO:0034315,1,0.731718134200362,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8696,GO:0034316,1,0.914350021512936,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
8699,GO:0034331,1,0.85729836593299,0,7,cell junction maintenance,BP,
8702,GO:0034334,1,0.916287152586393,0,4,adherens junction maintenance,BP,
8703,GO:0034338,1,0.937841341738228,0,3,short-chain carboxylesterase activity,MF,
8706,GO:0034342,1,0.955072258041178,0,2,response to type III interferon,BP,
8707,GO:0034343,1,0.935479956899424,0,3,type III interferon production,BP,
8708,GO:0034344,1,0.935479956899424,0,3,regulation of type III interferon production,BP,
8709,GO:0034346,1,0.977410879443256,0,1,positive regulation of type III interferon production,BP,
8711,GO:0034350,1,0.857584147598884,0,7,regulation of glial cell apoptotic process,BP,
8712,GO:0034351,1,0.857584147598884,0,7,negative regulation of glial cell apoptotic process,BP,
8713,GO:0034353,1,0.977336572808046,0,1,RNA pyrophosphohydrolase activity,MF,
8714,GO:0034355,1,0.977336572808046,0,1,NAD salvage,BP,
8715,GO:0034356,1,0.763621481777914,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
8717,GO:0034361,1,0.850454014526338,0,7,very-low-density lipoprotein particle,CC,
8718,GO:0034362,1,0.876680110038747,0,6,low-density lipoprotein particle,CC,
8719,GO:0034363,1,0.976504617803502,0,1,intermediate-density lipoprotein particle,CC,
8721,GO:0034365,1,0.976504617803502,0,1,discoidal high-density lipoprotein particle,CC,
8723,GO:0034367,1,0.796360510722091,0,10,protein-containing complex remodeling,BP,
8724,GO:0034368,1,0.814783074458907,0,9,protein-lipid complex remodeling,BP,
8725,GO:0034369,1,0.814783074458907,0,9,plasma lipoprotein particle remodeling,BP,
8726,GO:0034370,1,0.953786130658191,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8727,GO:0034371,1,0.976504617803502,0,1,chylomicron remodeling,BP,
8728,GO:0034372,1,0.953786130658191,0,2,very-low-density lipoprotein particle remodeling,BP,
8729,GO:0034374,1,0.932577987693368,0,3,low-density lipoprotein particle remodeling,BP,
8730,GO:0034375,1,0.833871737025498,0,8,high-density lipoprotein particle remodeling,BP,
8731,GO:0034377,1,0.700786691174148,0,16,plasma lipoprotein particle assembly,BP,
8732,GO:0034378,1,0.934847187148084,0,3,chylomicron assembly,BP,
8733,GO:0034379,1,0.871356905245478,0,6,very-low-density lipoprotein particle assembly,BP,
8734,GO:0034380,1,0.821080112125567,0,9,high-density lipoprotein particle assembly,BP,
8735,GO:0034381,1,0.474256568153143,0,33,plasma lipoprotein particle clearance,BP,
8736,GO:0034382,1,0.911442646161753,0,4,chylomicron remnant clearance,BP,
8737,GO:0034383,1,0.569387503492614,0,25,low-density lipoprotein particle clearance,BP,
8738,GO:0034384,1,0.894372516167537,0,5,high-density lipoprotein particle clearance,BP,
8739,GO:0034385,1,0.850454014526338,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8740,GO:0034386,1,0.979054784048604,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8741,GO:0034388,1,0.874750079902178,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8742,GO:0034389,1,0.730279129836937,0,14,lipid particle organization,BP,
8743,GO:0034390,1,0.736912603358099,0,14,smooth muscle cell apoptotic process,BP,
8744,GO:0034391,1,0.736912603358099,0,14,regulation of smooth muscle cell apoptotic process,BP,
8745,GO:0034392,1,0.920438486221472,0,4,negative regulation of smooth muscle cell apoptotic process,BP,
8746,GO:0034393,1,0.818611811389051,0,9,positive regulation of smooth muscle cell apoptotic process,BP,
8748,GO:0034395,1,0.97694440636113,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
8749,GO:0034397,1,0.822146882262703,0,9,telomere localization,BP,
8750,GO:0034398,1,0.895679486480879,0,5,telomere tethering at nuclear periphery,BP,
8751,GO:0034399,1,0.073533307479486,0,119,nuclear periphery,CC,
8752,GO:0034402,1,0.957541200345508,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
8754,GO:0034405,1,0.514194625369153,0,30,response to fluid shear stress,BP,
8755,GO:0034414,1,0.955799861090962,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
8756,GO:0034416,1,0.955166842267309,0,2,bisphosphoglycerate phosphatase activity,MF,
8757,GO:0034417,1,0.977318107723408,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8758,GO:0034418,1,0.954985196330228,0,2,urate biosynthetic process,BP,
8759,GO:0034421,1,0.935043255704119,0,3,post-translational protein acetylation,BP,
8760,GO:0034423,1,0.977264086496889,0,1,autophagosome lumen,CC,
8761,GO:0034427,1,0.791926022567513,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8762,GO:0034431,1,0.91310481226447,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8763,GO:0034432,1,0.91310481226447,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8764,GO:0034433,1,0.848895855930064,0,7,steroid esterification,BP,
8765,GO:0034434,1,0.848895855930064,0,7,sterol esterification,BP,
8766,GO:0034435,1,0.848895855930064,0,7,cholesterol esterification,BP,
8767,GO:0034436,1,0.93301217172624,0,3,glycoprotein transport,BP,
8768,GO:0034437,1,0.955744886819431,0,2,glycoprotein transporter activity,MF,
8769,GO:0034440,1,0.165440866818531,0,80,lipid oxidation,BP,
8770,GO:0034441,1,0.977123835967323,0,1,plasma lipoprotein particle oxidation,BP,
8772,GO:0034447,1,0.909797356161541,0,4,very-low-density lipoprotein particle clearance,BP,
8773,GO:0034448,1,0.911311542096873,0,4,EGO complex,CC,
8774,GO:0034450,1,0.767576471379547,0,12,ubiquitin-ubiquitin ligase activity,MF,
8775,GO:0034451,1,0.625835648359813,0,22,centriolar satellite,CC,
8778,GO:0034454,1,0.831446171358181,0,9,microtubule anchoring at centrosome,BP,
8779,GO:0034455,1,0.936464859261796,0,3,t-UTP complex,CC,
8780,GO:0034456,1,0.933818196677981,0,3,UTP-C complex,CC,
8782,GO:0034458,1,0.95654133817824,0,2,3'-5' RNA helicase activity,MF,
8783,GO:0034459,1,0.978813071508849,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8784,GO:0034462,1,0.977233931975529,0,1,small-subunit processome assembly,BP,
8785,GO:0034463,1,0.975080028268313,0,1,90S preribosome assembly,BP,
8786,GO:0034464,1,0.814118126523083,0,9,BBSome,CC,
8787,GO:0034465,1,0.914072462005279,0,4,response to carbon monoxide,BP,
8789,GO:0034471,1,0.646073192763665,0,19,ncRNA 5'-end processing,BP,
8790,GO:0034472,1,0.728345741365777,0,14,snRNA 3'-end processing,BP,
8791,GO:0034473,1,0.931872879780379,0,3,U1 snRNA 3'-end processing,BP,
8792,GO:0034474,1,0.980630180900654,0,1,U2 snRNA 3'-end processing,BP,
8793,GO:0034475,1,0.827805014117724,0,8,U4 snRNA 3'-end processing,BP,
8794,GO:0034476,1,0.931872879780379,0,3,U5 snRNA 3'-end processing,BP,
8795,GO:0034477,1,0.977336572808046,0,1,U6 snRNA 3'-end processing,BP,
8796,GO:0034481,1,0.917415255760298,0,4,chondroitin sulfotransferase activity,MF,
8797,GO:0034483,1,0.839067510372122,0,8,heparan sulfate sulfotransferase activity,MF,
8798,GO:0034485,1,0.915478462585799,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
8799,GO:0034497,1,0.76683574941303,0,12,protein localization to phagophore assembly site,BP,
8800,GO:0034498,1,0.838978361319533,0,8,early endosome to Golgi transport,BP,
8801,GO:0034499,1,0.959960790293025,0,2,late endosome to Golgi transport,BP,
8806,GO:0034506,1,0.978273888349958,0,1,chromosome, centromeric core domain,CC,
8808,GO:0034511,1,0.875183145015118,0,6,U3 snoRNA binding,MF,
8809,GO:0034512,1,0.977336572808046,0,1,box C/D snoRNA binding,MF,
8810,GO:0034513,1,0.887182694660258,0,5,box H/ACA snoRNA binding,MF,
8811,GO:0034515,1,0.955415441404044,0,2,proteasome storage granule,CC,
8812,GO:0034518,1,0.76595387155569,0,12,RNA cap binding complex,CC,
8813,GO:0034545,1,0.977050793171147,0,1,fumarylpyruvate hydrolase activity,MF,
8814,GO:0034551,1,0.815097172202716,0,9,mitochondrial respiratory chain complex III assembly,BP,
8815,GO:0034552,1,0.910787045692902,0,4,respiratory chain complex II assembly,BP,
8816,GO:0034553,1,0.910787045692902,0,4,mitochondrial respiratory chain complex II assembly,BP,
8817,GO:0034584,1,0.978085145472471,0,1,piRNA binding,MF,
8818,GO:0034587,1,0.834584958161174,0,8,piRNA metabolic process,BP,
8819,GO:0034589,1,0.978531621802318,0,1,hydroxyproline transport,BP,
8820,GO:0034590,1,0.978531621802318,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8821,GO:0034593,1,0.612097882301971,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8822,GO:0034594,1,0.896747688868897,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8823,GO:0034595,1,0.754488696047377,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8824,GO:0034596,1,0.843824582005217,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8825,GO:0034597,1,0.959162434431509,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8827,GO:0034602,1,0.978533881700099,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8828,GO:0034603,1,0.893145823984244,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8829,GO:0034604,1,0.893145823984244,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8834,GO:0034616,1,0.749194001042602,0,13,response to laminar fluid shear stress,BP,
8835,GO:0034617,1,0.936525728312644,0,3,tetrahydrobiopterin binding,MF,
8836,GO:0034618,1,0.915230804339703,0,4,arginine binding,MF,
8839,GO:0034625,1,0.892309679212437,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8840,GO:0034626,1,0.892309679212437,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8841,GO:0034627,1,0.958029329710443,0,2,'de novo' NAD biosynthetic process,BP,
8842,GO:0034628,1,0.958029329710443,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
8844,GO:0034634,1,0.9801861254092,0,1,glutathione transmembrane transporter activity,MF,
8845,GO:0034635,1,0.957834946081307,0,2,glutathione transport,BP,
8847,GO:0034638,1,0.870856222625642,0,6,phosphatidylcholine catabolic process,BP,
8848,GO:0034640,1,0.977536889157831,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8850,GO:0034642,1,0.978068950460407,0,1,mitochondrion migration along actin filament,BP,
8851,GO:0034643,1,0.66326071260839,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8854,GO:0034647,1,0.963822152965653,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8855,GO:0034648,1,0.921474259921047,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8856,GO:0034649,1,0.978137654399097,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8857,GO:0034650,1,0.894416672815808,0,5,cortisol metabolic process,BP,
8858,GO:0034651,1,0.894416672815808,0,5,cortisol biosynthetic process,BP,
8859,GO:0034653,1,0.978730009672984,0,1,retinoic acid catabolic process,BP,
8863,GO:0034657,1,0.914763933958278,0,4,GID complex,CC,
8865,GO:0034661,1,0.600045375932719,0,23,ncRNA catabolic process,BP,
8866,GO:0034663,1,0.814118528138032,0,9,endoplasmic reticulum chaperone complex,CC,
8867,GO:0034665,1,0.957451657756699,0,2,integrin alpha1-beta1 complex,CC,
8868,GO:0034666,1,0.93801822789232,0,3,integrin alpha2-beta1 complex,CC,
8869,GO:0034667,1,0.957575830396535,0,2,integrin alpha3-beta1 complex,CC,
8870,GO:0034669,1,0.979955563408742,0,1,integrin alpha4-beta7 complex,CC,
8871,GO:0034670,1,0.982548211091412,0,1,chemotaxis to arachidonic acid,BP,
8872,GO:0034673,1,0.959924651479773,0,2,inhibin-betaglycan-ActRII complex,CC,
8873,GO:0034676,1,0.979708581357752,0,1,integrin alpha6-beta4 complex,CC,
8874,GO:0034677,1,0.978017020091412,0,1,integrin alpha7-beta1 complex,CC,
8875,GO:0034678,1,0.957264148564883,0,2,integrin alpha8-beta1 complex,CC,
8876,GO:0034680,1,0.957744735983449,0,2,integrin alpha10-beta1 complex,CC,
8877,GO:0034681,1,0.978017020091412,0,1,integrin alpha11-beta1 complex,CC,
8878,GO:0034683,1,0.980578682093857,0,1,integrin alphav-beta3 complex,CC,
8879,GO:0034684,1,0.958671281115274,0,2,integrin alphav-beta5 complex,CC,
8880,GO:0034685,1,0.958262192157418,0,2,integrin alphav-beta6 complex,CC,
8881,GO:0034686,1,0.96280966743713,0,2,integrin alphav-beta8 complex,CC,
8882,GO:0034693,1,0.977246542044851,0,1,U11/U12 snRNP,CC,
8883,GO:0034694,1,0.679183366466368,0,18,response to prostaglandin,BP,
8884,GO:0034695,1,0.742149058302315,0,14,response to prostaglandin E,BP,
8885,GO:0034696,1,0.954991663811356,0,2,response to prostaglandin F,BP,
8887,GO:0034699,1,0.936172271587245,0,3,response to luteinizing hormone,BP,
8891,GO:0034705,1,0.518300531744188,0,30,potassium channel complex,CC,
8892,GO:0034706,1,0.849984327523982,0,8,sodium channel complex,CC,
8893,GO:0034707,1,0.763664263258372,0,12,chloride channel complex,CC,
8895,GO:0034709,1,0.751853389691496,0,12,methylosome,CC,
8896,GO:0034711,1,0.935109061970308,0,3,inhibin binding,MF,
8897,GO:0034713,1,0.838332470029768,0,8,type I transforming growth factor beta receptor binding,MF,
8898,GO:0034714,1,0.93544689367411,0,3,type III transforming growth factor beta receptor binding,MF,
8899,GO:0034715,1,0.867218711726808,0,6,pICln-Sm protein complex,CC,
8900,GO:0034718,1,0.979453298947337,0,1,SMN-Gemin2 complex,CC,
8901,GO:0034719,1,0.688384292420568,0,16,SMN-Sm protein complex,CC,
8902,GO:0034720,1,0.884760370907686,0,6,histone H3-K4 demethylation,BP,
8903,GO:0034721,1,0.963822152965653,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8904,GO:0034722,1,0.976888443648777,0,1,gamma-glutamyl-peptidase activity,MF,
8907,GO:0034727,1,0.979101482028327,0,1,piecemeal microautophagy of the nucleus,BP,
8909,GO:0034729,1,0.937374427966465,0,3,histone H3-K79 methylation,BP,
8910,GO:0034736,1,0.977679168026864,0,1,cholesterol O-acyltransferase activity,MF,
8911,GO:0034739,1,0.95478097401288,0,2,histone deacetylase activity (H4-K16 specific),MF,
8912,GO:0034750,1,0.957447129346186,0,2,Scrib-APC-beta-catenin complex,CC,
8913,GO:0034751,1,0.935342024808593,0,3,aryl hydrocarbon receptor complex,CC,
8914,GO:0034752,1,0.980071073247669,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8915,GO:0034753,1,0.980071073247669,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8917,GO:0034755,1,0.769063418691697,0,12,iron ion transmembrane transport,BP,
8918,GO:0034756,1,0.936462716791117,0,3,regulation of iron ion transport,BP,
8919,GO:0034757,1,0.981687969636549,0,1,negative regulation of iron ion transport,BP,
8920,GO:0034759,1,0.981687969636549,0,1,regulation of iron ion transmembrane transport,BP,
8921,GO:0034760,1,0.981687969636549,0,1,negative regulation of iron ion transmembrane transport,BP,
8928,GO:0034770,1,0.828669445199591,0,9,histone H4-K20 methylation,BP,
8929,GO:0034773,1,0.878293990653352,0,6,histone H4-K20 trimethylation,BP,
8931,GO:0034775,1,0.9801861254092,0,1,glutathione transmembrane transport,BP,
8932,GO:0034776,1,0.958750392858708,0,2,response to histamine,BP,
8933,GO:0034777,1,0.977232828627689,0,1,recycling endosome lumen,CC,
8934,GO:0034875,1,0.977467365682333,0,1,caffeine oxidase activity,MF,
8935,GO:0034959,1,0.979223678691072,0,1,endothelin maturation,BP,
8936,GO:0034963,1,0.976490366137579,0,1,box C/D snoRNA processing,BP,
8937,GO:0034964,1,0.977256678260932,0,1,box H/ACA snoRNA processing,BP,
8939,GO:0034969,1,0.795206318286832,0,10,histone arginine methylation,BP,
8940,GO:0034970,1,0.955154069419757,0,2,histone H3-R2 methylation,BP,
8941,GO:0034971,1,0.97737706733745,0,1,histone H3-R17 methylation,BP,
8942,GO:0034975,1,0.728019348144039,0,14,protein folding in endoplasmic reticulum,BP,
8944,GO:0034979,1,0.685938966645726,0,17,NAD-dependent protein deacetylase activity,MF,
8945,GO:0034982,1,0.793856533037591,0,10,mitochondrial protein processing,BP,
8946,GO:0034983,1,0.878120066767062,0,6,peptidyl-lysine deacetylation,BP,
8947,GO:0034986,1,0.980739394112815,0,1,iron chaperone activity,MF,
8948,GO:0034987,1,0.981712707428526,0,1,immunoglobulin receptor binding,MF,
8949,GO:0034988,1,0.981712707428526,0,1,Fc-gamma receptor I complex binding,MF,
8950,GO:0034991,1,0.956101915956827,0,2,nuclear meiotic cohesin complex,CC,
8951,GO:0034992,1,0.909277136100368,0,5,microtubule organizing center attachment site,CC,
8952,GO:0034993,1,0.909277136100368,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
8953,GO:0034998,1,0.977336572808046,0,1,oligosaccharyltransferase I complex,CC,
8955,GO:0035005,1,0.882756672702271,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8958,GO:0035020,1,0.723265293113766,0,15,regulation of Rac protein signal transduction,BP,
8959,GO:0035021,1,0.920644157827981,0,4,negative regulation of Rac protein signal transduction,BP,
8960,GO:0035022,1,0.916723746777032,0,4,positive regulation of Rac protein signal transduction,BP,
8962,GO:0035024,1,0.693031731263091,0,17,negative regulation of Rho protein signal transduction,BP,
8963,GO:0035025,1,0.752145764591091,0,13,positive regulation of Rho protein signal transduction,BP,
8964,GO:0035026,1,0.956877909238435,0,2,leading edge cell differentiation,BP,
8965,GO:0035032,1,0.873040952494404,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8966,GO:0035033,1,0.956946853804041,0,2,histone deacetylase regulator activity,MF,
8968,GO:0035035,1,0.579218981107212,0,25,histone acetyltransferase binding,MF,
8969,GO:0035036,1,0.658882887913918,0,18,sperm-egg recognition,BP,
8970,GO:0035037,1,0.978723091181721,0,1,sperm entry,BP,
8973,GO:0035054,1,0.977480224836951,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
8974,GO:0035061,1,0.919402028008994,0,4,interchromatin granule,CC,
8975,GO:0035063,1,0.977946468130337,0,1,nuclear speck organization,BP,
8979,GO:0035067,1,0.733504088460865,0,14,negative regulation of histone acetylation,BP,
8980,GO:0035068,1,0.824336282055694,0,9,micro-ribonucleoprotein complex,CC,
8981,GO:0035082,1,0.60449756344696,0,23,axoneme assembly,BP,
8982,GO:0035087,1,0.916867851714989,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8983,GO:0035088,1,0.507114623865793,0,31,establishment or maintenance of apical/basal cell polarity,BP,
8984,GO:0035089,1,0.754132771099853,0,13,establishment of apical/basal cell polarity,BP,
8985,GO:0035090,1,0.894789415886589,0,5,maintenance of apical/basal cell polarity,BP,
8987,GO:0035092,1,0.940075391831364,0,3,sperm chromatin condensation,BP,
8988,GO:0035093,1,0.9606445875089,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
8989,GO:0035094,1,0.617838800804779,0,22,response to nicotine,BP,
8990,GO:0035095,1,0.91941509075771,0,4,behavioral response to nicotine,BP,
8991,GO:0035097,1,0.215575038990915,0,70,histone methyltransferase complex,CC,
8992,GO:0035098,1,0.704388884999439,0,16,ESC/E(Z) complex,CC,
8993,GO:0035101,1,0.935007603008077,0,3,FACT complex,CC,
8997,GO:0035112,1,0.883789774493495,0,6,genitalia morphogenesis,BP,
9000,GO:0035116,1,0.691693161948957,0,17,embryonic hindlimb morphogenesis,BP,
9001,GO:0035120,1,0.983470795487712,0,1,post-embryonic appendage morphogenesis,BP,
9002,GO:0035127,1,0.983470795487712,0,1,post-embryonic limb morphogenesis,BP,
9003,GO:0035128,1,0.983470795487712,0,1,post-embryonic forelimb morphogenesis,BP,
9005,GO:0035137,1,0.639904683880224,0,21,hindlimb morphogenesis,BP,
9009,GO:0035162,1,0.755366019839109,0,13,embryonic hemopoiesis,BP,
9010,GO:0035166,1,0.935306070243989,0,3,post-embryonic hemopoiesis,BP,
9011,GO:0035173,1,0.736055702693606,0,14,histone kinase activity,MF,
9012,GO:0035174,1,0.876468102747242,0,6,histone serine kinase activity,MF,
9013,GO:0035175,1,0.977071421642845,0,1,histone kinase activity (H3-S10 specific),MF,
9014,GO:0035176,1,0.518856656637504,0,31,social behavior,BP,
9015,GO:0035184,1,0.916369900441188,0,4,histone threonine kinase activity,MF,
9016,GO:0035188,1,0.977555063335181,0,1,hatching,BP,
9017,GO:0035189,1,0.93491580059738,0,3,Rb-E2F complex,CC,
9021,GO:0035197,1,0.824674101167584,0,9,siRNA binding,MF,
9022,GO:0035198,1,0.625521725796637,0,21,miRNA binding,MF,
9023,GO:0035226,1,0.97743318825986,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9024,GO:0035227,1,0.97743318825986,0,1,regulation of glutamate-cysteine ligase activity,BP,
9025,GO:0035229,1,0.97743318825986,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9026,GO:0035234,1,0.879334716522918,0,6,ectopic germ cell programmed cell death,BP,
9029,GO:0035240,1,0.977169675328271,0,1,dopamine binding,MF,
9030,GO:0035241,1,0.933375248189752,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9031,GO:0035242,1,0.850987064876418,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9032,GO:0035243,1,0.912198147299399,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9033,GO:0035246,1,0.776162359221516,0,11,peptidyl-arginine N-methylation,BP,
9034,GO:0035247,1,0.812751218308419,0,9,peptidyl-arginine omega-N-methylation,BP,
9035,GO:0035248,1,0.977326624918034,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9036,GO:0035249,1,0.512979976531377,0,31,synaptic transmission, glutamatergic,BP,
9037,GO:0035250,1,0.607186526346405,0,22,UDP-galactosyltransferase activity,MF,
9038,GO:0035251,1,0.857571692936648,0,7,UDP-glucosyltransferase activity,MF,
9039,GO:0035252,1,0.879179973372247,0,6,UDP-xylosyltransferase activity,MF,
9040,GO:0035253,1,0.822939747366569,0,9,ciliary rootlet,CC,
9043,GO:0035256,1,0.875172816630247,0,6,G-protein coupled glutamate receptor binding,MF,
9046,GO:0035259,1,0.753171864215734,0,13,glucocorticoid receptor binding,MF,
9047,GO:0035261,1,0.965884859147277,0,2,external genitalia morphogenesis,BP,
9048,GO:0035262,1,0.981876228906368,0,1,gonad morphogenesis,BP,
9051,GO:0035267,1,0.654565962292608,0,19,NuA4 histone acetyltransferase complex,CC,
9052,GO:0035268,1,0.670293058779024,0,18,protein mannosylation,BP,
9053,GO:0035269,1,0.761002598457692,0,12,protein O-linked mannosylation,BP,
9056,GO:0035276,1,0.979530757041336,0,1,ethanol binding,MF,
9057,GO:0035278,1,0.776532269006264,0,12,miRNA mediated inhibition of translation,BP,
9058,GO:0035279,1,0.955688490073126,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9059,GO:0035280,1,0.858703812098444,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9060,GO:0035281,1,0.956256319935698,0,2,pre-miRNA export from nucleus,BP,
9061,GO:0035282,1,0.273535927436327,0,60,segmentation,BP,
9062,GO:0035283,1,0.977637592450911,0,1,central nervous system segmentation,BP,
9063,GO:0035284,1,0.977637592450911,0,1,brain segmentation,BP,
9064,GO:0035290,1,0.936078576165606,0,3,trunk segmentation,BP,
9067,GO:0035299,1,0.978625087571785,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9068,GO:0035303,1,0.0309917342076162,0,158,regulation of dephosphorylation,BP,
9069,GO:0035304,1,0.106375191978756,0,101,regulation of protein dephosphorylation,BP,
9070,GO:0035305,1,0.177084098581864,0,79,negative regulation of dephosphorylation,BP,
9071,GO:0035306,1,0.427329357452256,0,39,positive regulation of dephosphorylation,BP,
9072,GO:0035307,1,0.516513169715453,0,30,positive regulation of protein dephosphorylation,BP,
9073,GO:0035308,1,0.430310317398482,0,38,negative regulation of protein dephosphorylation,BP,
9075,GO:0035313,1,0.762676450530132,0,13,wound healing, spreading of epidermal cells,BP,
9077,GO:0035325,1,0.833033698423614,0,8,Toll-like receptor binding,MF,
9081,GO:0035330,1,0.796542408529242,0,11,regulation of hippo signaling,BP,
9082,GO:0035331,1,0.847211406761872,0,8,negative regulation of hippo signaling,BP,
9083,GO:0035332,1,0.963158401560768,0,2,positive regulation of hippo signaling,BP,
9086,GO:0035336,1,0.650301650436545,0,19,long-chain fatty-acyl-CoA metabolic process,BP,
9087,GO:0035337,1,0.487888262864331,0,32,fatty-acyl-CoA metabolic process,BP,
9088,GO:0035338,1,0.7448679911788,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9089,GO:0035339,1,0.911403641289831,0,4,SPOTS complex,CC,
9090,GO:0035349,1,0.933485551759478,0,3,coenzyme A transmembrane transport,BP,
9091,GO:0035350,1,0.955150321780958,0,2,FAD transmembrane transport,BP,
9092,GO:0035352,1,0.977234999346512,0,1,NAD transmembrane transport,BP,
9093,GO:0035354,1,0.9776748638294,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9094,GO:0035355,1,0.979791139459405,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9095,GO:0035356,1,0.891059974267866,0,5,cellular triglyceride homeostasis,BP,
9096,GO:0035357,1,0.738720100870455,0,14,peroxisome proliferator activated receptor signaling pathway,BP,
9097,GO:0035358,1,0.857784118297851,0,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9098,GO:0035359,1,0.978300724077137,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9099,GO:0035360,1,0.89646575924971,0,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9100,GO:0035363,1,0.912930731489619,0,4,histone locus body,CC,
9101,GO:0035368,1,0.915347528367297,0,4,selenocysteine insertion sequence binding,MF,
9102,GO:0035370,1,0.955007667494168,0,2,UBC13-UEV1A complex,CC,
9103,GO:0035371,1,0.689717901816128,0,18,microtubule plus-end,CC,
9105,GO:0035373,1,0.965359961383116,0,2,chondroitin sulfate proteoglycan binding,MF,
9106,GO:0035374,1,0.878964518709281,0,6,chondroitin sulfate binding,MF,
9107,GO:0035376,1,0.892761711291458,0,5,sterol import,BP,
9108,GO:0035381,1,0.977205278740426,0,1,ATP-gated ion channel activity,MF,
9109,GO:0035383,1,0.177304589146004,0,77,thioester metabolic process,BP,
9110,GO:0035384,1,0.385427961211874,0,43,thioester biosynthetic process,BP,
9111,GO:0035385,1,0.864838572002965,0,7,Roundabout signaling pathway,BP,
9112,GO:0035400,1,0.979359033789711,0,1,histone tyrosine kinase activity,MF,
9113,GO:0035401,1,0.979359033789711,0,1,histone kinase activity (H3-Y41 specific),MF,
9114,GO:0035402,1,0.955189903639192,0,2,histone kinase activity (H3-T11 specific),MF,
9115,GO:0035403,1,0.981880381810184,0,1,histone kinase activity (H3-T6 specific),MF,
9116,GO:0035404,1,0.818344608294258,0,9,histone-serine phosphorylation,BP,
9117,GO:0035405,1,0.916369900441188,0,4,histone-threonine phosphorylation,BP,
9118,GO:0035406,1,0.979359033789711,0,1,histone-tyrosine phosphorylation,BP,
9119,GO:0035407,1,0.955189903639192,0,2,histone H3-T11 phosphorylation,BP,
9120,GO:0035408,1,0.981880381810184,0,1,histone H3-T6 phosphorylation,BP,
9121,GO:0035409,1,0.979359033789711,0,1,histone H3-Y41 phosphorylation,BP,
9123,GO:0035425,1,0.934495607953853,0,3,autocrine signaling,BP,
9124,GO:0035426,1,0.918005777455516,0,4,extracellular matrix-cell signaling,BP,
9125,GO:0035434,1,0.878236135560428,0,6,copper ion transmembrane transport,BP,
9127,GO:0035437,1,0.77983311465926,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9128,GO:0035438,1,0.977057837615497,0,1,cyclic-di-GMP binding,MF,
9129,GO:0035441,1,0.981647503261278,0,1,cell migration involved in vasculogenesis,BP,
9130,GO:0035442,1,0.954829641473384,0,2,dipeptide transmembrane transport,BP,
9131,GO:0035443,1,0.9801861254092,0,1,tripeptide transmembrane transport,BP,
9132,GO:0035445,1,0.97745874848291,0,1,borate transmembrane transport,BP,
9135,GO:0035457,1,0.822349313970991,0,9,cellular response to interferon-alpha,BP,
9136,GO:0035458,1,0.760783956402821,0,12,cellular response to interferon-beta,BP,
9137,GO:0035459,1,0.644377993200997,0,20,cargo loading into vesicle,BP,
9138,GO:0035461,1,0.838069854499815,0,8,vitamin transmembrane transport,BP,
9139,GO:0035469,1,0.97942657938205,0,1,determination of pancreatic left/right asymmetry,BP,
9140,GO:0035470,1,0.977127370618276,0,1,positive regulation of vascular wound healing,BP,
9141,GO:0035473,1,0.956175734698991,0,2,lipase binding,MF,
9142,GO:0035482,1,0.953508232449706,0,2,gastric motility,BP,
9143,GO:0035483,1,0.97592036803824,0,1,gastric emptying,BP,
9144,GO:0035485,1,0.977144786495806,0,1,adenine/guanine mispair binding,MF,
9148,GO:0035494,1,0.934070208402794,0,3,SNARE complex disassembly,BP,
9149,GO:0035497,1,0.784889830718125,0,11,cAMP response element binding,MF,
9150,GO:0035498,1,0.977336572808046,0,1,carnosine metabolic process,BP,
9151,GO:0035500,1,0.95582726268114,0,2,MH2 domain binding,MF,
9152,GO:0035501,1,0.977311400824801,0,1,MH1 domain binding,MF,
9153,GO:0035502,1,0.935128767796007,0,3,metanephric part of ureteric bud development,BP,
9154,GO:0035504,1,0.976896461882296,0,1,regulation of myosin light chain kinase activity,BP,
9155,GO:0035505,1,0.976896461882296,0,1,positive regulation of myosin light chain kinase activity,BP,
9156,GO:0035507,1,0.882097416491095,0,6,regulation of myosin-light-chain-phosphatase activity,BP,
9157,GO:0035508,1,0.979585869508808,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9158,GO:0035509,1,0.918411863889816,0,4,negative regulation of myosin-light-chain-phosphatase activity,BP,
9159,GO:0035510,1,0.579256753788365,0,25,DNA dealkylation,BP,
9160,GO:0035511,1,0.891464407053296,0,5,oxidative DNA demethylation,BP,
9161,GO:0035513,1,0.913400688731346,0,4,oxidative RNA demethylation,BP,
9162,GO:0035514,1,0.933170004772178,0,3,DNA demethylase activity,MF,
9163,GO:0035515,1,0.913400688731346,0,4,oxidative RNA demethylase activity,MF,
9164,GO:0035516,1,0.978523023267082,0,1,oxidative DNA demethylase activity,MF,
9165,GO:0035517,1,0.938212446838285,0,3,PR-DUB complex,CC,
9167,GO:0035519,1,0.912579148066073,0,4,protein K29-linked ubiquitination,BP,
9168,GO:0035520,1,0.823910174276185,0,9,monoubiquitinated protein deubiquitination,BP,
9169,GO:0035521,1,0.91372232865491,0,4,monoubiquitinated histone deubiquitination,BP,
9170,GO:0035522,1,0.91372232865491,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9171,GO:0035523,1,0.920008221153814,0,4,protein K29-linked deubiquitination,BP,
9172,GO:0035524,1,0.897109679352199,0,5,proline transmembrane transport,BP,
9173,GO:0035525,1,0.977256678260932,0,1,NF-kappaB p50/p65 complex,CC,
9174,GO:0035526,1,0.957927897979773,0,2,retrograde transport, plasma membrane to Golgi,BP,
9175,GO:0035529,1,0.893525801654589,0,5,NADH pyrophosphatase activity,MF,
9176,GO:0035538,1,0.977560829187358,0,1,carbohydrate response element binding,MF,
9177,GO:0035539,1,0.953491609886851,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9179,GO:0035544,1,0.978684847602579,0,1,negative regulation of SNARE complex assembly,BP,
9180,GO:0035546,1,0.921700105314164,0,4,interferon-beta secretion,BP,
9181,GO:0035547,1,0.921700105314164,0,4,regulation of interferon-beta secretion,BP,
9182,GO:0035549,1,0.921700105314164,0,4,positive regulation of interferon-beta secretion,BP,
9183,GO:0035552,1,0.9342369736022,0,3,oxidative single-stranded DNA demethylation,BP,
9184,GO:0035553,1,0.934662529464522,0,3,oxidative single-stranded RNA demethylation,BP,
9187,GO:0035562,1,0.839656099296701,0,8,negative regulation of chromatin binding,BP,
9190,GO:0035568,1,0.977336572808046,0,1,N-terminal peptidyl-proline methylation,BP,
9191,GO:0035570,1,0.977336572808046,0,1,N-terminal peptidyl-serine methylation,BP,
9192,GO:0035572,1,0.977336572808046,0,1,N-terminal peptidyl-serine dimethylation,BP,
9193,GO:0035573,1,0.977336572808046,0,1,N-terminal peptidyl-serine trimethylation,BP,
9194,GO:0035574,1,0.957728055419923,0,2,histone H4-K20 demethylation,BP,
9195,GO:0035575,1,0.957728055419923,0,2,histone demethylase activity (H4-K20 specific),MF,
9196,GO:0035577,1,0.348647492981417,0,47,azurophil granule membrane,CC,
9197,GO:0035578,1,0.209198240558564,0,69,azurophil granule lumen,CC,
9200,GO:0035581,1,0.8841691353922,0,6,sequestering of extracellular ligand from receptor,BP,
9201,GO:0035582,1,0.939395121867032,0,3,sequestering of BMP in extracellular matrix,BP,
9202,GO:0035583,1,0.947300202664442,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9203,GO:0035584,1,0.78948267063547,0,10,calcium-mediated signaling using intracellular calcium source,BP,
9204,GO:0035585,1,0.977336572808046,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9205,GO:0035586,1,0.85188431743323,0,7,purinergic receptor activity,MF,
9206,GO:0035587,1,0.796122834374705,0,10,purinergic receptor signaling pathway,BP,
9207,GO:0035588,1,0.832241198986504,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9208,GO:0035589,1,0.892150800066654,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9209,GO:0035590,1,0.853442315592966,0,7,purinergic nucleotide receptor signaling pathway,BP,
9211,GO:0035594,1,0.933645893231834,0,3,ganglioside binding,MF,
9212,GO:0035596,1,0.955290400765373,0,2,methylthiotransferase activity,MF,
9213,GO:0035597,1,0.977203547045159,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9214,GO:0035598,1,0.97757757933815,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9215,GO:0035600,1,0.955290400765373,0,2,tRNA methylthiolation,BP,
9217,GO:0035602,1,0.978340654938138,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9218,GO:0035603,1,0.978340654938138,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9219,GO:0035604,1,0.978340654938138,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9220,GO:0035605,1,0.976686626112186,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9221,GO:0035606,1,0.952732666185431,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9222,GO:0035607,1,0.958396505359444,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9223,GO:0035608,1,0.95645082933675,0,2,protein deglutamylation,BP,
9224,GO:0035609,1,0.978651552334314,0,1,C-terminal protein deglutamylation,BP,
9225,GO:0035610,1,0.978651552334314,0,1,protein side chain deglutamylation,BP,
9226,GO:0035611,1,0.977316806676974,0,1,protein branching point deglutamylation,BP,
9227,GO:0035612,1,0.849088833430546,0,8,AP-2 adaptor complex binding,MF,
9228,GO:0035613,1,0.721122780013649,0,15,RNA stem-loop binding,MF,
9229,GO:0035614,1,0.932530811191114,0,3,snRNA stem-loop binding,MF,
9230,GO:0035615,1,0.784737074297339,0,11,clathrin adaptor activity,MF,
9231,GO:0035616,1,0.93713588865118,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9232,GO:0035617,1,0.935718051837204,0,3,stress granule disassembly,BP,
9233,GO:0035620,1,0.935265750514056,0,3,ceramide transporter activity,MF,
9234,GO:0035621,1,0.957098408499714,0,2,ER to Golgi ceramide transport,BP,
9236,GO:0035623,1,0.977547439051212,0,1,renal glucose absorption,BP,
9237,GO:0035624,1,0.959574822783892,0,2,receptor transactivation,BP,
9238,GO:0035625,1,0.977825063865157,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9239,GO:0035627,1,0.876907827371161,0,6,ceramide transport,BP,
9240,GO:0035630,1,0.938530574618027,0,3,bone mineralization involved in bone maturation,BP,
9241,GO:0035631,1,0.779035472900535,0,11,CD40 receptor complex,CC,
9242,GO:0035633,1,0.956420195610253,0,2,maintenance of permeability of blood-brain barrier,BP,
9243,GO:0035634,1,0.975895545121536,0,1,response to stilbenoid,BP,
9244,GO:0035635,1,0.674844662581062,0,18,entry of bacterium into host cell,BP,
9246,GO:0035638,1,0.978913832498589,0,1,signal maturation,BP,
9248,GO:0035640,1,0.768029935328564,0,12,exploration behavior,BP,
9249,GO:0035641,1,0.858531751400301,0,7,locomotory exploration behavior,BP,
9250,GO:0035642,1,0.97737706733745,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9252,GO:0035650,1,0.911902558524677,0,4,AP-1 adaptor complex binding,MF,
9253,GO:0035651,1,0.93329314931795,0,3,AP-3 adaptor complex binding,MF,
9254,GO:0035655,1,0.890800427901843,0,5,interleukin-18-mediated signaling pathway,BP,
9255,GO:0035658,1,0.933651352875648,0,3,Mon1-Ccz1 complex,CC,
9256,GO:0035659,1,0.977073400793012,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9257,GO:0035662,1,0.929456525114954,0,3,Toll-like receptor 4 binding,MF,
9258,GO:0035663,1,0.957367630252166,0,2,Toll-like receptor 2 binding,MF,
9259,GO:0035664,1,0.977115728022905,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9260,GO:0035665,1,0.977115728022905,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9261,GO:0035666,1,0.577595816833656,0,24,TRIF-dependent toll-like receptor signaling pathway,BP,
9262,GO:0035668,1,0.979530757041336,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9263,GO:0035669,1,0.979530757041336,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9264,GO:0035671,1,0.955018702635051,0,2,enone reductase activity,MF,
9265,GO:0035672,1,0.876163351759496,0,6,oligopeptide transmembrane transport,BP,
9266,GO:0035673,1,0.91762593659823,0,4,oligopeptide transmembrane transporter activity,MF,
9267,GO:0035674,1,0.955035970085911,0,2,tricarboxylic acid transmembrane transport,BP,
9268,GO:0035675,1,0.977266136864643,0,1,neuromast hair cell development,BP,
9269,GO:0035686,1,0.932730469337286,0,3,sperm fibrous sheath,CC,
9271,GO:0035691,1,0.976685371538767,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9272,GO:0035692,1,0.956282474988293,0,2,macrophage migration inhibitory factor receptor complex,CC,
9273,GO:0035693,1,0.976685371538767,0,1,NOS2-CD74 complex,CC,
9274,GO:0035694,1,0.914319935368324,0,4,mitochondrial protein catabolic process,BP,
9275,GO:0035695,1,0.978533881700099,0,1,mitophagy by induced vacuole formation,BP,
9276,GO:0035697,1,0.954843495551256,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9277,GO:0035698,1,0.954843495551256,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9278,GO:0035700,1,0.977114113326136,0,1,astrocyte chemotaxis,BP,
9279,GO:0035701,1,0.93697294610455,0,3,hematopoietic stem cell migration,BP,
9280,GO:0035709,1,0.977230147772224,0,1,memory T cell activation,BP,
9282,GO:0035711,1,0.977697391253987,0,1,T-helper 1 cell activation,BP,
9283,GO:0035712,1,0.977572090216096,0,1,T-helper 2 cell activation,BP,
9284,GO:0035718,1,0.954107715170642,0,2,macrophage migration inhibitory factor binding,MF,
9285,GO:0035720,1,0.936656279285619,0,3,intraciliary anterograde transport,BP,
9286,GO:0035721,1,0.772735369403543,0,12,intraciliary retrograde transport,BP,
9288,GO:0035723,1,0.820855367678625,0,9,interleukin-15-mediated signaling pathway,BP,
9290,GO:0035726,1,0.89496833013134,0,5,common myeloid progenitor cell proliferation,BP,
9291,GO:0035727,1,0.955280030048375,0,2,lysophosphatidic acid binding,MF,
9292,GO:0035728,1,0.787782801792044,0,11,response to hepatocyte growth factor,BP,
9293,GO:0035729,1,0.821570219228082,0,9,cellular response to hepatocyte growth factor stimulus,BP,
9294,GO:0035730,1,0.976168092491506,0,1,S-nitrosoglutathione binding,MF,
9295,GO:0035731,1,0.976168092491506,0,1,dinitrosyl-iron complex binding,MF,
9296,GO:0035732,1,0.976168092491506,0,1,nitric oxide storage,BP,
9297,GO:0035733,1,0.913069325084829,0,4,hepatic stellate cell activation,BP,
9298,GO:0035735,1,0.424552963618494,0,39,intraciliary transport involved in cilium assembly,BP,
9299,GO:0035739,1,0.914260815524113,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
9300,GO:0035740,1,0.955376719384815,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
9301,GO:0035743,1,0.811874448481125,0,9,CD4-positive, alpha-beta T cell cytokine production,BP,
9302,GO:0035744,1,0.97645861411996,0,1,T-helper 1 cell cytokine production,BP,
9303,GO:0035745,1,0.850766471171479,0,7,T-helper 2 cell cytokine production,BP,
9305,GO:0035748,1,0.877084474608107,0,6,myelin sheath abaxonal region,CC,
9306,GO:0035749,1,0.896588771433519,0,5,myelin sheath adaxonal region,CC,
9307,GO:0035750,1,0.979406678986524,0,1,protein localization to myelin sheath abaxonal region,BP,
9308,GO:0035751,1,0.774117585333211,0,11,regulation of lysosomal lumen pH,BP,
9309,GO:0035752,1,0.977169140436405,0,1,lysosomal lumen pH elevation,BP,
9310,GO:0035754,1,0.894485702381464,0,5,B cell chemotaxis,BP,
9311,GO:0035755,1,0.977255939027595,0,1,cardiolipin hydrolase activity,MF,
9312,GO:0035766,1,0.939397401156289,0,3,cell chemotaxis to fibroblast growth factor,BP,
9314,GO:0035768,1,0.939397401156289,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
9316,GO:0035771,1,0.897603338775007,0,5,interleukin-4-mediated signaling pathway,BP,
9319,GO:0035787,1,0.935450872820391,0,3,cell migration involved in kidney development,BP,
9320,GO:0035788,1,0.955136860941441,0,2,cell migration involved in metanephros development,BP,
9321,GO:0035789,1,0.955136860941441,0,2,metanephric mesenchymal cell migration,BP,
9322,GO:0035790,1,0.978095453703255,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9323,GO:0035791,1,0.826644111086491,0,9,platelet-derived growth factor receptor-beta signaling pathway,BP,
9324,GO:0035793,1,0.955136860941441,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9325,GO:0035794,1,0.28389699305663,0,55,positive regulation of mitochondrial membrane permeability,BP,
9327,GO:0035799,1,0.935475742817448,0,3,ureter maturation,BP,
9328,GO:0035800,1,0.95539510593775,0,2,deubiquitinase activator activity,MF,
9329,GO:0035801,1,0.955024562401921,0,2,adrenal cortex development,BP,
9330,GO:0035802,1,0.955024562401921,0,2,adrenal cortex formation,BP,
9331,GO:0035803,1,0.954146107532838,0,2,egg coat formation,BP,
9332,GO:0035809,1,0.836033022121647,0,8,regulation of urine volume,BP,
9333,GO:0035810,1,0.894043490559388,0,5,positive regulation of urine volume,BP,
9334,GO:0035811,1,0.980059247161619,0,1,negative regulation of urine volume,BP,
9335,GO:0035812,1,0.954969197658653,0,2,renal sodium excretion,BP,
9336,GO:0035813,1,0.954969197658653,0,2,regulation of renal sodium excretion,BP,
9337,GO:0035814,1,0.97723530628057,0,1,negative regulation of renal sodium excretion,BP,
9338,GO:0035815,1,0.977217150969366,0,1,positive regulation of renal sodium excretion,BP,
9340,GO:0035822,1,0.958149387744581,0,2,gene conversion,BP,
9341,GO:0035825,1,0.448531222582048,0,36,homologous recombination,BP,
9342,GO:0035838,1,0.958846391160667,0,2,growing cell tip,CC,
9343,GO:0035841,1,0.979990412670674,0,1,new growing cell tip,CC,
9344,GO:0035844,1,0.936858213307357,0,3,cloaca development,BP,
9347,GO:0035851,1,0.977373433671545,0,1,Krueppel-associated box domain binding,MF,
9348,GO:0035853,1,0.978691825377327,0,1,chromosome passenger complex localization to spindle midzone,BP,
9349,GO:0035855,1,0.771273858273716,0,12,megakaryocyte development,BP,
9350,GO:0035859,1,0.743845178809075,0,13,Seh1-associated complex,CC,
9351,GO:0035860,1,0.956388552555285,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9353,GO:0035862,1,0.979903954714144,0,1,dITP metabolic process,BP,
9354,GO:0035863,1,0.979903954714144,0,1,dITP catabolic process,BP,
9355,GO:0035864,1,0.871500899751878,0,6,response to potassium ion,BP,
9356,GO:0035865,1,0.932317430021064,0,3,cellular response to potassium ion,BP,
9357,GO:0035866,1,0.96280966743713,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
9358,GO:0035867,1,0.945922025831506,0,3,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9359,GO:0035868,1,0.958707622679815,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
9361,GO:0035870,1,0.956767900517799,0,2,dITP diphosphatase activity,MF,
9362,GO:0035871,1,0.82959993351116,0,9,protein K11-linked deubiquitination,BP,
9363,GO:0035872,1,0.489253585428499,0,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9364,GO:0035873,1,0.914782066796935,0,4,lactate transmembrane transport,BP,
9365,GO:0035877,1,0.913843648654937,0,4,death effector domain binding,MF,
9366,GO:0035878,1,0.856121765912206,0,7,nail development,BP,
9367,GO:0035879,1,0.935554812818666,0,3,plasma membrane lactate transport,BP,
9368,GO:0035880,1,0.955748745066992,0,2,embryonic nail plate morphogenesis,BP,
9369,GO:0035881,1,0.954989419583485,0,2,amacrine cell differentiation,BP,
9372,GO:0035887,1,0.977093250950237,0,1,aortic smooth muscle cell differentiation,BP,
9375,GO:0035897,1,0.892184808299446,0,5,proteolysis in other organism,BP,
9376,GO:0035898,1,0.935634005779581,0,3,parathyroid hormone secretion,BP,
9377,GO:0035900,1,0.872386870835868,0,6,response to isolation stress,BP,
9381,GO:0035907,1,0.893540050993552,0,5,dorsal aorta development,BP,
9384,GO:0035912,1,0.914044134329537,0,4,dorsal aorta morphogenesis,BP,
9386,GO:0035915,1,0.977207459862639,0,1,pore formation in membrane of other organism,BP,
9388,GO:0035922,1,0.977490942931953,0,1,foramen ovale closure,BP,
9391,GO:0035926,1,0.892291400538769,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
9392,GO:0035927,1,0.912117285260517,0,4,RNA import into mitochondrion,BP,
9393,GO:0035928,1,0.932963158327491,0,3,rRNA import into mitochondrion,BP,
9394,GO:0035929,1,0.856191030266594,0,7,steroid hormone secretion,BP,
9395,GO:0035930,1,0.913726242662454,0,4,corticosteroid hormone secretion,BP,
9396,GO:0035931,1,0.977278942128016,0,1,mineralocorticoid secretion,BP,
9397,GO:0035932,1,0.977278942128016,0,1,aldosterone secretion,BP,
9398,GO:0035933,1,0.934975174880766,0,3,glucocorticoid secretion,BP,
9399,GO:0035935,1,0.977575222695287,0,1,androgen secretion,BP,
9400,GO:0035936,1,0.980537269912031,0,1,testosterone secretion,BP,
9401,GO:0035938,1,0.980182444931288,0,1,estradiol secretion,BP,
9402,GO:0035945,1,0.97724799426136,0,1,mitochondrial ncRNA surveillance,BP,
9403,GO:0035946,1,0.97724799426136,0,1,mitochondrial mRNA surveillance,BP,
9405,GO:0035948,1,0.935352466366712,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9406,GO:0035962,1,0.978090544920442,0,1,response to interleukin-13,BP,
9407,GO:0035963,1,0.978090544920442,0,1,cellular response to interleukin-13,BP,
9408,GO:0035964,1,0.874270352807108,0,6,COPI-coated vesicle budding,BP,
9409,GO:0035965,1,0.893109475011014,0,5,cardiolipin acyl-chain remodeling,BP,
9413,GO:0035971,1,0.976563210951266,0,1,peptidyl-histidine dephosphorylation,BP,
9414,GO:0035973,1,0.860508083609234,0,7,aggrephagy,BP,
9416,GO:0035977,1,0.917488483592293,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
9417,GO:0035978,1,0.977311400824801,0,1,histone H2A-S139 phosphorylation,BP,
9418,GO:0035981,1,0.956151160087025,0,2,tongue muscle cell differentiation,BP,
9419,GO:0035983,1,0.934099444138976,0,3,response to trichostatin A,BP,
9420,GO:0035984,1,0.934099444138976,0,3,cellular response to trichostatin A,BP,
9421,GO:0035985,1,0.911222781605766,0,4,senescence-associated heterochromatin focus,CC,
9422,GO:0035986,1,0.93254758450745,0,3,senescence-associated heterochromatin focus assembly,BP,
9423,GO:0035987,1,0.484717996663717,0,34,endodermal cell differentiation,BP,
9425,GO:0035989,1,0.919496591592653,0,4,tendon development,BP,
9426,GO:0035990,1,0.954968508258989,0,2,tendon cell differentiation,BP,
9427,GO:0035992,1,0.954968508258989,0,2,tendon formation,BP,
9428,GO:0035993,1,0.93322281801307,0,3,deltoid tuberosity development,BP,
9430,GO:0035995,1,0.999055027153641,0,1,detection of muscle stretch,BP,
9431,GO:0035998,1,0.977185145506478,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
9432,GO:0035999,1,0.83442706655338,0,8,tetrahydrofolate interconversion,BP,
9434,GO:0036003,1,0.596419362868165,0,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
9435,GO:0036004,1,0.97658092509883,0,1,GAF domain binding,MF,
9436,GO:0036005,1,0.893864345940098,0,5,response to macrophage colony-stimulating factor,BP,
9437,GO:0036006,1,0.893864345940098,0,5,cellular response to macrophage colony-stimulating factor stimulus,BP,
9438,GO:0036009,1,0.976490366137579,0,1,protein-glutamine N-methyltransferase activity,MF,
9439,GO:0036010,1,0.676980851936218,0,18,protein localization to endosome,BP,
9440,GO:0036015,1,0.934556066974163,0,3,response to interleukin-3,BP,
9441,GO:0036016,1,0.934556066974163,0,3,cellular response to interleukin-3,BP,
9442,GO:0036017,1,0.907787909497055,0,4,response to erythropoietin,BP,
9443,GO:0036018,1,0.907787909497055,0,4,cellular response to erythropoietin,BP,
9444,GO:0036019,1,0.703000622198738,0,16,endolysosome,CC,
9445,GO:0036020,1,0.770276537137852,0,12,endolysosome membrane,CC,
9446,GO:0036021,1,0.912741875111741,0,4,endolysosome lumen,CC,
9447,GO:0036022,1,0.955344403433448,0,2,limb joint morphogenesis,BP,
9448,GO:0036023,1,0.955344403433448,0,2,embryonic skeletal limb joint morphogenesis,BP,
9449,GO:0036033,1,0.927230732576336,0,4,mediator complex binding,MF,
9450,GO:0036034,1,0.955027026000121,0,2,mediator complex assembly,BP,
9451,GO:0036035,1,0.758910437840141,0,13,osteoclast development,BP,
9453,GO:0036038,1,0.745139714258025,0,13,MKS complex,CC,
9454,GO:0036041,1,0.867643272050585,0,6,long-chain fatty acid binding,MF,
9455,GO:0036042,1,0.910019466772576,0,4,long-chain fatty acyl-CoA binding,MF,
9456,GO:0036046,1,0.977482283504336,0,1,protein demalonylation,BP,
9457,GO:0036047,1,0.977482283504336,0,1,peptidyl-lysine demalonylation,BP,
9458,GO:0036048,1,0.977482283504336,0,1,protein desuccinylation,BP,
9459,GO:0036049,1,0.977482283504336,0,1,peptidyl-lysine desuccinylation,BP,
9460,GO:0036054,1,0.977482283504336,0,1,protein-malonyllysine demalonylase activity,MF,
9461,GO:0036055,1,0.977482283504336,0,1,protein-succinyllysine desuccinylase activity,MF,
9462,GO:0036056,1,0.903276781939928,0,5,filtration diaphragm,CC,
9463,GO:0036057,1,0.903276781939928,0,5,slit diaphragm,CC,
9464,GO:0036064,1,0.129783908959634,0,92,ciliary basal body,CC,
9466,GO:0036066,1,0.733133389646332,0,14,protein O-linked fucosylation,BP,
9467,GO:0036071,1,0.977585479454205,0,1,N-glycan fucosylation,BP,
9470,GO:0036080,1,0.958448296382179,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9471,GO:0036085,1,0.97752501332436,0,1,GDP-fucose import into Golgi lumen,BP,
9473,GO:0036090,1,0.954919884050391,0,2,cleavage furrow ingression,BP,
9474,GO:0036091,1,0.917750278197485,0,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
9476,GO:0036093,1,0.93119878838252,0,3,germ cell proliferation,BP,
9478,GO:0036105,1,0.977873573779148,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9479,GO:0036109,1,0.78050248150095,0,11,alpha-linolenic acid metabolic process,BP,
9480,GO:0036111,1,0.977274096635437,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
9481,GO:0036112,1,0.954722702751688,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
9482,GO:0036114,1,0.976926156918786,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9483,GO:0036115,1,0.976926156918786,0,1,fatty-acyl-CoA catabolic process,BP,
9484,GO:0036116,1,0.976926156918786,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
9485,GO:0036117,1,0.954983922888314,0,2,hyaluranon cable,CC,
9486,GO:0036118,1,0.934236871547577,0,3,hyaluranon cable assembly,BP,
9487,GO:0036119,1,0.69472795847624,0,17,response to platelet-derived growth factor,BP,
9488,GO:0036120,1,0.710834306512282,0,16,cellular response to platelet-derived growth factor stimulus,BP,
9489,GO:0036122,1,0.939964510438951,0,3,BMP binding,MF,
9490,GO:0036123,1,0.892263338513061,0,5,histone H3-K9 dimethylation,BP,
9491,GO:0036124,1,0.740337569628613,0,14,histone H3-K9 trimethylation,BP,
9492,GO:0036125,1,0.977417970267519,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9493,GO:0036126,1,0.417774484141156,0,39,sperm flagellum,CC,
9496,GO:0036135,1,0.95854894309229,0,2,Schwann cell migration,BP,
9497,GO:0036137,1,0.954993935310529,0,2,kynurenine aminotransferase activity,MF,
9498,GO:0036138,1,0.980555440616315,0,1,peptidyl-histidine hydroxylation,BP,
9499,GO:0036139,1,0.980555440616315,0,1,peptidyl-histidine dioxygenase activity,MF,
9500,GO:0036140,1,0.980555440616315,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9501,GO:0036145,1,0.977114113326136,0,1,dendritic cell homeostasis,BP,
9502,GO:0036146,1,0.933456435846148,0,3,cellular response to mycotoxin,BP,
9503,GO:0036148,1,0.784161260978922,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9504,GO:0036149,1,0.853953929377103,0,7,phosphatidylinositol acyl-chain remodeling,BP,
9505,GO:0036150,1,0.765526709654412,0,12,phosphatidylserine acyl-chain remodeling,BP,
9506,GO:0036151,1,0.666255695928455,0,18,phosphatidylcholine acyl-chain remodeling,BP,
9507,GO:0036152,1,0.711617658115326,0,15,phosphatidylethanolamine acyl-chain remodeling,BP,
9508,GO:0036153,1,0.977304790581956,0,1,triglyceride acyl-chain remodeling,BP,
9509,GO:0036155,1,0.893211964315383,0,5,acylglycerol acyl-chain remodeling,BP,
9510,GO:0036156,1,0.967095931105687,0,2,inner dynein arm,CC,
9511,GO:0036157,1,0.943396849243974,0,3,outer dynein arm,CC,
9512,GO:0036158,1,0.880304716831424,0,6,outer dynein arm assembly,BP,
9513,GO:0036159,1,0.902135136120418,0,5,inner dynein arm assembly,BP,
9515,GO:0036166,1,0.936914724658147,0,3,phenotypic switching,BP,
9516,GO:0036179,1,0.977289143287563,0,1,osteoclast maturation,BP,
9517,GO:0036194,1,0.932386022246182,0,3,muscle cell projection,CC,
9518,GO:0036195,1,0.932386022246182,0,3,muscle cell projection membrane,CC,
9520,GO:0036213,1,0.977227904061852,0,1,contractile ring contraction,BP,
9521,GO:0036215,1,0.977370360650261,0,1,response to stem cell factor,BP,
9522,GO:0036216,1,0.977370360650261,0,1,cellular response to stem cell factor stimulus,BP,
9523,GO:0036219,1,0.975738091869388,0,1,GTP diphosphatase activity,MF,
9524,GO:0036220,1,0.976391248641661,0,1,ITP diphosphatase activity,MF,
9525,GO:0036222,1,0.976391248641661,0,1,XTP diphosphatase activity,MF,
9526,GO:0036228,1,0.956261705249922,0,2,protein localization to nuclear inner membrane,BP,
9528,GO:0036245,1,0.956356580767171,0,2,cellular response to menadione,BP,
9529,GO:0036250,1,0.977177188120818,0,1,peroxisome transport along microtubule,BP,
9530,GO:0036255,1,0.978077783305344,0,1,response to methylamine,BP,
9531,GO:0036257,1,0.503151219191413,0,30,multivesicular body organization,BP,
9532,GO:0036258,1,0.514866145675451,0,29,multivesicular body assembly,BP,
9533,GO:0036260,1,0.470576831956568,0,33,RNA capping,BP,
9534,GO:0036261,1,0.977951791724003,0,1,7-methylguanosine cap hypermethylation,BP,
9535,GO:0036265,1,0.912241744470203,0,4,RNA (guanine-N7)-methylation,BP,
9536,GO:0036266,1,0.977253662048664,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
9537,GO:0036269,1,0.976964294955507,0,1,swimming behavior,BP,
9538,GO:0036270,1,0.763585230330156,0,13,response to diuretic,BP,
9539,GO:0036284,1,0.958421690651933,0,2,tubulobulbar complex,CC,
9540,GO:0036289,1,0.879921278079759,0,6,peptidyl-serine autophosphorylation,BP,
9541,GO:0036290,1,0.978268115215051,0,1,protein trans-autophosphorylation,BP,
9542,GO:0036292,1,0.955269435003909,0,2,DNA rewinding,BP,
9545,GO:0036295,1,0.748100763792684,0,13,cellular response to increased oxygen levels,BP,
9548,GO:0036301,1,0.933850464443712,0,3,macrophage colony-stimulating factor production,BP,
9549,GO:0036302,1,0.903725187152796,0,5,atrioventricular canal development,BP,
9550,GO:0036303,1,0.781536608645843,0,12,lymph vessel morphogenesis,BP,
9551,GO:0036309,1,0.971270345565289,0,2,protein localization to M-band,BP,
9552,GO:0036310,1,0.83580573514901,0,8,annealing helicase activity,MF,
9554,GO:0036313,1,0.955246268306254,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
9555,GO:0036314,1,0.673298869568086,0,19,response to sterol,BP,
9556,GO:0036315,1,0.762232649542692,0,13,cellular response to sterol,BP,
9557,GO:0036316,1,0.977278942128016,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
9558,GO:0036317,1,0.977336572808046,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9559,GO:0036324,1,0.955636344672635,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
9560,GO:0036333,1,0.977264010199539,0,1,hepatocyte homeostasis,BP,
9561,GO:0036335,1,0.979323497874208,0,1,intestinal stem cell homeostasis,BP,
9562,GO:0036336,1,0.714684133661825,0,15,dendritic cell migration,BP,
9563,GO:0036337,1,0.916433697257094,0,4,Fas signaling pathway,BP,
9564,GO:0036342,1,0.792986523720628,0,11,post-anal tail morphogenesis,BP,
9565,GO:0036343,1,0.975410767138198,0,1,psychomotor behavior,BP,
9566,GO:0036344,1,0.720389794114278,0,15,platelet morphogenesis,BP,
9569,GO:0036353,1,0.837671865098052,0,8,histone H2A-K119 monoubiquitination,BP,
9570,GO:0036361,1,0.977247707407595,0,1,racemase activity, acting on amino acids and derivatives,MF,
9571,GO:0036363,1,0.95650971278454,0,2,transforming growth factor beta activation,BP,
9572,GO:0036367,1,0.977255278157001,0,1,light adaption,BP,
9573,GO:0036369,1,0.962359225565684,0,2,transcription factor catabolic process,BP,
9574,GO:0036371,1,0.981419609362148,0,1,protein localization to T-tubule,BP,
9575,GO:0036372,1,0.976194302499549,0,1,opsin transport,BP,
9576,GO:0036374,1,0.93329877131748,0,3,glutathione hydrolase activity,MF,
9577,GO:0036376,1,0.857320138136846,0,7,sodium ion export across plasma membrane,BP,
9578,GO:0036378,1,0.95477163241449,0,2,calcitriol biosynthetic process from calciol,BP,
9579,GO:0036379,1,0.782147808251408,0,12,myofilament,CC,
9580,GO:0036387,1,0.933010252629771,0,3,pre-replicative complex,CC,
9581,GO:0036388,1,0.933010252629771,0,3,pre-replicative complex assembly,BP,
9582,GO:0036392,1,0.977967794427033,0,1,chemokine (C-C motif) ligand 20 production,BP,
9583,GO:0036396,1,0.933035157925257,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
9584,GO:0036398,1,0.97757836626664,0,1,TCR signalosome,CC,
9585,GO:0036399,1,0.97757836626664,0,1,TCR signalosome assembly,BP,
9586,GO:0036402,1,0.869097602261736,0,6,proteasome-activating ATPase activity,MF,
9587,GO:0036403,1,0.977263035183062,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
9588,GO:0036404,1,0.982891111748644,0,1,conversion of ds siRNA to ss siRNA,BP,
9589,GO:0036414,1,0.977514784258995,0,1,histone citrullination,BP,
9590,GO:0036435,1,0.933863766543551,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
9591,GO:0036438,1,0.913957462733302,0,4,maintenance of lens transparency,BP,
9592,GO:0036440,1,0.977379167004355,0,1,citrate synthase activity,MF,
9593,GO:0036442,1,0.606496270632943,0,22,proton-exporting ATPase activity,MF,
9594,GO:0036444,1,0.835177298534854,0,8,calcium import into the mitochondrion,BP,
9595,GO:0036445,1,0.808058171090571,0,10,neuronal stem cell division,BP,
9596,GO:0036446,1,0.937094452026002,0,3,myofibroblast differentiation,BP,
9597,GO:0036449,1,0.869162349066972,0,7,microtubule minus-end,CC,
9598,GO:0036451,1,0.955184890372083,0,2,cap mRNA methylation,BP,
9599,GO:0036452,1,0.551384308722286,0,26,ESCRT complex,CC,
9600,GO:0036454,1,0.935665974993933,0,3,growth factor complex,CC,
9601,GO:0036455,1,0.976425583386905,0,1,iron-sulfur transferase activity,MF,
9602,GO:0036457,1,0.928838487370061,0,4,keratohyalin granule,CC,
9603,GO:0036458,1,0.977229204468921,0,1,hepatocyte growth factor binding,MF,
9604,GO:0036459,1,0.152984903587886,0,87,thiol-dependent ubiquitinyl hydrolase activity,MF,
9605,GO:0036461,1,0.953875792278368,0,2,BLOC-2 complex binding,MF,
9608,GO:0036465,1,0.450644953403247,0,37,synaptic vesicle recycling,BP,
9609,GO:0036466,1,0.958172180974684,0,2,synaptic vesicle recycling via endosome,BP,
9610,GO:0036470,1,0.976125001747232,0,1,tyrosine 3-monooxygenase activator activity,MF,
9611,GO:0036471,1,0.976125001747232,0,1,cellular response to glyoxal,BP,
9613,GO:0036474,1,0.593491040775749,0,23,cell death in response to hydrogen peroxide,BP,
9614,GO:0036475,1,0.642607205937886,0,20,neuron death in response to oxidative stress,BP,
9615,GO:0036476,1,0.912763994922209,0,4,neuron death in response to hydrogen peroxide,BP,
9617,GO:0036478,1,0.976125001747232,0,1,L-dopa decarboxylase activator activity,MF,
9618,GO:0036480,1,0.853528321652868,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9619,GO:0036481,1,0.870062817578906,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9620,GO:0036482,1,0.953934389544655,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9621,GO:0036483,1,0.978757578367693,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9622,GO:0036484,1,0.936078576165606,0,3,trunk neural crest cell migration,BP,
9623,GO:0036486,1,0.936078576165606,0,3,ventral trunk neural crest cell migration,BP,
9624,GO:0036487,1,0.981915309359245,0,1,nitric-oxide synthase inhibitor activity,MF,
9625,GO:0036488,1,0.953767792672218,0,2,CHOP-C/EBP complex,CC,
9626,GO:0036490,1,0.839236724431443,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
9627,GO:0036491,1,0.858341214227729,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9628,GO:0036492,1,0.878340390824827,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9629,GO:0036493,1,0.935418674230282,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
9630,GO:0036494,1,0.979574564347303,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9631,GO:0036496,1,0.954634196644226,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
9632,GO:0036497,1,0.977241696721364,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
9633,GO:0036498,1,0.223049310126803,0,67,IRE1-mediated unfolded protein response,BP,
9634,GO:0036499,1,0.666397427127875,0,18,PERK-mediated unfolded protein response,BP,
9635,GO:0036500,1,0.796900515534895,0,10,ATF6-mediated unfolded protein response,BP,
9636,GO:0036501,1,0.97860913145981,0,1,UFD1-NPL4 complex,CC,
9637,GO:0036502,1,0.977470719440766,0,1,Derlin-1-VIMP complex,CC,
9638,GO:0036503,1,0.145556819762885,0,86,ERAD pathway,BP,
9639,GO:0036505,1,0.977364330763283,0,1,prosaposin receptor activity,MF,
9640,GO:0036506,1,0.937200752883371,0,3,maintenance of unfolded protein,BP,
9641,GO:0036507,1,0.617096113537773,0,22,protein demannosylation,BP,
9642,GO:0036508,1,0.617096113537773,0,22,protein alpha-1,2-demannosylation,BP,
9643,GO:0036509,1,0.954975572522058,0,2,trimming of terminal mannose on B branch,BP,
9644,GO:0036510,1,0.93587424091466,0,3,trimming of terminal mannose on C branch,BP,
9645,GO:0036511,1,0.954975572522058,0,2,trimming of first mannose on A branch,BP,
9646,GO:0036512,1,0.954975572522058,0,2,trimming of second mannose on A branch,BP,
9647,GO:0036513,1,0.800224521315705,0,10,Derlin-1 retrotranslocation complex,CC,
9648,GO:0036514,1,0.902680026032822,0,5,dopaminergic neuron axon guidance,BP,
9649,GO:0036515,1,0.92359582753381,0,4,serotonergic neuron axon guidance,BP,
9650,GO:0036517,1,0.979762027781853,0,1,chemoattraction of serotonergic neuron axon,BP,
9651,GO:0036518,1,0.957579157126133,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9652,GO:0036524,1,0.976125001747232,0,1,protein deglycase activity,MF,
9653,GO:0036525,1,0.976125001747232,0,1,protein deglycation,BP,
9654,GO:0036526,1,0.976125001747232,0,1,peptidyl-cysteine deglycation,BP,
9655,GO:0036527,1,0.976125001747232,0,1,peptidyl-arginine deglycation,BP,
9656,GO:0036528,1,0.976125001747232,0,1,peptidyl-lysine deglycation,BP,
9657,GO:0036529,1,0.976125001747232,0,1,protein deglycation, glyoxal removal,BP,
9658,GO:0036530,1,0.976125001747232,0,1,protein deglycation, methylglyoxal removal,BP,
9659,GO:0036531,1,0.976125001747232,0,1,glutathione deglycation,BP,
9660,GO:0038001,1,0.954959909387221,0,2,paracrine signaling,BP,
9661,GO:0038002,1,0.979401696742059,0,1,endocrine signaling,BP,
9662,GO:0038003,1,0.912690713273592,0,4,opioid receptor signaling pathway,BP,
9663,GO:0038007,1,0.936533011392978,0,3,netrin-activated signaling pathway,BP,
9664,GO:0038016,1,0.955483878594128,0,2,insulin receptor internalization,BP,
9665,GO:0038018,1,0.95946001778044,0,2,Wnt receptor catabolic process,BP,
9666,GO:0038021,1,0.978493931402176,0,1,leptin receptor activity,MF,
9668,GO:0038024,1,0.401256513897695,0,42,cargo receptor activity,MF,
9669,GO:0038025,1,0.956799664045311,0,2,reelin receptor activity,MF,
9670,GO:0038026,1,0.936409076103095,0,3,reelin-mediated signaling pathway,BP,
9671,GO:0038027,1,0.923557384023319,0,4,apolipoprotein A-I-mediated signaling pathway,BP,
9672,GO:0038028,1,0.914768862022041,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9677,GO:0038036,1,0.872754402878254,0,6,sphingosine-1-phosphate receptor activity,MF,
9678,GO:0038037,1,0.935232266761074,0,3,G-protein coupled receptor dimeric complex,CC,
9679,GO:0038039,1,0.978587765114851,0,1,G-protein coupled receptor heterodimeric complex,CC,
9680,GO:0038042,1,0.912264837904438,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
9681,GO:0038044,1,0.921114057454939,0,4,transforming growth factor-beta secretion,BP,
9682,GO:0038047,1,0.977153966145555,0,1,morphine receptor activity,MF,
9683,GO:0038049,1,0.964322659152964,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9684,GO:0038051,1,0.980338817730491,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9685,GO:0038052,1,0.957834722883136,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9687,GO:0038062,1,0.978086618016055,0,1,protein tyrosine kinase collagen receptor activity,MF,
9689,GO:0038064,1,0.959753670219669,0,2,collagen receptor activity,MF,
9692,GO:0038083,1,0.514030110208974,0,31,peptidyl-tyrosine autophosphorylation,BP,
9694,GO:0038085,1,0.977248066779519,0,1,vascular endothelial growth factor binding,MF,
9695,GO:0038086,1,0.977783872954728,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9697,GO:0038091,1,0.977783872954728,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
9698,GO:0038092,1,0.878437326768117,0,6,nodal signaling pathway,BP,
9703,GO:0038097,1,0.979364042009095,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
9704,GO:0038098,1,0.977206017218068,0,1,sequestering of BMP from receptor via BMP binding,BP,
9705,GO:0038101,1,0.977083696668547,0,1,sequestering of nodal from receptor via nodal binding,BP,
9706,GO:0038107,1,0.938499247615923,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
9707,GO:0038108,1,0.933351302344524,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
9708,GO:0038109,1,0.977370360650261,0,1,Kit signaling pathway,BP,
9709,GO:0038110,1,0.841045757795346,0,8,interleukin-2-mediated signaling pathway,BP,
9711,GO:0038112,1,0.977247778643839,0,1,interleukin-8-mediated signaling pathway,BP,
9712,GO:0038113,1,0.95907616619488,0,2,interleukin-9-mediated signaling pathway,BP,
9713,GO:0038114,1,0.918201349958097,0,4,interleukin-21-mediated signaling pathway,BP,
9714,GO:0038123,1,0.9776748638294,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9715,GO:0038124,1,0.957915507230383,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9718,GO:0038129,1,0.95500297530483,0,2,ERBB3 signaling pathway,BP,
9719,GO:0038131,1,0.955267747007481,0,2,neuregulin receptor activity,MF,
9720,GO:0038132,1,0.920065962824561,0,4,neuregulin binding,MF,
9721,GO:0038145,1,0.934724628825476,0,3,macrophage colony-stimulating factor signaling pathway,BP,
9722,GO:0038154,1,0.977514784258995,0,1,interleukin-11-mediated signaling pathway,BP,
9723,GO:0038155,1,0.874754952195021,0,6,interleukin-23-mediated signaling pathway,BP,
9724,GO:0038158,1,0.955281112716713,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
9725,GO:0038161,1,0.977336572808046,0,1,prolactin signaling pathway,BP,
9726,GO:0038162,1,0.977148065011189,0,1,erythropoietin-mediated signaling pathway,BP,
9727,GO:0038163,1,0.976199190359362,0,1,thrombopoietin-mediated signaling pathway,BP,
9728,GO:0038165,1,0.939501687214958,0,3,oncostatin-M-mediated signaling pathway,BP,
9729,GO:0038166,1,0.892341578495433,0,5,angiotensin-activated signaling pathway,BP,
9730,GO:0038171,1,0.915646976622487,0,4,cannabinoid signaling pathway,BP,
9731,GO:0038172,1,0.978060610843588,0,1,interleukin-33-mediated signaling pathway,BP,
9733,GO:0038180,1,0.844618803678238,0,8,nerve growth factor signaling pathway,BP,
9734,GO:0038181,1,0.978890092158254,0,1,bile acid receptor activity,MF,
9735,GO:0038183,1,0.978890092158254,0,1,bile acid signaling pathway,BP,
9736,GO:0038186,1,0.978890092158254,0,1,lithocholic acid receptor activity,MF,
9737,GO:0038187,1,0.852176389634945,0,7,pattern recognition receptor activity,MF,
9738,GO:0038189,1,0.914728960026308,0,4,neuropilin signaling pathway,BP,
9739,GO:0038190,1,0.955535542734334,0,2,VEGF-activated neuropilin signaling pathway,BP,
9740,GO:0038191,1,0.6960723670729,0,17,neuropilin binding,MF,
9741,GO:0038192,1,0.977205278740426,0,1,gastric inhibitory peptide signaling pathway,BP,
9742,GO:0038193,1,0.97723530628057,0,1,thromboxane A2 signaling pathway,BP,
9743,GO:0038194,1,0.978120976366248,0,1,thyroid-stimulating hormone signaling pathway,BP,
9744,GO:0038195,1,0.97683296653735,0,1,urokinase plasminogen activator signaling pathway,BP,
9745,GO:0038201,1,0.703604370229263,0,16,TOR complex,CC,
9746,GO:0038202,1,0.504930893812898,0,31,TORC1 signaling,BP,
9747,GO:0038203,1,0.852735086193331,0,7,TORC2 signaling,BP,
9748,GO:0039003,1,0.978120976366248,0,1,pronephric field specification,BP,
9749,GO:0039007,1,0.979548525332537,0,1,pronephric nephron morphogenesis,BP,
9750,GO:0039008,1,0.979548525332537,0,1,pronephric nephron tubule morphogenesis,BP,
9751,GO:0039017,1,0.978120976366248,0,1,pattern specification involved in pronephros development,BP,
9752,GO:0039019,1,0.957896759830253,0,2,pronephric nephron development,BP,
9753,GO:0039020,1,0.979548525332537,0,1,pronephric nephron tubule development,BP,
9754,GO:0039022,1,0.979548525332537,0,1,pronephric duct development,BP,
9755,GO:0039023,1,0.979548525332537,0,1,pronephric duct morphogenesis,BP,
9756,GO:0039502,1,0.979287790694437,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9757,GO:0039503,1,0.979287790694437,0,1,suppression by virus of host innate immune response,BP,
9758,GO:0039506,1,0.957046906177807,0,2,modulation by virus of host molecular function,BP,
9759,GO:0039507,1,0.957046906177807,0,2,suppression by virus of host molecular function,BP,
9760,GO:0039513,1,0.977290481899322,0,1,suppression by virus of host catalytic activity,BP,
9761,GO:0039514,1,0.979287790694437,0,1,suppression by virus of host JAK-STAT cascade,BP,
9762,GO:0039516,1,0.977290481899322,0,1,modulation by virus of host catalytic activity,BP,
9763,GO:0039519,1,0.959071027142077,0,2,modulation by virus of host autophagy,BP,
9764,GO:0039520,1,0.979543613345996,0,1,induction by virus of host autophagy,BP,
9765,GO:0039521,1,0.979101482028327,0,1,suppression by virus of host autophagy,BP,
9766,GO:0039526,1,0.932491614906825,0,3,modulation by virus of host apoptotic process,BP,
9767,GO:0039528,1,0.631572650382364,0,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
9768,GO:0039529,1,0.724314774805519,0,15,RIG-I signaling pathway,BP,
9769,GO:0039530,1,0.819561992550213,0,9,MDA-5 signaling pathway,BP,
9770,GO:0039531,1,0.706840425466146,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9771,GO:0039532,1,0.799983727942329,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9772,GO:0039533,1,0.878044787087708,0,6,regulation of MDA-5 signaling pathway,BP,
9773,GO:0039534,1,0.912390972431439,0,4,negative regulation of MDA-5 signaling pathway,BP,
9774,GO:0039535,1,0.756582644873265,0,13,regulation of RIG-I signaling pathway,BP,
9775,GO:0039536,1,0.856253576429456,0,7,negative regulation of RIG-I signaling pathway,BP,
9776,GO:0039552,1,0.979509550510125,0,1,RIG-I binding,MF,
9777,GO:0039562,1,0.979287790694437,0,1,suppression by virus of host STAT activity,BP,
9778,GO:0039563,1,0.979287790694437,0,1,suppression by virus of host STAT1 activity,BP,
9779,GO:0039564,1,0.979287790694437,0,1,suppression by virus of host STAT2 activity,BP,
9780,GO:0039650,1,0.977290481899322,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
9781,GO:0039656,1,0.955066908117466,0,2,modulation by virus of host gene expression,BP,
9782,GO:0039663,1,0.933252847370079,0,3,membrane fusion involved in viral entry into host cell,BP,
9783,GO:0039689,1,0.93394635360922,0,3,negative stranded viral RNA replication,BP,
9784,GO:0039692,1,0.796008366438361,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
9785,GO:0039694,1,0.584161634280482,0,24,viral RNA genome replication,BP,
9786,GO:0039695,1,0.978813071508849,0,1,DNA-templated viral transcription,BP,
9787,GO:0039702,1,0.63153266190223,0,20,viral budding via host ESCRT complex,BP,
9788,GO:0039706,1,0.874006212885402,0,6,co-receptor binding,MF,
9789,GO:0039713,1,0.97771186916298,0,1,viral factory,CC,
9790,GO:0039714,1,0.97771186916298,0,1,cytoplasmic viral factory,CC,
9791,GO:0040001,1,0.619137972254745,0,22,establishment of mitotic spindle localization,BP,
9794,GO:0040009,1,0.925051293330148,0,4,regulation of growth rate,BP,
9798,GO:0040014,1,0.378309763981048,0,45,regulation of multicellular organism growth,BP,
9799,GO:0040015,1,0.823678709703661,0,9,negative regulation of multicellular organism growth,BP,
9800,GO:0040016,1,0.856878895476852,0,7,embryonic cleavage,BP,
9802,GO:0040018,1,0.665263870068867,0,19,positive regulation of multicellular organism growth,BP,
9804,GO:0040020,1,0.697374572073158,0,16,regulation of meiotic nuclear division,BP,
9806,GO:0040030,1,0.978044431999852,0,1,regulation of molecular function, epigenetic,BP,
9807,GO:0040031,1,0.867813473070547,0,6,snRNA modification,BP,
9808,GO:0040032,1,0.977164754479537,0,1,post-embryonic body morphogenesis,BP,
9809,GO:0040033,1,0.776532269006264,0,12,negative regulation of translation, ncRNA-mediated,BP,
9813,GO:0040038,1,0.957458902522469,0,2,polar body extrusion after meiotic divisions,BP,
9814,GO:0042000,1,0.97724364867942,0,1,translocation of peptides or proteins into host,BP,
9815,GO:0042007,1,0.976810988209424,0,1,interleukin-18 binding,MF,
9816,GO:0042008,1,0.97778708562591,0,1,interleukin-18 receptor activity,MF,
9817,GO:0042015,1,0.93395047224073,0,3,interleukin-20 binding,MF,
9818,GO:0042019,1,0.977194319940977,0,1,interleukin-23 binding,MF,
9819,GO:0042020,1,0.977194319940977,0,1,interleukin-23 receptor activity,MF,
9820,GO:0042022,1,0.977194319940977,0,1,interleukin-12 receptor complex,CC,
9821,GO:0042023,1,0.843297753693192,0,8,DNA endoreduplication,BP,
9822,GO:0042025,1,0.936279083399709,0,3,host cell nucleus,CC,
9824,GO:0042030,1,0.960443186054293,0,2,ATPase inhibitor activity,MF,
9825,GO:0042033,1,0.794615043518042,0,10,chemokine biosynthetic process,BP,
9827,GO:0042036,1,0.650345418017336,0,19,negative regulation of cytokine biosynthetic process,BP,
9828,GO:0042040,1,0.978498490151427,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9829,GO:0042043,1,0.822974234535105,0,9,neurexin family protein binding,MF,
9830,GO:0042044,1,0.763281548275578,0,12,fluid transport,BP,
9831,GO:0042045,1,0.896015627239476,0,5,epithelial fluid transport,BP,
9832,GO:0042048,1,0.90222281025411,0,5,olfactory behavior,BP,
9833,GO:0042053,1,0.797635045813335,0,10,regulation of dopamine metabolic process,BP,
9834,GO:0042054,1,0.330709893202221,0,50,histone methyltransferase activity,MF,
9835,GO:0042056,1,0.725678409798008,0,14,chemoattractant activity,MF,
9836,GO:0042058,1,0.213356824290359,0,69,regulation of epidermal growth factor receptor signaling pathway,BP,
9837,GO:0042059,1,0.418604537544335,0,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,
9840,GO:0042069,1,0.797635045813335,0,10,regulation of catecholamine metabolic process,BP,
9841,GO:0042073,1,0.338991449915272,0,49,intraciliary transport,BP,
9842,GO:0042074,1,0.88614248971339,0,6,cell migration involved in gastrulation,BP,
9844,GO:0042083,1,0.976975693894645,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
9845,GO:0042084,1,0.983098747328444,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9846,GO:0042088,1,0.594129283107184,0,23,T-helper 1 type immune response,BP,
9848,GO:0042090,1,0.89506257037856,0,5,interleukin-12 biosynthetic process,BP,
9849,GO:0042091,1,0.955533842726343,0,2,interleukin-10 biosynthetic process,BP,
9850,GO:0042092,1,0.576888547369757,0,24,type 2 immune response,BP,
9852,GO:0042094,1,0.77879443292504,0,11,interleukin-2 biosynthetic process,BP,
9853,GO:0042095,1,0.853296694023897,0,7,interferon-gamma biosynthetic process,BP,
9854,GO:0042097,1,0.955337951604235,0,2,interleukin-4 biosynthetic process,BP,
9857,GO:0042101,1,0.855536927378411,0,7,T cell receptor complex,CC,
9860,GO:0042105,1,0.977234438884145,0,1,alpha-beta T cell receptor complex,CC,
9863,GO:0042109,1,0.955238761684938,0,2,lymphotoxin A biosynthetic process,BP,
9867,GO:0042117,1,0.893548130863875,0,5,monocyte activation,BP,
9870,GO:0042126,1,0.912199137965007,0,4,nitrate metabolic process,BP,
9872,GO:0042128,1,0.977239207937073,0,1,nitrate assimilation,BP,
9876,GO:0042134,1,0.954048786233929,0,2,rRNA primary transcript binding,MF,
9877,GO:0042135,1,0.763556708923429,0,12,neurotransmitter catabolic process,BP,
9879,GO:0042137,1,0.977169319060442,0,1,sequestering of neurotransmitter,BP,
9880,GO:0042138,1,0.977239263257037,0,1,meiotic DNA double-strand break formation,BP,
9881,GO:0042140,1,0.977336572808046,0,1,late meiotic recombination nodule assembly,BP,
9882,GO:0042144,1,0.956749951279968,0,2,vacuole fusion, non-autophagic,BP,
9883,GO:0042147,1,0.224114199106922,0,68,retrograde transport, endosome to Golgi,BP,
9884,GO:0042148,1,0.833228523534871,0,8,strand invasion,BP,
9886,GO:0042157,1,0.0513818115535378,0,132,lipoprotein metabolic process,BP,
9887,GO:0042158,1,0.080870584011223,0,111,lipoprotein biosynthetic process,BP,
9888,GO:0042159,1,0.765941997818928,0,12,lipoprotein catabolic process,BP,
9890,GO:0042165,1,0.663867825733363,0,18,neurotransmitter binding,MF,
9891,GO:0042166,1,0.893502274542713,0,5,acetylcholine binding,MF,
9892,GO:0042167,1,0.868663346651302,0,6,heme catabolic process,BP,
9893,GO:0042168,1,0.566451433363375,0,25,heme metabolic process,BP,
9894,GO:0042169,1,0.585093427542624,0,25,SH2 domain binding,MF,
9895,GO:0042171,1,0.645197666398226,0,20,lysophosphatidic acid acyltransferase activity,MF,
9899,GO:0042178,1,0.79318640281837,0,10,xenobiotic catabolic process,BP,
9901,GO:0042181,1,0.563000001265845,0,25,ketone biosynthetic process,BP,
9902,GO:0042182,1,0.891138675674842,0,5,ketone catabolic process,BP,
9903,GO:0042214,1,0.977169675328271,0,1,terpene metabolic process,BP,
9905,GO:0042220,1,0.567574862505816,0,26,response to cocaine,BP,
9907,GO:0042222,1,0.953974756573228,0,2,interleukin-1 biosynthetic process,BP,
9908,GO:0042223,1,0.979148195395373,0,1,interleukin-3 biosynthetic process,BP,
9909,GO:0042226,1,0.799977580160489,0,10,interleukin-6 biosynthetic process,BP,
9910,GO:0042228,1,0.854066512496261,0,7,interleukin-8 biosynthetic process,BP,
9911,GO:0042231,1,0.97645861411996,0,1,interleukin-13 biosynthetic process,BP,
9912,GO:0042241,1,0.977545923000585,0,1,interleukin-18 biosynthetic process,BP,
9913,GO:0042245,1,0.956267228687858,0,2,RNA repair,BP,
9915,GO:0042247,1,0.977358216214398,0,1,establishment of planar polarity of follicular epithelium,BP,
9916,GO:0042249,1,0.741779839757462,0,14,establishment of planar polarity of embryonic epithelium,BP,
9917,GO:0042253,1,0.956095885430522,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
9919,GO:0042255,1,0.282817987871023,0,54,ribosome assembly,BP,
9920,GO:0042256,1,0.892825144206051,0,5,mature ribosome assembly,BP,
9921,GO:0042262,1,0.888057302772972,0,5,DNA protection,BP,
9922,GO:0042264,1,0.958872601555278,0,2,peptidyl-aspartic acid hydroxylation,BP,
9923,GO:0042265,1,0.980555440616315,0,1,peptidyl-asparagine hydroxylation,BP,
9924,GO:0042267,1,0.463604321360591,0,34,natural killer cell mediated cytotoxicity,BP,
9925,GO:0042268,1,0.868015937328622,0,6,regulation of cytolysis,BP,
9926,GO:0042269,1,0.699098804387139,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9927,GO:0042270,1,0.934013694297573,0,3,protection from natural killer cell mediated cytotoxicity,BP,
9928,GO:0042271,1,0.958635615422858,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9929,GO:0042272,1,0.962888977932843,0,2,nuclear RNA export factor complex,CC,
9932,GO:0042275,1,0.976917057219349,0,1,error-free postreplication DNA repair,BP,
9933,GO:0042276,1,0.652002063475156,0,19,error-prone translesion synthesis,BP,
9936,GO:0042281,1,0.955243836382123,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
9937,GO:0042282,1,0.978717895330391,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9938,GO:0042284,1,0.977148925366071,0,1,sphingolipid delta-4 desaturase activity,MF,
9939,GO:0042285,1,0.879179973372247,0,6,xylosyltransferase activity,MF,
9941,GO:0042288,1,0.814041190560458,0,9,MHC class I protein binding,MF,
9943,GO:0042292,1,0.977245957030739,0,1,URM1 activating enzyme activity,MF,
9944,GO:0042296,1,0.911430949281072,0,4,ISG15 transferase activity,MF,
9945,GO:0042297,1,0.928247728744038,0,4,vocal learning,BP,
9946,GO:0042301,1,0.872224135828303,0,6,phosphate ion binding,MF,
9948,GO:0042304,1,0.534968611204622,0,28,regulation of fatty acid biosynthetic process,BP,
9949,GO:0042306,1,0.396857936692282,0,42,regulation of protein import into nucleus,BP,
9950,GO:0042307,1,0.559574252875311,0,27,positive regulation of protein import into nucleus,BP,
9951,GO:0042308,1,0.854102924708167,0,7,negative regulation of protein import into nucleus,BP,
9954,GO:0042313,1,0.977217150969366,0,1,protein kinase C deactivation,BP,
9955,GO:0042316,1,0.979182692621462,0,1,penicillin metabolic process,BP,
9956,GO:0042320,1,0.979672264864762,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9957,GO:0042321,1,0.976933244458608,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9958,GO:0042323,1,0.976933244458608,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9962,GO:0042328,1,0.938289435806253,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
9964,GO:0042335,1,0.938290913557465,0,3,cuticle development,BP,
9965,GO:0042339,1,0.557435973979211,0,26,keratan sulfate metabolic process,BP,
9966,GO:0042340,1,0.852913295879161,0,7,keratan sulfate catabolic process,BP,
9967,GO:0042350,1,0.933495167564411,0,3,GDP-L-fucose biosynthetic process,BP,
9968,GO:0042351,1,0.95432805212256,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
9969,GO:0042352,1,0.978173894188352,0,1,GDP-L-fucose salvage,BP,
9972,GO:0042356,1,0.97674769101636,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
9973,GO:0042357,1,0.977121522229934,0,1,thiamine diphosphate metabolic process,BP,
9975,GO:0042360,1,0.97704900594132,0,1,vitamin E metabolic process,BP,
9976,GO:0042361,1,0.977510807911802,0,1,menaquinone catabolic process,BP,
9978,GO:0042363,1,0.913903604712345,0,4,fat-soluble vitamin catabolic process,BP,
9979,GO:0042364,1,0.838240796605545,0,8,water-soluble vitamin biosynthetic process,BP,
9980,GO:0042365,1,0.933636762950544,0,3,water-soluble vitamin catabolic process,BP,
9982,GO:0042369,1,0.955256547701099,0,2,vitamin D catabolic process,BP,
9983,GO:0042371,1,0.977905537403098,0,1,vitamin K biosynthetic process,BP,
9985,GO:0042374,1,0.954442056380602,0,2,phylloquinone metabolic process,BP,
9986,GO:0042376,1,0.954442056380602,0,2,phylloquinone catabolic process,BP,
9987,GO:0042377,1,0.977510807911802,0,1,vitamin K catabolic process,BP,
9989,GO:0042382,1,0.875235908852703,0,6,paraspeckles,CC,
9992,GO:0042392,1,0.891191312627577,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9994,GO:0042398,1,0.467914585818096,0,33,cellular modified amino acid biosynthetic process,BP,
9995,GO:0042401,1,0.740592244231683,0,13,cellular biogenic amine biosynthetic process,BP,
9996,GO:0042402,1,0.774321147126484,0,11,cellular biogenic amine catabolic process,BP,
9997,GO:0042403,1,0.804175632051222,0,10,thyroid hormone metabolic process,BP,
9998,GO:0042405,1,0.781991550206011,0,12,nuclear inclusion body,CC,
9999,GO:0042406,1,0.91193070526908,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10000,GO:0042407,1,0.707132357341274,0,15,cristae formation,BP,
10001,GO:0042412,1,0.977277200092737,0,1,taurine biosynthetic process,BP,
10002,GO:0042414,1,0.959274172172456,0,2,epinephrine metabolic process,BP,
10003,GO:0042415,1,0.856869828169153,0,7,norepinephrine metabolic process,BP,
10004,GO:0042416,1,0.833506116876359,0,8,dopamine biosynthetic process,BP,
10005,GO:0042417,1,0.668401231960319,0,18,dopamine metabolic process,BP,
10006,GO:0042418,1,0.977169675328271,0,1,epinephrine biosynthetic process,BP,
10007,GO:0042420,1,0.912867132486763,0,4,dopamine catabolic process,BP,
10008,GO:0042421,1,0.933535627795858,0,3,norepinephrine biosynthetic process,BP,
10009,GO:0042423,1,0.79626540580138,0,10,catecholamine biosynthetic process,BP,
10010,GO:0042424,1,0.892247943651626,0,5,catecholamine catabolic process,BP,
10011,GO:0042426,1,0.957040954023252,0,2,choline catabolic process,BP,
10012,GO:0042428,1,0.920709071689848,0,4,serotonin metabolic process,BP,
10013,GO:0042430,1,0.839132039212007,0,8,indole-containing compound metabolic process,BP,
10014,GO:0042436,1,0.932816318383674,0,3,indole-containing compound catabolic process,BP,
10015,GO:0042438,1,0.844358898203566,0,8,melanin biosynthetic process,BP,
10016,GO:0042439,1,0.873044848508985,0,6,ethanolamine-containing compound metabolic process,BP,
10017,GO:0042440,1,0.339182059377232,0,48,pigment metabolic process,BP,
10018,GO:0042441,1,0.97898069188158,0,1,eye pigment metabolic process,BP,
10020,GO:0042446,1,0.360897845218685,0,45,hormone biosynthetic process,BP,
10021,GO:0042447,1,0.874157150608194,0,6,hormone catabolic process,BP,
10023,GO:0042450,1,0.977195985462535,0,1,arginine biosynthetic process via ornithine,BP,
10025,GO:0042454,1,0.722246300312181,0,14,ribonucleoside catabolic process,BP,
10028,GO:0042462,1,0.766588271631846,0,12,eye photoreceptor cell development,BP,
10032,GO:0042473,1,0.873281798872218,0,6,outer ear morphogenesis,BP,
10036,GO:0042481,1,0.781513732266934,0,11,regulation of odontogenesis,BP,
10037,GO:0042482,1,0.891762219890179,0,5,positive regulation of odontogenesis,BP,
10038,GO:0042483,1,0.980159247126154,0,1,negative regulation of odontogenesis,BP,
10039,GO:0042487,1,0.893465196596271,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10040,GO:0042488,1,0.977244427651838,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10043,GO:0042492,1,0.897267346531035,0,5,gamma-delta T cell differentiation,BP,
10045,GO:0042494,1,0.957915507230383,0,2,detection of bacterial lipoprotein,BP,
10046,GO:0042495,1,0.9776748638294,0,1,detection of triacyl bacterial lipopeptide,BP,
10047,GO:0042496,1,0.957915507230383,0,2,detection of diacyl bacterial lipopeptide,BP,
10048,GO:0042497,1,0.9776748638294,0,1,triacyl lipopeptide binding,MF,
10049,GO:0042500,1,0.87433145590311,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10057,GO:0042536,1,0.933173642137195,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
10058,GO:0042537,1,0.740220901837301,0,13,benzene-containing compound metabolic process,BP,
10059,GO:0042538,1,0.891893702989223,0,5,hyperosmotic salinity response,BP,
10060,GO:0042539,1,0.958890064891962,0,2,hypotonic salinity response,BP,
10061,GO:0042541,1,0.872843809171748,0,6,hemoglobin biosynthetic process,BP,
10063,GO:0042543,1,0.975422392324926,0,1,protein N-linked glycosylation via arginine,BP,
10064,GO:0042546,1,0.9771102875795,0,1,cell wall biogenesis,BP,
10067,GO:0042554,1,0.70992224455843,0,15,superoxide anion generation,BP,
10068,GO:0042555,1,0.778650779325671,0,11,MCM complex,CC,
10069,GO:0042558,1,0.532775166539977,0,28,pteridine-containing compound metabolic process,BP,
10070,GO:0042559,1,0.722603027714385,0,14,pteridine-containing compound biosynthetic process,BP,
10071,GO:0042560,1,0.937269882184007,0,3,pteridine-containing compound catabolic process,BP,
10073,GO:0042564,1,0.978578831257478,0,1,NLS-dependent protein nuclear import complex,CC,
10074,GO:0042565,1,0.956256319935698,0,2,RNA nuclear export complex,CC,
10075,GO:0042567,1,0.958503078270374,0,2,insulin-like growth factor ternary complex,CC,
10076,GO:0042568,1,0.976177949021568,0,1,insulin-like growth factor binary complex,CC,
10078,GO:0042573,1,0.777972631296569,0,11,retinoic acid metabolic process,BP,
10080,GO:0042575,1,0.699357729258468,0,16,DNA polymerase complex,CC,
10081,GO:0042577,1,0.851786228609708,0,7,lipid phosphatase activity,MF,
10085,GO:0042582,1,0.0631296667627079,0,122,azurophil granule,CC,
10087,GO:0042584,1,0.917144859589546,0,4,chromaffin granule membrane,CC,
10088,GO:0042585,1,0.956235085930359,0,2,germinal vesicle,CC,
10089,GO:0042586,1,0.976471669318154,0,1,peptide deformylase activity,MF,
10091,GO:0042588,1,0.816989332800314,0,9,zymogen granule,CC,
10092,GO:0042589,1,0.854128614499991,0,7,zymogen granule membrane,CC,
10093,GO:0042590,1,0.20447704209681,0,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10097,GO:0042595,1,0.978093981058656,0,1,behavioral response to starvation,BP,
10098,GO:0042596,1,0.671268004907576,0,18,fear response,BP,
10099,GO:0042599,1,0.760959878689618,0,12,lamellar body,CC,
10100,GO:0042602,1,0.97599392288364,0,1,riboflavin reductase (NADPH) activity,MF,
10101,GO:0042605,1,0.727184590387514,0,14,peptide antigen binding,MF,
10102,GO:0042608,1,0.933053145037838,0,3,T cell receptor binding,MF,
10103,GO:0042609,1,0.894340650321106,0,5,CD4 receptor binding,MF,
10104,GO:0042610,1,0.977213758644807,0,1,CD8 receptor binding,MF,
10105,GO:0042611,1,0.754313914939739,0,12,MHC protein complex,CC,
10106,GO:0042612,1,0.809720549013045,0,9,MHC class I protein complex,CC,
10107,GO:0042613,1,0.931625463450351,0,3,MHC class II protein complex,CC,
10110,GO:0042624,1,0.97569188921866,0,1,ATPase activity, uncoupled,MF,
10111,GO:0042625,1,0.461035435839306,0,35,ATPase coupled ion transmembrane transporter activity,MF,
10112,GO:0042626,1,0.238497883551528,0,66,ATPase activity, coupled to transmembrane movement of substances,MF,
10113,GO:0042627,1,0.930651151938606,0,3,chylomicron,CC,
10114,GO:0042628,1,0.977234756534726,0,1,mating plug formation,BP,
10115,GO:0042629,1,0.784214543865567,0,11,mast cell granule,CC,
10116,GO:0042631,1,0.977835823295938,0,1,cellular response to water deprivation,BP,
10121,GO:0042636,1,0.916220231031848,0,4,negative regulation of hair cycle,BP,
10122,GO:0042637,1,0.913799450787491,0,4,catagen,BP,
10123,GO:0042640,1,0.91731347168322,0,4,anagen,BP,
10125,GO:0042643,1,0.977358216214398,0,1,actomyosin, actin portion,CC,
10126,GO:0042645,1,0.405836755856244,0,40,mitochondrial nucleoid,CC,
10127,GO:0042658,1,0.976685371538767,0,1,MHC class II protein binding, via antigen binding groove,MF,
10128,GO:0042659,1,0.859149921696209,0,7,regulation of cell fate specification,BP,
10129,GO:0042660,1,0.980452075850445,0,1,positive regulation of cell fate specification,BP,
10130,GO:0042661,1,0.936029061270108,0,3,regulation of mesodermal cell fate specification,BP,
10131,GO:0042662,1,0.977125613061449,0,1,negative regulation of mesodermal cell fate specification,BP,
10132,GO:0042663,1,0.954902751125859,0,2,regulation of endodermal cell fate specification,BP,
10133,GO:0042665,1,0.978097417232454,0,1,regulation of ectodermal cell fate specification,BP,
10134,GO:0042666,1,0.978097417232454,0,1,negative regulation of ectodermal cell fate specification,BP,
10136,GO:0042670,1,0.935333030366718,0,3,retinal cone cell differentiation,BP,
10138,GO:0042693,1,0.872324352270995,0,6,muscle cell fate commitment,BP,
10139,GO:0042695,1,0.896401725085107,0,5,thelarche,BP,
10140,GO:0042698,1,0.425334189323266,0,39,ovulation cycle,BP,
10141,GO:0042699,1,0.954917274247971,0,2,follicle-stimulating hormone signaling pathway,BP,
10142,GO:0042700,1,0.978814768496901,0,1,luteinizing hormone signaling pathway,BP,
10143,GO:0042701,1,0.958551697364443,0,2,progesterone secretion,BP,
10144,GO:0042704,1,0.957247073575449,0,2,uterine wall breakdown,BP,
10145,GO:0042709,1,0.977240407281889,0,1,succinate-CoA ligase complex,CC,
10146,GO:0042711,1,0.874321057035909,0,6,maternal behavior,BP,
10147,GO:0042713,1,0.937959672511642,0,3,sperm ejaculation,BP,
10148,GO:0042719,1,0.888079673447679,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10149,GO:0042720,1,0.95336080625482,0,2,mitochondrial inner membrane peptidase complex,CC,
10150,GO:0042721,1,0.889016876248076,0,5,mitochondrial inner membrane protein insertion complex,CC,
10151,GO:0042723,1,0.933559064455403,0,3,thiamine-containing compound metabolic process,BP,
10152,GO:0042726,1,0.855046953697246,0,7,flavin-containing compound metabolic process,BP,
10153,GO:0042727,1,0.954984168117085,0,2,flavin-containing compound biosynthetic process,BP,
10154,GO:0042728,1,0.978120976366248,0,1,flavin-containing compound catabolic process,BP,
10156,GO:0042731,1,0.914575932318802,0,4,PH domain binding,MF,
10157,GO:0042732,1,0.954429461062421,0,2,D-xylose metabolic process,BP,
10159,GO:0042734,1,0.43299924463824,0,39,presynaptic membrane,CC,
10160,GO:0042737,1,0.188317932099161,0,73,drug catabolic process,BP,
10161,GO:0042738,1,0.817069216017177,0,9,exogenous drug catabolic process,BP,
10163,GO:0042743,1,0.526254099665053,0,28,hydrogen peroxide metabolic process,BP,
10164,GO:0042744,1,0.76149320077584,0,12,hydrogen peroxide catabolic process,BP,
10165,GO:0042745,1,0.780445994571013,0,11,circadian sleep/wake cycle,BP,
10166,GO:0042747,1,0.913000814449179,0,4,circadian sleep/wake cycle, REM sleep,BP,
10167,GO:0042748,1,0.939667021761203,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
10168,GO:0042749,1,0.893273661038263,0,5,regulation of circadian sleep/wake cycle,BP,
10170,GO:0042753,1,0.881411806725843,0,6,positive regulation of circadian rhythm,BP,
10172,GO:0042755,1,0.73186026525165,0,14,eating behavior,BP,
10173,GO:0042756,1,0.93282376121701,0,3,drinking behavior,BP,
10174,GO:0042758,1,0.913067589361698,0,4,long-chain fatty acid catabolic process,BP,
10175,GO:0042759,1,0.824616177677333,0,9,long-chain fatty acid biosynthetic process,BP,
10176,GO:0042760,1,0.891993473595918,0,5,very long-chain fatty acid catabolic process,BP,
10177,GO:0042761,1,0.79493432943614,0,10,very long-chain fatty acid biosynthetic process,BP,
10178,GO:0042762,1,0.720606267712328,0,15,regulation of sulfur metabolic process,BP,
10179,GO:0042765,1,0.892646097017878,0,5,GPI-anchor transamidase complex,CC,
10180,GO:0042766,1,0.981526785894838,0,1,nucleosome mobilization,BP,
10181,GO:0042769,1,0.429393137426467,0,37,DNA damage response, detection of DNA damage,BP,
10184,GO:0042772,1,0.659857519553071,0,19,DNA damage response, signal transduction resulting in transcription,BP,
10185,GO:0042773,1,0.148238690373854,0,80,ATP synthesis coupled electron transport,BP,
10186,GO:0042774,1,0.977336572808046,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10187,GO:0042775,1,0.151700910326001,0,79,mitochondrial ATP synthesis coupled electron transport,BP,
10188,GO:0042776,1,0.90860991227419,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10189,GO:0042779,1,0.955799861090962,0,2,tRNA 3'-trailer cleavage,BP,
10190,GO:0042780,1,0.850949500318244,0,7,tRNA 3'-end processing,BP,
10191,GO:0042781,1,0.955799861090962,0,2,3'-tRNA processing endoribonuclease activity,MF,
10192,GO:0042788,1,0.501665051487495,0,29,polysomal ribosome,CC,
10193,GO:0042789,1,0.738362255821678,0,14,mRNA transcription by RNA polymerase II,BP,
10194,GO:0042790,1,0.76500345222615,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10195,GO:0042791,1,0.874782746440048,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10196,GO:0042795,1,0.21855843907136,0,67,snRNA transcription by RNA polymerase II,BP,
10197,GO:0042796,1,0.873291805908131,0,6,snRNA transcription by RNA polymerase III,BP,
10198,GO:0042797,1,0.874782746440048,0,6,tRNA transcription by RNA polymerase III,BP,
10199,GO:0042799,1,0.918963438268065,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10200,GO:0042800,1,0.701527008532669,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10203,GO:0042805,1,0.744227274962301,0,15,actinin binding,MF,
10204,GO:0042806,1,0.977336572808046,0,1,fucose binding,MF,
10205,GO:0042809,1,0.723770802989364,0,15,vitamin D receptor binding,MF,
10207,GO:0042816,1,0.896672643120296,0,5,vitamin B6 metabolic process,BP,
10208,GO:0042819,1,0.937204500653487,0,3,vitamin B6 biosynthetic process,BP,
10209,GO:0042820,1,0.977198217831443,0,1,vitamin B6 catabolic process,BP,
10210,GO:0042822,1,0.937183055175703,0,3,pyridoxal phosphate metabolic process,BP,
10211,GO:0042823,1,0.95905460875454,0,2,pyridoxal phosphate biosynthetic process,BP,
10212,GO:0042824,1,0.913524877321316,0,4,MHC class I peptide loading complex,CC,
10213,GO:0042825,1,0.934870674907325,0,3,TAP complex,CC,
10216,GO:0042832,1,0.819297818415636,0,9,defense response to protozoan,BP,
10217,GO:0042834,1,0.853746387324532,0,7,peptidoglycan binding,MF,
10218,GO:0042835,1,0.978882989247659,0,1,BRE binding,MF,
10219,GO:0042839,1,0.97687057577203,0,1,D-glucuronate metabolic process,BP,
10220,GO:0042840,1,0.97687057577203,0,1,D-glucuronate catabolic process,BP,
10221,GO:0042851,1,0.978170959920368,0,1,L-alanine metabolic process,BP,
10222,GO:0042853,1,0.978170959920368,0,1,L-alanine catabolic process,BP,
10225,GO:0042887,1,0.515819069059943,0,29,amide transmembrane transporter activity,MF,
10226,GO:0042891,1,0.854205546792722,0,7,antibiotic transport,BP,
10227,GO:0042895,1,0.872913039423765,0,6,antibiotic transmembrane transporter activity,MF,
10228,GO:0042903,1,0.95603927830098,0,2,tubulin deacetylase activity,MF,
10229,GO:0042904,1,0.955342239332865,0,2,9-cis-retinoic acid biosynthetic process,BP,
10230,GO:0042905,1,0.955342239332865,0,2,9-cis-retinoic acid metabolic process,BP,
10233,GO:0042921,1,0.740304350187853,0,14,glucocorticoid receptor signaling pathway,BP,
10234,GO:0042922,1,0.97592036803824,0,1,neuromedin U receptor binding,MF,
10235,GO:0042923,1,0.95490992631006,0,2,neuropeptide binding,MF,
10236,GO:0042937,1,0.9801861254092,0,1,tripeptide transmembrane transporter activity,MF,
10237,GO:0042938,1,0.954829641473384,0,2,dipeptide transport,BP,
10238,GO:0042939,1,0.957834946081307,0,2,tripeptide transport,BP,
10239,GO:0042940,1,0.934994159258387,0,3,D-amino acid transport,BP,
10240,GO:0042942,1,0.977257086605506,0,1,D-serine transport,BP,
10241,GO:0042946,1,0.977336572808046,0,1,glucoside transport,BP,
10242,GO:0042947,1,0.977336572808046,0,1,glucoside transmembrane transporter activity,MF,
10243,GO:0042953,1,0.885103026358264,0,6,lipoprotein transport,BP,
10244,GO:0042954,1,0.903135540227489,0,5,lipoprotein transporter activity,MF,
10245,GO:0042974,1,0.649321844214941,0,20,retinoic acid receptor binding,MF,
10246,GO:0042975,1,0.824820971616687,0,9,peroxisome proliferator activated receptor binding,MF,
10248,GO:0042978,1,0.956332576107565,0,2,ornithine decarboxylase activator activity,MF,
10249,GO:0042979,1,0.912492617222374,0,4,ornithine decarboxylase regulator activity,MF,
10252,GO:0042983,1,0.815636387295364,0,9,amyloid precursor protein biosynthetic process,BP,
10253,GO:0042984,1,0.815636387295364,0,9,regulation of amyloid precursor protein biosynthetic process,BP,
10254,GO:0042985,1,0.87369446423959,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10255,GO:0042986,1,0.955370960498731,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10257,GO:0042988,1,0.979270259441007,0,1,X11-like protein binding,MF,
10258,GO:0042989,1,0.866311294914033,0,6,sequestering of actin monomers,BP,
10259,GO:0042994,1,0.667626762852713,0,18,cytoplasmic sequestering of transcription factor,BP,
10261,GO:0042996,1,0.894694922857657,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10262,GO:0042997,1,0.934755765014929,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
10263,GO:0042998,1,0.957153619935201,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10264,GO:0042999,1,0.978784554554416,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10265,GO:0043000,1,0.956114086142717,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10266,GO:0043001,1,0.530517244953578,0,29,Golgi to plasma membrane protein transport,BP,
10267,GO:0043002,1,0.978784554554416,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10268,GO:0043004,1,0.978784554554416,0,1,cytoplasmic sequestering of CFTR protein,BP,
10270,GO:0043006,1,0.977254848732398,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10271,GO:0043008,1,0.832373358873838,0,8,ATP-dependent protein binding,MF,
10274,GO:0043011,1,0.815197714387014,0,9,myeloid dendritic cell differentiation,BP,
10276,GO:0043015,1,0.573326639381878,0,25,gamma-tubulin binding,MF,
10277,GO:0043016,1,0.977279275650516,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10278,GO:0043017,1,0.977279275650516,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
10279,GO:0043020,1,0.931037674731667,0,3,NADPH oxidase complex,CC,
10280,GO:0043021,1,0.084579676757115,0,110,ribonucleoprotein complex binding,MF,
10281,GO:0043022,1,0.349508556898044,0,47,ribosome binding,MF,
10282,GO:0043023,1,0.779168049790246,0,11,ribosomal large subunit binding,MF,
10283,GO:0043024,1,0.730919832693873,0,14,ribosomal small subunit binding,MF,
10285,GO:0043027,1,0.68659832546751,0,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
10286,GO:0043028,1,0.49045484271857,0,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
10288,GO:0043030,1,0.605484922209583,0,23,regulation of macrophage activation,BP,
10289,GO:0043031,1,0.913738871505454,0,4,negative regulation of macrophage activation,BP,
10290,GO:0043032,1,0.781927337544201,0,11,positive regulation of macrophage activation,BP,
10291,GO:0043033,1,0.98076969582673,0,1,isoamylase complex,CC,
10293,GO:0043035,1,0.978044431999852,0,1,chromatin insulator sequence binding,MF,
10296,GO:0043041,1,0.977828801233376,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10299,GO:0043045,1,0.879278932479089,0,6,DNA methylation involved in embryo development,BP,
10300,GO:0043046,1,0.853526993698312,0,7,DNA methylation involved in gamete generation,BP,
10301,GO:0043047,1,0.780813008374061,0,11,single-stranded telomeric DNA binding,MF,
10302,GO:0043048,1,0.97722968210587,0,1,dolichyl monophosphate biosynthetic process,BP,
10303,GO:0043060,1,0.977246943874661,0,1,meiotic metaphase I plate congression,BP,
10311,GO:0043083,1,0.924405253659293,0,4,synaptic cleft,CC,
10312,GO:0043084,1,0.915110128596567,0,4,penile erection,BP,
10317,GO:0043094,1,0.480150100370764,0,32,cellular metabolic compound salvage,BP,
10318,GO:0043095,1,0.975734410677856,0,1,regulation of GTP cyclohydrolase I activity,BP,
10319,GO:0043096,1,0.889202979383166,0,5,purine nucleobase salvage,BP,
10320,GO:0043097,1,0.775906281852566,0,11,pyrimidine nucleoside salvage,BP,
10321,GO:0043101,1,0.741665921720206,0,13,purine-containing compound salvage,BP,
10322,GO:0043102,1,0.871960081725596,0,6,amino acid salvage,BP,
10323,GO:0043103,1,0.932566914577384,0,3,hypoxanthine salvage,BP,
10324,GO:0043105,1,0.975734410677856,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10325,GO:0043111,1,0.956378730375382,0,2,replication fork arrest,BP,
10327,GO:0043113,1,0.520844795803993,0,30,receptor clustering,BP,
10328,GO:0043114,1,0.691066556216573,0,17,regulation of vascular permeability,BP,
10329,GO:0043116,1,0.856851224953825,0,7,negative regulation of vascular permeability,BP,
10330,GO:0043117,1,0.934629832707573,0,3,positive regulation of vascular permeability,BP,
10331,GO:0043120,1,0.932931991106957,0,3,tumor necrosis factor binding,MF,
10332,GO:0043121,1,0.89698978897676,0,5,neurotrophin binding,MF,
10335,GO:0043124,1,0.467615076853425,0,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
10337,GO:0043126,1,0.976896461882296,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10338,GO:0043128,1,0.976896461882296,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10339,GO:0043129,1,0.89828155010227,0,5,surfactant homeostasis,BP,
10341,GO:0043131,1,0.979243290333626,0,1,erythrocyte enucleation,BP,
10342,GO:0043132,1,0.977234999346512,0,1,NAD transport,BP,
10343,GO:0043136,1,0.977470046949509,0,1,glycerol-3-phosphatase activity,MF,
10344,GO:0043137,1,0.912375908562283,0,4,DNA replication, removal of RNA primer,BP,
10345,GO:0043138,1,0.766749180500079,0,12,3'-5' DNA helicase activity,MF,
10346,GO:0043139,1,0.853150716999093,0,7,5'-3' DNA helicase activity,MF,
10347,GO:0043140,1,0.859971521321578,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10348,GO:0043141,1,0.892102864693797,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10349,GO:0043142,1,0.748857247119785,0,13,single-stranded DNA-dependent ATPase activity,MF,
10350,GO:0043144,1,0.827918498611909,0,8,snoRNA processing,BP,
10354,GO:0043159,1,0.977845685106633,0,1,acrosomal matrix,CC,
10356,GO:0043162,1,0.666196386309759,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10357,GO:0043163,1,0.960148795687212,0,2,cell envelope organization,BP,
10362,GO:0043171,1,0.596601158162372,0,23,peptide catabolic process,BP,
10363,GO:0043173,1,0.724125541130938,0,14,nucleotide salvage,BP,
10364,GO:0043174,1,0.691330694402007,0,16,nucleoside salvage,BP,
10365,GO:0043175,1,0.458778068993474,0,35,RNA polymerase core enzyme binding,MF,
10366,GO:0043176,1,0.932833936673599,0,3,amine binding,MF,
10368,GO:0043178,1,0.35183669929856,0,48,alcohol binding,MF,
10369,GO:0043179,1,0.977217150969366,0,1,rhythmic excitation,BP,
10370,GO:0043181,1,0.977862671251014,0,1,vacuolar sequestering,BP,
10371,GO:0043183,1,0.954724741145924,0,2,vascular endothelial growth factor receptor 1 binding,MF,
10372,GO:0043184,1,0.892660482199538,0,5,vascular endothelial growth factor receptor 2 binding,MF,
10373,GO:0043185,1,0.977214446952929,0,1,vascular endothelial growth factor receptor 3 binding,MF,
10374,GO:0043186,1,0.853074788515475,0,7,P granule,CC,
10375,GO:0043189,1,0.654565962292608,0,19,H4/H2A histone acetyltransferase complex,CC,
10376,GO:0043190,1,0.879534000772481,0,6,ATP-binding cassette (ABC) transporter complex,CC,
10377,GO:0043194,1,0.832956823353544,0,9,axon initial segment,CC,
10378,GO:0043195,1,0.405183842512851,0,41,terminal bouton,CC,
10379,GO:0043196,1,0.935665609208143,0,3,varicosity,CC,
10381,GO:0043198,1,0.631960123653109,0,21,dendritic shaft,CC,
10382,GO:0043199,1,0.937370035962778,0,3,sulfate binding,MF,
10384,GO:0043201,1,0.809408520550947,0,10,response to leucine,BP,
10385,GO:0043202,1,0.201972467639498,0,71,lysosomal lumen,CC,
10386,GO:0043203,1,0.870541889680992,0,6,axon hillock,CC,
10387,GO:0043204,1,0.277847397583333,0,58,perikaryon,CC,
10389,GO:0043208,1,0.912564501018594,0,4,glycosphingolipid binding,MF,
10392,GO:0043218,1,0.765967067825883,0,12,compact myelin,CC,
10393,GO:0043219,1,0.91532296853895,0,4,lateral loop,CC,
10394,GO:0043220,1,0.82118418628978,0,9,Schmidt-Lanterman incisure,CC,
10395,GO:0043221,1,0.978116069108703,0,1,SMC family protein binding,MF,
10396,GO:0043224,1,0.952916946930288,0,2,nuclear SCF ubiquitin ligase complex,CC,
10397,GO:0043225,1,0.843384918961387,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10407,GO:0043236,1,0.631990388977701,0,21,laminin binding,MF,
10408,GO:0043237,1,0.919012764363872,0,4,laminin-1 binding,MF,
10409,GO:0043240,1,0.781195489362619,0,11,Fanconi anaemia nuclear complex,CC,
10410,GO:0043242,1,0.360347712780089,0,48,negative regulation of protein complex disassembly,BP,
10411,GO:0043243,1,0.612797945241377,0,23,positive regulation of protein complex disassembly,BP,
10414,GO:0043248,1,0.754486658337799,0,12,proteasome assembly,BP,
10415,GO:0043249,1,0.815786664201873,0,9,erythrocyte maturation,BP,
10416,GO:0043250,1,0.976899444301843,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10417,GO:0043251,1,0.976899444301843,0,1,sodium-dependent organic anion transport,BP,
10418,GO:0043252,1,0.784024353309762,0,11,sodium-independent organic anion transport,BP,
10421,GO:0043256,1,0.855764150994057,0,8,laminin complex,CC,
10422,GO:0043257,1,0.979790393365001,0,1,laminin-8 complex,CC,
10423,GO:0043259,1,0.945758693223895,0,3,laminin-10 complex,CC,
10424,GO:0043260,1,0.945729146259071,0,3,laminin-11 complex,CC,
10425,GO:0043262,1,0.933664911750833,0,3,adenosine-diphosphatase activity,MF,
10426,GO:0043266,1,0.413988813022036,0,41,regulation of potassium ion transport,BP,
10427,GO:0043267,1,0.756503624872158,0,13,negative regulation of potassium ion transport,BP,
10428,GO:0043268,1,0.732555463806965,0,15,positive regulation of potassium ion transport,BP,
10432,GO:0043273,1,0.979437276541294,0,1,CTPase activity,MF,
10433,GO:0043274,1,0.787464677541304,0,11,phospholipase binding,MF,
10435,GO:0043277,1,0.553681062568754,0,27,apoptotic cell clearance,BP,
10436,GO:0043278,1,0.685907445997658,0,17,response to morphine,BP,
10437,GO:0043279,1,0.228208310123278,0,67,response to alkaloid,BP,
10440,GO:0043291,1,0.966916312446891,0,2,RAVE complex,CC,
10442,GO:0043293,1,0.958218453287034,0,2,apoptosome,CC,
10443,GO:0043295,1,0.77473697663596,0,11,glutathione binding,MF,
10447,GO:0043300,1,0.547672306487051,0,27,regulation of leukocyte degranulation,BP,
10448,GO:0043301,1,0.896648422323178,0,5,negative regulation of leukocyte degranulation,BP,
10449,GO:0043302,1,0.747392968933837,0,13,positive regulation of leukocyte degranulation,BP,
10450,GO:0043303,1,0.548134937272764,0,27,mast cell degranulation,BP,
10451,GO:0043304,1,0.651992156094549,0,19,regulation of mast cell degranulation,BP,
10452,GO:0043305,1,0.955026357165286,0,2,negative regulation of mast cell degranulation,BP,
10453,GO:0043306,1,0.835183019878253,0,8,positive regulation of mast cell degranulation,BP,
10454,GO:0043307,1,0.911668303987733,0,4,eosinophil activation,BP,
10455,GO:0043308,1,0.911668303987733,0,4,eosinophil degranulation,BP,
10456,GO:0043309,1,0.954634434731137,0,2,regulation of eosinophil degranulation,BP,
10457,GO:0043311,1,0.954634434731137,0,2,positive regulation of eosinophil degranulation,BP,
10459,GO:0043313,1,0.919903871936858,0,4,regulation of neutrophil degranulation,BP,
10460,GO:0043314,1,0.960261102122348,0,2,negative regulation of neutrophil degranulation,BP,
10461,GO:0043315,1,0.978381611755302,0,1,positive regulation of neutrophil degranulation,BP,
10462,GO:0043316,1,0.95554683549096,0,2,cytotoxic T cell degranulation,BP,
10463,GO:0043317,1,0.977740774546047,0,1,regulation of cytotoxic T cell degranulation,BP,
10464,GO:0043318,1,0.977740774546047,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10465,GO:0043320,1,0.87499583731974,0,6,natural killer cell degranulation,BP,
10466,GO:0043321,1,0.958210763987479,0,2,regulation of natural killer cell degranulation,BP,
10467,GO:0043323,1,0.958210763987479,0,2,positive regulation of natural killer cell degranulation,BP,
10468,GO:0043324,1,0.97898069188158,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10469,GO:0043325,1,0.689650842190861,0,17,phosphatidylinositol-3,4-bisphosphate binding,MF,
10470,GO:0043328,1,0.910961005758171,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10471,GO:0043330,1,0.557368761121401,0,26,response to exogenous dsRNA,BP,
10473,GO:0043335,1,0.955186459662737,0,2,protein unfolding,BP,
10474,GO:0043337,1,0.978052764708119,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10475,GO:0043353,1,0.881296318267054,0,6,enucleate erythrocyte differentiation,BP,
10476,GO:0043354,1,0.979243290333626,0,1,enucleate erythrocyte maturation,BP,
10477,GO:0043366,1,0.956796593021788,0,2,beta selection,BP,
10479,GO:0043368,1,0.672847926339307,0,18,positive T cell selection,BP,
10480,GO:0043369,1,0.784536759606725,0,11,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
10483,GO:0043372,1,0.775896401291277,0,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10484,GO:0043373,1,0.835970278248686,0,8,CD4-positive, alpha-beta T cell lineage commitment,BP,
10486,GO:0043375,1,0.97809692635028,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10488,GO:0043379,1,0.895271261459659,0,5,memory T cell differentiation,BP,
10489,GO:0043380,1,0.911895673951855,0,4,regulation of memory T cell differentiation,BP,
10490,GO:0043382,1,0.932608408531151,0,3,positive regulation of memory T cell differentiation,BP,
10491,GO:0043383,1,0.937081661381421,0,3,negative T cell selection,BP,
10492,GO:0043385,1,0.977284794046506,0,1,mycotoxin metabolic process,BP,
10493,GO:0043387,1,0.977284794046506,0,1,mycotoxin catabolic process,BP,
10497,GO:0043394,1,0.621298524577519,0,23,proteoglycan binding,MF,
10498,GO:0043395,1,0.81920161537037,0,10,heparan sulfate proteoglycan binding,MF,
10499,GO:0043396,1,0.977531669431364,0,1,corticotropin-releasing hormone secretion,BP,
10500,GO:0043397,1,0.977531669431364,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10501,GO:0043398,1,0.935246303829608,0,3,HLH domain binding,MF,
10502,GO:0043400,1,0.956435536992941,0,2,cortisol secretion,BP,
10504,GO:0043402,1,0.943589623646357,0,3,glucocorticoid mediated signaling pathway,BP,
10517,GO:0043418,1,0.933611595700864,0,3,homocysteine catabolic process,BP,
10518,GO:0043422,1,0.782133000664009,0,11,protein kinase B binding,MF,
10519,GO:0043423,1,0.978572566538501,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10524,GO:0043435,1,0.935834148607585,0,3,response to corticotropin-releasing hormone,BP,
10526,GO:0043449,1,0.97726049325861,0,1,cellular alkene metabolic process,BP,
10527,GO:0043455,1,0.840767949013053,0,8,regulation of secondary metabolic process,BP,
10528,GO:0043456,1,0.911712605524349,0,4,regulation of pentose-phosphate shunt,BP,
10529,GO:0043457,1,0.693795379900175,0,16,regulation of cellular respiration,BP,
10530,GO:0043461,1,0.912532054967287,0,4,proton-transporting ATP synthase complex assembly,BP,
10532,GO:0043465,1,0.977336572808046,0,1,regulation of fermentation,BP,
10537,GO:0043474,1,0.97898069188158,0,1,pigment metabolic process involved in pigmentation,BP,
10546,GO:0043490,1,0.956260108186374,0,2,malate-aspartate shuttle,BP,
10548,GO:0043492,1,0.194756372003993,0,76,ATPase activity, coupled to movement of substances,MF,
10549,GO:0043495,1,0.861401160136964,0,7,protein membrane anchor,MF,
10551,GO:0043497,1,0.81695459952644,0,9,regulation of protein heterodimerization activity,BP,
10553,GO:0043501,1,0.789538209457654,0,11,skeletal muscle adaptation,BP,
10555,GO:0043504,1,0.935655639880743,0,3,mitochondrial DNA repair,BP,
10558,GO:0043508,1,0.762161243396381,0,12,negative regulation of JUN kinase activity,BP,
10559,GO:0043509,1,0.977226843172614,0,1,activin A complex,CC,
10560,GO:0043511,1,0.977226843172614,0,1,inhibin complex,CC,
10561,GO:0043512,1,0.977226843172614,0,1,inhibin A complex,CC,
10562,GO:0043515,1,0.898819193170405,0,5,kinetochore binding,MF,
10566,GO:0043519,1,0.977218762474379,0,1,regulation of myosin II filament organization,BP,
10567,GO:0043522,1,0.798966490646558,0,10,leucine zipper domain binding,MF,
10572,GO:0043531,1,0.527835213991346,0,29,ADP binding,MF,
10573,GO:0043532,1,0.98042508088655,0,1,angiostatin binding,MF,
10574,GO:0043533,1,0.90069660728228,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
10578,GO:0043537,1,0.60510931045958,0,23,negative regulation of blood vessel endothelial cell migration,BP,
10579,GO:0043538,1,0.97741559106125,0,1,regulation of actin phosphorylation,BP,
10581,GO:0043541,1,0.955884470440751,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10584,GO:0043544,1,0.977845685106633,0,1,lipoamide binding,MF,
10585,GO:0043545,1,0.852721405227592,0,7,molybdopterin cofactor metabolic process,BP,
10586,GO:0043546,1,0.876094425267871,0,6,molybdopterin cofactor binding,MF,
10592,GO:0043552,1,0.675545446989896,0,18,positive regulation of phosphatidylinositol 3-kinase activity,BP,
10593,GO:0043553,1,0.9347406629304,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
10594,GO:0043555,1,0.67081850456087,0,18,regulation of translation in response to stress,BP,
10595,GO:0043558,1,0.732273305635937,0,14,regulation of translational initiation in response to stress,BP,
10598,GO:0043562,1,0.792781583207722,0,10,cellular response to nitrogen levels,BP,
10599,GO:0043564,1,0.955443987234477,0,2,Ku70:Ku80 complex,CC,
10602,GO:0043568,1,0.901891852157197,0,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
10603,GO:0043569,1,0.937217672162646,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10604,GO:0043570,1,0.915871694107079,0,4,maintenance of DNA repeat elements,BP,
10605,GO:0043574,1,0.666914834058509,0,18,peroxisomal transport,BP,
10606,GO:0043576,1,0.755384415831531,0,13,regulation of respiratory gaseous exchange,BP,
10607,GO:0043578,1,0.945299967075242,0,3,nuclear matrix organization,BP,
10609,GO:0043584,1,0.813706123513802,0,10,nose development,BP,
10610,GO:0043585,1,0.961530456915933,0,2,nose morphogenesis,BP,
10611,GO:0043586,1,0.738162736288224,0,14,tongue development,BP,
10612,GO:0043587,1,0.838032504736412,0,8,tongue morphogenesis,BP,
10615,GO:0043596,1,0.39740701529924,0,41,nuclear replication fork,CC,
10616,GO:0043601,1,0.58033882533775,0,24,nuclear replisome,CC,
10617,GO:0043602,1,0.977249911957491,0,1,nitrate catabolic process,BP,
10620,GO:0043606,1,0.977485040241761,0,1,formamide metabolic process,BP,
10621,GO:0043610,1,0.981876921102702,0,1,regulation of carbohydrate utilization,BP,
10622,GO:0043614,1,0.958221369854046,0,2,multi-eIF complex,CC,
10626,GO:0043619,1,0.805155378740272,0,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10629,GO:0043622,1,0.916438830511095,0,4,cortical microtubule organization,BP,
10631,GO:0043625,1,0.911728196137338,0,4,delta DNA polymerase complex,CC,
10632,GO:0043626,1,0.976715735583364,0,1,PCNA complex,CC,
10634,GO:0043628,1,0.538407313977659,0,27,ncRNA 3'-end processing,BP,
10635,GO:0043629,1,0.981367095365806,0,1,ncRNA polyadenylation,BP,
10636,GO:0043630,1,0.981367095365806,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10637,GO:0043631,1,0.403205364681587,0,41,RNA polyadenylation,BP,
10639,GO:0043633,1,0.834707039223056,0,8,polyadenylation-dependent RNA catabolic process,BP,
10640,GO:0043634,1,0.852803449272173,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10643,GO:0043649,1,0.76394045756013,0,12,dicarboxylic acid catabolic process,BP,
10644,GO:0043650,1,0.834859542417634,0,8,dicarboxylic acid biosynthetic process,BP,
10645,GO:0043651,1,0.725979451774751,0,14,linoleic acid metabolic process,BP,
10646,GO:0043652,1,0.835062021124178,0,8,engulfment of apoptotic cell,BP,
10647,GO:0043653,1,0.830185357400661,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10648,GO:0043654,1,0.935607268758387,0,3,recognition of apoptotic cell,BP,
10649,GO:0043656,1,0.855781443458548,0,7,intracellular region of host,CC,
10650,GO:0043657,1,0.258504099537698,0,61,host cell,CC,
10651,GO:0043666,1,0.149714621127388,0,86,regulation of phosphoprotein phosphatase activity,BP,
10653,GO:0043682,1,0.96218893718623,0,2,copper-transporting ATPase activity,MF,
10654,GO:0043686,1,0.932594910524534,0,3,co-translational protein modification,BP,
10657,GO:0043696,1,0.900983785690315,0,5,dedifferentiation,BP,
10658,GO:0043697,1,0.900983785690315,0,5,cell dedifferentiation,BP,
10659,GO:0043733,1,0.976369312322026,0,1,DNA-3-methylbase glycosylase activity,MF,
10660,GO:0043734,1,0.911941991561838,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10661,GO:0043739,1,0.977552768382949,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10662,GO:0043754,1,0.983253238618624,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10663,GO:0043783,1,0.977240299425335,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
10664,GO:0043795,1,0.976793002735808,0,1,glyceraldehyde oxidoreductase activity,MF,
10665,GO:0043812,1,0.937466932509004,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10666,GO:0043813,1,0.901796240792188,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10667,GO:0043843,1,0.977254532392453,0,1,ADP-specific glucokinase activity,MF,
10668,GO:0043849,1,0.977347874624033,0,1,Ras palmitoyltransferase activity,MF,
10669,GO:0043865,1,0.977295823748791,0,1,methionine transmembrane transporter activity,MF,
10670,GO:0043874,1,0.977201064374776,0,1,acireductone synthase activity,MF,
10671,GO:0043890,1,0.977241213150024,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
10672,GO:0043891,1,0.976686626112186,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
10675,GO:0043902,1,0.0406415130637734,0,142,positive regulation of multi-organism process,BP,
10677,GO:0043914,1,0.97817487208623,0,1,NADPH:sulfur oxidoreductase activity,MF,
10678,GO:0043916,1,0.976369312322026,0,1,DNA-7-methylguanine glycosylase activity,MF,
10679,GO:0043921,1,0.587667640039499,0,24,modulation by host of viral transcription,BP,
10680,GO:0043922,1,0.796071128469827,0,10,negative regulation by host of viral transcription,BP,
10681,GO:0043923,1,0.705691304256232,0,16,positive regulation by host of viral transcription,BP,
10682,GO:0043928,1,0.47343648847461,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10683,GO:0043931,1,0.823040252807884,0,10,ossification involved in bone maturation,BP,
10684,GO:0043932,1,0.955246316625425,0,2,ossification involved in bone remodeling,BP,
10686,GO:0043946,1,0.977094453460896,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10687,GO:0043947,1,0.977094453460896,0,1,positive regulation by host of symbiont catalytic activity,BP,
10689,GO:0043950,1,0.901630602192044,0,5,positive regulation of cAMP-mediated signaling,BP,
10691,GO:0043954,1,0.595975209917219,0,24,cellular component maintenance,BP,
10693,GO:0043967,1,0.270660265564672,0,59,histone H4 acetylation,BP,
10694,GO:0043968,1,0.701257563416554,0,16,histone H2A acetylation,BP,
10695,GO:0043969,1,0.981883150047352,0,1,histone H2B acetylation,BP,
10696,GO:0043970,1,0.767994116224131,0,12,histone H3-K9 acetylation,BP,
10698,GO:0043973,1,0.97723019369405,0,1,histone H3-K4 acetylation,BP,
10699,GO:0043974,1,0.93725104491053,0,3,histone H3-K27 acetylation,BP,
10700,GO:0043981,1,0.714895848541309,0,15,histone H4-K5 acetylation,BP,
10701,GO:0043982,1,0.714895848541309,0,15,histone H4-K8 acetylation,BP,
10702,GO:0043983,1,0.851283908397584,0,7,histone H4-K12 acetylation,BP,
10703,GO:0043984,1,0.657911222480732,0,19,histone H4-K16 acetylation,BP,
10704,GO:0043985,1,0.871751809884413,0,6,histone H4-R3 methylation,BP,
10705,GO:0043987,1,0.912240645560338,0,4,histone H3-S10 phosphorylation,BP,
10706,GO:0043988,1,0.933054223775644,0,3,histone H3-S28 phosphorylation,BP,
10707,GO:0043990,1,0.977445147018904,0,1,histone H2A-S1 phosphorylation,BP,
10709,GO:0043995,1,0.802316268969097,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10710,GO:0043996,1,0.802316268969097,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10711,GO:0043997,1,0.977464698390232,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10712,GO:0043998,1,0.977623497301748,0,1,H2A histone acetyltransferase activity,MF,
10713,GO:0044003,1,0.476881032585616,0,34,modification by symbiont of host morphology or physiology,BP,
10714,GO:0044004,1,0.933640936044419,0,3,disruption by symbiont of host cell,BP,
10715,GO:0044007,1,0.980178763984006,0,1,dissemination or transmission of symbiont from host,BP,
10716,GO:0044020,1,0.911646986891719,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10717,GO:0044028,1,0.956568962692413,0,2,DNA hypomethylation,BP,
10718,GO:0044029,1,0.956568962692413,0,2,hypomethylation of CpG island,BP,
10719,GO:0044030,1,0.736237939665339,0,14,regulation of DNA methylation,BP,
10720,GO:0044033,1,0.871672825599269,0,6,multi-organism metabolic process,BP,
10721,GO:0044035,1,0.977019004885083,0,1,multi-organism catabolic process,BP,
10722,GO:0044036,1,0.933173212284894,0,3,cell wall macromolecule metabolic process,BP,
10723,GO:0044038,1,0.9771102875795,0,1,cell wall macromolecule biosynthetic process,BP,
10725,GO:0044053,1,0.97724364867942,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
10727,GO:0044058,1,0.76814425991762,0,12,regulation of digestive system process,BP,
10728,GO:0044060,1,0.642198381159205,0,20,regulation of endocrine process,BP,
10729,GO:0044062,1,0.913737225068314,0,4,regulation of excretion,BP,
10730,GO:0044065,1,0.839023991326683,0,8,regulation of respiratory system process,BP,
10731,GO:0044068,1,0.587864606154927,0,24,modulation by symbiont of host cellular process,BP,
10735,GO:0044088,1,0.431633582691618,0,38,regulation of vacuole organization,BP,
10737,GO:0044090,1,0.772114556876483,0,12,positive regulation of vacuole organization,BP,
10738,GO:0044091,1,0.6039464302363,0,23,membrane biogenesis,BP,
10741,GO:0044094,1,0.936279083399709,0,3,host cell nuclear part,CC,
10742,GO:0044105,1,0.975950307661365,0,1,L-xylulose reductase (NAD+) activity,MF,
10743,GO:0044106,1,0.134296135385234,0,87,cellular amine metabolic process,BP,
10744,GO:0044107,1,0.911760268767394,0,4,cellular alcohol metabolic process,BP,
10745,GO:0044108,1,0.911760268767394,0,4,cellular alcohol biosynthetic process,BP,
10746,GO:0044110,1,0.871631580384778,0,6,growth involved in symbiotic interaction,BP,
10747,GO:0044111,1,0.957651603328198,0,2,development involved in symbiotic interaction,BP,
10748,GO:0044115,1,0.977019004885083,0,1,development of symbiont involved in interaction with host,BP,
10749,GO:0044116,1,0.871631580384778,0,6,growth of symbiont involved in interaction with host,BP,
10750,GO:0044117,1,0.871631580384778,0,6,growth of symbiont in host,BP,
10751,GO:0044126,1,0.892616600866557,0,5,regulation of growth of symbiont in host,BP,
10752,GO:0044128,1,0.979193753737037,0,1,positive regulation of growth of symbiont in host,BP,
10753,GO:0044130,1,0.911589899194,0,4,negative regulation of growth of symbiont in host,BP,
10754,GO:0044144,1,0.892616600866557,0,5,modulation of growth of symbiont involved in interaction with host,BP,
10755,GO:0044145,1,0.977019004885083,0,1,modulation of development of symbiont involved in interaction with host,BP,
10756,GO:0044146,1,0.911589899194,0,4,negative regulation of growth of symbiont involved in interaction with host,BP,
10757,GO:0044147,1,0.977019004885083,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10758,GO:0044148,1,0.979193753737037,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10759,GO:0044154,1,0.852981709961499,0,7,histone H3-K14 acetylation,BP,
10761,GO:0044190,1,0.977098313568905,0,1,host cell mitochondrial envelope,CC,
10762,GO:0044194,1,0.933215632659577,0,3,cytolytic granule,CC,
10763,GO:0044205,1,0.936584120456492,0,3,'de novo' UMP biosynthetic process,BP,
10764,GO:0044206,1,0.911200675888666,0,4,UMP salvage,BP,
10765,GO:0044207,1,0.978405435382506,0,1,translation initiation ternary complex,CC,
10766,GO:0044208,1,0.954690721186012,0,2,'de novo' AMP biosynthetic process,BP,
10767,GO:0044209,1,0.95354348174636,0,2,AMP salvage,BP,
10768,GO:0044210,1,0.956025260789719,0,2,'de novo' CTP biosynthetic process,BP,
10769,GO:0044211,1,0.932533623404051,0,3,CTP salvage,BP,
10771,GO:0044213,1,0.805804825884049,0,10,intronic transcription regulatory region DNA binding,MF,
10772,GO:0044214,1,0.940818101692761,0,3,spanning component of plasma membrane,CC,
10773,GO:0044215,1,0.258504099537698,0,61,other organism,CC,
10774,GO:0044216,1,0.258504099537698,0,61,other organism cell,CC,
10775,GO:0044217,1,0.258504099537698,0,61,other organism part,CC,
10776,GO:0044218,1,0.978425880734245,0,1,other organism cell membrane,CC,
10777,GO:0044220,1,0.9789913408108,0,1,host cell perinuclear region of cytoplasm,CC,
10778,GO:0044221,1,0.978425880734245,0,1,host cell synapse,CC,
10779,GO:0044224,1,0.878815151632387,0,6,juxtaparanode region of axon,CC,
10780,GO:0044228,1,0.978906347986503,0,1,host cell surface,CC,
10781,GO:0044231,1,0.978425880734245,0,1,host cell presynaptic membrane,CC,
10782,GO:0044232,1,0.671489072322046,0,18,organelle membrane contact site,CC,
10783,GO:0044233,1,0.765571376717514,0,12,ER-mitochondrion membrane contact site,CC,
10788,GO:0044245,1,0.980272114660414,0,1,polysaccharide digestion,BP,
10802,GO:0044273,1,0.496837348429431,0,31,sulfur compound catabolic process,BP,
10804,GO:0044279,1,0.978425880734245,0,1,other organism membrane,CC,
10808,GO:0044284,1,0.976067746104584,0,1,mitochondrial crista junction,CC,
10810,GO:0044292,1,0.801152162354295,0,10,dendrite terminus,CC,
10811,GO:0044294,1,0.859317712816303,0,7,dendritic growth cone,CC,
10814,GO:0044298,1,0.861274610259827,0,7,cell body membrane,CC,
10815,GO:0044299,1,0.980268445158234,0,1,C-fiber,CC,
10816,GO:0044300,1,0.939540145721413,0,3,cerebellar mossy fiber,CC,
10817,GO:0044301,1,0.978692261125318,0,1,climbing fiber,CC,
10818,GO:0044302,1,0.940422760973074,0,3,dentate gyrus mossy fiber,CC,
10819,GO:0044304,1,0.429224736106039,0,40,main axon,CC,
10820,GO:0044305,1,0.980181708779369,0,1,calyx of Held,CC,
10822,GO:0044307,1,0.984326051482212,0,1,dendritic branch,CC,
10823,GO:0044308,1,0.960609981065621,0,2,axonal spine,CC,
10825,GO:0044313,1,0.940761420753736,0,3,protein K6-linked deubiquitination,BP,
10826,GO:0044314,1,0.910252126828736,0,4,protein K27-linked ubiquitination,BP,
10827,GO:0044316,1,0.97797313862591,0,1,cone cell pedicle,CC,
10828,GO:0044317,1,0.976757153908769,0,1,rod spherule,CC,
10829,GO:0044319,1,0.582064841296527,0,25,wound healing, spreading of cells,BP,
10830,GO:0044320,1,0.783026493385106,0,11,cellular response to leptin stimulus,BP,
10832,GO:0044322,1,0.564162056896171,0,26,endoplasmic reticulum quality control compartment,CC,
10833,GO:0044323,1,0.957595088097811,0,2,retinoic acid-responsive element binding,MF,
10834,GO:0044324,1,0.976082999969413,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
10835,GO:0044325,1,0.173145821479257,0,80,ion channel binding,MF,
10836,GO:0044326,1,0.956279871134907,0,2,dendritic spine neck,CC,
10837,GO:0044327,1,0.839370835245755,0,8,dendritic spine head,CC,
10838,GO:0044328,1,0.977336572808046,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10839,GO:0044329,1,0.977336572808046,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10840,GO:0044330,1,0.977336572808046,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10841,GO:0044331,1,0.747517738043618,0,13,cell-cell adhesion mediated by cadherin,BP,
10842,GO:0044332,1,0.906046100296176,0,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
10843,GO:0044334,1,0.956414195960915,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10844,GO:0044335,1,0.982776110657408,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10845,GO:0044336,1,0.935244256312732,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10846,GO:0044338,1,0.9559539693266,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
10847,GO:0044339,1,0.935787222046823,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
10848,GO:0044340,1,0.897865023073458,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
10851,GO:0044343,1,0.978674360350703,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10853,GO:0044345,1,0.978674360350703,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
10855,GO:0044349,1,0.977082433676462,0,1,DNA excision,BP,
10857,GO:0044352,1,0.916411623534214,0,4,pinosome,CC,
10858,GO:0044354,1,0.916411623534214,0,4,macropinosome,CC,
10859,GO:0044355,1,0.976838372814114,0,1,clearance of foreign intracellular DNA,BP,
10860,GO:0044356,1,0.976838372814114,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
10861,GO:0044359,1,0.85440177585099,0,7,modulation of molecular function in other organism,BP,
10862,GO:0044362,1,0.871651908745217,0,6,negative regulation of molecular function in other organism,BP,
10864,GO:0044375,1,0.954008379995457,0,2,regulation of peroxisome size,BP,
10865,GO:0044378,1,0.9573267605933,0,2,non-sequence-specific DNA binding, bending,MF,
10868,GO:0044387,1,0.857356242958254,0,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
10869,GO:0044388,1,0.889263483067826,0,5,small protein activating enzyme binding,MF,
10873,GO:0044393,1,0.934345475682394,0,3,microspike,CC,
10874,GO:0044395,1,0.977258668731482,0,1,protein targeting to vacuolar membrane,BP,
10875,GO:0044396,1,0.938285230881025,0,3,actin cortical patch organization,BP,
10877,GO:0044406,1,0.89126839899736,0,5,adhesion of symbiont to host,BP,
10879,GO:0044413,1,0.916356812184139,0,4,avoidance of host defenses,BP,
10880,GO:0044414,1,0.979287790694437,0,1,suppression of host defenses,BP,
10881,GO:0044415,1,0.916356812184139,0,4,evasion or tolerance of host defenses,BP,
10882,GO:0044416,1,0.954633709137921,0,2,induction by symbiont of host defense response,BP,
10883,GO:0044417,1,0.813608170117567,0,9,translocation of molecules into host,BP,
10898,GO:0044438,1,0.192242167106192,0,73,microbody part,CC,
10899,GO:0044439,1,0.192242167106192,0,73,peroxisomal part,CC,
10905,GO:0044447,1,0.725398671412574,0,16,axoneme part,CC,
10908,GO:0044450,1,0.0401429647183066,0,147,microtubule organizing center part,CC,
10911,GO:0044453,1,0.836321436630939,0,8,nuclear membrane part,CC,
10913,GO:0044455,1,0.0200699919028936,0,166,mitochondrial membrane part,CC,
10915,GO:0044458,1,0.759340846443796,0,12,motile cilium assembly,BP,
10919,GO:0044495,1,0.97592036803824,0,1,modulation of blood pressure in other organism,BP,
10920,GO:0044497,1,0.97592036803824,0,1,positive regulation of blood pressure in other organism,BP,
10921,GO:0044501,1,0.957327308573078,0,2,modulation of signal transduction in other organism,BP,
10922,GO:0044524,1,0.977093250950237,0,1,protein sulfhydration,BP,
10923,GO:0044528,1,0.913028013127321,0,4,regulation of mitochondrial mRNA stability,BP,
10925,GO:0044531,1,0.872383116736495,0,6,modulation of programmed cell death in other organism,BP,
10926,GO:0044532,1,0.872383116736495,0,6,modulation of apoptotic process in other organism,BP,
10927,GO:0044533,1,0.933640936044419,0,3,positive regulation of apoptotic process in other organism,BP,
10928,GO:0044539,1,0.935417640278648,0,3,long-chain fatty acid import,BP,
10929,GO:0044540,1,0.977093250950237,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
10930,GO:0044545,1,0.891515403412574,0,5,NSL complex,CC,
10931,GO:0044546,1,0.819705149320951,0,9,NLRP3 inflammasome complex assembly,BP,
10932,GO:0044547,1,0.893747195627364,0,5,DNA topoisomerase binding,MF,
10933,GO:0044548,1,0.784496676605408,0,11,S100 protein binding,MF,
10934,GO:0044549,1,0.975734410677856,0,1,GTP cyclohydrolase binding,MF,
10935,GO:0044550,1,0.738094268723563,0,14,secondary metabolite biosynthetic process,BP,
10937,GO:0044565,1,0.954751074529499,0,2,dendritic cell proliferation,BP,
10938,GO:0044571,1,0.909570267655372,0,4,[2Fe-2S] cluster assembly,BP,
10939,GO:0044594,1,0.977274096635437,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
10940,GO:0044595,1,0.976624973023742,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10941,GO:0044596,1,0.976624973023742,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
10944,GO:0044599,1,0.977336572808046,0,1,AP-5 adaptor complex,CC,
10945,GO:0044601,1,0.977027899375247,0,1,protein denucleotidylation,BP,
10946,GO:0044602,1,0.977027899375247,0,1,protein deadenylylation,BP,
10947,GO:0044603,1,0.977027899375247,0,1,protein adenylylhydrolase activity,MF,
10948,GO:0044609,1,0.95507356199696,0,2,DBIRD complex,CC,
10949,GO:0044610,1,0.977234999346512,0,1,FMN transmembrane transporter activity,MF,
10950,GO:0044611,1,0.939569868775692,0,3,nuclear pore inner ring,CC,
10951,GO:0044613,1,0.765394754715933,0,12,nuclear pore central transport channel,CC,
10952,GO:0044614,1,0.920338367173187,0,4,nuclear pore cytoplasmic filaments,CC,
10953,GO:0044615,1,0.833462694324,0,9,nuclear pore nuclear basket,CC,
10954,GO:0044620,1,0.951850414874843,0,2,ACP phosphopantetheine attachment site binding,MF,
10955,GO:0044648,1,0.977336572808046,0,1,histone H3-K4 dimethylation,BP,
10956,GO:0044650,1,0.912002836124082,0,4,adhesion of symbiont to host cell,BP,
10957,GO:0044665,1,0.525632470137386,0,29,MLL1/2 complex,CC,
10958,GO:0044666,1,0.782668508711774,0,11,MLL3/4 complex,CC,
10962,GO:0044713,1,0.975738091869388,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10963,GO:0044714,1,0.975738091869388,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
10964,GO:0044715,1,0.954001236153541,0,2,8-oxo-dGDP phosphatase activity,MF,
10965,GO:0044716,1,0.976915124173167,0,1,8-oxo-GDP phosphatase activity,MF,
10966,GO:0044717,1,0.976915124173167,0,1,8-hydroxy-dADP phosphatase activity,MF,
10967,GO:0044721,1,0.977177188120818,0,1,protein import into peroxisome matrix, substrate release,BP,
10968,GO:0044725,1,0.983360470381076,0,1,chromatin reprogramming in the zygote,BP,
10969,GO:0044727,1,0.983360470381076,0,1,DNA demethylation of male pronucleus,BP,
10971,GO:0044729,1,0.934575597070454,0,3,hemi-methylated DNA-binding,MF,
10972,GO:0044730,1,0.977019004885083,0,1,bone sialoprotein binding,MF,
10973,GO:0044732,1,0.977336572808046,0,1,mitotic spindle pole body,CC,
10974,GO:0044736,1,0.977336572808046,0,1,acid-sensing ion channel activity,MF,
10975,GO:0044743,1,0.414586271504262,0,38,protein transmembrane import into intracellular organelle,BP,
10977,GO:0044753,1,0.977340916052496,0,1,amphisome,CC,
10978,GO:0044754,1,0.830891351734305,0,8,autolysosome,CC,
10979,GO:0044764,1,0.524764250458265,0,29,multi-organism cellular process,BP,
10980,GO:0044766,1,0.218165434015711,0,68,multi-organism transport,BP,
10981,GO:0044769,1,0.661719564556888,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
10983,GO:0044771,1,0.955299046849052,0,2,meiotic cell cycle phase transition,BP,
10985,GO:0044773,1,0.109107776298423,0,99,mitotic DNA damage checkpoint,BP,
10986,GO:0044774,1,0.0953662098247167,0,105,mitotic DNA integrity checkpoint,BP,
10987,GO:0044778,1,0.954991431092414,0,2,meiotic DNA integrity checkpoint,BP,
10988,GO:0044779,1,0.977406519426437,0,1,meiotic spindle checkpoint,BP,
10990,GO:0044783,1,0.213927982388606,0,69,G1 DNA damage checkpoint,BP,
10991,GO:0044784,1,0.338443152371827,0,49,metaphase/anaphase transition of cell cycle,BP,
10992,GO:0044785,1,0.977406519426437,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
10994,GO:0044788,1,0.655316578481558,0,19,modulation by host of viral process,BP,
10995,GO:0044789,1,0.896782233891669,0,5,modulation by host of viral release from host cell,BP,
10996,GO:0044791,1,0.896782233891669,0,5,positive regulation by host of viral release from host cell,BP,
10997,GO:0044793,1,0.89636426738021,0,5,negative regulation by host of viral process,BP,
10998,GO:0044794,1,0.749654675795254,0,13,positive regulation by host of viral process,BP,
10999,GO:0044795,1,0.976473114298087,0,1,trans-Golgi network to recycling endosome transport,BP,
11000,GO:0044796,1,0.976715735583364,0,1,DNA polymerase processivity factor complex,CC,
11002,GO:0044800,1,0.933252847370079,0,3,multi-organism membrane fusion,BP,
11003,GO:0044803,1,0.913696109229249,0,4,multi-organism membrane organization,BP,
11004,GO:0044804,1,0.670231420116506,0,18,autophagy of nucleus,BP,
11005,GO:0044805,1,0.957569044710473,0,2,late nucleophagy,BP,
11006,GO:0044806,1,0.858675437083369,0,7,G-quadruplex DNA unwinding,BP,
11008,GO:0044818,1,0.564530297477888,0,26,mitotic G2/M transition checkpoint,BP,
11009,GO:0044819,1,0.218836242921934,0,68,mitotic G1/S transition checkpoint,BP,
11010,GO:0044821,1,0.914609098491402,0,4,meiotic telomere tethering at nuclear periphery,BP,
11011,GO:0044827,1,0.76904157127282,0,12,modulation by host of viral genome replication,BP,
11012,GO:0044828,1,0.917304372988203,0,4,negative regulation by host of viral genome replication,BP,
11013,GO:0044829,1,0.859595823677261,0,7,positive regulation by host of viral genome replication,BP,
11014,GO:0044830,1,0.956419915215592,0,2,modulation by host of viral RNA genome replication,BP,
11015,GO:0044837,1,0.858149016074737,0,7,actomyosin contractile ring organization,BP,
11018,GO:0044848,1,0.838216014930943,0,8,biological phase,BP,
11019,GO:0044849,1,0.816335612808827,0,9,estrous cycle,BP,
11020,GO:0044851,1,0.838216014930943,0,8,hair cycle phase,BP,
11022,GO:0044854,1,0.912188405444079,0,4,plasma membrane raft assembly,BP,
11023,GO:0044855,1,0.977283936514633,0,1,plasma membrane raft distribution,BP,
11024,GO:0044856,1,0.977283936514633,0,1,plasma membrane raft localization,BP,
11025,GO:0044857,1,0.912188405444079,0,4,plasma membrane raft organization,BP,
11026,GO:0044858,1,0.977283936514633,0,1,plasma membrane raft polarization,BP,
11027,GO:0044860,1,0.9143478929477,0,4,protein localization to plasma membrane raft,BP,
11028,GO:0044861,1,0.957389647954666,0,2,protein transport into plasma membrane raft,BP,
11029,GO:0044866,1,0.977179450989824,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11030,GO:0044867,1,0.977179450989824,0,1,modulation by host of viral catalytic activity,BP,
11031,GO:0044868,1,0.957849143626931,0,2,modulation by host of viral molecular function,BP,
11032,GO:0044869,1,0.977179450989824,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11033,GO:0044870,1,0.977179450989824,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11034,GO:0044871,1,0.977179450989824,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11035,GO:0044872,1,0.885103026358264,0,6,lipoprotein localization,BP,
11037,GO:0044878,1,0.911298539998756,0,4,mitotic cytokinesis checkpoint,BP,
11038,GO:0045002,1,0.851881358234197,0,7,double-strand break repair via single-strand annealing,BP,
11039,GO:0045003,1,0.793875591463513,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11040,GO:0045004,1,0.959403654494893,0,2,DNA replication proofreading,BP,
11041,GO:0045005,1,0.495148095279908,0,32,DNA-dependent DNA replication maintenance of fidelity,BP,
11042,GO:0045006,1,0.791151349510522,0,10,DNA deamination,BP,
11043,GO:0045007,1,0.932269915988429,0,3,depurination,BP,
11044,GO:0045008,1,0.830844575165721,0,8,depyrimidination,BP,
11045,GO:0045009,1,0.86955738654313,0,6,chitosome,CC,
11046,GO:0045010,1,0.427979436967716,0,38,actin nucleation,BP,
11047,GO:0045016,1,0.977631767242562,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11049,GO:0045019,1,0.801137481755134,0,10,negative regulation of nitric oxide biosynthetic process,BP,
11050,GO:0045022,1,0.432992148401699,0,38,early endosome to late endosome transport,BP,
11052,GO:0045025,1,0.956521388700872,0,2,mitochondrial degradosome,CC,
11053,GO:0045026,1,0.692173020301454,0,16,plasma membrane fusion,BP,
11054,GO:0045027,1,0.977217697347356,0,1,DNA end binding,MF,
11055,GO:0045028,1,0.892150800066654,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11056,GO:0045031,1,0.955152280951546,0,2,ATP-activated adenosine receptor activity,MF,
11057,GO:0045032,1,0.97744963657025,0,1,ADP-activated adenosine receptor activity,MF,
11058,GO:0045039,1,0.867016263974069,0,6,protein import into mitochondrial inner membrane,BP,
11059,GO:0045040,1,0.868449564003003,0,6,protein import into mitochondrial outer membrane,BP,
11060,GO:0045041,1,0.954674471958988,0,2,protein import into mitochondrial intermembrane space,BP,
11061,GO:0045046,1,0.87332543896457,0,6,protein import into peroxisome membrane,BP,
11062,GO:0045047,1,0.0868831046984586,0,101,protein targeting to ER,BP,
11063,GO:0045048,1,0.894132907869808,0,5,protein insertion into ER membrane,BP,
11064,GO:0045053,1,0.917448527445467,0,5,protein retention in Golgi apparatus,BP,
11065,GO:0045054,1,0.933926845668123,0,3,constitutive secretory pathway,BP,
11068,GO:0045058,1,0.55262669357487,0,27,T cell selection,BP,
11069,GO:0045059,1,0.874268054332704,0,6,positive thymic T cell selection,BP,
11070,GO:0045060,1,0.937081661381421,0,3,negative thymic T cell selection,BP,
11071,GO:0045061,1,0.785567146049682,0,11,thymic T cell selection,BP,
11072,GO:0045062,1,0.977070758524301,0,1,extrathymic T cell selection,BP,
11073,GO:0045063,1,0.765807761237971,0,12,T-helper 1 cell differentiation,BP,
11074,GO:0045064,1,0.795302401119606,0,10,T-helper 2 cell differentiation,BP,
11075,GO:0045065,1,0.95541680850073,0,2,cytotoxic T cell differentiation,BP,
11078,GO:0045070,1,0.505967606056302,0,31,positive regulation of viral genome replication,BP,
11080,GO:0045072,1,0.873879322220414,0,6,regulation of interferon-gamma biosynthetic process,BP,
11081,GO:0045073,1,0.813787382765966,0,9,regulation of chemokine biosynthetic process,BP,
11082,GO:0045074,1,0.955533842726343,0,2,regulation of interleukin-10 biosynthetic process,BP,
11083,GO:0045075,1,0.89506257037856,0,5,regulation of interleukin-12 biosynthetic process,BP,
11084,GO:0045076,1,0.834544888488145,0,8,regulation of interleukin-2 biosynthetic process,BP,
11085,GO:0045077,1,0.977226843172614,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11086,GO:0045078,1,0.894252737890457,0,5,positive regulation of interferon-gamma biosynthetic process,BP,
11087,GO:0045079,1,0.954094671486867,0,2,negative regulation of chemokine biosynthetic process,BP,
11088,GO:0045080,1,0.852965919814296,0,7,positive regulation of chemokine biosynthetic process,BP,
11089,GO:0045081,1,0.977875473699018,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11090,GO:0045082,1,0.977154786260896,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
11091,GO:0045083,1,0.97834396525392,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11092,GO:0045084,1,0.933837302077439,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
11093,GO:0045085,1,0.977091738047348,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
11094,GO:0045086,1,0.85412282070799,0,7,positive regulation of interleukin-2 biosynthetic process,BP,
11098,GO:0045091,1,0.814712447051306,0,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11099,GO:0045092,1,0.977861725014148,0,1,interleukin-18 receptor complex,CC,
11100,GO:0045095,1,0.551757887947616,0,26,keratin filament,CC,
11101,GO:0045098,1,0.977039913892843,0,1,type III intermediate filament,CC,
11104,GO:0045105,1,0.977844744365046,0,1,intermediate filament polymerization or depolymerization,BP,
11106,GO:0045110,1,0.875215708061958,0,6,intermediate filament bundle assembly,BP,
11108,GO:0045112,1,0.937758198260635,0,3,integrin biosynthetic process,BP,
11109,GO:0045113,1,0.955259252711629,0,2,regulation of integrin biosynthetic process,BP,
11110,GO:0045116,1,0.725453350032566,0,14,protein neddylation,BP,
11111,GO:0045117,1,0.691752839560101,0,16,azole transport,BP,
11114,GO:0045123,1,0.603309122071466,0,23,cellular extravasation,BP,
11116,GO:0045125,1,0.795884894628116,0,10,bioactive lipid receptor activity,MF,
11117,GO:0045127,1,0.976968710419452,0,1,N-acetylglucosamine kinase activity,MF,
11118,GO:0045128,1,0.977485731533649,0,1,negative regulation of reciprocal meiotic recombination,BP,
11119,GO:0045131,1,0.977379694555085,0,1,pre-mRNA branch point binding,MF,
11120,GO:0045132,1,0.327267433702811,0,50,meiotic chromosome segregation,BP,
11121,GO:0045134,1,0.912602900444116,0,4,uridine-diphosphatase activity,MF,
11124,GO:0045141,1,0.83952809185296,0,8,meiotic telomere clustering,BP,
11125,GO:0045142,1,0.957465861984948,0,2,triplex DNA binding,MF,
11126,GO:0045143,1,0.533823244876083,0,28,homologous chromosome segregation,BP,
11127,GO:0045144,1,0.891426667589712,0,5,meiotic sister chromatid segregation,BP,
11128,GO:0045145,1,0.955361918719106,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11129,GO:0045153,1,0.97655082936294,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11130,GO:0045155,1,0.956541317750213,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11131,GO:0045159,1,0.913666367542619,0,4,myosin II binding,MF,
11132,GO:0045161,1,0.866482227106776,0,7,neuronal ion channel clustering,BP,
11133,GO:0045162,1,0.923448005346098,0,4,clustering of voltage-gated sodium channels,BP,
11134,GO:0045163,1,0.982648823417392,0,1,clustering of voltage-gated potassium channels,BP,
11136,GO:0045167,1,0.977073400793012,0,1,asymmetric protein localization involved in cell fate determination,BP,
11138,GO:0045171,1,0.339795270393693,0,48,intercellular bridge,CC,
11139,GO:0045174,1,0.953310591884465,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11140,GO:0045176,1,0.833739228269392,0,9,apical protein localization,BP,
11142,GO:0045178,1,0.467225137625252,0,36,basal part of cell,CC,
11143,GO:0045179,1,0.896794350062181,0,5,apical cortex,CC,
11144,GO:0045180,1,0.904519357009037,0,5,basal cortex,CC,
11145,GO:0045182,1,0.410465804165023,0,40,translation regulator activity,MF,
11146,GO:0045183,1,0.977336572808046,0,1,translation factor activity, non-nucleic acid binding,MF,
11149,GO:0045186,1,0.98098088979697,0,1,zonula adherens assembly,BP,
11150,GO:0045187,1,0.893273661038263,0,5,regulation of circadian sleep/wake cycle, sleep,BP,
11151,GO:0045188,1,0.957072678797633,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11153,GO:0045191,1,0.59993443904729,0,23,regulation of isotype switching,BP,
11154,GO:0045196,1,0.959145864954655,0,2,establishment or maintenance of neuroblast polarity,BP,
11155,GO:0045197,1,0.530274939544264,0,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11156,GO:0045198,1,0.804892522280686,0,10,establishment of epithelial cell apical/basal polarity,BP,
11157,GO:0045199,1,0.894789415886589,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11158,GO:0045200,1,0.959145864954655,0,2,establishment of neuroblast polarity,BP,
11160,GO:0045204,1,0.937104330894,0,3,MAPK export from nucleus,BP,
11161,GO:0045208,1,0.977827866381898,0,1,MAPK phosphatase export from nucleus,BP,
11162,GO:0045209,1,0.977827866381898,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11163,GO:0045210,1,0.959700149061316,0,2,FasL biosynthetic process,BP,
11164,GO:0045211,1,0.0825340408179949,0,116,postsynaptic membrane,CC,
11165,GO:0045213,1,0.954754510640124,0,2,neurotransmitter receptor metabolic process,BP,
11166,GO:0045214,1,0.668764319399335,0,20,sarcomere organization,BP,
11168,GO:0045217,1,0.875191670665734,0,6,cell-cell junction maintenance,BP,
11169,GO:0045218,1,0.935406817894197,0,3,zonula adherens maintenance,BP,
11170,GO:0045219,1,0.97947157721625,0,1,regulation of FasL biosynthetic process,BP,
11171,GO:0045221,1,0.97947157721625,0,1,negative regulation of FasL biosynthetic process,BP,
11172,GO:0045222,1,0.976476000886788,0,1,CD4 biosynthetic process,BP,
11173,GO:0045223,1,0.976476000886788,0,1,regulation of CD4 biosynthetic process,BP,
11174,GO:0045225,1,0.976476000886788,0,1,negative regulation of CD4 biosynthetic process,BP,
11175,GO:0045226,1,0.95535390284035,0,2,extracellular polysaccharide biosynthetic process,BP,
11176,GO:0045229,1,0.960148795687212,0,2,external encapsulating structure organization,BP,
11177,GO:0045234,1,0.977116796240787,0,1,protein palmitoleylation,BP,
11178,GO:0045236,1,0.851924109306061,0,7,CXCR chemokine receptor binding,MF,
11179,GO:0045239,1,0.748918175615535,0,13,tricarboxylic acid cycle enzyme complex,CC,
11180,GO:0045240,1,0.784339804180425,0,11,dihydrolipoyl dehydrogenase complex,CC,
11181,GO:0045244,1,0.977240407281889,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11182,GO:0045251,1,0.977240299425335,0,1,electron transfer flavoprotein complex,CC,
11183,GO:0045252,1,0.854901499975618,0,7,oxoglutarate dehydrogenase complex,CC,
11184,GO:0045254,1,0.854270875353014,0,7,pyruvate dehydrogenase complex,CC,
11185,GO:0045257,1,0.890210003262809,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11186,GO:0045259,1,0.954538858382466,0,2,proton-transporting ATP synthase complex,CC,
11187,GO:0045263,1,0.97678273031622,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11188,GO:0045271,1,0.361903001252937,0,42,respiratory chain complex I,CC,
11189,GO:0045272,1,0.931327757258084,0,3,plasma membrane respiratory chain complex I,CC,
11190,GO:0045273,1,0.890210003262809,0,5,respiratory chain complex II,CC,
11191,GO:0045274,1,0.977242618752739,0,1,plasma membrane respiratory chain complex II,CC,
11192,GO:0045275,1,0.773898456609917,0,11,respiratory chain complex III,CC,
11193,GO:0045277,1,0.76405639735928,0,11,respiratory chain complex IV,CC,
11194,GO:0045281,1,0.890210003262809,0,5,succinate dehydrogenase complex,CC,
11195,GO:0045282,1,0.977242618752739,0,1,plasma membrane succinate dehydrogenase complex,CC,
11196,GO:0045283,1,0.890210003262809,0,5,fumarate reductase complex,CC,
11197,GO:0045292,1,0.679809083260525,0,17,mRNA cis splicing, via spliceosome,BP,
11198,GO:0045293,1,0.933035157925257,0,3,mRNA editing complex,CC,
11199,GO:0045294,1,0.836128089323585,0,8,alpha-catenin binding,MF,
11200,GO:0045295,1,0.832059117873943,0,9,gamma-catenin binding,MF,
11202,GO:0045297,1,0.977234756534726,0,1,post-mating behavior,BP,
11206,GO:0045322,1,0.955219412324127,0,2,unmethylated CpG binding,MF,
11207,GO:0045323,1,0.934206603328568,0,3,interleukin-1 receptor complex,CC,
11208,GO:0045324,1,0.778316458514006,0,11,late endosome to vacuole transport,BP,
11209,GO:0045329,1,0.891285297485998,0,5,carnitine biosynthetic process,BP,
11210,GO:0045332,1,0.75582570422466,0,14,phospholipid translocation,BP,
11211,GO:0045333,1,0.0265403507730813,0,155,cellular respiration,BP,
11212,GO:0045334,1,0.443159618287838,0,37,clathrin-coated endocytic vesicle,CC,
11214,GO:0045337,1,0.933467036872218,0,3,farnesyl diphosphate biosynthetic process,BP,
11215,GO:0045338,1,0.912196064103202,0,4,farnesyl diphosphate metabolic process,BP,
11216,GO:0045340,1,0.976125001747232,0,1,mercury ion binding,MF,
11217,GO:0045341,1,0.916114119170807,0,4,MHC class I biosynthetic process,BP,
11218,GO:0045342,1,0.895094056067003,0,5,MHC class II biosynthetic process,BP,
11219,GO:0045343,1,0.916114119170807,0,4,regulation of MHC class I biosynthetic process,BP,
11220,GO:0045345,1,0.916114119170807,0,4,positive regulation of MHC class I biosynthetic process,BP,
11221,GO:0045346,1,0.895094056067003,0,5,regulation of MHC class II biosynthetic process,BP,
11222,GO:0045347,1,0.936575065695593,0,3,negative regulation of MHC class II biosynthetic process,BP,
11223,GO:0045348,1,0.933747038706016,0,3,positive regulation of MHC class II biosynthetic process,BP,
11224,GO:0045349,1,0.913366245799484,0,4,interferon-alpha biosynthetic process,BP,
11225,GO:0045350,1,0.872401987247277,0,6,interferon-beta biosynthetic process,BP,
11226,GO:0045351,1,0.832885480671921,0,8,type I interferon biosynthetic process,BP,
11227,GO:0045352,1,0.977114653211488,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11228,GO:0045353,1,0.977114653211488,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11229,GO:0045354,1,0.913366245799484,0,4,regulation of interferon-alpha biosynthetic process,BP,
11230,GO:0045355,1,0.95442014562251,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11231,GO:0045356,1,0.956992882891564,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11232,GO:0045357,1,0.872401987247277,0,6,regulation of interferon-beta biosynthetic process,BP,
11233,GO:0045358,1,0.954409895733614,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11234,GO:0045359,1,0.914089150126605,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11235,GO:0045360,1,0.953974756573228,0,2,regulation of interleukin-1 biosynthetic process,BP,
11236,GO:0045362,1,0.953974756573228,0,2,positive regulation of interleukin-1 biosynthetic process,BP,
11237,GO:0045381,1,0.977545923000585,0,1,regulation of interleukin-18 biosynthetic process,BP,
11238,GO:0045399,1,0.979148195395373,0,1,regulation of interleukin-3 biosynthetic process,BP,
11239,GO:0045401,1,0.979148195395373,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11240,GO:0045402,1,0.955337951604235,0,2,regulation of interleukin-4 biosynthetic process,BP,
11241,GO:0045403,1,0.977550479987897,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
11242,GO:0045404,1,0.977279275650516,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
11243,GO:0045408,1,0.818448156998824,0,9,regulation of interleukin-6 biosynthetic process,BP,
11244,GO:0045409,1,0.957016449857844,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
11245,GO:0045410,1,0.875248167519555,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11246,GO:0045414,1,0.872656217326944,0,6,regulation of interleukin-8 biosynthetic process,BP,
11247,GO:0045415,1,0.933284696473719,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
11248,GO:0045416,1,0.93505382642894,0,3,positive regulation of interleukin-8 biosynthetic process,BP,
11249,GO:0045423,1,0.979148195395373,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11250,GO:0045425,1,0.979148195395373,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11259,GO:0045471,1,0.209549652467584,0,70,response to ethanol,BP,
11260,GO:0045472,1,0.858461655471758,0,7,response to ether,BP,
11262,GO:0045485,1,0.978635692665485,0,1,omega-6 fatty acid desaturase activity,MF,
11264,GO:0045495,1,0.853074788515475,0,7,pole plasm,CC,
11266,GO:0045503,1,0.754977486556961,0,15,dynein light chain binding,MF,
11267,GO:0045504,1,0.800006870194514,0,10,dynein heavy chain binding,MF,
11268,GO:0045505,1,0.664750040497477,0,21,dynein intermediate chain binding,MF,
11269,GO:0045509,1,0.955583985504958,0,2,interleukin-27 receptor activity,MF,
11270,GO:0045517,1,0.97658092509883,0,1,interleukin-20 receptor binding,MF,
11271,GO:0045518,1,0.97658092509883,0,1,interleukin-22 receptor binding,MF,
11272,GO:0045519,1,0.976298274726603,0,1,interleukin-23 receptor binding,MF,
11274,GO:0045541,1,0.890963013681317,0,5,negative regulation of cholesterol biosynthetic process,BP,
11275,GO:0045542,1,0.895635252469812,0,5,positive regulation of cholesterol biosynthetic process,BP,
11276,GO:0045545,1,0.900745722386022,0,5,syndecan binding,MF,
11277,GO:0045569,1,0.912965393839874,0,4,TRAIL binding,MF,
11278,GO:0045575,1,0.956134685336283,0,2,basophil activation,BP,
11279,GO:0045576,1,0.511660255962577,0,30,mast cell activation,BP,
11281,GO:0045578,1,0.935163972220175,0,3,negative regulation of B cell differentiation,BP,
11282,GO:0045579,1,0.802026691768616,0,10,positive regulation of B cell differentiation,BP,
11286,GO:0045583,1,0.95541680850073,0,2,regulation of cytotoxic T cell differentiation,BP,
11287,GO:0045585,1,0.95541680850073,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11288,GO:0045586,1,0.937999490629077,0,3,regulation of gamma-delta T cell differentiation,BP,
11289,GO:0045588,1,0.95878578130588,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11291,GO:0045590,1,0.977819468111063,0,1,negative regulation of regulatory T cell differentiation,BP,
11301,GO:0045603,1,0.860006199892501,0,7,positive regulation of endothelial cell differentiation,BP,
11304,GO:0045606,1,0.643691703448061,0,20,positive regulation of epidermal cell differentiation,BP,
11307,GO:0045616,1,0.462919762986626,0,35,regulation of keratinocyte differentiation,BP,
11308,GO:0045617,1,0.87426478943457,0,6,negative regulation of keratinocyte differentiation,BP,
11309,GO:0045618,1,0.720333556222409,0,15,positive regulation of keratinocyte differentiation,BP,
11315,GO:0045624,1,0.79397704593035,0,10,positive regulation of T-helper cell differentiation,BP,
11316,GO:0045625,1,0.894204265429477,0,5,regulation of T-helper 1 cell differentiation,BP,
11317,GO:0045626,1,0.957179222889693,0,2,negative regulation of T-helper 1 cell differentiation,BP,
11318,GO:0045627,1,0.93421822968486,0,3,positive regulation of T-helper 1 cell differentiation,BP,
11319,GO:0045628,1,0.832719563255259,0,8,regulation of T-helper 2 cell differentiation,BP,
11320,GO:0045629,1,0.934732854073882,0,3,negative regulation of T-helper 2 cell differentiation,BP,
11321,GO:0045630,1,0.890889807695897,0,5,positive regulation of T-helper 2 cell differentiation,BP,
11324,GO:0045634,1,0.897100346796552,0,5,regulation of melanocyte differentiation,BP,
11325,GO:0045636,1,0.939642354406259,0,3,positive regulation of melanocyte differentiation,BP,
11329,GO:0045643,1,0.977884513297394,0,1,regulation of eosinophil differentiation,BP,
11330,GO:0045645,1,0.977884513297394,0,1,positive regulation of eosinophil differentiation,BP,
11334,GO:0045649,1,0.78390380878347,0,11,regulation of macrophage differentiation,BP,
11335,GO:0045650,1,0.954814590835871,0,2,negative regulation of macrophage differentiation,BP,
11336,GO:0045651,1,0.821029229628951,0,9,positive regulation of macrophage differentiation,BP,
11342,GO:0045657,1,0.872607212341403,0,6,positive regulation of monocyte differentiation,BP,
11343,GO:0045658,1,0.935512799894777,0,3,regulation of neutrophil differentiation,BP,
11344,GO:0045659,1,0.957347955587175,0,2,negative regulation of neutrophil differentiation,BP,
11345,GO:0045660,1,0.977195732161524,0,1,positive regulation of neutrophil differentiation,BP,
11348,GO:0045663,1,0.824249677505076,0,9,positive regulation of myoblast differentiation,BP,
11351,GO:0045666,1,0.00614099704399531,0,233,positive regulation of neuron differentiation,BP,
11364,GO:0045713,1,0.858176257673674,0,7,low-density lipoprotein particle receptor biosynthetic process,BP,
11365,GO:0045714,1,0.878253291277068,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11366,GO:0045715,1,0.980578682093857,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11367,GO:0045716,1,0.933921954976819,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11368,GO:0045717,1,0.762451404955176,0,12,negative regulation of fatty acid biosynthetic process,BP,
11369,GO:0045719,1,0.899429716262949,0,5,negative regulation of glycogen biosynthetic process,BP,
11370,GO:0045721,1,0.853902857618042,0,7,negative regulation of gluconeogenesis,BP,
11371,GO:0045722,1,0.822867616997447,0,9,positive regulation of gluconeogenesis,BP,
11372,GO:0045723,1,0.817358314255965,0,9,positive regulation of fatty acid biosynthetic process,BP,
11373,GO:0045724,1,0.676824294222357,0,18,positive regulation of cilium assembly,BP,
11374,GO:0045725,1,0.835482249700914,0,9,positive regulation of glycogen biosynthetic process,BP,
11375,GO:0045726,1,0.979276497862459,0,1,positive regulation of integrin biosynthetic process,BP,
11377,GO:0045730,1,0.728953116764742,0,14,respiratory burst,BP,
11380,GO:0045737,1,0.532584288193561,0,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11381,GO:0045738,1,0.63373985284295,0,21,negative regulation of DNA repair,BP,
11383,GO:0045740,1,0.386054490378348,0,43,positive regulation of DNA replication,BP,
11384,GO:0045741,1,0.873624325213155,0,6,positive regulation of epidermal growth factor-activated receptor activity,BP,
11385,GO:0045742,1,0.573661634209655,0,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,
11386,GO:0045743,1,0.894922313944466,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11388,GO:0045745,1,0.754067073708023,0,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
11391,GO:0045751,1,0.977545923000585,0,1,negative regulation of Toll signaling pathway,BP,
11392,GO:0045759,1,0.956987085630461,0,2,negative regulation of action potential,BP,
11393,GO:0045760,1,0.879015278735742,0,6,positive regulation of action potential,BP,
11394,GO:0045761,1,0.789979235696098,0,11,regulation of adenylate cyclase activity,BP,
11395,GO:0045762,1,0.96252731648445,0,2,positive regulation of adenylate cyclase activity,BP,
11396,GO:0045763,1,0.961445063253262,0,2,negative regulation of cellular amino acid metabolic process,BP,
11397,GO:0045764,1,0.953901821701837,0,2,positive regulation of cellular amino acid metabolic process,BP,
11400,GO:0045769,1,0.983312144620177,0,1,negative regulation of asymmetric cell division,BP,
11401,GO:0045773,1,0.499242504893831,0,33,positive regulation of axon extension,BP,
11402,GO:0045776,1,0.587082001340183,0,24,negative regulation of blood pressure,BP,
11405,GO:0045779,1,0.855794673879429,0,7,negative regulation of bone resorption,BP,
11410,GO:0045792,1,0.862431983000156,0,7,negative regulation of cell size,BP,
11411,GO:0045793,1,0.820989419678629,0,9,positive regulation of cell size,BP,
11412,GO:0045794,1,0.920510019009239,0,4,negative regulation of cell volume,BP,
11413,GO:0045795,1,0.980531452822081,0,1,positive regulation of cell volume,BP,
11414,GO:0045799,1,0.959960918452438,0,2,positive regulation of chromatin assembly or disassembly,BP,
11417,GO:0045813,1,0.977125613061449,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
11420,GO:0045819,1,0.978182691647777,0,1,positive regulation of glycogen catabolic process,BP,
11422,GO:0045821,1,0.794189852686416,0,11,positive regulation of glycolytic process,BP,
11423,GO:0045822,1,0.805336695137607,0,10,negative regulation of heart contraction,BP,
11425,GO:0045824,1,0.467112748161983,0,34,negative regulation of innate immune response,BP,
11426,GO:0045829,1,0.934359971818926,0,3,negative regulation of isotype switching,BP,
11427,GO:0045830,1,0.701648390315188,0,16,positive regulation of isotype switching,BP,
11430,GO:0045835,1,0.874116115279692,0,6,negative regulation of meiotic nuclear division,BP,
11431,GO:0045836,1,0.874734336840764,0,6,positive regulation of meiotic nuclear division,BP,
11432,GO:0045837,1,0.832944030015616,0,8,negative regulation of membrane potential,BP,
11433,GO:0045838,1,0.800691339263768,0,10,positive regulation of membrane potential,BP,
11434,GO:0045839,1,0.394928388502337,0,42,negative regulation of mitotic nuclear division,BP,
11435,GO:0045840,1,0.426728013911525,0,39,positive regulation of mitotic nuclear division,BP,
11436,GO:0045841,1,0.515498628164267,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11437,GO:0045842,1,0.837172119888627,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11439,GO:0045844,1,0.411284171467789,0,41,positive regulation of striated muscle tissue development,BP,
11440,GO:0045851,1,0.422841355741711,0,38,pH reduction,BP,
11441,GO:0045852,1,0.934033778120509,0,3,pH elevation,BP,
11446,GO:0045869,1,0.850920442699454,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11447,GO:0045870,1,0.979678259337669,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11448,GO:0045872,1,0.977208955707023,0,1,positive regulation of rhodopsin gene expression,BP,
11449,GO:0045875,1,0.903580918778314,0,5,negative regulation of sister chromatid cohesion,BP,
11450,GO:0045876,1,0.80207718886335,0,10,positive regulation of sister chromatid cohesion,BP,
11451,GO:0045879,1,0.651167775418131,0,20,negative regulation of smoothened signaling pathway,BP,
11452,GO:0045880,1,0.619030721917949,0,22,positive regulation of smoothened signaling pathway,BP,
11453,GO:0045887,1,0.98087046460822,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11456,GO:0045898,1,0.749446750759065,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11457,GO:0045899,1,0.80138966468185,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11458,GO:0045900,1,0.916140969283258,0,4,negative regulation of translational elongation,BP,
11459,GO:0045901,1,0.935050544251548,0,3,positive regulation of translational elongation,BP,
11461,GO:0045905,1,0.956694316655034,0,2,positive regulation of translational termination,BP,
11462,GO:0045906,1,0.884380071949223,0,6,negative regulation of vasoconstriction,BP,
11463,GO:0045907,1,0.697150290485134,0,16,positive regulation of vasoconstriction,BP,
11464,GO:0045910,1,0.63221479484386,0,21,negative regulation of DNA recombination,BP,
11465,GO:0045911,1,0.656921532648193,0,19,positive regulation of DNA recombination,BP,
11467,GO:0045913,1,0.371277349563086,0,46,positive regulation of carbohydrate metabolic process,BP,
11468,GO:0045914,1,0.955240200086032,0,2,negative regulation of catecholamine metabolic process,BP,
11469,GO:0045915,1,0.891921093810173,0,5,positive regulation of catecholamine metabolic process,BP,
11470,GO:0045916,1,0.936948959071322,0,3,negative regulation of complement activation,BP,
11471,GO:0045917,1,0.956839275326128,0,2,positive regulation of complement activation,BP,
11472,GO:0045918,1,0.952808324714526,0,2,negative regulation of cytolysis,BP,
11473,GO:0045919,1,0.911023340005801,0,4,positive regulation of cytolysis,BP,
11474,GO:0045920,1,0.670151861668765,0,18,negative regulation of exocytosis,BP,
11476,GO:0045922,1,0.715218609090822,0,15,negative regulation of fatty acid metabolic process,BP,
11477,GO:0045923,1,0.680997788208802,0,18,positive regulation of fatty acid metabolic process,BP,
11478,GO:0045924,1,0.958631538639434,0,2,regulation of female receptivity,BP,
11479,GO:0045925,1,0.977243934022399,0,1,positive regulation of female receptivity,BP,
11492,GO:0045943,1,0.632293780612817,0,21,positive regulation of transcription by RNA polymerase I,BP,
11495,GO:0045947,1,0.671206320243051,0,18,negative regulation of translational initiation,BP,
11496,GO:0045948,1,0.598697665817265,0,23,positive regulation of translational initiation,BP,
11497,GO:0045950,1,0.955099818775512,0,2,negative regulation of mitotic recombination,BP,
11498,GO:0045953,1,0.832360877154314,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11499,GO:0045954,1,0.839999770574131,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11500,GO:0045955,1,0.857394026392567,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11501,GO:0045956,1,0.764421804842889,0,12,positive regulation of calcium ion-dependent exocytosis,BP,
11502,GO:0045963,1,0.955240200086032,0,2,negative regulation of dopamine metabolic process,BP,
11503,GO:0045964,1,0.891921093810173,0,5,positive regulation of dopamine metabolic process,BP,
11504,GO:0045967,1,0.966204836521933,0,2,negative regulation of growth rate,BP,
11505,GO:0045974,1,0.776532269006264,0,12,regulation of translation, ncRNA-mediated,BP,
11506,GO:0045976,1,0.956346503318032,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11511,GO:0045987,1,0.668726417848797,0,18,positive regulation of smooth muscle contraction,BP,
11512,GO:0045988,1,0.936365825705314,0,3,negative regulation of striated muscle contraction,BP,
11514,GO:0045990,1,0.915982243965174,0,4,carbon catabolite regulation of transcription,BP,
11515,GO:0045991,1,0.915982243965174,0,4,carbon catabolite activation of transcription,BP,
11516,GO:0045992,1,0.660165518146799,0,19,negative regulation of embryonic development,BP,
11517,GO:0045993,1,0.978680044021769,0,1,negative regulation of translational initiation by iron,BP,
11518,GO:0045994,1,0.957038160260355,0,2,positive regulation of translational initiation by iron,BP,
11521,GO:0046007,1,0.837353953474037,0,8,negative regulation of activated T cell proliferation,BP,
11522,GO:0046015,1,0.912707597922845,0,4,regulation of transcription by glucose,BP,
11523,GO:0046016,1,0.934155165956552,0,3,positive regulation of transcription by glucose,BP,
11524,GO:0046030,1,0.787151078804707,0,11,inositol trisphosphate phosphatase activity,MF,
11526,GO:0046032,1,0.976929947561585,0,1,ADP catabolic process,BP,
11527,GO:0046033,1,0.813395496557425,0,9,AMP metabolic process,BP,
11529,GO:0046035,1,0.976598435848024,0,1,CMP metabolic process,BP,
11531,GO:0046037,1,0.657677451682277,0,19,GMP metabolic process,BP,
11532,GO:0046038,1,0.976808759499397,0,1,GMP catabolic process,BP,
11534,GO:0046040,1,0.764126500408099,0,12,IMP metabolic process,BP,
11535,GO:0046041,1,0.954191349581851,0,2,ITP metabolic process,BP,
11536,GO:0046048,1,0.977354156610639,0,1,UDP metabolic process,BP,
11537,GO:0046049,1,0.815046709604301,0,9,UMP metabolic process,BP,
11539,GO:0046054,1,0.976218657093727,0,1,dGMP metabolic process,BP,
11540,GO:0046056,1,0.976915124173167,0,1,dADP metabolic process,BP,
11541,GO:0046057,1,0.976915124173167,0,1,dADP catabolic process,BP,
11543,GO:0046060,1,0.888890554966055,0,5,dATP metabolic process,BP,
11544,GO:0046061,1,0.931793635175985,0,3,dATP catabolic process,BP,
11545,GO:0046065,1,0.976414449986851,0,1,dCTP metabolic process,BP,
11546,GO:0046066,1,0.953680757613498,0,2,dGDP metabolic process,BP,
11547,GO:0046067,1,0.976915124173167,0,1,dGDP catabolic process,BP,
11548,GO:0046068,1,0.627550181750198,0,22,cGMP metabolic process,BP,
11549,GO:0046069,1,0.959356855847785,0,2,cGMP catabolic process,BP,
11550,GO:0046070,1,0.909910685559683,0,4,dGTP metabolic process,BP,
11551,GO:0046072,1,0.954358089954436,0,2,dTDP metabolic process,BP,
11552,GO:0046073,1,0.93297656334304,0,3,dTMP metabolic process,BP,
11553,GO:0046075,1,0.910644085720014,0,4,dTTP metabolic process,BP,
11554,GO:0046077,1,0.954358089954436,0,2,dUDP metabolic process,BP,
11555,GO:0046078,1,0.911431157524436,0,4,dUMP metabolic process,BP,
11556,GO:0046080,1,0.977157212746886,0,1,dUTP metabolic process,BP,
11557,GO:0046081,1,0.977157212746886,0,1,dUTP catabolic process,BP,
11558,GO:0046083,1,0.931395318022204,0,3,adenine metabolic process,BP,
11559,GO:0046084,1,0.931395318022204,0,3,adenine biosynthetic process,BP,
11560,GO:0046085,1,0.873605882603061,0,6,adenosine metabolic process,BP,
11561,GO:0046086,1,0.956005971510589,0,2,adenosine biosynthetic process,BP,
11562,GO:0046087,1,0.869372574426837,0,6,cytidine metabolic process,BP,
11563,GO:0046090,1,0.976933244458608,0,1,deoxyadenosine metabolic process,BP,
11564,GO:0046092,1,0.979162494088475,0,1,deoxycytidine metabolic process,BP,
11565,GO:0046098,1,0.913809135483254,0,4,guanine metabolic process,BP,
11566,GO:0046099,1,0.954513932197007,0,2,guanine biosynthetic process,BP,
11567,GO:0046100,1,0.890516923102692,0,5,hypoxanthine metabolic process,BP,
11568,GO:0046101,1,0.9113224418933,0,4,hypoxanthine biosynthetic process,BP,
11569,GO:0046102,1,0.932982097086015,0,3,inosine metabolic process,BP,
11570,GO:0046103,1,0.954711672088872,0,2,inosine biosynthetic process,BP,
11571,GO:0046104,1,0.935065488107336,0,3,thymidine metabolic process,BP,
11572,GO:0046108,1,0.977129601820744,0,1,uridine metabolic process,BP,
11573,GO:0046110,1,0.937078699042306,0,3,xanthine metabolic process,BP,
11574,GO:0046111,1,0.976933244458608,0,1,xanthine biosynthetic process,BP,
11575,GO:0046112,1,0.65289458778124,0,19,nucleobase biosynthetic process,BP,
11576,GO:0046113,1,0.8974095571521,0,5,nucleobase catabolic process,BP,
11577,GO:0046116,1,0.932152143990216,0,3,queuosine metabolic process,BP,
11578,GO:0046121,1,0.933028389609109,0,3,deoxyribonucleoside catabolic process,BP,
11579,GO:0046122,1,0.953731409463664,0,2,purine deoxyribonucleoside metabolic process,BP,
11580,GO:0046124,1,0.976933244458608,0,1,purine deoxyribonucleoside catabolic process,BP,
11581,GO:0046125,1,0.935065488107336,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
11582,GO:0046127,1,0.977465363898827,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11585,GO:0046130,1,0.870019375833518,0,6,purine ribonucleoside catabolic process,BP,
11588,GO:0046133,1,0.83023050578663,0,8,pyrimidine ribonucleoside catabolic process,BP,
11590,GO:0046135,1,0.73993896110619,0,13,pyrimidine nucleoside catabolic process,BP,
11591,GO:0046136,1,0.954465608371977,0,2,positive regulation of vitamin metabolic process,BP,
11593,GO:0046146,1,0.849518808386618,0,7,tetrahydrobiopterin metabolic process,BP,
11594,GO:0046148,1,0.408726064930572,0,40,pigment biosynthetic process,BP,
11595,GO:0046149,1,0.868663346651302,0,6,pigment catabolic process,BP,
11596,GO:0046160,1,0.958493941771161,0,2,heme a metabolic process,BP,
11597,GO:0046164,1,0.512213433935959,0,30,alcohol catabolic process,BP,
11599,GO:0046166,1,0.954599813198596,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
11600,GO:0046167,1,0.961252106607981,0,2,glycerol-3-phosphate biosynthetic process,BP,
11601,GO:0046168,1,0.978162152233292,0,1,glycerol-3-phosphate catabolic process,BP,
11602,GO:0046173,1,0.389147588349512,0,42,polyol biosynthetic process,BP,
11603,GO:0046174,1,0.674016063020637,0,18,polyol catabolic process,BP,
11604,GO:0046176,1,0.977336572808046,0,1,aldonic acid catabolic process,BP,
11605,GO:0046177,1,0.977336572808046,0,1,D-gluconate catabolic process,BP,
11606,GO:0046184,1,0.800227785962835,0,10,aldehyde biosynthetic process,BP,
11607,GO:0046185,1,0.811882328899325,0,9,aldehyde catabolic process,BP,
11608,GO:0046189,1,0.672236256662528,0,18,phenol-containing compound biosynthetic process,BP,
11609,GO:0046203,1,0.954116668731966,0,2,spermidine catabolic process,BP,
11610,GO:0046204,1,0.976176308571746,0,1,nor-spermidine metabolic process,BP,
11611,GO:0046208,1,0.932276847951102,0,3,spermine catabolic process,BP,
11613,GO:0046210,1,0.977249911957491,0,1,nitric oxide catabolic process,BP,
11614,GO:0046218,1,0.932816318383674,0,3,indolalkylamine catabolic process,BP,
11615,GO:0046222,1,0.977284794046506,0,1,aflatoxin metabolic process,BP,
11616,GO:0046223,1,0.977284794046506,0,1,aflatoxin catabolic process,BP,
11617,GO:0046272,1,0.977230511923351,0,1,stilbene catabolic process,BP,
11618,GO:0046292,1,0.934224141589997,0,3,formaldehyde metabolic process,BP,
11619,GO:0046293,1,0.978938285848068,0,1,formaldehyde biosynthetic process,BP,
11620,GO:0046294,1,0.954327408266799,0,2,formaldehyde catabolic process,BP,
11621,GO:0046295,1,0.976125001747232,0,1,glycolate biosynthetic process,BP,
11622,GO:0046305,1,0.977277200092737,0,1,alkanesulfonate biosynthetic process,BP,
11623,GO:0046316,1,0.977336572808046,0,1,gluconokinase activity,MF,
11624,GO:0046317,1,0.979208733901174,0,1,regulation of glucosylceramide biosynthetic process,BP,
11625,GO:0046318,1,0.979208733901174,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11626,GO:0046320,1,0.701500839332157,0,17,regulation of fatty acid oxidation,BP,
11627,GO:0046321,1,0.833284645330143,0,9,positive regulation of fatty acid oxidation,BP,
11628,GO:0046322,1,0.91675158916347,0,4,negative regulation of fatty acid oxidation,BP,
11631,GO:0046325,1,0.818608195197388,0,9,negative regulation of glucose import,BP,
11633,GO:0046327,1,0.977189187541157,0,1,glycerol biosynthetic process from pyruvate,BP,
11635,GO:0046329,1,0.537724556423033,0,28,negative regulation of JNK cascade,BP,
11639,GO:0046333,1,0.977414407292839,0,1,octopamine metabolic process,BP,
11640,GO:0046337,1,0.715438578050782,0,15,phosphatidylethanolamine metabolic process,BP,
11641,GO:0046338,1,0.955582342319677,0,2,phosphatidylethanolamine catabolic process,BP,
11642,GO:0046339,1,0.750224986768879,0,13,diacylglycerol metabolic process,BP,
11643,GO:0046340,1,0.93644078101795,0,3,diacylglycerol catabolic process,BP,
11644,GO:0046341,1,0.735943178522527,0,14,CDP-diacylglycerol metabolic process,BP,
11646,GO:0046349,1,0.782832205644086,0,11,amino sugar biosynthetic process,BP,
11648,GO:0046355,1,0.977611209058413,0,1,mannan catabolic process,BP,
11649,GO:0046356,1,0.954014366880882,0,2,acetyl-CoA catabolic process,BP,
11650,GO:0046359,1,0.977174864359116,0,1,butyrate catabolic process,BP,
11651,GO:0046360,1,0.977219791568534,0,1,2-oxobutyrate biosynthetic process,BP,
11652,GO:0046361,1,0.977219791568534,0,1,2-oxobutyrate metabolic process,BP,
11655,GO:0046368,1,0.912565970221029,0,4,GDP-L-fucose metabolic process,BP,
11656,GO:0046370,1,0.954570608664004,0,2,fructose biosynthetic process,BP,
11657,GO:0046379,1,0.95535390284035,0,2,extracellular polysaccharide metabolic process,BP,
11658,GO:0046380,1,0.978045412091061,0,1,N-acetylneuraminate biosynthetic process,BP,
11659,GO:0046381,1,0.976590379383944,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11660,GO:0046385,1,0.791951141725729,0,10,deoxyribose phosphate biosynthetic process,BP,
11661,GO:0046386,1,0.644054267445085,0,19,deoxyribose phosphate catabolic process,BP,
11663,GO:0046391,1,0.933316185561717,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
11666,GO:0046398,1,0.93635838116729,0,3,UDP-glucuronate metabolic process,BP,
11667,GO:0046403,1,0.977082433676462,0,1,polynucleotide 3'-phosphatase activity,MF,
11668,GO:0046404,1,0.93607074636704,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
11669,GO:0046415,1,0.893356768601098,0,5,urate metabolic process,BP,
11670,GO:0046416,1,0.977247707407595,0,1,D-amino acid metabolic process,BP,
11675,GO:0046437,1,0.977247707407595,0,1,D-amino acid biosynthetic process,BP,
11676,GO:0046439,1,0.894289761644463,0,5,L-cysteine metabolic process,BP,
11677,GO:0046440,1,0.935770857447579,0,3,L-lysine metabolic process,BP,
11678,GO:0046443,1,0.977190576982258,0,1,FAD metabolic process,BP,
11679,GO:0046444,1,0.977277200092737,0,1,FMN metabolic process,BP,
11680,GO:0046448,1,0.977245329737199,0,1,tropane alkaloid metabolic process,BP,
11681,GO:0046449,1,0.918569826154403,0,4,creatinine metabolic process,BP,
11682,GO:0046452,1,0.933267532062351,0,3,dihydrofolate metabolic process,BP,
11685,GO:0046459,1,0.761819915658507,0,12,short-chain fatty acid metabolic process,BP,
11686,GO:0046460,1,0.548187807156098,0,27,neutral lipid biosynthetic process,BP,
11687,GO:0046461,1,0.685191431885617,0,17,neutral lipid catabolic process,BP,
11688,GO:0046462,1,0.954967982182065,0,2,monoacylglycerol metabolic process,BP,
11689,GO:0046463,1,0.548187807156098,0,27,acylglycerol biosynthetic process,BP,
11690,GO:0046464,1,0.685191431885617,0,17,acylglycerol catabolic process,BP,
11691,GO:0046465,1,0.852811103886663,0,7,dolichyl diphosphate metabolic process,BP,
11693,GO:0046467,1,0.068307601746928,0,118,membrane lipid biosynthetic process,BP,
11694,GO:0046469,1,0.895144411146948,0,5,platelet activating factor metabolic process,BP,
11696,GO:0046471,1,0.571542704711992,0,25,phosphatidylglycerol metabolic process,BP,
11697,GO:0046473,1,0.519549417562943,0,30,phosphatidic acid metabolic process,BP,
11699,GO:0046475,1,0.712173074760928,0,15,glycerophospholipid catabolic process,BP,
11700,GO:0046476,1,0.89339507779939,0,5,glycosylceramide biosynthetic process,BP,
11701,GO:0046477,1,0.87194999361598,0,6,glycosylceramide catabolic process,BP,
11702,GO:0046478,1,0.978972485356465,0,1,lactosylceramide metabolic process,BP,
11703,GO:0046479,1,0.795636082059874,0,10,glycosphingolipid catabolic process,BP,
11705,GO:0046485,1,0.856021373080506,0,7,ether lipid metabolic process,BP,
11709,GO:0046490,1,0.890122115637635,0,5,isopentenyl diphosphate metabolic process,BP,
11710,GO:0046491,1,0.97601467912555,0,1,L-methylmalonyl-CoA metabolic process,BP,
11711,GO:0046493,1,0.951850414874843,0,2,lipid A metabolic process,BP,
11712,GO:0046495,1,0.977243563733998,0,1,nicotinamide riboside metabolic process,BP,
11714,GO:0046497,1,0.977336572808046,0,1,nicotinate nucleotide metabolic process,BP,
11715,GO:0046498,1,0.87211060378714,0,6,S-adenosylhomocysteine metabolic process,BP,
11716,GO:0046499,1,0.977565470883024,0,1,S-adenosylmethioninamine metabolic process,BP,
11718,GO:0046501,1,0.815986396682271,0,9,protoporphyrinogen IX metabolic process,BP,
11719,GO:0046502,1,0.954494914580415,0,2,uroporphyrinogen III metabolic process,BP,
11720,GO:0046503,1,0.499192961805612,0,31,glycerolipid catabolic process,BP,
11721,GO:0046504,1,0.895961369551916,0,5,glycerol ether biosynthetic process,BP,
11722,GO:0046511,1,0.958387513906507,0,2,sphinganine biosynthetic process,BP,
11723,GO:0046512,1,0.834555461230654,0,8,sphingosine biosynthetic process,BP,
11724,GO:0046513,1,0.396466072868413,0,41,ceramide biosynthetic process,BP,
11725,GO:0046514,1,0.776194219806634,0,11,ceramide catabolic process,BP,
11726,GO:0046519,1,0.763066167315843,0,12,sphingoid metabolic process,BP,
11727,GO:0046520,1,0.816268345513431,0,9,sphingoid biosynthetic process,BP,
11728,GO:0046521,1,0.977153966145555,0,1,sphingoid catabolic process,BP,
11729,GO:0046523,1,0.977452546187374,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11730,GO:0046525,1,0.977081799603037,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
11731,GO:0046526,1,0.977251621836658,0,1,D-xylulose reductase activity,MF,
11732,GO:0046527,1,0.735381851068156,0,14,glucosyltransferase activity,MF,
11736,GO:0046534,1,0.978672610061352,0,1,positive regulation of photoreceptor cell differentiation,BP,
11737,GO:0046538,1,0.9328598651858,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
11738,GO:0046539,1,0.976076229080863,0,1,histamine N-methyltransferase activity,MF,
11739,GO:0046540,1,0.579456793478745,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11740,GO:0046541,1,0.977285789746343,0,1,saliva secretion,BP,
11742,GO:0046544,1,0.979205583148739,0,1,development of secondary male sexual characteristics,BP,
11745,GO:0046548,1,0.934412840609887,0,3,retinal rod cell development,BP,
11746,GO:0046549,1,0.935333030366718,0,3,retinal cone cell development,BP,
11747,GO:0046554,1,0.976677817110756,0,1,malate dehydrogenase (NADP+) activity,MF,
11748,GO:0046570,1,0.976617063484132,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
11749,GO:0046573,1,0.977020177255539,0,1,lactonohydrolase activity,MF,
11750,GO:0046577,1,0.978019464833907,0,1,long-chain-alcohol oxidase activity,MF,
11752,GO:0046579,1,0.534912846613077,0,29,positive regulation of Ras protein signal transduction,BP,
11754,GO:0046581,1,0.938764694933619,0,3,intercellular canaliculus,CC,
11755,GO:0046586,1,0.954012700874573,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
11756,GO:0046587,1,0.977394331778874,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11757,GO:0046588,1,0.976079616251394,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
11758,GO:0046592,1,0.954796565456556,0,2,polyamine oxidase activity,MF,
11761,GO:0046598,1,0.869138274768717,0,6,positive regulation of viral entry into host cell,BP,
11762,GO:0046599,1,0.686838212212108,0,17,regulation of centriole replication,BP,
11763,GO:0046600,1,0.840568940154537,0,8,negative regulation of centriole replication,BP,
11764,GO:0046601,1,0.934808081339748,0,3,positive regulation of centriole replication,BP,
11765,GO:0046602,1,0.84158542540066,0,8,regulation of mitotic centrosome separation,BP,
11766,GO:0046604,1,0.938830281537211,0,3,positive regulation of mitotic centrosome separation,BP,
11767,GO:0046605,1,0.330949889645568,0,50,regulation of centrosome cycle,BP,
11768,GO:0046606,1,0.750435711621504,0,13,negative regulation of centrosome cycle,BP,
11769,GO:0046607,1,0.822849216164813,0,9,positive regulation of centrosome cycle,BP,
11770,GO:0046618,1,0.955041476911605,0,2,drug export,BP,
11771,GO:0046619,1,0.980519451299397,0,1,optic placode formation involved in camera-type eye formation,BP,
11774,GO:0046622,1,0.570962829699351,0,26,positive regulation of organ growth,BP,
11775,GO:0046623,1,0.9801861254092,0,1,sphingolipid-translocating ATPase activity,MF,
11776,GO:0046624,1,0.876634214043407,0,6,sphingolipid transporter activity,MF,
11777,GO:0046625,1,0.778425381226997,0,11,sphingolipid binding,MF,
11780,GO:0046628,1,0.828368361827714,0,9,positive regulation of insulin receptor signaling pathway,BP,
11781,GO:0046629,1,0.819113242675212,0,9,gamma-delta T cell activation,BP,
11784,GO:0046633,1,0.746481690449937,0,13,alpha-beta T cell proliferation,BP,
11786,GO:0046635,1,0.569691506360831,0,25,positive regulation of alpha-beta T cell activation,BP,
11789,GO:0046638,1,0.624169680741508,0,21,positive regulation of alpha-beta T cell differentiation,BP,
11791,GO:0046640,1,0.780916342125487,0,11,regulation of alpha-beta T cell proliferation,BP,
11792,GO:0046641,1,0.852600834341959,0,7,positive regulation of alpha-beta T cell proliferation,BP,
11793,GO:0046642,1,0.936753519800995,0,3,negative regulation of alpha-beta T cell proliferation,BP,
11794,GO:0046643,1,0.91801339074564,0,4,regulation of gamma-delta T cell activation,BP,
11795,GO:0046645,1,0.938358451023733,0,3,positive regulation of gamma-delta T cell activation,BP,
11798,GO:0046653,1,0.713166333579873,0,15,tetrahydrofolate metabolic process,BP,
11799,GO:0046654,1,0.852487670496982,0,7,tetrahydrofolate biosynthetic process,BP,
11800,GO:0046655,1,0.684599693083547,0,17,folic acid metabolic process,BP,
11801,GO:0046657,1,0.955425865318018,0,2,folic acid catabolic process,BP,
11802,GO:0046658,1,0.580674433752312,0,24,anchored component of plasma membrane,CC,
11805,GO:0046666,1,0.954535854109407,0,2,retinal cell programmed cell death,BP,
11806,GO:0046668,1,0.97809692635028,0,1,regulation of retinal cell programmed cell death,BP,
11807,GO:0046671,1,0.97809692635028,0,1,negative regulation of retinal cell programmed cell death,BP,
11810,GO:0046680,1,0.977216111314494,0,1,response to DDT,BP,
11812,GO:0046684,1,0.956703256601401,0,2,response to pyrethroid,BP,
11813,GO:0046685,1,0.517664927228304,0,29,response to arsenic-containing substance,BP,
11815,GO:0046687,1,0.976382198534325,0,1,response to chromate,BP,
11816,GO:0046688,1,0.601495263548579,0,22,response to copper ion,BP,
11817,GO:0046689,1,0.892204859761895,0,5,response to mercury ion,BP,
11818,GO:0046690,1,0.977751570891526,0,1,response to tellurium ion,BP,
11819,GO:0046695,1,0.932666674736368,0,3,SLIK (SAGA-like) complex,CC,
11820,GO:0046696,1,0.955198601823619,0,2,lipopolysaccharide receptor complex,CC,
11823,GO:0046703,1,0.807980874280208,0,9,natural killer cell lectin-like receptor binding,MF,
11824,GO:0046707,1,0.95729581265888,0,2,IDP metabolic process,BP,
11825,GO:0046709,1,0.95729581265888,0,2,IDP catabolic process,BP,
11826,GO:0046710,1,0.77092364068942,0,12,GDP metabolic process,BP,
11827,GO:0046711,1,0.976218657093727,0,1,GDP biosynthetic process,BP,
11828,GO:0046712,1,0.976915124173167,0,1,GDP catabolic process,BP,
11829,GO:0046713,1,0.97745874848291,0,1,borate transport,BP,
11830,GO:0046715,1,0.97745874848291,0,1,active borate transmembrane transporter activity,MF,
11831,GO:0046716,1,0.764993101950126,0,12,muscle cell cellular homeostasis,BP,
11832,GO:0046717,1,0.329497258741013,0,50,acid secretion,BP,
11834,GO:0046719,1,0.853191704486782,0,7,regulation by virus of viral protein levels in host cell,BP,
11835,GO:0046724,1,0.977267548769485,0,1,oxalic acid secretion,BP,
11836,GO:0046725,1,0.977831607808505,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11837,GO:0046726,1,0.915199472245031,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11838,GO:0046730,1,0.954633709137921,0,2,induction of host immune response by virus,BP,
11839,GO:0046732,1,0.954633709137921,0,2,active induction of host immune response by virus,BP,
11840,GO:0046745,1,0.977336572808046,0,1,viral capsid secondary envelopment,BP,
11841,GO:0046755,1,0.589444563155044,0,23,viral budding,BP,
11843,GO:0046778,1,0.955066908117466,0,2,modification by virus of host mRNA processing,BP,
11844,GO:0046782,1,0.258263039276543,0,60,regulation of viral transcription,BP,
11845,GO:0046784,1,0.832567262256307,0,8,viral mRNA export from host cell nucleus,BP,
11847,GO:0046786,1,0.979049930498949,0,1,viral replication complex formation and maintenance,BP,
11848,GO:0046790,1,0.919791870326495,0,4,virion binding,MF,
11849,GO:0046794,1,0.294483803493333,0,55,transport of virus,BP,
11850,GO:0046811,1,0.979665518965194,0,1,histone deacetylase inhibitor activity,MF,
11851,GO:0046813,1,0.933236504494919,0,3,receptor-mediated virion attachment to host cell,BP,
11852,GO:0046817,1,0.976570048009942,0,1,chemokine receptor antagonist activity,MF,
11854,GO:0046823,1,0.699418979457195,0,16,negative regulation of nucleocytoplasmic transport,BP,
11857,GO:0046826,1,0.85086722709359,0,7,negative regulation of protein export from nucleus,BP,
11859,GO:0046831,1,0.726528982292165,0,15,regulation of RNA export from nucleus,BP,
11860,GO:0046832,1,0.962558065044216,0,2,negative regulation of RNA export from nucleus,BP,
11861,GO:0046833,1,0.858627085828722,0,7,positive regulation of RNA export from nucleus,BP,
11864,GO:0046836,1,0.891985827751757,0,5,glycolipid transport,BP,
11865,GO:0046838,1,0.802800661256345,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11866,GO:0046839,1,0.531511320492144,0,29,phospholipid dephosphorylation,BP,
11867,GO:0046847,1,0.421590159008921,0,40,filopodium assembly,BP,
11868,GO:0046848,1,0.976766530509267,0,1,hydroxyapatite binding,MF,
11871,GO:0046851,1,0.837533727353646,0,8,negative regulation of bone remodeling,BP,
11874,GO:0046855,1,0.802800661256345,0,10,inositol phosphate dephosphorylation,BP,
11875,GO:0046856,1,0.638800128995666,0,21,phosphatidylinositol dephosphorylation,BP,
11876,GO:0046870,1,0.937715630449356,0,3,cadmium ion binding,MF,
11879,GO:0046874,1,0.976942561332237,0,1,quinolinate metabolic process,BP,
11882,GO:0046880,1,0.937773073350425,0,3,regulation of follicle-stimulating hormone secretion,BP,
11883,GO:0046881,1,0.937773073350425,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
11884,GO:0046882,1,0.977226843172614,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
11886,GO:0046884,1,0.918001701322958,0,4,follicle-stimulating hormone secretion,BP,
11887,GO:0046885,1,0.686657052747408,0,17,regulation of hormone biosynthetic process,BP,
11888,GO:0046886,1,0.854028642004999,0,7,positive regulation of hormone biosynthetic process,BP,
11893,GO:0046898,1,0.917093907666005,0,4,response to cycloheximide,BP,
11894,GO:0046899,1,0.95511525922257,0,2,nucleoside triphosphate adenylate kinase activity,MF,
11895,GO:0046900,1,0.954660844955961,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
11896,GO:0046901,1,0.977248508865168,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
11901,GO:0046911,1,0.976504617803502,0,1,metal chelating activity,MF,
11902,GO:0046912,1,0.935160089524218,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
11906,GO:0046920,1,0.894341276716365,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11907,GO:0046921,1,0.977585479454205,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11908,GO:0046922,1,0.955582762674199,0,2,peptide-O-fucosyltransferase activity,MF,
11909,GO:0046923,1,0.911354798909497,0,4,ER retention sequence binding,MF,
11912,GO:0046930,1,0.776828053774266,0,11,pore complex,CC,
11913,GO:0046931,1,0.719499071135693,0,15,pore complex assembly,BP,
11914,GO:0046933,1,0.931051645590284,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
11918,GO:0046940,1,0.911524842354011,0,4,nucleoside monophosphate phosphorylation,BP,
11921,GO:0046946,1,0.934545515365231,0,3,hydroxylysine metabolic process,BP,
11922,GO:0046947,1,0.934545515365231,0,3,hydroxylysine biosynthetic process,BP,
11923,GO:0046949,1,0.571943515117561,0,25,fatty-acyl-CoA biosynthetic process,BP,
11924,GO:0046950,1,0.852128251649692,0,7,cellular ketone body metabolic process,BP,
11925,GO:0046951,1,0.871459433732087,0,6,ketone body biosynthetic process,BP,
11926,GO:0046952,1,0.93421603604801,0,3,ketone body catabolic process,BP,
11927,GO:0046958,1,0.977568968907028,0,1,nonassociative learning,BP,
11928,GO:0046961,1,0.661719564556888,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11929,GO:0046963,1,0.954936179954223,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11930,GO:0046964,1,0.954936179954223,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
11931,GO:0046965,1,0.772933207847653,0,12,retinoid X receptor binding,MF,
11932,GO:0046966,1,0.559428453256137,0,27,thyroid hormone receptor binding,MF,
11933,GO:0046967,1,0.956130145999162,0,2,cytosol to ER transport,BP,
11934,GO:0046968,1,0.978273888349958,0,1,peptide antigen transport,BP,
11935,GO:0046969,1,0.955614941195307,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
11936,GO:0046970,1,0.977183191309273,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
11937,GO:0046972,1,0.802316268969097,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11938,GO:0046974,1,0.895495888886992,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11939,GO:0046975,1,0.88709581381978,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11940,GO:0046976,1,0.894255906186666,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11941,GO:0046977,1,0.913035728260438,0,4,TAP binding,MF,
11942,GO:0046978,1,0.913035728260438,0,4,TAP1 binding,MF,
11943,GO:0046979,1,0.933318309234705,0,3,TAP2 binding,MF,
11944,GO:0046980,1,0.978273888349958,0,1,tapasin binding,MF,
11947,GO:0046984,1,0.913057319890602,0,4,regulation of hemoglobin biosynthetic process,BP,
11948,GO:0046985,1,0.932952970899514,0,3,positive regulation of hemoglobin biosynthetic process,BP,
11949,GO:0046986,1,0.978680044021769,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11950,GO:0046996,1,0.977336572808046,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11952,GO:0047012,1,0.976988516646319,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
11953,GO:0047015,1,0.97615407253902,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
11954,GO:0047016,1,0.977228514995705,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
11955,GO:0047017,1,0.977336572808046,0,1,prostaglandin-F synthase activity,MF,
11958,GO:0047025,1,0.954474156632142,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
11959,GO:0047035,1,0.976223502460596,0,1,testosterone dehydrogenase (NAD+) activity,MF,
11961,GO:0047045,1,0.976591725161104,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
11962,GO:0047057,1,0.953149914608873,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
11963,GO:0047066,1,0.976136663128362,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
11965,GO:0047105,1,0.977249669661019,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
11967,GO:0047117,1,0.981680997075231,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11968,GO:0047130,1,0.979800091119017,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11969,GO:0047131,1,0.979800091119017,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11970,GO:0047134,1,0.889204788321588,0,5,protein-disulfide reductase activity,MF,
11971,GO:0047144,1,0.820310549656835,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
11972,GO:0047150,1,0.977196237704058,0,1,betaine-homocysteine S-methyltransferase activity,MF,
11973,GO:0047159,1,0.978201234381328,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11974,GO:0047166,1,0.977173166712633,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
11975,GO:0047179,1,0.953431500654,0,2,platelet-activating factor acetyltransferase activity,MF,
11976,GO:0047184,1,0.8939798252044,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11977,GO:0047186,1,0.978139615660206,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11978,GO:0047191,1,0.978201234381328,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11979,GO:0047192,1,0.936204268529529,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
11980,GO:0047220,1,0.977297596686693,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
11981,GO:0047223,1,0.933379597866983,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11982,GO:0047224,1,0.977248658952485,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11983,GO:0047237,1,0.955801153419869,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11984,GO:0047238,1,0.914720559752926,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11985,GO:0047256,1,0.978360477457001,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11986,GO:0047263,1,0.977340696152359,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11987,GO:0047273,1,0.977606333754223,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11988,GO:0047275,1,0.977805534390863,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11989,GO:0047277,1,0.977183797916049,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
11990,GO:0047280,1,0.978778146013818,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11991,GO:0047288,1,0.956244657255058,0,2,monosialoganglioside sialyltransferase activity,MF,
11992,GO:0047290,1,0.977026368011889,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
11993,GO:0047291,1,0.977237844310421,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
11994,GO:0047293,1,0.977021734723393,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
11995,GO:0047298,1,0.979054784048604,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11996,GO:0047322,1,0.961849877553005,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11997,GO:0047323,1,0.977222146725524,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
11998,GO:0047325,1,0.977558902737606,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11999,GO:0047326,1,0.977121003627211,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12000,GO:0047341,1,0.977698264772724,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12001,GO:0047349,1,0.979473479236001,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12002,GO:0047369,1,0.977336572808046,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12003,GO:0047372,1,0.819939535391547,0,9,acylglycerol lipase activity,MF,
12005,GO:0047389,1,0.957454131184582,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12006,GO:0047391,1,0.955100120524789,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12007,GO:0047395,1,0.977356057038789,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12008,GO:0047408,1,0.955440180404667,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12009,GO:0047409,1,0.955440180404667,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12010,GO:0047429,1,0.816640919795836,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12011,GO:0047444,1,0.976590379383944,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12012,GO:0047451,1,0.981680997075231,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12013,GO:0047464,1,0.97915495182912,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12014,GO:0047484,1,0.873925374465385,0,6,regulation of response to osmotic stress,BP,
12016,GO:0047493,1,0.936296427016427,0,3,ceramide cholinephosphotransferase activity,MF,
12018,GO:0047497,1,0.66326071260839,0,19,mitochondrion transport along microtubule,BP,
12019,GO:0047498,1,0.873948118718938,0,6,calcium-dependent phospholipase A2 activity,MF,
12020,GO:0047499,1,0.891730439744962,0,5,calcium-independent phospholipase A2 activity,MF,
12022,GO:0047536,1,0.977231939343979,0,1,2-aminoadipate transaminase activity,MF,
12023,GO:0047545,1,0.979956305315631,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12024,GO:0047555,1,0.91883820901965,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12025,GO:0047560,1,0.979280004496956,0,1,3-dehydrosphinganine reductase activity,MF,
12026,GO:0047578,1,0.977245829741298,0,1,4-hydroxyglutamate transaminase activity,MF,
12027,GO:0047598,1,0.977267548769485,0,1,7-dehydrocholesterol reductase activity,MF,
12028,GO:0047617,1,0.776008604314682,0,11,acyl-CoA hydrolase activity,MF,
12029,GO:0047620,1,0.977356057038789,0,1,acylglycerol kinase activity,MF,
12030,GO:0047621,1,0.977050793171147,0,1,acylpyruvate hydrolase activity,MF,
12031,GO:0047623,1,0.957034516120005,0,2,adenosine-phosphate deaminase activity,MF,
12032,GO:0047631,1,0.888535874536739,0,5,ADP-ribose diphosphatase activity,MF,
12033,GO:0047635,1,0.978170959920368,0,1,alanine-oxo-acid transaminase activity,MF,
12034,GO:0047658,1,0.977062668863997,0,1,alpha-amino-acid esterase activity,MF,
12035,GO:0047661,1,0.977247707407595,0,1,amino-acid racemase activity,MF,
12036,GO:0047676,1,0.979271039553575,0,1,arachidonate-CoA ligase activity,MF,
12037,GO:0047685,1,0.976902906900437,0,1,amine sulfotransferase activity,MF,
12038,GO:0047693,1,0.975738091869388,0,1,ATP diphosphatase activity,MF,
12039,GO:0047696,1,0.955135701126268,0,2,beta-adrenergic receptor kinase activity,MF,
12040,GO:0047708,1,0.977211244715833,0,1,biotinidase activity,MF,
12041,GO:0047710,1,0.976371591892653,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
12043,GO:0047726,1,0.977249911957491,0,1,iron-cytochrome-c reductase activity,MF,
12044,GO:0047734,1,0.977336572808046,0,1,CDP-glycerol diphosphatase activity,MF,
12045,GO:0047747,1,0.977241159487971,0,1,cholate-CoA ligase activity,MF,
12046,GO:0047750,1,0.953225619300393,0,2,cholestenol delta-isomerase activity,MF,
12047,GO:0047751,1,0.955018702635051,0,2,cholestenone 5-alpha-reductase activity,MF,
12048,GO:0047756,1,0.957369019037988,0,2,chondroitin 4-sulfotransferase activity,MF,
12049,GO:0047757,1,0.960873521979809,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12050,GO:0047760,1,0.97762185071701,0,1,butyrate-CoA ligase activity,MF,
12051,GO:0047800,1,0.977972166602,0,1,cysteamine dioxygenase activity,MF,
12052,GO:0047801,1,0.977221879931679,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12053,GO:0047840,1,0.976414449986851,0,1,dCTP diphosphatase activity,MF,
12054,GO:0047844,1,0.890218745307534,0,5,deoxycytidine deaminase activity,MF,
12055,GO:0047860,1,0.976632837998571,0,1,diiodophenylpyruvate reductase activity,MF,
12056,GO:0047874,1,0.977219501162098,0,1,dolichyldiphosphatase activity,MF,
12057,GO:0047888,1,0.977184099442717,0,1,fatty acid peroxidase activity,MF,
12058,GO:0047894,1,0.954259703136069,0,2,flavonol 3-sulfotransferase activity,MF,
12059,GO:0047915,1,0.97705221544528,0,1,ganglioside galactosyltransferase activity,MF,
12060,GO:0047933,1,0.981691455229918,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12061,GO:0047936,1,0.982108466062127,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12062,GO:0047939,1,0.97687057577203,0,1,L-glucuronate reductase activity,MF,
12063,GO:0047977,1,0.977240944844536,0,1,hepoxilin-epoxide hydrolase activity,MF,
12064,GO:0047982,1,0.977093250950237,0,1,homocysteine desulfhydrase activity,MF,
12065,GO:0048002,1,0.0332614966607744,0,149,antigen processing and presentation of peptide antigen,BP,
12066,GO:0048003,1,0.936650363305783,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12067,GO:0048006,1,0.978034634836764,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12068,GO:0048007,1,0.936650363305783,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12073,GO:0048012,1,0.780621055313155,0,11,hepatocyte growth factor receptor signaling pathway,BP,
12075,GO:0048014,1,0.979329690018506,0,1,Tie signaling pathway,BP,
12077,GO:0048016,1,0.516354040285024,0,31,inositol phosphate-mediated signaling,BP,
12080,GO:0048019,1,0.79573192615858,0,10,receptor antagonist activity,MF,
12081,GO:0048020,1,0.830768851672291,0,8,CCR chemokine receptor binding,MF,
12082,GO:0048021,1,0.940012646620187,0,3,regulation of melanin biosynthetic process,BP,
12083,GO:0048022,1,0.960654659224487,0,2,negative regulation of melanin biosynthetic process,BP,
12084,GO:0048023,1,0.978515768926212,0,1,positive regulation of melanin biosynthetic process,BP,
12085,GO:0048024,1,0.239328610193479,0,64,regulation of mRNA splicing, via spliceosome,BP,
12086,GO:0048025,1,0.663459916158646,0,18,negative regulation of mRNA splicing, via spliceosome,BP,
12087,GO:0048026,1,0.763412426081373,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12088,GO:0048027,1,0.604734592980016,0,22,mRNA 5'-UTR binding,MF,
12090,GO:0048030,1,0.975439797030923,0,1,disaccharide binding,MF,
12091,GO:0048033,1,0.977388822753119,0,1,heme o metabolic process,BP,
12092,GO:0048034,1,0.977388822753119,0,1,heme O biosynthetic process,BP,
12094,GO:0048038,1,0.721498894540012,0,14,quinone binding,MF,
12095,GO:0048039,1,0.869468198223734,0,6,ubiquinone binding,MF,
12096,GO:0048040,1,0.977216434697137,0,1,UDP-glucuronate decarboxylase activity,MF,
12098,GO:0048048,1,0.638694737235669,0,22,embryonic eye morphogenesis,BP,
12099,GO:0048050,1,0.874407035278102,0,6,post-embryonic eye morphogenesis,BP,
12100,GO:0048058,1,0.97760755041108,0,1,compound eye corneal lens development,BP,
12102,GO:0048069,1,0.895697846636064,0,5,eye pigmentation,BP,
12103,GO:0048070,1,0.766101192176395,0,12,regulation of developmental pigmentation,BP,
12104,GO:0048073,1,0.957574385724035,0,2,regulation of eye pigmentation,BP,
12105,GO:0048075,1,0.978537495053141,0,1,positive regulation of eye pigmentation,BP,
12106,GO:0048087,1,0.857087317198818,0,7,positive regulation of developmental pigmentation,BP,
12107,GO:0048096,1,0.838967873213165,0,8,chromatin-mediated maintenance of transcription,BP,
12108,GO:0048102,1,0.855026989238845,0,7,autophagic cell death,BP,
12110,GO:0048104,1,0.922268967718875,0,4,establishment of body hair or bristle planar orientation,BP,
12111,GO:0048105,1,0.922268967718875,0,4,establishment of body hair planar orientation,BP,
12113,GO:0048143,1,0.845963134974522,0,8,astrocyte activation,BP,
12118,GO:0048148,1,0.855963817435594,0,7,behavioral response to cocaine,BP,
12119,GO:0048149,1,0.919717561954133,0,4,behavioral response to ethanol,BP,
12121,GO:0048160,1,0.978814768496901,0,1,primary follicle stage,BP,
12122,GO:0048162,1,0.977029424191677,0,1,multi-layer follicle stage,BP,
12123,GO:0048165,1,0.958799772261469,0,2,fused antrum stage,BP,
12126,GO:0048169,1,0.689600660183398,0,17,regulation of long-term neuronal synaptic plasticity,BP,
12127,GO:0048170,1,0.917029618477871,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
12128,GO:0048172,1,0.86152298832591,0,7,regulation of short-term neuronal synaptic plasticity,BP,
12129,GO:0048179,1,0.955000345544675,0,2,activin receptor complex,CC,
12130,GO:0048180,1,0.977226843172614,0,1,activin complex,CC,
12131,GO:0048185,1,0.786572080360897,0,11,activin binding,MF,
12132,GO:0048188,1,0.771922096527806,0,12,Set1C/COMPASS complex,CC,
12134,GO:0048194,1,0.207695193654035,0,71,Golgi vesicle budding,BP,
12135,GO:0048199,1,0.240715739825877,0,64,vesicle targeting, to, from or within Golgi,BP,
12136,GO:0048200,1,0.874270352807108,0,6,Golgi transport vesicle coating,BP,
12137,GO:0048203,1,0.955017245859705,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12138,GO:0048205,1,0.874270352807108,0,6,COPI coating of Golgi vesicle,BP,
12139,GO:0048207,1,0.288249016843499,0,56,vesicle targeting, rough ER to cis-Golgi,BP,
12140,GO:0048208,1,0.288249016843499,0,56,COPII vesicle coating,BP,
12141,GO:0048209,1,0.956988820239562,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12142,GO:0048210,1,0.934211859093939,0,3,Golgi vesicle fusion to target membrane,BP,
12143,GO:0048211,1,0.955890945130948,0,2,Golgi vesicle docking,BP,
12144,GO:0048213,1,0.977313709367226,0,1,Golgi vesicle prefusion complex stabilization,BP,
12145,GO:0048227,1,0.83505483615996,0,8,plasma membrane to endosome transport,BP,
12147,GO:0048237,1,0.954705204679854,0,2,rough endoplasmic reticulum lumen,CC,
12148,GO:0048239,1,0.955073137981341,0,2,negative regulation of DNA recombination at telomere,BP,
12149,GO:0048240,1,0.853961558749184,0,7,sperm capacitation,BP,
12150,GO:0048243,1,0.915381125082467,0,4,norepinephrine secretion,BP,
12151,GO:0048244,1,0.977039913892843,0,1,phytanoyl-CoA dioxygenase activity,MF,
12152,GO:0048245,1,0.912247799583408,0,4,eosinophil chemotaxis,BP,
12153,GO:0048246,1,0.660831530515181,0,18,macrophage chemotaxis,BP,
12155,GO:0048250,1,0.95462554393275,0,2,iron import into the mitochondrion,BP,
12156,GO:0048251,1,0.843561480045861,0,8,elastic fiber assembly,BP,
12157,GO:0048254,1,0.913234185294088,0,4,snoRNA localization,BP,
12159,GO:0048256,1,0.833495990544971,0,8,flap endonuclease activity,MF,
12160,GO:0048257,1,0.955093706849055,0,2,3'-flap endonuclease activity,MF,
12163,GO:0048261,1,0.730979193892612,0,14,negative regulation of receptor-mediated endocytosis,BP,
12164,GO:0048262,1,0.890834682689844,0,5,determination of dorsal/ventral asymmetry,BP,
12165,GO:0048263,1,0.911446135236537,0,4,determination of dorsal identity,BP,
12166,GO:0048264,1,0.977393776273839,0,1,determination of ventral identity,BP,
12167,GO:0048265,1,0.840884230128149,0,8,response to pain,BP,
12168,GO:0048266,1,0.899442924834884,0,5,behavioral response to pain,BP,
12169,GO:0048268,1,0.723152194886055,0,15,clathrin coat assembly,BP,
12171,GO:0048270,1,0.977215205789047,0,1,methionine adenosyltransferase regulator activity,MF,
12172,GO:0048273,1,0.87673409439433,0,6,mitogen-activated protein kinase p38 binding,MF,
12174,GO:0048280,1,0.795670238413599,0,10,vesicle fusion with Golgi apparatus,BP,
12178,GO:0048289,1,0.913929179474125,0,4,isotype switching to IgE isotypes,BP,
12179,GO:0048290,1,0.871492861828474,0,6,isotype switching to IgA isotypes,BP,
12180,GO:0048291,1,0.835580621335324,0,8,isotype switching to IgG isotypes,BP,
12181,GO:0048293,1,0.913929179474125,0,4,regulation of isotype switching to IgE isotypes,BP,
12182,GO:0048294,1,0.956142215230923,0,2,negative regulation of isotype switching to IgE isotypes,BP,
12183,GO:0048295,1,0.955857948318758,0,2,positive regulation of isotype switching to IgE isotypes,BP,
12184,GO:0048296,1,0.891443991433204,0,5,regulation of isotype switching to IgA isotypes,BP,
12185,GO:0048297,1,0.97722241084861,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12186,GO:0048298,1,0.912229469936198,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12187,GO:0048302,1,0.855054533583716,0,7,regulation of isotype switching to IgG isotypes,BP,
12188,GO:0048304,1,0.894502486414759,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12189,GO:0048305,1,0.758281235263153,0,12,immunoglobulin secretion,BP,
12190,GO:0048306,1,0.417582859833946,0,38,calcium-dependent protein binding,MF,
12191,GO:0048308,1,0.713757310474002,0,15,organelle inheritance,BP,
12192,GO:0048311,1,0.74144112253233,0,14,mitochondrion distribution,BP,
12193,GO:0048312,1,0.880479268820771,0,6,intracellular distribution of mitochondria,BP,
12194,GO:0048313,1,0.730328391708459,0,14,Golgi inheritance,BP,
12196,GO:0048319,1,0.958410716254425,0,2,axial mesoderm morphogenesis,BP,
12197,GO:0048320,1,0.977676153662534,0,1,axial mesoderm formation,BP,
12199,GO:0048333,1,0.721684841811078,0,15,mesodermal cell differentiation,BP,
12200,GO:0048338,1,0.977879752558832,0,1,mesoderm structural organization,BP,
12201,GO:0048339,1,0.740373108953875,0,14,paraxial mesoderm development,BP,
12202,GO:0048340,1,0.862156841442004,0,7,paraxial mesoderm morphogenesis,BP,
12203,GO:0048341,1,0.915398145111871,0,4,paraxial mesoderm formation,BP,
12204,GO:0048352,1,0.977879752558832,0,1,paraxial mesoderm structural organization,BP,
12205,GO:0048364,1,0.97585624064459,0,1,root development,BP,
12207,GO:0048368,1,0.841447297162141,0,8,lateral mesoderm development,BP,
12208,GO:0048369,1,0.957944964193535,0,2,lateral mesoderm morphogenesis,BP,
12209,GO:0048370,1,0.957944964193535,0,2,lateral mesoderm formation,BP,
12210,GO:0048371,1,0.957944964193535,0,2,lateral mesodermal cell differentiation,BP,
12211,GO:0048372,1,0.957944964193535,0,2,lateral mesodermal cell fate commitment,BP,
12212,GO:0048377,1,0.957944964193535,0,2,lateral mesodermal cell fate specification,BP,
12213,GO:0048378,1,0.957944964193535,0,2,regulation of lateral mesodermal cell fate specification,BP,
12214,GO:0048382,1,0.955777223949718,0,2,mesendoderm development,BP,
12215,GO:0048384,1,0.621995083948945,0,21,retinoic acid receptor signaling pathway,BP,
12216,GO:0048385,1,0.780214457618361,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12217,GO:0048386,1,0.913522525977959,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
12218,GO:0048387,1,0.895381393863103,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12219,GO:0048388,1,0.955603404078633,0,2,endosomal lumen acidification,BP,
12220,GO:0048389,1,0.977115191442785,0,1,intermediate mesoderm development,BP,
12221,GO:0048390,1,0.977115191442785,0,1,intermediate mesoderm morphogenesis,BP,
12222,GO:0048391,1,0.977115191442785,0,1,intermediate mesoderm formation,BP,
12223,GO:0048392,1,0.977115191442785,0,1,intermediate mesodermal cell differentiation,BP,
12224,GO:0048403,1,0.978137654399097,0,1,brain-derived neurotrophic factor binding,MF,
12225,GO:0048406,1,0.91704500321101,0,4,nerve growth factor binding,MF,
12227,GO:0048408,1,0.910794692122193,0,4,epidermal growth factor binding,MF,
12232,GO:0048476,1,0.889845334740396,0,5,Holliday junction resolvase complex,CC,
12233,GO:0048477,1,0.362860398670153,0,46,oogenesis,BP,
12234,GO:0048478,1,0.85969134842453,0,7,replication fork protection,BP,
12240,GO:0048488,1,0.537693155499371,0,29,synaptic vesicle endocytosis,BP,
12243,GO:0048495,1,0.919310562999876,0,4,Roundabout binding,MF,
12244,GO:0048496,1,0.936648899346169,0,3,maintenance of animal organ identity,BP,
12245,GO:0048499,1,0.934242526506012,0,3,synaptic vesicle membrane organization,BP,
12246,GO:0048500,1,0.81132174219484,0,9,signal recognition particle,CC,
12255,GO:0048520,1,0.898040032777816,0,5,positive regulation of behavior,BP,
12256,GO:0048521,1,0.913487409459024,0,4,negative regulation of behavior,BP,
12259,GO:0048524,1,0.117305507978691,0,95,positive regulation of viral process,BP,
12261,GO:0048531,1,0.759605685790753,0,12,beta-1,3-galactosyltransferase activity,MF,
12262,GO:0048532,1,0.803957649497357,0,10,anatomical structure arrangement,BP,
12264,GO:0048535,1,0.764385296953866,0,12,lymph node development,BP,
12268,GO:0048539,1,0.91472189112153,0,4,bone marrow development,BP,
12272,GO:0048548,1,0.818213050361045,0,9,regulation of pinocytosis,BP,
12273,GO:0048549,1,0.916143580365489,0,4,positive regulation of pinocytosis,BP,
12274,GO:0048550,1,0.893138945194842,0,5,negative regulation of pinocytosis,BP,
12275,GO:0048557,1,0.864519140633941,0,7,embryonic digestive tract morphogenesis,BP,
12276,GO:0048560,1,0.954976129848911,0,2,establishment of anatomical structure orientation,BP,
12277,GO:0048561,1,0.977231646243059,0,1,establishment of animal organ orientation,BP,
12279,GO:0048563,1,0.856083947270121,0,7,post-embryonic animal organ morphogenesis,BP,
12281,GO:0048566,1,0.723194488221242,0,15,embryonic digestive tract development,BP,
12283,GO:0048569,1,0.735754344823455,0,14,post-embryonic animal organ development,BP,
12292,GO:0048596,1,0.741103398300502,0,15,embryonic camera-type eye morphogenesis,BP,
12293,GO:0048597,1,0.931433166973003,0,3,post-embryonic camera-type eye morphogenesis,BP,
12295,GO:0048599,1,0.540685584350275,0,28,oocyte development,BP,
12298,GO:0048611,1,0.977370360650261,0,1,embryonic ectodermal digestive tract development,BP,
12299,GO:0048617,1,0.907994636739482,0,5,embryonic foregut morphogenesis,BP,
12300,GO:0048619,1,0.977315886512553,0,1,embryonic hindgut morphogenesis,BP,
12301,GO:0048625,1,0.936136541228893,0,3,myoblast fate commitment,BP,
12303,GO:0048630,1,0.936100805923941,0,3,skeletal muscle tissue growth,BP,
12304,GO:0048631,1,0.936100805923941,0,3,regulation of skeletal muscle tissue growth,BP,
12305,GO:0048633,1,0.936100805923941,0,3,positive regulation of skeletal muscle tissue growth,BP,
12308,GO:0048636,1,0.411284171467789,0,41,positive regulation of muscle organ development,BP,
12314,GO:0048643,1,0.735234292860357,0,14,positive regulation of skeletal muscle tissue development,BP,
12321,GO:0048662,1,0.538954628953151,0,27,negative regulation of smooth muscle cell proliferation,BP,
12324,GO:0048665,1,0.85942471094326,0,7,neuron fate specification,BP,
12327,GO:0048668,1,0.686177079203142,0,17,collateral sprouting,BP,
12328,GO:0048669,1,0.935439350593038,0,3,collateral sprouting in absence of injury,BP,
12329,GO:0048670,1,0.765091047847765,0,12,regulation of collateral sprouting,BP,
12330,GO:0048671,1,0.939156606213863,0,3,negative regulation of collateral sprouting,BP,
12331,GO:0048672,1,0.814697021046675,0,9,positive regulation of collateral sprouting,BP,
12332,GO:0048674,1,0.977245268219983,0,1,collateral sprouting of injured axon,BP,
12334,GO:0048677,1,0.979759787231907,0,1,axon extension involved in regeneration,BP,
12336,GO:0048679,1,0.669669048569954,0,18,regulation of axon regeneration,BP,
12337,GO:0048680,1,0.911151949745571,0,4,positive regulation of axon regeneration,BP,
12338,GO:0048681,1,0.78318384128633,0,11,negative regulation of axon regeneration,BP,
12339,GO:0048682,1,0.957463920626385,0,2,sprouting of injured axon,BP,
12340,GO:0048686,1,0.977245268219983,0,1,regulation of sprouting of injured axon,BP,
12341,GO:0048687,1,0.977245268219983,0,1,positive regulation of sprouting of injured axon,BP,
12342,GO:0048688,1,0.977245268219983,0,1,negative regulation of sprouting of injured axon,BP,
12343,GO:0048689,1,0.977245268219983,0,1,formation of growth cone in injured axon,BP,
12344,GO:0048693,1,0.977245268219983,0,1,regulation of collateral sprouting of injured axon,BP,
12345,GO:0048694,1,0.977245268219983,0,1,positive regulation of collateral sprouting of injured axon,BP,
12346,GO:0048696,1,0.976892464585118,0,1,regulation of collateral sprouting in absence of injury,BP,
12347,GO:0048697,1,0.976892464585118,0,1,positive regulation of collateral sprouting in absence of injury,BP,
12350,GO:0048702,1,0.858920273001678,0,7,embryonic neurocranium morphogenesis,BP,
12351,GO:0048703,1,0.862968214723568,0,7,embryonic viscerocranium morphogenesis,BP,
12361,GO:0048714,1,0.767346140925954,0,12,positive regulation of oligodendrocyte differentiation,BP,
12367,GO:0048733,1,0.901824024245814,0,5,sebaceous gland development,BP,
12370,GO:0048739,1,0.894158956781421,0,6,cardiac muscle fiber development,BP,
12371,GO:0048741,1,0.740949990391933,0,14,skeletal muscle fiber development,BP,
12372,GO:0048742,1,0.898336093317581,0,5,regulation of skeletal muscle fiber development,BP,
12373,GO:0048743,1,0.956687197397791,0,2,positive regulation of skeletal muscle fiber development,BP,
12375,GO:0048747,1,0.556284235107009,0,28,muscle fiber development,BP,
12376,GO:0048749,1,0.97760755041108,0,1,compound eye development,BP,
12377,GO:0048752,1,0.919121345723603,0,4,semicircular canal morphogenesis,BP,
12380,GO:0048755,1,0.896892497181425,0,5,branching morphogenesis of a nerve,BP,
12383,GO:0048763,1,0.952270516090272,0,3,calcium-induced calcium release activity,MF,
12384,GO:0048764,1,0.97585624064459,0,1,trichoblast maturation,BP,
12385,GO:0048765,1,0.97585624064459,0,1,root hair cell differentiation,BP,
12386,GO:0048767,1,0.97585624064459,0,1,root hair elongation,BP,
12387,GO:0048769,1,0.980408967127189,0,2,sarcomerogenesis,BP,
12390,GO:0048786,1,0.675501337842697,0,19,presynaptic active zone,CC,
12391,GO:0048787,1,0.91620695595424,0,4,presynaptic active zone membrane,CC,
12392,GO:0048788,1,0.936075008631327,0,4,cytoskeleton of presynaptic active zone,CC,
12393,GO:0048791,1,0.679899688219949,0,18,calcium ion-regulated exocytosis of neurotransmitter,BP,
12394,GO:0048793,1,0.919444041238815,0,4,pronephros development,BP,
12395,GO:0048799,1,0.753348839533705,0,14,animal organ maturation,BP,
12396,GO:0048806,1,0.63121499412549,0,22,genitalia development,BP,
12397,GO:0048807,1,0.978823667602505,0,1,female genitalia morphogenesis,BP,
12401,GO:0048817,1,0.958207189885012,0,2,negative regulation of hair follicle maturation,BP,
12402,GO:0048818,1,0.914963581775102,0,4,positive regulation of hair follicle maturation,BP,
12403,GO:0048819,1,0.838216014930943,0,8,regulation of hair follicle maturation,BP,
12404,GO:0048820,1,0.725896197707033,0,15,hair follicle maturation,BP,
12405,GO:0048821,1,0.627185409723056,0,21,erythrocyte development,BP,
12406,GO:0048822,1,0.93917731085475,0,3,enucleate erythrocyte development,BP,
12409,GO:0048841,1,0.609999950297226,0,24,regulation of axon extension involved in axon guidance,BP,
12410,GO:0048842,1,0.892227467285746,0,6,positive regulation of axon extension involved in axon guidance,BP,
12411,GO:0048843,1,0.680574160257197,0,18,negative regulation of axon extension involved in axon guidance,BP,
12413,GO:0048845,1,0.844349336794453,0,8,venous blood vessel morphogenesis,BP,
12414,GO:0048846,1,0.560762678595337,0,28,axon extension involved in axon guidance,BP,
12415,GO:0048850,1,0.960322411593423,0,2,hypophysis morphogenesis,BP,
12416,GO:0048852,1,0.938448908347373,0,3,diencephalon morphogenesis,BP,
12417,GO:0048853,1,0.864572882027158,0,7,forebrain morphogenesis,BP,
12418,GO:0048854,1,0.616607856726547,0,23,brain morphogenesis,BP,
12419,GO:0048855,1,0.98016035220607,0,1,adenohypophysis morphogenesis,BP,
12423,GO:0048859,1,0.958530646528188,0,2,formation of anatomical boundary,BP,
12424,GO:0048861,1,0.91817001184258,0,4,leukemia inhibitory factor signaling pathway,BP,
12429,GO:0048867,1,0.976225115676963,0,1,stem cell fate determination,BP,
12435,GO:0048874,1,0.97757836626664,0,1,homeostasis of number of cells in a free-living population,BP,
12436,GO:0048875,1,0.858835012724457,0,7,chemical homeostasis within a tissue,BP,
12438,GO:0048880,1,0.935604509066971,0,3,sensory system development,BP,
12439,GO:0048882,1,0.977266136864643,0,1,lateral line development,BP,
12440,GO:0048884,1,0.977266136864643,0,1,neuromast development,BP,
12441,GO:0048886,1,0.977266136864643,0,1,neuromast hair cell differentiation,BP,
12442,GO:0048925,1,0.977266136864643,0,1,lateral line system development,BP,
12443,GO:0048934,1,0.876377639240057,0,6,peripheral nervous system neuron differentiation,BP,
12444,GO:0048935,1,0.876377639240057,0,6,peripheral nervous system neuron development,BP,
12445,GO:0048936,1,0.933935441682945,0,3,peripheral nervous system neuron axonogenesis,BP,
12447,GO:0050011,1,0.976980865585239,0,1,itaconyl-CoA hydratase activity,MF,
12448,GO:0050023,1,0.977152725313881,0,1,L-fuconate dehydratase activity,MF,
12449,GO:0050038,1,0.975950307661365,0,1,L-xylulose reductase (NADP+) activity,MF,
12450,GO:0050046,1,0.977336572808046,0,1,lathosterol oxidase activity,MF,
12451,GO:0050072,1,0.858306631699454,0,7,m7G(5')pppN diphosphatase activity,MF,
12452,GO:0050080,1,0.977229107474048,0,1,malonyl-CoA decarboxylase activity,MF,
12453,GO:0050104,1,0.976897457505169,0,1,L-gulonate 3-dehydrogenase activity,MF,
12454,GO:0050115,1,0.979028847768538,0,1,myosin-light-chain-phosphatase activity,MF,
12455,GO:0050119,1,0.960017630059577,0,2,N-acetylglucosamine deacetylase activity,MF,
12456,GO:0050124,1,0.978045412091061,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12457,GO:0050135,1,0.976890457067696,0,1,NAD(P)+ nucleosidase activity,MF,
12458,GO:0050136,1,0.397971999737999,0,38,NADH dehydrogenase (quinone) activity,MF,
12459,GO:0050144,1,0.977336572808046,0,1,nucleoside deoxyribosyltransferase activity,MF,
12460,GO:0050145,1,0.911524842354011,0,4,nucleoside phosphate kinase activity,MF,
12461,GO:0050146,1,0.979375587422559,0,1,nucleoside phosphotransferase activity,MF,
12462,GO:0050152,1,0.976636753703922,0,1,omega-amidase activity,MF,
12463,GO:0050178,1,0.9516519515049,0,2,phenylpyruvate tautomerase activity,MF,
12464,GO:0050185,1,0.983458129204454,0,1,phosphatidylinositol deacylase activity,MF,
12465,GO:0050201,1,0.978173894188352,0,1,fucokinase activity,MF,
12466,GO:0050211,1,0.955230676505037,0,2,procollagen galactosyltransferase activity,MF,
12467,GO:0050220,1,0.910519461721423,0,4,prostaglandin-E synthase activity,MF,
12469,GO:0050252,1,0.955715667362029,0,2,retinol O-fatty-acyltransferase activity,MF,
12470,GO:0050253,1,0.957021459355463,0,2,retinyl-palmitate esterase activity,MF,
12471,GO:0050262,1,0.977336572808046,0,1,ribosylnicotinamide kinase activity,MF,
12472,GO:0050265,1,0.938039353213287,0,3,RNA uridylyltransferase activity,MF,
12473,GO:0050277,1,0.978090544920442,0,1,sedoheptulokinase activity,MF,
12474,GO:0050290,1,0.978915494177296,0,1,sphingomyelin phosphodiesterase D activity,MF,
12475,GO:0050291,1,0.891686469028306,0,5,sphingosine N-acyltransferase activity,MF,
12476,GO:0050294,1,0.931900161404492,0,3,steroid sulfotransferase activity,MF,
12477,GO:0050308,1,0.894795682843417,0,5,sugar-phosphatase activity,MF,
12478,GO:0050309,1,0.977018613282344,0,1,sugar-terminal-phosphatase activity,MF,
12479,GO:0050313,1,0.976176308571746,0,1,sulfur dioxygenase activity,MF,
12480,GO:0050321,1,0.768756792548023,0,12,tau-protein kinase activity,MF,
12481,GO:0050333,1,0.977121522229934,0,1,thiamin-triphosphatase activity,MF,
12482,GO:0050337,1,0.97549368348403,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
12484,GO:0050347,1,0.955331427056851,0,2,trans-octaprenyltranstransferase activity,MF,
12485,GO:0050353,1,0.977322293518415,0,1,trimethyllysine dioxygenase activity,MF,
12486,GO:0050354,1,0.977336572808046,0,1,triokinase activity,MF,
12487,GO:0050355,1,0.978682228111654,0,1,triphosphatase activity,MF,
12488,GO:0050379,1,0.97915495182912,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12489,GO:0050405,1,0.961849877553005,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12490,GO:0050421,1,0.977259564888281,0,1,nitrite reductase (NO-forming) activity,MF,
12491,GO:0050427,1,0.667604363310886,0,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
12492,GO:0050428,1,0.875769674192635,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12496,GO:0050434,1,0.40675111202906,0,40,positive regulation of viral transcription,BP,
12498,GO:0050436,1,0.957879415866253,0,2,microfibril binding,MF,
12499,GO:0050444,1,0.977587862754326,0,1,aquacobalamin reductase (NADPH) activity,MF,
12500,GO:0050462,1,0.976590379383944,0,1,N-acetylneuraminate synthase activity,MF,
12501,GO:0050473,1,0.956447771861109,0,2,arachidonate 15-lipoxygenase activity,MF,
12502,GO:0050482,1,0.764271264677859,0,12,arachidonic acid secretion,BP,
12503,GO:0050497,1,0.955290400765373,0,2,transferase activity, transferring alkylthio groups,MF,
12504,GO:0050501,1,0.933562711111738,0,3,hyaluronan synthase activity,MF,
12505,GO:0050508,1,0.956113323816301,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12506,GO:0050509,1,0.956113323816301,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12507,GO:0050510,1,0.914944890833631,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12508,GO:0050512,1,0.97721578479866,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
12509,GO:0050542,1,0.908440935644332,0,4,icosanoid binding,MF,
12510,GO:0050543,1,0.908440935644332,0,4,icosatetraenoic acid binding,MF,
12511,GO:0050544,1,0.908440935644332,0,4,arachidonic acid binding,MF,
12512,GO:0050560,1,0.977642608882826,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12513,GO:0050561,1,0.978168024816591,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12514,GO:0050567,1,0.932426079361129,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
12515,GO:0050577,1,0.97674769101636,0,1,GDP-L-fucose synthase activity,MF,
12516,GO:0050610,1,0.953310591884465,0,2,methylarsonate reductase activity,MF,
12517,GO:0050613,1,0.955526563598924,0,2,delta14-sterol reductase activity,MF,
12518,GO:0050614,1,0.978518490751344,0,1,delta24-sterol reductase activity,MF,
12519,GO:0050632,1,0.976813211330368,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
12520,GO:0050650,1,0.649700060097116,0,20,chondroitin sulfate proteoglycan biosynthetic process,BP,
12521,GO:0050651,1,0.807321722858615,0,10,dermatan sulfate proteoglycan biosynthetic process,BP,
12522,GO:0050652,1,0.977977028244556,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12523,GO:0050653,1,0.977977028244556,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12524,GO:0050654,1,0.546909658621131,0,28,chondroitin sulfate proteoglycan metabolic process,BP,
12525,GO:0050655,1,0.788923734302532,0,11,dermatan sulfate proteoglycan metabolic process,BP,
12526,GO:0050656,1,0.916974596960808,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
12529,GO:0050659,1,0.958982941728051,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12530,GO:0050660,1,0.260603854210534,0,60,flavin adenine dinucleotide binding,MF,
12531,GO:0050661,1,0.445742405525114,0,36,NADP binding,MF,
12532,GO:0050662,1,0.00648756849160796,0,221,coenzyme binding,MF,
12534,GO:0050664,1,0.87425813624643,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12535,GO:0050665,1,0.799129727992948,0,10,hydrogen peroxide biosynthetic process,BP,
12536,GO:0050666,1,0.97723530628057,0,1,regulation of homocysteine metabolic process,BP,
12537,GO:0050667,1,0.78130618197478,0,11,homocysteine metabolic process,BP,
12538,GO:0050668,1,0.97723530628057,0,1,positive regulation of homocysteine metabolic process,BP,
12547,GO:0050682,1,0.960690366941674,0,2,AF-2 domain binding,MF,
12548,GO:0050684,1,0.106503880136011,0,100,regulation of mRNA processing,BP,
12549,GO:0050685,1,0.624461110583927,0,21,positive regulation of mRNA processing,BP,
12550,GO:0050686,1,0.529793039797917,0,28,negative regulation of mRNA processing,BP,
12551,GO:0050687,1,0.623114375227249,0,21,negative regulation of defense response to virus,BP,
12552,GO:0050688,1,0.308359144291749,0,53,regulation of defense response to virus,BP,
12553,GO:0050689,1,0.890597381808215,0,5,negative regulation of defense response to virus by host,BP,
12554,GO:0050690,1,0.624703282795128,0,21,regulation of defense response to virus by virus,BP,
12555,GO:0050691,1,0.5352021745717,0,28,regulation of defense response to virus by host,BP,
12556,GO:0050692,1,0.957146101862002,0,2,DBD domain binding,MF,
12557,GO:0050693,1,0.91788369924786,0,4,LBD domain binding,MF,
12558,GO:0050694,1,0.977252448864821,0,1,galactose 3-O-sulfotransferase activity,MF,
12559,GO:0050698,1,0.977252448864821,0,1,proteoglycan sulfotransferase activity,MF,
12561,GO:0050700,1,0.784356527796126,0,11,CARD domain binding,MF,
12562,GO:0050701,1,0.509341959689918,0,30,interleukin-1 secretion,BP,
12563,GO:0050702,1,0.586971649467134,0,24,interleukin-1 beta secretion,BP,
12564,GO:0050703,1,0.888513995054277,0,5,interleukin-1 alpha secretion,BP,
12565,GO:0050704,1,0.567138366813001,0,25,regulation of interleukin-1 secretion,BP,
12566,GO:0050705,1,0.91080208310329,0,4,regulation of interleukin-1 alpha secretion,BP,
12567,GO:0050706,1,0.637527106940207,0,20,regulation of interleukin-1 beta secretion,BP,
12572,GO:0050711,1,0.832361500851621,0,8,negative regulation of interleukin-1 secretion,BP,
12573,GO:0050712,1,0.976825338219214,0,1,negative regulation of interleukin-1 alpha secretion,BP,
12574,GO:0050713,1,0.892006127612838,0,5,negative regulation of interleukin-1 beta secretion,BP,
12577,GO:0050716,1,0.682822694843818,0,17,positive regulation of interleukin-1 secretion,BP,
12578,GO:0050717,1,0.932416124898192,0,3,positive regulation of interleukin-1 alpha secretion,BP,
12579,GO:0050718,1,0.73262830368555,0,14,positive regulation of interleukin-1 beta secretion,BP,
12580,GO:0050719,1,0.975965192706711,0,1,interleukin-1 alpha biosynthetic process,BP,
12581,GO:0050720,1,0.977470046949509,0,1,interleukin-1 beta biosynthetic process,BP,
12582,GO:0050721,1,0.975965192706711,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
12583,GO:0050722,1,0.977470046949509,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12584,GO:0050725,1,0.977470046949509,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
12585,GO:0050726,1,0.975965192706711,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
12587,GO:0050728,1,0.221759391377309,0,67,negative regulation of inflammatory response,BP,
12592,GO:0050733,1,0.895098184969336,0,5,RS domain binding,MF,
12593,GO:0050746,1,0.838977961889295,0,8,regulation of lipoprotein metabolic process,BP,
12594,GO:0050747,1,0.894888313172127,0,5,positive regulation of lipoprotein metabolic process,BP,
12595,GO:0050748,1,0.980578682093857,0,1,negative regulation of lipoprotein metabolic process,BP,
12597,GO:0050755,1,0.794615043518042,0,10,chemokine metabolic process,BP,
12598,GO:0050757,1,0.977264938181204,0,1,thymidylate synthase biosynthetic process,BP,
12599,GO:0050758,1,0.977264938181204,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12600,GO:0050760,1,0.977264938181204,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
12601,GO:0050764,1,0.412908874708074,0,40,regulation of phagocytosis,BP,
12602,GO:0050765,1,0.816550168644614,0,9,negative regulation of phagocytosis,BP,
12603,GO:0050766,1,0.54030240631841,0,28,positive regulation of phagocytosis,BP,
12609,GO:0050772,1,0.244046859115692,0,66,positive regulation of axonogenesis,BP,
12612,GO:0050775,1,0.581924191396307,0,25,positive regulation of dendrite morphogenesis,BP,
12617,GO:0050780,1,0.801736042789327,0,10,dopamine receptor binding,MF,
12618,GO:0050783,1,0.977245329737199,0,1,cocaine metabolic process,BP,
12619,GO:0050785,1,0.9767200093547,0,1,advanced glycation end-product receptor activity,MF,
12620,GO:0050786,1,0.84312091384546,0,7,RAGE receptor binding,MF,
12621,GO:0050787,1,0.95580288105033,0,2,detoxification of mercury ion,BP,
12627,GO:0050795,1,0.581237280388431,0,25,regulation of behavior,BP,
12631,GO:0050802,1,0.81731437935355,0,9,circadian sleep/wake cycle, sleep,BP,
12635,GO:0050806,1,0.155722771017851,0,85,positive regulation of synaptic transmission,BP,
12639,GO:0050811,1,0.819723240109705,0,9,GABA receptor binding,MF,
12640,GO:0050812,1,0.769146955245079,0,12,regulation of acyl-CoA biosynthetic process,BP,
12641,GO:0050815,1,0.874435521733903,0,6,phosphoserine residue binding,MF,
12642,GO:0050816,1,0.935814745409175,0,3,phosphothreonine residue binding,MF,
12648,GO:0050822,1,0.977768793829062,0,1,peptide stabilization,BP,
12649,GO:0050823,1,0.977768793829062,0,1,peptide antigen stabilization,BP,
12653,GO:0050833,1,0.933977923074141,0,3,pyruvate transmembrane transporter activity,MF,
12656,GO:0050847,1,0.86209146201954,0,7,progesterone receptor signaling pathway,BP,
12657,GO:0050848,1,0.386465889796323,0,44,regulation of calcium-mediated signaling,BP,
12658,GO:0050849,1,0.766280461227943,0,12,negative regulation of calcium-mediated signaling,BP,
12659,GO:0050850,1,0.60163092025141,0,23,positive regulation of calcium-mediated signaling,BP,
12662,GO:0050853,1,0.535270962571822,0,28,B cell receptor signaling pathway,BP,
12663,GO:0050854,1,0.467017616634132,0,34,regulation of antigen receptor-mediated signaling pathway,BP,
12664,GO:0050855,1,0.764487665421278,0,12,regulation of B cell receptor signaling pathway,BP,
12665,GO:0050856,1,0.584023127167435,0,24,regulation of T cell receptor signaling pathway,BP,
12666,GO:0050857,1,0.781155672836509,0,11,positive regulation of antigen receptor-mediated signaling pathway,BP,
12667,GO:0050858,1,0.694734023578208,0,16,negative regulation of antigen receptor-mediated signaling pathway,BP,
12668,GO:0050859,1,0.934187034103236,0,3,negative regulation of B cell receptor signaling pathway,BP,
12669,GO:0050860,1,0.726783874139276,0,14,negative regulation of T cell receptor signaling pathway,BP,
12670,GO:0050861,1,0.914666408092475,0,4,positive regulation of B cell receptor signaling pathway,BP,
12671,GO:0050862,1,0.854078600725966,0,7,positive regulation of T cell receptor signaling pathway,BP,
12680,GO:0050871,1,0.341641613871887,0,48,positive regulation of B cell activation,BP,
12685,GO:0050879,1,0.573273383460265,0,26,multicellular organismal movement,BP,
12687,GO:0050881,1,0.573273383460265,0,26,musculoskeletal movement,BP,
12688,GO:0050882,1,0.889470259522235,0,6,voluntary musculoskeletal movement,BP,
12689,GO:0050884,1,0.842714256613611,0,8,neuromuscular process controlling posture,BP,
12690,GO:0050885,1,0.572388920736029,0,26,neuromuscular process controlling balance,BP,
12691,GO:0050886,1,0.411549801272969,0,40,endocrine process,BP,
12695,GO:0050893,1,0.933240322446744,0,3,sensory processing,BP,
12697,GO:0050897,1,0.979903954714144,0,1,cobalt ion binding,MF,
12699,GO:0050901,1,0.804005927498151,0,10,leukocyte tethering or rolling,BP,
12700,GO:0050904,1,0.957777852049355,0,2,diapedesis,BP,
12701,GO:0050905,1,0.377678599942939,0,45,neuromuscular process,BP,
12702,GO:0050906,1,0.557308668252138,0,26,detection of stimulus involved in sensory perception,BP,
12703,GO:0050907,1,0.791971575846605,0,10,detection of chemical stimulus involved in sensory perception,BP,
12704,GO:0050908,1,0.918005102297648,0,4,detection of light stimulus involved in visual perception,BP,
12705,GO:0050909,1,0.761636274628186,0,12,sensory perception of taste,BP,
12706,GO:0050910,1,0.95852300475588,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
12707,GO:0050911,1,0.931389910460792,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
12708,GO:0050912,1,0.869151041438182,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12709,GO:0050913,1,0.853538774846276,0,7,sensory perception of bitter taste,BP,
12710,GO:0050915,1,0.977336572808046,0,1,sensory perception of sour taste,BP,
12711,GO:0050916,1,0.93787577129993,0,3,sensory perception of sweet taste,BP,
12712,GO:0050917,1,0.95974429750136,0,2,sensory perception of umami taste,BP,
12717,GO:0050922,1,0.488833849209983,0,33,negative regulation of chemotaxis,BP,
12718,GO:0050923,1,0.941043247919415,0,3,regulation of negative chemotaxis,BP,
12719,GO:0050924,1,0.979106290648909,0,1,positive regulation of negative chemotaxis,BP,
12720,GO:0050925,1,0.961127739618137,0,2,negative regulation of negative chemotaxis,BP,
12723,GO:0050928,1,0.979329690018506,0,1,negative regulation of positive chemotaxis,BP,
12724,GO:0050929,1,0.979106290648909,0,1,induction of negative chemotaxis,BP,
12727,GO:0050932,1,0.856880652777809,0,7,regulation of pigment cell differentiation,BP,
12728,GO:0050942,1,0.897522540594816,0,5,positive regulation of pigment cell differentiation,BP,
12729,GO:0050951,1,0.838881757277876,0,8,sensory perception of temperature stimulus,BP,
12732,GO:0050955,1,0.978377862362251,0,1,thermoception,BP,
12733,GO:0050957,1,0.978219729931701,0,1,equilibrioception,BP,
12734,GO:0050960,1,0.978377862362251,0,1,detection of temperature stimulus involved in thermoception,BP,
12735,GO:0050961,1,0.854427251682349,0,7,detection of temperature stimulus involved in sensory perception,BP,
12736,GO:0050962,1,0.918005102297648,0,4,detection of light stimulus involved in sensory perception,BP,
12737,GO:0050965,1,0.854427251682349,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12738,GO:0050966,1,0.958897111100163,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
12739,GO:0050968,1,0.978377862362251,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12740,GO:0050974,1,0.898188263072186,0,5,detection of mechanical stimulus involved in sensory perception,BP,
12741,GO:0050982,1,0.795575362423583,0,12,detection of mechanical stimulus,BP,
12742,GO:0050992,1,0.954491967142109,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12743,GO:0050993,1,0.954491967142109,0,2,dimethylallyl diphosphate metabolic process,BP,
12744,GO:0050994,1,0.54410268011681,0,28,regulation of lipid catabolic process,BP,
12745,GO:0050995,1,0.79964644381235,0,10,negative regulation of lipid catabolic process,BP,
12746,GO:0050996,1,0.811222438517121,0,10,positive regulation of lipid catabolic process,BP,
12748,GO:0050998,1,0.787465291864819,0,11,nitric-oxide synthase binding,MF,
12749,GO:0050999,1,0.509850776013665,0,30,regulation of nitric-oxide synthase activity,BP,
12750,GO:0051000,1,0.764772424818498,0,12,positive regulation of nitric-oxide synthase activity,BP,
12751,GO:0051001,1,0.915206749033894,0,4,negative regulation of nitric-oxide synthase activity,BP,
12754,GO:0051006,1,0.913750193096802,0,4,positive regulation of lipoprotein lipase activity,BP,
12755,GO:0051010,1,0.771588225814641,0,13,microtubule plus-end binding,MF,
12756,GO:0051011,1,0.813066882155961,0,10,microtubule minus-end binding,MF,
12757,GO:0051012,1,0.956796570417098,0,2,microtubule sliding,BP,
12758,GO:0051013,1,0.875925267925041,0,6,microtubule severing,BP,
12759,GO:0051014,1,0.878484380402053,0,6,actin filament severing,BP,
12761,GO:0051016,1,0.762879504398214,0,12,barbed-end actin filament capping,BP,
12764,GO:0051019,1,0.565765694289403,0,26,mitogen-activated protein kinase binding,MF,
12766,GO:0051021,1,0.914629908551904,0,4,GDP-dissociation inhibitor binding,MF,
12767,GO:0051022,1,0.914629908551904,0,4,Rho GDP-dissociation inhibitor binding,MF,
12768,GO:0051023,1,0.792834128845801,0,10,regulation of immunoglobulin secretion,BP,
12769,GO:0051024,1,0.889862247420923,0,5,positive regulation of immunoglobulin secretion,BP,
12770,GO:0051025,1,0.977431948995382,0,1,negative regulation of immunoglobulin secretion,BP,
12771,GO:0051026,1,0.913214340964058,0,4,chiasma assembly,BP,
12773,GO:0051029,1,0.873548967883871,0,6,rRNA transport,BP,
12774,GO:0051030,1,0.910856937218494,0,4,snRNA transport,BP,
12775,GO:0051031,1,0.486115539460543,0,33,tRNA transport,BP,
12776,GO:0051032,1,0.978188551837522,0,1,nucleic acid transmembrane transporter activity,MF,
12777,GO:0051033,1,0.978188551837522,0,1,RNA transmembrane transporter activity,MF,
12778,GO:0051036,1,0.892177976534322,0,5,regulation of endosome size,BP,
12779,GO:0051040,1,0.977480224836951,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12780,GO:0051042,1,0.977480224836951,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
12795,GO:0051057,1,0.493600856866786,0,33,positive regulation of small GTPase mediated signal transduction,BP,
12797,GO:0051059,1,0.544682590329765,0,27,NF-kappaB binding,MF,
12798,GO:0051066,1,0.954736716401375,0,2,dihydrobiopterin metabolic process,BP,
12799,GO:0051068,1,0.977845685106633,0,1,dihydrolipoamide metabolic process,BP,
12800,GO:0051081,1,0.363657117465492,0,46,nuclear envelope disassembly,BP,
12802,GO:0051083,1,0.954873060295104,0,2,'de novo' cotranslational protein folding,BP,
12805,GO:0051086,1,0.9771884822358,0,1,chaperone mediated protein folding independent of cofactor,BP,
12807,GO:0051088,1,0.935672318525495,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
12808,GO:0051089,1,0.97818659888727,0,1,constitutive protein ectodomain proteolysis,BP,
12814,GO:0051095,1,0.815672652366071,0,9,regulation of helicase activity,BP,
12815,GO:0051096,1,0.873338505570261,0,6,positive regulation of helicase activity,BP,
12816,GO:0051097,1,0.934003257209155,0,3,negative regulation of helicase activity,BP,
12821,GO:0051102,1,0.97829976864449,0,1,DNA ligation involved in DNA recombination,BP,
12822,GO:0051103,1,0.777676258764207,0,11,DNA ligation involved in DNA repair,BP,
12823,GO:0051105,1,0.872194891792484,0,6,regulation of DNA ligation,BP,
12824,GO:0051106,1,0.892426972327761,0,5,positive regulation of DNA ligation,BP,
12825,GO:0051107,1,0.977338729997246,0,1,negative regulation of DNA ligation,BP,
12826,GO:0051117,1,0.297862061507246,0,54,ATPase binding,MF,
12828,GO:0051120,1,0.955362220926073,0,2,hepoxilin A3 synthase activity,MF,
12829,GO:0051121,1,0.912390998010504,0,4,hepoxilin metabolic process,BP,
12830,GO:0051122,1,0.912390998010504,0,4,hepoxilin biosynthetic process,BP,
12831,GO:0051123,1,0.533734863359005,0,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,
12832,GO:0051124,1,0.888727169383667,0,6,synaptic growth at neuromuscular junction,BP,
12833,GO:0051125,1,0.616078470599464,0,22,regulation of actin nucleation,BP,
12834,GO:0051126,1,0.873067084009902,0,6,negative regulation of actin nucleation,BP,
12835,GO:0051127,1,0.77377770385909,0,12,positive regulation of actin nucleation,BP,
12840,GO:0051132,1,0.891189870420226,0,5,NK T cell activation,BP,
12841,GO:0051133,1,0.932271810155057,0,3,regulation of NK T cell activation,BP,
12842,GO:0051135,1,0.932271810155057,0,3,positive regulation of NK T cell activation,BP,
12843,GO:0051136,1,0.917789393669486,0,4,regulation of NK T cell differentiation,BP,
12844,GO:0051138,1,0.93742837918602,0,3,positive regulation of NK T cell differentiation,BP,
12845,GO:0051139,1,0.979485263702979,0,1,metal ion:proton antiporter activity,MF,
12846,GO:0051140,1,0.953312815118457,0,2,regulation of NK T cell proliferation,BP,
12847,GO:0051142,1,0.953312815118457,0,2,positive regulation of NK T cell proliferation,BP,
12850,GO:0051147,1,0.125901005631669,0,94,regulation of muscle cell differentiation,BP,
12851,GO:0051148,1,0.54449608435746,0,28,negative regulation of muscle cell differentiation,BP,
12852,GO:0051149,1,0.300756045883503,0,54,positive regulation of muscle cell differentiation,BP,
12853,GO:0051150,1,0.669021249373389,0,18,regulation of smooth muscle cell differentiation,BP,
12854,GO:0051151,1,0.859384683950826,0,7,negative regulation of smooth muscle cell differentiation,BP,
12855,GO:0051152,1,0.832377161542365,0,8,positive regulation of smooth muscle cell differentiation,BP,
12856,GO:0051153,1,0.273643888598423,0,59,regulation of striated muscle cell differentiation,BP,
12857,GO:0051154,1,0.648333469509663,0,20,negative regulation of striated muscle cell differentiation,BP,
12858,GO:0051155,1,0.491425923457162,0,32,positive regulation of striated muscle cell differentiation,BP,
12860,GO:0051160,1,0.977251621836658,0,1,L-xylitol catabolic process,BP,
12861,GO:0051164,1,0.977251621836658,0,1,L-xylitol metabolic process,BP,
12862,GO:0051167,1,0.890078446792012,0,5,xylulose 5-phosphate metabolic process,BP,
12870,GO:0051176,1,0.93695050801914,0,3,positive regulation of sulfur metabolic process,BP,
12871,GO:0051177,1,0.912200714105049,0,4,meiotic sister chromatid cohesion,BP,
12874,GO:0051181,1,0.517726959657904,0,29,cofactor transport,BP,
12875,GO:0051182,1,0.854580444827012,0,7,coenzyme transport,BP,
12876,GO:0051184,1,0.701071916670473,0,16,cofactor transmembrane transporter activity,MF,
12877,GO:0051185,1,0.874174314040862,0,6,coenzyme transmembrane transporter activity,MF,
12879,GO:0051187,1,0.448039126907176,0,35,cofactor catabolic process,BP,
12881,GO:0051189,1,0.852721405227592,0,7,prosthetic group metabolic process,BP,
12882,GO:0051192,1,0.951850414874843,0,2,prosthetic group binding,MF,
12884,GO:0051194,1,0.741338265462669,0,14,positive regulation of cofactor metabolic process,BP,
12887,GO:0051197,1,0.794189852686416,0,11,positive regulation of coenzyme metabolic process,BP,
12889,GO:0051204,1,0.481122485539345,0,32,protein insertion into mitochondrial membrane,BP,
12890,GO:0051205,1,0.401521220779784,0,40,protein insertion into membrane,BP,
12891,GO:0051208,1,0.224469609812803,0,70,sequestering of calcium ion,BP,
12892,GO:0051209,1,0.245391319553005,0,66,release of sequestered calcium ion into cytosol,BP,
12893,GO:0051213,1,0.200790036282285,0,73,dioxygenase activity,MF,
12896,GO:0051220,1,0.588280380666798,0,24,cytoplasmic sequestering of protein,BP,
12900,GO:0051225,1,0.114821857515631,0,99,spindle assembly,BP,
12901,GO:0051228,1,0.979259328479484,0,1,mitotic spindle disassembly,BP,
12902,GO:0051230,1,0.979259328479484,0,1,spindle disassembly,BP,
12903,GO:0051231,1,0.782476399043618,0,11,spindle elongation,BP,
12904,GO:0051232,1,0.977241427887366,0,1,meiotic spindle elongation,BP,
12905,GO:0051233,1,0.505123408945478,0,31,spindle midzone,CC,
12922,GO:0051255,1,0.798041148270732,0,10,spindle midzone assembly,BP,
12923,GO:0051256,1,0.835293749504813,0,8,mitotic spindle midzone assembly,BP,
12924,GO:0051257,1,0.977246943874661,0,1,meiotic spindle midzone assembly,BP,
12928,GO:0051261,1,0.199784376572499,0,75,protein depolymerization,BP,
12930,GO:0051264,1,0.977304790581956,0,1,mono-olein transacylation activity,MF,
12931,GO:0051265,1,0.977304790581956,0,1,diolein transacylation activity,MF,
12932,GO:0051267,1,0.977550479987897,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12937,GO:0051279,1,0.369975037182812,0,46,regulation of release of sequestered calcium ion into cytosol,BP,
12938,GO:0051280,1,0.79486645926499,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12939,GO:0051281,1,0.590267464440132,0,24,positive regulation of release of sequestered calcium ion into cytosol,BP,
12940,GO:0051282,1,0.239898717943348,0,67,regulation of sequestering of calcium ion,BP,
12941,GO:0051283,1,0.245391319553005,0,66,negative regulation of sequestering of calcium ion,BP,
12942,GO:0051284,1,0.79486645926499,0,10,positive regulation of sequestering of calcium ion,BP,
12943,GO:0051286,1,0.89802843126241,0,5,cell tip,CC,
12944,GO:0051287,1,0.303690887830761,0,52,NAD binding,MF,
12948,GO:0051292,1,0.80677491376354,0,10,nuclear pore complex assembly,BP,
12949,GO:0051293,1,0.524981323516319,0,30,establishment of spindle localization,BP,
12950,GO:0051294,1,0.605198948059342,0,23,establishment of spindle orientation,BP,
12951,GO:0051295,1,0.939270590726816,0,3,establishment of meiotic spindle localization,BP,
12952,GO:0051298,1,0.261214544453521,0,61,centrosome duplication,BP,
12953,GO:0051299,1,0.736256410828315,0,14,centrosome separation,BP,
12954,GO:0051300,1,0.977336572808046,0,1,spindle pole body organization,BP,
12958,GO:0051304,1,0.217510495834053,0,69,chromosome separation,BP,
12959,GO:0051305,1,0.897572040537207,0,5,chromosome movement towards spindle pole,BP,
12960,GO:0051306,1,0.315453004645402,0,52,mitotic sister chromatid separation,BP,
12961,GO:0051307,1,0.769559644869403,0,12,meiotic chromosome separation,BP,
12962,GO:0051308,1,0.977336572808046,0,1,male meiosis chromosome separation,BP,
12964,GO:0051311,1,0.977246943874661,0,1,meiotic metaphase plate congression,BP,
12966,GO:0051316,1,0.955084852407838,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
12970,GO:0051339,1,0.660627202576272,0,19,regulation of lyase activity,BP,
12971,GO:0051340,1,0.831104365436738,0,8,regulation of ligase activity,BP,
12973,GO:0051342,1,0.874116834389096,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12974,GO:0051343,1,0.933889252751786,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12975,GO:0051344,1,0.936012163560845,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12980,GO:0051349,1,0.84327487138651,0,8,positive regulation of lyase activity,BP,
12981,GO:0051350,1,0.820295014228362,0,9,negative regulation of lyase activity,BP,
12982,GO:0051351,1,0.850386813690984,0,7,positive regulation of ligase activity,BP,
12983,GO:0051352,1,0.977338729997246,0,1,negative regulation of ligase activity,BP,
12985,GO:0051354,1,0.799810465224825,0,10,negative regulation of oxidoreductase activity,BP,
12986,GO:0051365,1,0.977607956285531,0,1,cellular response to potassium ion starvation,BP,
12987,GO:0051371,1,0.920689692436871,0,5,muscle alpha-actinin binding,MF,
12988,GO:0051377,1,0.935550019159734,0,3,mannose-ethanolamine phosphotransferase activity,MF,
12989,GO:0051378,1,0.932833936673599,0,3,serotonin binding,MF,
12990,GO:0051379,1,0.95496025931719,0,2,epinephrine binding,MF,
12991,GO:0051380,1,0.977206121775138,0,1,norepinephrine binding,MF,
12992,GO:0051382,1,0.736035536307944,0,14,kinetochore assembly,BP,
12993,GO:0051383,1,0.659031610577395,0,19,kinetochore organization,BP,
12996,GO:0051386,1,0.856253312035537,0,7,regulation of neurotrophin TRK receptor signaling pathway,BP,
12997,GO:0051387,1,0.954978318121177,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
12998,GO:0051388,1,0.916003319018784,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12999,GO:0051389,1,0.962903911598343,0,2,inactivation of MAPKK activity,BP,
13000,GO:0051391,1,0.978203670882502,0,1,tRNA acetylation,BP,
13001,GO:0051392,1,0.978203670882502,0,1,tRNA N-acetyltransferase activity,MF,
13002,GO:0051393,1,0.812965643398987,0,11,alpha-actinin binding,MF,
13003,GO:0051400,1,0.83387668136842,0,8,BH domain binding,MF,
13006,GO:0051409,1,0.816875300878204,0,9,response to nitrosative stress,BP,
13007,GO:0051410,1,0.891214282478991,0,5,detoxification of nitrogen compound,BP,
13009,GO:0051413,1,0.97725007545978,0,1,response to cortisone,BP,
13010,GO:0051414,1,0.899255628252003,0,5,response to cortisol,BP,
13011,GO:0051415,1,0.875276965334832,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13012,GO:0051417,1,0.977336572808046,0,1,microtubule nucleation by spindle pole body,BP,
13013,GO:0051418,1,0.842076754188331,0,8,microtubule nucleation by microtubule organizing center,BP,
13014,GO:0051425,1,0.918990649432603,0,4,PTB domain binding,MF,
13017,GO:0051429,1,0.934459571568535,0,3,corticotropin-releasing hormone receptor binding,MF,
13018,GO:0051430,1,0.95658100870382,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
13019,GO:0051431,1,0.97687828832373,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
13020,GO:0051433,1,0.97874639877077,0,1,BH2 domain binding,MF,
13021,GO:0051434,1,0.912398181078422,0,4,BH3 domain binding,MF,
13022,GO:0051438,1,0.338714989753284,0,48,regulation of ubiquitin-protein transferase activity,BP,
13023,GO:0051443,1,0.50846786625993,0,30,positive regulation of ubiquitin-protein transferase activity,BP,
13024,GO:0051444,1,0.742496594511892,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
13025,GO:0051445,1,0.548237426939853,0,27,regulation of meiotic cell cycle,BP,
13026,GO:0051446,1,0.820469930390362,0,9,positive regulation of meiotic cell cycle,BP,
13027,GO:0051447,1,0.798828194654124,0,10,negative regulation of meiotic cell cycle,BP,
13030,GO:0051452,1,0.432730474721606,0,37,intracellular pH reduction,BP,
13031,GO:0051453,1,0.255169149784954,0,61,regulation of intracellular pH,BP,
13032,GO:0051454,1,0.934033778120509,0,3,intracellular pH elevation,BP,
13033,GO:0051455,1,0.977336572808046,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13034,GO:0051456,1,0.977234223585788,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13035,GO:0051457,1,0.614462704373629,0,22,maintenance of protein location in nucleus,BP,
13036,GO:0051458,1,0.957022021382159,0,2,corticotropin secretion,BP,
13037,GO:0051459,1,0.957022021382159,0,2,regulation of corticotropin secretion,BP,
13038,GO:0051461,1,0.957022021382159,0,2,positive regulation of corticotropin secretion,BP,
13039,GO:0051462,1,0.956435536992941,0,2,regulation of cortisol secretion,BP,
13040,GO:0051463,1,0.980100617401322,0,1,negative regulation of cortisol secretion,BP,
13041,GO:0051464,1,0.97585624064459,0,1,positive regulation of cortisol secretion,BP,
13042,GO:0051466,1,0.977531669431364,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13043,GO:0051480,1,0.0438146909311901,0,143,regulation of cytosolic calcium ion concentration,BP,
13044,GO:0051481,1,0.926722622134656,0,4,negative regulation of cytosolic calcium ion concentration,BP,
13045,GO:0051482,1,0.776213314606083,0,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
13046,GO:0051489,1,0.531168402985052,0,29,regulation of filopodium assembly,BP,
13047,GO:0051490,1,0.933246718073642,0,3,negative regulation of filopodium assembly,BP,
13048,GO:0051491,1,0.619510429462125,0,22,positive regulation of filopodium assembly,BP,
13051,GO:0051494,1,0.118010240086674,0,98,negative regulation of cytoskeleton organization,BP,
13054,GO:0051497,1,0.756175733697648,0,13,negative regulation of stress fiber assembly,BP,
13055,GO:0051499,1,0.95461162694526,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13056,GO:0051500,1,0.95461162694526,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13057,GO:0051503,1,0.760211486518579,0,12,adenine nucleotide transport,BP,
13058,GO:0051525,1,0.961631057135436,0,2,NFAT protein binding,MF,
13059,GO:0051536,1,0.250624688490194,0,61,iron-sulfur cluster binding,MF,
13060,GO:0051537,1,0.648436236039642,0,19,2 iron, 2 sulfur cluster binding,MF,
13061,GO:0051538,1,0.933112226932268,0,3,3 iron, 4 sulfur cluster binding,MF,
13062,GO:0051539,1,0.395304893980712,0,41,4 iron, 4 sulfur cluster binding,MF,
13063,GO:0051540,1,0.250624688490194,0,61,metal cluster binding,MF,
13064,GO:0051541,1,0.91580429431552,0,4,elastin metabolic process,BP,
13065,GO:0051542,1,0.959343719298257,0,2,elastin biosynthetic process,BP,
13066,GO:0051543,1,0.97724051499366,0,1,regulation of elastin biosynthetic process,BP,
13067,GO:0051545,1,0.97724051499366,0,1,negative regulation of elastin biosynthetic process,BP,
13069,GO:0051547,1,0.843426724274358,0,8,regulation of keratinocyte migration,BP,
13070,GO:0051548,1,0.960925606915626,0,2,negative regulation of keratinocyte migration,BP,
13071,GO:0051549,1,0.877740411255761,0,6,positive regulation of keratinocyte migration,BP,
13072,GO:0051552,1,0.977240461154453,0,1,flavone metabolic process,BP,
13073,GO:0051560,1,0.663528112798488,0,18,mitochondrial calcium ion homeostasis,BP,
13074,GO:0051561,1,0.812055069574707,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13075,GO:0051562,1,0.95521593375848,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
13076,GO:0051563,1,0.958138428491772,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13077,GO:0051567,1,0.574123387620338,0,26,histone H3-K9 methylation,BP,
13080,GO:0051570,1,0.697381103490613,0,17,regulation of histone H3-K9 methylation,BP,
13081,GO:0051571,1,0.737916136309151,0,14,positive regulation of histone H3-K4 methylation,BP,
13082,GO:0051572,1,0.939308504559369,0,3,negative regulation of histone H3-K4 methylation,BP,
13083,GO:0051573,1,0.822318321373629,0,9,negative regulation of histone H3-K9 methylation,BP,
13084,GO:0051574,1,0.863220161007233,0,7,positive regulation of histone H3-K9 methylation,BP,
13085,GO:0051575,1,0.895996140103065,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13087,GO:0051581,1,0.936812480751083,0,3,negative regulation of neurotransmitter uptake,BP,
13088,GO:0051582,1,0.954699632823036,0,2,positive regulation of neurotransmitter uptake,BP,
13091,GO:0051585,1,0.97749444321181,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13092,GO:0051586,1,0.976941636519895,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13095,GO:0051590,1,0.682774550794978,0,17,positive regulation of neurotransmitter transport,BP,
13098,GO:0051593,1,0.834169384603629,0,8,response to folic acid,BP,
13099,GO:0051595,1,0.93477477013895,0,3,response to methylglyoxal,BP,
13100,GO:0051596,1,0.954860242865957,0,2,methylglyoxal catabolic process,BP,
13101,GO:0051597,1,0.878811660800774,0,6,response to methylmercury,BP,
13102,GO:0051598,1,0.978793085453212,0,1,meiotic recombination checkpoint,BP,
13103,GO:0051599,1,0.920512830526107,0,4,response to hydrostatic pressure,BP,
13104,GO:0051601,1,0.85411713254308,0,7,exocyst localization,BP,
13105,GO:0051602,1,0.673822601651864,0,18,response to electrical stimulus,BP,
13108,GO:0051606,1,0.0780897235103523,0,114,detection of stimulus,BP,
13110,GO:0051608,1,0.812297479256828,0,9,histamine transport,BP,
13111,GO:0051610,1,0.938269190051983,0,3,serotonin uptake,BP,
13112,GO:0051611,1,0.958653005030552,0,2,regulation of serotonin uptake,BP,
13113,GO:0051612,1,0.958653005030552,0,2,negative regulation of serotonin uptake,BP,
13114,GO:0051615,1,0.979606195814574,0,1,histamine uptake,BP,
13115,GO:0051620,1,0.97749444321181,0,1,norepinephrine uptake,BP,
13116,GO:0051621,1,0.97749444321181,0,1,regulation of norepinephrine uptake,BP,
13117,GO:0051622,1,0.97749444321181,0,1,negative regulation of norepinephrine uptake,BP,
13118,GO:0051639,1,0.838951409290975,0,8,actin filament network formation,BP,
13122,GO:0051643,1,0.902474540522744,0,5,endoplasmic reticulum localization,BP,
13123,GO:0051645,1,0.770005476517214,0,12,Golgi localization,BP,
13124,GO:0051646,1,0.466750004326656,0,35,mitochondrion localization,BP,
13125,GO:0051647,1,0.686471606909499,0,18,nucleus localization,BP,
13130,GO:0051653,1,0.48283863886918,0,34,spindle localization,BP,
13131,GO:0051654,1,0.648692476691222,0,20,establishment of mitochondrion localization,BP,
13133,GO:0051657,1,0.850125192504742,0,8,maintenance of organelle location,BP,
13134,GO:0051660,1,0.917031730134067,0,4,establishment of centrosome localization,BP,
13135,GO:0051661,1,0.905719298672262,0,5,maintenance of centrosome location,BP,
13136,GO:0051664,1,0.956250505555545,0,2,nuclear pore localization,BP,
13138,GO:0051666,1,0.938285230881025,0,3,actin cortical patch localization,BP,
13140,GO:0051673,1,0.954621725822874,0,2,membrane disruption in other organism,BP,
13142,GO:0051683,1,0.85382828981346,0,7,establishment of Golgi localization,BP,
13143,GO:0051684,1,0.938639579463347,0,3,maintenance of Golgi location,BP,
13144,GO:0051685,1,0.977336572808046,0,1,maintenance of ER location,BP,
13145,GO:0051686,1,0.984153306469647,0,1,establishment of ER localization,BP,
13146,GO:0051693,1,0.638819424929775,0,21,actin filament capping,BP,
13147,GO:0051694,1,0.959748097941665,0,2,pointed-end actin filament capping,BP,
13148,GO:0051697,1,0.911906115485463,0,4,protein delipidation,BP,
13150,GO:0051702,1,0.305209059305566,0,53,interaction with symbiont,BP,
13151,GO:0051703,1,0.518856656637504,0,31,intraspecies interaction between organisms,BP,
13153,GO:0051705,1,0.444769894825289,0,38,multi-organism behavior,BP,
13155,GO:0051708,1,0.953407760728623,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
13156,GO:0051709,1,0.850474023013529,0,7,regulation of killing of cells of other organism,BP,
13157,GO:0051710,1,0.954176976775803,0,2,regulation of cytolysis in other organism,BP,
13158,GO:0051712,1,0.850474023013529,0,7,positive regulation of killing of cells of other organism,BP,
13159,GO:0051714,1,0.954176976775803,0,2,positive regulation of cytolysis in other organism,BP,
13160,GO:0051715,1,0.930557222476165,0,3,cytolysis in other organism,BP,
13162,GO:0051717,1,0.957326957527797,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13163,GO:0051721,1,0.575764446253581,0,25,protein phosphatase 2A binding,MF,
13164,GO:0051722,1,0.977246410255625,0,1,protein C-terminal methylesterase activity,MF,
13165,GO:0051723,1,0.977246410255625,0,1,protein methylesterase activity,MF,
13166,GO:0051724,1,0.977234999346512,0,1,NAD transmembrane transporter activity,MF,
13167,GO:0051725,1,0.954848613083508,0,2,protein de-ADP-ribosylation,BP,
13169,GO:0051728,1,0.977383416774801,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13170,GO:0051729,1,0.977383416774801,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13171,GO:0051731,1,0.917730418590706,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13172,GO:0051732,1,0.977094753002521,0,1,polyribonucleotide kinase activity,MF,
13173,GO:0051733,1,0.93607074636704,0,3,polydeoxyribonucleotide kinase activity,MF,
13174,GO:0051734,1,0.93607074636704,0,3,ATP-dependent polynucleotide kinase activity,MF,
13175,GO:0051736,1,0.977094753002521,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13176,GO:0051747,1,0.953655249931286,0,2,cytosine C-5 DNA demethylase activity,MF,
13177,GO:0051748,1,0.97722369219082,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13178,GO:0051750,1,0.976624973023742,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13179,GO:0051754,1,0.934513145415515,0,3,meiotic sister chromatid cohesion, centromeric,BP,
13180,GO:0051764,1,0.786140991905537,0,11,actin crosslink formation,BP,
13181,GO:0051765,1,0.955191450693796,0,2,inositol tetrakisphosphate kinase activity,MF,
13182,GO:0051766,1,0.895470426623276,0,5,inositol trisphosphate kinase activity,MF,
13183,GO:0051767,1,0.79800430175717,0,10,nitric-oxide synthase biosynthetic process,BP,
13184,GO:0051769,1,0.79800430175717,0,10,regulation of nitric-oxide synthase biosynthetic process,BP,
13185,GO:0051770,1,0.85603170548979,0,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13186,GO:0051771,1,0.932251705477459,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13188,GO:0051780,1,0.978381611755302,0,1,behavioral response to nutrient,BP,
13191,GO:0051783,1,0.0329922168611321,0,154,regulation of nuclear division,BP,
13192,GO:0051784,1,0.353058491698954,0,47,negative regulation of nuclear division,BP,
13193,GO:0051785,1,0.373113399366074,0,45,positive regulation of nuclear division,BP,
13194,GO:0051786,1,0.977606333754223,0,1,all-trans-retinol 13,14-reductase activity,MF,
13197,GO:0051790,1,0.912915698686434,0,4,short-chain fatty acid biosynthetic process,BP,
13198,GO:0051791,1,0.854743473751578,0,7,medium-chain fatty acid metabolic process,BP,
13199,GO:0051792,1,0.915560295125333,0,4,medium-chain fatty acid biosynthetic process,BP,
13200,GO:0051793,1,0.937788127702404,0,3,medium-chain fatty acid catabolic process,BP,
13201,GO:0051794,1,0.913799450787491,0,4,regulation of timing of catagen,BP,
13202,GO:0051795,1,0.933867992643155,0,3,positive regulation of timing of catagen,BP,
13203,GO:0051796,1,0.978515768926212,0,1,negative regulation of timing of catagen,BP,
13206,GO:0051799,1,0.937118070051201,0,3,negative regulation of hair follicle development,BP,
13207,GO:0051800,1,0.979546636342451,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13208,GO:0051805,1,0.957034319356571,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13210,GO:0051807,1,0.957034319356571,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
13211,GO:0051808,1,0.97724364867942,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
13212,GO:0051817,1,0.176914551299158,0,78,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
13213,GO:0051818,1,0.870870757541628,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13214,GO:0051821,1,0.980178763984006,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13215,GO:0051823,1,0.915008396004904,0,4,regulation of synapse structural plasticity,BP,
13217,GO:0051832,1,0.916356812184139,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13218,GO:0051833,1,0.979287790694437,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13219,GO:0051834,1,0.916356812184139,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
13220,GO:0051835,1,0.936241919112917,0,3,positive regulation of synapse structural plasticity,BP,
13221,GO:0051836,1,0.813608170117567,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13222,GO:0051851,1,0.333150699618914,0,49,modification by host of symbiont morphology or physiology,BP,
13223,GO:0051852,1,0.911033155979998,0,4,disruption by host of symbiont cells,BP,
13225,GO:0051864,1,0.843347747089753,0,8,histone demethylase activity (H3-K36 specific),MF,
13226,GO:0051865,1,0.318363808154666,0,52,protein autoubiquitination,BP,
13227,GO:0051866,1,0.977794446841555,0,1,general adaptation syndrome,BP,
13228,GO:0051870,1,0.978167046268588,0,1,methotrexate binding,MF,
13229,GO:0051873,1,0.911033155979998,0,4,killing by host of symbiont cells,BP,
13231,GO:0051877,1,0.955261480435445,0,2,pigment granule aggregation in cell center,BP,
13232,GO:0051879,1,0.499748987416632,0,31,Hsp90 protein binding,MF,
13233,GO:0051880,1,0.86325593323283,0,7,G-quadruplex DNA binding,MF,
13234,GO:0051881,1,0.330849572242908,0,48,regulation of mitochondrial membrane potential,BP,
13235,GO:0051882,1,0.708834042725691,0,15,mitochondrial depolarization,BP,
13236,GO:0051883,1,0.870870757541628,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13237,GO:0051884,1,0.91731347168322,0,4,regulation of timing of anagen,BP,
13238,GO:0051885,1,0.979762027781853,0,1,positive regulation of timing of anagen,BP,
13239,GO:0051886,1,0.979247205637664,0,1,negative regulation of timing of anagen,BP,
13240,GO:0051890,1,0.958207762516938,0,2,regulation of cardioblast differentiation,BP,
13241,GO:0051891,1,0.979276497862459,0,1,positive regulation of cardioblast differentiation,BP,
13242,GO:0051892,1,0.978487084078203,0,1,negative regulation of cardioblast differentiation,BP,
13244,GO:0051894,1,0.653414240982365,0,20,positive regulation of focal adhesion assembly,BP,
13245,GO:0051895,1,0.772378170704644,0,12,negative regulation of focal adhesion assembly,BP,
13248,GO:0051898,1,0.471585017252897,0,34,negative regulation of protein kinase B signaling,BP,
13249,GO:0051899,1,0.325742330535182,0,51,membrane depolarization,BP,
13250,GO:0051900,1,0.741154722655047,0,13,regulation of mitochondrial depolarization,BP,
13251,GO:0051901,1,0.889786315861149,0,5,positive regulation of mitochondrial depolarization,BP,
13252,GO:0051902,1,0.891862294252583,0,5,negative regulation of mitochondrial depolarization,BP,
13253,GO:0051903,1,0.977265812951165,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13256,GO:0051908,1,0.977517691181985,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13259,GO:0051919,1,0.977210306330478,0,1,positive regulation of fibrinolysis,BP,
13260,GO:0051920,1,0.826601683678089,0,8,peroxiredoxin activity,MF,
13261,GO:0051923,1,0.81790216667109,0,9,sulfation,BP,
13265,GO:0051930,1,0.734133509121332,0,14,regulation of sensory perception of pain,BP,
13266,GO:0051931,1,0.734133509121332,0,14,regulation of sensory perception,BP,
13267,GO:0051932,1,0.664268647882807,0,19,synaptic transmission, GABAergic,BP,
13275,GO:0051944,1,0.976941636519895,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
13276,GO:0051945,1,0.97749444321181,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13279,GO:0051953,1,0.893621433689682,0,5,negative regulation of amine transport,BP,
13282,GO:0051956,1,0.935299526553825,0,3,negative regulation of amino acid transport,BP,
13283,GO:0051957,1,0.87531062715521,0,6,positive regulation of amino acid transport,BP,
13284,GO:0051958,1,0.958005876693282,0,2,methotrexate transport,BP,
13290,GO:0051964,1,0.918533642185477,0,4,negative regulation of synapse assembly,BP,
13292,GO:0051966,1,0.593781509998534,0,24,regulation of synaptic transmission, glutamatergic,BP,
13293,GO:0051967,1,0.932938053002136,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
13294,GO:0051968,1,0.757359830911088,0,13,positive regulation of synaptic transmission, glutamatergic,BP,
13295,GO:0051969,1,0.916843157979647,0,4,regulation of transmission of nerve impulse,BP,
13296,GO:0051971,1,0.958925810599106,0,2,positive regulation of transmission of nerve impulse,BP,
13299,GO:0051974,1,0.832891634629052,0,8,negative regulation of telomerase activity,BP,
13302,GO:0051983,1,0.141879722928836,0,89,regulation of chromosome segregation,BP,
13303,GO:0051984,1,0.565795697440277,0,26,positive regulation of chromosome segregation,BP,
13304,GO:0051985,1,0.454345623520058,0,36,negative regulation of chromosome segregation,BP,
13305,GO:0051987,1,0.895070672307166,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13306,GO:0051988,1,0.768208141963205,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13307,GO:0051990,1,0.955013046052989,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
13308,GO:0051996,1,0.977218762474379,0,1,squalene synthase activity,MF,
13309,GO:0051998,1,0.853964717941893,0,7,protein carboxyl O-methyltransferase activity,MF,
13310,GO:0052027,1,0.957327308573078,0,2,modulation by symbiont of host signal transduction pathway,BP,
13311,GO:0052029,1,0.979287790694437,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13312,GO:0052031,1,0.934857719325141,0,3,modulation by symbiont of host defense response,BP,
13313,GO:0052037,1,0.979287790694437,0,1,negative regulation by symbiont of host defense response,BP,
13314,GO:0052040,1,0.872383116736495,0,6,modulation by symbiont of host programmed cell death,BP,
13315,GO:0052041,1,0.912330467483676,0,4,negative regulation by symbiont of host programmed cell death,BP,
13316,GO:0052042,1,0.933640936044419,0,3,positive regulation by symbiont of host programmed cell death,BP,
13317,GO:0052047,1,0.981612568936993,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13318,GO:0052053,1,0.977290481899322,0,1,negative regulation by symbiont of host catalytic activity,BP,
13319,GO:0052055,1,0.957046906177807,0,2,modulation by symbiont of host molecular function,BP,
13320,GO:0052056,1,0.957046906177807,0,2,negative regulation by symbiont of host molecular function,BP,
13321,GO:0052066,1,0.980578682093857,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13322,GO:0052097,1,0.97757836626664,0,1,interspecies quorum sensing,BP,
13323,GO:0052106,1,0.97757836626664,0,1,quorum sensing involved in interaction with host,BP,
13325,GO:0052148,1,0.977290481899322,0,1,modulation by symbiont of host catalytic activity,BP,
13326,GO:0052150,1,0.893215721434331,0,5,modulation by symbiont of host apoptotic process,BP,
13327,GO:0052151,1,0.95593063389646,0,2,positive regulation by symbiont of host apoptotic process,BP,
13328,GO:0052167,1,0.979287790694437,0,1,modulation by symbiont of host innate immune response,BP,
13329,GO:0052170,1,0.979287790694437,0,1,negative regulation by symbiont of host innate immune response,BP,
13330,GO:0052173,1,0.87461139733818,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13331,GO:0052190,1,0.980578682093857,0,1,modulation by symbiont of host phagocytosis,BP,
13332,GO:0052191,1,0.980578682093857,0,1,positive regulation by symbiont of host phagocytosis,BP,
13334,GO:0052199,1,0.954986273827277,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13335,GO:0052200,1,0.87461139733818,0,6,response to host defenses,BP,
13336,GO:0052203,1,0.93310804968383,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13337,GO:0052204,1,0.871651908745217,0,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13338,GO:0052205,1,0.85440177585099,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13339,GO:0052214,1,0.977019004885083,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13340,GO:0052227,1,0.977019004885083,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13341,GO:0052229,1,0.977019004885083,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13342,GO:0052231,1,0.980578682093857,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13343,GO:0052248,1,0.872383116736495,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13344,GO:0052250,1,0.957327308573078,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
13345,GO:0052251,1,0.954633709137921,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13346,GO:0052255,1,0.934857719325141,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13347,GO:0052261,1,0.979287790694437,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13348,GO:0052306,1,0.979287790694437,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13349,GO:0052309,1,0.979287790694437,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13350,GO:0052312,1,0.587667640039499,0,24,modulation of transcription in other organism involved in symbiotic interaction,BP,
13351,GO:0052314,1,0.977169675328271,0,1,phytoalexin metabolic process,BP,
13352,GO:0052330,1,0.933640936044419,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13353,GO:0052360,1,0.977019004885083,0,1,catabolism by host of symbiont macromolecule,BP,
13354,GO:0052361,1,0.977019004885083,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13355,GO:0052362,1,0.977019004885083,0,1,catabolism by host of symbiont protein,BP,
13356,GO:0052363,1,0.977019004885083,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13357,GO:0052364,1,0.977019004885083,0,1,catabolism by host of substance in symbiont,BP,
13358,GO:0052370,1,0.980578682093857,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13359,GO:0052381,1,0.977222146725524,0,1,tRNA dimethylallyltransferase activity,MF,
13360,GO:0052403,1,0.977179450989824,0,1,negative regulation by host of symbiont catalytic activity,BP,
13361,GO:0052405,1,0.91078644776995,0,4,negative regulation by host of symbiont molecular function,BP,
13362,GO:0052416,1,0.977019004885083,0,1,metabolism by host of symbiont macromolecule,BP,
13363,GO:0052417,1,0.977019004885083,0,1,metabolism by host of symbiont protein,BP,
13364,GO:0052418,1,0.977019004885083,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13365,GO:0052419,1,0.977019004885083,0,1,metabolism by host of substance in symbiont,BP,
13366,GO:0052422,1,0.954794702812007,0,2,modulation by host of symbiont catalytic activity,BP,
13367,GO:0052428,1,0.892764786583716,0,5,modulation by host of symbiont molecular function,BP,
13368,GO:0052433,1,0.872383116736495,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13369,GO:0052472,1,0.587667640039499,0,24,modulation by host of symbiont transcription,BP,
13370,GO:0052490,1,0.912330467483676,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13371,GO:0052493,1,0.979287790694437,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13372,GO:0052501,1,0.933640936044419,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13373,GO:0052509,1,0.954633709137921,0,2,positive regulation by symbiont of host defense response,BP,
13374,GO:0052510,1,0.954633709137921,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13375,GO:0052522,1,0.980578682093857,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
13378,GO:0052550,1,0.977050793171147,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13379,GO:0052552,1,0.934857719325141,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13380,GO:0052553,1,0.934857719325141,0,3,modulation by symbiont of host immune response,BP,
13381,GO:0052561,1,0.979287790694437,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13382,GO:0052562,1,0.979287790694437,0,1,negative regulation by symbiont of host immune response,BP,
13383,GO:0052564,1,0.89263655276505,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13384,GO:0052567,1,0.977050793171147,0,1,response to defense-related host reactive oxygen species production,BP,
13385,GO:0052572,1,0.89263655276505,0,5,response to host immune response,BP,
13386,GO:0052590,1,0.979829165235173,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13387,GO:0052591,1,0.979829165235173,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13388,GO:0052593,1,0.956022667783823,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13389,GO:0052594,1,0.956022667783823,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13390,GO:0052595,1,0.956022667783823,0,2,aliphatic-amine oxidase activity,MF,
13391,GO:0052596,1,0.956022667783823,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13392,GO:0052629,1,0.795418044242399,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13393,GO:0052642,1,0.977130583230793,0,1,lysophosphatidic acid phosphatase activity,MF,
13394,GO:0052646,1,0.842720662991152,0,8,alditol phosphate metabolic process,BP,
13395,GO:0052650,1,0.850680759728838,0,7,NADP-retinol dehydrogenase activity,MF,
13396,GO:0052651,1,0.954967982182065,0,2,monoacylglycerol catabolic process,BP,
13398,GO:0052654,1,0.958952381526928,0,2,L-leucine transaminase activity,MF,
13399,GO:0052655,1,0.958952381526928,0,2,L-valine transaminase activity,MF,
13400,GO:0052656,1,0.958952381526928,0,2,L-isoleucine transaminase activity,MF,
13401,GO:0052657,1,0.976808759499397,0,1,guanine phosphoribosyltransferase activity,MF,
13402,GO:0052658,1,0.877477431432226,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13403,GO:0052659,1,0.822027665601908,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13404,GO:0052666,1,0.977186760389047,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
13406,GO:0052692,1,0.976812100469062,0,1,raffinose alpha-galactosidase activity,MF,
13407,GO:0052695,1,0.853117478969973,0,7,cellular glucuronidation,BP,
13408,GO:0052696,1,0.891224796060667,0,5,flavonoid glucuronidation,BP,
13409,GO:0052697,1,0.891224796060667,0,5,xenobiotic glucuronidation,BP,
13410,GO:0052717,1,0.980071073247669,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13411,GO:0052718,1,0.980071073247669,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13412,GO:0052723,1,0.916915717609613,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13413,GO:0052724,1,0.916915717609613,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13414,GO:0052725,1,0.977558902737606,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13415,GO:0052726,1,0.977558902737606,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13416,GO:0052735,1,0.937258381860396,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
13417,GO:0052739,1,0.977212161545791,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13418,GO:0052740,1,0.977212161545791,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
13420,GO:0052743,1,0.786923933890085,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13421,GO:0052744,1,0.744769499239425,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13422,GO:0052745,1,0.660139875659044,0,19,inositol phosphate phosphatase activity,MF,
13423,GO:0052746,1,0.956661902602636,0,2,inositol phosphorylation,BP,
13424,GO:0052794,1,0.955014432118077,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13425,GO:0052795,1,0.955014432118077,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13426,GO:0052796,1,0.955014432118077,0,2,exo-alpha-(2->8)-sialidase activity,MF,
13427,GO:0052798,1,0.977217229594296,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
13428,GO:0052803,1,0.890952491940315,0,5,imidazole-containing compound metabolic process,BP,
13429,GO:0052805,1,0.932471033593407,0,3,imidazole-containing compound catabolic process,BP,
13430,GO:0052810,1,0.977988711058768,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13431,GO:0052811,1,0.917596177504688,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13432,GO:0052812,1,0.957613994197047,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13434,GO:0052815,1,0.976476000886788,0,1,medium-chain acyl-CoA hydrolase activity,MF,
13435,GO:0052821,1,0.976369312322026,0,1,DNA-7-methyladenine glycosylase activity,MF,
13436,GO:0052822,1,0.976369312322026,0,1,DNA-3-methylguanine glycosylase activity,MF,
13437,GO:0052825,1,0.977558902737606,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13438,GO:0052826,1,0.977318107723408,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13439,GO:0052827,1,0.955384147437378,0,2,inositol pentakisphosphate phosphatase activity,MF,
13440,GO:0052828,1,0.959162434431509,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13441,GO:0052829,1,0.977216192453007,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
13442,GO:0052830,1,0.977558902737606,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13443,GO:0052831,1,0.977558902737606,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13444,GO:0052832,1,0.915628296581455,0,4,inositol monophosphate 3-phosphatase activity,MF,
13445,GO:0052833,1,0.915628296581455,0,4,inositol monophosphate 4-phosphatase activity,MF,
13446,GO:0052834,1,0.915628296581455,0,4,inositol monophosphate phosphatase activity,MF,
13447,GO:0052835,1,0.977558902737606,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13448,GO:0052836,1,0.95573042753753,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13449,GO:0052839,1,0.95573042753753,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
13450,GO:0052840,1,0.91310481226447,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13451,GO:0052841,1,0.91310481226447,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13452,GO:0052842,1,0.91310481226447,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13453,GO:0052843,1,0.91310481226447,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13454,GO:0052844,1,0.91310481226447,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13455,GO:0052845,1,0.91310481226447,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13456,GO:0052846,1,0.91310481226447,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13457,GO:0052847,1,0.91310481226447,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13458,GO:0052848,1,0.91310481226447,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13459,GO:0052851,1,0.895869228814857,0,5,ferric-chelate reductase (NADPH) activity,MF,
13460,GO:0052858,1,0.977835354577982,0,1,peptidyl-lysine acetyltransferase activity,MF,
13461,GO:0052866,1,0.573320237036676,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13462,GO:0052890,1,0.977174864359116,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
13463,GO:0052894,1,0.977213145582803,0,1,norspermine:oxygen oxidoreductase activity,MF,
13464,GO:0052895,1,0.977213145582803,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
13465,GO:0052899,1,0.977062668863997,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13466,GO:0052901,1,0.954796565456556,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
13467,GO:0052902,1,0.977062668863997,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13468,GO:0052903,1,0.977062668863997,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13469,GO:0052904,1,0.977062668863997,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13470,GO:0052905,1,0.933533439989935,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13471,GO:0052906,1,0.97933974135811,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13472,GO:0052907,1,0.977336572808046,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13473,GO:0052909,1,0.977336572808046,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13474,GO:0052917,1,0.977241481608143,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13475,GO:0052918,1,0.980102462912112,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13476,GO:0052925,1,0.976914639972925,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
13477,GO:0052926,1,0.980102462912112,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13478,GO:0052927,1,0.977235739684677,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13479,GO:0052928,1,0.977235739684677,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13480,GO:0052929,1,0.977235739684677,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
13483,GO:0055003,1,0.867842118975697,0,8,cardiac myofibril assembly,BP,
13484,GO:0055005,1,0.979485263702979,0,1,ventricular cardiac myofibril assembly,BP,
13496,GO:0055018,1,0.977115191442785,0,1,regulation of cardiac muscle fiber development,BP,
13497,GO:0055020,1,0.977115191442785,0,1,positive regulation of cardiac muscle fiber development,BP,
13500,GO:0055023,1,0.680829216278761,0,18,positive regulation of cardiac muscle tissue growth,BP,
13502,GO:0055025,1,0.583347505769177,0,25,positive regulation of cardiac muscle tissue development,BP,
13504,GO:0055028,1,0.980765369020107,0,1,cortical microtubule,CC,
13505,GO:0055029,1,0.0572524172765087,0,127,nuclear DNA-directed RNA polymerase complex,CC,
13506,GO:0055037,1,0.0418184306590956,0,143,recycling endosome,CC,
13507,GO:0055038,1,0.241322279749781,0,63,recycling endosome membrane,CC,
13508,GO:0055048,1,0.980765369020107,0,1,anastral spindle assembly,BP,
13510,GO:0055057,1,0.808058171090571,0,10,neuroblast division,BP,
13511,GO:0055059,1,0.917230002185362,0,4,asymmetric neuroblast division,BP,
13512,GO:0055062,1,0.882543525093918,0,6,phosphate ion homeostasis,BP,
13513,GO:0055064,1,0.824666784785941,0,9,chloride ion homeostasis,BP,
13517,GO:0055070,1,0.697721298953046,0,16,copper ion homeostasis,BP,
13522,GO:0055077,1,0.955292052943267,0,2,gap junction hemi-channel activity,MF,
13523,GO:0055078,1,0.754686660398863,0,13,sodium ion homeostasis,BP,
13527,GO:0055083,1,0.727738306830999,0,15,monovalent inorganic anion homeostasis,BP,
13530,GO:0055087,1,0.935652523094808,0,3,Ski complex,CC,
13532,GO:0055089,1,0.785345242795389,0,11,fatty acid homeostasis,BP,
13534,GO:0055091,1,0.921361415924953,0,4,phospholipid homeostasis,BP,
13537,GO:0055094,1,0.70396665808762,0,16,response to lipoprotein particle,BP,
13538,GO:0055095,1,0.978083672960096,0,1,lipoprotein particle mediated signaling,BP,
13539,GO:0055096,1,0.978083672960096,0,1,low-density lipoprotein particle mediated signaling,BP,
13540,GO:0055100,1,0.934977456487999,0,3,adiponectin binding,MF,
13541,GO:0055102,1,0.830401538364105,0,8,lipase inhibitor activity,MF,
13542,GO:0055103,1,0.977550479987897,0,1,ligase regulator activity,MF,
13543,GO:0055105,1,0.86567942446754,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13544,GO:0055106,1,0.688715352924666,0,16,ubiquitin-protein transferase regulator activity,MF,
13545,GO:0055108,1,0.977192073118987,0,1,Golgi to transport vesicle transport,BP,
13546,GO:0055113,1,0.98337155848032,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13549,GO:0055118,1,0.936365825705314,0,3,negative regulation of cardiac muscle contraction,BP,
13551,GO:0055120,1,0.976307662974524,0,1,striated muscle dense body,CC,
13553,GO:0055129,1,0.912194629611591,0,4,L-proline biosynthetic process,BP,
13554,GO:0055131,1,0.890977453128741,0,5,C3HC4-type RING finger domain binding,MF,
13555,GO:0060001,1,0.981818019171465,0,1,minus-end directed microfilament motor activity,MF,
13556,GO:0060002,1,0.962097927156391,0,2,plus-end directed microfilament motor activity,MF,
13557,GO:0060003,1,0.96218893718623,0,2,copper ion export,BP,
13558,GO:0060004,1,0.787938007433823,0,11,reflex,BP,
13559,GO:0060005,1,0.958223484938643,0,2,vestibular reflex,BP,
13560,GO:0060007,1,0.978415670520972,0,1,linear vestibuloocular reflex,BP,
13563,GO:0060010,1,0.977609174873298,0,1,Sertoli cell fate commitment,BP,
13564,GO:0060011,1,0.934525880933992,0,3,Sertoli cell proliferation,BP,
13565,GO:0060012,1,0.977531669431364,0,1,synaptic transmission, glycinergic,BP,
13566,GO:0060013,1,0.898584459826049,0,5,righting reflex,BP,
13567,GO:0060014,1,0.97734492320892,0,1,granulosa cell differentiation,BP,
13568,GO:0060017,1,0.896034210341338,0,5,parathyroid gland development,BP,
13571,GO:0060020,1,0.876200552126572,0,6,Bergmann glial cell differentiation,BP,
13573,GO:0060022,1,0.89878977636354,0,5,hard palate development,BP,
13574,GO:0060023,1,0.918192815793862,0,4,soft palate development,BP,
13575,GO:0060024,1,0.957228058249942,0,2,rhythmic synaptic transmission,BP,
13576,GO:0060025,1,0.956563721129914,0,2,regulation of synaptic activity,BP,
13577,GO:0060026,1,0.788505689034468,0,11,convergent extension,BP,
13578,GO:0060027,1,0.858632144536794,0,7,convergent extension involved in gastrulation,BP,
13579,GO:0060028,1,0.896969909439545,0,5,convergent extension involved in axis elongation,BP,
13580,GO:0060029,1,0.916640218209669,0,4,convergent extension involved in organogenesis,BP,
13581,GO:0060031,1,0.979762027781853,0,1,mediolateral intercalation,BP,
13582,GO:0060032,1,0.980454992691561,0,1,notochord regression,BP,
13583,GO:0060033,1,0.879150760716033,0,6,anatomical structure regression,BP,
13592,GO:0060045,1,0.771494748132609,0,12,positive regulation of cardiac muscle cell proliferation,BP,
13593,GO:0060046,1,0.893335764910933,0,5,regulation of acrosome reaction,BP,
13596,GO:0060049,1,0.787921475142309,0,11,regulation of protein glycosylation,BP,
13597,GO:0060050,1,0.84122508751615,0,8,positive regulation of protein glycosylation,BP,
13598,GO:0060051,1,0.954901341931584,0,2,negative regulation of protein glycosylation,BP,
13599,GO:0060052,1,0.854152361610256,0,7,neurofilament cytoskeleton organization,BP,
13600,GO:0060053,1,0.958217446017379,0,2,neurofilament cytoskeleton,CC,
13601,GO:0060054,1,0.935059620504097,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,
13603,GO:0060056,1,0.852497141212965,0,7,mammary gland involution,BP,
13604,GO:0060057,1,0.934706239719594,0,3,apoptotic process involved in mammary gland involution,BP,
13605,GO:0060058,1,0.934706239719594,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
13606,GO:0060059,1,0.932421455717346,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13607,GO:0060060,1,0.980717007502023,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13608,GO:0060061,1,0.957642413131682,0,2,Spemann organizer formation,BP,
13609,GO:0060064,1,0.976892464585118,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
13611,GO:0060066,1,0.955281944757397,0,2,oviduct development,BP,
13612,GO:0060067,1,0.979762027781853,0,1,cervix development,BP,
13613,GO:0060068,1,0.87695542714126,0,6,vagina development,BP,
13615,GO:0060071,1,0.108612184234131,0,99,Wnt signaling pathway, planar cell polarity pathway,BP,
13616,GO:0060072,1,0.980086218384538,0,1,large conductance calcium-activated potassium channel activity,MF,
13617,GO:0060073,1,0.918001010687682,0,4,micturition,BP,
13618,GO:0060074,1,0.822028701635613,0,9,synapse maturation,BP,
13619,GO:0060075,1,0.93585665400646,0,3,regulation of resting membrane potential,BP,
13620,GO:0060076,1,0.74447179431274,0,14,excitatory synapse,CC,
13621,GO:0060077,1,0.821447218219135,0,9,inhibitory synapse,CC,
13622,GO:0060078,1,0.347883284966036,0,48,regulation of postsynaptic membrane potential,BP,
13623,GO:0060079,1,0.39456474082895,0,42,excitatory postsynaptic potential,BP,
13624,GO:0060080,1,0.882872473650308,0,6,inhibitory postsynaptic potential,BP,
13626,GO:0060083,1,0.958893071808354,0,2,smooth muscle contraction involved in micturition,BP,
13627,GO:0060084,1,0.979672264864762,0,1,synaptic transmission involved in micturition,BP,
13630,GO:0060088,1,0.895059015722167,0,5,auditory receptor cell stereocilium organization,BP,
13633,GO:0060091,1,0.891830921504469,0,5,kinocilium,CC,
13634,GO:0060092,1,0.977531669431364,0,1,regulation of synaptic transmission, glycinergic,BP,
13635,GO:0060099,1,0.899481531886757,0,5,regulation of phagocytosis, engulfment,BP,
13636,GO:0060100,1,0.899481531886757,0,5,positive regulation of phagocytosis, engulfment,BP,
13638,GO:0060117,1,0.78762008409595,0,11,auditory receptor cell development,BP,
13642,GO:0060123,1,0.922394489265968,0,4,regulation of growth hormone secretion,BP,
13643,GO:0060124,1,0.957379688489772,0,2,positive regulation of growth hormone secretion,BP,
13644,GO:0060125,1,0.980100617401322,0,1,negative regulation of growth hormone secretion,BP,
13645,GO:0060126,1,0.955880729335152,0,2,somatotropin secreting cell differentiation,BP,
13646,GO:0060127,1,0.977232789220866,0,1,prolactin secreting cell differentiation,BP,
13647,GO:0060128,1,0.977480224836951,0,1,corticotropin hormone secreting cell differentiation,BP,
13648,GO:0060129,1,0.956122778488393,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
13649,GO:0060134,1,0.957362735538488,0,2,prepulse inhibition,BP,
13651,GO:0060136,1,0.916505005365547,0,4,embryonic process involved in female pregnancy,BP,
13652,GO:0060137,1,0.872784033054034,0,6,maternal process involved in parturition,BP,
13653,GO:0060139,1,0.95593063389646,0,2,positive regulation of apoptotic process by virus,BP,
13654,GO:0060142,1,0.762512572609244,0,12,regulation of syncytium formation by plasma membrane fusion,BP,
13655,GO:0060143,1,0.780330625300347,0,11,positive regulation of syncytium formation by plasma membrane fusion,BP,
13657,GO:0060148,1,0.642171533327592,0,20,positive regulation of posttranscriptional gene silencing,BP,
13659,GO:0060151,1,0.957786712865917,0,2,peroxisome localization,BP,
13660,GO:0060152,1,0.957786712865917,0,2,microtubule-based peroxisome localization,BP,
13661,GO:0060154,1,0.934176107071555,0,3,cellular process regulating host cell cycle in response to virus,BP,
13663,GO:0060156,1,0.977465363898827,0,1,milk ejection reflex,BP,
13664,GO:0060157,1,0.959012681201047,0,2,urinary bladder development,BP,
13665,GO:0060158,1,0.911706600723975,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13666,GO:0060159,1,0.912225092241665,0,4,regulation of dopamine receptor signaling pathway,BP,
13667,GO:0060161,1,0.933862376377437,0,3,positive regulation of dopamine receptor signaling pathway,BP,
13669,GO:0060166,1,0.955091829845633,0,2,olfactory pit development,BP,
13670,GO:0060167,1,0.976933244458608,0,1,regulation of adenosine receptor signaling pathway,BP,
13671,GO:0060169,1,0.976933244458608,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13673,GO:0060171,1,0.978926281474837,0,1,stereocilium membrane,CC,
13676,GO:0060178,1,0.977234510015904,0,1,regulation of exocyst localization,BP,
13677,GO:0060179,1,0.935390543055479,0,3,male mating behavior,BP,
13678,GO:0060180,1,0.936902249681987,0,3,female mating behavior,BP,
13679,GO:0060183,1,0.977531669431364,0,1,apelin receptor signaling pathway,BP,
13680,GO:0060184,1,0.977383416774801,0,1,cell cycle switching,BP,
13681,GO:0060187,1,0.958684784376919,0,2,cell pole,CC,
13684,GO:0060193,1,0.503380256753473,0,31,positive regulation of lipase activity,BP,
13685,GO:0060197,1,0.956421693405231,0,2,cloacal septation,BP,
13686,GO:0060198,1,0.872663281680288,0,6,clathrin-sculpted vesicle,CC,
13687,GO:0060199,1,0.956673047953677,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13688,GO:0060200,1,0.978970842470338,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13689,GO:0060201,1,0.978970842470338,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13690,GO:0060203,1,0.956673047953677,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
13695,GO:0060214,1,0.976948078006485,0,1,endocardium formation,BP,
13696,GO:0060215,1,0.894745527327627,0,5,primitive hemopoiesis,BP,
13701,GO:0060228,1,0.952338093061652,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
13702,GO:0060229,1,0.836244252057383,0,8,lipase activator activity,MF,
13704,GO:0060232,1,0.912269149128917,0,4,delamination,BP,
13705,GO:0060235,1,0.944646459204626,0,3,lens induction in camera-type eye,BP,
13706,GO:0060236,1,0.4700295433771,0,35,regulation of mitotic spindle organization,BP,
13707,GO:0060242,1,0.854763330704828,0,7,contact inhibition,BP,
13708,GO:0060244,1,0.933682826939841,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
13709,GO:0060245,1,0.97799455983445,0,1,detection of cell density,BP,
13710,GO:0060246,1,0.97799455983445,0,1,detection of cell density by contact stimulus,BP,
13711,GO:0060248,1,0.97799455983445,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13714,GO:0060252,1,0.840698654107,0,8,positive regulation of glial cell proliferation,BP,
13717,GO:0060259,1,0.842861017916102,0,8,regulation of feeding behavior,BP,
13718,GO:0060260,1,0.600205837826034,0,23,regulation of transcription initiation from RNA polymerase II promoter,BP,
13719,GO:0060261,1,0.686294137746405,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13720,GO:0060263,1,0.836550939172385,0,8,regulation of respiratory burst,BP,
13721,GO:0060264,1,0.95375820242249,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13722,GO:0060265,1,0.975980020389663,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
13723,GO:0060266,1,0.95375820242249,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
13724,GO:0060267,1,0.936616741751222,0,3,positive regulation of respiratory burst,BP,
13725,GO:0060268,1,0.935184211963074,0,3,negative regulation of respiratory burst,BP,
13728,GO:0060278,1,0.977226843172614,0,1,regulation of ovulation,BP,
13729,GO:0060279,1,0.977226843172614,0,1,positive regulation of ovulation,BP,
13730,GO:0060281,1,0.857501461983603,0,7,regulation of oocyte development,BP,
13731,GO:0060282,1,0.936306595858639,0,3,positive regulation of oocyte development,BP,
13732,GO:0060283,1,0.95894964215503,0,2,negative regulation of oocyte development,BP,
13734,GO:0060285,1,0.725378162029726,0,15,cilium-dependent cell motility,BP,
13735,GO:0060287,1,0.914309878178379,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13736,GO:0060290,1,0.979815377247189,0,1,transdifferentiation,BP,
13737,GO:0060291,1,0.429647413291863,0,39,long-term synaptic potentiation,BP,
13738,GO:0060292,1,0.72248002434361,0,15,long term synaptic depression,BP,
13739,GO:0060293,1,0.853074788515475,0,7,germ plasm,CC,
13740,GO:0060294,1,0.813144647009992,0,9,cilium movement involved in cell motility,BP,
13741,GO:0060295,1,0.891512466307973,0,5,regulation of cilium movement involved in cell motility,BP,
13742,GO:0060296,1,0.891512466307973,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
13743,GO:0060297,1,0.944434502850296,0,3,regulation of sarcomere organization,BP,
13744,GO:0060298,1,0.958977178695198,0,2,positive regulation of sarcomere organization,BP,
13746,GO:0060301,1,0.977248066779519,0,1,positive regulation of cytokine activity,BP,
13748,GO:0060304,1,0.902837374511486,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13749,GO:0060306,1,0.714387108395274,0,16,regulation of membrane repolarization,BP,
13750,GO:0060307,1,0.808209882453532,0,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
13751,GO:0060309,1,0.975847258136945,0,1,elastin catabolic process,BP,
13752,GO:0060310,1,0.975847258136945,0,1,regulation of elastin catabolic process,BP,
13753,GO:0060311,1,0.975847258136945,0,1,negative regulation of elastin catabolic process,BP,
13754,GO:0060312,1,0.874946710071737,0,6,regulation of blood vessel remodeling,BP,
13755,GO:0060313,1,0.937064670045449,0,3,negative regulation of blood vessel remodeling,BP,
13756,GO:0060314,1,0.689310195263653,0,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,
13757,GO:0060315,1,0.831396716393641,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13758,GO:0060316,1,0.855570692654513,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13760,GO:0060318,1,0.916716347214179,0,4,definitive erythrocyte differentiation,BP,
13761,GO:0060319,1,0.955831261621976,0,2,primitive erythrocyte differentiation,BP,
13767,GO:0060327,1,0.977336572808046,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13769,GO:0060331,1,0.873556058933855,0,6,negative regulation of response to interferon-gamma,BP,
13770,GO:0060332,1,0.940716197423228,0,3,positive regulation of response to interferon-gamma,BP,
13773,GO:0060335,1,0.940716197423228,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13774,GO:0060336,1,0.873556058933855,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13776,GO:0060338,1,0.530161478982151,0,29,regulation of type I interferon-mediated signaling pathway,BP,
13777,GO:0060339,1,0.858372324357258,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13778,GO:0060340,1,0.82546533185501,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13780,GO:0060342,1,0.977160369896457,0,1,photoreceptor inner segment membrane,CC,
13788,GO:0060352,1,0.893031671664918,0,5,cell adhesion molecule production,BP,
13789,GO:0060353,1,0.932863423752184,0,3,regulation of cell adhesion molecule production,BP,
13790,GO:0060355,1,0.932863423752184,0,3,positive regulation of cell adhesion molecule production,BP,
13792,GO:0060363,1,0.854978041840512,0,7,cranial suture morphogenesis,BP,
13793,GO:0060364,1,0.916208370275228,0,4,frontal suture morphogenesis,BP,
13794,GO:0060366,1,0.981489937335134,0,1,lambdoid suture morphogenesis,BP,
13795,GO:0060367,1,0.981489937335134,0,1,sagittal suture morphogenesis,BP,
13796,GO:0060368,1,0.873516573229958,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13797,GO:0060369,1,0.91469551767239,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13798,GO:0060370,1,0.979701846522245,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13799,GO:0060371,1,0.935448250087729,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13800,GO:0060372,1,0.981712707428526,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13801,GO:0060373,1,0.91350208839294,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13802,GO:0060374,1,0.935849396333611,0,3,mast cell differentiation,BP,
13803,GO:0060375,1,0.977550479987897,0,1,regulation of mast cell differentiation,BP,
13804,GO:0060377,1,0.977550479987897,0,1,negative regulation of mast cell differentiation,BP,
13805,GO:0060378,1,0.98117982635878,0,1,regulation of brood size,BP,
13806,GO:0060379,1,0.85835287725522,0,7,cardiac muscle cell myoblast differentiation,BP,
13807,GO:0060380,1,0.977211244715833,0,1,regulation of single-stranded telomeric DNA binding,BP,
13808,GO:0060381,1,0.977211244715833,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
13809,GO:0060382,1,0.958984678111111,0,2,regulation of DNA strand elongation,BP,
13810,GO:0060383,1,0.978337815426243,0,1,positive regulation of DNA strand elongation,BP,
13811,GO:0060384,1,0.725025658717922,0,15,innervation,BP,
13812,GO:0060385,1,0.957342999018987,0,2,axonogenesis involved in innervation,BP,
13813,GO:0060386,1,0.979681255929253,0,1,synapse assembly involved in innervation,BP,
13815,GO:0060390,1,0.735600766886804,0,14,regulation of SMAD protein signal transduction,BP,
13816,GO:0060391,1,0.787099080769241,0,11,positive regulation of SMAD protein signal transduction,BP,
13817,GO:0060392,1,0.954537327001854,0,2,negative regulation of SMAD protein signal transduction,BP,
13822,GO:0060397,1,0.804100564791724,0,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
13823,GO:0060398,1,0.93935025760716,0,3,regulation of growth hormone receptor signaling pathway,BP,
13824,GO:0060399,1,0.959673711810115,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13825,GO:0060400,1,0.978825783950159,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13827,GO:0060402,1,0.179222415423593,0,80,calcium ion transport into cytosol,BP,
13828,GO:0060405,1,0.934442525976465,0,3,regulation of penile erection,BP,
13829,GO:0060406,1,0.956509746626236,0,2,positive regulation of penile erection,BP,
13830,GO:0060407,1,0.976933244458608,0,1,negative regulation of penile erection,BP,
13833,GO:0060413,1,0.809463347756369,0,10,atrial septum morphogenesis,BP,
13834,GO:0060414,1,0.960956536436997,0,2,aorta smooth muscle tissue morphogenesis,BP,
13839,GO:0060421,1,0.638593780383546,0,21,positive regulation of heart growth,BP,
13840,GO:0060423,1,0.955438359923704,0,2,foregut regionalization,BP,
13841,GO:0060424,1,0.955438359923704,0,2,lung field specification,BP,
13846,GO:0060430,1,0.961226226107366,0,2,lung saccule development,BP,
13847,GO:0060431,1,0.934216967236477,0,3,primary lung bud formation,BP,
13849,GO:0060434,1,0.956580898219736,0,2,bronchus morphogenesis,BP,
13851,GO:0060437,1,0.955105071050661,0,2,lung growth,BP,
13854,GO:0060440,1,0.873272612478773,0,6,trachea formation,BP,
13856,GO:0060442,1,0.823052994598024,0,9,branching involved in prostate gland morphogenesis,BP,
13857,GO:0060443,1,0.469489491938503,0,35,mammary gland morphogenesis,BP,
13858,GO:0060444,1,0.650451745046037,0,20,branching involved in mammary gland duct morphogenesis,BP,
13860,GO:0060447,1,0.981064490262434,0,1,bud outgrowth involved in lung branching,BP,
13861,GO:0060448,1,0.941085967171737,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
13862,GO:0060449,1,0.874186098129394,0,6,bud elongation involved in lung branching,BP,
13864,GO:0060453,1,0.893650069793705,0,5,regulation of gastric acid secretion,BP,
13865,GO:0060454,1,0.978377862362251,0,1,positive regulation of gastric acid secretion,BP,
13866,GO:0060455,1,0.955013119150496,0,2,negative regulation of gastric acid secretion,BP,
13867,GO:0060456,1,0.934640976292963,0,3,positive regulation of digestive system process,BP,
13868,GO:0060457,1,0.879561930189385,0,6,negative regulation of digestive system process,BP,
13869,GO:0060459,1,0.977232789220866,0,1,left lung development,BP,
13870,GO:0060460,1,0.977232789220866,0,1,left lung morphogenesis,BP,
13871,GO:0060462,1,0.897890311292229,0,5,lung lobe development,BP,
13872,GO:0060463,1,0.897890311292229,0,5,lung lobe morphogenesis,BP,
13873,GO:0060465,1,0.977716725298581,0,1,pharynx development,BP,
13874,GO:0060467,1,0.976779281456844,0,1,negative regulation of fertilization,BP,
13875,GO:0060474,1,0.953434620257836,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
13876,GO:0060478,1,0.954488545498601,0,2,acrosomal vesicle exocytosis,BP,
13883,GO:0060486,1,0.959108985982233,0,2,Clara cell differentiation,BP,
13885,GO:0060488,1,0.963371285293039,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13886,GO:0060489,1,0.963371285293039,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13887,GO:0060490,1,0.963371285293039,0,2,lateral sprouting involved in lung morphogenesis,BP,
13889,GO:0060492,1,0.955438359923704,0,2,lung induction,BP,
13890,GO:0060501,1,0.913732959896613,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13892,GO:0060503,1,0.977115191442785,0,1,bud dilation involved in lung branching,BP,
13893,GO:0060509,1,0.903175880065548,0,5,Type I pneumocyte differentiation,BP,
13894,GO:0060510,1,0.958440135315971,0,2,Type II pneumocyte differentiation,BP,
13899,GO:0060523,1,0.958907504098508,0,2,prostate epithelial cord elongation,BP,
13900,GO:0060525,1,0.846836798662578,0,8,prostate glandular acinus development,BP,
13901,GO:0060526,1,0.920169042396552,0,4,prostate glandular acinus morphogenesis,BP,
13902,GO:0060527,1,0.920169042396552,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13903,GO:0060528,1,0.940245141760028,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
13904,GO:0060529,1,0.957621299414374,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13911,GO:0060539,1,0.893768957254832,0,5,diaphragm development,BP,
13913,GO:0060542,1,0.979715688418652,0,1,regulation of strand invasion,BP,
13914,GO:0060544,1,0.647029000424479,0,19,regulation of necroptotic process,BP,
13915,GO:0060545,1,0.955790867154093,0,2,positive regulation of necroptotic process,BP,
13916,GO:0060546,1,0.816450577445292,0,9,negative regulation of necroptotic process,BP,
13917,GO:0060547,1,0.797468261917524,0,10,negative regulation of necrotic cell death,BP,
13920,GO:0060557,1,0.954465608371977,0,2,positive regulation of vitamin D biosynthetic process,BP,
13921,GO:0060558,1,0.893271290002749,0,5,regulation of calcidiol 1-monooxygenase activity,BP,
13922,GO:0060559,1,0.954465608371977,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
13924,GO:0060561,1,0.675320374156843,0,18,apoptotic process involved in morphogenesis,BP,
13927,GO:0060566,1,0.98339437073446,0,1,positive regulation of DNA-templated transcription, termination,BP,
13930,GO:0060573,1,0.942136662152308,0,3,cell fate specification involved in pattern specification,BP,
13934,GO:0060577,1,0.977232789220866,0,1,pulmonary vein morphogenesis,BP,
13935,GO:0060578,1,0.977232789220866,0,1,superior vena cava morphogenesis,BP,
13936,GO:0060579,1,0.942136662152308,0,3,ventral spinal cord interneuron fate commitment,BP,
13937,GO:0060581,1,0.942136662152308,0,3,cell fate commitment involved in pattern specification,BP,
13938,GO:0060584,1,0.956398610484097,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13939,GO:0060585,1,0.956398610484097,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
13940,GO:0060586,1,0.917318305659077,0,4,multicellular organismal iron ion homeostasis,BP,
13943,GO:0060591,1,0.93667533010507,0,3,chondroblast differentiation,BP,
13944,GO:0060592,1,0.918470597714918,0,4,mammary gland formation,BP,
13945,GO:0060594,1,0.960230027615833,0,2,mammary gland specification,BP,
13946,GO:0060595,1,0.978340654938138,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13947,GO:0060596,1,0.978921720490555,0,1,mammary placode formation,BP,
13948,GO:0060598,1,0.976584984177392,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
13949,GO:0060599,1,0.979762027781853,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13950,GO:0060600,1,0.810836127902319,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
13953,GO:0060603,1,0.587339090646489,0,25,mammary gland duct morphogenesis,BP,
13954,GO:0060605,1,0.936675177042521,0,3,tube lumen cavitation,BP,
13956,GO:0060611,1,0.977244427651838,0,1,mammary gland fat development,BP,
13957,GO:0060612,1,0.575719808533966,0,25,adipose tissue development,BP,
13958,GO:0060613,1,0.877135054159357,0,6,fat pad development,BP,
13959,GO:0060615,1,0.978340654938138,0,1,mammary gland bud formation,BP,
13960,GO:0060620,1,0.977336572808046,0,1,regulation of cholesterol import,BP,
13961,GO:0060623,1,0.933943586001895,0,3,regulation of chromosome condensation,BP,
13963,GO:0060628,1,0.766282977545365,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
13964,GO:0060631,1,0.934321443205707,0,3,regulation of meiosis I,BP,
13965,GO:0060632,1,0.726859271638865,0,14,regulation of microtubule-based movement,BP,
13966,GO:0060633,1,0.914457579765619,0,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
13969,GO:0060648,1,0.978340654938138,0,1,mammary gland bud morphogenesis,BP,
13970,GO:0060661,1,0.97722651415779,0,1,submandibular salivary gland formation,BP,
13971,GO:0060662,1,0.936675177042521,0,3,salivary gland cavitation,BP,
13972,GO:0060664,1,0.934437844391143,0,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
13973,GO:0060665,1,0.979615972568209,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
13974,GO:0060666,1,0.902855647295116,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13975,GO:0060667,1,0.978340654938138,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13976,GO:0060668,1,0.977875948852643,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13977,GO:0060669,1,0.61358858904589,0,22,embryonic placenta morphogenesis,BP,
13978,GO:0060670,1,0.799295554374179,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13979,GO:0060671,1,0.935423243747083,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13980,GO:0060672,1,0.935423243747083,0,3,epithelial cell morphogenesis involved in placental branching,BP,
13984,GO:0060677,1,0.904172365083404,0,5,ureteric bud elongation,BP,
13985,GO:0060678,1,0.97723479144629,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
13986,GO:0060681,1,0.936606470726018,0,3,branch elongation involved in ureteric bud branching,BP,
13987,GO:0060683,1,0.977293524652512,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
13988,GO:0060684,1,0.912635491015641,0,4,epithelial-mesenchymal cell signaling,BP,
13989,GO:0060685,1,0.936540637010352,0,3,regulation of prostatic bud formation,BP,
13990,GO:0060686,1,0.936540637010352,0,3,negative regulation of prostatic bud formation,BP,
13991,GO:0060687,1,0.878678560466239,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
13993,GO:0060689,1,0.937424701125362,0,3,cell differentiation involved in salivary gland development,BP,
13994,GO:0060690,1,0.977127370618276,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13995,GO:0060691,1,0.977127370618276,0,1,epithelial cell maturation involved in salivary gland development,BP,
13997,GO:0060694,1,0.977150839933651,0,1,regulation of cholesterol transporter activity,BP,
13998,GO:0060696,1,0.891425980672632,0,5,regulation of phospholipid catabolic process,BP,
13999,GO:0060697,1,0.977298954147329,0,1,positive regulation of phospholipid catabolic process,BP,
14000,GO:0060698,1,0.956356947974619,0,2,endoribonuclease inhibitor activity,MF,
14001,GO:0060699,1,0.912855927205979,0,4,regulation of endoribonuclease activity,BP,
14002,GO:0060700,1,0.816269645876149,0,9,regulation of ribonuclease activity,BP,
14003,GO:0060701,1,0.956356947974619,0,2,negative regulation of ribonuclease activity,BP,
14004,GO:0060702,1,0.956356947974619,0,2,negative regulation of endoribonuclease activity,BP,
14005,GO:0060703,1,0.977278942128016,0,1,deoxyribonuclease inhibitor activity,MF,
14008,GO:0060708,1,0.933610406533162,0,3,spongiotrophoblast differentiation,BP,
14009,GO:0060709,1,0.97732503311907,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14010,GO:0060710,1,0.873277515758887,0,6,chorio-allantoic fusion,BP,
14012,GO:0060712,1,0.770838893089041,0,12,spongiotrophoblast layer development,BP,
14013,GO:0060713,1,0.668327747644526,0,18,labyrinthine layer morphogenesis,BP,
14014,GO:0060715,1,0.936188430961395,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14016,GO:0060717,1,0.859115667585815,0,7,chorion development,BP,
14017,GO:0060718,1,0.898971296481379,0,5,chorionic trophoblast cell differentiation,BP,
14018,GO:0060720,1,0.957931374120895,0,2,spongiotrophoblast cell proliferation,BP,
14019,GO:0060721,1,0.957931374120895,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14020,GO:0060722,1,0.957931374120895,0,2,cell proliferation involved in embryonic placenta development,BP,
14021,GO:0060723,1,0.957931374120895,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14023,GO:0060730,1,0.97757836626664,0,1,regulation of intestinal epithelial structure maintenance,BP,
14024,GO:0060731,1,0.97757836626664,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14025,GO:0060732,1,0.874683656497133,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
14026,GO:0060733,1,0.958005796362084,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14027,GO:0060734,1,0.978840149938804,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14028,GO:0060735,1,0.976750064800153,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14031,GO:0060739,1,0.981064490262434,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14033,GO:0060742,1,0.840742738406163,0,8,epithelial cell differentiation involved in prostate gland development,BP,
14034,GO:0060743,1,0.977254118099066,0,1,epithelial cell maturation involved in prostate gland development,BP,
14035,GO:0060744,1,0.896401725085107,0,5,mammary gland branching involved in thelarche,BP,
14036,GO:0060745,1,0.921063507255615,0,4,mammary gland branching involved in pregnancy,BP,
14037,GO:0060746,1,0.856055311699955,0,7,parental behavior,BP,
14038,GO:0060748,1,0.978152358173514,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14040,GO:0060750,1,0.920406584119993,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14041,GO:0060751,1,0.899442342037847,0,5,branch elongation involved in mammary gland duct branching,BP,
14042,GO:0060753,1,0.871777004094728,0,6,regulation of mast cell chemotaxis,BP,
14043,GO:0060754,1,0.892433221616989,0,5,positive regulation of mast cell chemotaxis,BP,
14045,GO:0060760,1,0.441072505370084,0,37,positive regulation of response to cytokine stimulus,BP,
14047,GO:0060762,1,0.915006051249863,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14048,GO:0060763,1,0.957876171508378,0,2,mammary duct terminal end bud growth,BP,
14050,GO:0060765,1,0.613252847782063,0,22,regulation of androgen receptor signaling pathway,BP,
14051,GO:0060766,1,0.83723589958486,0,8,negative regulation of androgen receptor signaling pathway,BP,
14053,GO:0060768,1,0.835888661762744,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14054,GO:0060769,1,0.977699138804462,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14055,GO:0060770,1,0.870422398406427,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14056,GO:0060775,1,0.979762027781853,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14058,GO:0060788,1,0.803218229062021,0,10,ectodermal placode formation,BP,
14059,GO:0060789,1,0.873399031123417,0,6,hair follicle placode formation,BP,
14060,GO:0060795,1,0.683143282634077,0,17,cell fate commitment involved in formation of primary germ layer,BP,
14061,GO:0060800,1,0.957892276469561,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14062,GO:0060804,1,0.977480224836951,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14063,GO:0060809,1,0.979762027781853,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14064,GO:0060816,1,0.961128722457731,0,2,random inactivation of X chromosome,BP,
14065,GO:0060819,1,0.960740242443134,0,2,inactivation of X chromosome by genetic imprinting,BP,
14066,GO:0060821,1,0.981833277045491,0,1,inactivation of X chromosome by DNA methylation,BP,
14067,GO:0060823,1,0.977676153662534,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14070,GO:0060830,1,0.934556637992815,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14071,GO:0060831,1,0.755317117441283,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14073,GO:0060837,1,0.877691688969001,0,6,blood vessel endothelial cell differentiation,BP,
14077,GO:0060841,1,0.800304686373823,0,11,venous blood vessel development,BP,
14078,GO:0060842,1,0.938394720427143,0,3,arterial endothelial cell differentiation,BP,
14079,GO:0060843,1,0.982252137884812,0,1,venous endothelial cell differentiation,BP,
14080,GO:0060844,1,0.955353088205001,0,2,arterial endothelial cell fate commitment,BP,
14081,GO:0060846,1,0.933613270713367,0,3,blood vessel endothelial cell fate commitment,BP,
14082,GO:0060847,1,0.933613270713367,0,3,endothelial cell fate specification,BP,
14085,GO:0060853,1,0.977604713806028,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14087,GO:0060857,1,0.977235805361382,0,1,establishment of glial blood-brain barrier,BP,
14088,GO:0060872,1,0.902102992137803,0,5,semicircular canal development,BP,
14089,GO:0060873,1,0.981489937335134,0,1,anterior semicircular canal development,BP,
14090,GO:0060875,1,0.981489937335134,0,1,lateral semicircular canal development,BP,
14091,GO:0060876,1,0.977245145809998,0,1,semicircular canal formation,BP,
14092,GO:0060887,1,0.977336572808046,0,1,limb epidermis development,BP,
14095,GO:0060900,1,0.867240575697554,0,7,embryonic camera-type eye formation,BP,
14096,GO:0060901,1,0.978515768926212,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14097,GO:0060903,1,0.955845210189976,0,2,positive regulation of meiosis I,BP,
14098,GO:0060904,1,0.978215840467631,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14099,GO:0060907,1,0.935504690424463,0,3,positive regulation of macrophage cytokine production,BP,
14100,GO:0060911,1,0.852846728763485,0,7,cardiac cell fate commitment,BP,
14101,GO:0060912,1,0.977336572808046,0,1,cardiac cell fate specification,BP,
14102,GO:0060913,1,0.977278500836114,0,1,cardiac cell fate determination,BP,
14104,GO:0060915,1,0.978340654938138,0,1,mesenchymal cell differentiation involved in lung development,BP,
14105,GO:0060916,1,0.918204269250618,0,4,mesenchymal cell proliferation involved in lung development,BP,
14106,GO:0060920,1,0.939348811399654,0,3,cardiac pacemaker cell differentiation,BP,
14107,GO:0060921,1,0.95884003687115,0,2,sinoatrial node cell differentiation,BP,
14108,GO:0060922,1,0.979675262318631,0,1,atrioventricular node cell differentiation,BP,
14109,GO:0060923,1,0.892930873916411,0,5,cardiac muscle cell fate commitment,BP,
14110,GO:0060926,1,0.939348811399654,0,3,cardiac pacemaker cell development,BP,
14111,GO:0060928,1,0.979675262318631,0,1,atrioventricular node cell development,BP,
14112,GO:0060931,1,0.95884003687115,0,2,sinoatrial node cell development,BP,
14113,GO:0060932,1,0.978921720490555,0,1,His-Purkinje system cell differentiation,BP,
14114,GO:0060935,1,0.936697104760812,0,3,cardiac fibroblast cell differentiation,BP,
14115,GO:0060936,1,0.936697104760812,0,3,cardiac fibroblast cell development,BP,
14116,GO:0060938,1,0.936697104760812,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14117,GO:0060939,1,0.936697104760812,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14118,GO:0060940,1,0.955621509127686,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14119,GO:0060947,1,0.918515020273042,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14120,GO:0060948,1,0.960428843012661,0,2,cardiac vascular smooth muscle cell development,BP,
14121,GO:0060956,1,0.921161494500731,0,4,endocardial cell differentiation,BP,
14122,GO:0060957,1,0.977368081221408,0,1,endocardial cell fate commitment,BP,
14129,GO:0060971,1,0.939917340478953,0,3,embryonic heart tube left/right pattern formation,BP,
14130,GO:0060972,1,0.706578977246185,0,16,left/right pattern formation,BP,
14132,GO:0060976,1,0.527896864381324,0,30,coronary vasculature development,BP,
14133,GO:0060977,1,0.814909543296548,0,10,coronary vasculature morphogenesis,BP,
14134,GO:0060978,1,0.957848065029568,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
14135,GO:0060979,1,0.944316665557202,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14136,GO:0060982,1,0.863521426611914,0,7,coronary artery morphogenesis,BP,
14137,GO:0060986,1,0.604519683596884,0,23,endocrine hormone secretion,BP,
14138,GO:0060987,1,0.977238478814369,0,1,lipid tube,CC,
14139,GO:0060988,1,0.956175301979391,0,2,lipid tube assembly,BP,
14140,GO:0060992,1,0.786965888997189,0,11,response to fungicide,BP,
14142,GO:0060994,1,0.955577274854704,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14143,GO:0060995,1,0.957216438815259,0,2,cell-cell signaling involved in kidney development,BP,
14147,GO:0060999,1,0.526125567759396,0,30,positive regulation of dendritic spine development,BP,
14148,GO:0061000,1,0.844533774358639,0,8,negative regulation of dendritic spine development,BP,
14150,GO:0061002,1,0.938841316016537,0,3,negative regulation of dendritic spine morphogenesis,BP,
14151,GO:0061003,1,0.774598153347903,0,12,positive regulation of dendritic spine morphogenesis,BP,
14152,GO:0061004,1,0.851226121076917,0,7,pattern specification involved in kidney development,BP,
14156,GO:0061010,1,0.982813836561076,0,1,gall bladder development,BP,
14159,GO:0061015,1,0.95395161394343,0,2,snRNA import into nucleus,BP,
14162,GO:0061028,1,0.486399972031087,0,33,establishment of endothelial barrier,BP,
14163,GO:0061029,1,0.787364939150837,0,11,eyelid development in camera-type eye,BP,
14164,GO:0061030,1,0.978251716857322,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14165,GO:0061031,1,0.977232789220866,0,1,endodermal digestive tract morphogenesis,BP,
14166,GO:0061032,1,0.9773907392528,0,1,visceral serous pericardium development,BP,
14167,GO:0061034,1,0.978533881700099,0,1,olfactory bulb mitral cell layer development,BP,
14171,GO:0061038,1,0.926074299204521,0,4,uterus morphogenesis,BP,
14172,GO:0061040,1,0.981876228906368,0,1,female gonad morphogenesis,BP,
14179,GO:0061047,1,0.93356963392953,0,3,positive regulation of branching involved in lung morphogenesis,BP,
14180,GO:0061048,1,0.977040650790622,0,1,negative regulation of branching involved in lung morphogenesis,BP,
14181,GO:0061049,1,0.755898870478722,0,13,cell growth involved in cardiac muscle cell development,BP,
14182,GO:0061050,1,0.805860440588567,0,10,regulation of cell growth involved in cardiac muscle cell development,BP,
14183,GO:0061051,1,0.882588393185601,0,6,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14184,GO:0061052,1,0.913103865239487,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14186,GO:0061054,1,0.978152358173514,0,1,dermatome development,BP,
14187,GO:0061055,1,0.959213054351061,0,2,myotome development,BP,
14188,GO:0061056,1,0.977336572808046,0,1,sclerotome development,BP,
14190,GO:0061072,1,0.882009715042595,0,6,iris morphogenesis,BP,
14191,GO:0061073,1,0.957621943620304,0,2,ciliary body morphogenesis,BP,
14192,GO:0061074,1,0.954989419583485,0,2,regulation of neural retina development,BP,
14193,GO:0061075,1,0.954989419583485,0,2,positive regulation of neural retina development,BP,
14195,GO:0061078,1,0.975447519545245,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14196,GO:0061081,1,0.873530611138033,0,6,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14197,GO:0061082,1,0.715011662075179,0,15,myeloid leukocyte cytokine production,BP,
14198,GO:0061083,1,0.91389008809975,0,4,regulation of protein refolding,BP,
14199,GO:0061084,1,0.91389008809975,0,4,negative regulation of protein refolding,BP,
14200,GO:0061085,1,0.818945429702316,0,9,regulation of histone H3-K27 methylation,BP,
14201,GO:0061086,1,0.915302249790854,0,4,negative regulation of histone H3-K27 methylation,BP,
14202,GO:0061087,1,0.875125884352783,0,6,positive regulation of histone H3-K27 methylation,BP,
14204,GO:0061091,1,0.979150183380015,0,1,regulation of phospholipid translocation,BP,
14205,GO:0061092,1,0.979150183380015,0,1,positive regulation of phospholipid translocation,BP,
14206,GO:0061097,1,0.285818928774276,0,56,regulation of protein tyrosine kinase activity,BP,
14207,GO:0061098,1,0.546745172852607,0,27,positive regulation of protein tyrosine kinase activity,BP,
14208,GO:0061099,1,0.584773737291636,0,24,negative regulation of protein tyrosine kinase activity,BP,
14213,GO:0061107,1,0.977234756534726,0,1,seminal vesicle development,BP,
14214,GO:0061108,1,0.977234756534726,0,1,seminal vesicle epithelium development,BP,
14215,GO:0061110,1,0.960195149638724,0,2,dense core granule biogenesis,BP,
14216,GO:0061113,1,0.97799455983445,0,1,pancreas morphogenesis,BP,
14218,GO:0061133,1,0.88898170771085,0,5,endopeptidase activator activity,MF,
14224,GO:0061141,1,0.981447762631557,0,1,lung ciliated cell differentiation,BP,
14227,GO:0061149,1,0.977115191442785,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14228,GO:0061150,1,0.977115191442785,0,1,renal system segmentation,BP,
14229,GO:0061151,1,0.977115191442785,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14230,GO:0061152,1,0.954800553001974,0,2,trachea submucosa development,BP,
14231,GO:0061153,1,0.954800553001974,0,2,trachea gland development,BP,
14232,GO:0061154,1,0.779092514531201,0,11,endothelial tube morphogenesis,BP,
14233,GO:0061155,1,0.977115191442785,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14234,GO:0061156,1,0.937161988006628,0,3,pulmonary artery morphogenesis,BP,
14237,GO:0061162,1,0.727336734064799,0,15,establishment of monopolar cell polarity,BP,
14238,GO:0061163,1,0.977336572808046,0,1,endoplasmic reticulum polarization,BP,
14240,GO:0061179,1,0.851494773855953,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14242,GO:0061183,1,0.978152358173514,0,1,regulation of dermatome development,BP,
14243,GO:0061184,1,0.978152358173514,0,1,positive regulation of dermatome development,BP,
14244,GO:0061187,1,0.959755279749927,0,2,regulation of chromatin silencing at rDNA,BP,
14245,GO:0061188,1,0.959755279749927,0,2,negative regulation of chromatin silencing at rDNA,BP,
14246,GO:0061193,1,0.976225115676963,0,1,taste bud development,BP,
14247,GO:0061196,1,0.91796123042517,0,4,fungiform papilla development,BP,
14248,GO:0061197,1,0.91796123042517,0,4,fungiform papilla morphogenesis,BP,
14249,GO:0061198,1,0.936660122253412,0,3,fungiform papilla formation,BP,
14250,GO:0061200,1,0.893061040702371,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
14251,GO:0061202,1,0.893061040702371,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
14252,GO:0061205,1,0.978152358173514,0,1,paramesonephric duct development,BP,
14253,GO:0061209,1,0.933546438024081,0,3,cell proliferation involved in mesonephros development,BP,
14255,GO:0061216,1,0.977115191442785,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14257,GO:0061218,1,0.933290031479337,0,3,negative regulation of mesonephros development,BP,
14258,GO:0061227,1,0.977115191442785,0,1,pattern specification involved in mesonephros development,BP,
14259,GO:0061245,1,0.507114623865793,0,31,establishment or maintenance of bipolar cell polarity,BP,
14260,GO:0061289,1,0.957216438815259,0,2,Wnt signaling pathway involved in kidney development,BP,
14261,GO:0061290,1,0.957216438815259,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14264,GO:0061300,1,0.958246862310815,0,2,cerebellum vasculature development,BP,
14265,GO:0061301,1,0.980891292605022,0,1,cerebellum vasculature morphogenesis,BP,
14267,GO:0061303,1,0.916359386046259,0,4,cornea development in camera-type eye,BP,
14274,GO:0061314,1,0.904194184128074,0,5,Notch signaling involved in heart development,BP,
14275,GO:0061316,1,0.933586444894395,0,3,canonical Wnt signaling pathway involved in heart development,BP,
14276,GO:0061317,1,0.954884852394151,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
14277,GO:0061318,1,0.772712320626695,0,12,renal filtration cell differentiation,BP,
14279,GO:0061324,1,0.977699138804462,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14280,GO:0061325,1,0.933569078417479,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
14283,GO:0061337,1,0.244320501224514,0,66,cardiac conduction,BP,
14284,GO:0061339,1,0.727336734064799,0,15,establishment or maintenance of monopolar cell polarity,BP,
14285,GO:0061341,1,0.959570410356636,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14286,GO:0061343,1,0.918818476263248,0,4,cell adhesion involved in heart morphogenesis,BP,
14287,GO:0061346,1,0.959570410356636,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
14288,GO:0061347,1,0.979762027781853,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14289,GO:0061348,1,0.979762027781853,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14290,GO:0061349,1,0.979762027781853,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14291,GO:0061350,1,0.979762027781853,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14293,GO:0061354,1,0.979762027781853,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14294,GO:0061355,1,0.914223477457294,0,4,Wnt protein secretion,BP,
14295,GO:0061356,1,0.914223477457294,0,4,regulation of Wnt protein secretion,BP,
14296,GO:0061357,1,0.935603595376392,0,3,positive regulation of Wnt protein secretion,BP,
14297,GO:0061358,1,0.977153966145555,0,1,negative regulation of Wnt protein secretion,BP,
14298,GO:0061364,1,0.939612181298481,0,3,apoptotic process involved in luteolysis,BP,
14299,GO:0061365,1,0.913750193096802,0,4,positive regulation of triglyceride lipase activity,BP,
14300,GO:0061369,1,0.978152358173514,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14301,GO:0061370,1,0.955917309965783,0,2,testosterone biosynthetic process,BP,
14302,GO:0061371,1,0.450007718192935,0,37,determination of heart left/right asymmetry,BP,
14306,GO:0061386,1,0.962233835537111,0,2,closure of optic fissure,BP,
14308,GO:0061394,1,0.954804667417535,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14309,GO:0061395,1,0.977076340765746,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14310,GO:0061400,1,0.977336572808046,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14311,GO:0061408,1,0.933287806091869,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
14312,GO:0061418,1,0.196191454414945,0,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14313,GO:0061419,1,0.897287107953677,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14314,GO:0061428,1,0.915025792333469,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14316,GO:0061433,1,0.977183191309273,0,1,cellular response to caloric restriction,BP,
14322,GO:0061441,1,0.956892595273206,0,2,renal artery morphogenesis,BP,
14323,GO:0061443,1,0.957711003658623,0,2,endocardial cushion cell differentiation,BP,
14324,GO:0061444,1,0.979889458219309,0,1,endocardial cushion cell development,BP,
14325,GO:0061445,1,0.977368081221408,0,1,endocardial cushion cell fate commitment,BP,
14327,GO:0061450,1,0.83048850518409,0,8,trophoblast cell migration,BP,
14329,GO:0061459,1,0.981028080218143,0,1,L-arginine transmembrane transporter activity,MF,
14332,GO:0061470,1,0.918924204967374,0,4,T follicular helper cell differentiation,BP,
14333,GO:0061474,1,0.977253021553287,0,1,phagolysosome membrane,CC,
14335,GO:0061478,1,0.826816799904384,0,9,response to platelet aggregation inhibitor,BP,
14336,GO:0061481,1,0.975966066517488,0,1,response to TNF agonist,BP,
14337,GO:0061484,1,0.936892322656842,0,3,hematopoietic stem cell homeostasis,BP,
14338,GO:0061485,1,0.980974448482977,0,1,memory T cell proliferation,BP,
14339,GO:0061495,1,0.977336572808046,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14340,GO:0061502,1,0.922992887011273,0,4,early endosome to recycling endosome transport,BP,
14341,GO:0061505,1,0.959391502315882,0,2,DNA topoisomerase II activity,MF,
14342,GO:0061507,1,0.977057837615497,0,1,cyclic-GMP-AMP binding,MF,
14343,GO:0061511,1,0.915889906286285,0,4,centriole elongation,BP,
14344,GO:0061512,1,0.514592842512934,0,30,protein localization to cilium,BP,
14345,GO:0061513,1,0.934565764540628,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
14346,GO:0061515,1,0.348540314847255,0,48,myeloid cell development,BP,
14349,GO:0061519,1,0.977852279067884,0,1,macrophage homeostasis,BP,
14350,GO:0061525,1,0.902479756779238,0,5,hindgut development,BP,
14351,GO:0061526,1,0.977266136864643,0,1,acetylcholine secretion,BP,
14352,GO:0061528,1,0.979054784048604,0,1,aspartate secretion,BP,
14353,GO:0061534,1,0.984274680421787,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14354,GO:0061535,1,0.942636668996647,0,3,glutamate secretion, neurotransmission,BP,
14355,GO:0061536,1,0.977531669431364,0,1,glycine secretion,BP,
14356,GO:0061537,1,0.977531669431364,0,1,glycine secretion, neurotransmission,BP,
14357,GO:0061542,1,0.976624973023742,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
14358,GO:0061547,1,0.977715841262133,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14359,GO:0061548,1,0.839708689001805,0,8,ganglion development,BP,
14360,GO:0061549,1,0.876771606292259,0,6,sympathetic ganglion development,BP,
14361,GO:0061550,1,0.917304402609835,0,4,cranial ganglion development,BP,
14362,GO:0061551,1,0.938232763011958,0,3,trigeminal ganglion development,BP,
14363,GO:0061552,1,0.977248066779519,0,1,ganglion morphogenesis,BP,
14366,GO:0061573,1,0.977336572808046,0,1,actin filament bundle retrograde transport,BP,
14367,GO:0061574,1,0.934871682584595,0,3,ASAP complex,CC,
14368,GO:0061575,1,0.9088143112835,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14369,GO:0061577,1,0.842343371461204,0,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14370,GO:0061578,1,0.788446343894858,0,11,Lys63-specific deubiquitinase activity,MF,
14371,GO:0061580,1,0.978364242501752,0,1,colon epithelial cell migration,BP,
14372,GO:0061582,1,0.958893810799144,0,2,intestinal epithelial cell migration,BP,
14373,GO:0061588,1,0.914772237261693,0,4,calcium activated phospholipid scrambling,BP,
14374,GO:0061589,1,0.914772237261693,0,4,calcium activated phosphatidylserine scrambling,BP,
14375,GO:0061590,1,0.914772237261693,0,4,calcium activated phosphatidylcholine scrambling,BP,
14376,GO:0061591,1,0.914772237261693,0,4,calcium activated galactosylceramide scrambling,BP,
14377,GO:0061598,1,0.978498490151427,0,1,molybdopterin adenylyltransferase activity,MF,
14378,GO:0061599,1,0.978498490151427,0,1,molybdopterin molybdotransferase activity,MF,
14379,GO:0061604,1,0.977245957030739,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14380,GO:0061605,1,0.977245957030739,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
14381,GO:0061608,1,0.819274280683976,0,9,nuclear import signal receptor activity,MF,
14382,GO:0061611,1,0.9771102875795,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14385,GO:0061617,1,0.829508400239768,0,8,MICOS complex,CC,
14386,GO:0061618,1,0.983677045510208,0,1,sublamina densa,CC,
14389,GO:0061622,1,0.954793658653224,0,2,glycolytic process through glucose-1-phosphate,BP,
14390,GO:0061623,1,0.976746502113978,0,1,glycolytic process from galactose,BP,
14391,GO:0061624,1,0.912368362030743,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14393,GO:0061627,1,0.977196237704058,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
14394,GO:0061628,1,0.95878038207736,0,2,H3K27me3 modified histone binding,MF,
14395,GO:0061629,1,0.91519109544703,0,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
14396,GO:0061630,1,0.0124951846610083,0,198,ubiquitin protein ligase activity,MF,
14397,GO:0061631,1,0.557382425911199,0,26,ubiquitin conjugating enzyme activity,MF,
14398,GO:0061635,1,0.851156013794144,0,7,regulation of protein complex stability,BP,
14401,GO:0061642,1,0.979762027781853,0,1,chemoattraction of axon,BP,
14402,GO:0061643,1,0.957579157126133,0,2,chemorepulsion of axon,BP,
14403,GO:0061645,1,0.900671201766862,0,5,endocytic patch,CC,
14404,GO:0061646,1,0.979076571761333,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14405,GO:0061647,1,0.460152076091841,0,36,histone H3-K9 modification,BP,
14406,GO:0061649,1,0.937442048647741,0,3,ubiquitin modification-dependent histone binding,MF,
14407,GO:0061650,1,0.54427613119085,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14408,GO:0061656,1,0.976536959915807,0,1,SUMO conjugating enzyme activity,MF,
14409,GO:0061659,1,0.0111375380613277,0,203,ubiquitin-like protein ligase activity,MF,
14410,GO:0061663,1,0.980884112301414,0,1,NEDD8 ligase activity,MF,
14411,GO:0061665,1,0.893023705127725,0,5,SUMO ligase activity,MF,
14412,GO:0061668,1,0.874661789185901,0,6,mitochondrial ribosome assembly,BP,
14413,GO:0061669,1,0.958631518056973,0,2,spontaneous neurotransmitter secretion,BP,
14414,GO:0061673,1,0.895031698993932,0,5,mitotic spindle astral microtubule,CC,
14415,GO:0061676,1,0.87523019701625,0,6,importin-alpha family protein binding,MF,
14417,GO:0061685,1,0.977336572808046,0,1,diphthine methylesterase activity,MF,
14419,GO:0061689,1,0.937143674204932,0,3,tricellular tight junction,CC,
14421,GO:0061697,1,0.977482283504336,0,1,protein-glutaryllysine deglutarylase activity,MF,
14422,GO:0061698,1,0.977482283504336,0,1,protein deglutarylation,BP,
14423,GO:0061699,1,0.977482283504336,0,1,peptidyl-lysine deglutarylation,BP,
14424,GO:0061700,1,0.814123927651855,0,9,GATOR2 complex,CC,
14425,GO:0061702,1,0.85352221651483,0,7,inflammasome complex,CC,
14426,GO:0061709,1,0.980385271392752,0,1,reticulophagy,BP,
14427,GO:0061711,1,0.954707480914658,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
14428,GO:0061712,1,0.97757757933815,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14430,GO:0061723,1,0.958075588356616,0,2,glycophagy,BP,
14431,GO:0061724,1,0.881388688374145,0,6,lipophagy,BP,
14433,GO:0061727,1,0.954860242865957,0,2,methylglyoxal catabolic process to lactate,BP,
14434,GO:0061731,1,0.935640111087652,0,3,ribonucleoside-diphosphate reductase activity,MF,
14435,GO:0061732,1,0.871790199272978,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14437,GO:0061734,1,0.902840211755618,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14438,GO:0061736,1,0.979668142642056,0,1,engulfment of target by autophagosome,BP,
14439,GO:0061737,1,0.955179742564803,0,2,leukotriene signaling pathway,BP,
14440,GO:0061738,1,0.933614447995745,0,3,late endosomal microautophagy,BP,
14441,GO:0061739,1,0.935311498498614,0,3,protein lipidation involved in autophagosome assembly,BP,
14444,GO:0061743,1,0.977125613061449,0,1,motor learning,BP,
14445,GO:0061744,1,0.95499994069804,0,2,motor behavior,BP,
14446,GO:0061749,1,0.958887392340766,0,2,forked DNA-dependent helicase activity,MF,
14447,GO:0061750,1,0.977238761605145,0,1,acid sphingomyelin phosphodiesterase activity,MF,
14448,GO:0061752,1,0.955100953893423,0,2,telomeric repeat-containing RNA binding,MF,
14449,GO:0061753,1,0.979668142642056,0,1,substrate localization to autophagosome,BP,
14450,GO:0061756,1,0.75216519719079,0,13,leukocyte adhesion to vascular endothelial cell,BP,
14451,GO:0061757,1,0.954912370908017,0,2,leukocyte adhesion to arterial endothelial cell,BP,
14452,GO:0061760,1,0.977352273994558,0,1,antifungal innate immune response,BP,
14453,GO:0061762,1,0.959097349337088,0,2,CAMKK-AMPK signaling cascade,BP,
14454,GO:0061763,1,0.955113158018947,0,2,multivesicular body-lysosome fusion,BP,
14455,GO:0061767,1,0.979815377247189,0,1,negative regulation of lung blood pressure,BP,
14456,GO:0061768,1,0.97900768116547,0,1,magnesium:sodium antiporter activity,MF,
14457,GO:0061769,1,0.977336572808046,0,1,ribosylnicotinate kinase activity,MF,
14458,GO:0061770,1,0.977225496233081,0,1,translation elongation factor binding,MF,
14459,GO:0061771,1,0.934501071701152,0,3,response to caloric restriction,BP,
14460,GO:0061772,1,0.977692160983474,0,1,drug transport across blood-nerve barrier,BP,
14461,GO:0061778,1,0.801259767698351,0,10,intracellular chloride channel activity,MF,
14462,GO:0061780,1,0.982813836561076,0,1,mitotic cohesin loading,BP,
14463,GO:0061783,1,0.932142377355698,0,3,peptidoglycan muralytic activity,MF,
14464,GO:0061789,1,0.980181708779369,0,1,dense core granule priming,BP,
14465,GO:0061792,1,0.979945174734083,0,1,secretory granule maturation,BP,
14466,GO:0061798,1,0.978402639635041,0,1,GTP 3',8'-cyclase activity,MF,
14467,GO:0061799,1,0.978402639635041,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14468,GO:0061809,1,0.976890457067696,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
14469,GO:0061817,1,0.93828053834119,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
14470,GO:0061819,1,0.936651224036823,0,3,telomeric DNA-containing double minutes formation,BP,
14471,GO:0061820,1,0.818152389095992,0,9,telomeric D-loop disassembly,BP,
14472,GO:0061821,1,0.917547682108984,0,4,telomeric D-loop binding,MF,
14473,GO:0061825,1,0.978177805188509,0,1,podosome core,CC,
14474,GO:0061827,1,0.954708215269064,0,2,sperm head,CC,
14475,GO:0061828,1,0.981086954756831,0,1,apical tubulobulbar complex,CC,
14476,GO:0061829,1,0.981086954756831,0,1,basal tubulobulbar complex,CC,
14477,GO:0061833,1,0.956281689007956,0,2,protein localization to tricellular tight junction,BP,
14480,GO:0061845,1,0.977558902737606,0,1,neuron projection branch point,CC,
14481,GO:0061846,1,0.977558902737606,0,1,dendritic spine cytoplasm,CC,
14482,GO:0061847,1,0.977237726899621,0,1,response to cholecystokinin,BP,
14483,GO:0061849,1,0.958887392340766,0,2,telomeric G-quadruplex DNA binding,MF,
14484,GO:0061850,1,0.976043880359759,0,1,growth cone leading edge,CC,
14485,GO:0061851,1,0.977280289452042,0,1,leading edge of lamellipodium,CC,
14486,GO:0061857,1,0.95595158049819,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14487,GO:0061880,1,0.977066069175998,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14488,GO:0061881,1,0.977066069175998,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
14489,GO:0061884,1,0.977206121775138,0,1,regulation of mini excitatory postsynaptic potential,BP,
14490,GO:0061885,1,0.977206121775138,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
14491,GO:0061888,1,0.935243242970966,0,3,regulation of astrocyte activation,BP,
14492,GO:0061889,1,0.979336650063101,0,1,negative regulation of astrocyte activation,BP,
14493,GO:0061890,1,0.954979706469072,0,2,positive regulation of astrocyte activation,BP,
14494,GO:0061896,1,0.978865395948723,0,1,all-trans retinol 3,4-desaturase activity,MF,
14495,GO:0061897,1,0.978865395948723,0,1,all-trans retinal 3,4-desaturase activity,MF,
14496,GO:0061898,1,0.978865395948723,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14497,GO:0061899,1,0.978865395948723,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14499,GO:0061912,1,0.405472440458431,0,41,selective autophagy,BP,
14501,GO:0061920,1,0.981883150047352,0,1,protein propionyltransferase activity,MF,
14502,GO:0061921,1,0.981883150047352,0,1,peptidyl-lysine propionylation,BP,
14503,GO:0061930,1,0.979243290333626,0,1,regulation of erythrocyte enucleation,BP,
14504,GO:0061931,1,0.979243290333626,0,1,positive regulation of erythrocyte enucleation,BP,
14505,GO:0061944,1,0.978560907835489,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14506,GO:0061945,1,0.934891965396134,0,3,regulation of protein K48-linked ubiquitination,BP,
14507,GO:0061951,1,0.431857539418961,0,38,establishment of protein localization to plasma membrane,BP,
14510,GO:0061980,1,0.539231867929136,0,28,regulatory RNA binding,MF,
14512,GO:0061983,1,0.871705610365815,0,6,meiosis II cell cycle process,BP,
14513,GO:0062009,1,0.841748010499759,0,8,secondary palate development,BP,
14517,GO:0065001,1,0.960112047108626,0,2,specification of axis polarity,BP,
14518,GO:0065002,1,0.31644732397531,0,50,intracellular protein transmembrane transport,BP,
14521,GO:0065005,1,0.670034757929035,0,18,protein-lipid complex assembly,BP,
14525,GO:0065010,1,0.977336572808046,0,1,extracellular membrane-bounded organelle,CC,
14526,GO:0070001,1,0.729566890437501,0,14,aspartic-type peptidase activity,MF,
14527,GO:0070003,1,0.649540393857202,0,18,threonine-type peptidase activity,MF,
14528,GO:0070004,1,0.977336572808046,0,1,cysteine-type exopeptidase activity,MF,
14529,GO:0070006,1,0.71512946496802,0,15,metalloaminopeptidase activity,MF,
14530,GO:0070008,1,0.803179631494762,0,10,serine-type exopeptidase activity,MF,
14532,GO:0070012,1,0.955078570533334,0,2,oligopeptidase activity,MF,
14534,GO:0070016,1,0.80354016821809,0,10,armadillo repeat domain binding,MF,
14535,GO:0070022,1,0.917909646827918,0,4,transforming growth factor beta receptor complex,CC,
14536,GO:0070025,1,0.977259564888281,0,1,carbon monoxide binding,MF,
14537,GO:0070026,1,0.953967617566631,0,2,nitric oxide binding,MF,
14538,GO:0070032,1,0.954960581661236,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
14539,GO:0070033,1,0.954960581661236,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
14540,GO:0070034,1,0.63244325531504,0,21,telomerase RNA binding,MF,
14542,GO:0070037,1,0.976313901643852,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
14543,GO:0070039,1,0.956854883226006,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
14544,GO:0070042,1,0.97740912877249,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14545,GO:0070044,1,0.912716196146588,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
14546,GO:0070050,1,0.913262330190121,0,4,neuron cellular homeostasis,BP,
14547,GO:0070051,1,0.957455228408242,0,2,fibrinogen binding,MF,
14548,GO:0070052,1,0.957687275661438,0,2,collagen V binding,MF,
14549,GO:0070053,1,0.957097836540846,0,2,thrombospondin receptor activity,MF,
14550,GO:0070054,1,0.934426130199848,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14551,GO:0070055,1,0.934426130199848,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
14552,GO:0070059,1,0.330591310952492,0,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
14553,GO:0070060,1,0.9821221836366,0,1,'de novo' actin filament nucleation,BP,
14554,GO:0070061,1,0.933483408731318,0,3,fructose binding,MF,
14556,GO:0070063,1,0.309366488478533,0,53,RNA polymerase binding,MF,
14557,GO:0070064,1,0.66397497123601,0,19,proline-rich region binding,MF,
14558,GO:0070069,1,0.580301950303588,0,23,cytochrome complex,CC,
14559,GO:0070070,1,0.84773115188241,0,8,proton-transporting V-type ATPase complex assembly,BP,
14560,GO:0070071,1,0.773537829124542,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14561,GO:0070072,1,0.84773115188241,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14563,GO:0070077,1,0.977879752558832,0,1,histone arginine demethylation,BP,
14564,GO:0070078,1,0.977879752558832,0,1,histone H3-R2 demethylation,BP,
14565,GO:0070079,1,0.977879752558832,0,1,histone H4-R3 demethylation,BP,
14566,GO:0070081,1,0.934827956226793,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14567,GO:0070083,1,0.934827956226793,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
14569,GO:0070086,1,0.913758278812411,0,4,ubiquitin-dependent endocytosis,BP,
14570,GO:0070087,1,0.884099914610007,0,6,chromo shadow domain binding,MF,
14571,GO:0070091,1,0.914141720030992,0,4,glucagon secretion,BP,
14572,GO:0070092,1,0.936136691930253,0,3,regulation of glucagon secretion,BP,
14573,GO:0070094,1,0.977257323243146,0,1,positive regulation of glucagon secretion,BP,
14574,GO:0070095,1,0.977498670770955,0,1,fructose-6-phosphate binding,MF,
14575,GO:0070096,1,0.977662033732478,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14576,GO:0070097,1,0.958930103114103,0,2,delta-catenin binding,MF,
14577,GO:0070098,1,0.606073079803358,0,22,chemokine-mediated signaling pathway,BP,
14578,GO:0070099,1,0.878173386552041,0,6,regulation of chemokine-mediated signaling pathway,BP,
14579,GO:0070100,1,0.918640617602541,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
14580,GO:0070101,1,0.955962534657394,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
14581,GO:0070102,1,0.74102239113616,0,14,interleukin-6-mediated signaling pathway,BP,
14582,GO:0070103,1,0.977067417464841,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14583,GO:0070104,1,0.977067417464841,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
14584,GO:0070106,1,0.840450595039303,0,8,interleukin-27-mediated signaling pathway,BP,
14585,GO:0070110,1,0.956373368796995,0,2,ciliary neurotrophic factor receptor complex,CC,
14586,GO:0070119,1,0.978374109598402,0,1,ciliary neurotrophic factor binding,MF,
14587,GO:0070120,1,0.939955608416876,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
14588,GO:0070121,1,0.979548525332537,0,1,Kupffer's vesicle development,BP,
14589,GO:0070122,1,0.91468713154722,0,4,isopeptidase activity,MF,
14590,GO:0070123,1,0.980200106945111,0,1,transforming growth factor beta receptor activity, type III,MF,
14591,GO:0070124,1,0.954141529930424,0,2,mitochondrial translational initiation,BP,
14592,GO:0070125,1,0.12953262083999,0,86,mitochondrial translational elongation,BP,
14593,GO:0070126,1,0.123681286935518,0,88,mitochondrial translational termination,BP,
14594,GO:0070127,1,0.834206379503093,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14595,GO:0070129,1,0.662651698962418,0,18,regulation of mitochondrial translation,BP,
14596,GO:0070130,1,0.977336572808046,0,1,negative regulation of mitochondrial translation,BP,
14597,GO:0070131,1,0.776579966252819,0,11,positive regulation of mitochondrial translation,BP,
14598,GO:0070137,1,0.919444647160498,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14599,GO:0070138,1,0.935994749099876,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14600,GO:0070139,1,0.919444647160498,0,4,SUMO-specific endopeptidase activity,MF,
14601,GO:0070140,1,0.935994749099876,0,3,SUMO-specific isopeptidase activity,MF,
14602,GO:0070141,1,0.894603655287312,0,5,response to UV-A,BP,
14603,GO:0070142,1,0.876856603013926,0,6,synaptic vesicle budding,BP,
14604,GO:0070143,1,0.978957680252699,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14605,GO:0070145,1,0.977642608882826,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14606,GO:0070150,1,0.954794994607254,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
14607,GO:0070159,1,0.977241912338293,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14610,GO:0070162,1,0.895936438254278,0,5,adiponectin secretion,BP,
14611,GO:0070163,1,0.895936438254278,0,5,regulation of adiponectin secretion,BP,
14612,GO:0070164,1,0.916719151480284,0,4,negative regulation of adiponectin secretion,BP,
14613,GO:0070165,1,0.977336572808046,0,1,positive regulation of adiponectin secretion,BP,
14614,GO:0070166,1,0.825379376033923,0,9,enamel mineralization,BP,
14617,GO:0070169,1,0.622598881957959,0,22,positive regulation of biomineral tissue development,BP,
14618,GO:0070170,1,0.958196404105942,0,2,regulation of tooth mineralization,BP,
14619,GO:0070171,1,0.980159247126154,0,1,negative regulation of tooth mineralization,BP,
14620,GO:0070172,1,0.977594247778204,0,1,positive regulation of tooth mineralization,BP,
14621,GO:0070176,1,0.977123580494828,0,1,DRM complex,CC,
14622,GO:0070178,1,0.977247707407595,0,1,D-serine metabolic process,BP,
14623,GO:0070179,1,0.977247707407595,0,1,D-serine biosynthetic process,BP,
14624,GO:0070180,1,0.975482170416274,0,1,large ribosomal subunit rRNA binding,MF,
14625,GO:0070181,1,0.828255019485698,0,8,small ribosomal subunit rRNA binding,MF,
14626,GO:0070182,1,0.66543577376404,0,18,DNA polymerase binding,MF,
14627,GO:0070183,1,0.977308290890772,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14628,GO:0070184,1,0.977225496233081,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
14629,GO:0070187,1,0.872044137746713,0,6,shelterin complex,CC,
14630,GO:0070189,1,0.911585374281661,0,4,kynurenine metabolic process,BP,
14631,GO:0070191,1,0.955032707553054,0,2,methionine-R-sulfoxide reductase activity,MF,
14632,GO:0070192,1,0.441538396939043,0,37,chromosome organization involved in meiotic cell cycle,BP,
14635,GO:0070195,1,0.978585086896467,0,1,growth hormone receptor complex,CC,
14636,GO:0070197,1,0.914609098491402,0,4,meiotic attachment of telomere to nuclear envelope,BP,
14637,GO:0070198,1,0.565880165148369,0,26,protein localization to chromosome, telomeric region,BP,
14638,GO:0070199,1,0.595345591299057,0,23,establishment of protein localization to chromosome,BP,
14639,GO:0070200,1,0.730166174778735,0,14,establishment of protein localization to telomere,BP,
14641,GO:0070202,1,0.776493241384015,0,11,regulation of establishment of protein localization to chromosome,BP,
14642,GO:0070203,1,0.794515066829366,0,10,regulation of establishment of protein localization to telomere,BP,
14644,GO:0070207,1,0.665294370243225,0,18,protein homotrimerization,BP,
14646,GO:0070209,1,0.977628451901769,0,1,ASTRA complex,CC,
14647,GO:0070212,1,0.91833630862732,0,4,protein poly-ADP-ribosylation,BP,
14648,GO:0070213,1,0.920088872237127,0,4,protein auto-ADP-ribosylation,BP,
14649,GO:0070221,1,0.909317316752405,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14653,GO:0070230,1,0.760045422527109,0,12,positive regulation of lymphocyte apoptotic process,BP,
14657,GO:0070234,1,0.813182281720291,0,9,positive regulation of T cell apoptotic process,BP,
14660,GO:0070242,1,0.700792352513366,0,16,thymocyte apoptotic process,BP,
14661,GO:0070243,1,0.782567999409461,0,11,regulation of thymocyte apoptotic process,BP,
14662,GO:0070244,1,0.875922103533482,0,6,negative regulation of thymocyte apoptotic process,BP,
14663,GO:0070245,1,0.8934720569728,0,5,positive regulation of thymocyte apoptotic process,BP,
14664,GO:0070252,1,0.348783970737639,0,50,actin-mediated cell contraction,BP,
14665,GO:0070254,1,0.832062916675128,0,8,mucus secretion,BP,
14666,GO:0070255,1,0.852723215454565,0,7,regulation of mucus secretion,BP,
14667,GO:0070256,1,0.976933244458608,0,1,negative regulation of mucus secretion,BP,
14668,GO:0070257,1,0.872867608084091,0,6,positive regulation of mucus secretion,BP,
14669,GO:0070259,1,0.955736325898446,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14670,GO:0070260,1,0.977336572808046,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14671,GO:0070262,1,0.727587885184835,0,14,peptidyl-serine dephosphorylation,BP,
14672,GO:0070265,1,0.401078915580163,0,40,necrotic cell death,BP,
14673,GO:0070266,1,0.507042891253042,0,30,necroptotic process,BP,
14674,GO:0070267,1,0.977846626163901,0,1,oncosis,BP,
14676,GO:0070269,1,0.831635383742481,0,8,pyroptosis,BP,
14677,GO:0070273,1,0.6009289577708,0,23,phosphatidylinositol-4-phosphate binding,MF,
14678,GO:0070274,1,0.954647649571186,0,2,RES complex,CC,
14680,GO:0070279,1,0.475110123462577,0,33,vitamin B6 binding,MF,
14681,GO:0070280,1,0.978077783305344,0,1,pyridoxal binding,MF,
14682,GO:0070283,1,0.977047568657905,0,1,radical SAM enzyme activity,MF,
14683,GO:0070286,1,0.795299993139869,0,11,axonemal dynein complex assembly,BP,
14684,GO:0070288,1,0.953147657860971,0,2,ferritin complex,CC,
14685,GO:0070290,1,0.89578577548264,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
14686,GO:0070291,1,0.914005274061407,0,4,N-acylethanolamine metabolic process,BP,
14687,GO:0070292,1,0.957092806447129,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
14688,GO:0070293,1,0.77909662598739,0,11,renal absorption,BP,
14689,GO:0070294,1,0.936340783488153,0,3,renal sodium ion absorption,BP,
14690,GO:0070295,1,0.933464755391399,0,3,renal water absorption,BP,
14691,GO:0070296,1,0.686473076963175,0,18,sarcoplasmic reticulum calcium ion transport,BP,
14697,GO:0070305,1,0.938960221984711,0,3,response to cGMP,BP,
14698,GO:0070306,1,0.676325573208559,0,18,lens fiber cell differentiation,BP,
14699,GO:0070307,1,0.837183210050103,0,8,lens fiber cell development,BP,
14700,GO:0070309,1,0.957336671847713,0,2,lens fiber cell morphogenesis,BP,
14704,GO:0070317,1,0.444318531724471,0,37,negative regulation of G0 to G1 transition,BP,
14706,GO:0070320,1,0.977270366277077,0,1,inward rectifier potassium channel inhibitor activity,MF,
14707,GO:0070324,1,0.894871192075298,0,5,thyroid hormone binding,MF,
14709,GO:0070326,1,0.932920625802357,0,3,very-low-density lipoprotein particle receptor binding,MF,
14710,GO:0070327,1,0.936461602695058,0,3,thyroid hormone transport,BP,
14712,GO:0070329,1,0.955010019310361,0,2,tRNA seleno-modification,BP,
14714,GO:0070335,1,0.980723508683735,0,1,aspartate binding,MF,
14715,GO:0070336,1,0.957510280861011,0,2,flap-structured DNA binding,MF,
14716,GO:0070337,1,0.979715688418652,0,1,3'-flap-structured DNA binding,MF,
14717,GO:0070339,1,0.93599080523792,0,3,response to bacterial lipopeptide,BP,
14718,GO:0070340,1,0.957915507230383,0,2,detection of bacterial lipopeptide,BP,
14720,GO:0070343,1,0.978523023267082,0,1,white fat cell proliferation,BP,
14723,GO:0070346,1,0.977278942128016,0,1,positive regulation of fat cell proliferation,BP,
14724,GO:0070350,1,0.978523023267082,0,1,regulation of white fat cell proliferation,BP,
14725,GO:0070358,1,0.895268396303654,0,5,actin polymerization-dependent cell motility,BP,
14726,GO:0070365,1,0.838376510969195,0,8,hepatocyte differentiation,BP,
14727,GO:0070369,1,0.938787790625511,0,3,beta-catenin-TCF7L2 complex,CC,
14728,GO:0070370,1,0.88984290151045,0,5,cellular heat acclimation,BP,
14733,GO:0070375,1,0.935495780116583,0,3,ERK5 cascade,BP,
14734,GO:0070376,1,0.977337863649096,0,1,regulation of ERK5 cascade,BP,
14735,GO:0070377,1,0.977337863649096,0,1,negative regulation of ERK5 cascade,BP,
14736,GO:0070381,1,0.956219417942125,0,2,endosome to plasma membrane transport vesicle,CC,
14737,GO:0070382,1,0.076298859541995,0,114,exocytic vesicle,CC,
14738,GO:0070383,1,0.87034050385165,0,6,DNA cytosine deamination,BP,
14740,GO:0070390,1,0.977073400793012,0,1,transcription export complex 2,CC,
14741,GO:0070391,1,0.871285440344999,0,6,response to lipoteichoic acid,BP,
14742,GO:0070401,1,0.95480118555341,0,2,NADP+ binding,MF,
14743,GO:0070402,1,0.745616064127102,0,13,NADPH binding,MF,
14744,GO:0070403,1,0.759536666257581,0,12,NAD+ binding,MF,
14745,GO:0070404,1,0.932082167994167,0,3,NADH binding,MF,
14747,GO:0070407,1,0.977463370009173,0,1,oxidation-dependent protein catabolic process,BP,
14748,GO:0070408,1,0.979699975406857,0,1,carbamoyl phosphate metabolic process,BP,
14749,GO:0070409,1,0.979699975406857,0,1,carbamoyl phosphate biosynthetic process,BP,
14751,GO:0070411,1,0.826913281529401,0,9,I-SMAD binding,MF,
14753,GO:0070413,1,0.977366323426459,0,1,trehalose metabolism in response to stress,BP,
14754,GO:0070417,1,0.859782554390415,0,7,cellular response to cold,BP,
14755,GO:0070418,1,0.979258937761796,0,1,DNA-dependent protein kinase complex,CC,
14757,GO:0070423,1,0.500695064138256,0,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,
14758,GO:0070424,1,0.877670884619012,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14759,GO:0070425,1,0.978645391491612,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14760,GO:0070426,1,0.955010437114349,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14761,GO:0070427,1,0.934348333347126,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14762,GO:0070428,1,0.978645391491612,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14763,GO:0070429,1,0.978645391491612,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14764,GO:0070431,1,0.834061868021783,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14765,GO:0070432,1,0.934613071160076,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14766,GO:0070433,1,0.978645391491612,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14767,GO:0070434,1,0.955010437114349,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14768,GO:0070435,1,0.955379811810859,0,2,Shc-EGFR complex,CC,
14769,GO:0070436,1,0.956607581213789,0,2,Grb2-EGFR complex,CC,
14770,GO:0070444,1,0.916066028427945,0,4,oligodendrocyte progenitor proliferation,BP,
14771,GO:0070445,1,0.916066028427945,0,4,regulation of oligodendrocyte progenitor proliferation,BP,
14772,GO:0070446,1,0.977183191309273,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
14773,GO:0070447,1,0.95517119011582,0,2,positive regulation of oligodendrocyte progenitor proliferation,BP,
14774,GO:0070458,1,0.933039177896942,0,3,cellular detoxification of nitrogen compound,BP,
14775,GO:0070459,1,0.891578650931412,0,5,prolactin secretion,BP,
14776,GO:0070460,1,0.978120976366248,0,1,thyroid-stimulating hormone secretion,BP,
14777,GO:0070461,1,0.559785901579893,0,26,SAGA-type complex,CC,
14778,GO:0070463,1,0.977742569448237,0,1,tubulin-dependent ATPase activity,MF,
14779,GO:0070469,1,0.154824509765381,0,78,respiratory chain,CC,
14780,GO:0070470,1,0.910127577242504,0,4,plasma membrane respiratory chain,CC,
14781,GO:0070471,1,0.936363786199529,0,3,uterine smooth muscle contraction,BP,
14782,GO:0070472,1,0.936363786199529,0,3,regulation of uterine smooth muscle contraction,BP,
14783,GO:0070474,1,0.936363786199529,0,3,positive regulation of uterine smooth muscle contraction,BP,
14785,GO:0070476,1,0.975482170416274,0,1,rRNA (guanine-N7)-methylation,BP,
14786,GO:0070478,1,0.978429587389303,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14787,GO:0070481,1,0.977346733797665,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14789,GO:0070483,1,0.977506139705084,0,1,detection of hypoxia,BP,
14790,GO:0070486,1,0.780904677419862,0,11,leukocyte aggregation,BP,
14791,GO:0070487,1,0.895836707867807,0,5,monocyte aggregation,BP,
14792,GO:0070488,1,0.95122874116923,0,2,neutrophil aggregation,BP,
14793,GO:0070489,1,0.978224588290102,0,1,T cell aggregation,BP,
14795,GO:0070492,1,0.911473186534766,0,4,oligosaccharide binding,MF,
14796,GO:0070493,1,0.856063201465548,0,7,thrombin-activated receptor signaling pathway,BP,
14797,GO:0070494,1,0.936266459078784,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14798,GO:0070495,1,0.936266459078784,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
14799,GO:0070498,1,0.114658031624069,0,94,interleukin-1-mediated signaling pathway,BP,
14800,GO:0070506,1,0.977272718880293,0,1,high-density lipoprotein particle receptor activity,MF,
14802,GO:0070508,1,0.892761711291458,0,5,cholesterol import,BP,
14804,GO:0070510,1,0.980711588698504,0,1,regulation of histone H4-K20 methylation,BP,
14805,GO:0070512,1,0.980711588698504,0,1,positive regulation of histone H4-K20 methylation,BP,
14806,GO:0070513,1,0.831908917128823,0,8,death domain binding,MF,
14807,GO:0070522,1,0.915418333460373,0,4,ERCC4-ERCC1 complex,CC,
14808,GO:0070524,1,0.976801477693147,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
14809,GO:0070525,1,0.741888174953165,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14811,GO:0070528,1,0.655667533031158,0,19,protein kinase C signaling,BP,
14813,GO:0070531,1,0.894622704869585,0,5,BRCA1-A complex,CC,
14816,GO:0070536,1,0.581589707574706,0,25,protein K63-linked deubiquitination,BP,
14817,GO:0070537,1,0.933498672652727,0,3,histone H2A K63-linked deubiquitination,BP,
14818,GO:0070538,1,0.976813211330368,0,1,oleic acid binding,MF,
14819,GO:0070539,1,0.977779749525129,0,1,linoleic acid binding,MF,
14820,GO:0070541,1,0.936451086666292,0,3,response to platinum ion,BP,
14822,GO:0070544,1,0.843347747089753,0,8,histone H3-K36 demethylation,BP,
14823,GO:0070545,1,0.913468360024601,0,4,PeBoW complex,CC,
14824,GO:0070548,1,0.981792338239022,0,1,L-glutamine aminotransferase activity,MF,
14825,GO:0070550,1,0.982813836561076,0,1,rDNA condensation,BP,
14826,GO:0070551,1,0.977336572808046,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14827,GO:0070552,1,0.933430301253064,0,3,BRISC complex,CC,
14828,GO:0070553,1,0.977336572808046,0,1,nicotinic acid receptor activity,MF,
14830,GO:0070557,1,0.954473981807012,0,2,PCNA-p21 complex,CC,
14831,GO:0070560,1,0.977336572808046,0,1,protein secretion by platelet,BP,
14835,GO:0070564,1,0.954986983033474,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
14836,GO:0070566,1,0.574528403468248,0,25,adenylyltransferase activity,MF,
14838,GO:0070568,1,0.893257276540047,0,5,guanylyltransferase activity,MF,
14839,GO:0070569,1,0.855367168844955,0,7,uridylyltransferase activity,MF,
14840,GO:0070570,1,0.641778346326831,0,20,regulation of neuron projection regeneration,BP,
14841,GO:0070571,1,0.750584222158282,0,13,negative regulation of neuron projection regeneration,BP,
14842,GO:0070572,1,0.911151949745571,0,4,positive regulation of neuron projection regeneration,BP,
14843,GO:0070573,1,0.977336572808046,0,1,metallodipeptidase activity,MF,
14845,GO:0070576,1,0.955268263389418,0,2,vitamin D 24-hydroxylase activity,MF,
14846,GO:0070577,1,0.716421416877843,0,16,lysine-acetylated histone binding,MF,
14847,GO:0070578,1,0.818594749947559,0,9,RISC-loading complex,CC,
14848,GO:0070579,1,0.927432200242288,0,4,methylcytosine dioxygenase activity,MF,
14849,GO:0070584,1,0.62094186329432,0,21,mitochondrion morphogenesis,BP,
14851,GO:0070586,1,0.831825441283629,0,8,cell-cell adhesion involved in gastrulation,BP,
14852,GO:0070587,1,0.851178910152314,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14854,GO:0070589,1,0.9771102875795,0,1,cellular component macromolecule biosynthetic process,BP,
14855,GO:0070593,1,0.980717007502023,0,1,dendrite self-avoidance,BP,
14856,GO:0070601,1,0.833335917076572,0,8,centromeric sister chromatid cohesion,BP,
14857,GO:0070602,1,0.933320000314911,0,3,regulation of centromeric sister chromatid cohesion,BP,
14859,GO:0070611,1,0.977264548218315,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14860,GO:0070612,1,0.977264548218315,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
14862,GO:0070615,1,0.978328810823739,0,1,nucleosome-dependent ATPase activity,MF,
14863,GO:0070618,1,0.977273500775011,0,1,Grb2-Sos complex,CC,
14864,GO:0070625,1,0.977214446952929,0,1,zymogen granule exocytosis,BP,
14865,GO:0070626,1,0.976876239670921,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
14866,GO:0070627,1,0.978411021284441,0,1,ferrous iron import,BP,
14868,GO:0070631,1,0.977336572808046,0,1,spindle pole body localization,BP,
14869,GO:0070632,1,0.977336572808046,0,1,establishment of spindle pole body localization,BP,
14870,GO:0070633,1,0.785544931057251,0,11,transepithelial transport,BP,
14871,GO:0070634,1,0.93625845958693,0,3,transepithelial ammonium transport,BP,
14872,GO:0070637,1,0.977243563733998,0,1,pyridine nucleoside metabolic process,BP,
14873,GO:0070638,1,0.977243563733998,0,1,pyridine nucleoside catabolic process,BP,
14874,GO:0070640,1,0.935306187449406,0,3,vitamin D3 metabolic process,BP,
14875,GO:0070643,1,0.977001800900464,0,1,vitamin D 25-hydroxylase activity,MF,
14876,GO:0070644,1,0.938234736759825,0,3,vitamin D response element binding,MF,
14879,GO:0070649,1,0.957458902522469,0,2,formin-nucleated actin cable assembly,BP,
14880,GO:0070650,1,0.977336572808046,0,1,actin filament bundle distribution,BP,
14881,GO:0070651,1,0.977346733797665,0,1,nonfunctional rRNA decay,BP,
14882,GO:0070652,1,0.836837003144694,0,8,HAUS complex,CC,
14884,GO:0070662,1,0.957317274277071,0,2,mast cell proliferation,BP,
14888,GO:0070666,1,0.957317274277071,0,2,regulation of mast cell proliferation,BP,
14889,GO:0070667,1,0.977426114024553,0,1,negative regulation of mast cell proliferation,BP,
14890,GO:0070668,1,0.957317274277071,0,2,positive regulation of mast cell proliferation,BP,
14891,GO:0070669,1,0.822021118745128,0,9,response to interleukin-2,BP,
14892,GO:0070670,1,0.545741303616047,0,27,response to interleukin-4,BP,
14894,GO:0070672,1,0.803827376541878,0,10,response to interleukin-15,BP,
14895,GO:0070673,1,0.831742185852983,0,8,response to interleukin-18,BP,
14896,GO:0070676,1,0.932719407076162,0,3,intralumenal vesicle formation,BP,
14897,GO:0070678,1,0.977272141799898,0,1,preprotein binding,MF,
14898,GO:0070679,1,0.890074943560407,0,6,inositol 1,4,5 trisphosphate binding,MF,
14899,GO:0070681,1,0.932426079361129,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
14900,GO:0070682,1,0.933342281323,0,3,proteasome regulatory particle assembly,BP,
14901,GO:0070685,1,0.977219281465144,0,1,macropinocytic cup,CC,
14902,GO:0070694,1,0.977336572808046,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14903,GO:0070695,1,0.901622451249492,0,5,FHF complex,CC,
14904,GO:0070696,1,0.800736113217963,0,10,transmembrane receptor protein serine/threonine kinase binding,MF,
14905,GO:0070697,1,0.958210681345106,0,2,activin receptor binding,MF,
14906,GO:0070699,1,0.958210681345106,0,2,type II activin receptor binding,MF,
14907,GO:0070700,1,0.835681772720525,0,8,BMP receptor binding,MF,
14908,GO:0070701,1,0.981801364122942,0,1,mucus layer,CC,
14909,GO:0070702,1,0.981801364122942,0,1,inner mucus layer,CC,
14910,GO:0070703,1,0.981801364122942,0,1,outer mucus layer,CC,
14911,GO:0070704,1,0.956454673482018,0,2,sterol desaturase activity,MF,
14912,GO:0070715,1,0.97757836626664,0,1,sodium-dependent organic cation transport,BP,
14913,GO:0070717,1,0.632407039649049,0,21,poly-purine tract binding,MF,
14914,GO:0070723,1,0.700685624666107,0,17,response to cholesterol,BP,
14915,GO:0070724,1,0.977480224836951,0,1,BMP receptor complex,CC,
14917,GO:0070728,1,0.877290733411537,0,6,leucine binding,MF,
14918,GO:0070733,1,0.977027899375247,0,1,protein adenylyltransferase activity,MF,
14920,GO:0070735,1,0.977684350864559,0,1,protein-glycine ligase activity,MF,
14921,GO:0070736,1,0.977684350864559,0,1,protein-glycine ligase activity, initiating,MF,
14922,GO:0070739,1,0.874781958677238,0,6,protein-glutamic acid ligase activity,MF,
14923,GO:0070740,1,0.874781958677238,0,6,tubulin-glutamic acid ligase activity,MF,
14924,GO:0070741,1,0.606703046213401,0,23,response to interleukin-6,BP,
14925,GO:0070742,1,0.768223728981947,0,12,C2H2 zinc finger domain binding,MF,
14926,GO:0070743,1,0.976298274726603,0,1,interleukin-23 complex,CC,
14927,GO:0070757,1,0.840276487583357,0,8,interleukin-35-mediated signaling pathway,BP,
14928,GO:0070761,1,0.872595665563124,0,6,pre-snoRNP complex,CC,
14929,GO:0070762,1,0.977336572808046,0,1,nuclear pore transmembrane ring,CC,
14930,GO:0070765,1,0.874052308496371,0,6,gamma-secretase complex,CC,
14931,GO:0070772,1,0.977453520119005,0,1,PAS complex,CC,
14932,GO:0070773,1,0.976729717365953,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
14933,GO:0070774,1,0.978610907250826,0,1,phytoceramidase activity,MF,
14936,GO:0070777,1,0.95675717930725,0,2,D-aspartate transport,BP,
14937,GO:0070778,1,0.913896409149578,0,4,L-aspartate transmembrane transport,BP,
14938,GO:0070779,1,0.95675717930725,0,2,D-aspartate import across plasma membrane,BP,
14939,GO:0070780,1,0.954654608653479,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
14940,GO:0070781,1,0.979895406366628,0,1,response to biotin,BP,
14941,GO:0070782,1,0.977225146377743,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
14942,GO:0070813,1,0.893308772815561,0,5,hydrogen sulfide metabolic process,BP,
14943,GO:0070814,1,0.915117427027785,0,4,hydrogen sulfide biosynthetic process,BP,
14944,GO:0070815,1,0.913867934816161,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14945,GO:0070816,1,0.715423729959638,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14946,GO:0070818,1,0.977093853074133,0,1,protoporphyrinogen oxidase activity,MF,
14950,GO:0070826,1,0.978411021284441,0,1,paraferritin complex,CC,
14951,GO:0070827,1,0.919231810809841,0,4,chromatin maintenance,BP,
14952,GO:0070828,1,0.727663568979925,0,15,heterochromatin organization,BP,
14953,GO:0070829,1,0.960019013574672,0,2,heterochromatin maintenance,BP,
14955,GO:0070831,1,0.866078922812636,0,7,basement membrane assembly,BP,
14956,GO:0070836,1,0.933533093329773,0,3,caveola assembly,BP,
14961,GO:0070842,1,0.936214605198446,0,3,aggresome assembly,BP,
14962,GO:0070843,1,0.978364242501752,0,1,misfolded protein transport,BP,
14963,GO:0070844,1,0.978364242501752,0,1,polyubiquitinated protein transport,BP,
14964,GO:0070845,1,0.978364242501752,0,1,polyubiquitinated misfolded protein transport,BP,
14965,GO:0070846,1,0.978364242501752,0,1,Hsp90 deacetylation,BP,
14966,GO:0070847,1,0.832925787142566,0,8,core mediator complex,CC,
14970,GO:0070852,1,0.942007941589191,0,3,cell body fiber,CC,
14971,GO:0070853,1,0.962303373019383,0,2,myosin VI binding,MF,
14972,GO:0070856,1,0.979945916904744,0,1,myosin VI light chain binding,MF,
14975,GO:0070860,1,0.977237667938357,0,1,RNA polymerase I core factor complex,CC,
14976,GO:0070861,1,0.661552542543897,0,19,regulation of protein exit from endoplasmic reticulum,BP,
14977,GO:0070862,1,0.797150300213833,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14978,GO:0070863,1,0.846475677831266,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14980,GO:0070874,1,0.899429716262949,0,5,negative regulation of glycogen metabolic process,BP,
14981,GO:0070875,1,0.817242071745392,0,10,positive regulation of glycogen metabolic process,BP,
14982,GO:0070876,1,0.913655942745017,0,4,SOSS complex,CC,
14983,GO:0070877,1,0.95647790485036,0,2,microprocessor complex,CC,
14984,GO:0070878,1,0.84208335672724,0,8,primary miRNA binding,MF,
14985,GO:0070883,1,0.897126637182233,0,5,pre-miRNA binding,MF,
14986,GO:0070884,1,0.724785108816232,0,15,regulation of calcineurin-NFAT signaling cascade,BP,
14987,GO:0070885,1,0.93785614897738,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
14988,GO:0070886,1,0.821498971868685,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
14991,GO:0070889,1,0.955022784381648,0,2,platelet alpha granule organization,BP,
14992,GO:0070890,1,0.980592472679763,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14997,GO:0070898,1,0.983441880501405,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14998,GO:0070899,1,0.977391564461141,0,1,mitochondrial tRNA wobble uridine modification,BP,
14999,GO:0070900,1,0.813509368134482,0,9,mitochondrial tRNA modification,BP,
15000,GO:0070901,1,0.91295558480602,0,4,mitochondrial tRNA methylation,BP,
15001,GO:0070902,1,0.977041386033977,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
15002,GO:0070903,1,0.977189607327329,0,1,mitochondrial tRNA thio-modification,BP,
15003,GO:0070904,1,0.980592472679763,0,1,transepithelial L-ascorbic acid transport,BP,
15004,GO:0070905,1,0.954982502511185,0,2,serine binding,MF,
15005,GO:0070911,1,0.483903470503174,0,32,global genome nucleotide-excision repair,BP,
15006,GO:0070914,1,0.781010138333019,0,11,UV-damage excision repair,BP,
15007,GO:0070915,1,0.911966088370431,0,4,lysophosphatidic acid receptor activity,MF,
15010,GO:0070922,1,0.821235898320477,0,9,small RNA loading onto RISC,BP,
15012,GO:0070926,1,0.978117050614166,0,1,regulation of ATP:ADP antiporter activity,BP,
15013,GO:0070931,1,0.979683877602165,0,1,Golgi-associated vesicle lumen,CC,
15015,GO:0070933,1,0.824375994493288,0,9,histone H4 deacetylation,BP,
15016,GO:0070934,1,0.919257522557687,0,4,CRD-mediated mRNA stabilization,BP,
15017,GO:0070935,1,0.782129490564134,0,11,3'-UTR-mediated mRNA stabilization,BP,
15018,GO:0070936,1,0.337250982952074,0,49,protein K48-linked ubiquitination,BP,
15019,GO:0070937,1,0.899368507825943,0,5,CRD-mediated mRNA stability complex,CC,
15020,GO:0070938,1,0.793093073155728,0,11,contractile ring,CC,
15021,GO:0070939,1,0.936937972282464,0,3,Dsl1/NZR complex,CC,
15022,GO:0070940,1,0.893512456971316,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15023,GO:0070942,1,0.9117444596094,0,4,neutrophil mediated cytotoxicity,BP,
15024,GO:0070943,1,0.932785141675233,0,3,neutrophil mediated killing of symbiont cell,BP,
15025,GO:0070944,1,0.954899813546093,0,2,neutrophil mediated killing of bacterium,BP,
15026,GO:0070945,1,0.954899813546093,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
15027,GO:0070947,1,0.976844813365906,0,1,neutrophil mediated killing of fungus,BP,
15028,GO:0070948,1,0.933165365934772,0,3,regulation of neutrophil mediated cytotoxicity,BP,
15029,GO:0070949,1,0.954698486406634,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15030,GO:0070950,1,0.977330687541506,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15031,GO:0070951,1,0.977330687541506,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15032,GO:0070953,1,0.976844813365906,0,1,regulation of neutrophil mediated killing of fungus,BP,
15033,GO:0070960,1,0.954698486406634,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15034,GO:0070961,1,0.954698486406634,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15035,GO:0070962,1,0.977330687541506,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15036,GO:0070963,1,0.977330687541506,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15037,GO:0070965,1,0.976844813365906,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15038,GO:0070966,1,0.937096169920006,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15039,GO:0070970,1,0.842410794859674,0,8,interleukin-2 secretion,BP,
15040,GO:0070971,1,0.720654620866207,0,15,endoplasmic reticulum exit site,CC,
15041,GO:0070972,1,0.0511665384778877,0,125,protein localization to endoplasmic reticulum,BP,
15042,GO:0070973,1,0.921423422731104,0,4,protein localization to endoplasmic reticulum exit site,BP,
15043,GO:0070975,1,0.980889856692845,0,1,FHA domain binding,MF,
15044,GO:0070976,1,0.977278281642956,0,1,TIR domain binding,MF,
15045,GO:0070977,1,0.805354733947817,0,11,bone maturation,BP,
15046,GO:0070979,1,0.536147178771606,0,27,protein K11-linked ubiquitination,BP,
15047,GO:0070980,1,0.977240461154453,0,1,biphenyl catabolic process,BP,
15048,GO:0070981,1,0.977238873856341,0,1,L-asparagine biosynthetic process,BP,
15049,GO:0070982,1,0.977238873856341,0,1,L-asparagine metabolic process,BP,
15050,GO:0070984,1,0.978408229264601,0,1,SET domain binding,MF,
15051,GO:0070985,1,0.954220938663773,0,2,TFIIK complex,CC,
15052,GO:0070986,1,0.770065978611083,0,12,left/right axis specification,BP,
15053,GO:0070987,1,0.665305744932974,0,18,error-free translesion synthesis,BP,
15055,GO:0070989,1,0.789922553317097,0,11,oxidative demethylation,BP,
15056,GO:0070990,1,0.869436178551949,0,6,snRNP binding,MF,
15057,GO:0070991,1,0.933856222864861,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15058,GO:0070992,1,0.95306573054468,0,2,translation initiation complex,CC,
15059,GO:0070993,1,0.95756337591719,0,2,translation preinitiation complex,CC,
15060,GO:0070995,1,0.977488852731628,0,1,NADPH oxidation,BP,
15062,GO:0071001,1,0.933322826371864,0,3,U4/U6 snRNP,CC,
15063,GO:0071004,1,0.681866640438443,0,17,U2-type prespliceosome,CC,
15064,GO:0071005,1,0.955079756539491,0,2,U2-type precatalytic spliceosome,CC,
15065,GO:0071006,1,0.93358992042943,0,3,U2-type catalytic step 1 spliceosome,CC,
15066,GO:0071007,1,0.515936866908303,0,29,U2-type catalytic step 2 spliceosome,CC,
15067,GO:0071008,1,0.911684437806445,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15068,GO:0071010,1,0.607601443054801,0,22,prespliceosome,CC,
15069,GO:0071011,1,0.494287398464008,0,31,precatalytic spliceosome,CC,
15070,GO:0071012,1,0.872409319790854,0,6,catalytic step 1 spliceosome,CC,
15071,GO:0071013,1,0.114156432948634,0,96,catalytic step 2 spliceosome,CC,
15072,GO:0071014,1,0.813418998718356,0,9,post-mRNA release spliceosomal complex,CC,
15073,GO:0071020,1,0.95469848346002,0,2,post-spliceosomal complex,CC,
15074,GO:0071021,1,0.977070758524301,0,1,U2-type post-spliceosomal complex,CC,
15075,GO:0071025,1,0.708431463542622,0,15,RNA surveillance,BP,
15076,GO:0071026,1,0.97724799426136,0,1,cytoplasmic RNA surveillance,BP,
15077,GO:0071027,1,0.741767241844627,0,13,nuclear RNA surveillance,BP,
15078,GO:0071028,1,0.741767241844627,0,13,nuclear mRNA surveillance,BP,
15079,GO:0071029,1,0.869004000490313,0,6,nuclear ncRNA surveillance,BP,
15080,GO:0071030,1,0.954887285838757,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15081,GO:0071031,1,0.954218722299992,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15082,GO:0071033,1,0.89026681375857,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15083,GO:0071034,1,0.914883905617755,0,4,CUT catabolic process,BP,
15084,GO:0071035,1,0.869004000490313,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15085,GO:0071038,1,0.889199504764854,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15086,GO:0071042,1,0.912105147534817,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15087,GO:0071043,1,0.914883905617755,0,4,CUT metabolic process,BP,
15089,GO:0071045,1,0.977024058709545,0,1,nuclear histone mRNA catabolic process,BP,
15090,GO:0071046,1,0.869004000490313,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15091,GO:0071047,1,0.912105147534817,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15092,GO:0071048,1,0.954887285838757,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15093,GO:0071049,1,0.954218722299992,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15094,GO:0071051,1,0.888351841416317,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15095,GO:0071062,1,0.978503044010862,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15096,GO:0071065,1,0.977481596433604,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15097,GO:0071071,1,0.833879148837174,0,8,regulation of phospholipid biosynthetic process,BP,
15098,GO:0071072,1,0.913579371860556,0,4,negative regulation of phospholipid biosynthetic process,BP,
15099,GO:0071073,1,0.934054033799432,0,3,positive regulation of phospholipid biosynthetic process,BP,
15100,GO:0071074,1,0.977171785634976,0,1,eukaryotic initiation factor eIF2 binding,MF,
15101,GO:0071077,1,0.933485551759478,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15103,GO:0071104,1,0.95907616619488,0,2,response to interleukin-9,BP,
15104,GO:0071105,1,0.978944896609324,0,1,response to interleukin-11,BP,
15105,GO:0071106,1,0.933485551759478,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15106,GO:0071107,1,0.941904323016984,0,3,response to parathyroid hormone,BP,
15107,GO:0071108,1,0.593883869679031,0,25,protein K48-linked deubiquitination,BP,
15108,GO:0071109,1,0.963675024133187,0,2,superior temporal gyrus development,BP,
15109,GO:0071110,1,0.979895406366628,0,1,histone biotinylation,BP,
15110,GO:0071133,1,0.977481596433604,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15111,GO:0071139,1,0.95782056978594,0,2,resolution of recombination intermediates,BP,
15112,GO:0071140,1,0.95782056978594,0,2,resolution of mitotic recombination intermediates,BP,
15113,GO:0071141,1,0.86633816469757,0,7,SMAD protein complex,CC,
15114,GO:0071144,1,0.96316530556527,0,2,heteromeric SMAD protein complex,CC,
15115,GO:0071148,1,0.962046816352144,0,2,TEAD-1-YAP complex,CC,
15116,GO:0071149,1,0.957047639081529,0,2,TEAD-2-YAP complex,CC,
15118,GO:0071157,1,0.666674171289172,0,18,negative regulation of cell cycle arrest,BP,
15120,GO:0071159,1,0.953767351783693,0,2,NF-kappaB complex,CC,
15121,GO:0071163,1,0.932572471116674,0,3,DNA replication preinitiation complex assembly,BP,
15122,GO:0071164,1,0.977951791724003,0,1,RNA trimethylguanosine synthase activity,MF,
15124,GO:0071168,1,0.611117626159325,0,22,protein localization to chromatin,BP,
15125,GO:0071169,1,0.834477862271574,0,8,establishment of protein localization to chromatin,BP,
15126,GO:0071173,1,0.52711748042969,0,29,spindle assembly checkpoint,BP,
15127,GO:0071174,1,0.52711748042969,0,29,mitotic spindle checkpoint,BP,
15128,GO:0071203,1,0.878074142620646,0,6,WASH complex,CC,
15129,GO:0071204,1,0.874042393294429,0,6,histone pre-mRNA 3'end processing complex,CC,
15130,GO:0071205,1,0.925704610275615,0,4,protein localization to juxtaparanode region of axon,BP,
15131,GO:0071207,1,0.956372422168875,0,2,histone pre-mRNA stem-loop binding,MF,
15132,GO:0071208,1,0.909432312135186,0,4,histone pre-mRNA DCP binding,MF,
15133,GO:0071209,1,0.931618288736068,0,3,U7 snRNA binding,MF,
15136,GO:0071215,1,0.978577042266034,0,1,cellular response to abscisic acid stimulus,BP,
15138,GO:0071218,1,0.644403004678113,0,20,cellular response to misfolded protein,BP,
15140,GO:0071220,1,0.93599080523792,0,3,cellular response to bacterial lipoprotein,BP,
15141,GO:0071221,1,0.93599080523792,0,3,cellular response to bacterial lipopeptide,BP,
15143,GO:0071223,1,0.871285440344999,0,6,cellular response to lipoteichoic acid,BP,
15144,GO:0071224,1,0.93468244769676,0,3,cellular response to peptidoglycan,BP,
15145,GO:0071225,1,0.915877308838723,0,4,cellular response to muramyl dipeptide,BP,
15146,GO:0071226,1,0.979148195395373,0,1,cellular response to molecule of fungal origin,BP,
15150,GO:0071233,1,0.845554294561619,0,8,cellular response to leucine,BP,
15154,GO:0071243,1,0.692093026159314,0,16,cellular response to arsenic-containing substance,BP,
15155,GO:0071245,1,0.977898356454244,0,1,cellular response to carbon monoxide,BP,
15156,GO:0071247,1,0.976382198534325,0,1,cellular response to chromate,BP,
15158,GO:0071253,1,0.893479447441037,0,5,connexin binding,MF,
15159,GO:0071256,1,0.908511234246471,0,4,translocon complex,CC,
15160,GO:0071257,1,0.895506096687594,0,5,cellular response to electrical stimulus,BP,
15161,GO:0071258,1,0.978381611755302,0,1,cellular response to gravity,BP,
15163,GO:0071262,1,0.958005796362084,0,2,regulation of translational initiation in response to starvation,BP,
15164,GO:0071264,1,0.958005796362084,0,2,positive regulation of translational initiation in response to starvation,BP,
15165,GO:0071265,1,0.851976145147629,0,7,L-methionine biosynthetic process,BP,
15166,GO:0071266,1,0.977093250950237,0,1,'de novo' L-methionine biosynthetic process,BP,
15167,GO:0071267,1,0.871960081725596,0,6,L-methionine salvage,BP,
15168,GO:0071268,1,0.977236761020266,0,1,homocysteine biosynthetic process,BP,
15169,GO:0071275,1,0.977224430389603,0,1,cellular response to aluminum ion,BP,
15172,GO:0071279,1,0.915680352508014,0,4,cellular response to cobalt ion,BP,
15173,GO:0071280,1,0.756789654700378,0,12,cellular response to copper ion,BP,
15174,GO:0071281,1,0.873976198629492,0,6,cellular response to iron ion,BP,
15175,GO:0071283,1,0.953966701692904,0,2,cellular response to iron(III) ion,BP,
15176,GO:0071284,1,0.918211047845585,0,4,cellular response to lead ion,BP,
15178,GO:0071286,1,0.948784768743039,0,3,cellular response to magnesium ion,BP,
15179,GO:0071287,1,0.874988388901138,0,6,cellular response to manganese ion,BP,
15180,GO:0071294,1,0.832449810060023,0,8,cellular response to zinc ion,BP,
15183,GO:0071301,1,0.980884112301414,0,1,cellular response to vitamin B1,BP,
15186,GO:0071307,1,0.955295803700581,0,2,cellular response to vitamin K,BP,
15188,GO:0071312,1,0.620588950681015,0,22,cellular response to alkaloid,BP,
15189,GO:0071313,1,0.93080086590563,0,4,cellular response to caffeine,BP,
15190,GO:0071314,1,0.977301899279593,0,1,cellular response to cocaine,BP,
15191,GO:0071315,1,0.935963693078363,0,3,cellular response to morphine,BP,
15192,GO:0071316,1,0.87111878366981,0,6,cellular response to nicotine,BP,
15193,GO:0071317,1,0.935963693078363,0,3,cellular response to isoquinoline alkaloid,BP,
15194,GO:0071318,1,0.770290820265313,0,12,cellular response to ATP,BP,
15195,GO:0071320,1,0.525915622623387,0,30,cellular response to cAMP,BP,
15196,GO:0071321,1,0.938960221984711,0,3,cellular response to cGMP,BP,
15198,GO:0071324,1,0.979123887660731,0,1,cellular response to disaccharide stimulus,BP,
15200,GO:0071329,1,0.979123887660731,0,1,cellular response to sucrose stimulus,BP,
15202,GO:0071332,1,0.954912961460024,0,2,cellular response to fructose stimulus,BP,
15204,GO:0071335,1,0.97722651415779,0,1,hair follicle cell proliferation,BP,
15205,GO:0071336,1,0.97722651415779,0,1,regulation of hair follicle cell proliferation,BP,
15206,GO:0071338,1,0.97722651415779,0,1,positive regulation of hair follicle cell proliferation,BP,
15207,GO:0071339,1,0.525632470137386,0,29,MLL1 complex,CC,
15208,GO:0071340,1,0.875696033724734,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
15209,GO:0071344,1,0.954194802980174,0,2,diphosphate metabolic process,BP,
15213,GO:0071348,1,0.978944896609324,0,1,cellular response to interleukin-11,BP,
15215,GO:0071350,1,0.820855367678625,0,9,cellular response to interleukin-15,BP,
15216,GO:0071351,1,0.890800427901843,0,5,cellular response to interleukin-18,BP,
15217,GO:0071352,1,0.822021118745128,0,9,cellular response to interleukin-2,BP,
15218,GO:0071353,1,0.557356452805148,0,26,cellular response to interleukin-4,BP,
15219,GO:0071354,1,0.606703046213401,0,23,cellular response to interleukin-6,BP,
15220,GO:0071355,1,0.95907616619488,0,2,cellular response to interleukin-9,BP,
15224,GO:0071360,1,0.76561820713582,0,12,cellular response to exogenous dsRNA,BP,
15225,GO:0071361,1,0.84875658742143,0,8,cellular response to ethanol,BP,
15226,GO:0071362,1,0.916537261776834,0,4,cellular response to ether,BP,
15229,GO:0071371,1,0.749163726760688,0,13,cellular response to gonadotropin stimulus,BP,
15230,GO:0071372,1,0.839101342591877,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15231,GO:0071373,1,0.955086112431143,0,2,cellular response to luteinizing hormone stimulus,BP,
15232,GO:0071374,1,0.959897604615436,0,2,cellular response to parathyroid hormone stimulus,BP,
15234,GO:0071376,1,0.935834148607585,0,3,cellular response to corticotropin-releasing hormone stimulus,BP,
15237,GO:0071379,1,0.742665474470415,0,14,cellular response to prostaglandin stimulus,BP,
15238,GO:0071380,1,0.774940330125882,0,12,cellular response to prostaglandin E stimulus,BP,
15242,GO:0071386,1,0.961747845368216,0,2,cellular response to corticosterone stimulus,BP,
15243,GO:0071387,1,0.979280783508255,0,1,cellular response to cortisol stimulus,BP,
15244,GO:0071389,1,0.876367578551064,0,6,cellular response to mineralocorticoid stimulus,BP,
15245,GO:0071391,1,0.78562475764644,0,11,cellular response to estrogen stimulus,BP,
15246,GO:0071392,1,0.598295382245079,0,23,cellular response to estradiol stimulus,BP,
15247,GO:0071393,1,0.97830024638832,0,1,cellular response to progesterone stimulus,BP,
15248,GO:0071394,1,0.855069483316376,0,7,cellular response to testosterone stimulus,BP,
15251,GO:0071397,1,0.793222049947416,0,11,cellular response to cholesterol,BP,
15253,GO:0071400,1,0.957406202493191,0,2,cellular response to oleic acid,BP,
15254,GO:0071401,1,0.977236605385541,0,1,cellular response to triglyceride,BP,
15255,GO:0071402,1,0.672744773574964,0,18,cellular response to lipoprotein particle stimulus,BP,
15256,GO:0071403,1,0.955705813488614,0,2,cellular response to high density lipoprotein particle stimulus,BP,
15257,GO:0071404,1,0.770463941301922,0,12,cellular response to low-density lipoprotein particle stimulus,BP,
15259,GO:0071409,1,0.938452136411128,0,3,cellular response to cycloheximide,BP,
15260,GO:0071415,1,0.93080086590563,0,4,cellular response to purine-containing compound,BP,
15262,GO:0071418,1,0.976740537538781,0,1,cellular response to amine stimulus,BP,
15263,GO:0071420,1,0.958750392858708,0,2,cellular response to histamine,BP,
15264,GO:0071421,1,0.957014126318962,0,2,manganese ion transmembrane transport,BP,
15265,GO:0071422,1,0.934481387981746,0,3,succinate transmembrane transport,BP,
15266,GO:0071423,1,0.977163816563072,0,1,malate transmembrane transport,BP,
15268,GO:0071425,1,0.735592785051484,0,14,hematopoietic stem cell proliferation,BP,
15271,GO:0071428,1,0.708601144461836,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15272,GO:0071431,1,0.497252026909741,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15273,GO:0071435,1,0.958522010889218,0,2,potassium ion export,BP,
15274,GO:0071437,1,0.749782873982412,0,13,invadopodium,CC,
15275,GO:0071438,1,0.914151263802326,0,4,invadopodium membrane,CC,
15276,GO:0071439,1,0.838556202058094,0,8,clathrin complex,CC,
15277,GO:0071440,1,0.893004496746498,0,5,regulation of histone H3-K14 acetylation,BP,
15278,GO:0071441,1,0.978093981058656,0,1,negative regulation of histone H3-K14 acetylation,BP,
15279,GO:0071442,1,0.934188995892017,0,3,positive regulation of histone H3-K14 acetylation,BP,
15280,GO:0071447,1,0.876372479736015,0,6,cellular response to hydroperoxide,BP,
15281,GO:0071449,1,0.976094815674079,0,1,cellular response to lipid hydroperoxide,BP,
15282,GO:0071450,1,0.645802734474339,0,19,cellular response to oxygen radical,BP,
15283,GO:0071451,1,0.645802734474339,0,19,cellular response to superoxide,BP,
15285,GO:0071454,1,0.980923580995754,0,1,cellular response to anoxia,BP,
15286,GO:0071455,1,0.875896933415608,0,6,cellular response to hyperoxia,BP,
15288,GO:0071458,1,0.893995062979965,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
15290,GO:0071460,1,0.953634654753415,0,2,cellular response to cell-matrix adhesion,BP,
15292,GO:0071462,1,0.957468154270856,0,2,cellular response to water stimulus,BP,
15293,GO:0071464,1,0.979172403723587,0,1,cellular response to hydrostatic pressure,BP,
15295,GO:0071467,1,0.744796517821659,0,13,cellular response to pH,BP,
15296,GO:0071468,1,0.875092163441363,0,6,cellular response to acidic pH,BP,
15298,GO:0071471,1,0.978702271597768,0,1,cellular response to non-ionic osmotic stress,BP,
15299,GO:0071472,1,0.85501207641611,0,7,cellular response to salt stress,BP,
15301,GO:0071475,1,0.933267248716196,0,3,cellular hyperosmotic salinity response,BP,
15302,GO:0071476,1,0.859016034275916,0,7,cellular hypotonic response,BP,
15303,GO:0071477,1,0.958890064891962,0,2,cellular hypotonic salinity response,BP,
15306,GO:0071480,1,0.56175525018574,0,26,cellular response to gamma radiation,BP,
15307,GO:0071481,1,0.794981929798097,0,11,cellular response to X-ray,BP,
15309,GO:0071483,1,0.956429761191157,0,2,cellular response to blue light,BP,
15310,GO:0071484,1,0.957382894544724,0,2,cellular response to light intensity,BP,
15311,GO:0071485,1,0.977587862754326,0,1,cellular response to absence of light,BP,
15312,GO:0071486,1,0.979333557504635,0,1,cellular response to high light intensity,BP,
15313,GO:0071492,1,0.957244543956049,0,2,cellular response to UV-A,BP,
15314,GO:0071493,1,0.873282756005212,0,6,cellular response to UV-B,BP,
15315,GO:0071494,1,0.918856728820751,0,4,cellular response to UV-C,BP,
15318,GO:0071498,1,0.682670777698656,0,17,cellular response to fluid shear stress,BP,
15319,GO:0071499,1,0.852202313109076,0,7,cellular response to laminar fluid shear stress,BP,
15320,GO:0071500,1,0.894824823913977,0,5,cellular response to nitrosative stress,BP,
15321,GO:0071501,1,0.835638927268582,0,8,cellular response to sterol depletion,BP,
15322,GO:0071502,1,0.933620693187866,0,3,cellular response to temperature stimulus,BP,
15325,GO:0071505,1,0.955309395928292,0,2,response to mycophenolic acid,BP,
15326,GO:0071506,1,0.955309395928292,0,2,cellular response to mycophenolic acid,BP,
15327,GO:0071514,1,0.676625955068627,0,18,genetic imprinting,BP,
15328,GO:0071526,1,0.543378972930601,0,29,semaphorin-plexin signaling pathway,BP,
15329,GO:0071528,1,0.978134712125068,0,1,tRNA re-export from nucleus,BP,
15330,GO:0071532,1,0.917583779027774,0,4,ankyrin repeat binding,MF,
15331,GO:0071535,1,0.912806562367758,0,4,RING-like zinc finger domain binding,MF,
15332,GO:0071538,1,0.977237726899621,0,1,SH2 domain-mediated complex assembly,BP,
15333,GO:0071539,1,0.577972517926925,0,26,protein localization to centrosome,BP,
15334,GO:0071540,1,0.979372125543436,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15335,GO:0071541,1,0.851118521902902,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15336,GO:0071542,1,0.690897171003741,0,17,dopaminergic neuron differentiation,BP,
15337,GO:0071543,1,0.91310481226447,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15338,GO:0071544,1,0.976729717365953,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15339,GO:0071545,1,0.767129141727254,0,12,inositol phosphate catabolic process,BP,
15340,GO:0071546,1,0.955872541234842,0,2,pi-body,CC,
15341,GO:0071547,1,0.977291572676308,0,1,piP-body,CC,
15344,GO:0071550,1,0.812365409526289,0,9,death-inducing signaling complex assembly,BP,
15345,GO:0071554,1,0.933173212284894,0,3,cell wall organization or biogenesis,BP,
15346,GO:0071556,1,0.661680092619686,0,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,
15347,GO:0071557,1,0.900671931622218,0,5,histone H3-K27 demethylation,BP,
15348,GO:0071558,1,0.900671931622218,0,5,histone demethylase activity (H3-K27 specific),MF,
15351,GO:0071561,1,0.979162890786681,0,1,nucleus-vacuole junction,CC,
15352,GO:0071564,1,0.76928459973614,0,12,npBAF complex,CC,
15353,GO:0071565,1,0.77365253922225,0,12,nBAF complex,CC,
15354,GO:0071566,1,0.977361864416425,0,1,UFM1 activating enzyme activity,MF,
15355,GO:0071567,1,0.953999250564355,0,2,UFM1 hydrolase activity,MF,
15356,GO:0071568,1,0.954292301397077,0,2,UFM1 transferase activity,MF,
15357,GO:0071569,1,0.869804499459607,0,6,protein ufmylation,BP,
15358,GO:0071573,1,0.977355342295836,0,1,shelterin complex assembly,BP,
15359,GO:0071575,1,0.977861725014148,0,1,integral component of external side of plasma membrane,CC,
15369,GO:0071586,1,0.954873959873984,0,2,CAAX-box protein processing,BP,
15370,GO:0071593,1,0.936387432192009,0,3,lymphocyte aggregation,BP,
15371,GO:0071595,1,0.955184890372083,0,2,Nem1-Spo7 phosphatase complex,CC,
15372,GO:0071596,1,0.94297825308024,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15373,GO:0071598,1,0.891806359305641,0,5,neuronal ribonucleoprotein granule,CC,
15376,GO:0071602,1,0.978610907250826,0,1,phytosphingosine biosynthetic process,BP,
15378,GO:0071604,1,0.678307236280043,0,18,transforming growth factor beta production,BP,
15379,GO:0071605,1,0.851147692554467,0,7,monocyte chemotactic protein-1 production,BP,
15380,GO:0071606,1,0.977192875115681,0,1,chemokine (C-C motif) ligand 4 production,BP,
15381,GO:0071608,1,0.912857209909139,0,4,macrophage inflammatory protein-1 alpha production,BP,
15382,GO:0071609,1,0.839231461340732,0,8,chemokine (C-C motif) ligand 5 production,BP,
15383,GO:0071611,1,0.955032312164966,0,2,granulocyte colony-stimulating factor production,BP,
15384,GO:0071612,1,0.983862025803767,0,1,IP-10 production,BP,
15385,GO:0071614,1,0.97715189095406,0,1,linoleic acid epoxygenase activity,MF,
15386,GO:0071615,1,0.977467365682333,0,1,oxidative deethylation,BP,
15387,GO:0071616,1,0.385427961211874,0,43,acyl-CoA biosynthetic process,BP,
15388,GO:0071617,1,0.645197666398226,0,20,lysophospholipid acyltransferase activity,MF,
15389,GO:0071619,1,0.977235574341747,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
15391,GO:0071622,1,0.549268654467609,0,26,regulation of granulocyte chemotaxis,BP,
15392,GO:0071623,1,0.979106290648909,0,1,negative regulation of granulocyte chemotaxis,BP,
15393,GO:0071624,1,0.687658578586754,0,16,positive regulation of granulocyte chemotaxis,BP,
15394,GO:0071625,1,0.796664633496042,0,11,vocalization behavior,BP,
15395,GO:0071629,1,0.977024058709545,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
15396,GO:0071630,1,0.939080337966876,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
15397,GO:0071633,1,0.977320372736755,0,1,dihydroceramidase activity,MF,
15398,GO:0071634,1,0.693036627629452,0,17,regulation of transforming growth factor beta production,BP,
15399,GO:0071635,1,0.875118186981041,0,6,negative regulation of transforming growth factor beta production,BP,
15400,GO:0071636,1,0.842067458471719,0,8,positive regulation of transforming growth factor beta production,BP,
15401,GO:0071637,1,0.851147692554467,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15402,GO:0071638,1,0.955346253387642,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
15403,GO:0071639,1,0.890948766149213,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
15404,GO:0071640,1,0.912857209909139,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
15405,GO:0071641,1,0.955466836363502,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
15406,GO:0071642,1,0.955411851194715,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
15407,GO:0071643,1,0.977192875115681,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15408,GO:0071644,1,0.977192875115681,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15409,GO:0071649,1,0.858954934948073,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
15410,GO:0071650,1,0.932999938640715,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
15411,GO:0071651,1,0.920657576746503,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15412,GO:0071655,1,0.955032312164966,0,2,regulation of granulocyte colony-stimulating factor production,BP,
15413,GO:0071656,1,0.977238535630964,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
15414,GO:0071657,1,0.977278500836114,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
15415,GO:0071658,1,0.983862025803767,0,1,regulation of IP-10 production,BP,
15416,GO:0071660,1,0.983862025803767,0,1,positive regulation of IP-10 production,BP,
15417,GO:0071664,1,0.917801116554875,0,4,catenin-TCF7L2 complex,CC,
15418,GO:0071665,1,0.977650173421349,0,1,gamma-catenin-TCF7L2 complex,CC,
15419,GO:0071670,1,0.892311380411297,0,5,smooth muscle cell chemotaxis,BP,
15420,GO:0071671,1,0.912897397048732,0,4,regulation of smooth muscle cell chemotaxis,BP,
15421,GO:0071672,1,0.933948622022895,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
15422,GO:0071673,1,0.977465696982126,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15425,GO:0071676,1,0.956786806840152,0,2,negative regulation of mononuclear cell migration,BP,
15427,GO:0071678,1,0.981124354768868,0,1,olfactory bulb axon guidance,BP,
15428,GO:0071679,1,0.843708003298339,0,8,commissural neuron axon guidance,BP,
15429,GO:0071680,1,0.897523933975542,0,5,response to indole-3-methanol,BP,
15430,GO:0071681,1,0.897523933975542,0,5,cellular response to indole-3-methanol,BP,
15431,GO:0071682,1,0.832337468449919,0,8,endocytic vesicle lumen,CC,
15432,GO:0071684,1,0.977555063335181,0,1,organism emergence from protective structure,BP,
15433,GO:0071688,1,0.959799359471947,0,3,striated muscle myosin thick filament assembly,BP,
15434,GO:0071691,1,0.98057432577256,0,1,cardiac muscle thin filament assembly,BP,
15435,GO:0071692,1,0.904483315224089,0,5,protein localization to extracellular region,BP,
15436,GO:0071694,1,0.904483315224089,0,5,maintenance of protein location in extracellular region,BP,
15438,GO:0071696,1,0.784928574599188,0,11,ectodermal placode development,BP,
15439,GO:0071697,1,0.803218229062021,0,10,ectodermal placode morphogenesis,BP,
15440,GO:0071698,1,0.958161561770872,0,2,olfactory placode development,BP,
15441,GO:0071699,1,0.958161561770872,0,2,olfactory placode morphogenesis,BP,
15442,GO:0071701,1,0.979003600878698,0,1,regulation of MAPK export from nucleus,BP,
15447,GO:0071707,1,0.976627599644752,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
15448,GO:0071709,1,0.677879143520964,0,18,membrane assembly,BP,
15449,GO:0071711,1,0.730459058960423,0,15,basement membrane organization,BP,
15450,GO:0071712,1,0.783504720791084,0,11,ER-associated misfolded protein catabolic process,BP,
15451,GO:0071713,1,0.978882989247659,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15452,GO:0071715,1,0.653185208740924,0,19,icosanoid transport,BP,
15453,GO:0071723,1,0.93687117788835,0,3,lipopeptide binding,MF,
15454,GO:0071724,1,0.957915507230383,0,2,response to diacyl bacterial lipopeptide,BP,
15455,GO:0071725,1,0.9776748638294,0,1,response to triacyl bacterial lipopeptide,BP,
15456,GO:0071726,1,0.957915507230383,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15457,GO:0071727,1,0.9776748638294,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15458,GO:0071731,1,0.786070675287432,0,11,response to nitric oxide,BP,
15459,GO:0071732,1,0.801563161313007,0,10,cellular response to nitric oxide,BP,
15460,GO:0071733,1,0.938546794082892,0,3,transcriptional activation by promoter-enhancer looping,BP,
15461,GO:0071763,1,0.873234034534813,0,6,nuclear membrane organization,BP,
15462,GO:0071765,1,0.978451758946981,0,1,nuclear inner membrane organization,BP,
15466,GO:0071782,1,0.665011044023697,0,18,endoplasmic reticulum tubular network,CC,
15467,GO:0071786,1,0.71530393385228,0,15,endoplasmic reticulum tubular network organization,BP,
15468,GO:0071787,1,0.912108513097638,0,4,endoplasmic reticulum tubular network formation,BP,
15469,GO:0071789,1,0.977336572808046,0,1,spindle pole body localization to nuclear envelope,BP,
15470,GO:0071790,1,0.977336572808046,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15471,GO:0071796,1,0.976657447192621,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
15472,GO:0071797,1,0.912585246215525,0,4,LUBAC complex,CC,
15473,GO:0071798,1,0.958390925561149,0,2,response to prostaglandin D,BP,
15474,GO:0071799,1,0.958390925561149,0,2,cellular response to prostaglandin D stimulus,BP,
15475,GO:0071800,1,0.673949059810757,0,18,podosome assembly,BP,
15476,GO:0071801,1,0.748229017787295,0,13,regulation of podosome assembly,BP,
15477,GO:0071802,1,0.978432365235465,0,1,negative regulation of podosome assembly,BP,
15478,GO:0071803,1,0.80043366226138,0,10,positive regulation of podosome assembly,BP,
15479,GO:0071804,1,0.174518272131377,0,80,cellular potassium ion transport,BP,
15480,GO:0071805,1,0.174518272131377,0,80,potassium ion transmembrane transport,BP,
15482,GO:0071812,1,0.977467365682333,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15483,GO:0071813,1,0.770885847408277,0,12,lipoprotein particle binding,MF,
15484,GO:0071814,1,0.770885847408277,0,12,protein-lipid complex binding,MF,
15485,GO:0071816,1,0.911770758177731,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15486,GO:0071817,1,0.89109325300348,0,5,MMXD complex,CC,
15487,GO:0071818,1,0.933323751944119,0,3,BAT3 complex,CC,
15488,GO:0071819,1,0.953872844755469,0,2,DUBm complex,CC,
15490,GO:0071821,1,0.980722786404672,0,1,FANCM-MHF complex,CC,
15492,GO:0071825,1,0.5868152658547,0,24,protein-lipid complex subunit organization,BP,
15493,GO:0071826,1,0.00941013859636123,0,205,ribonucleoprotein complex subunit organization,BP,
15494,GO:0071827,1,0.613761490011562,0,22,plasma lipoprotein particle organization,BP,
15495,GO:0071830,1,0.911442646161753,0,4,triglyceride-rich lipoprotein particle clearance,BP,
15496,GO:0071837,1,0.838674629264668,0,8,HMG box domain binding,MF,
15497,GO:0071838,1,0.935463697828744,0,3,cell proliferation in bone marrow,BP,
15498,GO:0071839,1,0.933823770903244,0,3,apoptotic process in bone marrow,BP,
15500,GO:0071847,1,0.956647766228793,0,2,TNFSF11-mediated signaling pathway,BP,
15501,GO:0071848,1,0.977467365682333,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15502,GO:0071850,1,0.728995395488429,0,14,mitotic cell cycle arrest,BP,
15503,GO:0071855,1,0.850093557036023,0,7,neuropeptide receptor binding,MF,
15504,GO:0071863,1,0.915197138489046,0,4,regulation of cell proliferation in bone marrow,BP,
15505,GO:0071864,1,0.915197138489046,0,4,positive regulation of cell proliferation in bone marrow,BP,
15506,GO:0071865,1,0.934869602422768,0,3,regulation of apoptotic process in bone marrow,BP,
15507,GO:0071866,1,0.934869602422768,0,3,negative regulation of apoptotic process in bone marrow,BP,
15512,GO:0071871,1,0.821669690516144,0,9,response to epinephrine,BP,
15513,GO:0071872,1,0.840821486808105,0,8,cellular response to epinephrine stimulus,BP,
15514,GO:0071873,1,0.97774346757813,0,1,response to norepinephrine,BP,
15515,GO:0071874,1,0.97774346757813,0,1,cellular response to norepinephrine stimulus,BP,
15518,GO:0071878,1,0.981915309359245,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15519,GO:0071879,1,0.9376899748777,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15520,GO:0071880,1,0.855042295014715,0,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15522,GO:0071885,1,0.977336572808046,0,1,N-terminal protein N-methyltransferase activity,MF,
15524,GO:0071888,1,0.832322686468233,0,8,macrophage apoptotic process,BP,
15526,GO:0071893,1,0.977115191442785,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15527,GO:0071894,1,0.955425807000959,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
15529,GO:0071896,1,0.923761084370236,0,4,protein localization to adherens junction,BP,
15531,GO:0071898,1,0.933750930663794,0,3,regulation of estrogen receptor binding,BP,
15532,GO:0071899,1,0.933750930663794,0,3,negative regulation of estrogen receptor binding,BP,
15536,GO:0071907,1,0.94060586626271,0,3,determination of digestive tract left/right asymmetry,BP,
15537,GO:0071908,1,0.97942657938205,0,1,determination of intestine left/right asymmetry,BP,
15538,GO:0071909,1,0.97942657938205,0,1,determination of stomach left/right asymmetry,BP,
15539,GO:0071910,1,0.959025898051375,0,2,determination of liver left/right asymmetry,BP,
15540,GO:0071914,1,0.978090544920442,0,1,prominosome,CC,
15541,GO:0071918,1,0.956293642566546,0,2,urea transmembrane transport,BP,
15542,GO:0071920,1,0.955000782721203,0,2,cleavage body,CC,
15543,GO:0071921,1,0.877574180239972,0,6,cohesin loading,BP,
15544,GO:0071922,1,0.897932554747748,0,5,regulation of cohesin loading,BP,
15545,GO:0071926,1,0.915646976622487,0,4,endocannabinoid signaling pathway,BP,
15546,GO:0071929,1,0.955310122613709,0,2,alpha-tubulin acetylation,BP,
15547,GO:0071930,1,0.937275961340884,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15548,GO:0071931,1,0.977336572808046,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15549,GO:0071933,1,0.858529762458003,0,7,Arp2/3 complex binding,MF,
15550,GO:0071934,1,0.955421353043865,0,2,thiamine transmembrane transport,BP,
15551,GO:0071936,1,0.843829113440715,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
15553,GO:0071942,1,0.934102795365246,0,3,XPC complex,CC,
15555,GO:0071947,1,0.939185447930404,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
15556,GO:0071949,1,0.626325241155542,0,21,FAD binding,MF,
15557,GO:0071951,1,0.977287315003688,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
15558,GO:0071953,1,0.95503713184276,0,2,elastic fiber,CC,
15559,GO:0071955,1,0.960024033590201,0,2,recycling endosome to Golgi transport,BP,
15560,GO:0071960,1,0.976043880359759,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
15561,GO:0071962,1,0.932587202492285,0,3,mitotic sister chromatid cohesion, centromeric,BP,
15562,GO:0071963,1,0.977094153484742,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
15563,GO:0071971,1,0.873187968193896,0,6,extracellular exosome assembly,BP,
15564,GO:0071985,1,0.536569402752994,0,28,multivesicular body sorting pathway,BP,
15565,GO:0071986,1,0.871394657795378,0,6,Ragulator complex,CC,
15566,GO:0071987,1,0.917117468020203,0,4,WD40-repeat domain binding,MF,
15567,GO:0071988,1,0.980765369020107,0,1,protein localization to spindle pole body,BP,
15568,GO:0071997,1,0.9801861254092,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15570,GO:0072003,1,0.978120976366248,0,1,kidney rudiment formation,BP,
15571,GO:0072004,1,0.978120976366248,0,1,kidney field specification,BP,
15573,GO:0072007,1,0.937874238034597,0,3,mesangial cell differentiation,BP,
15574,GO:0072008,1,0.937874238034597,0,3,glomerular mesangial cell differentiation,BP,
15576,GO:0072010,1,0.755475192001034,0,13,glomerular epithelium development,BP,
15578,GO:0072014,1,0.919531122100098,0,4,proximal tubule development,BP,
15579,GO:0072015,1,0.828002036633422,0,9,glomerular visceral epithelial cell development,BP,
15580,GO:0072017,1,0.87250959118894,0,7,distal tubule development,BP,
15581,GO:0072019,1,0.977223059619356,0,1,proximal convoluted tubule development,BP,
15582,GO:0072021,1,0.964830661225928,0,2,ascending thin limb development,BP,
15583,GO:0072025,1,0.978120976366248,0,1,distal convoluted tubule development,BP,
15587,GO:0072036,1,0.97799455983445,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15588,GO:0072038,1,0.956873162315381,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15589,GO:0072039,1,0.956873162315381,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15590,GO:0072040,1,0.956873162315381,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15591,GO:0072044,1,0.849388839059046,0,8,collecting duct development,BP,
15592,GO:0072047,1,0.911424212058644,0,4,proximal/distal pattern formation involved in nephron development,BP,
15593,GO:0072048,1,0.851226121076917,0,7,renal system pattern specification,BP,
15596,GO:0072053,1,0.956344588634659,0,2,renal inner medulla development,BP,
15597,GO:0072054,1,0.956344588634659,0,2,renal outer medulla development,BP,
15598,GO:0072055,1,0.979172403723587,0,1,renal cortex development,BP,
15599,GO:0072059,1,0.979172403723587,0,1,cortical collecting duct development,BP,
15600,GO:0072060,1,0.978160194037388,0,1,outer medullary collecting duct development,BP,
15601,GO:0072061,1,0.955458171310005,0,2,inner medullary collecting duct development,BP,
15602,GO:0072069,1,0.978120976366248,0,1,DCT cell differentiation,BP,
15603,GO:0072070,1,0.823949524937092,0,9,loop of Henle development,BP,
15608,GO:0072076,1,0.938676809502497,0,3,nephrogenic mesenchyme development,BP,
15613,GO:0072081,1,0.911424212058644,0,4,specification of nephron tubule identity,BP,
15614,GO:0072086,1,0.911424212058644,0,4,specification of loop of Henle identity,BP,
15619,GO:0072092,1,0.96537901863696,0,2,ureteric bud invasion,BP,
15620,GO:0072093,1,0.944132637036301,0,3,metanephric renal vesicle formation,BP,
15621,GO:0072095,1,0.957611755208093,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15622,GO:0072096,1,0.977115191442785,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15623,GO:0072097,1,0.977115191442785,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15624,GO:0072098,1,0.977115191442785,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15625,GO:0072099,1,0.977115191442785,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15626,GO:0072100,1,0.977115191442785,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15627,GO:0072101,1,0.977115191442785,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15634,GO:0072109,1,0.81783737169001,0,9,glomerular mesangium development,BP,
15635,GO:0072110,1,0.852261778175574,0,7,glomerular mesangial cell proliferation,BP,
15637,GO:0072112,1,0.772712320626695,0,12,glomerular visceral epithelial cell differentiation,BP,
15638,GO:0072114,1,0.979548525332537,0,1,pronephros morphogenesis,BP,
15639,GO:0072124,1,0.852261778175574,0,7,regulation of glomerular mesangial cell proliferation,BP,
15640,GO:0072125,1,0.934273576170219,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
15641,GO:0072126,1,0.912240059720531,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
15642,GO:0072127,1,0.97723479144629,0,1,renal capsule development,BP,
15643,GO:0072128,1,0.97723479144629,0,1,renal capsule morphogenesis,BP,
15644,GO:0072129,1,0.97723479144629,0,1,renal capsule formation,BP,
15645,GO:0072130,1,0.97723479144629,0,1,renal capsule specification,BP,
15649,GO:0072134,1,0.960547139763628,0,2,nephrogenic mesenchyme morphogenesis,BP,
15650,GO:0072135,1,0.956590056621314,0,2,kidney mesenchymal cell proliferation,BP,
15651,GO:0072136,1,0.956590056621314,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
15652,GO:0072137,1,0.969925888567593,0,2,condensed mesenchymal cell proliferation,BP,
15653,GO:0072138,1,0.955108884637864,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
15654,GO:0072139,1,0.977227380413047,0,1,glomerular parietal epithelial cell differentiation,BP,
15656,GO:0072143,1,0.937874238034597,0,3,mesangial cell development,BP,
15657,GO:0072144,1,0.937874238034597,0,3,glomerular mesangial cell development,BP,
15659,GO:0072156,1,0.96612254290365,0,2,distal tubule morphogenesis,BP,
15660,GO:0072160,1,0.809170624216879,0,10,nephron tubule epithelial cell differentiation,BP,
15661,GO:0072161,1,0.913388356999881,0,4,mesenchymal cell differentiation involved in kidney development,BP,
15662,GO:0072162,1,0.956466512160237,0,2,metanephric mesenchymal cell differentiation,BP,
15665,GO:0072166,1,0.9773907392528,0,1,posterior mesonephric tubule development,BP,
15672,GO:0072176,1,0.86569647012104,0,7,nephric duct development,BP,
15673,GO:0072177,1,0.964830661225928,0,2,mesonephric duct development,BP,
15674,GO:0072178,1,0.89726537340337,0,5,nephric duct morphogenesis,BP,
15675,GO:0072179,1,0.955057799280384,0,2,nephric duct formation,BP,
15676,GO:0072182,1,0.826427554560169,0,9,regulation of nephron tubule epithelial cell differentiation,BP,
15677,GO:0072183,1,0.977831607808505,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15683,GO:0072192,1,0.977115191442785,0,1,ureter epithelial cell differentiation,BP,
15685,GO:0072194,1,0.979172403723587,0,1,kidney smooth muscle tissue development,BP,
15687,GO:0072198,1,0.977115191442785,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15688,GO:0072199,1,0.977115191442785,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15689,GO:0072200,1,0.977115191442785,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
15690,GO:0072201,1,0.877953266866172,0,6,negative regulation of mesenchymal cell proliferation,BP,
15693,GO:0072204,1,0.957216438815259,0,2,cell-cell signaling involved in metanephros development,BP,
15694,GO:0072205,1,0.903638299394268,0,5,metanephric collecting duct development,BP,
15696,GO:0072208,1,0.979172403723587,0,1,metanephric smooth muscle tissue development,BP,
15697,GO:0072209,1,0.97733048160298,0,1,metanephric mesangial cell differentiation,BP,
15699,GO:0072213,1,0.97723479144629,0,1,metanephric capsule development,BP,
15700,GO:0072214,1,0.979172403723587,0,1,metanephric cortex development,BP,
15703,GO:0072217,1,0.893032998994166,0,5,negative regulation of metanephros development,BP,
15704,GO:0072218,1,0.964830661225928,0,2,metanephric ascending thin limb development,BP,
15705,GO:0072219,1,0.979172403723587,0,1,metanephric cortical collecting duct development,BP,
15706,GO:0072221,1,0.978120976366248,0,1,metanephric distal convoluted tubule development,BP,
15707,GO:0072223,1,0.933706888018886,0,3,metanephric glomerular mesangium development,BP,
15708,GO:0072224,1,0.877097591253676,0,6,metanephric glomerulus development,BP,
15709,GO:0072229,1,0.977223059619356,0,1,metanephric proximal convoluted tubule development,BP,
15711,GO:0072235,1,0.943718290157793,0,3,metanephric distal tubule development,BP,
15712,GO:0072236,1,0.943756133507831,0,3,metanephric loop of Henle development,BP,
15713,GO:0072237,1,0.962909762902955,0,2,metanephric proximal tubule development,BP,
15714,GO:0072239,1,0.933706888018886,0,3,metanephric glomerulus vasculature development,BP,
15715,GO:0072240,1,0.978120976366248,0,1,metanephric DCT cell differentiation,BP,
15717,GO:0072244,1,0.979759787231907,0,1,metanephric glomerular epithelium development,BP,
15718,GO:0072248,1,0.979759787231907,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15719,GO:0072249,1,0.979759787231907,0,1,metanephric glomerular visceral epithelial cell development,BP,
15720,GO:0072254,1,0.97733048160298,0,1,metanephric glomerular mesangial cell differentiation,BP,
15721,GO:0072255,1,0.97733048160298,0,1,metanephric glomerular mesangial cell development,BP,
15722,GO:0072257,1,0.884983941711885,0,6,metanephric nephron tubule epithelial cell differentiation,BP,
15723,GO:0072262,1,0.955368300850216,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15724,GO:0072265,1,0.97723479144629,0,1,metanephric capsule morphogenesis,BP,
15725,GO:0072266,1,0.97723479144629,0,1,metanephric capsule formation,BP,
15726,GO:0072267,1,0.97723479144629,0,1,metanephric capsule specification,BP,
15727,GO:0072268,1,0.933196007774066,0,3,pattern specification involved in metanephros development,BP,
15728,GO:0072272,1,0.954939118927708,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
15730,GO:0072274,1,0.979759787231907,0,1,metanephric glomerular basement membrane development,BP,
15731,GO:0072278,1,0.955735025342183,0,2,metanephric comma-shaped body morphogenesis,BP,
15734,GO:0072284,1,0.914662457493318,0,4,metanephric S-shaped body morphogenesis,BP,
15735,GO:0072285,1,0.97799455983445,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15736,GO:0072287,1,0.985354357558574,0,1,metanephric distal tubule morphogenesis,BP,
15738,GO:0072298,1,0.935340967021764,0,3,regulation of metanephric glomerulus development,BP,
15739,GO:0072299,1,0.9773907392528,0,1,negative regulation of metanephric glomerulus development,BP,
15740,GO:0072300,1,0.956981139193129,0,2,positive regulation of metanephric glomerulus development,BP,
15741,GO:0072301,1,0.955368300850216,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15742,GO:0072302,1,0.9773907392528,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15743,GO:0072303,1,0.977470046949509,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
15744,GO:0072304,1,0.978120976366248,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15745,GO:0072305,1,0.978120976366248,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15746,GO:0072307,1,0.884983941711885,0,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15747,GO:0072308,1,0.977831607808505,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15748,GO:0072309,1,0.978120976366248,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15749,GO:0072310,1,0.828002036633422,0,9,glomerular epithelial cell development,BP,
15750,GO:0072311,1,0.772712320626695,0,12,glomerular epithelial cell differentiation,BP,
15751,GO:0072312,1,0.979759787231907,0,1,metanephric glomerular epithelial cell differentiation,BP,
15752,GO:0072313,1,0.979759787231907,0,1,metanephric glomerular epithelial cell development,BP,
15753,GO:0072318,1,0.898008552118946,0,5,clathrin coat disassembly,BP,
15754,GO:0072319,1,0.877550837279227,0,6,vesicle uncoating,BP,
15755,GO:0072320,1,0.936278601535556,0,3,volume-sensitive chloride channel activity,MF,
15757,GO:0072329,1,0.106859199554592,0,99,monocarboxylic acid catabolic process,BP,
15761,GO:0072334,1,0.954138233994557,0,2,UDP-galactose transmembrane transport,BP,
15762,GO:0072337,1,0.766912110841969,0,12,modified amino acid transport,BP,
15763,GO:0072338,1,0.899441625048991,0,5,cellular lactam metabolic process,BP,
15765,GO:0072343,1,0.977150839933651,0,1,pancreatic stellate cell proliferation,BP,
15766,GO:0072344,1,0.91223175927769,0,4,rescue of stalled ribosome,BP,
15767,GO:0072345,1,0.895147593872103,0,5,NAADP-sensitive calcium-release channel activity,MF,
15768,GO:0072347,1,0.423120119759027,0,39,response to anesthetic,BP,
15769,GO:0072348,1,0.612407329530943,0,22,sulfur compound transport,BP,
15770,GO:0072349,1,0.825495158198025,0,9,modified amino acid transmembrane transporter activity,MF,
15771,GO:0072350,1,0.461578030677133,0,34,tricarboxylic acid metabolic process,BP,
15772,GO:0072354,1,0.977071421642845,0,1,histone kinase activity (H3-T3 specific),MF,
15773,GO:0072355,1,0.977071421642845,0,1,histone H3-T3 phosphorylation,BP,
15774,GO:0072356,1,0.978273888349958,0,1,chromosome passenger complex localization to kinetochore,BP,
15775,GO:0072357,1,0.858143591075388,0,7,PTW/PP1 phosphatase complex,CC,
15778,GO:0072361,1,0.964340618020054,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15779,GO:0072362,1,0.981301751095756,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15780,GO:0072363,1,0.98271690246479,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15781,GO:0072364,1,0.964824463149448,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15782,GO:0072365,1,0.981794074226056,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15783,GO:0072366,1,0.98271690246479,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15784,GO:0072367,1,0.922282522513898,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
15785,GO:0072368,1,0.960245273854165,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15786,GO:0072369,1,0.960471490191081,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
15788,GO:0072378,1,0.850381983324741,0,7,blood coagulation, fibrin clot formation,BP,
15789,GO:0072379,1,0.933323751944119,0,3,ER membrane insertion complex,CC,
15790,GO:0072382,1,0.985494407024008,0,1,minus-end-directed vesicle transport along microtubule,BP,
15791,GO:0072383,1,0.864978559916659,0,7,plus-end-directed vesicle transport along microtubule,BP,
15794,GO:0072386,1,0.847418719293767,0,8,plus-end-directed organelle transport along microtubule,BP,
15795,GO:0072387,1,0.955808767443883,0,2,flavin adenine dinucleotide metabolic process,BP,
15796,GO:0072388,1,0.977190576982258,0,1,flavin adenine dinucleotide biosynthetic process,BP,
15797,GO:0072389,1,0.978120976366248,0,1,flavin adenine dinucleotide catabolic process,BP,
15799,GO:0072395,1,0.195801647317475,0,73,signal transduction involved in cell cycle checkpoint,BP,
15800,GO:0072396,1,0.878929009711828,0,6,response to cell cycle checkpoint signaling,BP,
15801,GO:0072401,1,0.199446820770301,0,72,signal transduction involved in DNA integrity checkpoint,BP,
15802,GO:0072402,1,0.878929009711828,0,6,response to DNA integrity checkpoint signaling,BP,
15803,GO:0072413,1,0.255188601076926,0,61,signal transduction involved in mitotic cell cycle checkpoint,BP,
15804,GO:0072414,1,0.980672904175816,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15805,GO:0072422,1,0.199446820770301,0,72,signal transduction involved in DNA damage checkpoint,BP,
15806,GO:0072423,1,0.878929009711828,0,6,response to DNA damage checkpoint signaling,BP,
15807,GO:0072425,1,0.787512724620288,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15808,GO:0072428,1,0.977155194195259,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
15809,GO:0072429,1,0.933351544766598,0,3,response to intra-S DNA damage checkpoint signaling,BP,
15810,GO:0072431,1,0.26112444209255,0,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
15811,GO:0072432,1,0.980672904175816,0,1,response to G1 DNA damage checkpoint signaling,BP,
15812,GO:0072434,1,0.961195031125988,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15813,GO:0072487,1,0.893348642990343,0,5,MSL complex,CC,
15814,GO:0072488,1,0.854101137866076,0,7,ammonium transmembrane transport,BP,
15815,GO:0072492,1,0.977098313568905,0,1,host cell mitochondrial intermembrane space,CC,
15818,GO:0072501,1,0.921653241073277,0,4,cellular divalent inorganic anion homeostasis,BP,
15819,GO:0072502,1,0.921653241073277,0,4,cellular trivalent inorganic anion homeostasis,BP,
15821,GO:0072505,1,0.882543525093918,0,6,divalent inorganic anion homeostasis,BP,
15822,GO:0072506,1,0.882543525093918,0,6,trivalent inorganic anion homeostasis,BP,
15825,GO:0072510,1,0.979252292085138,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
15827,GO:0072512,1,0.487332543337823,0,32,trivalent inorganic cation transport,BP,
15828,GO:0072513,1,0.97590265256551,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
15829,GO:0072517,1,0.97771186916298,0,1,host cell viral assembly compartment,CC,
15830,GO:0072518,1,0.980200842627725,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15834,GO:0072523,1,0.427444183489319,0,38,purine-containing compound catabolic process,BP,
15837,GO:0072526,1,0.912177747105281,0,4,pyridine-containing compound catabolic process,BP,
15840,GO:0072529,1,0.543736215629383,0,27,pyrimidine-containing compound catabolic process,BP,
15841,GO:0072530,1,0.832024666648322,0,8,purine-containing compound transmembrane transport,BP,
15842,GO:0072531,1,0.852718371437332,0,7,pyrimidine-containing compound transmembrane transport,BP,
15843,GO:0072534,1,0.981461828224432,0,1,perineuronal net,CC,
15844,GO:0072535,1,0.977481596433604,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15845,GO:0072536,1,0.977194319940977,0,1,interleukin-23 receptor complex,CC,
15849,GO:0072540,1,0.891576793308082,0,5,T-helper 17 cell lineage commitment,BP,
15850,GO:0072542,1,0.853803571689616,0,7,protein phosphatase activator activity,MF,
15851,GO:0072545,1,0.977225496233081,0,1,tyrosine binding,MF,
15852,GO:0072546,1,0.795526350720867,0,10,ER membrane protein complex,CC,
15853,GO:0072553,1,0.915765343622263,0,4,terminal button organization,BP,
15854,GO:0072554,1,0.977240541901661,0,1,blood vessel lumenization,BP,
15855,GO:0072555,1,0.976986827483947,0,1,17-beta-ketosteroid reductase activity,MF,
15856,GO:0072556,1,0.978425880734245,0,1,other organism presynaptic membrane,CC,
15857,GO:0072557,1,0.953604871710738,0,2,IPAF inflammasome complex,CC,
15858,GO:0072558,1,0.933432330336698,0,3,NLRP1 inflammasome complex,CC,
15859,GO:0072559,1,0.871393220069413,0,6,NLRP3 inflammasome complex,CC,
15860,GO:0072560,1,0.977466030284502,0,1,type B pancreatic cell maturation,BP,
15862,GO:0072563,1,0.954982327729981,0,2,endothelial microparticle,CC,
15863,GO:0072564,1,0.977040650790622,0,1,blood microparticle formation,BP,
15864,GO:0072566,1,0.955115805143162,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
15865,GO:0072567,1,0.757389578345046,0,12,chemokine (C-X-C motif) ligand 2 production,BP,
15866,GO:0072570,1,0.977547818524953,0,1,ADP-D-ribose binding,MF,
15867,GO:0072572,1,0.977223187418302,0,1,poly-ADP-D-ribose binding,MF,
15868,GO:0072573,1,0.978645391491612,0,1,tolerance induction to lipopolysaccharide,BP,
15869,GO:0072574,1,0.819546105933484,0,9,hepatocyte proliferation,BP,
15870,GO:0072575,1,0.819546105933484,0,9,epithelial cell proliferation involved in liver morphogenesis,BP,
15871,GO:0072576,1,0.803527541852868,0,10,liver morphogenesis,BP,
15873,GO:0072578,1,0.878610589775496,0,6,neurotransmitter-gated ion channel clustering,BP,
15874,GO:0072579,1,0.978498490151427,0,1,glycine receptor clustering,BP,
15875,GO:0072582,1,0.976986827483947,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15876,GO:0072583,1,0.46010274098893,0,36,clathrin-dependent endocytosis,BP,
15877,GO:0072584,1,0.837383082450652,0,8,caveolin-mediated endocytosis,BP,
15878,GO:0072586,1,0.978711825902159,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15879,GO:0072587,1,0.978711825902159,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15880,GO:0072588,1,0.821871303661835,0,8,box H/ACA RNP complex,CC,
15881,GO:0072589,1,0.908311655919766,0,4,box H/ACA scaRNP complex,CC,
15882,GO:0072590,1,0.979758293437428,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15883,GO:0072591,1,0.979758293437428,0,1,citrate-L-glutamate ligase activity,MF,
15884,GO:0072592,1,0.954958166112643,0,2,oxygen metabolic process,BP,
15888,GO:0072599,1,0.0815583316282297,0,104,establishment of protein localization to endoplasmic reticulum,BP,
15889,GO:0072602,1,0.917636050451688,0,4,interleukin-4 secretion,BP,
15891,GO:0072604,1,0.654256884516748,0,19,interleukin-6 secretion,BP,
15892,GO:0072606,1,0.728731179249745,0,14,interleukin-8 secretion,BP,
15894,GO:0072610,1,0.913704316040151,0,4,interleukin-12 secretion,BP,
15896,GO:0072615,1,0.977192875115681,0,1,interleukin-17 secretion,BP,
15897,GO:0072616,1,0.978248333561943,0,1,interleukin-18 secretion,BP,
15898,GO:0072619,1,0.977824597077808,0,1,interleukin-21 secretion,BP,
15899,GO:0072641,1,0.881277794358165,0,6,type I interferon secretion,BP,
15900,GO:0072642,1,0.881277794358165,0,6,interferon-alpha secretion,BP,
15901,GO:0072643,1,0.817979748714812,0,9,interferon-gamma secretion,BP,
15905,GO:0072658,1,0.982675003825129,0,1,maintenance of protein location in membrane,BP,
15907,GO:0072660,1,0.982675003825129,0,1,maintenance of protein location in plasma membrane,BP,
15908,GO:0072662,1,0.681992072101998,0,17,protein localization to peroxisome,BP,
15909,GO:0072663,1,0.681992072101998,0,17,establishment of protein localization to peroxisome,BP,
15912,GO:0072669,1,0.847943281707886,0,7,tRNA-splicing ligase complex,CC,
15913,GO:0072671,1,0.977253662048664,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
15914,GO:0072672,1,0.916103359718794,0,4,neutrophil extravasation,BP,
15915,GO:0072673,1,0.721321088639631,0,15,lamellipodium morphogenesis,BP,
15916,GO:0072674,1,0.924260039370734,0,4,multinuclear osteoclast differentiation,BP,
15917,GO:0072675,1,0.924260039370734,0,4,osteoclast fusion,BP,
15919,GO:0072677,1,0.871793436948183,0,6,eosinophil migration,BP,
15920,GO:0072678,1,0.571141370404238,0,25,T cell migration,BP,
15921,GO:0072679,1,0.93264054532106,0,3,thymocyte migration,BP,
15922,GO:0072680,1,0.977481596433604,0,1,extracellular matrix-dependent thymocyte migration,BP,
15923,GO:0072681,1,0.977481596433604,0,1,fibronectin-dependent thymocyte migration,BP,
15924,GO:0072682,1,0.97768694948875,0,1,eosinophil extravasation,BP,
15925,GO:0072683,1,0.954843495551256,0,2,T cell extravasation,BP,
15926,GO:0072684,1,0.978069931767821,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15927,GO:0072686,1,0.144722898786176,0,88,mitotic spindle,CC,
15929,GO:0072695,1,0.955073137981341,0,2,regulation of DNA recombination at telomere,BP,
15930,GO:0072697,1,0.785420846497894,0,11,protein localization to cell cortex,BP,
15932,GO:0072702,1,0.979608076448615,0,1,response to methyl methanesulfonate,BP,
15933,GO:0072703,1,0.979608076448615,0,1,cellular response to methyl methanesulfonate,BP,
15936,GO:0072708,1,0.912770265229132,0,4,response to sorbitol,BP,
15937,GO:0072709,1,0.955666234361222,0,2,cellular response to sorbitol,BP,
15938,GO:0072710,1,0.823101151816462,0,9,response to hydroxyurea,BP,
15939,GO:0072711,1,0.84220049011451,0,8,cellular response to hydroxyurea,BP,
15940,GO:0072714,1,0.977090519923487,0,1,response to selenite ion,BP,
15941,GO:0072715,1,0.977090519923487,0,1,cellular response to selenite ion,BP,
15942,GO:0072716,1,0.913872135551881,0,4,response to actinomycin D,BP,
15943,GO:0072717,1,0.935069297182286,0,3,cellular response to actinomycin D,BP,
15944,GO:0072718,1,0.81983792533315,0,9,response to cisplatin,BP,
15945,GO:0072719,1,0.874929965212697,0,6,cellular response to cisplatin,BP,
15946,GO:0072720,1,0.977336572808046,0,1,response to dithiothreitol,BP,
15947,GO:0072733,1,0.932993800841606,0,3,response to staurosporine,BP,
15948,GO:0072734,1,0.932993800841606,0,3,cellular response to staurosporine,BP,
15949,GO:0072737,1,0.954998582246983,0,2,response to diamide,BP,
15950,GO:0072738,1,0.954998582246983,0,2,cellular response to diamide,BP,
15951,GO:0072739,1,0.955017498160604,0,2,response to anisomycin,BP,
15952,GO:0072740,1,0.977165313198381,0,1,cellular response to anisomycin,BP,
15953,GO:0072741,1,0.937862691774573,0,3,protein localization to cell division site,BP,
15954,GO:0072749,1,0.97712861412132,0,1,cellular response to cytochalasin B,BP,
15956,GO:0072752,1,0.980328565819108,0,1,cellular response to rapamycin,BP,
15957,GO:0072755,1,0.97801408721604,0,1,cellular response to benomyl,BP,
15958,GO:0072757,1,0.914161979392794,0,4,cellular response to camptothecin,BP,
15959,GO:0075044,1,0.91882980674248,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15960,GO:0075071,1,0.91882980674248,0,4,autophagy involved in symbiotic interaction,BP,
15961,GO:0075109,1,0.979287790694437,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15962,GO:0075111,1,0.979287790694437,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15963,GO:0075112,1,0.979287790694437,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15964,GO:0075114,1,0.979287790694437,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15965,GO:0075136,1,0.87461139733818,0,6,response to host,BP,
15966,GO:0075341,1,0.977236976644177,0,1,host cell PML body,CC,
15967,GO:0075509,1,0.935194243496949,0,3,endocytosis involved in viral entry into host cell,BP,
15968,GO:0075519,1,0.975704866754846,0,1,microtubule-dependent intracellular transport of viral material,BP,
15969,GO:0075521,1,0.975704866754846,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15970,GO:0075522,1,0.800406994517089,0,10,IRES-dependent viral translational initiation,BP,
15971,GO:0075525,1,0.892524568824509,0,5,viral translational termination-reinitiation,BP,
15972,GO:0075528,1,0.934857719325141,0,3,modulation by virus of host immune response,BP,
15973,GO:0075606,1,0.975704866754846,0,1,transport of viral material towards nucleus,BP,
15974,GO:0075713,1,0.832470816669009,0,8,establishment of integrated proviral latency,BP,
15975,GO:0075732,1,0.95878695632466,0,2,viral penetration into host nucleus,BP,
15976,GO:0075733,1,0.314982382053384,0,52,intracellular transport of virus,BP,
15977,GO:0080008,1,0.491115912102684,0,32,Cul4-RING E3 ubiquitin ligase complex,CC,
15979,GO:0080019,1,0.957027150185686,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
15980,GO:0080023,1,0.955184890372083,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15981,GO:0080025,1,0.647515452470092,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
15982,GO:0080058,1,0.976742927377338,0,1,protein deglutathionylation,BP,
15983,GO:0080084,1,0.901420796764994,0,5,5S rDNA binding,MF,
15985,GO:0080101,1,0.976223502460596,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
15986,GO:0080111,1,0.664331817475843,0,19,DNA demethylation,BP,
15987,GO:0080120,1,0.954873959873984,0,2,CAAX-box protein maturation,BP,
15988,GO:0080121,1,0.955217372481423,0,2,AMP transport,BP,
15989,GO:0080122,1,0.933485551759478,0,3,AMP transmembrane transporter activity,MF,
15990,GO:0080129,1,0.976378416388115,0,1,proteasome core complex assembly,BP,
15994,GO:0080146,1,0.977093250950237,0,1,L-cysteine desulfhydrase activity,MF,
15995,GO:0080147,1,0.97585624064459,0,1,root hair cell development,BP,
15996,GO:0080154,1,0.874706318311249,0,6,regulation of fertilization,BP,
15997,GO:0080163,1,0.977242427501846,0,1,regulation of protein serine/threonine phosphatase activity,BP,
16000,GO:0080184,1,0.955008348457946,0,2,response to phenylpropanoid,BP,
16001,GO:0085020,1,0.85262023583199,0,7,protein K6-linked ubiquitination,BP,
16003,GO:0085032,1,0.97757679309931,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
16004,GO:0086001,1,0.476824977186615,0,35,cardiac muscle cell action potential,BP,
16005,GO:0086002,1,0.599581017830697,0,24,cardiac muscle cell action potential involved in contraction,BP,
16006,GO:0086003,1,0.537780379476173,0,29,cardiac muscle cell contraction,BP,
16007,GO:0086004,1,0.656768755345665,0,20,regulation of cardiac muscle cell contraction,BP,
16008,GO:0086005,1,0.725963175872821,0,15,ventricular cardiac muscle cell action potential,BP,
16009,GO:0086006,1,0.958151626408876,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
16010,GO:0086007,1,0.957009077184335,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
16011,GO:0086008,1,0.977337432210077,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16012,GO:0086009,1,0.651917211713836,0,20,membrane repolarization,BP,
16013,GO:0086010,1,0.658795789325955,0,20,membrane depolarization during action potential,BP,
16014,GO:0086011,1,0.801605548350008,0,10,membrane repolarization during action potential,BP,
16015,GO:0086012,1,0.791420420078972,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16016,GO:0086013,1,0.858147079375003,0,7,membrane repolarization during cardiac muscle cell action potential,BP,
16017,GO:0086014,1,0.808709417178693,0,10,atrial cardiac muscle cell action potential,BP,
16018,GO:0086015,1,0.959327236414624,0,2,SA node cell action potential,BP,
16019,GO:0086016,1,0.894842065308126,0,5,AV node cell action potential,BP,
16020,GO:0086017,1,0.956294146831135,0,2,Purkinje myocyte action potential,BP,
16021,GO:0086018,1,0.959327236414624,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
16022,GO:0086019,1,0.722424619696897,0,15,cell-cell signaling involved in cardiac conduction,BP,
16023,GO:0086020,1,0.95899263304491,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16024,GO:0086021,1,0.95899263304491,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16025,GO:0086023,1,0.930766156245243,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16026,GO:0086024,1,0.981425242372094,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16027,GO:0086026,1,0.808709417178693,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
16028,GO:0086027,1,0.894842065308126,0,5,AV node cell to bundle of His cell signaling,BP,
16029,GO:0086028,1,0.912848326944865,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16030,GO:0086029,1,0.956294146831135,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16031,GO:0086036,1,0.918379393411479,0,4,regulation of cardiac muscle cell membrane potential,BP,
16032,GO:0086038,1,0.977336572808046,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16033,GO:0086039,1,0.981506086750235,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16034,GO:0086040,1,0.97877215664454,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16035,GO:0086042,1,0.880725885431235,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16036,GO:0086043,1,0.912848326944865,0,4,bundle of His cell action potential,BP,
16037,GO:0086044,1,0.977490942931953,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16038,GO:0086045,1,0.957215229608542,0,2,membrane depolarization during AV node cell action potential,BP,
16039,GO:0086046,1,0.981419609362148,0,1,membrane depolarization during SA node cell action potential,BP,
16040,GO:0086047,1,0.978316932853619,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
16041,GO:0086048,1,0.956896162960959,0,2,membrane depolarization during bundle of His cell action potential,BP,
16042,GO:0086053,1,0.95899263304491,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16043,GO:0086054,1,0.977490942931953,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16044,GO:0086055,1,0.977490942931953,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16045,GO:0086056,1,0.978432365235465,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16046,GO:0086057,1,0.978106252905452,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16047,GO:0086064,1,0.701654882678794,0,16,cell communication by electrical coupling involved in cardiac conduction,BP,
16048,GO:0086065,1,0.50868905901537,0,31,cell communication involved in cardiac conduction,BP,
16049,GO:0086066,1,0.808709417178693,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16050,GO:0086067,1,0.877902243025406,0,6,AV node cell to bundle of His cell communication,BP,
16051,GO:0086068,1,0.956294146831135,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16052,GO:0086069,1,0.822665694614126,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16053,GO:0086070,1,0.941171388464484,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16054,GO:0086072,1,0.977247148564094,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16055,GO:0086073,1,0.901239585715659,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16056,GO:0086075,1,0.937378717753717,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16057,GO:0086076,1,0.977490942931953,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16058,GO:0086077,1,0.95899263304491,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16059,GO:0086078,1,0.977490942931953,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16060,GO:0086079,1,0.977490942931953,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16061,GO:0086080,1,0.84830475327985,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16062,GO:0086082,1,0.977247148564094,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16063,GO:0086083,1,0.901239585715659,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16064,GO:0086089,1,0.977337432210077,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16065,GO:0086091,1,0.696964989094926,0,17,regulation of heart rate by cardiac conduction,BP,
16066,GO:0086092,1,0.97877215664454,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16068,GO:0086098,1,0.956062027217243,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
16069,GO:0086100,1,0.978074838772482,0,1,endothelin receptor signaling pathway,BP,
16071,GO:0089700,1,0.915890910242737,0,4,protein kinase D signaling,BP,
16072,GO:0089701,1,0.888960353571285,0,5,U2AF,CC,
16073,GO:0089709,1,0.95505164936042,0,2,L-histidine transmembrane transport,BP,
16074,GO:0089717,1,0.901838864078367,0,5,spanning component of membrane,CC,
16076,GO:0089720,1,0.870231005572423,0,6,caspase binding,MF,
16077,GO:0090009,1,0.92142273098762,0,4,primitive streak formation,BP,
16078,GO:0090022,1,0.658998633300172,0,18,regulation of neutrophil chemotaxis,BP,
16079,GO:0090023,1,0.704376338950878,0,15,positive regulation of neutrophil chemotaxis,BP,
16080,GO:0090024,1,0.979106290648909,0,1,negative regulation of neutrophil chemotaxis,BP,
16083,GO:0090027,1,0.956786806840152,0,2,negative regulation of monocyte chemotaxis,BP,
16084,GO:0090030,1,0.854829274233899,0,7,regulation of steroid hormone biosynthetic process,BP,
16085,GO:0090031,1,0.955897479324216,0,2,positive regulation of steroid hormone biosynthetic process,BP,
16086,GO:0090032,1,0.913628321918219,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16087,GO:0090034,1,0.955851267922347,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16088,GO:0090035,1,0.955851267922347,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
16089,GO:0090036,1,0.78658965972515,0,11,regulation of protein kinase C signaling,BP,
16090,GO:0090037,1,0.873844006579033,0,6,positive regulation of protein kinase C signaling,BP,
16091,GO:0090038,1,0.956106865400026,0,2,negative regulation of protein kinase C signaling,BP,
16092,GO:0090042,1,0.823857299788041,0,9,tubulin deacetylation,BP,
16093,GO:0090043,1,0.861761699438436,0,7,regulation of tubulin deacetylation,BP,
16094,GO:0090044,1,0.976991038494323,0,1,positive regulation of tubulin deacetylation,BP,
16095,GO:0090045,1,0.85471386591696,0,7,positive regulation of deacetylase activity,BP,
16096,GO:0090049,1,0.541721316723699,0,28,regulation of cell migration involved in sprouting angiogenesis,BP,
16097,GO:0090050,1,0.718331275785472,0,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,
16098,GO:0090051,1,0.754403375442801,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16099,GO:0090063,1,0.915683055425301,0,4,positive regulation of microtubule nucleation,BP,
16100,GO:0090065,1,0.974854758144779,0,1,regulation of production of siRNA involved in RNA interference,BP,
16102,GO:0090067,1,0.978740367579142,0,1,regulation of thalamus size,BP,
16104,GO:0090069,1,0.749038515216839,0,13,regulation of ribosome biogenesis,BP,
16105,GO:0090070,1,0.834318103002912,0,8,positive regulation of ribosome biogenesis,BP,
16106,GO:0090071,1,0.916821832002775,0,4,negative regulation of ribosome biogenesis,BP,
16107,GO:0090073,1,0.834089682435942,0,8,positive regulation of protein homodimerization activity,BP,
16110,GO:0090077,1,0.647184966178209,0,20,foam cell differentiation,BP,
16111,GO:0090079,1,0.686792799427371,0,17,translation regulator activity, nucleic acid binding,MF,
16112,GO:0090080,1,0.959964073520646,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16113,GO:0090081,1,0.977125613061449,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16114,GO:0090082,1,0.977125613061449,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16117,GO:0090085,1,0.782144345170749,0,11,regulation of protein deubiquitination,BP,
16118,GO:0090086,1,0.931576934021409,0,3,negative regulation of protein deubiquitination,BP,
16120,GO:0090088,1,0.954829641473384,0,2,regulation of oligopeptide transport,BP,
16121,GO:0090089,1,0.954829641473384,0,2,regulation of dipeptide transport,BP,
16123,GO:0090091,1,0.919248559975531,0,4,positive regulation of extracellular matrix disassembly,BP,
16132,GO:0090107,1,0.938261129083475,0,3,regulation of high-density lipoprotein particle assembly,BP,
16133,GO:0090108,1,0.977212701443733,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16135,GO:0090110,1,0.753586145365543,0,13,cargo loading into COPII-coated vesicle,BP,
16136,GO:0090113,1,0.97722651415779,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
16137,GO:0090114,1,0.247784369045295,0,63,COPII-coated vesicle budding,BP,
16138,GO:0090116,1,0.937502206556863,0,3,C-5 methylation of cytosine,BP,
16139,GO:0090118,1,0.898729766895221,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
16140,GO:0090119,1,0.978733464945066,0,1,vesicle-mediated cholesterol transport,BP,
16141,GO:0090128,1,0.874175009516691,0,6,regulation of synapse maturation,BP,
16142,GO:0090129,1,0.892607427141461,0,5,positive regulation of synapse maturation,BP,
16144,GO:0090131,1,0.976972650957465,0,1,mesenchyme migration,BP,
16146,GO:0090135,1,0.935444987190181,0,3,actin filament branching,BP,
16148,GO:0090138,1,0.977923788098153,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16149,GO:0090140,1,0.659434218111665,0,19,regulation of mitochondrial fission,BP,
16150,GO:0090141,1,0.748606245225651,0,13,positive regulation of mitochondrial fission,BP,
16151,GO:0090148,1,0.769818816474168,0,12,membrane fission,BP,
16152,GO:0090149,1,0.956467194785988,0,2,mitochondrial membrane fission,BP,
16154,GO:0090151,1,0.75290296538979,0,12,establishment of protein localization to mitochondrial membrane,BP,
16155,GO:0090153,1,0.743987465636105,0,13,regulation of sphingolipid biosynthetic process,BP,
16156,GO:0090154,1,0.833935281031789,0,8,positive regulation of sphingolipid biosynthetic process,BP,
16157,GO:0090155,1,0.913315205643603,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16158,GO:0090156,1,0.932712506920903,0,3,cellular sphingolipid homeostasis,BP,
16159,GO:0090158,1,0.891346566254408,0,5,endoplasmic reticulum membrane organization,BP,
16160,GO:0090160,1,0.838197668946853,0,8,Golgi to lysosome transport,BP,
16161,GO:0090161,1,0.789340373081207,0,11,Golgi ribbon formation,BP,
16163,GO:0090164,1,0.958747559563506,0,2,asymmetric Golgi ribbon formation,BP,
16164,GO:0090166,1,0.874331477811829,0,6,Golgi disassembly,BP,
16165,GO:0090168,1,0.915527208631815,0,4,Golgi reassembly,BP,
16166,GO:0090169,1,0.583200294555503,0,25,regulation of spindle assembly,BP,
16167,GO:0090170,1,0.912480250656645,0,4,regulation of Golgi inheritance,BP,
16169,GO:0090175,1,0.103861488365985,0,101,regulation of establishment of planar polarity,BP,
16170,GO:0090176,1,0.979598670893542,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16171,GO:0090177,1,0.757244652363999,0,13,establishment of planar polarity involved in neural tube closure,BP,
16172,GO:0090178,1,0.757244652363999,0,13,regulation of establishment of planar polarity involved in neural tube closure,BP,
16173,GO:0090179,1,0.773661706738326,0,12,planar cell polarity pathway involved in neural tube closure,BP,
16175,GO:0090182,1,0.954689479767677,0,2,regulation of secretion of lysosomal enzymes,BP,
16178,GO:0090185,1,0.815456249690074,0,9,negative regulation of kidney development,BP,
16179,GO:0090186,1,0.900014029406973,0,5,regulation of pancreatic juice secretion,BP,
16180,GO:0090187,1,0.977212701443733,0,1,positive regulation of pancreatic juice secretion,BP,
16181,GO:0090188,1,0.921007730477391,0,4,negative regulation of pancreatic juice secretion,BP,
16184,GO:0090191,1,0.954846578043401,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
16187,GO:0090194,1,0.934273576170219,0,3,negative regulation of glomerulus development,BP,
16188,GO:0090195,1,0.814670975829506,0,9,chemokine secretion,BP,
16189,GO:0090196,1,0.852419426951099,0,7,regulation of chemokine secretion,BP,
16190,GO:0090197,1,0.872201684914345,0,6,positive regulation of chemokine secretion,BP,
16191,GO:0090198,1,0.977330687541506,0,1,negative regulation of chemokine secretion,BP,
16193,GO:0090200,1,0.535824172939005,0,27,positive regulation of release of cytochrome c from mitochondria,BP,
16195,GO:0090202,1,0.938546794082892,0,3,gene looping,BP,
16196,GO:0090204,1,0.935122381889503,0,3,protein localization to nuclear pore,BP,
16197,GO:0090205,1,0.87534665833131,0,6,positive regulation of cholesterol metabolic process,BP,
16198,GO:0090206,1,0.890963013681317,0,5,negative regulation of cholesterol metabolic process,BP,
16199,GO:0090207,1,0.653119572334561,0,19,regulation of triglyceride metabolic process,BP,
16200,GO:0090208,1,0.780963825475299,0,11,positive regulation of triglyceride metabolic process,BP,
16201,GO:0090209,1,0.913558778207324,0,4,negative regulation of triglyceride metabolic process,BP,
16202,GO:0090210,1,0.956202665495824,0,2,regulation of establishment of blood-brain barrier,BP,
16203,GO:0090212,1,0.978377862362251,0,1,negative regulation of establishment of blood-brain barrier,BP,
16204,GO:0090214,1,0.957931374120895,0,2,spongiotrophoblast layer developmental growth,BP,
16205,GO:0090218,1,0.659915198126068,0,19,positive regulation of lipid kinase activity,BP,
16206,GO:0090219,1,0.91367697638769,0,4,negative regulation of lipid kinase activity,BP,
16207,GO:0090220,1,0.83952809185296,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16208,GO:0090222,1,0.962087569276196,0,2,centrosome-templated microtubule nucleation,BP,
16209,GO:0090224,1,0.440409771816708,0,38,regulation of spindle organization,BP,
16210,GO:0090226,1,0.975945040540022,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
16211,GO:0090230,1,0.916732503573858,0,4,regulation of centromere complex assembly,BP,
16212,GO:0090231,1,0.731919729961377,0,14,regulation of spindle checkpoint,BP,
16213,GO:0090232,1,0.838524429190616,0,8,positive regulation of spindle checkpoint,BP,
16214,GO:0090233,1,0.977271761485294,0,1,negative regulation of spindle checkpoint,BP,
16215,GO:0090234,1,0.936447757712273,0,3,regulation of kinetochore assembly,BP,
16216,GO:0090235,1,0.866816429403003,0,7,regulation of metaphase plate congression,BP,
16217,GO:0090237,1,0.894351161199591,0,5,regulation of arachidonic acid secretion,BP,
16218,GO:0090238,1,0.913403698637256,0,4,positive regulation of arachidonic acid secretion,BP,
16219,GO:0090239,1,0.780676608756577,0,11,regulation of histone H4 acetylation,BP,
16220,GO:0090240,1,0.854885333602817,0,7,positive regulation of histone H4 acetylation,BP,
16221,GO:0090241,1,0.912505061462962,0,4,negative regulation of histone H4 acetylation,BP,
16222,GO:0090244,1,0.939812274109223,0,3,Wnt signaling pathway involved in somitogenesis,BP,
16223,GO:0090245,1,0.921722983088763,0,4,axis elongation involved in somitogenesis,BP,
16224,GO:0090246,1,0.978674360350703,0,1,convergent extension involved in somitogenesis,BP,
16225,GO:0090247,1,0.977258170732843,0,1,cell motility involved in somitogenic axis elongation,BP,
16226,GO:0090249,1,0.977258170732843,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
16227,GO:0090251,1,0.983642580778407,0,1,protein localization involved in establishment of planar polarity,BP,
16229,GO:0090258,1,0.95743826467989,0,2,negative regulation of mitochondrial fission,BP,
16230,GO:0090259,1,0.93556748110102,0,3,regulation of retinal ganglion cell axon guidance,BP,
16231,GO:0090260,1,0.979106290648909,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16234,GO:0090266,1,0.748719685159375,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16235,GO:0090267,1,0.857761367011193,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16236,GO:0090269,1,0.94163005329836,0,3,fibroblast growth factor production,BP,
16237,GO:0090270,1,0.94163005329836,0,3,regulation of fibroblast growth factor production,BP,
16238,GO:0090271,1,0.96122661308205,0,2,positive regulation of fibroblast growth factor production,BP,
16239,GO:0090272,1,0.979615972568209,0,1,negative regulation of fibroblast growth factor production,BP,
16244,GO:0090280,1,0.897761544142845,0,5,positive regulation of calcium ion import,BP,
16246,GO:0090283,1,0.936559920067165,0,3,regulation of protein glycosylation in Golgi,BP,
16247,GO:0090284,1,0.98079564260322,0,1,positive regulation of protein glycosylation in Golgi,BP,
16248,GO:0090285,1,0.954901341931584,0,2,negative regulation of protein glycosylation in Golgi,BP,
16249,GO:0090286,1,0.909277136100368,0,5,cytoskeletal anchoring at nuclear membrane,BP,
16252,GO:0090289,1,0.978645391491612,0,1,regulation of osteoclast proliferation,BP,
16253,GO:0090291,1,0.978645391491612,0,1,negative regulation of osteoclast proliferation,BP,
16254,GO:0090292,1,0.945299967075242,0,3,nuclear matrix anchoring at nuclear membrane,BP,
16255,GO:0090296,1,0.913627118030177,0,4,regulation of mitochondrial DNA replication,BP,
16256,GO:0090297,1,0.976640658183698,0,1,positive regulation of mitochondrial DNA replication,BP,
16257,GO:0090298,1,0.935484840260266,0,3,negative regulation of mitochondrial DNA replication,BP,
16258,GO:0090299,1,0.977038435138114,0,1,regulation of neural crest formation,BP,
16259,GO:0090301,1,0.977038435138114,0,1,negative regulation of neural crest formation,BP,
16263,GO:0090306,1,0.91885184995646,0,4,spindle assembly involved in meiosis,BP,
16264,GO:0090307,1,0.261391092214979,0,61,mitotic spindle assembly,BP,
16265,GO:0090308,1,0.842046678237568,0,8,regulation of methylation-dependent chromatin silencing,BP,
16266,GO:0090309,1,0.916827973926627,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16267,GO:0090310,1,0.960130960210405,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
16272,GO:0090315,1,0.91229261214644,0,4,negative regulation of protein targeting to membrane,BP,
16274,GO:0090317,1,0.516150650131813,0,29,negative regulation of intracellular protein transport,BP,
16275,GO:0090322,1,0.646341518390988,0,19,regulation of superoxide metabolic process,BP,
16276,GO:0090323,1,0.975447519545245,0,1,prostaglandin secretion involved in immune response,BP,
16277,GO:0090324,1,0.892611234678259,0,5,negative regulation of oxidative phosphorylation,BP,
16278,GO:0090325,1,0.956474323474206,0,2,regulation of locomotion involved in locomotory behavior,BP,
16279,GO:0090326,1,0.977589454991973,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16280,GO:0090327,1,0.978402639635041,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
16281,GO:0090329,1,0.38600109560065,0,43,regulation of DNA-dependent DNA replication,BP,
16282,GO:0090330,1,0.701048701503287,0,16,regulation of platelet aggregation,BP,
16283,GO:0090331,1,0.817708834047622,0,9,negative regulation of platelet aggregation,BP,
16284,GO:0090335,1,0.839635597285787,0,8,regulation of brown fat cell differentiation,BP,
16285,GO:0090336,1,0.935389272217789,0,3,positive regulation of brown fat cell differentiation,BP,
16286,GO:0090340,1,0.977212701443733,0,1,positive regulation of secretion of lysosomal enzymes,BP,
16287,GO:0090341,1,0.97695353931833,0,1,negative regulation of secretion of lysosomal enzymes,BP,
16289,GO:0090343,1,0.79470103222794,0,10,positive regulation of cell aging,BP,
16290,GO:0090344,1,0.659598839213868,0,19,negative regulation of cell aging,BP,
16291,GO:0090345,1,0.977249911957491,0,1,cellular organohalogen metabolic process,BP,
16292,GO:0090346,1,0.977249911957491,0,1,cellular organofluorine metabolic process,BP,
16293,GO:0090360,1,0.934605875592074,0,3,platelet-derived growth factor production,BP,
16294,GO:0090361,1,0.934605875592074,0,3,regulation of platelet-derived growth factor production,BP,
16295,GO:0090362,1,0.956404218274718,0,2,positive regulation of platelet-derived growth factor production,BP,
16296,GO:0090365,1,0.977228007191649,0,1,regulation of mRNA modification,BP,
16297,GO:0090367,1,0.977228007191649,0,1,negative regulation of mRNA modification,BP,
16298,GO:0090370,1,0.978543811086441,0,1,negative regulation of cholesterol efflux,BP,
16299,GO:0090381,1,0.977125613061449,0,1,regulation of heart induction,BP,
16300,GO:0090382,1,0.474245072303906,0,33,phagosome maturation,BP,
16301,GO:0090383,1,0.617625206893162,0,21,phagosome acidification,BP,
16302,GO:0090385,1,0.874839254606443,0,6,phagosome-lysosome fusion,BP,
16303,GO:0090386,1,0.960075746002459,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16304,GO:0090387,1,0.960075746002459,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16305,GO:0090389,1,0.981086241880611,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16306,GO:0090394,1,0.916144937225047,0,4,negative regulation of excitatory postsynaptic potential,BP,
16309,GO:0090400,1,0.854708226110613,0,7,stress-induced premature senescence,BP,
16310,GO:0090402,1,0.955018658300525,0,2,oncogene-induced cell senescence,BP,
16311,GO:0090403,1,0.93516309618198,0,3,oxidative stress-induced premature senescence,BP,
16313,GO:0090409,1,0.977236574092238,0,1,malonyl-CoA synthetase activity,MF,
16314,GO:0090410,1,0.977236574092238,0,1,malonate catabolic process,BP,
16315,GO:0090416,1,0.977255169974039,0,1,nicotinate transmembrane transporter activity,MF,
16316,GO:0090420,1,0.976793002735808,0,1,naphthalene-containing compound metabolic process,BP,
16317,GO:0090422,1,0.954810610075237,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
16318,GO:0090427,1,0.977230147772224,0,1,activation of meiosis,BP,
16319,GO:0090435,1,0.853995980766323,0,7,protein localization to nuclear envelope,BP,
16321,GO:0090472,1,0.978427734470736,0,1,dibasic protein processing,BP,
16322,GO:0090480,1,0.936723145713767,0,3,purine nucleotide-sugar transmembrane transport,BP,
16323,GO:0090481,1,0.798470399380304,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16327,GO:0090498,1,0.957958538731554,0,2,extrinsic component of Golgi membrane,CC,
16328,GO:0090500,1,0.955014609244507,0,2,endocardial cushion to mesenchymal transition,BP,
16330,GO:0090502,1,0.261266732182228,0,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
16331,GO:0090503,1,0.45978493489284,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
16332,GO:0090504,1,0.572366384390552,0,26,epiboly,BP,
16333,GO:0090505,1,0.582064841296527,0,25,epiboly involved in wound healing,BP,
16334,GO:0090520,1,0.81576330775582,0,9,sphingolipid mediated signaling pathway,BP,
16335,GO:0090521,1,0.91602254069208,0,4,glomerular visceral epithelial cell migration,BP,
16336,GO:0090527,1,0.827725915243092,0,9,actin filament reorganization,BP,
16337,GO:0090529,1,0.977147198817636,0,1,cell septum assembly,BP,
16338,GO:0090533,1,0.855506209846661,0,7,cation-transporting ATPase complex,CC,
16339,GO:0090537,1,0.978328810823739,0,1,CERF complex,CC,
16340,GO:0090541,1,0.95642176221986,0,2,MIT domain binding,MF,
16343,GO:0090554,1,0.963857353631067,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16344,GO:0090556,1,0.963857353631067,0,2,phosphatidylserine-translocating ATPase activity,MF,
16345,GO:0090557,1,0.844350734728364,0,8,establishment of endothelial intestinal barrier,BP,
16346,GO:0090558,1,0.97585624064459,0,1,plant epidermis development,BP,
16348,GO:0090560,1,0.977225205059921,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
16350,GO:0090571,1,0.933496145217429,0,3,RNA polymerase II transcription repressor complex,CC,
16352,GO:0090576,1,0.841252286587927,0,8,RNA polymerase III transcription factor complex,CC,
16353,GO:0090579,1,0.938546794082892,0,3,dsDNA loop formation,BP,
16354,GO:0090594,1,0.852206922898287,0,7,inflammatory response to wounding,BP,
16356,GO:0090599,1,0.900085127214068,0,5,alpha-glucosidase activity,MF,
16357,GO:0090600,1,0.978155297178691,0,1,alpha-1,3-glucosidase activity,MF,
16358,GO:0090601,1,0.979243290333626,0,1,enucleation,BP,
16359,GO:0090611,1,0.893490106139826,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16360,GO:0090615,1,0.956449474242405,0,2,mitochondrial mRNA processing,BP,
16361,GO:0090616,1,0.978792659281888,0,1,mitochondrial mRNA 3'-end processing,BP,
16362,GO:0090624,1,0.977336572808046,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16363,GO:0090625,1,0.977336572808046,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16364,GO:0090627,1,0.97585624064459,0,1,plant epidermal cell differentiation,BP,
16366,GO:0090646,1,0.759830556041264,0,12,mitochondrial tRNA processing,BP,
16367,GO:0090647,1,0.874015369889411,0,6,modulation of age-related behavioral decline,BP,
16368,GO:0090649,1,0.902427699877365,0,5,response to oxygen-glucose deprivation,BP,
16369,GO:0090650,1,0.902427699877365,0,5,cellular response to oxygen-glucose deprivation,BP,
16370,GO:0090656,1,0.715405704957493,0,15,t-circle formation,BP,
16371,GO:0090657,1,0.782547629291443,0,11,telomeric loop disassembly,BP,
16372,GO:0090659,1,0.76311386269312,0,13,walking behavior,BP,
16373,GO:0090661,1,0.88580338876853,0,5,box H/ACA telomerase RNP complex,CC,
16374,GO:0090662,1,0.619269389584849,0,21,ATP hydrolysis coupled transmembrane transport,BP,
16375,GO:0090665,1,0.775860995560311,0,12,glycoprotein complex,CC,
16376,GO:0090666,1,0.911882074313258,0,4,scaRNA localization to Cajal body,BP,
16377,GO:0090667,1,0.981241211437756,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16378,GO:0090668,1,0.981241211437756,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16379,GO:0090669,1,0.912655544790298,0,4,telomerase RNA stabilization,BP,
16380,GO:0090670,1,0.646406100766851,0,19,RNA localization to Cajal body,BP,
16381,GO:0090671,1,0.646406100766851,0,19,telomerase RNA localization to Cajal body,BP,
16382,GO:0090672,1,0.646406100766851,0,19,telomerase RNA localization,BP,
16383,GO:0090673,1,0.980866871995554,0,1,endothelial cell-matrix adhesion,BP,
16384,GO:0090677,1,0.954998834942678,0,2,reversible differentiation,BP,
16385,GO:0090678,1,0.954998834942678,0,2,cell dedifferentiation involved in phenotypic switching,BP,
16386,GO:0090685,1,0.646406100766851,0,19,RNA localization to nucleus,BP,
16387,GO:0090694,1,0.960538467427994,0,2,Scc2-Scc4 cohesin loading complex,CC,
16388,GO:0090713,1,0.895271261459659,0,5,immunological memory process,BP,
16389,GO:0090715,1,0.895271261459659,0,5,immunological memory formation process,BP,
16390,GO:0090722,1,0.960465042210147,0,2,receptor-receptor interaction,MF,
16391,GO:0090723,1,0.78079208707495,0,11,growth cone part,CC,
16392,GO:0090724,1,0.914974729472434,0,4,central region of growth cone,CC,
16393,GO:0090725,1,0.954713875997461,0,2,peripheral region of growth cone,CC,
16394,GO:0090731,1,0.976504617803502,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
16396,GO:0090735,1,0.793875591463513,0,10,DNA repair complex assembly,BP,
16397,GO:0090737,1,0.715405704957493,0,15,telomere maintenance via telomere trimming,BP,
16398,GO:0090741,1,0.86955738654313,0,6,pigment granule membrane,CC,
16399,GO:0093001,1,0.977526487075175,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16401,GO:0097001,1,0.833829443683646,0,8,ceramide binding,MF,
16402,GO:0097003,1,0.955931474193662,0,2,adipokinetic hormone receptor activity,MF,
16403,GO:0097006,1,0.319214832017576,0,51,regulation of plasma lipoprotein particle levels,BP,
16404,GO:0097009,1,0.737116309712307,0,14,energy homeostasis,BP,
16405,GO:0097010,1,0.936237030912851,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
16408,GO:0097014,1,0.256090848250261,0,63,ciliary plasm,CC,
16409,GO:0097016,1,0.958570273952786,0,2,L27 domain binding,MF,
16410,GO:0097017,1,0.955048585135793,0,2,renal protein absorption,BP,
16411,GO:0097018,1,0.977249750036021,0,1,renal albumin absorption,BP,
16412,GO:0097020,1,0.977647646633619,0,1,COPII adaptor activity,MF,
16414,GO:0097025,1,0.938719001829239,0,3,MPP7-DLG1-LIN7 complex,CC,
16415,GO:0097026,1,0.981417496679661,0,1,dendritic cell dendrite assembly,BP,
16416,GO:0097027,1,0.851494597440187,0,7,ubiquitin-protein transferase activator activity,MF,
16417,GO:0097028,1,0.678783190000769,0,17,dendritic cell differentiation,BP,
16418,GO:0097029,1,0.977330687541506,0,1,mature conventional dendritic cell differentiation,BP,
16419,GO:0097035,1,0.574862101144577,0,26,regulation of membrane lipid distribution,BP,
16420,GO:0097036,1,0.976831881023541,0,1,regulation of plasma membrane sterol distribution,BP,
16421,GO:0097037,1,0.977707907070227,0,1,heme export,BP,
16423,GO:0097039,1,0.897941162933567,0,5,protein linear polyubiquitination,BP,
16424,GO:0097045,1,0.978946960685112,0,1,phosphatidylserine exposure on blood platelet,BP,
16425,GO:0097048,1,0.91679742013397,0,4,dendritic cell apoptotic process,BP,
16426,GO:0097049,1,0.89399932936957,0,5,motor neuron apoptotic process,BP,
16427,GO:0097050,1,0.815717078267858,0,9,type B pancreatic cell apoptotic process,BP,
16428,GO:0097051,1,0.939256363500314,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16429,GO:0097052,1,0.954993935310529,0,2,L-kynurenine metabolic process,BP,
16430,GO:0097055,1,0.955080321060831,0,2,agmatine biosynthetic process,BP,
16431,GO:0097056,1,0.913980412691729,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16432,GO:0097057,1,0.953944739093385,0,2,TRAF2-GSTP1 complex,CC,
16433,GO:0097058,1,0.977122811666712,0,1,CRLF-CLCF1 complex,CC,
16434,GO:0097059,1,0.977122811666712,0,1,CNTFR-CLCF1 complex,CC,
16437,GO:0097062,1,0.756486344343803,0,13,dendritic spine maintenance,BP,
16438,GO:0097064,1,0.444427773150432,0,37,ncRNA export from nucleus,BP,
16440,GO:0097066,1,0.714852369190326,0,15,response to thyroid hormone,BP,
16441,GO:0097067,1,0.80169121716231,0,10,cellular response to thyroid hormone stimulus,BP,
16442,GO:0097068,1,0.934925171104388,0,3,response to thyroxine,BP,
16443,GO:0097069,1,0.955908231498647,0,2,cellular response to thyroxine stimulus,BP,
16444,GO:0097070,1,0.979712696207635,0,1,ductus arteriosus closure,BP,
16446,GO:0097086,1,0.977916093621233,0,1,amniotic stem cell differentiation,BP,
16447,GO:0097089,1,0.977039913892843,0,1,methyl-branched fatty acid metabolic process,BP,
16448,GO:0097090,1,0.899789199448218,0,5,presynaptic membrane organization,BP,
16449,GO:0097091,1,0.91900376797021,0,4,synaptic vesicle clustering,BP,
16450,GO:0097094,1,0.78832671658482,0,11,craniofacial suture morphogenesis,BP,
16451,GO:0097100,1,0.891233376109211,0,5,supercoiled DNA binding,MF,
16452,GO:0097101,1,0.933613270713367,0,3,blood vessel endothelial cell fate specification,BP,
16453,GO:0097102,1,0.955360445166109,0,2,endothelial tip cell fate specification,BP,
16454,GO:0097104,1,0.922382372137477,0,4,postsynaptic membrane assembly,BP,
16455,GO:0097105,1,0.921445496901466,0,4,presynaptic membrane assembly,BP,
16456,GO:0097106,1,0.8641085868003,0,7,postsynaptic density organization,BP,
16457,GO:0097107,1,0.923856018089776,0,4,postsynaptic density assembly,BP,
16458,GO:0097108,1,0.981216035439939,0,1,hedgehog family protein binding,MF,
16459,GO:0097109,1,0.957574866152959,0,2,neuroligin family protein binding,MF,
16460,GO:0097110,1,0.375199472913154,0,45,scaffold protein binding,MF,
16461,GO:0097111,1,0.961124008492271,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16462,GO:0097112,1,0.978498490151427,0,1,gamma-aminobutyric acid receptor clustering,BP,
16463,GO:0097113,1,0.897925072051096,0,5,AMPA glutamate receptor clustering,BP,
16464,GO:0097114,1,0.957691355623148,0,2,NMDA glutamate receptor clustering,BP,
16465,GO:0097116,1,0.978828322309819,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
16466,GO:0097117,1,0.980735784579197,0,1,guanylate kinase-associated protein clustering,BP,
16467,GO:0097118,1,0.980542358885447,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16468,GO:0097119,1,0.915539057741355,0,4,postsynaptic density protein 95 clustering,BP,
16469,GO:0097120,1,0.64012996759288,0,20,receptor localization to synapse,BP,
16470,GO:0097123,1,0.977233370615845,0,1,cyclin A1-CDK2 complex,CC,
16471,GO:0097124,1,0.955050131737303,0,2,cyclin A2-CDK2 complex,CC,
16472,GO:0097125,1,0.954830819166475,0,2,cyclin B1-CDK1 complex,CC,
16473,GO:0097129,1,0.93517864739436,0,3,cyclin D2-CDK4 complex,CC,
16474,GO:0097134,1,0.954907745317007,0,2,cyclin E1-CDK2 complex,CC,
16475,GO:0097135,1,0.955031284437828,0,2,cyclin E2-CDK2 complex,CC,
16476,GO:0097136,1,0.872686596935546,0,6,Bcl-2 family protein complex,CC,
16477,GO:0097144,1,0.975913291000001,0,1,BAX complex,CC,
16478,GO:0097145,1,0.977229107474048,0,1,BAK complex,CC,
16479,GO:0097149,1,0.934993050434827,0,3,centralspindlin complex,CC,
16481,GO:0097151,1,0.882872473650308,0,6,positive regulation of inhibitory postsynaptic potential,BP,
16483,GO:0097153,1,0.757805215192763,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16484,GO:0097154,1,0.911141643167979,0,4,GABAergic neuron differentiation,BP,
16485,GO:0097155,1,0.963849719869671,0,2,fasciculation of sensory neuron axon,BP,
16486,GO:0097156,1,0.980149299505197,0,1,fasciculation of motor neuron axon,BP,
16488,GO:0097158,1,0.977023285677638,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
16490,GO:0097161,1,0.980149299505197,0,1,DH domain binding,MF,
16491,GO:0097162,1,0.977575222695287,0,1,MADS box domain binding,MF,
16493,GO:0097165,1,0.894859470232235,0,5,nuclear stress granule,CC,
16494,GO:0097166,1,0.981833277045491,0,1,lens epithelial cell proliferation,BP,
16496,GO:0097168,1,0.978775580097182,0,1,mesenchymal stem cell proliferation,BP,
16497,GO:0097169,1,0.930770825528799,0,3,AIM2 inflammasome complex,CC,
16498,GO:0097176,1,0.911755796684145,0,4,epoxide metabolic process,BP,
16499,GO:0097177,1,0.932437666818501,0,3,mitochondrial ribosome binding,MF,
16501,GO:0097179,1,0.908347757594172,0,4,protease inhibitor complex,CC,
16502,GO:0097180,1,0.95347625555,0,2,serine protease inhibitor complex,CC,
16503,GO:0097186,1,0.724087753692846,0,15,amelogenesis,BP,
16509,GO:0097194,1,0.20870349707883,0,70,execution phase of apoptosis,BP,
16510,GO:0097195,1,0.95649186668899,0,2,pilomotor reflex,BP,
16511,GO:0097196,1,0.955033013371459,0,2,Shu complex,CC,
16512,GO:0097197,1,0.87288790207481,0,6,tetraspanin-enriched microdomain,CC,
16513,GO:0097198,1,0.959454629294187,0,2,histone H3-K36 trimethylation,BP,
16514,GO:0097199,1,0.892203633473984,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16515,GO:0097200,1,0.77641053133948,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16517,GO:0097202,1,0.760798613457172,0,12,activation of cysteine-type endopeptidase activity,BP,
16518,GO:0097205,1,0.765399203940085,0,12,renal filtration,BP,
16519,GO:0097208,1,0.891560140327407,0,5,alveolar lamellar body,CC,
16520,GO:0097209,1,0.916434203695668,0,4,epidermal lamellar body,CC,
16521,GO:0097210,1,0.957742242695987,0,2,response to gonadotropin-releasing hormone,BP,
16522,GO:0097211,1,0.957742242695987,0,2,cellular response to gonadotropin-releasing hormone,BP,
16523,GO:0097212,1,0.954942534330073,0,2,lysosomal membrane organization,BP,
16524,GO:0097213,1,0.977233101863847,0,1,regulation of lysosomal membrane permeability,BP,
16525,GO:0097222,1,0.978792659281888,0,1,mitochondrial mRNA polyadenylation,BP,
16526,GO:0097223,1,0.132880802660919,0,90,sperm part,CC,
16527,GO:0097224,1,0.977094753002521,0,1,sperm connecting piece,CC,
16528,GO:0097225,1,0.793934227365678,0,10,sperm midpiece,CC,
16529,GO:0097226,1,0.97723632169056,0,1,sperm mitochondrial sheath,CC,
16530,GO:0097227,1,0.91524127921428,0,4,sperm annulus,CC,
16531,GO:0097228,1,0.764069879762645,0,12,sperm principal piece,CC,
16532,GO:0097229,1,0.976706523423559,0,1,sperm end piece,CC,
16533,GO:0097231,1,0.977075364613206,0,1,cell motility in response to calcium ion,BP,
16534,GO:0097232,1,0.977626797903883,0,1,lamellar body membrane,CC,
16535,GO:0097233,1,0.977626797903883,0,1,alveolar lamellar body membrane,CC,
16537,GO:0097238,1,0.953470040303817,0,2,cellular response to methylglyoxal,BP,
16538,GO:0097240,1,0.914609098491402,0,4,chromosome attachment to the nuclear envelope,BP,
16539,GO:0097241,1,0.955002326937032,0,2,hematopoietic stem cell migration to bone marrow,BP,
16542,GO:0097255,1,0.890779365132194,0,5,R2TP complex,CC,
16543,GO:0097264,1,0.872847752504905,0,6,self proteolysis,BP,
16545,GO:0097272,1,0.979712696207635,0,1,ammonia homeostasis,BP,
16546,GO:0097273,1,0.979712696207635,0,1,creatinine homeostasis,BP,
16547,GO:0097274,1,0.957896370742005,0,2,urea homeostasis,BP,
16548,GO:0097275,1,0.979712696207635,0,1,cellular ammonia homeostasis,BP,
16549,GO:0097276,1,0.979712696207635,0,1,cellular creatinine homeostasis,BP,
16550,GO:0097277,1,0.979712696207635,0,1,cellular urea homeostasis,BP,
16551,GO:0097278,1,0.955070208395236,0,2,complement-dependent cytotoxicity,BP,
16552,GO:0097283,1,0.891401061801429,0,5,keratinocyte apoptotic process,BP,
16553,GO:0097284,1,0.781010344749982,0,11,hepatocyte apoptotic process,BP,
16554,GO:0097286,1,0.782919429573034,0,11,iron ion import,BP,
16555,GO:0097291,1,0.977198702465349,0,1,renal phosphate ion absorption,BP,
16556,GO:0097296,1,0.762117808709867,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16557,GO:0097298,1,0.978177805188509,0,1,regulation of nucleus size,BP,
16558,GO:0097300,1,0.451190027428776,0,35,programmed necrotic cell death,BP,
16559,GO:0097305,1,0.0833519982424031,0,113,response to alcohol,BP,
16560,GO:0097306,1,0.40129025308605,0,43,cellular response to alcohol,BP,
16561,GO:0097309,1,0.955184890372083,0,2,cap1 mRNA methylation,BP,
16562,GO:0097310,1,0.977336572808046,0,1,cap2 mRNA methylation,BP,
16564,GO:0097322,1,0.874394218280166,0,6,7SK snRNA binding,MF,
16565,GO:0097325,1,0.957521599462893,0,2,melanocyte proliferation,BP,
16567,GO:0097329,1,0.770384039609331,0,12,response to antimetabolite,BP,
16568,GO:0097332,1,0.95537315290699,0,2,response to antipsychotic drug,BP,
16569,GO:0097338,1,0.978692696830699,0,1,response to clozapine,BP,
16570,GO:0097340,1,0.791678378829309,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16571,GO:0097341,1,0.791678378829309,0,11,zymogen inhibition,BP,
16572,GO:0097342,1,0.873894214999527,0,6,ripoptosome,CC,
16573,GO:0097343,1,0.93913542534827,0,3,ripoptosome assembly,BP,
16574,GO:0097344,1,0.954899233902176,0,2,Rix1 complex,CC,
16575,GO:0097345,1,0.325804189586457,0,49,mitochondrial outer membrane permeabilization,BP,
16576,GO:0097346,1,0.597652142620398,0,23,INO80-type complex,CC,
16577,GO:0097350,1,0.934862389876456,0,3,neutrophil clearance,BP,
16578,GO:0097352,1,0.465247391358594,0,34,autophagosome maturation,BP,
16579,GO:0097354,1,0.820823269878864,0,9,prenylation,BP,
16580,GO:0097356,1,0.980991621982789,0,1,perinucleolar compartment,CC,
16581,GO:0097359,1,0.96273612131564,0,2,UDP-glucosylation,BP,
16582,GO:0097360,1,0.958001925909981,0,2,chorionic trophoblast cell proliferation,BP,
16583,GO:0097361,1,0.912323216900344,0,4,CIA complex,CC,
16584,GO:0097362,1,0.955708780401827,0,2,MCM8-MCM9 complex,CC,
16585,GO:0097363,1,0.957296193735338,0,2,protein O-GlcNAc transferase activity,MF,
16586,GO:0097366,1,0.592496275202524,0,24,response to bronchodilator,BP,
16588,GO:0097368,1,0.916233386619899,0,4,establishment of Sertoli cell barrier,BP,
16589,GO:0097371,1,0.85914160192852,0,7,MDM2/MDM4 family protein binding,MF,
16590,GO:0097372,1,0.977076665296094,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
16591,GO:0097374,1,0.977248066779519,0,1,sensory neuron axon guidance,BP,
16592,GO:0097376,1,0.976812100469062,0,1,interneuron axon guidance,BP,
16593,GO:0097381,1,0.900117398762938,0,5,photoreceptor disc membrane,CC,
16594,GO:0097382,1,0.979903954714144,0,1,deoxynucleoside-diphosphatase activity,MF,
16595,GO:0097383,1,0.979903954714144,0,1,dIDP diphosphatase activity,MF,
16596,GO:0097384,1,0.855589910278469,0,7,cellular lipid biosynthetic process,BP,
16598,GO:0097393,1,0.983470795487712,0,1,telomeric repeat-containing RNA transcription,BP,
16599,GO:0097394,1,0.983470795487712,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16603,GO:0097403,1,0.977399377001488,0,1,cellular response to raffinose,BP,
16604,GO:0097409,1,0.977186615032769,0,1,glial cytoplasmic inclusion,CC,
16605,GO:0097411,1,0.91705677335874,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16606,GO:0097413,1,0.852023171104399,0,7,Lewy body,CC,
16607,GO:0097414,1,0.977186615032769,0,1,classical Lewy body,CC,
16609,GO:0097421,1,0.544915906104443,0,27,liver regeneration,BP,
16610,GO:0097422,1,0.893040541495957,0,5,tubular endosome,CC,
16611,GO:0097425,1,0.935908582296148,0,3,smooth endoplasmic reticulum part,CC,
16612,GO:0097427,1,0.898444828812864,0,5,microtubule bundle,CC,
16613,GO:0097428,1,0.789709293080895,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16614,GO:0097431,1,0.572047415803603,0,26,mitotic spindle pole,CC,
16615,GO:0097433,1,0.892444761194965,0,5,dense body,CC,
16618,GO:0097441,1,0.939352987674355,0,3,basal dendrite,CC,
16619,GO:0097442,1,0.979634006006681,0,1,CA3 pyramidal cell dendrite,CC,
16620,GO:0097443,1,0.895907741864915,0,5,sorting endosome,CC,
16621,GO:0097444,1,0.979228783404055,0,1,spine apparatus,CC,
16624,GO:0097450,1,0.956229615862642,0,2,astrocyte end-foot,CC,
16625,GO:0097451,1,0.956229615862642,0,2,glial limiting end-foot,CC,
16626,GO:0097452,1,0.915530052558595,0,4,GAIT complex,CC,
16627,GO:0097454,1,0.938310885335135,0,3,Schwann cell microvillus,CC,
16628,GO:0097457,1,0.962150305777552,0,2,hippocampal mossy fiber,CC,
16630,GO:0097462,1,0.977186615032769,0,1,Lewy neurite,CC,
16631,GO:0097466,1,0.917488483592293,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
16632,GO:0097468,1,0.780984223346874,0,11,programmed cell death in response to reactive oxygen species,BP,
16633,GO:0097470,1,0.900131427361543,0,5,ribbon synapse,CC,
16634,GO:0097472,1,0.500635937658592,0,31,cyclin-dependent protein kinase activity,MF,
16635,GO:0097473,1,0.979333557504635,0,1,retinal rod cell apoptotic process,BP,
16636,GO:0097475,1,0.937185082326885,0,3,motor neuron migration,BP,
16639,GO:0097484,1,0.695722483267568,0,17,dendrite extension,BP,
16641,GO:0097486,1,0.954949258641165,0,2,multivesicular body lumen,CC,
16642,GO:0097487,1,0.932328567070686,0,3,multivesicular body, internal vesicle,CC,
16643,GO:0097489,1,0.977254848732398,0,1,multivesicular body, internal vesicle lumen,CC,
16644,GO:0097490,1,0.916806188506284,0,4,sympathetic neuron projection extension,BP,
16645,GO:0097491,1,0.916806188506284,0,4,sympathetic neuron projection guidance,BP,
16646,GO:0097493,1,0.912125888259403,0,6,structural molecule activity conferring elasticity,MF,
16647,GO:0097494,1,0.916682845531745,0,4,regulation of vesicle size,BP,
16648,GO:0097497,1,0.977486770047155,0,1,blood vessel endothelial cell delamination,BP,
16649,GO:0097498,1,0.957421268344159,0,2,endothelial tube lumen extension,BP,
16650,GO:0097499,1,0.873129908420621,0,6,protein localization to non-motile cilium,BP,
16651,GO:0097500,1,0.936095556643275,0,3,receptor localization to non-motile cilium,BP,
16653,GO:0097502,1,0.534106014540645,0,28,mannosylation,BP,
16654,GO:0097503,1,0.735617478813581,0,14,sialylation,BP,
16655,GO:0097504,1,0.779752114568638,0,11,Gemini of coiled bodies,CC,
16656,GO:0097505,1,0.979693238170433,0,1,Rad6-Rad18 complex,CC,
16657,GO:0097506,1,0.890545099531098,0,5,deaminated base DNA N-glycosylase activity,MF,
16658,GO:0097510,1,0.97720905362474,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
16659,GO:0097512,1,0.975693745070028,0,1,cardiac myofibril,CC,
16660,GO:0097513,1,0.943689910526149,0,3,myosin II filament,CC,
16662,GO:0097524,1,0.916912918406563,0,4,sperm plasma membrane,CC,
16663,GO:0097525,1,0.243955070768269,0,62,spliceosomal snRNP complex,CC,
16664,GO:0097526,1,0.513600139658235,0,29,spliceosomal tri-snRNP complex,CC,
16665,GO:0097527,1,0.891951235776255,0,5,necroptotic signaling pathway,BP,
16668,GO:0097531,1,0.817050011140803,0,9,mast cell migration,BP,
16669,GO:0097532,1,0.955317247711792,0,2,stress response to acid chemical,BP,
16670,GO:0097533,1,0.955317247711792,0,2,cellular stress response to acid chemical,BP,
16671,GO:0097534,1,0.958827231344992,0,2,lymphoid lineage cell migration,BP,
16672,GO:0097535,1,0.958827231344992,0,2,lymphoid lineage cell migration into thymus,BP,
16673,GO:0097536,1,0.977275518901569,0,1,thymus epithelium morphogenesis,BP,
16674,GO:0097539,1,0.807857358991448,0,10,ciliary transition fiber,CC,
16675,GO:0097541,1,0.977336572808046,0,1,axonemal basal plate,CC,
16676,GO:0097542,1,0.406272875825072,0,41,ciliary tip,CC,
16677,GO:0097543,1,0.957216785358223,0,2,ciliary inversin compartment,CC,
16678,GO:0097546,1,0.572929394926771,0,25,ciliary base,CC,
16679,GO:0097550,1,0.872747253889579,0,6,transcriptional preinitiation complex,CC,
16680,GO:0097553,1,0.215449756742281,0,72,calcium ion transmembrane import into cytosol,BP,
16681,GO:0097573,1,0.976742927377338,0,1,glutathione oxidoreductase activity,MF,
16682,GO:0097574,1,0.958610866077596,0,2,lateral part of cell,CC,
16683,GO:0097575,1,0.958610866077596,0,2,lateral cell cortex,CC,
16684,GO:0097576,1,0.956749951279968,0,2,vacuole fusion,BP,
16685,GO:0097577,1,0.931410782830451,0,3,sequestering of iron ion,BP,
16687,GO:0097598,1,0.979434221499239,0,1,sperm cytoplasmic droplet,CC,
16688,GO:0097602,1,0.681563326941594,0,17,cullin family protein binding,MF,
16689,GO:0097603,1,0.978377862362251,0,1,temperature-gated ion channel activity,MF,
16690,GO:0097617,1,0.748409693163601,0,13,annealing activity,MF,
16691,GO:0097621,1,0.977237189735326,0,1,monoamine oxidase activity,MF,
16692,GO:0097623,1,0.979137448691392,0,1,potassium ion export across plasma membrane,BP,
16693,GO:0097625,1,0.981028080218143,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16694,GO:0097626,1,0.981028080218143,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16695,GO:0097627,1,0.981028080218143,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16696,GO:0097629,1,0.893659318044142,0,5,extrinsic component of omegasome membrane,CC,
16697,GO:0097630,1,0.977336572808046,0,1,intrinsic component of omegasome membrane,CC,
16698,GO:0097631,1,0.977336572808046,0,1,integral component of omegasome membrane,CC,
16699,GO:0097632,1,0.957116342952208,0,2,extrinsic component of phagophore assembly site membrane,CC,
16700,GO:0097635,1,0.9585881005758,0,2,extrinsic component of autophagosome membrane,CC,
16701,GO:0097636,1,0.956164034596222,0,2,intrinsic component of autophagosome membrane,CC,
16702,GO:0097637,1,0.956164034596222,0,2,integral component of autophagosome membrane,CC,
16703,GO:0097638,1,0.96226012564414,0,2,L-arginine import across plasma membrane,BP,
16704,GO:0097639,1,0.981028080218143,0,1,L-lysine import across plasma membrane,BP,
16705,GO:0097640,1,0.981028080218143,0,1,L-ornithine import across plasma membrane,BP,
16706,GO:0097642,1,0.933978343735012,0,3,calcitonin family receptor activity,MF,
16707,GO:0097643,1,0.976077923097182,0,1,amylin receptor activity,MF,
16708,GO:0097644,1,0.955699375653669,0,2,calcitonin family binding,MF,
16709,GO:0097646,1,0.912264837904438,0,4,calcitonin family receptor signaling pathway,BP,
16710,GO:0097647,1,0.931720661342773,0,3,amylin receptor signaling pathway,BP,
16711,GO:0097648,1,0.935232266761074,0,3,G-protein coupled receptor complex,CC,
16713,GO:0097655,1,0.977336572808046,0,1,serpin family protein binding,MF,
16715,GO:0097676,1,0.94382695337012,0,3,histone H3-K36 dimethylation,BP,
16716,GO:0097677,1,0.875556975101799,0,6,STAT family protein binding,MF,
16717,GO:0097680,1,0.936183427822927,0,3,double-strand break repair via classical nonhomologous end joining,BP,
16718,GO:0097681,1,0.967137767023688,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16719,GO:0097682,1,0.977218461871496,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
16720,GO:0097688,1,0.897925072051096,0,5,glutamate receptor clustering,BP,
16721,GO:0097692,1,0.980070334258351,0,1,histone H3-K4 monomethylation,BP,
16722,GO:0097694,1,0.943422795650116,0,3,establishment of RNA localization to telomere,BP,
16723,GO:0097695,1,0.943422795650116,0,3,establishment of protein-containing complex localization to telomere,BP,
16725,GO:0097698,1,0.976887434728886,0,1,telomere maintenance via base-excision repair,BP,
16726,GO:0097699,1,0.978671734657205,0,1,vascular endothelial cell response to fluid shear stress,BP,
16727,GO:0097707,1,0.976136663128362,0,1,ferroptosis,BP,
16729,GO:0097709,1,0.873636732046342,0,6,connective tissue replacement,BP,
16731,GO:0097712,1,0.977336572808046,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16733,GO:0097720,1,0.579288838620235,0,25,calcineurin-mediated signaling,BP,
16735,GO:0097724,1,0.977138442822308,0,1,sperm flagellum movement,BP,
16736,GO:0097726,1,0.976421137356499,0,1,LEM domain binding,MF,
16737,GO:0097729,1,0.417774484141156,0,39,9+2 motile cilium,CC,
16740,GO:0097732,1,0.891830921504469,0,5,9+2 non-motile cilium,CC,
16742,GO:0097734,1,0.678694476811109,0,17,extracellular exosome biogenesis,BP,
16743,GO:0097742,1,0.937978740305772,0,3,de novo centriole assembly,BP,
16744,GO:0097745,1,0.932331410027725,0,3,mitochondrial tRNA 5'-end processing,BP,
16747,GO:0097749,1,0.98016477210318,0,1,membrane tubulation,BP,
16748,GO:0097752,1,0.933498525776069,0,3,regulation of DNA stability,BP,
16749,GO:0097753,1,0.97805129392465,0,1,membrane bending,BP,
16752,GO:0098501,1,0.891337875622196,0,5,polynucleotide dephosphorylation,BP,
16753,GO:0098502,1,0.932184852019245,0,3,DNA dephosphorylation,BP,
16754,GO:0098503,1,0.977082433676462,0,1,DNA 3' dephosphorylation,BP,
16755,GO:0098504,1,0.977082433676462,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16756,GO:0098505,1,0.796947202918638,0,10,G-rich strand telomeric DNA binding,MF,
16757,GO:0098506,1,0.977082433676462,0,1,polynucleotide 3' dephosphorylation,BP,
16758,GO:0098507,1,0.956192767308905,0,2,polynucleotide 5' dephosphorylation,BP,
16759,GO:0098508,1,0.955013290421855,0,2,endothelial to hematopoietic transition,BP,
16760,GO:0098518,1,0.934275509548888,0,3,polynucleotide phosphatase activity,MF,
16761,GO:0098519,1,0.893737786115433,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16762,GO:0098528,1,0.91581843802226,0,4,skeletal muscle fiber differentiation,BP,
16763,GO:0098530,1,0.979715688418652,0,1,positive regulation of strand invasion,BP,
16766,GO:0098533,1,0.752390075515954,0,13,ATPase dependent transmembrane transport complex,CC,
16767,GO:0098534,1,0.516013116215601,0,30,centriole assembly,BP,
16768,GO:0098535,1,0.937978740305772,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16769,GO:0098536,1,0.936817406091651,0,3,deuterosome,CC,
16771,GO:0098543,1,0.856243198746821,0,7,detection of other organism,BP,
16772,GO:0098547,1,0.977233931975529,0,1,lumenal side of Golgi membrane,CC,
16774,GO:0098553,1,0.661680092619686,0,18,lumenal side of endoplasmic reticulum membrane,CC,
16775,GO:0098554,1,0.739834668448105,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
16776,GO:0098556,1,0.884221220053785,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16777,GO:0098559,1,0.933302525191253,0,3,cytoplasmic side of early endosome membrane,CC,
16778,GO:0098560,1,0.955103560389519,0,2,cytoplasmic side of late endosome membrane,CC,
16780,GO:0098563,1,0.71307816991597,0,15,intrinsic component of synaptic vesicle membrane,CC,
16781,GO:0098573,1,0.218887024361741,0,66,intrinsic component of mitochondrial membrane,CC,
16782,GO:0098574,1,0.91270449528848,0,4,cytoplasmic side of lysosomal membrane,CC,
16783,GO:0098575,1,0.954956314548584,0,2,lumenal side of lysosomal membrane,CC,
16784,GO:0098576,1,0.912370151571973,0,4,lumenal side of membrane,CC,
16785,GO:0098577,1,0.980491792086748,0,1,inactive sex chromosome,CC,
16786,GO:0098581,1,0.836771893637951,0,8,detection of external biotic stimulus,BP,
16787,GO:0098582,1,0.958188602606467,0,2,innate vocalization behavior,BP,
16788,GO:0098586,1,0.442659374297809,0,37,cellular response to virus,BP,
16792,GO:0098592,1,0.934309444778982,0,3,cytoplasmic side of apical plasma membrane,CC,
16793,GO:0098594,1,0.97578570321186,0,1,mucin granule,CC,
16794,GO:0098596,1,0.928247728744038,0,4,imitative learning,BP,
16795,GO:0098597,1,0.913646655058094,0,5,observational learning,BP,
16796,GO:0098598,1,0.928247728744038,0,4,learned vocalization behavior or vocal learning,BP,
16797,GO:0098599,1,0.795785222485378,0,10,palmitoyl hydrolase activity,MF,
16799,GO:0098619,1,0.977167880885857,0,1,selenocysteine-tRNA ligase activity,MF,
16800,GO:0098621,1,0.979621985961865,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16801,GO:0098625,1,0.978053254996564,0,1,methylselenol reductase activity,MF,
16802,GO:0098626,1,0.978053254996564,0,1,methylseleninic acid reductase activity,MF,
16803,GO:0098629,1,0.977336572808046,0,1,trans-Golgi network membrane organization,BP,
16804,GO:0098631,1,0.460879846333427,0,35,cell adhesion mediator activity,MF,
16805,GO:0098632,1,0.525159472245179,0,29,cell-cell adhesion mediator activity,MF,
16806,GO:0098633,1,0.97725198476669,0,1,collagen fibril binding,MF,
16807,GO:0098634,1,0.920027150400883,0,4,cell-matrix adhesion mediator activity,MF,
16808,GO:0098636,1,0.699941874092174,0,17,protein complex involved in cell adhesion,CC,
16809,GO:0098639,1,0.920027150400883,0,4,collagen binding involved in cell-matrix adhesion,MF,
16810,GO:0098641,1,0.645883029391613,0,19,cadherin binding involved in cell-cell adhesion,MF,
16811,GO:0098642,1,0.886954258768636,0,6,network-forming collagen trimer,CC,
16814,GO:0098645,1,0.886954258768636,0,6,collagen network,CC,
16815,GO:0098646,1,0.977262961465507,0,1,collagen sheet,CC,
16816,GO:0098647,1,0.955872913097059,0,2,collagen beaded filament,CC,
16817,GO:0098648,1,0.982224150622458,0,1,collagen anchoring fibril,CC,
16818,GO:0098651,1,0.886954258768636,0,6,basement membrane collagen trimer,CC,
16819,GO:0098652,1,0.982224150622458,0,1,collagen type VII anchoring fibril,CC,
16827,GO:0098664,1,0.932833936673599,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
16828,GO:0098679,1,0.964340618020054,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16829,GO:0098680,1,0.974854758144779,0,1,template-free RNA nucleotidyltransferase,MF,
16831,GO:0098693,1,0.490713393557391,0,33,regulation of synaptic vesicle cycle,BP,
16832,GO:0098698,1,0.923856018089776,0,4,postsynaptic specialization assembly,BP,
16833,GO:0098700,1,0.954858312790649,0,2,neurotransmitter loading into synaptic vesicle,BP,
16834,GO:0098703,1,0.87784916422213,0,6,calcium ion import across plasma membrane,BP,
16835,GO:0098705,1,0.978939526031261,0,1,copper ion import across plasma membrane,BP,
16836,GO:0098706,1,0.917542341487635,0,4,ferric iron import across plasma membrane,BP,
16837,GO:0098711,1,0.876912777099624,0,6,iron ion import across plasma membrane,BP,
16839,GO:0098713,1,0.977234930342947,0,1,leucine import across plasma membrane,BP,
16840,GO:0098719,1,0.823056154627759,0,9,sodium ion import across plasma membrane,BP,
16842,GO:0098725,1,0.977336572808046,0,1,symmetric cell division,BP,
16846,GO:0098734,1,0.795785222485378,0,10,macromolecule depalmitoylation,BP,
16847,GO:0098735,1,0.940620053450958,0,3,positive regulation of the force of heart contraction,BP,
16848,GO:0098736,1,0.981915309359245,0,1,negative regulation of the force of heart contraction,BP,
16852,GO:0098745,1,0.977091738047348,0,1,Dcp1-Dcp2 complex,CC,
16853,GO:0098746,1,0.978970842470338,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16854,GO:0098748,1,0.784737074297339,0,11,endocytic adaptor activity,MF,
16855,GO:0098749,1,0.978810524870098,0,1,cerebellar neuron development,BP,
16856,GO:0098751,1,0.585169837660209,0,25,bone cell development,BP,
16858,GO:0098756,1,0.918201349958097,0,4,response to interleukin-21,BP,
16859,GO:0098757,1,0.918201349958097,0,4,cellular response to interleukin-21,BP,
16860,GO:0098758,1,0.955228549573728,0,2,response to interleukin-8,BP,
16861,GO:0098759,1,0.955228549573728,0,2,cellular response to interleukin-8,BP,
16864,GO:0098770,1,0.962148744174045,0,2,FBXO family protein binding,MF,
16868,GO:0098779,1,0.841139074688466,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16871,GO:0098787,1,0.732550239212328,0,14,mRNA cleavage involved in mRNA processing,BP,
16872,GO:0098789,1,0.784006025853012,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16874,GO:0098792,1,0.798066972438612,0,10,xenophagy,BP,
16877,GO:0098795,1,0.955688490073126,0,2,mRNA cleavage involved in gene silencing,BP,
16880,GO:0098798,1,0.00557024907557048,0,218,mitochondrial protein complex,CC,
16881,GO:0098799,1,0.75587221066879,0,12,outer mitochondrial membrane protein complex,CC,
16882,GO:0098800,1,0.0943571409798582,0,99,inner mitochondrial membrane protein complex,CC,
16883,GO:0098801,1,0.777952714317245,0,11,regulation of renal system process,BP,
16884,GO:0098802,1,0.142033846250895,0,89,plasma membrane receptor complex,CC,
16885,GO:0098803,1,0.204062507586044,0,66,respiratory chain complex,CC,
16887,GO:0098808,1,0.955038176598612,0,2,mRNA cap binding,MF,
16888,GO:0098809,1,0.977259564888281,0,1,nitrite reductase activity,MF,
16891,GO:0098814,1,0.89471251562972,0,5,spontaneous synaptic transmission,BP,
16892,GO:0098815,1,0.58888005321772,0,24,modulation of excitatory postsynaptic potential,BP,
16893,GO:0098816,1,0.977206121775138,0,1,mini excitatory postsynaptic potential,BP,
16894,GO:0098821,1,0.942387498386671,0,3,BMP receptor activity,MF,
16895,GO:0098822,1,0.977245957030739,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
16896,GO:0098826,1,0.912126621660647,0,4,endoplasmic reticulum tubular network membrane,CC,
16898,GO:0098828,1,0.882872473650308,0,6,modulation of inhibitory postsynaptic potential,BP,
16899,GO:0098829,1,0.980244214686269,0,1,intestinal folate absorption,BP,
16900,GO:0098830,1,0.97898069188158,0,1,presynaptic endosome,CC,
16901,GO:0098831,1,0.917519016031176,0,5,presynaptic active zone cytoplasmic component,CC,
16902,GO:0098833,1,0.979081401788691,0,1,presynaptic endocytic zone,CC,
16903,GO:0098835,1,0.979081401788691,0,1,presynaptic endocytic zone membrane,CC,
16904,GO:0098837,1,0.933402315589477,0,3,postsynaptic recycling endosome,CC,
16905,GO:0098838,1,0.977315155888289,0,1,reduced folate transmembrane transport,BP,
16906,GO:0098839,1,0.859341457498212,0,7,postsynaptic density membrane,CC,
16908,GO:0098842,1,0.954987689753791,0,2,postsynaptic early endosome,CC,
16909,GO:0098843,1,0.873970461957985,0,6,postsynaptic endocytic zone,CC,
16910,GO:0098844,1,0.916603729593032,0,4,postsynaptic endocytic zone membrane,CC,
16911,GO:0098845,1,0.871166798773668,0,6,postsynaptic endosome,CC,
16912,GO:0098847,1,0.745518058254881,0,13,sequence-specific single stranded DNA binding,MF,
16917,GO:0098862,1,0.169568102866386,0,81,cluster of actin-based cell projections,CC,
16918,GO:0098868,1,0.738366621834859,0,14,bone growth,BP,
16919,GO:0098869,1,0.233786743306865,0,63,cellular oxidant detoxification,BP,
16920,GO:0098870,1,0.937147909058496,0,3,action potential propagation,BP,
16921,GO:0098871,1,0.977060608428229,0,1,postsynaptic actin cytoskeleton,CC,
16922,GO:0098875,1,0.978909675844624,0,1,epididymosome,CC,
16923,GO:0098876,1,0.238980675237021,0,65,vesicle-mediated transport to the plasma membrane,BP,
16924,GO:0098877,1,0.797907713593961,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16925,GO:0098878,1,0.678207927370586,0,18,neurotransmitter receptor complex,CC,
16926,GO:0098881,1,0.934812485174361,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16927,GO:0098883,1,0.977125613061449,0,1,synapse disassembly,BP,
16928,GO:0098884,1,0.916603729593032,0,4,postsynaptic neurotransmitter receptor internalization,BP,
16929,GO:0098885,1,0.980778347430777,0,1,modification of postsynaptic actin cytoskeleton,BP,
16930,GO:0098886,1,0.957034371082694,0,2,modification of dendritic spine,BP,
16931,GO:0098887,1,0.893516570649354,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
16932,GO:0098888,1,0.980809327017822,0,1,extrinsic component of presynaptic membrane,CC,
16933,GO:0098890,1,0.980809327017822,0,1,extrinsic component of postsynaptic membrane,CC,
16934,GO:0098900,1,0.540444949781039,0,29,regulation of action potential,BP,
16935,GO:0098901,1,0.673691438908914,0,19,regulation of cardiac muscle cell action potential,BP,
16936,GO:0098902,1,0.899370436648641,0,5,regulation of membrane depolarization during action potential,BP,
16937,GO:0098903,1,0.87836153802646,0,6,regulation of membrane repolarization during action potential,BP,
16938,GO:0098904,1,0.95524835588474,0,2,regulation of AV node cell action potential,BP,
16939,GO:0098905,1,0.953975451938868,0,2,regulation of bundle of His cell action potential,BP,
16940,GO:0098906,1,0.977490942931953,0,1,regulation of Purkinje myocyte action potential,BP,
16941,GO:0098907,1,0.981419609362148,0,1,regulation of SA node cell action potential,BP,
16942,GO:0098908,1,0.956323228086314,0,2,regulation of neuronal action potential,BP,
16943,GO:0098909,1,0.901514965701561,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16944,GO:0098910,1,0.901285838768296,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16945,GO:0098911,1,0.825271136841664,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16946,GO:0098912,1,0.978432365235465,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16947,GO:0098914,1,0.959463047356627,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16948,GO:0098915,1,0.936103707676997,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
16950,GO:0098917,1,0.916663400146409,0,4,retrograde trans-synaptic signaling,BP,
16951,GO:0098918,1,0.97712861412132,0,1,structural constituent of synapse,MF,
16952,GO:0098920,1,0.957449567479766,0,2,retrograde trans-synaptic signaling by lipid,BP,
16953,GO:0098921,1,0.957449567479766,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
16954,GO:0098923,1,0.98072639761374,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16955,GO:0098924,1,0.98072639761374,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16956,GO:0098926,1,0.98058884423125,0,1,postsynaptic signal transduction,BP,
16957,GO:0098927,1,0.407292778550404,0,41,vesicle-mediated transport between endosomal compartments,BP,
16958,GO:0098928,1,0.97444445561972,0,2,presynaptic signal transduction,BP,
16960,GO:0098935,1,0.939392457518795,0,3,dendritic transport,BP,
16961,GO:0098936,1,0.959606221729521,0,2,intrinsic component of postsynaptic membrane,CC,
16962,GO:0098937,1,0.939392457518795,0,3,anterograde dendritic transport,BP,
16963,GO:0098939,1,0.98028018591534,0,1,dendritic transport of mitochondrion,BP,
16964,GO:0098943,1,0.956274029958322,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
16965,GO:0098948,1,0.980363699947147,0,1,intrinsic component of postsynaptic specialization membrane,CC,
16966,GO:0098953,1,0.93491226805982,0,3,receptor diffusion trapping,BP,
16967,GO:0098957,1,0.917192596182142,0,4,anterograde axonal transport of mitochondrion,BP,
16968,GO:0098960,1,0.893684503848103,0,5,postsynaptic neurotransmitter receptor activity,MF,
16969,GO:0098967,1,0.934812485174361,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
16970,GO:0098968,1,0.979287790694437,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16971,GO:0098969,1,0.816213307917027,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16972,GO:0098970,1,0.93491226805982,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
16973,GO:0098971,1,0.958292816157639,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16974,GO:0098972,1,0.98028018591534,0,1,anterograde dendritic transport of mitochondrion,BP,
16975,GO:0098973,1,0.97712861412132,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16976,GO:0098974,1,0.97712861412132,0,1,postsynaptic actin cytoskeleton organization,BP,
16977,GO:0098976,1,0.917238217736993,0,4,excitatory chemical synaptic transmission,BP,
16978,GO:0098978,1,0.960582373686365,0,2,glutamatergic synapse,CC,
16979,GO:0098982,1,0.958578102287763,0,2,GABA-ergic synapse,CC,
16980,GO:0098983,1,0.958578102287763,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
16982,GO:0098985,1,0.960582373686365,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
16983,GO:0098988,1,0.979990412670674,0,1,G-protein coupled glutamate receptor activity,MF,
16984,GO:0098989,1,0.958123582932387,0,2,NMDA selective glutamate receptor signaling pathway,BP,
16985,GO:0098993,1,0.831306393840167,0,8,anchored component of synaptic vesicle membrane,CC,
16987,GO:0099004,1,0.959097349337088,0,2,calmodulin dependent kinase signaling pathway,BP,
16988,GO:0099010,1,0.938635575271041,0,3,modification of postsynaptic structure,BP,
16989,GO:0099011,1,0.958780331424261,0,2,neuronal dense core vesicle exocytosis,BP,
16990,GO:0099022,1,0.954841729364962,0,2,vesicle tethering,BP,
16993,GO:0099039,1,0.9801861254092,0,1,sphingolipid translocation,BP,
16994,GO:0099044,1,0.954841729364962,0,2,vesicle tethering to endoplasmic reticulum,BP,
16995,GO:0099046,1,0.976838372814114,0,1,clearance of foreign intracellular nucleic acids,BP,
16996,GO:0099053,1,0.935482574035359,0,3,activating signal cointegrator 1 complex,CC,
16997,GO:0099054,1,0.789427039968742,0,11,presynapse assembly,BP,
16998,GO:0099055,1,0.959606221729521,0,2,integral component of postsynaptic membrane,CC,
16999,GO:0099060,1,0.980363699947147,0,1,integral component of postsynaptic specialization membrane,CC,
17000,GO:0099061,1,0.980363699947147,0,1,integral component of postsynaptic density membrane,CC,
17001,GO:0099068,1,0.8333745981841,0,9,postsynapse assembly,BP,
17002,GO:0099072,1,0.699351233890214,0,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
17003,GO:0099073,1,0.956810406477347,0,2,mitochondrion-derived vesicle,CC,
17004,GO:0099074,1,0.955365673245036,0,2,mitochondrion to lysosome transport,BP,
17005,GO:0099075,1,0.955365673245036,0,2,mitochondrion-derived vesicle mediated transport,BP,
17006,GO:0099077,1,0.979710077742808,0,1,histone-dependent DNA binding,MF,
17007,GO:0099078,1,0.829791803625408,0,8,BORC complex,CC,
17010,GO:0099082,1,0.976225115676963,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17011,GO:0099083,1,0.976225115676963,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17012,GO:0099084,1,0.8641085868003,0,7,postsynaptic specialization organization,BP,
17014,GO:0099089,1,0.984153306469647,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17015,GO:0099093,1,0.957285059568788,0,2,calcium export from the mitochondrion,BP,
17016,GO:0099094,1,0.494722584795543,0,33,ligand-gated cation channel activity,MF,
17017,GO:0099095,1,0.977485040241761,0,1,ligand-gated anion channel activity,MF,
17018,GO:0099098,1,0.977536889157831,0,1,microtubule polymerization based movement,BP,
17021,GO:0099116,1,0.688853954691447,0,16,tRNA 5'-end processing,BP,
17023,GO:0099122,1,0.93817546146046,0,3,RNA polymerase II C-terminal domain binding,MF,
17024,GO:0099130,1,0.977231897780445,0,1,estrogen binding,MF,
17025,GO:0099131,1,0.619269389584849,0,21,ATP hydrolysis coupled ion transmembrane transport,BP,
17026,GO:0099132,1,0.516000523463443,0,30,ATP hydrolysis coupled cation transmembrane transport,BP,
17027,GO:0099133,1,0.843384918961387,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17028,GO:0099146,1,0.980363699947147,0,1,intrinsic component of postsynaptic density membrane,CC,
17029,GO:0099159,1,0.980778347430777,0,1,regulation of modification of postsynaptic structure,BP,
17030,GO:0099163,1,0.98072639761374,0,1,synaptic signaling by nitric oxide,BP,
17031,GO:0099170,1,0.934742779256647,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17032,GO:0099172,1,0.755475083343026,0,13,presynapse organization,BP,
17034,GO:0099174,1,0.935807096786089,0,3,regulation of presynapse organization,BP,
17037,GO:0099186,1,0.97712861412132,0,1,structural constituent of postsynapse,MF,
17038,GO:0099188,1,0.97712861412132,0,1,postsynaptic cytoskeleton organization,BP,
17039,GO:0099240,1,0.959606221729521,0,2,intrinsic component of synaptic membrane,CC,
17040,GO:0099243,1,0.980809327017822,0,1,extrinsic component of synaptic membrane,CC,
17041,GO:0099402,1,0.97585624064459,0,1,plant organ development,BP,
17042,GO:0099403,1,0.966213703304616,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17043,GO:0099404,1,0.966213703304616,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17044,GO:0099500,1,0.796555242480779,0,10,vesicle fusion to plasma membrane,BP,
17045,GO:0099501,1,0.3122062483683,0,52,exocytic vesicle membrane,CC,
17047,GO:0099504,1,0.180588416940689,0,79,synaptic vesicle cycle,BP,
17051,GO:0099515,1,0.830373495430514,0,9,actin filament-based transport,BP,
17052,GO:0099516,1,0.454021620408794,0,36,ion antiporter activity,MF,
17055,GO:0099519,1,0.977336572808046,0,1,dense core granule cytoskeletal transport,BP,
17056,GO:0099522,1,0.97720549091223,0,1,region of cytosol,CC,
17057,GO:0099523,1,0.97720549091223,0,1,presynaptic cytosol,CC,
17058,GO:0099524,1,0.97720549091223,0,1,postsynaptic cytosol,CC,
17059,GO:0099525,1,0.958780331424261,0,2,presynaptic dense core vesicle exocytosis,BP,
17060,GO:0099526,1,0.97444445561972,0,2,presynapse to nucleus signaling pathway,BP,
17061,GO:0099527,1,0.98058884423125,0,1,postsynapse to nucleus signaling pathway,BP,
17062,GO:0099528,1,0.815724577501133,0,9,G-protein coupled neurotransmitter receptor activity,MF,
17063,GO:0099529,1,0.893684503848103,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17065,GO:0099532,1,0.960723134715802,0,2,synaptic vesicle endosomal processing,BP,
17068,GO:0099538,1,0.976225115676963,0,1,synaptic signaling via neuropeptide,BP,
17069,GO:0099540,1,0.976225115676963,0,1,trans-synaptic signaling by neuropeptide,BP,
17070,GO:0099541,1,0.936437023818104,0,3,trans-synaptic signaling by lipid,BP,
17071,GO:0099542,1,0.936437023818104,0,3,trans-synaptic signaling by endocannabinoid,BP,
17072,GO:0099543,1,0.98072639761374,0,1,trans-synaptic signaling by soluble gas,BP,
17073,GO:0099545,1,0.979021937244501,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17074,GO:0099547,1,0.934742779256647,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17075,GO:0099548,1,0.98072639761374,0,1,trans-synaptic signaling by nitric oxide,BP,
17076,GO:0099550,1,0.934768721663924,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
17077,GO:0099551,1,0.976225115676963,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17078,GO:0099552,1,0.978057177773034,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17079,GO:0099553,1,0.978057177773034,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17080,GO:0099557,1,0.979021937244501,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17081,GO:0099563,1,0.769078652471564,0,12,modification of synaptic structure,BP,
17082,GO:0099565,1,0.355043184062476,0,47,chemical synaptic transmission, postsynaptic,BP,
17084,GO:0099569,1,0.936075008631327,0,4,presynaptic cytoskeleton,CC,
17085,GO:0099571,1,0.977060608428229,0,1,postsynaptic cytoskeleton,CC,
17087,GO:0099578,1,0.934742779256647,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
17088,GO:0099580,1,0.979911386033018,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17090,GO:0099589,1,0.932833936673599,0,3,serotonin receptor activity,MF,
17091,GO:0099590,1,0.877156773342165,0,6,neurotransmitter receptor internalization,BP,
17092,GO:0099601,1,0.593690149922299,0,24,regulation of neurotransmitter receptor activity,BP,
17093,GO:0099602,1,0.870960957401463,0,6,neurotransmitter receptor regulator activity,MF,
17094,GO:0099604,1,0.692888931085198,0,18,ligand-gated calcium channel activity,MF,
17095,GO:0099606,1,0.981793032647552,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17096,GO:0099607,1,0.981793032647552,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17097,GO:0099609,1,0.959933122599895,0,2,microtubule lateral binding,MF,
17098,GO:0099612,1,0.884340395626765,0,6,protein localization to axon,BP,
17099,GO:0099617,1,0.977672287852091,0,1,matrix side of mitochondrial inner membrane,CC,
17100,GO:0099622,1,0.724059627829065,0,15,cardiac muscle cell membrane repolarization,BP,
17101,GO:0099623,1,0.793418150775246,0,11,regulation of cardiac muscle cell membrane repolarization,BP,
17102,GO:0099624,1,0.959463047356627,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17103,GO:0099625,1,0.789879266542926,0,11,ventricular cardiac muscle cell membrane repolarization,BP,
17104,GO:0099627,1,0.977336572808046,0,1,neurotransmitter receptor cycle,BP,
17105,GO:0099628,1,0.93491226805982,0,3,neurotransmitter receptor diffusion trapping,BP,
17106,GO:0099630,1,0.977336572808046,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17107,GO:0099631,1,0.953502647255668,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
17108,GO:0099632,1,0.748332400590636,0,13,protein transport within plasma membrane,BP,
17109,GO:0099634,1,0.859341457498212,0,7,postsynaptic specialization membrane,CC,
17110,GO:0099637,1,0.748332400590636,0,13,neurotransmitter receptor transport,BP,
17111,GO:0099638,1,0.873483997385675,0,6,endosome to plasma membrane protein transport,BP,
17112,GO:0099639,1,0.873483997385675,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17116,GO:0099699,1,0.959606221729521,0,2,integral component of synaptic membrane,CC,
17117,GO:0099738,1,0.555466701785391,0,28,cell cortex region,CC,
17118,GO:0100002,1,0.97732503311907,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
17119,GO:0100012,1,0.977125613061449,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17120,GO:0100057,1,0.981066987224602,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17123,GO:0101005,1,0.152984903587886,0,87,ubiquitinyl hydrolase activity,MF,
17124,GO:0101006,1,0.932475336622759,0,3,protein histidine phosphatase activity,MF,
17125,GO:0101020,1,0.954853961206842,0,2,estrogen 16-alpha-hydroxylase activity,MF,
17126,GO:0101023,1,0.788777862931236,0,11,vascular endothelial cell proliferation,BP,
17127,GO:0101030,1,0.976716347107442,0,1,tRNA-guanine transglycosylation,BP,
17128,GO:0101031,1,0.779998462833291,0,11,chaperone complex,CC,
17129,GO:0102005,1,0.976906351266314,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
17130,GO:0102007,1,0.977020177255539,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
17131,GO:0102008,1,0.979131868564929,0,1,cytosolic dipeptidase activity,MF,
17132,GO:0102009,1,0.977165684003898,0,1,proline dipeptidase activity,MF,
17133,GO:0102077,1,0.977218310459923,0,1,oleamide hydrolase activity,MF,
17134,GO:0102084,1,0.955167802157117,0,2,L-dopa O-methyltransferase activity,MF,
17135,GO:0102092,1,0.959394162680512,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17136,GO:0102113,1,0.980555440616315,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17137,GO:0102121,1,0.955088972219681,0,2,ceramidase activity,MF,
17138,GO:0102131,1,0.981680997075231,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17139,GO:0102132,1,0.981680997075231,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17140,GO:0102148,1,0.933187918163112,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
17141,GO:0102158,1,0.912370967001907,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17142,GO:0102166,1,0.979226035213429,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17143,GO:0102167,1,0.979226035213429,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17144,GO:0102200,1,0.979288568837767,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17145,GO:0102250,1,0.956178276708108,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17146,GO:0102336,1,0.892309679212437,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17147,GO:0102337,1,0.892309679212437,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17148,GO:0102338,1,0.892309679212437,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17149,GO:0102339,1,0.97725282871171,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17150,GO:0102340,1,0.97725282871171,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17151,GO:0102341,1,0.97725282871171,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17152,GO:0102342,1,0.97725282871171,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
17153,GO:0102343,1,0.912370967001907,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17154,GO:0102344,1,0.912370967001907,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17155,GO:0102345,1,0.912370967001907,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17156,GO:0102389,1,0.977268319780716,0,1,polyprenol reductase activity,MF,
17157,GO:0102390,1,0.977265332913864,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
17158,GO:0102391,1,0.916078715815025,0,4,decanoate-CoA ligase activity,MF,
17159,GO:0102420,1,0.914997633247189,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17160,GO:0102485,1,0.962041028632365,0,2,dATP phosphohydrolase activity,MF,
17161,GO:0102486,1,0.962041028632365,0,2,dCTP phosphohydrolase activity,MF,
17162,GO:0102487,1,0.962041028632365,0,2,dUTP phosphohydrolase activity,MF,
17163,GO:0102488,1,0.962041028632365,0,2,dTTP phosphohydrolase activity,MF,
17164,GO:0102489,1,0.962041028632365,0,2,GTP phosphohydrolase activity,MF,
17165,GO:0102490,1,0.962041028632365,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17166,GO:0102491,1,0.962041028632365,0,2,dGTP phosphohydrolase activity,MF,
17167,GO:0102499,1,0.956178276708108,0,2,SHG alpha-glucan phosphorylase activity,MF,
17168,GO:0102500,1,0.98076969582673,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17169,GO:0102521,1,0.955374635254681,0,2,tRNA-4-demethylwyosine synthase activity,MF,
17170,GO:0102522,1,0.977230956930846,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
17171,GO:0102524,1,0.977336572808046,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17172,GO:0102567,1,0.763245994926098,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17173,GO:0102568,1,0.763245994926098,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17174,GO:0102571,1,0.979226035213429,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17175,GO:0102704,1,0.977342241478123,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17176,GO:0102707,1,0.977254324184692,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
17177,GO:0102751,1,0.977127620109969,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
17178,GO:0102752,1,0.977454821840281,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
17179,GO:0102756,1,0.892309679212437,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17180,GO:0102758,1,0.976493225590869,0,1,very-long-chain enoyl-CoA reductase activity,MF,
17181,GO:0102769,1,0.977015465853354,0,1,dihydroceramide glucosyltransferase activity,MF,
17182,GO:0102773,1,0.978662971072444,0,1,dihydroceramide kinase activity,MF,
17183,GO:0102797,1,0.979089442523572,0,1,geranial:oxygen oxidoreductase activity,MF,
17184,GO:0102798,1,0.979089442523572,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17185,GO:0102867,1,0.97728405824096,0,1,molybdenum cofactor sulfurtransferase activity,MF,
17186,GO:0102938,1,0.955167802157117,0,2,orcinol O-methyltransferase activity,MF,
17187,GO:0102953,1,0.93329877131748,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17188,GO:0102965,1,0.957027150185686,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
17189,GO:0102991,1,0.9113477338788,0,4,myristoyl-CoA hydrolase activity,MF,
17190,GO:0103025,1,0.977228211873771,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17191,GO:0103045,1,0.977213057172693,0,1,methione N-acyltransferase activity,MF,
17192,GO:0103046,1,0.979131868564929,0,1,alanylglutamate dipeptidase activity,MF,
17193,GO:0103053,1,0.953939816724577,0,2,1-ethyladenine demethylase activity,MF,
17194,GO:0103066,1,0.976988516646319,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17195,GO:0103067,1,0.976988516646319,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
17196,GO:0103068,1,0.93329877131748,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17197,GO:0103073,1,0.977218310459923,0,1,anandamide amidohydrolase activity,MF,
17200,GO:0106001,1,0.935928937767156,0,3,intestinal hexose absorption,BP,
17202,GO:0106004,1,0.954226296864097,0,2,tRNA (guanine-N7)-methylation,BP,
17203,GO:0106005,1,0.980039279721722,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17204,GO:0106014,1,0.954617251280844,0,2,regulation of inflammatory response to wounding,BP,
17205,GO:0106015,1,0.954617251280844,0,2,negative regulation of inflammatory response to wounding,BP,
17206,GO:0106017,1,0.939541287484148,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17207,GO:0106018,1,0.74598856789444,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17208,GO:0106019,1,0.806620327800158,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17209,GO:0106020,1,0.955897245770815,0,2,regulation of vesicle docking,BP,
17210,GO:0106022,1,0.978167535553689,0,1,positive regulation of vesicle docking,BP,
17212,GO:0106028,1,0.979021937244501,0,1,neuron projection retraction,BP,
17214,GO:0106044,1,0.976125001747232,0,1,guanine deglycation,BP,
17215,GO:0106045,1,0.976125001747232,0,1,guanine deglycation, methylglyoxal removal,BP,
17216,GO:0106046,1,0.976125001747232,0,1,guanine deglycation, glyoxal removal,BP,
17217,GO:0106049,1,0.894061974748761,0,5,regulation of cellular response to osmotic stress,BP,
17218,GO:0106050,1,0.977186760389047,0,1,tRNA 2'-O-methyltransferase activity,MF,
17219,GO:0106056,1,0.724785108816232,0,15,regulation of calcineurin-mediated signaling,BP,
17220,GO:0106057,1,0.93785614897738,0,3,negative regulation of calcineurin-mediated signaling,BP,
17221,GO:0106058,1,0.821498971868685,0,9,positive regulation of calcineurin-mediated signaling,BP,
17222,GO:0106068,1,0.853158769128868,0,7,SUMO ligase complex,CC,
17223,GO:0106070,1,0.90288556504614,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17224,GO:0106071,1,0.941023531418974,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17225,GO:0106072,1,0.959480914258466,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17226,GO:0106073,1,0.960607917591374,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17227,GO:0106074,1,0.781698773818605,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17228,GO:0106075,1,0.977464698390232,0,1,peptide N-succinyltransferase activity,MF,
17229,GO:0106077,1,0.914069282974158,0,4,histone succinylation,BP,
17230,GO:0106078,1,0.977464698390232,0,1,histone succinyltransferase activity,MF,
17231,GO:0106083,1,0.909277136100368,0,5,nuclear membrane protein complex,CC,
17232,GO:0106088,1,0.980525634536972,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17233,GO:0106089,1,0.980525634536972,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17234,GO:0106094,1,0.909277136100368,0,5,nuclear membrane microtubule tethering complex,CC,
17235,GO:0106101,1,0.977145668861862,0,1,ER-dependent peroxisome localization,BP,
17236,GO:0106104,1,0.958553810284875,0,2,regulation of glutamate receptor clustering,BP,
17237,GO:0110008,1,0.977418866468644,0,1,ncRNA deadenylation,BP,
17238,GO:0110009,1,0.957458902522469,0,2,formin-nucleated actin cable organization,BP,
17239,GO:0110011,1,0.904969468595843,0,5,regulation of basement membrane organization,BP,
17240,GO:0110017,1,0.953566767049371,0,2,cap-independent translational initiation of linear mRNA,BP,
17242,GO:0110021,1,0.955578856673515,0,2,cardiac muscle myoblast proliferation,BP,
17243,GO:0110022,1,0.955578856673515,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17244,GO:0110024,1,0.955578856673515,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
17245,GO:0110025,1,0.977421568104285,0,1,DNA strand resection involved in replication fork processing,BP,
17246,GO:0110026,1,0.977421568104285,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17247,GO:0110028,1,0.980765369020107,0,1,positive regulation of mitotic spindle organization,BP,
17248,GO:0110029,1,0.977485731533649,0,1,negative regulation of meiosis I,BP,
17250,GO:0110057,1,0.979498931900578,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17251,GO:0110059,1,0.979498931900578,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17252,GO:0110075,1,0.976136663128362,0,1,regulation of ferroptosis,BP,
17253,GO:0110076,1,0.976136663128362,0,1,negative regulation of ferroptosis,BP,
17254,GO:0110095,1,0.931538891704271,0,3,cellular detoxification of aldehyde,BP,
17255,GO:0110096,1,0.8891896631424,0,5,cellular response to aldehyde,BP,
17256,GO:0120009,1,0.893385245881272,0,5,intermembrane lipid transfer,BP,
17257,GO:0120012,1,0.979438040142143,0,1,intermembrane sphingolipid transfer,BP,
17258,GO:0120013,1,0.893385245881272,0,5,intermembrane lipid transfer activity,MF,
17259,GO:0120016,1,0.979438040142143,0,1,intermembrane sphingolipid transfer activity,MF,
17260,GO:0120017,1,0.979438040142143,0,1,intermembrane ceramide transfer activity,MF,
17264,GO:0120033,1,0.653033505199372,0,19,negative regulation of plasma membrane bounded cell projection assembly,BP,
17270,GO:0120043,1,0.978914663408024,0,1,stereocilium shaft,CC,
17271,GO:0120044,1,0.978914663408024,0,1,stereocilium base,CC,
17272,GO:0120048,1,0.977336572808046,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17273,GO:0120049,1,0.977336572808046,0,1,snRNA (adenine-N6)-methylation,BP,
17274,GO:0120060,1,0.97592036803824,0,1,regulation of gastric emptying,BP,
17275,GO:0120061,1,0.97592036803824,0,1,negative regulation of gastric emptying,BP,
17276,GO:0120063,1,0.97592036803824,0,1,stomach smooth muscle contraction,BP,
17277,GO:0120068,1,0.97592036803824,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17278,GO:0120069,1,0.97592036803824,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
17279,GO:0120077,1,0.980525634536972,0,1,angiogenic sprout fusion,BP,
17280,GO:0120078,1,0.980525634536972,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17281,GO:0120092,1,0.977646805539183,0,1,crotonyl-CoA hydratase activity,MF,
17282,GO:0120093,1,0.977646805539183,0,1,regulation of peptidyl-lysine crotonylation,BP,
17283,GO:0120094,1,0.977646805539183,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17284,GO:0120103,1,0.821440857939049,0,9,centriolar subdistal appendage,CC,
17285,GO:0120108,1,0.977202658023853,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
17287,GO:0120114,1,0.166074840203744,0,79,Sm-like protein family complex,CC,
17288,GO:0140007,1,0.911951631117907,0,4,KICSTOR complex,CC,
17289,GO:0140009,1,0.977910332198578,0,1,L-aspartate import across plasma membrane,BP,
17294,GO:0140031,1,0.955172572921795,0,2,phosphorylation-dependent protein binding,MF,
17295,GO:0140033,1,0.716421416877843,0,16,acetylation-dependent protein binding,MF,
17297,GO:0140035,1,0.876860462916105,0,6,ubiquitination-like modification-dependent protein binding,MF,
17298,GO:0140036,1,0.876860462916105,0,6,ubiquitin-dependent protein binding,MF,
17299,GO:0140041,1,0.976125001747232,0,1,cellular detoxification of methylglyoxal,BP,
17300,GO:0140052,1,0.93576429648692,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
17301,GO:0140053,1,0.027824272626618,0,153,mitochondrial gene expression,BP,
17303,GO:0140058,1,0.755491677352339,0,13,neuron projection arborization,BP,
17304,GO:0140059,1,0.895145987694779,0,5,dendrite arborization,BP,
17305,GO:0140064,1,0.981883150047352,0,1,peptide crotonyltransferase activity,MF,
17306,GO:0140065,1,0.981883150047352,0,1,peptide butyryltransferase activity,MF,
17307,GO:0140066,1,0.959933429922599,0,2,peptidyl-lysine crotonylation,BP,
17308,GO:0140067,1,0.981883150047352,0,1,peptidyl-lysine butyrylation,BP,
17309,GO:0140068,1,0.981883150047352,0,1,histone crotonyltransferase activity,MF,
17310,GO:0140069,1,0.981883150047352,0,1,histone butyryltransferase activity,MF,
17311,GO:0140074,1,0.9792675283463,0,1,cardiac endothelial to mesenchymal transition,BP,
17312,GO:0140078,1,0.792776100293509,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17313,GO:0140080,1,0.792776100293509,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17320,GO:0140104,1,0.548706023080353,0,27,molecular carrier activity,MF,
17322,GO:0140112,1,0.648652654920655,0,19,extracellular vesicle biogenesis,BP,
17323,GO:0140115,1,0.839423998537554,0,8,export across plasma membrane,BP,
17325,GO:0140135,1,0.956235747779954,0,2,mechanosensitive cation channel activity,MF,
17326,GO:0140142,1,0.676274270924802,0,18,nucleocytoplasmic carrier activity,MF,
17327,GO:0140161,1,0.932817832194378,0,3,monocarboxylate:sodium symporter activity,MF,
17328,GO:0140192,1,0.962988972904656,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17331,GO:0140196,1,0.98072639761374,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17332,GO:0140199,1,0.981915309359245,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17333,GO:0140200,1,0.981425242372094,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17334,GO:0150003,1,0.934680292835163,0,3,regulation of spontaneous synaptic transmission,BP,
17336,GO:0150011,1,0.860947552980073,0,7,regulation of neuron projection arborization,BP,
17337,GO:0150012,1,0.860947552980073,0,7,positive regulation of neuron projection arborization,BP,
17338,GO:0150018,1,0.937179607892307,0,3,basal dendrite development,BP,
17339,GO:0150019,1,0.937179607892307,0,3,basal dendrite morphogenesis,BP,
17340,GO:0150020,1,0.937179607892307,0,3,basal dendrite arborization,BP,
17341,GO:0150031,1,0.980200842627725,0,1,regulation of protein localization to lysosome,BP,
17342,GO:0150033,1,0.980200842627725,0,1,negative regulation of protein localization to lysosome,BP,
17345,GO:1900003,1,0.932390583753455,0,3,regulation of serine-type endopeptidase activity,BP,
17346,GO:1900004,1,0.932390583753455,0,3,negative regulation of serine-type endopeptidase activity,BP,
17347,GO:1900006,1,0.326338641814083,0,52,positive regulation of dendrite development,BP,
17349,GO:1900016,1,0.834828474626382,0,8,negative regulation of cytokine production involved in inflammatory response,BP,
17351,GO:1900019,1,0.915496437818645,0,4,regulation of protein kinase C activity,BP,
17352,GO:1900020,1,0.915496437818645,0,4,positive regulation of protein kinase C activity,BP,
17354,GO:1900025,1,0.7643336450526,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
17357,GO:1900028,1,0.913715867451046,0,4,negative regulation of ruffle assembly,BP,
17360,GO:1900036,1,0.977239318481576,0,1,positive regulation of cellular response to heat,BP,
17361,GO:1900037,1,0.795579213500787,0,10,regulation of cellular response to hypoxia,BP,
17362,GO:1900038,1,0.872886567909289,0,6,negative regulation of cellular response to hypoxia,BP,
17363,GO:1900039,1,0.976501776607104,0,1,positive regulation of cellular response to hypoxia,BP,
17364,GO:1900040,1,0.898717732482723,0,5,regulation of interleukin-2 secretion,BP,
17365,GO:1900041,1,0.933781003166736,0,3,negative regulation of interleukin-2 secretion,BP,
17366,GO:1900042,1,0.962459723036981,0,2,positive regulation of interleukin-2 secretion,BP,
17367,GO:1900044,1,0.845961223045451,0,8,regulation of protein K63-linked ubiquitination,BP,
17368,GO:1900045,1,0.900842887480851,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17372,GO:1900060,1,0.913315205643603,0,4,negative regulation of ceramide biosynthetic process,BP,
17373,GO:1900062,1,0.977969251463639,0,1,regulation of replicative cell aging,BP,
17374,GO:1900063,1,0.940993041631237,0,3,regulation of peroxisome organization,BP,
17378,GO:1900081,1,0.981915309359245,0,1,regulation of arginine catabolic process,BP,
17379,GO:1900082,1,0.981915309359245,0,1,negative regulation of arginine catabolic process,BP,
17380,GO:1900084,1,0.917654248310534,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
17381,GO:1900085,1,0.977270366277077,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
17382,GO:1900086,1,0.939002424327979,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
17383,GO:1900087,1,0.60148745308823,0,23,positive regulation of G1/S transition of mitotic cell cycle,BP,
17384,GO:1900094,1,0.938499247615923,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17385,GO:1900095,1,0.983105671181624,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17386,GO:1900098,1,0.977127370618276,0,1,regulation of plasma cell differentiation,BP,
17387,GO:1900100,1,0.977127370618276,0,1,positive regulation of plasma cell differentiation,BP,
17389,GO:1900102,1,0.779700608078851,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
17391,GO:1900104,1,0.934236871547577,0,3,regulation of hyaluranon cable assembly,BP,
17392,GO:1900106,1,0.934236871547577,0,3,positive regulation of hyaluranon cable assembly,BP,
17393,GO:1900107,1,0.960479873173393,0,2,regulation of nodal signaling pathway,BP,
17394,GO:1900108,1,0.977083696668547,0,1,negative regulation of nodal signaling pathway,BP,
17395,GO:1900109,1,0.954198105240855,0,2,regulation of histone H3-K9 dimethylation,BP,
17396,GO:1900110,1,0.954198105240855,0,2,negative regulation of histone H3-K9 dimethylation,BP,
17397,GO:1900112,1,0.823690055047372,0,9,regulation of histone H3-K9 trimethylation,BP,
17398,GO:1900113,1,0.893756304504263,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17399,GO:1900114,1,0.958914476071562,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17400,GO:1900115,1,0.78730962974139,0,11,extracellular regulation of signal transduction,BP,
17401,GO:1900116,1,0.78730962974139,0,11,extracellular negative regulation of signal transduction,BP,
17402,GO:1900117,1,0.638231233917329,0,20,regulation of execution phase of apoptosis,BP,
17403,GO:1900118,1,0.875251375030554,0,6,negative regulation of execution phase of apoptosis,BP,
17404,GO:1900119,1,0.761048589221788,0,12,positive regulation of execution phase of apoptosis,BP,
17407,GO:1900122,1,0.870735313480369,0,6,positive regulation of receptor binding,BP,
17408,GO:1900125,1,0.876794879314203,0,6,regulation of hyaluronan biosynthetic process,BP,
17409,GO:1900126,1,0.93804869305982,0,3,negative regulation of hyaluronan biosynthetic process,BP,
17410,GO:1900127,1,0.934715998904709,0,3,positive regulation of hyaluronan biosynthetic process,BP,
17411,GO:1900130,1,0.977873573779148,0,1,regulation of lipid binding,BP,
17412,GO:1900131,1,0.977873573779148,0,1,negative regulation of lipid binding,BP,
17413,GO:1900133,1,0.934363823055402,0,3,regulation of renin secretion into blood stream,BP,
17414,GO:1900134,1,0.978057177773034,0,1,negative regulation of renin secretion into blood stream,BP,
17415,GO:1900135,1,0.977330687541506,0,1,positive regulation of renin secretion into blood stream,BP,
17416,GO:1900138,1,0.934630151199433,0,3,negative regulation of phospholipase A2 activity,BP,
17417,GO:1900139,1,0.979153362770796,0,1,negative regulation of arachidonic acid secretion,BP,
17418,GO:1900141,1,0.977249750036021,0,1,regulation of oligodendrocyte apoptotic process,BP,
17419,GO:1900142,1,0.977249750036021,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
17420,GO:1900145,1,0.960479873173393,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17421,GO:1900146,1,0.977083696668547,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17422,GO:1900147,1,0.95854894309229,0,2,regulation of Schwann cell migration,BP,
17423,GO:1900148,1,0.977336572808046,0,1,negative regulation of Schwann cell migration,BP,
17424,GO:1900149,1,0.980778347430777,0,1,positive regulation of Schwann cell migration,BP,
17425,GO:1900150,1,0.954719574814709,0,2,regulation of defense response to fungus,BP,
17429,GO:1900161,1,0.977298954147329,0,1,regulation of phospholipid scramblase activity,BP,
17430,GO:1900163,1,0.977298954147329,0,1,positive regulation of phospholipid scramblase activity,BP,
17431,GO:1900164,1,0.938499247615923,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17432,GO:1900165,1,0.935286171873154,0,3,negative regulation of interleukin-6 secretion,BP,
17433,GO:1900169,1,0.962516536802474,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17434,GO:1900170,1,0.977336572808046,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17435,GO:1900175,1,0.960479873173393,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17436,GO:1900176,1,0.977083696668547,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17437,GO:1900180,1,0.15405141255508,0,84,regulation of protein localization to nucleus,BP,
17438,GO:1900181,1,0.71959816659597,0,15,negative regulation of protein localization to nucleus,BP,
17439,GO:1900182,1,0.282689570141176,0,57,positive regulation of protein localization to nucleus,BP,
17440,GO:1900186,1,0.935355029317478,0,3,negative regulation of clathrin-dependent endocytosis,BP,
17441,GO:1900193,1,0.891688092828812,0,5,regulation of oocyte maturation,BP,
17442,GO:1900194,1,0.977716725298581,0,1,negative regulation of oocyte maturation,BP,
17443,GO:1900195,1,0.954933625400884,0,2,positive regulation of oocyte maturation,BP,
17444,GO:1900200,1,0.978120976366248,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17445,GO:1900204,1,0.978120976366248,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17446,GO:1900205,1,0.978120976366248,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17447,GO:1900208,1,0.954325931979077,0,2,regulation of cardiolipin metabolic process,BP,
17448,GO:1900210,1,0.954325931979077,0,2,positive regulation of cardiolipin metabolic process,BP,
17449,GO:1900211,1,0.978120976366248,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17450,GO:1900212,1,0.978120976366248,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17451,GO:1900214,1,0.978120976366248,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17452,GO:1900215,1,0.978120976366248,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17453,GO:1900217,1,0.978120976366248,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17454,GO:1900218,1,0.978120976366248,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17455,GO:1900220,1,0.959941714921574,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17457,GO:1900222,1,0.95600229598012,0,2,negative regulation of amyloid-beta clearance,BP,
17458,GO:1900223,1,0.886768317857314,0,6,positive regulation of amyloid-beta clearance,BP,
17459,GO:1900224,1,0.983008226798335,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17460,GO:1900225,1,0.819705149320951,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17461,GO:1900226,1,0.915294911742218,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
17462,GO:1900227,1,0.91642700192018,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17463,GO:1900238,1,0.955136860941441,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17464,GO:1900239,1,0.936914724658147,0,3,regulation of phenotypic switching,BP,
17465,GO:1900241,1,0.97733048160298,0,1,positive regulation of phenotypic switching,BP,
17466,GO:1900242,1,0.881053635053672,0,6,regulation of synaptic vesicle endocytosis,BP,
17467,GO:1900243,1,0.97931575040249,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17468,GO:1900244,1,0.956447121744145,0,2,positive regulation of synaptic vesicle endocytosis,BP,
17469,GO:1900245,1,0.940483986607638,0,3,positive regulation of MDA-5 signaling pathway,BP,
17470,GO:1900246,1,0.902686136286759,0,5,positive regulation of RIG-I signaling pathway,BP,
17471,GO:1900247,1,0.781316920085912,0,11,regulation of cytoplasmic translational elongation,BP,
17472,GO:1900248,1,0.959754657894878,0,2,negative regulation of cytoplasmic translational elongation,BP,
17473,GO:1900259,1,0.977165313198381,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17474,GO:1900260,1,0.977165313198381,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17475,GO:1900262,1,0.870504653700503,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17476,GO:1900264,1,0.870504653700503,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17477,GO:1900271,1,0.663909062689348,0,19,regulation of long-term synaptic potentiation,BP,
17478,GO:1900272,1,0.875032263621913,0,6,negative regulation of long-term synaptic potentiation,BP,
17479,GO:1900273,1,0.789551435994522,0,11,positive regulation of long-term synaptic potentiation,BP,
17480,GO:1900274,1,0.689334297629749,0,17,regulation of phospholipase C activity,BP,
17481,GO:1900275,1,0.957777182206658,0,2,negative regulation of phospholipase C activity,BP,
17482,GO:1900276,1,0.97771186916298,0,1,regulation of proteinase activated receptor activity,BP,
17483,GO:1900363,1,0.765516917709896,0,12,regulation of mRNA polyadenylation,BP,
17484,GO:1900364,1,0.836296084885926,0,8,negative regulation of mRNA polyadenylation,BP,
17485,GO:1900365,1,0.936982951350981,0,3,positive regulation of mRNA polyadenylation,BP,
17486,GO:1900368,1,0.935968544084917,0,3,regulation of RNA interference,BP,
17487,GO:1900369,1,0.955633987628056,0,2,negative regulation of RNA interference,BP,
17488,GO:1900370,1,0.979425050177671,0,1,positive regulation of RNA interference,BP,
17492,GO:1900376,1,0.922211263621771,0,4,regulation of secondary metabolite biosynthetic process,BP,
17493,GO:1900377,1,0.960654659224487,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17494,GO:1900378,1,0.959988015790638,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17496,GO:1900390,1,0.953934264174439,0,2,regulation of iron ion import,BP,
17500,GO:1900409,1,0.763770726221506,0,12,positive regulation of cellular response to oxidative stress,BP,
17501,GO:1900424,1,0.747134298650784,0,13,regulation of defense response to bacterium,BP,
17502,GO:1900425,1,0.89503030850494,0,5,negative regulation of defense response to bacterium,BP,
17503,GO:1900426,1,0.8519534052282,0,7,positive regulation of defense response to bacterium,BP,
17504,GO:1900449,1,0.650045674650837,0,20,regulation of glutamate receptor signaling pathway,BP,
17505,GO:1900450,1,0.979021937244501,0,1,negative regulation of glutamate receptor signaling pathway,BP,
17506,GO:1900451,1,0.916938059761571,0,4,positive regulation of glutamate receptor signaling pathway,BP,
17507,GO:1900452,1,0.918371067237052,0,4,regulation of long term synaptic depression,BP,
17508,GO:1900453,1,0.95581138768409,0,2,negative regulation of long term synaptic depression,BP,
17510,GO:1900483,1,0.977258668731482,0,1,regulation of protein targeting to vacuolar membrane,BP,
17511,GO:1900533,1,0.976926156918786,0,1,palmitic acid metabolic process,BP,
17512,GO:1900535,1,0.976926156918786,0,1,palmitic acid biosynthetic process,BP,
17516,GO:1900619,1,0.977266136864643,0,1,acetate ester metabolic process,BP,
17517,GO:1900620,1,0.977266136864643,0,1,acetate ester biosynthetic process,BP,
17518,GO:1900623,1,0.937396544260327,0,3,regulation of monocyte aggregation,BP,
17519,GO:1900625,1,0.937396544260327,0,3,positive regulation of monocyte aggregation,BP,
17520,GO:1900673,1,0.955006871087954,0,2,olefin metabolic process,BP,
17521,GO:1900736,1,0.97771186916298,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17522,GO:1900737,1,0.97771186916298,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17523,GO:1900739,1,0.527830156597872,0,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17524,GO:1900740,1,0.527830156597872,0,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17527,GO:1900746,1,0.805551560635944,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
17528,GO:1900747,1,0.915424905654916,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
17529,GO:1900748,1,0.922077048200989,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
17530,GO:1900750,1,0.77473697663596,0,11,oligopeptide binding,MF,
17531,GO:1900753,1,0.978579725475159,0,1,doxorubicin transport,BP,
17532,GO:1900756,1,0.958720440289158,0,2,protein processing in phagocytic vesicle,BP,
17533,GO:1900825,1,0.917424640191375,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17534,GO:1900827,1,0.982675003825129,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17535,GO:1900864,1,0.813509368134482,0,9,mitochondrial RNA modification,BP,
17536,GO:1901003,1,0.977336572808046,0,1,negative regulation of fermentation,BP,
17537,GO:1901004,1,0.976634144479229,0,1,ubiquinone-6 metabolic process,BP,
17538,GO:1901006,1,0.976634144479229,0,1,ubiquinone-6 biosynthetic process,BP,
17539,GO:1901016,1,0.526735835766215,0,30,regulation of potassium ion transmembrane transporter activity,BP,
17540,GO:1901017,1,0.825599540744402,0,9,negative regulation of potassium ion transmembrane transporter activity,BP,
17541,GO:1901018,1,0.831766636954852,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17543,GO:1901020,1,0.695030355189103,0,16,negative regulation of calcium ion transmembrane transporter activity,BP,
17545,GO:1901026,1,0.93913542534827,0,3,ripoptosome assembly involved in necroptotic process,BP,
17546,GO:1901028,1,0.37408439578314,0,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17547,GO:1901029,1,0.84986337722034,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17548,GO:1901030,1,0.450708130136334,0,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17549,GO:1901031,1,0.506504691873515,0,30,regulation of response to reactive oxygen species,BP,
17550,GO:1901032,1,0.727173100850403,0,14,negative regulation of response to reactive oxygen species,BP,
17551,GO:1901033,1,0.854129825023753,0,7,positive regulation of response to reactive oxygen species,BP,
17553,GO:1901069,1,0.954257286416252,0,2,guanosine-containing compound catabolic process,BP,
17555,GO:1901071,1,0.698722988436605,0,16,glucosamine-containing compound metabolic process,BP,
17556,GO:1901072,1,0.891688536919125,0,5,glucosamine-containing compound catabolic process,BP,
17557,GO:1901073,1,0.957853679000455,0,2,glucosamine-containing compound biosynthetic process,BP,
17558,GO:1901074,1,0.980514722030696,0,1,regulation of engulfment of apoptotic cell,BP,
17559,GO:1901076,1,0.980514722030696,0,1,positive regulation of engulfment of apoptotic cell,BP,
17560,GO:1901077,1,0.917629482123325,0,4,regulation of relaxation of muscle,BP,
17561,GO:1901078,1,0.981425242372094,0,1,negative regulation of relaxation of muscle,BP,
17562,GO:1901086,1,0.979182692621462,0,1,benzylpenicillin metabolic process,BP,
17563,GO:1901090,1,0.955192024808627,0,2,regulation of protein tetramerization,BP,
17564,GO:1901091,1,0.955192024808627,0,2,negative regulation of protein tetramerization,BP,
17565,GO:1901093,1,0.955192024808627,0,2,regulation of protein homotetramerization,BP,
17566,GO:1901094,1,0.955192024808627,0,2,negative regulation of protein homotetramerization,BP,
17567,GO:1901096,1,0.807235706429212,0,10,regulation of autophagosome maturation,BP,
17568,GO:1901097,1,0.915661181259194,0,4,negative regulation of autophagosome maturation,BP,
17569,GO:1901098,1,0.883866636331955,0,6,positive regulation of autophagosome maturation,BP,
17574,GO:1901142,1,0.877918494286079,0,6,insulin metabolic process,BP,
17575,GO:1901143,1,0.957481054049854,0,2,insulin catabolic process,BP,
17576,GO:1901145,1,0.956873162315381,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17577,GO:1901147,1,0.978120976366248,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17578,GO:1901159,1,0.890078446792012,0,5,xylulose 5-phosphate biosynthetic process,BP,
17579,GO:1901160,1,0.859345857917992,0,7,primary amino compound metabolic process,BP,
17580,GO:1901162,1,0.955080321060831,0,2,primary amino compound biosynthetic process,BP,
17581,GO:1901163,1,0.83048850518409,0,8,regulation of trophoblast cell migration,BP,
17582,GO:1901164,1,0.931450808791043,0,3,negative regulation of trophoblast cell migration,BP,
17583,GO:1901165,1,0.891634762640576,0,5,positive regulation of trophoblast cell migration,BP,
17584,GO:1901166,1,0.936078576165606,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
17585,GO:1901184,1,0.172173805076422,0,79,regulation of ERBB signaling pathway,BP,
17586,GO:1901185,1,0.341517907212003,0,48,negative regulation of ERBB signaling pathway,BP,
17587,GO:1901186,1,0.547795150085846,0,27,positive regulation of ERBB signaling pathway,BP,
17588,GO:1901187,1,0.957846450444557,0,2,regulation of ephrin receptor signaling pathway,BP,
17589,GO:1901189,1,0.977240541901661,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17590,GO:1901193,1,0.976430758027218,0,1,regulation of formation of translation preinitiation complex,BP,
17591,GO:1901194,1,0.976430758027218,0,1,negative regulation of formation of translation preinitiation complex,BP,
17593,GO:1901202,1,0.9772401914015,0,1,negative regulation of extracellular matrix assembly,BP,
17595,GO:1901207,1,0.97822361693353,0,1,regulation of heart looping,BP,
17600,GO:1901222,1,0.341106861290187,0,48,regulation of NIK/NF-kappaB signaling,BP,
17601,GO:1901223,1,0.834100661149007,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17602,GO:1901224,1,0.426708636806068,0,38,positive regulation of NIK/NF-kappaB signaling,BP,
17603,GO:1901228,1,0.978544712616752,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17604,GO:1901229,1,0.977258170732843,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17605,GO:1901231,1,0.977258170732843,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17606,GO:1901232,1,0.977258170732843,0,1,regulation of convergent extension involved in axis elongation,BP,
17607,GO:1901233,1,0.977258170732843,0,1,negative regulation of convergent extension involved in axis elongation,BP,
17608,GO:1901252,1,0.955237226824737,0,2,regulation of intracellular transport of viral material,BP,
17609,GO:1901253,1,0.976133335782055,0,1,negative regulation of intracellular transport of viral material,BP,
17610,GO:1901254,1,0.97859489893645,0,1,positive regulation of intracellular transport of viral material,BP,
17611,GO:1901255,1,0.957872626609967,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17612,GO:1901256,1,0.933850464443712,0,3,regulation of macrophage colony-stimulating factor production,BP,
17613,GO:1901257,1,0.977238535630964,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
17614,GO:1901258,1,0.977278500836114,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
17617,GO:1901269,1,0.951850414874843,0,2,lipooligosaccharide metabolic process,BP,
17618,GO:1901271,1,0.951850414874843,0,2,lipooligosaccharide biosynthetic process,BP,
17619,GO:1901291,1,0.977172651211672,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
17622,GO:1901295,1,0.954884852394151,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17623,GO:1901296,1,0.977125613061449,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17624,GO:1901297,1,0.977240541901661,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17625,GO:1901298,1,0.818319966651506,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17626,GO:1901299,1,0.893741040365126,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17627,GO:1901300,1,0.915646032090786,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
17628,GO:1901301,1,0.956559174166108,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
17629,GO:1901303,1,0.977278942128016,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17630,GO:1901304,1,0.977062668863997,0,1,regulation of spermidine biosynthetic process,BP,
17631,GO:1901307,1,0.977062668863997,0,1,positive regulation of spermidine biosynthetic process,BP,
17632,GO:1901314,1,0.940995512635375,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17633,GO:1901315,1,0.940995512635375,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
17634,GO:1901317,1,0.910428485470567,0,4,regulation of flagellated sperm motility,BP,
17635,GO:1901318,1,0.977336572808046,0,1,negative regulation of flagellated sperm motility,BP,
17636,GO:1901321,1,0.977125613061449,0,1,positive regulation of heart induction,BP,
17637,GO:1901328,1,0.97712861412132,0,1,response to cytochalasin B,BP,
17640,GO:1901337,1,0.977268319780716,0,1,thioester transport,BP,
17641,GO:1901338,1,0.93315447487499,0,3,catecholamine binding,MF,
17642,GO:1901339,1,0.876142676641057,0,6,regulation of store-operated calcium channel activity,BP,
17643,GO:1901340,1,0.978371292809043,0,1,negative regulation of store-operated calcium channel activity,BP,
17644,GO:1901341,1,0.916154403028639,0,4,positive regulation of store-operated calcium channel activity,BP,
17648,GO:1901350,1,0.98066458184821,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17649,GO:1901355,1,0.958000305202302,0,2,response to rapamycin,BP,
17654,GO:1901373,1,0.976813211330368,0,1,lipid hydroperoxide transport,BP,
17655,GO:1901374,1,0.977266136864643,0,1,acetate ester transport,BP,
17656,GO:1901376,1,0.977284794046506,0,1,organic heteropentacyclic compound metabolic process,BP,
17657,GO:1901377,1,0.977284794046506,0,1,organic heteropentacyclic compound catabolic process,BP,
17658,GO:1901379,1,0.461227255154279,0,36,regulation of potassium ion transmembrane transport,BP,
17659,GO:1901380,1,0.825599540744402,0,9,negative regulation of potassium ion transmembrane transport,BP,
17660,GO:1901381,1,0.799341653243829,0,11,positive regulation of potassium ion transmembrane transport,BP,
17661,GO:1901382,1,0.958001925909981,0,2,regulation of chorionic trophoblast cell proliferation,BP,
17662,GO:1901385,1,0.73427556329666,0,14,regulation of voltage-gated calcium channel activity,BP,
17663,GO:1901386,1,0.892368248896694,0,5,negative regulation of voltage-gated calcium channel activity,BP,
17664,GO:1901387,1,0.936100081310827,0,3,positive regulation of voltage-gated calcium channel activity,BP,
17665,GO:1901388,1,0.977253118713482,0,1,regulation of transforming growth factor beta activation,BP,
17666,GO:1901389,1,0.977253118713482,0,1,negative regulation of transforming growth factor beta activation,BP,
17667,GO:1901407,1,0.815183485746909,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17668,GO:1901409,1,0.852026997848425,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17669,GO:1901419,1,0.978577042266034,0,1,regulation of response to alcohol,BP,
17670,GO:1901421,1,0.978577042266034,0,1,positive regulation of response to alcohol,BP,
17671,GO:1901474,1,0.891771850281707,0,5,azole transmembrane transporter activity,MF,
17672,GO:1901475,1,0.933977923074141,0,3,pyruvate transmembrane transport,BP,
17673,GO:1901490,1,0.917579517641088,0,4,regulation of lymphangiogenesis,BP,
17674,GO:1901491,1,0.958067508682587,0,2,negative regulation of lymphangiogenesis,BP,
17675,GO:1901492,1,0.957746604767816,0,2,positive regulation of lymphangiogenesis,BP,
17676,GO:1901503,1,0.895961369551916,0,5,ether biosynthetic process,BP,
17677,GO:1901505,1,0.471828949009141,0,33,carbohydrate derivative transmembrane transporter activity,MF,
17678,GO:1901509,1,0.956377609485367,0,2,regulation of endothelial tube morphogenesis,BP,
17679,GO:1901522,1,0.650297147817756,0,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
17680,GO:1901523,1,0.977336572808046,0,1,icosanoid catabolic process,BP,
17681,GO:1901524,1,0.737674831778915,0,14,regulation of mitophagy,BP,
17682,GO:1901525,1,0.877069987694554,0,6,negative regulation of mitophagy,BP,
17683,GO:1901526,1,0.841139074688466,0,8,positive regulation of mitophagy,BP,
17684,GO:1901529,1,0.956206330220192,0,2,positive regulation of anion channel activity,BP,
17687,GO:1901534,1,0.956420264059366,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17688,GO:1901535,1,0.903167488660853,0,5,regulation of DNA demethylation,BP,
17689,GO:1901536,1,0.95531023337633,0,2,negative regulation of DNA demethylation,BP,
17690,GO:1901537,1,0.945427136313973,0,3,positive regulation of DNA demethylation,BP,
17691,GO:1901538,1,0.879278932479089,0,6,changes to DNA methylation involved in embryo development,BP,
17692,GO:1901545,1,0.977399377001488,0,1,response to raffinose,BP,
17693,GO:1901550,1,0.820567365863886,0,9,regulation of endothelial cell development,BP,
17694,GO:1901551,1,0.978437915425202,0,1,negative regulation of endothelial cell development,BP,
17695,GO:1901552,1,0.956579484598604,0,2,positive regulation of endothelial cell development,BP,
17696,GO:1901555,1,0.98058013405168,0,1,response to paclitaxel,BP,
17697,GO:1901558,1,0.977150839933651,0,1,response to metformin,BP,
17698,GO:1901561,1,0.97801408721604,0,1,response to benomyl,BP,
17699,GO:1901563,1,0.895149043430758,0,5,response to camptothecin,BP,
17703,GO:1901567,1,0.613730044769179,0,21,fatty acid derivative binding,MF,
17705,GO:1901569,1,0.891963728778996,0,5,fatty acid derivative catabolic process,BP,
17707,GO:1901571,1,0.653185208740924,0,19,fatty acid derivative transport,BP,
17710,GO:1901580,1,0.983470795487712,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17711,GO:1901581,1,0.983470795487712,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17712,GO:1901582,1,0.983470795487712,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17713,GO:1901585,1,0.977309833254781,0,1,regulation of acid-sensing ion channel activity,BP,
17714,GO:1901594,1,0.978377862362251,0,1,response to capsazepine,BP,
17717,GO:1901607,1,0.302935244152856,0,53,alpha-amino acid biosynthetic process,BP,
17718,GO:1901611,1,0.816419059231037,0,9,phosphatidylglycerol binding,MF,
17719,GO:1901612,1,0.874443473637097,0,6,cardiolipin binding,MF,
17721,GO:1901616,1,0.436520750188972,0,37,organic hydroxy compound catabolic process,BP,
17723,GO:1901618,1,0.719642814597014,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17724,GO:1901620,1,0.854970176572741,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17725,GO:1901621,1,0.895258920326208,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17726,GO:1901622,1,0.977257204622413,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17728,GO:1901626,1,0.878529759374821,0,6,regulation of postsynaptic membrane organization,BP,
17729,GO:1901628,1,0.936474655426025,0,3,positive regulation of postsynaptic membrane organization,BP,
17730,GO:1901629,1,0.958283414169963,0,2,regulation of presynaptic membrane organization,BP,
17731,GO:1901630,1,0.976504617803502,0,1,negative regulation of presynaptic membrane organization,BP,
17732,GO:1901631,1,0.981342035946395,0,1,positive regulation of presynaptic membrane organization,BP,
17733,GO:1901639,1,0.979903954714144,0,1,XDP catabolic process,BP,
17734,GO:1901640,1,0.979903954714144,0,1,XTP binding,MF,
17735,GO:1901641,1,0.979903954714144,0,1,ITP binding,MF,
17736,GO:1901642,1,0.87103970142498,0,6,nucleoside transmembrane transport,BP,
17741,GO:1901656,1,0.956399970140832,0,2,glycoside transport,BP,
17743,GO:1901658,1,0.53562011334758,0,27,glycosyl compound catabolic process,BP,
17745,GO:1901660,1,0.880168469662554,0,6,calcium ion export,BP,
17747,GO:1901662,1,0.954442056380602,0,2,quinone catabolic process,BP,
17748,GO:1901663,1,0.722872109944903,0,14,quinone biosynthetic process,BP,
17749,GO:1901664,1,0.935056477416925,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17750,GO:1901666,1,0.935056477416925,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
17751,GO:1901668,1,0.932093614999955,0,3,regulation of superoxide dismutase activity,BP,
17752,GO:1901671,1,0.95371179695179,0,2,positive regulation of superoxide dismutase activity,BP,
17753,GO:1901673,1,0.658869598857193,0,19,regulation of mitotic spindle assembly,BP,
17754,GO:1901674,1,0.93725104491053,0,3,regulation of histone H3-K27 acetylation,BP,
17755,GO:1901675,1,0.980395868335849,0,1,negative regulation of histone H3-K27 acetylation,BP,
17756,GO:1901676,1,0.978166067632628,0,1,positive regulation of histone H3-K27 acetylation,BP,
17757,GO:1901678,1,0.816587407970852,0,9,iron coordination entity transport,BP,
17758,GO:1901679,1,0.833066119735849,0,8,nucleotide transmembrane transport,BP,
17759,GO:1901680,1,0.982477643801759,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17761,GO:1901682,1,0.6592654079975,0,19,sulfur compound transmembrane transporter activity,MF,
17762,GO:1901685,1,0.683539317147639,0,16,glutathione derivative metabolic process,BP,
17763,GO:1901687,1,0.683539317147639,0,16,glutathione derivative biosynthetic process,BP,
17768,GO:1901702,1,0.977155194195259,0,1,salt transmembrane transporter activity,MF,
17771,GO:1901723,1,0.892425181686205,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17773,GO:1901725,1,0.861627417879538,0,7,regulation of histone deacetylase activity,BP,
17774,GO:1901726,1,0.98331018341154,0,1,negative regulation of histone deacetylase activity,BP,
17775,GO:1901727,1,0.895630114944967,0,5,positive regulation of histone deacetylase activity,BP,
17776,GO:1901731,1,0.955129878011043,0,2,positive regulation of platelet aggregation,BP,
17777,GO:1901739,1,0.814346955274386,0,9,regulation of myoblast fusion,BP,
17778,GO:1901740,1,0.97718705023542,0,1,negative regulation of myoblast fusion,BP,
17779,GO:1901741,1,0.833371492658403,0,8,positive regulation of myoblast fusion,BP,
17780,GO:1901748,1,0.93329877131748,0,3,leukotriene D4 metabolic process,BP,
17781,GO:1901750,1,0.93329877131748,0,3,leukotriene D4 biosynthetic process,BP,
17782,GO:1901751,1,0.977240944844536,0,1,leukotriene A4 metabolic process,BP,
17786,GO:1901799,1,0.390814968464814,0,42,negative regulation of proteasomal protein catabolic process,BP,
17788,GO:1901804,1,0.977243004293828,0,1,beta-glucoside metabolic process,BP,
17789,GO:1901805,1,0.977243004293828,0,1,beta-glucoside catabolic process,BP,
17790,GO:1901834,1,0.977091738047348,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17791,GO:1901835,1,0.977091738047348,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17792,GO:1901836,1,0.782838907466594,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17793,GO:1901837,1,0.9549210652642,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17794,GO:1901838,1,0.819822613716839,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17795,GO:1901841,1,0.892729237905071,0,5,regulation of high voltage-gated calcium channel activity,BP,
17796,GO:1901842,1,0.954613464106596,0,2,negative regulation of high voltage-gated calcium channel activity,BP,
17797,GO:1901843,1,0.957009077184335,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17798,GO:1901844,1,0.856335214004731,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17799,GO:1901856,1,0.955242566423298,0,2,negative regulation of cellular respiration,BP,
17800,GO:1901857,1,0.889446024668174,0,5,positive regulation of cellular respiration,BP,
17801,GO:1901858,1,0.913627118030177,0,4,regulation of mitochondrial DNA metabolic process,BP,
17802,GO:1901859,1,0.935484840260266,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
17803,GO:1901860,1,0.976640658183698,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
17806,GO:1901863,1,0.411284171467789,0,41,positive regulation of muscle tissue development,BP,
17807,GO:1901873,1,0.958144374078149,0,2,regulation of post-translational protein modification,BP,
17808,GO:1901874,1,0.958144374078149,0,2,negative regulation of post-translational protein modification,BP,
17809,GO:1901879,1,0.310271056104926,0,55,regulation of protein depolymerization,BP,
17810,GO:1901880,1,0.410559734455079,0,42,negative regulation of protein depolymerization,BP,
17811,GO:1901881,1,0.818208554651498,0,9,positive regulation of protein depolymerization,BP,
17813,GO:1901889,1,0.709302561957509,0,16,negative regulation of cell junction assembly,BP,
17814,GO:1901890,1,0.583629355452933,0,25,positive regulation of cell junction assembly,BP,
17816,GO:1901895,1,0.980070334258351,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17818,GO:1901897,1,0.939045955171679,0,3,regulation of relaxation of cardiac muscle,BP,
17819,GO:1901898,1,0.981425242372094,0,1,negative regulation of relaxation of cardiac muscle,BP,
17820,GO:1901906,1,0.91310481226447,0,4,diadenosine pentaphosphate metabolic process,BP,
17821,GO:1901907,1,0.91310481226447,0,4,diadenosine pentaphosphate catabolic process,BP,
17822,GO:1901908,1,0.91310481226447,0,4,diadenosine hexaphosphate metabolic process,BP,
17823,GO:1901909,1,0.91310481226447,0,4,diadenosine hexaphosphate catabolic process,BP,
17824,GO:1901910,1,0.91310481226447,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17825,GO:1901911,1,0.91310481226447,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17826,GO:1901917,1,0.977287315003688,0,1,regulation of exoribonuclease activity,BP,
17827,GO:1901919,1,0.977287315003688,0,1,positive regulation of exoribonuclease activity,BP,
17828,GO:1901950,1,0.977336572808046,0,1,dense core granule transport,BP,
17829,GO:1901962,1,0.977232227459996,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
17830,GO:1901963,1,0.955322806785539,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17831,GO:1901964,1,0.977115191442785,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17832,GO:1901970,1,0.837172119888627,0,8,positive regulation of mitotic sister chromatid separation,BP,
17833,GO:1901976,1,0.508839203502238,0,30,regulation of cell cycle checkpoint,BP,
17834,GO:1901977,1,0.872321021364281,0,6,negative regulation of cell cycle checkpoint,BP,
17835,GO:1901978,1,0.819508150576761,0,9,positive regulation of cell cycle checkpoint,BP,
17836,GO:1901979,1,0.96041822972575,0,2,regulation of inward rectifier potassium channel activity,BP,
17837,GO:1901980,1,0.982757393361554,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17840,GO:1901984,1,0.669139420704064,0,18,negative regulation of protein acetylation,BP,
17847,GO:1901992,1,0.292717243765626,0,55,positive regulation of mitotic cell cycle phase transition,BP,
17848,GO:1901993,1,0.955299046849052,0,2,regulation of meiotic cell cycle phase transition,BP,
17849,GO:1901994,1,0.955299046849052,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17850,GO:1901998,1,0.476410156403212,0,33,toxin transport,BP,
17851,GO:1902001,1,0.72758901830502,0,15,fatty acid transmembrane transport,BP,
17854,GO:1902010,1,0.977755183855241,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17855,GO:1902017,1,0.443766784034993,0,37,regulation of cilium assembly,BP,
17856,GO:1902018,1,0.816473550719613,0,9,negative regulation of cilium assembly,BP,
17857,GO:1902019,1,0.891512466307973,0,5,regulation of cilium-dependent cell motility,BP,
17858,GO:1902022,1,0.936802078360287,0,3,L-lysine transport,BP,
17859,GO:1902023,1,0.918577792101286,0,4,L-arginine transport,BP,
17860,GO:1902031,1,0.872371618515874,0,6,regulation of NADP metabolic process,BP,
17861,GO:1902033,1,0.894203425080729,0,5,regulation of hematopoietic stem cell proliferation,BP,
17862,GO:1902035,1,0.915001286274894,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17864,GO:1902037,1,0.93340674633112,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
17865,GO:1902038,1,0.977714074656462,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17869,GO:1902044,1,0.956497688227655,0,2,regulation of Fas signaling pathway,BP,
17870,GO:1902045,1,0.977240407281889,0,1,negative regulation of Fas signaling pathway,BP,
17871,GO:1902047,1,0.8926407114696,0,5,polyamine transmembrane transport,BP,
17872,GO:1902065,1,0.820508392355271,0,9,response to L-glutamate,BP,
17873,GO:1902071,1,0.976501776607104,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17874,GO:1902073,1,0.976501776607104,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17877,GO:1902083,1,0.902273757859926,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17878,GO:1902093,1,0.931546071743334,0,3,positive regulation of flagellated sperm motility,BP,
17879,GO:1902098,1,0.978890092158254,0,1,calcitriol binding,MF,
17880,GO:1902099,1,0.360770312149504,0,46,regulation of metaphase/anaphase transition of cell cycle,BP,
17881,GO:1902100,1,0.515498628164267,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17882,GO:1902101,1,0.837172119888627,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17883,GO:1902102,1,0.977406519426437,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17884,GO:1902103,1,0.977406519426437,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17888,GO:1902108,1,0.290238269113436,0,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17889,GO:1902109,1,0.932453128467411,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17890,GO:1902110,1,0.311105788644106,0,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17891,GO:1902115,1,0.0434908527971873,0,143,regulation of organelle assembly,BP,
17892,GO:1902116,1,0.513498338963402,0,30,negative regulation of organelle assembly,BP,
17893,GO:1902117,1,0.27915449126733,0,59,positive regulation of organelle assembly,BP,
17894,GO:1902121,1,0.978890092158254,0,1,lithocholic acid binding,MF,
17895,GO:1902145,1,0.977336572808046,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17896,GO:1902151,1,0.977336572808046,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17897,GO:1902153,1,0.977336572808046,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17898,GO:1902162,1,0.953285150425668,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17899,GO:1902164,1,0.953285150425668,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17902,GO:1902167,1,0.975489847893166,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17903,GO:1902170,1,0.767855090471755,0,12,cellular response to reactive nitrogen species,BP,
17904,GO:1902172,1,0.891401061801429,0,5,regulation of keratinocyte apoptotic process,BP,
17905,GO:1902173,1,0.977503996603002,0,1,negative regulation of keratinocyte apoptotic process,BP,
17906,GO:1902174,1,0.954893555246084,0,2,positive regulation of keratinocyte apoptotic process,BP,
17909,GO:1902177,1,0.890921166256358,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17910,GO:1902178,1,0.97852755097097,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
17913,GO:1902188,1,0.712325805058003,0,15,positive regulation of viral release from host cell,BP,
17914,GO:1902202,1,0.955187789080178,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17915,GO:1902205,1,0.977067417464841,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17916,GO:1902206,1,0.977067417464841,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17917,GO:1902211,1,0.977336572808046,0,1,regulation of prolactin signaling pathway,BP,
17918,GO:1902213,1,0.977336572808046,0,1,positive regulation of prolactin signaling pathway,BP,
17919,GO:1902214,1,0.958632780831044,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
17920,GO:1902215,1,0.977067417464841,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17921,GO:1902216,1,0.981134319492779,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17922,GO:1902218,1,0.894061974748761,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17923,GO:1902219,1,0.915695768291045,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17924,GO:1902220,1,0.976382198534325,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17925,GO:1902221,1,0.910032543376827,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17926,GO:1902222,1,0.910032543376827,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17927,GO:1902224,1,0.852128251649692,0,7,ketone body metabolic process,BP,
17928,GO:1902226,1,0.954831773504612,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
17929,GO:1902227,1,0.977067417464841,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17930,GO:1902228,1,0.977244427651838,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
17934,GO:1902232,1,0.954862154310258,0,2,regulation of positive thymic T cell selection,BP,
17935,GO:1902233,1,0.977067417464841,0,1,negative regulation of positive thymic T cell selection,BP,
17936,GO:1902235,1,0.565916038876228,0,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17937,GO:1902236,1,0.744408625712136,0,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17938,GO:1902237,1,0.795385111258661,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17939,GO:1902238,1,0.978431439490802,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17940,GO:1902239,1,0.978431439490802,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17943,GO:1902255,1,0.929173037772381,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17944,GO:1902256,1,0.957450714890542,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17945,GO:1902257,1,0.977714074656462,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17946,GO:1902259,1,0.824783396580839,0,9,regulation of delayed rectifier potassium channel activity,BP,
17947,GO:1902260,1,0.938889780956865,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
17948,GO:1902261,1,0.961566146938095,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17949,GO:1902262,1,0.91311279491154,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
17950,GO:1902263,1,0.938511049940083,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
17951,GO:1902267,1,0.912492617222374,0,4,regulation of polyamine transmembrane transport,BP,
17952,GO:1902268,1,0.954165761722485,0,2,negative regulation of polyamine transmembrane transport,BP,
17953,GO:1902269,1,0.956332576107565,0,2,positive regulation of polyamine transmembrane transport,BP,
17954,GO:1902271,1,0.978890092158254,0,1,D3 vitamins binding,MF,
17956,GO:1902282,1,0.977337432210077,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17957,GO:1902283,1,0.978268115215051,0,1,negative regulation of primary amine oxidase activity,BP,
17958,GO:1902284,1,0.560762678595337,0,28,neuron projection extension involved in neuron projection guidance,BP,
17959,GO:1902285,1,0.785630526250906,0,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
17960,GO:1902287,1,0.802155155012299,0,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,
17961,GO:1902292,1,0.976506036682807,0,1,cell cycle DNA replication initiation,BP,
17962,GO:1902296,1,0.977586273211756,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17963,GO:1902298,1,0.961239894991068,0,2,cell cycle DNA replication maintenance of fidelity,BP,
17964,GO:1902299,1,0.933010252629771,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
17965,GO:1902302,1,0.958522010889218,0,2,regulation of potassium ion export,BP,
17966,GO:1902304,1,0.978946960685112,0,1,positive regulation of potassium ion export,BP,
17967,GO:1902305,1,0.432040131030332,0,39,regulation of sodium ion transmembrane transport,BP,
17968,GO:1902306,1,0.824126985350541,0,9,negative regulation of sodium ion transmembrane transport,BP,
17969,GO:1902307,1,0.757701826769737,0,13,positive regulation of sodium ion transmembrane transport,BP,
17970,GO:1902308,1,0.934849164866677,0,3,regulation of peptidyl-serine dephosphorylation,BP,
17971,GO:1902309,1,0.956623888845485,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
17972,GO:1902310,1,0.977241696721364,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
17973,GO:1902311,1,0.977109179462284,0,1,regulation of copper ion transmembrane transport,BP,
17974,GO:1902315,1,0.976506036682807,0,1,nuclear cell cycle DNA replication initiation,BP,
17975,GO:1902319,1,0.977586273211756,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17976,GO:1902336,1,0.955535542734334,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
17977,GO:1902337,1,0.856314215382094,0,7,regulation of apoptotic process involved in morphogenesis,BP,
17978,GO:1902338,1,0.935544863379541,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17979,GO:1902339,1,0.934706239719594,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
17980,GO:1902356,1,0.977163816563072,0,1,oxaloacetate(2-) transmembrane transport,BP,
17981,GO:1902358,1,0.876724227889668,0,6,sulfate transmembrane transport,BP,
17982,GO:1902359,1,0.955003823448705,0,2,Notch signaling pathway involved in somitogenesis,BP,
17983,GO:1902362,1,0.977301899279593,0,1,melanocyte apoptotic process,BP,
17984,GO:1902363,1,0.980765369020107,0,1,regulation of protein localization to spindle pole body,BP,
17985,GO:1902365,1,0.980765369020107,0,1,positive regulation of protein localization to spindle pole body,BP,
17986,GO:1902366,1,0.955003823448705,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17987,GO:1902367,1,0.955003823448705,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
17990,GO:1902378,1,0.977248066779519,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
17991,GO:1902379,1,0.979762027781853,0,1,chemoattractant activity involved in axon guidance,MF,
17992,GO:1902380,1,0.977244078037487,0,1,positive regulation of endoribonuclease activity,BP,
17993,GO:1902387,1,0.977336572808046,0,1,ceramide 1-phosphate binding,MF,
17994,GO:1902388,1,0.977336572808046,0,1,ceramide 1-phosphate transporter activity,MF,
17995,GO:1902389,1,0.977336572808046,0,1,ceramide 1-phosphate transport,BP,
17996,GO:1902396,1,0.978158235523689,0,1,protein localization to bicellular tight junction,BP,
17997,GO:1902400,1,0.26112444209255,0,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
17998,GO:1902402,1,0.255188601076926,0,61,signal transduction involved in mitotic DNA damage checkpoint,BP,
17999,GO:1902403,1,0.255188601076926,0,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,
18000,GO:1902410,1,0.874359994912116,0,6,mitotic cytokinetic process,BP,
18001,GO:1902412,1,0.939844551723937,0,3,regulation of mitotic cytokinesis,BP,
18002,GO:1902414,1,0.844349905081715,0,8,protein localization to cell junction,BP,
18003,GO:1902415,1,0.815009338862258,0,9,regulation of mRNA binding,BP,
18004,GO:1902416,1,0.85345066698112,0,7,positive regulation of mRNA binding,BP,
18005,GO:1902423,1,0.958158896081552,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
18006,GO:1902425,1,0.958158896081552,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
18007,GO:1902426,1,0.977271761485294,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
18009,GO:1902442,1,0.977992609722739,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
18010,GO:1902443,1,0.977992609722739,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
18011,GO:1902445,1,0.931181941495757,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
18012,GO:1902455,1,0.914622060443816,0,4,negative regulation of stem cell population maintenance,BP,
18013,GO:1902459,1,0.879998507561702,0,6,positive regulation of stem cell population maintenance,BP,
18014,GO:1902460,1,0.978775580097182,0,1,regulation of mesenchymal stem cell proliferation,BP,
18015,GO:1902462,1,0.978775580097182,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
18016,GO:1902463,1,0.954180345483504,0,2,protein localization to cell leading edge,BP,
18017,GO:1902464,1,0.97862774125784,0,1,regulation of histone H3-K27 trimethylation,BP,
18018,GO:1902466,1,0.97862774125784,0,1,positive regulation of histone H3-K27 trimethylation,BP,
18019,GO:1902473,1,0.857799541007667,0,7,regulation of protein localization to synapse,BP,
18020,GO:1902474,1,0.877700897993588,0,6,positive regulation of protein localization to synapse,BP,
18022,GO:1902476,1,0.496394965981884,0,32,chloride transmembrane transport,BP,
18023,GO:1902480,1,0.977244252119362,0,1,protein localization to mitotic spindle,BP,
18024,GO:1902488,1,0.981876921102702,0,1,cholangiocyte apoptotic process,BP,
18028,GO:1902498,1,0.940771342355046,0,3,regulation of protein autoubiquitination,BP,
18029,GO:1902499,1,0.977318107723408,0,1,positive regulation of protein autoubiquitination,BP,
18030,GO:1902504,1,0.977381283509465,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
18031,GO:1902510,1,0.872136394624401,0,6,regulation of apoptotic DNA fragmentation,BP,
18032,GO:1902511,1,0.977278942128016,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18033,GO:1902512,1,0.931224751625484,0,3,positive regulation of apoptotic DNA fragmentation,BP,
18034,GO:1902513,1,0.874314383902226,0,6,regulation of organelle transport along microtubule,BP,
18035,GO:1902514,1,0.861939879133914,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
18036,GO:1902523,1,0.957157609751758,0,2,positive regulation of protein K63-linked ubiquitination,BP,
18037,GO:1902524,1,0.955377877573266,0,2,positive regulation of protein K48-linked ubiquitination,BP,
18038,GO:1902525,1,0.890671162970978,0,5,regulation of protein monoubiquitination,BP,
18039,GO:1902527,1,0.910754225114513,0,4,positive regulation of protein monoubiquitination,BP,
18040,GO:1902528,1,0.981624451753423,0,1,regulation of protein linear polyubiquitination,BP,
18041,GO:1902530,1,0.981624451753423,0,1,positive regulation of protein linear polyubiquitination,BP,
18045,GO:1902544,1,0.954056351208241,0,2,regulation of DNA N-glycosylase activity,BP,
18046,GO:1902546,1,0.975966066517488,0,1,positive regulation of DNA N-glycosylase activity,BP,
18047,GO:1902547,1,0.805551560635944,0,10,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18048,GO:1902548,1,0.915424905654916,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18049,GO:1902554,1,0.176292513008531,0,78,serine/threonine protein kinase complex,CC,
18050,GO:1902555,1,0.515076186531198,0,29,endoribonuclease complex,CC,
18051,GO:1902559,1,0.954936179954223,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
18052,GO:1902560,1,0.977160758322415,0,1,GMP reductase complex,CC,
18053,GO:1902562,1,0.399186559520027,0,41,H4 histone acetyltransferase complex,CC,
18054,GO:1902563,1,0.919903871936858,0,4,regulation of neutrophil activation,BP,
18055,GO:1902564,1,0.960261102122348,0,2,negative regulation of neutrophil activation,BP,
18056,GO:1902565,1,0.978381611755302,0,1,positive regulation of neutrophil activation,BP,
18057,GO:1902566,1,0.954634434731137,0,2,regulation of eosinophil activation,BP,
18058,GO:1902568,1,0.954634434731137,0,2,positive regulation of eosinophil activation,BP,
18059,GO:1902570,1,0.815991561005684,0,9,protein localization to nucleolus,BP,
18060,GO:1902571,1,0.932390583753455,0,3,regulation of serine-type peptidase activity,BP,
18061,GO:1902572,1,0.932390583753455,0,3,negative regulation of serine-type peptidase activity,BP,
18062,GO:1902576,1,0.912650744277959,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
18063,GO:1902579,1,0.218165434015711,0,68,multi-organism localization,BP,
18064,GO:1902581,1,0.89328924386554,0,5,multi-organism cellular localization,BP,
18065,GO:1902583,1,0.89328924386554,0,5,multi-organism intracellular transport,BP,
18066,GO:1902594,1,0.95878695632466,0,2,multi-organism nuclear import,BP,
18067,GO:1902595,1,0.954608404476648,0,2,regulation of DNA replication origin binding,BP,
18068,GO:1902600,1,0.151383447918742,0,82,proton transmembrane transport,BP,
18069,GO:1902603,1,0.933489787659786,0,3,carnitine transmembrane transport,BP,
18070,GO:1902605,1,0.97728553924589,0,1,heterotrimeric G-protein complex assembly,BP,
18071,GO:1902606,1,0.97585624064459,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18072,GO:1902608,1,0.97585624064459,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18073,GO:1902612,1,0.977286802326789,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18074,GO:1902613,1,0.977286802326789,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
18075,GO:1902616,1,0.977156409538995,0,1,acyl carnitine transmembrane transport,BP,
18078,GO:1902622,1,0.616312958629143,0,21,regulation of neutrophil migration,BP,
18079,GO:1902623,1,0.979106290648909,0,1,negative regulation of neutrophil migration,BP,
18080,GO:1902624,1,0.658762434566117,0,18,positive regulation of neutrophil migration,BP,
18081,GO:1902626,1,0.930360507926856,0,3,assembly of large subunit precursor of preribosome,BP,
18082,GO:1902629,1,0.976750064800153,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
18083,GO:1902630,1,0.980600816341379,0,1,regulation of membrane hyperpolarization,BP,
18084,GO:1902631,1,0.980600816341379,0,1,negative regulation of membrane hyperpolarization,BP,
18085,GO:1902636,1,0.953992854931651,0,2,kinociliary basal body,CC,
18088,GO:1902656,1,0.87784916422213,0,6,calcium ion import into cytosol,BP,
18089,GO:1902659,1,0.934532126731027,0,3,regulation of glucose mediated signaling pathway,BP,
18090,GO:1902661,1,0.934532126731027,0,3,positive regulation of glucose mediated signaling pathway,BP,
18091,GO:1902667,1,0.546632595993988,0,29,regulation of axon guidance,BP,
18092,GO:1902668,1,0.666334048162708,0,19,negative regulation of axon guidance,BP,
18093,GO:1902669,1,0.871877609448648,0,7,positive regulation of axon guidance,BP,
18096,GO:1902683,1,0.956228158045622,0,2,regulation of receptor localization to synapse,BP,
18097,GO:1902685,1,0.978504864188684,0,1,positive regulation of receptor localization to synapse,BP,
18098,GO:1902686,1,0.297052371819538,0,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
18099,GO:1902688,1,0.977336572808046,0,1,regulation of NAD metabolic process,BP,
18100,GO:1902689,1,0.977336572808046,0,1,negative regulation of NAD metabolic process,BP,
18101,GO:1902692,1,0.711979976555327,0,16,regulation of neuroblast proliferation,BP,
18102,GO:1902710,1,0.977485040241761,0,1,GABA receptor complex,CC,
18103,GO:1902711,1,0.977485040241761,0,1,GABA-A receptor complex,CC,
18104,GO:1902713,1,0.916099496598316,0,4,regulation of interferon-gamma secretion,BP,
18105,GO:1902714,1,0.955128778201235,0,2,negative regulation of interferon-gamma secretion,BP,
18106,GO:1902715,1,0.959144062225651,0,2,positive regulation of interferon-gamma secretion,BP,
18107,GO:1902722,1,0.933741491765586,0,3,positive regulation of prolactin secretion,BP,
18108,GO:1902723,1,0.977616107347336,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
18109,GO:1902724,1,0.958883219015756,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18110,GO:1902725,1,0.980041499003466,0,1,negative regulation of satellite cell differentiation,BP,
18111,GO:1902728,1,0.958883219015756,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18112,GO:1902730,1,0.934734983011878,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18113,GO:1902731,1,0.963941039849754,0,2,negative regulation of chondrocyte proliferation,BP,
18114,GO:1902732,1,0.97701939608159,0,1,positive regulation of chondrocyte proliferation,BP,
18115,GO:1902737,1,0.97859489893645,0,1,dendritic filopodium,CC,
18116,GO:1902739,1,0.881277794358165,0,6,regulation of interferon-alpha secretion,BP,
18117,GO:1902741,1,0.881277794358165,0,6,positive regulation of interferon-alpha secretion,BP,
18118,GO:1902742,1,0.620076962033804,0,22,apoptotic process involved in development,BP,
18119,GO:1902743,1,0.476931415723238,0,34,regulation of lamellipodium organization,BP,
18120,GO:1902744,1,0.918422820662156,0,4,negative regulation of lamellipodium organization,BP,
18121,GO:1902745,1,0.663951730415448,0,19,positive regulation of lamellipodium organization,BP,
18122,GO:1902746,1,0.977243394693151,0,1,regulation of lens fiber cell differentiation,BP,
18125,GO:1902751,1,0.597501835855319,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18126,GO:1902766,1,0.954408041204571,0,2,skeletal muscle satellite cell migration,BP,
18127,GO:1902767,1,0.977751570891526,0,1,isoprenoid biosynthetic process via mevalonate,BP,
18128,GO:1902769,1,0.983349377140154,0,1,regulation of choline O-acetyltransferase activity,BP,
18129,GO:1902771,1,0.983349377140154,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18130,GO:1902773,1,0.977410587049509,0,1,GTPase activator complex,CC,
18131,GO:1902774,1,0.873543460634224,0,6,late endosome to lysosome transport,BP,
18132,GO:1902775,1,0.937526676568787,0,3,mitochondrial large ribosomal subunit assembly,BP,
18133,GO:1902803,1,0.646708129929696,0,20,regulation of synaptic vesicle transport,BP,
18134,GO:1902804,1,0.934587965598243,0,3,negative regulation of synaptic vesicle transport,BP,
18135,GO:1902805,1,0.959347763915956,0,2,positive regulation of synaptic vesicle transport,BP,
18138,GO:1902808,1,0.514053508457749,0,30,positive regulation of cell cycle G1/S phase transition,BP,
18139,GO:1902809,1,0.934473845041091,0,3,regulation of skeletal muscle fiber differentiation,BP,
18140,GO:1902811,1,0.956151160087025,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
18141,GO:1902816,1,0.914494480004681,0,4,regulation of protein localization to microtubule,BP,
18142,GO:1902817,1,0.914494480004681,0,4,negative regulation of protein localization to microtubule,BP,
18143,GO:1902822,1,0.932634397144905,0,3,regulation of late endosome to lysosome transport,BP,
18144,GO:1902823,1,0.977589454991973,0,1,negative regulation of late endosome to lysosome transport,BP,
18145,GO:1902824,1,0.954018203578744,0,2,positive regulation of late endosome to lysosome transport,BP,
18146,GO:1902838,1,0.979243290333626,0,1,regulation of nuclear migration along microtubule,BP,
18147,GO:1902846,1,0.980765369020107,0,1,positive regulation of mitotic spindle elongation,BP,
18149,GO:1902850,1,0.0689336765556463,0,122,microtubule cytoskeleton organization involved in mitosis,BP,
18150,GO:1902855,1,0.800273700325964,0,10,regulation of non-motile cilium assembly,BP,
18151,GO:1902856,1,0.957602544318966,0,2,negative regulation of non-motile cilium assembly,BP,
18152,GO:1902857,1,0.855197537356237,0,7,positive regulation of non-motile cilium assembly,BP,
18153,GO:1902858,1,0.977223059619356,0,1,propionyl-CoA metabolic process,BP,
18154,GO:1902860,1,0.977223059619356,0,1,propionyl-CoA biosynthetic process,BP,
18155,GO:1902866,1,0.954989419583485,0,2,regulation of retina development in camera-type eye,BP,
18156,GO:1902868,1,0.954989419583485,0,2,positive regulation of retina development in camera-type eye,BP,
18157,GO:1902869,1,0.954989419583485,0,2,regulation of amacrine cell differentiation,BP,
18158,GO:1902871,1,0.954989419583485,0,2,positive regulation of amacrine cell differentiation,BP,
18161,GO:1902884,1,0.763770726221506,0,12,positive regulation of response to oxidative stress,BP,
18162,GO:1902889,1,0.980491792086748,0,1,protein localization to spindle microtubule,BP,
18163,GO:1902890,1,0.97585624064459,0,1,regulation of root hair elongation,BP,
18164,GO:1902891,1,0.97585624064459,0,1,negative regulation of root hair elongation,BP,
18168,GO:1902896,1,0.955951426434509,0,2,terminal web assembly,BP,
18169,GO:1902897,1,0.956434294012045,0,2,regulation of postsynaptic density protein 95 clustering,BP,
18170,GO:1902902,1,0.779271577265404,0,11,negative regulation of autophagosome assembly,BP,
18174,GO:1902908,1,0.978515768926212,0,1,regulation of melanosome transport,BP,
18175,GO:1902910,1,0.978515768926212,0,1,positive regulation of melanosome transport,BP,
18176,GO:1902911,1,0.139657350311799,0,89,protein kinase complex,CC,
18177,GO:1902912,1,0.977336572808046,0,1,pyruvate kinase complex,CC,
18179,GO:1902914,1,0.724406300666285,0,15,regulation of protein polyubiquitination,BP,
18180,GO:1902915,1,0.881522123793306,0,6,negative regulation of protein polyubiquitination,BP,
18181,GO:1902916,1,0.837654529189335,0,8,positive regulation of protein polyubiquitination,BP,
18183,GO:1902931,1,0.851818318705153,0,7,negative regulation of alcohol biosynthetic process,BP,
18184,GO:1902932,1,0.747652489749064,0,13,positive regulation of alcohol biosynthetic process,BP,
18186,GO:1902937,1,0.977225496233081,0,1,inward rectifier potassium channel complex,CC,
18187,GO:1902938,1,0.955132383245231,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
18188,GO:1902939,1,0.977336572808046,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18189,GO:1902941,1,0.978381611755302,0,1,regulation of voltage-gated chloride channel activity,BP,
18190,GO:1902943,1,0.978381611755302,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18191,GO:1902946,1,0.845686373106729,0,8,protein localization to early endosome,BP,
18193,GO:1902948,1,0.983349377140154,0,1,negative regulation of tau-protein kinase activity,BP,
18195,GO:1902950,1,0.872080028646528,0,6,regulation of dendritic spine maintenance,BP,
18196,GO:1902951,1,0.955012349055439,0,2,negative regulation of dendritic spine maintenance,BP,
18197,GO:1902952,1,0.955779547133463,0,2,positive regulation of dendritic spine maintenance,BP,
18198,GO:1902953,1,0.918995580665892,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
18199,GO:1902954,1,0.964711140807524,0,2,regulation of early endosome to recycling endosome transport,BP,
18200,GO:1902955,1,0.983349377140154,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18201,GO:1902956,1,0.932461804328165,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18202,GO:1902957,1,0.97749444321181,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18203,GO:1902958,1,0.953934389544655,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18204,GO:1902959,1,0.842452890408549,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18205,GO:1902960,1,0.960965448079421,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18206,GO:1902961,1,0.876690747543265,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18207,GO:1902962,1,0.961764778252735,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18208,GO:1902963,1,0.961764778252735,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18209,GO:1902965,1,0.883697941650384,0,6,regulation of protein localization to early endosome,BP,
18210,GO:1902966,1,0.883697941650384,0,6,positive regulation of protein localization to early endosome,BP,
18211,GO:1902969,1,0.820294694385657,0,9,mitotic DNA replication,BP,
18212,GO:1902975,1,0.976506036682807,0,1,mitotic DNA replication initiation,BP,
18213,GO:1902977,1,0.977175534560933,0,1,mitotic DNA replication preinitiation complex assembly,BP,
18214,GO:1902983,1,0.977586273211756,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18216,GO:1902990,1,0.935561911980316,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
18220,GO:1902994,1,0.957475468330477,0,2,regulation of phospholipid efflux,BP,
18221,GO:1902995,1,0.957475468330477,0,2,positive regulation of phospholipid efflux,BP,
18223,GO:1902997,1,0.983349377140154,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18225,GO:1903000,1,0.976504617803502,0,1,regulation of lipid transport across blood brain barrier,BP,
18226,GO:1903002,1,0.976504617803502,0,1,positive regulation of lipid transport across blood brain barrier,BP,
18227,GO:1903003,1,0.873508325575573,0,6,positive regulation of protein deubiquitination,BP,
18228,GO:1903004,1,0.978120976366248,0,1,regulation of protein K63-linked deubiquitination,BP,
18229,GO:1903006,1,0.978120976366248,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18230,GO:1903007,1,0.978120976366248,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18232,GO:1903010,1,0.793293512824001,0,11,regulation of bone development,BP,
18233,GO:1903011,1,0.94170900892453,0,3,negative regulation of bone development,BP,
18234,GO:1903012,1,0.913586484145727,0,4,positive regulation of bone development,BP,
18235,GO:1903015,1,0.977179450989824,0,1,regulation of exo-alpha-sialidase activity,BP,
18236,GO:1903016,1,0.977179450989824,0,1,negative regulation of exo-alpha-sialidase activity,BP,
18237,GO:1903018,1,0.490118023108704,0,32,regulation of glycoprotein metabolic process,BP,
18238,GO:1903019,1,0.743491932358127,0,13,negative regulation of glycoprotein metabolic process,BP,
18239,GO:1903020,1,0.703508836999565,0,16,positive regulation of glycoprotein metabolic process,BP,
18242,GO:1903027,1,0.981047362125192,0,1,regulation of opsonization,BP,
18243,GO:1903028,1,0.981047362125192,0,1,positive regulation of opsonization,BP,
18244,GO:1903031,1,0.954936502191712,0,2,regulation of microtubule plus-end binding,BP,
18245,GO:1903033,1,0.954936502191712,0,2,positive regulation of microtubule plus-end binding,BP,
18252,GO:1903044,1,0.833884736969151,0,8,protein localization to membrane raft,BP,
18253,GO:1903045,1,0.979633255010586,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18257,GO:1903051,1,0.300796992385471,0,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
18260,GO:1903054,1,0.89003349390203,0,5,negative regulation of extracellular matrix organization,BP,
18262,GO:1903059,1,0.916691055737004,0,4,regulation of protein lipidation,BP,
18263,GO:1903061,1,0.916691055737004,0,4,positive regulation of protein lipidation,BP,
18264,GO:1903069,1,0.814438072048038,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18265,GO:1903070,1,0.933874936311812,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18266,GO:1903071,1,0.852275629384748,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18267,GO:1903072,1,0.976125001747232,0,1,regulation of death-inducing signaling complex assembly,BP,
18268,GO:1903073,1,0.976125001747232,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18270,GO:1903077,1,0.684493466215541,0,17,negative regulation of protein localization to plasma membrane,BP,
18272,GO:1903093,1,0.934911938765762,0,3,regulation of protein K48-linked deubiquitination,BP,
18273,GO:1903094,1,0.953337709552515,0,2,negative regulation of protein K48-linked deubiquitination,BP,
18274,GO:1903095,1,0.95647790485036,0,2,ribonuclease III complex,CC,
18275,GO:1903096,1,0.977406519426437,0,1,protein localization to meiotic spindle midzone,BP,
18276,GO:1903108,1,0.979208733901174,0,1,regulation of mitochondrial transcription,BP,
18277,GO:1903109,1,0.979208733901174,0,1,positive regulation of mitochondrial transcription,BP,
18278,GO:1903115,1,0.641823817176394,0,21,regulation of actin filament-based movement,BP,
18279,GO:1903116,1,0.957010991329029,0,2,positive regulation of actin filament-based movement,BP,
18280,GO:1903119,1,0.937862691774573,0,3,protein localization to actin cytoskeleton,BP,
18282,GO:1903122,1,0.976125001747232,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18283,GO:1903126,1,0.977222279119496,0,1,negative regulation of centriole-centriole cohesion,BP,
18285,GO:1903135,1,0.933197864689001,0,3,cupric ion binding,MF,
18286,GO:1903136,1,0.892664969257945,0,5,cuprous ion binding,MF,
18287,GO:1903140,1,0.820567365863886,0,9,regulation of establishment of endothelial barrier,BP,
18288,GO:1903141,1,0.978437915425202,0,1,negative regulation of establishment of endothelial barrier,BP,
18289,GO:1903142,1,0.956579484598604,0,2,positive regulation of establishment of endothelial barrier,BP,
18290,GO:1903143,1,0.979123887660731,0,1,adrenomedullin receptor complex,CC,
18292,GO:1903147,1,0.836386369924882,0,8,negative regulation of autophagy of mitochondrion,BP,
18293,GO:1903165,1,0.977274802144166,0,1,response to polycyclic arene,BP,
18294,GO:1903167,1,0.976125001747232,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18295,GO:1903168,1,0.976125001747232,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18297,GO:1903170,1,0.653168726961002,0,19,negative regulation of calcium ion transmembrane transport,BP,
18298,GO:1903173,1,0.955678484358601,0,2,fatty alcohol metabolic process,BP,
18299,GO:1903176,1,0.976125001747232,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18300,GO:1903178,1,0.976125001747232,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18301,GO:1903179,1,0.954247545431864,0,2,regulation of dopamine biosynthetic process,BP,
18302,GO:1903181,1,0.954247545431864,0,2,positive regulation of dopamine biosynthetic process,BP,
18303,GO:1903182,1,0.976536959915807,0,1,regulation of SUMO transferase activity,BP,
18304,GO:1903184,1,0.976125001747232,0,1,L-dopa metabolic process,BP,
18305,GO:1903185,1,0.976125001747232,0,1,L-dopa biosynthetic process,BP,
18306,GO:1903189,1,0.976125001747232,0,1,glyoxal metabolic process,BP,
18307,GO:1903195,1,0.976125001747232,0,1,regulation of L-dopa biosynthetic process,BP,
18308,GO:1903197,1,0.976125001747232,0,1,positive regulation of L-dopa biosynthetic process,BP,
18309,GO:1903198,1,0.976125001747232,0,1,regulation of L-dopa decarboxylase activity,BP,
18310,GO:1903200,1,0.976125001747232,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18313,GO:1903203,1,0.658128388811017,0,19,regulation of oxidative stress-induced neuron death,BP,
18314,GO:1903204,1,0.717879411129859,0,15,negative regulation of oxidative stress-induced neuron death,BP,
18315,GO:1903205,1,0.621893445649812,0,21,regulation of hydrogen peroxide-induced cell death,BP,
18316,GO:1903206,1,0.727173100850403,0,14,negative regulation of hydrogen peroxide-induced cell death,BP,
18317,GO:1903207,1,0.912763994922209,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
18318,GO:1903208,1,0.912763994922209,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
18319,GO:1903209,1,0.78173528287523,0,11,positive regulation of oxidative stress-induced cell death,BP,
18321,GO:1903215,1,0.977228007191649,0,1,negative regulation of protein targeting to mitochondrion,BP,
18322,GO:1903223,1,0.9372579881595,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18323,GO:1903224,1,0.919219885383575,0,4,regulation of endodermal cell differentiation,BP,
18324,GO:1903225,1,0.962638307204396,0,2,negative regulation of endodermal cell differentiation,BP,
18325,GO:1903231,1,0.977373176117378,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18326,GO:1903232,1,0.890175860251301,0,5,melanosome assembly,BP,
18327,GO:1903233,1,0.960968184500113,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18328,GO:1903236,1,0.935676798760353,0,3,regulation of leukocyte tethering or rolling,BP,
18329,GO:1903237,1,0.975918599927231,0,1,negative regulation of leukocyte tethering or rolling,BP,
18330,GO:1903238,1,0.958768906201684,0,2,positive regulation of leukocyte tethering or rolling,BP,
18331,GO:1903242,1,0.881478495938887,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
18332,GO:1903243,1,0.900544356316392,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
18333,GO:1903244,1,0.97883677363974,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18334,GO:1903248,1,0.981915309359245,0,1,regulation of citrulline biosynthetic process,BP,
18335,GO:1903249,1,0.981915309359245,0,1,negative regulation of citrulline biosynthetic process,BP,
18336,GO:1903251,1,0.895351867654542,0,5,multi-ciliated epithelial cell differentiation,BP,
18337,GO:1903259,1,0.977336572808046,0,1,exon-exon junction complex disassembly,BP,
18338,GO:1903265,1,0.831628218552042,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18339,GO:1903276,1,0.954829552662049,0,2,regulation of sodium ion export across plasma membrane,BP,
18340,GO:1903278,1,0.954829552662049,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18341,GO:1903279,1,0.956415007048148,0,2,regulation of calcium:sodium antiporter activity,BP,
18342,GO:1903281,1,0.956415007048148,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18343,GO:1903282,1,0.97749444321181,0,1,regulation of glutathione peroxidase activity,BP,
18344,GO:1903284,1,0.97749444321181,0,1,positive regulation of glutathione peroxidase activity,BP,
18345,GO:1903285,1,0.97749444321181,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18346,GO:1903286,1,0.934905945608737,0,3,regulation of potassium ion import,BP,
18347,GO:1903288,1,0.954829552662049,0,2,positive regulation of potassium ion import,BP,
18348,GO:1903292,1,0.955694315394242,0,2,protein localization to Golgi membrane,BP,
18349,GO:1903293,1,0.357713390951022,0,46,phosphatase complex,CC,
18350,GO:1903294,1,0.957699235379252,0,2,regulation of glutamate secretion, neurotransmission,BP,
18351,GO:1903296,1,0.957699235379252,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18352,GO:1903297,1,0.892303007191534,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18353,GO:1903298,1,0.892303007191534,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18356,GO:1903301,1,0.897934869686975,0,5,positive regulation of hexokinase activity,BP,
18357,GO:1903305,1,0.197850378355453,0,73,regulation of regulated secretory pathway,BP,
18358,GO:1903306,1,0.76873244738399,0,12,negative regulation of regulated secretory pathway,BP,
18359,GO:1903307,1,0.53343574937049,0,28,positive regulation of regulated secretory pathway,BP,
18365,GO:1903319,1,0.751343568863512,0,13,positive regulation of protein maturation,BP,
18368,GO:1903322,1,0.0890022105383975,0,107,positive regulation of protein modification by small protein conjugation or removal,BP,
18370,GO:1903333,1,0.891444325415787,0,5,negative regulation of protein folding,BP,
18371,GO:1903335,1,0.911419555483128,0,4,regulation of vacuolar transport,BP,
18372,GO:1903336,1,0.977589454991973,0,1,negative regulation of vacuolar transport,BP,
18373,GO:1903337,1,0.954018203578744,0,2,positive regulation of vacuolar transport,BP,
18374,GO:1903347,1,0.918411863889816,0,4,negative regulation of bicellular tight junction assembly,BP,
18375,GO:1903348,1,0.935536471377357,0,3,positive regulation of bicellular tight junction assembly,BP,
18376,GO:1903349,1,0.873397473331072,0,6,omegasome membrane,CC,
18379,GO:1903352,1,0.919916503171473,0,4,L-ornithine transmembrane transport,BP,
18380,GO:1903358,1,0.717682277552066,0,15,regulation of Golgi organization,BP,
18381,GO:1903361,1,0.892945304167112,0,5,protein localization to basolateral plasma membrane,BP,
18383,GO:1903363,1,0.239483755330717,0,64,negative regulation of cellular protein catabolic process,BP,
18385,GO:1903365,1,0.935698321092904,0,3,regulation of fear response,BP,
18386,GO:1903367,1,0.977465363898827,0,1,positive regulation of fear response,BP,
18387,GO:1903371,1,0.920776990256763,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18388,GO:1903373,1,0.938486371084044,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
18389,GO:1903375,1,0.957342999018987,0,2,facioacoustic ganglion development,BP,
18390,GO:1903376,1,0.853528321652868,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18391,GO:1903377,1,0.912122236383173,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18392,GO:1903378,1,0.956592835614934,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18393,GO:1903381,1,0.978757578367693,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18394,GO:1903382,1,0.978757578367693,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18395,GO:1903383,1,0.953934389544655,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18396,GO:1903384,1,0.953934389544655,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18397,GO:1903385,1,0.957541725770824,0,2,regulation of homophilic cell adhesion,BP,
18398,GO:1903387,1,0.979342831397086,0,1,positive regulation of homophilic cell adhesion,BP,
18400,GO:1903392,1,0.755912447701561,0,13,negative regulation of adherens junction organization,BP,
18401,GO:1903393,1,0.625960329493951,0,22,positive regulation of adherens junction organization,BP,
18402,GO:1903394,1,0.9772401914015,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
18403,GO:1903400,1,0.940356910136698,0,3,L-arginine transmembrane transport,BP,
18404,GO:1903401,1,0.936802078360287,0,3,L-lysine transmembrane transport,BP,
18405,GO:1903405,1,0.81290561434345,0,9,protein localization to nuclear body,BP,
18406,GO:1903406,1,0.977898356454244,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18407,GO:1903408,1,0.977898356454244,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18409,GO:1903416,1,0.933903844413021,0,3,response to glycoside,BP,
18410,GO:1903420,1,0.980187597468939,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18411,GO:1903421,1,0.755911729799223,0,13,regulation of synaptic vesicle recycling,BP,
18412,GO:1903422,1,0.937552940545662,0,3,negative regulation of synaptic vesicle recycling,BP,
18413,GO:1903423,1,0.898101343578253,0,5,positive regulation of synaptic vesicle recycling,BP,
18415,GO:1903427,1,0.667446018449227,0,18,negative regulation of reactive oxygen species biosynthetic process,BP,
18417,GO:1903429,1,0.718665731702733,0,15,regulation of cell maturation,BP,
18418,GO:1903430,1,0.911956772436403,0,4,negative regulation of cell maturation,BP,
18419,GO:1903431,1,0.86176313943295,0,7,positive regulation of cell maturation,BP,
18420,GO:1903432,1,0.586165649527667,0,24,regulation of TORC1 signaling,BP,
18421,GO:1903433,1,0.95590692671226,0,2,regulation of constitutive secretory pathway,BP,
18422,GO:1903434,1,0.978109197951545,0,1,negative regulation of constitutive secretory pathway,BP,
18423,GO:1903435,1,0.977302692452835,0,1,positive regulation of constitutive secretory pathway,BP,
18424,GO:1903436,1,0.958185378446522,0,2,regulation of mitotic cytokinetic process,BP,
18425,GO:1903438,1,0.958185378446522,0,2,positive regulation of mitotic cytokinetic process,BP,
18426,GO:1903439,1,0.955699375653669,0,2,calcitonin family receptor complex,CC,
18427,GO:1903440,1,0.976077923097182,0,1,amylin receptor complex,CC,
18428,GO:1903441,1,0.854240215035947,0,7,protein localization to ciliary membrane,BP,
18429,GO:1903442,1,0.978077783305344,0,1,response to lipoic acid,BP,
18430,GO:1903444,1,0.977486770047155,0,1,negative regulation of brown fat cell differentiation,BP,
18431,GO:1903445,1,0.932425796689104,0,3,protein transport from ciliary membrane to plasma membrane,BP,
18432,GO:1903450,1,0.98177844622591,0,1,regulation of G1 to G0 transition,BP,
18433,GO:1903452,1,0.98177844622591,0,1,positive regulation of G1 to G0 transition,BP,
18434,GO:1903461,1,0.977452221993755,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18435,GO:1903463,1,0.935977497759918,0,3,regulation of mitotic cell cycle DNA replication,BP,
18436,GO:1903464,1,0.955456861383189,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
18437,GO:1903465,1,0.979615972568209,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
18438,GO:1903487,1,0.955438686107251,0,2,regulation of lactation,BP,
18439,GO:1903489,1,0.977127370618276,0,1,positive regulation of lactation,BP,
18440,GO:1903490,1,0.958185378446522,0,2,positive regulation of mitotic cytokinesis,BP,
18441,GO:1903504,1,0.748719685159375,0,13,regulation of mitotic spindle checkpoint,BP,
18445,GO:1903509,1,0.103156703528003,0,100,liposaccharide metabolic process,BP,
18446,GO:1903510,1,0.179202182508521,0,78,mucopolysaccharide metabolic process,BP,
18447,GO:1903513,1,0.5695280802498,0,25,endoplasmic reticulum to cytosol transport,BP,
18448,GO:1903514,1,0.699425474934336,0,17,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
18449,GO:1903515,1,0.981506086750235,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18450,GO:1903516,1,0.93429561686686,0,3,regulation of single strand break repair,BP,
18451,GO:1903517,1,0.977339164903848,0,1,negative regulation of single strand break repair,BP,
18452,GO:1903518,1,0.95596214232702,0,2,positive regulation of single strand break repair,BP,
18453,GO:1903519,1,0.934706239719594,0,3,regulation of mammary gland involution,BP,
18454,GO:1903521,1,0.934706239719594,0,3,positive regulation of mammary gland involution,BP,
18456,GO:1903523,1,0.69650598199568,0,17,negative regulation of blood circulation,BP,
18458,GO:1903525,1,0.899307319104337,0,5,regulation of membrane tubulation,BP,
18459,GO:1903526,1,0.957007087127971,0,2,negative regulation of membrane tubulation,BP,
18460,GO:1903527,1,0.939717772300706,0,3,positive regulation of membrane tubulation,BP,
18465,GO:1903537,1,0.955066438701796,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18466,GO:1903538,1,0.955066438701796,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
18467,GO:1903539,1,0.816213307917027,0,9,protein localization to postsynaptic membrane,BP,
18468,GO:1903540,1,0.816213307917027,0,9,establishment of protein localization to postsynaptic membrane,BP,
18469,GO:1903541,1,0.727508333343962,0,14,regulation of exosomal secretion,BP,
18470,GO:1903542,1,0.955400541507589,0,2,negative regulation of exosomal secretion,BP,
18471,GO:1903543,1,0.727508333343962,0,14,positive regulation of exosomal secretion,BP,
18472,GO:1903544,1,0.977692160983474,0,1,response to butyrate,BP,
18473,GO:1903545,1,0.977692160983474,0,1,cellular response to butyrate,BP,
18474,GO:1903546,1,0.914649519308792,0,4,protein localization to photoreceptor outer segment,BP,
18475,GO:1903547,1,0.953403083786226,0,2,regulation of growth hormone activity,BP,
18476,GO:1903551,1,0.873187968193896,0,6,regulation of extracellular exosome assembly,BP,
18477,GO:1903553,1,0.914512060038114,0,4,positive regulation of extracellular exosome assembly,BP,
18479,GO:1903556,1,0.542120197550812,0,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
18482,GO:1903564,1,0.920362723593169,0,4,regulation of protein localization to cilium,BP,
18483,GO:1903565,1,0.977679168026864,0,1,negative regulation of protein localization to cilium,BP,
18484,GO:1903566,1,0.941379828660145,0,3,positive regulation of protein localization to cilium,BP,
18485,GO:1903567,1,0.955426405357803,0,2,regulation of protein localization to ciliary membrane,BP,
18486,GO:1903568,1,0.977679168026864,0,1,negative regulation of protein localization to ciliary membrane,BP,
18487,GO:1903569,1,0.977241105829248,0,1,positive regulation of protein localization to ciliary membrane,BP,
18488,GO:1903570,1,0.977783872954728,0,1,regulation of protein kinase D signaling,BP,
18489,GO:1903572,1,0.977783872954728,0,1,positive regulation of protein kinase D signaling,BP,
18491,GO:1903575,1,0.955048146916513,0,2,cornified envelope assembly,BP,
18492,GO:1903576,1,0.977212342356133,0,1,response to L-arginine,BP,
18495,GO:1903580,1,0.618064139418628,0,22,positive regulation of ATP metabolic process,BP,
18496,GO:1903584,1,0.978602910472053,0,1,regulation of histone deubiquitination,BP,
18497,GO:1903586,1,0.978602910472053,0,1,positive regulation of histone deubiquitination,BP,
18498,GO:1903587,1,0.893619570032769,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18499,GO:1903588,1,0.935504305132428,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18500,GO:1903589,1,0.955238604253023,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18501,GO:1903593,1,0.93189675517312,0,3,regulation of histamine secretion by mast cell,BP,
18502,GO:1903595,1,0.93189675517312,0,3,positive regulation of histamine secretion by mast cell,BP,
18503,GO:1903596,1,0.977270366277077,0,1,regulation of gap junction assembly,BP,
18504,GO:1903598,1,0.977270366277077,0,1,positive regulation of gap junction assembly,BP,
18506,GO:1903608,1,0.857706439292802,0,7,protein localization to cytoplasmic stress granule,BP,
18507,GO:1903609,1,0.977270366277077,0,1,negative regulation of inward rectifier potassium channel activity,BP,
18508,GO:1903613,1,0.979394793419172,0,1,regulation of protein tyrosine phosphatase activity,BP,
18509,GO:1903615,1,0.979394793419172,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18510,GO:1903621,1,0.977182733233895,0,1,protein localization to photoreceptor connecting cilium,BP,
18511,GO:1903624,1,0.857686927991557,0,7,regulation of DNA catabolic process,BP,
18512,GO:1903625,1,0.977278942128016,0,1,negative regulation of DNA catabolic process,BP,
18513,GO:1903626,1,0.91580010037158,0,4,positive regulation of DNA catabolic process,BP,
18514,GO:1903630,1,0.976559094427684,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18515,GO:1903632,1,0.976559094427684,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
18516,GO:1903636,1,0.975447519545245,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18517,GO:1903638,1,0.975447519545245,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18519,GO:1903645,1,0.975447519545245,0,1,negative regulation of chaperone-mediated protein folding,BP,
18520,GO:1903649,1,0.657417647482396,0,19,regulation of cytoplasmic transport,BP,
18521,GO:1903650,1,0.952972606437405,0,2,negative regulation of cytoplasmic transport,BP,
18522,GO:1903651,1,0.824878614863623,0,9,positive regulation of cytoplasmic transport,BP,
18523,GO:1903659,1,0.977253118713482,0,1,regulation of complement-dependent cytotoxicity,BP,
18524,GO:1903660,1,0.977253118713482,0,1,negative regulation of complement-dependent cytotoxicity,BP,
18525,GO:1903670,1,0.383096172168888,0,44,regulation of sprouting angiogenesis,BP,
18526,GO:1903671,1,0.6365299600709,0,21,negative regulation of sprouting angiogenesis,BP,
18527,GO:1903672,1,0.602131590681245,0,23,positive regulation of sprouting angiogenesis,BP,
18528,GO:1903673,1,0.977174189107549,0,1,mitotic cleavage furrow formation,BP,
18529,GO:1903674,1,0.977171785634976,0,1,regulation of cap-dependent translational initiation,BP,
18530,GO:1903676,1,0.977171785634976,0,1,positive regulation of cap-dependent translational initiation,BP,
18531,GO:1903677,1,0.933208315211791,0,3,regulation of cap-independent translational initiation,BP,
18532,GO:1903679,1,0.933208315211791,0,3,positive regulation of cap-independent translational initiation,BP,
18533,GO:1903689,1,0.890476558197282,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18534,GO:1903690,1,0.923807699045662,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18535,GO:1903691,1,0.963930420305096,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18536,GO:1903697,1,0.977636758470033,0,1,negative regulation of microvillus assembly,BP,
18537,GO:1903699,1,0.983884367225861,0,1,tarsal gland development,BP,
18538,GO:1903701,1,0.979276497862459,0,1,substantia propria of cornea development,BP,
18539,GO:1903704,1,0.974854758144779,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
18543,GO:1903709,1,0.983884367225861,0,1,uterine gland development,BP,
18544,GO:1903715,1,0.913719155878518,0,4,regulation of aerobic respiration,BP,
18545,GO:1903717,1,0.979699975406857,0,1,response to ammonia,BP,
18546,GO:1903718,1,0.979699975406857,0,1,cellular response to ammonia,BP,
18547,GO:1903719,1,0.932729019102638,0,3,regulation of I-kappaB phosphorylation,BP,
18548,GO:1903721,1,0.932729019102638,0,3,positive regulation of I-kappaB phosphorylation,BP,
18549,GO:1903722,1,0.95426987988979,0,2,regulation of centriole elongation,BP,
18550,GO:1903723,1,0.976076229080863,0,1,negative regulation of centriole elongation,BP,
18551,GO:1903724,1,0.977661182860647,0,1,positive regulation of centriole elongation,BP,
18553,GO:1903726,1,0.832796388848114,0,8,negative regulation of phospholipid metabolic process,BP,
18554,GO:1903727,1,0.574752762151453,0,25,positive regulation of phospholipid metabolic process,BP,
18555,GO:1903729,1,0.820459935054776,0,9,regulation of plasma membrane organization,BP,
18557,GO:1903748,1,0.914669145979534,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18559,GO:1903750,1,0.91163977336809,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18560,GO:1903751,1,0.91163977336809,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18561,GO:1903753,1,0.914642400241233,0,4,negative regulation of p38MAPK cascade,BP,
18562,GO:1903755,1,0.976536959915807,0,1,positive regulation of SUMO transferase activity,BP,
18563,GO:1903756,1,0.956501569031578,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18564,GO:1903758,1,0.956501569031578,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18565,GO:1903759,1,0.977486770047155,0,1,signal transduction involved in regulation of aerobic respiration,BP,
18566,GO:1903760,1,0.957813703590558,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18567,GO:1903762,1,0.97822361693353,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18568,GO:1903763,1,0.91603230927278,0,4,gap junction channel activity involved in cell communication by electrical coupling,MF,
18569,GO:1903764,1,0.979137448691392,0,1,regulation of potassium ion export across plasma membrane,BP,
18570,GO:1903767,1,0.977254532392453,0,1,sweet taste receptor complex,CC,
18571,GO:1903768,1,0.977254532392453,0,1,taste receptor complex,CC,
18572,GO:1903770,1,0.977339164903848,0,1,negative regulation of beta-galactosidase activity,BP,
18573,GO:1903772,1,0.8904593285924,0,5,regulation of viral budding via host ESCRT complex,BP,
18574,GO:1903774,1,0.932995201668712,0,3,positive regulation of viral budding via host ESCRT complex,BP,
18575,GO:1903775,1,0.955383787899417,0,2,regulation of DNA double-strand break processing,BP,
18576,GO:1903778,1,0.957869979253019,0,2,protein localization to vacuolar membrane,BP,
18577,GO:1903779,1,0.43014790541945,0,40,regulation of cardiac conduction,BP,
18578,GO:1903781,1,0.957010991329029,0,2,positive regulation of cardiac conduction,BP,
18579,GO:1903786,1,0.977284794046506,0,1,regulation of glutathione biosynthetic process,BP,
18580,GO:1903788,1,0.977284794046506,0,1,positive regulation of glutathione biosynthetic process,BP,
18582,GO:1903792,1,0.75555273161563,0,13,negative regulation of anion transport,BP,
18583,GO:1903793,1,0.622307766569539,0,21,positive regulation of anion transport,BP,
18584,GO:1903795,1,0.91754048736991,0,4,regulation of inorganic anion transmembrane transport,BP,
18585,GO:1903796,1,0.959622709065141,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18586,GO:1903797,1,0.978381611755302,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18589,GO:1903800,1,0.851657731968431,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18590,GO:1903801,1,0.977234930342947,0,1,L-leucine import across plasma membrane,BP,
18591,GO:1903803,1,0.977176859905498,0,1,L-glutamine import across plasma membrane,BP,
18592,GO:1903817,1,0.91754415647215,0,4,negative regulation of voltage-gated potassium channel activity,BP,
18593,GO:1903818,1,0.94498380686684,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18594,GO:1903823,1,0.977339164903848,0,1,telomere single strand break repair,BP,
18595,GO:1903824,1,0.977339164903848,0,1,negative regulation of telomere single strand break repair,BP,
18597,GO:1903826,1,0.918877124564672,0,4,arginine transmembrane transport,BP,
18601,GO:1903830,1,0.685487917382772,0,17,magnesium ion transmembrane transport,BP,
18603,GO:1903837,1,0.977247286473335,0,1,regulation of mRNA 3'-UTR binding,BP,
18604,GO:1903839,1,0.977247286473335,0,1,positive regulation of mRNA 3'-UTR binding,BP,
18608,GO:1903847,1,0.961174456819424,0,2,regulation of aorta morphogenesis,BP,
18609,GO:1903849,1,0.961174456819424,0,2,positive regulation of aorta morphogenesis,BP,
18610,GO:1903850,1,0.977268667773355,0,1,regulation of cristae formation,BP,
18611,GO:1903852,1,0.977268667773355,0,1,positive regulation of cristae formation,BP,
18612,GO:1903859,1,0.810762615314338,0,10,regulation of dendrite extension,BP,
18613,GO:1903860,1,0.955944514337712,0,2,negative regulation of dendrite extension,BP,
18614,GO:1903861,1,0.848150963650472,0,8,positive regulation of dendrite extension,BP,
18615,GO:1903862,1,0.890903320985536,0,5,positive regulation of oxidative phosphorylation,BP,
18616,GO:1903867,1,0.84044400729239,0,8,extraembryonic membrane development,BP,
18617,GO:1903874,1,0.957735936693075,0,2,ferrous iron transmembrane transport,BP,
18618,GO:1903881,1,0.977967794427033,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18619,GO:1903883,1,0.977967794427033,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18620,GO:1903884,1,0.977967794427033,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18621,GO:1903886,1,0.977967794427033,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18622,GO:1903888,1,0.97585624064459,0,1,regulation of plant epidermal cell differentiation,BP,
18623,GO:1903889,1,0.97585624064459,0,1,negative regulation of plant epidermal cell differentiation,BP,
18624,GO:1903891,1,0.91356357807411,0,4,regulation of ATF6-mediated unfolded protein response,BP,
18625,GO:1903892,1,0.955659090736782,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
18626,GO:1903893,1,0.977249040346596,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
18627,GO:1903894,1,0.746527166163686,0,13,regulation of IRE1-mediated unfolded protein response,BP,
18628,GO:1903895,1,0.913264548422821,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18629,GO:1903896,1,0.856526821391484,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18630,GO:1903897,1,0.818722569345059,0,9,regulation of PERK-mediated unfolded protein response,BP,
18631,GO:1903898,1,0.893428991676366,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18632,GO:1903899,1,0.936829258205008,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
18635,GO:1903902,1,0.319039657364347,0,51,positive regulation of viral life cycle,BP,
18636,GO:1903903,1,0.936889331462972,0,3,regulation of establishment of T cell polarity,BP,
18637,GO:1903905,1,0.958669956614626,0,2,positive regulation of establishment of T cell polarity,BP,
18638,GO:1903906,1,0.977283936514633,0,1,regulation of plasma membrane raft polarization,BP,
18639,GO:1903909,1,0.89835424700048,0,5,regulation of receptor clustering,BP,
18640,GO:1903911,1,0.937170285442738,0,3,positive regulation of receptor clustering,BP,
18641,GO:1903912,1,0.916081368355929,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
18642,GO:1903916,1,0.977241696721364,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18643,GO:1903917,1,0.977241696721364,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18644,GO:1903918,1,0.981006640035432,0,1,regulation of actin filament severing,BP,
18645,GO:1903919,1,0.981006640035432,0,1,negative regulation of actin filament severing,BP,
18646,GO:1903921,1,0.958720440289158,0,2,regulation of protein processing in phagocytic vesicle,BP,
18647,GO:1903923,1,0.958720440289158,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
18648,GO:1903924,1,0.977231897780445,0,1,estradiol binding,MF,
18649,GO:1903925,1,0.977155194195259,0,1,response to bisphenol A,BP,
18650,GO:1903926,1,0.977155194195259,0,1,cellular response to bisphenol A,BP,
18651,GO:1903929,1,0.977492340558073,0,1,primary palate development,BP,
18652,GO:1903935,1,0.871379973172658,0,6,response to sodium arsenite,BP,
18653,GO:1903936,1,0.89113168196245,0,5,cellular response to sodium arsenite,BP,
18654,GO:1903937,1,0.977844744365046,0,1,response to acrylamide,BP,
18655,GO:1903939,1,0.977628451901769,0,1,regulation of TORC2 signaling,BP,
18656,GO:1903943,1,0.97718705023542,0,1,regulation of hepatocyte apoptotic process,BP,
18657,GO:1903944,1,0.97718705023542,0,1,negative regulation of hepatocyte apoptotic process,BP,
18658,GO:1903947,1,0.97822361693353,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18659,GO:1903949,1,0.957010991329029,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18660,GO:1903952,1,0.97822361693353,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18661,GO:1903954,1,0.97822361693353,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18664,GO:1903960,1,0.806347275768945,0,10,negative regulation of anion transmembrane transport,BP,
18665,GO:1903961,1,0.934434670705744,0,3,positive regulation of anion transmembrane transport,BP,
18666,GO:1903963,1,0.764271264677859,0,12,arachidonate transport,BP,
18667,GO:1903964,1,0.957207457166097,0,2,monounsaturated fatty acid metabolic process,BP,
18668,GO:1903966,1,0.957207457166097,0,2,monounsaturated fatty acid biosynthetic process,BP,
18669,GO:1903969,1,0.954831773504612,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18670,GO:1903970,1,0.977067417464841,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18671,GO:1903971,1,0.977244427651838,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18672,GO:1903972,1,0.954831773504612,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18673,GO:1903973,1,0.977067417464841,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18674,GO:1903974,1,0.977244427651838,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18675,GO:1903975,1,0.873933510831086,0,6,regulation of glial cell migration,BP,
18676,GO:1903976,1,0.933187202891252,0,3,negative regulation of glial cell migration,BP,
18677,GO:1903977,1,0.958458562736824,0,2,positive regulation of glial cell migration,BP,
18678,GO:1903978,1,0.919752276964787,0,4,regulation of microglial cell activation,BP,
18679,GO:1903979,1,0.979336650063101,0,1,negative regulation of microglial cell activation,BP,
18680,GO:1903980,1,0.954979706469072,0,2,positive regulation of microglial cell activation,BP,
18682,GO:1903995,1,0.977228058558821,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18683,GO:1903997,1,0.977228058558821,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18684,GO:1903998,1,0.938382565637922,0,3,regulation of eating behavior,BP,
18685,GO:1903999,1,0.955705827877339,0,2,negative regulation of eating behavior,BP,
18686,GO:1904000,1,0.981876921102702,0,1,positive regulation of eating behavior,BP,
18688,GO:1904017,1,0.960951738112299,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18691,GO:1904020,1,0.955718961733806,0,2,regulation of G-protein coupled receptor internalization,BP,
18692,GO:1904021,1,0.977687816756146,0,1,negative regulation of G-protein coupled receptor internalization,BP,
18693,GO:1904022,1,0.977531669431364,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18694,GO:1904023,1,0.977336572808046,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18695,GO:1904024,1,0.977336572808046,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18696,GO:1904026,1,0.955102212504326,0,2,regulation of collagen fibril organization,BP,
18697,GO:1904027,1,0.97725198476669,0,1,negative regulation of collagen fibril organization,BP,
18698,GO:1904028,1,0.977336572808046,0,1,positive regulation of collagen fibril organization,BP,
18701,GO:1904031,1,0.508554669103737,0,30,positive regulation of cyclin-dependent protein kinase activity,BP,
18704,GO:1904037,1,0.674247296594144,0,18,positive regulation of epithelial cell apoptotic process,BP,
18705,GO:1904041,1,0.977587862754326,0,1,regulation of cystathionine beta-synthase activity,BP,
18706,GO:1904042,1,0.977587862754326,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18707,GO:1904044,1,0.932731254709984,0,3,response to aldosterone,BP,
18708,GO:1904045,1,0.977230780265659,0,1,cellular response to aldosterone,BP,
18709,GO:1904046,1,0.95375672446416,0,2,negative regulation of vascular endothelial growth factor production,BP,
18710,GO:1904047,1,0.933408724072715,0,3,S-adenosyl-L-methionine binding,MF,
18711,GO:1904048,1,0.978747259715764,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18712,GO:1904050,1,0.978747259715764,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18713,GO:1904054,1,0.981876921102702,0,1,regulation of cholangiocyte proliferation,BP,
18714,GO:1904056,1,0.981876921102702,0,1,positive regulation of cholangiocyte proliferation,BP,
18715,GO:1904057,1,0.97701229250306,0,1,negative regulation of sensory perception of pain,BP,
18716,GO:1904058,1,0.937513355303408,0,3,positive regulation of sensory perception of pain,BP,
18717,GO:1904059,1,0.985499444207997,0,1,regulation of locomotor rhythm,BP,
18721,GO:1904073,1,0.980806806708981,0,1,regulation of trophectodermal cell proliferation,BP,
18722,GO:1904075,1,0.980806806708981,0,1,positive regulation of trophectodermal cell proliferation,BP,
18723,GO:1904090,1,0.908347757594172,0,4,peptidase inhibitor complex,CC,
18724,GO:1904098,1,0.935002132334975,0,3,regulation of protein O-linked glycosylation,BP,
18725,GO:1904100,1,0.935002132334975,0,3,positive regulation of protein O-linked glycosylation,BP,
18726,GO:1904106,1,0.977340916052496,0,1,protein localization to microvillus,BP,
18728,GO:1904116,1,0.936284429885685,0,3,response to vasopressin,BP,
18729,GO:1904117,1,0.936284429885685,0,3,cellular response to vasopressin,BP,
18730,GO:1904121,1,0.97704900594132,0,1,phosphatidylethanolamine transporter activity,MF,
18731,GO:1904124,1,0.977244427651838,0,1,microglial cell migration,BP,
18732,GO:1904139,1,0.977244427651838,0,1,regulation of microglial cell migration,BP,
18733,GO:1904141,1,0.977244427651838,0,1,positive regulation of microglial cell migration,BP,
18734,GO:1904152,1,0.763071826129671,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18735,GO:1904153,1,0.815697848706197,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18736,GO:1904154,1,0.935531200138421,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
18737,GO:1904155,1,0.977628865784681,0,1,DN2 thymocyte differentiation,BP,
18738,GO:1904156,1,0.977628865784681,0,1,DN3 thymocyte differentiation,BP,
18739,GO:1904167,1,0.983035352101957,0,1,regulation of thyroid hormone receptor activity,BP,
18740,GO:1904168,1,0.983035352101957,0,1,negative regulation of thyroid hormone receptor activity,BP,
18741,GO:1904170,1,0.978947786077945,0,1,regulation of bleb assembly,BP,
18742,GO:1904172,1,0.978947786077945,0,1,positive regulation of bleb assembly,BP,
18743,GO:1904177,1,0.938872468205493,0,3,regulation of adipose tissue development,BP,
18744,GO:1904179,1,0.938872468205493,0,3,positive regulation of adipose tissue development,BP,
18745,GO:1904180,1,0.891862294252583,0,5,negative regulation of membrane depolarization,BP,
18746,GO:1904181,1,0.855395680512817,0,7,positive regulation of membrane depolarization,BP,
18747,GO:1904192,1,0.981876921102702,0,1,regulation of cholangiocyte apoptotic process,BP,
18748,GO:1904193,1,0.981876921102702,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18749,GO:1904195,1,0.981876921102702,0,1,regulation of granulosa cell proliferation,BP,
18750,GO:1904197,1,0.981876921102702,0,1,positive regulation of granulosa cell proliferation,BP,
18751,GO:1904199,1,0.978316932853619,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18752,GO:1904200,1,0.981876921102702,0,1,iodide transmembrane transport,BP,
18753,GO:1904201,1,0.981876921102702,0,1,regulation of iodide transport,BP,
18754,GO:1904202,1,0.981876921102702,0,1,negative regulation of iodide transport,BP,
18755,GO:1904204,1,0.981876921102702,0,1,regulation of skeletal muscle hypertrophy,BP,
18756,GO:1904206,1,0.981876921102702,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18757,GO:1904207,1,0.95528124796075,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18758,GO:1904209,1,0.95528124796075,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18759,GO:1904210,1,0.976773506009764,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18760,GO:1904211,1,0.95671461195575,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18761,GO:1904212,1,0.981876921102702,0,1,regulation of iodide transmembrane transport,BP,
18762,GO:1904213,1,0.981876921102702,0,1,negative regulation of iodide transmembrane transport,BP,
18763,GO:1904217,1,0.933380526092221,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18764,GO:1904219,1,0.933380526092221,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18765,GO:1904220,1,0.91222150680622,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18766,GO:1904222,1,0.933380526092221,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18767,GO:1904226,1,0.977228313431764,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18768,GO:1904227,1,0.977228313431764,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18769,GO:1904229,1,0.980739394112815,0,1,regulation of succinate dehydrogenase activity,BP,
18770,GO:1904231,1,0.980739394112815,0,1,positive regulation of succinate dehydrogenase activity,BP,
18771,GO:1904232,1,0.980739394112815,0,1,regulation of aconitate hydratase activity,BP,
18772,GO:1904234,1,0.980739394112815,0,1,positive regulation of aconitate hydratase activity,BP,
18773,GO:1904235,1,0.981612568936993,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18774,GO:1904237,1,0.981612568936993,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18775,GO:1904238,1,0.937874238034597,0,3,pericyte cell differentiation,BP,
18776,GO:1904239,1,0.976773506009764,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18777,GO:1904240,1,0.976773506009764,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18778,GO:1904245,1,0.955040601457368,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
18779,GO:1904246,1,0.977091738047348,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
18780,GO:1904247,1,0.977433809299614,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18783,GO:1904259,1,0.904969468595843,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18784,GO:1904261,1,0.904969468595843,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18785,GO:1904262,1,0.783162361791789,0,11,negative regulation of TORC1 signaling,BP,
18786,GO:1904263,1,0.835372678319502,0,8,positive regulation of TORC1 signaling,BP,
18787,GO:1904265,1,0.980077723305283,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18788,GO:1904266,1,0.980778347430777,0,1,regulation of Schwann cell chemotaxis,BP,
18789,GO:1904268,1,0.980778347430777,0,1,positive regulation of Schwann cell chemotaxis,BP,
18790,GO:1904271,1,0.977246943874661,0,1,L-proline import across plasma membrane,BP,
18791,GO:1904274,1,0.977231814346738,0,1,tricellular tight junction assembly,BP,
18792,GO:1904282,1,0.977182886223586,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18793,GO:1904283,1,0.977182886223586,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18794,GO:1904288,1,0.917202575477523,0,4,BAT3 complex binding,MF,
18795,GO:1904289,1,0.956594001149948,0,2,regulation of mitotic DNA damage checkpoint,BP,
18796,GO:1904290,1,0.978733464945066,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18797,GO:1904292,1,0.559861934576068,0,26,regulation of ERAD pathway,BP,
18798,GO:1904293,1,0.745702928685626,0,13,negative regulation of ERAD pathway,BP,
18799,GO:1904294,1,0.749947646930748,0,13,positive regulation of ERAD pathway,BP,
18800,GO:1904298,1,0.978381611755302,0,1,regulation of transcytosis,BP,
18801,GO:1904300,1,0.978381611755302,0,1,positive regulation of transcytosis,BP,
18802,GO:1904301,1,0.978381611755302,0,1,regulation of maternal process involved in parturition,BP,
18803,GO:1904303,1,0.978381611755302,0,1,positive regulation of maternal process involved in parturition,BP,
18804,GO:1904304,1,0.954820631577137,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18805,GO:1904306,1,0.954820631577137,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
18806,GO:1904313,1,0.978215840467631,0,1,response to methamphetamine hydrochloride,BP,
18807,GO:1904315,1,0.893684503848103,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18808,GO:1904316,1,0.978381611755302,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18809,GO:1904317,1,0.978381611755302,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18810,GO:1904321,1,0.846182179775713,0,8,response to forskolin,BP,
18811,GO:1904322,1,0.846182179775713,0,8,cellular response to forskolin,BP,
18812,GO:1904327,1,0.958190094972015,0,2,protein localization to cytosolic proteasome complex,BP,
18813,GO:1904328,1,0.977280289452042,0,1,regulation of myofibroblast contraction,BP,
18814,GO:1904338,1,0.878383757232424,0,6,regulation of dopaminergic neuron differentiation,BP,
18815,GO:1904339,1,0.980692433869784,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18816,GO:1904340,1,0.933149487105599,0,3,positive regulation of dopaminergic neuron differentiation,BP,
18817,GO:1904350,1,0.841761547348253,0,8,regulation of protein catabolic process in the vacuole,BP,
18818,GO:1904351,1,0.934550564169193,0,3,negative regulation of protein catabolic process in the vacuole,BP,
18819,GO:1904352,1,0.92171857523239,0,4,positive regulation of protein catabolic process in the vacuole,BP,
18820,GO:1904353,1,0.581020100300403,0,25,regulation of telomere capping,BP,
18821,GO:1904354,1,0.846075307879556,0,8,negative regulation of telomere capping,BP,
18822,GO:1904355,1,0.701309013052274,0,16,positive regulation of telomere capping,BP,
18823,GO:1904356,1,0.278409396420315,0,58,regulation of telomere maintenance via telomere lengthening,BP,
18824,GO:1904357,1,0.570035855104626,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18825,GO:1904358,1,0.458641837520938,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18827,GO:1904376,1,0.654004590778411,0,19,negative regulation of protein localization to cell periphery,BP,
18829,GO:1904378,1,0.937200752883371,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
18830,GO:1904379,1,0.958190094972015,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18831,GO:1904380,1,0.656956008687578,0,19,endoplasmic reticulum mannose trimming,BP,
18832,GO:1904381,1,0.958242820850737,0,2,Golgi apparatus mannose trimming,BP,
18833,GO:1904382,1,0.917488483592293,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18834,GO:1904383,1,0.977225380209976,0,1,response to sodium phosphate,BP,
18835,GO:1904385,1,0.729354317747844,0,14,cellular response to angiotensin,BP,
18836,GO:1904386,1,0.934925171104388,0,3,response to L-phenylalanine derivative,BP,
18837,GO:1904387,1,0.955908231498647,0,2,cellular response to L-phenylalanine derivative,BP,
18838,GO:1904393,1,0.981342035946395,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18839,GO:1904395,1,0.981342035946395,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18840,GO:1904396,1,0.943353944597413,0,3,regulation of neuromuscular junction development,BP,
18841,GO:1904398,1,0.962568097273794,0,2,positive regulation of neuromuscular junction development,BP,
18842,GO:1904404,1,0.980884112301414,0,1,response to formaldehyde,BP,
18843,GO:1904406,1,0.801137481755134,0,10,negative regulation of nitric oxide metabolic process,BP,
18845,GO:1904408,1,0.976451322230561,0,1,melatonin binding,MF,
18846,GO:1904412,1,0.977879752558832,0,1,regulation of cardiac ventricle development,BP,
18847,GO:1904414,1,0.977879752558832,0,1,positive regulation of cardiac ventricle development,BP,
18848,GO:1904415,1,0.873069331873397,0,6,regulation of xenophagy,BP,
18849,GO:1904417,1,0.873069331873397,0,6,positive regulation of xenophagy,BP,
18850,GO:1904424,1,0.823312928100192,0,9,regulation of GTP binding,BP,
18851,GO:1904426,1,0.95789949587029,0,2,positive regulation of GTP binding,BP,
18853,GO:1904428,1,0.94068858104522,0,3,negative regulation of tubulin deacetylation,BP,
18854,GO:1904429,1,0.853527572053804,0,7,regulation of t-circle formation,BP,
18855,GO:1904430,1,0.935269823345483,0,3,negative regulation of t-circle formation,BP,
18856,GO:1904431,1,0.912621348119592,0,4,positive regulation of t-circle formation,BP,
18857,GO:1904432,1,0.953934264174439,0,2,regulation of ferrous iron binding,BP,
18858,GO:1904434,1,0.953934264174439,0,2,positive regulation of ferrous iron binding,BP,
18859,GO:1904435,1,0.953934264174439,0,2,regulation of transferrin receptor binding,BP,
18860,GO:1904437,1,0.953934264174439,0,2,positive regulation of transferrin receptor binding,BP,
18861,GO:1904447,1,0.980244214686269,0,1,folic acid import across plasma membrane,BP,
18862,GO:1904448,1,0.979054784048604,0,1,regulation of aspartate secretion,BP,
18863,GO:1904450,1,0.979054784048604,0,1,positive regulation of aspartate secretion,BP,
18864,GO:1904454,1,0.981296092286635,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18865,GO:1904455,1,0.959602653001688,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18866,GO:1904457,1,0.977243004293828,0,1,positive regulation of neuronal action potential,BP,
18867,GO:1904464,1,0.97708744433209,0,1,regulation of matrix metallopeptidase secretion,BP,
18868,GO:1904465,1,0.97708744433209,0,1,negative regulation of matrix metallopeptidase secretion,BP,
18869,GO:1904467,1,0.809023112645918,0,10,regulation of tumor necrosis factor secretion,BP,
18870,GO:1904468,1,0.935231730305087,0,3,negative regulation of tumor necrosis factor secretion,BP,
18871,GO:1904469,1,0.865082568024783,0,7,positive regulation of tumor necrosis factor secretion,BP,
18872,GO:1904475,1,0.960925722301145,0,2,regulation of Ras GTPase binding,BP,
18873,GO:1904477,1,0.980149299505197,0,1,positive regulation of Ras GTPase binding,BP,
18874,GO:1904481,1,0.977246279505823,0,1,response to tetrahydrofolate,BP,
18875,GO:1904482,1,0.977246279505823,0,1,cellular response to tetrahydrofolate,BP,
18876,GO:1904491,1,0.911604585547268,0,4,protein localization to ciliary transition zone,BP,
18877,GO:1904498,1,0.937862691774573,0,3,protein localization to mitotic actomyosin contractile ring,BP,
18878,GO:1904499,1,0.977699138804462,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18879,GO:1904501,1,0.977699138804462,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18880,GO:1904502,1,0.901931171508907,0,5,regulation of lipophagy,BP,
18881,GO:1904504,1,0.901931171508907,0,5,positive regulation of lipophagy,BP,
18882,GO:1904505,1,0.916763695844501,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18883,GO:1904506,1,0.916763695844501,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18884,GO:1904515,1,0.977628451901769,0,1,positive regulation of TORC2 signaling,BP,
18885,GO:1904526,1,0.81707234042276,0,9,regulation of microtubule binding,BP,
18886,GO:1904527,1,0.935753426671161,0,3,negative regulation of microtubule binding,BP,
18887,GO:1904528,1,0.872952323364286,0,6,positive regulation of microtubule binding,BP,
18888,GO:1904529,1,0.95751870076032,0,2,regulation of actin filament binding,BP,
18889,GO:1904530,1,0.977448028039374,0,1,negative regulation of actin filament binding,BP,
18890,GO:1904531,1,0.979612589015614,0,1,positive regulation of actin filament binding,BP,
18891,GO:1904533,1,0.934925762999356,0,3,regulation of telomeric loop disassembly,BP,
18892,GO:1904534,1,0.95520576961532,0,2,negative regulation of telomeric loop disassembly,BP,
18893,GO:1904535,1,0.978772584715751,0,1,positive regulation of telomeric loop disassembly,BP,
18894,GO:1904542,1,0.977268667773355,0,1,regulation of free ubiquitin chain polymerization,BP,
18895,GO:1904544,1,0.977268667773355,0,1,positive regulation of free ubiquitin chain polymerization,BP,
18896,GO:1904550,1,0.977212161545791,0,1,response to arachidonic acid,BP,
18897,GO:1904555,1,0.977246943874661,0,1,L-proline transmembrane transport,BP,
18898,GO:1904556,1,0.977246943874661,0,1,L-tryptophan transmembrane transport,BP,
18899,GO:1904562,1,0.962212744441446,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18900,GO:1904565,1,0.977465696982126,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18901,GO:1904566,1,0.977465696982126,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18902,GO:1904567,1,0.977394331778874,0,1,response to wortmannin,BP,
18903,GO:1904568,1,0.977394331778874,0,1,cellular response to wortmannin,BP,
18904,GO:1904569,1,0.977090519923487,0,1,regulation of selenocysteine incorporation,BP,
18905,GO:1904570,1,0.977090519923487,0,1,negative regulation of selenocysteine incorporation,BP,
18906,GO:1904572,1,0.977090519923487,0,1,negative regulation of mRNA binding,BP,
18907,GO:1904573,1,0.977090519923487,0,1,regulation of selenocysteine insertion sequence binding,BP,
18908,GO:1904574,1,0.977090519923487,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
18913,GO:1904580,1,0.955006955112332,0,2,regulation of intracellular mRNA localization,BP,
18914,GO:1904582,1,0.955006955112332,0,2,positive regulation of intracellular mRNA localization,BP,
18915,GO:1904585,1,0.977225380209976,0,1,response to putrescine,BP,
18916,GO:1904586,1,0.977225380209976,0,1,cellular response to putrescine,BP,
18917,GO:1904587,1,0.917488483592293,0,4,response to glycoprotein,BP,
18918,GO:1904589,1,0.362051374574156,0,46,regulation of protein import,BP,
18919,GO:1904590,1,0.854102924708167,0,7,negative regulation of protein import,BP,
18920,GO:1904591,1,0.522495878085692,0,30,positive regulation of protein import,BP,
18921,GO:1904594,1,0.98339437073446,0,1,regulation of termination of RNA polymerase II transcription,BP,
18922,GO:1904595,1,0.98339437073446,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18923,GO:1904596,1,0.9767200093547,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18924,GO:1904597,1,0.9767200093547,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18925,GO:1904599,1,0.9767200093547,0,1,advanced glycation end-product binding,MF,
18926,GO:1904603,1,0.9767200093547,0,1,regulation of advanced glycation end-product receptor activity,BP,
18927,GO:1904604,1,0.9767200093547,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
18928,GO:1904612,1,0.958939830843954,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18929,GO:1904613,1,0.958939830843954,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18930,GO:1904616,1,0.95751870076032,0,2,regulation of actin binding,BP,
18931,GO:1904617,1,0.977448028039374,0,1,negative regulation of actin binding,BP,
18932,GO:1904618,1,0.979612589015614,0,1,positive regulation of actin binding,BP,
18933,GO:1904627,1,0.976838372814114,0,1,response to phorbol 13-acetate 12-myristate,BP,
18934,GO:1904628,1,0.976838372814114,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
18935,GO:1904631,1,0.9772332175853,0,1,response to glucoside,BP,
18936,GO:1904636,1,0.934933354289565,0,3,response to ionomycin,BP,
18937,GO:1904637,1,0.934933354289565,0,3,cellular response to ionomycin,BP,
18938,GO:1904645,1,0.653427283393141,0,20,response to amyloid-beta,BP,
18939,GO:1904646,1,0.684293313669057,0,18,cellular response to amyloid-beta,BP,
18940,GO:1904647,1,0.982133495157006,0,1,response to rotenone,BP,
18942,GO:1904666,1,0.657736916257992,0,18,regulation of ubiquitin protein ligase activity,BP,
18943,GO:1904667,1,0.864654261609626,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18944,GO:1904668,1,0.760807212151883,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18945,GO:1904672,1,0.915393140073571,0,4,regulation of somatic stem cell population maintenance,BP,
18946,GO:1904673,1,0.956873162315381,0,2,negative regulation of somatic stem cell population maintenance,BP,
18947,GO:1904674,1,0.956657476687131,0,2,positive regulation of somatic stem cell population maintenance,BP,
18948,GO:1904675,1,0.977356057038789,0,1,regulation of somatic stem cell division,BP,
18949,GO:1904677,1,0.977356057038789,0,1,positive regulation of somatic stem cell division,BP,
18950,GO:1904680,1,0.617100569006658,0,21,peptide transmembrane transporter activity,MF,
18951,GO:1904681,1,0.977274802144166,0,1,response to 3-methylcholanthrene,BP,
18954,GO:1904685,1,0.956803293810726,0,2,positive regulation of metalloendopeptidase activity,BP,
18955,GO:1904688,1,0.89468803848868,0,5,regulation of cytoplasmic translational initiation,BP,
18956,GO:1904689,1,0.976430758027218,0,1,negative regulation of cytoplasmic translational initiation,BP,
18957,GO:1904690,1,0.916291342346697,0,4,positive regulation of cytoplasmic translational initiation,BP,
18958,GO:1904691,1,0.977221745526101,0,1,negative regulation of type B pancreatic cell proliferation,BP,
18959,GO:1904693,1,0.93902472275994,0,3,midbrain morphogenesis,BP,
18960,GO:1904694,1,0.941171706284338,0,3,negative regulation of vascular smooth muscle contraction,BP,
18961,GO:1904695,1,0.977174189107549,0,1,positive regulation of vascular smooth muscle contraction,BP,
18962,GO:1904700,1,0.977259176932945,0,1,granulosa cell apoptotic process,BP,
18963,GO:1904701,1,0.977125613061449,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18964,GO:1904705,1,0.525000852722252,0,29,regulation of vascular smooth muscle cell proliferation,BP,
18965,GO:1904706,1,0.776440219722703,0,11,negative regulation of vascular smooth muscle cell proliferation,BP,
18966,GO:1904707,1,0.660843869739161,0,19,positive regulation of vascular smooth muscle cell proliferation,BP,
18967,GO:1904708,1,0.977259176932945,0,1,regulation of granulosa cell apoptotic process,BP,
18968,GO:1904711,1,0.977125613061449,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18969,GO:1904713,1,0.977336572808046,0,1,beta-catenin destruction complex binding,MF,
18970,GO:1904714,1,0.872499954101632,0,6,regulation of chaperone-mediated autophagy,BP,
18971,GO:1904715,1,0.933433456902337,0,3,negative regulation of chaperone-mediated autophagy,BP,
18972,GO:1904716,1,0.977240998510346,0,1,positive regulation of chaperone-mediated autophagy,BP,
18973,GO:1904717,1,0.958553810284875,0,2,regulation of AMPA glutamate receptor clustering,BP,
18974,GO:1904719,1,0.97724545341032,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
18975,GO:1904720,1,0.955187697930387,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18976,GO:1904721,1,0.977431948995382,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18977,GO:1904722,1,0.977244078037487,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18978,GO:1904723,1,0.977125613061449,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18980,GO:1904732,1,0.957317758586557,0,2,regulation of electron transfer activity,BP,
18981,GO:1904734,1,0.975176901475366,0,1,positive regulation of electron transfer activity,BP,
18982,GO:1904738,1,0.777827048213397,0,12,vascular associated smooth muscle cell migration,BP,
18983,GO:1904742,1,0.918988011202781,0,4,regulation of telomeric DNA binding,BP,
18984,GO:1904743,1,0.963244175343143,0,2,negative regulation of telomeric DNA binding,BP,
18985,GO:1904744,1,0.954061420313975,0,2,positive regulation of telomeric DNA binding,BP,
18986,GO:1904746,1,0.935544863379541,0,3,negative regulation of apoptotic process involved in development,BP,
18987,GO:1904747,1,0.934706239719594,0,3,positive regulation of apoptotic process involved in development,BP,
18988,GO:1904748,1,0.856314215382094,0,7,regulation of apoptotic process involved in development,BP,
18989,GO:1904749,1,0.914023307718323,0,4,regulation of protein localization to nucleolus,BP,
18990,GO:1904750,1,0.980373208015615,0,1,negative regulation of protein localization to nucleolus,BP,
18991,GO:1904751,1,0.932326667171569,0,3,positive regulation of protein localization to nucleolus,BP,
18992,GO:1904752,1,0.777827048213397,0,12,regulation of vascular associated smooth muscle cell migration,BP,
18993,GO:1904753,1,0.933978336616542,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
18994,GO:1904754,1,0.832849755103653,0,9,positive regulation of vascular associated smooth muscle cell migration,BP,
18995,GO:1904760,1,0.937094452026002,0,3,regulation of myofibroblast differentiation,BP,
18996,GO:1904761,1,0.957933981255663,0,2,negative regulation of myofibroblast differentiation,BP,
18997,GO:1904762,1,0.978248817033486,0,1,positive regulation of myofibroblast differentiation,BP,
18998,GO:1904764,1,0.97720549091223,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
18999,GO:1904766,1,0.980550353995309,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
19000,GO:1904768,1,0.955433755107487,0,2,all-trans-retinol binding,MF,
19001,GO:1904772,1,0.977264010199539,0,1,response to tetrachloromethane,BP,
19002,GO:1904776,1,0.877356137178964,0,6,regulation of protein localization to cell cortex,BP,
19003,GO:1904777,1,0.977336572808046,0,1,negative regulation of protein localization to cell cortex,BP,
19004,GO:1904778,1,0.897709472436042,0,5,positive regulation of protein localization to cell cortex,BP,
19005,GO:1904779,1,0.884100259207609,0,6,regulation of protein localization to centrosome,BP,
19006,GO:1904781,1,0.904695315085188,0,5,positive regulation of protein localization to centrosome,BP,
19007,GO:1904782,1,0.979021937244501,0,1,negative regulation of NMDA glutamate receptor activity,BP,
19008,GO:1904783,1,0.95676571026587,0,2,positive regulation of NMDA glutamate receptor activity,BP,
19009,GO:1904784,1,0.979501966862249,0,1,NLRP1 inflammasome complex assembly,BP,
19010,GO:1904790,1,0.977355342295836,0,1,regulation of shelterin complex assembly,BP,
19011,GO:1904792,1,0.977355342295836,0,1,positive regulation of shelterin complex assembly,BP,
19012,GO:1904793,1,0.977699138804462,0,1,regulation of euchromatin binding,BP,
19013,GO:1904796,1,0.894480263249354,0,5,regulation of core promoter binding,BP,
19014,GO:1904797,1,0.979950369533019,0,1,negative regulation of core promoter binding,BP,
19015,GO:1904798,1,0.912787537811912,0,4,positive regulation of core promoter binding,BP,
19016,GO:1904799,1,0.978205132383139,0,1,regulation of neuron remodeling,BP,
19017,GO:1904800,1,0.978205132383139,0,1,negative regulation of neuron remodeling,BP,
19018,GO:1904803,1,0.975489847893166,0,1,regulation of translation involved in cellular response to UV,BP,
19019,GO:1904806,1,0.977336572808046,0,1,regulation of protein oxidation,BP,
19020,GO:1904808,1,0.977336572808046,0,1,positive regulation of protein oxidation,BP,
19021,GO:1904812,1,0.978203670882502,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19022,GO:1904813,1,0.0824325224665659,0,109,ficolin-1-rich granule lumen,CC,
19023,GO:1904814,1,0.7438445429948,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19024,GO:1904815,1,0.955045504400984,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
19025,GO:1904816,1,0.778891354405882,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19026,GO:1904823,1,0.955145538314789,0,2,purine nucleobase transmembrane transport,BP,
19027,GO:1904826,1,0.981066987224602,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19028,GO:1904828,1,0.981066987224602,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19029,GO:1904829,1,0.977093250950237,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19030,GO:1904831,1,0.977093250950237,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
19031,GO:1904833,1,0.95371179695179,0,2,positive regulation of removal of superoxide radicals,BP,
19032,GO:1904835,1,0.977248066779519,0,1,dorsal root ganglion morphogenesis,BP,
19034,GO:1904842,1,0.977225496233081,0,1,response to nitroglycerin,BP,
19035,GO:1904843,1,0.977225496233081,0,1,cellular response to nitroglycerin,BP,
19036,GO:1904844,1,0.953468961072301,0,2,response to L-glutamine,BP,
19037,GO:1904845,1,0.953468961072301,0,2,cellular response to L-glutamine,BP,
19038,GO:1904847,1,0.939397401156289,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
19039,GO:1904849,1,0.960465042210147,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
19040,GO:1904850,1,0.977355342295836,0,1,negative regulation of establishment of protein localization to telomere,BP,
19041,GO:1904851,1,0.812937934558461,0,9,positive regulation of establishment of protein localization to telomere,BP,
19042,GO:1904854,1,0.977509008442652,0,1,proteasome core complex binding,MF,
19043,GO:1904861,1,0.864251995450023,0,7,excitatory synapse assembly,BP,
19044,GO:1904862,1,0.959017242046053,0,2,inhibitory synapse assembly,BP,
19045,GO:1904867,1,0.81290561434345,0,9,protein localization to Cajal body,BP,
19046,GO:1904868,1,0.965284204259488,0,2,telomerase catalytic core complex assembly,BP,
19047,GO:1904869,1,0.831927452072609,0,8,regulation of protein localization to Cajal body,BP,
19048,GO:1904871,1,0.831927452072609,0,8,positive regulation of protein localization to Cajal body,BP,
19049,GO:1904872,1,0.661545061786738,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19050,GO:1904874,1,0.705309870433284,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19051,GO:1904875,1,0.955072712946488,0,2,regulation of DNA ligase activity,BP,
19052,GO:1904876,1,0.977338729997246,0,1,negative regulation of DNA ligase activity,BP,
19053,GO:1904877,1,0.977219646724561,0,1,positive regulation of DNA ligase activity,BP,
19054,GO:1904878,1,0.983015507273046,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19055,GO:1904879,1,0.956161015356669,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19056,GO:1904880,1,0.955032231942858,0,2,response to hydrogen sulfide,BP,
19057,GO:1904881,1,0.977268667773355,0,1,cellular response to hydrogen sulfide,BP,
19058,GO:1904882,1,0.965284204259488,0,2,regulation of telomerase catalytic core complex assembly,BP,
19059,GO:1904884,1,0.965284204259488,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19060,GO:1904885,1,0.900608514704431,0,5,beta-catenin destruction complex assembly,BP,
19061,GO:1904886,1,0.67724836606728,0,18,beta-catenin destruction complex disassembly,BP,
19063,GO:1904889,1,0.977073400793012,0,1,regulation of excitatory synapse assembly,BP,
19064,GO:1904891,1,0.977073400793012,0,1,positive regulation of excitatory synapse assembly,BP,
19068,GO:1904895,1,0.977040650790622,0,1,ESCRT complex assembly,BP,
19069,GO:1904896,1,0.794264273120407,0,10,ESCRT complex disassembly,BP,
19070,GO:1904902,1,0.977040650790622,0,1,ESCRT III complex assembly,BP,
19071,GO:1904903,1,0.794264273120407,0,10,ESCRT III complex disassembly,BP,
19072,GO:1904907,1,0.966213703304616,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19073,GO:1904908,1,0.966213703304616,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19074,GO:1904910,1,0.977355342295836,0,1,regulation of establishment of RNA localization to telomere,BP,
19075,GO:1904911,1,0.977355342295836,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19076,GO:1904913,1,0.977355342295836,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19077,GO:1904914,1,0.977355342295836,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19079,GO:1904924,1,0.977243143114247,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19081,GO:1904928,1,0.962365572809001,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
19082,GO:1904929,1,0.876844692305555,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19083,GO:1904933,1,0.979762027781853,0,1,regulation of cell proliferation in midbrain,BP,
19084,GO:1904934,1,0.979762027781853,0,1,negative regulation of cell proliferation in midbrain,BP,
19085,GO:1904938,1,0.902680026032822,0,5,planar cell polarity pathway involved in axon guidance,BP,
19086,GO:1904947,1,0.977402785868578,0,1,folic acid import into mitochondrion,BP,
19087,GO:1904948,1,0.785361087928891,0,11,midbrain dopaminergic neuron differentiation,BP,
19091,GO:1904953,1,0.839952632072191,0,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19092,GO:1904954,1,0.955105029098352,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19093,GO:1904955,1,0.979762027781853,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19094,GO:1904956,1,0.913244355671121,0,4,regulation of midbrain dopaminergic neuron differentiation,BP,
19095,GO:1904958,1,0.933149487105599,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
19096,GO:1904959,1,0.957317758586557,0,2,regulation of cytochrome-c oxidase activity,BP,
19097,GO:1904960,1,0.975176901475366,0,1,positive regulation of cytochrome-c oxidase activity,BP,
19098,GO:1904970,1,0.977340916052496,0,1,brush border assembly,BP,
19099,GO:1904971,1,0.978813071508849,0,1,regulation of viral translation,BP,
19100,GO:1904973,1,0.978813071508849,0,1,positive regulation of viral translation,BP,
19101,GO:1904975,1,0.957892094247776,0,2,response to bleomycin,BP,
19102,GO:1904976,1,0.957892094247776,0,2,cellular response to bleomycin,BP,
19103,GO:1904977,1,0.977330687541506,0,1,lymphatic endothelial cell migration,BP,
19104,GO:1904978,1,0.938152559279796,0,3,regulation of endosome organization,BP,
19105,GO:1904979,1,0.977232630646704,0,1,negative regulation of endosome organization,BP,
19106,GO:1904980,1,0.98068592548081,0,1,positive regulation of endosome organization,BP,
19107,GO:1904983,1,0.977221338241196,0,1,glycine import into mitochondrion,BP,
19108,GO:1904990,1,0.977245054537837,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19109,GO:1904992,1,0.977245054537837,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19110,GO:1904994,1,0.855271379486741,0,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,
19111,GO:1904995,1,0.953815639227869,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
19112,GO:1904996,1,0.896701543077537,0,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
19113,GO:1904997,1,0.954912370908017,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19114,GO:1904998,1,0.977353684283692,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19115,GO:1904999,1,0.977040650790622,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
19116,GO:1905000,1,0.981712707428526,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19119,GO:1905007,1,0.8975686807705,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19120,GO:1905024,1,0.957813703590558,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19121,GO:1905026,1,0.97822361693353,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19122,GO:1905031,1,0.940295064097275,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19123,GO:1905033,1,0.97822361693353,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19124,GO:1905034,1,0.977352273994558,0,1,regulation of antifungal innate immune response,BP,
19125,GO:1905035,1,0.977352273994558,0,1,negative regulation of antifungal innate immune response,BP,
19126,GO:1905037,1,0.145673565744291,0,87,autophagosome organization,BP,
19127,GO:1905038,1,0.743987465636105,0,13,regulation of membrane lipid metabolic process,BP,
19129,GO:1905040,1,0.977248066779519,0,1,otic placode development,BP,
19130,GO:1905041,1,0.958656116570325,0,2,regulation of epithelium regeneration,BP,
19131,GO:1905042,1,0.977233332492656,0,1,negative regulation of epithelium regeneration,BP,
19132,GO:1905044,1,0.977336572808046,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19133,GO:1905045,1,0.977336572808046,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19136,GO:1905050,1,0.853227572844051,0,7,positive regulation of metallopeptidase activity,BP,
19137,GO:1905051,1,0.953622297107143,0,2,regulation of base-excision repair,BP,
19138,GO:1905053,1,0.953622297107143,0,2,positive regulation of base-excision repair,BP,
19139,GO:1905062,1,0.977277629841002,0,1,positive regulation of cardioblast proliferation,BP,
19140,GO:1905063,1,0.892075427618924,0,5,regulation of vascular smooth muscle cell differentiation,BP,
19141,GO:1905064,1,0.955706593761425,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
19142,GO:1905065,1,0.933430717688382,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
19143,GO:1905066,1,0.954884852394151,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
19144,GO:1905067,1,0.977125613061449,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19145,GO:1905068,1,0.977240541901661,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
19146,GO:1905069,1,0.97827869321164,0,1,allantois development,BP,
19147,GO:1905071,1,0.95810103366194,0,2,occluding junction disassembly,BP,
19148,GO:1905073,1,0.95810103366194,0,2,regulation of occluding junction disassembly,BP,
19149,GO:1905075,1,0.95810103366194,0,2,positive regulation of occluding junction disassembly,BP,
19150,GO:1905076,1,0.977192875115681,0,1,regulation of interleukin-17 secretion,BP,
19151,GO:1905077,1,0.977192875115681,0,1,negative regulation of interleukin-17 secretion,BP,
19152,GO:1905089,1,0.984193312343742,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19153,GO:1905090,1,0.984193312343742,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19154,GO:1905097,1,0.880004387128342,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19155,GO:1905098,1,0.915800238462755,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
19156,GO:1905099,1,0.980149299505197,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19157,GO:1905103,1,0.978251716857322,0,1,integral component of lysosomal membrane,CC,
19159,GO:1905123,1,0.957629760164715,0,2,regulation of glucosylceramidase activity,BP,
19160,GO:1905132,1,0.977406519426437,0,1,regulation of meiotic chromosome separation,BP,
19161,GO:1905133,1,0.977406519426437,0,1,negative regulation of meiotic chromosome separation,BP,
19162,GO:1905143,1,0.976948078006485,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19165,GO:1905146,1,0.823232547220479,0,9,lysosomal protein catabolic process,BP,
19166,GO:1905150,1,0.958893300253294,0,2,regulation of voltage-gated sodium channel activity,BP,
19167,GO:1905152,1,0.979815004509215,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19168,GO:1905153,1,0.880869087272184,0,6,regulation of membrane invagination,BP,
19169,GO:1905154,1,0.97931575040249,0,1,negative regulation of membrane invagination,BP,
19170,GO:1905155,1,0.899481531886757,0,5,positive regulation of membrane invagination,BP,
19171,GO:1905161,1,0.97931575040249,0,1,protein localization to phagocytic vesicle,BP,
19172,GO:1905162,1,0.97931575040249,0,1,regulation of phagosome maturation,BP,
19173,GO:1905165,1,0.88171369083646,0,6,regulation of lysosomal protein catabolic process,BP,
19174,GO:1905166,1,0.934550564169193,0,3,negative regulation of lysosomal protein catabolic process,BP,
19175,GO:1905167,1,0.965450422794792,0,2,positive regulation of lysosomal protein catabolic process,BP,
19176,GO:1905168,1,0.977963425496755,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19177,GO:1905169,1,0.97931575040249,0,1,regulation of protein localization to phagocytic vesicle,BP,
19178,GO:1905171,1,0.97931575040249,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19179,GO:1905172,1,0.978813071508849,0,1,RISC complex binding,MF,
19180,GO:1905174,1,0.954998834942678,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19181,GO:1905176,1,0.97733048160298,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19182,GO:1905202,1,0.955690610524585,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
19183,GO:1905203,1,0.956047651776242,0,2,regulation of connective tissue replacement,BP,
19184,GO:1905204,1,0.9767200093547,0,1,negative regulation of connective tissue replacement,BP,
19185,GO:1905205,1,0.97883677363974,0,1,positive regulation of connective tissue replacement,BP,
19186,GO:1905206,1,0.895602428255456,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
19187,GO:1905207,1,0.531590711263934,0,29,regulation of cardiocyte differentiation,BP,
19188,GO:1905208,1,0.753796046920529,0,13,negative regulation of cardiocyte differentiation,BP,
19189,GO:1905209,1,0.705480156056391,0,16,positive regulation of cardiocyte differentiation,BP,
19190,GO:1905214,1,0.782429214820818,0,11,regulation of RNA binding,BP,
19191,GO:1905215,1,0.977090519923487,0,1,negative regulation of RNA binding,BP,
19192,GO:1905216,1,0.835884516167974,0,8,positive regulation of RNA binding,BP,
19193,GO:1905222,1,0.97747240446093,0,1,atrioventricular canal morphogenesis,BP,
19194,GO:1905223,1,0.980150036483403,0,1,epicardium morphogenesis,BP,
19195,GO:1905224,1,0.958504358353369,0,2,clathrin-coated pit assembly,BP,
19196,GO:1905232,1,0.915918465872609,0,4,cellular response to L-glutamate,BP,
19197,GO:1905242,1,0.977662033732478,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19198,GO:1905244,1,0.840760930922472,0,8,regulation of modification of synaptic structure,BP,
19199,GO:1905245,1,0.842452890408549,0,8,regulation of aspartic-type peptidase activity,BP,
19200,GO:1905246,1,0.960965448079421,0,2,negative regulation of aspartic-type peptidase activity,BP,
19201,GO:1905247,1,0.876690747543265,0,6,positive regulation of aspartic-type peptidase activity,BP,
19202,GO:1905255,1,0.980219963787828,0,1,regulation of RNA binding transcription factor activity,BP,
19203,GO:1905258,1,0.953610601723975,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19204,GO:1905259,1,0.953610601723975,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19205,GO:1905267,1,0.955799861090962,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
19206,GO:1905268,1,0.423644713745063,0,40,negative regulation of chromatin organization,BP,
19208,GO:1905271,1,0.975575624730868,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19209,GO:1905273,1,0.975575624730868,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19210,GO:1905274,1,0.980778347430777,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19212,GO:1905277,1,0.977427947414801,0,1,negative regulation of epithelial tube formation,BP,
19214,GO:1905279,1,0.977336572808046,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19215,GO:1905285,1,0.977879752558832,0,1,fibrous ring of heart morphogenesis,BP,
19216,GO:1905286,1,0.954999374573835,0,2,serine-type peptidase complex,CC,
19217,GO:1905288,1,0.880315927015421,0,6,vascular associated smooth muscle cell apoptotic process,BP,
19218,GO:1905292,1,0.936067872742437,0,3,regulation of neural crest cell differentiation,BP,
19219,GO:1905294,1,0.936067872742437,0,3,positive regulation of neural crest cell differentiation,BP,
19220,GO:1905301,1,0.978747259715764,0,1,regulation of macropinocytosis,BP,
19221,GO:1905302,1,0.978747259715764,0,1,negative regulation of macropinocytosis,BP,
19222,GO:1905304,1,0.981876228906368,0,1,regulation of cardiac myofibril assembly,BP,
19223,GO:1905305,1,0.981876228906368,0,1,negative regulation of cardiac myofibril assembly,BP,
19224,GO:1905309,1,0.982813836561076,0,1,positive regulation of cohesin loading,BP,
19225,GO:1905310,1,0.936067872742437,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19226,GO:1905312,1,0.936067872742437,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19227,GO:1905313,1,0.977229869789122,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19228,GO:1905314,1,0.83206158580559,0,9,semi-lunar valve development,BP,
19229,GO:1905317,1,0.97884689532132,0,1,inferior endocardial cushion morphogenesis,BP,
19230,GO:1905319,1,0.977336572808046,0,1,mesenchymal stem cell migration,BP,
19231,GO:1905320,1,0.977336572808046,0,1,regulation of mesenchymal stem cell migration,BP,
19232,GO:1905322,1,0.977336572808046,0,1,positive regulation of mesenchymal stem cell migration,BP,
19233,GO:1905323,1,0.880753941944579,0,6,telomerase holoenzyme complex assembly,BP,
19235,GO:1905331,1,0.754256677637576,0,13,negative regulation of morphogenesis of an epithelium,BP,
19237,GO:1905333,1,0.953508232449706,0,2,regulation of gastric motility,BP,
19238,GO:1905335,1,0.984968049552094,0,1,regulation of aggrephagy,BP,
19239,GO:1905337,1,0.984968049552094,0,1,positive regulation of aggrephagy,BP,
19240,GO:1905340,1,0.911974846992645,0,4,regulation of protein localization to kinetochore,BP,
19241,GO:1905341,1,0.977271761485294,0,1,negative regulation of protein localization to kinetochore,BP,
19242,GO:1905342,1,0.911974846992645,0,4,positive regulation of protein localization to kinetochore,BP,
19243,GO:1905344,1,0.977336572808046,0,1,prostaglandin catabolic process,BP,
19244,GO:1905348,1,0.515076186531198,0,29,endonuclease complex,CC,
19245,GO:1905349,1,0.976534869380187,0,1,ciliary transition zone assembly,BP,
19246,GO:1905354,1,0.605823635459232,0,22,exoribonuclease complex,CC,
19247,GO:1905355,1,0.979228783404055,0,1,spine apparatus assembly,BP,
19248,GO:1905359,1,0.977406519426437,0,1,protein localization to meiotic spindle,BP,
19249,GO:1905360,1,0.652414086687996,0,19,GTPase complex,CC,
19250,GO:1905365,1,0.977232630646704,0,1,regulation of intralumenal vesicle formation,BP,
19251,GO:1905366,1,0.977232630646704,0,1,negative regulation of intralumenal vesicle formation,BP,
19254,GO:1905370,1,0.977243143114247,0,1,serine-type endopeptidase complex,CC,
19255,GO:1905371,1,0.957351836016142,0,2,ceramide phosphoethanolamine metabolic process,BP,
19256,GO:1905373,1,0.957351836016142,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
19258,GO:1905384,1,0.954945306066908,0,2,regulation of protein localization to presynapse,BP,
19259,GO:1905386,1,0.954945306066908,0,2,positive regulation of protein localization to presynapse,BP,
19260,GO:1905392,1,0.97585624064459,0,1,plant organ morphogenesis,BP,
19261,GO:1905394,1,0.936225736721809,0,3,retromer complex binding,MF,
19262,GO:1905395,1,0.955041284314577,0,2,response to flavonoid,BP,
19263,GO:1905397,1,0.954652108028425,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19264,GO:1905402,1,0.954652108028425,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19265,GO:1905403,1,0.977192875115681,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19266,GO:1905404,1,0.976935120036144,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19267,GO:1905405,1,0.982813836561076,0,1,regulation of mitotic cohesin loading,BP,
19268,GO:1905406,1,0.982813836561076,0,1,positive regulation of mitotic cohesin loading,BP,
19269,GO:1905407,1,0.977582311210414,0,1,regulation of creatine transmembrane transporter activity,BP,
19270,GO:1905408,1,0.977582311210414,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19271,GO:1905419,1,0.977138442822308,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
19272,GO:1905421,1,0.97585624064459,0,1,regulation of plant organ morphogenesis,BP,
19273,GO:1905422,1,0.97585624064459,0,1,negative regulation of plant organ morphogenesis,BP,
19274,GO:1905424,1,0.954998221623838,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19275,GO:1905426,1,0.954998221623838,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19276,GO:1905429,1,0.977213758644807,0,1,response to glycine,BP,
19277,GO:1905430,1,0.977213758644807,0,1,cellular response to glycine,BP,
19278,GO:1905435,1,0.977336572808046,0,1,regulation of histone H3-K4 trimethylation,BP,
19279,GO:1905437,1,0.977336572808046,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19280,GO:1905438,1,0.979762027781853,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19281,GO:1905443,1,0.978704879340009,0,1,regulation of clathrin coat assembly,BP,
19282,GO:1905445,1,0.978704879340009,0,1,positive regulation of clathrin coat assembly,BP,
19283,GO:1905446,1,0.890332456867342,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19284,GO:1905447,1,0.97749444321181,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19285,GO:1905448,1,0.910838496322031,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19286,GO:1905449,1,0.957600949852275,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19287,GO:1905451,1,0.957600949852275,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19290,GO:1905458,1,0.978222645418197,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19291,GO:1905459,1,0.880315927015421,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19292,GO:1905460,1,0.980806806708981,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
19293,GO:1905461,1,0.897549720475435,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
19294,GO:1905462,1,0.958454665881755,0,2,regulation of DNA duplex unwinding,BP,
19295,GO:1905463,1,0.979678259337669,0,1,negative regulation of DNA duplex unwinding,BP,
19296,GO:1905464,1,0.978337815426243,0,1,positive regulation of DNA duplex unwinding,BP,
19297,GO:1905468,1,0.97931575040249,0,1,regulation of clathrin-coated pit assembly,BP,
19298,GO:1905469,1,0.97931575040249,0,1,negative regulation of clathrin-coated pit assembly,BP,
19299,GO:1905474,1,0.976892464585118,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
19301,GO:1905476,1,0.61041557533803,0,22,negative regulation of protein localization to membrane,BP,
19303,GO:1905502,1,0.976522973447213,0,1,acetyl-CoA binding,MF,
19304,GO:1905508,1,0.566832662676296,0,27,protein localization to microtubule organizing center,BP,
19305,GO:1905515,1,0.350649270219407,0,47,non-motile cilium assembly,BP,
19306,GO:1905516,1,0.893992346999507,0,5,positive regulation of fertilization,BP,
19307,GO:1905517,1,0.617822788383649,0,21,macrophage migration,BP,
19308,GO:1905521,1,0.711376299202463,0,15,regulation of macrophage migration,BP,
19309,GO:1905522,1,0.910787272502129,0,4,negative regulation of macrophage migration,BP,
19310,GO:1905523,1,0.835015282378053,0,8,positive regulation of macrophage migration,BP,
19311,GO:1905524,1,0.981115454630038,0,1,negative regulation of protein autoubiquitination,BP,
19312,GO:1905535,1,0.979304890123551,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19313,GO:1905537,1,0.979304890123551,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19314,GO:1905538,1,0.956628046764339,0,2,polysome binding,MF,
19315,GO:1905547,1,0.97701939608159,0,1,regulation of telomeric heterochromatin assembly,BP,
19316,GO:1905549,1,0.97701939608159,0,1,positive regulation of telomeric heterochromatin assembly,BP,
19317,GO:1905550,1,0.954382077493159,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19318,GO:1905552,1,0.954382077493159,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
19319,GO:1905553,1,0.934810390852826,0,3,regulation of blood vessel branching,BP,
19320,GO:1905555,1,0.957098776057585,0,2,positive regulation blood vessel branching,BP,
19321,GO:1905562,1,0.788777862931236,0,11,regulation of vascular endothelial cell proliferation,BP,
19322,GO:1905563,1,0.977150839933651,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19323,GO:1905564,1,0.807237241323555,0,10,positive regulation of vascular endothelial cell proliferation,BP,
19324,GO:1905572,1,0.977314069153504,0,1,ganglioside GM1 transport to membrane,BP,
19325,GO:1905573,1,0.955002510091894,0,2,ganglioside GM1 binding,MF,
19326,GO:1905574,1,0.977314069153504,0,1,ganglioside GM2 binding,MF,
19327,GO:1905575,1,0.977314069153504,0,1,ganglioside GM3 binding,MF,
19328,GO:1905576,1,0.955002510091894,0,2,ganglioside GT1b binding,MF,
19329,GO:1905577,1,0.977314069153504,0,1,ganglioside GP1c binding,MF,
19330,GO:1905578,1,0.977245268219983,0,1,regulation of ERBB3 signaling pathway,BP,
19331,GO:1905580,1,0.977245268219983,0,1,positive regulation of ERBB3 signaling pathway,BP,
19332,GO:1905581,1,0.977019004885083,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19333,GO:1905590,1,0.977468034691993,0,1,fibronectin fibril organization,BP,
19334,GO:1905594,1,0.976451322230561,0,1,resveratrol binding,MF,
19335,GO:1905595,1,0.955423880786512,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19336,GO:1905596,1,0.977898834755835,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19337,GO:1905597,1,0.977019004885083,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19338,GO:1905598,1,0.977898834755835,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19339,GO:1905599,1,0.977019004885083,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
19340,GO:1905600,1,0.933786108484908,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19341,GO:1905601,1,0.977898834755835,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19342,GO:1905602,1,0.95489399880413,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19343,GO:1905606,1,0.935807096786089,0,3,regulation of presynapse assembly,BP,
19344,GO:1905610,1,0.979304890123551,0,1,regulation of mRNA cap binding,BP,
19345,GO:1905612,1,0.979304890123551,0,1,positive regulation of mRNA cap binding,BP,
19346,GO:1905616,1,0.957108759167174,0,2,regulation of miRNA mediated inhibition of translation,BP,
19347,GO:1905618,1,0.957108759167174,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19348,GO:1905634,1,0.881446622990617,0,6,regulation of protein localization to chromatin,BP,
19349,GO:1905636,1,0.976606448497193,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19350,GO:1905642,1,0.977336572808046,0,1,negative regulation of DNA methylation,BP,
19351,GO:1905643,1,0.979857838446937,0,1,positive regulation of DNA methylation,BP,
19352,GO:1905647,1,0.977246943874661,0,1,proline import across plasma membrane,BP,
19353,GO:1905651,1,0.939321142396626,0,3,regulation of artery morphogenesis,BP,
19354,GO:1905653,1,0.939321142396626,0,3,positive regulation of artery morphogenesis,BP,
19355,GO:1905661,1,0.955669428228281,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19356,GO:1905663,1,0.955669428228281,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
19357,GO:1905664,1,0.955012349055439,0,2,regulation of calcium ion import across plasma membrane,BP,
19358,GO:1905666,1,0.824935180167903,0,9,regulation of protein localization to endosome,BP,
19359,GO:1905668,1,0.824935180167903,0,9,positive regulation of protein localization to endosome,BP,
19360,GO:1905671,1,0.934841098666346,0,3,regulation of lysosome organization,BP,
19361,GO:1905672,1,0.977224430389603,0,1,negative regulation of lysosome organization,BP,
19362,GO:1905687,1,0.979710077742808,0,1,regulation of diacylglycerol kinase activity,BP,
19363,GO:1905689,1,0.979710077742808,0,1,positive regulation of diacylglycerol kinase activity,BP,
19364,GO:1905696,1,0.95855481156248,0,2,regulation of polysome binding,BP,
19365,GO:1905698,1,0.978813071508849,0,1,positive regulation of polysome binding,BP,
19366,GO:1905705,1,0.98058013405168,0,1,cellular response to paclitaxel,BP,
19368,GO:1905710,1,0.28389699305663,0,55,positive regulation of membrane permeability,BP,
19369,GO:1905711,1,0.978052764708119,0,1,response to phosphatidylethanolamine,BP,
19370,GO:1905715,1,0.977252924886945,0,1,regulation of cornification,BP,
19371,GO:1905716,1,0.977252924886945,0,1,negative regulation of cornification,BP,
19372,GO:1905719,1,0.95514959246875,0,2,protein localization to perinuclear region of cytoplasm,BP,
19373,GO:1905720,1,0.980765369020107,0,1,cytoplasmic microtubule bundle,CC,
19374,GO:1905764,1,0.936651224036823,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19375,GO:1905765,1,0.936651224036823,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19376,GO:1905767,1,0.980448429378373,0,1,regulation of double-stranded telomeric DNA binding,BP,
19377,GO:1905768,1,0.980448429378373,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19378,GO:1905770,1,0.936029061270108,0,3,regulation of mesodermal cell differentiation,BP,
19379,GO:1905771,1,0.977125613061449,0,1,negative regulation of mesodermal cell differentiation,BP,
19380,GO:1905773,1,0.938112550770681,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19381,GO:1905774,1,0.978337815426243,0,1,regulation of DNA helicase activity,BP,
19382,GO:1905776,1,0.978337815426243,0,1,positive regulation of DNA helicase activity,BP,
19383,GO:1905777,1,0.933506788527541,0,3,regulation of exonuclease activity,BP,
19384,GO:1905778,1,0.95520576961532,0,2,negative regulation of exonuclease activity,BP,
19385,GO:1905779,1,0.977287315003688,0,1,positive regulation of exonuclease activity,BP,
19386,GO:1905793,1,0.962898460955761,0,2,protein localization to pericentriolar material,BP,
19387,GO:1905794,1,0.982781455866292,0,1,response to puromycin,BP,
19388,GO:1905795,1,0.982781455866292,0,1,cellular response to puromycin,BP,
19389,GO:1905799,1,0.975663975657374,0,1,regulation of intraciliary retrograde transport,BP,
19390,GO:1905809,1,0.787548727389175,0,11,negative regulation of synapse organization,BP,
19391,GO:1905818,1,0.309135764404866,0,53,regulation of chromosome separation,BP,
19392,GO:1905819,1,0.50295991035307,0,31,negative regulation of chromosome separation,BP,
19393,GO:1905820,1,0.821058746226826,0,9,positive regulation of chromosome separation,BP,
19394,GO:1905832,1,0.923987201150581,0,4,positive regulation of spindle assembly,BP,
19395,GO:1905838,1,0.95520576961532,0,2,regulation of telomeric D-loop disassembly,BP,
19396,GO:1905839,1,0.95520576961532,0,2,negative regulation of telomeric D-loop disassembly,BP,
19397,GO:1905843,1,0.983440580125596,0,1,regulation of cellular response to gamma radiation,BP,
19398,GO:1905853,1,0.976504617803502,0,1,regulation of heparan sulfate binding,BP,
19399,GO:1905855,1,0.976504617803502,0,1,positive regulation of heparan sulfate binding,BP,
19400,GO:1905858,1,0.976504617803502,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19401,GO:1905860,1,0.976504617803502,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19402,GO:1905863,1,0.960243629152381,0,2,invadopodium organization,BP,
19404,GO:1905874,1,0.956434294012045,0,2,regulation of postsynaptic density organization,BP,
19405,GO:1905878,1,0.982568770098616,0,1,invadopodium disassembly,BP,
19406,GO:1905879,1,0.857501461983603,0,7,regulation of oogenesis,BP,
19407,GO:1905880,1,0.95894964215503,0,2,negative regulation of oogenesis,BP,
19408,GO:1905881,1,0.936306595858639,0,3,positive regulation of oogenesis,BP,
19409,GO:1905890,1,0.976504617803502,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
19416,GO:1905902,1,0.936029061270108,0,3,regulation of mesoderm formation,BP,
19417,GO:1905903,1,0.977125613061449,0,1,negative regulation of mesoderm formation,BP,
19421,GO:1905912,1,0.977144564979688,0,1,regulation of calcium ion export across plasma membrane,BP,
19422,GO:1905913,1,0.977144564979688,0,1,negative regulation of calcium ion export across plasma membrane,BP,
19423,GO:1905918,1,0.977225611664607,0,1,regulation of CoA-transferase activity,BP,
19424,GO:1905920,1,0.977225611664607,0,1,positive regulation of CoA-transferase activity,BP,
19425,GO:1905927,1,0.982568770098616,0,1,regulation of invadopodium disassembly,BP,
19426,GO:1905929,1,0.982568770098616,0,1,positive regulation of invadopodium disassembly,BP,
19427,GO:1905936,1,0.952872377967085,0,2,regulation of germ cell proliferation,BP,
19428,GO:1905937,1,0.976106588627001,0,1,negative regulation of germ cell proliferation,BP,
19429,GO:1905938,1,0.976199190359362,0,1,positive regulation of germ cell proliferation,BP,
19431,GO:1905940,1,0.934216156729937,0,3,negative regulation of gonad development,BP,
19433,GO:1905942,1,0.977245268219983,0,1,regulation of formation of growth cone in injured axon,BP,
19434,GO:1905943,1,0.977245268219983,0,1,negative regulation of formation of growth cone in injured axon,BP,
19435,GO:1905952,1,0.200914232055955,0,73,regulation of lipid localization,BP,
19436,GO:1905953,1,0.581261019451377,0,25,negative regulation of lipid localization,BP,
19437,GO:1905954,1,0.386914142398171,0,43,positive regulation of lipid localization,BP,
19438,GO:1905957,1,0.978577042266034,0,1,regulation of cellular response to alcohol,BP,
19439,GO:1905959,1,0.978577042266034,0,1,positive regulation of cellular response to alcohol,BP,
19440,GO:1905961,1,0.835106253293922,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19442,GO:1990001,1,0.846648863185092,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19443,GO:1990003,1,0.979903954714144,0,1,IDP phosphatase activity,MF,
19444,GO:1990005,1,0.954927018174119,0,2,granular vesicle,CC,
19445,GO:1990008,1,0.977072742778256,0,1,neurosecretory vesicle,CC,
19446,GO:1990009,1,0.979333557504635,0,1,retinal cell apoptotic process,BP,
19447,GO:1990023,1,0.756148397861895,0,13,mitotic spindle midzone,CC,
19448,GO:1990026,1,0.97779490773721,0,1,hippocampal mossy fiber expansion,CC,
19449,GO:1990029,1,0.977490942931953,0,1,vasomotion,BP,
19450,GO:1990031,1,0.977488852731628,0,1,pinceau fiber,CC,
19451,GO:1990032,1,0.978692261125318,0,1,parallel fiber,CC,
19452,GO:1990034,1,0.936393629916181,0,3,calcium ion export across plasma membrane,BP,
19453,GO:1990036,1,0.981506086750235,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19454,GO:1990037,1,0.933037332992932,0,3,Lewy body core,CC,
19455,GO:1990038,1,0.977186615032769,0,1,Lewy body corona,CC,
19456,GO:1990046,1,0.976640658183698,0,1,stress-induced mitochondrial fusion,BP,
19457,GO:1990047,1,0.977236000849141,0,1,spindle matrix,CC,
19458,GO:1990048,1,0.977336572808046,0,1,anterograde neuronal dense core vesicle transport,BP,
19459,GO:1990050,1,0.869643920123129,0,6,phosphatidic acid transporter activity,MF,
19460,GO:1990051,1,0.979612589015614,0,1,activation of protein kinase C activity,BP,
19461,GO:1990070,1,0.975836455221134,0,1,TRAPPI protein complex,CC,
19462,GO:1990071,1,0.956910316717507,0,2,TRAPPII protein complex,CC,
19463,GO:1990072,1,0.953718648645177,0,2,TRAPPIII protein complex,CC,
19464,GO:1990074,1,0.977780665142944,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19465,GO:1990075,1,0.934965609673459,0,3,periciliary membrane compartment,CC,
19466,GO:1990086,1,0.936771921669363,0,3,lens fiber cell apoptotic process,BP,
19469,GO:1990108,1,0.959505397400286,0,2,protein linear deubiquitination,BP,
19470,GO:1990111,1,0.91291348220395,0,4,spermatoproteasome complex,CC,
19471,GO:1990112,1,0.955184890372083,0,2,RQC complex,CC,
19472,GO:1990116,1,0.955184890372083,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19473,GO:1990117,1,0.975913291000001,0,1,B cell receptor apoptotic signaling pathway,BP,
19474,GO:1990124,1,0.860990776805059,0,7,messenger ribonucleoprotein complex,CC,
19475,GO:1990126,1,0.701299829034767,0,16,retrograde transport, endosome to plasma membrane,BP,
19476,GO:1990127,1,0.978431439490802,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19477,GO:1990130,1,0.893023941756179,0,5,GATOR1 complex,CC,
19478,GO:1990131,1,0.932643822449317,0,3,Gtr1-Gtr2 GTPase complex,CC,
19479,GO:1990134,1,0.97915217069862,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19480,GO:1990136,1,0.97725015781072,0,1,linoleate 9S-lipoxygenase activity,MF,
19482,GO:1990144,1,0.871709239454476,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19483,GO:1990145,1,0.955680233818743,0,2,maintenance of translational fidelity,BP,
19484,GO:1990164,1,0.955266406481579,0,2,histone H2A phosphorylation,BP,
19485,GO:1990165,1,0.977202658023853,0,1,single-strand break-containing DNA binding,MF,
19486,GO:1990166,1,0.933441851551568,0,3,protein localization to site of double-strand break,BP,
19487,GO:1990167,1,0.93868132625651,0,3,protein K27-linked deubiquitination,BP,
19488,GO:1990168,1,0.93754825946885,0,3,protein K33-linked deubiquitination,BP,
19489,GO:1990169,1,0.888728432908975,0,5,stress response to copper ion,BP,
19491,GO:1990172,1,0.979791139459405,0,1,G-protein coupled receptor catabolic process,BP,
19492,GO:1990173,1,0.795981624862228,0,10,protein localization to nucleoplasm,BP,
19493,GO:1990174,1,0.978106252905452,0,1,phosphodiesterase decapping endonuclease activity,MF,
19494,GO:1990175,1,0.978179760085014,0,1,EH domain binding,MF,
19495,GO:1990179,1,0.937862691774573,0,3,protein localization to actomyosin contractile ring,BP,
19496,GO:1990180,1,0.932307531490772,0,3,mitochondrial tRNA 3'-end processing,BP,
19497,GO:1990182,1,0.678694476811109,0,17,exosomal secretion,BP,
19498,GO:1990188,1,0.97726281457492,0,1,euchromatin binding,MF,
19499,GO:1990189,1,0.954201465212538,0,2,peptide-serine-N-acetyltransferase activity,MF,
19500,GO:1990190,1,0.976043880359759,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
19501,GO:1990204,1,0.123638363118193,0,89,oxidoreductase complex,CC,
19502,GO:1990226,1,0.892217722348659,0,5,histone methyltransferase binding,MF,
19504,GO:1990239,1,0.915088481493879,0,4,steroid hormone binding,MF,
19505,GO:1990246,1,0.912370967001907,0,4,uniplex complex,CC,
19506,GO:1990247,1,0.859066538159595,0,7,N6-methyladenosine-containing RNA binding,MF,
19507,GO:1990253,1,0.821229661459893,0,9,cellular response to leucine starvation,BP,
19508,GO:1990254,1,0.91477207001216,0,4,keratin filament binding,MF,
19509,GO:1990256,1,0.983903499842992,0,1,signal clustering,BP,
19510,GO:1990258,1,0.976490366137579,0,1,histone glutamine methylation,BP,
19511,GO:1990259,1,0.976490366137579,0,1,histone-glutamine methyltransferase activity,MF,
19512,GO:1990261,1,0.977336572808046,0,1,pre-mRNA catabolic process,BP,
19513,GO:1990262,1,0.977286802326789,0,1,anti-Mullerian hormone signaling pathway,BP,
19514,GO:1990264,1,0.955350002403047,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
19515,GO:1990266,1,0.374419462694775,0,43,neutrophil migration,BP,
19516,GO:1990269,1,0.956844860505311,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19517,GO:1990275,1,0.977333391481175,0,1,preribosome binding,MF,
19518,GO:1990280,1,0.980491792086748,0,1,RNA localization to chromatin,BP,
19519,GO:1990298,1,0.977224850709475,0,1,bub1-bub3 complex,CC,
19520,GO:1990314,1,0.844084884546271,0,8,cellular response to insulin-like growth factor stimulus,BP,
19521,GO:1990316,1,0.843101174507049,0,8,Atg1/ULK1 kinase complex,CC,
19522,GO:1990332,1,0.978268115215051,0,1,Ire1 complex,CC,
19524,GO:1990356,1,0.976536959915807,0,1,sumoylated E2 ligase complex,CC,
19525,GO:1990357,1,0.933555075099222,0,3,terminal web,CC,
19527,GO:1990380,1,0.833165041511227,0,9,Lys48-specific deubiquitinase activity,MF,
19528,GO:1990381,1,0.751112162780355,0,13,ubiquitin-specific protease binding,MF,
19529,GO:1990384,1,0.976641957177529,0,1,hyaloid vascular plexus regression,BP,
19530,GO:1990386,1,0.977192073118987,0,1,mitotic cleavage furrow ingression,BP,
19531,GO:1990390,1,0.977737190205982,0,1,protein K33-linked ubiquitination,BP,
19533,GO:1990393,1,0.897478614652551,0,5,3M complex,CC,
19534,GO:1990399,1,0.958656116570325,0,2,epithelium regeneration,BP,
19535,GO:1990401,1,0.977293524652512,0,1,embryonic lung development,BP,
19536,GO:1990402,1,0.977229869789122,0,1,embryonic liver development,BP,
19537,GO:1990403,1,0.838440855554667,0,8,embryonic brain development,BP,
19538,GO:1990404,1,0.955902809568939,0,2,protein ADP-ribosylase activity,MF,
19539,GO:1990405,1,0.921330599048488,0,4,protein antigen binding,MF,
19540,GO:1990406,1,0.955699375653669,0,2,CGRP receptor complex,CC,
19541,GO:1990407,1,0.976077923097182,0,1,calcitonin gene-related peptide binding,MF,
19542,GO:1990408,1,0.955699375653669,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
19543,GO:1990409,1,0.979123887660731,0,1,adrenomedullin binding,MF,
19544,GO:1990410,1,0.956448217153359,0,2,adrenomedullin receptor signaling pathway,BP,
19545,GO:1990414,1,0.917856177687468,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19546,GO:1990415,1,0.934637128320792,0,3,Pex17p-Pex14p docking complex,CC,
19547,GO:1990416,1,0.879795076628105,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19548,GO:1990418,1,0.954969135710002,0,2,response to insulin-like growth factor stimulus,BP,
19549,GO:1990421,1,0.983470795487712,0,1,subtelomeric heterochromatin,CC,
19550,GO:1990423,1,0.936883708829471,0,3,RZZ complex,CC,
19551,GO:1990425,1,0.944498910415918,0,3,ryanodine receptor complex,CC,
19552,GO:1990426,1,0.961239894991068,0,2,mitotic recombination-dependent replication fork processing,BP,
19553,GO:1990428,1,0.957255307056634,0,2,miRNA transport,BP,
19554,GO:1990429,1,0.934637128320792,0,3,peroxisomal importomer complex,CC,
19555,GO:1990430,1,0.96280966743713,0,2,extracellular matrix protein binding,MF,
19557,GO:1990440,1,0.813676477099316,0,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19558,GO:1990441,1,0.91246682228257,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19559,GO:1990442,1,0.930799078848477,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
19560,GO:1990446,1,0.911047694733483,0,4,U1 snRNP binding,MF,
19561,GO:1990448,1,0.980341014091011,0,1,exon-exon junction complex binding,MF,
19562,GO:1990450,1,0.977215948449627,0,1,linear polyubiquitin binding,MF,
19563,GO:1990452,1,0.956020574024957,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19564,GO:1990454,1,0.93525960022083,0,3,L-type voltage-gated calcium channel complex,CC,
19565,GO:1990456,1,0.978087599727129,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19566,GO:1990459,1,0.874483967508364,0,6,transferrin receptor binding,MF,
19567,GO:1990460,1,0.937209363759353,0,3,leptin receptor binding,MF,
19568,GO:1990462,1,0.853891952106853,0,7,omegasome,CC,
19569,GO:1990481,1,0.912170129242083,0,4,mRNA pseudouridine synthesis,BP,
19570,GO:1990498,1,0.9626018999753,0,2,mitotic spindle microtubule,CC,
19571,GO:1990502,1,0.979945174734083,0,1,dense core granule maturation,BP,
19572,GO:1990504,1,0.939545582871523,0,3,dense core granule exocytosis,BP,
19573,GO:1990505,1,0.961239894991068,0,2,mitotic DNA replication maintenance of fidelity,BP,
19574,GO:1990511,1,0.914870040781833,0,4,piRNA biosynthetic process,BP,
19575,GO:1990518,1,0.978813071508849,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19576,GO:1990519,1,0.956188464797075,0,2,pyrimidine nucleotide import into mitochondrion,BP,
19577,GO:1990523,1,0.977536889157831,0,1,bone regeneration,BP,
19578,GO:1990535,1,0.919575918198967,0,4,neuron projection maintenance,BP,
19579,GO:1990542,1,0.21636290451965,0,67,mitochondrial transmembrane transport,BP,
19580,GO:1990546,1,0.976991038494323,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
19581,GO:1990564,1,0.890140017501162,0,5,protein polyufmylation,BP,
19582,GO:1990565,1,0.977046486326053,0,1,HSP90-CDC37 chaperone complex,CC,
19583,GO:1990569,1,0.958153794208925,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
19584,GO:1990570,1,0.977336572808046,0,1,GDP-mannose transmembrane transport,BP,
19585,GO:1990572,1,0.974854758144779,0,1,TERT-RMRP complex,CC,
19586,GO:1990573,1,0.934007843577371,0,3,potassium ion import across plasma membrane,BP,
19587,GO:1990575,1,0.956001891906948,0,2,mitochondrial L-ornithine transmembrane transport,BP,
19589,GO:1990579,1,0.978268115215051,0,1,peptidyl-serine trans-autophosphorylation,BP,
19590,GO:1990583,1,0.977192073118987,0,1,phospholipase D activator activity,MF,
19591,GO:1990589,1,0.960023133286639,0,2,ATF4-CREB1 transcription factor complex,CC,
19592,GO:1990590,1,0.954841136726314,0,2,ATF1-ATF4 transcription factor complex,CC,
19593,GO:1990592,1,0.890140017501162,0,5,protein K69-linked ufmylation,BP,
19594,GO:1990597,1,0.935623580911799,0,3,AIP1-IRE1 complex,CC,
19595,GO:1990599,1,0.936651224036823,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
19596,GO:1990603,1,0.977587862754326,0,1,dark adaptation,BP,
19597,GO:1990604,1,0.93619820512851,0,3,IRE1-TRAF2-ASK1 complex,CC,
19598,GO:1990613,1,0.97778708562591,0,1,mitochondrial membrane fusion,BP,
19599,GO:1990617,1,0.953705595488797,0,2,CHOP-ATF4 complex,CC,
19600,GO:1990619,1,0.955614941195307,0,2,histone H3-K9 deacetylation,BP,
19601,GO:1990622,1,0.95383388588254,0,2,CHOP-ATF3 complex,CC,
19602,GO:1990630,1,0.978268115215051,0,1,IRE1-RACK1-PP2A complex,CC,
19603,GO:1990635,1,0.916531734785535,0,4,proximal dendrite,CC,
19604,GO:1990637,1,0.936762663903449,0,3,response to prolactin,BP,
19605,GO:1990641,1,0.956347601527246,0,2,response to iron ion starvation,BP,
19606,GO:1990646,1,0.977394331778874,0,1,cellular response to prolactin,BP,
19607,GO:1990654,1,0.979055188315136,0,1,sebum secreting cell proliferation,BP,
19608,GO:1990666,1,0.957690487444256,0,2,PCSK9-LDLR complex,CC,
19609,GO:1990667,1,0.955423880786512,0,2,PCSK9-AnxA2 complex,CC,
19610,GO:1990668,1,0.871893363093878,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19611,GO:1990682,1,0.977244427651838,0,1,CSF1-CSF1R complex,CC,
19612,GO:1990698,1,0.955818356303744,0,2,palmitoleoyltransferase activity,MF,
19613,GO:1990700,1,0.978192456350214,0,1,nucleolar chromatin organization,BP,
19614,GO:1990705,1,0.981876921102702,0,1,cholangiocyte proliferation,BP,
19615,GO:1990707,1,0.983470795487712,0,1,nuclear subtelomeric heterochromatin,CC,
19616,GO:1990712,1,0.894786602363209,0,5,HFE-transferrin receptor complex,CC,
19617,GO:1990715,1,0.978304543608055,0,1,mRNA CDS binding,MF,
19618,GO:1990716,1,0.977075364613206,0,1,axonemal central apparatus,CC,
19619,GO:1990723,1,0.961614663540086,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19620,GO:1990726,1,0.885963443345189,0,5,Lsm1-7-Pat1 complex,CC,
19621,GO:1990729,1,0.97718705023542,0,1,primary miRNA modification,BP,
19622,GO:1990730,1,0.956417578016377,0,2,VCP-NSFL1C complex,CC,
19623,GO:1990736,1,0.978316932853619,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19624,GO:1990737,1,0.935743306773022,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
19625,GO:1990738,1,0.977336572808046,0,1,pseudouridine 5'-phosphatase activity,MF,
19626,GO:1990739,1,0.981876921102702,0,1,granulosa cell proliferation,BP,
19627,GO:1990742,1,0.954683849295828,0,2,microvesicle,CC,
19628,GO:1990743,1,0.934456599341638,0,3,protein sialylation,BP,
19629,GO:1990744,1,0.97718705023542,0,1,primary miRNA methylation,BP,
19630,GO:1990745,1,0.915128643169516,0,4,EARP complex,CC,
19631,GO:1990748,1,0.213022173889518,0,67,cellular detoxification,BP,
19632,GO:1990751,1,0.980778347430777,0,1,Schwann cell chemotaxis,BP,
19633,GO:1990752,1,0.60046318629415,0,25,microtubule end,CC,
19634,GO:1990755,1,0.977336572808046,0,1,mitotic spindle microtubule depolymerization,BP,
19635,GO:1990756,1,0.934036956720182,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
19636,GO:1990758,1,0.977140513983898,0,1,mitotic sister chromatid biorientation,BP,
19637,GO:1990761,1,0.955512550608172,0,2,growth cone lamellipodium,CC,
19638,GO:1990763,1,0.898478655951528,0,5,arrestin family protein binding,MF,
19639,GO:1990764,1,0.977280289452042,0,1,myofibroblast contraction,BP,
19640,GO:1990769,1,0.955223404416083,0,2,proximal neuron projection,CC,
19641,GO:1990771,1,0.979955563408742,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19642,GO:1990773,1,0.97708744433209,0,1,matrix metallopeptidase secretion,BP,
19643,GO:1990774,1,0.790965559668388,0,11,tumor necrosis factor secretion,BP,
19644,GO:1990776,1,0.700075570026816,0,16,response to angiotensin,BP,
19648,GO:1990784,1,0.978284451696701,0,1,response to dsDNA,BP,
19649,GO:1990785,1,0.940514198805367,0,3,response to water-immersion restraint stress,BP,
19650,GO:1990786,1,0.978284451696701,0,1,cellular response to dsDNA,BP,
19651,GO:1990791,1,0.955452729527066,0,2,dorsal root ganglion development,BP,
19652,GO:1990796,1,0.977360397723863,0,1,photoreceptor cell terminal bouton,CC,
19653,GO:1990809,1,0.912126686083352,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19654,GO:1990812,1,0.935056245596465,0,3,growth cone filopodium,CC,
19655,GO:1990817,1,0.977235739684677,0,1,RNA adenylyltransferase activity,MF,
19656,GO:1990822,1,0.877505147589662,0,6,basic amino acid transmembrane transport,BP,
19658,GO:1990825,1,0.797374282765254,0,10,sequence-specific mRNA binding,MF,
19659,GO:1990828,1,0.977225380209976,0,1,hepatocyte dedifferentiation,BP,
19661,GO:1990832,1,0.97720549091223,0,1,slow axonal transport,BP,
19662,GO:1990833,1,0.97720549091223,0,1,clathrin-uncoating ATPase activity,MF,
19663,GO:1990834,1,0.933889472806365,0,3,response to odorant,BP,
19665,GO:1990839,1,0.977237726899621,0,1,response to endothelin,BP,
19667,GO:1990845,1,0.87673820838947,0,6,adaptive thermogenesis,BP,
19668,GO:1990851,1,0.940713101547573,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
19669,GO:1990859,1,0.977237726899621,0,1,cellular response to endothelin,BP,
19670,GO:1990868,1,0.897132937926076,0,5,response to chemokine,BP,
19671,GO:1990869,1,0.897132937926076,0,5,cellular response to chemokine,BP,
19672,GO:1990874,1,0.525000852722252,0,29,vascular smooth muscle cell proliferation,BP,
19673,GO:1990876,1,0.980349065970807,0,1,cytoplasmic side of nuclear pore,CC,
19674,GO:1990879,1,0.955184890372083,0,2,CST complex,CC,
19675,GO:1990882,1,0.978203670882502,0,1,rRNA acetylation,BP,
19676,GO:1990883,1,0.978203670882502,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19677,GO:1990884,1,0.978203670882502,0,1,RNA acetylation,BP,
19678,GO:1990889,1,0.977153140349371,0,1,H4K20me3 modified histone binding,MF,
19681,GO:1990909,1,0.847662525245832,0,8,Wnt signalosome,CC,
19682,GO:1990910,1,0.933286976698571,0,3,response to hypobaric hypoxia,BP,
19683,GO:1990911,1,0.954948831398663,0,2,response to psychosocial stress,BP,
19684,GO:1990913,1,0.977253118713482,0,1,sperm head plasma membrane,CC,
19685,GO:1990917,1,0.977253118713482,0,1,ooplasm,CC,
19686,GO:1990918,1,0.956588055837423,0,2,double-strand break repair involved in meiotic recombination,BP,
19687,GO:1990923,1,0.955936084954463,0,2,PET complex,CC,
19688,GO:1990926,1,0.978733464945066,0,1,short-term synaptic potentiation,BP,
19689,GO:1990927,1,0.958487476680765,0,2,calcium ion regulated lysosome exocytosis,BP,
19690,GO:1990928,1,0.958893736813176,0,2,response to amino acid starvation,BP,
19691,GO:1990930,1,0.976966065818135,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
19692,GO:1990931,1,0.978523023267082,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19693,GO:1990936,1,0.954998834942678,0,2,vascular smooth muscle cell dedifferentiation,BP,
19694,GO:1990938,1,0.978251716857322,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19695,GO:1990939,1,0.502309553530857,0,34,ATP-dependent microtubule motor activity,MF,
19696,GO:1990948,1,0.885879870953814,0,5,ubiquitin ligase inhibitor activity,MF,
19697,GO:1990955,1,0.978337815426243,0,1,G-rich single-stranded DNA binding,MF,
19698,GO:1990966,1,0.914216149528076,0,4,ATP generation from poly-ADP-D-ribose,BP,
19699,GO:1990967,1,0.954955430639654,0,2,multi-organism toxin transport,BP,
19700,GO:1990968,1,0.980219963787828,0,1,modulation by host of RNA binding by virus,BP,
19701,GO:1990969,1,0.980219963787828,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19702,GO:1990983,1,0.977257562307464,0,1,tRNA demethylation,BP,
19703,GO:1990984,1,0.977257562307464,0,1,tRNA demethylase activity,MF,
19704,GO:2000001,1,0.695508330735734,0,16,regulation of DNA damage checkpoint,BP,
19705,GO:2000002,1,0.892617200596785,0,5,negative regulation of DNA damage checkpoint,BP,
19706,GO:2000003,1,0.977336572808046,0,1,positive regulation of DNA damage checkpoint,BP,
19707,GO:2000004,1,0.977115191442785,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19708,GO:2000005,1,0.977115191442785,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19709,GO:2000006,1,0.977115191442785,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19710,GO:2000007,1,0.977115191442785,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
19714,GO:2000011,1,0.977230147772224,0,1,regulation of adaxial/abaxial pattern formation,BP,
19715,GO:2000015,1,0.932711853450385,0,3,regulation of determination of dorsal identity,BP,
19716,GO:2000016,1,0.976082999969413,0,1,negative regulation of determination of dorsal identity,BP,
19717,GO:2000017,1,0.955570077154237,0,2,positive regulation of determination of dorsal identity,BP,
19719,GO:2000019,1,0.978152358173514,0,1,negative regulation of male gonad development,BP,
19723,GO:2000035,1,0.915454289621042,0,4,regulation of stem cell division,BP,
19724,GO:2000036,1,0.660935973049554,0,19,regulation of stem cell population maintenance,BP,
19725,GO:2000040,1,0.978674360350703,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19726,GO:2000041,1,0.978674360350703,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19727,GO:2000042,1,0.826748177939508,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
19729,GO:2000047,1,0.892672094292641,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
19730,GO:2000048,1,0.954063512300494,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
19731,GO:2000049,1,0.935663689533993,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
19732,GO:2000050,1,0.711192396982404,0,16,regulation of non-canonical Wnt signaling pathway,BP,
19733,GO:2000051,1,0.923798559169933,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
19734,GO:2000052,1,0.802698154666008,0,10,positive regulation of non-canonical Wnt signaling pathway,BP,
19735,GO:2000053,1,0.961816422363229,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19736,GO:2000054,1,0.978674360350703,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19737,GO:2000055,1,0.982776110657408,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19739,GO:2000059,1,0.449544932447037,0,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,
19741,GO:2000064,1,0.894416672815808,0,5,regulation of cortisol biosynthetic process,BP,
19742,GO:2000065,1,0.934176816901087,0,3,negative regulation of cortisol biosynthetic process,BP,
19743,GO:2000066,1,0.978152358173514,0,1,positive regulation of cortisol biosynthetic process,BP,
19744,GO:2000067,1,0.97585624064459,0,1,regulation of root morphogenesis,BP,
19745,GO:2000074,1,0.855790797902541,0,7,regulation of type B pancreatic cell development,BP,
19746,GO:2000077,1,0.958358792931524,0,2,negative regulation of type B pancreatic cell development,BP,
19747,GO:2000078,1,0.954378478827711,0,2,positive regulation of type B pancreatic cell development,BP,
19748,GO:2000079,1,0.978674360350703,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19749,GO:2000080,1,0.978674360350703,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19750,GO:2000095,1,0.821126420653809,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19751,GO:2000096,1,0.876624719452668,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19754,GO:2000101,1,0.977356057038789,0,1,regulation of mammary stem cell proliferation,BP,
19755,GO:2000103,1,0.977356057038789,0,1,positive regulation of mammary stem cell proliferation,BP,
19756,GO:2000104,1,0.660214328574667,0,19,negative regulation of DNA-dependent DNA replication,BP,
19757,GO:2000105,1,0.770584722621029,0,12,positive regulation of DNA-dependent DNA replication,BP,
19760,GO:2000108,1,0.622594055206479,0,21,positive regulation of leukocyte apoptotic process,BP,
19761,GO:2000109,1,0.871692764014247,0,6,regulation of macrophage apoptotic process,BP,
19762,GO:2000110,1,0.933962297469505,0,3,negative regulation of macrophage apoptotic process,BP,
19763,GO:2000111,1,0.955081995648127,0,2,positive regulation of macrophage apoptotic process,BP,
19766,GO:2000114,1,0.68051646282564,0,18,regulation of establishment of cell polarity,BP,
19769,GO:2000118,1,0.978380674722635,0,1,regulation of sodium-dependent phosphate transport,BP,
19770,GO:2000121,1,0.832384593645855,0,8,regulation of removal of superoxide radicals,BP,
19771,GO:2000124,1,0.956346623100781,0,2,regulation of endocannabinoid signaling pathway,BP,
19774,GO:2000137,1,0.961541513584975,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
19776,GO:2000142,1,0.517295981553638,0,30,regulation of DNA-templated transcription, initiation,BP,
19777,GO:2000143,1,0.914457579765619,0,4,negative regulation of DNA-templated transcription, initiation,BP,
19778,GO:2000144,1,0.604863065050897,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19782,GO:2000152,1,0.910806721631931,0,4,regulation of ubiquitin-specific protease activity,BP,
19783,GO:2000156,1,0.955936341449626,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19784,GO:2000157,1,0.953337709552515,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19785,GO:2000158,1,0.95539510593775,0,2,positive regulation of ubiquitin-specific protease activity,BP,
19786,GO:2000167,1,0.97942657938205,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19787,GO:2000169,1,0.902273757859926,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19789,GO:2000172,1,0.955944514337712,0,2,regulation of branching morphogenesis of a nerve,BP,
19790,GO:2000173,1,0.978205132383139,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19791,GO:2000174,1,0.978222645418197,0,1,regulation of pro-T cell differentiation,BP,
19792,GO:2000176,1,0.978222645418197,0,1,positive regulation of pro-T cell differentiation,BP,
19793,GO:2000177,1,0.413464753754518,0,41,regulation of neural precursor cell proliferation,BP,
19794,GO:2000178,1,0.753882227339132,0,13,negative regulation of neural precursor cell proliferation,BP,
19795,GO:2000179,1,0.636027474524364,0,21,positive regulation of neural precursor cell proliferation,BP,
19797,GO:2000182,1,0.956781047714462,0,2,regulation of progesterone biosynthetic process,BP,
19798,GO:2000191,1,0.735787967759223,0,14,regulation of fatty acid transport,BP,
19799,GO:2000192,1,0.900370109021087,0,5,negative regulation of fatty acid transport,BP,
19800,GO:2000193,1,0.832859223114649,0,8,positive regulation of fatty acid transport,BP,
19801,GO:2000194,1,0.854736194885248,0,7,regulation of female gonad development,BP,
19802,GO:2000195,1,0.955086100713406,0,2,negative regulation of female gonad development,BP,
19803,GO:2000196,1,0.955581560538378,0,2,positive regulation of female gonad development,BP,
19804,GO:2000197,1,0.877802060124601,0,6,regulation of ribonucleoprotein complex localization,BP,
19805,GO:2000199,1,0.977447707014576,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19806,GO:2000200,1,0.977447707014576,0,1,regulation of ribosomal subunit export from nucleus,BP,
19807,GO:2000202,1,0.977447707014576,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19808,GO:2000206,1,0.977447707014576,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19809,GO:2000208,1,0.977447707014576,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19811,GO:2000210,1,0.871756254889423,0,6,positive regulation of anoikis,BP,
19812,GO:2000211,1,0.979154157352942,0,1,regulation of glutamate metabolic process,BP,
19813,GO:2000212,1,0.979154157352942,0,1,negative regulation of glutamate metabolic process,BP,
19814,GO:2000224,1,0.978152358173514,0,1,regulation of testosterone biosynthetic process,BP,
19815,GO:2000225,1,0.978152358173514,0,1,negative regulation of testosterone biosynthetic process,BP,
19818,GO:2000229,1,0.977150839933651,0,1,regulation of pancreatic stellate cell proliferation,BP,
19819,GO:2000230,1,0.977150839933651,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
19820,GO:2000232,1,0.782443757904658,0,11,regulation of rRNA processing,BP,
19821,GO:2000233,1,0.957678047153878,0,2,negative regulation of rRNA processing,BP,
19822,GO:2000234,1,0.834318103002912,0,8,positive regulation of rRNA processing,BP,
19824,GO:2000242,1,0.51733897773317,0,29,negative regulation of reproductive process,BP,
19827,GO:2000251,1,0.795570126319449,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19828,GO:2000252,1,0.955705827877339,0,2,negative regulation of feeding behavior,BP,
19829,GO:2000253,1,0.939816933193636,0,3,positive regulation of feeding behavior,BP,
19830,GO:2000254,1,0.952872377967085,0,2,regulation of male germ cell proliferation,BP,
19831,GO:2000255,1,0.976106588627001,0,1,negative regulation of male germ cell proliferation,BP,
19832,GO:2000256,1,0.976199190359362,0,1,positive regulation of male germ cell proliferation,BP,
19834,GO:2000258,1,0.936948959071322,0,3,negative regulation of protein activation cascade,BP,
19835,GO:2000259,1,0.956839275326128,0,2,positive regulation of protein activation cascade,BP,
19837,GO:2000270,1,0.876651622277895,0,6,negative regulation of fibroblast apoptotic process,BP,
19839,GO:2000272,1,0.63218642462279,0,21,negative regulation of signaling receptor activity,BP,
19840,GO:2000273,1,0.629009485006655,0,21,positive regulation of signaling receptor activity,BP,
19841,GO:2000275,1,0.953896052982661,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
19842,GO:2000276,1,0.977229396982722,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
19843,GO:2000277,1,0.976125001747232,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19845,GO:2000279,1,0.554337382268084,0,27,negative regulation of DNA biosynthetic process,BP,
19846,GO:2000280,1,0.97585624064459,0,1,regulation of root development,BP,
19847,GO:2000282,1,0.958470491270399,0,2,regulation of cellular amino acid biosynthetic process,BP,
19848,GO:2000283,1,0.981915309359245,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19849,GO:2000284,1,0.976125001747232,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
19850,GO:2000286,1,0.934085620120163,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
19853,GO:2000295,1,0.97749444321181,0,1,regulation of hydrogen peroxide catabolic process,BP,
19854,GO:2000297,1,0.979358648410172,0,1,negative regulation of synapse maturation,BP,
19855,GO:2000298,1,0.955393686400944,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19856,GO:2000299,1,0.977644285777341,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19857,GO:2000300,1,0.661774237658994,0,19,regulation of synaptic vesicle exocytosis,BP,
19858,GO:2000301,1,0.934587965598243,0,3,negative regulation of synaptic vesicle exocytosis,BP,
19859,GO:2000302,1,0.959347763915956,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19860,GO:2000303,1,0.743987465636105,0,13,regulation of ceramide biosynthetic process,BP,
19861,GO:2000304,1,0.833935281031789,0,8,positive regulation of ceramide biosynthetic process,BP,
19862,GO:2000307,1,0.977481596433604,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19863,GO:2000309,1,0.977481596433604,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19864,GO:2000310,1,0.819113170829643,0,9,regulation of NMDA receptor activity,BP,
19865,GO:2000311,1,0.827810063564811,0,9,regulation of AMPA receptor activity,BP,
19866,GO:2000312,1,0.937353644055812,0,3,regulation of kainate selective glutamate receptor activity,BP,
19868,GO:2000314,1,0.977038435138114,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19871,GO:2000318,1,0.91136263370377,0,4,positive regulation of T-helper 17 type immune response,BP,
19874,GO:2000321,1,0.95403114594056,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19875,GO:2000322,1,0.855979244290291,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19876,GO:2000323,1,0.875950078689994,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19877,GO:2000324,1,0.977212161545791,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
19878,GO:2000325,1,0.980018558258962,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19879,GO:2000327,1,0.980018558258962,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19880,GO:2000328,1,0.932531191935368,0,3,regulation of T-helper 17 cell lineage commitment,BP,
19881,GO:2000329,1,0.977468034691993,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19882,GO:2000330,1,0.95403114594056,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
19883,GO:2000331,1,0.977589454991973,0,1,regulation of terminal button organization,BP,
19884,GO:2000332,1,0.977040650790622,0,1,regulation of blood microparticle formation,BP,
19885,GO:2000334,1,0.977040650790622,0,1,positive regulation of blood microparticle formation,BP,
19886,GO:2000338,1,0.955115805143162,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19887,GO:2000340,1,0.955115805143162,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19888,GO:2000341,1,0.792564992608092,0,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19889,GO:2000342,1,0.955108066621288,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19890,GO:2000343,1,0.829843802892442,0,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19891,GO:2000344,1,0.913030967439114,0,4,positive regulation of acrosome reaction,BP,
19892,GO:2000345,1,0.858051816222683,0,7,regulation of hepatocyte proliferation,BP,
19893,GO:2000346,1,0.956221450903942,0,2,negative regulation of hepatocyte proliferation,BP,
19894,GO:2000347,1,0.917097696954437,0,4,positive regulation of hepatocyte proliferation,BP,
19895,GO:2000348,1,0.915682209625985,0,4,regulation of CD40 signaling pathway,BP,
19896,GO:2000349,1,0.978645391491612,0,1,negative regulation of CD40 signaling pathway,BP,
19899,GO:2000353,1,0.842590566808066,0,8,positive regulation of endothelial cell apoptotic process,BP,
19900,GO:2000354,1,0.912358494834827,0,4,regulation of ovarian follicle development,BP,
19901,GO:2000355,1,0.977181342858884,0,1,negative regulation of ovarian follicle development,BP,
19902,GO:2000359,1,0.976779281456844,0,1,regulation of binding of sperm to zona pellucida,BP,
19903,GO:2000360,1,0.976779281456844,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19904,GO:2000361,1,0.978697921976875,0,1,regulation of prostaglandin-E synthase activity,BP,
19905,GO:2000363,1,0.978697921976875,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19906,GO:2000367,1,0.954488545498601,0,2,regulation of acrosomal vesicle exocytosis,BP,
19907,GO:2000368,1,0.954488545498601,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
19908,GO:2000369,1,0.727663105092512,0,15,regulation of clathrin-dependent endocytosis,BP,
19909,GO:2000370,1,0.916304749279933,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19910,GO:2000371,1,0.877453184548171,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19911,GO:2000373,1,0.877453184548171,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19912,GO:2000374,1,0.977207459862639,0,1,regulation of oxygen metabolic process,BP,
19916,GO:2000380,1,0.863686079263733,0,7,regulation of mesoderm development,BP,
19917,GO:2000381,1,0.917208165579644,0,4,negative regulation of mesoderm development,BP,
19918,GO:2000382,1,0.983008226798335,0,1,positive regulation of mesoderm development,BP,
19919,GO:2000383,1,0.978097417232454,0,1,regulation of ectoderm development,BP,
19920,GO:2000384,1,0.978097417232454,0,1,negative regulation of ectoderm development,BP,
19921,GO:2000386,1,0.955581560538378,0,2,positive regulation of ovarian follicle development,BP,
19922,GO:2000387,1,0.976779281456844,0,1,regulation of antral ovarian follicle growth,BP,
19923,GO:2000388,1,0.976779281456844,0,1,positive regulation of antral ovarian follicle growth,BP,
19924,GO:2000389,1,0.935324552914268,0,3,regulation of neutrophil extravasation,BP,
19925,GO:2000391,1,0.935324552914268,0,3,positive regulation of neutrophil extravasation,BP,
19926,GO:2000392,1,0.82325044892171,0,9,regulation of lamellipodium morphogenesis,BP,
19927,GO:2000393,1,0.957051229477856,0,2,negative regulation of lamellipodium morphogenesis,BP,
19928,GO:2000394,1,0.899010140227294,0,5,positive regulation of lamellipodium morphogenesis,BP,
19929,GO:2000395,1,0.953725026992111,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19930,GO:2000397,1,0.953725026992111,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
19932,GO:2000402,1,0.936846340228183,0,3,negative regulation of lymphocyte migration,BP,
19934,GO:2000404,1,0.638880161533634,0,20,regulation of T cell migration,BP,
19935,GO:2000405,1,0.979499690722262,0,1,negative regulation of T cell migration,BP,
19936,GO:2000406,1,0.716041326349038,0,15,positive regulation of T cell migration,BP,
19937,GO:2000407,1,0.954843495551256,0,2,regulation of T cell extravasation,BP,
19938,GO:2000409,1,0.977147632645646,0,1,positive regulation of T cell extravasation,BP,
19939,GO:2000410,1,0.977481596433604,0,1,regulation of thymocyte migration,BP,
19940,GO:2000412,1,0.977481596433604,0,1,positive regulation of thymocyte migration,BP,
19941,GO:2000413,1,0.977481596433604,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19942,GO:2000415,1,0.977481596433604,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
19943,GO:2000416,1,0.933937482831169,0,3,regulation of eosinophil migration,BP,
19944,GO:2000417,1,0.97768694948875,0,1,negative regulation of eosinophil migration,BP,
19945,GO:2000418,1,0.955255779169272,0,2,positive regulation of eosinophil migration,BP,
19946,GO:2000419,1,0.97768694948875,0,1,regulation of eosinophil extravasation,BP,
19947,GO:2000420,1,0.97768694948875,0,1,negative regulation of eosinophil extravasation,BP,
19948,GO:2000422,1,0.977264086496889,0,1,regulation of eosinophil chemotaxis,BP,
19949,GO:2000424,1,0.977264086496889,0,1,positive regulation of eosinophil chemotaxis,BP,
19950,GO:2000425,1,0.938729349856186,0,3,regulation of apoptotic cell clearance,BP,
19951,GO:2000426,1,0.977697391253987,0,1,negative regulation of apoptotic cell clearance,BP,
19952,GO:2000427,1,0.960146359202827,0,2,positive regulation of apoptotic cell clearance,BP,
19953,GO:2000434,1,0.952406578764793,0,2,regulation of protein neddylation,BP,
19954,GO:2000435,1,0.952406578764793,0,2,negative regulation of protein neddylation,BP,
19955,GO:2000449,1,0.954843495551256,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19956,GO:2000451,1,0.977147632645646,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19957,GO:2000452,1,0.954843495551256,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19958,GO:2000454,1,0.977147632645646,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19959,GO:2000458,1,0.977114113326136,0,1,regulation of astrocyte chemotaxis,BP,
19960,GO:2000463,1,0.689038437698877,0,17,positive regulation of excitatory postsynaptic potential,BP,
19961,GO:2000465,1,0.879478421086831,0,6,regulation of glycogen (starch) synthase activity,BP,
19962,GO:2000466,1,0.936822665053278,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19963,GO:2000467,1,0.938678578810477,0,3,positive regulation of glycogen (starch) synthase activity,BP,
19964,GO:2000468,1,0.97749444321181,0,1,regulation of peroxidase activity,BP,
19965,GO:2000470,1,0.97749444321181,0,1,positive regulation of peroxidase activity,BP,
19966,GO:2000474,1,0.978296901024895,0,1,regulation of opioid receptor signaling pathway,BP,
19967,GO:2000479,1,0.765756652176848,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19968,GO:2000480,1,0.851897405699061,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19969,GO:2000481,1,0.920203575329749,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
19970,GO:2000482,1,0.745713519465272,0,13,regulation of interleukin-8 secretion,BP,
19971,GO:2000483,1,0.894890540621282,0,5,negative regulation of interleukin-8 secretion,BP,
19972,GO:2000484,1,0.833364820505154,0,8,positive regulation of interleukin-8 secretion,BP,
19973,GO:2000489,1,0.934155573318976,0,3,regulation of hepatic stellate cell activation,BP,
19974,GO:2000490,1,0.955664607929009,0,2,negative regulation of hepatic stellate cell activation,BP,
19975,GO:2000491,1,0.977496905693895,0,1,positive regulation of hepatic stellate cell activation,BP,
19978,GO:2000504,1,0.977240407281889,0,1,positive regulation of blood vessel remodeling,BP,
19979,GO:2000508,1,0.91161432219738,0,4,regulation of dendritic cell chemotaxis,BP,
19980,GO:2000510,1,0.91161432219738,0,4,positive regulation of dendritic cell chemotaxis,BP,
19983,GO:2000516,1,0.725562756531083,0,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
19984,GO:2000520,1,0.954561147290906,0,2,regulation of immunological synapse formation,BP,
19985,GO:2000521,1,0.954561147290906,0,2,negative regulation of immunological synapse formation,BP,
19986,GO:2000532,1,0.977249750036021,0,1,regulation of renal albumin absorption,BP,
19987,GO:2000533,1,0.977249750036021,0,1,negative regulation of renal albumin absorption,BP,
19988,GO:2000535,1,0.876859764919918,0,6,regulation of entry of bacterium into host cell,BP,
19989,GO:2000536,1,0.980578682093857,0,1,negative regulation of entry of bacterium into host cell,BP,
19990,GO:2000537,1,0.978572566538501,0,1,regulation of B cell chemotaxis,BP,
19991,GO:2000538,1,0.978572566538501,0,1,positive regulation of B cell chemotaxis,BP,
19992,GO:2000542,1,0.920008822689921,0,4,negative regulation of gastrulation,BP,
19993,GO:2000543,1,0.955184890372083,0,2,positive regulation of gastrulation,BP,
19994,GO:2000544,1,0.939397401156289,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19995,GO:2000546,1,0.960465042210147,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19996,GO:2000551,1,0.89086306082219,0,5,regulation of T-helper 2 cell cytokine production,BP,
19997,GO:2000552,1,0.976844813365906,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
19998,GO:2000553,1,0.911987526167855,0,4,positive regulation of T-helper 2 cell cytokine production,BP,
19999,GO:2000561,1,0.914260815524113,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20000,GO:2000562,1,0.955699871100914,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20001,GO:2000563,1,0.956647318096907,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
20002,GO:2000564,1,0.955376719384815,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20003,GO:2000566,1,0.977050079530036,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20004,GO:2000567,1,0.977230147772224,0,1,regulation of memory T cell activation,BP,
20005,GO:2000568,1,0.977230147772224,0,1,positive regulation of memory T cell activation,BP,
20006,GO:2000569,1,0.977572090216096,0,1,regulation of T-helper 2 cell activation,BP,
20007,GO:2000570,1,0.977572090216096,0,1,positive regulation of T-helper 2 cell activation,BP,
20009,GO:2000574,1,0.83252461539803,0,8,regulation of microtubule motor activity,BP,
20010,GO:2000576,1,0.889394742228876,0,5,positive regulation of microtubule motor activity,BP,
20011,GO:2000580,1,0.910026278494797,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
20012,GO:2000582,1,0.910026278494797,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
20013,GO:2000583,1,0.978095453703255,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
20014,GO:2000584,1,0.978095453703255,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
20015,GO:2000586,1,0.863197739331406,0,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
20016,GO:2000587,1,0.899252680639012,0,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
20017,GO:2000588,1,0.959921365597194,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
20018,GO:2000589,1,0.955136860941441,0,2,regulation of metanephric mesenchymal cell migration,BP,
20019,GO:2000591,1,0.955136860941441,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
20020,GO:2000592,1,0.978120976366248,0,1,regulation of metanephric DCT cell differentiation,BP,
20021,GO:2000594,1,0.978120976366248,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20022,GO:2000601,1,0.877395747293676,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20023,GO:2000606,1,0.977427947414801,0,1,regulation of cell proliferation involved in mesonephros development,BP,
20024,GO:2000607,1,0.977427947414801,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20025,GO:2000609,1,0.934202436013994,0,3,regulation of thyroid hormone generation,BP,
20026,GO:2000611,1,0.956040963100243,0,2,positive regulation of thyroid hormone generation,BP,
20027,GO:2000612,1,0.978120976366248,0,1,regulation of thyroid-stimulating hormone secretion,BP,
20028,GO:2000615,1,0.80276452597566,0,10,regulation of histone H3-K9 acetylation,BP,
20029,GO:2000616,1,0.956894145762945,0,2,negative regulation of histone H3-K9 acetylation,BP,
20030,GO:2000617,1,0.878390215537228,0,6,positive regulation of histone H3-K9 acetylation,BP,
20031,GO:2000618,1,0.897281653372974,0,5,regulation of histone H4-K16 acetylation,BP,
20032,GO:2000619,1,0.933760777990926,0,3,negative regulation of histone H4-K16 acetylation,BP,
20033,GO:2000620,1,0.960942991943897,0,2,positive regulation of histone H4-K16 acetylation,BP,
20034,GO:2000622,1,0.917218782139692,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20035,GO:2000623,1,0.917218782139692,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20036,GO:2000625,1,0.956551900016026,0,2,regulation of miRNA catabolic process,BP,
20037,GO:2000627,1,0.956551900016026,0,2,positive regulation of miRNA catabolic process,BP,
20038,GO:2000628,1,0.853175721500511,0,7,regulation of miRNA metabolic process,BP,
20039,GO:2000630,1,0.893014019177671,0,5,positive regulation of miRNA metabolic process,BP,
20042,GO:2000637,1,0.655683407195461,0,19,positive regulation of gene silencing by miRNA,BP,
20043,GO:2000638,1,0.955769745696842,0,2,regulation of SREBP signaling pathway,BP,
20044,GO:2000639,1,0.955769745696842,0,2,negative regulation of SREBP signaling pathway,BP,
20045,GO:2000641,1,0.684092238714172,0,17,regulation of early endosome to late endosome transport,BP,
20046,GO:2000642,1,0.952972606437405,0,2,negative regulation of early endosome to late endosome transport,BP,
20047,GO:2000643,1,0.838855265365972,0,8,positive regulation of early endosome to late endosome transport,BP,
20048,GO:2000644,1,0.819908465454379,0,9,regulation of receptor catabolic process,BP,
20049,GO:2000645,1,0.935773008362778,0,3,negative regulation of receptor catabolic process,BP,
20050,GO:2000646,1,0.89645306215815,0,5,positive regulation of receptor catabolic process,BP,
20052,GO:2000648,1,0.609574455615401,0,23,positive regulation of stem cell proliferation,BP,
20053,GO:2000649,1,0.503469554297192,0,32,regulation of sodium ion transmembrane transporter activity,BP,
20054,GO:2000650,1,0.844637007254973,0,8,negative regulation of sodium ion transmembrane transporter activity,BP,
20055,GO:2000651,1,0.809160110387581,0,10,positive regulation of sodium ion transmembrane transporter activity,BP,
20056,GO:2000653,1,0.935344057479607,0,3,regulation of genetic imprinting,BP,
20057,GO:2000654,1,0.978093981058656,0,1,regulation of cellular response to testosterone stimulus,BP,
20058,GO:2000655,1,0.978093981058656,0,1,negative regulation of cellular response to testosterone stimulus,BP,
20059,GO:2000656,1,0.977159588916266,0,1,regulation of apolipoprotein binding,BP,
20060,GO:2000657,1,0.977159588916266,0,1,negative regulation of apolipoprotein binding,BP,
20061,GO:2000659,1,0.854531312426156,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
20062,GO:2000660,1,0.893209603986913,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
20063,GO:2000661,1,0.979049930498949,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20070,GO:2000668,1,0.91679742013397,0,4,regulation of dendritic cell apoptotic process,BP,
20071,GO:2000669,1,0.956634218930598,0,2,negative regulation of dendritic cell apoptotic process,BP,
20072,GO:2000670,1,0.95836413281182,0,2,positive regulation of dendritic cell apoptotic process,BP,
20073,GO:2000671,1,0.934471472188658,0,3,regulation of motor neuron apoptotic process,BP,
20074,GO:2000672,1,0.934471472188658,0,3,negative regulation of motor neuron apoptotic process,BP,
20075,GO:2000674,1,0.815717078267858,0,9,regulation of type B pancreatic cell apoptotic process,BP,
20076,GO:2000675,1,0.914908555287998,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
20077,GO:2000676,1,0.891617379700123,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
20080,GO:2000679,1,0.696736587667322,0,16,positive regulation of transcription regulatory region DNA binding,BP,
20081,GO:2000683,1,0.955249595711484,0,2,regulation of cellular response to X-ray,BP,
20082,GO:2000685,1,0.977311400824801,0,1,positive regulation of cellular response to X-ray,BP,
20083,GO:2000690,1,0.978487084078203,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20084,GO:2000691,1,0.978487084078203,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20086,GO:2000697,1,0.956023303829672,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20088,GO:2000699,1,0.977427947414801,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20089,GO:2000701,1,0.977427947414801,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20090,GO:2000702,1,0.977427947414801,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20091,GO:2000703,1,0.977427947414801,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20092,GO:2000705,1,0.960195149638724,0,2,regulation of dense core granule biogenesis,BP,
20093,GO:2000706,1,0.977916093621233,0,1,negative regulation of dense core granule biogenesis,BP,
20094,GO:2000707,1,0.981880381810184,0,1,positive regulation of dense core granule biogenesis,BP,
20095,GO:2000718,1,0.976043880359759,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20096,GO:2000719,1,0.976043880359759,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20097,GO:2000721,1,0.978782419364536,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20098,GO:2000722,1,0.977336572808046,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20099,GO:2000724,1,0.977336572808046,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20100,GO:2000725,1,0.606485458026989,0,23,regulation of cardiac muscle cell differentiation,BP,
20101,GO:2000726,1,0.788331964501826,0,11,negative regulation of cardiac muscle cell differentiation,BP,
20102,GO:2000727,1,0.769508026170465,0,12,positive regulation of cardiac muscle cell differentiation,BP,
20103,GO:2000733,1,0.977427947414801,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20104,GO:2000734,1,0.977427947414801,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20109,GO:2000740,1,0.977916093621233,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20111,GO:2000742,1,0.977215289100987,0,1,regulation of anterior head development,BP,
20112,GO:2000744,1,0.977215289100987,0,1,positive regulation of anterior head development,BP,
20113,GO:2000752,1,0.977298954147329,0,1,regulation of glucosylceramide catabolic process,BP,
20114,GO:2000753,1,0.977298954147329,0,1,positive regulation of glucosylceramide catabolic process,BP,
20115,GO:2000754,1,0.977298954147329,0,1,regulation of sphingomyelin catabolic process,BP,
20116,GO:2000755,1,0.977298954147329,0,1,positive regulation of sphingomyelin catabolic process,BP,
20118,GO:2000757,1,0.685529384736134,0,17,negative regulation of peptidyl-lysine acetylation,BP,
20120,GO:2000759,1,0.97901746091873,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20121,GO:2000761,1,0.97901746091873,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20122,GO:2000765,1,0.599735385029806,0,23,regulation of cytoplasmic translation,BP,
20123,GO:2000766,1,0.880265717987249,0,6,negative regulation of cytoplasmic translation,BP,
20124,GO:2000767,1,0.837370498814044,0,8,positive regulation of cytoplasmic translation,BP,
20125,GO:2000768,1,0.977227380413047,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
20127,GO:2000773,1,0.738314168728041,0,14,negative regulation of cellular senescence,BP,
20128,GO:2000774,1,0.813028213070441,0,9,positive regulation of cellular senescence,BP,
20129,GO:2000775,1,0.977216111314494,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
20130,GO:2000777,1,0.954941571122791,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
20131,GO:2000778,1,0.699588793514837,0,16,positive regulation of interleukin-6 secretion,BP,
20132,GO:2000779,1,0.338139870685042,0,49,regulation of double-strand break repair,BP,
20133,GO:2000780,1,0.664451774792574,0,19,negative regulation of double-strand break repair,BP,
20134,GO:2000781,1,0.734659261946416,0,14,positive regulation of double-strand break repair,BP,
20135,GO:2000785,1,0.472689581236274,0,34,regulation of autophagosome assembly,BP,
20136,GO:2000786,1,0.790292148325065,0,11,positive regulation of autophagosome assembly,BP,
20137,GO:2000790,1,0.95994809446991,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20138,GO:2000791,1,0.95994809446991,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20139,GO:2000793,1,0.966226949380095,0,2,cell proliferation involved in heart valve development,BP,
20141,GO:2000795,1,0.981447762631557,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20142,GO:2000797,1,0.977916093621233,0,1,regulation of amniotic stem cell differentiation,BP,
20143,GO:2000798,1,0.977916093621233,0,1,negative regulation of amniotic stem cell differentiation,BP,
20144,GO:2000804,1,0.98339437073446,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20145,GO:2000806,1,0.98339437073446,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20146,GO:2000807,1,0.940147355481837,0,3,regulation of synaptic vesicle clustering,BP,
20147,GO:2000808,1,0.979546636342451,0,1,negative regulation of synaptic vesicle clustering,BP,
20148,GO:2000809,1,0.959781111801428,0,2,positive regulation of synaptic vesicle clustering,BP,
20151,GO:2000812,1,0.978130788430595,0,1,regulation of barbed-end actin filament capping,BP,
20152,GO:2000816,1,0.50295991035307,0,31,negative regulation of mitotic sister chromatid separation,BP,
20153,GO:2000819,1,0.955791544973248,0,2,regulation of nucleotide-excision repair,BP,
20154,GO:2000820,1,0.979857838446937,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20155,GO:2000821,1,0.95459161806598,0,2,regulation of grooming behavior,BP,
20156,GO:2000822,1,0.935698321092904,0,3,regulation of behavioral fear response,BP,
20157,GO:2000823,1,0.913020808228421,0,4,regulation of androgen receptor activity,BP,
20158,GO:2000825,1,0.913020808228421,0,4,positive regulation of androgen receptor activity,BP,
20160,GO:2000827,1,0.97724799426136,0,1,mitochondrial RNA surveillance,BP,
20161,GO:2000828,1,0.957244488201179,0,2,regulation of parathyroid hormone secretion,BP,
20162,GO:2000830,1,0.979615972568209,0,1,positive regulation of parathyroid hormone secretion,BP,
20163,GO:2000831,1,0.893229264152952,0,5,regulation of steroid hormone secretion,BP,
20164,GO:2000832,1,0.958111257249249,0,2,negative regulation of steroid hormone secretion,BP,
20165,GO:2000833,1,0.932291875040536,0,3,positive regulation of steroid hormone secretion,BP,
20166,GO:2000834,1,0.977575222695287,0,1,regulation of androgen secretion,BP,
20167,GO:2000836,1,0.977575222695287,0,1,positive regulation of androgen secretion,BP,
20168,GO:2000843,1,0.980537269912031,0,1,regulation of testosterone secretion,BP,
20169,GO:2000845,1,0.980537269912031,0,1,positive regulation of testosterone secretion,BP,
20170,GO:2000846,1,0.913726242662454,0,4,regulation of corticosteroid hormone secretion,BP,
20171,GO:2000847,1,0.958111257249249,0,2,negative regulation of corticosteroid hormone secretion,BP,
20172,GO:2000848,1,0.953681743024025,0,2,positive regulation of corticosteroid hormone secretion,BP,
20173,GO:2000849,1,0.934975174880766,0,3,regulation of glucocorticoid secretion,BP,
20174,GO:2000850,1,0.958111257249249,0,2,negative regulation of glucocorticoid secretion,BP,
20175,GO:2000851,1,0.97585624064459,0,1,positive regulation of glucocorticoid secretion,BP,
20176,GO:2000855,1,0.977278942128016,0,1,regulation of mineralocorticoid secretion,BP,
20177,GO:2000857,1,0.977278942128016,0,1,positive regulation of mineralocorticoid secretion,BP,
20178,GO:2000858,1,0.977278942128016,0,1,regulation of aldosterone secretion,BP,
20179,GO:2000860,1,0.977278942128016,0,1,positive regulation of aldosterone secretion,BP,
20180,GO:2000864,1,0.980182444931288,0,1,regulation of estradiol secretion,BP,
20181,GO:2000878,1,0.954829641473384,0,2,positive regulation of oligopeptide transport,BP,
20182,GO:2000880,1,0.954829641473384,0,2,positive regulation of dipeptide transport,BP,
20183,GO:2000909,1,0.977336572808046,0,1,regulation of sterol import,BP,
20184,GO:2000969,1,0.958379394336032,0,2,positive regulation of AMPA receptor activity,BP,
20191,GO:2000983,1,0.95280819463599,0,2,regulation of ATP citrate synthase activity,BP,
20192,GO:2000984,1,0.95280819463599,0,2,negative regulation of ATP citrate synthase activity,BP,
20193,GO:2000987,1,0.977465363898827,0,1,positive regulation of behavioral fear response,BP,
20194,GO:2001012,1,0.913388356999881,0,4,mesenchymal cell differentiation involved in renal system development,BP,
20195,GO:2001013,1,0.958886817700579,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20196,GO:2001014,1,0.783573075615425,0,11,regulation of skeletal muscle cell differentiation,BP,
20197,GO:2001015,1,0.958038387321997,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20198,GO:2001016,1,0.913830963014204,0,4,positive regulation of skeletal muscle cell differentiation,BP,
20203,GO:2001024,1,0.651494731193764,0,19,negative regulation of response to drug,BP,
20206,GO:2001027,1,0.962349265750713,0,2,negative regulation of endothelial cell chemotaxis,BP,
20208,GO:2001029,1,0.979530757041336,0,1,regulation of cellular glucuronidation,BP,
20209,GO:2001031,1,0.979530757041336,0,1,positive regulation of cellular glucuronidation,BP,
20210,GO:2001032,1,0.781795048798142,0,11,regulation of double-strand break repair via nonhomologous end joining,BP,
20211,GO:2001033,1,0.890968689836246,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
20212,GO:2001034,1,0.897897263635264,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20213,GO:2001035,1,0.956151160087025,0,2,regulation of tongue muscle cell differentiation,BP,
20214,GO:2001037,1,0.956151160087025,0,2,positive regulation of tongue muscle cell differentiation,BP,
20215,GO:2001038,1,0.582384915880061,0,24,regulation of cellular response to drug,BP,
20216,GO:2001039,1,0.727173100850403,0,14,negative regulation of cellular response to drug,BP,
20217,GO:2001040,1,0.875296689665388,0,6,positive regulation of cellular response to drug,BP,
20218,GO:2001044,1,0.801528383174273,0,10,regulation of integrin-mediated signaling pathway,BP,
20219,GO:2001045,1,0.958501148467688,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20220,GO:2001046,1,0.896578436145314,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20223,GO:2001055,1,0.977230147772224,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
20226,GO:2001069,1,0.95511692870505,0,2,glycogen binding,MF,
20227,GO:2001070,1,0.95719895609313,0,2,starch binding,MF,
20228,GO:2001074,1,0.95502300820876,0,2,regulation of metanephric ureteric bud development,BP,
20229,GO:2001076,1,0.95502300820876,0,2,positive regulation of metanephric ureteric bud development,BP,
20230,GO:2001106,1,0.960925722301145,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20231,GO:2001108,1,0.980149299505197,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20232,GO:2001109,1,0.981833277045491,0,1,regulation of lens epithelial cell proliferation,BP,
20233,GO:2001111,1,0.981833277045491,0,1,positive regulation of lens epithelial cell proliferation,BP,
20234,GO:2001135,1,0.840525276121683,0,8,regulation of endocytic recycling,BP,
20235,GO:2001136,1,0.977634260136634,0,1,negative regulation of endocytic recycling,BP,
20236,GO:2001137,1,0.940139360507108,0,3,positive regulation of endocytic recycling,BP,
20237,GO:2001138,1,0.873672997932646,0,6,regulation of phospholipid transport,BP,
20238,GO:2001140,1,0.873672997932646,0,6,positive regulation of phospholipid transport,BP,
20240,GO:2001142,1,0.977255169974039,0,1,nicotinate transport,BP,
20241,GO:2001144,1,0.977228007191649,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20242,GO:2001145,1,0.977228007191649,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20243,GO:2001148,1,0.954829641473384,0,2,regulation of dipeptide transmembrane transport,BP,
20244,GO:2001150,1,0.954829641473384,0,2,positive regulation of dipeptide transmembrane transport,BP,
20245,GO:2001151,1,0.977531669431364,0,1,regulation of renal water transport,BP,
20246,GO:2001153,1,0.977531669431364,0,1,positive regulation of renal water transport,BP,
20247,GO:2001160,1,0.955583332769874,0,2,regulation of histone H3-K79 methylation,BP,
20248,GO:2001162,1,0.955583332769874,0,2,positive regulation of histone H3-K79 methylation,BP,
20249,GO:2001163,1,0.977235574341747,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20250,GO:2001165,1,0.977235574341747,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20251,GO:2001166,1,0.894446259384695,0,5,regulation of histone H2B ubiquitination,BP,
20252,GO:2001168,1,0.915301600488852,0,4,positive regulation of histone H2B ubiquitination,BP,
20255,GO:2001171,1,0.676508529137642,0,18,positive regulation of ATP biosynthetic process,BP,
20256,GO:2001173,1,0.977222279119496,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
20257,GO:2001176,1,0.955027026000121,0,2,regulation of mediator complex assembly,BP,
20258,GO:2001178,1,0.955027026000121,0,2,positive regulation of mediator complex assembly,BP,
20261,GO:2001181,1,0.931819696357275,0,3,positive regulation of interleukin-10 secretion,BP,
20262,GO:2001182,1,0.913704316040151,0,4,regulation of interleukin-12 secretion,BP,
20263,GO:2001183,1,0.977162298331179,0,1,negative regulation of interleukin-12 secretion,BP,
20264,GO:2001184,1,0.956273641974258,0,2,positive regulation of interleukin-12 secretion,BP,
20266,GO:2001186,1,0.977182886223586,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
20267,GO:2001187,1,0.977050079530036,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
20268,GO:2001188,1,0.954561147290906,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20269,GO:2001189,1,0.954561147290906,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20270,GO:2001197,1,0.904969468595843,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20271,GO:2001198,1,0.932940902432811,0,3,regulation of dendritic cell differentiation,BP,
20272,GO:2001199,1,0.976972214684652,0,1,negative regulation of dendritic cell differentiation,BP,
20273,GO:2001200,1,0.95493469895164,0,2,positive regulation of dendritic cell differentiation,BP,
20274,GO:2001201,1,0.961239954457295,0,2,regulation of transforming growth factor-beta secretion,BP,
20275,GO:2001202,1,0.981612568936993,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20276,GO:2001203,1,0.979247205637664,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20277,GO:2001204,1,0.864602425304959,0,7,regulation of osteoclast development,BP,
20278,GO:2001205,1,0.94170900892453,0,3,negative regulation of osteoclast development,BP,
20279,GO:2001206,1,0.933390266888908,0,3,positive regulation of osteoclast development,BP,
20280,GO:2001212,1,0.860805175546688,0,7,regulation of vasculogenesis,BP,
20281,GO:2001213,1,0.979695484131236,0,1,negative regulation of vasculogenesis,BP,
20282,GO:2001214,1,0.897268745464841,0,5,positive regulation of vasculogenesis,BP,
20283,GO:2001222,1,0.603658823955775,0,24,regulation of neuron migration,BP,
20284,GO:2001223,1,0.876951892273416,0,6,negative regulation of neuron migration,BP,
20285,GO:2001224,1,0.748202711591932,0,14,positive regulation of neuron migration,BP,
20286,GO:2001225,1,0.892457755663756,0,5,regulation of chloride transport,BP,
20287,GO:2001226,1,0.955330005104359,0,2,negative regulation of chloride transport,BP,
20288,GO:2001228,1,0.968659608942987,0,2,regulation of response to gamma radiation,BP,
20289,GO:2001229,1,0.984971087864129,0,1,negative regulation of response to gamma radiation,BP,
20298,GO:2001241,1,0.764109412034117,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
20302,GO:2001245,1,0.957211042710374,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20303,GO:2001246,1,0.978201234381328,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20304,GO:2001247,1,0.978543811086441,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20305,GO:2001251,1,0.0890762509772411,0,111,negative regulation of chromosome organization,BP,
20307,GO:2001253,1,0.977393776273839,0,1,regulation of histone H3-K36 trimethylation,BP,
20308,GO:2001256,1,0.835646900986467,0,8,regulation of store-operated calcium entry,BP,
20309,GO:2001257,1,0.183823882831338,0,78,regulation of cation channel activity,BP,
20310,GO:2001258,1,0.637024833752113,0,20,negative regulation of cation channel activity,BP,
20311,GO:2001259,1,0.525533594738802,0,30,positive regulation of cation channel activity,BP,
20312,GO:2001267,1,0.63239741741225,0,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20313,GO:2001268,1,0.889301997046268,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20314,GO:2001269,1,0.711223506098179,0,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20315,GO:2001270,1,0.91441056230121,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20316,GO:2001271,1,0.93693422254834,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20317,GO:2001272,1,0.975966066517488,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20319,GO:2001274,1,0.956958337561233,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
20321,GO:2001279,1,0.91396922154608,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
20322,GO:2001280,1,0.955992147607759,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
20323,GO:2001286,1,0.917588665606409,0,4,regulation of caveolin-mediated endocytosis,BP,
20324,GO:2001287,1,0.9555076914457,0,2,negative regulation of caveolin-mediated endocytosis,BP,
20325,GO:2001288,1,0.981624451753423,0,1,positive regulation of caveolin-mediated endocytosis,BP,
20326,GO:2001293,1,0.943127772731899,0,3,malonyl-CoA metabolic process,BP,
20327,GO:2001294,1,0.977229107474048,0,1,malonyl-CoA catabolic process,BP,
20328,GO:2001295,1,0.965107029366396,0,2,malonyl-CoA biosynthetic process,BP,
20329,GO:2001300,1,0.977240944844536,0,1,lipoxin metabolic process,BP,
20330,GO:2001301,1,0.977240944844536,0,1,lipoxin biosynthetic process,BP,
20331,GO:2001302,1,0.977240944844536,0,1,lipoxin A4 metabolic process,BP,
20332,GO:2001303,1,0.977240944844536,0,1,lipoxin A4 biosynthetic process,BP,
20333,GO:2001304,1,0.977240944844536,0,1,lipoxin B4 metabolic process,BP,
20334,GO:2001306,1,0.977240944844536,0,1,lipoxin B4 biosynthetic process,BP,
20335,GO:2001311,1,0.977130583230793,0,1,lysobisphosphatidic acid metabolic process,BP,
6953,GO:0030575,1.00000000000003,0.823030702435596,0,9,nuclear body organization,BP,
